PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Braga, FAV; Kar, G; Berg, M; Carpaij, OA; Polanski, K; Simon, LM; Brouwer, S; Gomes, T; Hesse, L; Jiang, J; Fasouli, ES; Efremova, M; Vento-Tormo, R; Talavera-Lopez, C; Jonker, MR; Affleck, K; Palit, S; Strzelecka, PM; Firth, HV; Mahbubani, KT; Cvejic, A; Meyer, KB; Saeb-Parsy, K; Luinge, M; Brandsma, CA; Timens, W; Angelidis, I; Strunz, M; Koppelman, GH; van Oosterhout, AJ; Schiller, HB; Theis, FJ; van den Berge, M; Nawijn, MC; Teichmann, SA				Braga, Felipe A. Vieira; Kar, Gozde; Berg, Marijn; Carpaij, Orestes A.; Polanski, Krzysztof; Simon, Lukas M.; Brouwer, Sharon; Gomes, Tomas; Hesse, Laura; Jiang, Jian; Fasouli, Eirini S.; Efremova, Mirjana; Vento-Tormo, Roser; Talavera-Lopez, Carlos; Jonker, Marnix R.; Affleck, Karen; Palit, Subarna; Strzelecka, Paulina M.; Firth, Helen V.; Mahbubani, Krishnaa T.; Cvejic, Ana; Meyer, Kerstin B.; Saeb-Parsy, Kourosh; Luinge, Marjan; Brandsma, Corry-Anke; Timens, Wim; Angelidis, Ilias; Strunz, Maximilian; Koppelman, Gerard H.; van Oosterhout, Antoon J.; Schiller, Herbert B.; Theis, Fabian J.; van den Berge, Maarten; Nawijn, Martijn C.; Teichmann, Sarah A.			A cellular census of human lungs identifies novel cell states in health and in asthma	NATURE MEDICINE			English	Article							EPITHELIAL-CELLS; PROSTAGLANDIN D-2; RNA-SEQ; EXPRESSION; INFLAMMATION; PATHOGENESIS; MACROPHAGES; PHENOTYPE; DISEASE; GENE	Human lungs enable efficient gas exchange and form an interface with the environment, which depends on mucosal immunity for protection against infectious agents. Tightly controlled interactions between structural and immune cells are required to maintain lung homeostasis. Here, we use single-cell transcriptomics to chart the cellular landscape of upper and lower airways and lung parenchyma in healthy lungs, and lower airways in asthmatic lungs. We report location-dependent airway epithelial cell states and a novel subset of tissue-resident memory T cells. In the lower airways of patients with asthma, mucous cell hyperplasia is shown to stem from a novel mucous ciliated cell state, as well as goblet cell hyperplasia. We report the presence of pathogenic effector type 2 helper T cells (T(H)2) in asthmatic lungs and find evidence for type 2 cytokines in maintaining the altered epithelial cell states. Unbiased analysis of cell-cell interactions identifies a shift from airway structural cell communication in healthy lungs to a T(H)2-dominated interactome in asthmatic lungs.	[Braga, Felipe A. Vieira; Kar, Gozde; Polanski, Krzysztof; Gomes, Tomas; Fasouli, Eirini S.; Efremova, Mirjana; Vento-Tormo, Roser; Talavera-Lopez, Carlos; Strzelecka, Paulina M.; Firth, Helen V.; Cvejic, Ana; Meyer, Kerstin B.; Teichmann, Sarah A.] Wellcome Sanger Inst, Cambridge, England; [Braga, Felipe A. Vieira; Kar, Gozde; Fasouli, Eirini S.; Teichmann, Sarah A.] Open Targets, Cambridge, England; [Berg, Marijn; Brouwer, Sharon; Hesse, Laura; Jiang, Jian; Jonker, Marnix R.; Luinge, Marjan; Brandsma, Corry-Anke; Timens, Wim; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Berg, Marijn; Carpaij, Orestes A.; Brouwer, Sharon; Hesse, Laura; Jiang, Jian; Jonker, Marnix R.; Luinge, Marjan; Brandsma, Corry-Anke; Timens, Wim; Koppelman, Gerard H.; van den Berge, Maarten; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Groningen, Netherlands; [Carpaij, Orestes A.; van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Simon, Lukas M.; Palit, Subarna; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Affleck, Karen; van Oosterhout, Antoon J.] GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Resp Therapy Area, Stevenage, Herts, England; [Palit, Subarna] Tech Univ Munich, TranslaTUM, Munich, Germany; [Palit, Subarna] Tech Univ Munich, Inst Virol, Munich, Germany; [Palit, Subarna] German Ctr Infect Res, Partner Site Munich, Munich, Germany; [Strzelecka, Paulina M.; Cvejic, Ana] Univ Cambridge, Dept Haematol, Cambridge, England; [Strzelecka, Paulina M.; Cvejic, Ana] Cambridge Stem Cell Inst, Cambridge, England; [Mahbubani, Krishnaa T.; Saeb-Parsy, Kourosh] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Dept Surg, Cambridge, England; [Angelidis, Ilias; Strunz, Maximilian; Schiller, Herbert B.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Helmholtz Zentrum Munchen, Munich, Germany; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Theis, Fabian J.] Tech Univ Munich, Dept Math, Garching, Germany; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Cavendish Lab, Condensed Matter Theory Grp, Cambridge, England	Wellcome Trust Sanger Institute; University of Groningen; University of Groningen; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; GlaxoSmithKline; Technical University of Munich; Technical University of Munich; German Center for Infection Research; University of Cambridge; University of Cambridge; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen; Technical University of Munich; University of Cambridge	Teichmann, SA (corresponding author), Wellcome Sanger Inst, Cambridge, England.; Teichmann, SA (corresponding author), Open Targets, Cambridge, England.; Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.; Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Groningen, Netherlands.; Teichmann, SA (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Condensed Matter Theory Grp, Cambridge, England.	m.c.nawijn@umcg.nl; st9@sanger.ac.uk	Jiang, Jian/AGF-0671-2022; Koppelman, Gerard/AAG-9187-2020; Strzelecka, Paulina/AAW-6958-2021; Timens, Wim/K-5570-2013; Talavera-Lopez, Carlos/AFH-6676-2022; Mahbubani, Krishnaa T/A-5403-2009; Theis, Fabian J/ABD-5212-2021	Timens, Wim/0000-0002-4146-6363; Mahbubani, Krishnaa T/0000-0002-1327-2334; Theis, Fabian J/0000-0002-2419-1943; Berg, Marijn/0000-0002-9870-1571; Vieira Braga, Felipe Augusto/0000-0003-0206-9258; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Talavera-Lopez, Carlos/0000-0001-8590-2393; van den Berge, Maarten/0000-0002-9336-7340; Fasouli, Eirini Sofia/0000-0003-1621-3396; Koppelman, Gerard/0000-0001-8567-3252; Jiang, Jian/0000-0003-0877-429X; Polanski, Krzysztof/0000-0002-2586-9576; Nawijn, Martijn/0000-0003-3372-6521; Hesse, Laura/0000-0002-0009-4903; Cvejic, Ana/0000-0003-3204-9311; Jonker, Marnix R./0000-0001-6309-871X; Simon, Lukas/0000-0001-6148-8861; Efremova, Mirjana/0000-0002-8107-9974	Open Targets collaboration; GlaxoSmithKline; University Medical Center Groningen; Wellcome [WT206194]; Lung Foundation Netherlands [5.1.14.020, 4.1.18.226]; Health-Holland; Top Sector Life Sciences and Health; Human Cell Atlas Wellcome Stragetic Science Support [211276/Z/18/Z]; EMBO; HFSP; Marie Curie ENLIGHT-TEN training network; European Union [753039]; Helmholtz Association; German Center for Lung Research (DZL); German Research Foundation (DFG) within the Collaborative Research Centre [1243]; Helmholtz Association [A17, ZT-I-0007]; Chan Zuckerberg Initiative D.A.F. (advised fund of Silicon Valley Community Foundation) [182835]; European Research Council [677501 - ZF_Blood]	Open Targets collaboration; GlaxoSmithKline(GlaxoSmithKline); University Medical Center Groningen; Wellcome; Lung Foundation Netherlands; Health-Holland; Top Sector Life Sciences and Health; Human Cell Atlas Wellcome Stragetic Science Support; EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); Marie Curie ENLIGHT-TEN training network; European Union(European Commission); Helmholtz Association(Helmholtz Association); German Center for Lung Research (DZL); German Research Foundation (DFG) within the Collaborative Research Centre(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); Chan Zuckerberg Initiative D.A.F. (advised fund of Silicon Valley Community Foundation); European Research Council(European Research Council (ERC)European Commission)	We thank J. Eliasova (scientific illustrator) for support with design of figures, the Sanger Single Cell Genomics Core Facility for support with the SmartSeq2 protocol, E. Rawlins for feedback and critical reading of the manuscript, L. Mamanova for the technical support, as well as all the members of the Teichmann lab for scientific input. We are grateful to the Cambridge Biorepository for Translational Medicine (CBTM) for the provision of tissue from deceased organ donors, to all tissue donors, and to K. Sjollema and the UMCG Imaging and Microscopy Center. We gratefully acknowledge the provision of human biomaterial and clinical data from the CPC-M bioArchive and its partners at the Asklepios Biobank Gauting, the Klinikum der Universitat Munchen, and the Ludwig-Maximilians-Universitat Munchen. This project was funded by and part of the Open Targets collaboration (https://www.opentargets.org), a GlaxoSmithKline collaborative agreement with University Medical Center Groningen, Wellcome (WT206194), the Lung Foundation Netherlands (projects no. 5.1.14.020 and 4.1.18.226), Health-Holland, Top Sector Life Sciences and Health, and Human Cell Atlas Wellcome Stragetic Science Support (211276/Z/18/Z). R.V.-T. was supported by EMBO and HFSP Long Term fellowships. T.G. by the Marie Curie ENLIGHT-TEN training network. L.M.S. acknowledges funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 753039. H.B.S. acknowledges funding by the Helmholtz Association and the German Center for Lung Research (DZL). F.J.T. acknowledges financial support by the German Research Foundation (DFG) within the Collaborative Research Centre 1243. F.J.T acknowledges subproject A17, by the Helmholtz Association (Incubator grant sparse2big, grant number ZT-I-0007) and by the Chan Zuckerberg Initiative D.A.F. (advised fund of Silicon Valley Community Foundation), grant number 182835. A.C. and P.M.S. acknowledge European Research Council (project 677501 - ZF_Blood). This publication is part of the Human Cell Atlas (www.humancellatlas.org/publications).	Alcala SE, 2014, AM J RESP CELL MOL, V51, P363, DOI 10.1165/rcmb.2013-0396OC; Arima Masafumi, 2011, Korean Journal of Internal Medicine, V26, P8, DOI 10.3904/kjim.2011.26.1.8; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Baumann U, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01837; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Condon TV, 2011, J LEUKOCYTE BIOL, V90, P883, DOI 10.1189/jlb.0311134; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Gomi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116507; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Harkness LM, 2015, PHARMACOL THERAPEUT, V148, P17, DOI 10.1016/j.pharmthera.2014.11.010; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; HOL BEA, 1991, INT ARCH ALLER A IMM, V96, P12, DOI 10.1159/000235528; Holgate Stephen T, 2004, Proc Am Thorac Soc, V1, P93, DOI 10.1513/pats.2306034; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Krotova K, 2017, AM J RESP CELL MOL, V57, P238, DOI 10.1165/rcmb.2016-0366OC; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Luo W, 2016, AM J RESP CELL MOL, V54, P177, DOI 10.1165/rcmb.2014-0381OC; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mereu E., 2018, BIORXIV, DOI [10.1101/314831, DOI 10.1101/314831]; Mitchell A, 2008, EUR J IMMUNOL, V38, P3459, DOI 10.1002/eji.200838415; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Muehling LM, 2017, J ALLERGY CLIN IMMUN, V140, P1523, DOI 10.1016/j.jaci.2017.02.025; Oja AE, 2018, MUCOSAL IMMUNOL, V11, P654, DOI 10.1038/mi.2017.94; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Song J, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0341-7; Tata PR, 2017, DEVELOPMENT, V144, P755, DOI 10.1242/dev.143784; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Truyen E, 2006, THORAX, V61, P202, DOI 10.1136/thx.2005.052399; Urawa M, 2016, J THROMB HAEMOST, V14, P1588, DOI 10.1111/jth.13362; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vogl T, 1999, J BIOL CHEM, V274, P25291, DOI 10.1074/jbc.274.36.25291; Wambre E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam9171; Weckmann M, 2011, PEDIAT ALLERG IMM-UK, V22, P25, DOI 10.1111/j.1399-3038.2010.01027.x; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Wu CA, 2010, CELL IMMUNOL, V264, P32, DOI 10.1016/j.cellimm.2010.04.008; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wujak LA, 2016, RESP PHYSIOL NEUROBI, V220, P54, DOI 10.1016/j.resp.2015.09.008; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Young M. D., 2018, PREPRINT, DOI [10.1101/303727, DOI 10.1101/303727]	51	320	324	12	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1153	+		10.1038/s41591-019-0468-5	http://dx.doi.org/10.1038/s41591-019-0468-5			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31209336	Green Submitted			2022-12-27	WOS:000474430400030
J	Ng, S; Nachbagauer, R; Balmaseda, A; Stadlbauer, D; Ojeda, S; Patel, M; Rajabhathor, A; Lopez, R; Guglia, AF; Sanchez, N; Amanat, F; Gresh, L; Kuan, G; Krammer, F; Gordon, A				Ng, Sophia; Nachbagauer, Raffael; Balmaseda, Angel; Stadlbauer, Daniel; Ojeda, Sergio; Patel, Mayuri; Rajabhathor, Arvind; Lopez, Roger; Guglia, Andrea F.; Sanchez, Nery; Amanat, Fatima; Gresh, Lionel; Kuan, Guillermina; Krammer, Florian; Gordon, Aubree			Novel correlates of protection against pandemic H1N1 influenza A virus infection	NATURE MEDICINE			English	Article							SEASONAL INFLUENZA; ANTIBODY; NEURAMINIDASE; VACCINE; HUMANS; TRANSMISSION; ASSOCIATION; CHILDREN; IMMUNITY; ADULTS	Influenza viruses remain a severe threat to human health, causing up to 650,000 deaths annually(1,2). Seasonal influenza virus vaccines can prevent infection, but are rendered ineffective by antigenic drift. To provide improved protection from infection, novel influenza virus vaccines that target the conserved epitopes of influenza viruses, specifically those in the hemagglutinin stalk and neuraminidase, are currently being developed3. Antibodies against the hemagglutinin stalk confer protection in animal studies(4-6). However, no data exist on natural infections in humans, and these antibodies do not show activity in the hemagglutination inhibition assay, the hemagglutination inhibition titer being the current correlate of protection against influenza virus infection(7-9). While previous studies have investigated the protective effect of cellular immune responses and neuraminidase-inhibiting antibodies, additional serological correlates of protection from infection could aid the development of broadly protective or universal influenza virus vaccines(10-13). To address this gap, we performed a household transmission study to identify alternative correlates of protection from infection and disease in naturally exposed individuals. Using this study, we determined 50% protective titers and levels for hemagglutination inhibition, full-length hemagglutinin, neuraminidase and hemagglutinin stalk-specific antibodies. Further, we found that hemagglutinin stalk antibodies independently correlated with protection from influenza virus infection.	[Ng, Sophia; Patel, Mayuri; Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Ng, Sophia; Patel, Mayuri; Gordon, Aubree] St Jude Ctr Excellence Influenza Res & Surveillan, Memphis, TN 38105 USA; [Ng, Sophia; Nachbagauer, Raffael; Stadlbauer, Daniel; Patel, Mayuri; Rajabhathor, Arvind; Amanat, Fatima; Krammer, Florian; Gordon, Aubree] Ctr Excellence Influenza Res & Surveillance, Bethesda, MD 20892 USA; [Nachbagauer, Raffael; Stadlbauer, Daniel; Rajabhathor, Arvind; Guglia, Andrea F.; Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Nachbagauer, Raffael; Stadlbauer, Daniel; Rajabhathor, Arvind; Amanat, Fatima; Krammer, Florian] Ctr Res Influenza Pathogenesis, New York, NY 10029 USA; [Balmaseda, Angel; Lopez, Roger] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua; [Balmaseda, Angel; Ojeda, Sergio; Lopez, Roger; Sanchez, Nery; Gresh, Lionel; Kuan, Guillermina] Sustainable Sci Inst, Managua, Nicaragua; [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua	University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai	Gordon, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Gordon, A (corresponding author), St Jude Ctr Excellence Influenza Res & Surveillan, Memphis, TN 38105 USA.; Krammer, F; Gordon, A (corresponding author), Ctr Excellence Influenza Res & Surveillance, Bethesda, MD 20892 USA.; Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Krammer, F (corresponding author), Ctr Res Influenza Pathogenesis, New York, NY 10029 USA.	florian.krammer@mssm.edu; gordonal@umich.edu	Nachbagauer, Raffael/H-7798-2019; Krammer, Florian/H-3237-2019; Ng, Sophia/AAA-1461-2019; Gordon, Aubree/X-1113-2019; Stadlbauer, Daniel/AAV-7433-2020	Nachbagauer, Raffael/0000-0001-5568-5420; Krammer, Florian/0000-0003-4121-776X; Ng, Sophia/0000-0001-7817-7744; Gordon, Aubree/0000-0002-9352-7877; Stadlbauer, Daniel/0000-0001-6792-7650; Gresh, Lionel/0000-0002-2333-1748; Rajabhathor, Arvind/0000-0003-0847-8749	National Institute for Allergy and Infectious Diseases [R01 AI120997, HHSN272201400008C, HHSN272201400006C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120997] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank past and present members of the study team based at the Health Center Socrates Flores Vivas, the National Virology Laboratory at the Centro Nacional de Diagnostico y Referencia, and the Sustainable Sciences Institute in Nicaragua for their dedication and high-quality work. We are grateful to the study participants and their families. Lastly, we thank F. Busto Carrillo for assistance in generating the figures. This work was supported by the National Institute for Allergy and Infectious Diseases (award no. R01 AI120997 to A.G. and contract nos. HHSN272201400008C to F.K. and HHSN272201400006C to A.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu TM, 2018, J INFECT DIS, V218, P1054, DOI 10.1093/infdis/jiy291; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Cauchemez S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003061; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; Choi EJ, 2018, J VIROL, V92, DOI 10.1128/JVI.01200-18; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Vries RD, 2017, VACCINE, V35, P238, DOI 10.1016/j.vaccine.2016.11.082; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103; He WQ, 2015, J VIROL, V89, P3610, DOI 10.1128/JVI.03099-14; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Jacobsen H, 2017, MBIO, V8, DOI 10.1128/mBio.01463-17; Kosik I, 2019, J EXP MED, V216, P304, DOI 10.1084/jem.20181624; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; McElhaney JE, 2013, EXPERT REV VACCINES, V12, P759, DOI 10.1586/14760584.2013.811193; Monto AS, 2015, J INFECT DIS, V212, P1191, DOI 10.1093/infdis/jiv195; Nachbagauer R, 2017, CLIN MICROBIOL INFEC, V23, P222, DOI 10.1016/j.cmi.2017.02.009; Nachbagauer R, 2018, CURR OPIN IMMUNOL, V53, P51, DOI 10.1016/j.coi.2018.04.001; Nachbagauer R, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0026-4; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ng S, 2017, VACCINE, V35, P6202, DOI 10.1016/j.vaccine.2017.09.036; Ng S, 2016, PEDIATR INFECT DIS J, V35, P583, DOI 10.1097/INF.0000000000001083; Ng S, 2013, J INFECT DIS, V208, P1320, DOI 10.1093/infdis/jit372; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Park JK, 2018, MBIO, V9, DOI [10.1128/mBio.02284-17, 10.1128/mbio.02284-17]; Paules CI, 2018, NEW ENGL J MED, V378, P7, DOI 10.1056/NEJMp1714916; Paules CI, 2017, IMMUNITY, V47, P599, DOI 10.1016/j.immuni.2017.09.007; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rajendran M, 2017, MBIO, V8, DOI [10.1128/mBio.02281-16, 10.1128/mbio.02281-16]; Roush SW, 2008, MANUAL SURVEILLANCE; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020; Wohlbold TJ, 2016, J VIROL, V90, P851, DOI 10.1128/JVI.02275-15; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	42	84	85	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					962	+		10.1038/s41591-019-0463-x	http://dx.doi.org/10.1038/s41591-019-0463-x			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31160818	Green Accepted			2022-12-27	WOS:000470844400028
J	Rodon, J; Soria, JC; Berger, R; Miller, WH; Rubin, E; Kugel, A; Tsimberidou, A; Saintigny, P; Ackerstein, A; Brana, I; Loriot, Y; Afshar, M; Miller, V; Wunder, F; Bresson, C; Martini, JF; Raynaud, J; Mendelsohn, J; Batist, G; Onn, A; Tabernero, J; Schilsky, RL; Lazar, V; Lee, JJ; Kurzrock, R				Rodon, Jordi; Soria, Jean-Charles; Berger, Raanan; Miller, Wilson H.; Rubin, Eitan; Kugel, Aleksandra; Tsimberidou, Apostolia; Saintigny, Pierre; Ackerstein, Aliza; Brana, Irene; Loriot, Yohann; Afshar, Mohammad; Miller, Vincent; Wunder, Fanny; Bresson, Catherine; Martini, Jean-Francois; Raynaud, Jacques; Mendelsohn, John; Batist, Gerald; Onn, Amir; Tabernero, Josep; Schilsky, Richard L.; Lazar, Vladimir; Lee, J. Jack; Kurzrock, Razelle			Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial	NATURE MEDICINE			English	Article							CLINICAL-TRIALS; LUNG-CANCER; THERAPY; INHIBITORS; TUMORS; LANDSCAPE; MUTATION; DNA	Precision medicine focuses on DNA abnormalities, but not all tumors have tractable genomic alterations. The WINTHER trial (NCT01856296) navigated patients to therapy on the basis of fresh biopsy-derived DNA sequencing (arm A; 236 gene panel) or RNA expression (arm B; comparing tumor to normal). The clinical management committee (investigators from five countries) recommended therapies, prioritizing genomic matches; physicians determined the therapy given. Matching scores were calculated post-hoc for each patient, according to drugs received: for DNA, the number of alterations matched divided by the total alteration number; for RNA, expression-matched drug ranks. Overall, 303 patients consented; 107 (35%; 69 in arm A and 38 in arm B) were evaluable for therapy. The median number of previous therapies was three. The most common diagnoses were colon, head and neck, and lung cancers. Among the 107 patients, the rate of stable disease >= 6 months and partial or complete response was 26.2% (arm A: 23.2%; arm B: 31.6% (P = 0.37)). The patient proportion with WINTHER versus previous therapy progression-free survival ratio of >1.5 was 22.4%, which did not meet the pre-specified primary end point. Fewer previous therapies, better performance status and higher matching score correlated with longer progression-free survival (all P < 0.05, multivariate). Our study shows that genomic and transcriptomic profiling are both useful for improving therapy recommendations and patient outcome, and expands personalized cancer treatment.	[Rodon, Jordi; Brana, Irene; Tabernero, Josep] Vall dHebron Inst Oncol VHIO, Barcelona, Spain; [Rodon, Jordi; Tsimberidou, Apostolia] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Soria, Jean-Charles; Loriot, Yohann] Gustave Roussy, Villejuif, France; [Berger, Raanan; Ackerstein, Aliza; Onn, Amir] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Miller, Wilson H.; Batist, Gerald] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, QCROC Quebec Canc Consortium, Montreal, PQ, Canada; [Miller, Wilson H.; Batist, Gerald] McGill Univ, Rossy Canc Network, Montreal, PQ, Canada; [Rubin, Eitan; Kugel, Aleksandra] Ben Gurion Univ Negev, Beer Sheva, Israel; [Saintigny, Pierre] Ctr Leon Berard, Lyon, France; [Afshar, Mohammad] Ariana Pharmaceut, Paris, France; [Miller, Vincent] Fdn Med Inc, Cambridge, MA USA; [Wunder, Fanny; Bresson, Catherine; Mendelsohn, John; Schilsky, Richard L.; Lazar, Vladimir; Kurzrock, Razelle] Worldwide Innovat Network WIN Assoc, WIN Consortium, Villejuif, France; [Martini, Jean-Francois] Pfizer Inc, San Diego, CA USA; [Raynaud, Jacques] ARC Fdn Canc Res, Villejuif, France; [Mendelsohn, John] Univ Texas MD Anderson Canc Ctr, Sheikh Khalifa Bin Zayad Al Nahyan Inst Personali, Houston, TX 77030 USA; [Schilsky, Richard L.] ASCO, Alexandria, VA USA; [Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Kurzrock, Razelle] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	Vall d'Hebron Institut d'Oncologia (VHIO); University of Texas System; UTMD Anderson Cancer Center; UNICANCER; Gustave Roussy; Chaim Sheba Medical Center; McGill University; McGill University; Ben Gurion University; UNICANCER; Centre Leon Berard; Foundation Medicine; Pfizer; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Kurzrock, R (corresponding author), Worldwide Innovat Network WIN Assoc, WIN Consortium, Villejuif, France.; Kurzrock, R (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	rkurzrock@ucsd.edu	Kurzrock, Razelle/AAU-9782-2020; BRESSON, CATHERINE/AAQ-2084-2020; Lee, Jack/P-7331-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Soria, Jean-Charles/F-3619-2014; Tabernero, Josep/AAG-5026-2019; Lazar, Vladimir/AAV-2087-2020; Loriot, Yohann/W-5572-2019; Lazar, Vladimir/AAQ-2086-2020; Rubin, Eitan/E-5256-2011	Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Tabernero, Josep/0000-0002-2495-8139; Rubin, Eitan/0000-0002-7807-4005; Saintigny, Pierre/0000-0002-8090-9323; Miller, Wilson H./0000-0002-7408-1574; Tsimberidou, Apostolia M./0000-0003-2713-233X; Brana, Irene/0000-0002-1068-9601	European Union [306125]; ARC Foundation for Cancer Research (France); Lilly France SAS; Novartis Pharmaceuticals Corporation; Pfizer Oncology; Fero/J.P. Morgan Private Bank Clinical Oncology Research Grant; National Cancer Institute [P30 P30-CA023100]; Israeli Science Foundation [1188/16]; Instituto Salud Carlos III-Programa Rio Hortega Contract grant [CM15/00255]; Canadian Institutes for Health Research [MOP-142281]; Canadian Cancer Society [703811]; NATIONAL CANCER INSTITUTE [P30CA023100, P30CA016672] Funding Source: NIH RePORTER	European Union(European Commission); ARC Foundation for Cancer Research (France); Lilly France SAS; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Oncology; Fero/J.P. Morgan Private Bank Clinical Oncology Research Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israeli Science Foundation(Israel Science Foundation); Instituto Salud Carlos III-Programa Rio Hortega Contract grant; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr John Mendelsohn, President Emeritus of The University of Texas, MD Anderson Cancer Center, Director of Sheikh Khalifa Bin Zayad Al Nahyan Institute for Personalized Cancer Therapy (IPCT), Houston, TX, USA, Chairman of the WIN Association-WIN Consortium, Villejuif, France, and co-author of the Letter died on 7 January 2019. Dr Mendelsohn was a brilliant scientist and visionary, an optimist and a truly inspirational leader. The WINTHER study was one of his very last projects. The research leading to these results has received funding from the European Union Seventh Framework Program (FP7/2007-2013 under grant agreement no. 306125). This work was funded in part by the ARC Foundation for Cancer Research (France), Pfizer Oncology, Lilly France SAS and Novartis Pharmaceuticals Corporation. This work was also funded in part by The Fero/J.P. Morgan Private Bank Clinical Oncology Research Grant, the National Cancer Institute grant P30 P30-CA023100 (R.K.), the Israeli Science Foundation grant 1188/16 (E.R.), Instituto Salud Carlos III-Programa Rio Hortega Contract grant CM15/00255 (I.B.), the Canadian Institutes for Health Research (grant MOP-142281 to W.H.M.) and the Canadian Cancer Society (grant 703811 to W.H.M.).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieg-Bourne CC, 2017, CANCER RES, V77, P6313, DOI 10.1158/0008-5472.CAN-17-1569; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; ECOG-ACRIN Cancer Research Group & National Cancer Institute, 2016, EX SUMM INT AN NCI M; Jardim DLF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv253; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Ganesan P, 2013, MOL CANCER THER, V12, P2857, DOI 10.1158/1535-7163.MCT-13-0319-T; Garrido-Laguna I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038033; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Holsinger FC, 2013, J CLIN ONCOL, V31, pE137, DOI 10.1200/JCO.2012.43.2716; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Janjigian YY, 2014, CANCER DISCOV, V4, P1036, DOI 10.1158/2159-8290.CD-14-0326; Janku F, 2014, CELL REP, V6, P377, DOI 10.1016/j.celrep.2013.12.035; Janku F, 2012, ONCOTARGET, V3, P1566, DOI 10.18632/oncotarget.716; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kato S, 2017, CANCER RES, V77, P4238, DOI 10.1158/0008-5472.CAN-17-0628; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Lazar V, 2015, ONCOTARGET, V6, P14139, DOI 10.18632/oncotarget.3741; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Rodon J, 2015, ANN ONCOL, V26, P1791, DOI 10.1093/annonc/mdv191; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Schwaederle M, 2016, JAMA ONCOL, V2, P1452, DOI 10.1001/jamaoncol.2016.2129; Schwaederle M, 2016, MOL CANCER THER, V15, P743, DOI 10.1158/1535-7163.MCT-15-0795; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Tsimberidou Apostolia-Maria, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00002; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Wheler JJ, 2016, CANCER RES, V76, P3690, DOI 10.1158/0008-5472.CAN-15-3043; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X	40	225	232	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					751	+		10.1038/s41591-019-0424-4	http://dx.doi.org/10.1038/s41591-019-0424-4			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31011205	Green Accepted			2022-12-27	WOS:000468247800018
J	Mohammad, HP; Barbash, O; Creasy, CL				Mohammad, Helai P.; Barbash, Olena; Creasy, Caretha L.			Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer	NATURE MEDICINE			English	Review							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITOR; METHYLTRANSFERASE GENE EZH2; RECURRENT SOMATIC MUTATIONS; CONVENTIONAL CARE REGIMENS; SMALL-MOLECULE INHIBITORS; BET BROMODOMAIN PROTEINS; CHEMICAL PROBE; SELECTIVE-INHIBITION; DNA METHYLATION	Epigenetic dysregulation is a common feature of most cancers, often occurring directly through alteration of epigenetic machinery. Over the last several years, a new generation of drugs directed at epigenetic modulators have entered clinical development, and results from these trials are now being disclosed. Unlike first-generation epigenetic therapies, these new agents are selective, and many are targeted to proteins which are mutated or translocated in cancer. This review will provide a summary of the epigenetic modulatory agents currently in clinical development and discuss the opportunities and challenges in their development. As these drugs advance in the clinic, drug discovery has continued with a focus on both novel and existing epigenetic targets. We will provide an overview of these efforts and the strategies being employed.	[Mohammad, Helai P.; Barbash, Olena; Creasy, Caretha L.] GlaxoSmithKline, Epigenet Dept, Oncol, Collegeville, PA 19426 USA	GlaxoSmithKline	Creasy, CL (corresponding author), GlaxoSmithKline, Epigenet Dept, Oncol, Collegeville, PA 19426 USA.	caretha.l.creasy@gsk.com		Creasy, Caretha/0000-0002-3735-6401				Agrawal K, 2018, PHARMACOL THERAPEUT, V188, P45, DOI 10.1016/j.pharmthera.2018.02.006; Alekseyenko AA, 2015, GENE DEV, V29, P1507, DOI 10.1101/gad.267583.115; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Amita Patnaik R. D. C, 2018, J CLIN ONCOL, V36, P2550; Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Andres Forero-Torres S. R, 2017, BLOOD, V130, P4048; Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; Asangani IA, 2016, MOL CANCER RES, V14, P324, DOI 10.1158/1541-7786.MCR-15-0472; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Bae N, 2017, NAT CHEM BIOL, V13, P750, DOI 10.1038/nchembio.2377; Baker Glen B., 1992, Journal of Psychiatry and Neuroscience, V17, P206; Bamborough P, 2016, ACS MED CHEM LETT, V7, P552, DOI 10.1021/acsmedchemlett.6b00092; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Blum KA, 2018, ANN ONCOL, V29; Bodor C, 2013, BLOOD, V122, P3165, DOI 10.1182/blood-2013-04-496893; Borah JC, 2011, CHEM BIOL, V18, P531, DOI 10.1016/j.chembiol.2010.12.021; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Broderick J. M, 2018, FDA HALTS ENROLLMENT; Brown PJ, 2015, FUTURE MED CHEM, V7, P1901, DOI 10.4155/fmc.15.127; Brunetto AT, 2013, CLIN CANCER RES, V19, P5494, DOI 10.1158/1078-0432.CCR-13-0735; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Chen PL, 2016, J MED CHEM, V59, P1410, DOI 10.1021/acs.jmedchem.5b00209; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Chiba S, 2017, INT J HEMATOL, V105, P17, DOI 10.1007/s12185-016-2122-z; CHITAMBAR CR, 1991, AM J HEMATOL, V37, P100, DOI 10.1002/ajh.2830370207; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Clark PGK, 2015, ANGEW CHEM INT EDIT, V54, P6217, DOI 10.1002/anie.201501394; CONSTANTINIDES PG, 1978, DEV BIOL, V66, P57, DOI 10.1016/0012-1606(78)90273-7; Cruickshank B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00654; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dawson M, 2017, BLOOD, V130; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Demont EH, 2014, ACS MED CHEM LETT, V5, P1190, DOI 10.1021/ml5002932; Drew Rasco A. T, 2017, CANC RES S, V77; Drouin L, 2015, J MED CHEM, V58, P2553, DOI 10.1021/jm501963e; Duan LL, 2015, CHEM BIOL, V22, P1185, DOI 10.1016/j.chembiol.2015.08.007; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Eigl BJ, 2015, INVEST NEW DRUG, V33, P969, DOI 10.1007/s10637-015-0252-4; Ember SWJ, 2014, ACS CHEM BIOL, V9, P1160, DOI 10.1021/cb500072z; Erb MA, 2017, NATURE, V543, P270, DOI 10.1038/nature21688; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Evens AM, 2016, CLIN CANCER RES, V22, P1059, DOI 10.1158/1078-0432.CCR-15-0624; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fedorov O, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500723; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Galli M, 2010, ANN HEMATOL, V89, P185, DOI 10.1007/s00277-009-0793-8; Gautam Borthakur J. E. W, 2018, J CLIN ONCOL S, V36, P7019; Gehling VS, 2016, BIOORG MED CHEM LETT, V26, P4350, DOI 10.1016/j.bmcl.2016.07.026; Gerhart SV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28002-y; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goswami S, 2018, J CLIN INVEST, V128, P3813, DOI 10.1172/JCI99760; Gounder M, 2018, ANN ONCOL, V29, P581; Guan B, 2011, AM J SURG PATHOL, V35, P625, DOI 10.1097/PAS.0b013e318212782a; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guzman ML, 2014, MOL CANCER THER, V13, P1979, DOI 10.1158/1535-7163.MCT-13-0963; Harb W, 2018, ANN ONCOL          S, V29; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hatch SB, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0116-6; Heijnen WT, 2015, J CLIN PSYCHOPHARM, V35, P700, DOI 10.1097/JCP.0000000000000409; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Honma D, 2017, CANCER SCI, V108, P2069, DOI 10.1111/cas.13326; Issa JPJ, 2015, LANCET ONCOL, V16, P1099, DOI 10.1016/S1470-2045(15)00038-8; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Italiano A, 2018, LANCET ONCOL, V19, P649, DOI 10.1016/S1470-2045(18)30145-1; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jambhekar A, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026484; James LI, 2013, J MED CHEM, V56, P7358, DOI 10.1021/jm400919p; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kantarjian HM, 2017, LANCET ONCOL, V18, P1317, DOI 10.1016/S1470-2045(17)30576-4; Kim ES, 2017, DRUGS, V77, P1705, DOI 10.1007/s40265-017-0813-2; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knipstein J, 2011, EXPERT OPIN INV DRUG, V20, P1455, DOI 10.1517/13543784.2011.613822; Knutson SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111840; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kuendgen Andrea, 2018, Oncotarget, V9, P27882, DOI 10.18632/oncotarget.25328; Kuhn MWM, 2016, CANCER DISCOV, V6, P1166, DOI 10.1158/2159-8290.CD-16-0237; Kung PP, 2018, J MED CHEM, V61, P650, DOI 10.1021/acs.jmedchem.7b01375; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Linnekamp JF, 2017, CANCER TREAT REV, V54, P10, DOI 10.1016/j.ctrv.2017.01.004; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lubbert M, 2016, ANN HEMATOL, V95, P191, DOI 10.1007/s00277-015-2547-0; Martin MP, 2013, ACS CHEM BIOL, V8, P2360, DOI 10.1021/cb4003283; MARUYAMA D, 2017, BLOOD S1, V130; Maruyama D, 2017, BLOOD S, V130, P1; McAllister TE, 2016, J MED CHEM, V59, P1308, DOI 10.1021/acs.jmedchem.5b01758; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McGrath JP, 2016, CANCER RES, V76, P1975, DOI 10.1158/0008-5472.CAN-15-2333; Mohammad HP, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1117700; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Morschhauser F, 2018, 23 C EUR HEM ASS; Morschhauser F, 2017, HEMATOL ONCOL SS2, V35, P24; Mould DP, 2015, MED RES REV, V35, P586, DOI 10.1002/med.21334; Moustakim M, 2017, ANGEW CHEM INT EDIT, V56, P827, DOI 10.1002/anie.201610816; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; O'Brien MM, 2016, BLOOD, V128, P2780; O'Dwyer PJ, 2016, CANC RES S, V76; ODWYER PJ, 2016, CANCER RES S14, V76; Palmer WS, 2016, J MED CHEM, V59, P1440, DOI 10.1021/acs.jmedchem.5b00405; Pappalardi M. B, 2018, P AACR ANN M 2018; Pappano WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131716; Parikh SA, 2013, J THORAC ONCOL, V8, P1335, DOI 10.1097/JTO.0b013e3182a00f41; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perna F, 2010, BLOOD, V116, P2812, DOI 10.1182/blood-2010-02-270611; Pfister SX, 2017, NAT REV DRUG DISCOV, V16, P241, DOI 10.1038/nrd.2016.256; Picaud S, 2015, J MED CHEM, V58, P2718, DOI 10.1021/jm501893k; Pili R, 2017, CLIN CANCER RES, V23, P7199, DOI 10.1158/1078-0432.CCR-17-1178; Ponnaluri VKC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1247-6; Poulard C, 2016, ONCOTARGET, V7, P67532, DOI 10.18632/oncotarget.11376; Prebet T, 2014, J CLIN ONCOL, V32, P1242, DOI 10.1200/JCO.2013.50.3102; Qian CG, 2012, CLIN CANCER RES, V18, P4104, DOI 10.1158/1078-0432.CCR-12-0055; Qin C, 2018, J MED CHEM, V61, P6685, DOI 10.1021/acs.jmedchem.8b00506; Qin Y, 2019, ONCOGENE, V38, P390, DOI 10.1038/s41388-018-0451-5; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Ren CY, 2016, ACS MED CHEM LETT, V7, P601, DOI 10.1021/acsmedchemlett.6b00042; Rhyasen GW, 2016, MOL CANCER THER, V15, P2563, DOI 10.1158/1535-7163.MCT-16-0141; Robaa D, 2016, CHEMMEDCHEM, V11, P2327, DOI 10.1002/cmdc.201600362; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sankar S, 2014, CLIN CANCER RES, V20, P4584, DOI 10.1158/1078-0432.CCR-14-0072; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Sapna Pradyuman Patel J. E. W, 2018, J CLIN ONCOL, V36; Sarina Anne Piha-Paul J. C. S, 2018, J CLIN ONCOL, V36, P2510; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Sharma H, 2018, CURR TOP MED CHEM, V18, P505, DOI 10.2174/1568026618666180518091144; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030815; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Shukla N, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.2780.2780; Silverman LB, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.838.838; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Somervaille T., 2016, 58 ANN M EXP AM SOC, V128, P4060, DOI DOI 10.1182/blood.V128.22.4060.4060; SORM F, 1968, NEOPLASMA, V15, P339; Sorna V, 2013, J MED CHEM, V56, P9496, DOI 10.1021/jm400870h; Stahl M, 2016, EXPERT OPIN INV DRUG, V25, P307, DOI 10.1517/13543784.2016.1146251; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Stein EM, 2015, BLOOD, V126, P2547, DOI DOI 10.1182/blood.V126.23.2547.2547; Stein EM, 2018, BLOOD, V131, P2661, DOI 10.1182/blood-2017-12-818948; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; Stuckey JI, 2016, NAT CHEM BIOL, V12, P180, DOI 10.1038/nchembio.2007; Stuhlmiller TJ, 2015, CELL REP, V11, P390, DOI 10.1016/j.celrep.2015.03.037; Suraweera A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00092; Tan P, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.68; Tanaka M, 2016, NAT CHEM BIOL, V12, P1089, DOI [10.1038/NCHEMBIO.2209, 10.1038/nchembio.2209]; Theodoulou NH, 2016, J MED CHEM, V59, P1425, DOI 10.1021/acs.jmedchem.5b00256; Tim Somervaille O. S, 2016, BLOOD, V128, P4060; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vaswani RG, 2016, J MED CHEM, V59, P9928, DOI 10.1021/acs.jmedchem.6b01315; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; VIDALI G, 1978, P NATL ACAD SCI USA, V75, P2239, DOI 10.1073/pnas.75.5.2239; Vinogradova M, 2016, NAT CHEM BIOL, V12, P531, DOI 10.1038/nchembio.2085; Wan LL, 2017, NATURE, V543, P265, DOI 10.1038/nature21687; Wang JX, 2012, MOL CANCER RES, V10, P326, DOI 10.1158/1541-7786.MCR-11-0440; Warren K, 2018, CANC RES S, V78; Waters NJ, 2017, EUR J DRUG METAB PH, V42, P891, DOI 10.1007/s13318-017-0404-3; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Whittaker SJ, 2010, J CLIN ONCOL, V28, P4485, DOI 10.1200/JCO.2010.28.9066; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wigle TJ, 2011, FEBS LETT, V585, P3011, DOI 10.1016/j.febslet.2011.08.018; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Woods DM, 2015, CANCER IMMUNOL RES, V3, P1375, DOI 10.1158/2326-6066.CIR-15-0077-T; Wyce A, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0043-9; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang H, 2014, LEUKEMIA, V28, P1280, DOI 10.1038/leu.2013.355; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yap TA, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.4203.4203; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251; YOSHIDA M, 1987, CANCER RES, V47, P3688; Younes A, 2011, LANCET ONCOL, V12, P1222, DOI 10.1016/S1470-2045(11)70265-0; Yuan Y, 2012, ACS CHEM BIOL, V7, P1152, DOI 10.1021/cb300139y; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zauderer M.G., 2018, J CLIN ONCOL S, V36; Zawistowski JS, 2017, CANCER DISCOV, V7, P302, DOI 10.1158/2159-8290.CD-16-0653; Zhang W, 2015, EPIGENETICS-US, V10, P736, DOI 10.1080/15592294.2015.1062206; Zhu HR, 2016, CELL REP, V16, P2829, DOI 10.1016/j.celrep.2016.08.032	220	182	184	11	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					403	418		10.1038/s41591-019-0376-8	http://dx.doi.org/10.1038/s41591-019-0376-8			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842676				2022-12-27	WOS:000460643100017
J	Hellmann, MD; Snyder, A				Hellmann, Matthew D.; Snyder, Alexandra			Adding to the checkpoint blockade armamentarium	NATURE MEDICINE			English	Editorial Material							EXPRESSION; RECEPTORS; CANCER		[Hellmann, Matthew D.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Hellmann, Matthew D.] Weill Cornell Med Coll, New York, NY USA; [Snyder, Alexandra] Merck, Rahway, NJ 07065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Merck & Company	Snyder, A (corresponding author), Merck, Rahway, NJ 07065 USA.	alex.snyder@merck.com						Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Bastidas-Legarda LY, 2019, IMMUNOLOGY, V156, P319, DOI 10.1111/imm.13039; Bossard C, 2012, INT J CANCER, V131, P855, DOI 10.1002/ijc.26453; Gooden M, 2011, P NATL ACAD SCI USA, V108, P10656, DOI 10.1073/pnas.1100354108; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Gunturi A, 2005, EUR J IMMUNOL, V35, P766, DOI 10.1002/eji.200425735; Kim N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02041; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Massarelli E, 2019, JAMA ONCOL, V5, P67, DOI 10.1001/jamaoncol.2018.4051; van Montfoort N, 2018, CELL, V175, P1744, DOI 10.1016/j.cell.2018.10.028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447	11	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					203	205		10.1038/s41591-019-0350-5	http://dx.doi.org/10.1038/s41591-019-0350-5			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728540				2022-12-27	WOS:000457842100013
J	Wang, YH; Wiesnoski, DH; Helmink, BA; Gopalakrishnan, V; Choi, K; DuPont, HL; Jiang, ZD; Abu-Sbeih, H; Sanchez, CA; Chang, CC; Parra, ER; Francisco-Cruz, A; Raju, GS; Stroehlein, JR; Campbell, MT; Gao, JJ; Subudhi, SK; Maru, DM; Blando, JM; Lazar, AJ; Allison, JP; Sharma, P; Tetzlaff, MT; Wargo, JA; Jenq, RR				Wang, Yinghong; Wiesnoski, Diana H.; Helmink, Beth A.; Gopalakrishnan, Vancheswaran; Choi, Kati; DuPont, Hebert L.; Jiang, Zhi-Dong; Abu-Sbeih, Hamzah; Sanchez, Christopher A.; Chang, Chia-Chi; Parra, Edwin R.; Francisco-Cruz, Alejandro; Raju, Gottumukkala S.; Stroehlein, John R.; Campbell, Matthew T.; Gao, Jianjun; Subudhi, Sumit K.; Maru, Dipen M.; Blando, Jorge M.; Lazar, Alexander J.; Allison, James P.; Sharma, Padmanee; Tetzlaff, Michael T.; Wargo, Jennifer A.; Jenq, Robert R.			Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis	NATURE MEDICINE			English	Article							CYTOTOXIC T-CELLS; ADVERSE EVENTS; BLOCKADE; IMMUNOTHERAPY; IPILIMUMAB; CANCER	We report the first case series of immune checkpoint inhibitors (ICI)-associated colitis successfully treated with fecal microbiota transplantation, with reconstitution of the gut microbiome and a relative increase in the proportion of regulatory T-cells within the colonic mucosa. These preliminary data provide evidence that modulation of the gut microbiome may abrogate ICI-associated colitis.	[Wang, Yinghong; Abu-Sbeih, Hamzah; Raju, Gottumukkala S.; Stroehlein, John R.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Div Internal Med, Houston, TX 77030 USA; [Wiesnoski, Diana H.; Sanchez, Christopher A.; Chang, Chia-Chi; Wargo, Jennifer A.; Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA; [Helmink, Beth A.; Gopalakrishnan, Vancheswaran; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Surg Oncol, Houston, TX 77030 USA; [Choi, Kati] Baylor Coll Med, Dept Internal Med, Houston, TX 77030 USA; [DuPont, Hebert L.; Jiang, Zhi-Dong] Univ Texas Houston, Ctr Infect Dis, Sch Publ Hlth, Houston, TX USA; [DuPont, Hebert L.] Kelsey Res Fdn, Houston, TX USA; [Parra, Edwin R.; Francisco-Cruz, Alejandro; Tetzlaff, Michael T.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Div Pathol Lab Med, Houston, TX 77030 USA; [Campbell, Matthew T.; Gao, Jianjun; Subudhi, Sumit K.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Div Canc Med, Houston, TX 77030 USA; [Maru, Dipen M.; Lazar, Alexander J.; Tetzlaff, Michael T.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Div Pathol Lab Med, Houston, TX 77030 USA; [Blando, Jorge M.; Allison, James P.; Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Div Basic Sci Res, Houston, TX 77030 USA; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat, Div Canc Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, YH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Div Internal Med, Houston, TX 77030 USA.	ywang59@mdanderson.org	Abu-Sbeih, Hamzah/M-8472-2018; Gopalakrishnan, Vancheswaran/S-9550-2019; DuPont, Herbert/AAH-6776-2021; Francisco-Cruz, Alejandro/AIC-9273-2022; Lazar, Alexander J/A-3416-2008	Abu-Sbeih, Hamzah/0000-0003-3577-6741; Gopalakrishnan, Vancheswaran/0000-0002-8704-035X; Lazar, Alexander J/0000-0002-6395-4499; Helmink, Beth/0000-0002-8206-0351	MD Anderson Cancer Center's Melanoma Moon Shot Program [710499-80-111538-19]; American Association for Cancer Research Stand Up to Cancer [SU2C-AACR-IRG-19-17]; National Institutes of Health [R01 CA219896-01A1, R01 HL124112]; Cancer Prevention and Research Institute of Texas [RR160089]; NATIONAL CANCER INSTITUTE [T32CA009599, R01CA219896] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124112] Funding Source: NIH RePORTER	MD Anderson Cancer Center's Melanoma Moon Shot Program; American Association for Cancer Research Stand Up to Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for the following funding support: Andrew Sabin Family Fellows Program (private donation to J.A.W); MD Anderson Cancer Center's Melanoma Moon Shot Program (grant no. 710499-80-111538-19, to J.A.W.); American Association for Cancer Research Stand Up to Cancer (grant no. SU2C-AACR-IRG-19-17, to J.A.W.); National Institutes of Health (grant no. R01 CA219896-01A1, to J.A.W.); National Institutes of Health (grant no. R01 HL124112, to R.R.J.); Cancer Prevention and Research Institute of Texas (grant no. RR160089, to R.R.J.).	Abu-Sbeih H., 2018, J IMMUNOTHER CANCER, V6, P1; Beck KE, 2006, J CLIN ONCOL, V24, P2283, DOI 10.1200/JCO.2005.04.5716; Bertrand A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0455-8; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Chen JH, 2017, AM J SURG PATHOL, V41, P643, DOI 10.1097/PAS.0000000000000829; Cramer Peyton, 2017, Curr Gastroenterol Rep, V19, P3, DOI 10.1007/s11894-017-0540-6; Dadu R, 2016, CANCER J, V22, P121, DOI 10.1097/PPO.0000000000000186; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Horvat TZ, 2015, J CLIN ONCOL, V33, P3193, DOI 10.1200/JCO.2015.60.8448; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Johnston RL, 2009, DIGEST DIS SCI, V54, P2538, DOI 10.1007/s10620-008-0641-z; Kappeler A, 2000, HISTOL HISTOPATHOL, V15, P167, DOI 10.14670/HH-15.167; Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Minor DR, 2009, CANCER BIOTHER RADIO, V24, P321, DOI 10.1089/cbr.2008.0607; Nancey S, 2006, GASTROENTEROLOGY, V131, P485, DOI 10.1053/j.gastro.2006.05.018; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wang F, 2018, P NATL ACAD SCI USA, V115, P157, DOI 10.1073/pnas.1712901115	30	327	344	12	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1804	+		10.1038/s41591-018-0238-9	http://dx.doi.org/10.1038/s41591-018-0238-9			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30420754	Green Accepted			2022-12-27	WOS:000452392200007
J	Schwemmer, MA; Skomrock, ND; Sederberg, PB; Ting, JE; Sharma, G; Bockbrader, MA; Friedenberg, DA				Schwemmer, Michael A.; Skomrock, Nicholas D.; Sederberg, Per B.; Ting, Jordyn E.; Sharma, Gaurav; Bockbrader, Marcia A.; Friedenberg, David A.			Meeting brain-computer interface user performance expectations using a deep neural network decoding framework	NATURE MEDICINE			English	Article							MACHINE INTERFACES; MUSCLE STIMULATION; POTENTIAL USERS; WANT OPINIONS; PRIORITIES; TETRAPLEGIA; COMMUNICATION; MOVEMENTS; RELEASE; GRASP	Brain-computer interface (BCI) neurotechnology has the potential to reduce disability associated with paralysis by translating neural activity into control of assistive devices(1-9). Surveys of potential end-users have identified key BCI system features(10-14), including high accuracy, minimal daily setup, rapid response times, and multifunctionality. These performance characteristics are primarily influenced by the BCI's neural decoding algorithm(1,15), which is trained to associate neural activation patterns with intended user actions. Here, we introduce a new deep neural network(16) decoding framework for BCI systems enabling discrete movements that addresses these four key performance characteristics. Using intracortical data from a participant with tetraplegia, we provide offline results demonstrating that our decoder is highly accurate, sustains this performance beyond a year without explicit daily retraining by combining it with an unsupervised updating procedure(3,17- 20), responds faster than competing methods(8), and can increase functionality with minimal retraining by using a technique known as transfer learning(21). We then show that our participant can use the decoder in real-time to reanimate his paralyzed forearm with functional electrical stimulation (FES), enabling accurate manipulation of three objects from the grasp and release test (GRT)(22). These results demonstrate that deep neural network decoders can advance the clinical translation of BCI technology.	[Schwemmer, Michael A.; Skomrock, Nicholas D.; Friedenberg, David A.] Battelle Mem Inst, Adv Analyt, 505 King Ave, Columbus, OH 43201 USA; [Sederberg, Per B.] Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA; [Ting, Jordyn E.; Sharma, Gaurav] Battelle Mem Inst, Med Devices & Neuromodulat, 505 King Ave, Columbus, OH 43201 USA; [Bockbrader, Marcia A.] Ohio State Univ, Neurol Inst, Columbus, OH 43210 USA; [Bockbrader, Marcia A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	Battelle Memorial Institute; University of Virginia; Battelle Memorial Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schwemmer, MA (corresponding author), Battelle Mem Inst, Adv Analyt, 505 King Ave, Columbus, OH 43201 USA.	schwemmer@battelle.org	Bockbrader, Marcia/U-7844-2019; Bockbrader, Marcia/J-6203-2013	Bockbrader, Marcia/0000-0001-6419-0630; Bockbrader, Marcia/0000-0001-6419-0630; Friedenberg, David/0000-0002-4404-8941	Battelle Memorial Institute; Department of Physical Medicine Rehabilitation; Ohio State University Neurological Institute	Battelle Memorial Institute; Department of Physical Medicine Rehabilitation; Ohio State University Neurological Institute	We thank the study participant and his family for their dedication and support. We thank D. Weber and H. Bresler for assistance in editing the manuscript; M. Zhang, S. Colachis, H. Trivedi, A. Singh, and P. Ganzer for their assistance with the sessions, data collection, and help editing the manuscript; and R. Kittel for help with figure formatting. Financial support for this study came from Battelle Memorial Institute and The Ohio State University Neurological Institute and Department of Physical Medicine & Rehabilitation. M. A. B. also acknowledges the invaluable mentorship of the Rehabilitation Medicine Scientist Training Program at the Association of Academic Physiatrists. M.A.S. would also like to thank his brother E. Schwemmer for being a source of inspiration for this work.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Ajemian R, 2017, NATURE, V544, P416, DOI 10.1038/544416c; Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bacher D, 2015, NEUROREHAB NEURAL RE, V29, P462, DOI 10.1177/1545968314554624; Bishop W, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026001; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Chaudhary U, 2016, NAT REV NEUROL, V12, P513, DOI 10.1038/nrneurol.2016.113; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Colachis SC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00208; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Collinger JL, 2013, J REHABIL RES DEV, V50, P145, DOI 10.1682/JRRD.2011.11.0213; Evans N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130019; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Flint RD, 2016, J NEUROSCI, V36, P3623, DOI 10.1523/JNEUROSCI.2339-15.2016; Friedenberg D. A, 2016, CHANCE, V29, P4, DOI [10.1080/09332480.2016.1263093, DOI 10.1080/09332480.2016.1263093]; Friedenberg DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08120-9; Friedenberg DA, 2016, IEEE ENG MED BIO, P3084, DOI 10.1109/EMBC.2016.7591381; Gilja V, 2015, NAT MED, V21, P1142, DOI 10.1038/nm.3953; Glaser J. I., 2017, PREPRINT; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Huggins JE, 2015, ARCH PHYS MED REHAB, V96, pS38, DOI 10.1016/j.apmr.2014.05.028; Huggins JE, 2011, AMYOTROPH LATERAL SC, V12, P318, DOI 10.3109/17482968.2011.572978; Jarosiewicz Beata, 2016, J Physiol Paris, V110, P382, DOI 10.1016/j.jphysparis.2017.03.001; Jarosiewicz B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7328; Jarosiewicz B, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046012; Kao JC, 2014, P IEEE, V102, P666, DOI 10.1109/JPROC.2014.2307357; Lebedev MA, 2017, PHYSIOL REV, V97, P767, DOI 10.1152/physrev.00027.2016; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li Z, 2011, NEURAL COMPUT, V23, P3162, DOI 10.1162/NECO_a_00207; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Nuyujukian P, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/066003; Pandarinath C, 2017, ELIFE, V6, DOI 10.7554/eLife.18554; PECKHAM PH, 1980, ANN BIOMED ENG, V8, P369, DOI 10.1007/BF02363440; Perge JA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036004; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Reed S., 2014, PREPRINT; Rosenberg C., 2005, 7 IEEE WORKSH APPL C; Ruder S., 2016, ARXIV; Sharma G., 2015, BIOELECTRON MED, V2, P63, DOI [10.15424/bioelectronmed.2015.00010, DOI 10.15424/BIOELECTRONMED.2015.00010]; Sharma G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33807; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sussillo D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13749; Taylor P, 2002, SPINAL CORD, V40, P560, DOI 10.1038/sj.sc.3101373; Wang F, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6c31; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; WUOLLE KS, 1994, J HAND SURG-AM, V19A, P209, DOI 10.1016/0363-5023(94)90008-6; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519	52	67	69	4	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1669	+		10.1038/s41591-018-0171-y	http://dx.doi.org/10.1038/s41591-018-0171-y			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30250141				2022-12-27	WOS:000449404200017
J	Fujimori, K; Ishikawa, M; Otomo, A; Atsuta, N; Nakamura, R; Akiyama, T; Hadano, S; Aoki, M; Saya, H; Sobue, G; Okano, H				Fujimori, Koki; Ishikawa, Mitsuru; Otomo, Asako; Atsuta, Naoki; Nakamura, Ryoichi; Akiyama, Tetsuya; Hadano, Shinji; Aoki, Masashi; Saya, Hideyuki; Sobue, Gen; Okano, Hideyuki			Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; FRONTOTEMPORAL LOBAR DEGENERATION; METHYLPYRIDINIUM ION; LIPID-PEROXIDATION; DOPAMINE AGONIST; IN-VITRO; PRAMIPEXOLE; MUTATIONS; TDP-43	Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS patients have no familial history, making the modeling of sporadic ALS (SALS) essential to the development of ALS therapeutics. However, as mutations underlying ALS pathogenesis have not yet been identified, it remains difficult to establish useful models of SALS. Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients' full genetic information, we have established a large number of in vitro cellular models of SALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. We therefore developed a system for case clustering capable of subdividing these heterogeneous SALS models by their in vitro characteristics. We further evaluated multiple-phenotype rescue of these subclassified SALS models using agents selected from non-SOD1 FALS models, and identified ropinirole as a potential therapeutic candidate. Integration of the datasets acquired in this study permitted the visualization of molecular pathologies shared across a wide range of SALS models.	[Fujimori, Koki; Ishikawa, Mitsuru; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo, Japan; [Otomo, Asako; Hadano, Shinji] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Otomo, Asako; Hadano, Shinji] Tokai Univ, Dept Mol Life Sci, Sch Med, Isehara, Kanagawa, Japan; [Otomo, Asako] Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan; [Atsuta, Naoki; Nakamura, Ryoichi; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi, Japan; [Akiyama, Tetsuya; Aoki, Masashi] Tohoku Univ, Dept Neurol, Grad Sch Med, Sendai, Miyagi, Japan; [Hadano, Shinji] Tokai Univ, Res Ctr Brain & Nervous Dis, Grad Sch Med, Isehara, Kanagawa, Japan; [Saya, Hideyuki] Keio Univ, Inst Adv Med Res, Div Gene Regulat, Sch Med,Shinjuku Ku, Tokyo, Japan; [Sobue, Gen] Nagoya Univ, Res Div Dementia & Neurodegenerat Dis, Grad Sch Med, Nagoya, Aichi, Japan	Keio University; Tokai University; Tokai University; Tokai University; Nagoya University; Tohoku University; Tokai University; Keio University; Nagoya University	Okano, H (corresponding author), Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo, Japan.	hidokano@a2.keio.jp	Okano, Hideyuki/X-9131-2019; Okano, Hideyuki/I-7584-2019; Akiyama, Tetsuya/GOE-4034-2022; Hadano, Shinji/ABA-5052-2021; Atsuta, naoki/I-7412-2014; Otomo, Asako/AAA-6374-2019	Okano, Hideyuki/0000-0001-7482-5935; Hadano, Shinji/0000-0002-4997-3968; Otomo, Asako/0000-0002-7849-4309; Saya, Hideyuki/0000-0001-6610-1902; Akiyama, Tetsuya/0000-0002-8076-1242				Abramova NA, 2002, J NEUROSCI RES, V67, P494, DOI 10.1002/jnr.10127; Alves CJ, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00332, 10.3389/fncel.2015.00289]; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Borasio GD, 1998, J NEUROL NEUROSUR PS, V65, P263, DOI 10.1136/jnnp.65.2.263; Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007; Cassarino DS, 1998, J NEUROCHEM, V71, P295; Cheah BC, 2010, IDRUGS, V13, P911; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Cooper RL, 1999, COMP BIOCHEM PHYS B, V122, P199, DOI 10.1016/S0305-0491(98)10160-8; Corcia P, 2012, THER CLIN RISK MANAG, V8, P359, DOI 10.2147/TCRM.S21981; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Da Cruz S, 2017, ACTA NEUROPATHOL, V134, P97, DOI 10.1007/s00401-017-1688-8; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Danzeisen R, 2006, J PHARMACOL EXP THER, V316, P189, DOI 10.1124/jpet.105.092312; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Ferrari-Toninelli Giulia, 2010, BMC Pharmacology, V10, P2, DOI 10.1186/1471-2210-10-2; Fujimori K, 2017, STEM CELL REP, V9, P1675, DOI 10.1016/j.stemcr.2017.09.024; Fujimori K, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0267-6; Gu M, 2004, J NEUROCHEM, V91, P1075, DOI 10.1111/j.1471-4159.2004.02804.x; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Ichiyanagi N, 2016, STEM CELL REP, V6, P496, DOI 10.1016/j.stemcr.2016.02.011; Iida A, 2011, HUM MOL GENET, V20, P3684, DOI 10.1093/hmg/ddr268; Iida A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.011; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Imamura K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf3962; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kuzel MD, 1999, AM J HEALTH-SYST PH, V56, P217, DOI 10.1093/ajhp/56.3.217; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsumoto T, 2016, STEM CELL REP, V6, P422, DOI 10.1016/j.stemcr.2016.01.010; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; MIZUSAWA H, 1989, ACTA NEUROPATHOL, V79, P37, DOI 10.1007/BF00308955; Nakamura R, 2013, J NEUROL NEUROSUR PS, V84, P1365, DOI 10.1136/jnnp-2013-306020; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OKAMOTO K, 1991, ACTA NEUROPATHOL, V81, P610, DOI 10.1007/BF00296370; Okano H, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-22; Okuno H, 2017, CONGENIT ANOM, V57, P96, DOI 10.1111/cga.12206; Philips T., 2015, CURR PROTOC PHARM, V69, P67; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sethy VH, 1997, BRAIN RES, V754, P181, DOI 10.1016/S0006-8993(97)00075-9; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang H, 2008, AMYOTROPH LATERAL SC, V9, P50, DOI 10.1080/17482960701791234; Watanabe H, 2016, J NEUROL NEUROSUR PS, V87, P851, DOI 10.1136/jnnp-2015-311541; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yuan N, 2007, EUR J NEUROSCI, V26, P2417, DOI 10.1111/j.1460-9568.2007.05870.x; Zinman L, 2011, LANCET NEUROL, V10, P481, DOI 10.1016/S1474-4422(11)70024-2	58	172	173	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1579	+		10.1038/s41591-018-0140-5	http://dx.doi.org/10.1038/s41591-018-0140-5			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30127392				2022-12-27	WOS:000446577900021
J	Rafiq, S; Brentjens, RJ				Rafiq, Sarwish; Brentjens, Renier J.			Tumors evading CARs-the chase is on	NATURE MEDICINE			English	Editorial Material							T-CELLS; CART-19 IMMUNOTHERAPY; RESISTANCE		[Rafiq, Sarwish; Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Rafiq, Sarwish; Brentjens, Renier J.] Mem Sloan Kettering Canc Ctr, Cellular Therapeut Ctr, 1275 York Ave, New York, NY 10021 USA; [Brentjens, Renier J.] Weill Cornell Grad Sch Med Sci, Dept Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Brentjens, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Brentjens, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Therapeut Ctr, 1275 York Ave, New York, NY 10021 USA.; Brentjens, RJ (corresponding author), Weill Cornell Grad Sch Med Sci, Dept Pharmacol, New York, NY 10065 USA.	brentjer@mskcc.org		Rafiq, Sarwish/0000-0002-9295-3065				Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; Avanzi MP, 2018, CELL REP, V23, P2130, DOI 10.1016/j.celrep.2018.04.051; Bagashev A, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00383-18; Cho JH, 2018, CELL, V173, P1426, DOI 10.1016/j.cell.2018.03.038; Fischer J, 2017, J IMMUNOTHER, V40, P187, DOI 10.1097/CJI.0000000000000169; Jackson HJ, 2016, NAT REV CLIN ONCOL, V13, P370, DOI 10.1038/nrclinonc.2016.36; Majzner RG, 2018, CANCER DISCOV, V8, P1219, DOI 10.1158/2159-8290.CD-18-0442; Orlando EJ, 2018, NAT MED, V24, P1504, DOI 10.1038/s41591-018-0146-z; Rafiq S, 2018, NAT BIOTECHNOL, V36, P847, DOI 10.1038/nbt.4195; Ruella M, 2018, NAT MED, V24, P1499, DOI 10.1038/s41591-018-0201-9; Sommermeyer D, 2017, LEUKEMIA, V31, P2191, DOI 10.1038/leu.2017.57; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020	12	21	23	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1492	1493		10.1038/s41591-018-0212-6	http://dx.doi.org/10.1038/s41591-018-0212-6			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297897				2022-12-27	WOS:000446577900005
J	Zhang, YJ; Gendron, TF; Ebbert, MTW; O'Raw, AD; Yue, M; Jansen-West, K; Zhang, X; Prudencio, M; Chew, J; Cook, CN; Daughrity, LM; Tong, JM; Song, YP; Pickles, SR; Castanedes-Casey, M; Kurti, A; Rademakers, R; Oskarsson, B; Dickson, DW; Hu, WQ; Gitler, AD; Fryer, JD; Petrucelli, L				Zhang, Yong-Jie; Gendron, Tania F.; Ebbert, Mark T. W.; O'Raw, Aliesha D.; Yue, Mei; Jansen-West, Karen; Zhang, Xu; Prudencio, Mercedes; Chew, Jeannie; Cook, Casey N.; Daughrity, Lillian M.; Tong, Jimei; Song, Yuping; Pickles, Sarah R.; Castanedes-Casey, Monica; Kurti, Aishe; Rademakers, Rosa; Oskarsson, Bjorn; Dickson, Dennis W.; Hu, Wenqian; Gitler, Aaron D.; Fryer, John D.; Petrucelli, Leonard			Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis	NATURE MEDICINE			English	Article							C9ORF72 HEXANUCLEOTIDE REPEAT; RNA FOCI; ANTISENSE TRANSCRIPTS; GGGGCC REPEAT; EXPANSION; TOXICITY; NEURODEGENERATION; DROSOPHILA; SEQUESTER; PATHOLOGY	The major genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is a C9orf72 G(4)C(2) repeat expansion(1,2). Proposed mechanisms by which the expansion causes c9FTD/ALS include toxicity from repeat-containing RNA and from dipeptide repeat proteins translated from these transcripts. To investigate the contribution of poly(GR) dipeptide repeat proteins to c9FTD/ALS pathogenesis in a mammalian in vivo model, we generated mice that expressed GFP-(GR)(100) in the brain. GFP-(GR)(100) mice developed age-dependent neurodegeneration, brain atrophy, and motor and memory deficits through the accumulation of diffuse, cytoplasmic poly(GR). Poly(GR) co-localized with ribosomal subunits and the translation initiation factor elF3 eta in GFP-(GR)(100) mice and, of importance, in c9FTD/ALS patients. Combined with the differential expression of ribosome-associated genes in GFP-(GR)(100) mice, these findings demonstrate poly(GR)-mediated ribosomal distress. Indeed, poly(GR) inhibited canonical and non-canonical protein translation in HEK293T cells, and also induced the formation of stress granules and delayed their disassembly. These data suggest that poly(GR) contributes to c9FTD/ALS by impairing protein translation and stress granule dynamics, consequently causing chronic cellular stress and preventing cells from mounting an effective stress response. Decreasing poly(GR) and/or interrupting interactions between poly(GR) and ribosomal and stress granule-associated proteins may thus represent potential therapeutic strategies to restore homeostasis.	[Zhang, Yong-Jie; Gendron, Tania F.; Ebbert, Mark T. W.; O'Raw, Aliesha D.; Yue, Mei; Jansen-West, Karen; Prudencio, Mercedes; Chew, Jeannie; Cook, Casey N.; Daughrity, Lillian M.; Tong, Jimei; Song, Yuping; Pickles, Sarah R.; Castanedes-Casey, Monica; Kurti, Aishe; Rademakers, Rosa; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Zhang, Yong-Jie; Gendron, Tania F.; Prudencio, Mercedes; Chew, Jeannie; Cook, Casey N.; Rademakers, Rosa; Dickson, Dennis W.; Fryer, John D.; Petrucelli, Leonard] Mayo Clin, Coll Med, Mayo Grad Sch, Neurobiol Dis Grad Program, Rochester, MN 55905 USA; [Zhang, Xu; Hu, Wenqian] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Oskarsson, Bjorn] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Stanford University	Petrucelli, L (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.; Petrucelli, L (corresponding author), Mayo Clin, Coll Med, Mayo Grad Sch, Neurobiol Dis Grad Program, Rochester, MN 55905 USA.	petrucelli.leonard@mayo.edu	Hu, Wenqian/H-6094-2019; Zhang, Xu/GYD-9462-2022	Hu, Wenqian/0000-0003-3577-3604; Zhang, Xu/0000-0002-9784-0481; Prudencio, Mercedes/0000-0002-4894-4858; O'Raw, Aliesha/0000-0002-6618-3036; Oskarsson, Bjorn/0000-0002-1725-9866; Ebbert, Mark/0000-0001-9158-4440; Gitler, Aaron/0000-0001-8603-1526	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R35NS097273, P01NS084974, P01NS099114, R01NS088689, R35NS097263(10)]; Mayo Clinic Foundation; Amyotrophic Lateral Sclerosis Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097273, R01NS088689, R35NS097263, P01NS099114, P01NS084974] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Foundation; Amyotrophic Lateral Sclerosis Association; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to all patients who agreed to donate post-mortem tissue. This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R35NS097273 (L.P.); P01NS084974 (L.P., D.W.D., R.R. and B.O.); P01NS099114 (T.F.G. and L.P.); R01NS088689 (L.P.); R35NS097263(10) (A.D.G.)); the Mayo Clinic Foundation (L.P.); the Amyotrophic Lateral Sclerosis Association (T.F.G., L.P., Y.-J.Z. and M.P.), the Robert Packard Center for ALS Research at Johns Hopkins (A.D.G. and L.P.) and the Target ALS Foundation (T.F.G., A.D.G., L.P. and Y.-J.Z.). We would like to thank J. N. Stankowski, E. A. Perkerson, L. Rousseau and V. Phillips for technical support. This manuscript is dedicated to Dr Antimo D'Aniello.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Boeynaems S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20877; Cheng WW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02495-z; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; Conlon EG, 2016, ELIFE, V5, DOI 10.7554/eLife.17820; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gendron TF, 2015, ACTA NEUROPATHOL, V130, P559, DOI 10.1007/s00401-015-1474-4; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Green KM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02200-0; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hertz MI, 2013, MOL CELL BIOL, V33, P1016, DOI 10.1128/MCB.00879-12; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kanekura K, 2016, HUM MOL GENET, V25, P1803, DOI 10.1093/hmg/ddw052; Kramer NJ, 2016, SCIENCE, V353, P708, DOI 10.1126/science.aaf7791; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Lopez-Gonzalez R, 2016, NEURON, V92, P383, DOI 10.1016/j.neuron.2016.09.015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Saberi S, 2018, ACTA NEUROPATHOL, V135, P459, DOI 10.1007/s00401-017-1793-8; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shi KY, 2017, P NATL ACAD SCI USA, V114, pE1111, DOI 10.1073/pnas.1620293114; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Yang DJ, 2015, ACTA NEUROPATHOL, V130, P525, DOI 10.1007/s00401-015-1448-6; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	44	170	171	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1136	+		10.1038/s41591-018-0071-1	http://dx.doi.org/10.1038/s41591-018-0071-1			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29942091	Green Accepted			2022-12-27	WOS:000440955500019
J	McDermott, DF; Huseni, MA; Atkins, MB; Motzer, RJ; Rini, BI; Escudier, B; Fong, L; Joseph, RW; Pal, SK; Reeves, JA; Sznol, M; Hainsworth, J; Rathmell, WK; Stadler, WM; Hutson, T; Gore, ME; Ravaud, A; Bracarda, S; Suarez, C; Danielli, R; Gruenwald, V; Choueiri, TK; Nickles, D; Jhunjhunwala, S; Piault-Louis, E; Thobhani, A; Qiu, JH; Chen, DS; Hegde, PS; Schiff, C; Fine, GD; Powles, T				McDermott, David F.; Huseni, Mahrukh A.; Atkins, Michael B.; Motzer, Robert J.; Rini, Brian I.; Escudier, Bernard; Fong, Lawrence; Joseph, Richard W.; Pal, Sumanta K.; Reeves, James A.; Sznol, Mario; Hainsworth, John; Rathmell, W. Kimryn; Stadler, Walter M.; Hutson, Thomas; Gore, Martin E.; Ravaud, Alain; Bracarda, Sergio; Suarez, Cristina; Danielli, Riccardo; Gruenwald, Viktor; Choueiri, Toni K.; Nickles, Dorothee; Jhunjhunwala, Suchit; Piault-Louis, Elisabeth; Thobhani, Alpa; Qiu, Jiaheng; Chen, Daniel S.; Hegde, Priti S.; Schiff, Christina; Fine, Gregg D.; Powles, Thomas			Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUPPRESSOR-CELLS; PD-L1 EXPRESSION; TUMOR-GROWTH; SINGLE-ARM; PHASE-III; CANCER; NIVOLUMAB; PATHWAY; MULTICENTER	We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib in 305 patients with treatment-naive metastatic renal cell carcinoma. Co-primary endpoints were progression-free survival (PFS) in intent-to-treat and PD-L1+ populations. Intent-to-treat PFS hazard ratios for atezolizumab + bevacizumab or atezolizumab monotherapy versus sunitinib were 1.0 (95% confidence interval (CI), 0.69-1.45) and 1.19 (95% CI, 0.82-1.71), respectively; PD-L1+ PFS hazard ratios were 0.64 (95% CI, 0.38-1.08) and 1.03 (95% CI, 0.63-1.67), respectively. Exploratory biomarker analyses indicated that tumor mutation and neoantigen burden were not associated with PFS. Angiogenesis, T-effector/IFN-gamma response, and myeloid inflammatory gene expression signatures were strongly and differentially associated with PFS within and across the treatments. These molecular profiles suggest that prediction of outcomes with anti-VEGF and immunotherapy may be possible and offer mechanistic insights into how blocking VEGF may overcome resistance to immune checkpoint blockade.	[McDermott, David F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Huseni, Mahrukh A.; Nickles, Dorothee; Jhunjhunwala, Suchit; Piault-Louis, Elisabeth; Qiu, Jiaheng; Chen, Daniel S.; Hegde, Priti S.; Schiff, Christina; Fine, Gregg D.] Genentech Inc, San Francisco, CA 94080 USA; [Atkins, Michael B.] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA; [Motzer, Robert J.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Rini, Brian I.] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA; [Escudier, Bernard] Gustave Roussy, Villejuif, France; [Fong, Lawrence] Univ Calif San Francisco, San Francisco Sch Med, San Francisco, CA 94143 USA; [Joseph, Richard W.] Mayo Clin Hosp Florida, Jacksonville, FL USA; [Pal, Sumanta K.] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Reeves, James A.] Florida Canc Specialists, Ft Myers, FL USA; [Sznol, Mario] Yale Sch Med, New Haven, CT USA; [Hainsworth, John] Sarah Cannon Res Inst, Nashville, TN USA; [Rathmell, W. Kimryn] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Stadler, Walter M.] Univ Chicago Med, Chicago, IL USA; [Hutson, Thomas] Texas Oncol Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [Gore, Martin E.] Royal Marsden Hosp, London, England; [Ravaud, Alain] CHU Hop Bordeaux, Hop St Andre, Bordeaux, France; [Bracarda, Sergio] Azienda USL Toscana Sudest, Osped San Donato, Arezzo, Italy; [Suarez, Cristina] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain; [Danielli, Riccardo] Univ Senese, Azienda Osped, Ctr Immune Oncol, Siena, Italy; [Gruenwald, Viktor] Zentrum Innere Med, Med Hsch, Hannover, Germany; [Choueiri, Toni K.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Thobhani, Alpa] Roche Prod Ltd, Welwyn Garden City, Herts, England; [Powles, Thomas] Queen Mary Univ London, Barts Canc Inst, London, England; [Powles, Thomas] Queen Mary Univ London, Royal Free Hosp, London, England	Harvard University; Beth Israel Deaconess Medical Center; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center; Cleveland Clinic Foundation; UNICANCER; Gustave Roussy; University of California System; University of California San Francisco; City of Hope; Florida Cancer Specialists; Yale University; Sarah Cannon Research Institute; Vanderbilt University; Baylor University Medical Center; Royal Marsden NHS Foundation Trust; CHU Bordeaux; IRCCS Policlinico San Donato; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); University of Siena; University Hospital of Siena; Harvard University; Dana-Farber Cancer Institute; Roche Holding; University of London; Queen Mary University London; University of London; Queen Mary University London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	McDermott, DF (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	dmcdermo@bidmc.harvard.edu	Choueiri, Toni/K-5238-2019; Chen, Daniel Shin-Yu/AGD-8923-2022; Miquel, Josep Maria/AAG-3508-2019; Jhunjhunwala, Suchit/GNH-2256-2022; Hutson, Thomas/AAS-9639-2020	Choueiri, Toni/0000-0002-9201-3217; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Jhunjhunwala, Suchit/0000-0003-3484-0588; Hutson, Thomas/0000-0002-4529-4212; Bracarda, Sergio/0000-0002-0703-2959; Sznol, Mario/0000-0002-4359-8749; Ravaud, Alain/0000-0001-9455-6744; Suarez, Cristina/0000-0002-0502-5528	P.S. Davies of Health Interactions, Inc. by F. Hoffmann-La Roche, AG; F. Hoffmann-La Roche, AG; NCI [P50 CA101942-13, P30 CA008748, P30 CA14599]; NATIONAL CANCER INSTITUTE [P30CA008748, P30CA068485, P30CA014599, P50CA101942] Funding Source: NIH RePORTER	P.S. Davies of Health Interactions, Inc. by F. Hoffmann-La Roche, AG; F. Hoffmann-La Roche, AG(Hoffmann-La Roche); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank A. Bailey for her contributions to development of the protocol and Z. Boyd for his contributions to the development of the PD-L1 IHC assay and its implementation in this study. Support for third-party writing assistance for this manuscript-by P.S. Davies of Health Interactions, Inc.-was provided by F. Hoffmann-La Roche, AG. This study was sponsored by F. Hoffmann-La Roche, AG. Authors were funded by NCI grants P50 CA101942-13 to D.F.M, M.B.A., and T.K.C.; P30 CA008748 to R.J.M.; and P30 CA14599 to W.M.S.	Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Brauer MJ, 2013, CLIN CANCER RES, V19, P3681, DOI 10.1158/1078-0432.CCR-12-3635; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Choueiri TK, 2014, ANN ONCOL, V25, P2178, DOI 10.1093/annonc/mdu445; Choueiri TK, 2017, P AM SOC CLIN ONCO S, V35, P4504, DOI DOI 10.1200/JC0.2017.35.15_; Clark JI, 2017, CLIN GENITOURIN CANC, V15, P31, DOI 10.1016/j.clgc.2016.10.008; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Draghiciu O, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.989764; Elamin YY, 2015, CANCER MICROENVIRON, V8, P15, DOI 10.1007/s12307-014-0160-8; Escudier B, 2018, J CLIN ONCOL, V36, P765, DOI 10.1200/JCO.2017.74.7352; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; George DJ, 2003, NEW ENGL J MED, V349, P419, DOI 10.1056/NEJMp030061; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2014, CANCER IMMUNOL RES, V2, P632, DOI 10.1158/2326-6066.CIR-14-0053; Hsieh JJ, 2017, EUR UROL, V71, P405, DOI 10.1016/j.eururo.2016.10.007; Kaelin WG, 2003, J AM SOC NEPHROL, V14, P2703, DOI 10.1097/01.ASN.0000092803.69761.41; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Liu Q, 2016, CYTOKINE GROWTH F R, V31, P61, DOI 10.1016/j.cytogfr.2016.08.002; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Najjar YG, 2017, CLIN CANCER RES, V23, P2346, DOI 10.1158/1078-0432.CCR-15-1823; Osada T, 2008, CANCER IMMUNOL IMMUN, V57, P1115, DOI 10.1007/s00262-007-0441-x; Powles T, 2015, J IMMUNOTHER CANC S2, V3, P83; Prima V, 2017, P NATL ACAD SCI USA, V114, P1117, DOI 10.1073/pnas.1612920114; Reck M, 2017, ANN ONCOL, V28, DOI 10.1093/annonc/mdx760.002; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sumida K, 2012, EUR J IMMUNOL, V42, P2060, DOI 10.1002/eji.201142335; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Turajlic S, 2017, LANCET ONCOL, V18, P1009, DOI 10.1016/S1470-2045(17)30516-8; Voss MH, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4523; Wallin JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12624; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Yuan M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6530410; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	63	647	667	9	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					749	+		10.1038/s41591-018-0053-3	http://dx.doi.org/10.1038/s41591-018-0053-3			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29867230	Green Accepted			2022-12-27	WOS:000434281300020
J	Karlsson, T; Rask-Andersen, M; Pan, G; Hoglund, J; Wadelius, C; Ek, WE; Johansson, A				Karlsson, Torgny; Rask-Andersen, Mathias; Pan, Gang; Hoglund, Julia; Wadelius, Claes; Ek, Weronica E.; Johansson, Asa			Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; TISSUE; OBESITY; BIAS	Visceral adipose tissue (VAT)-fat stored around the internal organs-has been suggested as an independent risk factor for cardiovascular and metabolic disease(1-3), as well as all-cause, cardiovascular-specific and cancer-specific mortality(4,5). Yet, the contribution of genetics to VAT, as well as its disease-related effects, are largely unexplored due to the requirement for advanced imaging technologies to accurately measure VAT. Here, we develop sex-stratified, nonlinear prediction models (coefficient of determination = 0.76; typical 95% confidence interval (CI) = 0.74-0.78) for VAT mass using the UK Biobank cohort. We performed a genome-wide association study for predicted VAT mass and identified 102 novel visceral adiposity loci. Predicted VAT mass was associated with increased risk of hypertension, heart attack/angina, type 2 diabetes and hyperlipidemia, and Mendelian randomization analysis showed visceral fat to be a causal risk factor for all four diseases. In particular, a large difference in causal effect between the sexes was found for type 2 diabetes, with an odds ratio of 7.34 (95% CI= 4.48-12.0) in females and an odds ratio of 2.50 (95% CI =1.98-3.14) in males. Our findings bolster the role of visceral adiposity as a potentially independent risk factor, in particular for type 2 diabetes in Caucasian females. Independent validation in other cohorts is necessary to determine whether the findings can translate to other ethnicities, or outside the UK.	[Karlsson, Torgny; Rask-Andersen, Mathias; Pan, Gang; Hoglund, Julia; Wadelius, Claes; Ek, Weronica E.; Johansson, Asa] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden	Uppsala University	Karlsson, T; Johansson, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	torgny.karlsson@igp.uu.se; asa.johansson@igp.uu.se	Johansson, Åsa/AAG-6799-2021; Johansson, Åsa/G-5270-2011	Johansson, Åsa/0000-0002-2915-4498; Johansson, Åsa/0000-0002-2915-4498; Karlsson, Torgny/0000-0001-8095-6149; Hoglund, Julia/0000-0001-8061-3947; Pan, Gang/0000-0003-4243-1821	SNIC through the Uppsala Multidisciplinary Center for Advanced Computational Science [b2016021, sens2017538]; Swedish Society for Medical Research; Swedish Research Council [2015-03327]; Kjell and Marta Beijers Foundation; Goran Gustafssons Foundation; Marcus Borgstrom Foundation; Ake Wiberg Foundation [M16-0210]; Swedish Heart and Lung Foundation [20170484]; Swedish Diabetes Foundation; Science for Life Laboratory	SNIC through the Uppsala Multidisciplinary Center for Advanced Computational Science; Swedish Society for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kjell and Marta Beijers Foundation; Goran Gustafssons Foundation; Marcus Borgstrom Foundation; Ake Wiberg Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Foundation; Science for Life Laboratory	We acknowledge all of the participants and staff involved in UKBB for their valuable contribution. This research was conducted using the UKBB Resource under application number 15152, following the restrictions on data availability set up by the UKBB. The computations were performed on resources provided by SNIC through the Uppsala Multidisciplinary Center for Advanced Computational Science under projects b2016021 and sens2017538. The research was funded by the Swedish Society for Medical Research (M.R.-A. and A.J.), Swedish Research Council (A.J., 2015-03327), Kjell and Marta Beijers Foundation (A.J.), Goran Gustafssons Foundation (A.J.), Marcus Borgstrom Foundation (A.J.), Ake Wiberg Foundation (A.J., M16-0210), Swedish Heart and Lung Foundation (A.J., 20170484), Swedish Diabetes Foundation (C.W.) and Science for Life Laboratory (A.J.).	Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Ahsan M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007005; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Brown JC, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22898; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P307, DOI 10.1089/bio.2015.29031.hmm; Chu AY, 2017, NAT GENET, V49, P125, DOI 10.1038/ng.3738; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eastwood SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075085; Emdin CA, 2017, JAMA-J AM MED ASSOC, V317, P626, DOI 10.1001/jama.2016.21042; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Gomez-Hernandez A, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1216783; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216; Katzmarzyk PT, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.15; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Moreno-Navarrete JM, 2017, OBESITY, V25, P1723, DOI 10.1002/oby.21956; Nagano H, 2018, P NATL ACAD SCI USA, V115, P8370, DOI 10.1073/pnas.1804243115; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Neamat-Allah J, 2015, EUR J NUTR, V54, P701, DOI 10.1007/s00394-014-0748-2; Neamat-Allah J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091586; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; R Core Development Team, 2016, R LANG ENV STAT COMP; Samouda H, 2013, OBESITY, V21, pE41, DOI 10.1002/oby.20033; Sodini SM, 2018, GENETICS, V209, P941, DOI 10.1534/genetics.117.300630; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Sung YJ, 2016, INT J OBESITY, V40, P662, DOI 10.1038/ijo.2015.217; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Weeks JP, 2010, J STAT SOFTW, V35, P1; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	44	83	86	8	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1390	+		10.1038/s41591-019-0563-7	http://dx.doi.org/10.1038/s41591-019-0563-7			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501611				2022-12-27	WOS:000484832800021
J	Stower, H				Stower, Hannah			Widespread tissue genetic mosaics	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1029	1029		10.1038/s41591-019-0526-z	http://dx.doi.org/10.1038/s41591-019-0526-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270497	Bronze			2022-12-27	WOS:000474430400009
J	Stower, H				Stower, Hannah			Delaying diabetes onset	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1029	1029		10.1038/s41591-019-0527-y	http://dx.doi.org/10.1038/s41591-019-0527-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270499	Bronze			2022-12-27	WOS:000474430400010
J	Ribas, A; Lawrence, D; Atkinson, V; Agarwal, S; Miller, WH; Carlino, MS; Fisher, R; Long, GV; Hodi, FS; Tsoi, J; Grasso, CS; Mookerjee, B; Zhao, Q; Ghori, R; Moreno, BH; Ibrahim, N; Hamid, O				Ribas, Antoni; Lawrence, Donald; Atkinson, Victoria; Agarwal, Sachin; Miller, Wilson H., Jr.; Carlino, Matteo S.; Fisher, Rosalie; Long, Georgina V.; Hodi, F. Stephen; Tsoi, Jennifer; Grasso, Catherine S.; Mookerjee, Bijoyesh; Zhao, Qing; Ghori, Razi; Moreno, Blanca Homet; Ibrahim, Nageatte; Hamid, Omid			Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma	NATURE MEDICINE			English	Article							MUTATIONAL LANDSCAPE; OPEN-LABEL; SURVIVAL; VEMURAFENIB; COMBINATION; DABRAFENIB; IPILIMUMAB; EXPRESSION; RESISTANCE; PHASE-3	Oncogene-targeted therapy with B-Raf proto-oncogene (BRAF) and mitogen-activated protein kinase kinase (MEK) inhibitors induces a high initial response rate in patients with BRAF(V600)-mutated melanoma, with a median duration of response of approximately 1 year(1-3). Immunotherapy with antibodies to programmed death 1 (PD-1) produces lower response rates but with long response duration. Preclinical models suggest that combining BRAF and MEK inhibitors with PD-1 blockade therapy improves antitumor activity(4-6), which may provide additional treatment options for patients unlikely to have long-lasting responses to either mode of therapy alone. We enrolled 15 patients with BRAF(V600)-mutated metastatic melanoma in a first-in-human clinical trial of dabrafenib, trametinib and pembrolizumab (NCT02130466). Eleven patients (73%) experienced grade 3/4 treatment-related adverse events, the most common being elevation of liver function tests and pyrexia, most of which resolved with drug interruption or discontinuation of either the anti-PD-1 antibody or the targeted therapy combination. Eleven patients (73%; 95% confidence interval = 45-92%) had an objective response, and six (40%; 95% confidence interval = 16-68%) continued with a response at a median follow-up of 27 months (range = 10.3-38.4+ months) for all patients. This study suggests that this triple-combined therapy may benefit a subset of patients with BRAF(V600)-mutated metastatic melanoma by increasing the frequency of long-lasting antitumor responses.	[Ribas, Antoni; Tsoi, Jennifer; Grasso, Catherine S.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Lawrence, Donald] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Atkinson, Victoria] Greenslopes Private Hosp, Gallipoli Med Res Fdn, Greenslopes, Qld, Australia; [Agarwal, Sachin] Indiana Univ Hlth, Goshen Ctr Canc Care, Goshen, IN USA; [Miller, Wilson H., Jr.] Segal Canc Ctr, Montreal, PQ, Canada; [Miller, Wilson H., Jr.] Jewish Gen Hosp, Montreal, PQ, Canada; [Miller, Wilson H., Jr.] McGill Univ, Montreal, PQ, Canada; [Carlino, Matteo S.] Westmead Hosp, Sydney, NSW, Australia; [Carlino, Matteo S.] Blacktown Hosp, Sydney, NSW, Australia; [Carlino, Matteo S.; Long, Georgina V.] Univ Sydney, Sydney, NSW, Australia; [Carlino, Matteo S.; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Fisher, Rosalie] Auckland Dist Hlth Board, Auckland, New Zealand; [Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Mookerjee, Bijoyesh] Novartis, E Hanover, NJ USA; [Zhao, Qing; Ghori, Razi; Moreno, Blanca Homet; Ibrahim, Nageatte] Merck & Co Inc, Kenilworth, NJ USA; [Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; Indiana University System; McGill University; McGill University; University of Sydney; Blacktown & Mount Druitt Hospital; University of Sydney; Melanoma Institute Australia; Auckland District Health Board; Royal North Shore Hospital; Harvard University; Dana-Farber Cancer Institute; Novartis; Merck & Company; Angeles Clinic & Research Institute	Ribas, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	aribas@mednet.ucla.edu	Long, Georgina V/C-1771-2013; Carlino, Matteo/GRS-7198-2022	Long, Georgina V/0000-0001-8894-3545; Carlino, Matteo/0000-0002-7861-4104	Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA; Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA; NIH [R35 CA197633, P01 CA168585]; Parker Institute for Cancer Immunotherapy	Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA; Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy	Funding for this research was provided by Merck Sharpe & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The authors thank the patients and their families, all primary investigators and site personnel for participation in the study. The authors thank S. Ebbinghaus and S. Diede for study design and oversight, M. Bucci, J. Siegel and N. Cote for data acquisition, A. L. Webber for biomarker analysis, M. Nebozhyn for GEP analysis, R. Cristescu for WES analysis; Y. Cui for CD8 analysis, and R. Mogg for biomarker analysis. Editorial assistance was provided by D. Mitra of the ApotheCom pembrolizumab team. This assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. A. R., J.T. and C.S.G. were funded by NIH grants R35 CA197633 and P01 CA168585, and by the Parker Institute for Cancer Immunotherapy.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, KEYTRUDA PEMBR INJ I; [Anonymous], 2015, TAF 50 MG HARD CAPS; [Anonymous], 2018, MEKINIST TRAM TABL O; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Deken MA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238557; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Grasso CS, 2018, CANCER DISCOV, V8, P730, DOI 10.1158/2159-8290.CD-17-1327; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Moreno BH, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1052212; Nuckols JD, 1999, J CUTAN PATHOL, V26, P169, DOI 10.1111/j.1600-0560.1999.tb01824.x; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; RIBAS A, 2015, J CLIN ONCOL S, V33; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Schachter J, 2017, LANCET, V390, P1853, DOI 10.1016/S0140-6736(17)31601-X; Schadendorf D, 2017, EUR J CANCER, V82, P45, DOI 10.1016/j.ejca.2017.05.033; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Vella LJ, 2014, CANCER IMMUNOL RES, V2, P351, DOI 10.1158/2326-6066.CIR-13-0181; Vilain RE, 2017, CLIN CANCER RES, V23, P5024, DOI 10.1158/1078-0432.CCR-16-0698; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684	38	170	171	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					936	+		10.1038/s41591-019-0476-5	http://dx.doi.org/10.1038/s41591-019-0476-5			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171879	Green Published, Green Accepted			2022-12-27	WOS:000470844400024
J	Niewczas, MA; Pavkov, ME; Skupien, J; Smiles, A; Dom, ZIM; Wilson, JM; Park, J; Nair, V; Schlafly, A; Saulnier, PJ; Satake, E; Simeone, CA; Shah, H; Qiu, CX; Looker, HC; Fiorina, P; Ware, CF; Sun, JK; Doria, A; Kretzler, M; Susztak, K; Duffin, KL; Nelson, RG; Krolewski, AS				Niewczas, Monika A.; Pavkov, Meda E.; Skupien, Jan; Smiles, Adam; Dom, Zaipul I. Md; Wilson, Jonathan M.; Park, Jihwan; Nair, Viji; Schlafly, Andrew; Saulnier, Pierre-Jean; Satake, Eiichiro; Simeone, Christopher A.; Shah, Hetal; Qiu, Chengxiang; Looker, Helen C.; Fiorina, Paolo; Ware, Carl F.; Sun, Jennifer K.; Doria, Alessandro; Kretzler, Matthias; Susztak, Katalin; Duffin, Kevin L.; Nelson, Robert G.; Krolewski, Andrzej S.			A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes	NATURE MEDICINE			English	Article							URINARY ALBUMIN EXCRETION; CHRONIC KIDNEY-DISEASE; TNF RECEPTORS 1; FOLLOW-UP; AMERICAN-INDIANS; GENE-EXPRESSION; NEPHROPATHY; PROGRESSION; DECLINE; BIOMARKERS	Chronic inflammation is postulated to be involved in the development of end-stage renal disease in diabetes, but which specific circulating inflammatory proteins contribute to this risk remain unknown. To study this, we examined 194 circulating inflammatory proteins in subjects from three independent cohorts with type 1 and type 2 diabetes. In each cohort, we identified an extremely robust kidney risk inflammatory signature (KRIS), consisting of 17 proteins enriched in tumor necrosis factor-receptor superfamily members, that was associated with a 10-year risk of end-stage renal disease. All these proteins had a systemic, non-kidney source. Our prospective study findings provide strong evidence that KRIS proteins contribute to the inflammatory process underlying end-stage renal disease development in both types of diabetes. These proteins point to new therapeutic targets and new prognostic tests to identify subjects at risk of end-stage renal disease, as well as biomarkers to measure responses to treatment of diabetic kidney disease.	[Niewczas, Monika A.; Skupien, Jan; Smiles, Adam; Dom, Zaipul I. Md; Schlafly, Andrew; Satake, Eiichiro; Simeone, Christopher A.; Shah, Hetal; Sun, Jennifer K.; Doria, Alessandro; Krolewski, Andrzej S.] Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA; [Niewczas, Monika A.; Dom, Zaipul I. Md; Satake, Eiichiro; Shah, Hetal; Sun, Jennifer K.; Doria, Alessandro; Krolewski, Andrzej S.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Pavkov, Meda E.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; [Skupien, Jan] Jagiellonian Univ, Med Coll, Dept Metab Dis, Krakow, Poland; [Wilson, Jonathan M.; Duffin, Kevin L.] Eli Lilly & Co, Lilly Res Labs, Diabet & Complicat Dept, Indianapolis, IN 46285 USA; [Park, Jihwan; Qiu, Chengxiang; Susztak, Katalin] Univ Penn, Dept Med, Renal Elect & Hypertens Div, Perelman Sch Med,Dept Genet, Philadelphia, PA 19104 USA; [Nair, Viji; Kretzler, Matthias] Univ Michigan, Nephrol Internal Med & Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Saulnier, Pierre-Jean; Looker, Helen C.; Nelson, Robert G.] NIDDK, Chron Kidney Dis Sect, Phoenix, AZ USA; [Saulnier, Pierre-Jean] Univ Poitiers, CHU Poitiers, INSERM, Clin Invest Ctr CIC1402, Poitiers, France; [Fiorina, Paolo] Harvard Med Sch, Boston Childrens Hosp, Nephrol Div, Boston, MA 02115 USA; [Fiorina, Paolo] Univ Milan, Dept Biomed & Clin Sci L Sacco, Romeo & Enrica Invernizzi Pediat Ctr, Milan, Italy; [Ware, Carl F.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Centers for Disease Control & Prevention - USA; Jagiellonian University; Collegium Medicum Jagiellonian University; Eli Lilly; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Milan; Luigi Sacco Hospital; Sanford Burnham Prebys Medical Discovery Institute	Niewczas, MA; Krolewski, AS (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.; Niewczas, MA; Krolewski, AS (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	Monika.Niewczas@joslin.harvard.edu; Andrzej.Krolewski@joslin.harvard.edu	Sun, Jennifer K/AAP-2734-2020; Qiu, Chengxiang/X-5040-2019; Susztak, Katalin/ABE-7474-2021; SAULNIER, Pierre-Jean/H-7218-2016; Doria, Alessandro/H-9157-2018	Sun, Jennifer K/0000-0003-0915-6303; Qiu, Chengxiang/0000-0002-6346-8669; Susztak, Katalin/0000-0002-1005-3726; SAULNIER, Pierre-Jean/0000-0003-1862-4252; Park, Jihwan/0000-0002-5728-912X; Niewczas, Monika/0000-0003-2371-595X; Doria, Alessandro/0000-0002-3830-4304	National Institutes of Health [DK41526, DP3DK112177, DK 087635, DK108220]; Joslin Diabetes Center [P30 DK036836]; Novo Nordisk Foundation [NNF OC0013659]; JDRF [5-CDA-2015-89-A-B]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Romeo ed Enrica Invernizzi Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, ZIADK069062, P30DK036836, DP3DK112177, R01DK041526, R01DK087635, R01DK076077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Center; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); JDRF(Juvenile Diabetes Research Foundation); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Romeo ed Enrica Invernizzi Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants: from the National Institutes of Health to A.S.K. (DK41526 and DP3DK112177), K.S. (DK 087635 and DK108220) and the Joslin Diabetes Center (P30 DK036836); from the Novo Nordisk Foundation to A.S.K. (NNF OC0013659); and from the JDRF to M.A.N. (5-CDA-2015-89-A-B). The study was also supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. P.F. is supported by the Romeo ed Enrica Invernizzi Foundation. We would like to acknowledge E. Mills and N. Rashidi from Olink Proteomics Inc. for their assistance with protein measurements.	Afshinnia F, 2016, KIDNEY INT REP, V1, P256, DOI 10.1016/j.ekir.2016.08.007; Al-Lamki RS, 2015, KIDNEY INT, V87, P281, DOI 10.1038/ki.2014.285; Anders HJ, 2002, J CLIN INVEST, V109, P251, DOI 10.1172/JCI14040; Araki S, 2007, DIABETOLOGIA, V50, P867, DOI 10.1007/s00125-006-0586-8; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Barr ELM, 2018, DIABETES CARE, V41, P739, DOI 10.2337/dc17-1919; Beckerman P, 2017, EBIOMEDICINE, V24, P267, DOI 10.1016/j.ebiom.2017.09.014; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Coca SG, 2017, J AM SOC NEPHROL, V28, P2786, DOI 10.1681/ASN.2016101101; Cortvrindt C, 2017, PATHOLOGY, V49, P247, DOI 10.1016/j.pathol.2017.01.003; Croft M, 2017, NAT REV RHEUMATOL, V13, P217, DOI 10.1038/nrrheum.2017.22; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Forsblom C, 2014, DIABETES CARE, V37, P2334, DOI 10.2337/dc14-0225; Forssmann U, 2001, J LEUKOCYTE BIOL, V70, P357; Ganz P, 2016, JAMA-J AM MED ASSOC, V315, P2532, DOI 10.1001/jama.2016.5951; Gohda T, 2018, DIABETES RES CLIN PR, V141, P62, DOI 10.1016/j.diabres.2018.04.026; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Krolewski AS, 2017, KIDNEY INT, V91, P1300, DOI 10.1016/j.kint.2016.10.046; Krolewski AS, 2015, DIABETES CARE, V38, P954, DOI 10.2337/dc15-0184; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; McInnes IB, 2004, CURR OPIN PHARMACOL, V4, P392, DOI 10.1016/j.coph.2004.04.003; Mehrotra P, 2017, AM J PHYSIOL-RENAL, V312, pF385, DOI 10.1152/ajprenal.00462.2016; Menne J, 2017, NEPHROL DIAL TRANSPL, V32, P307, DOI 10.1093/ndt/gfv459; Moriwaki Y, 2007, ACTA DIABETOL, V44, P215, DOI 10.1007/s00592-007-0007-6; Nair V, 2018, KIDNEY INT, V93, P439, DOI 10.1016/j.kint.2017.08.013; Navarro JF, 2005, KIDNEY INT, V68, P98; Navarro-Gonzalez JF, 2015, J AM SOC NEPHROL, V26, P220, DOI 10.1681/ASN.2014010012; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; NELSON RG, 1988, DIABETOLOGIA, V31, P730, DOI 10.1007/BF00274774; Ngo D, 2016, CIRCULATION, V134, P270, DOI 10.1161/CIRCULATIONAHA.116.021803; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nowak N, 2018, KIDNEY INT, V93, P1198, DOI 10.1016/j.kint.2017.11.024; O'Shea JJ, 2014, CELL, V157, P227, DOI 10.1016/j.cell.2014.03.010; Omote K, 2014, AM J PHYSIOL-RENAL, V306, pF1335, DOI 10.1152/ajprenal.00509.2013; Paykov ME, 2015, KIDNEY INT, V87, P812, DOI 10.1038/ki.2014.330; Pichler R, 2017, AM J PHYSIOL-RENAL, V312, pF716, DOI 10.1152/ajprenal.00314.2016; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Saito R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87877; Saulnier PJ, 2014, DIABETES CARE, V37, P1425, DOI 10.2337/dc13-2580; SchulzKnappe P, 1996, J EXP MED, V183, P295, DOI 10.1084/jem.183.1.295; Sharma K, 2018, SEMIN NEPHROL, V38, P99, DOI 10.1016/j.semnephrol.2018.02.001; Sica GL, 2001, BLOOD, V97, P2702, DOI 10.1182/blood.V97.9.2702; Skupien J, 2014, DIABETES CARE, V37, P2601, DOI 10.2337/dc13-1983; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tanamas SK, 2016, DIABETES CARE, V39, P2004, DOI 10.2337/dc16-0795; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tuttle KR, 2018, NEPHROL DIAL TRANSPL, V33, P1950, DOI 10.1093/ndt/gfx377; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Wheelock KM, 2017, NEPHROL DIAL TRANSPL, V32, P2145, DOI 10.1093/ndt/gfx303; Yamanouchi M, 2017, KIDNEY INT, V92, P258, DOI 10.1016/j.kint.2017.02.010; 2018, CIRCULATION, V137, P999, DOI DOI 10.1161/CIRCULATIONAHA.117.028213	64	166	170	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					805	+		10.1038/s41591-019-0415-5	http://dx.doi.org/10.1038/s41591-019-0415-5			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31011203	Green Accepted			2022-12-27	WOS:000468247800024
J	Stower, H				Stower, Hannah			Cancer risk	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					710	710		10.1038/s41591-019-0452-0	http://dx.doi.org/10.1038/s41591-019-0452-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068708	Bronze			2022-12-27	WOS:000468247800006
J	Stower, H				Stower, Hannah			Maternal infection linked to psychiatric disorders	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					541	541		10.1038/s41591-019-0430-6	http://dx.doi.org/10.1038/s41591-019-0430-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30948851	Bronze			2022-12-27	WOS:000463342800010
J	Ladner, JT; Grubaugh, ND; Pybus, OG; Andersen, KG				Ladner, Jason T.; Grubaugh, Nathan D.; Pybus, Oliver G.; Andersen, Kristian G.			Precision epidemiology for infectious disease control	NATURE MEDICINE			English	Article							EBOLA-VIRUS; REAL-TIME; GENOMIC EPIDEMIOLOGY; SEXUAL TRANSMISSION; ZIKA VIRUS; OUTBREAK; EVOLUTION; IMPACT; IMPLEMENTATION; CORONAVIRUS	Advances in genomics and computing are transforming the capacity for the characterization of biological systems, and researchers are now poised for a precision-focused transformation in the way they prepare for, and respond to, infectious diseases. This includes the use of genome-based approaches to inform molecular diagnosis and individual-level treatment regimens. In addition, advances in the speed and granularity of pathogen genome generation have improved the capability to track and understand pathogen transmission, leading to potential improvements in the design and implementation of population-level public health interventions. In this Perspective, we outline several trends that are driving the development of precision epidemiology of infectious disease and their implications for scientists' ability to respond to outbreaks.	[Ladner, Jason T.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ USA; [Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England; [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA	Northern Arizona University; Yale University; University of Oxford; Scripps Research Institute	Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.	andersen@scripps.edu	Pybus, Oliver G/B-2640-2012; Ladner, Jason/G-3486-2011	Pybus, Oliver G/0000-0002-8797-2667; Ladner, Jason/0000-0001-7751-4366; Grubaugh, Nathan/0000-0003-2031-1933	Oxford Martin School; NIH NCATS [CTSA UL1TR001114]; NIAID [HHSN272201400048C, R21AI137690, U19AI135995]; Ray Thomas Foundation; State of Arizona Technology and Research Initiative Fund (TRIF); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI135995, R21AI137690] Funding Source: NIH RePORTER	Oxford Martin School; NIH NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ray Thomas Foundation; State of Arizona Technology and Research Initiative Fund (TRIF); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	O.G.P. is supported by the Oxford Martin School. K.G.A. is a Pew Biomedical Scholar and is supported by NIH NCATS CTSA UL1TR001114, NIAID HHSN272201400048C, NIAID R21AI137690, NIAID U19AI135995, and The Ray Thomas Foundation. J.T.L. is supported by the State of Arizona Technology and Research Initiative Fund (TRIF), administered by the Arizona Board of Regents, through Northern Arizona University.	Alexandrov V, 2016, NAT BIOTECHNOL, V34, P838, DOI 10.1038/nbt.3587; Allard MW, 2018, CURR OPIN BIOTECH, V49, P224, DOI 10.1016/j.copbio.2017.11.002; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ampofo WK, 2015, VACCINE, V33, P4368, DOI 10.1016/j.vaccine.2015.06.090; Andersen KG, 2015, CELL, V162, P738, DOI 10.1016/j.cell.2015.07.020; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P237; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009; Bissonnette L, 2012, J PERS MED, V2, P50, DOI 10.3390/jpm2020050; Bogue MA, 2018, NUCLEIC ACIDS RES, V46, pD843, DOI 10.1093/nar/gkx1082; Both L, 2013, VACCINE, V31, P1553, DOI 10.1016/j.vaccine.2013.01.025; Boulding H, 2012, HUM MUTAT, V33, P874, DOI 10.1002/humu.22069; Bourgeois FT, 2007, J AM MED INFORM ASSN, V14, P765, DOI 10.1197/jamia.M2134; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2007, EUROSURVEILLANCE, V12; Butler D, 2015, NATURE NEWS, DOI [10.1038/nature.2015.18584, DOI 10.1038/NATURE.2015.18584]; CANN AJ, 1984, NUCLEIC ACIDS RES, V12, P7787, DOI 10.1093/nar/12.20.7787; Center for Food Safety & Nutrition A, 2018, WHOL GEN SEQ PROGR G; Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Doud MB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006271; du Plessis L, 2015, TRENDS MICROBIOL, V23, P383, DOI 10.1016/j.tim.2015.04.007; Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040; Eyre DW, 2018, NEW ENGL J MED, V379, P1322, DOI 10.1056/NEJMoa1714373; Faria N. R., 2018, Science (Washington), V361, P894, DOI 10.1126/science.aat7115; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harrington J, 2013, SLEEP BREATH, V17, P1071, DOI 10.1007/s11325-013-0804-9; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790; Jackson BR, 2016, CLIN INFECT DIS, V63, P380, DOI 10.1093/cid/ciw242; Johansson MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002549; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kugelman JR, 2015, MBIO, V6, DOI 10.1128/mBio.02227-14; Kuhnert D, 2016, MOL BIOL EVOL, V33, P2102, DOI 10.1093/molbev/msw064; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Little SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098443; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7; Milinovich GJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0690-1; Miller S., 2019, LAB VALIDATION CLIN, DOI [10.1101/330381, DOI 10.1101/330381]; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Neher RA, 2016, P NATL ACAD SCI USA, V113, pE1701, DOI 10.1073/pnas.1525578113; Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381; Nsoesie E. O., 2016, PLOS CURR, V8; Pan HQ, 2012, HUM MUTAT, V33, P849, DOI 10.1002/humu.22074; Perrin L, 1998, SCIENCE, V280, P1871, DOI 10.1126/science.280.5371.1871; Poon AFY, 2016, LANCET HIV, V3, pE231, DOI 10.1016/S2352-3018(16)00046-1; Popovich KJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0570-0; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; Schon T, 2017, CLIN MICROBIOL INFEC, V23, P154, DOI 10.1016/j.cmi.2016.10.022; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siddle KJ, 2018, NEW ENGL J MED, V379, P1745, DOI 10.1056/NEJMoa1804498; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763; Stadler Tanja, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.02bc6d927ecee7bbd33532ec8ba6a25f; Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013; Stevens EL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00808; Timme RE, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000185; Torkamani A, 2017, CELL, V170, P828, DOI 10.1016/j.cell.2017.08.007; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WHO, 2017, R D BLUEPR M PATH GE; World Health Organization, 2016, GUID MAN ETH ISS INF; Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115; Yozwiak NL, 2016, CELL, V166, P5, DOI 10.1016/j.cell.2016.06.029; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zola SM, 2013, AM J ALZHEIMERS DIS, V28, P179, DOI 10.1177/1533317512470484	87	52	54	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					206	211		10.1038/s41591-019-0345-2	http://dx.doi.org/10.1038/s41591-019-0345-2			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728537	Green Published, Green Accepted, Bronze			2022-12-27	WOS:000457842100014
J	Bensch, F; van der Veen, EL; Lub-de Hooge, MN; Jorritsma-Smit, A; Boellaard, R; Kok, IC; Oosting, SF; Schroder, CP; Hiltermann, TJN; van der Wekken, AJ; Groen, HJM; Kwee, TC; Elias, SG; Gietema, JA; Bohorquez, SS; de Crespigny, A; Williams, SP; Mancao, C; Brouwers, AH; Fine, BM; de Vries, EGE				Bensch, Frederike; van der Veen, Elly L.; Lub-de Hooge, Marjolijn N.; Jorritsma-Smit, Annelies; Boellaard, Ronald; Kok, Iris C.; Oosting, Sjoukje F.; Schroder, Carolina P.; Hiltermann, T. Jeroen N.; van der Wekken, Anthonie J.; Groen, Harry J. M.; Kwee, Thomas C.; Elias, Sjoerd G.; Gietema, Jourik A.; Bohorquez, Sandra Sanabria; de Crespigny, Alex; Williams, Simon-Peter; Mancao, Christoph; Brouwers, Adrienne H.; Fine, Bernard M.; de Vries, Elisabeth G. E.			Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer	NATURE MEDICINE			English	Article							PULMONARY SQUAMOUS-CELL; 1 ANTIBODY; EXPRESSION; PET; ATEZOLIZUMAB; MULTICENTER; CARCINOMA; ZR-89-TRASTUZUMAB; BIODISTRIBUTION; HETEROGENEITY	Programmed cell death protein-1/ligand-1 (PD-1/PD-L1) blockade is effective in a subset of patients with several tumor types, but predicting patient benefit using approved diagnostics is inexact, as some patients with PD-L1-negative tumors also show clinical benefit(1,2). Moreover, all biopsy-based tests are subject to the errors and limitations of invasive tissue collection(3-11). Preclinical studies of positron-emission tomography (PET) imaging with antibodies to PD-L1 suggested that this imaging method might be an approach to selecting patients(12,13). Such a technique, however, requires substantial clinical development and validation. Here we present the initial results from a first-in-human study to assess the feasibility of imaging with zirconium-89-labeled atezolizumab (anti-PD-L1), including biodistribution, and secondly test its potential to predict response to PD-L1 blockade (ClinicalTrials. gov identifiers NCT02453984 and NCT02478099). We imaged 22 patients across three tumor types before the start of atezolizumab therapy. The PET signal, a function of tracer exposure and target expression, was high in lymphoid tissues and at sites of inflammation. In tumors, uptake was generally high but heterogeneous, varying within and among lesions, patients, and tumor types. Intriguingly, clinical responses in our patients were better correlated with pretreatment PET signal than with immunohistochemistry- or RNA-sequencing-based predictive biomarkers, encouraging further development of molecular PET imaging for assessment of PD-L1 status and clinical response prediction.	[Bensch, Frederike; van der Veen, Elly L.; Kok, Iris C.; Oosting, Sjoukje F.; Schroder, Carolina P.; Gietema, Jourik A.; de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Lub-de Hooge, Marjolijn N.; Jorritsma-Smit, Annelies] Univ Groningen, Univ Med Ctr Groningen, Clin Pharm & Pharmacol, Groningen, Netherlands; [Lub-de Hooge, Marjolijn N.; Boellaard, Ronald; Kwee, Thomas C.; Brouwers, Adrienne H.] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Groningen, Netherlands; [Hiltermann, T. Jeroen N.; van der Wekken, Anthonie J.; Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Pulm Oncol, Groningen, Netherlands; [Elias, Sjoerd G.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bohorquez, Sandra Sanabria; de Crespigny, Alex; Williams, Simon-Peter; Fine, Bernard M.] Genentech Inc, San Francisco, CA USA; [Mancao, Christoph] Genentech Inc, Basel, Switzerland	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Roche Holding; Genentech; Roche Holding; Genentech	de Vries, EGE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	e.g.e.de.vries@umcg.nl	Hooge, Marjolijn/AAR-8840-2020; van der Wekken, Anthonie/AAE-2328-2021; Elias, Sjoerd G/E-6057-2011; , HiltermannTJN/ABA-9144-2021; Groen, Harry/AAP-2242-2021	Elias, Sjoerd G/0000-0003-3903-4024; de Vries, Elisabeth/0000-0002-8949-7425; Groen, Harry J.M./0000-0002-2978-5265; Gietema, Jourik/0000-0003-0629-7354; Brouwers, Adrienne/0000-0003-2698-1516; Kok, Iris/0000-0002-8155-8676; van der Wekken, Anthonie/0000-0001-7175-0026	Dutch Cancer Society [RUG 2016-10034]; ERC Advanced grant OnQview [ERC 293445]; personal Dutch Cancer Society fellowship [RUG 2014-6625]; Hoffmann-La Roche/Genentech	Dutch Cancer Society(KWF Kankerbestrijding); ERC Advanced grant OnQview; personal Dutch Cancer Society fellowship; Hoffmann-La Roche/Genentech	We thank patients and their families for participating in this study. This work was supported by the Dutch Cancer Society grant RUG 2016-10034 (POINTING) and the ERC Advanced grant OnQview ERC 293445, both awarded to E.G.E.d.V., a personal Dutch Cancer Society fellowship RUG 2014-6625 awarded to F.B., and a research grant from Hoffmann-La Roche/Genentech, which was made available to the UMCG.	Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Chatterjee S, 2016, ONCOTARGET, V7, P10215, DOI 10.18632/oncotarget.7143; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; den Hollander MW, 2015, J NUCL MED, V56, P1310, DOI 10.2967/jnumed.115.154401; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Dong ZY, 2017, CLIN CANCER RES, V23, P3012, DOI 10.1158/1078-0432.CCR-16-2554; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emens LA, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2859; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Frings V, 2014, RADIOLOGY, V273, P539, DOI 10.1148/radiol.14132807; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gaykema SBM, 2014, CLIN CANCER RES, V20, P3945, DOI 10.1158/1078-0432.CCR-14-0491; Gniadek TJ, 2017, MODERN PATHOL, V30, P530, DOI 10.1038/modpathol.2016.213; Hegde PS, 2016, CLIN CANCER RES, V22, P1865, DOI 10.1158/1078-0432.CCR-15-1507; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Heskamp S, 2015, CANCER RES, V75, P2928, DOI 10.1158/0008-5472.CAN-14-3477; Johnson DB, 2014, CURR TREAT OPTION ON, V15, P658, DOI 10.1007/s11864-014-0305-5; Kim JM, 2016, ANN ONCOL, V27, P1492, DOI 10.1093/annonc/mdw217; Kowanetz M, 2016, ANN ONCOL, V27, P15; Lamberts LE, 2016, CLIN CANCER RES, V22, P1642, DOI 10.1158/1078-0432.CCR-15-1272; Lamberts LE, 2015, J CLIN ONCOL, V33, P1491, DOI 10.1200/JCO.2014.57.8278; Madore J, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12340; Makris NE, 2014, J NUCL MED, V55, P264, DOI 10.2967/jnumed.113.130112; McDermott DF, 2016, J CLIN ONCOL, V34, P833, DOI 10.1200/JCO.2015.63.7421; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; Munnink THO, 2011, J NUCL MED, V52, P2001, DOI 10.2967/jnumed.111.092809; Ogembo JG, 2012, J IMMUNOL, V188, P4496, DOI 10.4049/jimmunol.1103086; Petrylak DP, 2018, JAMA ONCOL, V4, P537, DOI 10.1001/jamaoncol.2017.5440; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rehman JA, 2017, MODERN PATHOL, V30, P340, DOI 10.1038/modpathol.2016.186; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sanmamed MF, 2014, CANCER J, V20, P256, DOI 10.1097/PPO.0000000000000061; Scheel AH, 2016, MODERN PATHOL, V29, P1165, DOI 10.1038/modpathol.2016.117; Smith J, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0494-2; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Scheltinga AGTT, 2014, MABS-AUSTIN, V6, P1051, DOI 10.4161/mabs.29097; Verel I, 2003, J NUCL MED, V44, P1271	40	318	331	5	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1852	+		10.1038/s41591-018-0255-8	http://dx.doi.org/10.1038/s41591-018-0255-8			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30478423	Green Submitted			2022-12-27	WOS:000452392200014
J	Falcao, AM; van Bruggen, D; Marques, S; Meijer, M; Jakel, S; Agirre, E; Samudyata; Floriddia, EM; Vanichkina, DP; Ffrench-Constant, C; Williams, A; Guerreiro-Cacais, AO; Castelo-Branco, G				Falcao, Ana Mendanha; van Bruggen, David; Marques, Sueli; Meijer, Mandy; Jakel, Sarah; Agirre, Eneritz; Samudyata; Floriddia, Elisa M.; Vanichkina, Darya P.; Ffrench-Constant, Charles; Williams, Anna; Guerreiro-Cacais, Andre Ortlieb; Castelo-Branco, Goncalo			Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis	NATURE MEDICINE			English	Article							GENE; PROGENITORS; REGULATOR; CYTOSCAPE; PACKAGE; LESIONS; MOUSE	Multiple sclerosis (MS) is characterized by an immune system attack targeting myelin, which is produced by oligodendrocytes (OLs). We performed single-cell transcriptomic analysis of OL lineage cells from the spinal cord of mice induced with experimental autoimmune encephalomyelitis (EAE), which mimics several aspects of MS. We found unique OLs and OL precursor cells (OPCs) in EAE and uncovered several genes specifically alternatively spliced in these cells. Surprisingly, EAE-specific OL lineage populations expressed genes involved in antigen processing and presentation via major histocompatibility complex class I and II (MHC-I and -II), and in immunoprotection, suggesting alternative functions of these cells in a disease context. Importantly, we found that disease-specific oligodendroglia are also present in human MS brains and that a substantial number of genes known to be susceptibility genes for MS, so far mainly associated with immune cells, are expressed in the OL lineage cells. Finally, we demonstrate that OPCs can phagocytose and that MHC-II-expressing OPCs can activate memory and effector CD4-positive T cells. Our results suggest that OLs and OPCs are not passive targets but instead active immunomodulators in MS. The disease-specific OL lineage cells, for which we identify several biomarkers, may represent novel direct targets for immunomodulatory therapeutic approaches in MS.	[Falcao, Ana Mendanha; van Bruggen, David; Marques, Sueli; Meijer, Mandy; Agirre, Eneritz; Samudyata; Floriddia, Elisa M.; Castelo-Branco, Goncalo] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Biomedicum, Stockholm, Sweden; [Jakel, Sarah; Ffrench-Constant, Charles; Williams, Anna] Univ Edinburgh, Edinburgh BioQuarter, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Jakel, Sarah; Ffrench-Constant, Charles; Williams, Anna] Univ Edinburgh, Edinburgh BioQuarter, MS Soc Edinburgh Ctr, Edinburgh, Midlothian, Scotland; [Vanichkina, Darya P.] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [Vanichkina, Darya P.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Guerreiro-Cacais, Andre Ortlieb] Karolinska Inst, Dept Clin Neurosci CNS, CMM, Stockholm, Sweden; [Castelo-Branco, Goncalo] Karolinska Inst, Ming Wai Lau Ctr Reparat Med, Stockholm Node, Stockholm, Sweden	Karolinska Institutet; University of Edinburgh; University of Edinburgh; University of Sydney; Centenary Institute; University of Queensland; Karolinska Institutet; Karolinska Institutet	Falcao, AM; Castelo-Branco, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, Biomedicum, Stockholm, Sweden.; Castelo-Branco, G (corresponding author), Karolinska Inst, Ming Wai Lau Ctr Reparat Med, Stockholm Node, Stockholm, Sweden.	ana.mendanha.falcao@ki.se; goncalo.castelo-branco@ki.se	Castelo-Branco, Gonçalo/O-9162-2019; Agirre, Eneritz/M-2913-2019; Castelo-Branco, Goncalo/A-8357-2015; Falcao, Ana Luisa/AAF-8371-2021; Guerreiro-Cacais, Andre Ortlieb/AAE-8417-2019; Vanichkina, Darya/F-9409-2014	Castelo-Branco, Gonçalo/0000-0003-2247-9393; Agirre, Eneritz/0000-0002-5012-0305; Falcao, Ana Luisa/0000-0003-4356-5936; Williams, Anna/0000-0002-6329-382X; Marques, Sueli/0000-0003-3368-4392; Floriddia, Elisa/0000-0003-2304-8114; Jakel, Sarah/0000-0002-9634-2472; van Bruggen, David/0000-0001-6794-7731; Samudyata, Samudyata/0000-0002-1062-2626; Meijer, Mandy/0000-0003-3314-1224; Vanichkina, Darya/0000-0002-0406-164X; Guerreiro-Cacais, Andre Ortlieb/0000-0002-4561-2823	University of Sydney HPC Grand Challenge Award; Boehringer Ingelheim Travel Grant; UK Multiple Sclerosis Society; European Union, Horizon 2020, Marie-Sklodowska Curie Actions [EC 789492, SOLO 794689]; European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); Swedish Research Council [2015-03558]; European Union (Horizon 2020 Research and Innovation Programme/European Research Council Consolidator Grant EPIScOPE) [681893]; Swedish Brain Foundation [FO2017-0075]; Ming Wai Lau Centre for Reparative Medicine; Petrus och Augusta Hedlunds Foundation [M-2014-0041, M-2016-0428]; Karolinska Institutet; Wellcome Trust Investigator award; MRC [MR/L016400/1, MR/K026666/1, MR/P016022/1] Funding Source: UKRI	University of Sydney HPC Grand Challenge Award; Boehringer Ingelheim Travel Grant(Boehringer Ingelheim); UK Multiple Sclerosis Society; European Union, Horizon 2020, Marie-Sklodowska Curie Actions; European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union (Horizon 2020 Research and Innovation Programme/European Research Council Consolidator Grant EPIScOPE); Swedish Brain Foundation; Ming Wai Lau Centre for Reparative Medicine; Petrus och Augusta Hedlunds Foundation; Karolinska Institutet(Karolinska Institutet); Wellcome Trust Investigator award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Nanni, A. Moshref, Tony Jimenez-Beristain and J. Soderlund for laboratory management and support. We thank Eukaryotic Single Cell Genomics Facility, WABI Long Term Bioinformatic Support (Leif Wigge) at SciLifeLab, the FACS facilities at CMB (B. Panagel), Science for Life Laboratory, the National Genomics Infrastructure and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure. We wish to acknowledge A. G. Rothfuchs for advice and reagents, M. Jagodic for advice, M. Bartosovic for assistance, R. Berglund and M. N'diaye for providing the tools to perform the phagocytosis experiments. The bioinformatics computations were performed on resources provided by the Swedish National Infrastructure for Computing at UPPMAX, Uppsala University. Postmortem MS tissue used for IHC was provided via a UK prospective donor scheme with full ethical approval from the UK Multiple Sclerosis Tissue Bank (MREC/02/02/39). D.P.V. would like to acknowledge the University of Sydney HPC service for providing HPC resources that have contributed to the research reported in this paper. This work was supported in part by a University of Sydney HPC Grand Challenge Award. D.P.V. was supported in part by a Boehringer Ingelheim Travel Grant. C.f.-C. is funded by a Wellcome Trust Investigator award. A.W. is funded by UK Multiple Sclerosis Society. S.J. is funded by European Union, Horizon 2020, Marie-Sklodowska Curie Actions (grant no. EC 789492); A.M.F. by the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS). E.A. is funded by European Union, Horizon 2020, Marie-Sklodowska Curie Actions (grant no. SOLO 794689). Work in G.C.-B.'s research group was supported by Swedish Research Council (grant no. 2015-03558), European Union (Horizon 2020 Research and Innovation Programme/European Research Council Consolidator Grant EPIScOPE, grant agreement 681893), Swedish Brain Foundation (grant no. FO2017-0075), Ming Wai Lau Centre for Reparative Medicine, Petrus och Augusta Hedlunds Foundation (grant nos. M-2014-0041 and M-2016-0428) and Karolinska Institutet.	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; BERGSTEINSDOTTIR K, 1992, P NATL ACAD SCI USA, V89, P9054, DOI 10.1073/pnas.89.19.9054; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Capello E, 1997, ANN NEUROL, V41, P797, DOI 10.1002/ana.410410616; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Haile Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0376-7; Huang YH, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1248-5; Huynh JL, 2014, NAT NEUROSCI, V17, P121, DOI 10.1038/nn.3588; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Larocca JN, 2007, CURR PROTOC CELL BIO, V33, P3251; LEE SC, 1989, J NEUROIMMUNOL, V25, P261, DOI 10.1016/0165-5728(89)90145-8; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; Marques S, 2018, DEV CELL, V46, P504, DOI 10.1016/j.devcel.2018.07.005; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Moyon S, 2015, J NEUROSCI, V35, P4, DOI 10.1523/JNEUROSCI.0849-14.2015; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Ogata T, 2011, NEUROSCIENCE, V176, P132, DOI 10.1016/j.neuroscience.2010.12.015; Patsopoulos N, 2018, BIORXIV, DOI 10.1101/143933; Peferoen L, 2014, IMMUNOLOGY, V141, P302, DOI 10.1111/imm.12163; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Sibinga NES, 2002, J BIOL CHEM, V277, P16202, DOI 10.1074/jbc.M200935200; Skene NG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00016; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Traka M, 2016, NAT NEUROSCI, V19, P65, DOI 10.1038/nn.4193; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Wolfert MA, 2013, NAT CHEM BIOL, V9, P776, DOI [10.1038/NCHEMBIO.1403, 10.1038/nchembio.1403]; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zeis T, 2008, J MOL NEUROSCI, V35, P91, DOI 10.1007/s12031-008-9042-1; Zeis T, 2016, BRAIN RES, V1641, P139, DOI 10.1016/j.brainres.2015.09.021; Zeisel A, 2013, BIOINFORMATICS, V29, P1355, DOI 10.1093/bioinformatics/btt145	46	188	193	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1837	+		10.1038/s41591-018-0236-y	http://dx.doi.org/10.1038/s41591-018-0236-y			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30420755	Green Accepted			2022-12-27	WOS:000452392200012
J	Klughammer, J; Kiesel, B; Roetzer, T; Fortelny, N; Nemc, A; Nenning, KH; Furtner, J; Sheffield, NC; Datlinger, P; Peter, N; Nowosielski, M; Augustin, M; Mischkulnig, M; Strobel, T; Alpar, D; Erguner, B; Senekowitsch, M; Moser, P; Freyschlag, CF; Kerschbaumer, J; Thome, C; Grams, AE; Stockhammer, G; Kitzwoegerer, M; Oberndorfer, S; Marhold, F; Weis, S; Trenkler, J; Buchroithner, J; Pichler, J; Haybaeck, J; Krassnig, S; Ali, KM; von Campe, G; Payer, F; Sherif, C; Preiser, J; Hauser, T; Winkler, PA; Kleindienst, W; Wurtz, F; Brandner-Kokalj, T; Stultschnig, M; Schweiger, S; Dieckmann, K; Preusser, M; Langs, G; Baumann, B; Knosp, E; Widhalm, G; Marosi, C; Hainfellner, JA; Woehrer, A; Bock, C				Klughammer, Johanna; Kiesel, Barbara; Roetzer, Thomas; Fortelny, Nikolaus; Nemc, Amelie; Nenning, Karl-Heinz; Furtner, Julia; Sheffield, Nathan C.; Datlinger, Paul; Peter, Nadine; Nowosielski, Martha; Augustin, Marco; Mischkulnig, Mario; Stroebel, Thomas; Alpar, Donat; Erguener, Bekir; Senekowitsch, Martin; Moser, Patrizia; Freyschlag, Christian F.; Kerschbaumer, Johannes; Thome, Claudius; Grams, Astrid E.; Stockhammer, Guenther; Kitzwoegerer, Melitta; Oberndorfer, Stefan; Marhold, Franz; Weis, Serge; Trenkler, Johannes; Buchroithner, Johanna; Pichler, Josef; Haybaeck, Johannes; Krassnig, Stefanie; Ali, Kariem Mahdy; von Campe, Gord; Payer, Franz; Sherif, Camillo; Preiser, Julius; Hauser, Thomas; Winkler, Peter A.; Kleindienst, Waltraud; Wuertz, Franz; Brandner-Kokalj, Tanisa; Stultschnig, Martin; Schweiger, Stefan; Dieckmann, Karin; Preusser, Matthias; Langs, Georg; Baumann, Bernhard; Knosp, Engelbert; Widhalm, Georg; Marosi, Christine; Hainfellner, Johannes A.; Woehrer, Adelheid; Bock, Christoph			The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space	NATURE MEDICINE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; MGMT PROMOTER METHYLATION; BURROWS-WHEELER TRANSFORM; CENTRAL-NERVOUS-SYSTEM; CLONAL EVOLUTION; INTRATUMORAL HETEROGENEITY; READ ALIGNMENT; IMAGE-ANALYSIS; GENOME; CANCER	Glioblastoma is characterized by widespread genetic and transcriptional heterogeneity, yet little is known about the role of the epigenome in glioblastoma disease progression. Here, we present genome-scale maps of DNA methylation in matched primary and recurring glioblastoma tumors, using data from a highly annotated clinical cohort that was selected through a national patient registry. We demonstrate the feasibility of DNA methylation mapping in a large set of routinely collected FFPE samples, and we validate bisulfite sequencing as a multipurpose assay that allowed us to infer a range of different genetic, epigenetic, and transcriptional characteristics of the profiled tumor samples. On the basis of these data, we identified subtle differences between primary and recurring tumors, links between DNA methylation and the tumor microenvironment, and an association of epigenetic tumor heterogeneity with patient survival. In summary, this study establishes an open resource for dissecting DNA methylation heterogeneity in a genetically diverse and heterogeneous cancer, and it demonstrates the feasibility of integrating epigenomics, radiology, and digital pathology for a national cohort, thereby leveraging existing samples and data collected as part of routine clinical practice.	[Klughammer, Johanna; Fortelny, Nikolaus; Nemc, Amelie; Datlinger, Paul; Alpar, Donat; Erguener, Bekir; Senekowitsch, Martin; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Kiesel, Barbara; Mischkulnig, Mario; Knosp, Engelbert; Widhalm, Georg] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Kiesel, Barbara; Roetzer, Thomas; Furtner, Julia; Peter, Nadine; Mischkulnig, Mario; Stroebel, Thomas; Dieckmann, Karin; Preusser, Matthias; Knosp, Engelbert; Widhalm, Georg; Marosi, Christine; Hainfellner, Johannes A.; Woehrer, Adelheid] Med Univ Vienna, Cent Nervous Syst Tumor Unit, Comprehens Canc Ctr, Vienna, Austria; [Roetzer, Thomas; Peter, Nadine; Stroebel, Thomas; Hainfellner, Johannes A.; Woehrer, Adelheid] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Nenning, Karl-Heinz; Langs, Georg] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Computat Imaging Res Lab, Vienna, Austria; [Furtner, Julia] Med Univ Vienna, Div Neuroradiol & Musculoskeletal Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Sheffield, Nathan C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Nowosielski, Martha; Stockhammer, Guenther] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Nowosielski, Martha] Univ Med Ctr, German Canc Res Ctr, Neurol, Heidelberg, Germany; [Augustin, Marco; Baumann, Bernhard] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Moser, Patrizia; Haybaeck, Johannes] Med Univ Innsbruck, Dept Pathol, Innsbruck, Austria; [Freyschlag, Christian F.; Kerschbaumer, Johannes; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Grams, Astrid E.] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria; [Kitzwoegerer, Melitta] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Pathol, St Polten, Austria; [Oberndorfer, Stefan] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Neurol, St Polten, Austria; [Marhold, Franz] Karl Landsteiner Univ Hlth Sci, Univ Hosp St Poelten, Dept Neurosurg, St Polten, Austria; [Weis, Serge] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Neuropathol, Neuromed Campus Wagner Jauregg, Linz, Austria; [Trenkler, Johannes] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Neuroradiol, Neuromed Campus Wagner Jauregg, Linz, Austria; [Buchroithner, Johanna] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Neurosurg, Neuromed Campus Wagner Jauregg, Linz, Austria; [Pichler, Josef] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Internal Med, Neuromed Campus Wagner Jauregg, Linz, Austria; [Haybaeck, Johannes; Krassnig, Stefanie] Med Univ Graz, Inst Pathol, Dept Neuropathol, Diagnost & Res Ctr Mol BioMed, Graz, Austria; [Haybaeck, Johannes] Otto von Guericke Univ, Med Fac, Dept Pathol, Magdeburg, Germany; [Ali, Kariem Mahdy; von Campe, Gord] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Payer, Franz] Med Univ Graz, Dept Neurol, Graz, Austria; [Sherif, Camillo] Krankenanstalt Rudolfstiftung Wien, Dept Neurosurg, Vienna, Austria; [Preiser, Julius] Krankenanstalt Rudolfstiftung Wien, Dept Pathol, Vienna, Austria; [Hauser, Thomas; Winkler, Peter A.] Paracelsus Private Med Univ, Christian Doppler Klin, Dept Neurosurg, Salzburg, Austria; [Kleindienst, Waltraud] Paracelsus Private Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Wuertz, Franz; Brandner-Kokalj, Tanisa] State Hosp Klagenfurt, Inst Pathol, Klagenfurt, Austria; [Stultschnig, Martin] State Hosp Klagenfurt, Dept Neurol, Klagenfurt, Austria; [Schweiger, Stefan] Gen Hosp Wiener Neustadt, Dept Neurosurg, Wiener Neustadt, Austria; [Dieckmann, Karin] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria; [Preusser, Matthias; Marosi, Christine] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, Saarland Informat Campus, Saarbrucken, Germany; [Bock, Christoph] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Virginia; Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Medical University of Vienna; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Johannes Kepler University Linz; Kepler University Hospital; Johannes Kepler University Linz; Kepler University Hospital; Johannes Kepler University Linz; Kepler University Hospital; Johannes Kepler University Linz; Kepler University Hospital; Medical University of Graz; Otto von Guericke University; Medical University of Graz; Medical University of Graz; Rudolfstiftung Hospital; Rudolfstiftung Hospital; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Max Planck Society	Woehrer, A (corresponding author), Med Univ Vienna, Cent Nervous Syst Tumor Unit, Comprehens Canc Ctr, Vienna, Austria.; Woehrer, A (corresponding author), Med Univ Vienna, Inst Neurol, Vienna, Austria.	adelheid.woehrer@meduniwien.ac.at	Bock, Christoph/AAE-7618-2019; Grams, Astrid/AAH-6325-2019; Trenkler, Johannes/AAL-4353-2020; Widhalm, Georg/AFK-1669-2022; Roetzer, Thomas/ABA-7278-2020; Nowosielski, Martha/AAD-5442-2022; Stefan Oberndorfer, FEAN/AAY-8436-2020; Kerschbaumer, Johannes/N-4940-2015; Freyschlag, Christian/K-5913-2019; Sheffield, Nathan/ABG-8124-2020; Preusser, Matthias/C-8530-2011	Bock, Christoph/0000-0001-6091-3088; Trenkler, Johannes/0000-0001-6060-4234; Widhalm, Georg/0000-0001-6014-0273; Roetzer, Thomas/0000-0001-8875-7304; Freyschlag, Christian/0000-0002-8228-8217; Sheffield, Nathan/0000-0001-5643-4068; Preusser, Matthias/0000-0003-3541-2315; Nenning, Karl-Heinz/0000-0002-1073-9891; Fortelny, Nikolaus/0000-0003-4025-9968; Woehrer, Adelheid/0000-0001-8435-8189; Marhold, Franz/0000-0001-8338-8060; Furtner, Julia/0000-0001-8258-3681; Kiesel, Barbara/0000-0003-0939-9831; Alpar, Donat/0000-0002-2638-5418; Baumann, Bernhard/0000-0001-6419-1932	Austrian Science Fund grant [FWF KLI394, FWF I2714-B31]; Marie Curie Career Integration Grant (European Union's Seventh Framework Programme) [PCIG12-GA-2012-333595]; ERA-NET project grant [EpiMark FWF I 1575-B19]; ERC Starting Grant (European Union's Horizon 2020 research and innovation programme) [640396, 679146]; New Frontiers Group award of the Austrian Academy of Sciences; Roche Austria; Austrian Society of Neurology	Austrian Science Fund grant; Marie Curie Career Integration Grant (European Union's Seventh Framework Programme); ERA-NET project grant; ERC Starting Grant (European Union's Horizon 2020 research and innovation programme); New Frontiers Group award of the Austrian Academy of Sciences; Roche Austria(Roche Holding); Austrian Society of Neurology	We thank all patients who have donated their samples for this study. We also thank G. Wilk, M. Muck, S. Schmid, and U. Andel for technical assistance with immunohistochemical stainings, macrodissection, and tumor tissue shavings; S. Mages for contributing to the interactive data visualization; the Biomedical Sequencing Facility at CeMM for assistance with next-generation sequencing; and all members of the Bock lab for their help and advice. The study was funded in part by an Austrian Science Fund grant (FWF KLI394) to A.W., a Marie Curie Career Integration Grant (European Union's Seventh Framework Programme grant agreement no. PCIG12-GA-2012-333595) to C.B., an ERA-NET project grant (EpiMark FWF I 1575-B19) to C.B., an Austrian Science Fund grant (FWF I2714-B31) to G.L. and K.-H.N, and an ERC Starting Grant (European Union's Horizon 2020 research and innovation programme, grant agreement no. 640396) to B.B. Moreover, C.B. is supported by a New Frontiers Group award of the Austrian Academy of Sciences and by an ERC Starting Grant (European Union's Horizon 2020 research and innovation programme, grant agreement no. 679146). Activities of the Austrian Brain Tumor Registry are supported by unrestricted research grants of Roche Austria to J.A.H. and the Austrian Society of Neurology to S.O. Some of the samples used for this research project were kindly provided by Biobank Graz.	Aldape K, 2018, NEURO-ONCOLOGY, V20, P873, DOI 10.1093/neuonc/noy020; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Beier CP, 2012, STEM CELLS DEV, V21, P2753, DOI 10.1089/scd.2011.0660; Bienkowski M, 2015, CLIN NEUROPATHOL, V34, P250, DOI 10.5414/NP300904; Bock C, 2016, NAT BIOTECHNOL, V34, P726, DOI 10.1038/nbt.3605; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Gentleman R, 2004, BIOCONDUCTOR PROJECT; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Hao JJ, 2016, NAT GENET, V48, P1500, DOI 10.1038/ng.3683; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Klughammer J, 2015, CELL REP, V13, P2621, DOI 10.1016/j.celrep.2015.11.024; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuilman T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0617-1; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumar A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0530-z; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawson JT, 2018, BIOINFORMATICS, V34, P2649, DOI 10.1093/bioinformatics/bty083; Lee JK, 2017, NAT GENET, V49, P594, DOI 10.1038/ng.3806; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Li S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0472-5; Lin DC, 2017, CANCER RES, V77, P2255, DOI 10.1158/0008-5472.CAN-16-2822; Liu Q, 2015, ACTA NEUROPATHOL, V130, P587, DOI 10.1007/s00401-015-1470-8; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Makambi KH, 2003, J APPL STAT, V30, P225, DOI 10.1080/0266476022000023767; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; McCord M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00318; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Nowosielski M, 2018, NEURO-ONCOLOGY, V20, P557, DOI 10.1093/neuonc/nox162; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Phansalkar Neerad, 2011, 2011 International Conference on Communications and Signal Processing (ICCSP), P218, DOI 10.1109/ICCSP.2011.5739305; Porz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096873; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sahm F, 2017, LANCET ONCOL, V18, P682, DOI 10.1016/S1470-2045(17)30155-9; Sahm F, 2016, ACTA NEUROPATHOL, V131, P903, DOI 10.1007/s00401-015-1519-8; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sheffield NC, 2017, NAT MED, V23, P386, DOI 10.1038/nm.4273; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stefanits H, 2016, CLIN NEUROPATHOL, V35, P3, DOI 10.5414/NP300907; Strojnik T, 2009, ANTICANCER RES, V29, P3269; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Veillard AC, 2016, NAT METHODS, V13, pI, DOI 10.1038/nmeth.f.391; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Wang QH, 2018, CANCER CELL, V33, P152, DOI 10.1016/j.ccell.2017.12.012; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wemmert S, 2005, NEOPLASIA, V7, P883, DOI 10.1593/neo.05307; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Woehrer A, 2014, CURR OPIN NEUROL, V27, P666, DOI 10.1097/WCO.0000000000000144; Wohrer A, 2009, J NEURO-ONCOL, V95, P401, DOI 10.1007/s11060-009-9938-9; Xi Y, 2009, BMC BIOINFORMATICS, V10, P232, DOI DOI 10.1186/1471-2105-10-232; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668	86	140	144	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1611	+		10.1038/s41591-018-0156-x	http://dx.doi.org/10.1038/s41591-018-0156-x			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30150718	Green Submitted, Green Accepted			2022-12-27	WOS:000446577900024
J	Stower, H				Stower, Hannah			Live bacterial therapies for metabolic disease	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1491	1491		10.1038/s41591-018-0229-x	http://dx.doi.org/10.1038/s41591-018-0229-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297894	Bronze			2022-12-27	WOS:000446577900035
J	Colby, DJ; Trautmann, L; Pinyakorn, S; Leyre, L; Pagliuzza, A; Kroon, E; Rolland, M; Takata, H; Buranapraditkun, S; Intasan, J; Chomchey, N; Muir, R; Haddad, EK; Tovanabutra, S; Ubolyam, S; Bolton, DL; Fullmer, BA; Gorelick, RJ; Fox, L; Crowell, TA; Trichavaroj, R; O'Connell, R; Chomont, N; Kim, JH; Michael, NL; Robb, ML; Phanuphak, N; Ananworanich, J				Colby, Donn J.; Trautmann, Lydie; Pinyakorn, Suteeraporn; Leyre, Louise; Pagliuzza, Amelie; Kroon, Eugene; Rolland, Morgane; Takata, Hiroshi; Buranapraditkun, Supranee; Intasan, Jintana; Chomchey, Nitiya; Muir, Roshell; Haddad, Elias K.; Tovanabutra, Sodsai; Ubolyam, Sasiwimol; Bolton, Diane L.; Fullmer, Brandie A.; Gorelick, Robert J.; Fox, Lawrence; Crowell, Trevor A.; Trichavaroj, Rapee; O'Connell, Robert; Chomont, Nicolas; Kim, Jerome H.; Michael, Nelson L.; Robb, Merlin L.; Phanuphak, Nittaya; Ananworanich, Jintanat		Rv411 Study Grp	Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection	NATURE MEDICINE			English	Article							LATENT RESERVOIR; THERAPY; CELLS; PROLIFERATION; PERSISTENCE; MACAQUES; PLASMA	Antiretroviral therapy during the earliest stage of acute HIV infection (Fiebig I) might minimize establishment of a latent HIV reservoir and thereby facilitate viremic control after analytical treatment interruption. We show that 8 participants, who initiated treatment during Fiebig I and were treated for a median of 2.8 years, all experienced rapid viral load rebound following analytical treatment interruption, indicating that additional strategies are required to control or eradicate HIV.	[Colby, Donn J.; Kroon, Eugene; Intasan, Jintana; Chomchey, Nitiya; Phanuphak, Nittaya; Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand; [Trautmann, Lydie; Pinyakorn, Suteeraporn; Rolland, Morgane; Takata, Hiroshi; Buranapraditkun, Supranee; Tovanabutra, Sodsai; Bolton, Diane L.; Crowell, Trevor A.; Kim, Jerome H.; Michael, Nelson L.; Robb, Merlin L.; Ananworanich, Jintanat] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Trautmann, Lydie; Pinyakorn, Suteeraporn; Rolland, Morgane; Takata, Hiroshi; Buranapraditkun, Supranee; Tovanabutra, Sodsai; Bolton, Diane L.; Crowell, Trevor A.; Robb, Merlin L.; Ananworanich, Jintanat] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Leyre, Louise; Pagliuzza, Amelie; Chomont, Nicolas] Univ Montreal, Ctr Rech CHUM, Montreal, PQ, Canada; [Leyre, Louise; Pagliuzza, Amelie; Chomont, Nicolas] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Buranapraditkun, Supranee] Chulalongkorn Univ, Fac Med, Dept Med, Div Allergy & Clin Immunol, Bangkok, Thailand; [Buranapraditkun, Supranee] Chulalongkorn Univ, Fac Med, Chulalongkorn Vaccine Res Ctr, Bangkok, Thailand; [Muir, Roshell; Haddad, Elias K.] Drexel Univ, Coll Med, Dept Med, Div Infect Dis & HIV Med, Philadelphia, PA USA; [Ubolyam, Sasiwimol] Thai Red Cross AIDS Res Ctr, HIV NAT, Bangkok, Thailand; [Fullmer, Brandie A.; Gorelick, Robert J.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Fox, Lawrence] NIAID, Div AIDS, Rockville, MD USA; [Trichavaroj, Rapee; O'Connell, Robert] Armed Forces Res Inst Med Sci United States Compo, Dept Retrovirol, Bangkok, Thailand; [Ananworanich, Jintanat] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea; Yale Univ, Sch Med, Dept Neurol, New Haven, CT USA; Univ Calif San Francisco, San Francisco, CA USA; Natl Canc Ctr, NIH, CCR, Frederick, MD USA; NIAID, NIH, Bethesda, MD USA; Univ Missouri St Louis, Missouri Inst Mental Hlth, St Louis, MO USA; EMMES Corp, Rockville, MD USA	Thai Red Cross Society; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Universite de Montreal; Universite de Montreal; Chulalongkorn University; Chulalongkorn University; Drexel University; Thai Red Cross Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Amsterdam; International Vaccine Institute; Yale University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Missouri System; University of Missouri Saint Louis; Emmes Corporation	Ananworanich, J (corresponding author), Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand.; Ananworanich, J (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.; Ananworanich, J (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Ananworanich, J (corresponding author), Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands.	jananworanich@hivresearch.org	Crowell, Trevor A./W-3904-2019; Phanuphak, Nittaya/AAA-8579-2019; Chomont, Nicolas/ABG-2545-2020; Ananworanich, Jintanat/AAC-6348-2021	Crowell, Trevor A./0000-0001-5947-265X; Chomont, Nicolas/0000-0001-9747-5018; Ananworanich, Jintanat/0000-0003-1369-3224; Trautmann, Lydie/0000-0002-3012-0009; colby, donn j./0000-0003-3931-5926; Takata, Hiroshi/0000-0003-1457-6919; Subra, Caroline/0000-0001-5272-0972	NIH [R01AI108433]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DoD) [W81XWH-07-2-0067]; Division of AIDS at the U.S. National Institute of Allergy and Infectious Diseases [W81XWH-07-2-0067]; Thai Red Cross AIDS Research Centre; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DoD)(United States Department of Defense); Division of AIDS at the U.S. National Institute of Allergy and Infectious Diseases; Thai Red Cross AIDS Research Centre; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to the participants who have made this research possible. We thank T. Schacker for providing data on the lymph nodes from one participant. This work was supported by the NIH grant R01AI108433, a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and the U.S. Department of Defense (DoD), the Division of AIDS at the U.S. National Institute of Allergy and Infectious Diseases, and by an intramural grant from the Thai Red Cross AIDS Research Centre. The US Army Medical Research Acquisition Activity (820 Chandler Street, Fort Detrick, MD 21702-5014, USA) is the awarding and administering acquisition office for the cooperative agreement. It is also supported in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. Antiretroviral therapy was supported by the Thai Government Pharmaceutical Organization, Gilead, Merck and ViiV Healthcare. The views expressed are those of the authors. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, the US Army, or the Department of Defense, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government, including the US National Institutes of Health.	Altman JD, 2011, J IMMUNOL, V187; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bolton DL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006445; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Conway JM, 2015, P NATL ACAD SCI USA, V112, P5467, DOI 10.1073/pnas.1419162112; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; De Souza MS, 2015, AIDS, V29, P793, DOI 10.1097/QAD.0000000000000616; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Deleage Claire, 2016, Pathog Immun, V1, P68; Dominguez MH, 2013, J IMMUNOL METHODS, V391, P133, DOI 10.1016/j.jim.2013.03.002; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Heipertz RA, 2013, AIDS RES HUM RETROV, V29, P1310, DOI [10.1089/aid.2013.0087, 10.1089/AID.2013.0087]; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hill AL, 2014, P NATL ACAD SCI USA, V111, P13475, DOI 10.1073/pnas.1406663111; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Land S, 2009, J VIROL METHODS, V159, P185, DOI 10.1016/j.jviromet.2009.03.016; Muir R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005777; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Procopio F. A., EBIOMEDICINE, V2; Rhee SY, 2017, EBIOMEDICINE, V18, P225, DOI 10.1016/j.ebiom.2017.03.024; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Sneller MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8848; Somsouk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116306; Takata H, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1809; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821	35	172	174	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					923	+		10.1038/s41591-018-0026-6	http://dx.doi.org/10.1038/s41591-018-0026-6			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892063	Green Accepted			2022-12-27	WOS:000438187700018
J	Wang, G; Biswas, AK; Ma, WC; Kandpal, M; Coker, C; Grandgenett, PM; Hollingsworth, MA; Jain, R; Tanji, K; Lopez-Pintado, S; Borczuk, A; Hebert, D; Jenkitkasemwong, S; Hojyo, S; Davuluri, RV; Knutson, MD; Fukada, T; Acharyya, S				Wang, Gang; Biswas, Anup K.; Ma, Wanchao; Kandpal, Manoj; Coker, Courtney; Grandgenett, Paul M.; Hollingsworth, Michael A.; Jain, Rinku; Tanji, Kurenai; Lopez-Pintado, Sara; Borczuk, Alain; Hebert, Doreen; Jenkitkasemwong, Supak; Hojyo, Shintaro; Davuluri, Ramana V.; Knutson, Mitchell D.; Fukada, Toshiyuki; Acharyya, Swarnali			Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle	NATURE MEDICINE			English	Article							MYOSIN HEAVY-CHAIN; E3 LIGASE MURF1; LUNG-CANCER; BONE METASTASIS; TRANSPORTER ZIP14; GENE-EXPRESSION; MOUSE MODELS; TUMOR-CELLS; ZINC; ATROPHY	Patients with metastatic cancer experience a severe loss of skeletal muscle mass and function known as cachexia. Cachexia is associated with poor prognosis and accelerated death in patients with cancer, yet its underlying mechanisms remain poorly understood. Here, we identify the metal-ion transporter ZRT-and IRT-like protein 14 (ZIP14) as a critical mediator of cancerinduced cachexia. ZIP14 is upregulated in cachectic muscles of mice and in patients with metastatic cancer and can be induced by TNF-alpha and TGF-beta cytokines. Strikingly, germline ablation or muscle-specific depletion of Zip14 markedly reduces muscle atrophy in metastatic cancer models. We find that ZIP14-mediated zinc uptake in muscle progenitor cells represses the expression of MyoD and Mef2c and blocks muscle-cell differentiation. Importantly, ZIP14-mediated zinc accumulation in differentiated muscle cells induces myosin heavy chain loss. These results highlight a previously unrecognized role for altered zinc homeostasis in metastatic cancer-induced muscle wasting and implicate ZIP14 as a therapeutic target for its treatment.	[Wang, Gang; Biswas, Anup K.; Ma, Wanchao; Coker, Courtney; Acharyya, Swarnali] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Kandpal, Manoj; Davuluri, Ramana V.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Grandgenett, Paul M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Jain, Rinku] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA; [Tanji, Kurenai] Columbia Univ, Irving Med Ctr, Div Neuropathol, Dept Pathol & Cell Biol, New York, NY USA; [Tanji, Kurenai] New York Presbyterian Hosp, New York, NY USA; [Lopez-Pintado, Sara] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Borczuk, Alain] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Hebert, Doreen; Acharyya, Swarnali] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY 10027 USA; [Jenkitkasemwong, Supak; Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Hojyo, Shintaro] Deutsch Rheuma Forschungszentrum Berlin, Osteoimmunol, Berlin, Germany; [Fukada, Toshiyuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Mol & Cellular Physiol, Tokushima, Japan; [Acharyya, Swarnali] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA	Columbia University; Northwestern University; Feinberg School of Medicine; University of Nebraska System; University of Nebraska Medical Center; Icahn School of Medicine at Mount Sinai; Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Columbia University; Cornell University; Columbia University; NewYork-Presbyterian Hospital; State University System of Florida; University of Florida; Deutsches Rheuma-Forschungszentrum (DRFZ); Tokushima Bunri University; Columbia University	Acharyya, S (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Acharyya, S (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY 10027 USA.; Acharyya, S (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	sa3141@cumc.columbia.edu	Borczuk, Alain/AFU-5278-2022; kandpal, Manoj/V-4469-2019; Wang, Gang/Q-7267-2019; BORCZUK, alain/AHA-5172-2022; kandpal, Manoj/ABG-6846-2021; Borczuk, Alain/AAI-8226-2021	Borczuk, Alain/0000-0001-6807-8064; kandpal, Manoj/0000-0002-0595-8627; Borczuk, Alain/0000-0001-6807-8064; Wang, Gang/0000-0002-0297-6467	NASA Ames Research Center [NNA06CB93G]; National Institutes of Health (NIH) [P50CA127297, U01CA210240, 5R50CA211462]; National Cancer Institute [R00CA172697]; Institutional start-up funds from CUIMC; Herbert Irving Comprehensive Cancer Center's Cancer Center Support Grant-Inter-Programmatic Pilot Project [5P30CA013696-43];  [DK080706]; NATIONAL CANCER INSTITUTE [R00CA172697, P30CA013696, P50CA127297, R50CA211462, U01CA210240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080706] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011297] Funding Source: NIH RePORTER	NASA Ames Research Center(National Aeronautics & Space Administration (NASA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institutional start-up funds from CUIMC; Herbert Irving Comprehensive Cancer Center's Cancer Center Support Grant-Inter-Programmatic Pilot Project; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank A. Ferrando (Columbia University Medical Center, CUMC), G. Karsenty (CUMC), T. Oskarsson (Deutsches Krebsforschungszentrum/German Cancer Center), D. Guttridge (Ohio State University), U. Klein (Leeds, UK) and members of the Acharyya laboratory for helpful insights throughout the study. We thank J. Massague (Memorial Sloan Kettering Cancer Center), J. Sage (Stanford University) and Y. Kang (Princeton University) for sharing cell lines. We would like to thank K. Macrenaris and R. Sponenburg from Northwestern University Quantitative Bio-element Imaging Center (QBIC), supported by NASA Ames Research Center NNA06CB93G, and Y. Zhang and K. Schey from Vanderbilt University Imaging Mass Spectrometry Center for invaluable help with single-fiber mass spectrometry analyses. We would like to thank L. Munoz and T. Waddell from the Department of Pathology and Cell Biology at New York Presbyterian Hospital Center for muscle collection during autopsies. University of Nebraska Medical Center Rapid Autopsy Program was supported by National Institutes of Health (NIH) P50CA127297, U01CA210240 and 5R50CA211462 (to P.M.G. and M.A.H.). Establishment of the congenic Balb/c Zip14-knockout mice was supported by DK080706 (to M.D.K.). Establishment of lung cancer models was supported by National Cancer Institute R00CA172697 (to S.A.). This work was supported by Institutional start-up funds from CUIMC to S.A. and by Herbert Irving Comprehensive Cancer Center's 5P30CA013696-43 Cancer Center Support Grant-Inter-Programmatic Pilot Project to S.A. Schematic models were generated in part using Servier Medical Art, licensed under a Creative Commons Attribution (CC BY) 3.0 License, with further modifications in some cases.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Aydemir TB, 2018, J NUTR, V148, P174, DOI 10.1093/jn/nxx041; Azoulay E, 2004, MEDICINE, V83, P360, DOI 10.1097/01.md.0000145370.63676.fb; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Buclez PO, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.35; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cosper PF, 2012, INT J CANCER, V130, P2722, DOI 10.1002/ijc.26298; COUSINS RJ, 1988, FASEB J, V2, P2884, DOI 10.1096/fasebj.2.13.2458983; CRAWFORD AJ, 1987, EXP NEUROL, V95, P265, DOI 10.1016/0014-4886(87)90137-3; DALAL BI, 1993, AM J PATHOL, V143, P381; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eley HL, 2008, BRIT J CANCER, V98, P443, DOI 10.1038/sj.bjc.6604150; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; GUPTA SK, 1993, J SURG ONCOL, V52, P172, DOI 10.1002/jso.2930520311; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Kang Y., 2017, COLD SPRING HARB PER; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Larsson S, 1987, In Vivo, V1, P131; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Motohashi N., 2014, JOVE-J VIS EXP, V86, P50846; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; Penna F, 2016, SEMIN CELL DEV BIOL, V54, P20, DOI 10.1016/j.semcdb.2015.09.002; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Roberts BM, 2013, FASEB J, V27, P2600, DOI 10.1096/fj.12-222844; Russell ST, 2010, BRIT J CANCER, V102, P833, DOI 10.1038/sj.bjc.6605562; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sandri M, 2016, SEMIN CELL DEV BIOL, V54, P11, DOI 10.1016/j.semcdb.2015.11.002; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmitt TL, 2007, J MOL MED, V85, P647, DOI 10.1007/s00109-007-0177-2; Shum AMY, 2015, PHYSIOL GENOMICS, V47, P588, DOI 10.1152/physiolgenomics.00128.2014; Siren PMA, 2010, J CACHEXIA SARCOPENI, V1, P23, DOI 10.1007/s13539-010-0009-z; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summermatter S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00305-16; Talbert EE, 2016, SEMIN CELL DEV BIOL, V54, P82, DOI 10.1016/j.semcdb.2015.09.009; TALMADGE JE, 1982, J NATL CANCER I, V69, P975; Vogler TO, 2016, METHODS MOL BIOL, V1460, P141, DOI 10.1007/978-1-4939-3810-0_11; Volodin A, 2017, P NATL ACAD SCI USA, V114, pE1375, DOI 10.1073/pnas.1612988114; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081	79	75	79	5	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					770	+		10.1038/s41591-018-0054-2	http://dx.doi.org/10.1038/s41591-018-0054-2			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875463	Green Accepted			2022-12-27	WOS:000434281300022
J	Zacharakis, N; Chinnasamy, H; Black, M; Xu, H; Lu, YC; Zheng, ZL; Pasetto, A; Langhan, M; Shelton, T; Prickett, T; Gartner, J; Jia, L; Trebska-McGowan, K; Somerville, RP; Robbins, PF; Rosenberg, SA; Goff, SL; Feldman, SA				Zacharakis, Nikolaos; Chinnasamy, Harshini; Black, Mary; Xu, Hui; Lu, Yong-Chen; Zheng, Zhili; Pasetto, Anna; Langhan, Michelle; Shelton, Thomas; Prickett, Todd; Gartner, Jared; Jia, Li; Trebska-McGowan, Katarzyna; Somerville, Robert P.; Robbins, Paul F.; Rosenberg, Steven A.; Goff, Stephanie L.; Feldman, Steven A.			Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer	NATURE MEDICINE			English	Article							ANTITUMOR-ACTIVITY; EPITHELIAL CANCER; LYMPHOCYTES; PATIENT; TUMOR; TCR; IMMUNOTHERAPY; PEMBROLIZUMAB; EXPRESSION; RECEPTORS	Immunotherapy using either checkpoint blockade or the adoptive transfer of antitumor lymphocytes has shown effectiveness in treating cancers with high levels of somatic mutations-such as melanoma, smoking-induced lung cancers and bladder cancer-with little effect in other common epithelial cancers that have lower mutation rates, such as those arising in the gastrointestinal tract, breast and ovary(1-7). Adoptive transfer of autologous lymphocytes that specifically target proteins encoded by somatically mutated genes has mediated substantial objective clinical regressions in patients with metastatic bile duct, colon and cervical cancers(8-11). We present a patient with chemorefractory hormone receptor (HR)-positive metastatic breast cancer who was treated with tumor-infiltrating lymphocytes (TILs) reactive against mutant versions of four proteins-SLC3A2, KIAA0368, CADPS2 and CTSB. Adoptive transfer of these mutant-protein-specific TILs in conjunction with interleukin (IL)-2 and checkpoint blockade mediated the complete durable regression of metastatic breast cancer, which is now ongoing for > 22 months, and it represents a new immunotherapy approach for the treatment of these patients.	[Zacharakis, Nikolaos; Chinnasamy, Harshini; Black, Mary; Xu, Hui; Lu, Yong-Chen; Zheng, Zhili; Pasetto, Anna; Langhan, Michelle; Shelton, Thomas; Prickett, Todd; Gartner, Jared; Jia, Li; Somerville, Robert P.; Robbins, Paul F.; Rosenberg, Steven A.; Goff, Stephanie L.; Feldman, Steven A.] NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Trebska-McGowan, Katarzyna] Virginia Commonwealth Univ, Dept Surg, Sch Med, Richmond, VA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University	Rosenberg, SA (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	sar@mail.nih.gov	Pasetto, Anna/K-6430-2012; Goff, Stephanie/AAR-7743-2021; Lu, Yong-Chen/G-4520-2014; Pasetto, Anna/AAD-6141-2019	Pasetto, Anna/0000-0002-5254-2173; Goff, Stephanie/0000-0003-3317-9804; Lu, Yong-Chen/0000-0002-0275-9825; 	Center for Cancer Research at the National Cancer Institute (NCI) at the US National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZICBC011569, ZIABC010984, ZICBC010948] Funding Source: NIH RePORTER	Center for Cancer Research at the National Cancer Institute (NCI) at the US National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank A. Mixon and S. Farid of the Surgery Branch FACS Core for assistance with data acquisition and cell sorting, and J. Yang and E. Tran for their valuable discussions. This work was supported by the Center for Cancer Research at the National Cancer Institute (NCI) at the US National Institutes of Health (NIH).	Abate-Daga D, 2013, BLOOD, V122, P1399, DOI 10.1182/blood-2013-04-495531; Aldrich J, 1997, STAT SCI, V12, P162; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Assadipour Y, 2017, CLIN CANCER RES, V23, P4347, DOI 10.1158/1078-0432.CCR-16-1423; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Haga-Friedman A, 2012, J IMMUNOL, V188, P5538, DOI 10.4049/jimmunol.1103020; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Jin JJ, 2012, J IMMUNOTHER, V35, P283, DOI 10.1097/CJI.0b013e31824e801f; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lefebvre C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002201; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102	22	411	434	5	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					724	+		10.1038/s41591-018-0040-8	http://dx.doi.org/10.1038/s41591-018-0040-8			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29867227	Green Accepted			2022-12-27	WOS:000434281300017
J	Stower, H				Stower, Hannah			Predicting pancreatic cancer survival via the tumor microbiome	NATURE MEDICINE			English	Editorial Material																		2019, CELL, V178, P795	1	1	1	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1330	1330		10.1038/s41591-019-0587-z	http://dx.doi.org/10.1038/s41591-019-0587-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501604	Bronze			2022-12-27	WOS:000484832800009
J	Bai, P; Liu, Y; Xue, S; Hamri, GCE; Saxena, P; Ye, HF; Xie, MQ; Fussenegger, M				Bai, Peng; Liu, Ying; Xue, Shuai; Hamri, Ghislaine Charpin-El; Saxena, Pratik; Ye, Haifeng; Xie, Mingqi; Fussenegger, Martin			A fully human transgene switch to regulate therapeutic protein production by cooling sensation	NATURE MEDICINE			English	Article							BETA-CELLS; RECEPTOR; CHANNELS; TRPM8; COLD; HOMEOSTASIS; EXPRESSION; CACHEXIA; MENTHOL; CANCER	The ability to safely control transgene expression with simple synthetic gene switches is critical for effective gene-and cell-based therapies. In the present study, the signaling pathway controlled by human transient receptor potential (TRP) melastatin 8 (hTRPM8), a TRP channel family member(1), is harnessed to control transgene expression. Human TRPM8 signaling is stimulated by menthol, an innocuous, natural, cooling compound, or by exposure to a cool environment (15-18 degrees C). By functionally linking hTRPM8-induced signaling to a synthetic promoter containing elements that bind nuclear factor of activated T cells, a synthetic gene circuit was designed that can be adjusted by exposure to either a cool environment or menthol. It was shown that this gene switch is functional in various cell types and human primary cells, as well as in mice implanted with engineered cells. In response to transdermal delivery of menthol, microencapsulated cell implants harboring this gene circuit, coupled to expression of either of two therapeutic proteins, insulin or a modified, activin type IIB, receptor ligand trap protein (mActRIIB(ECD)-hFc), could alleviate hyperglycemia in alloxan-treated mice (a model of type 1 diabetes) or reverse muscle atrophy in dexamethasone-treated mice (a model of muscle wasting), respectively. This fully human-derived orthogonal transgene switch should be amenable to a wide range of clinical applications.	[Bai, Peng; Liu, Ying; Saxena, Pratik; Xie, Mingqi; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Xue, Shuai; Ye, Haifeng] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China; [Xue, Shuai; Ye, Haifeng] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Hamri, Ghislaine Charpin-El] Inst Univ Technol Lyon 1, Dept Genie Biol, Villeurbanne, France; [Fussenegger, Martin] Univ Basel, Fac Sci, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; East China Normal University; East China Normal University; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.; Fussenegger, M (corresponding author), Univ Basel, Fac Sci, Basel, Switzerland.	fussenegger@bsse.ethz.ch		Ye, Haifeng/0000-0002-5482-8116; Xie, Mingqi/0000-0001-5657-532X	Chinese Scholarship Council; National Centre of Competence in Research Molecular Systems Engineering; European Research Council [785800]; National Natural Science Foundation of China [31861143016]; Science and Technology Commission of Shanghai Municipality [18JC1411000]; Thousand Youth Talents Plan of China	Chinese Scholarship Council(China Scholarship Council); National Centre of Competence in Research Molecular Systems Engineering; European Research Council(European Research Council (ERC)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Thousand Youth Talents Plan of China	We thank F. Viana for providing prTRPM8, F. Kuhn for providing phTRPM8 and X. Dong for providing pmTRPM8. We also thank M. Daoud-El Baba, J. Jiang and J. Yin for supporting the in vivo work; V. Jaggin, M. Di Tacchio and Y. Zhang for assistance with flow cytometry; T. Lummen for help with time-lapse microscopy and A. Ponti for support with statistical analysis. This work was supported by a personal fellowship from the Chinese Scholarship Council to P. B., by the National Centre of Competence in Research Molecular Systems Engineering and in part by the European Research Council advanced grant (ElectroGene, no. 785800) (both to M. F.). This work was also financially supported by grants from the National Natural Science Foundation of China (no. 31861143016), the Science and Technology Commission of Shanghai Municipality (no. 18JC1411000) and the Thousand Youth Talents Plan of China to H.Y.	Anguela XM, 2016, NAT BIOTECHNOL, V34, P824, DOI 10.1038/nbt.3645; Asuthkar S, 2015, J BIOL CHEM, V290, P2670, DOI 10.1074/jbc.M114.610873; Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007; Auslander S, 2017, ANGEW CHEM INT EDIT, V56, P6396, DOI 10.1002/anie.201609229; Bai P, 2016, J HEPATOL, V65, P84, DOI 10.1016/j.jhep.2016.03.020; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Fluri DA, 2008, J CONTROL RELEASE, V131, P211, DOI 10.1016/j.jconrel.2008.07.036; FRITSCHY WM, 1994, TRANSPLANT INT, V7, P264, DOI 10.1111/j.1432-2277.1994.tb01572.x; Heng BC, 2013, METAB ENG, V18, P9, DOI 10.1016/j.ymben.2013.02.004; Hq Han X. Z, 2015, European Patent, Patent No. [EP3286206A1, 3286206]; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; Johnson JD, 2016, DIABETOLOGIA, V59, P2047, DOI 10.1007/s00125-016-4059-4; Kaufmann KB, 2013, EMBO MOL MED, V5, P1642, DOI 10.1002/emmm.201202287; Kobayashi T, 2006, XENOTRANSPLANTATION, V13, P547, DOI 10.1111/j.1399-3089.2006.00349.x; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lanitis E, 2012, MOL THER, V20, P633, DOI 10.1038/mt.2011.256; Le Guiner C, 2007, CURR GENE THER, V7, P334; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Liu Y, 2018, NUCLEIC ACIDS RES, V46, P9864, DOI 10.1093/nar/gky805; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Maus MV, 2013, CANCER IMMUNOL RES, V1, P26, DOI 10.1158/2326-6066.CIR-13-0006; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004; Orive G, 2015, TRENDS PHARMACOL SCI, V36, P537, DOI 10.1016/j.tips.2015.05.003; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; ROONEY JW, 1994, EMBO J, V13, P625, DOI 10.1002/j.1460-2075.1994.tb06300.x; Schlatter S, 2002, GENE, V282, P19, DOI 10.1016/S0378-1119(01)00824-1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Shao JW, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2298; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Vaithilingam V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059120; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Wang H, 2018, NAT BIOMED ENG, V2, P114, DOI 10.1038/s41551-018-0192-3; Wieland M, 2012, METHODS, V56, P351, DOI 10.1016/j.ymeth.2012.01.005; Williams GR, 2016, LANCET ONCOL, V17, pE220, DOI 10.1016/S1470-2045(16)00167-4; Xie M, 2016, SCIENCE, V354, P1296, DOI 10.1126/science.aaf4006; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakrzewski JL, 2014, NAT BIOTECHNOL, V32, P786, DOI 10.1038/nbt.2960; Zekorn Tobias D. C., 1995, Xenotransplantation, V2, P116, DOI 10.1111/j.1399-3089.1995.tb00076.x; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	52	26	27	5	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1266	+		10.1038/s41591-019-0501-8	http://dx.doi.org/10.1038/s41591-019-0501-8			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31285633	Green Accepted			2022-12-27	WOS:000480414600025
J	Chowdhury, S; Castro, S; Coker, C; Hinchliffe, TE; Arpaia, N; Danino, T				Chowdhury, Sreyan; Castro, Samuel; Coker, Courtney; Hinchliffe, Taylor E.; Arpaia, Nicholas; Danino, Tal			Programmable bacteria induce durable tumor regression and systemic antitumor immunity	NATURE MEDICINE			English	Article							CD47 BLOCKADE; CANCER; CELLS; IMMUNOTHERAPY; INNATE; TARGET	Synthetic biology is driving a new era of medicine through the genetic programming of living cells(1,2). This transformative approach allows for the creation of engineered systems that intelligently sense and respond to diverse environments, ultimately adding specificity and efficacy that extends beyond the capabilities of molecular-based therapeutics(3-6). One particular area of focus has been the engineering of bacteria as therapeutic delivery systems to selectively release therapeutic payloads in vivo(7-11). Here we engineered a non-pathogenic Escherichia coli strain to specifically lyse within the tumor microenvironment and release an encoded nanobody antagonist of CD47 (CD47nb)(12), an anti-phagocytic receptor that is commonly overexpressed in several human cancer types(13,14). We show that delivery of CD47nb by tumor-colonizing bacteria increases activation of tumor-infiltrating T cells, stimulates rapid tumor regression, prevents metastasis and leads to long-term survival in a syngeneic tumor model in mice. Moreover, we report that local injection of CD47nb-expressing bacteria stimulates systemic tumor-antigen-specific immune responses that reduce the growth of untreated tumors, providing proof-of-concept for an abscopal effect induced by an engineered bacterial immunotherapy. Thus, engineered bacteria may be used for safe and local delivery of immunotherapeutic payloads leading to systemic antitumor immunity.	[Chowdhury, Sreyan; Castro, Samuel; Coker, Courtney; Hinchliffe, Taylor E.; Danino, Tal] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Chowdhury, Sreyan; Arpaia, Nicholas] Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Arpaia, Nicholas; Danino, Tal] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA; [Danino, Tal] Columbia Univ, Data Sci Inst, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Danino, T (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.; Arpaia, N (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Arpaia, N; Danino, T (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.; Danino, T (corresponding author), Columbia Univ, Data Sci Inst, New York, NY 10027 USA.	na2697@cumc.columbia.edu; td2506@columbia.edu	Arpaia, Nicholas/R-2549-2018	Arpaia, Nicholas/0000-0002-0657-0528; Chowdhury, Sreyan/0000-0001-9995-2965	NIH Pathway to Independence Award [R00CA197649-02]; DoD Idea Development Award [LC160314]; DoD Era of Hope Scholar Award [BC160541]; NIH [R01GM069811, K22AI127847]; Searle Scholars Program [SSP-2017-2179]; Bonnie J. Addario Lung Cancer Foundation Young Investigators Team Award; Roy and Diana Vagelos Precision Medicine Pilot Grant; NATIONAL CANCER INSTITUTE [R00CA197649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI127847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224, R01GM069811] Funding Source: NIH RePORTER	NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD Idea Development Award; DoD Era of Hope Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Bonnie J. Addario Lung Cancer Foundation Young Investigators Team Award; Roy and Diana Vagelos Precision Medicine Pilot Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH Pathway to Independence Award (R00CA197649-02) (to T.D.), DoD Idea Development Award (LC160314) (to T.D.), DoD Era of Hope Scholar Award (BC160541) (to T.D.), NIH R01GM069811 (to T.D.), NIH K22AI127847 (to N.A.), Searle Scholars Program SSP-2017-2179 (to N.A.), Bonnie J. Addario Lung Cancer Foundation Young Investigators Team Award (to N.A. and T.D.) and the Roy and Diana Vagelos Precision Medicine Pilot Grant (to N.A. and T. D.). Research reported in this publication was performed in the Columbia University Department of Microbiology and Immunology Flow Cytometry Core facility. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank K.T. Fortson and O. Velasquez for technical assistance with flow cytometry experiments and in vivo tumor experiments, respectively; M.O. Din for input pertaining to SLC characterization experiments; and V. Yeong and members of the Obermeyer group for assistance with affinity chromatography and protein purification. We thank R.L. Vincent, T.M. Savage, K.A. Kaiser and L.F. Loffredo for critical review of the manuscript.	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Armstrong AC, 2002, J IMMUNOL, V168, P3983, DOI 10.4049/jimmunol.168.8.3983; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; BERENDT MJ, 1978, J EXP MED, V148, P1550, DOI 10.1084/jem.148.6.1550; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chen YY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002944; Chien Tiffany, 2017, Curr Opin Syst Biol, V5, P1, DOI 10.1016/j.coisb.2017.05.009; Coley W B, 1891, Ann Surg, V14, P199, DOI 10.1097/00000658-189112000-00015; Danino T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3519; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Derman AI, 2012, J BACTERIOL, V194, P2715, DOI 10.1128/JB.06550-11; Din MO, 2016, NATURE, V536, P81, DOI 10.1038/nature18930; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fischbach MA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005568; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GERDES K, 1986, EMBO J, V5, P2023, DOI 10.1002/j.1460-2075.1986.tb04459.x; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Helmink BA, 2019, NAT MED, V25, P377, DOI 10.1038/s41591-019-0377-7; Huang YT, 2017, J THORAC DIS, V9, pE168, DOI 10.21037/jtd.2017.02.30; Ingram JR, 2017, P NATL ACAD SCI USA, V114, P10184, DOI 10.1073/pnas.1710776114; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jiang SN, 2010, MOL THER, V18, P635, DOI 10.1038/mt.2009.295; Kauder SE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201832; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Liu XJ, 2018, CELL REP, V24, P2101, DOI 10.1016/j.celrep.2018.07.062; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; MALMGREN RA, 1955, CANCER RES, V15, P473; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Pedrolli DB, 2019, TRENDS BIOTECHNOL, V37, P100, DOI 10.1016/j.tibtech.2018.09.005; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Skinner SO, 2013, NAT PROTOC, V8, P1100, DOI 10.1038/nprot.2013.066; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Tsung K, 2006, SURG ONCOL, V15, P25, DOI 10.1016/j.suronc.2006.05.002; Veillette A, 2018, TRENDS IMMUNOL, V39, P173, DOI 10.1016/j.it.2017.12.005; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu MR, 2019, NAT REV CANCER, V19, P187, DOI 10.1038/s41568-019-0121-0; Zheng JH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9537; Zhou SB, 2018, NAT REV CANCER, V18, P727, DOI 10.1038/s41568-018-0070-z	43	194	199	44	310	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1057	+		10.1038/s41591-019-0498-z	http://dx.doi.org/10.1038/s41591-019-0498-z			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270504	Green Accepted, Green Submitted			2022-12-27	WOS:000474430400018
J	Li, HX; Ning, SY; Ghandi, M; Kryukov, GV; Gopal, S; Deik, A; Souza, A; Pierce, K; Keskula, P; Hernandez, D; Ann, J; Shkoza, D; Apfel, V; Zou, YL; Vazquez, F; Barretina, J; Pagliarini, RA; Galli, GG; Root, DE; Hahn, WC; Tsherniak, A; Giannakis, M; Schreiber, SL; Clish, CB; Garraway, LA; Sellers, WR				Li, Haoxin; Ning, Shaoyang; Ghandi, Mahmoud; Kryukov, Gregory V.; Gopal, Shuba; Deik, Amy; Souza, Amanda; Pierce, Kerry; Keskula, Paula; Hernandez, Desiree; Ann, Julie; Shkoza, Dojna; Apfel, Verena; Zou, Yilong; Vazquez, Francisca; Barretina, Jordi; Pagliarini, Raymond A.; Galli, Giorgio G.; Root, David E.; Hahn, William C.; Tsherniak, Aviad; Giannakis, Marios; Schreiber, Stuart L.; Clish, Clary B.; Garraway, Levi A.; Sellers, William R.			The landscape of cancer cell line metabolism	NATURE MEDICINE			English	Article							ONCOMETABOLITE	Despite considerable efforts to identify cancer metabolic alterations that might unveil druggable vulnerabilities, systematic characterizations of metabolism as it relates to functional genomic features and associated dependencies remain uncommon. To further understand the metabolic diversity of cancer, we profiled 225 metabolites in 928 cell lines from more than 20 cancer types in the Cancer Cell Line Encyclopedia (CCLE) using liquid chromatography-mass spectrometry (LC-MS). This resource enables unbiased association analysis linking the cancer metabolome to genetic alterations, epigenetic features and gene dependencies. Additionally, by screening barcoded cell lines, we demonstrated that aberrant ASNS hypermethylation sensitizes subsets of gastric and hepatic cancers to asparaginase therapy. Finally, our analysis revealed distinct synthesis and secretion patterns of kynurenine, an immune-suppressive metabolite, in model cancer cell lines. Together, these findings and related methodology provide comprehensive resources that will help clarify the landscape of cancer metabolism.	[Li, Haoxin; Ghandi, Mahmoud; Kryukov, Gregory V.; Gopal, Shuba; Deik, Amy; Souza, Amanda; Pierce, Kerry; Keskula, Paula; Hernandez, Desiree; Zou, Yilong; Vazquez, Francisca; Root, David E.; Hahn, William C.; Tsherniak, Aviad; Giannakis, Marios; Schreiber, Stuart L.; Clish, Clary B.; Garraway, Levi A.; Sellers, William R.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Li, Haoxin; Hahn, William C.; Giannakis, Marios; Garraway, Levi A.; Sellers, William R.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ning, Shaoyang] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Ann, Julie; Shkoza, Dojna; Barretina, Jordi; Pagliarini, Raymond A.] Novartis Inst Biomed Res, Cambridge, MA USA; [Apfel, Verena; Galli, Giorgio G.] Novartis Inst Biomed Res, Basel, Switzerland; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Novartis; Novartis; Harvard University	Sellers, WR (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Sellers, WR (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	wsellers@broadinstitute.org	Vazquez, Francisca/ABC-4620-2020; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Giannakis, Marios/Z-4908-2019; Vazquez, Francisca/AAA-3751-2020	Clish, Clary B/0000-0001-8259-9245; Vazquez, Francisca/0000-0002-2857-4685; Galli, Giorgio/0000-0002-9401-060X; Keskula, Paula/0000-0002-0458-9153; Zou, Yilong/0000-0001-8198-6067; Ghandi, Mahmoud/0000-0003-1897-2265; Kryukov, Gregory/0000-0002-6131-9483	NCI Cancer Center Support Grant [NIH 5 P30 CA06516]; Novartis; R35 Outstanding Investigator Award from the National Cancer Institute; NCI's Cancer Target Discovery and Development (CTD2) Network [U01 CA217848];  [U01 CA176058]; NATIONAL CANCER INSTITUTE [U01CA217848, U01CA176058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis(Novartis); R35 Outstanding Investigator Award from the National Cancer Institute; NCI's Cancer Target Discovery and Development (CTD2) Network; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank E. Gelfand for assistance with project management. We acknowledge J. Jane-Valbuena, S. Gill, V. Viswanathan, L. Dailey, and R. Almeida for helpful discussions. The PRISM team including J. Roth, S. Bender, K. Gore, C. Zhu, and J. Fonseka provided valuable help for the pooled CCLE cancer cell line screening at the Broad Institute. We thank Dana-Farber/Harvard Cancer Center in Boston, MA for the use of the Specialized Histopathology Core, which provided histology and immunohistochemistry service. Dana-Farber/Harvard Cancer Center is supported in part by an NCI Cancer Center Support Grant #NIH 5 P30 CA06516. The CCLE project was supported by grants from Novartis and R35 Outstanding Investigator Award from the National Cancer Institute (L.A.G.) and U01 CA176058 (W.C.H.). This work was supported in part by the NCI's Cancer Target Discovery and Development (CTD2) Network (grant number U01 CA217848, awarded to S. L. S.). H. Li is a fellow in the Herchel Smith graduate fellowship program.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brochez L, 2017, EUR J CANCER, V76, P167, DOI 10.1016/j.ejca.2017.01.011; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Casebeer AW, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.30_suppl.46; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hettmer S, 2015, ELIFE, V4, DOI 10.7554/eLife.09436; INDIVERI C, 1991, BIOCHIM BIOPHYS ACTA, V1065, P231, DOI 10.1016/0005-2736(91)90235-Z; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Knott SRV, 2018, NATURE, V554, P378, DOI 10.1038/nature25465; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Shim EH, 2014, CANCER DISCOV, V4, P1290, DOI 10.1158/2159-8290.CD-13-0696; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460	29	197	198	8	139	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					850	+		10.1038/s41591-019-0404-8	http://dx.doi.org/10.1038/s41591-019-0404-8			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068703	Green Accepted			2022-12-27	WOS:000468247800028
J	Dijkman, K; Sombroek, CC; Vervenne, RAW; Hofman, SO; Boot, C; Remarque, EJ; Kocken, CHM; Ottenhoff, THM; Kondova, I; Khayum, MA; Haanstra, KG; Vierboom, MPM; Verreck, FAW				Dijkman, Karin; Sombroek, Claudia C.; Vervenne, Richard A. W.; Hofman, Sam O.; Boot, Charelle; Remarque, Edmond J.; Kocken, Clemens H. M.; Ottenhoff, Tom H. M.; Kondova, Ivanela; Khayum, Mohammed A.; Haanstra, Krista G.; Vierboom, Michel P. M.; Verreck, Frank A. W.			Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques	NATURE MEDICINE			English	Article							T-CELLS; VACCINATION; PROTECTION; MEMORY; ASSOCIATION; POPULATION; CHALLENGE; MONOCYTES; PULMONARY; RESPONSES	Tuberculosis (TB) remains the deadliest infectious disease(1), and the widely used Bacillus Calmette-Guerin (BCG) vaccine fails to curb the epidemic. An improved vaccination strategy could provide a cost-effective intervention to break the transmission cycle and prevent antimicrobial resistance(2,3). Limited knowledge of the host responses critically involved in protective immunity hampers the development of improved TB vaccination regimens. Therefore, assessment of new strategies in preclinical models to select the best candidate vaccines before clinical vaccine testing remains indispensable. We have previously established in rhesus macaques (Macaca mulatta) that pulmonary mucosal BCG delivery reduces TB disease where standard intradermal injection fails(4,5). Here, we show that pulmonary BCG prevents infection by using a repeated limiting-dose Mycobacterium tuberculosis challenge model and identify polyfunctional T-helper type 17 (T(H)17) cells, interleukin-10 and immunoglobulin A as correlates of local protective immunity. These findings warrant further research into mucosal immunization strategies and their translation to clinical application to more effectively prevent the spread of TB.	[Dijkman, Karin; Sombroek, Claudia C.; Vervenne, Richard A. W.; Hofman, Sam O.; Boot, Charelle; Remarque, Edmond J.; Kocken, Clemens H. M.; Kondova, Ivanela; Khayum, Mohammed A.; Haanstra, Krista G.; Vierboom, Michel P. M.; Verreck, Frank A. W.] Biomed Primate Res Ctr, Rijswijk, Netherlands; [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dijkman, K; Verreck, FAW (corresponding author), Biomed Primate Res Ctr, Rijswijk, Netherlands.	dijkman@bprc.nl; verreck@bprc.nl	Dijkman, Karin/AAR-1994-2020; Remarque, Ed/AAE-8643-2020	Dijkman, Karin/0000-0002-5395-505X; Kocken, Clemens/0000-0002-4784-1734	Bill & Melinda Gates Foundation [OPP1130668]; European Commission under the Horizon 2020 program [643381]; 2017 grant from the Norwegian Agency for Development Coordination (NORAD)	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Commission under the Horizon 2020 program; 2017 grant from the Norwegian Agency for Development Coordination (NORAD)	We thank G. Koopman and R. Bontrop for reviewing the manuscript. We thank the BPRC animal and veterinary care teams and the clinical laboratory personnel for their excellent expert contributions to this study. We thank K. Franken from the Ottenhoff laboratory at Leiden University Medical Centre for providing us with the recombinant ESAT6-CFP10 fusion protein. We thank F. van Hassel for her assistance with figure editing. The NR-15404 Mycobacterium tuberculosis Erdman K01 (TMC107) reagent was obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, National Institute of Allergy and Infectious Diseases, NIH. The PET-CT infrastructure and TB team management was supported by a grant from the Bill & Melinda Gates Foundation, grant no. OPP1130668. This work was performed under the Tuberculosis Vaccine Initiative (TBVI)-governed TBVAC 2020 network program for advancing TB vaccine candidates, from early discovery through preclinical and into early clinical development, supported by the European Commission under the Horizon 2020 program, grant no. 643381 and a 2017 grant from the Norwegian Agency for Development Coordination (NORAD) to TBVI.	Aguilo N, 2016, J INFECT DIS, V213, P831, DOI 10.1093/infdis/jiv503; Cadena AM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007305; Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141; Coppola M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37793; Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hoft DF, 2018, MUCOSAL IMMUNOL, V11, P486, DOI 10.1038/mi.2017.67; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Jensen KH, 2018, ACTA ONCOL, V57, P1127, DOI 10.1080/0284186X.2018.1433877; Kauffman KD, 2018, MUCOSAL IMMUNOL, V11, P462, DOI 10.1038/mi.2017.60; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lee RS, 2016, EUR RESPIR J, V48, P1682, DOI 10.1183/13993003.00893-2016; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Logan E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01529; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003; Moguche AO, 2015, J EXP MED, V212, P715, DOI 10.1084/jem.20141518; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Naranbhai V, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0120-7; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Picchi H, 2018, CLIN MICROBIOL INFEC, V24, P216, DOI 10.1016/j.cmi.2017.12.003; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; R Core Team, 2018, R LANG ENV STAT COMP; Rakshit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10773-5; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Roederer M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005100; Rogers PM, 1928, NEW ENGL J MED, V198, P740, DOI 10.1056/NEJM192805241981410; Scriba TJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006687; Shen HB, 2018, CELL MOL IMMUNOL, V15, P216, DOI 10.1038/cmi.2017.128; Simmons JD, 2018, NAT REV IMMUNOL, V18, P575, DOI 10.1038/s41577-018-0025-3; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; Urbanowski ME, 2018, J INFECT DIS, V218, P53, DOI 10.1093/infdis/jiy127; Verreck FAW, 2017, TUBERCULOSIS, V104, P46, DOI 10.1016/j.tube.2017.02.003; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; White AG, 2017, JOVE-J VIS EXP, DOI 10.3791/56375; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	44	124	125	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					255	+		10.1038/s41591-018-0319-9	http://dx.doi.org/10.1038/s41591-018-0319-9			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30664782				2022-12-27	WOS:000457842100022
J	Stower, H				Stower, Hannah			Investigating the moral machine	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					19	19		10.1038/s41591-018-0330-1	http://dx.doi.org/10.1038/s41591-018-0330-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617326	Bronze			2022-12-27	WOS:000455027700013
J	Rotinen, M; You, SY; Yang, JL; Coetzee, SG; Reis-Sobreiro, M; Huang, WC; Huang, FJ; Pan, XL; Yanez, A; Hazelett, DJ; Chu, CY; Steadman, K; Morrissey, CM; Nelson, PS; Corey, E; Chung, LWK; Freedland, SJ; Di Vizio, D; Garraway, IP; Murali, R; Knudsen, BS; Freeman, MR				Rotinen, Mirja; You, Sungyong; Yang, Julie; Coetzee, Simon G.; Reis-Sobreiro, Mariana; Huang, Wen-Chin; Huang, Fangjin; Pan, Xinlei; Yanez, Alberto; Hazelett, Dennis J.; Chu, Chia-Yi; Steadman, Kenneth; Morrissey, Colm M.; Nelson, Peter S.; Corey, Eva; Chung, Leland W. K.; Freedland, Stephen J.; Di Vizio, Dolores; Garraway, Isla P.; Murali, Ramachandran; Knudsen, Beatrice S.; Freeman, Michael R.			ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis	NATURE MEDICINE			English	Article							R/BIOCONDUCTOR PACKAGE; TRANSCRIPTION FACTORS; RECEPTOR; MECHANISM; CELLS; MODEL; CLASSIFICATION; HETEROGENEITY; HOMEODOMAIN; ACTIVATION	Treatment of prostate cancer (PC) by androgen suppression promotes the emergence of aggressive variants that are androgen receptor (AR) independent. Here we identify the transcription factor ONECUT2 (OC2) as a master regulator of AR networks in metastatic castration-resistant prostate cancer (mCRPC). OC2 acts as a survival factor in mCRPC models, suppresses the AR transcriptional program by direct regulation of AR target genes and the AR licensing factor FOXA1, and activates genes associated with neural differentiation and progression to lethal disease. OC2 appears active in a substantial subset of human prostate adenocarcinoma and neuroendocrine tumors. Inhibition of OC2 by a newly identified small molecule suppresses metastasis in mice. These findings suggest that OC2 displaces AR-dependent growth and survival mechanisms in many cases where AR remains expressed, but where its activity is bypassed. OC2 is also a potential drug target in the metastatic phase of aggressive PC.	[Rotinen, Mirja; You, Sungyong; Yang, Julie; Reis-Sobreiro, Mariana; Huang, Wen-Chin; Huang, Fangjin; Steadman, Kenneth; Freedland, Stephen J.; Di Vizio, Dolores; Knudsen, Beatrice S.; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Rotinen, Mirja; You, Sungyong; Yang, Julie; Reis-Sobreiro, Mariana; Huang, Wen-Chin; Huang, Fangjin; Steadman, Kenneth; Freedland, Stephen J.; Di Vizio, Dolores; Knudsen, Beatrice S.; Freeman, Michael R.] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Coetzee, Simon G.; Hazelett, Dennis J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA; [Pan, Xinlei; Murali, Ramachandran] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Immunol, Los Angeles, CA 90048 USA; [Yanez, Alberto] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Yanez, Alberto] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Chu, Chia-Yi; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Morrissey, Colm M.; Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA; [Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Urol, Los Angeles, CA 90095 USA; [Huang, Wen-Chin] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; China Medical University Taiwan	Freeman, MR (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA.; Freeman, MR (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA.	michael.freeman@cshs.org	Steadman, Kenneth/HIK-2501-2022; You, Sungyong/AAJ-7372-2020; Rotinen, Mirja/AAA-2322-2019; Boyer, Alberto Yáñez/R-1587-2018; Steadman, Kenneth A/J-3883-2013; Huang, Wen-Chin/X-5879-2019; Coetzee, Simon Gert/C-1218-2014	You, Sungyong/0000-0003-3513-1783; Boyer, Alberto Yáñez/0000-0002-7719-1963; Coetzee, Simon Gert/0000-0003-4267-5930; Pan, Xinlei/0000-0003-4964-3720; Huang, Wen-Chin/0000-0003-2342-9099; ROTINEN, MIRJA/0000-0002-0755-8360; Murali, Ramachandran/0000-0002-8384-2793	Department of Defense (DOD) [W81XWH-16-1-0567]; NCI [U54 CA143931, 1R01CA143777, 1R01CA220327, 2P01CA098912]; NIDDK [1R01DK087806]; Prostate Cancer Foundation Challenge Grant [17CHAL04]; Spielberg Discovery Fund in Prostate Cancer Research; Jean Perkins Foundation; Movember/PCR GAP1 Unique TMAs Project; DOD [W81XWH-14-1-0152, PC130244]; Urology Care Foundation Research Scholar Award; Chesapeake Urology Associates Research Scholar Fund; 2018 Donna and Jesse Garber Award for Cancer Research; Samuel Oschin Comprehensive Cancer Institute; Cedars-Sinai Medical Center; Urology Care Foundation Research Scholars Program of AUA Western Section Research Scholar Fund; NATIONAL CANCER INSTITUTE [P30CA016042, U54CA143931, U54CA143930, R01CA220327, P01CA098912] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Prostate Cancer Foundation Challenge Grant; Spielberg Discovery Fund in Prostate Cancer Research; Jean Perkins Foundation; Movember/PCR GAP1 Unique TMAs Project; DOD(United States Department of Defense); Urology Care Foundation Research Scholar Award; Chesapeake Urology Associates Research Scholar Fund; 2018 Donna and Jesse Garber Award for Cancer Research; Samuel Oschin Comprehensive Cancer Institute; Cedars-Sinai Medical Center; Urology Care Foundation Research Scholars Program of AUA Western Section Research Scholar Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Department of Defense (DOD) grant no. W81XWH-16-1-0567 (M.R.F); NCI grant no. 1R01CA143777 (M.R.F.); NCI grant no. 1R01CA220327 (M.R.F. and S.J.F.); NIDDK grant no. 1R01DK087806 (M.R.F.); Prostate Cancer Foundation Challenge Grant grant no. 17CHAL04 (I.P.G.); Spielberg Discovery Fund in Prostate Cancer Research (B.S.K. and M.R.F.); NCI grant no. 2P01CA098912 (L.W.K.C.); Jean Perkins Foundation (I.P.G.); Movember/PCR GAP1 Unique TMAs Project (I.P.G.); DOD grant no. PC131996 (I.P.G.); DOD grant no. PC130244 (I.P.G.); NCI grant no. U54 CA143931 (I.P.G.); DOD grant no. W81XWH-14-1-0152 (S.Y.); Urology Care Foundation Research Scholar Award and Chesapeake Urology Associates Research Scholar Fund (M.R.); 2018 Donna and Jesse Garber Award for Cancer Research, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center (M.R.); Urology Care Foundation Research Scholars Program of AUA Western Section Research Scholar Fund (S.Y.). The authors are very appreciative of technical and conceptual contributions from N. Bhowmick, R. Matusik, V. Placencio, K. Kelly, M. Beshiri, W.R. Wiedemeyer, P.J. Aspuria, C. Spinelli, H. Soule, and the Biobank & Translational Research Core at Cedars-Sinai Medical Center.	Akamatsu S, 2015, CELL REP, V12, P922, DOI 10.1016/j.celrep.2015.07.012; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; D'Antonio JM, 2008, PROSTATE, V68, P698, DOI 10.1002/pros.20677; Epstein JI, 2014, AM J SURG PATHOL, V38, P756, DOI 10.1097/PAS.0000000000000208; Espana A, 2012, MOL CELL NEUROSCI, V50, P93, DOI 10.1016/j.mcn.2012.04.002; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Grozinsky-Glasberg S, 2012, NEUROENDOCRINOLOGY, V96, P173, DOI 10.1159/000338793; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Iyaguchi D, 2007, STRUCTURE, V15, P75, DOI 10.1016/j.str.2006.11.004; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jin HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4972; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim J, 2017, ONCOGENE, V36, P4072, DOI 10.1038/onc.2017.50; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Latham JPF, 2000, CANCER RES, V60, P334; Levine DM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r93; Leyten GHJM, 2015, CLIN CANCER RES, V21, P3061, DOI 10.1158/1078-0432.CCR-14-3334; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Parimi V, 2014, AM J CLIN EXP UROL, V2, P273; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rotinen M, 2009, J ENDOCRINOL, V200, P85, DOI 10.1677/JOE-08-0134; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Shiau CK, 2011, NUCLEIC ACIDS RES, V39, pD520, DOI 10.1093/nar/gkq1075; Shukla S, 2017, CANCER CELL, V32, P792, DOI 10.1016/j.ccell.2017.10.008; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun YN, 2014, MOL CELL BIOCHEM, V390, P19, DOI 10.1007/s11010-013-1950-x; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vanhorenbeeck V, 2007, DEV BIOL, V305, P685, DOI 10.1016/j.ydbio.2007.02.027; Wong C, 2012, JOVE-J VIS EXP, DOI 10.3791/4218; Wyatt AW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0426-y; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Zou M, 2017, CANCER DISCOV, V7, P736, DOI 10.1158/2159-8290.CD-16-1174	56	163	173	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1887	+		10.1038/s41591-018-0241-1	http://dx.doi.org/10.1038/s41591-018-0241-1			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30478421	Green Accepted			2022-12-27	WOS:000452392200018
J	Bar-On, Y; Gruell, H; Schoofs, T; Pai, JA; Nogueira, L; Butler, AL; Millard, K; Lehmann, C; Suarez, I; Oliveira, TY; Karagounis, T; Cohen, YZ; Wyen, C; Scholten, S; Handl, L; Belblidia, S; Dizon, JP; Vehreschild, JJ; Witmer-Pack, M; Shimeliovich, I; Jain, K; Fiddike, K; Seaton, KE; Yates, NL; Horowitz, J; Gulick, RM; Pfeifer, N; Tomaras, GD; Seaman, MS; Fatkenheuer, G; Caskey, M; Klein, F; Nussenzweig, MC				Bar-On, Yotam; Gruell, Henning; Schoofs, Till; Pai, Joy A.; Nogueira, Lilian; Butler, Allison L.; Millard, Katrina; Lehmann, Clara; Suarez, Isabelle; Oliveira, Thiago Y.; Karagounis, Theodora; Cohen, Yehuda Z.; Wyen, Christoph; Scholten, Stefan; Handl, Lisa; Belblidia, Shiraz; Dizon, Juan P.; Vehreschild, Joerg J.; Witmer-Pack, Maggi; Shimeliovich, Irina; Jain, Kanika; Fiddike, Kerstin; Seaton, Kelly E.; Yates, Nicole L.; Horowitz, Jill; Gulick, Roy M.; Pfeifer, Nico; Tomaras, Georgia D.; Seaman, Michael S.; Faetkenheuer, Gerd; Caskey, Marina; Klein, Florian; Nussenzweig, Michel C.			Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; MONOCLONAL-ANTIBODY; ANTI-HIV-1 ANTIBODIES; PASSIVE IMMUNOTHERAPY; ANTIRETROVIRAL DRUGS; SUPPRESSES VIREMIA; IMMUNE-RESPONSES; DURABLE CONTROL; HUMANIZED MICE; THERAPY	Monotherapy of HIV-1 infection with single antiretroviral agents is ineffective because error-prone HIV-1 replication leads to the production of drug-resistant viral variants(1,2). Combinations of drugs can establish long-term control, however, antiretroviral therapy (ART) requires daily dosing, can cause side effects and does not eradicate the infection(3,4). Although anti-HIV-1 antibodies constitute a potential alternative to ART(5,6), treatment of viremic individuals with a single antibody also results in emergence of resistant viral variants(7-9). Moreover, combinations of first-generation anti-HIV-1 broadly neutralizing antibodies (bNAbs) had little measurable effect on the infection(10-12). Here we report on a phase 1b clinical trial (NCT02825797) in which two potent bNAbs, 3BNC117(13) and 10-1074(14), were administered in combination to seven HIV-1 viremic individuals. Infusions of 30 mg kg(-1) of each of the antibodies were well-tolerated. In the four individuals with dual antibody-sensitive viruses, immunotherapy resulted in an average reduction in HIV-1 viral load of 2.05 log(10) copies per ml that remained significantly reduced for three months following the first of up to three infusions. In addition, none of these individuals developed resistance to both antibodies. Larger studies will be necessary to confirm the efficacy of antibody combinations in reducing HIV-1 viremia and limiting the emergence of resistant viral variants.	[Bar-On, Yotam; Schoofs, Till; Pai, Joy A.; Nogueira, Lilian; Butler, Allison L.; Millard, Katrina; Oliveira, Thiago Y.; Karagounis, Theodora; Cohen, Yehuda Z.; Belblidia, Shiraz; Dizon, Juan P.; Witmer-Pack, Maggi; Shimeliovich, Irina; Horowitz, Jill; Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Gruell, Henning; Schoofs, Till; Jain, Kanika; Klein, Florian] Univ Hosp Cologne, Lab Expt Immunol, Inst Virol, Cologne, Germany; [Gruell, Henning; Lehmann, Clara; Suarez, Isabelle; Wyen, Christoph; Vehreschild, Joerg J.; Fiddike, Kerstin; Faetkenheuer, Gerd] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Gruell, Henning; Lehmann, Clara; Suarez, Isabelle; Vehreschild, Joerg J.; Faetkenheuer, Gerd; Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Lehmann, Clara; Suarez, Isabelle; Klein, Florian] Univ Cologne, CMMC, Cologne, Germany; [Wyen, Christoph] Praxis Ebertpl, Cologne, Germany; [Scholten, Stefan] Praxis Hohenstaufenring, Cologne, Germany; [Handl, Lisa; Pfeifer, Nico] Univ Tubingen, Methods Med Informat, Dept Comp Sci, Tubingen, Germany; [Seaton, Kelly E.; Yates, Nicole L.; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Gulick, Roy M.] Weill Cornell Med, Div Infect Dis, New York, NY USA; [Pfeifer, Nico] Univ Tubingen, Med Fac, Tubingen, Germany; [Pfeifer, Nico] German Ctr Infect Res, Partner Site Tubingen, Tubingen, Germany; [Pfeifer, Nico] Max Planck Inst Informat, Saarbrucken, Germany; [Tomaras, Georgia D.] Duke Univ, Dept Surg, Durham, NC USA; [Tomaras, Georgia D.] Duke Univ, Dept Immunol, Durham, NC USA; [Tomaras, Georgia D.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Seaman, Michael S.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; Duke University; Cornell University; Eberhard Karls University of Tubingen; German Center for Infection Research; Max Planck Society; Duke University; Duke University; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University	Caskey, M; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.; Klein, F (corresponding author), Univ Hosp Cologne, Lab Expt Immunol, Inst Virol, Cologne, Germany.; Klein, F (corresponding author), German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, CMMC, Cologne, Germany.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	mcaskey@rockefeller.edu; florian.klein@uk-koeln.de; nussen@rockefeller.edu	Oliveira, Thiago Y/ABF-5186-2020; Pfeifer, Nico/G-1559-2016; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Vehreschild, Jorg Janne/G-6764-2013	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Cohen, Yehuda/0000-0001-6987-1478; Grull, Henning/0000-0002-0725-7138; Eisenberg, Lisa/0000-0002-1041-7948; Vehreschild, Jorg Janne/0000-0002-5446-7170; Karagounis, Theodora/0000-0003-1481-9589; Pfeifer, Nico/0000-0002-4647-8566; Seaton, Kelly/0000-0002-2009-3270	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [OPP1092074, OPP1124068, CAVIMC OPP1146996]; NIH [1UM1 AI100663, R01AI-129795]; Heisenberg-Program of the DFG [KL 2389/2-1]; European Research Council [ERC-StG639961]; German Center for Infection Research (DZIF); Einstein-Rockefeller-CUNY Center for AIDS Research [1P30AI124414-01A1]; BEAT-HIV Delaney grant [UM1 AI126620]; Robertson fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129795, UM1AI126620, P30AI124414, UM1AI100663] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heisenberg-Program of the DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research (DZIF); Einstein-Rockefeller-CUNY Center for AIDS Research; BEAT-HIV Delaney grant; Robertson fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all study participants who devoted time to our research; members of the Klein and Nussenzweig laboratories for helpful discussions, especially P. Mendoza, C.-L. Lu, J. C. C. Lorenzi, L. Cohn and M. Jankovic; R. Levin, G. Kremer and D. Weiland for study coordination; the Rockefeller University Hospital Clinical Research Support Office and nursing staff as well as C. Golder, E. Thomas, M. Platten, S. Margane and T. Kummerle for help with recruitment and study implementation; C. Ruping and M. Schlotz for help with sample processing; S. Kiss for ophthalmologic assessments; T. Keler and the Celldex Therapeutics team for 3BNC117 and 10-1074 manufacturing and regulatory support; C. Conrad for regulatory support; U. Kerkweg for pharmaceutical services; H. Janicki, M. Ercanoglu, P. Schommers and R. Kaiser for help with virus cultures; P. Fast and H. Park for clinical monitoring; S. McMillan, S. Mosher, S. Sawant, D. Beaumont, M. Sarzotti-Kelsoe, K. Greene, H. Gao and D. Montefiori for help with PK assay development, validation, reporting and/or project management; and S. Schlesinger for input on study design. This work was supported by The Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1092074, OPP1124068 (M.C.N.), CAVIMC OPP1146996 (G.D.T., M.S.S.); the NIH grants 1UM1 AI100663 and R01AI-129795 (M.C.N.); the Heisenberg-Program of the DFG (KL 2389/2-1), the European Research Council (ERC-StG639961) and the German Center for Infection Research (DZIF) (F.K.); the Einstein-Rockefeller-CUNY Center for AIDS Research (1P30AI124414-01A1); BEAT-HIV Delaney grant UM1 AI126620 (M.C.); and the Robertson fund. M.C.N. is a Howard Hughes Medical Institute Investigator.	Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Bailey J, 2004, CURR OPIN IMMUNOL, V16, P470, DOI 10.1016/j.coi.2004.05.005; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cohen YZ, 2018, J VIROL, V92, DOI 10.1128/JVI.01883-17; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hraber P, 2015, VIRUSES-BASEL, V7, P5443, DOI 10.3390/v7102881; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keizer RJ, 2010, CLIN PHARMACOKINET, V49, P493, DOI 10.2165/11531280-000000000-00000; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Ndung'u T, 2012, AIDS, V26, P1255, DOI 10.1097/QAD.0b013e32835461b5; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012	39	145	145	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1701	+		10.1038/s41591-018-0186-4	http://dx.doi.org/10.1038/s41591-018-0186-4			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30258217	Green Accepted			2022-12-27	WOS:000449404200022
J	McCarthy, MM				McCarthy, Margaret M.			PSYCHIATRIC DISORDERS Intersection of schizophrenia genetics and placental complications	NATURE MEDICINE			English	Editorial Material							SEX-DIFFERENCES; NEURODEVELOPMENT	Genetic risk scores in schizophrenia are influenced by pregnancy complications that compromise the placenta, enhancing association of genes involved in metabolism and cellular stress with schizophrenia risk.	[McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [McCarthy, Margaret M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	McCarthy, MM (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.; McCarthy, MM (corresponding author), Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA.	mmccarthy@som.umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726				Bale TL, 2016, DIALOGUES CLIN NEURO, V18, P459; Bogaert AF, 2018, P NATL ACAD SCI USA, V115, P302, DOI 10.1073/pnas.1705895114; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; McCarthy MM, 2017, NAT REV NEUROSCI, V18, P471, DOI 10.1038/nrn.2017.61; Ursini G, 2018, NAT MED, V24, P792, DOI 10.1038/s41591-018-0021-y; Walker CK, 2015, JAMA PEDIATR, V169, P154, DOI 10.1001/jamapediatrics.2014.2645	6	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					707	708		10.1038/s41591-018-0066-y	http://dx.doi.org/10.1038/s41591-018-0066-y			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875456				2022-12-27	WOS:000434281300013
J	Ursini, G; Punzi, G; Chen, Q; Marenco, S; Robinson, JF; Porcelli, A; Hamilton, EG; Mitjans, M; Maddalena, G; Begemann, M; Seidel, J; Yanamori, H; Jaffe, AE; Berman, KF; Egan, MF; Straub, RE; Colantuoni, C; Blasi, G; Hashimoto, R; Rujescu, D; Ehrenreich, H; Bertolino, A; Weinberger, DR				Ursini, Gianluca; Punzi, Giovanna; Chen, Qiang; Marenco, Stefano; Robinson, Joshua F.; Porcelli, Annamaria; Hamilton, Emily G.; Mitjans, Marina; Maddalena, Giancarlo; Begemann, Martin; Seidel, Jan; Yanamori, Hidenaga; Jaffe, Andrew E.; Berman, Karen F.; Egan, Michael F.; Straub, Richard E.; Colantuoni, Carlo; Blasi, Giuseppe; Hashimoto, Ryota; Rujescu, Dan; Ehrenreich, Hannelore; Bertolino, Alessandro; Weinberger, Daniel R.			Convergence of placenta biology and genetic risk for schizophrenia	NATURE MEDICINE			English	Article							OBSTETRIC COMPLICATIONS; SEX-DIFFERENCES; ASSOCIATION; PREECLAMPSIA; INFLAMMATION; METHYLATION; INTEGRATION; GENOTYPE; HYPOXIA; GROWTH	Defining the environmental context in which genes enhance disease susceptibility can provide insight into the pathogenesis of complex disorders. We report that the intra-uterine environment modulates the association of schizophrenia with genomic risk (in this study, genome-wide association study-derived polygenic risk scores (PRSs)). In independent samples from the United States, Italy, and Germany, the liability of schizophrenia explained by PRS is more than five times greater in the presence of early-life complications (ELCs) compared with their absence. Patients with ELC histories have significantly higher PRS than patients without ELC histories, which is confirmed in additional samples from Germany and Japan. The gene set composed of schizophrenia loci that interact with ELCs is highly expressed in placenta, is differentially expressed in placentae from complicated in comparison with normal pregnancies, and is differentially upregulated in placentae from male compared with female offspring. Pathway analyses reveal that genes driving the PRS-ELC interaction are involved in cellular stress response; genes that do not drive such interaction implicate orthogonal biological processes (for example, synaptic function). We conclude that a subset of the most significant genetic variants associated with schizophrenia converge on a developmental trajectory sensitive to events that affect the placental response to stress, which may offer insights into sex biases and primary prevention.	[Ursini, Gianluca; Punzi, Giovanna; Chen, Qiang; Jaffe, Andrew E.; Straub, Richard E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD 21205 USA; [Ursini, Gianluca; Punzi, Giovanna; Porcelli, Annamaria; Maddalena, Giancarlo; Blasi, Giuseppe; Bertolino, Alessandro] Aldo Moro Univ, Dept Basic Med Sci Neurosci & Sense Organs, Grp Psychiat Neurosci, Bari, Italy; [Ursini, Gianluca; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Ursini, Gianluca; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Behav Sci, Baltimore, MD 21218 USA; [Marenco, Stefano; Berman, Karen F.] NIMH, Clin & Translat Neurosci Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Marenco, Stefano] NIMH, Human Brain Collect Core, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Robinson, Joshua F.; Hamilton, Emily G.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA USA; [Mitjans, Marina; Begemann, Martin; Seidel, Jan; Ehrenreich, Hannelore] Max Planck Inst Expt Med, DFG Res Ctr Nanoscale Microscopy & Mol Physiol Br, Clin Neurosci, Gottingen, Germany; [Yanamori, Hidenaga; Hashimoto, Ryota] Osaka Univ, Dept Psychiat, Grad Sch Med, Osaka, Japan; [Jaffe, Andrew E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Egan, Michael F.] Merck & Co Inc, Merck Res Labs, Whitehouse Stn, NJ USA; [Colantuoni, Carlo; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Colantuoni, Carlo; Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Colantuoni, Carlo; Weinberger, Daniel R.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka, Japan; [Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat, Halle, Germany; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Universita degli Studi di Bari Aldo Moro; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California San Francisco; Max Planck Society; Osaka University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Merck & Company; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Osaka University; Martin Luther University Halle Wittenberg; Johns Hopkins University	Weinberger, DR (corresponding author), Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD 21205 USA.; Weinberger, DR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.; Weinberger, DR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Behav Sci, Baltimore, MD 21218 USA.; Weinberger, DR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Weinberger, DR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Weinberger, DR (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.; Weinberger, DR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	drweinberger@libd.org	Jaffe, Andrew/GPF-5693-2022; chen, qiang/GWZ-7308-2022; Blasi, Giuseppe/HHS-5404-2022; Rujescu, Dan/GRS-3875-2022; Ursini, Gianluca/AAA-8242-2019; chen, qiang/HGU-5418-2022; Ehrenreich, Hannelore/AAS-6079-2020; Marenco, Stefano/A-2409-2008; Mitjans, Marina/C-4758-2018	Jaffe, Andrew/0000-0001-6886-1454; Marenco, Stefano/0000-0002-2488-2365; Mitjans, Marina/0000-0001-5543-7320; Punzi, Giovanna/0000-0001-7530-3880; Ehrenreich, Hannelore/0000-0001-8371-5711; Colantuoni, Carlo/0000-0001-6818-6380; Ursini, Gianluca/0000-0002-4733-5196; Robinson, Joshua/0000-0002-2421-4535; Hamilton, Emily/0000-0001-7955-6244	Intramural Research Program of the NIMH [95-M-0150, ZIA MH002942-05]; NARSAD grant [20337]; "Ricerca Finalizzata" grant [PE-2011-02347951]; Max Planck Society; Max Planck Forderstiftung; DFG (CNMPB); EXTRABRAIN EU-FP7; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT);  [P50MH094268]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002652, ZIAMH002942] Funding Source: NIH RePORTER	Intramural Research Program of the NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD grant(NARSAD); "Ricerca Finalizzata" grant; Max Planck Society(Max Planck Society); Max Planck Forderstiftung(Max Planck Society); DFG (CNMPB)(German Research Foundation (DFG)); EXTRABRAIN EU-FP7; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the Lieber and Maltz families for their visionary support that funded the analytic work of this project. We thank all of the participants in the study and their families. We thank Joo Heon Shin for help with the gene expression analyses, and Barbara Gelao, Marina Mancini, Raffaella Romano, Rita Masellis, and Grazia Caforio for help with data acquisition. We also thank Sally Cheung and John Meyer for data management, and Susan Fisher for guidance with placental datasets and review of the manuscript. We thank the Psychiatry Genomics Consortium for providing the statistics for PRS calculation, and Thomas F. McNeil for providing the scale for ELC scoring. We also thank all of the authors of the publicly available placental datasets that have been used in this study. The collection of the ELC and genetic data for the American samples was supported by direct funding from the Intramural Research Program of the NIMH to the Clinical Brain Disorders Branch (D.R.W., PI, protocol 95-M-0150, NCT00001486, annual report number: ZIA MH002942-05), with supplemental analytic support from the Clinical and Translational Neuroscience Branch (K.F.B., PI). G.U. received partial support from P50MH094268. The collection of ELCs and genetic data for the Italian sample has been supported by the NARSAD grant no. 20337 and the "Ricerca Finalizzata" grant no. PE-2011-02347951 (both awarded to A.B.). The GRAS data collection has been supported by funding from the Max Planck Society, the Max Planck Forderstiftung, the DFG (CNMPB), EXTRABRAIN EU-FP7, and the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) (to H.E.).	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; ANGERMEYER MC, 1990, SCHIZOPHRENIA BULL, V16, P293, DOI 10.1093/schbul/16.2.293; Begemann M, 2010, ARCH GEN PSYCHIAT, V67, P879, DOI 10.1001/archgenpsychiatry.2010.107; Bloom Barbara, 2011, Vital Health Stat 10, P1; Bonnin A, 2012, NEUROPSYCHOPHARMACOL, V37, P299, DOI 10.1038/npp.2011.194; Bronson SL, 2016, NEUROPSYCHOPHARMACOL, V41, P207, DOI 10.1038/npp.2015.231; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Burton GJ, 2017, PLACENTA, V60, P134, DOI 10.1016/j.placenta.2017.06.007; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0061; Byrne M, 2007, SCHIZOPHR RES, V97, P51, DOI 10.1016/j.schres.2007.07.018; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cotechini T, 2015, PLACENTA, V36, P960, DOI 10.1016/j.placenta.2015.05.016; Dalman C, 1999, ARCH GEN PSYCHIAT, V56, P234, DOI 10.1001/archpsyc.56.3.234; Danilack VA, 2015, AM J OBSTET GYNECOL; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Ferguson KK, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.174; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Hashimoto-Torii K, 2014, NEURON, V82, P560, DOI 10.1016/j.neuron.2014.03.002; HEWSON D, 1987, AM J EPIDEMIOL, V125, P484, DOI 10.1093/oxfordjournals.aje.a114554; Hjorthoj C, 2017, LANCET PSYCHIAT, V4, P295, DOI 10.1016/S2215-0366(17)30078-0; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Hwang SS, 2017, J PEDIATR-US, V191, P69, DOI 10.1016/j.jpeds.2017.08.045; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leavey K, 2016, HYPERTENSION, V68, P137, DOI 10.1161/HYPERTENSIONAHA.116.07293; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; MCNEIL TF, 1994, ACTA PSYCHIAT SCAND, V89, P196, DOI 10.1111/j.1600-0447.1994.tb08092.x; MCNEIL TF, 1994, J PSYCHIAT RES, V28, P519, DOI 10.1016/0022-3956(94)90042-6; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mikaelsson MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3311; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; Niemela S, 2016, AM J PSYCHIAT, V173, P799, DOI 10.1176/appi.ajp.2016.15060800; OCALLAGHAN E, 1990, PSYCHOL MED, V20, P89, DOI 10.1017/S0033291700013258; Ochoa S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/916198; Ohi K, 2015, SCHIZOPHRENIA BULL, V41, P909, DOI 10.1093/schbul/sbu171; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2018, R LANG ENV STAT COMP; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Redman Cwg, 2014, Pregnancy Hypertens, V4, P241, DOI [10.1016/j.preghy.2014.04.009, 10.1016/j.preghy.2014.04.008]; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Ribbe K, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-91; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosenberg KR, 2007, J REPROD IMMUNOL, V76, P91, DOI 10.1016/j.jri.2007.03.011; Ross RG, 2016, AM J PSYCHIAT, V173, P509, DOI 10.1176/appi.ajp.2015.15091188; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stepniak B, 2014, LANCET PSYCHIAT, V1, P444, DOI 10.1016/S2215-0366(14)70379-7; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Ursini G, 2016, EPIGENETICS-US, V11, P11, DOI 10.1080/15592294.2015.1117736; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Verdoux H, 2002, ACTA PSYCHIAT SCAND, V106, P212, DOI 10.1034/j.1600-0447.2002.02398.x; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; Wollmann HA, 1998, HORM RES, V49, P1, DOI 10.1159/000053079; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	79	123	123	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					792	+		10.1038/s41591-018-0021-y	http://dx.doi.org/10.1038/s41591-018-0021-y			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29808008	Green Submitted			2022-12-27	WOS:000434281300024
J	Doan, T; Hinterwirth, A; Worden, L; Arzika, AM; Maliki, R; Abdou, A; Kane, S; Zhong, L; Cummings, SL; Sakar, S; Chen, C; Cook, C; Lebas, E; Chow, ED; Nachamkin, I; Porco, TC; Keenan, JD; Lietman, TM				Doan, T.; Hinterwirth, A.; Worden, L.; Arzika, A. M.; Maliki, R.; Abdou, A.; Kane, S.; Zhong, L.; Cummings, S. L.; Sakar, S.; Chen, C.; Cook, C.; Lebas, E.; Chow, E. D.; Nachamkin, I.; Porco, T. C.; Keenan, J. D.; Lietman, T. M.			Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution	NATURE MEDICINE			English	Article							GLOBAL ENTERIC MULTICENTER; MACROLIDE RESISTANCE; CAMPYLOBACTER-UPSALIENSIS; CHILDHOOD MORTALITY; READ ALIGNMENT; CHILDREN; JEJUNI; DIVERSITY; DIAGNOSIS; COUNTRIES	The MORDOR I trial(1), conducted in Niger, Malawi and Tanzania, demonstrated that mass azithromycin distribution to preschool children reduced childhood mortality'. However, the large but simple trial design precluded determination of the mechanisms involved. Here we examined the gut microbiome of preschool children from 30 Nigerien communities randomized to either biannual azithromycin or placebo. Gut microbiome gamma-diversity was not significantly altered (P = 0.08), but the relative abundances of two Campylobacter species, along with another 33 gut bacteria, were significantly reduced in children treated with azithromycin at the 24-month followup. Metagenomic analysis revealed functional differences in gut bacteria between treatment groups. Resistome analysis showed an increase in macrolide resistance gene expression in gut microbiota in communities treated with azithromycin (P = 0.004). These results suggest that prolonged mass azithromycin distribution to reduce childhood mortality reduces certain gut bacteria, including known pathogens, while selecting for antibiotic resistance.	[Doan, T.; Hinterwirth, A.; Worden, L.; Zhong, L.; Cummings, S. L.; Sakar, S.; Chen, C.; Cook, C.; Lebas, E.; Porco, T. C.; Keenan, J. D.; Lietman, T. M.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Doan, T.; Porco, T. C.; Keenan, J. D.; Lietman, T. M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Arzika, A. M.; Maliki, R.; Kane, S.] Carter Ctr, Niamey, Niger; [Abdou, A.] Minist Publ Hlth, Niamey, Niger; [Abdou, A.] Programme Natl Soins Oculaires, Niamey, Niger; [Chow, E. D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Nachamkin, I.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Porco, T. C.; Lietman, T. M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Lietman, T. M.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Doan, T (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.; Doan, T (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	Thuy.Doan@ucsf.edu	Keenan, Jeremy David/AAO-5882-2020	Keenan, Jeremy David/0000-0002-7118-1457; Nachamkin, Irving/0000-0003-4811-9716; Doan, Thuy/0000-0003-2733-8370	Bill and Melinda Gates Foundation [OPP1032340]; Peierls Foundation; Research to Prevent Blindness Career Development Award [127613A]; Research to Prevent Blindness; Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Peierls Foundation; Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank S. Kumar for the helpful discussions regarding the gut pathogens identified in this study. We thank the program officers from the trial's sponsor: Bill and Melinda Gates Foundation, R. Izadnegandar, J. Jacobson, T. Kanyok, E. Shutes, C. Damman, A. Sarangi and L. Lamberti. We also thank the members of the Data and Safety Monitoring Committee: University of Washington, J. Walson; Liverpool School of Tropical Medicine, A. Hightower; Loyola University, E. Anderson; Berhan Public Health & Eye Care Consultancy, W. Alemayehu; Tulane University, L. Rajan. This work was supported by the Bill and Melinda Gates Foundation (award no. OPP1032340 to T.M.L.), the Peierls Foundation (T.M.L.), a Research to Prevent Blindness Career Development Award (award no. 127613A to T.D.) and an unrestricted grant from Research to Prevent Blindness. The funding organizations had no role in the analysis or interpretation of the data or the preparation of the manuscript.	Amour C, 2016, CLIN INFECT DIS, V63, P1171, DOI 10.1093/cid/ciw542; Amza A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003128; Amza A, 2013, AM J TROP MED HYG, V88, P138, DOI 10.4269/ajtmh.2012.12-0284; Bolinger H, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00416-17, 10.1128/aem.00416-17]; Bourke B, 1998, CLIN MICROBIOL REV, V11, P440, DOI 10.1128/CMR.11.3.440; Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14; Chandramohan D, 2019, NEW ENGL J MED, V380, P2197, DOI 10.1056/NEJMoa1811400; Doan T, 2019, NEW ENGL J MED, V380, P2271, DOI 10.1056/NEJMc1901535; Doan T, 2017, OPHTHALMOLOGY, V124, P1247, DOI 10.1016/j.ophtha.2017.03.045; Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104; Founou LL, 2018, MICROB DRUG RESIST, V24, P648, DOI 10.1089/mdr.2017.0383; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gibreel A, 2005, ANTIMICROB AGENTS CH, V49, P2753, DOI 10.1128/AAC.49.7.2753-2759.2005; Hunt M, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000131; Jimenez SG, 1999, PEDIATR INFECT DIS J, V18, P988, DOI 10.1097/00006454-199911000-00011; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Keenan JD, 2018, NEW ENGL J MED, V378, P1583, DOI [10.1056/nejmoa1715474, 10.1056/NEJMoa1715474]; Keenan JD, 2019, NEW ENGL J MED, V380, P2207, DOI 10.1056/NEJMoa1817213; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Kotloff KL, 2019, LANCET GLOB HEALTH, V7, pE568, DOI 10.1016/S2214-109X(19)30076-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Lakin SM, 2017, NUCLEIC ACIDS RES, V45, pD574, DOI 10.1093/nar/gkw1009; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; McMullan BJ, 2015, AUST PRESCR, V38, P87, DOI 10.18773/austprescr.2015.030; Nachamkin I, 2002, EMERG INFECT DIS, V8, P1501, DOI 10.3201/eid0812.020115; Nachamkin I, 2002, MICROBES INFECT, V4, P399, DOI 10.1016/S1286-4579(02)01553-8; O'Brien KS, 2019, LANCET INFECT DIS, V19, pE14, DOI 10.1016/S1473-3099(18)30444-4; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Oldenburg CE, 2020, CLIN INFECT DIS, V70, P525, DOI 10.1093/cid/ciz455; Patrick ME, 2018, EPIDEMIOL INFECT, V146, P1, DOI 10.1017/S0950268817002370; Same RG, 2018, PEDIATR REV, V39, P533, DOI 10.1542/pir.2017-0285; Schiaffino F, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01911-18; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sie A, 2018, AM J TROP MED HYG, V99, P789, DOI 10.4269/ajtmh.18-0342; Sire JM, 2013, PAEDIATR INT CHILD H, V33, P139, DOI 10.1179/2046905512Y.0000000046; Doan T, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy182; Doan T, 2017, CLIN INFECT DIS, V64, P1147, DOI 10.1093/cid/cix141; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Yoshioka S, 2016, PEERJ, V4, DOI 10.7717/peerj.1543; Zhao H, 2017, MOL MICROBIOL, V106, P847, DOI 10.1111/mmi.13853; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	46	60	60	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1370	+		10.1038/s41591-019-0533-0	http://dx.doi.org/10.1038/s41591-019-0533-0			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31406349				2022-12-27	WOS:000484832800018
J	Petrini, FM; Bumbasirevic, M; Valle, G; Ilic, V; Mijovic, P; Cvancara, P; Barberi, F; Katic, N; Bortolotti, D; Andreu, D; Lechler, K; Lesic, A; Mazic, S; Mijovic, B; Guiraud, D; Stieglitz, T; Alexandersson, A; Micera, S; Raspopovic, S				Petrini, Francesco Maria; Bumbasirevic, Marko; Valle, Giacomo; Ilic, Vladimir; Mijovic, Pavle; Cvancara, Paul; Barberi, Federica; Katic, Natalija; Bortolotti, Dario; Andreu, David; Lechler, Knut; Lesic, Aleksandar; Mazic, Sanja; Mijovic, Bogdan; Guiraud, David; Stieglitz, Thomas; Alexandersson, Asgeir; Micera, Silvestro; Raspopovic, Stanisa			Sensory feedback restoration in leg amputees improves walking speed, metabolic cost and phantom pain	NATURE MEDICINE			English	Article							LOWER-LIMB AMPUTATIONS; PROSTHETIC KNEE-JOINT; ENERGY-COST; BALANCE CONFIDENCE; GAIT SYMMETRY; PERFORMANCE; TIME; EFFICIENCY; INTERFACE	Conventional leg prostheses do not convey sensory information about motion or interaction with the ground to aboveknee amputees, thereby reducing confidence and walking speed in the users that is associated with high mental and physical fatigue(1-4). The lack of physiological feedback from the remaining extremity to the brain also contributes to the generation of phantom limb pain from the missing legs(5,)(6). To determine whether neural sensory feedback restoration addresses these issues, we conducted a study with two transfemoral amputees, implanted with four intraneural stimulation electrodes' in the remaining tibial nerve (ClinicalTrials. gov identifier NCT03350061). Participants were evaluated while using a neuroprosthetic device consisting of a prosthetic leg equipped with foot and knee sensors. These sensors drive neural stimulation, which elicits sensations of knee motion and the sole of the foot touching the ground. We found that walking speed and self-reported confidence increased while mental and physical fatigue decreased for both participants during neural sensory feedback compared to the no stimulation trials. Furthermore, participants exhibited reduced phantom limb pain with neural sensory feedback. The results from these proof-of-concept cases provide the rationale for larger population studies investigating the clinical utility of neuroprostheses that restore sensory feedback.	[Petrini, Francesco Maria; Raspopovic, Stanisa] Swiss Fed Inst Technol Zurich, Inst Robot & Intelligent Syst, Dept Hlth Sci & Technol, Zurich, Switzerland; [Petrini, Francesco Maria; Barberi, Federica; Bortolotti, Dario; Raspopovic, Stanisa] SensArs Neuroprosthet, Lausanne, Switzerland; [Petrini, Francesco Maria; Valle, Giacomo; Barberi, Federica; Micera, Silvestro] Ecole Polytech Fed Lausanne, Sch Engn, Ctr Neuroprosthet, Bertarelli Fdn Chair Translat Neuroengn, Lausanne, Switzerland; [Petrini, Francesco Maria; Valle, Giacomo; Barberi, Federica; Micera, Silvestro] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland; [Bumbasirevic, Marko; Lesic, Aleksandar] Univ Belgrade, Sch Med, Dept Orthopaed Surg, Belgrade, Serbia; [Bumbasirevic, Marko; Lesic, Aleksandar] Clin Ctr Serbia, Clin Orthopaed Surg & Traumatol, Belgrade, Serbia; [Valle, Giacomo; Barberi, Federica; Micera, Silvestro] St Anna Sch Adv Studies, BioRobot Inst, Pisa, Italy; [Ilic, Vladimir] Univ Belgrade, Sch Med, Fac Sport & Phys Educ, Belgrade, Serbia; [Mijovic, Pavle; Mijovic, Bogdan] mBrainTrain Doo, Belgrade, Serbia; [Cvancara, Paul; Stieglitz, Thomas] Univ Freiburg, Dept Microsyst Engn, Lab Biomed Microtechnol, Freiburg, Germany; [Katic, Natalija] Inst Mihajlo Pupin, Belgrade, Serbia; [Andreu, David; Guiraud, David] Univ Montpellier, INRIA, Montpellier, France; [Lechler, Knut; Alexandersson, Asgeir] Ossur, Reykjavik, Iceland; [Mazic, Sanja] Univ Belgrade, Inst Med Physiol, Sch Med, Belgrade, Serbia; [Stieglitz, Thomas] Univ Freiburg, Cluster Excellence BrainLinks BrainTools, Freiburg, Germany; [Stieglitz, Thomas] Univ Freiburg, Bernstein Ctr Freiburg, Freiburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Belgrade; Clinical Centre of Serbia; Scuola Superiore Sant'Anna; University of Belgrade; University of Freiburg; University of Belgrade; Inria; Universite de Montpellier; University of Belgrade; University of Freiburg; University of Freiburg	Raspopovic, S (corresponding author), Swiss Fed Inst Technol Zurich, Inst Robot & Intelligent Syst, Dept Hlth Sci & Technol, Zurich, Switzerland.; Raspopovic, S (corresponding author), SensArs Neuroprosthet, Lausanne, Switzerland.	stanisa.raspopovic@hest.ethz.ch	Stieglitz, Thomas/C-7916-2013; Micera, Silvestro/AAD-6630-2021; Raspopovic, Stanisa/H-1649-2018; Guiraud, David/AAY-6963-2021; Valle, Giacomo/AAE-6490-2019	Stieglitz, Thomas/0000-0002-7349-4254; Raspopovic, Stanisa/0000-0003-0567-9051; Guiraud, David/0000-0002-4184-6243; Valle, Giacomo/0000-0002-2637-8007; Alexandersson, Asgeir/0000-0003-1723-499X; Ilic, Vladimir/0000-0002-3769-7767; Barberi, Federica/0000-0002-1887-6284; mazic, sanja/0000-0001-7230-6816	European Research Council [759998]; European Commission [754497]; Swiss National Science Foundation [176006]	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors are deeply grateful to the study participants who freely donated months of their life for the advancement of knowledge and for a better future for traumatic leg amputees. Thanks are also due to T. Palibrk for helping during the surgical implantation/explantation of the TIMEs and M. Marazzi for helping during the data analysis. European Research Council grant no. 759998 (FeelAgain), European Commission grant no. 754497 (SensAgain) and Swiss National Science Foundation grant no. 176006 (SYMBIO-LEG) funded this research.	Andreu D, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026001; Asano M, 2007, GERONTOLOGY, V53, P373, DOI 10.1159/000104830; Bellmann M, 2012, ARCH PHYS MED REHAB, V93, P541, DOI 10.1016/j.apmr.2011.10.017; Boretius T, 2010, BIOSENS BIOELECTRON, V26, P62, DOI 10.1016/j.bios.2010.05.010; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Charkhkar H, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aac964; CLIPPINGER FW, 1982, CLIN ORTHOP RELAT R, P202; Clites TR, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8373; Crea S, 2017, PHYS THER, V97, P198, DOI 10.2522/ptj.20150441; Cruccu G, 2007, EUR J NEUROL, V14, P952, DOI 10.1111/j.1468-1331.2007.01916.x; Deeny S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112091; Detrembleur C, 2005, GAIT POSTURE, V21, P333, DOI 10.1016/j.gaitpost.2004.04.005; Dietrich C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00270; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Gailey R, 2010, J REHABIL RES DEV, V47, P317, DOI 10.1682/JRRD.2009.04.0039; Genin JJ, 2008, EUR J APPL PHYSIOL, V103, P655, DOI 10.1007/s00421-008-0764-0; Giraudet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118556; Hafner BJ, 2009, J REHABIL RES DEV, V46, P417, DOI 10.1682/JRRD.2008.01.0007; Hargrove L., 2016, JAMA-J AM MED ASSOC, V63, P1405; ISREAL JB, 1980, HUM FACTORS, V22, P211, DOI 10.1177/001872088002200210; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Kim LH, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa966a; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571; MELZACK R, 1968, P423; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Miller WC, 2001, ARCH PHYS MED REHAB, V82, P1238, DOI 10.1053/apmr.2001.25079; Modan M, 1998, AM J CARDIOL, V82, P1242, DOI 10.1016/S0002-9149(98)00601-8; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Naschitz JE, 2008, QJM-INT J MED, V101, P251, DOI 10.1093/qjmed/hcm131; Nolan L, 2003, GAIT POSTURE, V17, P142, DOI 10.1016/S0966-6362(02)00066-8; Orendurff MS, 2006, J REHABIL RES DEV, V43, P239, DOI 10.1682/JRRD.2005.06.0095; Peduzzi de Castro M, 2014, PM&R, V6; Petrini FM, 2019, ANN NEUROL, V85, P137, DOI 10.1002/ana.25384; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Raspopovic S, 2017, P IEEE, V105, P34, DOI 10.1109/JPROC.2016.2600560; Raspopovic S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006820; Rossini PM, 2010, CLIN NEUROPHYSIOL, V121, P777, DOI 10.1016/j.clinph.2010.01.001; Rusaw D, 2012, J REHABIL RES DEV, V49, P1239, DOI 10.1682/JRRD.2011.05.0088; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Soin A, 2015, NEUROMODULATION, V18, P197, DOI 10.1111/ner.12266; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Strayer DL, 2015, HUM FACTORS, V57, P1300, DOI 10.1177/0018720815575149; Tan DW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008669; Traballesi M, 2008, GAIT POSTURE, V27, P70, DOI 10.1016/j.gaitpost.2007.01.006; Valle G, 2018, NEURON, V100, P37, DOI 10.1016/j.neuron.2018.08.033; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; WATERS RL, 1976, J BONE JOINT SURG AM, V58, P42, DOI 10.2106/00004623-197658010-00007; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Wickens CD., 1977, P HUMAN FACTORS SOC, V21, P282, DOI [10.1177/107118137702100404, DOI 10.1177/107118137702100404]; Williams RM, 2006, ARCH PHYS MED REHAB, V87, P989, DOI 10.1016/j.apmr.2006.03.006; Zink R, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046017	57	88	88	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1356	+		10.1038/s41591-019-0567-3	http://dx.doi.org/10.1038/s41591-019-0567-3			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501600	Green Accepted			2022-12-27	WOS:000484832800016
J	Poyet, M; Groussin, M; Gibbons, SM; Avila-Pacheco, J; Jiang, X; Kearney, SM; Perrotta, AR; Berdy, B; Zhao, S; Lieberman, TD; Swanson, PK; Smith, M; Roesemann, S; Alexander, JE; Rich, SA; Livny, J; Vlamakis, H; Clish, C; Bullock, K; Deik, A; Scott, J; Pierce, KA; Xavier, RJ; Alm, EJ				Poyet, M.; Groussin, M.; Gibbons, S. M.; Avila-Pacheco, J.; Jiang, X.; Kearney, S. M.; Perrotta, A. R.; Berdy, B.; Zhao, S.; Lieberman, T. D.; Swanson, P. K.; Smith, M.; Roesemann, S.; Alexander, J. E.; Rich, S. A.; Livny, J.; Vlamakis, H.; Clish, C.; Bullock, K.; Deik, A.; Scott, J.; Pierce, K. A.; Xavier, R. J.; Alm, E. J.			A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research	NATURE MEDICINE			English	Article							FAECALIBACTERIUM-PRAUSNITZII; REFERENCE GENOMES; READ ALIGNMENT; DONOR; TRANSPLANTATION; DIVERSITY; STRAINS; DETERMINANTS; FERMENTATION; CLOSTRIDIA	Our understanding of how the gut microbiome interacts with its human host has been restrained by limited access to longitudinal datasets to examine stability and dynamics, and by having only a few isolates to test mechanistic hypotheses. Here, we present the Broad Institute-OpenBiome Microbiome Library (BIO-ML), a comprehensive collection of 7,758 gut bacterial isolates paired with 3,632 genome sequences and longitudinal multi-omics data. We show that microbial species maintain stable population sizes within and across humans and that commonly used 'omics' survey methods are more reliable when using averages over multiple days of sampling. Variation of gut metabolites within people over time is associated with amino acid levels, and differences across people are associated with differences in bile acids. Finally, we show that genomic diversification can be used to infer eco-evolutionary dynamics and in vivo selection pressures for strains within individuals. The BIO-ML is a unique resource designed to enable hypothesis-driven microbiome research.	[Poyet, M.; Groussin, M.; Gibbons, S. M.; Jiang, X.; Kearney, S. M.; Perrotta, A. R.; Berdy, B.; Zhao, S.; Lieberman, T. D.; Swanson, P. K.; Alm, E. J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Poyet, M.; Groussin, M.; Gibbons, S. M.; Jiang, X.; Kearney, S. M.; Perrotta, A. R.; Berdy, B.; Zhao, S.; Lieberman, T. D.; Xavier, R. J.; Alm, E. J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Poyet, M.; Groussin, M.; Gibbons, S. M.; Avila-Pacheco, J.; Jiang, X.; Kearney, S. M.; Berdy, B.; Lieberman, T. D.; Roesemann, S.; Alexander, J. E.; Rich, S. A.; Livny, J.; Vlamakis, H.; Clish, C.; Bullock, K.; Deik, A.; Scott, J.; Pierce, K. A.; Xavier, R. J.; Alm, E. J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gibbons, S. M.] Inst Syst Biol, Seattle, WA USA; [Swanson, P. K.; Smith, M.; Alm, E. J.] Finch Therapeut, Somerville, MA 02143 USA; [Smith, M.; Alm, E. J.] OpenBiome, Somerville, MA 02140 USA; [Xavier, R. J.; Alm, E. J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, R. J.; Alm, E. J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Institute for Systems Biology (ISB); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Alm, EJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Xavier, RJ; Alm, EJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Xavier, RJ; Alm, EJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Alm, EJ (corresponding author), Finch Therapeut, Somerville, MA 02143 USA.; Alm, EJ (corresponding author), OpenBiome, Somerville, MA 02140 USA.; Xavier, RJ; Alm, EJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ; Alm, EJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.	xavier@molbio.mgh.harvard.edu; ejalm@mit.edu	Clish, Clary B/ABB-9374-2021; Berdy, Brittany/AAH-4876-2021; Gibbons, Sean M./ABH-2562-2020; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Gibbons, Sean M./0000-0002-8724-7916; Jiang, Xiaofang/0000-0002-0955-8284; Roesemann, Shane/0000-0002-9466-0733; Avila, Julian/0000-0001-9388-3946; /0000-0001-5430-3937	Broad Institute [4000017]	Broad Institute	The authors are thankful to M. Sovie, C. Kim, W Kelley, E. Lee, W. Pettee, J. Watson and P. Panchal from OpenBiome for their assistance in processing materials and donor metadata used in this study. This work was funded by a grant from the Broad Institute (Broad Next 10 grant 4000017).	Ahern PP, 2014, IMMUNITY, V40, P815, DOI 10.1016/j.immuni.2014.05.012; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barboza M, 2009, APPL ENVIRON MICROB, V75, P7319, DOI 10.1128/AEM.00842-09; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Conway T, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0006-2014; Cover TL, 2016, MBIO, V7, DOI 10.1128/mBio.01869-15; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116; Faith J.J., 2013, SCIENCE, V341; Fischer M, 2017, GUT MICROBES, V8, P205, DOI 10.1080/19490976.2017.1283469; Flameling I. A., 2018, GUT MICROBIOTA BRAIN, DOI [10.5772/intechopen.78666, DOI 10.5772/INTECHOPEN.78666]; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Garud N. R., 2017, EVOLUTIONARY DYNAMIC, DOI [10.1101/210955, DOI 10.1101/210955]; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jauffrit F, 2016, MOL BIOL EVOL, V33, P2170, DOI 10.1093/molbev/msw088; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; Kearney SM, 2018, ISME J, V12, P2403, DOI 10.1038/s41396-018-0192-z; Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau JT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0327-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; Mullish BH, 2017, HEPATOLOGY, V66, P1354, DOI 10.1002/hep.29369; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; O'Sullivan JF, 2017, J CLIN INVEST, V127, P4394, DOI 10.1172/JCI95995; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Ratner M, 2015, NAT BIOTECHNOL, V33, P787, DOI 10.1038/nbt0815-787; Rettedal EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5714; Ronda C, 2019, NAT METHODS, V16, P167, DOI 10.1038/s41592-018-0301-y; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shen TCD, 2015, J CLIN INVEST, V125, P2841, DOI 10.1172/JCI79214; Smillie CS, 2018, CELL HOST MICROBE, V23, P229, DOI 10.1016/j.chom.2018.01.003; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tramontano M, 2018, NAT MICROBIOL, V3, P514, DOI 10.1038/s41564-018-0123-9; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007; Zhao S, 2018, ADAPTIVE EVOLUTION G, DOI [10.1101/208009, DOI 10.1101/208009]; Zou YQ, 2019, NAT BIOTECHNOL, V37, P179, DOI 10.1038/s41587-018-0008-8	73	124	126	4	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1442	+		10.1038/s41591-019-0559-3	http://dx.doi.org/10.1038/s41591-019-0559-3			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31477907				2022-12-27	WOS:000484832800028
J	Stower, H				Stower, Hannah			Rapid lower respiratory tract infectious diagnosis	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1189	1189		10.1038/s41591-019-0552-x	http://dx.doi.org/10.1038/s41591-019-0552-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388175	Bronze			2022-12-27	WOS:000480414600008
J	MacPherson, A; Kimmelman, J				MacPherson, Amanda; Kimmelman, Jonathan			Ethical development of stem-cell-based interventions	NATURE MEDICINE			English	Article							SPINAL-CORD-INJURY; HIGH-DOSE CHEMOTHERAPY; GENE-THERAPY; BONE-MARROW; METACHROMATIC LEUKODYSTROPHY; TARGET POPULATIONS; CLINICAL-TRIALS; OPEN-LABEL; HIGH-COST; TRANSPLANTATION	The process of developing new and complex stem-cell-based therapeutics is incremental and requires decades of sustained collaboration among different stakeholders. In this Perspective, we address key ethical and policy challenges confronting the clinical translation of stem-cell-based interventions (SCBIs), including premature diffusion of SCBIs to clinical practice, assessment of risk in trials, obtaining valid informed consent for research participants, balanced and complete scientific reporting and public communications, regulation, and equitable access to treatment. We propose a way forward for translating these therapies with the above challenges in mind.	[MacPherson, Amanda; Kimmelman, Jonathan] McGill Univ, STREAM Res Grp, Biomed Eth Unit, Montreal, PQ, Canada	McGill University	Kimmelman, J (corresponding author), McGill Univ, STREAM Res Grp, Biomed Eth Unit, Montreal, PQ, Canada.	jonathan.kimmelman@mcgill.ca			CIHR grant [PJT-148726]	CIHR grant(Canadian Institutes of Health Research (CIHR))	We thank D. Sipp for helpful feedback on a draft of this manuscript; faults remain our own. We acknowledge the contributions of many scholars whose work we were unable to cite. This work was funded by CIHR grant PJT-148726.	Aach J, 2017, ELIFE, V6, DOI 10.7554/eLife.20674; Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Akyurekli C, 2015, STEM CELL REV REP, V11, P150, DOI 10.1007/s12015-014-9545-9; Almeida-Porada G, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.20; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Anderson AJ, 2017, STEM CELL REP, V8, P249, DOI 10.1016/j.stemcr.2016.12.018; Anderson JA, 2014, BIOETHICS, V28, P138, DOI 10.1111/j.1467-8519.2012.01979.x; [Anonymous], 2017, STEM CELL REP, V8, P194, DOI 10.1016/j.stemcr.2017.02.001; [Anonymous], 1996, BRIT MED J, V313, P1448; [Anonymous], 1979, BIOASS MAL POSS CARC, P5; [Anonymous], 2018, LONG TERM FOLL UP AD; [Anonymous], 2004, NIH GUID INF CONS GE; [Anonymous], 2018, THER GOODS HUM CELLS; [Anonymous], 2019, EXP PROGR REG MED TH; [Anonymous], 2006, GUID IND GEN THER CL; [Anonymous], 2015, AUSTR STEM CELL HDB; [Anonymous], 2018, REP REC WORKGR STUD; [Anonymous], 2017, REG CONS HUM CELLS T, P3; APPELBAUM PS, 1982, INT J LAW PSYCHIAT, V5, P319, DOI 10.1016/0160-2527(82)90026-7; Ballen KK, 2002, TRANSFUSION, V42, P1279, DOI 10.1046/j.1537-2995.2002.00191.x; Balolong E, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2302430; Berger I, 2016, CELL STEM CELL, V19, P158, DOI 10.1016/j.stem.2016.07.015; Berkowitz AL, 2016, NEW ENGL J MED, V375, P196, DOI 10.1056/NEJMc1600188; Borlongan CV, 2016, LANCET, V388, P736, DOI 10.1016/S0140-6736(16)31259-4; Boucher AA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0313-y; Boulis NM, 2012, NAT REV NEUROL, V8, P172, DOI 10.1038/nrneurol.2011.191; Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Bryant A, 2016, JAMA NEUROL, V73, P652, DOI 10.1001/jamaneurol.2016.0113; Bubela T, 2013, STEM CELLS DEV, V22, P89, DOI 10.1089/scd.2013.0398; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Caplan AI, 2014, STEM CELL TRANSL MED, V3, P560, DOI 10.5966/sctm.2013-0180; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carpenter D., 2009, GOVT MARKETS NEW THE, P164; Caulfield T, 2016, SCIENCE, V352, P776, DOI 10.1126/science.aaf4620; Clevers H., 2017, STAT NEWS; Cohen IG, 2016, JAMA-J AM MED ASSOC, V316, P273, DOI 10.1001/jama.2016.4930; Cohen IG, 2015, SCIENCE, V348, P178, DOI 10.1126/science.aaa8153; Cohen PD, 2012, LANCET NEUROL, V11, P1022, DOI 10.1016/S1474-4422(12)70277-6; Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases Institute of Medicine, 2016, MIT REPL TECHN ETH S; Connolly R, 2014, TRAVEL MED INFECT DI, V12, P695, DOI 10.1016/j.tmaid.2014.09.008; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Cosh E, 2007, J COMMER BIOTECHNOL, V13, P263, DOI DOI 10.1057/PALGRAVE.JCB.3050062; Cossu G, 2018, LANCET, V391, P883, DOI 10.1016/S0140-6736(17)31366-1; Cyranoski D, 2018, NATURE, V563, P607, DOI 10.1038/d41586-018-07545-0; Cyranoski D, 2018, NATURE, V557, P619, DOI 10.1038/d41586-018-05278-8; Darnovsky M, 2013, NATURE, V499, P127, DOI 10.1038/499127a; De Los Angeles A, 2015, NATURE, V525, pE6, DOI 10.1038/nature15513; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Djulbegovic B, 2018, J CLIN EPIDEMIOL, V98, P24, DOI 10.1016/j.jclinepi.2018.01.011; Dlouhy BJ, 2014, J NEUROSURG-SPINE, V21, P618, DOI 10.3171/2014.5.SPINE13992; Doerflinger RM, 1999, KENNEDY INST ETHIC J, V9, P137, DOI 10.1353/ken.1999.0011; Downing NS, 2017, JAMA-J AM MED ASSOC, V317, P1854, DOI 10.1001/jama.2017.5150; Emanuel EJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5204; Faden RR, 2003, HASTINGS CENT REP, V33, P13, DOI 10.2307/3527822; Fain K, 2013, JAMA-J AM MED ASSOC, V310, P202, DOI 10.1001/jama.2013.7900; Fan X, 2017, NEURAL REGEN RES, V12, P815, DOI 10.4103/1673-5374.206653; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Frank S, 2005, NEUROLOGY, V65, P1101, DOI 10.1212/01.wnl.0000171957.90640.b5; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman TB, 1999, NEW ENGL J MED, V341, P988, DOI 10.1056/NEJM199909233411311; Fukuda T, 2003, BLOOD, V102, P827, DOI 10.1182/blood-2003-02-0456; Fung M, 2017, STEM CELL REP, V8, P1190, DOI 10.1016/j.stemcr.2017.03.013; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Goel A, 2016, J CRANIOVERTEBRAL JU, V7, P121, DOI 10.4103/0974-8237.181880; Gratwohl A, 2015, LANCET HAEMATOL, V2, pE91, DOI 10.1016/S2352-3026(15)00028-9; Gratwohl A, 2010, JAMA-J AM MED ASSOC, V303, P1617, DOI 10.1001/jama.2010.491; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Henderson GE, 2006, SOC SCI MED, V62, P239, DOI 10.1016/j.socscimed.2005.05.022; Henderson GE, 2004, MOL THER, V10, P225, DOI 10.1016/j.ymthe.2004.05.013; Heneghan C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6295; Hettle R, 2015, EXPLORING ASSESSMENT; Hey SP, 2014, KENNEDY INST ETHIC J, V24, P121, DOI 10.1353/ken.2014.0017; Hey SP, 2014, NEUROLOGY, V82, P77, DOI 10.1212/01.wnl.0000438226.10353.1c; HILLMAN AL, 1991, NEW ENGL J MED, V324, P1362, DOI 10.1056/NEJM199105093241911; Horng Sam, 2003, IRB, V25, P11, DOI 10.2307/3564408; Hunsberger JG, 2016, LANCET NEUROL, V15, P219, DOI 10.1016/S1474-4422(15)00332-4; Hwang TJ, 2018, J CLIN ONCOL, V36, P1805, DOI 10.1200/JCO.2017.77.1592; Hyun I, 2016, NATURE, V533, P169, DOI 10.1038/533169a; Ishii Tetsuya, 2018, Reprod Biomed Soc Online, V5, P93, DOI 10.1016/j.rbms.2018.01.002; ISSCR, 2016, GUID STEM CELL RES C; ISSCR, 2008, PAT HDB STEM CELL TH; Jaklevic M. C., 2017, NEED SCRUTINY MISLEA; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Kamenova K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010496; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kim SH, 2014, SCI CULT-UK, V23, P293, DOI 10.1080/09505431.2013.860095; Kimmelman J, 2005, HUM GENE THER, V16, P502, DOI 10.1089/hum.2005.16.502; Kimmelman J., 2009, GENE TRANSFER ETHICS; Kimmelman J, 2016, LANCET, V387, P1979, DOI 10.1016/S0140-6736(16)30390-7; Kimmelman J, 2016, J MED ETHICS, V42, P50, DOI 10.1136/medethics-2015-102882; Kimmelman J, 2011, MOVEMENT DISORD, V26, P1415, DOI 10.1002/mds.23770; Kite's YescartaTM, 2017, GILEAD SCI; Knoepfler P., NICHE KNOEPFLER LAB; Knoepfler PS, 2015, ADV DRUG DELIVER REV, V82-83, P192, DOI 10.1016/j.addr.2014.12.001; Kolata G, 2001, N Y Times Web, P24; Konomi K, 2015, CELL STEM CELL, V16, P350, DOI 10.1016/j.stem.2015.03.012; Kwon BK, 2013, EXP NEUROL, V248, P30, DOI 10.1016/j.expneurol.2013.05.012; Kwon BK, 2012, J NEUROTRAUM, V29, P2727, DOI 10.1089/neu.2012.2550; Lalu MM, 2016, ELIFE, V5, DOI 10.7554/eLife.17850; Lanthier N, 2018, LANCET GASTROENTEROL, V3, P3, DOI 10.1016/S2468-1253(17)30359-X; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Li MD, 2014, REGEN MED, V9, P27, DOI [10.2217/RME.13.80, 10.2217/rme.13.80]; Lin JK, 2018, J CLIN ONCOL, V36, P3192, DOI 10.1200/JCO.2018.79.0642; Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z; London AJ, 2016, JAMA INTERN MED, V176, P883, DOI 10.1001/jamainternmed.2016.2534; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; LU DR, 1993, SCI CHINA SER B, V36, P1342; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Machin N, 2018, BLOOD ADV, V2, P1792, DOI 10.1182/bloodadvances.2018021345; Majhail NS, 2012, BONE MARROW TRANSPL, V47, P1385, DOI 10.1038/bmt.2011.214; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Marks P, 2018, NEW ENGL J MED, V378, P954, DOI 10.1056/NEJMsr1715626; Martin PJ, 2010, BIOL BLOOD MARROW TR, V16, pS169, DOI 10.1016/j.bbmt.2009.12.057; Martinho AM, 2017, REGEN MED, V12, P419, DOI [10.2217/rme-2017-0002, 10.2217/rme-2017-0015]; Mello MM, 2001, HEALTH AFFAIR, V20, P101, DOI 10.1377/hlthaff.20.5.101; Mukherjee S., 2017, FORTUNE; Munsie M, 2017, REGEN MED, V12, P777, DOI 10.2217/rme-2017-0070; Munsie M, 2014, STEM CELLS DEV, V23, P34, DOI 10.1089/scd.2014.0332; Murdoch B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019414; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Newsome PN, 2018, LANCET GASTROENTEROL, V3, P25, DOI 10.1016/S2468-1253(17)30326-6; Nichols K., 2016, TRANSLATIONAL SCI; Nigro P, 2018, PHARMACOL RES, V127, P77, DOI 10.1016/j.phrs.2017.02.015; Nisbet MC, 2004, PUBLIC OPIN QUART, V68, P131, DOI 10.1093/poq/nfh009; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Okada K, 2018, CLIN THER, V40, P1076, DOI 10.1016/j.clinthera.2018.05.008; Oransky I., 2018, STAT NEWS; Palacios-Gonzalez C, 2017, J LAW BIOSCI, V4, P50, DOI 10.1093/jlb/lsw065; Pease AM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1680; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Perkins KM, 2018, MMWR-MORBID MORTAL W, V67, P1397, DOI 10.15585/mmwr.mm6750a5; Peters R, 2018, NAT REV DRUG DISCOV, V17, P493, DOI 10.1038/nrd.2018.70; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Quesenberry PJ, 2005, SCIENCE, V308, P1121, DOI 10.1126/science.1104432; Rasiel EB, 2005, MED DECIS MAKING, V25, P609, DOI 10.1177/0272989X05282642; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Redmond DE, 2002, NEUROSCIENTIST, V8, P457, DOI 10.1177/107385802237703; Rettig R. A., 2007, FALSE HOPE BONE MARR; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; SCHWARTZ LM, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.D8164; Scott C. T., 2010, AJOB PRIMARY RES, V1, P4; Servick K., 2016, SCIENCE, DOI [10.1126/science.aal0500, DOI 10.1126/SCIENCE.AAL0500]; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Sipp D, 2018, NATURE, V561, P455, DOI 10.1038/d41586-018-06756-9; Sipp D, 2018, PERSPECT BIOL MED, V61, P25, DOI 10.1353/pbm.2018.0025; Sipp D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0426; Sipp D, 2012, REGEN MED, V7, P105, DOI [10.2217/RME.12.75, 10.2217/rme.12.75]; Snyder J, 2018, JAMA-J AM MED ASSOC, V319, P1935, DOI 10.1001/jama.2018.3057; Spahr L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053719; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Sulmasy DP, 2010, CANCER-AM CANCER SOC, V116, P3702, DOI 10.1002/cncr.25201; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015; The ALS Association, 2018, RIGHT TRY OFF STAT; The Goldwater Institute, 2014, EVERYONE DESERVES RI; Thirabanjasak D, 2010, J AM SOC NEPHROL, V21, P1218, DOI 10.1681/ASN.2009111156; Thomas ED, 1999, BRIT J HAEMATOL, V105, P330, DOI 10.1111/j.1365-2141.1999.01337.x; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Tirrell M., 2018, CNBC; Tiwari SS, 2018, CELL STEM CELL, V23, P649, DOI 10.1016/j.stem.2018.10.007; Turner L, 2018, REGEN MED, V13, P643, DOI 10.2217/rme-2018-0033; Turner L, 2016, CELL STEM CELL, V19, P154, DOI 10.1016/j.stem.2016.06.007; van Besien K, 2001, BONE MARROW TRANSPL, V28, P545, DOI 10.1038/sj.bmt.1703208; Victory J., 2016, JOURNALISTS 9 TIPS C; Vogel G., 2016, SCIENCE, DOI [10.1126/science.aal0519, DOI 10.1126/SCIENCE.AAL0519]; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weinfurt KP, 2007, J CLIN ONCOL, V25, P223, DOI 10.1200/JCO.2006.08.9029; Wenner DM, 2015, CELL STEM CELL, V17, P135, DOI 10.1016/j.stem.2015.07.016; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; Wirth E, 2011, CELL STEM CELL, V8, P476, DOI 10.1016/j.stem.2011.04.008; World Medical Association, 2008, WORLD MED J, V54, P122; Yla-Herttuala S, 2015, MOL THER, V23, P217, DOI 10.1038/mt.2014.248; Zarzeczny A, 2010, NAT BIOTECHNOL, V28, P1243, DOI 10.1038/nbt1210-1243b; Zhang JY, 2017, REGEN MED, V12, P647, DOI 10.2217/rme-2017-0035; Zoon K. C., 2001, LETT SPONSORS RES HU	180	14	15	1	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1037	1044		10.1038/s41591-019-0511-6	http://dx.doi.org/10.1038/s41591-019-0511-6			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270501				2022-12-27	WOS:000474430400015
J	Dedrick, RM; Guerrero-Bustamante, CA; Garlena, RA; Russell, DA; Ford, K; Harris, K; Gilmour, KC; Soothill, J; Jacobs-Sera, D; Schooley, RT; Hatfull, GF; Spencer, H				Dedrick, Rebekah M.; Guerrero-Bustamante, Carlos A.; Garlena, Rebecca A.; Russell, Daniel A.; Ford, Katrina; Harris, Kathryn; Gilmour, Kimberly C.; Soothill, James; Jacobs-Sera, Deborah; Schooley, Robert T.; Hatfull, Graham F.; Spencer, Helen			Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus	NATURE MEDICINE			English	Article							NONTUBERCULOUS MYCOBACTERIA; HOST-RANGE	A 15-year-old patient with cystic fibrosis with a disseminated Mycobacterium abscessus infection was treated with a three-phage cocktail following bilateral lung transplantation. Effective lytic phage derivatives that efficiently kill the infectious M. abscessus strain were developed by genome engineering and forward genetics. Intravenous phage treatment was well tolerated and associated with objective clinical improvement, including sternal wound closure, improved liver function, and substantial resolution of infected skin nodules.	[Dedrick, Rebekah M.; Guerrero-Bustamante, Carlos A.; Garlena, Rebecca A.; Russell, Daniel A.; Jacobs-Sera, Deborah; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Ford, Katrina; Harris, Kathryn; Gilmour, Kimberly C.; Soothill, James; Spencer, Helen] Great Ormond St Hosp Sick Children, London, England; [Schooley, Robert T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of California System; University of California San Diego	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.; Spencer, H (corresponding author), Great Ormond St Hosp Sick Children, London, England.	gfh@pitt.edu; helen.spencer@gosh.nhs.uk		Guerrero, Carlos/0000-0002-7256-5188; Dedrick, Rebekah/0000-0002-3666-711X	National Institutes of Health [GM116884]; Howard Hughes Medical Institute [54308198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sampson, L. Holst, and S. Pinches for the discovery of BPs, Muddy, and ZoeJ, respectively, and the students and faculty in the Mycobacterial Genetics Course at the University of KwaZulu Natal and in the SEA-PHAGES program for their contributions in isolating and characterizing the collection of phages used here. Further information about the phages, who isolated them and from where is available at https://phagesdb.org.We thank the Great Ormond Street Hospital staff in the Departments of Microbiology, Cell Therapy, and Pharmacy for excellent technical assistance, C. Murphy for assistance with strains and sera, J. Standing and B. Margetts for assistance with figures, D. Bain at the University of Pittsburgh for the ICP-MS analysis, and A. Betsko for electron microscopy. We greatly appreciate the advice of J. Hartley on regulatory aspects, and thank C. Hamilton for help with translation. We thank T. Mavrich for comments on the manuscript and we are grateful to S. Strathdee for general advice and comments on the manuscript. This work was funded by the National Institutes of Health (grant GM116884 to G.F.H.) and the Howard Hughes Medical Institute (grant 54308198 to G.F.H.).	Adler Frederick R, 2009, Proc Am Thorac Soc, V6, P619, DOI 10.1513/pats.2009008-088TL; Bloom BR, 2017, MAJOR INFECT DIS, DOI 10.1596/978-1-4648-0524-0/ch11; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; Chan BK, 2018, EVOL MED PUBLIC HLTH, P60, DOI 10.1093/emph/eoy005; Dedrick RM, 2019, TUBERCULOSIS, V115, P14, DOI 10.1016/j.tube.2019.01.002; Furukawa BS, 2018, SEMIN RESP CRIT CARE, V39, P383, DOI 10.1055/s-0038-1651495; Griffith David E, 2014, F1000Prime Rep, V6, P107, DOI 10.12703/P6-107; Hatfull GF, 2015, J VIROL, V89, P8107, DOI 10.1128/JVI.01340-15; Honda JR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02029; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Kakasis A, 2019, INT J ANTIMICROB AG, V53, P16, DOI 10.1016/j.ijantimicag.2018.09.004; Koz'min-Sokolov B N, 1975, Probl Tuberk, P75; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Martiniano SL, 2017, PEDIATR PULM, V52, pS29, DOI 10.1002/ppul.23825; Osmani M, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12835; Russell DA, 2018, METHODS MOL BIOL, V1681, P109, DOI 10.1007/978-1-4939-7343-9_9; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Schooley RT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00954-17; Sula L, 1981, Czech Med, V4, P209; Trigo G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002183; 2012, J COMPUT BIOL, V19, P455, DOI DOI 10.1089/CMB.2012.0021	21	511	527	33	291	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					730	+		10.1038/s41591-019-0437-z	http://dx.doi.org/10.1038/s41591-019-0437-z			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068712	Green Accepted, Green Submitted			2022-12-27	WOS:000468247800014
J	Le Tourneau, C; Borcoman, E; Kamal, M				Le Tourneau, Christophe; Borcoman, Edith; Kamal, Maud			Molecular profiling in precision medicine oncology	NATURE MEDICINE			English	Editorial Material							TUMORS; CANCERS	Three innovative precision medicine studies show the utility of evidence beyond that from tumor DNA sequencing to guide therapy in patients with cancer.	[Le Tourneau, Christophe; Borcoman, Edith; Kamal, Maud] Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France; [Le Tourneau, Christophe; Borcoman, Edith; Kamal, Maud] Inst Curie, Dept Drug Dev & Innovat D3i, St Cloud, France; [Le Tourneau, Christophe] INSERM, U900, Res Unit, St Cloud, France; [Le Tourneau, Christophe] Paris Saclay Univ, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Le Tourneau, C (corresponding author), Inst Curie, Dept Drug Dev & Innovat D3i, Paris, France.; Le Tourneau, C (corresponding author), Inst Curie, Dept Drug Dev & Innovat D3i, St Cloud, France.; Le Tourneau, C (corresponding author), INSERM, U900, Res Unit, St Cloud, France.; Le Tourneau, C (corresponding author), Paris Saclay Univ, Paris, France.	Christophe.LeTourneau@curie.fr		Le Tourneau, Christophe/0000-0001-9772-4686				Belin L, 2017, ANN ONCOL, V28, P590, DOI 10.1093/annonc/mdw666; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Rodon J, 2019, NAT MED, V25, P751, DOI 10.1038/s41591-019-0424-4; Rothwell DG, 2019, NAT MED, V25, P738, DOI 10.1038/s41591-019-0380-z; Sicklick JK, 2019, NAT MED, V25, P744, DOI 10.1038/s41591-019-0407-5; Stockley TL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0364-2; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Yates LR, 2018, ANN ONCOL, V29, P30, DOI 10.1093/annonc/mdx707	11	34	34	3	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					711	712		10.1038/s41591-019-0442-2	http://dx.doi.org/10.1038/s41591-019-0442-2			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31036881				2022-12-27	WOS:000468247800010
J	Feng, XD; Guan, DX; Auen, T; Choi, JW; Hernandez, MAS; Lee, J; Chun, H; Faruk, F; Kaplun, E; Herbert, Z; Copps, KD; Ozcan, U				Feng, Xudong; Guan, Dongxian; Auen, Thomas; Choi, Jae Won; Hernandez, Mario Andres Salazar; Lee, Jaemin; Chun, Hyonho; Faruk, Farhana; Kaplun, Esther; Herbert, Zachary; Copps, Kyle D.; Ozcan, Umut			IL1R1 is required for celastrol's leptin-sensitization and antiobesity effects	NATURE MEDICINE			English	Article							UNFOLDED PROTEIN RESPONSE; RECEPTOR SUPERFAMILY; INSULIN SENSITIVITY; ENERGY-BALANCE; OBESITY; INFLAMMATION; RESISTANCE; STRESS; EXPRESSION; ANAKINRA	Celastrol, a pentacyclic triterpene, is the most potent antiobesity agent that has been reported thus far(1). The mechanism of celastrol's leptin-sensitizing and antiobesity effects has not yet been elucidated. In this study, we identified interleukin-1 receptor 1 (IL1R1) as a mediator of celastrol's action by using temporally resolved analysis of the hypothalamic transcriptome in celastrol-treated DIO, lean, and db/db mice. We demonstrate that IL1R1-deficient mice are completely resistant to the effects of celastrol in leptin sensitization and treatment of obesity, diabetes, and nonalcoholic steatohepatitis. Thus, we conclude that IL1R1 is a gatekeeper for celastrol's metabolic actions.	[Feng, Xudong; Guan, Dongxian; Auen, Thomas; Choi, Jae Won; Hernandez, Mario Andres Salazar; Lee, Jaemin; Faruk, Farhana; Kaplun, Esther; Copps, Kyle D.; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Chun, Hyonho] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Herbert, Zachary] Harvard Med Sch, Dana Farber Canc Inst, Mol Biol Core Facil, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ozcan, U (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu	Lee, Jaemin/AAP-4875-2021; Salazar, Mario/GSN-2646-2022	Lee, Jaemin/0000-0002-0224-7141	Department of Medicine; Smith President's Innovation Award from Boston Children's Hospital; National Institutes of Health [R01DK098496, R56DK098496]; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098496] Funding Source: NIH RePORTER	Department of Medicine; Smith President's Innovation Award from Boston Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was mainly supported by the funds provided to U.O. from the Department of Medicine, the Smith President's Innovation Award from Boston Children's Hospital, and grants R01DK098496 and R56DK098496 provided to U.O. by the National Institutes of Health, as well as by support from the Fidelity Biosciences Research Initiative.	Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Iurlaro R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00479-16; Jiao P, 2012, ENDOCRINOLOGY, V153, P154, DOI 10.1210/en.2011-1346; Joyce BR, 2013, EUKARYOT CELL, V12, P979, DOI 10.1128/EC.00021-13; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; Liu JL, 2016, CELL, V167, P1052, DOI 10.1016/j.cell.2016.10.015; Liu JL, 2015, CELL, V161, P999, DOI 10.1016/j.cell.2015.05.011; McGillicuddy FC, 2013, AM J PHYSIOL-ENDOC M, V305, pE834, DOI 10.1152/ajpendo.00297.2013; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan WW, 2018, NAT REV NEUROSCI, V19, P95, DOI 10.1038/nrn.2017.168; Pang IK, 2013, NAT IMMUNOL, V14, P246, DOI 10.1038/ni.2514; Peelman F, 2014, J ENDOCRINOL, V223, pT9, DOI 10.1530/JOE-14-0264; Sadagurski M, 2010, DIABETOLOGIA, V53, P525, DOI 10.1007/s00125-009-1580-8; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Schwartz Michael W, 2013, J Clin Invest, V123, P2344, DOI 10.1172/JCI69346; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; Vasilyev FF, 2015, CELL MOL IMMUNOL, V12, P222, DOI 10.1038/cmi.2014.43; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002	36	50	57	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					575	+		10.1038/s41591-019-0358-x	http://dx.doi.org/10.1038/s41591-019-0358-x			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30833749	Green Accepted			2022-12-27	WOS:000463342800018
J	Malehmir, M; Pfister, D; Gallage, S; Szydlowska, M; Inverso, D; Kotsiliti, E; Leone, V; Peiseler, M; Surewaard, BGJ; Rath, D; Ali, A; Wolf, MJ; Drescher, H; Healy, ME; Dauch, D; Kroy, D; Krenkel, O; Kohlhepp, M; Engleitner, T; Olkus, A; Sijmonsma, T; Volz, J; Deppermann, C; Stegner, D; Helbling, P; Nombela-Arrieta, C; Rafiei, A; Hinterleitner, M; Rall, M; Baku, F; Borst, O; Wilson, CL; Leslie, J; O'Connor, T; Weston, CJ; Adams, DH; Sheriff, L; Teijeiro, A; Prinz, M; Bogeska, R; Anstee, N; Bongers, MN; Notohamiprodjo, M; Geisler, T; Withers, DJ; Ware, J; Mann, DA; Augustin, HG; Vegiopoulos, A; Milsom, MD; Rose, AJ; Lalor, PF; Llovet, JM; Pinyol, R; Tacke, F; Rad, R; Matter, M; Djouder, N; Kubes, P; Knolle, PA; Unger, K; Zender, L; Nieswandt, B; Gawaz, M; Weber, A; Heikenwalder, M				Malehmir, Mohsen; Pfister, Dominik; Gallage, Suchira; Szydlowska, Marta; Inverso, Donato; Kotsiliti, Elena; Leone, Valentina; Peiseler, Moritz; Surewaard, Bas G. J.; Rath, Dominik; Ali, Adnan; Wolf, Monika Julia; Drescher, Hannah; Healy, Marc E.; Dauch, Daniel; Kroy, Daniela; Krenkel, Oliver; Kohlhepp, Marlene; Engleitner, Thomas; Olkus, Alexander; Sijmonsma, Tjeerd; Volz, Julia; Deppermann, Carsten; Stegner, David; Helbling, Patrick; Nombela-Arrieta, Cesar; Rafiei, Anahita; Hinterleitner, Martina; Rall, Marcel; Baku, Florian; Borst, Oliver; Wilson, Caroline L.; Leslie, Jack; O'Connor, Tracy; Weston, Christopher J.; Adams, David H.; Sheriff, Lozan; Teijeiro, Ana; Prinz, Marco; Bogeska, Ruzhica; Anstee, Natasha; Bongers, Malte N.; Notohamiprodjo, Mike; Geisler, Tobias; Withers, Dominic J.; Ware, Jerry; Mann, Derek A.; Augustin, Hellmut G.; Vegiopoulos, Alexandros; Milsom, Michael D.; Rose, Adam J.; Lalor, Patricia F.; Llovet, Josep M.; Pinyol, Roser; Tacke, Frank; Rad, Roland; Matter, Matthias; Djouder, Nabil; Kubes, Paul; Knolle, Percy A.; Unger, Kristian; Zender, Lars; Nieswandt, Bernhard; Gawaz, Meinrad; Weber, Achim; Heikenwalder, Mathias			Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer	NATURE MEDICINE			English	Article							CAUSES NONALCOHOLIC STEATOHEPATITIS; SET ENRICHMENT ANALYSIS; IN-VIVO DEPLETION; NF-KAPPA-B; GLYCOPROTEIN-VI; HEPATOCELLULAR-CARCINOMA; ANTIPLATELET THERAPY; FACTOR BINDING; MOUSE MODEL; INFLAMMATION	Non-alcoholic fatty liver disease ranges from steatosis to non-alcoholic steatohepatitis (NASH), potentially progressing to cirrhosis and hepatocellular carcinoma (HCC). Here, we show that platelet number, platelet activation and platelet aggregation are increased in NASH but not in steatosis or insulin resistance. Antiplatelet therapy (APT; aspirin/clopidogrel, ticagrelor) but not nonsteroidal anti-inflammatory drug (NSAID) treatment with sulindac prevented NASH and subsequent HCC development. Intravital microscopy showed that liver colonization by platelets depended primarily on Kupffer cells at early and late stages of NASH, involving hyaluronan-CD44 binding. APT reduced intrahepatic platelet accumulation and the frequency of platelet-immune cell interaction, thereby limiting hepatic immune cell trafficking. Consequently, intrahepatic cytokine and chemokine release, macrovesicular steatosis and liver damage were attenuated. Platelet cargo, platelet adhesion and platelet activation but not platelet aggregation were identified as pivotal for NASH and subsequent hepatocarcinogenesis. In particular, platelet-derived GPIb alpha proved critical for development of NASH and subsequent HCC, independent of its reported cognate ligands vWF, P-selectin or Mac-1, offering a potential target against NASH.	[Malehmir, Mohsen; Wolf, Monika Julia; Healy, Marc E.; Weber, Achim] Univ Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Malehmir, Mohsen; Wolf, Monika Julia; Healy, Marc E.; Weber, Achim] Univ Zurich Hosp, Zurich, Switzerland; [Pfister, Dominik; Gallage, Suchira; Szydlowska, Marta; Kotsiliti, Elena; Leone, Valentina; Ali, Adnan; Olkus, Alexander; Sijmonsma, Tjeerd; Heikenwalder, Mathias] German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Heidelberg, Germany; [Inverso, Donato; Augustin, Hellmut G.] DKFZ ZMBH Alliance, German Canc Res Ctr Heidelberg, Div Vasc Oncol & Metastasis, Heidelberg, Germany; [Inverso, Donato; Augustin, Hellmut G.] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany; [Kotsiliti, Elena; O'Connor, Tracy; Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Leone, Valentina; Unger, Kristian] Helmholtz Zentrum Munchen, Res Unit Radiat Cytogenet, Neuherberg, Germany; [Peiseler, Moritz; Kubes, Paul] Univ Calgary, Cumming Sch Med, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Peiseler, Moritz; Surewaard, Bas G. J.; Kubes, Paul] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Surewaard, Bas G. J.; Kubes, Paul] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Surewaard, Bas G. J.] Univ Med Ctr, Dept Med Microbiol, Utrmeecht, Netherlands; [Rath, Dominik; Rall, Marcel; Baku, Florian; Borst, Oliver; Gawaz, Meinrad] Eberhard Karls Univ Tubingen, Internal Med Clin 3, Dept Cardiol & Circulatory Dis, Tubingen, Germany; [Drescher, Hannah; Kroy, Daniela; Krenkel, Oliver; Kohlhepp, Marlene; Tacke, Frank] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Dauch, Daniel; Hinterleitner, Martina; Zender, Lars] Univ Hosp Tubingen, Dept Internal Med 8, Tubingen, Germany; [Dauch, Daniel; Hinterleitner, Martina; Zender, Lars] Eberhard Karls Univ Tubingen, Inst Physiol, Dept Physiol 1, Tubingen, Germany; [Engleitner, Thomas; Rad, Roland] Tech Univ Munich, Ctr Translat Canc Res TranslaTUM, Munich, Germany; [Engleitner, Thomas; Rad, Roland] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, Munich, Germany; [Engleitner, Thomas; Rad, Roland] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Olkus, Alexander] Heidelberg Univ, Fac Med, Heidelberg, Germany; [Volz, Julia; Deppermann, Carsten; Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Univ Hosp, Inst Expt Biomed, Wurzburg, Germany; [Volz, Julia; Deppermann, Carsten; Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Helbling, Patrick; Nombela-Arrieta, Cesar; Rafiei, Anahita] Univ Hosp, Hematol, Zurich, Switzerland; [Helbling, Patrick; Nombela-Arrieta, Cesar; Rafiei, Anahita] Univ Zurich, Zurich, Switzerland; [Wilson, Caroline L.; Leslie, Jack; Mann, Derek A.] Newcastle Univ, Inst Cellular Med, Newcastle Fibrosis Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [O'Connor, Tracy; Knolle, Percy A.] Tech Univ Munich, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Weston, Christopher J.; Adams, David H.; Lalor, Patricia F.] Ctr Liver Res, Birmingham, W Midlands, England; [Weston, Christopher J.; Adams, David H.; Lalor, Patricia F.] Natl Inst Hlth Res NIHR Birmingham Liver Biomed R, Birmingham, W Midlands, England; [Adams, David H.] Univ Hosp Birmingham NHS Trust, Liver Unit, Birmingham, W Midlands, England; [Sheriff, Lozan] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Teijeiro, Ana; Djouder, Nabil] CNIO, Spanish Natl Canc Res Ctr, Canc Cell Biol Programme, Growth Factors Nutrients & Canc Grp, Madrid, Spain; [Prinz, Marco] Univ Freiburg, Fac Med, Inst Neuropathol, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr CIBSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Fac Med, Ctr NeuroModulat, Freiburg, Germany; [Bogeska, Ruzhica; Anstee, Natasha; Milsom, Michael D.] Deutsch Krebsforschungszentrum DKFZ, Div Expt Hematol, Heidelberg, Germany; [Bogeska, Ruzhica; Anstee, Natasha; Milsom, Michael D.] DKFZ ZMBH Alliance, Deutsch Krebsforschungszentrum DKFZ, Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany; [Bongers, Malte N.; Notohamiprodjo, Mike] Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Geisler, Tobias] Eberhard Karls Univ Tubingen, Univ Hosp, Dept Cardiovasc Med, Tubingen, Germany; [Withers, Dominic J.] MRC London Inst Med Sci, Metab Signalling Grp, London, England; [Withers, Dominic J.] Imperial Coll London, Fac Med, Inst Clin Sci, London, England; [Ware, Jerry] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Vegiopoulos, Alexandros] German Canc Res Ctr, DKFZ Jr Grp Metab & Stem Cell Plast, Heidelberg, Germany; [Rose, Adam J.] Monash Univ, Nutrient Metab & Signalling Lab, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic, Australia; [Rose, Adam J.] Monash Univ, Biomed Discovery Inst, Metab Diabet & Obes Program, Clayton, Vic, Australia; [Llovet, Josep M.] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Mt Sinai Liver Canc Program,Tisch Canc Inst, Div Liver Dis,Dept Med,Dept Pathol, New York, NY 10029 USA; [Llovet, Josep M.; Pinyol, Roser] Univ Barcelona, Hosp Clin, Liver Canc Translat Res Lab, IDIBAPS,Liver Unit, Barcelona, Catalonia, Spain; [Llovet, Josep M.] ICREA, Barcelona, Catalonia, Spain; [Matter, Matthias] Univ Hosp Basel, Inst Pathol, Basel, Switzerland; [Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany	University of Zurich; University of Zurich; University Zurich Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Calgary; University of Calgary; University of Calgary; Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Wurzburg; University of Wurzburg; University of Zurich; University Zurich Hospital; University of Zurich; Newcastle University - UK; Technical University of Munich; University of Birmingham; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Imperial College London; University of Arkansas System; University of Arkansas Medical Sciences; Helmholtz Association; German Cancer Research Center (DKFZ); Monash University; Monash University; Icahn School of Medicine at Mount Sinai; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ)	Weber, A (corresponding author), Univ Zurich, Dept Pathol & Mol Pathol, Zurich, Switzerland.; Weber, A (corresponding author), Univ Zurich Hosp, Zurich, Switzerland.; Heikenwalder, M (corresponding author), German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Heidelberg, Germany.; Heikenwalder, M (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany.	achim.weber@usz.ch; heikenwaelder@helmholtz-muenchen.de	Unger, Kristian/F-3730-2018; Augustin, Hellmut/AAA-5246-2020; Pfister, Dominik/AAK-7358-2021; Geisler, Tobias/AAO-4472-2020; Teijeiro, Ana/G-2788-2016; Llovet, Josep M/ABB-6264-2021; Stegner, David/AAA-4948-2019; Tacke, Frank/ABF-2212-2020; Pinyol, Roser/AAA-4404-2019; Inverso, Donato/AAA-5387-2022; Adams, David H/C-9092-2009; Djouder, Nabil/E-4135-2015; Lalor, Patricia/AAB-9621-2019; Rose, Adam John/AAC-6274-2019; Mir, Mohsen Maleh/P-5890-2019; Heikenwalder, Mathias/AAA-2269-2020; Inverso, Donato/GOV-7283-2022; Llovet, Josep M/D-4340-2014; Milsom, Michael/AAK-4600-2020	Unger, Kristian/0000-0002-0374-2320; Augustin, Hellmut/0000-0002-7173-4242; Pfister, Dominik/0000-0002-0542-2638; Llovet, Josep M/0000-0003-0547-2667; Stegner, David/0000-0003-1059-9865; Adams, David H/0000-0001-6776-0336; Djouder, Nabil/0000-0001-8423-1030; Lalor, Patricia/0000-0001-8733-5273; Rose, Adam John/0000-0001-9132-8244; Mir, Mohsen Maleh/0000-0001-6915-5850; Llovet, Josep M/0000-0003-0547-2667; Gallage, Suchira/0000-0002-1956-3597; Healy, Marc/0000-0001-9441-1166; Weston, Chris/0000-0002-9651-1264; Drescher, Hannah/0000-0001-9945-1239; Knolle, Percy A./0000-0003-2983-0414; Inverso, Donato/0000-0003-0987-3345; Matter, Matthias/0000-0002-2005-5266; Pinyol, Roser/0000-0002-0288-6314; Helbling, Patrick/0000-0001-6488-2805; Borst, Oliver/0000-0003-4002-4085; Weber, Achim/0000-0003-0073-3637; Szydlowska, Marta/0000-0002-4660-899X; Nombela-Arrieta, Cesar/0000-0003-0415-259X; leslie, jack/0000-0001-6443-2396; Teijeiro, Ana/0000-0003-2276-7950; Peiseler, Moritz/0000-0001-6195-3866; Bogeska, Ruzhica/0000-0002-2064-1695; Mann, Derek/0000-0003-0950-243X; /0000-0002-3567-254X; Anstee, Natasha/0000-0003-2093-1403	University Zurich (Zurich Integrative Human Physiology (ZHIP) Sprint Fellowship); Hartmann Muller Stiftung, Zurich; Swiss National Science Foundation [320030_182764/1]; ERC; EOS grant; Research Foundation Flanders (FWO) [30826052]; Deutsche Krebshilfe projects [70113166, 70113167]; Helmholtz-Gemeinschaft, Zukunftsthema 'Immunology and Inflammation [ZT-0027]; European Union [667273]; DFG [SFB/TR 240, 374031971]; German Research Foundation (DFG) [FOR2314, SFB685]; Gottfried Wilhelm Leibniz Program; German Ministry for Education and Research (BMBF) (eMed/Multiscale HCC); German Universities Excellence Initiative (third funding line: 'future concept'); German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST); EMBO Long-term Fellowship; Asociacion Espanola Contra el Cancer (Accelerator award: HUNTER); Spanish National Health Institute [SAF2013-41027]; Generalitat de Catalunya [SGR 1162, SGR-1358]; Samuel Waxman Cancer Research Foundation; US Department of Defense [CA150272P3]; European Commission [667273-2]; National Cancer Institute [P30 CA196521]; CRUK grant [C18342/A23390]; MRC grant [MR/K001949/1]; German Research Foundation (DFG); German Research Foundation [374031971, KFO274, SFB/TR240]; Wellcome Trust [098565/Z/12/Z]; Medical Research Council [MC-A654-5QB40]; CRUK project Cancer Research UK Programme Grant [C18342/A23390]; Deutsche Forschungsgemeinschaft [SFB-TR209];  [SFBTR 209];  [SFBTR179]; MRC [G0300102, G0300101, G0700301, MR/M009157/1, G0802577, G0400496, MC_PC_14123] Funding Source: UKRI	University Zurich (Zurich Integrative Human Physiology (ZHIP) Sprint Fellowship); Hartmann Muller Stiftung, Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC(European Research Council (ERC)European Commission); EOS grant; Research Foundation Flanders (FWO)(FWO); Deutsche Krebshilfe projects; Helmholtz-Gemeinschaft, Zukunftsthema 'Immunology and Inflammation; European Union(European Commission); DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; German Ministry for Education and Research (BMBF) (eMed/Multiscale HCC)(Federal Ministry of Education & Research (BMBF)); German Universities Excellence Initiative (third funding line: 'future concept'); German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST); EMBO Long-term Fellowship(European Molecular Biology Organization (EMBO)); Asociacion Espanola Contra el Cancer (Accelerator award: HUNTER); Spanish National Health Institute(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Samuel Waxman Cancer Research Foundation; US Department of Defense(United States Department of Defense); European Commission(European CommissionEuropean Commission Joint Research Centre); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CRUK grant; MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK project Cancer Research UK Programme Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Heide, J. Hetzer, R. Hillermann, C. Gropp, F. Muller, S. Prokosch, D. Kull, R. Dunkl, O. Seelbach, M. Bawohl, R. Maire, M. Bieri, C. Mittmann, H. HoncharovaBiletska, A. Fitsche, A. Adili, P. Munzer, T. Nussbaumer, F. Prutek, G. Dharmalingam and I. Singh for excellent technical assistance. We thank K. Nikolaou for the help with the human cohort recruitment and analysis. M. Malehmir was partially supported by grants from the University Zurich (Zurich Integrative Human Physiology (ZHIP) Sprint Fellowship) and from the Hartmann Muller Stiftung, Zurich. A.W. was supported by a grant from the Swiss National Science Foundation (320030_182764/1). M. Heikenwaelder was supported by an ERC Consolidator grant (HepatoMetaboPath), an EOS grant, SFBTR 209, SFBTR179, Research Foundation Flanders (FWO) under grant 30826052 (EOS Convention MODEL-IDI), Deutsche Krebshilfe projects 70113166 and 70113167, and the Helmholtz-Gemeinschaft, Zukunftsthema 'Immunology and Inflammation' (ZT-0027). This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement 667273 and the DFG (SFB/TR 240 (project 374031971) to B.N. and D. S.), ERC Consolidator grant 'CholangioConcept' (to L.Z.), and the German Research Foundation (DFG): grants FOR2314, SFB685 and the Gottfried Wilhelm Leibniz Program (to L.Z.). Further funding was provided by the German Ministry for Education and Research (BMBF) (eMed/Multiscale HCC), the German Universities Excellence Initiative (third funding line: 'future concept'), the German Center for Translational Cancer Research (DKTK) and the German-Israeli Cooperation in Cancer Research (DKFZ-MOST) (to L.Z. and M. Heikenwaelder). D. I. was supported by an EMBO Long-term Fellowship. J.M.L. is supported by Asociacion Espanola Contra el Cancer (Accelerator award: HUNTER), Spanish National Health Institute (SAF2013-41027), Generalitat de Catalunya (SGR 1162 and AGAUR, SGR-1358), the Samuel Waxman Cancer Research Foundation, the US Department of Defense (CA150272P3), the European Commission Horizon 2020 Program (HEPCAR, proposal number 667273-2), and the National Cancer Institute (P30 CA196521). D. A. M. is supported by CRUK grant C18342/A23390 and MRC grant MR/K001949/1. M. P. is supported by the German Research Foundation (DFG). M. G., T. G. and D. R. was supported by grants from the German Research Foundation (KFO274 and SFB/TR240 (project 374031971)). D. J. W. received a Wellcome Trust Strategic Award (098565/Z/12/Z) and funding from the Medical Research Council (MC-A654-5QB40). C.L.W. was funded by CRUK project Cancer Research UK Programme Grant C18342/A23390. H. G. A. has been supported by the Deutsche Forschungsgemeinschaft (SFB-TR209 'Liver Cancer').	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; [Anonymous], 1997, Cardiovasc Res, V35, P2; [Anonymous], 2002, Med Etika Bioet, V9, P12; Bayindir-Buchhalter I, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708613; Bender M, 2011, J THROMB HAEMOST, V9, P1423, DOI 10.1111/j.1538-7836.2011.04328.x; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Blenner MA, 2014, J BIOL CHEM, V289, P5565, DOI 10.1074/jbc.M113.511220; Boege Y, 2017, CANCER CELL, V32, P342, DOI 10.1016/j.ccell.2017.08.010; Chauhan A, 2016, HEPATOLOGY, V64, P1774, DOI 10.1002/hep.28526; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; Drescher HK, 2017, J HEPATOL, V66, P1251, DOI 10.1016/j.jhep.2017.02.001; Dutting S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15838; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; El-Serag HB, 2014, HEPATOLOGY, V60, P1767, DOI 10.1002/hep.27222; Fleet SE, 2017, GASTROENTEROL CLIN N, V46, P217, DOI 10.1016/j.gtc.2017.01.002; Franchi F, 2017, NAT REV CARDIOL, V14, P361, DOI 10.1038/nrcardio.2017.18; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Fujita K, 2008, GUT, V57, P1583, DOI 10.1136/gut.2007.144550; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gruner S, 2003, BLOOD, V102, P4021, DOI 10.1182/blood-2003-05-1391; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Haemmerle M, 2018, CANCER CELL, V33, P965, DOI 10.1016/j.ccell.2018.03.002; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2007, CLIN VACCINE IMMUNOL, V14, P1532, DOI 10.1128/CVI.00298-07; International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use, 2001, J Postgrad Med, V47, P45; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kanaji T, 2002, BLOOD, V100, P2102, DOI 10.1182/blood-2002-03-0997; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kopec AK, 2017, J CLIN INVEST, V127, P3152, DOI [10.1172/JCI92744, 10.1172/jci92744]; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; KROLL MH, 1991, J CLIN INVEST, V88, P1568, DOI 10.1172/JCI115468; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370; Levin YS, 2014, J MAGN RESON IMAGING, V39, P567, DOI 10.1002/jmri.24193; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Margetts J, 2018, BRIT J CANCER, V118, P248, DOI 10.1038/bjc.2017.386; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Merkle EM, 2006, RADIOGRAPHICS, V26, P1409, DOI 10.1148/rg.265055711; Michelson AD, 2003, J THROMB THROMBOLYS, V16, P7, DOI 10.1023/B:THRO.0000014586.77684.82; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nieswandt B, 2000, BLOOD, V96, P2520; Nieswandt B, 2001, J EXP MED, V193, P459, DOI 10.1084/jem.193.4.459; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Ozakyol A, 2017, J GASTROINTEST CANC, V48, P238, DOI 10.1007/s12029-017-9959-0; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; Schulte V, 2003, BLOOD, V101, P3948, DOI 10.1182/blood-2002-10-3242; Shen H, 2014, ALIMENT PHARM THER, V40, P1066, DOI 10.1111/apt.12944; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Subramaniam M, 1996, BLOOD, V87, P1238, DOI 10.1182/blood.V87.4.1238.bloodjournal8741238; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; Thon JN, 2012, BLOOD, V120, P1552, DOI 10.1182/blood-2012-04-408724; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Townsend SA, 2016, BRIT MED BULL, V119, P143, DOI 10.1093/bmb/ldw031; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang B, 2016, CELL METAB, V23, P492, DOI 10.1016/j.cmet.2016.01.001; Wang YM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15559; Werner M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138655; Weston CJ, 2015, J CLIN INVEST, V125, P501, DOI 10.1172/JCI73722; Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; Wong VWS, 2016, LANCET GASTROENTEROL, V1, P56, DOI 10.1016/S2468-1253(16)30011-5; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251	85	160	164	7	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					641	+		10.1038/s41591-019-0379-5	http://dx.doi.org/10.1038/s41591-019-0379-5			32	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30936549	Green Submitted			2022-12-27	WOS:000463342800026
J	Newman, S; Fan, LY; Pribnow, A; Silkov, A; Rice, SV; Lee, S; Shao, Y; Shaner, B; Mulder, H; Nakitandwe, J; Shurtleff, S; Azzato, EM; Wu, G; Zhou, X; Barnhill, R; Easton, J; Nichols, KE; Ellison, DW; Downing, JR; Pappo, A; Potter, PM; Zhang, JH; Bahrami, A				Newman, Scott; Fan, Liying; Pribnow, Allison; Silkov, Antonina; Rice, Stephen V.; Lee, Seungjae; Shao, Ying; Shaner, Bridget; Mulder, Heather; Nakitandwe, Joy; Shurtleff, Sheila; Azzato, Elizabeth M.; Wu, Gang; Zhou, Xin; Barnhill, Raymond; Easton, John; Nichols, Kim E.; Ellison, David W.; Downing, James R.; Pappo, Alberto; Potter, Philip M.; Zhang, Jinghui; Bahrami, Armita			Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas	NATURE MEDICINE			English	Article							BRAF MUTATIONS; KINASE; CANCER; TPL-2; INHIBITION; ACTIVATION; LANDSCAPE; RESOURCE; PLATFORM; SEK-1	Spitzoid melanoma is a specific morphologic variant of melanoma that most commonly affects children and adolescents, and ranges on the spectrum of malignancy from low grade to overtly malignant. These tumors are generally driven by fusions of ALK, RET, NTRK1/3, MET, ROS1 and BRAF(1,2). However, in approximately 50% of cases no genetic driver has been established(2). Clinical whole-genome and transcriptome sequencing (RNA-Seq) of a spitzoid tumor from an adolescent revealed a novel gene fusion of MAP3K8, encoding a serine-threonine kinase that activates MEK3,4. The patient, who had exhausted all other therapeutic options, was treated with a MEK inhibitor and underwent a transient clinical response. We subsequently analyzed spitzoid tumors from 49 patients by RNA-Seq and found in-frame fusions or C-terminal truncations of MAP3K8 in 33% of cases. The fusion transcripts and truncated genes all contained MAP3K8 exons 1-8 but lacked the autoinhibitory final exon. Data mining of RNA-Seq from the Cancer Genome Atlas (TCGA) uncovered analogous MAP3K8 rearrangements in 1.5% of adult melanomas. Thus, MAP3K8 rearrangements-uncovered by comprehensive clinical sequencing of a single case-are the most common genetic event in spitzoid melanoma, are present in adult melanomas and could be amenable to MEK inhibition.	[Newman, Scott; Silkov, Antonina; Rice, Stephen V.; Shao, Ying; Shaner, Bridget; Mulder, Heather; Wu, Gang; Zhou, Xin; Easton, John; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Fan, Liying; Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Pribnow, Allison; Nichols, Kim E.; Pappo, Alberto; Bahrami, Armita] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Pribnow, Allison] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol, Palo Alto, CA 94304 USA; [Lee, Seungjae; Nakitandwe, Joy; Shurtleff, Sheila; Azzato, Elizabeth M.; Ellison, David W.; Downing, James R.; Bahrami, Armita] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Barnhill, Raymond] Inst Curie, Dept Pathol, Paris, France; [Barnhill, Raymond] Inst Curie, Dept Translat Res, Paris, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Stanford University; St Jude Children's Research Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Newman, S; Zhang, JH (corresponding author), St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Bahrami, A (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Bahrami, A (corresponding author), St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	scott.newman@stjude.org; jinghui.zhang@stjude.org; armita.bahrami@stjude.org	Nichols, Kim/AAP-8592-2020; Bahrami, Armita/N-3262-2018; Zhang, Jing/GWZ-7332-2022; Wu, Gang/M-8012-2014; Ellison, David/N-4806-2018	Nichols, Kim/0000-0002-5581-6555; Bahrami, Armita/0000-0002-8515-2649; Wu, Gang/0000-0002-1678-5864; Easton, John/0000-0003-4503-6608; Newman, Scott/0000-0001-9309-4752; Lee, Seungjae/0000-0001-9081-2835	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital	American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC))	We thank S. Brady for critical review of the manuscript. This work was funded by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen X, 2015, NAT METHODS, V12, P527, DOI 10.1038/nmeth.3394; Clark AM, 2004, GENE CHROMOSOME CANC, V41, P99, DOI 10.1002/gcc.20069; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Erny KM, 1996, ONCOGENE, V13, P2015; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Gruosso T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9583; Gutman DA, 2017, CANCER RES, V77, pE75, DOI 10.1158/0008-5472.CAN-17-0629; Hagemann D, 1999, ONCOGENE, V18, P1391, DOI 10.1038/sj.onc.1202431; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Hu X, 2018, NUCLEIC ACIDS RES, V46, pD1144, DOI 10.1093/nar/gkx1018; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Lazova R, 2017, MODERN PATHOL, V30, P640, DOI 10.1038/modpathol.2016.237; Lee JH, 2016, CANCER RES, V76, P6712, DOI 10.1158/0008-5472.CAN-15-3274; Lee S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11200; Liang WS, 2017, GENOME RES, V27, P524, DOI 10.1101/gr.213348.116; Little AS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001752; Lu C, 2015, J INVEST DERMATOL, V135, P816, DOI 10.1038/jid.2014.425; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Ranzani M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12316; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rusch M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06485-7; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Seynnaeve B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45704; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Wiesner T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4116; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	45	37	37	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					597	+		10.1038/s41591-019-0373-y	http://dx.doi.org/10.1038/s41591-019-0373-y			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30833747	Green Accepted			2022-12-27	WOS:000463342800021
J	Turajlic, S				Turajlic, Samra			Standing on the shoulders of giants	NATURE MEDICINE			English	Editorial Material									[Turajlic, Samra] Royal Marsden NHS Fdn Trust, Renal Unit, London, England; [Turajlic, Samra] Royal Marsden NHS Fdn Trust, Skin Unit, London, England; [Turajlic, Samra] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Francis Crick Institute	Turajlic, S (corresponding author), Royal Marsden NHS Fdn Trust, Renal Unit, London, England.; Turajlic, S (corresponding author), Royal Marsden NHS Fdn Trust, Skin Unit, London, England.; Turajlic, S (corresponding author), Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England.	samra.turajlic@crick.ac.uk		turajlic, samra/0000-0001-8846-136X					0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					357	357		10.1038/s41591-019-0389-3	http://dx.doi.org/10.1038/s41591-019-0389-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842663	Bronze			2022-12-27	WOS:000460643100004
J	Zhang, JL; Li, JL; Saucier, JB; Feng, YM; Jiang, YJ; Sinson, J; McCombs, AK; Schmitt, ES; Peacock, S; Chen, S; Dai, HZ; Ge, XY; Wang, GL; Shaw, CA; Mei, H; Breman, A; Xia, F; Yang, YP; Purgason, A; Pourpak, A; Chen, Z; Wang, X; Wang, Y; Kulkarni, S; Choy, KW; Wapner, RJ; Van den Veyver, IB; Beaudet, A; Parmar, S; Wong, LJ; Eng, CM				Zhang, Jinglan; Li, Jianli; Saucier, Jennifer B.; Feng, Yanming; Jiang, Yanjun; Sinson, Jefferson; McCombs, Anne K.; Schmitt, Eric S.; Peacock, Sandra; Chen, Stella; Dai, Hongzheng; Ge, Xiaoyan; Wang, Guoli; Shaw, Chad A.; Mei, Hui; Breman, Amy; Xia, Fan; Yang, Yaping; Purgason, Anne; Pourpak, Alan; Chen, Zhao; Wang, Xia; Wang, Yue; Kulkarni, Shashikant; Choy, Kwong Wai; Wapner, Ronald J.; Van den Veyver, Ignatia B.; Beaudet, Arthur; Parmar, Sheetal; Wong, Lee-Jun; Eng, Christine M.			Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA	NATURE MEDICINE			English	Article							SEX-CHROMOSOME ANEUPLOIDIES; MATERNAL PLASMA; DIAGNOSIS; ACHONDROPLASIA; GUIDELINES; FAMILY	Current non-invasive prenatal screening is targeted toward the detection of chromosomal abnormalities in the fetus(1,2). However, screening for many dominant monogenic disorders associated with de novo mutations is not available, despite their relatively high incidence(3). Here we report on the development and validation of, and early clinical experience with, a new approach for non-invasive prenatal sequencing for a panel of causative genes for frequent dominant monogenic diseases. Cell-free DNA (cfDNA) extracted from maternal plasma was barcoded, enriched, and then analyzed by next-generation sequencing (NGS) for targeted regions. Low-level fetal variants were identified by a statistical analysis adjusted for NGS read count and fetal fraction. Pathogenic or likely pathogenic variants were confirmed by a secondary amplicon-based test on cfDNA. Clinical tests were performed on 422 pregnancies with or without abnormal ultrasound findings or family history. Follow-up studies on cases with available outcome results confirmed 20 true-positive, 127 true-negative, zero false-positive, and zero-false negative results. The initial clinical study demonstrated that this non-invasive test can provide valuable molecular information for the detection of a wide spectrum of dominant monogenic diseases, complementing current screening for aneuploidies or carrier screening for recessive disorders.	[Zhang, Jinglan; Dai, Hongzheng; Ge, Xiaoyan; Shaw, Chad A.; Mei, Hui; Breman, Amy; Xia, Fan; Yang, Yaping; Chen, Zhao; Wang, Xia; Wang, Yue; Kulkarni, Shashikant; Van den Veyver, Ignatia B.; Beaudet, Arthur; Wong, Lee-Jun; Eng, Christine M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Li, Jianli; Feng, Yanming; Jiang, Yanjun; Sinson, Jefferson; Schmitt, Eric S.; Peacock, Sandra; Chen, Stella; Wang, Guoli; Purgason, Anne; Pourpak, Alan] Baylor Genet, Houston, TX USA; [Saucier, Jennifer B.; Parmar, Sheetal] Natera Inc, San Carlos, CA USA; [McCombs, Anne K.] Baylor Coll Med, Off Clin Res, Houston, TX 77030 USA; [Shaw, Chad A.] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China; [Choy, Kwong Wai] Chinese Univ Hong Kong Baylor Coll Med Joint Ctr, Hong Kong, Peoples R China; [Wapner, Ronald J.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Chinese University of Hong Kong; Columbia University; Baylor College of Medicine	Zhang, JL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jinglanz@bcm.edu	Zhang, Jinglan/AAI-1793-2020; Van den Veyver, Ignatia B/AAF-4510-2021; Xia, Fan/GQP-4575-2022; Choy, Richard/AAW-8230-2020	Van den Veyver, Ignatia B/0000-0002-0651-5924; Choy, Richard/0000-0002-3616-6200; Schmitt, Eric/0000-0002-4098-1275; Zhang, Jinglan/0000-0002-4600-7123	Baylor Genetics Laboratories; Baylor College of Medicine; Vice-Chancellor Discretionary Fund for CUHK-Baylor College of Medicine Joint Centre for Medical Genetics	Baylor Genetics Laboratories; Baylor College of Medicine; Vice-Chancellor Discretionary Fund for CUHK-Baylor College of Medicine Joint Centre for Medical Genetics	Baylor Genetics Laboratories and Baylor College of Medicine provided funds to support this study. A.K.M. was supported by institutional funds from Baylor College of Medicine. K.W.C. was partially supported by Vice-Chancellor Discretionary Fund for CUHK-Baylor College of Medicine Joint Centre for Medical Genetics. We thank all contributing healthcare providers for their work and support on this study.	Agatisa PK, 2015, PRENATAL DIAG, V35, P692, DOI 10.1002/pd.4594; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; Chitty LS, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023085; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Dar P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.08.006; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; FRIEDMAN JM, 1981, OBSTET GYNECOL, V57, P745; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Krakow D, 2009, GENET MED, V11, P127, DOI 10.1097/GIM.0b013e3181971ccb; Lench N, 2013, PRENATAL DIAG, V33, P555, DOI 10.1002/pd.4124; Lo KK, 2016, AM J HUM GENET, V98, P34, DOI 10.1016/j.ajhg.2015.11.016; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; McCullough RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109173; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; NELSON WB, 1978, AM J HUM GENET, V30, P160; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Nisbet DL, 1999, PRENATAL DIAG, V19, P642, DOI 10.1002/(SICI)1097-0223(199907)19:7<642::AID-PD610>3.0.CO;2-1; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Petersen AK, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.10.005; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Rowley PT, 1998, AM J HUM GENET, V63, P1160, DOI 10.1086/302042; Samango-Sprouse C, 2013, PRENATAL DIAG, V33, P643, DOI 10.1002/pd.4159; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Toriello HV, 2008, GENET MED, V10, P457, DOI 10.1097/GIM.0b013e318176fabb; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; You YQ, 2014, GENET MED, V16, P594, DOI 10.1038/gim.2013.197	33	117	120	6	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					439	+		10.1038/s41591-018-0334-x	http://dx.doi.org/10.1038/s41591-018-0334-x			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30692697				2022-12-27	WOS:000460643100022
J	Benedetti, B				Benedetti, Brett			Human skeletal stem cells identified	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1637	1637		10.1038/s41591-018-0260-y	http://dx.doi.org/10.1038/s41591-018-0260-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401863	Bronze			2022-12-27	WOS:000449404200007
J	Churchyard, GJ				Churchyard, Gavin J.			A stratified approach to tuberculosis treatment	NATURE MEDICINE			English	Editorial Material							MOXIFLOXACIN		[Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin J.] South African Med Res Council, Adv Care & Treatment TB HIV, Johannesburg, South Africa	University of Witwatersrand; South African Medical Research Council	Churchyard, GJ (corresponding author), Aurum Inst, Johannesburg, South Africa.; Churchyard, GJ (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.; Churchyard, GJ (corresponding author), South African Med Res Council, Adv Care & Treatment TB HIV, Johannesburg, South Africa.	gchurchyard@auruminstitute.org		Churchyard, Gavin/0000-0002-4269-3699				Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002202; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Savic, 2018, NAT MED, DOI [10.1038/s41591-018-0224-2, DOI 10.1038/S41591-018-0224-2]; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2017, TREATMENT TUBERCULOS	7	7	7	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1639	1641		10.1038/s41591-018-0244-y	http://dx.doi.org/10.1038/s41591-018-0244-y			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401868				2022-12-27	WOS:000449404200010
J	Imperial, MZ; Nahid, P; Phillips, PPJ; Davies, GR; Fielding, K; Hanna, D; Hermann, D; Wallis, RS; Johnson, JL; Lienhardt, C; Savic, RM				Imperial, Marjorie Z.; Nahid, Payam; Phillips, Patrick P. J.; Davies, Geraint R.; Fielding, Katherine; Hanna, Debra; Hermann, David; Wallis, Robert S.; Johnson, John L.; Lienhardt, Christian; Savic, Rada M.			A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis	NATURE MEDICINE			English	Article							CLINICAL-TRIAL; RISK-FACTORS; MOXIFLOXACIN; RIFAPENTINE; RELAPSE	Tuberculosis kills more people than any other infectious disease. Three pivotal trials testing 4-month regimens failed to meet non-inferiority margins; however, approximately four-fifths of participants were cured. Through a pooled analysis of patient-level data with external validation, we identify populations eligible for 4-month treatment, define phenotypes that are hard to treat and evaluate the impact of adherence and dosing strategy on outcomes. In 3,405 participants included in analyses, baseline smear grade of 3+ relative to <2+, HIV seropositivity and adherence of <= 90% were significant risk factors for unfavorable outcome. Four-month regimens were non-inferior in participants with minimal disease defined by <2+ sputum smear grade or non-cavitary disease. A hard-to-treat phenotype, defined by high smear grades and cavitation, may require durations >6 months to cure all. Regimen duration can be selected in order to improve outcomes, providing a stratified medicine approach as an alternative to the 'one-size-fits-all' treatment currently used worldwide.	[Imperial, Marjorie Z.; Nahid, Payam; Phillips, Patrick P. J.; Savic, Rada M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Davies, Geraint R.] Univ Liverpool, Liverpool, Merseyside, England; [Fielding, Katherine] London Sch Hyg & Trop Med, Tucson, AZ USA; [Hanna, Debra] Crit Path Inst, Tucson, AZ USA; [Hanna, Debra; Hermann, David] Bill & Melinda Gates Fdn, Seattle, WA USA; [Wallis, Robert S.] Aurum Inst, Johannesburg, South Africa; [Wallis, Robert S.] ACT4TB HIV, Johannesburg, South Africa; [Johnson, John L.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Johnson, John L.] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA; [Lienhardt, Christian] WHO, Global TB Programme, Geneva, Switzerland; [Lienhardt, Christian] Univ Montpellier, IRD, INSERM, Unite Mixte Int TransVIHMI UMI 233 IRD U1175, Montpellier, France	University of California System; University of California San Francisco; University of Liverpool; Bill & Melinda Gates Foundation; Case Western Reserve University; University Hospitals of Cleveland; World Health Organization; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Savic, RM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	rada.savic@ucsf.edu	Lienhardt, Christian/AAU-4969-2021; Wallis, Robert S./A-8018-2009	Lienhardt, Christian/0000-0003-0233-893X; Nahid, Payam/0000-0003-2811-1311; Fielding, Katherine/0000-0002-6524-3754; Wallis, Robert S./0000-0001-6152-5183; Davies, Geraint/0000-0002-3819-490X	World Health Organization; Bill and Melinda Gates Foundation [A127340]; US National Institute of Allergy and Infectious Diseases (NIAID) [1R01AI104589]; Tuberculosis Research Unit at Case Western Reserve University [DMID 01-009]; NIAID [NO1-AI95383, HHSN266200700022C/NO1-AI-70022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tuberculosis Research Unit at Case Western Reserve University; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The analyses conducted for this study were sponsored by the World Health Organization and the Bill and Melinda Gates Foundation (A127340). Partial support for P.N. and P.P.J.P. was also received from the US National Institute of Allergy and Infectious Diseases (NIAID; 1R01AI104589). The authors alone are responsible for the views expressed in this publication, and they do not necessarily represent the decisions, policy or views of the World Health Organization. Data used in the preparation of this article were obtained from the Platform for Aggregations of Clinical TB Studies (TB-PACTS; https://c-path.org/programs/tb-pacts/).TB-PACTS is a public partnership launched in May 2015 by Critical Path Institute, the Special Programme for Research and Training in Tropical Diseases, the Global Alliance for TB Drug Development, and St. George's, University of London. DMID 01-009 data were obtained from the sponsor. DMID 01-009 was supported by the Tuberculosis Research Unit at Case Western Reserve University, established with funds from NIAID under contracts NO1-AI95383 and HHSN266200700022C/NO1-AI-70022. We thank the study participants; the staff at clinical sites; all investigators for each of the four trials; the data management team at Critical Path Institute (K. Romero, B. Stafford and D. Hartley); C. Mendel, J. Neaton, and A. Vernon for their review of the manuscript; and the TBReFLECT (TB Re-analysis of Fluoroquinolone Executed Clinical Trials) Steering Committee.	Alipanah N, 2016, INT J TUBERC LUNG D, V20, P1522, DOI 10.5588/ijtld.16.0217; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; DiStefano MJ, 2016, GLOB HEALTH-SCI PRAC, V4, P211, DOI 10.9745/GHSP-D-16-00018; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1981, BRIT J DIS CHEST, V75, P331, DOI 10.1016/0007-0971(81)90022-X; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Goldberg S., 2015, TBTC STUDY; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Jo KW, 2014, RESP MED, V108, P654, DOI 10.1016/j.rmed.2014.01.010; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002202; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; Ngwatu BK, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01596-2017; Savic RM, 2017, CLIN PHARMACOL THER, V102, P321, DOI 10.1002/cpt.634; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172; Vernon AA, 2004, AM J RESP CRIT CARE, V170, P1040, DOI 10.1164/rccm.2409005; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; World Health Organization, 2017, TREATMENT TUBERCULOS; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174	21	139	141	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1708	+		10.1038/s41591-018-0224-2	http://dx.doi.org/10.1038/s41591-018-0224-2			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30397355	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000449404200023
J	Xue, KM; Jolly, JK; Barnard, AR; Rudenko, A; Salvetti, AP; Patricio, MI; Edwards, TL; Groppe, M; Orlans, HO; Tolmachova, T; Black, GC; Webster, AR; Lotery, AJ; Holder, GE; Downes, SM; Seabra, MC; MacLaren, RE				Xue, Kanmin; Jolly, Jasleen K.; Barnard, Alun R.; Rudenko, Anna; Salvetti, Anna P.; Patricio, Maria I.; Edwards, Thomas L.; Groppe, Markus; Orlans, Harry O.; Tolmachova, Tanya; Black, Graeme C.; Webster, Andrew R.; Lotery, Andrew J.; Holder, Graham E.; Downes, Susan M.; Seabra, Miguel C.; MacLaren, Robert E.			Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia	NATURE MEDICINE			English	Article							NATURAL-HISTORY; VISUAL FUNCTION; AUTOFLUORESCENCE; INJECTION; EFFICACY; PIGMENT; VECTOR; SAFETY	Retinal gene therapy is increasingly recognized as a novel molecular intervention that has huge potential in treating common causes of blindness, the majority of which have a genetic aetiology(1-5). Choroideremia is a chronic X-linked retinal degeneration that was first described in 1872(6). It leads to progressive blindness due to deficiency of Rab-escort protein 1 (REP1). We designed an adeno-associated viral vector to express REP1 and assessed it in a gene therapy clinical trial by subretinal injection in 14 patients with choroideremia. The primary endpoint was vision change in treated eyes 2 years after surgery compared to unoperated fellow eyes. Despite complications in two patients, visual acuity improved in the 14 treated eyes over controls (median 4.5 letter gain, versus 1.5 letter loss, P = 0.04), with 6 treated eyes gaining more than one line of vision (>5 letters). The results suggest that retinal gene therapy can sustain and improve visual acuity in a cohort of predominantly late-stage choroideremia patients in whom rapid visual acuity loss would ordinarily be predicted.	[Xue, Kanmin; Jolly, Jasleen K.; Barnard, Alun R.; Salvetti, Anna P.; Patricio, Maria I.; Edwards, Thomas L.; Groppe, Markus; Orlans, Harry O.; Downes, Susan M.; MacLaren, Robert E.] Univ Oxford, Nuffield Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England; [Xue, Kanmin; Jolly, Jasleen K.; Barnard, Alun R.; Rudenko, Anna; Salvetti, Anna P.; Patricio, Maria I.; Edwards, Thomas L.; Groppe, Markus; Orlans, Harry O.; Downes, Susan M.; MacLaren, Robert E.] Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England; [Tolmachova, Tanya] Imperial Coll, Natl Heart & Lung Inst, Mol Med Sect, London, England; [Black, Graeme C.] St Marys Hosp, Manchester Ctr Genom Med, Univ Hosp NHS Fdn Trust, Div Evolut & Genom Sci Neurosci & Mental Hlth Dom, Manchester, Lancs, England; [Black, Graeme C.] St Marys Hosp, Acad Hlth Sci Ctr, Manchester, Lancs, England; [Webster, Andrew R.; Holder, Graham E.; MacLaren, Robert E.] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Webster, Andrew R.; Holder, Graham E.; Seabra, Miguel C.] UCL, Inst Ophthalmol, London, England; [Lotery, Andrew J.] Univ Southampton, Clin Neurosci Grp, Clin & Expt Sci, Fac Med, Southampton, Hants, England; [Holder, Graham E.] Natl Univ Singapore, Dept Ophthalmol, Singapore, Singapore; [Seabra, Miguel C.] Univ Nova Lisboa, Nova Med Sch, Chron Dis Res Ctr, Lisbon, Portugal	University of Oxford; Oxford University Hospitals NHS Foundation Trust; Imperial College London; University of Manchester; University of Manchester; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Southampton; National University of Singapore; Universidade Nova de Lisboa	MacLaren, RE (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Nuffield Lab Ophthalmol, Oxford, England.; MacLaren, RE (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford Eye Hosp, Oxford, England.; MacLaren, RE (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, London, England.	enquiries@eye.ox.ac.uk	Seabra, Miguel C/M-3280-2013; wei, wei/HHR-8613-2022; Xue, Kanmin/AIC-7111-2022; Jolly, Jasleen Kaur/AAC-1873-2019; Seabra, Miguel/AAC-3099-2019; Black, Graeme/K-7374-2015	Seabra, Miguel C/0000-0002-6404-4892; Jolly, Jasleen Kaur/0000-0001-9878-4621; Salvetti, Anna Paola/0000-0002-5513-2241; Edwards, Thomas/0000-0003-0238-7416; Black, Graeme/0000-0001-8727-6592; MacLaren, Robert/0000-0002-3096-4682; Groppe, Markus/0000-0003-1963-3484; Xue, Kanmin/0000-0003-0065-9131; Lotery, Andrew/0000-0001-5541-4305	Health Innovation Challenge Fund [HICF-1009-006]; UK Department of Health; Wellcome Trust; Health Foundation; Fight for Sight; Lanvern Foundation; Special Trustees of Moorfields Eye Hospital; Royal College of Surgeons of Edinburgh; National Institute for Health Research (NIHR) Biomedical Research Centres (BRC) at the Oxford University Hospitals NHS Foundation Trust; Moorfields Eye Hospital NHS Foundation Trust; MRC [MR/N00101X/1] Funding Source: UKRI	Health Innovation Challenge Fund; UK Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); Health Foundation; Fight for Sight; Lanvern Foundation; Special Trustees of Moorfields Eye Hospital; Royal College of Surgeons of Edinburgh; National Institute for Health Research (NIHR) Biomedical Research Centres (BRC) at the Oxford University Hospitals NHS Foundation Trust(National Institute for Health Research (NIHR)); Moorfields Eye Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all trial participants for their commitment to attending extensive follow-up visits, K. M. Jasani for helping with collection of the OCT and adverse events data, M. Hassall for helping with analysis of the AF data, and staff members of the Eye Research Group Oxford (ERGO) for their support throughout the study. This work was supported primarily by a grant (HICF-1009-006) from the Health Innovation Challenge Fund, a funding partnership between the UK Department of Health and the Wellcome Trust. Additional funding support was from the Health Foundation; Fight for Sight; the Lanvern Foundation; the Special Trustees of Moorfields Eye Hospital; the Royal College of Surgeons of Edinburgh and the National Institute for Health Research (NIHR) Biomedical Research Centres (BRC) at the Oxford University Hospitals NHS Foundation Trust (which includes the University of Oxford) and Moorfields Eye Hospital NHS Foundation Trust (which includes the University College London Institute of Ophthalmology).	Aleman TS, 2017, OPHTHALMOLOGY, V124, P359, DOI 10.1016/j.ophtha.2016.10.022; Aylward JW, 2018, OPHTHALMOLOGY, V125, P1122, DOI 10.1016/j.ophtha.2018.02.004; Barnard Alun R, 2014, Cold Spring Harb Perspect Med, V5, pa017293, DOI 10.1101/cshperspect.a017293; Bennett J, 2017, MOL THER, V25, P1076, DOI 10.1016/j.ymthe.2017.03.008; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; Dimopoulos IS, 2018, AM J OPHTHALMOL, V193, P130, DOI 10.1016/j.ajo.2018.06.011; Duncan JL, 2002, EXP EYE RES, V74, P371, DOI 10.1006/exer.2001.1126; Edwards TL, 2018, NAT BIOMED ENG, V2, P649, DOI 10.1038/s41551-018-0248-4; Edwards TL, 2016, NEW ENGL J MED, V374, P1996, DOI 10.1056/NEJMc1509501; Edwards TL, 2015, OPHTHALMOLOGY, V122, P1274, DOI 10.1016/j.ophtha.2014.12.036; Fischer MD, 2016, HUM GENE THER METHOD, V27, P150, DOI 10.1089/hgtb.2016.086; Ghazi NG, 2016, HUM GENET, V135, P327, DOI 10.1007/s00439-016-1637-y; Hariri AH, 2017, AM J OPHTHALMOL, V179, P110, DOI 10.1016/j.ajo.2017.05.002; Heon E, 2016, INVEST OPHTH VIS SCI, V57, pOCT377, DOI 10.1167/iovs.15-18421; Jacobson SG, 2006, INVEST OPHTH VIS SCI, V47, P4113, DOI 10.1167/iovs.06-0424; Jolly JK, 2017, INVEST OPHTH VIS SCI, V58, P5575, DOI 10.1167/iovs.17-22486; Jolly JK, 2016, INVEST OPHTH VIS SCI, V57, P4498, DOI 10.1167/iovs.15-18362; MacLaren RE, 2014, LANCET, V383, P1129, DOI 10.1016/S0140-6736(13)62117-0; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mauthner H, 1872, BER NATURW MED VER I, V2, P191; Morgan JIW, 2014, INVEST OPHTH VIS SCI, V55, P6381, DOI 10.1167/iovs.13-13454; Patircio MI, 2017, MOL THER-NUCL ACIDS, V6, P198, DOI 10.1016/j.omtn.2016.12.006; Patricio MI, 2018, MOL THER-METH CLIN D, V9, P288, DOI 10.1016/j.omtm.2018.03.009; Richter-Mueksch S, 2011, EYE, V25, P1317, DOI 10.1038/eye.2011.156; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sahel JA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017111; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simunovic MP, 2017, JAMA OPHTHALMOL, V135, P234, DOI 10.1001/jamaophthalmol.2016.5630; Vandenberghe L.H., 2011, SCI TRANSL MED, V3; Vandenberghe LH, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017442; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Xue K, 2017, EYE, V31, P1308, DOI 10.1038/eye.2017.158; Xue KM, 2016, INVEST OPHTH VIS SCI, V57, P3674, DOI 10.1167/iovs.15-18364	36	97	99	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1507	+		10.1038/s41591-018-0185-5	http://dx.doi.org/10.1038/s41591-018-0185-5			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297895	Green Accepted, Green Submitted			2022-12-27	WOS:000446577900011
J	Cejas, P; Drier, Y; Dreijerink, KMA; Brosens, LAA; Deshpande, V; Epstein, CB; Conemans, EB; Morsink, FHM; Graham, MK; Valk, GD; Vriens, MR; Fernandez-del Castillo, C; Ferrone, CR; Adar, T; Bowden, M; Whitton, HJ; Da Silva, A; Font-Tello, A; Long, HW; Gaskell, E; Shoresh, N; Heaphy, CM; Sicinska, E; Kulke, MH; Chung, DC; Bernstein, BE; Shivdasani, RA				Cejas, Paloma; Drier, Yotam; Dreijerink, Koen M. A.; Brosens, Lodewijk A. A.; Deshpande, Vikram; Epstein, Charles B.; Conemans, Elfi B.; Morsink, Folkert H. M.; Graham, Mindy K.; Valk, Gerlof D.; Vriens, Menno R.; Fernandez-del Castillo, Carlos; Ferrone, Cristina R.; Adar, Tomer; Bowden, Michaela; Whitton, Holly J.; Da Silva, Annacarolina; Font-Tello, Alba; Long, Henry W.; Gaskell, Elizabeth; Shoresh, Noam; Heaphy, Christopher M.; Sicinska, Ewa; Kulke, Matthew H.; Chung, Daniel C.; Bernstein, Bradley E.; Shivdasani, Ramesh A.			Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors	NATURE MEDICINE			English	Article							ALPHA-CELL; TRANSCRIPTION FACTORS; ENDOCRINE PANCREAS; SUPER-ENHANCERS; BETA-CELLS; PAX4; ARX; DIFFERENTIATION; EPIDEMIOLOGY; IDENTITY	Most pancreatic neuroendocrine tumors ( PNETs) do not produce excess hormones and are therefore considered 'non-functional'(1-3). As clinical behaviors vary widely and distant metastases are eventually lethal(2,4), biological classifications might guide treatment. Using enhancer maps to infer gene regulatory programs, we find that non-functional PNETs fall into two major subtypes, with epigenomes and transcriptomes that partially resemble islet alpha- and beta-cells. Transcription factors ARX and PDX1 specify these normal cells, respectively(5,6), and 84% of 142 non-functional PNETs expressed one or the other factor, occasionally both. Among 103 cases, distant relapses occurred almost exclusively in patients with ARX(+)PDX1(-) tumors and, within this subtype, in cases with alternative lengthening of telomeres. These markedly different outcomes belied similar clinical presentations and histology and, in one cohort, occurred irrespective of MEN1 mutation. This robust molecular stratification provides insight into cell lineage correlates of non-functional PNETs, accurately predicts disease course and can inform postoperative clinical decisions.	[Cejas, Paloma; Bowden, Michaela; Kulke, Matthew H.; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cejas, Paloma; Font-Tello, Alba; Long, Henry W.; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Cejas, Paloma] Hosp La Paz, Inst Hlth Res, Translat Oncol Lab, Madrid, Spain; [Drier, Yotam; Epstein, Charles B.; Whitton, Holly J.; Gaskell, Elizabeth; Shoresh, Noam; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Drier, Yotam; Deshpande, Vikram; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drier, Yotam; Deshpande, Vikram; Vriens, Menno R.; Adar, Tomer; Chung, Daniel C.; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02115 USA; [Dreijerink, Koen M. A.; Conemans, Elfi B.; Valk, Gerlof D.] UMC Utrecht Canc Ctr, Dept Endocrine Oncol, Utrecht, Netherlands; [Dreijerink, Koen M. A.; Conemans, Elfi B.] Amsterdam UMC, Dept Internal Med, Amsterdam, Netherlands; [Brosens, Lodewijk A. A.; Morsink, Folkert H. M.] UMC Utrecht Canc Ctr, Dept Pathol, Utrecht, Netherlands; [Graham, Mindy K.; Heaphy, Christopher M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Vriens, Menno R.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Fernandez-del Castillo, Carlos; Ferrone, Cristina R.] UMC Utrecht Canc Ctr, Dept Surg Oncol, Utrecht, Netherlands; [Adar, Tomer; Chung, Daniel C.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Da Silva, Annacarolina; Sicinska, Ewa] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA; [Kulke, Matthew H.; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Kulke, Matthew H.; Shivdasani, Ramesh A.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Cejas, Paloma; Drier, Yotam] Hebrew Univ Jerusalem, Fac Med, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Amsterdam; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hebrew University of Jerusalem	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Drier, Y; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Drier, Y; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Drier, Y; Bernstein, BE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Drier, Y (corresponding author), Hebrew Univ Jerusalem, Fac Med, Lautenberg Ctr Immunol & Canc Res, Jerusalem, Israel.	yotam.drier@mail.huji.ac.il; bernstein.bradley@mgh.harvard.edu; ramesh_shivdasani@dfci.harvard.edu	Drier, Yotam/K-5208-2012; Graham, Mindy/AAJ-2880-2021; Brosens, Lodewijk A.A./E-8792-2018; Castillo, Carlos Fenandez-del/AAO-2602-2020	Drier, Yotam/0000-0003-1725-2995; Graham, Mindy/0000-0003-2521-0373; Brosens, Lodewijk A.A./0000-0003-1341-8994; Dreijerink, Koen/0000-0002-3140-3502; Bowden, Michaela/0000-0003-4375-7823; Heaphy, Christopher/0000-0003-4264-1810; Epstein, Charles B./0000-0001-8358-8345	Neuroendocrine Tumor Research Foundation; SPORE program in gastrointestinal cancers (National Cancer Institute) [P50CA127003]; North American Neuroendocrine Tumor Society; Instituto de Salud Carlos III of the Spanish Economy and Competitiveness Ministry [PI18-01604]; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER	Neuroendocrine Tumor Research Foundation; SPORE program in gastrointestinal cancers (National Cancer Institute); North American Neuroendocrine Tumor Society; Instituto de Salud Carlos III of the Spanish Economy and Competitiveness Ministry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present study has been supported by the Neuroendocrine Tumor Research Foundation (R.A.S., B.E.B., M.H.K. and D.C.C.), the SPORE program in gastrointestinal cancers (P50CA127003-National Cancer Institute, R.A.S.), the North American Neuroendocrine Tumor Society (C.M.H.) and a grant (no. PI18-01604 to P.C.) from Instituto de Salud Carlos III of the Spanish Economy and Competitiveness Ministry.	Ackermann AM, 2016, MOL METAB, V5, P233, DOI 10.1016/j.molmet.2016.01.002; Arda HE, 2018, CELL SYST, V7, P310, DOI 10.1016/j.cels.2018.07.007; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cejas P, 2016, NAT MED, V22, P685, DOI 10.1038/nm.4085; Chan CS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06498-2; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Cohen AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14400; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Conemans EB, 2018, J ENDOCRINOL INVEST, V41, P655, DOI 10.1007/s40618-017-0783-y; de Laat JM, 2015, J CLIN ENDOCR METAB, V100, P3288, DOI 10.1210/JC.2015-2015; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Falconi M, 2016, NEUROENDOCRINOLOGY, V103, P153, DOI 10.1159/000443171; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gutierrez GD, 2017, J CLIN INVEST, V127, P244, DOI 10.1172/JCI88017; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Kouvaraki MA, 2005, J SURG ONCOL, V89, P170, DOI 10.1002/jso.20178; Kulke MH, 2010, PANCREAS, V39, P735, DOI 10.1097/MPA.0b013e3181ebb168; Larsen HL, 2017, SEMIN CELL DEV BIOL, V66, P51, DOI 10.1016/j.semcdb.2017.01.005; Lawrence B, 2011, ENDOCRIN METAB CLIN, V40, P1, DOI 10.1016/j.ecl.2010.12.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marinoni I, 2014, GASTROENTEROLOGY, V146, P453, DOI 10.1053/j.gastro.2013.10.020; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Metz DC, 2008, GASTROENTEROLOGY, V135, P1469, DOI 10.1053/j.gastro.2008.05.047; Ooi WF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12983; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasquali L, 2014, NAT GENET, V46, P136, DOI 10.1038/ng.2870; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramond C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165480; Rindi G., 2017, WHO CLASSIFICATION T; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Sadanandam A, 2015, CANCER DISCOV, V5, P1296, DOI 10.1158/2159-8290.CD-15-0068; Scarpa A, 2017, NATURE, V543, P65, DOI 10.1038/nature21063; Singhi AD, 2017, CLIN CANCER RES, V23, P600, DOI 10.1158/1078-0432.CCR-16-1113; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; Swisa A, 2017, J CLIN INVEST, V127, P230, DOI 10.1172/JCI88015; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00992-9; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Wang YJ, 2016, DIABETES, V65, P3028, DOI 10.2337/db16-0405; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	53	90	92	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1260	+		10.1038/s41591-019-0493-4	http://dx.doi.org/10.1038/s41591-019-0493-4			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31263286	Green Accepted			2022-12-27	WOS:000480414600024
J	Chan, KR; Gan, ES; Chan, CYY; Liang, C; Low, JZH; Zhang, SLX; Ong, EZ; Bhatta, A; Wijaya, L; Lee, YH; Low, JGH; Ooi, EE				Chan, Kuan Rong; Gan, Esther Shuyi; Chan, Candice Yuen Yue; Liang, Cui; Low, John Zhong Heng; Zhang, Summer Li-Xin; Ong, Eugenia Ziying; Bhatta, Ashwin; Wijaya, Limin; Lee, Yie Hou; Low, Jenny Guek-Hong; Ooi, Eng Eong			Metabolic perturbations and cellular stress underpin susceptibility to symptomatic live-attenuated yellow fever infection	NATURE MEDICINE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM; VIRUS; DENGUE; IMMUNOGENICITY; VACCINATION; VACCINES; IMMUNITY; SAFETY; DEATH	Flaviviral infections result in a wide spectrum of clinical outcomes, ranging from asymptomatic infection to severe disease. Although the correlates of severe disease have been explored(1-4), the pathophysiology that differentiates symptomatic from asymptomatic infection remains undefined. To understand the molecular underpinnings of symptomatic infection, the blood transcriptomic and metabolomic profiles of individuals were examined before and after inoculation with the live yellow fever viral vaccine (YF17D). It was found that individuals with adaptive endoplasmic reticulum (ER) stress and reduced tricarboxylic acid cycle activity at baseline showed increased susceptibility to symptomatic outcome. YF17D infection in these individuals induced maladaptive ER stress, triggering downstream proinflammatory responses that correlated with symptomatic outcome. The findings of the present study thus suggest that the ER stress response and immunometabolism underpin symptomatic yellow fever and possibly even other flaviviral infections. Modulating either ER stress or metabolism could be exploited for prophylaxis against symptomatic flaviviral infection outcome.	[Chan, Kuan Rong; Gan, Esther Shuyi; Chan, Candice Yuen Yue; Zhang, Summer Li-Xin; Bhatta, Ashwin; Low, Jenny Guek-Hong; Ooi, Eng Eong] Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Gan, Esther Shuyi; Ong, Eugenia Ziying; Low, Jenny Guek-Hong; Ooi, Eng Eong] SingHlth Duke NUS ViREMiCS, Viral Res & Expt Med Ctr, Singapore, Singapore; [Chan, Candice Yuen Yue; Wijaya, Limin; Low, Jenny Guek-Hong] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore; [Liang, Cui; Lee, Yie Hou; Low, Jenny Guek-Hong; Ooi, Eng Eong] Singapore MIT Alliance Res & Technol, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore; [Low, John Zhong Heng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Lee, Yie Hou] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [Ooi, Eng Eong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	National University of Singapore; Singapore General Hospital; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; KK Women's & Children's Hospital; National University of Singapore	Chan, KR; Low, JGH; Ooi, EE (corresponding author), Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore.; Low, JGH; Ooi, EE (corresponding author), SingHlth Duke NUS ViREMiCS, Viral Res & Expt Med Ctr, Singapore, Singapore.; Low, JGH (corresponding author), Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.; Low, JGH; Ooi, EE (corresponding author), Singapore MIT Alliance Res & Technol, Antimicrobial Resistance Interdisciplinary Res Gr, Singapore, Singapore.; Ooi, EE (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	kuanrong.chan@duke-nus.edu.sg; jenny.low@singhealth.com.sg; engeong.ooi@duke-nus.edu.sg		Ooi, Eng Eong/0000-0002-0520-1544; Chan, Kuan Rong/0000-0002-2427-671X; Gan, Esther/0000-0003-4992-424X	J.G.-H.L.'s Clinician-Scientist Award from National Medicine Research Council of Singapore [NMRC/CSA-INV/0013/2016]; E.E.O.'s Senior Clinician-Scientist Award from National Medicine Research Council of Singapore [NMRC/CSA/060/2014]; National Medicine Research Council of Singapore [NMRC/CG/M003/2017]; Tanoto Foundation	J.G.-H.L.'s Clinician-Scientist Award from National Medicine Research Council of Singapore; E.E.O.'s Senior Clinician-Scientist Award from National Medicine Research Council of Singapore; National Medicine Research Council of Singapore; Tanoto Foundation	We thank all the participants, research coordinators and nurses at the SingHealth Investigational Medicine Unit for their time and assistance in the conduct of the clinical trials. We also thank the anonymous reviewers for their constructive comments. This work is supported by J.G.-H.L.'s Clinician-Scientist Award (NMRC/CSA-INV/0013/2016) and E.E.O.'s Senior Clinician-Scientist Award (NMRC/CSA/060/2014) and Centre Grant (NMRC/CG/M003/2017), all from the National Medicine Research Council of Singapore. We also thank the Tanoto Foundation for their generous support for ViREMiCS.	Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800; Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; CAIRESJUNIOR LC, 2018, NAT COMM, V0009; Chan CYY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96031; Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.164, 10.1038/NMICROBIOL.2016.164]; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Douglas DN, 2016, J BIOL CHEM, V291, P1974, DOI 10.1074/jbc.M115.674861; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Kaufman RJ, 2014, BBA-MOL CELL RES, V1843, P2233, DOI 10.1016/j.bbamcr.2014.03.022; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lindsey NP, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw045; Low JG, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0651-z; Mahmoudabadi G, 2017, P NATL ACAD SCI USA, V114, pE4324, DOI 10.1073/pnas.1701670114; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009; Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/ERV.12.6, 10.1586/erv.12.6]; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Pfister M, 2005, AM J TROP MED HYG, V72, P339, DOI 10.4269/ajtmh.2005.72.339; PRYOR WA, 1994, P NATL ACAD SCI USA, V91, P11173, DOI 10.1073/pnas.91.23.11173; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016; Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wang XL, 2011, BIOCHEM J, V435, P285, DOI 10.1042/BJ20101864; Wang Y, 2018, J CELL BIOL, V217, P1915, DOI 10.1083/jcb.201708007	47	21	22	3	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1218	+		10.1038/s41591-019-0510-7	http://dx.doi.org/10.1038/s41591-019-0510-7			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31308506				2022-12-27	WOS:000480414600019
J	Stower, H				Stower, Hannah			The benefits of foot calluses	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1189	1189		10.1038/s41591-019-0555-7	http://dx.doi.org/10.1038/s41591-019-0555-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388178	Bronze			2022-12-27	WOS:000480414600010
J	Stower, H				Stower, Hannah			Evading the immune system	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					710	710		10.1038/s41591-019-0453-z	http://dx.doi.org/10.1038/s41591-019-0453-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068709	Bronze			2022-12-27	WOS:000468247800007
J	Dallner, OS; Marinis, JM; Lu, YH; Birsoy, K; Werner, E; Fayzikhodjaeva, G; Dill, BD; Molina, H; Moscati, A; Kutalik, Z; Marques-Vidal, P; Kilpelainen, TO; Grarup, N; Linneberg, A; Zhang, YX; Vaughan, R; Loos, RJF; Lazar, MA; Friedman, JM				Dallner, Olof S.; Marinis, Jill M.; Lu, Yi-Hsueh.; Birsoy, Kivanc; Werner, Emory; Fayzikhodjaeva, Gulya; Dill, Brian D.; Molina, Henrik; Moscati, Arden; Kutalik, Zoltan; Marques-Vidal, Pedro; Kilpelainen, Tuomas O.; Grarup, Niels; Linneberg, Allan; Zhang, Yinxin; Vaughan, Roger; Loos, Ruth J. F.; Lazar, Mitchell A.; Friedman, Jeffrey M.			Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity	NATURE MEDICINE			English	Article							GENE-EXPRESSION; ADIPOSE-TISSUE; OB RNA; STORAGE; MICE; TRANSCRIPTION; PROMOTER; PROTOCOL; WEIGHT	Quantitative changes in leptin concentration lead to alterations in food intake and body weight, but the regulatory mechanisms that control leptin gene expression are poorly understood. Here we report that fat-specific and quantitative leptin expression is controlled by redundant cis elements and trans factors interacting with the proximal promoter together with a long non-coding RNA (lncOb). Diet-induced obese mice lacking lncOb show increased fat mass with reduced plasma leptin levels and lose weight after leptin treatment, whereas control mice do not. Consistent with this finding, large-scale genetic studies of humans reveal a significant association of single-nucleotide polymorphisms (SNPs) in the region of human lncOb with lower plasma leptin levels and obesity. These results show that reduced leptin gene expression can lead to a hypoleptinemic, leptin-responsive form of obesity and provide a framework for elucidating the pathogenic mechanism in the subset of obese patients with low endogenous leptin levels.	[Dallner, Olof S.; Lu, Yi-Hsueh.; Werner, Emory; Fayzikhodjaeva, Gulya; Zhang, Yinxin; Friedman, Jeffrey M.] Rockefeller Univ, Lab Mol Genet, 1230 York Ave, New York, NY 10021 USA; [Marinis, Jill M.; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marinis, Jill M.; Lazar, Mitchell A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Birsoy, Kivanc] Rockefeller Univ, Lab Metab Regulat & Genet, 1230 York Ave, New York, NY 10021 USA; [Dill, Brian D.; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Moscati, Arden; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Kutalik, Zoltan] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Marques-Vidal, Pedro] Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland; [Kilpelainen, Tuomas O.; Grarup, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Linneberg, Allan] Frederiksberg Bispebjerg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Vaughan, Roger] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Vaughan, Roger] Rockefeller Univ, Dept Biostat, 1230 York Ave, New York, NY 10021 USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Childhood & Dev Inst, New York, NY 10029 USA; [Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Novo Nordisk Foundation; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rockefeller University; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Lab Mol Genet, 1230 York Ave, New York, NY 10021 USA.; Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	friedj@rockefeller.edu	Grarup, Niels/K-2807-2015; Colaus, PsyColaus/K-6607-2013; Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Kilpeläinen, Tuomas/F-8569-2012; Lazar, Mitchell A/AAF-3738-2019; Kutalik, Zoltan/HHZ-5697-2022; Marques-Vidal, Pedro/C-9449-2009	Grarup, Niels/0000-0001-5526-1070; Loos, Ruth J F/0000-0002-8532-5087; Kilpeläinen, Tuomas/0000-0002-8349-3028; Kutalik, Zoltan/0000-0001-8285-7523; Linneberg, Allan/0000-0002-0994-0184; Lazar, Mitchell/0000-0001-8653-1280; Marques-Vidal, Pedro/0000-0002-4548-8500; Dill, Brian/0000-0002-4532-3044; Birsoy, Kivanc/0000-0002-7579-9895; Zhang, Yinxin/0000-0001-5909-3676	Swedish Research Council; Swedish Medical Research Society; Sweden-America Foundation; NIH [R01-DK49780]; JPB Foundation; NCATS CTSA program [UL1-TR001866]; CEN [5402133]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Research Society; Sweden-America Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NCATS CTSA program; CEN	We thank S. Malik and R. G. Roeder for valuable discussions. We acknowledge technical support from S. Schmidt and R. Sarnoff. We also thank the Gene Targeting Core at Rockefeller University for assistance with CRISPR targeting. O.S.D. acknowledges support from the Swedish Research Council, the Swedish Medical Research Society, and the Sweden-America Foundation. This work was supported by NIH grant R01-DK49780 (M.A.L.), the JPB Foundation (M.A.L.), and CEN 5402133 (J.M.F.). The study was supported in part by the NCATS CTSA program (UL1-TR001866) (R.V.). The Sohn Conference Foundation and the Leona M. and Harry B. Helmsley Charitable Trust are acknowledged for mass spectrometry instrumentation. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (https://www.metabol.ku.dk).	Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cope N. F., 2009, COLD SPRING HARB PRO, V2009; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; delaBrousse FC, 1996, P NATL ACAD SCI USA, V93, P4096, DOI 10.1073/pnas.93.9.4096; Downey P, 2008, INT J EPIDEMIOL, V37, P46, DOI 10.1093/ije/dyn031; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Emmett MJ, 2017, NATURE, V546, P544, DOI 10.1038/nature22819; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hogan B, 1994, MANIPULATING MOUSE E; Hong SG, 2017, NAT MED, V23, P223, DOI 10.1038/nm.4245; Ioffe E, 1998, P NATL ACAD SCI USA, V95, P11852, DOI 10.1073/pnas.95.20.11852; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kilpelainen TO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10494; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu YH, 2015, MOL METAB, V4, P392, DOI 10.1016/j.molmet.2015.02.002; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miura S, 2004, BIOCHEM BIOPH RES CO, V325, P812, DOI 10.1016/j.bbrc.2004.10.117; Ottaway N, 2015, CELL METAB, V21, P877, DOI 10.1016/j.cmet.2015.04.015; Peakman TC, 2008, INT J EPIDEMIOL, V37, P2, DOI 10.1093/ije/dyn019; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Sallam T, 2018, NAT MED, V24, P304, DOI 10.1038/nm.4479; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun XH, 2017, BIOCHEM J, V474, P2925, DOI 10.1042/BCJ20170280; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Waki H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002311; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004	44	52	52	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					507	+		10.1038/s41591-019-0370-1	http://dx.doi.org/10.1038/s41591-019-0370-1			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842678				2022-12-27	WOS:000460643100030
J	Shen, CJ; Zheng, D; Li, KX; Yang, JM; Pan, HQ; Yu, XD; Fu, JY; Zhu, Y; Sun, QX; Tang, MY; Zhang, Y; Sun, P; Xie, Y; Duan, SM; Hu, HL; Li, XM				Shen, Chen-Jie; Zheng, Di; Li, Ke-Xin; Yang, Jian-Ming; Pan, Hao-Qi; Yu, Xiao-Dan; Fu, Jia-Yu; Zhu, Yi; Sun, Qi-Xin; Tang, Meng-Yu; Zhang, Ying; Sun, Peng; Xie, Yi; Duan, Shumin; Hu, Hailan; Li, Xiao-Ming			Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior	NATURE MEDICINE			English	Article							NEURAL CIRCUITS; NEURONS; REWARD; ANXIETY; MEMORY; STRESS; SUSCEPTIBILITY; TRANSMISSION; METAANALYSIS; HIPPOCAMPUS	Major depressive disorder is a devastating psychiatric disease that afflicts up to 17% of the world's population. Postmortem brain analyses and imaging studies of patients with depression have implicated basal lateral amygdala (BLA) dysfunction in the pathophysiology of depression. However, the circuit and molecular mechanisms through which BLA neurons modulate depressive behavior are largely uncharacterized. Here, in mice, we identified that BLA cholecystokinin (CCK) glutamatergic neurons mediated negative reinforcement via D2 medium spiny neurons (MSNs) in the nucleus accumbens (NAc) and that chronic social defeat selectively potentiated excitatory transmission of the CCKBLA-D2(NAc) circuit in susceptible mice via reduction of presynaptic cannabinoid type-1 receptor (CB1R). Knockdown of CB1R in the CCKBLA-D2(NAc) circuit elevated synaptic activity and promoted stress susceptibility. Notably, selective inhibition of the CCKBLA-D2(NAc) circuit or administration of synthetic cannabinoids in the NAc was sufficient to produce antidepressant-like effects. Overall, our studies reveal the circuit and molecular mechanisms of depression.	[Shen, Chen-Jie; Zheng, Di; Li, Ke-Xin; Yang, Jian-Ming; Pan, Hao-Qi; Yu, Xiao-Dan; Fu, Jia-Yu; Zhu, Yi; Sun, Qi-Xin; Tang, Meng-Yu; Zhang, Ying; Sun, Peng; Xie, Yi; Duan, Shumin; Hu, Hailan; Li, Xiao-Ming] Zhejiang Univ, Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Sch Med, Ctr Neurosci, Hangzhou, Zhejiang, Peoples R China; [Shen, Chen-Jie; Zheng, Di; Li, Ke-Xin; Yang, Jian-Ming; Pan, Hao-Qi; Yu, Xiao-Dan; Fu, Jia-Yu; Zhu, Yi; Sun, Qi-Xin; Tang, Meng-Yu; Zhang, Ying; Sun, Peng; Xie, Yi; Duan, Shumin; Hu, Hailan; Li, Xiao-Ming] Zhejiang Univ, Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Sch Med, Dept Neurol,NHC,Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Shen, Chen-Jie; Zheng, Di; Li, Ke-Xin; Yang, Jian-Ming; Pan, Hao-Qi; Yu, Xiao-Dan; Fu, Jia-Yu; Zhu, Yi; Sun, Qi-Xin; Tang, Meng-Yu; Zhang, Ying; Sun, Peng; Xie, Yi; Duan, Shumin; Hu, Hailan; Li, Xiao-Ming] Zhejiang Univ, Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Sch Med, CAMS Key Lab Med Neurobiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, XM (corresponding author), Zhejiang Univ, Joint Inst Genet & Genome Med Zhejiang Univ & Uni, Sch Med, Ctr Neurosci, Hangzhou, Zhejiang, Peoples R China.	lixm@zju.edu.cn	Shen, Chenjie/AAL-2029-2021; Fu, JY/GRR-6179-2022	Li, Ke-Xin/0000-0003-3879-294X; shen, chenjie/0000-0002-3272-9344	Major Research Plan of the National Natural Science Foundation of China [91432306]; Key Project of the National Natural Science Foundation of China [31430034]; National Key Research and Development Plan [2016YFA0501000]; Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2017PT31038, 2018PT31041]; Funds for Creative Research Groups of China [81521062]; Program for Changjiang Scholars and Innovative Research Teams in University; Program of Introducing Talents of Discipline to Universities [B13026]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan; Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences; Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); Program for Changjiang Scholars and Innovative Research Teams in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	We thank Z. J. Huang (Cold Spring Harbor Laboratory, USA) and M. He (Fudan University, China) for providing CCK-ires-Cre mice; X. Zhang (Qingdao University, China) and F. Wang (The Fourth Military Medical University, China) for providing CB<INF>1</INF>R agonist HU210; and Y.-H. Cui (Zhejiang University, China) for stimulating discussions and critical comments. This work was supported by Major Research Plan of the National Natural Science Foundation of China (grant 91432306), Key Project of the National Natural Science Foundation of China (grant 31430034), National Key Research and Development Plan (grant 2016YFA0501000), Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (grants 2017PT31038 and 2018PT31041), Funds for Creative Research Groups of China (grant 81521062), Program for Changjiang Scholars and Innovative Research Teams in University and Program of Introducing Talents of Discipline to Universities (grant B13026) to X.-M.L.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Araque A, 2017, NEUROPHARMACOLOGY, V124, P13, DOI 10.1016/j.neuropharm.2017.06.017; Ashtari M, 1999, PSYCHOL MED, V29, P629, DOI 10.1017/S0033291799008405; Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Beyeler A, 2016, NEURON, V90, P348, DOI 10.1016/j.neuron.2016.03.004; Beyer CE, 2010, NEUROBIOL DIS, V39, P148, DOI 10.1016/j.nbd.2010.03.020; Bowers ME, 2015, NEUROPSYCHOPHARMACOL, V40, P688, DOI 10.1038/npp.2014.225; Cai HJ, 2014, NAT NEUROSCI, V17, P1240, DOI 10.1038/nn.3767; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; D'Agostino G, 2016, ELIFE, V5, DOI 10.7554/eLife.12225; de la Mora MP, 2007, EUR J NEUROSCI, V26, P3614, DOI 10.1111/j.1460-9568.2007.05963.x; Derks NM, 2012, J NEUROENDOCRINOL, V24, P1447, DOI 10.1111/j.1365-2826.2012.02355.x; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Eggan SM, 2010, NEUROSCIENCE, V169, P1651, DOI 10.1016/j.neuroscience.2010.06.011; Francis TC, 2017, BIOL PSYCHIAT, V81, P645, DOI 10.1016/j.biopsych.2016.09.007; Francis TC, 2015, BIOL PSYCHIAT, V77, P212, DOI 10.1016/j.biopsych.2014.07.021; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Haring M, 2012, NEUROSCIENCE, V204, P145, DOI 10.1016/j.neuroscience.2011.12.035; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Hamilton PJ, 2018, NEUROPSYCHOPHARMACOL, V43, P272, DOI 10.1038/npp.2017.88; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hoffman AF, 2001, J NEUROPHYSIOL, V85, P72, DOI 10.1152/jn.2001.85.1.72; Hu HL, 2016, ANNU REV NEUROSCI, V39, P297, DOI 10.1146/annurev-neuro-070815-014106; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Kim J, 2016, NAT NEUROSCI, V19, P1636, DOI 10.1038/nn.4414; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Li YD, 2017, NAT NEUROSCI, V20, P559, DOI 10.1038/nn.4517; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Lutz B, 2015, NAT REV NEUROSCI, V16, P705, DOI 10.1038/nrn4036; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Martin M, 2002, PSYCHOPHARMACOLOGY, V159, P379, DOI 10.1007/s00213-001-0946-5; Mathur BN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00066; Medrihan L, 2017, NEURON, V95, P564, DOI 10.1016/j.neuron.2017.06.044; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Sanchis-Segura C, 2004, PSYCHOPHARMACOLOGY, V176, P223, DOI 10.1007/s00213-004-1877-8; Savanthrapadian S, 2014, J NEUROSCI, V34, P8197, DOI 10.1523/JNEUROSCI.5433-13.2014; Sherrin T, 2009, MOL PSYCHIATR, V14, P291, DOI 10.1038/sj.mp.4002121; Shin S, 2015, NAT NEUROSCI, V18, P1017, DOI 10.1038/nn.4028; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P1165, DOI 10.1016/j.psyneuen.2008.06.004; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Toledo-Rodriguez Maria, 2007, V403, P123, DOI 10.1007/978-1-59745-529-9_8; Valverde O, 2012, NEUROSCIENCE, V204, P193, DOI 10.1016/j.neuroscience.2011.09.031; Vogel E, 2016, NEURON, V91, P644, DOI 10.1016/j.neuron.2016.06.036; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Xiong QJ, 2015, NATURE, V521, P348, DOI 10.1038/nature14225; Zhou TT, 2017, SCIENCE, V357, P162, DOI 10.1126/science.aak9726	61	84	92	8	134	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					337	+		10.1038/s41591-018-0299-9	http://dx.doi.org/10.1038/s41591-018-0299-9			29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30643290				2022-12-27	WOS:000457842100031
J	Bacman, SR; Kauppila, JHK; Pereira, CV; Nissanka, N; Miranda, M; Pinto, M; Williams, SL; Larsson, NG; Stewart, JB; Moraes, CT				Bacman, Sandra R.; Kauppila, Johanna H. K.; Pereira, Claudia, V; Nissanka, Nadee; Miranda, Maria; Pinto, Milena; Williams, Sion L.; Larsson, Nils-Goeran; Stewart, James B.; Moraes, Carlos T.			MitoTALEN reduces mutant mtDNA load and restores tRNA(Ala) levels in a mouse model of heteroplasmic mtDNA mutation	NATURE MEDICINE			English	Article							MITOCHONDRIAL-DNA; ELIMINATION; PHENOTYPE; DELETIONS; DOMAIN	Mutations in the mitochondrial DNA ( mtDNA) are responsible for several metabolic disorders, commonly involving muscle and the central nervous system(1). Because of the critical role of mtDNA in oxidative phosphorylation, the majority of pathogenic mtDNA mutations are heteroplasmic, co-existing with wild-type molecules(1). Using a mouse model with a heteroplasmic mtDNA mutation(2), we tested whether mitochondrialtargeted TALENs (mitoTALENs)(3,4) could reduce the mutant mtDNA load in muscle and heart. AAV9-mitoTALEN was administered via intramuscular, intravenous, and intraperitoneal injections. Muscle and heart were efficiently transduced and showed a robust reduction in mutant mtDNA, which was stable over time. The molecular defect, namely a decrease in transfer RNA(Ala) levels, was restored by the treatment. These results showed that mitoTALENs, when expressed in affected tissues, could revert disease-related phenotypes in mice.	[Bacman, Sandra R.; Pereira, Claudia, V; Nissanka, Nadee; Pinto, Milena; Williams, Sion L.; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Kauppila, Johanna H. K.; Miranda, Maria; Larsson, Nils-Goeran; Stewart, James B.] Max Planck Inst Biol & Ageing, Dept Mitochondrial Biol, Cologne, Germany	University of Miami; Max Planck Society	Bacman, SR; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	sbacman@med.miami.edu; cmoraes@med.miami.edu	Stewart, James B/C-9633-2011; Larsson, Nils-Göran/GVS-5578-2022; Moraes, Carlos/AAT-3818-2021; pinto, milena/K-6095-2017	Stewart, James B/0000-0002-2902-4968; Larsson, Nils-Göran/0000-0001-5100-996X; Nissanka, Nadee/0000-0002-4639-7192; pinto, milena/0000-0001-9202-1527; Miranda, Maria/0000-0002-0817-553X	National Institutes of Health [5R01EY010804]; NIH [1R01AG036871, 1R01NS079965]; Muscular Dystrophy Association; JDM Fund for Mitochondrial Research; American Heart Association [16PRE30480009]; Biscardi family; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); JDM Fund for Mitochondrial Research; American Heart Association(American Heart Association); Biscardi family; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported primarily by the National Institutes of Health Grant 5R01EY010804, with additional support from 1R01AG036871 and 1R01NS079965 (NIH) and the Muscular Dystrophy Association (CTM). We also acknowledge support from The JDM Fund for Mitochondrial Research and the Biscardi family. N.N. is supported by an American Heart Association predoctoral fellowship (16PRE30480009). We are grateful to the University of Miami Flow Cytometry core facility (SCCC) for expert assistance.	Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; El-Hattab AW, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00025; Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676; Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126; Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037; Kelly RDW, 2012, NUCLEIC ACIDS RES, V40, P10124, DOI 10.1093/nar/gks770; Lamb BM, 2013, NUCLEIC ACIDS RES, V41, P9779, DOI 10.1093/nar/gkt754; Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; MORAES CT, 1992, AM J HUM GENET, V50, P934; Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449; Pinto M, 2018, J NEUROSCI, V38, P1042, DOI 10.1523/JNEUROSCI.1384-17.2017; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	27	123	129	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1696	+		10.1038/s41591-018-0166-8	http://dx.doi.org/10.1038/s41591-018-0166-8			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30250143	Green Accepted, Green Submitted			2022-12-27	WOS:000449404200021
J	Stower, H				Stower, Hannah			Interpreting the unknown	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1491	1491		10.1038/s41591-018-0227-z	http://dx.doi.org/10.1038/s41591-018-0227-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297893	Bronze			2022-12-27	WOS:000446577900032
J	Volkow, ND; Baler, R				Volkow, Nora D.; Baler, Ruben			A prescription for better opioid prescribing?	NATURE MEDICINE			English	Editorial Material							OVERDOSE; DRUG		[Volkow, Nora D.; Baler, Ruben] NIDA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Bonnie RJ, 2017, PAIN MANAGEMENT AND THE OPIOID EPIDEMIC: BALANCING SOCIETAL AND INDIVIDUAL BENEFITS AND RISKS OF PRESCRIPTION OPIOID USE, P1, DOI 10.17226/24781; Chauhan BF, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0538-8; Doctor JN, 2018, SCIENCE, V361, P588, DOI 10.1126/science.aat4595; Liang YY, 2015, J PAIN, V16, P318, DOI 10.1016/j.jpain.2014.11.007; Manchikanti L, 2017, PAIN PHYSICIAN, V20, pS3; Penti Brian, 2016, J Opioid Manag, V12, P269, DOI 10.5055/jom.2016.0342; Pezalla EJ, 2017, J PAIN RES, V10, DOI 10.2147/JPR.S129553; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Seth P, 2018, AM J PUBLIC HEALTH, V108, P500, DOI 10.2105/AJPH.2017.304265; Sun EC, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j760; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626	12	5	5	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1496	1498		10.1038/s41591-018-0214-4	http://dx.doi.org/10.1038/s41591-018-0214-4			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297898				2022-12-27	WOS:000446577900008
J	Chen, CY; Caporizzo, MA; Bedi, K; Vite, A; Bogush, AI; Robison, P; Heffler, JG; Salomon, AK; Kelly, NA; Babu, A; Morley, MP; Margulies, KB; Prosser, BL				Chen, Christina Yingxian; Caporizzo, Matthew A.; Bedi, Kenneth; Vite, Alexia; Bogush, Alexey, I; Robison, Patrick; Heffler, Julie G.; Salomon, Alex K.; Kelly, Neil A.; Babu, Apoorva; Morley, Michael P.; Margulies, Kenneth B.; Prosser, Benjamin L.			Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure	NATURE MEDICINE			English	Article							PRESSURE-OVERLOAD HYPERTROPHY; CARDIAC-HYPERTROPHY; CONTRACTILE DYSFUNCTION; PULMONARY-HYPERTENSION; VENTRICULAR MYOCYTES; CYTOSKELETAL ROLE; PROTEIN; RAT; QUANTIFICATION; MYOCARDIUM	Detyrosinated microtubules provide mechanical resistance that can impede the motion of contracting cardiomyocytes. However, the functional effects of microtubule detyrosination in heart failure or in human hearts have not previously been studied. Here, we utilize mass spectrometry and single-myocyte mechanical assays to characterize changes to the cardiomyocyte cytoskeleton and their functional consequences in human heart failure. Proteomic analysis of left ventricle tissue reveals a consistent upregulation and stabilization of intermediate filaments and microtubules in failing human hearts. As revealed by super-resolution imaging, failing cardiomyocytes are characterized by a dense, heavily detyrosinated microtubule network, which is associated with increased myocyte stiffness and impaired contractility. Pharmacological suppression of detyrosinated microtubules lowers the viscoelasticity of failing myocytes and restores 40-50% of lost contractile function; reduction of microtubule detyrosination using a genetic approach also softens cardiomyocytes and improves contractile kinetics. Together, these data demonstrate that a modified cytoskeletal network impedes contractile function in cardiomyocytes from failing human hearts and that targeting detyrosinated microtubules could represent a new inotropic strategy for improving cardiac function.	[Chen, Christina Yingxian; Caporizzo, Matthew A.; Bogush, Alexey, I; Robison, Patrick; Heffler, Julie G.; Salomon, Alex K.; Kelly, Neil A.; Margulies, Kenneth B.; Prosser, Benjamin L.] Univ Penn, Dept Physiol, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bedi, Kenneth; Vite, Alexia; Babu, Apoorva; Morley, Michael P.; Margulies, Kenneth B.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Babu, Apoorva; Morley, Michael P.; Margulies, Kenneth B.; Prosser, Benjamin L.] Univ Penn, Penn Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Prosser, BL (corresponding author), Univ Penn, Dept Physiol, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Prosser, BL (corresponding author), Univ Penn, Penn Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	bpros@pennmedicine.upenn.edu	; Chen, Christina Yingxian/O-5676-2016	Vite, Alexia/0000-0002-6589-8996; Chen, Christina Yingxian/0000-0002-8013-1515; Babu, Apoorva/0000-0003-3661-5261; Prosser, Benjamin/0000-0003-3696-9131; Morley, Michael/0000-0002-0958-7376	National Institutes of Health (NIH) [R01-HL133080, T32 R05346-09]; American Heart Association [17POST33440043]; Center for Engineering MechanoBiology through National Science Foundation's Science and Technology Center program [15-48571]; NIH [HL089847, HL105993]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954, R01HL133080, R01HL105993, R01HL089847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR053461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Center for Engineering MechanoBiology through National Science Foundation's Science and Technology Center program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like thank the Quantitative Proteomics Resource Core of the Perelman School of Medicine and the Penn Center for Musculoskeletal Disorders Histology Core at the University of Pennsylvania. This work was supported by funding from the National Institutes of Health (NIH) R01-HL133080 to B.L.P. and T32 R05346-09 to P.R., the American Heart Association 17POST33440043 to M.A.C., and by the Center for Engineering MechanoBiology through a grant from the National Science Foundation's Science and Technology Center program: 15-48571. The procurement of human heart tissue was enabled by grants from the NIH (HL089847 and HL105993) to K.B.M.	Agnetti G, 2014, CARDIOVASC RES, V102, P24, DOI 10.1093/cvr/cvu003; Bailey BA, 1997, J MOL CELL CARDIOL, V29, P1823, DOI 10.1006/jmcc.1997.0422; Burke MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86898; Caporizzo Matthew Alexander, 2015, Nanobiomedicine (Rij), V2; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng GM, 2010, J BIOL CHEM, V285, P38125, DOI 10.1074/jbc.M110.148650; Collins JF, 1996, J MOL CELL CARDIOL, V28, P1435, DOI 10.1006/jmcc.1996.0134; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Gomez AM, 2000, CIRC RES, V86, P30, DOI 10.1161/01.RES.86.1.30; Ishibashi Y, 1996, AM J PHYSIOL-HEART C, V271, pH1978, DOI 10.1152/ajpheart.1996.271.5.H1978; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kerr JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9526; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lemler MS, 2000, AM J PHYSIOL-HEART C, V279, pH1365; Miragoli M, 2016, CELL REP, V14, P140, DOI 10.1016/j.celrep.2015.12.014; Prins KW, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006195; Prins Kurt W, 2016, JACC Basic Transl Sci, V1, P122; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Robison P, 2017, J PHYSIOL-LONDON, V595, P3931, DOI 10.1113/JP273046; Robison P, 2016, SCIENCE, V352, DOI 10.1126/science.aaf0659; ROCHDI I, 1994, EUR J CLIN PHARMACOL, V46, P351; Shiels H, 2007, MOL CELL BIOCHEM, V294, P173, DOI 10.1007/s11010-006-9257-9; Simithy J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01384-9; Stones R, 2013, J MOL CELL CARDIOL, V56, P91, DOI 10.1016/j.yjmcc.2012.12.010; Tagawa H, 1998, CIRC RES, V82, P751, DOI 10.1161/01.RES.82.7.751; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang XJ, 1999, J MOL CELL CARDIOL, V31, P319, DOI 10.1006/jmcc.1998.0885; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhang CM, 2014, CIRCULATION, V129, P1742, DOI 10.1161/CIRCULATIONAHA.113.008452; Zile MR, 2001, J AM COLL CARDIOL, V37, P1080, DOI 10.1016/S0735-1097(00)01207-9	40	105	106	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1225	+		10.1038/s41591-018-0046-2	http://dx.doi.org/10.1038/s41591-018-0046-2			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29892068	Green Accepted			2022-12-27	WOS:000440955500028
J	Hoyles, L; Fernandez-Real, JM; Federici, M; Serino, M; Abbott, J; Charpentier, J; Heymes, C; Luque, JL; Anthony, E; Barton, RH; Chilloux, J; Myridakis, A; Martinez-Gili, L; Moreno-Navarrete, JM; Benhamed, F; Azalbert, V; Blasco-Baque, V; Puig, J; Xifra, G; Ricart, W; Tomlinson, C; Woodbridge, M; Cardellini, M; Davato, F; Cardolini, I; Porzio, O; Gentileschi, P; Lopez, F; Foufelle, F; Butcher, SA; Holmes, E; Nicholson, JK; Postic, C; Burcelin, R; Dumas, ME				Hoyles, Lesley; Fernandez-Real, Jose-Manuel; Federici, Massimo; Serino, Matteo; Abbott, James; Charpentier, Julie; Heymes, Christophe; Latorre Luque, Jessica; Anthony, Elodie; Barton, Richard H.; Chilloux, Julien; Myridakis, Antonis; Martinez-Gili, Laura; Maria Moreno-Navarrete, Jose; Benhamed, Fadila; Azalbert, Vincent; Blasco-Baque, Vincent; Puig, Josep; Xifra, Gemma; Ricart, Wifredo; Tomlinson, Christopher; Woodbridge, Mark; Cardellini, Marina; Davato, Francesca; Cardolini, Iris; Porzio, Ottavia; Gentileschi, Paolo; Lopez, Frederic; Foufelle, Fabienne; Butcher, Sarah A.; Holmes, Elaine; Nicholson, Jeremy K.; Postic, Catherine; Burcelin, Remy; Dumas, Marc-Emmanuel			Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women	NATURE MEDICINE			English	Article							FATTY LIVER-DISEASE; HUMAN GUT MICROBIOME; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLISM; GLUCOSE; DIET; IMPACT; ASSOCIATION; PHENOTYPE	Hepatic steatosis is a multifactorial condition that is often observed in obese patients and is a prelude to non-alcoholic fatty liver disease. Here, we combine shotgun sequencing of fecal metagenomes with molecular phenomics (hepatic transcriptome and plasma and urine metabolomes) in two well-characterized cohorts of morbidly obese women recruited to the FLORINASH study. We reveal molecular networks linking the gut microbiome and the host phenome to hepatic steatosis. Patients with steatosis have low microbial gene richness and increased genetic potential for the processing of dietary lipids and endotoxin biosynthesis (notably from Proteobacteria), hepatic inflammation and dysregulation of aromatic and branched-chain amino acid metabolism. We demonstrated that fecal microbiota transplants and chronic treatment with phenylacetic acid, a microbial product of aromatic amino acid metabolism, successfully trigger steatosis and branched-chain amino acid metabolism. Molecular phenomic signatures were predictive (area under the curve = 87%) and consistent with the gut microbiome having an effect on the steatosis phenome (> 75% shared variation) and, therefore, actionable via microbiome-based therapies.	[Hoyles, Lesley; Abbott, James; Barton, Richard H.; Chilloux, Julien; Myridakis, Antonis; Martinez-Gili, Laura; Tomlinson, Christopher; Woodbridge, Mark; Butcher, Sarah A.; Holmes, Elaine; Nicholson, Jeremy K.; Dumas, Marc-Emmanuel] Imperial Coll London, Dept Surg & Canc, Div Integrat Syst Med & Digest Dis, London, England; [Fernandez-Real, Jose-Manuel; Latorre Luque, Jessica; Maria Moreno-Navarrete, Jose; Puig, Josep; Xifra, Gemma; Ricart, Wifredo] Univ Girona, Hosp Girona Dr Josep Trueta, Dept Endocrinol Diabet & Nutr, Madrid, Spain; [Fernandez-Real, Jose-Manuel; Latorre Luque, Jessica; Maria Moreno-Navarrete, Jose; Puig, Josep; Xifra, Gemma; Ricart, Wifredo] Univ Girona, Hosp Girona Dr Josep Trueta, Dept Med, Madrid, Spain; [Fernandez-Real, Jose-Manuel; Latorre Luque, Jessica; Maria Moreno-Navarrete, Jose; Puig, Josep; Xifra, Gemma; Ricart, Wifredo] Inst Salud Carlos III, CIBERobn Pathophysiol Obes & Nutr, Madrid, Spain; [Federici, Massimo; Cardellini, Marina; Davato, Francesca; Cardolini, Iris] Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier, Rome, Italy; [Serino, Matteo; Charpentier, Julie; Heymes, Christophe; Azalbert, Vincent; Blasco-Baque, Vincent; Lopez, Frederic; Burcelin, Remy] INSERM, Toulouse, France; [Serino, Matteo; Charpentier, Julie; Heymes, Christophe; Azalbert, Vincent; Blasco-Baque, Vincent; Lopez, Frederic; Burcelin, Remy] UPS, Unite Mixte Rech UMR 1048, Inst Malad Metab & Cardiovascu I2MC, Team Intestinal Risk Factors Diabet Dyslipid & He, Toulouse, France; [Anthony, Elodie; Benhamed, Fadila; Postic, Catherine] Univ Paris 05, Inst Cochin, CNRS, UMR 8104,INSERM,U1016, Paris, France; [Porzio, Ottavia; Gentileschi, Paolo] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Porzio, Ottavia] Bambino Gesu Pediat Hosp, Dept Lab Med, Rome, Italy; [Foufelle, Fabienne] UPMC Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMRS 1138, Paris, France	Imperial College London; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Rome Tor Vergata; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Rome Tor Vergata; IRCCS Bambino Gesu; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Dumas, ME (corresponding author), Imperial Coll London, Dept Surg & Canc, Div Integrat Syst Med & Digest Dis, London, England.; Fernandez-Real, JM (corresponding author), Univ Girona, Hosp Girona Dr Josep Trueta, Dept Endocrinol Diabet & Nutr, Madrid, Spain.; Fernandez-Real, JM (corresponding author), Univ Girona, Hosp Girona Dr Josep Trueta, Dept Med, Madrid, Spain.; Fernandez-Real, JM (corresponding author), Inst Salud Carlos III, CIBERobn Pathophysiol Obes & Nutr, Madrid, Spain.; Federici, M (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier, Rome, Italy.; Burcelin, R (corresponding author), INSERM, Toulouse, France.; Burcelin, R (corresponding author), UPS, Unite Mixte Rech UMR 1048, Inst Malad Metab & Cardiovascu I2MC, Team Intestinal Risk Factors Diabet Dyslipid & He, Toulouse, France.	jmfreal@idibgi.org; federicm@uniroma2.it; remy.burcelin@inserm.fr; m.dumas@imperial.ac.uk	Dumas, Marc-Emmanuel/C-1736-2008; Moreno-Navarrete, José María/ABG-5548-2021; Nicholson, Jeremy K/B-3395-2012; Cardellini, Marina/AAC-1096-2019; Hoyles, Lesley/N-9847-2015; Heymes, Christophe/Y-9368-2019; Fernández-Real, Jose Manuel/AGH-3599-2022; Holmes, Elaine/ABE-6606-2020; Martinez-Gili, Laura/GPT-3558-2022; Moreno-Navarrete, José María/H-9772-2015; burcelin, remy/M-6013-2014; Holmes, Elaine/A-2189-2015; Blasco Baque, Vincent/AHA-9524-2022; Federici, Massimo/G-9940-2012; Serino, Matteo/O-3310-2018	Dumas, Marc-Emmanuel/0000-0001-9523-7024; Moreno-Navarrete, José María/0000-0002-2883-511X; Nicholson, Jeremy K/0000-0002-8123-8349; Hoyles, Lesley/0000-0002-6418-342X; Heymes, Christophe/0000-0002-6666-6193; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Holmes, Elaine/0000-0002-0556-8389; Martinez-Gili, Laura/0000-0001-5271-9672; Moreno-Navarrete, José María/0000-0002-2883-511X; Federici, Massimo/0000-0003-4989-5194; Serino, Matteo/0000-0003-4644-8532; Myridakis, Antonis/0000-0003-1690-6651; Rayah Benhamed, Fadila/0000-0003-4905-6585; Latorre Luque, Jessica/0000-0002-7603-1458; Woodbridge, Mark/0000-0002-0650-9751; Abbott, James/0000-0001-7701-4249; Barton, Richard H./0000-0001-7469-2845; PORZIO, OTTAVIA/0000-0001-5931-8679; Blasco-Baque, Vincent/0000-0003-3012-8980; FOUFELLE, Fabienne/0000-0002-0752-622X	EU-FP7 FLORINASH [Health-F2-2009-241913]; Medical Research Council [MR/L01632X/1]; MRC Intermediate Research Fellowship in Data Science [MR/L01632X/1]; Agence Nationale de la Recherche [RPV09003BBA, ANR 09-GEN TRANSFLORAP, GAD 08-2_378258]; Ministry of University (MIUR) Progetti di Ricerca di Interesse Nazionale (PAIN) [2015MPESJS 004]; Ministry of Health Ricerca Finalizzata [RF-2011-02349921]; Fondazione Roma call for Non -Communicable Diseases NCD 2014; Ministry of Health FIS project, CIBERobn Pathophysiology of Obesity and Nutrition and FEDER funds [15/01934]; EU METACARDIS [HEALTH -F4-2012-305312]; Neuron II [291840]; MRC [MR/M501797/1]; Imperial College National Institute of Biomedical Research; Clinical Phenotyping Centre; MRC [MR/L01632X/1] Funding Source: UKRI; Medical Research Council [MR/M501797/1] Funding Source: researchfish	EU-FP7 FLORINASH; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Intermediate Research Fellowship in Data Science(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministry of University (MIUR) Progetti di Ricerca di Interesse Nazionale (PAIN)(Ministry of Education, Universities and Research (MIUR)); Ministry of Health Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Fondazione Roma call for Non -Communicable Diseases NCD 2014; Ministry of Health FIS project, CIBERobn Pathophysiology of Obesity and Nutrition and FEDER funds; EU METACARDIS; Neuron II; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College National Institute of Biomedical Research; Clinical Phenotyping Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank N. J. Gooderham for critical reading of the manuscript. This work was supported by EU-FP7 FLORINASH (Health-F2-2009-241913) to R.B., M.F., J.-M.F.-R., F.F., C.P., E.H. and J.K.N. This work used the computing resources of the UK MEDical BlOinformatics partnership aggregation, integration, visualization and analysis of large, complex data (UK MED-BIO), which is supported by the Medical Research Council (grant number MR/L01632X/1). L.H. is in receipt of an MRC Intermediate Research Fellowship in Data Science (MR/L01632X/1, UK MED-BIO). This work was also supported by funding to R.B. ((Region Midi-Pyrenees 2009-2014 RPV09003BBA), Agence Nationale de la Recherche ANR 09-GEN TRANSFLORAP and GAD 08-2_378258), to M.F. (Ministry of University (MIUR) Progetti di Ricerca di Interesse Nazionale (PAIN) protocol number 2015MPESJS 004, Ministry of Health Ricerca Finalizzata RF-2011-02349921, Fondazione Roma call for Non -Communicable Diseases NCD 2014), to J.-M.F.-R. (Ministry of Health FIS project 15/01934, CIBERobn Pathophysiology of Obesity and Nutrition and FEDER funds) and to M.-E.D. (EU METACARDIS under agreement HEALTH -F4-2012-305312, Neuron II under agreement 291840 and the MRC MR/M501797/1). We acknowledge the support of the Imperial College National Institute of Biomedical Research and the Clinical Phenotyping Centre for support.	Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Davidovic L, 2011, GENOME RES, V21, P2190, DOI 10.1101/gr.116764.110; Grasa MD, 2017, EUR J ENDOCRINOL, V176, P393, DOI [10.1530/EJE-16-0834, 10.1530/eje-16-0834]; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Dumas ME, 2017, CELL REP, V20, P136, DOI 10.1016/j.celrep.2017.06.039; Dumas ME, 2014, GASTROENTEROLOGY, V146, P46, DOI 10.1053/j.gastro.2013.11.001; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fujisaka S, 2016, J CLIN INVEST, V126, P4430, DOI 10.1172/JCI86674; Grasset E, 2017, CELL METAB, V25, P1075, DOI 10.1016/j.cmet.2017.04.013; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Hoyles L, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0461-0; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Kadar H, 2016, ARCH BIOCHEM BIOPHYS, V597, P12, DOI 10.1016/j.abb.2016.03.029; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Latorre J, 2017, INT J OBESITY, V41, P620, DOI 10.1038/ijo.2017.21; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lluch J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142334; Lonardo A, 2016, WORLD J GASTROENTERO, V22, P9674, DOI 10.3748/wjg.v22.i44.9674; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicolas S, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167356; Pallister T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13722-4; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rodriguez-Martinez A, 2017, BIOINFORMATICS, V33, P773, DOI 10.1093/bioinformatics/btw697; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schugar RC, 2017, CELL REP, V19, P2451, DOI 10.1016/j.celrep.2017.05.077; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Sharifnia T, 2015, AM J PHYSIOL-GASTR L, V309, pG270, DOI 10.1152/ajpgi.00304.2014; Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001; Smilde AK, 2009, BIOINFORMATICS, V25, P401, DOI 10.1093/bioinformatics/btn634; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	76	278	287	12	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1070	+		10.1038/s41591-018-0061-3	http://dx.doi.org/10.1038/s41591-018-0061-3			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29942096	Green Accepted, Green Submitted			2022-12-27	WOS:000438187700035
J	[Anonymous]				[Anonymous]			Green light for data sharing	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					898	898		10.1038/s41591-018-0122-7	http://dx.doi.org/10.1038/s41591-018-0122-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988136				2022-12-27	WOS:000438187700011
J	Giavridis, T; van der Stegen, SJC; Eyquem, J; Hamieh, M; Piersigilli, A; Sadelain, M				Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Eyquem, Justin; Hamieh, Mohamad; Piersigilli, Alessandra; Sadelain, Michel			CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; BLOOD-BRAIN-BARRIER; SELECTIVE INHIBITOR; HUMAN ASTROCYTES; PROTEIN JLP; IN-VIVO; RECEPTOR; THERAPY; MANAGEMENT	Chimeric antigen receptor (CAR) therapy targeting CD19 is an effective treatment for refractory B cell malignancies, especially acute lymphoblastic leukemia (ALL)(1). Although a majority of patients will achieve a complete response following a single infusion of CD19-targeted CAR-modified T cells (CD19 CAR T cells)(2-4), the broad applicability of this treatment is hampered by severe cytokine release syndrome (CRS), which is characterized by fever, hypotension and respiratory insufficiency associated with elevated serum cytokines, including interleukin-6 (IL-6)(2,5). CRS usually occurs within days of T cell infusion at the peak of CAR T cell expansion. In ALL, it is most frequent and more severe in patients with high tumor burden(2-4). CRS may respond to IL-6 receptor blockade but can require further treatment with high dose corticosteroids to curb potentially lethal severity(2-9). Improved therapeutic and preventive treatments require a better understanding of CRS physiopathology, which has so far remained elusive. Here we report a murine model of CRS that develops within 2-3 d of CAR T cell infusion and that is potentially lethal and responsive to IL-6 receptor blockade. We show that its severity is mediated not by CAR T cell-derived cytokines, but by IL-6, IL-1 and nitric oxide (NO) produced by recipient macrophages, which enables new therapeutic interventions.	[Giavridis, Theodoros; van der Stegen, Sjoukje J. C.; Eyquem, Justin; Hamieh, Mohamad; Sadelain, Michel] Sloan Kettering Inst, Ctr Cell Engn & Immunol Program, New York, NY 10065 USA; [Piersigilli, Alessandra] Rockefeller Univ, Lab Comparat Pathol, Weill Cornell Med, 1230 York Ave, New York, NY 10021 USA; [Piersigilli, Alessandra] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Sloan Kettering Inst, Ctr Cell Engn & Immunol Program, New York, NY 10065 USA.	m-sadelain@mskcc.org	Eyquem, Justin/AAW-5753-2020; Hamieh, Mohamad/AAX-3056-2020	Giavridis, Theodoros/0000-0002-8716-781X; Eyquem, Justin/0000-0001-8262-1190	Alexander S. Onassis Public Benefit Foundation; Juno Therapeutics; MSK Cancer Center Support Grant/Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Alexander S. Onassis Public Benefit Foundation; Juno Therapeutics; MSK Cancer Center Support Grant/Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Alexander S. Onassis Public Benefit Foundation for their support (T.G.). We thank the following MSK core facilities for their outstanding support: flow cytometry core facility, laboratory of comparative pathology, animal facility, integrated genomics operation and bioinformatics core. We thank G. Gunset, Z. Zhao, A. Dobrin and P. Lindenbergh for their assistance with some experiments. This study was supported by Juno Therapeutics and the MSK Cancer Center Support Grant/Core Grant (P30 CA008748).	Barrett DM, 2014, CURR OPIN PEDIATR, V26, P43, DOI 10.1097/MOP.0000000000000043; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Cray C, 2009, COMPARATIVE MED, V59, P517; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; GUTIERREZ EG, 1994, J NEUROIMMUNOL, V55, P153, DOI 10.1016/0165-5728(94)90005-1; Hay KA, 2017, BLOOD, V130, P2295, DOI 10.1182/blood-2017-06-793141; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Liu J, 1996, J IMMUNOL, V157, P3569; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Ohashi Y, 1998, J CLIN INVEST, V102, P2061, DOI 10.1172/JCI4394; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Oluwole OO, 2016, J LEUKOCYTE BIOL, V100, P1265, DOI 10.1189/jlb.5BT1115-524R; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Saini AS, 2014, NAT IMMUNOL, V15, P275, DOI 10.1038/ni.2806; SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Tucker TA, 2008, EUR J IMMUNOL, V38, P864, DOI 10.1002/eji.200737828; van der Stegen SJC, 2013, J IMMUNOL, V191, P4589, DOI 10.4049/jimmunol.1301523; Vandevelde M, 2012, VET NEUROPATHOLOGY E, V29; Wang HM, 2015, J BIOL CHEM, V290, P5256, DOI 10.1074/jbc.M114.618496; Wang HM, 2013, IMMUNOBIOLOGY, V218, P835, DOI 10.1016/j.imbio.2012.10.002; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	44	573	616	6	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					731	+		10.1038/s41591-018-0041-7	http://dx.doi.org/10.1038/s41591-018-0041-7			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29808005	Green Accepted			2022-12-27	WOS:000434281300018
J	Apazoglou, K; Farley, S; Gorgievski, V; Belzeaux, R; Lopez, JP; Grenier, J; Ibrahim, E; El Khoury, MA; Tse, YC; Mongredien, R; Barbe, A; de Macedo, CEA; Jaworski, W; Bochereau, A; Orrico, A; Isingrini, E; Guinaudie, C; Mikasova, L; Louis, F; Gautron, S; Groc, L; Massaad, C; Yildirim, F; Vialou, V; Dumas, S; Marti, F; Mechawar, N; Morice, E; Wong, TP; Caboche, J; Turecki, G; Giros, B; Tzavara, ET				Apazoglou, Kallia; Farley, Severine; Gorgievski, Victor; Belzeaux, Raoul; Lopez, Juan Pablo; Grenier, Julien; Ibrahim, El Cherif; El Khoury, Marie-Anne; Tse, Yiu C.; Mongredien, Raphaele; Barbe, Alexandre; de Macedo, Carlos E. A.; Jaworski, Wojciech; Bochereau, Ariane; Orrico, Alejandro; Isingrini, Elsa; Guinaudie, Chloe; Mikasova, Lenka; Louis, Franck; Gautron, Sophie; Groc, Laurent; Massaad, Charbel; Yildirim, Ferah; Vialou, Vincent; Dumas, Sylvie; Marti, Fabio; Mechawar, Naguib; Morice, Elise; Wong, Tak P.; Caboche, Jocelyne; Turecki, Gustavo; Giros, Bruno; Tzavara, Eleni T.			Antidepressive effects of targeting ELK-1 signal transduction	NATURE MEDICINE			English	Article							MAJOR DEPRESSIVE EPISODE; MAP KINASE; GENE-EXPRESSION; TRANSCRIPTIONAL SIGNATURES; BEHAVIORAL-RESPONSES; MOOD DISORDERS; MOUSE MODEL; STRESS; RECEPTORS; MICE	Depression, a devastating psychiatric disorder, is a leading cause of disability worldwide. Current antidepressants address specific symptoms of the disease, but there is vast room for improvement(1). In this respect, new compounds that act beyond classical antidepressants to target signal transduction pathways governing synaptic plasticity and cellular resilience are highly warranted(2-4). The extracellular signal-regulated kinase (ERK) pathway is implicated in mood regulation(5-7), but its pleiotropic functions and lack of target specificity prohibit optimal drug development. Here, we identified the transcription factor ELK-1, an ERK downstream partner(8), as a specific signaling module in the pathophysiology and treatment of depression that can be targeted independently of ERK. ELK1 mRNA was upregulated in postmortem hippocampal tissues from depressed suicides; in blood samples from depressed individuals, failure to reduce ELK1 expression was associated with resistance to treatment. In mice, hippocampal ELK-1 overexpression per se produced depressive behaviors; conversely, the selective inhibition of ELK-1 activation prevented depression- like molecular, plasticity and behavioral states induced by stress. Our work stresses the importance of target selectivity for a successful approach for signal-transduction-based antidepressants, singles out ELK-1 as a depression-relevant transducer downstream of ERK and brings proof-of-concept evidence for the druggability of ELK-1.	[Apazoglou, Kallia; Farley, Severine; Gorgievski, Victor; El Khoury, Marie-Anne; Mongredien, Raphaele; Barbe, Alexandre; de Macedo, Carlos E. A.; Jaworski, Wojciech; Bochereau, Ariane; Orrico, Alejandro; Louis, Franck; Gautron, Sophie; Vialou, Vincent; Marti, Fabio; Caboche, Jocelyne; Giros, Bruno; Tzavara, Eleni T.] Univ Paris 06, Sorbonne Univ, CNRS UMR8246, INSERM UMRS 1130,Neurosci Paris Seine IBPS, Paris, France; [Belzeaux, Raoul; Lopez, Juan Pablo; Tse, Yiu C.; Isingrini, Elsa; Guinaudie, Chloe; Mechawar, Naguib; Wong, Tak P.; Turecki, Gustavo; Giros, Bruno] McGill Univ, Fac Med, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [Belzeaux, Raoul] Pole Psychiat Univ Solaris, St Marguerite Hosp, AP HM, Marseille, France; [Belzeaux, Raoul; Ibrahim, El Cherif; Giros, Bruno; Tzavara, Eleni T.] FondaMental Fdn, Creteil, France; [Grenier, Julien; Massaad, Charbel] Univ Paris 05, INSERM UMR S ERL 3649 1124, Paris, France; [Ibrahim, El Cherif] Aix Marseille Univ, CNRS, INT, UMR 7289, Marseille, France; [Mikasova, Lenka; Groc, Laurent] Univ Bordeaux, CNRS UMR 5297, Interdisciplinary Inst Neurosci, Bordeaux, France; [Yildirim, Ferah] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Dept Neuropsychiat, Berlin, Germany; [Yildirim, Ferah] Charite Univ Med Berlin, NeuroCure Cluster Excellence, Berlin, Germany; [Dumas, Sylvie] Oramacell, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; McGill University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Giros, B; Tzavara, ET (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS UMR8246, INSERM UMRS 1130,Neurosci Paris Seine IBPS, Paris, France.; Giros, B (corresponding author), McGill Univ, Fac Med, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada.; Giros, B; Tzavara, ET (corresponding author), FondaMental Fdn, Creteil, France.	bruno.giros@mcgill.ca; eleni.tzavara@inserm.fr	Lopez, Juan Pablo/ABF-2377-2020; IBRAHIM, El Chérif/K-3899-2016; Belzeaux, Raoul/AGZ-3125-2022; Gautron, Sophie L/O-3216-2017; GIROS, Bruno/ABD-5790-2021; vialou, vincent/F-2968-2013; Lopez, Juan Pablo/AAM-5727-2021; Macedo, Carlos Eduardo/A-7184-2013; Elsa, Isingrini/T-2406-2018	Lopez, Juan Pablo/0000-0002-5812-4220; IBRAHIM, El Chérif/0000-0003-3973-7862; Gautron, Sophie L/0000-0002-4510-7640; GIROS, Bruno/0000-0001-5876-9822; vialou, vincent/0000-0002-8212-751X; Macedo, Carlos Eduardo/0000-0001-9708-3313; Turecki, Gustavo/0000-0003-4075-2736; Wong, Tak Pan/0000-0001-8611-4911; GRENIER, Julien/0000-0002-1897-1329; Yildirim, Ferah/0000-0003-2979-6623; Orrico Sanchez, Alejandro/0000-0002-3780-3187; Apazoglou, Kalliopi/0000-0003-2152-5239; Elsa, Isingrini/0000-0002-0698-4237; marti, fabio/0000-0002-3604-457X	ERANET NEURON (Grant WM2NA); Labex-Biopsy; FRC (Fondation Recherche pour le Cerveau); National Hospital Clinical Research Program (Assistance Publique-Hopitaux de Marseille) [2010-19]; Conseil Regional d'Aquitaine; Canadian Institute for Health Research; FondaMental Servier postdoctoral fellowship; MRT (Ministere Recherche Technologie, Ecole Doctorale MTCI) graduate award; Bodossakis Foundation Young Scientist Award	ERANET NEURON (Grant WM2NA); Labex-Biopsy; FRC (Fondation Recherche pour le Cerveau); National Hospital Clinical Research Program (Assistance Publique-Hopitaux de Marseille); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); FondaMental Servier postdoctoral fellowship; MRT (Ministere Recherche Technologie, Ecole Doctorale MTCI) graduate award; Bodossakis Foundation Young Scientist Award	We thank P. Greengard, G. G. Nomikos and R. H. Perlis for critical reading of the manuscript. We want to acknowledge M.-J. Brisorgueil and A. Besnard for help with immunohistochemistry experiments, C. Tecker for qPCR experiments in mice, P. Vanhoutte for TDE design and the Imaging Platform at the Institut de la Vision (Paris, France) for slide scanning. This research was supported in part by ERANET NEURON (Grant WM2NA; N.M., C.M., E.T.T.), Labex-Biopsy (AIM: E.T.T.; SignAddict: J.C.), FRC (Fondation Recherche pour le Cerveau; E.T.T.), the National Hospital Clinical Research Program (Assistance Publique-Hopitaux de Marseille; PHRC no. 2010-19: R.B.), Conseil Regional d'Aquitaine (L.M., L.G.) and the Canadian Institute for Health Research (B.G. and G.T.). R.B. was supported by a FondaMental Servier postdoctoral fellowship, and K.A. was supported by an MRT (Ministere Recherche Technologie, Ecole Doctorale MTCI) graduate award. B.G. is the holder of the Graham Boeckh Chair, and E.T.T. is a past recipient of the Bodossakis Foundation Young Scientist Award.	Bell JA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.155; Belzeaux R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.112; Besnard A, 2011, J NEUROSCI, V31, P14296, DOI 10.1523/JNEUROSCI.2890-11.2011; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Chen E, 2011, MOL PSYCHIATR, V16, P729, DOI 10.1038/mp.2010.53; Consoloni JL, 2018, EUR NEUROPSYCHOPHARM, V28, P401, DOI 10.1016/j.euroneuro.2017.12.015; Crozatier C, 2007, NEUROSCIENCE, V144, P1470, DOI 10.1016/j.neuroscience.2006.11.030; Dournes C, 2013, PROG NEURO-PSYCHOPH, V40, P213, DOI 10.1016/j.pnpbp.2012.07.019; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Einat H, 2003, J NEUROSCI, V23, P7311; Errington ML, 1997, NATURE, V387, P666, DOI 10.1038/42625; Farley S, 2010, INT J NEUROPSYCHOPH, V13, P1207, DOI 10.1017/S1461145709991076; Gould TD, 2002, J PSYCHOSOM RES, V53, P687, DOI 10.1016/S0022-3999(02)00426-9; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Gur TL, 2007, J NEUROSCI, V27, P7860, DOI 10.1523/JNEUROSCI.2051-07.2007; Gutierrez-Mecinas M, 2011, P NATL ACAD SCI USA, V108, P13806, DOI 10.1073/pnas.1104383108; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Herve M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00248; Ionescu DF, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.33; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Jeon SW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030381; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kruk-Slomka M, 2014, PHARMACOL REP, V66, P638, DOI 10.1016/j.pharep.2014.02.002; Labonte B, 2017, NAT MED, V23, P1102, DOI 10.1038/nm.4386; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Li X, 2006, J PHARMACOL EXP THER, V319, P254, DOI 10.1124/jpet.106.103143; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Menke A, 2012, NEUROPSYCHOPHARMACOL, V37, P1455, DOI 10.1038/npp.2011.331; Mombereau C, 2004, NEUROPSYCHOPHARMACOL, V29, P1050, DOI 10.1038/sj.npp.1300413; Morice E, 2013, NEUROBIOL DIS, V58, P156, DOI 10.1016/j.nbd.2013.05.016; Mouri A, 2007, MOL PHARMACOL, V71, P1598, DOI 10.1124/mol.106.032961; Moutsimilli L, 2008, NEUROPHARMACOLOGY, V54, P497, DOI 10.1016/j.neuropharm.2007.10.022; Nasca C, 2015, P NATL ACAD SCI USA, V112, P14960, DOI 10.1073/pnas.1516016112; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; NOLTE J, 2009, HUMAN BRAIN INTRO IT; Perlis RH, 2016, WORLD PSYCHIATRY, V15, P228, DOI 10.1002/wps.20345; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Qi XL, 2008, NEUROBIOL DIS, V31, P278, DOI 10.1016/j.nbd.2008.05.003; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tse YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027215; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; Tzavara ET, 2006, BIOL PSYCHIAT, V59, P508, DOI 10.1016/j.biopsych.2005.08.019; Tzavara ET, 2004, FASEB J, V18, P1410, DOI 10.1096/fj.04-1575fje; Uher R, 2014, AM J PSYCHIAT, V171, P1278, DOI 10.1176/appi.ajp.2014.14010094; Viereckel T, 2016, SCI REP-UK, V6, DOI 10.1038/srep35203; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Yang CH, 2012, J NEUROSCI, V32, P7550, DOI 10.1523/JNEUROSCI.5902-11.2012; Yuan LL, 2016, J NEUROGENET, V30, P178, DOI 10.1080/01677063.2016.1245303	60	23	23	3	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					591	+		10.1038/s41591-018-0011-0	http://dx.doi.org/10.1038/s41591-018-0011-0			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736027	Green Published			2022-12-27	WOS:000432126800015
J	Barcena, C; Valdes-Mas, R; Mayoral, P; Garabaya, C; Durand, S; Rodriguez, F; Fernandez-Garcia, MT; Salazar, N; Nogacka, AM; Garatachea, N; Bossut, N; Aprahamian, F; Lucia, A; Kroemer, G; Freije, JMP; Quiros, PM; Lopez-Otin, C				Barcena, Clea; Valdes-Mas, Rafael; Mayoral, Pablo; Garabaya, Cecilia; Durand, Sylvere; Rodriguez, Francisco; Teresa Fernandez-Garcia, Maria; Salazar, Nuria; Nogacka, Alicja M.; Garatachea, Nuria; Bossut, Noelie; Aprahamian, Fanny; Lucia, Alejandro; Kroemer, Guido; Freije, Jose M. P.; Quiros, Pedro M.; Lopez-Otin, Carlos			Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice	NATURE MEDICINE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; BILE-ACIDS; METABOLITES; ACTIVATION; PHYSIOLOGY; NUTRIENT; GENETICS; SHAPE	The gut microbiome is emerging as a key regulator of several metabolic, immune and neuroendocrine pathways(1,2). Gut microbiome deregulation has been implicated in major conditions such as obesity, type 2 diabetes, cardiovascular disease, non-alcoholic fatty acid liver disease and cancer(3-6), but its precise role in aging remains to be elucidated. Here, we find that two different mouse models of progeria are characterized by intestinal dysbiosis with alterations that include an increase in the abundance of Proteobacteria and Cyanobacteria, and a decrease in the abundance of Verrucomicrobia. Consistent with these findings, we found that human progeria patients also display intestinal dysbiosis and that long-lived humans (that is, centenarians) exhibit a substantial increase in Verrucomicrobia and a reduction in Proteobacteria. Fecal microbiota transplantation from wild-type mice enhanced healthspan and lifespan in both progeroid mouse models, and transplantation with the verrucomicrobia Akkermansia muciniphila was sufficient to exert beneficial effects. Moreover, metabolomic analysis of ileal content points to the restoration of secondary bile acids as a possible mechanism for the beneficial effects of reestablishing a healthy microbiome. Our results demonstrate that correction of the accelerated aging-associated intestinal dysbiosis is beneficial, suggesting the existence of a link between aging and the gut microbiota that provides a rationale for microbiome-based interventions against age-related diseases.	[Barcena, Clea; Valdes-Mas, Rafael; Mayoral, Pablo; Garabaya, Cecilia; Rodriguez, Francisco; Freije, Jose M. P.; Quiros, Pedro M.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Durand, Sylvere; Bossut, Noelie; Aprahamian, Fanny; Kroemer, Guido] Gustave Roussy Canc Campus, Cell Biol & Metabol Platforms, Villejuif, France; [Durand, Sylvere; Bossut, Noelie; Aprahamian, Fanny; Kroemer, Guido] Ctr Rech Cordeliers, Equipe 11 Labellisee Ligue Canc, Paris, France; [Durand, Sylvere; Bossut, Noelie; Aprahamian, Fanny; Kroemer, Guido] INSERM, U1138, Paris, France; [Durand, Sylvere; Bossut, Noelie; Aprahamian, Fanny; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Teresa Fernandez-Garcia, Maria] Univ Oviedo, IUOPA, Unidad Histopatol Mol, Oviedo, Spain; [Salazar, Nuria; Nogacka, Alicja M.] CSIC, IPLA, Dept Microbiol & Biochem Dairy Prod, Villaviciosa, Spain; [Salazar, Nuria; Nogacka, Alicja M.] Inst Invest Sanitaria Principado Asturias ISPA, Diet Microbiota & Hlth Grp, Oviedo, Spain; [Garatachea, Nuria] Univ Zaragoza, Dept Physiatry & Nursing, Fac Hlth & Sport Sci, Huesca, Spain; [Garatachea, Nuria] Univ Zaragoza, GENUD, Zaragoza, Spain; [Lucia, Alejandro] Univ Europea Madrid, Fac Sport Sci, Madrid, Spain; [Lucia, Alejandro] Inst Invest Hosp 12 Octubre i 12, Madrid, Spain; [Lucia, Alejandro] CIBERFES, Madrid, Spain; [Kroemer, Guido] Univ Paris 06, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Freije, Jose M. P.; Quiros, Pedro M.; Lopez-Otin, Carlos] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA); University of Zaragoza; University of Zaragoza; European University of Madrid; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Quiros, PM; Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain.; Quiros, PM; Lopez-Otin, C (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.	pmquiros@gmail.com; clo@uniovi.es	KROEMER, Guido/B-4263-2013; Quiros, Pedro M/L-3186-2017; Valdés-Mas, Rafael/AAC-2879-2021; Freije, José M.P./A-6535-2008; Garatachea, Nuria/ABF-8732-2020; Kroemer, Guido/AAY-9859-2020; Salazar, Nuria/D-2189-2015; Barcena, Clea/AAB-4606-2020; López-Otín, Carlos/AAB-2106-2020	KROEMER, Guido/0000-0002-9334-4405; Quiros, Pedro M/0000-0002-7793-6291; Valdés-Mas, Rafael/0000-0002-0737-5425; Freije, José M.P./0000-0002-4688-8266; Salazar, Nuria/0000-0003-1435-7628; Barcena, Clea/0000-0002-7452-2536; López-Otín, Carlos/0000-0001-6964-1904; Mayoral, Pablo/0000-0003-3567-3777; Nogacka, Alicja/0000-0001-8300-6149; Lucia, Alejandro/0000-0002-5565-0997	FPI - Ministerio de Economia y Competividad (MINECO); Juan de la Cierva - Ministerio de Economia y Competividad (MINECO); Fondo de Investigaciones Sanitarias; Fondos FEDER [PI15/00558]; European Union; Ligue contre le Cancer; Agence National de la Recherche (ANR); ANR; ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix); Fondation pour la Recherche Medicale (FRM); Fundacion Bancaria Caja de Ahorros de Asturias; Ministerio de Economia y Competitividad-FEDER; Gobierno del Principado de Asturias; European Research Council; Instituto de Salud Carlos III (RTICC); Progeria Research Foundation	FPI - Ministerio de Economia y Competividad (MINECO); Juan de la Cierva - Ministerio de Economia y Competividad (MINECO); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fondos FEDER(European Commission); European Union(European Commission); Ligue contre le Cancer(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Chancelerie des universites de Paris (Legs Poix); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fundacion Bancaria Caja de Ahorros de Asturias; Ministerio de Economia y Competitividad-FEDER(Spanish Government); Gobierno del Principado de Asturias(Principality of Asturias); European Research Council(European Research Council (ERC)European Commission); Instituto de Salud Carlos III (RTICC)(Instituto de Salud Carlos III); Progeria Research Foundation	The authors thank M. Stamsnijder and the Progeria Family Circle, and all the participants that have kindly engaged in our study. The authors also thank G. Velasco, Y. Espanol, A.R. Folgueras, X.M. Caravia, J.M. Fraile, I. Varela, M. Mittelbrunn and K. Iribarren for helpful comments and advice; R. Feijoo, A. Moyano, D.A. Puente, S.A. Miranda, M.S. Pitiot, V. Garcia de la Fuente and M.C. Muniz for excellent technical assistance; M. Gueimonde and C.G. de los Reyes-Gavilan (IPLA-CSIC) for providing A. muciniphila; C. Mayolas for help with logistic organization. The authors acknowledge generous support by J. I. Cabrera. A.M.N. is a recipient of a FPI predoctoral contract and N.S. is supported by a Juan de la Cierva postdoctoral contract, both granted by Ministerio de Economia y Competividad (MINECO). A.L.'s research on aging is funded by Fondo de Investigaciones Sanitarias and Fondos FEDER (PI15/00558). The metabolomics platform is supported by H2020 European Union project OncoBiome. G. K. is supported by Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR) -Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix), Fondation pour la Recherche Medicale (FRM); a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea; the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumiere; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM). The Instituto Universitario de Oncologia is supported by Fundacion Bancaria Caja de Ahorros de Asturias. J.M.P.F. is supported by Ministerio de Economia y Competitividad-FEDER and Gobierno del Principado de Asturias. C.L.-O. is supported by grants from the European Research Council (DeAge, ERC Advanced Grant), Ministerio de Economia y Competitividad-FEDER, Instituto de Salud Carlos III (RTICC) and Progeria Research Foundation.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Barcena C, 2018, CELL REP, V24, P2392, DOI 10.1016/j.celrep.2018.07.089; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Bodogai M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4271; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cabreiro F, 2013, EMBO MOL MED, V5, P1300, DOI 10.1002/emmm.201100972; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Enot DP, 2015, CELL CYCLE, V14, P2399, DOI 10.1080/15384101.2015.1064206; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leulier F, 2017, CELL METAB, V25, P522, DOI 10.1016/j.cmet.2017.02.001; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; Maharshak N, 2013, GUT MICROBES, V4, P316, DOI 10.4161/gmic.25486; O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Pierre JF, 2016, AM J PHYSIOL-GASTR L, V311, pG286, DOI 10.1152/ajpgi.00202.2016; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Wang YH, 2018, NAT MED, V24, P1804, DOI 10.1038/s41591-018-0238-9; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9; Zitvogel L, 2017, NAT REV MICROBIOL, V15, P465, DOI 10.1038/nrmicro.2017.44	47	188	199	20	188	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1234	+		10.1038/s41591-019-0504-5	http://dx.doi.org/10.1038/s41591-019-0504-5			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31332389	Green Submitted			2022-12-27	WOS:000480414600021
J	Brodin, P				Brodin, Petter			Seeking the ultimate challenge	NATURE MEDICINE			English	Editorial Material								Petter Brodin is a pediatrician at the Karolinska University Hospital and an immunologist at Science for Life Laboratory. His lab combines state-of-the-art experimental methods and computational tools to monitor human immune systems in the most comprehensive way possible.	[Brodin, Petter] Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden; [Brodin, Petter] Karolinska Univ Hosp, Dept Newborn Children, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brodin, P (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden.; Brodin, P (corresponding author), Karolinska Univ Hosp, Dept Newborn Children, Stockholm, Sweden.	Petter.Brodin@ki.se	Brodin, Petter/C-3317-2011	Brodin, Petter/0000-0002-8103-0046					0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1026	1026		10.1038/s41591-019-0497-0	http://dx.doi.org/10.1038/s41591-019-0497-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270493	Bronze			2022-12-27	WOS:000474430400003
J	Stower, H				Stower, Hannah			The processed food trap	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					877	877		10.1038/s41591-019-0489-0	http://dx.doi.org/10.1038/s41591-019-0489-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171872	Bronze			2022-12-27	WOS:000470844400013
J	Chertow, DS				Chertow, Daniel S.			Understanding long-term effects of Ebola virus disease	NATURE MEDICINE			English	Editorial Material							COGNITIVE IMPAIRMENT; SURVIVORS; MANIFESTATIONS	Human survivors of Ebola virus disease are more likely than uninfected controls to develop memory loss, uveitis, and other abnormal conditions, and Ebola virus remains in semen much longer than previously thought.	[Chertow, Daniel S.] NIAID, Crit Care Med Dept, NIH, Clin Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chertow, Daniel S.] NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chertow, DS (corresponding author), NIAID, Crit Care Med Dept, NIH, Clin Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Chertow, DS (corresponding author), NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA.	chertowd@cc.nih.gov		Chertow, Daniel/0000-0002-1675-1728				Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506; Chertow DS, 2016, ANN INTERN MED, V165, P301, DOI 10.7326/M15-3066; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3; Group P. I. S., 2019, NEW ENGL J MED, V380, P924; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Shantha JG, 2017, OPHTHALMOLOGY, V124, P170, DOI 10.1016/j.ophtha.2016.10.011; Steptoe PJ, 2018, OPHTHALMOLOGY, V125, pE19, DOI 10.1016/j.ophtha.2017.09.009; Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158; Uyeki TM, 2016, NEW ENGL J MED, V374, P636, DOI 10.1056/NEJMoa1504874	11	6	6	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					714	715		10.1038/s41591-019-0444-0	http://dx.doi.org/10.1038/s41591-019-0444-0			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31036880				2022-12-27	WOS:000468247800012
J	Steiner, E; Tata, M; Frisen, J				Steiner, Embla; Tata, Mathew; Frisen, Jonas			A fresh look at adult neurogenesis	NATURE MEDICINE			English	Editorial Material							HIPPOCAMPAL NEUROGENESIS		[Steiner, Embla; Tata, Mathew; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	jonas.frisen@ki.se		Tata, Mathew/0000-0002-0960-5677				Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 2018, CELL STEM CELL, V23, P25, DOI 10.1016/j.stem.2018.04.004; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Lucassen PJ, 2020, MOL PSYCHIATR, V25, P2207, DOI 10.1038/s41380-018-0337-5; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002	12	12	13	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					542	543		10.1038/s41591-019-0408-4	http://dx.doi.org/10.1038/s41591-019-0408-4			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30911138				2022-12-27	WOS:000463342800011
J	Keenan, TE; Burke, KP; Van Allen, EM				Keenan, Tanya E.; Burke, Kelly P.; Van Allen, Eliezer M.			Genomic correlates of response to immune checkpoint blockade	NATURE MEDICINE			English	Review							CELL LUNG-CANCER; CD8(+) T-CELLS; PD-1 BLOCKADE; ACQUIRED-RESISTANCE; OPEN-LABEL; IFN-GAMMA; TUMOR MICROENVIRONMENT; HODGKIN LYMPHOMA; TGF-BETA; MUTATIONAL LANDSCAPE	Despite impressive durable responses, immune checkpoint inhibitors do not provide a long-term benefit to the majority of patients with cancer. Understanding genomic correlates of response and resistance to checkpoint blockade may enhance benefits for patients with cancer by elucidating biomarkers for patient stratification and resistance mechanisms for therapeutic targeting. Here we review emerging genomic markers of checkpoint blockade response, including those related to neoantigens, antigen presentation, DNA repair, and oncogenic pathways. Compelling evidence also points to a role for T cell functionality, checkpoint regulators, chromatin modifiers, and copy-number alterations in mediating selective response to immune checkpoint blockade. Ultimately, efforts to contextualize genomic correlates of response into the larger understanding of tumor immune biology will build a foundation for the development of novel biomarkers and therapies to overcome resistance to checkpoint blockade.	[Keenan, Tanya E.; Burke, Kelly P.; Van Allen, Eliezer M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Keenan, Tanya E.; Van Allen, Eliezer M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Burke, Kelly P.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Van Allen, EM (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Van Allen, EM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	Eliezerm_vanallen@dfci.harvard.edu		Van Allen, Eliezer/0000-0002-0201-4444; Keenan, Tanya/0000-0001-5300-9998	BroadIgnite; BroadNext10; NIH [R01CA227388, K08CA188615, U01CA233100]; Center for Immuno-Oncology at the Dana- Farber Cancer Institute; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]; NATIONAL CANCER INSTITUTE [U01CA233100, K08CA188615, R01CA227388] Funding Source: NIH RePORTER	BroadIgnite; BroadNext10; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Immuno-Oncology at the Dana- Farber Cancer Institute; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by BroadIgnite (E.M.V.A.), BroadNext10 (E.M.V.A., D.M.), NIH R01CA227388 (E.M.V.A.), NIH K08CA188615 (E.M.V.A.), and NIH U01CA233100 (E.M.V.A). This work was also supported by the Center for Immuno-Oncology at the Dana- Farber Cancer Institute and a Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C-AACR-DT17-15). Stand Up To Cancer (SU2C) is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.	Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Anagnostou V, 2017, CLIN CANCER RES, V23, P4959, DOI 10.1158/1078-0432.CCR-16-3065; Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Anderson KG, 2017, CANCER CELL, V31, P311, DOI 10.1016/j.ccell.2017.02.008; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Armand P, 2018, J CLIN ONCOL, V36, P1428, DOI 10.1200/JCO.2017.76.0793; Auslander N, 2018, NAT MED, V24, P1545, DOI 10.1038/s41591-018-0157-9; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Bhangoo MS, 2018, ONCOLOGIST, V23, P518, DOI 10.1634/theoncologist.2017-0342; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Busch SE, 2016, J IMMUNOL, V197, P4493, DOI 10.4049/jimmunol.1600576; Canadas I, 2018, NAT MED, V24, P1143, DOI 10.1038/s41591-018-0116-5; Carbognin L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130142; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Carlo MI, 2017, KIDNEY CANCER, V1, P49, DOI 10.3233/KCA-160003; Chakravarthy A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06654-8; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Chen R, 2017, J CLIN ONCOL, V35, P2125, DOI 10.1200/JCO.2016.72.1316; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Colli LM, 2016, CANCER RES, V76, P3767, DOI 10.1158/0008-5472.CAN-16-0170; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Cullis J, 2018, COLD SPRING HARB PER, V8; Danaher P, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0367-1; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Deng JH, 2018, CANCER DISCOV, V8, P216, DOI 10.1158/2159-8290.CD-17-0915; Dong ZY, 2017, CLIN CANCER RES, V23, P3012, DOI 10.1158/1078-0432.CCR-16-2554; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Emens LA, 2017, EUR J CANCER, V81, P116, DOI 10.1016/j.ejca.2017.01.035; Fehlings M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00627-z; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; FOLEY EJ, 1953, CANCER RES, V13, P835; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gainor JF, 2016, CLIN CANCER RES, V22, P4585, DOI 10.1158/1078-0432.CCR-15-3101; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; George S, 2017, IMMUNITY, V46, P197, DOI 10.1016/j.immuni.2017.02.001; Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Goel S, 2017, NATURE, V548, P471, DOI 10.1038/nature23465; Goh G, 2016, ONCOTARGET, V7, P3393, DOI 10.18632/oncotarget.6494; Goodman AM, 2018, JAMA ONCOL, V4, P1237, DOI 10.1001/jamaoncol.2018.1701; Gopalakrishnan V, 2018, CANCER CELL, V33, P570, DOI 10.1016/j.ccell.2018.03.015; Graham DB, 2018, NAT MED, V24, P1762, DOI 10.1038/s41591-018-0203-7; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hansen AR, 2016, JAMA ONCOL, V2, P15, DOI 10.1001/jamaoncol.2015.4685; Harrington KJ, 2018, ANN ONCOL, V29, P712; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Hellmann MD, 2018, CANCER CELL, V33, P853, DOI 10.1016/j.ccell.2018.04.001; Hellmann MD, 2018, CANCER CELL, V33, P843, DOI 10.1016/j.ccell.2018.03.018; Huang L, 2018, CLIN CANCER RES, V24, P3366, DOI 10.1158/1078-0432.CCR-17-2483; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jelinic P, 2018, JNCI-J NATL CANCER I, V110, P787, DOI 10.1093/jnci/djx277; Jerby-Arnon L, 2018, CELL, V175, P984; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Johanns TM, 2016, CANCER DISCOV, V6, P1230, DOI 10.1158/2159-8290.CD-16-0575; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kaufman HL, 2016, LANCET ONCOL, V17, P1374, DOI 10.1016/S1470-2045(16)30364-3; Kearney CJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3451; Kim ST, 2018, NAT MED, V24, P1449, DOI 10.1038/s41591-018-0101-z; Kirkwood J. M, 2018, CANC RES, V78; Kitapma S, 2019, CANCER DISCOV, V9, P34, DOI 10.1158/2159-8290.CD-18-0689; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; Lan Y, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan5488; Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lee CK, 2018, JAMA ONCOL, V4, P210, DOI 10.1001/jamaoncol.2017.4427; Leone RD, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0360-8; Linnebacher M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/841451; Liu XS, 2017, CELL, V168, P600, DOI 10.1016/j.cell.2017.01.014; Luksza M, 2017, NATURE, V551, P517, DOI 10.1038/nature24473; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Marty R, 2018, CELL, V175, P416, DOI 10.1016/j.cell.2018.08.048; Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Meric-Bernstam F, 2018, J IMMUNOTHER CANCER, V6, P114; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Milo I, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1435; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Mouw KW, 2017, CANCER DISCOV, V7, P675, DOI 10.1158/2159-8290.CD-17-0226; Nayak L, 2017, BLOOD, V129, P3071, DOI 10.1182/blood-2017-01-764209; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Ott PA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0218-5; Page DB, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0130-4; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Panda A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121522; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Patel SA, 2018, IMMUNITY, V48, P417, DOI 10.1016/j.immuni.2018.03.007; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Prat A, 2017, CANCER RES, V77, P3540, DOI 10.1158/0008-5472.CAN-16-3556; Ratner L, 2018, NEW ENGL J MED, V378, P1947, DOI 10.1056/NEJMc1803181; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Riaz N, 2016, NAT GENET, V48, P1327, DOI 10.1038/ng.3677; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rizvi H, 2018, J CLIN ONCOL, V36, P633, DOI 10.1200/JCO.2017.75.3384; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Roemer MGM, 2016, J CLIN ONCOL, V34, P2690, DOI 10.1200/JCO.2016.66.4482; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schaer DA, 2018, CELL REP, V22, P2978, DOI 10.1016/j.celrep.2018.02.053; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Seiwert T. Y, 2018, CANCER RES, V73, pLB; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Sharma A, 2019, CLIN CANCER RES, V25, P1233, DOI 10.1158/1078-0432.CCR-18-0762; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Shen JF, 2018, NAT MED, V24, P556, DOI 10.1038/s41591-018-0012-z; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Shukla SA, 2018, CELL, V173, P624, DOI 10.1016/j.cell.2018.03.026; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Skoulidis F, 2018, CANCER DISCOV, V8, P822, DOI 10.1158/2159-8290.CD-18-0099; SMITH HJ, 1966, BRIT J CANCER, V20, P831, DOI 10.1038/bjc.1966.95; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Strauss J, 2018, CLIN CANCER RES, V24, P1287, DOI 10.1158/1078-0432.CCR-17-2653; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Sucker A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15440; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Syn NL, 2017, LANCET ONCOL, V18, pE731, DOI 10.1016/S1470-2045(17)30607-1; Tang J, 2018, ANN ONCOL, V29, P84, DOI 10.1093/annonc/mdx755; Tao JJ, 2018, ANNU REV MED, V69, P319, DOI 10.1146/annurev-med-062016-050343; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Teo MY, 2018, J CLIN ONCOL, V36, P1685, DOI 10.1200/JCO.2017.75.7740; Thorlund K, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k698; TOLANEY SM, 2018, J CLIN ONCOL, V36; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2015, CANCER IMMUNOL RES, V3, P855, DOI 10.1158/2326-6066.CIR-15-0024; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voss MH, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4523; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang SX, 2018, ONCOGENE, V37, P3924, DOI 10.1038/s41388-018-0245-9; Wartewig T, 2017, NATURE, V552, P121, DOI 10.1038/nature24649; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yarchoan M, 2017, NAT REV CANCER, V17, P209, DOI 10.1038/nrc.2016.154; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015	192	239	244	6	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					389	402		10.1038/s41591-019-0382-x	http://dx.doi.org/10.1038/s41591-019-0382-x			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842677	Green Accepted			2022-12-27	WOS:000460643100016
J	Maeder, ML; Stefanidakis, M; Wilson, CJ; Baral, R; Barrera, LA; Bounoutas, GS; Bumcrot, D; Chao, HS; Ciulla, DM; DaSilva, JA; Dass, A; Dhanapal, V; Fennell, TJ; Friedland, AE; Giannoukos, G; Gloskowski, SW; Glucksmann, A; Gotta, GM; Jayaram, H; Haskett, SJ; Hopkins, B; Horng, JE; Joshi, S; Marco, E; Mepani, R; Reyon, D; Ta, T; Tabbaa, DG; Samuelsson, SJ; Shen, S; Skor, MN; Stetkiewicz, P; Wang, TY; Yudkoff, C; Myer, VE; Albright, CF; Jiang, HY				Maeder, Morgan L.; Stefanidakis, Michael; Wilson, Christopher J.; Baral, Reshica; Barrera, Luis Alberto; Bounoutas, George S.; Bumcrot, David; Chao, Hoson; Ciulla, Dawn M.; DaSilva, Jennifer A.; Dass, Abhishek; Dhanapal, Vidya; Fennell, Tim J.; Friedland, Ari E.; Giannoukos, Georgia; Gloskowski, Sebastian W.; Glucksmann, Alexandra; Gotta, Gregory M.; Jayaram, Hariharan; Haskett, Scott J.; Hopkins, Bei; Horng, Joy E.; Joshi, Shivangi; Marco, Eugenio; Mepani, Rina; Reyon, Deepak; Ta, Terence; Tabbaa, Diana G.; Samuelsson, Steven J.; Shen, Shen; Skor, Maxwell N.; Stetkiewicz, Pam; Wang, Tongyao; Yudkoff, Clifford; Myer, Vic E.; Albright, Charles F.; Jiang, Haiyan			Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10	NATURE MEDICINE			English	Article							CONE PHOTORECEPTORS; CEP290; BLINDNESS; THERAPY; IDENTIFICATION; MUTATIONS; CAS9; ROD	Leber congenital amaurosis type 10 is a severe retinal dystrophy caused by mutations in the CEP290 gene(1,2). We developed EDIT-101, a candidate genome-editing therapeutic, to remove the aberrant splice donor created by the IVS26 mutation in the CEP290 gene and restore normal CEP290 expression. Key to this therapeutic, we identified a pair of Staphylococcus aureus Cas9 guide RNAs that were highly active and specific to the human CEP290 target sequence. In vitro experiments in human cells and retinal explants demonstrated the molecular mechanism of action and nuclease specificity. Subretinal delivery of EDIT-101 in humanized CEP290 mice showed rapid and sustained CEP290 gene editing. A comparable surrogate non-human primate (NHP) vector also achieved productive editing of the NHP CEP290 gene at levels that met the target therapeutic threshold, and demonstrated the ability of CRISPR/Cas9 to edit somatic primate cells in vivo. These results support further development of EDIT-101 for LCA10 and additional CRISPR-based medicines for other inherited retinal disorders.	[Maeder, Morgan L.; Stefanidakis, Michael; Wilson, Christopher J.; Baral, Reshica; Barrera, Luis Alberto; Bounoutas, George S.; Bumcrot, David; Chao, Hoson; Ciulla, Dawn M.; DaSilva, Jennifer A.; Dass, Abhishek; Dhanapal, Vidya; Friedland, Ari E.; Giannoukos, Georgia; Gloskowski, Sebastian W.; Glucksmann, Alexandra; Gotta, Gregory M.; Jayaram, Hariharan; Haskett, Scott J.; Hopkins, Bei; Horng, Joy E.; Joshi, Shivangi; Marco, Eugenio; Mepani, Rina; Reyon, Deepak; Ta, Terence; Tabbaa, Diana G.; Samuelsson, Steven J.; Shen, Shen; Skor, Maxwell N.; Stetkiewicz, Pam; Wang, Tongyao; Yudkoff, Clifford; Myer, Vic E.; Albright, Charles F.; Jiang, Haiyan] Editas Med, Cambridge, MA 02141 USA; [Fennell, Tim J.] Fulcrum Genom, Somerville, MA USA		Maeder, ML (corresponding author), Editas Med, Cambridge, MA 02141 USA.	morganLmaeder@gmail.com	Reyon, Deepak/HCH-3183-2022; Marco, Eugenio/F-4583-2011	Marco, Eugenio/0000-0002-3675-263X; Wilson, Christopher/0000-0002-9146-522X; Horng, Joy/0000-0001-7702-7381	Editas Medicine	Editas Medicine	We thank B. Tucker and colleagues at the University of Iowa for the LCA10 patient fibroblasts, and the patients for their generous donation of biopsy samples. We thank B. Rabe for advice and technological assistance in establishing retinal explant model. We thank M. McCartney and N. Sprehe from Lions Eye Institute for Transplant and Research for invaluable help and services with human retinal explant experiments, and we thank the donors and their families for their generous donation. We thank our Editas colleagues P. Baciu, D. Balderson and G. Cox for helpful discussions and scientific input, and K. LeClair, W. Jaworowicz and G. Wilmes for helpful discussions and for manufacturing expertise and materials supply. This work was fully funded by Editas Medicine.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bothmer A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13905; Boye SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092928; Boye SE, 2012, HUM GENE THER, V23, P1101, DOI 10.1089/hum.2012.125; Burnight ER, 2014, GENE THER, V21, P662, DOI 10.1038/gt.2014.39; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Collin RWJ, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.3; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Drivas TG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5370; Drivas TG, 2014, ADV EXP MED BIOL, V801, P519, DOI 10.1007/978-1-4614-3209-8_66; Feodorova Y, 2015, METHODSX, V2, P39, DOI 10.1016/j.mex.2015.01.002; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Garanto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079369; GELLER AM, 1993, VISION RES, V33, P1509, DOI 10.1016/0042-6989(93)90144-L; GELLER AM, 1992, J OPT SOC AM A, V9, P472, DOI 10.1364/JOSAA.9.000472; Gerard X, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.21; Giannoukos G, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4561-9; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021; Park J, 2017, NAT METHODS, V14, P548, DOI 10.1038/nmeth.4262; Spark Therapeutics, 2017, LUXTURNA VOR NEP RZY; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Stone EM, 2017, OPHTHALMOLOGY, V124, P1314, DOI 10.1016/j.ophtha.2017.04.008; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117	32	277	289	9	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					229	+		10.1038/s41591-018-0327-9	http://dx.doi.org/10.1038/s41591-018-0327-9			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30664785				2022-12-27	WOS:000457842100018
J	Scriba, TJ; Nemes, E				Scriba, Thomas J.; Nemes, Elisa			Protection against tuberculosis by mucosal BCG administration	NATURE MEDICINE			English	Editorial Material							MYCOBACTERIUM-TUBERCULOSIS; VACCINE; INFECTION		[Scriba, Thomas J.] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, Cape Town, South Africa; Univ Cape Town, Div Immunol, Dept Pathol, Cape Town, South Africa	University of Cape Town; University of Cape Town	Scriba, TJ (corresponding author), Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, Cape Town, South Africa.	Thomas.scriba@uct.ac.za	Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/AAH-9413-2020	Scriba, Thomas/0000-0002-0641-1359; 				Cadena AM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007305; Dijkman K, 2019, NAT MED, V25, P255, DOI 10.1038/s41591-018-0319-9; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Qin L, 2007, J INFECT DIS, V196, P1304, DOI 10.1086/522428; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	10	3	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					199	201		10.1038/s41591-019-0347-0	http://dx.doi.org/10.1038/s41591-019-0347-0			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30692698				2022-12-27	WOS:000457842100011
J	Chen, JH; Kao, YR; Sun, DQ; Todorova, TI; Reynolds, D; Narayanagari, SR; Montagna, C; Will, B; Verma, A; Steidl, U				Chen, Jiahao; Kao, Yun-Ruei; Sun, Daqian; Todorova, Tihomira I.; Reynolds, David; Narayanagari, Swathi-Rao; Montagna, Cristina; Will, Britta; Verma, Amit; Steidl, Ulrich			Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level	NATURE MEDICINE			English	Article							CLONAL HEMATOPOIESIS; PROGENITOR CELLS; ATRX MUTATIONS; GENOME; DEFICIENCIES; EXPANSION	Myelodysplastic syndromes (MDS) frequently progress to acute myeloid leukemia (AML); however, the cells leading to malignant transformation have not been directly elucidated. As progression of MDS to AML in humans provides a biological system to determine the cellular origins and mechanisms of neoplastic transformation, we studied highly fractionated stem cell populations in longitudinal samples of patients with MDS who progressed to AML. Targeted deep sequencing combined with single-cell sequencing of sorted cell populations revealed that stem cells at the MDS stage, including immuno-phenotypically and functionally defined pre-MDS stem cells (pre-MDS-SC), had a significantly higher subclonal complexity compared to blast cells and contained a large number of aging-related variants. Single-cell targeted resequencing of highly fractionated stem cells revealed a pattern of nonlinear, parallel clonal evolution, with distinct subclones within pre-MDS-SC and MDS-SC contributing to generation of MDS blasts or progression to AML, respectively. Furthermore, phenotypically aberrant stem cell clones expanded during transformation and stem cell subclones that were not detectable in MDS blasts became dominant upon AML progression. These results reveal a crucial role of diverse stem cell compartments during MDS progression to AML and have implications for current bulk cell-focused precision oncology approaches, both in MDS and possibly other cancers that evolve from premalignant conditions, that may miss pre-existing rare aberrant stem cells that drive disease progression and leukemic transformation.	[Chen, Jiahao; Kao, Yun-Ruei; Todorova, Tihomira I.; Will, Britta; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Sun, Daqian; Narayanagari, Swathi-Rao; Will, Britta; Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Res & R, Bronx, NY 10467 USA; [Sun, Daqian; Narayanagari, Swathi-Rao] Albert Einstein Coll Med, Stem Cell Isolat & Xenotransplantat Facil, Bronx, NY 10467 USA; [Reynolds, David] Albert Einstein Coll Med, Genom Core Facil, Bronx, NY 10467 USA; [Montagna, Cristina] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Montagna, Cristina] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Will, Britta; Verma, Amit; Steidl, Ulrich] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA; [Will, Britta; Verma, Amit; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA; [Verma, Amit] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Steidl, U (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.; Verma, A; Steidl, U (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Res & R, Bronx, NY 10467 USA.; Verma, A; Steidl, U (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA.; Verma, A; Steidl, U (corresponding author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA.	amit.verma@einstein.yu.edu; ulrich.steidl@einstein.yu.edu		Chen, Jiahao/0000-0001-7719-3216; Will, Britta/0000-0002-9534-6690	NIH [R01CA166429, R01CA217092, R01HL139487, R01DK103961, K01DK105134]; Translational Research Program grants from the Leukemia & Lymphoma Society; Taub Foundation; Evans Foundation; Einstein Training Program in Stem Cell Research from the Empire State Stem Cell Fund through New York State Department of Health Contract [C30292GG]; Albert Einstein Cancer Center core support grant [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA166429, R01CA217092, R01CA230756] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103961, K01DK105134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Program grants from the Leukemia & Lymphoma Society; Taub Foundation; Evans Foundation; Einstein Training Program in Stem Cell Research from the Empire State Stem Cell Fund through New York State Department of Health Contract; Albert Einstein Cancer Center core support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Schultes from the Department of Cell Biology for expert technical assistance. We thank A. Fiallo from the Einstein Genomics Core Facility for technical assistance in single-cell targeted sequencing, and S. Maqbool and S. Mi from Einstein Epigenomics Core Facility for assistance in targeted sequencing with the HiSeq platform. We thank V. Thiruthuvanathan from the Department of Cell Biology for assistance in processing the patient samples. We also thank W. Li for advice regarding whole-genome amplification, and F. C. Chan, C. Steidl, and H. Steidl for helpful discussion. This work was supported by NIH grants no. R01CA166429, no. R01CA217092 (to U.S.), no. R01HL139487, no. R01DK103961 (to A.V.), and no. K01DK105134 (to B.W.); Translational Research Program grants from the Leukemia & Lymphoma Society (to U.S. and A.V., respectively); a research grant from the Taub Foundation for MDS Research (to U.S.); and a research grant from the Evans Foundation (to A.V.). J.C. was supported by The Einstein Training Program in Stem Cell Research from the Empire State Stem Cell Fund through New York State Department of Health Contract (no. C30292GG). U.S. is a Research Scholar of the Leukemia and Lymphoma Society and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine. This work was supported through the Albert Einstein Cancer Center core support grant (no. P30CA013330).	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; Arends CM, 2018, LEUKEMIA, V32, P1908, DOI 10.1038/s41375-018-0047-7; Bacher U, 2007, HAEMATOLOGICA, V92, P744, DOI 10.3324/haematol.10869; Barreyro L, 2012, BLOOD, V120, P1290, DOI 10.1182/blood-2012-01-404699; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Chung SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2025; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; FIALKOW PJ, 1987, NEW ENGL J MED, V317, P468, DOI 10.1056/NEJM198708203170802; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Haferlach T, 2014, LEUKEMIA, V28, P241, DOI 10.1038/leu.2013.336; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Herbaux C, 2015, AM J HEMATOL, V90, P737, DOI 10.1002/ajh.24073; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jan M, 2011, P NATL ACAD SCI USA, V108, P5009, DOI 10.1073/pnas.1100551108; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lu R, 2018, CLONAL LEVEL LINEAGE, DOI [10.1101/262774, DOI 10.1101/262774]; Makishima H, 2017, NAT GENET, V49, P204, DOI 10.1038/ng.3742; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McIntosh BE, 2015, STEM CELL REP, V4, P171, DOI 10.1016/j.stemcr.2014.12.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Mitchell K, 2018, J EXP MED, V215, P1709, DOI 10.1084/jem.20180147; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Popic V, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0647-8; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Shastri A, 2017, BLOOD, V129, P1586, DOI 10.1182/blood-2016-10-696062; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Smith MA, 2017, NAT METHODS, V14, P549, DOI 10.1038/nmeth.4303; Steensma DP, 2004, BLOOD, V103, P2019, DOI 10.1182/blood-2003-09-3360; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Terwijn M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107587; Thomas D, 2017, BLOOD, V129, P1577, DOI 10.1182/blood-2016-10-696054; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132041; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yanagisawa B, 2016, EXP HEMATOL, V44, P1130, DOI 10.1016/j.exphem.2016.08.010; Yu YX, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1016	60	121	128	3	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					103	+		10.1038/s41591-018-0267-4	http://dx.doi.org/10.1038/s41591-018-0267-4			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30510255	Green Accepted			2022-12-27	WOS:000455027700028
J	Scheper, W; Kelderman, S; Fanchi, LF; Linnemann, C; Bendle, G; de Rooij, MAJ; Hirt, C; Mezzadra, R; Slagter, M; Dijkstra, K; Kluin, RJC; Snaebjornsson, P; Milne, K; Nelson, BH; Zijlmans, H; Kenter, G; Voest, EE; Haanen, JBAG; Schumacher, TN				Scheper, Wouter; Kelderman, Sander; Fanchi, Lorenzo F.; Linnemann, Carsten; Bendle, Gavin; de Rooij, Marije A. J.; Hirt, Christian; Mezzadra, Riccardo; Slagter, Maarten; Dijkstra, Krijn; Kluin, Roelof J. C.; Snaebjornsson, Petur; Milne, Katy; Nelson, Brad H.; Zijlmans, Henry; Kenter, Gemma; Voest, Emile E.; Haanen, John B. A. G.; Schumacher, Ton N.			Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers	NATURE MEDICINE			English	Article							EXOME ANALYSIS REVEALS; T-CELL REACTIVITY; PD-1 BLOCKADE; FAVORABLE PROGNOSIS; LANDSCAPE; IDENTIFICATION; LYMPHOCYTES; ANTIBODY	Infiltration of human cancers by T cells is generally interpreted as a sign of immune recognition, and there is a growing effort to reactivate dysfunctional T cells at such tumor sites(1). However, these efforts only have value if the intratumoral T cell receptor (TCR) repertoire of such cells is intrinsically tumor reactive, and this has not been established in an unbiased manner for most human cancers. To address this issue, we analyzed the intrinsic tumor reactivity of the intratumoral TCR repertoire of CD8(+) T cells in ovarian and colorectal cancer-two tumor types for which T cell infiltrates form a positive prognostic marker(2,3). Data obtained demonstrate that a capacity to recognize autologous tumor is limited to approximately 10% of intratumoral CD8(+) T cells. Furthermore, in two of four patient samples tested, no tumor-reactive TCRs were identified, despite infiltration of their tumors by T cells. These data indicate that the intrinsic capacity of intratumoral T cells to recognize adjacent tumor tissue can be rare and variable, and suggest that clinical efforts to reactivate intratumoral T cells will benefit from approaches that simultaneously increase the quality of the intratumoral TCR repertoire.	[Scheper, Wouter; Fanchi, Lorenzo F.; Mezzadra, Riccardo; Slagter, Maarten; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Kelderman, Sander; Linnemann, Carsten; Bendle, Gavin; de Rooij, Marije A. J.; Dijkstra, Krijn; Voest, Emile E.; Haanen, John B. A. G.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Hirt, Christian] Univ Basel, Dept Biomed, Basel, Switzerland; [Slagter, Maarten] Netherlands Canc Inst, Oncode Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Kluin, Roelof J. C.] Netherlands Canc Inst, Cent Genom Facil, Amsterdam, Netherlands; [Snaebjornsson, Petur] Netherlands Canc Inst, Div Pathol, Amsterdam, Netherlands; [Milne, Katy; Nelson, Brad H.] BC Canc, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Zijlmans, Henry; Kenter, Gemma] Netherlands Canc Inst, Dept Gynecol Oncol, Amsterdam, Netherlands; [Voest, Emile E.; Haanen, John B. A. G.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Basel; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.	t.schumacher@nki.nl	Haanen, John/AAD-8534-2022; Schumacher, Ton/Y-2432-2019; Haanen, John/AAD-8578-2022	Haanen, John/0000-0001-5884-7704; Schumacher, Ton/0000-0003-0517-8804; Nelson, Brad/0000-0002-4445-5539; Milne, Katy/0000-0001-5616-1821; Mezzadra, Riccardo/0000-0002-7737-8461; Kluin, Roel/0000-0002-5133-142X; de Rooij, Marije A.J./0000-0002-4982-310X	Dutch Cancer Society Queen Wilhelmina Award [NKI 2013-6122]; EU H2020 [633592]; K.G. Jebsen Foundation; Krebsliga Beider Basel; BC Cancer Foundation	Dutch Cancer Society Queen Wilhelmina Award; EU H2020; K.G. Jebsen Foundation; Krebsliga Beider Basel; BC Cancer Foundation	We thank M. van Zon, N. Bakker, and N. van Rooij for handling of patient material; A. Pfauth for flow cytometric support; S. Reijm for technical assistance; D. Thommen for critical reading of the manuscript; R. van Kerkhoven and M. Nieuwland for support with next generation sequencing; B. Thijssen for helpful discussion on Bayesian analysis; L. Wessels for discussions; the NKI-AVL Core Facility Molecular Pathology & Biobanking for supplying NKI-AVL Biobank material and laboratory support; H. Spits and R. Schotte (AIMM Therapeutics) for sharing reagents for B cell immortalization; K. van de Vijver for histological support; and M. Kranendonk for critical reading of the manuscript and histological support. This work was supported by the Dutch Cancer Society Queen Wilhelmina Award NKI 2013-6122, EU H2020 grant 633592 (APERIM), and the K.G. Jebsen Foundation (T.N.S.), Krebsliga Beider Basel (C.H.), and BC Cancer Foundation (B.H.N.).	Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Bobisse S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03301-0; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Dahlin AM, 2011, MODERN PATHOL, V24, P671, DOI 10.1038/modpathol.2010.234; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gelman A., 2021, BAYESIAN DATA ANAL; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; Ochi T, 2015, CANCER IMMUNOL RES, V3, P1070, DOI 10.1158/2326-6066.CIR-14-0222; Pasetto A, 2016, CANCER IMMUNOL RES, V4, P734, DOI 10.1158/2326-6066.CIR-16-0001; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Webb JR, 2016, GYNECOL ONCOL, V141, P293, DOI 10.1016/j.ygyno.2016.03.008; Ye QR, 2014, CLIN CANCER RES, V20, P44, DOI 10.1158/1078-0432.CCR-13-0945; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	34	258	269	6	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					89	+		10.1038/s41591-018-0266-5	http://dx.doi.org/10.1038/s41591-018-0266-5			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30510250				2022-12-27	WOS:000455027700026
J	Jiang, P; Gu, SQ; Pan, D; Fu, JX; Sahu, A; Hu, XH; Li, ZY; Traugh, N; Bu, X; Li, B; Liu, J; Freeman, GJ; Brown, MA; Wucherpfennig, KW; Liu, XS				Jiang, Peng; Gu, Shengqing; Pan, Deng; Fu, Jingxin; Sahu, Avinash; Hu, Xihao; Li, Ziyi; Traugh, Nicole; Bu, Xia; Li, Bo; Liu, Jun; Freeman, Gordon J.; Brown, Myles A.; Wucherpfennig, Kai W.; Liu, X. Shirley			Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response	NATURE MEDICINE			English	Article							GRANZYME-B INHIBITOR; PD-1 BLOCKADE; TUMOR MICROENVIRONMENT; BREAST-CANCER; METASTATIC MELANOMA; ACQUIRED-RESISTANCE; CHECKPOINT BLOCKADE; CLINICAL-RESPONSE; CTLA-4 BLOCKADE; IMMUNE CELLS	Cancer treatment by immune checkpoint blockade (ICB) can bring long-lasting clinical benefits, but only a fraction of patients respond to treatment. To predict ICB response, we developed TIDE, a computational method to model two primary mechanisms of tumor immune evasion: the induction of T cell dysfunction in tumors with high infiltration of cytotoxic T lymphocytes (CTL) and the prevention of T cell infiltration in tumors with low CTL level. We identified signatures of T cell dysfunction from large tumor cohorts by testing how the expression of each gene in tumors interacts with the CTL infiltration level to influence patient survival. We also modeled factors that exclude T cell infiltration into tumors using expression signatures from immunosuppressive cells. Using this framework and pre-treatment RNA-Seq or NanoString tumor expression profiles, TIDE predicted the outcome of melanoma patients treated with first-line anti-PD1 or anti-CTLA4 more accurately than other biomarkers such as PD-L1 level and mutation load. TIDE also revealed new candidate ICB resistance regulators, such as SERPINB9, demonstrating utility for immunotherapy research.	[Jiang, Peng; Sahu, Avinash; Hu, Xihao; Li, Bo; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Jiang, Peng; Sahu, Avinash; Hu, Xihao; Li, Bo; Liu, X. Shirley] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gu, Shengqing; Traugh, Nicole; Bu, Xia; Freeman, Gordon J.; Brown, Myles A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pan, Deng; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Pan, Deng; Wucherpfennig, Kai W.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Fu, Jingxin; Li, Ziyi; Liu, X. Shirley] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Liu, Jun] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Brown, Myles A.; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Li, Bo] UT Southwestern, Dept Bioinformat, Dallas, TX USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tongji University; Harvard University; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Liu, XS (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Liu, XS (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Liu, XS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu; xsliu@jimmy.harvard.edu	Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021; Freeman, Gordon/AAC-5380-2019	Brown, Myles/0000-0002-8213-1658; Freeman, Gordon/0000-0002-7210-5616; Sahu, Avinash/0000-0002-2193-6276; Pan, Deng/0000-0002-6475-0463; Jiang, Peng/0000-0002-7828-5486; Fu, Jingxin/0000-0002-4028-3661; Gu, Shengqing/0000-0002-4200-0864; Traugh, Nicole/0000-0002-1194-8177; Liu, Xiaole/0000-0003-4736-7339	Cancer Immunologic Data Commons grant of the National Cancer Institute (NCI) [1U24CA224316-01]; Pathway to Independence Award grant of NCI [1K99CA218900-01]; Specialized Center grant of NCI [1P50CA206963-01]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P50CA206963, K99CA218900] Funding Source: NIH RePORTER	Cancer Immunologic Data Commons grant of the National Cancer Institute (NCI); Pathway to Independence Award grant of NCI; Specialized Center grant of NCI; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by the Cancer Immunologic Data Commons (1U24CA224316-01) grant of the National Cancer Institute (NCI), the Pathway to Independence Award (1K99CA218900-01) grant of NCI (to P.J.), the Specialized Center (1P50CA206963-01) grant of NCI (to G.J.F.), and the Breast Cancer Research Foundation (to X.S.L.). D.P. is a Cancer Research Institute/Robertson Foundation Fellow.	Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bladergroen BA, 2001, J IMMUNOL, V166, P3218, DOI 10.4049/jimmunol.166.5.3218; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Freedman D.A., 2009, STAT MODELS THEORY P; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Giordano M, 2015, EMBO J, V34, P2042, DOI 10.15252/embj.201490786; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Hirst CE, 2001, MOL HUM REPROD, V7, P1133, DOI 10.1093/molehr/7.12.1133; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Horvath IB, 2016, NAT METHODS, V13, P9, DOI 10.1038/nmeth.3692; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Khong HT, 2002, CANCER RES, V62, P3020; Kleinbaum D. G., 1998, BIOMETR J, V40, P107, DOI DOI 10.1002/(SICI)1521-4036(199804)40:1; Kroemer G, 2018, NAT REV IMMUNOL, V18, P87, DOI 10.1038/nri.2018.4; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Miyan M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0983-9; Nathanson T, 2017, CANCER IMMUNOL RES, V5, P84, DOI 10.1158/2326-6066.CIR-16-0019; Nishino M, 2017, NAT REV CLIN ONCOL, V14, P655, DOI 10.1038/nrclinonc.2017.88; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Prat A, 2017, CANCER RES, V77, P3540, DOI 10.1158/0008-5472.CAN-16-3556; Remark R, 2013, CLIN CANCER RES, V19, P4079, DOI 10.1158/1078-0432.CCR-12-3847; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086862; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wakamatsu E, 2013, P NATL ACAD SCI USA, V110, P1023, DOI 10.1073/pnas.1220688110; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Woo EY, 2001, CANCER RES, V61, P4766; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	63	1314	1330	35	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1550	+		10.1038/s41591-018-0136-1	http://dx.doi.org/10.1038/s41591-018-0136-1			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30127393	Green Accepted			2022-12-27	WOS:000446577900018
J	Gomez, D; Baylis, RA; Durgin, BG; Newman, AAC; Alencar, GF; Mahan, S; St Hilaire, C; Muller, W; Waisman, A; Francis, SE; Pinteaux, E; Randolph, GJ; Gram, H; Owens, GK				Gomez, Delphine; Baylis, Richard A.; Durgin, Brittany G.; Newman, Alexandra A. C.; Alencar, Gabriel F.; Mahan, Sidney; St Hilaire, Cynthia; Mueller, Werner; Waisman, Ari; Francis, Sheila E.; Pinteaux, Emmanuel; Randolph, Gwendalyn J.; Gram, Hermann; Owens, Gary K.			Interleukin-1 beta has atheroprotective effects in advanced atherosclerotic lesions of mice	NATURE MEDICINE			English	Article							VASCULAR SMOOTH-MUSCLE; C-REACTIVE PROTEIN; RECEPTOR ANTAGONIST; CELLS; MACROPHAGE; CORONARY; INFLAMMATION; PROLIFERATION; CANAKINUMAB; PLAQUES	Despite decades of research, our understanding of the processes controlling late-stage atherosclerotic plaque stability remains poor. A prevailing hypothesis is that reducing inflammation may improve advanced plaque stability, as recently tested in the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, in which post-myocardial infarction subjects were treated with an IL-1 beta antibody. Here, we performed intervention studies in which smooth muscle cell (SMC) lineage-tracing Apoe(-/-) mice with advanced atherosclerosis were treated with anti-IL-1 beta or IgG control antibodies. Surprisingly, we found that IL-1 beta antibody treatment between 18 and 26 weeks of Western diet feeding induced a marked reduction in SMC and collagen content, but increased macrophage numbers in the fibrous cap. Moreover, although IL-1 beta antibody treatment had no effect on lesion size, it completely inhibited beneficial outward remodeling. We also found that SMC-specific knockout of Il1r1 (encoding IL-1 receptor type 1) resulted in smaller lesions nearly devoid of SMCs and lacking a fibrous cap, whereas macrophage-selective loss of IL-1R1 had no effect on lesion size or composition. Taken together, these results show that IL-1 beta has multiple beneficial effects in late-stage murine atherosclerosis, including promotion of outward remodeling and formation and maintenance of an SMC- and collagen-rich fibrous cap.	[Gomez, Delphine; Baylis, Richard A.; Durgin, Brittany G.; Newman, Alexandra A. C.; Alencar, Gabriel F.; Owens, Gary K.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 23806 USA; [Gomez, Delphine; Durgin, Brittany G.; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 23806 USA; [Gomez, Delphine; Mahan, Sidney; St Hilaire, Cynthia] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA USA; [Gomez, Delphine; St Hilaire, Cynthia] Univ Pittsburgh, Div Cardiol, Sch Med, Pittsburgh, PA USA; [Baylis, Richard A.; Newman, Alexandra A. C.; Alencar, Gabriel F.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Mueller, Werner; Pinteaux, Emmanuel] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Francis, Sheila E.] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Randolph, Gwendalyn J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Gram, Hermann] Novartis Inst Biomed Res, Basel, Switzerland	University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; University of Manchester; Johannes Gutenberg University of Mainz; University of Sheffield; Washington University (WUSTL); Novartis	Owens, GK (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 23806 USA.; Owens, GK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 23806 USA.	gko@virginia.edu	Müller, W. E. G./AAR-8651-2020; Muller, Werner/B-9044-2008; Gomez, Delphine/J-6349-2019; St. Hilaire, Cynthia/R-8205-2017; Waisman, Ari/C-7383-2015	Müller, W. E. G./0000-0002-8223-3689; Muller, Werner/0000-0002-1297-9725; Gomez, Delphine/0000-0002-3880-6961; St. Hilaire, Cynthia/0000-0003-1871-6915; Francis, Sheila/0000-0001-6552-0339; Newman, Alexandra/0000-0001-8938-2428; Pinteaux, Emmanuel/0000-0002-9986-4401; Waisman, Ari/0000-0003-4304-8234; Durgin, Brittany/0000-0003-4066-1770	NIH [R01 HL121008,, R01 HL132904, R01 HL136314]; Scientific Development Grant from the American Heart Association [15SDG25860021]; NIH grant [F30 HL136188]; Predoctoral Fellowship from the American Heart Association [14PRE20380659]; FP7/EU Project MUGEN [MUGEN LSHG-CT-2005-005203]; MRC research [G0801296];  [K22HL117917]; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL117917, R01HL136314, R01HL121008, R01HL132904, R01HL141425, F30HL136188, T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Development Grant from the American Heart Association(American Heart Association); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Fellowship from the American Heart Association(American Heart Association); FP7/EU Project MUGEN; MRC research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Owens laboratory members for their input. We thank P. Libby, M. Nahrendorf, and P. Swirski for their constructive discussion during the project completion. We thank E. Greene for her assistance in generating the SMC-specific Il1r1 knockout mice, A. Nguyen for performing retro-orbital injections, and M. McCanna for technical support. We thank the University of Pittsburgh Center for Biologic Imaging for their assistance with confocal microscopy. This work was supported by NIH grants R01 HL121008, R01 HL132904, and R01 HL136314 to G.K.O. D.G. was supported by Scientific Development Grant 15SDG25860021 from the American Heart Association. R.A.B. was supported by NIH grant F30 HL136188. B.G.D. was supported by a Predoctoral Fellowship from the American Heart Association (14PRE20380659). C.S.H. was supported by K22HL117917. The generation of the IL1R1<SUP>fl/fl</SUP> mice was funded by FP7/EU Project MUGEN (MUGEN LSHG-CT-2005-005203) to W.M. and by MRC research (G0801296) to E.P.	Abdulaal WH, 2016, EUR J IMMUNOL, V46, P912, DOI 10.1002/eji.201546075; Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; Baylis RA, 2017, ARTERIOSCL THROM VAS, V37, pE174, DOI 10.1161/ATVBAHA.117.310097; Baylis RA, 2017, CIRC RES, V120, P775, DOI 10.1161/CIRCRESAHA.116.310101; Bhaskar V, 2011, ATHEROSCLEROSIS, V216, P313, DOI 10.1016/j.atherosclerosis.2011.02.026; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Cherepanova OA, 2016, NAT MED, V22, P657, DOI 10.1038/nm.4109; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Everett BM, 2018, J AM COLL CARDIOL, V71, P2392, DOI 10.1016/j.jacc.2018.03.002; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Freitag DF, 2015, LANCET DIABETES ENDO, V3, P243, DOI 10.1016/S2213-8587(15)00034-0; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Haka AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044823; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Harrington RA, 2017, NEW ENGL J MED, V377, P1197, DOI 10.1056/NEJMe1709904; Hawker KM, 1998, AM J PHYSIOL-LUNG C, V275, pL469, DOI 10.1152/ajplung.1998.275.3.L469; Howard C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-94; Ibanez B, 2017, CIRC RES, V121, P1320, DOI 10.1161/CIRCRESAHA.117.312200; Isoda K, 2004, ARTERIOSCL THROM VAS, V24, P1068, DOI 10.1161/01.ATV.0000127025.48140.a3; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; LOPPNOW H, 1990, J CLIN INVEST, V85, P731, DOI 10.1172/JCI114498; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morton AC, 2015, EUR HEART J, V36, P377, DOI 10.1093/eurheartj/ehu272; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shemesh S, 2012, ATHEROSCLEROSIS, V222, P329, DOI 10.1016/j.atherosclerosis.2011.12.010; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sui YP, 2014, J EXP MED, V211, P869, DOI 10.1084/jem.20131281; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; VADIVELOO PK, 1994, ARTERY, V21, P161; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wanschel A, 2013, ARTERIOSCL THROM VAS, V33, P886, DOI 10.1161/ATVBAHA.112.300941; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Yahagi K, 2016, NAT REV CARDIOL, V13, P79, DOI 10.1038/nrcardio.2015.164; Zhao XN, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017348	61	132	133	0	24	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1418	+		10.1038/s41591-018-0124-5	http://dx.doi.org/10.1038/s41591-018-0124-5			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30038218	Green Submitted, Green Accepted			2022-12-27	WOS:000444174100027
J	Tata, B; Mimouni, NEH; Barbotin, AL; Malone, SA; Loyens, A; Pigny, P; Dewailly, D; Catteau-Jonard, S; Sundstrom-Poromaa, I; Piltonen, TT; Dal Bello, F; Medana, C; Prevot, V; Clasadonte, J; Giacobini, P				Tata, Brooke; Mimouni, Nour El Houda; Barbotin, Anne-Laure; Malone, Samuel A.; Loyens, Anne; Pigny, Pascal; Dewailly, Didier; Catteau-Jonard, Sophie; Sundstrom-Poromaa, Inger; Piltonen, Terhi T.; Dal Bello, Federica; Medana, Claudio; Prevot, Vincent; Clasadonte, Jerome; Giacobini, Paolo			Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood	NATURE MEDICINE			English	Article							ANTAGONIST CETRORELIX; SEXUAL-DIFFERENTIATION; GONADOTROPIN-SECRETION; INHIBITING SUBSTANCE; MATERNAL SERUM; PREGNANT-WOMEN; NEURONS; BRAIN; MECHANISMS; FERTILITY	Polycystic ovary syndrome (PCOS) is the main cause of female infertility worldwide and corresponds with a high degree of comorbidities and economic burden. How PCOS is passed on from one generation to the next is not clear, but it may be a developmental condition. Most women with PCOS exhibit higher levels of circulating luteinizing hormone, suggestive of heightened gonadotropin-releasing hormone (GnRH) release, and anti-Mullerian hormone (AMH) as compared to healthy women. Excess AMH in utero may affect the development of the female fetus. However, as AMH levels drop during pregnancy in women with normal fertility, it was unclear whether their levels were also elevated in pregnant women with PCOS. Here we measured AMH in a cohort of pregnant women with PCOS and control pregnant women and found that AMH is significantly more elevated in the former group versus the latter. To determine whether the elevation of AMH during pregnancy in women with PCOS is a bystander effect or a driver of the condition in the offspring, we modeled our clinical findings by treating pregnant mice with AMH and followed the neuroendocrine phenotype of their female progeny postnatally. This treatment resulted in maternal neuroendocrine-driven testosterone excess and diminished placental metabolism of testosterone to estradiol, resulting in a masculinization of the exposed female fetus and a PCOS-like reproductive and neuroendocrine phenotype in adulthood. We found that the affected females had persistently hyperactivated GnRH neurons and that GnRH antagonist treatment in the adult female offspring restored their neuroendocrine phenotype to a normal state. These findings highlight a critical role for excess prenatal AMH exposure and subsequent aberrant GnRH receptor signaling in the neuroendocrine dysfunctions of PCOS, while offering a new potential therapeutic avenue to treat the condition during adulthood.	[Tata, Brooke; Mimouni, Nour El Houda; Barbotin, Anne-Laure; Malone, Samuel A.; Loyens, Anne; Dewailly, Didier; Catteau-Jonard, Sophie; Prevot, Vincent; Clasadonte, Jerome; Giacobini, Paolo] Jean Pierre Aubert Res Ctr JPArc, Lab Dev & Plast Neuroendocrine Brain, Inserm, UMR S 1172, Lille, France; [Tata, Brooke; Mimouni, Nour El Houda; Malone, Samuel A.; Loyens, Anne; Pigny, Pascal; Dewailly, Didier; Catteau-Jonard, Sophie; Prevot, Vincent; Clasadonte, Jerome; Giacobini, Paolo] Univ Lille, FHU Days Hlth 1000, Lille, France; [Barbotin, Anne-Laure] CHU Lille, Inst Biol Reprod Spermiol CECOS, Lille, France; [Pigny, Pascal] CHU Lille, Lab Biochim & Hormonol, Ctr Biol Pathol, Lille, France; [Dewailly, Didier; Catteau-Jonard, Sophie] CHU Lille, Serv Gynecol Endocrinienne & Med Reprod, Hop Jeanne Flandre, Lille, France; [Sundstrom-Poromaa, Inger] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Piltonen, Terhi T.] Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland; [Piltonen, Terhi T.] Univ Oulu, Oulu, Finland; [Piltonen, Terhi T.] Med Res Ctr, Oulu, Finland; [Dal Bello, Federica; Medana, Claudio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Uppsala University; University of Oulu; University of Oulu; University of Turin	Giacobini, P (corresponding author), Jean Pierre Aubert Res Ctr JPArc, Lab Dev & Plast Neuroendocrine Brain, Inserm, UMR S 1172, Lille, France.; Giacobini, P (corresponding author), Univ Lille, FHU Days Hlth 1000, Lille, France.	paolo.giacobini@inserm.fr	giacobini, paolo/P-5451-2015; Prevot, Vincent/E-5720-2016; Giacobini, Paolo/P-9878-2019; DAL BELLO, FEDERICA/C-2612-2017	giacobini, paolo/0000-0002-3075-1441; Prevot, Vincent/0000-0001-7185-3615; Giacobini, Paolo/0000-0002-3075-1441; Piltonen, Terhi/0000-0002-9921-7300; DEWAILLY, DIDIER/0000-0001-8521-5163; DAL BELLO, FEDERICA/0000-0003-0726-3025; Mimouni, Nour El Houda/0000-0001-8471-8551; Malone, Samuel/0000-0002-6824-6854; pigny, pascal/0000-0003-3926-4487	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (ERC-2016-CoG) [725149/REPRODAMH]; Institut National de la Sante et de la Recherche Medicale (INSERM), France [U1172]; Centre Hospitalier Regional Universitaire, CHU de Lille, France (Bonus H); Agence Nationale de la Recherche (ANR), France [ANR-14-CE12-0015-01]; Bourse France L'Oreal-UNESCO Pour les Femmes et la Science; Horizon 2020 Marie Sklodowska-Curie actions - European Research Fellowship [H2020-MSCA-IF-2014]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (ERC-2016-CoG); Institut National de la Sante et de la Recherche Medicale (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre Hospitalier Regional Universitaire, CHU de Lille, France (Bonus H); Agence Nationale de la Recherche (ANR), France(French National Research Agency (ANR)); Bourse France L'Oreal-UNESCO Pour les Femmes et la Science; Horizon 2020 Marie Sklodowska-Curie actions - European Research Fellowship	We thank M. Tardivel (microscopy core facility), M. H. Gevaert (histology core facility), D. Taillieu and J. Devassine (animal core facility), and the BICeL core facility of the Lille University School of Medicine for expert technical assistance. We are deeply indebted to P. Ciofi (U1215, Neurocentre Magendie, Institut National de la Sante et de la Recherche Medicale, Bordeaux, France) for his helpful feedback and discussion of the data. This work was supported by: the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (ERC-2016-CoG to P.G. grant agreement no 725149/REPRODAMH); the Institut National de la Sante et de la Recherche Medicale (INSERM), France (grant number U1172); the Centre Hospitalier Regional Universitaire, CHU de Lille, France (Bonus H to P.G. and Ph.D. fellowship to N.E.H.M.); Agence Nationale de la Recherche (ANR), France (ANR-14-CE12-0015-01 RoSes and GnRH to P.G.); Bourse France L'Oreal-UNESCO Pour les Femmes et la Science to B.K.T; Horizon 2020 Marie Sklodowska-Curie actions - European Research Fellowship (H2020-MSCA-IF-2014) to J.C.	Abbott DH, 2017, HUM REPROD, V32, P923, DOI 10.1093/humrep/dex036; Abbott DH, 2013, MOL CELL ENDOCRINOL, V373, P21, DOI 10.1016/j.mce.2013.01.013; Azziz R, 2016, FERTIL STERIL, V106, P4, DOI 10.1016/j.fertnstert.2016.05.009; Balland E, 2014, CELL METAB, V19, P293, DOI 10.1016/j.cmet.2013.12.015; Belle M, 2017, CELL, V169, DOI 10.1016/j.cell.2017.03.008; Belle M, 2014, CELL REP, V9, P1191, DOI 10.1016/j.celrep.2014.10.037; Caldwell ASL, 2017, P NATL ACAD SCI USA, V114, pE3334, DOI 10.1073/pnas.1616467114; Casoni F, 2016, DEVELOPMENT, V143, P3969, DOI 10.1242/dev.139444; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; CHANG RJ, 1982, J CLIN ENDOCR METAB, V54, P490, DOI 10.1210/jcem-54-3-490; Cimino I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10055; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Clarkson J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0115; Clarkson J, 2014, J NEUROSCI, V34, P15297, DOI 10.1523/JNEUROSCI.3061-14.2014; Cook CL, 2002, FERTIL STERIL, V77, P141, DOI 10.1016/S0015-0282(01)02944-2; CORBIER P, 1992, ARCH INT PHYSIOL BIO, V100, P127, DOI 10.3109/13813459209035274; De Vries GJ, 2006, NEUROSCIENCE, V138, P947, DOI 10.1016/j.neuroscience.2005.07.050; Defazio RA, 2002, MOL ENDOCRINOL, V16, P2255, DOI 10.1210/me.2002-0155; Duijkers IJM, 1998, HUM REPROD, V13, P2392, DOI 10.1093/humrep/13.9.2392; Dumesic DA, 2016, J CLIN ENDOCR METAB, V101, P4178, DOI 10.1210/jc.2016-2586; Dumesic DA, 2013, STEROIDS, V78, P782, DOI 10.1016/j.steroids.2013.04.004; Ezeh U, 2013, J CLIN ENDOCR METAB, V98, pE1088, DOI 10.1210/jc.2013-1295; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Granfors M, 2013, J CLIN ENDOCR METAB, V98, P2687, DOI 10.1210/jc.2013-1302; Halmos G, 1996, P NATL ACAD SCI USA, V93, P2398, DOI 10.1073/pnas.93.6.2398; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Herbison AE, 2016, NAT REV ENDOCRINOL, V12, P452, DOI 10.1038/nrendo.2016.70; Herde MK, 2011, ENDOCRINOLOGY, V152, P3832, DOI 10.1210/en.2011-1228; Hrabovszky Erik, 2011, Front Endocrinol (Lausanne), V2, P80, DOI 10.3389/fendo.2011.00080; Huang CC, 2015, HUM REPROD, V30, P937, DOI 10.1093/humrep/dev010; HUANG XP, 1993, BRAIN RES, V624, P309, DOI 10.1016/0006-8993(93)90094-4; Jayasena CN, 2014, NAT REV ENDOCRINOL, V10, P624, DOI 10.1038/nrendo.2014.102; Katulski K, 2015, GYNECOL ENDOCRINOL, V31, P87, DOI 10.3109/09513590.2014.974535; Koninger A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-60; La Marca A, 2005, HUM REPROD, V20, P1569, DOI 10.1093/humrep/deh819; Lizneva D, 2016, FERTIL STERIL, V106, P1510, DOI 10.1016/j.fertnstert.2016.07.1121; Maliqueo M, 2015, HUM REPROD, V30, P692, DOI 10.1093/humrep/deu351; Maliqueo M, 2013, EUR J OBSTET GYN R B, V166, P151, DOI 10.1016/j.ejogrb.2012.10.015; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; McAllister JM, 2015, TRENDS ENDOCRIN MET, V26, P118, DOI 10.1016/j.tem.2014.12.004; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Moore AM, 2017, FRONT NEUROENDOCRIN, V46, P1, DOI 10.1016/j.yfrne.2017.05.002; Moore AM, 2015, P NATL ACAD SCI USA, V112, P596, DOI 10.1073/pnas.1415038112; Moore AM, 2013, ENDOCRINOLOGY, V154, P796, DOI 10.1210/en.2012-1954; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Novembri R, 2015, PLACENTA, V36, P731, DOI 10.1016/j.placenta.2015.04.009; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Pankhurst MW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12783; Pankhurst MW, 2013, AM J PHYSIOL-ENDOC M, V305, pE1241, DOI 10.1152/ajpendo.00395.2013; Pellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582; Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727; Pigny P, 2006, J CLIN ENDOCR METAB, V91, P941, DOI 10.1210/jc.2005-2076; Piltonen T, 2005, HUM REPROD, V20, P1820, DOI 10.1093/humrep/deh850; Pinski J, 1996, ENDOCRINOLOGY, V137, P3430, DOI 10.1210/en.137.8.3430; Prevot V, 2018, ENDOCR REV, V39, P333, DOI 10.1210/er.2017-00235; RAGIN RC, 1992, PROTEIN EXPRES PURIF, V3, P236, DOI 10.1016/1046-5928(92)90020-W; REBAR R, 1976, J CLIN INVEST, V57, P1320, DOI 10.1172/JCI108400; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Roland AV, 2014, FRONT NEUROENDOCRIN, V35, P494, DOI 10.1016/j.yfrne.2014.04.002; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1989, MOL BRAIN RES, V6, P297, DOI 10.1016/0169-328X(89)90075-2; Sir-Petermann T, 2002, HUM REPROD, V17, P2573, DOI 10.1093/humrep/17.10.2573; Sir-Petermann T, 2007, J CLIN ENDOCR METAB, V92, P4637, DOI 10.1210/jc.2007-1036; SOKKA T, 1990, J ENDOCRINOL, V127, P297, DOI 10.1677/joe.0.1270297; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Steyn FJ, 2013, ENDOCRINOLOGY, V154, P4939, DOI 10.1210/en.2013-1502; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Vidal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039001; Wang HY, 2014, J CHROMATOGR A, V1345, P98, DOI 10.1016/j.chroma.2014.04.019; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Xu C, 2017, EMBO MOL MED, V9, P1379, DOI 10.15252/emmm.201607376	74	192	204	10	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					834	+		10.1038/s41591-018-0035-5	http://dx.doi.org/10.1038/s41591-018-0035-5			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29760445	Green Accepted			2022-12-27	WOS:000434281300028
J	Liu, XX; Rivera, SC; Faes, L; Di Ruffano, LF; Yau, C; Keane, PA; Ashrafian, H; Darzi, A; Vollmer, SJ; Deeks, J; Bachmann, L; Holmes, C; Chan, AW; Moher, D; Calvert, MJ; Denniston, AK				Liu, Xiaoxuan; Rivera, Samantha Cruz; Faes, Livia; Di Ruffano, Lavinia Ferrante; Yau, Christopher; Keane, Pearse A.; Ashrafian, Hutan; Darzi, Ara; Vollmer, Sebastian J.; Deeks, Jonathan; Bachmann, Lucas; Holmes, Christopher; Chan, An Wen; Moher, David; Calvert, Melanie J.; Denniston, Alastair K.		CONSORT-AI SPIRIT-AI Steering Grp	Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed	NATURE MEDICINE			English	Editorial Material									[Liu, Xiaoxuan; Denniston, Alastair K.] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Liu, Xiaoxuan; Denniston, Alastair K.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Liu, Xiaoxuan; Holmes, Christopher; Denniston, Alastair K.] Hlth Data Res UK, London, England; [Liu, Xiaoxuan; Faes, Livia] Moorfields Eye Hosp NHS Fdn Trust, London, England; [Rivera, Samantha Cruz; Calvert, Melanie J.; Denniston, Alastair K.] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England; [Faes, Livia] Cantonal Hosp Lucerne, Dept Ophthalmol, Luzern, Switzerland; [Di Ruffano, Lavinia Ferrante; Deeks, Jonathan] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Yau, Christopher] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Yau, Christopher; Vollmer, Sebastian J.; Holmes, Christopher] Alan Turing Inst, London, England; [Keane, Pearse A.; Denniston, Alastair K.] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res BRC Ophthalmol, London, England; [Ashrafian, Hutan; Darzi, Ara] Imperial Coll London, Patient Safety Translat Res Ctr, London, England; [Vollmer, Sebastian J.] Univ Warwick, Coventry, W Midlands, England; [Bachmann, Lucas] Medignition, Zurich, Switzerland; [Chan, An Wen] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON, Canada; [Moher, David] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	University of Birmingham; University of Birmingham; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Birmingham; Lucerne Cantonal Hospital; University of Birmingham; University of Birmingham; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Imperial College London; University of Warwick; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Denniston, AK (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Hlth Data Res UK, London, England.; Denniston, AK (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England.; Denniston, AK (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res BRC Ophthalmol, London, England.	a.denniston@bham.ac.uk	Deeks, Jon/AAV-5745-2020; Calvert, Melanie/F-7055-2011; Keane, Pearse/AAE-5709-2019; Denniston, Alastair/ABD-1238-2020	Deeks, Jon/0000-0002-8850-1971; Calvert, Melanie/0000-0002-1856-837X; Keane, Pearse/0000-0002-9239-745X; Denniston, Alastair/0000-0001-7849-0087; Cruz Rivera, Samantha/0000-0002-1566-6804; Liu, Xiaoxuan/0000-0002-1286-0038; Yau, Christopher/0000-0001-7615-8523	Wellcome Trust; Health Data Research UK; Alan Turing Institute; MRC [MC_PC_19005] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Health Data Research UK; Alan Turing Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This initiative is funded by the Wellcome Trust, Health Data Research UK and the Alan Turing Institute.	Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2013, LANCET, V381, P91, DOI 10.1016/S0140-6736(12)62160-6; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; EQUATOR Network, REP GUID DEV; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; US Food & Drug Administration, ART INT MACH LEARN S	6	60	60	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1467	1468		10.1038/s41591-019-0603-3	http://dx.doi.org/10.1038/s41591-019-0603-3			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31551578	Green Submitted			2022-12-27	WOS:000489166700005
J	Licher, S; Ahmad, S; Karamujic-Comic, H; Voortman, T; Leening, MJG; Ikram, MA; Ikram, MK				Licher, Silvan; Ahmad, Shahzad; Karamujic-Comic, Hata; Voortman, Trudy; Leening, Maarten J. G.; Ikram, M. Arfan; Ikram, M. Kamran			Genetic predisposition, modifiable-risk-factor profile and long-term dementia risk in the general population	NATURE MEDICINE			English	Article							APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; COGNITIVE DECLINE; INTERVENTION; GENOTYPE; HEALTH; SMOKING; MIDLIFE; AGE	The exact etiology of dementia is still unclear, but both genetic and lifestyle factors are thought to be key drivers of this complex disease. The recognition of familial patterns of dementia has led to the discovery of genetic factors that have a role in the pathogenesis of dementia, including the apolipoprotein E (APOE) genotype and a large and still-growing number of genetic variants(1,2). Beyond genetic architecture, several modifiable risk factors have been implicated in the development of dementia(3). Prevention trials of measures to halt or delay cognitive decline are increasingly recruiting older individuals who are genetically predisposed to dementia. However, it remains unclear whether targeted health and lifestyle interventions can attenuate or even offset increased genetic risk. Here, we leverage long-term data on both genetic and modifiable risk factors from 6,352 individuals aged 55 years and older in the population-based Rotterdam Study. In this study, we demonstrate that, in individuals at low and intermediate genetic risk, favorable modifiable-risk profiles are related to a lower risk of dementia compared to unfavorable profiles. In contrast, these protective associations were not found in those at high genetic risk.	[Licher, Silvan; Ahmad, Shahzad; Karamujic-Comic, Hata; Voortman, Trudy; Leening, Maarten J. G.; Ikram, M. Arfan; Ikram, M. Kamran] Erasmus MC, Dept Epidemiol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Leening, Maarten J. G.] Erasmus MC, Dept Cardiol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Leening, Maarten J. G.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Ikram, M. Kamran] Erasmus MC, Dept Neurol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC	Licher, S; Ikram, MK (corresponding author), Erasmus MC, Dept Epidemiol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.; Ikram, MK (corresponding author), Erasmus MC, Dept Neurol, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.	s.licher@erasmusmc.nl; m.ikram@erasmusmc.nl	Ahmad, Shahzad/AAY-7240-2020; Ikram, M. Arfan/AAM-5225-2021; Voortman, Trudy/C-2963-2015	Voortman, Trudy/0000-0003-2830-6813; Leening, Maarten J. G./0000-0002-4143-4839; Ikram, Mohammad Arfan/0000-0003-0372-8585; Ahmad, Shahzad/0000-0002-8658-3790	Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Consortium for Healthy Ageing; Dutch Heart Foundation [2012T008]; Dutch Cancer Society [NKI-20157737]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (project: ORACLE) [678543]	Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Consortium for Healthy Ageing; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Cancer Society(KWF Kankerbestrijding); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (project: ORACLE)	We acknowledge the dedication, commitment, and contributions of inhabitants, general practitioners, and pharmacists of the Ommoord district who took part in the Rotterdam Study. We acknowledge F. J. A. van Rooij as data manager, and B. C. T. Leening-Kieboom as study coordinator. We thank J. Verkroost-van Heemst for her invaluable contribution to data collection. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. Further support was obtained from the Netherlands Consortium for Healthy Ageing and the Dutch Heart Foundation (2012T008) and the Dutch Cancer Society (NKI-20157737). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (project: ORACLE, grant agreement no.: 678543).	Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; [Anonymous], 2019, RISK RED COGN DECL D; Anttila T, 2004, BMJ-BRIT MED J, V329, P539, DOI 10.1136/bmj.38181.418958.BE; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Boyle PA, 2019, ANN NEUROL, V85, P114, DOI 10.1002/ana.25380; Chang L, 2016, NEUROLOGY, V87, P585, DOI 10.1212/WNL.0000000000002939; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Bruijn RFAG, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0377-5; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4; Karlsson IK, 2015, NEUROBIOL AGING, V36, P1751, DOI 10.1016/j.neurobiolaging.2015.01.008; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; Licher S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002741; Licher S, 2019, AM J PSYCHIAT, V176, P543, DOI 10.1176/appi.ajp.2018.18050566; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; McGuinness B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003160.pub3; Merchant C, 1999, NEUROLOGY, V52, P1408, DOI 10.1212/WNL.52.7.1408; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Peters R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022846; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Rutten-Jacobs LC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4168; Samieri C, 2018, JAMA-J AM MED ASSOC, V320, P657, DOI 10.1001/jama.2018.11499; Solomon A, 2018, JAMA NEUROL, V75, P462, DOI 10.1001/jamaneurol.2017.4365; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; van der Lee SJ, 2018, LANCET NEUROL, V17, P434, DOI [10.1016/s1474-4422(18)30053-X, 10.1016/S1474-4422(18)30053-X]; Voortman T, 2017, EUR J EPIDEMIOL, V32, P993, DOI 10.1007/s10654-017-0295-2	40	74	75	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1364	+		10.1038/s41591-019-0547-7	http://dx.doi.org/10.1038/s41591-019-0547-7			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31451782	Green Accepted			2022-12-27	WOS:000484832800017
J	Qi, XY; Yun, CY; Sun, LL; Xia, JL; Wu, Q; Wang, Y; Wang, LN; Zhang, YM; Liang, XY; Wang, LY; Gonzalez, FJ; Patterson, AD; Liu, HY; Mu, LS; Zhou, ZH; Zhao, Y; Li, R; Liu, P; Zhong, C; Pang, YL; Jiang, CT; Qiao, J				Qi, Xinyu; Yun, Chuyu; Sun, Lulu; Xia, Jialin; Wu, Qing; Wang, Ying; Wang, Lina; Zhang, Yangming; Liang, Xianyi; Wang, Liying; Gonzalez, Frank J.; Patterson, Andrew D.; Liu, Huiying; Mu, Liangshan; Zhou, Zehong; Zhao, Yue; Li, Rong; Liu, Ping; Zhong, Chao; Pang, Yanli; Jiang, Changtao; Qiao, Jie			Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome	NATURE MEDICINE			English	Article							MACROPHAGE POLARIZATION; CELLS	Polycystic ovary syndrome (PCOS) is characterized by androgen excess, ovulatory dysfunction and polycystic ovaries(1), and is often accompanied by insulin resistance(2). The mechanism of ovulatory dysfunction and insulin resistance in PCOS remains elusive, thus limiting the development of therapeutics. Improved metabolic health is associated with a relatively high microbiota gene content and increased microbial diversity(3,4). This study aimed to investigate the impact of the gut microbiota and its metabolites on the regulation of PCOS-associated ovarian dysfunction and insulin resistance. Here, we report that Bacteroides vulgatus was markedly elevated in the gut microbiota of individuals with PCOS, accompanied by reduced glycodeoxycholic acid and tauroursodeoxycholic acid levels. Transplantation of fecal microbiota from women with PCOS or B. vulgatus-colonized recipient mice resulted in increased disruption of ovarian functions, insulin resistance, altered bile acid metabolism, reduced interleukin-22 secretion and infertility. Mechanistically, glycodeoxycholic acid induced intestinal group 3 innate lymphoid cell IL-22 secretion through GATA binding protein 3, and IL-22 in turn improved the PCOS phenotype. This finding is consistent with the reduced levels of IL-22 in individuals with PCOS. This study suggests that modifying the gut microbiota, altering bile acid metabolism and/or increasing IL-22 levels may be of value for the treatment of PCOS.	[Qi, Xinyu; Yun, Chuyu; Sun, Lulu; Xia, Jialin; Wu, Qing; Wang, Ying; Wang, Lina; Zhang, Yangming; Liang, Xianyi; Wang, Liying; Liu, Huiying; Mu, Liangshan; Zhou, Zehong; Zhao, Yue; Li, Rong; Liu, Ping; Pang, Yanli; Jiang, Changtao; Qiao, Jie] Peking Univ, Hosp 3, Sch Basic Med Sci, Dept Obstet & Gynecol,Ctr Obes & Metab Dis Res, Beijing, Peoples R China; [Yun, Chuyu; Sun, Lulu; Xia, Jialin; Wu, Qing; Zhang, Yangming; Liang, Xianyi; Liu, Huiying; Jiang, Changtao] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Yun, Chuyu; Sun, Lulu; Xia, Jialin; Wu, Qing; Zhang, Yangming; Liang, Xianyi; Liu, Huiying; Jiang, Changtao] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Wang, Ying; Wang, Lina; Wang, Liying; Mu, Liangshan; Zhou, Zehong; Zhao, Yue; Li, Rong; Liu, Ping; Pang, Yanli; Qiao, Jie] Peking Univ, Key Lab Assisted Reprod, Minist Educ, Beijing, Peoples R China; [Wang, Ying; Wang, Lina; Wang, Liying; Li, Rong; Liu, Ping; Qiao, Jie] Natl Clin Res Ctr Obstet & Gynecol, Beijing, Peoples R China; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Zhao, Yue; Li, Rong; Liu, Ping; Pang, Yanli; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China; [Zhong, Chao] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing Key Lab Tumor Syst Biol,Sch Basic Med Sci, Beijing, Peoples R China; [Qiao, Jie] Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China; [Qiao, Jie] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Peking University; Peking University	Pang, YL; Jiang, CT; Qiao, J (corresponding author), Peking Univ, Hosp 3, Sch Basic Med Sci, Dept Obstet & Gynecol,Ctr Obes & Metab Dis Res, Beijing, Peoples R China.; Jiang, CT (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.; Jiang, CT (corresponding author), Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China.; Pang, YL; Qiao, J (corresponding author), Peking Univ, Key Lab Assisted Reprod, Minist Educ, Beijing, Peoples R China.; Qiao, J (corresponding author), Natl Clin Res Ctr Obstet & Gynecol, Beijing, Peoples R China.; Pang, YL; Qiao, J (corresponding author), Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China.; Qiao, J (corresponding author), Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China.; Qiao, J (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.	yanlipang@bjmu.edu.cn; jiangchangtao@bjmu.edu.cn; jie.qiao@263.net	Zhang, Yangming/GSG-7593-2022; Patterson, Andrew/ABF-1575-2020	Zhang, Yangming/0000-0002-0341-7851; Patterson, Andrew/0000-0003-2073-0070; Jiang, Changtao/0000-0002-5206-2372; Sun, Lulu/0000-0001-8876-5099; Qiao, Jie/0000-0003-2126-1376	National Key Research and Development Program of China [2016YFC1000201]; National Natural Science Foundation of China [91857115, 81521002, 81730038, 81771650]; Clinical Medicine Plus X-Young Scholars Project of Peking University [PKU2019LCXQ025, PKU2018LCXQ013]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Medicine Plus X-Young Scholars Project of Peking University	This work was supported by the National Key Research and Development Program of China (2018YFC1003200 and 2018YFC1003900 to Y.P.), National Natural Science Foundation of China (91857115 to C.J.; 81521002 and 81730038 to J.Q.; and 81771650 to R.L.), Clinical Medicine Plus X-Young Scholars Project of Peking University (PKU2019LCXQ025 and PKU2018LCXQ013 to Y.P. and C.J.) and the National Key Research and Development Program of China (2016YFC1000201 to R.L.).	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bouchard MF, 2005, ENDOCRINOLOGY, V146, P4905, DOI 10.1210/en.2005-0187; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Hand TW, 2016, TRENDS ENDOCRIN MET, V27, P831, DOI 10.1016/j.tem.2016.08.003; Lindheim L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168390; Liu R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00324; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Pang YL, 2016, J BIOL CHEM, V291, P12336, DOI 10.1074/jbc.M115.702654; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Shindo K, 1998, GUT, V42, P266, DOI 10.1136/gut.42.2.266; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Tata B, 2018, NAT MED, V24, P834, DOI 10.1038/s41591-018-0035-5; Torres PJ, 2018, J CLIN ENDOCR METAB, V103, P1502, DOI 10.1210/jc.2017-02153; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van Houten ELAF, 2014, REPROD BIOL, V14, P32, DOI 10.1016/j.repbio.2013.09.007; Yuan XX, 2016, P NATL ACAD SCI USA, V113, P2708, DOI 10.1073/pnas.1523236113; Zhao Y, 2015, J CLIN ENDOCR METAB, V100, P201, DOI 10.1210/jc.2014-2419; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	26	192	212	42	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1225	+		10.1038/s41591-019-0509-0	http://dx.doi.org/10.1038/s41591-019-0509-0			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31332392	Green Accepted			2022-12-27	WOS:000480414600020
J	Stower, H				Stower, Hannah			Preventing HIV transmission	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					877	877		10.1038/s41591-019-0490-7	http://dx.doi.org/10.1038/s41591-019-0490-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171873	Bronze			2022-12-27	WOS:000470844400011
J	Parikh, NS; Elkind, MSV				Parikh, Neal S.; Elkind, Mitchell S. V.			Divergent effects of lipids on stroke	NATURE MEDICINE			English	Editorial Material							000 PARTICIPANTS; METAANALYSIS; CHOLESTEROL; EFFICACY; THERAPY; SAFETY; RISK		[Parikh, Neal S.; Elkind, Mitchell S. V.] Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Elkind, Mitchell S. V.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	Columbia University; Columbia University	Elkind, MSV (corresponding author), Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10032 USA.; Elkind, MSV (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.	mse13@columbia.edu		Parikh, Neal/0000-0002-8802-2380				Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Elkind MSV, 2009, CEREBROVASC DIS, V28, P266, DOI 10.1159/000228709; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Hindy G, 2018, STROKE, V49, P820, DOI 10.1161/STROKEAHA.117.019653; Karatasakis A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006910; Sun LL, 2019, NAT MED, V25, P569, DOI 10.1038/s41591-019-0366-x; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326	10	3	3	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					543	544		10.1038/s41591-019-0413-7	http://dx.doi.org/10.1038/s41591-019-0413-7			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30911137				2022-12-27	WOS:000463342800012
J	Pou, C; Nkulikiyimfura, D; Henckel, E; Olin, A; Lakshmikanth, T; Mikes, J; Wang, J; Chen, Y; Bernhardsson, AK; Gustafsson, A; Bohlin, K; Brodin, P				Pou, Christian; Nkulikiyimfura, Dieudonne; Henckel, Ewa; Olin, Axel; Lakshmikanth, Tadepally; Mikes, Jaromir; Wang, Jun; Chen, Yang; Bernhardsson, Anna Karin; Gustafsson, Anna; Bohlin, Kajsa; Brodin, Petter			The repertoire of maternal anti-viral antibodies in human newborns	NATURE MEDICINE			English	Article							GESTATIONAL-AGE; VIRUS; VACCINATION; VARICELLA	All circulating immunoglobulin G (IgG) antibodies in human newborns are of maternal origin(1) and transferred across the placenta to provide passive immunity until newborn IgG production takes over 15 weeks after birth(2). However, maternal IgG can also negatively interfere with newborn vaccine responses(3). The concentration of IgG increases sharply during the third trimester of gestation and children delivered extremely preterm are believed to largely lack this passive immunity(1,2,4). Antibodies to individual viruses have been reported(5-12), but the global repertoire of maternal IgG, its variation in children, and the epitopes targeted are poorly understood. Here, we assess antibodies against 93,904 epitopes from 206 viruses in 32 preterm and 46 term motherchild dyads. We find that extremely preterm children receive comparable repertoires of IgG as term children, albeit at lower absolute concentrations and consequent shorter half-life. Neutralization of the clinically important respiratory syncytial virus (RS-virus) was also comparable until three months of age. These findings have implications for understanding infectious disease susceptibility, vaccine development, and vaccine scheduling in newborn children.	[Pou, Christian; Nkulikiyimfura, Dieudonne; Olin, Axel; Lakshmikanth, Tadepally; Mikes, Jaromir; Wang, Jun; Chen, Yang; Bernhardsson, Anna Karin; Brodin, Petter] Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden; [Henckel, Ewa; Gustafsson, Anna; Bohlin, Kajsa] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Henckel, Ewa; Bernhardsson, Anna Karin; Gustafsson, Anna; Bohlin, Kajsa; Brodin, Petter] Karolinska Univ Hosp, Dept Newborn Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brodin, P (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden.; Brodin, P (corresponding author), Karolinska Univ Hosp, Dept Newborn Med, Stockholm, Sweden.	petter.brodin@ki.se	Tadepally, Lakshmikanth/P-5154-2019; Olin, Axel/AAX-7229-2021; Brodin, Petter/C-3317-2011; Henckel, Ewa/AAD-3185-2019; Mikes, Jaromir/X-3588-2019	Tadepally, Lakshmikanth/0000-0001-7256-5770; Brodin, Petter/0000-0002-8103-0046; Henckel, Ewa/0000-0003-0775-1563; Mikes, Jaromir/0000-0002-9941-7855; Nkulikiyimfura, Dieudonne/0000-0002-6981-2053; Olin, Axel/0000-0002-1161-4476	European Research Council [ERC-StG-677559]; Wallenberg Clinical Fellow grant [MMW 2017.0127]; Karolinska Institutet; Swedish Research council [2015-03028]	European Research Council(European Research Council (ERC)European Commission); Wallenberg Clinical Fellow grant; Karolinska Institutet(Karolinska Institutet); Swedish Research council(Swedish Research CouncilEuropean Commission)	We are grateful to all the families taking part in this study, all colleagues at the Karolinska University Hospital neonatology and delivery wards. We are also indebted to S. Elledge and T. Kula at Harvard University for sharing the VirScan bacteriophage library and their assistance. The study was funded by a European Research Council starting grant (no. ERC-StG-677559), Wallenberg Clinical Fellow grant (no. MMW 2017.0127), Karolinska Institutet (KI Research Assistant 2015 grant), and the Swedish Research council (grant no. 2015-03028) to P.B.	Aizawa Y, 2015, EMERG INFECT DIS, V21, P1966, DOI 10.3201/eid2111.150267; CONWAY SP, 1985, ARCH DIS CHILD, V60, P208, DOI 10.1136/adc.60.3.208; Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000; Francis JP, 2009, CLIN VACCINE IMMUNOL, V16, P1633, DOI 10.1128/CVI.00247-09; Hernandez-Trujillo VP, 2014, J CLIN IMMUNOL, V34, P627, DOI 10.1007/s10875-014-0056-x; HOBBS JR, 1967, LANCET, V1, P757, DOI 10.1016/S0140-6736(67)91369-4; Jennewein MF, 2017, SEMIN IMMUNOPATHOL, V39, P605, DOI 10.1007/s00281-017-0653-x; Jennewein MF, 2017, TRENDS IMMUNOL, V38, P358, DOI 10.1016/j.it.2017.02.004; Jiang Y, 2017, MBIO, V8, DOI [10.1128/mBio.00678-17, 10.1128/mbio.00678-17]; Leuridan E, 2011, VACCINE, V29, P2222, DOI 10.1016/j.vaccine.2010.06.004; Leuridan E, 2010, BMJ, V340, pc1626, DOI 10.1136/bmj.c1626; Lozano NA, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12972; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Resch Bernhard, 2011, Open Microbiol J, V5, P135, DOI 10.2174/1874285801105010135; Salimonu L S, 1978, Int J Gynaecol Obstet, V16, P119; Scheltema NM, 2017, LANCET GLOB HEALTH, V5, pE984, DOI 10.1016/S2214-109X(17)30344-3; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; van den Hof S, 2002, EPIDEMIOL INFECT, V128, P47, DOI 10.1017/S0950268801006409; van der Zwet WC, 2002, PEDIATRICS, V109, P79, DOI 10.1542/peds.109.1.79; Watanaveeradej V, 2003, AM J TROP MED HYG, V69, P123, DOI 10.4269/ajtmh.2003.69.123; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698	24	58	61	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					591	+		10.1038/s41591-019-0392-8	http://dx.doi.org/10.1038/s41591-019-0392-8			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30886409	Bronze			2022-12-27	WOS:000463342800020
J	Feehley, T; Plunkett, CH; Bao, RY; Hong, SMC; Culleen, E; Belda-Ferre, P; Campbell, E; Aitoro, R; Nocerino, R; Paparo, L; Andrade, J; Antonopoulos, DA; Canani, RB; Nagler, CR				Feehley, Taylor; Plunkett, Catherine H.; Bao, Riyue; Hong, Sung Min Choi; Culleen, Elliot; Belda-Ferre, Pedro; Campbell, Evelyn; Aitoro, Rosita; Nocerino, Rita; Paparo, Lorella; Andrade, Jorge; Antonopoulos, Dionysios A.; Canani, Roberto Berni; Nagler, Cathryn R.			Healthy infants harbor intestinal bacteria that protect against food allergy	NATURE MEDICINE			English	Article							MICROBIOME; BUTYRATE; SENSITIZATION; HOMEOSTASIS; EXPRESSION; INDUCTION; PACKAGE; SHAPES; CELLS	There has been a striking generational increase in life-threatening food allergies in Westernized societies(1,2). One hypothesis to explain this rising prevalence is that twenty-first century lifestyle practices, including misuse of antibiotics, dietary changes, and higher rates of Caesarean birth and formula feeding have altered intestinal bacterial communities; early-life alterations may be particularly detrimental(3,4). To better understand how commensal bacteria regulate food allergy in humans, we colonized germ-free mice with feces from healthy or cow's milk allergic (CMA) infants(5). We found that germ-free mice colonized with bacteria from healthy, but not CMA, infants were protected against anaphylactic responses to a cow's milk allergen. Differences in bacterial composition separated the healthy and CMA populations in both the human donors and the colonized mice. Healthy and CMA colonized mice also exhibited unique transcriptome signatures in the ileal epithelium. Correlation of ileal bacteria with genes upregulated in the ileum of healthy or CMA colonized mice identified a clostridial species, Anaerostipes caccae, that protected against an allergic response to food. Our findings demonstrate that intestinal bacteria are critical for regulating allergic responses to dietary antigens and suggest that interventions that modulate bacterial communities may be therapeutically relevant for food allergy.	[Feehley, Taylor; Plunkett, Catherine H.; Hong, Sung Min Choi; Culleen, Elliot; Belda-Ferre, Pedro; Campbell, Evelyn; Nagler, Cathryn R.] Univ Chicago, Dept Pathol & Comm Immunol, Chicago, IL 60637 USA; [Bao, Riyue; Andrade, Jorge] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Bao, Riyue; Andrade, Jorge] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Aitoro, Rosita; Nocerino, Rita; Paparo, Lorella] Univ Naples Federico II, Sect Pediat, Dept Translat Med Sci, Naples, Italy; [Antonopoulos, Dionysios A.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.] Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Canani, Roberto Berni] Univ Naples Federico II, European Lab Invest Food Induced Dis, Naples, Italy; [Canani, Roberto Berni] Univ Naples Federico II, CEINGE Adv Biotechnol, Naples, Italy	University of Chicago; University of Chicago; University of Chicago; University of Naples Federico II; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Nagler, CR (corresponding author), Univ Chicago, Dept Pathol & Comm Immunol, Chicago, IL 60637 USA.	cnagler@bsd.uchicago.edu	NOCERINO, RITA/AAC-1966-2022; Nocerino, Rita/ABD-8087-2020; Belda-Ferre, Pedro/C-9825-2010; Antonopoulos, Dionysios/ABE-6212-2020; Canani, Roberto Berni/AAC-4810-2022; Paparo, Lorella/AAC-1720-2022	NOCERINO, RITA/0000-0003-4681-546X; Belda-Ferre, Pedro/0000-0001-6532-1161; Antonopoulos, Dionysios/0000-0002-2238-5031; Canani, Roberto Berni/0000-0002-5169-9574; Paparo, Lorella/0000-0002-5562-1408	Sunshine Charitable Foundation; University of Chicago Institute for Translational Medicine [CTSA ULI TR000430]; National Institutes of Health (NIH) [AI134923, DK42086]; Italian Ministry of Health [PE-2011-02348447]; Biological Sciences Division at the University of Chicago; Institute for Translational Medicine/Clinical and Translational Award [NIH 5UL1TR002389-02]; University of Chicago Comprehensive Cancer Center Support Grant [NIH P30CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI134923, T32AI007090, R01AI106302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM109439] Funding Source: NIH RePORTER	Sunshine Charitable Foundation; University of Chicago Institute for Translational Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health(Ministry of Health, Italy); Biological Sciences Division at the University of Chicago(University of Chicago); Institute for Translational Medicine/Clinical and Translational Award; University of Chicago Comprehensive Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the children and families for their participation in this study. We are grateful to D. Wesemann, E. Forbes-Blom, G. Nunez, M. Rothenberg, M. Alegre and J. Colson for discussion. We thank S. Wang, M. Bauer and A. Kemter for assistance with some experiments, M. Jarsulic for technical assistance with computing infrastructure, K. Hernandez for discussion of the statistical results and C. Weber for histopathological evaluation of all intestinal sections. Statistical consultation was also provided by M. Giurcanu of the University of Chicago Biostatistics Laboratory. We are grateful to B. Theriault and her staff at the University of Chicago Gnotobiotic Research Animal Facility for superb animal care and experimental support. This work was supported by the Sunshine Charitable Foundation (C.R.N.), a pilot award from the University of Chicago Institute for Translational Medicine (CTSA ULI TR000430, C.R.N.), National Institutes of Health (NIH) grants AI134923 (C.R.N.), DK42086 (D.A.A.) and an Italian Ministry of Health grant PE-2011-02348447 (R.B.C.). The Center for Research Informatics is funded by the Biological Sciences Division at the University of Chicago with additional support provided by the Institute for Translational Medicine/Clinical and Translational Award (NIH 5UL1TR002389-02), and the University of Chicago Comprehensive Cancer Center Support Grant (NIH P30CA014599). Bioinformatics analysis was performed on Gardner High-Performance Computing clusters at the Center for Research Informatics at the University of Chicago. A provisional US patent application (62/755,945) was filed on 5 November 2018.	Al-Dwairi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046716; Andrew S., 2016, FASTQC QUALITY CONTR; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger CN, 2017, CELL METAB, V26, P738, DOI 10.1016/j.cmet.2017.09.003; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Iweala OI, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0616-7; Jiang LJ, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00092-17; Kim YG, 2017, SCIENCE, V356, P312, DOI 10.1126/science.aag2029; Kurakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126226; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Nik AM, 2013, BIOTECHNIQUES, V55, P42, DOI 10.2144/000114055; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ostroukhova M, 2012, AM J PHYSIOL-LUNG C, V302, pL300, DOI 10.1152/ajplung.00221.2011; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Pinheiro J, 2000, MIXED EFFECTS MODELS; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Plunkett CH, 2017, J IMMUNOL, V198, P581, DOI 10.4049/jimmunol.1601266; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; ROELEN BAJ, 1994, DEV BIOL, V166, P716, DOI 10.1006/dbio.1994.1350; Schwiertz A, 2002, SYST APPL MICROBIOL, V25, P46, DOI 10.1078/0723-2020-00096; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sicherer SH, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0194; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Wesemann DR, 2016, IMMUNITY, V44, P728, DOI 10.1016/j.immuni.2016.02.002; Yanez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang MF, 2001, IMMUNOL CELL BIOL, V79, P291, DOI 10.1046/j.1440-1711.2001.01013.x; Zhu Y, 2015, ONCOTARGET, V6, P21443, DOI 10.18632/oncotarget.4167	56	180	189	27	205	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					448	+		10.1038/s41591-018-0324-z	http://dx.doi.org/10.1038/s41591-018-0324-z			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30643289	Green Accepted			2022-12-27	WOS:000460643100023
J	Nave, KA; Ehrenreich, H				Nave, Klaus-Armin; Ehrenreich, Hannelore			Time to revisit oligodendrocytes in multiple sclerosis	NATURE MEDICINE			English	Editorial Material							HETEROGENEITY		[Nave, Klaus-Armin; Ehrenreich, Hannelore] Max Planck Inst Expt Med, Gottingen, Germany	Max Planck Society	Nave, KA (corresponding author), Max Planck Inst Expt Med, Gottingen, Germany.	nave@em.mpg.de	Ehrenreich, Hannelore/AAS-6079-2020					Crawford AH, 2016, AM J PATHOL, V186, P511, DOI 10.1016/j.ajpath.2015.11.005; Duncan ID, 2018, P NATL ACAD SCI USA, V115, pE11807, DOI 10.1073/pnas.1808064115; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Franklin RJM, 2017, NAT REV NEUROSCI, V18, P753, DOI 10.1038/nrn.2017.136; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; Jakle S, 2019, NATURE, DOI [10.1038/s41586-019-0903-2, DOI 10.1038/S41586-019-0903-2]; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Yeung MSY, 2019, NATURE, V566, P538, DOI 10.1038/s41586-018-0842-3; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011	12	7	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					364	366		10.1038/s41591-019-0388-4	http://dx.doi.org/10.1038/s41591-019-0388-4			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30804516				2022-12-27	WOS:000460643100013
J	Stower, H				Stower, Hannah			Sequencing for rapid response to Lassa fever	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					197	197		10.1038/s41591-019-0363-0	http://dx.doi.org/10.1038/s41591-019-0363-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728532	Bronze			2022-12-27	WOS:000457842100006
J	Formenti, SC; Rudqvist, NP; Golden, E; Cooper, B; Wennerberg, E; Lhuillier, C; Vanpouille-Box, C; Friedman, K; de Andrade, LF; Wucherpfennig, KW; Heguy, A; Imai, N; Gnjatic, S; Emerson, RO; Zhou, XK; Zhang, T; Chachoua, A; Demaria, S				Formenti, Silvia C.; Rudqvist, Nils-Petter; Golden, Encouse; Cooper, Benjamin; Wennerberg, Erik; Lhuillier, Claire; Vanpouille-Box, Claire; Friedman, Kent; de Andrade, Lucas Ferrari; Wucherpfennig, Kai W.; Heguy, Adriana; Imai, Naoko; Gnjatic, Sacha; Emerson, Ryan O.; Zhou, Xi Kathy; Zhang, Tuo; Chachoua, Abraham; Demaria, Sandra			Radiotherapy induces responses of lung cancer to CTLA-4 blockade	NATURE MEDICINE			English	Article							NEURAL-NETWORKS; SOLID TUMORS; CELL; RADIATION; SEQ; SUPPRESSION; REPERTOIRE; IPILIMUMAB; SURVIVAL; MUTATION	Focal radiation therapy enhances systemic responses to anti-CTLA-4 antibodies in preclinical studies and in some patients with melanoma(1-3), but its efficacy in inducing systemic responses (abscopal responses) against tumors unresponsive to CTLA-4 blockade remained uncertain. Radiation therapy promotes the activation of anti-tumor T cells, an effect dependent on type I interferon induction in the irradiated tumor(4-6). The latter is essential for achieving abscopal responses in murine cancers(6). The mechanisms underlying abscopal responses in patients treated with radiation therapy and CTLA-4 blockade remain unclear. Here we report that radiation therapy and CTLA-4 blockade induced systemic anti-tumor T cells in chemo-refractory metastatic non-small-cell lung cancer (NSCLC), where anti-CTLA-4 antibodies had failed to demonstrate significant efficacy alone or in combination with chemotherapy(7,8). Objective responses were observed in 18% of enrolled patients, and 31% had disease control. Increased serum interferon-beta after radiation and early dynamic changes of blood T cell clones were the strongest response predictors, confirming preclinical mechanistic data. Functional analysis in one responding patient showed the rapid in vivo expansion of CD8 T cells recognizing a neoantigen encoded in a gene upregulated by radiation, supporting the hypothesis that one explanation for the abscopal response is radiation-induced exposure of immunogenic mutations to the immune system.	[Formenti, Silvia C.; Rudqvist, Nils-Petter; Golden, Encouse; Wennerberg, Erik; Lhuillier, Claire; Vanpouille-Box, Claire; Demaria, Sandra] Weill Cornell Med, Dept Radiat Oncol, New York, NY 10065 USA; [Cooper, Benjamin] NYU, Sch Med, Dept Radiat Oncol, New York, NY USA; [Friedman, Kent] NYU, Dept Radiol, Sch Med, 560 1St Ave, New York, NY 10016 USA; [de Andrade, Lucas Ferrari; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [de Andrade, Lucas Ferrari; Wucherpfennig, Kai W.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA USA; [Heguy, Adriana] NYU, Sch Med, Dept Pathol, New York, NY USA; [Heguy, Adriana] NYU Langone Hlth, Genome Technol Ctr, Div Adv Res Technol, New York, NY USA; [Imai, Naoko; Gnjatic, Sacha] Icahn Sch Med Mt Sinai, Immunol, Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA; [Emerson, Ryan O.] Adapt Biotechnol, Seattle, WA USA; [Zhou, Xi Kathy] Weill Cornell Med, Div Biostat & Epidemiol, Dept Healthcare Policy & Res, New York, NY USA; [Zhang, Tuo] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Chachoua, Abraham] NYU, Sch Med, Dept Med, New York, NY USA; [Demaria, Sandra] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Golden, Encouse] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA	Cornell University; New York University; New York University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai; Cornell University; Cornell University; New York University; Cornell University; University of California System; University of California San Francisco	Formenti, SC; Demaria, S (corresponding author), Weill Cornell Med, Dept Radiat Oncol, New York, NY 10065 USA.; Demaria, S (corresponding author), Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA.	formenti@med.cornell.edu; szd3005@med.cornell.edu	Demaria, Sandra/AAA-5816-2020; Vanpouille-Box, Claire/AAO-5355-2021; Heguy, Adriana/GPP-3907-2022	Demaria, Sandra/0000-0003-4426-0499; Vanpouille-Box, Claire/0000-0001-7213-0670; Wennerberg, Erik/0000-0001-7689-5988; Formenti, Silvia/0000-0002-8227-8924; Rudqvist, Nils/0000-0002-9720-3124; Cooper, Benjamin/0000-0002-7044-7989; Gnjatic, Sacha/0000-0001-5643-9520	NCI [R01CA198533, R01CA201246]; Cancer Center support grant at the Laura and Isaac Perlmutter Cancer Center, NYULH [P30CA016087]; DOD [W81XWH-17-1-0029]; Cancer Center support grant [P30CA196521]; Friends for Life Neuroblastoma Fellowship; National Cancer Institute (NCI) [R01 CA173750]; NATIONAL CANCER INSTITUTE [P30CA196521, P30CA016087, R01CA173750, R01CA201246, R01CA198533] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center support grant at the Laura and Isaac Perlmutter Cancer Center, NYULH; DOD(United States Department of Defense); Cancer Center support grant; Friends for Life Neuroblastoma Fellowship; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We to acknowledge J. Goldberg for the initial design of the clinical trial, K. Pilones for assistance with DNA preparation, L. Chriboga for help with immunohistochemistry, D. Morrison for blood processing, and the NYULH Genome Technology Center (GTC) technical personnel for sequencing. We thank S. Chandraseckhar for data management, M. Fenton-Kerimian for patient care, and G. Inghirami for providing the PDX mice. We thank Bristol Meyer Squibb, New York, NY, USA, for providing ipilimumab for this research study. We are indebted to G. Koretzky for insightful discussion and review of the manuscript. The immunological studies were funded by NCI grants no. R01CA198533 and no. R01CA201246 (to S.D.). The NYU Experimental Pathology Immunohistochemistry Core Laboratory and the GTC are partially supported by the Cancer Center support grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center, NYULH. E.W. is supported by a DOD W81XWH-17-1-0029 post-doctoral fellowship. S. G. acknowledges the Human Immune Monitoring Center at Mount Sinai and Cancer Center support grant P30CA196521. L.F.A. was funded by a Friends for Life Neuroblastoma Fellowship and K.W.W. was supported by National Cancer Institute (NCI) grant no. R01 CA173750.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Andrade LF, 2018, SCIENCE, V359, P1537, DOI 10.1126/science.aao0505; Demaria S, 2016, TRENDS CANCER, V2, P286, DOI 10.1016/j.trecan.2016.05.002; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; DeWitt WS, 2015, J VIROL, V89, P4517, DOI 10.1128/JVI.03474-14; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Formenti SC, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1274479; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Gainor JF, 2016, CLIN CANCER RES, V22, P4585, DOI 10.1158/1078-0432.CCR-15-3101; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Golden EB, 2013, CANCER IMMUNOL RES, V1, P365, DOI 10.1158/2326-6066.CIR-13-0115; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koguchi Y, 2015, CANCER RES, V75, P5084, DOI 10.1158/0008-5472.CAN-15-2303; Konno H, 2018, ONCOGENE, V37, P2037, DOI 10.1038/s41388-017-0120-0; Kuo P, 2014, CLIN CANCER RES, V20, P5558, DOI 10.1158/1078-0432.CCR-14-1138; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rudqvist NP, 2018, CANCER IMMUNOL RES, V6, P139, DOI 10.1158/2326-6066.CIR-17-0134; Ruocco MG, 2012, J CLIN INVEST, V122, P3718, DOI 10.1172/JCI61931; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2; Sidhom JW, 2018, CANCER IMMUNOL RES, V6, P151, DOI 10.1158/2326-6066.CIR-17-0114; Sim GC, 2014, J CLIN INVEST, V124, P99, DOI 10.1172/JCI46266; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Song KH, 2016, EUR J CELL BIOL, V95, P219, DOI 10.1016/j.ejcb.2016.04.002; Spigel DR, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9017; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Tang DN, 2013, CANCER IMMUNOL RES, V1, P229, DOI 10.1158/2326-6066.CIR-13-0020; Tang F, 2017, STAT ANAL DATA MIN, V10, P363, DOI 10.1002/sam.11348; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Wang WS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-146; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wu D, 2014, CLIN CANCER RES, V20, P4540, DOI 10.1158/1078-0432.CCR-13-3231; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zatloukal P, 2009, J CLIN ONCOL S, V27	56	427	439	3	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1845	+		10.1038/s41591-018-0232-2	http://dx.doi.org/10.1038/s41591-018-0232-2			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30397353	Green Accepted			2022-12-27	WOS:000452392200013
J	Guo, GL; Xie, W				Guo, Grace L.; Xie, Wen			Metformin action through the microbiome and bile acids	NATURE MEDICINE			English	Editorial Material							FARNESOID X RECEPTOR; URSODEOXYCHOLIC ACID		[Guo, Grace L.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Guo, Grace L.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Guo, Grace L.] VA New Jersey Hlth Care Syst, Vet Adm Med Ctr, E Orange, NJ 07018 USA; [Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Guo, GL (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA.; Guo, GL (corresponding author), Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.; Guo, GL (corresponding author), VA New Jersey Hlth Care Syst, Vet Adm Med Ctr, E Orange, NJ 07018 USA.	guo@eohsi.rutgers.edu	Xie, Wen/M-1768-2016	guo, grace/0000-0002-2666-0635				Chiang JYL, 2017, DIGEST DIS, V35, P241, DOI 10.1159/000450981; Chow MD, 2017, MOL ASPECTS MED, V56, P34, DOI 10.1016/j.mam.2017.04.004; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Mueller M, 2015, J HEPATOL, V62, P1398, DOI 10.1016/j.jhep.2014.12.034; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Sterne, 1957, MAROC MED, V36, P1295; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4	11	8	8	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1789	1790		10.1038/s41591-018-0273-6	http://dx.doi.org/10.1038/s41591-018-0273-6			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30523325				2022-12-27	WOS:000452392200003
J	Pollyea, DA; Stevens, BM; Jones, CL; Winters, A; Pei, SS; Minhajuddin, M; D'Alessandro, A; Culp-Hill, R; Riemondy, KA; Gillen, AE; Hesselberth, JR; Abbott, D; Schatz, D; Gutman, JA; Purev, E; Smith, C; Jordan, CT				Pollyea, Daniel A.; Stevens, Brett M.; Jones, Courtney L.; Winters, Amanda; Pei, Shanshan; Minhajuddin, Mohammad; D'Alessandro, Angelo; Culp-Hill, Rachel; Riemondy, Kent A.; Gillen, Austin E.; Hesselberth, Jay R.; Abbott, Diana; Schatz, Derek; Gutman, Jonathan A.; Purev, Enkhtsetseg; Smith, Clayton; Jordan, Craig T.			Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia	NATURE MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; BCL-2 FAMILY; THERAPEUTIC STRATEGY; INHIBITION; MECHANISMS; ABT-199; DIAGNOSIS; ABT-737; RISK; AML	Acute myeloid leukemia (AML) is the most common acute leukemia in adults. Leukemia stem cells (LSCs) drive the initiation and perpetuation of AML, are quantifiably associated with worse clinical outcomes, and often persist after conventional chemotherapy resulting in relapse(1-5). In this report, we show that treatment of older patients with AML with the B cell lymphoma 2 (BCL-2) inhibitor venetoclax in combination with azacitidine results in deep and durable remissions and is superior to conventional treatments. We hypothesized that these promising clinical results were due to targeting LSCs. Analysis of LSCs from patients undergoing treatment with venetoclax + azacitidine showed disruption of the tricarboxylic acid (TCA) cycle manifested by decreased alpha-ketoglutarate and increased succinate levels, suggesting inhibition of electron transport chain complex II. In vitro modeling confirmed inhibition of complex II via reduced glutathionylation of succinate dehydrogenase. These metabolic perturbations suppress oxidative phosphorylation (OXPHOS), which efficiently and selectively targets LSCs. Our findings show for the first time that a therapeutic intervention can eradicate LSCs in patients with AML by disrupting the metabolic machinery driving energy metabolism, resulting in promising clinical activity in a patient population with historically poor outcomes.	[Pollyea, Daniel A.; Stevens, Brett M.; Jones, Courtney L.; Pei, Shanshan; Minhajuddin, Mohammad; Schatz, Derek; Gutman, Jonathan A.; Purev, Enkhtsetseg; Smith, Clayton; Jordan, Craig T.] Univ Colorado, Sch Med, Div Hematol, Aurora, CO 80045 USA; [Winters, Amanda] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [D'Alessandro, Angelo; Culp-Hill, Rachel; Hesselberth, Jay R.] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA; [Riemondy, Kent A.; Gillen, Austin E.; Hesselberth, Jay R.] Univ Colorado, RNA Biosci Initiat, Sch Med, Aurora, CO USA; [Abbott, Diana] Univ Colorado, Dept Biostat & Informat, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jordan, CT (corresponding author), Univ Colorado, Sch Med, Div Hematol, Aurora, CO 80045 USA.	Craig.jordan@ucdenver.edu	Culp-Hill, Rachel/K-8315-2019; Stevens, Brett/AAL-1800-2021; Culp-Hill, Rachel/AAH-3234-2021; PEI, SHANSHAN/D-8200-2016; Minhajuddin, Mohammad/AAC-9227-2022; D'Alessandro, Angelo/AAA-4695-2019; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; D'Alessandro, Angelo/0000-0002-2258-6490; jordan, craig/0000-0003-0869-3465; Riemondy, Kent/0000-0003-0750-1273; Pollyea, Daniel/0000-0001-6519-4860; Winters, Amanda/0000-0001-7916-7505; Gillen, Austin/0000-0003-2928-6308	University of Colorado Department of Medicine Outstanding Early Career Scholar Program; University of Colorado RNA Bioscience Initiative; American Cancer Society [25A5072]; Colorado Clinical and Translational Sciences Institute [AEF CCTSI YR9 CO 2301425]; Webb-Waring Early Career award 2017 - Boettcher Foundation; Nancy Carroll Allen Chair in Hematology Research; NIH [R01CA200707]; NATIONAL CANCER INSTITUTE [R01CA200707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119550] Funding Source: NIH RePORTER	University of Colorado Department of Medicine Outstanding Early Career Scholar Program; University of Colorado RNA Bioscience Initiative; American Cancer Society(American Cancer Society); Colorado Clinical and Translational Sciences Institute; Webb-Waring Early Career award 2017 - Boettcher Foundation; Nancy Carroll Allen Chair in Hematology Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	In memory of Richard Berger, a warrior in all aspects of life, who bravely confronted every obstacle and brought courage and inspiration to us, his family and all who were privileged enough to know him. Grant support: D.A.P is supported by the University of Colorado Department of Medicine Outstanding Early Career Scholar Program. B.M.S. and C.T.J are supported by a pilot grant provided by the University of Colorado RNA Bioscience Initiative. C.L.J. was supported by the American Cancer Society (25A5072) and the Colorado Clinical and Translational Sciences Institute (AEF CCTSI YR9 CO 2301425). A.D. is supported by the Webb-Waring Early Career award 2017 sponsored by the Boettcher Foundation. C.T.J. is generously supported by the Nancy Carroll Allen Chair in Hematology Research and NIH (grant R01CA200707). We thank J. DeGregori and E. Pietras for their comments on our manuscript.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bogenberger JM, 2014, LEUKEMIA, V28, P1657, DOI 10.1038/leu.2014.44; Bogenberger JM, 2015, LEUKEMIA LYMPHOMA, V56, P226, DOI 10.3109/10428194.2014.910657; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chan SM, 2015, NAT MED, V21, P178, DOI 10.1038/nm.3788; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; DiNardo CL, 2018, LANCET ONCOL, V19, P216, DOI 10.1016/S1470-2045(18)30010-X; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Ho TC, 2016, BLOOD, V128, P1671, DOI 10.1182/blood-2016-02-695312; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Konopleva M, 2016, CANCER DISCOV, V6, P1106, DOI 10.1158/2159-8290.CD-16-0313; Kurtz SE, 2017, P NATL ACAD SCI USA, V114, pE7554, DOI 10.1073/pnas.1703094114; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee KM, 2017, CELL METAB, V26, P633, DOI 10.1016/j.cmet.2017.09.009; Nemkov T, 2015, AMINO ACIDS, V47, P2345, DOI 10.1007/s00726-015-2019-9; Ng SWK, 2016, NATURE, V540, P433, DOI 10.1038/nature20598; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Pei S, 2018, CELL STEM CELL, V23, P86, DOI 10.1016/j.stem.2018.05.021; Pei SS, 2016, J BIOL CHEM, V291, P21984, DOI 10.1074/jbc.M116.750653; Pollyea DA, 2017, BLOOD, V129, P1627, DOI 10.1182/blood-2016-10-696039; Pollyea DA, 2014, HAEMATOLOGICA, V99, P1277, DOI 10.3324/haematol.2013.085209; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001	40	335	342	5	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1859	+		10.1038/s41591-018-0233-1	http://dx.doi.org/10.1038/s41591-018-0233-1			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30420752	Green Accepted			2022-12-27	WOS:000452392200015
J	Scala, S; Basso-Ricci, L; Dionisio, F; Pellin, D; Giannelli, S; Salerio, FA; Leonardelli, L; Cicalese, MP; Ferrua, F; Aiuti, A; Biasco, L				Scala, Serena; Basso-Ricci, Luca; Dionisio, Francesca; Pellin, Danilo; Giannelli, Stefania; Salerio, Federica Andrea; Leonardelli, Lorena; Cicalese, Maria Pia; Ferrua, Francesca; Aiuti, Alessandro; Biasco, Luca			Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans	NATURE MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; GENE-THERAPY; BAYESIAN NETWORKS; CLONAL DYNAMICS; IN-VIVO; TRACKING; OUTCOMES; ORIGIN; TRIAL	Hematopoietic stem and progenitor cells (HSPC) are endowed with the role of generating and maintaining lifelong the extremely diverse pool of blood cells(1). Clinically, transplantation of human HSPC from an allogeneic healthy donor or infusion of autologous gene-corrected HSPC can effectively replenish defective blood cell production caused by congenital or acquired disorders(2-9). However, due to methodological and ethical constraints that have limited the study of human HSPC primarily to in vitro assays(10) or xenotransplantation models(11,12), the in vivo activity of HSPC has to date remained relatively unexplored in humans(13-16). Here we report a comprehensive study of the frequencies, dynamics and output of seven HSPC subtypes in humans that was performed by tracking 148,093 individual clones in six patients treated with lentiviral gene therapy using autologous HSPC transplantation and followed for up to 5 years. We discovered that primitive multipotent progenitor and hematopoietic stem cell (HSC) populations have distinct roles during the initial reconstitution after transplant, compared with subsequent steady-state phases. Furthermore, we showed that a fraction of in vitro-activated HSC are resilient and undergo a defined delayed activation period upon transplant. Finally, our data support the concept that early lymphoid-biased progenitors might be capable of long-term survival, such that they can be maintained independently of their continuous production from HSC. Overall, this study provides comprehensive data on HSPC dynamics after autologous transplantation and gene therapy in humans.	[Scala, Serena; Basso-Ricci, Luca; Dionisio, Francesca; Giannelli, Stefania; Salerio, Federica Andrea; Leonardelli, Lorena; Cicalese, Maria Pia; Ferrua, Francesca; Aiuti, Alessandro; Biasco, Luca] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR TIGET, Milan, Italy; [Pellin, Danilo; Biasco, Luca] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA 02115 USA; [Cicalese, Maria Pia; Ferrua, Francesca; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy; [Ferrua, Francesca; Aiuti, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Aiuti, A; Biasco, L (corresponding author), IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR TIGET, Milan, Italy.; Biasco, L (corresponding author), Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA 02115 USA.; Aiuti, A (corresponding author), IRCCS San Raffaele Sci Inst, Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy.; Aiuti, A (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	aiuti.alessandro@hsr.it; luca.biasco@childrens.harvard.edu	Scala, Serena/Y-6756-2019; Giannelli, Stefania/AAR-2316-2020; Ferrua, Francesca/K-4340-2016; Basso-Ricci, Luca/AAN-6176-2020	Scala, Serena/0000-0002-8579-3809; Ferrua, Francesca/0000-0002-5695-4490; Basso-Ricci, Luca/0000-0002-5907-005X	Fondazione Telethon (TIGET Core Grant B2); Italian Ministero della Salute (Programma di Rete) [NET-2011-02350069]; European Commission [ERARE-3-JTC 2015 EUROCID]	Fondazione Telethon (TIGET Core Grant B2)(Fondazione Telethon); Italian Ministero della Salute (Programma di Rete); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Fondazione Telethon (TIGET Core Grant B2, A.A.), the Italian Ministero della Salute (Programma di Rete, NET-2011-02350069, A.A.) and the European Commission (ERARE-3-JTC 2015 EUROCID, A.A.). The work of D.P. and L.B. on bioinformatics and statistical analyses of the results and on manuscript preparation phases was performed utilizing the resources of the Gene Therapy Program of the Dana Farber/Boston Children's Cancer and Blood Disorders Center. We thank F. Ciceri, M. G. Roncarolo and all medical and nursing staff of the Pediatric Immunohematology and Bone Marrow Transplantation Unit of the San Raffaele Scientific Institute and the San Raffaele Stem Cell Programme; S. Zancan, M. Casiraghi, S. Darin, M. Facchini, G. Tomaselli and all TIGET Clinical Trial Office personnel for clinical trial management and support; the GlaxoSmithKline research and development team for revising the manuscript; M. Gabaldo for support with project management; and P. Massariello, G. Vallanti, M. Manfredini and other MolMed staff for patient cell manipulation. We thank A. Ditadi for critically reviewing the manuscript. We thank C. Villa, E. Canonico and M. Romano of the Flow Cytometry Resource, Advanced Cytometry Technical Applications Laboratory (FRACTAL) at Ospedale San Raffaele for cell sorting and technical help with instrumentation. We are indebted to the patients and their families for their commitment.	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2016, NAT BIOTECHNOL, V34, P721, DOI 10.1038/nbt.3629; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Arredondo-Vega FX, 2002, BLOOD, V99, P1005, DOI 10.1182/blood.V99.3.1005; Basso-Ricci L, 2017, CYTOM PART A, V91A, P952, DOI 10.1002/cyto.a.23148; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cavazzana-Calvo M, 2011, BLOOD, V117, P4420, DOI 10.1182/blood-2010-09-255679; Cicalese MP, 2015, HUM GENE THER, V26, P210, DOI 10.1089/hum.2015.047; De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Jabbour E, 2015, CANCER-AM CANCER SOC, V121, P2517, DOI 10.1002/cncr.29383; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kim S, 2014, CELL STEM CELL, V14, P473, DOI 10.1016/j.stem.2013.12.012; Konno A., 2004, BLOOD, V141, P1491; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Pittavino M, 2017, ACTA TROP, V173, P191, DOI 10.1016/j.actatropica.2017.04.034; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Simons L, 2018, J ALLERGY CLIN IMMUN, V141, P1491, DOI 10.1016/j.jaci.2017.10.034; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; Wu CF, 2014, CELL STEM CELL, V14, P486, DOI 10.1016/j.stem.2014.01.020; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045; Zakrzewski JL, 2008, NAT BIOTECHNOL, V26, P453, DOI 10.1038/nbt1395; Zonari E, 2017, STEM CELL REP, V8, P977, DOI 10.1016/j.stemcr.2017.02.010	32	69	71	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1683	+		10.1038/s41591-018-0195-3	http://dx.doi.org/10.1038/s41591-018-0195-3			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30275570				2022-12-27	WOS:000449404200019
J	Ackerman, ME; Das, J; Pittala, S; Broge, T; Linde, C; Suscovich, TJ; Brown, EP; Bradley, T; Natarajan, H; Lin, S; Sassic, JK; O'Keefe, S; Mehta, N; Goodman, D; Sips, M; Weiner, JA; Tomaras, GD; Haynes, BF; Lauffenburger, DA; Bailey-Kellogg, C; Roederer, M; Alter, G				Ackerman, Margaret E.; Das, Jishnu; Pittala, Srivamshi; Broge, Thomas; Linde, Caitlyn; Suscovich, Todd J.; Brown, Eric P.; Bradley, Todd; Natarajan, Harini; Lin, Shu; Sassic, Jessica K.; O'Keefe, Sean; Mehta, Nickita; Goodman, Derrick; Sips, Magdalena; Weiner, Joshua A.; Tomaras, Georgia D.; Haynes, Barton F.; Lauffenburger, Douglas A.; Bailey-Kellogg, Chris; Roederer, Mario; Alter, Galit			Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV	NATURE MEDICINE			English	Article							EFFECTOR FUNCTION; HUMORAL IMMUNITY; HIGH-THROUGHPUT; FC-RECEPTOR; IGG FC; BINDING; MODELS; EFFICACY; RECRUITMENT; CHALLENGES	Antibodies are the primary correlate of protection for most licensed vaccines; however, their mechanisms of protection may vary, ranging from physical blockade to clearance via the recruitment of innate immunity. Here, we uncover striking functional diversity in vaccine-induced antibodies that is driven by immunization site and is associated with reduced risk of SIV infection in nonhuman primates. While equivalent levels of protection were observed following intramuscular (IM) and aerosol (AE) immunization with an otherwise identical DNA prime-Ad5 boost regimen, reduced risk of infection was associated with IgG-driven antibody-dependent monocyte-mediated phagocytosis in the IM vaccinees, but with vaccine-elicited IgA-driven neutrophil-mediated phagocytosis in AE-immunized animals. Thus, although route-independent correlates indicate a critical role for phagocytic Fc-effector activity in protection from SIV, the site of immunization may drive this Fc activity via distinct innate effector cells and antibody isotypes. Moreover, the same correlates predicted protection from SHIV infection in a second nonhuman primate vaccine trial using a disparate IM canarypox prime-protein boost strategy, analogous to that used in the first moderately protective human HIV vaccine trial. These data identify orthogonal functional humoral mechanisms, initiated by distinct vaccination routes and immunization strategies, pointing to multiple, potentially complementary correlates of immunity that may support the rational design of a protective vaccine against HIV.	[Ackerman, Margaret E.; Brown, Eric P.; Natarajan, Harini; Lin, Shu; Weiner, Joshua A.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Das, Jishnu; Broge, Thomas; Linde, Caitlyn; Suscovich, Todd J.; Sassic, Jessica K.; O'Keefe, Sean; Mehta, Nickita; Sips, Magdalena; Alter, Galit] Harvard & MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Pittala, Srivamshi; Bailey-Kellogg, Chris] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Bradley, Todd; Goodman, Derrick; Tomaras, Georgia D.; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Lauffenburger, Douglas A.] MIT, Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Roederer, Mario] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Dartmouth College; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Dartmouth College; Duke University; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ackerman, ME (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.; Alter, G (corresponding author), Harvard & MIT, Ragon Inst MGH, Cambridge, MA 02139 USA.	margaret.e.ackerman@dartmouth.edu; galter@partners.org	Das, Jishnu/AAK-4950-2020; Bradley, Todd/AAB-3550-2020; Roederer, Mario/G-1887-2011	Das, Jishnu/0000-0002-5747-064X; Weiner, Joshua/0000-0003-1054-0628; Ackerman, Margaret/0000-0002-4253-3476; Sassic, Jessica/0000-0003-4562-3212; Sips, Magdalena/0000-0002-6480-9672	Bill and Melinda Gates Foundation [OPP1032817, OPP1114729]; National Institutes of Health [R37 AI080289, R01 AI102291, P01 AI120756, R01 AI131975, R01 AI102660]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI120756, R01AI131975, R37AI080289, ZIAAI005021] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank W. E. Johnson (Boston University) for his help with statistical review. These studies were supported by the Bill and Melinda Gates Foundation (OPP1032817 and OPP1114729) and the National Institutes of Health (R37 AI080289, R01 AI102291, P01 AI120756, R01 AI131975, and R01 AI102660).	Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; [Anonymous], 2013, R LANG ENV STAT COMP; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Boesch AW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00589; Boesch AW, 2014, MABS-AUSTIN, V6, P915, DOI 10.4161/mabs.28808; Bolton DL, 2017, VACCINE, V35, P639, DOI 10.1016/j.vaccine.2016.12.008; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bradley T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15711; Brown EP, 2015, J IMMUNOL METHODS, V425, P27, DOI 10.1016/j.jim.2015.06.005; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chan YN, 2016, J IMMUNOL, V197, P2936, DOI 10.4049/jimmunol.1502252; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COX DR, 1972, J R STAT SOC B, V34, P187; Drasgow F., 2006, ENCY STAT SCI; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hastie T., 2009, UNSUPERVISED LEARNIN; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Jacobsen FW, 2011, J IMMUNOL, V186, P341, DOI 10.4049/jimmunol.1001685; Johansson EL, 2001, INFECT IMMUN, V69, P7481, DOI 10.1128/IAI.69.12.7481-7486.2001; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kozlowski PA, 1997, INFECT IMMUN, V65, P1387, DOI 10.1128/IAI.65.4.1387-1394.1997; Lau KS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001338; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Lopez-Paz D., 2013, 26 INT C NEUR INF PR, V1; Mahan AE, 2015, J IMMUNOL METHODS, V417, P34, DOI 10.1016/j.jim.2014.12.004; McAndrew EG, 2011, JOVE-J VIS EXP, DOI 10.3791/3588; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sholukh AM, 2015, VACCINE, V33, P2086, DOI 10.1016/j.vaccine.2015.02.020; Sips M, 2016, MUCOSAL IMMUNOL, V9, P1584, DOI 10.1038/mi.2016.12; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Therneau T.M., 2000, MODELING SURVIVAL DA; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Trist HM, 2014, J IMMUNOL, V192, P792, DOI 10.4049/jimmunol.1301554; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; Watkins JD, 2013, AIDS, V27, pF13, DOI 10.1097/QAD.0b013e328360eac6; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730	59	75	76	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1590	+		10.1038/s41591-018-0161-0	http://dx.doi.org/10.1038/s41591-018-0161-0			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30177821	Green Accepted, Green Submitted			2022-12-27	WOS:000446577900022
J	Auslander, N; Zhang, G; Lee, JS; Frederick, DT; Miao, BC; Moll, T; Tian, T; Wei, Z; Madan, S; Sullivan, RJ; Boland, G; Flaherty, K; Herlyn, M; Ruppin, E				Auslander, Noam; Zhang, Gao; Lee, Joo Sang; Frederick, Dennie T.; Miao, Benchun; Moll, Tabea; Tian, Tian; Wei, Zhi; Madan, Sanna; Sullivan, Ryan J.; Boland, Genevieve; Flaherty, Keith; Herlyn, Meenhard; Ruppin, Eytan			Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma	NATURE MEDICINE			English	Article							SPONTANEOUS REGRESSION; PD-1 BLOCKADE; MECHANISMS; NEUROBLASTOMA; RESISTANCE; PATHWAYS; CTLA-4	Immune checkpoint blockade (ICB) therapy provides remarkable clinical gains and has been very successful in treatment of melanoma. However, only a subset of patients with advanced tumors currently benefit from ICB therapies, which at times incur considerable side effects and costs. Constructing predictors of patient response has remained a serious challenge because of the complexity of the immune response and the shortage of large cohorts of ICB-treated patients that include both 'omics' and response data. Here we build immuno-predictive score (IMPRES), a predictor of ICB response in melanoma which encompasses 15 pairwise transcriptomics relations between immune checkpoint genes. It is based on two key conjectures: (i) immune mechanisms underlying spontaneous regression in neuroblastoma can predict melanoma response to ICB, and (ii) key immune interactions can be captured via specific pairwise relations of the expression of immune checkpoint genes. IMPRES is validated on nine published datasets(1-6) and on a newly generated dataset with 31 patients treated with anti-PD-1 and 10 with anti-CTLA-4, spanning 297 samples in total. It achieves an overall accuracy of AUC = 0.83, outperforming existing predictors and capturing almost all true responders while misclassifying less than half of the nonresponders. Future studies are warranted to determine the value of the approach presented here in other cancer types.	[Auslander, Noam; Lee, Joo Sang; Madan, Sanna; Ruppin, Eytan] Univ Maryland, Dept Comp Sci, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Auslander, Noam; Lee, Joo Sang; Madan, Sanna; Ruppin, Eytan] NCI, CDSL, NIH, Rockville, MD 20850 USA; [Zhang, Gao; Herlyn, Meenhard] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Zhang, Gao; Herlyn, Meenhard] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Frederick, Dennie T.; Miao, Benchun; Sullivan, Ryan J.; Flaherty, Keith] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Moll, Tabea; Boland, Genevieve] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Tian, Tian; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); The Wistar Institute; The Wistar Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; New Jersey Institute of Technology	Ruppin, E (corresponding author), Univ Maryland, Dept Comp Sci, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.; Ruppin, E (corresponding author), NCI, CDSL, NIH, Rockville, MD 20850 USA.	eyruppin@gmail.com	, AndyWei/H-4415-2012; Tian, Tian/L-5058-2019; Boland, Genevieve/AAP-2767-2021	Tian, Tian/0000-0001-6147-1082; Wei, Zhi/0000-0001-6059-4267	Israeli Science Foundation (ISF) [41/11]; intramural program at the CCR, NCI; NCI-UMD partnership for integrative cancer research; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH [5P01CA114046, 5P50CA174523, 1U54CA224070]; Peer Reviewed Cancer Research Program Grant [WX1XWH-16-1-0119, CA150619];  [R33-CA225291-01]; NATIONAL CANCER INSTITUTE [U54CA224070, P30CA010815, R33CA225291, P50CA174523, P01CA114046, ZIABC011802] Funding Source: NIH RePORTER	Israeli Science Foundation (ISF)(Israel Science Foundation); intramural program at the CCR, NCI; NCI-UMD partnership for integrative cancer research; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peer Reviewed Cancer Research Program Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank M. Leiserson, S. Patkar, E. Persi, W. Robinson, Z. Ronai, Y. Saadon, Y. Samuels and J. Wherry for their helpful comments. N.A., J.S.L. and E.R. were partially supported by a grant from the Israeli Science Foundation (ISF, grant no. 41/11) and R33-CA225291-01. E.R. is supported by the intramural program at the CCR, NCI. N.A. is supported by the NCI-UMD partnership for integrative cancer research. M.H. and K.F. are supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. M.H. is supported by NIH grants 5P01CA114046, 5P50CA174523 and 1U54CA224070, and the Peer Reviewed Cancer Research Program Grant WX1XWH-16-1-0119 [CA150619].	Ahrends T, 2016, CANCER RES, V76, P2921, DOI 10.1158/0008-5472.CAN-15-3130; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Bramhall RJ, 2014, EJSO-EUR J SURG ONC, V40, P34, DOI 10.1016/j.ejso.2013.09.026; Brodeur GM, 2014, NAT REV CLIN ONCOL, V11, P704, DOI 10.1038/nrclinonc.2014.168; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; Diede SJ, 2014, NAT REV CANCER, V14, P71, DOI 10.1038/nrc3656; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jenkins RW, 2018, CANCER DISCOV, V8, P196, DOI 10.1158/2159-8290.CD-17-0833; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Marraco SAF, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00310; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Prat A, 2017, CANCER RES, V77, P3540, DOI 10.1158/0008-5472.CAN-16-3556; Ramsay AG, 2013, BRIT J HAEMATOL, V162, P313, DOI 10.1111/bjh.12380; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Su ZQ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0523-y; Tinker AV, 2006, CANCER CELL, V9, P333, DOI 10.1016/j.ccr.2006.05.001; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang QX, 2016, IMMUNITY, V44, P1034, DOI 10.1016/j.immuni.2016.04.017; Zippelius A, 2015, CANCER IMMUNOL RES, V3, P236, DOI 10.1158/2326-6066.CIR-14-0226	30	264	269	7	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1545	+		10.1038/s41591-018-0157-9	http://dx.doi.org/10.1038/s41591-018-0157-9			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30127394	Green Accepted			2022-12-27	WOS:000446577900017
J	He, Y; Wu, W; Zheng, HM; Li, P; McDonald, D; Sheng, HF; Chen, MX; Chen, ZH; Ji, GY; Zheng, ZDX; Mujagond, P; Chen, XJ; Rong, ZH; Chen, P; Lyu, LY; Wang, X; Wu, CB; Yu, N; Xu, YJ; Yin, J; Raes, J; Knight, R; Ma, WJ; Zhou, HW				He, Yan; Wu, Wei; Zheng, Hui-Min; Li, Pan; McDonald, Daniel; Sheng, Hua-Fang; Chen, Mu-Xuan; Chen, Zi-Hui; Ji, Gui-Yuan; Zheng, Zhong-Dai-Xi; Mujagond, Prabhakar; Chen, Xiao-Jiao; Rong, Zu-Hua; Chen, Peng; Lyu, Li-Yi; Wang, Xian; Wu, Chong-Bin; Yu, Nan; Xu, Yan-Jun; Yin, Jia; Raes, Jeroen; Knight, Rob; Ma, Wen-Jun; Zhou, Hong-Wei			Regional variation limits applications of healthy gut microbiome reference ranges and disease models	NATURE MEDICINE			English	Article							OBESITY; METAGENOMICS	Dysbiosis, departure of the gut microbiome from a healthy state, has been suggested to be a powerful biomarker of disease incidence and progression(1-3). Diagnostic applications have been proposed for inflammatory bowel disease diagnosis and prognosis(4), colorectal cancer prescreening(5) and therapeutic choices in melanoma(6). Noninvasive sampling could facilitate large-scale public health applications, including early diagnosis and risk assessment in metabolic(7) and cardiovascular diseases(8). To understand the generalizability of microbiota-based diagnostic models of metabolic disease, we characterized the gut microbiota of 7,009 individuals from 14 districts within 1 province in China. Among phenotypes, host location showed the strongest associations with microbiota variations. Microbiota-based metabolic disease models developed in one location failed when used elsewhere, suggesting that such models cannot be extrapolated. Interpolated models performed much better, especially in diseases with obvious microbiota-related characteristics. Interpolation efficiency decreased as geographic scale increased, indicating a need to build localized baseline and disease models to predict metabolic risks.	[He, Yan; Zheng, Hui-Min; Li, Pan; Sheng, Hua-Fang; Chen, Mu-Xuan; Chen, Xiao-Jiao; Rong, Zu-Hua; Yu, Nan; Zhou, Hong-Wei] Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Guangdong, Peoples R China; [Wu, Wei; Zheng, Hui-Min; Li, Pan; Zheng, Zhong-Dai-Xi; Rong, Zu-Hua; Zhou, Hong-Wei] Southern Med Univ, Sch Publ Hlth, Dept Environm Hlth, Guangzhou, Guangdong, Peoples R China; [Wu, Wei; Chen, Zi-Hui; Ji, Gui-Yuan; Ma, Wen-Jun] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [McDonald, Daniel; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Mujagond, Prabhakar] NCR Biotech Sci Cluster, UNESCO Reg Ctr Biotechnol, Gut Infect & Inflammat Biol Lab, Faridabad, India; [Chen, Peng] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Lyu, Li-Yi; Wang, Xian; Wu, Chong-Bin] Shenzhen Fun Poo Biotech Co Ltd, Shenzhen, Peoples R China; [Xu, Yan-Jun] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Yin, Jia] Southern Med Univ, NanFang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Raes, Jeroen] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Raes, Jeroen] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Microbiol Unit, Brussels, Belgium; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, Jacobs Sch Engn, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [Zhou, Hong-Wei] Southern Med Univ, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; University of California System; University of California San Diego; Southern Medical University - China; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Southern Medical University - China; KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of California System; University of California San Diego; University of California System; University of California San Diego; Southern Medical University - China	Zhou, HW (corresponding author), Southern Med Univ, Zhujiang Hosp, Div Lab Med, Guangzhou, Guangdong, Peoples R China.; Zhou, HW (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Environm Hlth, Guangzhou, Guangdong, Peoples R China.; Ma, WJ (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.; Zhou, HW (corresponding author), Southern Med Univ, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	mawj@gdiph.org.cn; biodegradation@gmail.com	马, 文军/GQQ-7852-2022; Zhou, Hongwei/B-4193-2008; raes, jeroen/D-7835-2018	raes, jeroen/0000-0002-1337-041X; He, Yan/0000-0002-6611-2959; Li, Pan/0000-0003-1645-6670; Chen, Xiao-Jiao/0000-0003-3954-9570; Zheng, Huimin/0000-0003-3489-0964; Knight, Rob/0000-0002-0975-9019	National Projects of Major Infectious Disease Control and Prevention [2017ZX10103011]; National Natural Science Foundation of China [NSFC31570497, 31322003, 81671171]; China Postdoctoral Science Foundation [C1090132]; Science and Technology Planning Project of Guangdong Province, China [2015A030401055]	National Projects of Major Infectious Disease Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Planning Project of Guangdong Province, China	We acknowledge the contributions of the 308 local CDC investigators and registered nurses for their help with collection point maintenance and metadata and stool sample collection. We thank all volunteers who participated in this project. This study was supported by the National Projects of Major Infectious Disease Control and Prevention (2017ZX10103011 (H.W.Z.)), National Natural Science Foundation of China (NSFC31570497 (H.W.Z.), 31322003 (H.W.Z.), and 81671171 (J.Y.)), China Postdoctoral Science Foundation (C1090132 (Y.H.)) and the Science and Technology Planning Project of Guangdong Province, China (2015A030401055 (W.W.)).	Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Bouter KE, 2017, GASTROENTEROLOGY, V152, P1671, DOI 10.1053/j.gastro.2016.12.048; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dubinsky M, 2015, GASTROENTEROLOGY, V149, P1265, DOI 10.1053/j.gastro.2015.08.006; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Graham C, 2015, NUTR REV, V73, P376, DOI 10.1093/nutrit/nuv004; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; He Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0081-x; Konstantinov SR, 2013, NAT REV GASTRO HEPAT, V10, P741, DOI 10.1038/nrgastro.2013.178; Liao M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17851-8; Lim MY, 2017, GUT, V66, P1031, DOI 10.1136/gutjnl-2015-311326; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; McDonald D, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0117-2; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Stagaman K, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00122-17; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wieland A, 2015, ALIMENT PHARM THER, V42, P1051, DOI 10.1111/apt.13376; Winglee K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0338-7; Xie HL, 2016, CELL SYST, V3, P572, DOI 10.1016/j.cels.2016.10.004; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou YL, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00188-17	37	378	395	11	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1532	+		10.1038/s41591-018-0164-x	http://dx.doi.org/10.1038/s41591-018-0164-x			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30150716				2022-12-27	WOS:000446577900015
J	Stower, H				Stower, Hannah			Gene editing for Duchenne muscular dystrophy	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1491	1491		10.1038/s41591-018-0225-1	http://dx.doi.org/10.1038/s41591-018-0225-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297891				2022-12-27	WOS:000446577900033
J	Probert, C; Curtis, C				Probert, Christopher; Curtis, Christina			A role for chromatin regulatory dynamics in breast cancer evolution	NATURE MEDICINE			English	Editorial Material							TUMORS		[Probert, Christopher; Curtis, Christina] Stanford Univ, Dept Genet, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Dept Med, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University	Curtis, C (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Dept Med, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA.	cncurtis@stanford.edu		Curtis, Christina/0000-0003-0166-3802				Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Chen H, 2018, CELL, V173, P386, DOI 10.1016/j.cell.2018.03.027; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Patten DK, 2018, NAT MED, V24, P1469, DOI 10.1038/s41591-018-0091-x; Pogrebniak KL, 2018, TRENDS GENET, V34, P639, DOI 10.1016/j.tig.2018.05.007; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	11	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1309	1311		10.1038/s41591-018-0182-8	http://dx.doi.org/10.1038/s41591-018-0182-8			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30177822				2022-12-27	WOS:000444174100008
J	Barry, KC; Hsu, J; Broz, ML; Cueto, FJ; Binnewies, M; Combes, AJ; Nelson, AE; Loo, K; Kumar, R; Rosenblum, MD; Alvarado, MD; Wolf, DM; Bogunovic, D; Bhardwaj, N; Daud, AI; Ha, PK; Ryan, WR; Pollack, JL; Samad, B; Asthana, S; Chan, V; Krummel, MF				Barry, Kevin C.; Hsu, Joy; Broz, Miranda L.; Cueto, Francisco J.; Binnewies, Mikhail; Combes, Alexis J.; Nelson, Amanda E.; Loo, Kimberly; Kumar, Raj; Rosenblum, Michael D.; Alvarado, Michael D.; Wolf, Denise M.; Bogunovic, Dusan; Bhardwaj, Nina; Daud, Adil, I; Ha, Patrick K.; Ryan, William R.; Pollack, Joshua L.; Samad, Bushra; Asthana, Saurabh; Chan, Vincent; Krummel, Matthew F.			A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments	NATURE MEDICINE			English	Article							T-CELL; CANCER-IMMUNOTHERAPY; IN-VIVO; READ ALIGNMENT; MELANOMA; RECEPTOR; IMMUNITY; EXPRESSION; BLOCKADE; MICE	Intratumoral stimulatory dendritic cells (SDCs) play an important role in stimulating cytotoxic T cells and driving immune responses against cancer. Understanding the mechanisms that regulate their abundance in the tumor microenvironment (TME) could unveil new therapeutic opportunities. We find that in human melanoma, SDC abundance is associated with intratumoral expression of the gene encoding the cytokine FLT3LG. FLT3LG is predominantly produced by lymphocytes, notably natural killer (NK) cells in mouse and human tumors. NK cells stably form conjugates with SDCs in the mouse TME, and genetic and cellular ablation of NK cells in mice demonstrates their importance in positively regulating SDC abundance in tumor through production of FLT3L. Although anti-PD-1 'checkpoint' immunotherapy for cancer largely targets T cells, we find that NK cell frequency correlates with protective SDCs in human cancers, with patient responsiveness to anti-PD-1 immunotherapy, and with increased overall survival. Our studies reveal that innate immune SDCs and NK cells cluster together as an excellent prognostic tool for T cell-directed immunotherapy and that these innate cells are necessary for enhanced T cell tumor responses, suggesting this axis as a target for new therapies.	[Barry, Kevin C.; Hsu, Joy; Broz, Miranda L.; Cueto, Francisco J.; Binnewies, Mikhail; Combes, Alexis J.; Nelson, Amanda E.; Kumar, Raj; Samad, Bushra; Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Barry, Kevin C.; Hsu, Joy; Broz, Miranda L.; Combes, Alexis J.; Nelson, Amanda E.; Loo, Kimberly; Kumar, Raj; Samad, Bushra; Asthana, Saurabh; Chan, Vincent; Krummel, Matthew F.] Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA; [Cueto, Francisco J.] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Cueto, Francisco J.] Univ Autonoma Madrid, Fac Med, Dept Biochem, Madrid, Spain; [Loo, Kimberly] Univ Calif San Francisco, Melanoma Clin Res Unit, San Francisco, CA 94143 USA; [Loo, Kimberly; Rosenblum, Michael D.; Alvarado, Michael D.; Daud, Adil, I] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Wolf, Denise M.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Bogunovic, Dusan] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Bhardwaj, Nina] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Ha, Patrick K.; Ryan, William R.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Pollack, Joshua L.] Pionyr Immunotherapeut, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.; Krummel, MF (corresponding author), Univ Calif San Francisco, UCSF Immunoprofiler Initiat, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu	Cueto, Francisco J/AGN-4489-2022; Daud, Adil/T-3079-2019	Cueto, Francisco J/0000-0002-7457-9583; Daud, Adil/0000-0002-6617-8421; Hsu, Joy/0000-0001-6571-9276; Samad, Bushra/0000-0002-2893-0897; Bhardwaj, Nina/0000-0003-1865-4187; Combes, Alexis/0000-0002-9110-6542; Barry, Kevin/0000-0003-1064-5964	National Institutes of Health (NIH) [R01CA197363]; AbbVie of the Immunoprofiler Consortium; Amgen of the Immunoprofiler Consortium; Bristol-Myers Squibb of the Immunoprofiler Consortium; NIH [5P30CA082103]; Genentech Predoctoral Research Fellowship; Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award; Achievement Reward for College Scientists Scholarship; Cancer Research Institute; Fibrolamellar Cancer Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA197363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114787, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP2AR068130] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AbbVie of the Immunoprofiler Consortium(AbbVie); Amgen of the Immunoprofiler Consortium(Amgen); Bristol-Myers Squibb of the Immunoprofiler Consortium(Bristol-Myers Squibb); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Predoctoral Research Fellowship; Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award; Achievement Reward for College Scientists Scholarship; Cancer Research Institute; Fibrolamellar Cancer Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Lanier, J. Roose and L. Fong for advice, and we thank M. Spasic and N. Khurana for support with response data. This work was supported by National Institutes of Health (NIH) grant R01CA197363, awarded to M.F.K. Acquisition and processing of human melanoma samples in cohort A described in this study was funded in part by contributions from AbbVie, Amgen, and Bristol-Myers Squibb as members of the Immunoprofiler Consortium. Further support came from NIH grant 5P30CA082103, awarded to the University of California, San Francisco (UCSF) Hellen Diller Family Comprehensive Cancer Center. M.B. was supported by the Genentech Predoctoral Research Fellowship, the Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award, and the Achievement Reward for College Scientists Scholarship. K.C.B. was supported by a postdoctoral fellowship from the Cancer Research Institute and Fibrolamellar Cancer Foundation.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cheng PF, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14183; CORBETT TH, 1975, CANCER RES, V35, P2434; Dougall WC, 2017, IMMUNOL REV, V276, P112, DOI 10.1111/imr.12518; Du XL, 2006, GENOMICS, V87, P693, DOI 10.1016/j.ygeno.2006.02.003; Engelhardt JJ, 2012, CANCER CELL, V21, P402, DOI 10.1016/j.ccr.2012.01.008; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; FIDLER IJ, 1975, CANCER RES, V35, P218; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Goding SR, 2017, CLIN IMMUNOL, V177, P76, DOI 10.1016/j.clim.2016.06.013; GRAF LH, 1984, SOMAT CELL MOLEC GEN, V10, P139, DOI 10.1007/BF01534903; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Khanna KM, 2010, J IMMUNOL, V185, P239, DOI 10.4049/jimmunol.0901047; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Loo K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93433; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pinkard H, 2016, NAT METHODS, V13, P807, DOI 10.1038/nmeth.3991; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sanchez-Paulete AR, 2016, CANCER DISCOV, V6, P71, DOI 10.1158/2159-8290.CD-15-0510; Solanilla A, 2000, LEUKEMIA, V14, P153, DOI 10.1038/sj.leu.2401635; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wu C., 2016, NUCLEIC ACIDS RES, V44, pD1; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	46	450	463	10	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1178	1191		10.1038/s41591-018-0085-8	http://dx.doi.org/10.1038/s41591-018-0085-8			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29942093	Green Accepted			2022-12-27	WOS:000440955500024
J	Lambrechts, D; Wauters, E; Boeckx, B; Aibar, S; Nittner, D; Burton, O; Bassez, A; Decaluwe, H; Pircher, A; Van den Eynde, K; Weynand, B; Verbeken, E; De Leyn, P; Liston, A; Vansteenkiste, J; Carmeliet, P; Aerts, S; Thienpont, B				Lambrechts, Diether; Wauters, Els; Boeckx, Bram; Aibar, Sara; Nittner, David; Burton, Oliver; Bassez, Ayse; Decaluwe, Herbert; Pircher, Andreas; Van den Eynde, Kathleen; Weynand, Birgit; Verbeken, Erik; De Leyn, Paul; Liston, Adrian; Vansteenkiste, Johan; Carmeliet, Peter; Aerts, Stein; Thienpont, Bernard			Phenotype molding of stromal cells in the lung tumor microenvironment	NATURE MEDICINE			English	Article							VESSEL NORMALIZATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HETEROGENEITY; REVEALS; ANGIOGENESIS; ADENOCARCINOMA; METHYLATION; FIBROBLASTS; METASTASIS	Cancer cells are embedded in the tumor microenvironment (TME), a complex ecosystem of stromal cells. Here, we present a 52,698-cell catalog of the TME transcriptome in human lung tumors at single-cell resolution, validated in independent samples where 40,250 additional cells were sequenced. By comparing with matching non-malignant lung samples, we reveal a highly complex TME that profoundly molds stromal cells. We identify 52 stromal cell subtypes, including novel subpopulations in cell types hitherto considered to be homogeneous, as well as transcription factors underlying their heterogeneity. For instance, we discover fibroblasts expressing different collagen sets, endothelial cells downregulating immune cell homing and genes coregulated with established immune checkpoint transcripts and correlating with T-cell activity. By assessing marker genes for these cell subtypes in bulk RNA-sequencing data from 1,572 patients, we illustrate how these correlate with survival, while immuno-histochemistry for selected markers validates them as separate cellular entities in an independent series of lung tumors. Hence, in providing a comprehensive catalog of stromal cells types and by characterizing their phenotype and co-optive behavior, this resource provides deeper insights into lung cancer biology that will be helpful in advancing lung cancer diagnosis and therapy.	[Lambrechts, Diether; Boeckx, Bram; Bassez, Ayse; Pircher, Andreas; Carmeliet, Peter; Thienpont, Bernard] VIB, Ctr Canc Biol, Leuven, Belgium; [Lambrechts, Diether; Boeckx, Bram; Bassez, Ayse] Katholieke Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium; [Wauters, Els; Vansteenkiste, Johan] Univ Hosp KU Leuven, Resp Oncol Unit Pneumol, Leuven, Belgium; [Wauters, Els; Vansteenkiste, Johan] Univ Hosp KU Leuven, Leuven Lung Canc Grp, Leuven, Belgium; [Wauters, Els; Vansteenkiste, Johan] Katholieke Univ Leuven, Lab Pneumol, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [Aibar, Sara; Aerts, Stein] Katholieke Univ Leuven, Dept Human Genet, Lab Computat Biol, Leuven, Belgium; [Aibar, Sara; Burton, Oliver; Liston, Adrian; Aerts, Stein] VIB KU Leuven Ctr Brain & Dis Res, Leuven, Belgium; [Nittner, David] VIB, Histopathol Expertise Ctr, Leuven Ctr Canc Biol, Leuven, Belgium; [Nittner, David] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium; [Burton, Oliver; Liston, Adrian] Katholieke Univ Leuven, Lab Genet Autoimmun, Dept Microbiol & Immunol, Leuven, Belgium; [Decaluwe, Herbert] Univ Hosp KU Leuven, Dept Thorac Surg, Leuven, Belgium; [Decaluwe, Herbert; De Leyn, Paul] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Leuven, Belgium; [Pircher, Andreas; Carmeliet, Peter] Katholieke Univ Leuven, Lab Angiogenesis & Vasc Metab, Dept Oncol, Leuven, Belgium; [Van den Eynde, Kathleen; Weynand, Birgit; Verbeken, Erik] Katholieke Univ Leuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium; [Carmeliet, Peter] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongsan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China; [Thienpont, Bernard] Katholieke Univ Leuven, Dept Human Genet, Lab Funct Epigenet, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven; Sun Yat Sen University; KU Leuven	Lambrechts, D; Thienpont, B (corresponding author), VIB, Ctr Canc Biol, Leuven, Belgium.; Lambrechts, D (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Lab Translat Genet, Leuven, Belgium.; Thienpont, B (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Lab Funct Epigenet, Leuven, Belgium.	diether.lambrechts@kuleuven.vib.be; bernard.thienpont@kuleuven.be	Weynand, Birgit/H-9587-2019; Vansteenkiste, Johan F/B-8191-2014; Thienpont, Bernard/AAG-5423-2019; Aerts, Stein/A-1100-2009; Lambrechts, Diether/AAJ-3167-2020; Decaluwe, Herbert/A-2436-2009; Carmeliet, Peter/AAQ-5140-2020; Pircher, Andreas/L-2150-2019; Aibar, Sara/K-5717-2015	Vansteenkiste, Johan F/0000-0002-6721-2775; Aerts, Stein/0000-0002-8006-0315; Lambrechts, Diether/0000-0002-3429-302X; Decaluwe, Herbert/0000-0002-0877-7717; Carmeliet, Peter/0000-0001-7961-1821; Pircher, Andreas/0000-0002-7747-3012; Aibar, Sara/0000-0001-6104-7134; Bassez, Ayse/0000-0002-0432-1536; Nittner, David/0000-0002-2939-2453; Wauters, Els/0000-0002-0115-0030; Burton, Oliver/0000-0003-3884-7373; Thienpont, Bernard/0000-0002-8772-6845	VIB TechWatch Grant; Foundation Against Cancer grants [2016-070]; ERC Consolidator Grants [724226_cis-CONTROL]; Funds for Research - Flanders [1701018N, G065615N]; Austrian Science Fund (FWF) [J3730-B26]; KU Leuven grants (SymBioSys) [PFV/10/016]	VIB TechWatch Grant; Foundation Against Cancer grants; ERC Consolidator Grants; Funds for Research - Flanders; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); KU Leuven grants (SymBioSys)	We thank M. De Waegeneer, T. Van Brussel, G. Peuteman, E. Vanderheyden and B. Tembuyser for technical assistance. This work was supported by a VIB TechWatch Grant to D.L. and B.T., Foundation Against Cancer grants to S.Aerts (2016-070) and E.W., ERC Consolidator Grants to S. Aerts (724226_cis-CONTROL) and D.L. (CHAMELEON), Funds for Research - Flanders grants to H.D. (1701018N) and D.L. (G065615N), an Austrian Science Fund (FWF) grant to A.P. (J3730-B26) and KU Leuven grants to D.L. and S.Aerts (PFV/10/016 SymBioSys), and to B.T. (BOFZAP).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Clevers H, 2017, CELL SYST, V4, P255, DOI 10.1016/j.cels.2017.03.006; Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Djureinovic D, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86837; Eberhard A, 2000, CANCER RES, V60, P1388; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gunthner R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/731023; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Ishibashi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46662; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Li HP, 2017, NAT GENET, V49, P708, DOI 10.1038/ng.3818; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1188-0; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Shaykhiev R, 2013, AM J RESP CELL MOL, V49, P418, DOI 10.1165/rcmb.2012-0396OC; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2015, GENOME RES, V25, P1491, DOI 10.1101/gr.190595.115; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang NP, 1999, ARTERIOSCL THROM VAS, V19, P2078, DOI 10.1161/01.ATV.19.9.2078; Wauters E, 2015, THORAX, V70, P1113, DOI 10.1136/thoraxjnl-2015-207288; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhang Y, 2017, CANCER CELL, V32, P377, DOI 10.1016/j.ccell.2017.08.004; Zhang Y, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00032	54	669	688	20	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1277	+		10.1038/s41591-018-0096-5	http://dx.doi.org/10.1038/s41591-018-0096-5			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29988129				2022-12-27	WOS:000440955500033
J	Raffatellu, M				Raffatellu, Manuela			Learning from bacterial competition in the host to develop antimicrobials	NATURE MEDICINE			English	Article							CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; PSEUDOMONAS-AERUGINOSA; GUT MICROBIOTA; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; COLONIZATION RESISTANCE; ANTIBACTERIAL ACTIVITY; CLOSTRIDIUM-DIFFICILE; SIDEROPHORE CEPHALOSPORIN; INTESTINAL COLONIZATION	In recent years, the alarming increase of antibiotic resistance, compounded by the simultaneous decrease in development of new antibiotics, has created serious concerns for public health. Moreover, current antibiotics also target the beneficial commensal microbes (microbiota) that inhabit our body, sometimes with significant health consequences. The answer to the antibiotic crisis thus involves broad, creative efforts to develop new treatments for infectious agents. Here I discuss what can be learned from investigating microbial competition in vivo and how this knowledge can be utilized to devise new narrow-spectrum therapeutics that target bacterial pathogens while minimizing deleterious effects to the microbiota.	[Raffatellu, Manuela] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Raffatellu, Manuela] Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, La Jolla, CA 92093 USA; [Raffatellu, Manuela] Chiba Univ Univ Calif San Diego Ctr Mucosal Immun, La Jolla, CA 92093 USA; [Raffatellu, Manuela] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California San Diego	Raffatellu, M (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.; Raffatellu, M (corresponding author), Univ Calif San Diego, Dept Pediat, Div Host Microbe Syst & Therapeut, La Jolla, CA 92093 USA.; Raffatellu, M (corresponding author), Chiba Univ Univ Calif San Diego Ctr Mucosal Immun, La Jolla, CA 92093 USA.; Raffatellu, M (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.	manuelar@ucsd.edu			NIH Public Health Service Grants [AI114625, AI126277, AI121928, AI126465]; Burroughs Wellcome Fund	NIH Public Health Service Grants; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	M.R. would like to thank S.P. Nuccio for helpful discussions and editing of the manuscript. M.R. is supported by NIH Public Health Service Grants AI114625, AI126277, AI121928, and AI126465. M.R. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Alteri CJ, 2016, VIRULENCE MECH BACTE, V4, P337; [Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Bo G, 2000, CLIN MICROBIOL INFEC, V6, P6, DOI 10.1111/j.1469-0691.2000.tb02032.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chairatana P, 2015, CHEM SCI, V6, P4458, DOI 10.1039/c5sc00962f; Charlop-Powers Z, 2016, P NATL ACAD SCI USA, V113, P14811, DOI 10.1073/pnas.1615581113; Chatzidaki-Livanis M, 2016, P NATL ACAD SCI USA, V113, P3627, DOI 10.1073/pnas.1522510113; Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477; Choi VM, 2016, NAT MED, V22, P563, DOI 10.1038/nm.4077; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Costa KC, 2017, SCIENCE, V355, P170, DOI 10.1126/science.aag3180; Costa KC, 2015, MBIO, V6, DOI 10.1128/mBio.01520-15; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Curtis MM, 2014, MBIO, V5, DOI 10.1128/mBio.02165-14; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; FAO/WHO, 2001, EXPERT CONSULTATION; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; Gong JQ, 2006, BRIT J DERMATOL, V155, P680, DOI 10.1111/j.1365-2133.2006.07410.x; Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hassan M, 2012, J APPL MICROBIOL, V113, P723, DOI 10.1111/j.1365-2672.2012.05338.x; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Hecht AL, 2016, EMBO REP, V17, P1281, DOI 10.15252/embr.201642282; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Ilott NE, 2016, ISME J, V10, P2389, DOI 10.1038/ismej.2016.40; Ito A, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01454-17; Ito A, 2016, ANTIMICROB AGENTS CH, V60, P7396, DOI 10.1128/AAC.01405-16; Ji C, 2012, FUTURE MED CHEM, V4, P297, DOI [10.4155/FMC.11.191, 10.4155/fmc.11.191]; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kim A, 2015, ANTIMICROB AGENTS CH, V59, P7743, DOI 10.1128/AAC.00831-15; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kohira N, 2016, ANTIMICROB AGENTS CH, V60, P729, DOI 10.1128/AAC.01695-15; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Maffioli SI, 2017, CELL, V169, P1240, DOI 10.1016/j.cell.2017.05.042; Medema MH, 2015, NAT CHEM BIOL, V11, P639, DOI [10.1038/NCHEMBIO.1884, 10.1038/nchembio.1884]; Meletis G, 2012, HIPPOKRATIA, V16, P303; Mike LA, 2016, P NATL ACAD SCI USA, V113, P13468, DOI 10.1073/pnas.1606324113; Mislin GLA, 2014, METALLOMICS, V6, P408, DOI 10.1039/c3mt00359k; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mousa WK, 2017, NAT PROD REP, V34, P1302, DOI 10.1039/c7np00021a; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Nothias LF, 2016, P NATL ACAD SCI USA, V113, P14477, DOI 10.1073/pnas.1618221114; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Paharik AE, 2017, CELL HOST MICROBE, V22, P746, DOI 10.1016/j.chom.2017.11.001; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P383, DOI [10.1586/ERI.13.14, 10.1586/eri.13.14]; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rebuffat S, 2012, BIOCHEM SOC T, V40, P1456, DOI 10.1042/BST20120183; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Sassone-Corsi M, 2016, NATURE, V540, P280, DOI 10.1038/nature20557; Sassone-Corsi M, 2016, P NATL ACAD SCI USA, V113, P13462, DOI 10.1073/pnas.1606290113; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Schwaber MJ, 2008, JAMA-J AM MED ASSOC, V300, P2911, DOI 10.1001/jama.2008.896; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Stubbendieck RM, 2016, J BACTERIOL, V198, P2145, DOI 10.1128/JB.00275-16; Tacconelli E, 2017, GLOBAL PRIORITY LIST; Tan SY, 2015, SINGAP MED J, V56, P366, DOI 10.11622/smedj.2015105; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Thomas X, 2004, J BIOL CHEM, V279, P28233, DOI 10.1074/jbc.M400228200; Tillotson Glenn S, 2016, Infect Dis (Auckl), V9, P45, DOI 10.4137/idrt.s31567; Tomaras AP, 2013, ANTIMICROB AGENTS CH, V57, P4197, DOI 10.1128/AAC.00629-13; Traxler MF, 2012, MOL MICROBIOL, V86, P628, DOI 10.1111/mmi.12008; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Vassiliadis G, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P309, DOI 10.1007/978-1-4419-7692-5_16; Ventola C Lee, 2015, P T, V40, P277; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Zheng TF, 2014, J AM CHEM SOC, V136, P9677, DOI 10.1021/ja503911p; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10	110	37	40	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1097	1103		10.1038/s41591-018-0145-0	http://dx.doi.org/10.1038/s41591-018-0145-0			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082869				2022-12-27	WOS:000440955500013
J	Rangarajan, S; Bone, NB; Zmijewskal, AA; Jiang, SN; Park, DW; Bernard, K; Locy, ML; Ravi, S; Deshane, J; Mannon, RB; Abraham, E; Darley-Usmar, V; Thannickal, VJ; Zmijewski, JW				Rangarajan, Sunad; Bone, Nathaniel B.; Zmijewskal, Anna A.; Jiang, Shaoning; Park, Dae Won; Bernard, Karen; Locy, Morgan L.; Ravi, Saranya; Deshane, Jessy; Mannon, Roslyn B.; Abraham, Edward; Darley-Usmar, Victor; Thannickal, Victor J.; Zmijewski, Jaroslaw W.			Metformin reverses established lung fibrosis in a bleomycin model	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; IDIOPATHIC PULMONARY-FIBROSIS; AMPK; MITOCHONDRIA; REPAIR; TISSUE; INFLAMMATION; HOMEOSTASIS; MECHANISMS; INHIBITOR	Fibrosis is a pathological result of a dysfunctional repair response to tissue injury and occurs in a number of organs, including the lungs(1). Cellular metabolism regulates tissue repair and remodelling responses to injury (2-4). AMPK is a critical sensor of cellular bioenergetics and controls the switch from anabolic to catabolic metabolisms. However, the role of AMPK in fibrosis is not well understood. Here, we demonstrate that in humans with idiopathic pulmonary fibrosis (IPF) and in an experimental mouse model of lung fibrosis, AMPK activity is lower in fibrotic regions associated with metabolically active and apoptosis-resistant myofibroblasts. Pharmacological activation of AMPK in myofibroblasts from lungs of humans with IPF display lower fibrotic activity, along with enhanced mitochondria! biogenesis and normalization of sensitivity to apoptosis. In a bleomycin model of lung fibrosis in mice, metformin therapeutically accelerates the resolution of well-established fibrosis in an AMPK-dependent manner. These studies implicate deficient AMPK activation in non-resolving, pathologic fibrotic processes, and support a role for metformin (or other AMPK activators) to reverse established fibrosis by facilitating deactivation and apoptosis of myofibroblasts.	[Rangarajan, Sunad; Bone, Nathaniel B.; Zmijewskal, Anna A.; Jiang, Shaoning; Park, Dae Won; Bernard, Karen; Locy, Morgan L.; Deshane, Jessy; Mannon, Roslyn B.; Thannickal, Victor J.; Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Park, Dae Won] Korea Univ Ansan Hosp, Div Infect Dis, Ansan, South Korea; [Ravi, Saranya; Darley-Usmar, Victor] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Abraham, Edward] Univ Miami, Sch Med, Off Dean, Miami, FL USA	University of Alabama System; University of Alabama Birmingham; Korea University; Korea University Medicine (KU Medicine); University of Alabama System; University of Alabama Birmingham; University of Miami	Thannickal, VJ; Zmijewski, JW (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	vthannickal@uabmc.edu; zmijewsk@uab.edu	Mannon, Roslyn Bernstein/AIB-6720-2022; Mannon, Roslyn/Q-9740-2019; Kim, Il/L-6481-2019; Mannon, Roslyn/X-1407-2019; Ha, C/GZL-9046-2022; Rangarajan, Sunad/AAQ-5285-2021	Mannon, Roslyn/0000-0003-1776-3680; Rangarajan, Sunad/0000-0001-5313-4828; Locy, Morgan/0000-0002-3812-5867; Park, Dae Won/0000-0002-7653-686X; Darley-Usmar, Victor/0000-0001-8921-7086	Neuroscience Molecular Detection and Stereology Core (UAB) [P30 NS047466]; National Institutes of Health (NIH) [HL107585]; US Department of Defense [W81XWH-17-1-0577]; Pulmonary, Allergy and Critical Care Medicine (UAB) Translational Program; NIH [P01 HL114470, R01 AG046210, HL135399]; Department of Veterans Affairs Merit Award [I01BX003056]; UAB Nathan Shock Center [P30 AG 050886]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128502, K08HL135399, R01HL107585, F30HL136195, P01HL114470, R01HL139617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210, P30AG050886] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003272, I01BX003056] Funding Source: NIH RePORTER	Neuroscience Molecular Detection and Stereology Core (UAB); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Pulmonary, Allergy and Critical Care Medicine (UAB) Translational Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); UAB Nathan Shock Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank B. Viollet (INSERM) and G. Shailendra (Henry Ford Health System) for providing AMPK alpha 1/2<SUP>-/-</SUP> MEFs and AMPK alpha 1<SUP>-/-</SUP> mice. The authors thank Y. Liu (Medicine, UAB) for technical support, and J. Creighton (Anesthesiology, UAB) and the Neuroscience Molecular Detection and Stereology Core P30 NS047466 (UAB) for help with lung tissue samples/processing. This work was supported in part by the National Institutes of Health (NIH, HL107585), the US Department of Defense (W81XWH-17-1-0577) and the Pulmonary, Allergy and Critical Care Medicine (UAB) Translational Program for ARDS grants to J.W.Z. V.J.T. was supported by NIH grants P01 HL114470 and R01 AG046210, and a Department of Veterans Affairs Merit Award I01BX003056. Su.R. was supported by NIH K08 (HL135399). V.D.-U. received support from UAB Nathan Shock Center (P30 AG 050886).	Ashley SL, 2016, AM J RESP CELL MOL, V54, P482, DOI 10.1165/rcmb.2015-0148OC; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Franco-Barraza J., 2016, CURR PROTOC CELL BIO, V71; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013; Jiang SN, 2014, J IMMUNOL, V192, P4795, DOI 10.4049/jimmunol.1302764; Jiang SN, 2013, J BIOL CHEM, V288, P26013, DOI 10.1074/jbc.M113.489468; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kobayashi K, 2016, J IMMUNOL, V197, P504, DOI 10.4049/jimmunol.1600265; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Li L, 2015, ONCOTARGET, V6, P43605, DOI 10.18632/oncotarget.6186; Lim JY, 2012, J CELL PHYSIOL, V227, P1081, DOI 10.1002/jcp.22824; Liu ZY, 2015, MOL MED, V21, P937, DOI 10.2119/molmed.2015.00198; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Park IH, 2014, OTOLARYNG HEAD NECK, V150, P148, DOI 10.1177/0194599813513880; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Riera CE, 2015, NAT MED, V21, P1400, DOI 10.1038/nm.4005; Romero Y, 2016, AGING CELL, V15, P1103, DOI 10.1111/acel.12514; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Sato N, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0420-x; Shaw RJ, 2013, NAT MED, V19, P1570, DOI 10.1038/nm.3414; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thakur S, 2015, AM J PATHOL, V185, P2168, DOI 10.1016/j.ajpath.2015.04.014; Thannickal VJ, 2014, J CLIN INVEST, V124, P4673, DOI 10.1172/JCI74368; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu GY, 2018, NAT MED, V24, P39, DOI 10.1038/nm.4447	46	249	264	26	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1121	+		10.1038/s41591-018-0087-6	http://dx.doi.org/10.1038/s41591-018-0087-6			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29967351	Green Accepted			2022-12-27	WOS:000440955500017
J	Desai, P; Mencia-Trinchant, N; Savenkov, O; Simon, MS; Cheang, G; Lee, S; Samuel, M; Ritchie, EK; Guzman, ML; Ballman, KV; Roboz, GJ; Hassane, DC				Desai, Pinkal; Mencia-Trinchant, Nuria; Savenkov, Oleksandr; Simon, Michael S.; Cheang, Gloria; Lee, Sangmin; Samuel, Michael; Ritchie, Ellen K.; Guzman, Monica L.; Ballman, Karla V.; Roboz, Gail J.; Hassane, Duane C.			Somatic mutations precede myeloid leukemia years before diagnosis	NATURE MEDICINE			English	Article							CLONAL HEMATOPOIESIS; CANCER; MALIGNANCIES; NEOPLASMS; EVOLUTION; OUTCOMES; GENOME; COMMON	The pattern of somatic mutations observed at diagnosis of acute myeloid leukemia (AML) has been well-characterized. However, the premalignant mutational landscape of AML and its impact on risk and time to diagnosis is unknown. Here we identified 212 women from the Women's Health Initiative who were healthy at study baseline, but eventually developed AML during follow-up (median time: 9.6 years). Deep sequencing was performed on peripheral blood DNA of these cases and compared to age-matched controls that did not develop AML. We discovered that mutations in IDH1, IDH2, TP53, DNMT3A, TET2 and spliceosome genes significantly increased the odds of developing AML. All subjects with TP53 mutations (n = 21 out of 21 patients) and IDH1 and IDH2 (n = 15 out of 15 patients) mutations eventually developed AML in our study. The presence of detectable mutations years before diagnosis suggests that there is a period of latency that precedes AML during which early detection, monitoring and interventional studies should be considered.	[Desai, Pinkal; Mencia-Trinchant, Nuria; Lee, Sangmin; Samuel, Michael; Ritchie, Ellen K.; Guzman, Monica L.; Roboz, Gail J.; Hassane, Duane C.] Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10065 USA; [Savenkov, Oleksandr; Ballman, Karla V.] Weill Cornell Med Coll, Heath Care Policy & Res, New York, NY USA; [Simon, Michael S.] Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Cheang, Gloria] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Hassane, Duane C.] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA; [Hassane, Duane C.] Weill Cornell Med Coll, Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA	Cornell University; Cornell University; Barbara Ann Karmanos Cancer Institute; Cornell University; Cornell University; Cornell University	Desai, P; Hassane, DC (corresponding author), Weill Cornell Med Coll, Div Hematol & Oncol, New York, NY 10065 USA.; Hassane, DC (corresponding author), Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10065 USA.; Hassane, DC (corresponding author), Weill Cornell Med Coll, Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA.	pid9006@med.cornell.edu; dhassane@med.cornell.edu	Hassane, Duane/AAA-3456-2021	MENCIA TRINCHANT, Nuria/0000-0003-1376-8708	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; Cancer Center Support Grant [NIH:NCI P30CA022453]; Sandra and Edward Meyer Cancer Center; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Center Support Grant; Sandra and Edward Meyer Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge all our donors to Leukemia Fighters, without whom this work would not have been possible; the women who generously participated in the WHI study. We thank J. Z. Xiang and the Weill Cornell Genomics Core Facility as well as J. Catalano of the Englander Institute for Precision Medicine for assistance in sequencing; L. -B. Yan for technical assistance. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221, and the Cancer Center Support Grant NIH:NCI P30CA022453. We acknowledge the dedicated efforts of investigators and staff at the WHI clinical centers, the WHI Clinical Coordinating Center, and the National Heart, Lung and Blood program office (listing available at http://www.whi.org). We are additionally grateful for funding from the Sandra and Edward Meyer Cancer Center, which partially supported this study (D.C.H.).	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; [Anonymous], 2017, CANC DISCOV, V7; Bergstralh EJ, 1996, EPIDEMIOLOGY, V7, P331; Bowman RL, 2018, CELL STEM CELL, V22, P157, DOI 10.1016/j.stem.2018.01.011; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Coombs CC, 2017, CELL STEM CELL, V21, P374, DOI 10.1016/j.stem.2017.07.010; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kadia TM, 2016, CANCER-AM CANCER SOC, V122, P3484, DOI 10.1002/cncr.30203; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Montalban-Bravo G, 2018, CURR OPIN HEMATOL, V25, P146, DOI 10.1097/MOH.0000000000000400; Mori T, 2016, LEUKEMIA, V30, P2270, DOI 10.1038/leu.2016.212; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Palmisano M, 2007, HAEMATOLOGICA, V92, P1268, DOI 10.3324/haematol.11202; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Sabapathy K, 2018, NAT REV CLIN ONCOL, V15, P13, DOI 10.1038/nrclinonc.2017.151; Samuelsen SO, 1997, BIOMETRIKA, V84, P379, DOI 10.1093/biomet/84.2.379; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoon JH, 2013, BLOOD, V122; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	34	288	295	5	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1015	+		10.1038/s41591-018-0081-z	http://dx.doi.org/10.1038/s41591-018-0081-z			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988143	Green Accepted, Green Submitted			2022-12-27	WOS:000438187700030
J	Norelli, M; Camisa, B; Barbiera, G; Falcone, L; Purevdorj, A; Genua, M; Sanvito, F; Ponzoni, M; Doglioni, C; Cristofori, P; Traversari, C; Bordignon, C; Ciceri, F; Ostuni, R; Bonini, C; Casucci, M; Bondanza, A				Norelli, Margherita; Camisa, Barbara; Barbiera, Giulia; Falcone, Laura; Purevdorj, Ayurzana; Genua, Marco; Sanvito, Francesca; Ponzoni, Maurilio; Doglioni, Claudio; Cristofori, Patrizia; Traversari, Catia; Bordignon, Claudio; Ciceri, Fabio; Ostuni, Renato; Bonini, Chiara; Casucci, Monica; Bondanza, Attilio			Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN IMMUNE-SYSTEM; B-CELL; IMMUNODEFICIENT MICE; STEM-CELLS; THERAPY; IMMUNOTHERAPY; PERSISTENCE; REMISSIONS; LYMPHOMA	In the clinic, chimeric antigen receptor-modified T (CAR T) cell therapy is frequently associated with life-threatening cytokine-release syndrome (CRS) and neurotoxicity. Understanding the nature of these pathologies and developing treatments for them are hampered by the lack of appropriate animal models. Herein, we describe a mouse model recapitulating key features of CRS and neurotoxicity. In humanized mice with high leukemia burden, CAR T cell-mediated clearance of cancer triggered high fever and elevated IL-6 levels, which are hallmarks of CRS. Human monocytes were the major source of IL-1 and IL-6 during CRS. Accordingly, the syndrome was prevented by monocyte depletion or by blocking IL-6 receptor with tocilizumab. Nonetheless, tocilizumab failed to protect mice from delayed lethal neurotoxicity, characterized by meningeal inflammation. Instead, the IL-1 receptor antagonist anakinra abolished both CRS and neurotoxicity, resulting in substantially extended leukemia-free survival. These findings offer a therapeutic strategy to tackle neurotoxicity and open new avenues to safer CAR T cell therapies.	[Norelli, Margherita; Camisa, Barbara; Falcone, Laura; Purevdorj, Ayurzana; Casucci, Monica; Bondanza, Attilio] San Raffaele Hosp Sci Inst, Innovat Immunotherapies Unit, Milan, Italy; [Norelli, Margherita; Bordignon, Claudio; Ciceri, Fabio; Bonini, Chiara; Bondanza, Attilio] Univ Vita Salute San Raffaele, Milan, Italy; [Barbiera, Giulia; Genua, Marco; Ostuni, Renato] San Raffaele Telethon Inst Gene Therapy SR Tiget, Genom Innate Immune Syst Unit, Milan, Italy; [Sanvito, Francesca; Ponzoni, Maurilio; Doglioni, Claudio] San Raffaele Hosp Sci Inst, Pathol Unit, Milan, Italy; [Cristofori, Patrizia] San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Traversari, Catia; Bordignon, Claudio] Molmed Spa, Milan, Italy; [Ciceri, Fabio] San Raffaele Hosp Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy; [Bonini, Chiara] San Raffaele Hosp Sci Inst, Expt Hematol Unit, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bondanza, A (corresponding author), San Raffaele Hosp Sci Inst, Innovat Immunotherapies Unit, Milan, Italy.; Bondanza, A (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	attilio.bondanza@gmail.com	camisa, barbara/AAN-1897-2020; Barbiera, Giulia/AAO-3751-2020; Falcone, Laura/AAN-5913-2020; Casucci, Monica/AAN-4115-2020; Genua, Marco/J-4159-2018	camisa, barbara/0000-0002-3867-2457; Barbiera, Giulia/0000-0003-1789-9596; BONINI, Maria Chiara/0000-0002-0772-1674; Sanvito, Francesca/0000-0002-4046-8420; Casucci, Monica/0000-0003-4500-9060; Genua, Marco/0000-0002-0764-8163	Italian Association for Cancer Research (AIRC) (MFAG grant) [13390, 20247]; Italian Association for Cancer Research (AIRC) (Investigator grant) [17706]; Fondazione Telethon	Italian Association for Cancer Research (AIRC) (MFAG grant); Italian Association for Cancer Research (AIRC) (Investigator grant)(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon(Fondazione TelethonEuropean Commission)	We thank G. Dotti (University of North Carolina) and H. Abken (University of Cologne) for providing the original CAR constructs, F. Falkenburg (Leiden University Medical Center) for providing ALL-CM leukemic cells and L. Naldini (San Raffaele-Telethon Institute for Gene Therapy) for providing lentiviral vectors. We thank R. Norato (San Raffaele Scientific Institute) for histology technical support. This work was supported by the Italian Association for Cancer Research (AIRC) (MFAG grant no. 13390 and Investigator grant no. 17706 to B.A.; MFAG grant no. 20247 to O.R.).	Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Bondanza A, 2011, BLOOD, V117, P6469, DOI 10.1182/blood-2010-11-320366; Bouma G, 2005, EUR J IMMUNOL, V35, P225, DOI 10.1002/eji.200425513; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Casucci M, 2013, BLOOD, V122, P3461, DOI 10.1182/blood-2013-04-493361; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Fox E, 2010, J NEUROIMMUNOL, V223, P138, DOI 10.1016/j.jneuroim.2010.03.022; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Kaneko S, 2009, BLOOD, V113, P1006, DOI 10.1182/blood-2008-05-156059; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Koo GC, 2009, EXPERT REV VACCINES, V8, P113, DOI 10.1586/14760584.8.1.113; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Mastaglio S, 2017, BLOOD, V130, P606, DOI 10.1182/blood-2016-08-732636; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Nijmeijer BA, 2002, BLOOD, V100, P654, DOI 10.1182/blood.V100.2.654; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Singh N, 2017, CYTOTHERAPY, V19, P867, DOI 10.1016/j.jcyt.2017.04.001; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Topp MS, 2015, LANCET ONCOL, V16, P57, DOI 10.1016/S1470-2045(14)71170-2; Turtle CJ, 2017, J CLIN ONCOL, V35, P3010, DOI 10.1200/JCO.2017.72.8519; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wils EJ, 2011, J IMMUNOL, V187, P2974, DOI 10.4049/jimmunol.1004209; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	42	650	691	11	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					739	+		10.1038/s41591-018-0036-4	http://dx.doi.org/10.1038/s41591-018-0036-4			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29808007				2022-12-27	WOS:000434281300019
J	Vaccari, M; Fourati, S; Gordon, SN; Brown, DR; Bissa, M; Schifanella, L; de Castro, IS; Doster, MN; Galli, V; Omsland, M; Fujikawa, D; Gorini, G; Liyanage, NPM; Trinh, HV; McKinnon, KM; Foulds, KE; Keele, BF; Roederer, M; Koup, RA; Shen, XY; Tomaras, GD; Wong, MP; Munoz, KJ; Gach, JS; Forthal, DN; Montefiori, DC; Venzon, DJ; Felber, BK; Rosati, M; Pavlakis, GN; Rao, M; Sekaly, RP; Franchini, G				Vaccari, Monica; Fourati, Slim; Gordon, Shari N.; Brown, Dallas R.; Bissa, Massimilano; Schifanella, Luca; de Castro, Isabela Silva; Doster, Melvin N.; Galli, Veronica; Omsland, Maria; Fujikawa, Dai; Gorini, Giacomo; Liyanage, Namal P. M.; Trinh, Hung V.; McKinnon, Katherine M.; Foulds, Kathryn E.; Keele, Brandon F.; Roederer, Mario; Koup, Richard A.; Shen, Xiaoying; Tomaras, Georgia D.; Wong, Marcus P.; Munoz, Karissa J.; Gach, Johannes S.; Forthal, Donald N.; Montefiori, David C.; Venzon, David J.; Felber, Barbara K.; Rosati, Margherita; Pavlakis, George N.; Rao, Mangala; Sekaly, Rafick-Pierre; Franchini, Genoveffa			HIV vaccine candidate activation of hypoxia and the inflammasome in CD14(+) monocytes is associated with a decreased risk of SIVmac251 acquisition	NATURE MEDICINE			English	Article							VIRUS VECTOR ALVAC; RHESUS MACAQUES; IMMUNE-RESPONSES; DOUBLE-BLIND; CYTOKINE RESPONSES; MUCOSAL INFECTION; EFFICACY TRIAL; CELL SUBSETS; T-CELLS; PROTECTION	Qualitative differences in the innate and adaptive responses elicited by different HIV vaccine candidates have not been thoroughly investigated. We tested the ability of the Aventis Pasteur live recombinant canarypox vector (ALVAC)-SIV, DNA-SIV and Ad26-SIV vaccine prime modalities together with two ALVAC-SIV + gp120 protein boosts to reduce the risk of SIVmac251 acquisition in rhesus macaques. We found that the DNA and ALVAC prime regimens were effective, but the Ad26 prime was not. The activation of hypoxia and the inflammasome in CD14(+) CD16(-) monocytes, gut-homing CCR5-negative CD4(+) T helper 2 (T(H)2) cells and antibodies to variable region 2 correlated with a decreased risk of SIVmac251 acquisition. By contrast, signal transducer and activator of transcription 3 activation in CD16(+) monocytes was associated with an increased risk of virus acquisition. The Ad26 prime regimen induced the accumulation of CX3CR1(+) CD163(+) macrophages in lymph nodes and of long-lasting CD4(+) T(H)17 cells in the gut and lungs. Our data indicate that the selective engagement of monocyte subsets following a vaccine prime influences long-term immunity, uncovering an unexpected association of CD14(+) innate monocytes with a reduced risk of SIVmac251 acquisition.	[Vaccari, Monica; Gordon, Shari N.; Brown, Dallas R.; Bissa, Massimilano; Schifanella, Luca; de Castro, Isabela Silva; Doster, Melvin N.; Galli, Veronica; Omsland, Maria; Fujikawa, Dai; Gorini, Giacomo; Liyanage, Namal P. M.; Franchini, Genoveffa] NCI, Anim Models & Retroviral Vaccines Sect, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Fourati, Slim; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Trinh, Hung V.; Rao, Mangala] Henry M Jackson Fdn Adv Mil Med, US Mil HIV Res Program, Bethesda, MD USA; [Trinh, Hung V.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [McKinnon, Katherine M.] NCI, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Foulds, Kathryn E.; Roederer, Mario; Koup, Richard A.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Keele, Brandon F.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Shen, Xiaoying; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Wong, Marcus P.; Munoz, Karissa J.; Gach, Johannes S.; Forthal, Donald N.] Univ Calif Irvine, Dept Med, Div Infect Dis, Sch Med, Irvine, CA 92717 USA; [Montefiori, David C.] Duke Univ, Sch Med, Div Surg Sci, Durham, NC USA; [Venzon, David J.] NCI, Biostat & Data Management Sect, Ctr Canc Res, Bethesda, MD 20892 USA; [Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Rosati, Margherita; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; University of California System; University of California Irvine; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Franchini, G (corresponding author), NCI, Anim Models & Retroviral Vaccines Sect, Vaccine Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	franchig@mail.nih.gov	Venzon, David J/B-3078-2008; Liyanage, Namal P M/AAU-1392-2021; Trinh, Hung/AAD-5469-2019; Roederer, Mario/G-1887-2011; Galli, Veronica/AAC-2502-2022	Liyanage, Namal P M/0000-0001-7362-3282; Trinh, Hung/0000-0001-8014-9291; Gach, Johannes/0000-0002-5043-5710; Fourati, Slim/0000-0001-6609-7587; Silva de Castro, Isabela/0000-0003-2186-4556; Wong, Marcus/0000-0001-6554-2976; Bissa, Massimiliano/0000-0003-3455-3992; Gorini, Giacomo/0000-0003-2872-1531	National Cancer Institute, NIH [HHSN261200800001E]; NIAID program [HHSN27201100016C]; Collaboration for Aids Vaccine Discovery (CAVD) from the Bill and Melinda Gates Foundation [OPP1032325, OPP1147555]; NATIONAL CANCER INSTITUTE [ZIABC011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005021, ZIAAI005014, R01AI118581, ZIAAI005073, ZICAI005103] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID program; Collaboration for Aids Vaccine Discovery (CAVD) from the Bill and Melinda Gates Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Ahern for editorial and graphical support and all of the staff at Advanced BioScience Laboratories for helping with the execution of the animal study. We thank J. Lucas, J. Peel and Y. Lin for specific binding and total antibody assays and G. Overman and N. Yates for assay and technical assistance. We thank D. Barouch (Harvard Medical School) for providing the Ad26-SIV recombinant vaccine. This work was mostly supported with federal funds from the intramural program of the National Cancer Institute, NIH, including contract no. HHSN261200800001E (G.F.). Contributions were made by the extramural NIAID program (HHSN27201100016C; D.M.), the Henry M. Jackson Foundation, the US Department of Defense and the Collaboration for Aids Vaccine Discovery (CAVD) grants OPP1032325 (R.A.K.) and OPP1147555 (R.A.K.) from the Bill and Melinda Gates Foundation. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Auclair S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006888; Autissier P, 2010, J IMMUNOL METHODS, V360, P119, DOI 10.1016/j.jim.2010.06.017; Baden LR, 2015, J INFECT DIS, V211, P518, DOI 10.1093/infdis/jiu485; Bao WW, 2018, J CELL BIOCHEM, V119, P850, DOI 10.1002/jcb.26249; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Byrne BG, 2013, MBIO, V4, DOI 10.1128/mBio.00620-12; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Chung YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34533; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fan SQ, 2010, NEOPLASIA, V12, P346, DOI 10.1593/neo.10144; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Gundem G, 2012, GENOME MED, V4, DOI 10.1186/gm327; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ignatius R, 2000, J VIROL, V74, P11329, DOI 10.1128/JVI.74.23.11329-11338.2000; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Kung CP, 2008, J VIROL, V82, P5486, DOI 10.1128/JVI.00125-08; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Liu FL, 2017, J IMMUNOL, V199, P3293, DOI 10.4049/jimmunol.1700698; Ludtke A, 2016, J INFECT DIS, V214, pS275, DOI 10.1093/infdis/jiw260; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Panchanathan R, 2016, ONCOTARGET, V7, P28183, DOI 10.18632/oncotarget.8594; Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Rao SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039416; Reinhardt-Heller K, 2017, BIOL BLOOD MARROW TR, V23, P2057, DOI 10.1016/j.bbmt.2017.08.008; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Rodriguez-Rocha H, 2011, VIROLOGY, V416, P9, DOI 10.1016/j.virol.2011.04.017; Romano JW, 1997, IMMUNOL INVEST, V26, P15, DOI 10.3109/08820139709048912; Rosati M, 2008, VACCINE, V26, P5223, DOI 10.1016/j.vaccine.2008.03.090; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Schiffner T, 2013, J VIROL, V87, P10163, DOI 10.1128/JVI.01161-13; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; STOTT EJ, 1991, NATURE, V353, P393, DOI 10.1038/353393a0; Strbo N, 2013, J IMMUNOL, V190, P2495, DOI 10.4049/jimmunol.1202655; Strickland SL, 2011, AIDS RES HUM RETROV, V27, P1327, DOI 10.1089/aid.2011.0100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suschak JJ, 2015, J IMMUNOL, V194, P630, DOI 10.4049/jimmunol.1402530; Teigler JE, 2014, J VIROL, V88, P1809, DOI 10.1128/JVI.02386-13; Teigler JE, 2012, J VIROL, V86, P9590, DOI 10.1128/JVI.00740-12; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Winning S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5134329; Yago T, 2017, J CLIN MED, V6, DOI 10.3390/jcm6090081; Yu QG, 2006, VACCINE, V24, P6376, DOI 10.1016/j.vaccine.2006.06.011; Zhu HQ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00512; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	75	38	38	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					847	+		10.1038/s41591-018-0025-7	http://dx.doi.org/10.1038/s41591-018-0025-7			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29785023	Green Accepted			2022-12-27	WOS:000434281300029
J	Wang, L; Zhao, ZB; Ozark, PA; Fantini, D; Marshall, SA; Rendleman, EJ; Cozzolino, KA; Louis, N; He, XY; Morgan, MA; Takahashi, YH; Collings, CK; Smith, ER; Ntziachristos, P; Savas, JN; Zou, LH; Hashizume, R; Meeks, JJ; Shilatifard, A				Wang, Lu; Zhao, Zibo; Ozark, Patrick A.; Fantini, Damiano; Marshall, Stacy A.; Rendleman, Emily J.; Cozzolino, Kira A.; Louis, Nundia; He, Xingyao; Morgan, Marc A.; Takahashi, Yoh-hei; Collings, Clayton K.; Smith, Edwin R.; Ntziachristos, Panagiotis; Savas, Jeffrey N.; Zou, Lihua; Hashizume, Rintaro; Meeks, Joshua J.; Shilatifard, Ali			Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy	NATURE MEDICINE			English	Article							EZH2 INHIBITION REGARDLESS; HISTONE H3K4 METHYLASES; ACUTE MYELOID-LEUKEMIA; UVEAL MELANOMA-CELLS; TUMOR-SUPPRESSOR; BREAST-CANCER; OVARIAN-CANCER; BAP1 STATUS; GENE; COMPLEXES	The lysine methyltransferase KMT2C (also known as MLL3), a subunit of the COMPASS complex, implements monomethylation of Lys4 on histone H3 (H3K4) at gene enhancers. KMT2C (hereafter referred to as MLL3) frequently incurs point mutations across a range of human tumor types, but precisely how these lesions alter MLL3 function and contribute to oncogenesis is unclear. Here we report a cancer mutational hotspot in MLL3 within the region encoding its plant homeodomain (PHD) repeats and demonstrate that this domain mediates association of MLL3 with the histone H2A deubiquitinase and tumor suppressor BAP1. Cancer-associated mutations in the sequence encoding the MLL3 PHD repeats disrupt the interaction between MLL3 and BAP1 and correlate with poor patient survival. Cancer cells that had PHD-associated MLL3 mutations or lacked BAP1 showed reduced recruitment of MLL3 and the H3K27 demethylase KDM6A (also known as UTX) to gene enhancers. As a result, inhibition of the H3K27 methyltransferase activity of the Polycomb repressive complex 2 (PRC2) in tumor cells harboring BAP1 or MLL3 mutations restored normal gene expression patterns and impaired cell proliferation in vivo. This study provides mechanistic insight into the oncogenic effects of PHD-associated mutations in MLL3 and suggests that restoration of a balanced state of Polycomb-COMPASS activity may have therapeutic efficacy in tumors that bear mutations in the genes encoding these epigenetic factors.	[Wang, Lu; Zhao, Zibo; Ozark, Patrick A.; Fantini, Damiano; Marshall, Stacy A.; Rendleman, Emily J.; Morgan, Marc A.; Takahashi, Yoh-hei; Smith, Edwin R.; Ntziachristos, Panagiotis; Zou, Lihua; Meeks, Joshua J.; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611 USA; [Wang, Lu; Zhao, Zibo; Ozark, Patrick A.; Marshall, Stacy A.; Rendleman, Emily J.; Cozzolino, Kira A.; Morgan, Marc A.; Takahashi, Yoh-hei; Collings, Clayton K.; Smith, Edwin R.; Ntziachristos, Panagiotis; Zou, Lihua; Hashizume, Rintaro; Meeks, Joshua J.; Shilatifard, Ali] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Louis, Nundia; He, Xingyao; Hashizume, Rintaro] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Savas, Jeffrey N.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Simpson Querrey Ctr Epigenet, Chicago, IL 60611 USA.; Shilatifard, A (corresponding author), Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA.	ash@northwestern.edu	Ntziachristos, Panagiotis/CAG-2071-2022; Zhao, Zibo/GWQ-3444-2022	Ozark, Patrick/0000-0002-4047-5102	Training Program in Signal Transduction and Cancer [T32 CA070085]; Robert H. Lurie Comprehensive Cancer Center-Translational Bridge Program Fellowship in Lymphoma Research; NCI [R50CA211428]; NIDCD [DC013805]; NCI's Outstanding Investigator Award [R35CA197569]; NATIONAL CANCER INSTITUTE [T32CA070085, R35CA197569, R50CA211428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013805] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003692] Funding Source: NIH RePORTER	Training Program in Signal Transduction and Cancer; Robert H. Lurie Comprehensive Cancer Center-Translational Bridge Program Fellowship in Lymphoma Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI's Outstanding Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank F. Zhang (MIT) for the kind gifts of the Px330 and lentiCRISPR v2 vectors. L.W. is supported by the Training Program in Signal Transduction and Cancer (T32 CA070085). Z.Z. is supported by the Robert H. Lurie Comprehensive Cancer Center-Translational Bridge Program Fellowship in Lymphoma Research. E.R.S. is supported by NCI grant R50CA211428. Studies in J.N.S.'s laboratory are supported by NIDCD grant DC013805, and studies related to COMPASS in A.S.'s laboratory are supported by NCI's Outstanding Investigator Award R35CA197569.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cha Y, 2013, CELL SIGNAL, V25, P1245, DOI 10.1016/j.cellsig.2013.01.016; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Cui TT, 2012, CARCINOGENESIS, V33, P2326, DOI 10.1093/carcin/bgs273; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2016, GENE DEV, V30, P2021, DOI 10.1101/gad.284109.116; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Klaus CR, 2014, J PHARMACOL EXP THER, V350, P646, DOI 10.1124/jpet.114.214577; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; LaFave LM, 2016, NAT MED, V22, P578, DOI 10.1038/nm.4094; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li WD, 2013, BLOOD, V121, P1478, DOI 10.1182/blood-2012-12-470559; Li Y, 2011, CANCER RES, V71, P6106, DOI 10.1158/0008-5472.CAN-10-4291; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohan M, 2012, CELL, V149, P498, DOI 10.1016/j.cell.2012.03.025; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Morgan MA, 2013, MOL CELL BIOL, V33, P1698, DOI 10.1128/MCB.00203-13; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Qin S, 2014, ONCOL REP, V31, P2351, DOI 10.3892/or.2014.3109; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schoumacher M, 2016, NAT MED, V22, P577, DOI 10.1038/nm.4098; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Nguyen TMH, 2016, GYNECOL ONCOL, V140, P545, DOI 10.1016/j.ygyno.2015.12.006; Toska E, 2017, SCIENCE, V355, P1324, DOI 10.1126/science.aah6893; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Wang L, 2017, GENE DEV, V31, P2056, DOI 10.1101/gad.306092.117; Wang S, 2015, ONCOGENE, V34, P2575, DOI 10.1038/onc.2014.201; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	93	95	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					758	+		10.1038/s41591-018-0034-6	http://dx.doi.org/10.1038/s41591-018-0034-6			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29785026	Green Accepted			2022-12-27	WOS:000434281300021
J	Stower, H				Stower, Hannah			A beneficial inflammation	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1189	1189		10.1038/s41591-019-0554-8	http://dx.doi.org/10.1038/s41591-019-0554-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388179	Bronze			2022-12-27	WOS:000480414600011
J	Segovia, C; San Jose-Eneriz, E; Munera-Maravilla, E; Martinez-Fernandez, M; Garate, L; Miranda, E; Vilas-Zornoza, A; Lodewijk, I; Rubio, C; Segrelles, C; Valcarcel, LV; Rabal, O; Casares, N; Bernardini, A; Suarez-Cabrera, C; Lopez-Calderon, FF; Fortes, P; Casado, JA; Duenas, M; Villacampa, F; Lasarte, JJ; Guerrero-Ramos, F; de Velasco, G; Oyarzabal, J; Castellano, D; Agirre, X; Prosper, F; Paramio, JM				Segovia, Cristina; San Jose-Eneriz, Edurne; Munera-Maravilla, Ester; Martinez-Fernandez, Monica; Garate, Leire; Miranda, Estibaliz; Vilas-Zornoza, Amaia; Lodewijk, Iris; Rubio, Carolina; Segrelles, Carmen; Vitores Valcarcel, Luis; Rabal, Obdulia; Casares, Noelia; Bernardini, Alejandra; Suarez-Cabrera, Cristian; Lopez-Calderon, Fernando F.; Fortes, Puri; Casado, Jose A.; Duenas, Marta; Villacampa, Felipe; Jose Lasarte, Juan; Guerrero-Ramos, Felix; de Velasco, Guillermo; Oyarzabal, Julen; Castellano, Daniel; Agirre, Xabier; Prosper, Felipe; Paramio, Jesus M.			Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression	NATURE MEDICINE			English	Article							CISPLATIN-INELIGIBLE PATIENTS; PIK3CA GENE ALTERATIONS; SINGLE-ARM; PEMBROLIZUMAB; THERAPY; MULTICENTER; EXPRESSION	Bladder cancer is lethal in its advanced, muscle-invasive phase with very limited therapeutic advances(1,2). Recent molecular characterization has defined new (epi) genetic drivers and potential targets for bladder cancer(3,4). The immune checkpoint inhibitors have shown remarkable efficacy but only in a limited fraction of bladder cancer patients(5-8). Here, we show that high G9a (EHMT2) expression is associated with poor clinical outcome in bladder cancer and that targeting G9a/DNMT methyltransferase activity with a novel inhibitor (CM-272) induces apoptosis and immunogenic cell death. Using an immunocompetent quadruple-knockout (Pten(loxP/loxP); Trp53(loxP/loxP); Rb1(loxP/loxP); Rbl1(-/-)) transgenic mouse model of aggressive metastatic, muscle-invasive bladder cancer, we demonstrate that CM-272 + cisplatin treatment results in statistically significant regression of established tumors and metastases. The antitumor effect is significantly improved when CM-272 is combined with anti-programmed cell death ligand 1, even in the absence of cisplatin. These effects are associated with an endogenous antitumor immune response and immunogenic cell death with the conversion of a cold immune tumor into a hot tumor. Finally, increased G9a expression was associated with resistance to programmed cell death protein 1 inhibition in a cohort of patients with bladder cancer. In summary, these findings support new and promising opportunities for the treatment of bladder cancer using a combination of epigenetic inhibitors and immune checkpoint blockade.	[Segovia, Cristina; Munera-Maravilla, Ester; Martinez-Fernandez, Monica; Lodewijk, Iris; Segrelles, Carmen; Bernardini, Alejandra; Lopez-Calderon, Fernando F.; Duenas, Marta; Castellano, Daniel; Paramio, Jesus M.] CIEMAT, Mol Oncol Unit, Madrid, Spain; [Segovia, Cristina; San Jose-Eneriz, Edurne; Martinez-Fernandez, Monica; Garate, Leire; Miranda, Estibaliz; Vilas-Zornoza, Amaia; Rubio, Carolina; Segrelles, Carmen; Vitores Valcarcel, Luis; Bernardini, Alejandra; Lopez-Calderon, Fernando F.; Duenas, Marta; Villacampa, Felipe; Castellano, Daniel; Agirre, Xabier; Prosper, Felipe; Paramio, Jesus M.] Ctr Invest Biomed Red Canc, Madrid, Spain; [Segovia, Cristina; Munera-Maravilla, Ester; Martinez-Fernandez, Monica; Rubio, Carolina; Suarez-Cabrera, Cristian; Lopez-Calderon, Fernando F.; Duenas, Marta; Villacampa, Felipe; Guerrero-Ramos, Felix; de Velasco, Guillermo; Paramio, Jesus M.] Univ Hosp 12 Octubre, Inst Biomed Res, Madrid, Spain; [San Jose-Eneriz, Edurne; Miranda, Estibaliz; Vilas-Zornoza, Amaia; Vitores Valcarcel, Luis; Agirre, Xabier; Prosper, Felipe] Univ Navarra, IDISNA, Ctr Invest Med Aplicada, Hematooncol Program, Pamplona, Spain; [Garate, Leire; Prosper, Felipe] Univ Navarra, Clin Univ Navarra, Hematol & Cell Therapy Dept, Pamplona, Spain; [Vitores Valcarcel, Luis] Univ Navarra, TECNUN, San Sebastian, Spain; [Rabal, Obdulia; Oyarzabal, Julen] Univ Navarra, Ctr Invest Med Aplicada, Small Mol Discovery Platform, Mol Therapeut Program, Pamplona, Spain; [Casares, Noelia; Jose Lasarte, Juan] Univ Navarra, IDISNA, Ctr Invest Med Aplicada, Immunol & Immunotherapy Program, Pamplona, Spain; [Fortes, Puri] Univ Navarra, IDISNA, Ctr Invest Med Aplicada, Gene Therapy & Regulat Gene Express Program, Pamplona, Spain; [Casado, Jose A.] Inst Invest Sanitaria Fdn Jimenez Diaz, Ctr Invest Biomed Red Enfermedades Raras & Adv Th, Div Hematopoiet Innovat Therapies CIEMAT, Madrid, Spain; [Guerrero-Ramos, Felix] Univ Hosp 12 Octubre, Urol Dept, Madrid, Spain; [de Velasco, Guillermo; Castellano, Daniel] Univ Hosp 12 Octubre, Med Oncol Dept, Madrid, Spain; [Martinez-Fernandez, Monica] Univ Santiago de Compostela, Mobile Genomes & Dis Lab CIMUS, La Coruna, Spain	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario 12 de Octubre; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Fundacion Jimenez Diaz; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Universidade de Santiago de Compostela	Paramio, JM (corresponding author), CIEMAT, Mol Oncol Unit, Madrid, Spain.; Agirre, X; Prosper, F; Paramio, JM (corresponding author), Ctr Invest Biomed Red Canc, Madrid, Spain.; Paramio, JM (corresponding author), Univ Hosp 12 Octubre, Inst Biomed Res, Madrid, Spain.; Agirre, X; Prosper, F (corresponding author), Univ Navarra, IDISNA, Ctr Invest Med Aplicada, Hematooncol Program, Pamplona, Spain.; Prosper, F (corresponding author), Univ Navarra, Clin Univ Navarra, Hematol & Cell Therapy Dept, Pamplona, Spain.	xaguirre@unav.es; fprosper@unav.es; jesusm.paramio@ciemat.es	Lasarte, Juan José/AAN-6548-2020; Bernardini, Alejandra L/S-4285-2018; Fortes, Puri/J-7872-2016; Cabrera, Cristian Suárez/S-4235-2018; Prosper, Felipe/H-6859-2017; Rubio Martin, Carolina Rubio/H-4709-2015; Paramio, Jesus M/M-8482-2014; segovia, cristina/H-2532-2015; Agirre, Xabier/ABE-4110-2020; Rubio, Carolina/GLT-0837-2022; Vilas-Zornoza, Amaia/AAD-4004-2020; Casares, Noelia/AAA-5568-2019; San Jose-Eneriz, Edurne/AAD-7288-2020; Oyarzabal, Julen/K-7393-2017; Casado, Jose A/H-5077-2015	Lasarte, Juan José/0000-0003-1641-3881; Bernardini, Alejandra L/0000-0001-5722-9904; Fortes, Puri/0000-0001-7571-6220; Cabrera, Cristian Suárez/0000-0003-1897-1596; Prosper, Felipe/0000-0001-6115-8790; Rubio Martin, Carolina Rubio/0000-0003-0098-2297; Paramio, Jesus M/0000-0001-7520-3177; segovia, cristina/0000-0003-3027-5905; Vilas-Zornoza, Amaia/0000-0001-6693-0989; Casares, Noelia/0000-0003-3817-6434; San Jose-Eneriz, Edurne/0000-0001-5786-5273; Valcarcel, Luis Vitores/0000-0003-3769-5419; Duenas, Marta/0000-0003-0857-9726; Villacampa, Felipe/0000-0001-6779-6945; Guerrero-Ramos, Felix/0000-0002-0767-3465; Lodewijk, Iris/0000-0002-5208-8249; Oyarzabal, Julen/0000-0003-1941-7255; Casado, Jose A/0000-0003-2479-1508	European Regional Development Fund (FEDER) grants from MINECO [SAF2015-66015-R, SAF2016-78568-R]; Instituto de Salud Carlos III [RD12/0036/0009, RD12/0036/0068, PI14/01867, PI16/02024, PI17/00701, CB16/12/00489, CB16/12/00228]; Departamento de Salud del Gobierno de Navarra [40/2016]; Gobierno de Navarra Industria [0011-1411-2017-000028, 0011-1411-2017-000029, 0011-1411-2017-000030]; Gobierno de Navarra Industria (Proyecto DIANA); Fundacion Fuentes Dutor; Fundacion La Caixa Hepacare Project	European Regional Development Fund (FEDER) grants from MINECO; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Departamento de Salud del Gobierno de Navarra; Gobierno de Navarra Industria; Gobierno de Navarra Industria (Proyecto DIANA); Fundacion Fuentes Dutor; Fundacion La Caixa Hepacare Project	We acknowledge the patients and their families. We particularly thank all the people from the Paramio and Prosper laboratories for discussion and suggestions. We express our acknowledgement to F.X. Real (CNIO) for his critical reading of the manuscript and helpful comments. This study was cofunded by European Regional Development Fund (FEDER) grants from MINECO (no. SAF2015-66015-R to J.M.P. and no. SAF2016-78568-R to J.J.L.), Instituto de Salud Carlos III (RETIC no. RD12/0036/0009 to J.M.P., RTICC no. RD12/0036/0068 to F.P., no. PI14/01867 to F.P., no. PI16/02024 to X. A., no. PI17/00701 to F.P., CIBERONC no. CB16/12/00489 to F.P., CIBERONC no. CB16/12/00228 to J.M.P. and ERANET-TRANSCAN-2 EPICA to F.P.), Departamento de Salud del Gobierno de Navarra no. 40/2016 to X.A. and Gobierno de Navarra Industria (0011-1411-2017-000028; 0011-1411-2017-000029; 0011-1411-2017-000030; Proyecto DIANA to F.P.). We also thank the Fundacion Fuentes Dutor (to J.O.) and Fundacion La Caixa Hepacare Project (to J.J.L.) for financial support.	Apaolaza I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00555-y; Balar AV, 2017, LANCET ONCOL, V18, P1483, DOI 10.1016/S1470-2045(17)30616-2; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Barcena-Varela M, 2019, HEPATOLOGY, V69, P587, DOI 10.1002/hep.30168; Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683; Casciello F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00487; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Costa C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00828; Coward WR, 2018, AM J RESP CELL MOL, V58, P449, DOI 10.1165/rcmb.2017-0286OC; Cribbs A, 2018, J BIOL CHEM, V293, P2422, DOI 10.1074/jbc.RA117.000698; Duenas M, 2015, MOL CARCINOGEN, V54, P566, DOI 10.1002/mc.22125; Earl J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1450-3; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138390; Li X, 2017, J AUTOIMMUN, V80, P85, DOI 10.1016/j.jaut.2017.02.007; Martinez-Fernandez M, 2015, ONCOTARGET, V6, P42258, DOI 10.18632/oncotarget.5546; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Mozzetta C., MOL CELL; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Plimack ER, 2017, LANCET ONCOL, V18, P212, DOI 10.1016/S1470-2045(17)30007-4; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Roman-Gomez J, 2009, J CLIN ONCOL, V27, P1316, DOI 10.1200/JCO.2008.19.3441; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Rubio C, 2019, CLIN CANCER RES, V25, P390, DOI 10.1158/1078-0432.CCR-18-0685; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; Santos M, 2014, CANCER RES, V74, P6565, DOI 10.1158/0008-5472.CAN-14-1218; Segovia C, 2017, ONCOTARGET, V8, P10531, DOI 10.18632/oncotarget.14453; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Stone ML, 2017, P NATL ACAD SCI USA, V114, pE10981, DOI 10.1073/pnas.1712514114; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweis RF, 2014, ACS MED CHEM LETT, V5, P205, DOI 10.1021/ml400496h; Topper MJ, 2017, CELL, V171, P1284, DOI 10.1016/j.cell.2017.10.022; Wang Y, 2008, CANCER RES, V68, P1136, DOI 10.1158/0008-5472.CAN-07-5021; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Zibelman M, 2016, FUTURE ONCOL, V12, P2227, DOI 10.2217/fon-2016-0135	44	80	81	2	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1073	+		10.1038/s41591-019-0499-y	http://dx.doi.org/10.1038/s41591-019-0499-y			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270502				2022-12-27	WOS:000474430400020
J	Lu, LL; Smith, MT; Yu, KKQ; Luedemann, C; Suscovich, TJ; Grace, PS; Cain, A; Yu, WH; McKitrick, TR; Lauffenburger, D; Cummings, RD; Mayanja-Kizza, H; Hawn, TR; Boom, WH; Stein, CM; Fortune, SM; Seshadri, C; Alter, G				Lu, Lenette L.; Smith, Malisa T.; Yu, Krystle K. Q.; Luedemann, Corinne; Suscovich, Todd J.; Grace, Patricia S.; Cain, Adam; Yu, Wen Han; McKitrick, Tanya R.; Lauffenburger, Douglas; Cummings, Richard D.; Mayanja-Kizza, Harriet; Hawn, Thomas R.; Boom, W. Henry; Stein, Catherine M.; Fortune, Sarah M.; Seshadri, Chetan; Alter, Galit			IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure	NATURE MEDICINE			English	Article							T-CELLS; MICROARRAY STRATEGY; B-CELLS; INFECTION; ANTIBODIES; VACCINE; PROTECTION; CONTACTS; ACTIVATION; PREVENTION	Exposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical outcomes including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb infection is identified using the tuberculin skin test and interferon-gamma (IFN-gamma) release assay IGRA, and a positive result may prompt chemoprophylaxis to prevent progression to tuberculosis. In the present study, we report on a cohort of Ugandan individuals who were household contacts of patients with TB. These individuals were highly exposed to Mtb but tested negative disease by IFN-gamma release assay and tuberculin skin test, 'resisting' development of classic LTBI. We show that 'resisters' possess IgM, class-switched IgG antibody responses and non-IFN-gamma T cell responses to the Mtb-specific proteins ESAT6 and CFP10, immunologic evidence of exposure to Mtb. Compared to subjects with classic LTBI, 'resisters' display enhanced antibody avidity and distinct Mtb-specific IgG Fc profiles. These data reveal a distinctive adaptive immune profile among Mtb-exposed subjects, supporting an expanded definition of the host response to Mtb exposure, with implications for public health and the design of clinical trials.	[Lu, Lenette L.; Fortune, Sarah M.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Lu, Lenette L.; Luedemann, Corinne; Suscovich, Todd J.; Grace, Patricia S.; Cain, Adam; Yu, Wen Han; Fortune, Sarah M.; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Smith, Malisa T.; Yu, Krystle K. Q.; Hawn, Thomas R.; Seshadri, Chetan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Yu, Wen Han; Lauffenburger, Douglas] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [McKitrick, Tanya R.; Cummings, Richard D.] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda; [Boom, W. Henry; Stein, Catherine M.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Boom, W. Henry; Stein, Catherine M.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Stein, Catherine M.] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Makerere University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University	Alter, G (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Seshadri, C (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	seshadri@u.washington.edu; galter@mgh.harvard.edu	Mayanja-Kizza, Harriet/AAM-5372-2020; Stein, Catherine/P-9498-2019	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Stein, Catherine/0000-0002-9763-5023; Fortune, Sarah/0000-0001-7565-9975; Yu, Wen-Han/0000-0002-1671-9744; McKitrick, Tanya/0000-0002-1312-6089	Gates Foundation [OPP1109001, OPP1151840, OPP1156795]; Ragon Institute; Samana Cay MGH scholar program;  [K08-AI130357];  [U01-AI115642];  [R01-AI124348];  [P41GM103694]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI115642, K08AI130357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103694] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute; Samana Cay MGH scholar program; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Gates Foundation for their support under the supplement no. OPP1109001 and grant nos. OPP1151840 and OPP1156795. We would also like to acknowledge the ongoing support from the Ragon Institute (to G.A. and S.M.F.) and the Samana Cay MGH scholar program to G.A. This work was supported by the following grants (grant no. K08-AI130357 to L.L.L., grant no. U01-AI115642 to W.H.B. and H.M.-K., grant no. R01-AI124348 to W.H.B., and C.M.S. and T.R.H. as multi-PI, and grant no. P41GM103694 to R.D.C.). We thank T. Ottenhoff and D. Lingwood for antigens and P. Sorger for access to the Operetta High-Content Imaging Fluorescence Microscope. We gratefully acknowledge the invaluable contribution made by the Kawempe study team's medical officers, health visitors, laboratory and data personnel in Uganda and the United States. The present study would not have been possible without the generous participation of the Ugandan patients with TB and their families. Finally, we would also like to sincerely thank the initial catalysts of this project, G. Kaplan and W. Hannekom, and K. Makar and the Gates Foundation Discovery Team for all their support.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Arias-Bouda LMP, 2003, CLIN DIAGN LAB IMMUN, V10, P702, DOI 10.1128/CDLI.10.4.702-709.2003; Barber DL, 2010, BLOOD, V116, P3485, DOI 10.1182/blood-2010-05-286336; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chheng P, 2015, CLIN EPIDEMIOL, V7, P411, DOI 10.2147/CLEP.S82389; Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x; Chung AW, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0380-3; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; De Rosa SC, 2012, CYTOM PART A, V81A, P1019, DOI 10.1002/cyto.a.22218; DEVADATT.S, 1970, B WORLD HEALTH ORGAN, V42, P337; DICKIE HA, 1950, ANN INTERN MED, V33, P941, DOI 10.7326/0003-4819-33-4-941; Finak G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003806; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, J IMMUNOL, V155, P2515; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Hanifa Y, 2009, INT J TUBERC LUNG D, V13, P39; Hatherill M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0015-2016; Heimburg-Molinaro J., 2011, CURR PROT PROTEIN SC, V64, P1; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Ladel CH, 1997, INFECT IMMUN, V65, P1936, DOI 10.1128/IAI.65.5.1936-1938.1997; Li H, 2017, P NATL ACAD SCI USA, V114, P5023, DOI 10.1073/pnas.1611776114; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Ma NN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-352; Maglione PJ, 2008, J IMMUNOL, V180, P3329, DOI 10.4049/jimmunol.180.5.3329; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Mandalakas AM, 2012, INT J TUBERC LUNG D, V16, P1033, DOI 10.5588/ijtld.12.0027; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mayer-Barber KD, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018424; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Meermeier Erin W, 2018, F1000Res, V7, DOI 10.12688/f1000research.13224.1; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Myers JA, 1947, AM J NURS, V47, P661, DOI 10.2307/3457892; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Pierangeli SS, 2008, NAT PROTOC, V3, P840, DOI 10.1038/nprot.2008.48; Sakai S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005667; Sallin MA, 2017, CELL REP, V18, P3091, DOI 10.1016/j.celrep.2017.03.007; Schlottmann SA, 2006, J IMMUNOL METHODS, V309, P75, DOI 10.1016/j.jim.2005.11.019; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Seshadri C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175844; Seshadri C, 2015, J IMMUNOL, V195, P4595, DOI 10.4049/jimmunol.1501285; Simmons JD, 2018, NAT REV IMMUNOL, V18, P575, DOI 10.1038/s41577-018-0025-3; Song XZ, 2015, GLYCOCONJUGATE J, V32, P465, DOI 10.1007/s10719-015-9584-8; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Stein CM, 2019, CLIN INFECT DIS, V68, P1705, DOI 10.1093/cid/ciy751; Stein CM, 2018, AM J EPIDEMIOL, V187, P1477, DOI 10.1093/aje/kwx380; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Walker NF, 2013, FUTURE VIROL, V8, P57, DOI 10.2217/FVL.12.123; Wallis RS, 2016, FRONT MICROBIOL, V7, DOI [10.3359/fmicb.2016.00669, 10.3389/fmicb.2016.00669]; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	62	103	106	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					977	+		10.1038/s41591-019-0441-3	http://dx.doi.org/10.1038/s41591-019-0441-3			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31110348	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000470844400030
J	Sullivan, RJ; Hamid, O; Gonzalez, R; Infante, JR; Patel, MR; Hodi, FS; Lewis, KD; Tawbi, HA; Hernandez, G; Wongchenko, MJ; Chang, YM; Roberts, L; Ballinger, M; Yan, YB; Cha, E; Hwu, P				Sullivan, Ryan J.; Hamid, Omid; Gonzalez, Rene; Infante, Jeffrey R.; Patel, Manish R.; Hodi, F. Stephen; Lewis, Karl D.; Tawbi, Hussein A.; Hernandez, Genevive; Wongchenko, Matthew J.; Chang, YiMeng; Roberts, Louise; Ballinger, Marcus; Yan, Yibing; Cha, Edward; Hwu, Patrick			Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients	NATURE MEDICINE			English	Article							SIGNALING PATHWAY; T-CELL; DOUBLE-BLIND; OPEN-LABEL; INHIBITION; PEMBROLIZUMAB; DABRAFENIB; COMBINATION; IPILIMUMAB; EXPRESSION	Melanoma treatment has progressed in the past decade with the development and approval of immune checkpoint inhibitors targeting programmed death 1 (PD-1) or its ligand (PD-L1) and cytotoxic T lymphocyte-associated antigen 4, as well as small molecule inhibitors of BRAF and/or MEK for the subgroup of patients with BRAF(V600) mutations(1-9). BRAF/MEK-targeted therapies have effects on the tumor microenvironment that support their combination with PD-1/PD-L1 inhibitors(10-20). This phase Ib study (ClinicalTrials.gov, number NCT01656642) evaluated the safety and anti-tumor activity of combining atezolizumab (anti-PD-L1) with vemurafenib (BRAF inhibitor), or cobimetinib (MEK inhibitor) + vemurafenib, in patients with BRAF(V600)-mutated metastatic melanoma. Triple combination therapy with atezolizumab + cobimetinib + vemurafenib, after a 28-d run-in period with cobimetinib + vemurafenib, had substantial but manageable toxicity. Exploratory biomarker data show that the cobimetinib + vemurafenib run-in was associated with an increase in proliferating CD4(+) T-helper cells but not with an increase in T-regulatory cells, as observed in the vemurafenib-only runin period. The confirmed objective response rate was 71.8% (95% confidence interval 55.1-85.0). The estimated median duration of response was 17.4 months (95% confidence interval 10.6-25.3) with ongoing response in 39.3% of patients after 29.9 months of follow-up. Further investigation in a phase III trial is underway.	[Sullivan, Ryan J.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA USA; [Gonzalez, Rene; Lewis, Karl D.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Infante, Jeffrey R.] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA; [Patel, Manish R.] Florida Canc Specialists & Res Inst, Sarah Cannon Res Inst, Sarasota, FL USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Tawbi, Hussein A.; Hwu, Patrick] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Hernandez, Genevive; Wongchenko, Matthew J.; Chang, YiMeng; Roberts, Louise; Ballinger, Marcus; Yan, Yibing; Cha, Edward] Genentech Inc, San Francisco, CA 94080 USA	Harvard University; Massachusetts General Hospital; Angeles Clinic & Research Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Sarah Cannon Research Institute; Tennessee Oncology; Florida Cancer Specialists; Sarah Cannon Research Institute; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; Genentech	Sullivan, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	rsullivan7@mgh.harvard.edu	gonzález, rene/W-2081-2019		S. Lecagoonporn (MD Anderson Cancer Center, Houston, TX, USA); F. Hoffmann-La Roche Ltd.	S. Lecagoonporn (MD Anderson Cancer Center, Houston, TX, USA); F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	Research support was provided by S. Lecagoonporn (MD Anderson Cancer Center, Houston, TX, USA). Medical writing support was provided by M. Sweetlove and J. Sah (ApotheCom, San Francisco, CA, USA) and was funded by F. Hoffmann-La Roche Ltd.	Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cooper ZA, 2014, CANCER IMMUNOL RES, V2, P643, DOI 10.1158/2326-6066.CIR-13-0215; Cooper ZA, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26615; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hamid O., 2015, PIGM CELL MELANOMA R, V28, P778; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Khalili JS, 2012, CLIN CANCER RES, V18, P5329, DOI 10.1158/1078-0432.CCR-12-1632; Kono M, 2006, MOL CANCER RES, V4, P779, DOI 10.1158/1541-7786.MCR-06-0077; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2017, EUR J CANCER, V72, pS122, DOI 10.1016/S0959-8049(17)30482-3; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Long GV, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12098; RAPISUWON S, 2018, J CLIN ONCOL S, V36; Ribas A, 2017, ANN ONCOL, V28, P428, DOI [10.1093/annonc/mdx377, DOI 10.1093/ANNONC/MDX377]; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Sapkota B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22890; Schilling B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25218; Sullivan R, 2016, J TRANSL MED, V14; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vella LJ, 2014, CANCER IMMUNOL RES, V2, P351, DOI 10.1158/2326-6066.CIR-13-0181; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wongchenko MJ, 2017, CLIN CANCER RES, V23, P5238, DOI 10.1158/1078-0432.CCR-17-0172	40	139	142	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					929	+		10.1038/s41591-019-0474-7	http://dx.doi.org/10.1038/s41591-019-0474-7			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171876				2022-12-27	WOS:000470844400023
J	Stower, H				Stower, Hannah			Understanding the effects of spaceflight	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					710	710		10.1038/s41591-019-0455-x	http://dx.doi.org/10.1038/s41591-019-0455-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068707	Bronze			2022-12-27	WOS:000468247800005
J	Sandrone, S; Moreno-Zambrano, D; Kipnis, J; van Gijn, J				Sandrone, Stefano; Moreno-Zambrano, Daniel; Kipnis, Jonathan; van Gijn, Jan			A (delayed) history of the brain lymphatic system	NATURE MEDICINE			English	Editorial Material							RAT		[Sandrone, Stefano] Imperial Coll London, Fac Med, Div Brain Sci, C3NL, London, England; [Moreno-Zambrano, Daniel] Univ Catolica Santiago Guayaquil, Guayaquil, Ecuador; [Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA USA; [van Gijn, Jan] Univ Utrecht, Utrecht, Netherlands	Imperial College London; University of Virginia; Utrecht University	Sandrone, S (corresponding author), Imperial Coll London, Fac Med, Div Brain Sci, C3NL, London, England.	sandrone.stefano@gmail.com	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X; Moreno-Zambrano, Daniel/0000-0002-0659-1011				Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738; ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843; Arieti S., 2008, DIZIONARIO BIOGRAFIC, V71; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; BRIERLEY JB, 1948, J ANAT, V82, P153; Catani M., 2015, BRAIN RENAISSANCE VE; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; Da Mesquita S, 2018, NEURON, V100, P375, DOI 10.1016/j.neuron.2018.09.022; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Di Matteo B, 2015, CLIN ORTHOP RELAT R, V473, P783, DOI 10.1007/s11999-014-3909-y; Foldi M., 1968, J VASC RES, V5, P250; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; LECCO V, 1953, Arch Ital Otol Rinol Laringol, V64, P287; Li JC, 1996, ANN ANAT, V178, P259, DOI 10.1016/S0940-9602(96)80059-8; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lukic IK, 2003, LANCET, V362, P2110, DOI 10.1016/S0140-6736(03)15114-8; Mascagni P, 1787, VASORUM LYMPHATICORU	18	37	39	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					538	540		10.1038/s41591-019-0417-3	http://dx.doi.org/10.1038/s41591-019-0417-3			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30948855				2022-12-27	WOS:000463342800005
J	Stower, H				Stower, Hannah			Remote neonate monitoring	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					541	541		10.1038/s41591-019-0429-z	http://dx.doi.org/10.1038/s41591-019-0429-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30948852	Bronze			2022-12-27	WOS:000463342800009
J	Baumann-Dudenhoeffer, AM; D'Souza, AW; Tarr, PI; Warner, BB; Dantas, G				Baumann-Dudenhoeffer, Aimee M.; D'Souza, Alaric W.; Tarr, Phillip I.; Warner, Barbara B.; Dantas, Gautam			Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes	NATURE MEDICINE			English	Article							INTESTINAL MICROBIOTA; HUMAN-MILK; DYNAMICS; FORMULAS; MOTHERS; PROTEIN; HEALTH; GROWTH	Commensal gut bacterial communities (microbiomes) are predicted to influence human health and disease(1,2). Neonatal gut microbiomes are colonized with maternal and environmental flora and mature toward a stable composition over 2-3 years(3,4). To study pre- and postnatal determinants of infant microbiome development, we analyzed 402 fecal metagenomes from 60 infants aged 0-8 months, using longitudinal generalized linear mixed models (GLMMs). Distinct microbiome signatures correlated with breastfeeding, formula ingredients, and maternal gestational weight gain (GWG). Amino acid synthesis pathway accretion in breastfed microbiomes complemented normative breastmilk composition. Prebiotic oligosaccharides, designed to promote breastfed-like microflora(5), predicted functional pathways distinct from breastfed infant microbiomes. Soy formula in six infants was positively associated with Lachnospiraceae and pathways suggesting a short-chain fatty acid (SCFA)-rich environment, including glycerol to 1-butanol fermentation, which is potentially dysbiotic. GWG correlated with altered carbohydrate degradation and enriched vitamin synthesis pathways. Maternal and postnatal antibiotics predicted microbiome alterations, while delivery route had no persistent effects. Domestic water source correlates suggest water may be an underap-preciated determinant of microbiome acquisition. Clinically important microbial pathways with statistically significant dietary correlates included dysbiotic markers(6,7), core entero-type features(8), and synthesis pathways for enteroprotective(9) and immunomodulatory(10,11) metabolites, epigenetic mediators(1), and developmentally critical vitamins(12), warranting further investigation.	[Baumann-Dudenhoeffer, Aimee M.; Warner, Barbara B.] Washington Univ, Sch Med, Dept Pediat, Div Newborn Med, St Louis, MO 63110 USA; [Baumann-Dudenhoeffer, Aimee M.; D'Souza, Alaric W.; Dantas, Gautam] Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA; [Tarr, Phillip I.] Washington Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, St Louis, MO 63110 USA; [Tarr, Phillip I.; Dantas, Gautam] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Dantas, Gautam] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Baumann-Dudenhoeffer, AM (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Newborn Med, St Louis, MO 63110 USA.; Baumann-Dudenhoeffer, AM; Dantas, G (corresponding author), Washington Univ, Sch Med, Edison Family Ctr Genome Sci & Syst Biol, St Louis, MO 63130 USA.; Dantas, G (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Dantas, G (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Dantas, G (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.	dudenhoeffer@wustl.edu; dantas@wustl.edu	D'Souza, Alaric Wences/AAA-3575-2022	D'Souza, Alaric Wences/0000-0002-8744-8136; Dantas, Gautam/0000-0003-0455-8370	Edward Mallinckrodt, Jr. Foundation; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R01GM099538]; National Institutes of Diabetes and Digestive and Kidney Diseases of the NIH [K08-DK102673]; Institutional Program Unifying Population and Laboratory-Based Sciences Burroughs Wellcome Fund; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [R01HD092414];  [P30DK052574]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK102673, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099538] Funding Source: NIH RePORTER	Edward Mallinckrodt, Jr. Foundation; National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Diabetes and Digestive and Kidney Diseases of the NIH; Institutional Program Unifying Population and Laboratory-Based Sciences Burroughs Wellcome Fund; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by awards to G.D. through the Edward Mallinckrodt, Jr. Foundation (Scholar Award), and the National Institute of General Medical Sciences (http://www.nigms.nih.gov/) of the National Institutes of Health (NIH) under award number R01GM099538. A.M.B.-D. was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases of the NIH under award number K08-DK102673. A.W.D. received support from the Institutional Program Unifying Population and Laboratory-Based Sciences Burroughs Wellcome Fund grant to Washington University. B.B.W. and P.I.T. received support for the cohort and sample collection from the Children's Discovery Institute of Washington University and St. Louis Children's Hospital, and P.I.T. is supported by P30DK052574 (Biobank Core). P.I.T., B.B.W., and G.D. are also supported in part by a grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (https://www.nichd.nih.gov/) of the NIH under award number R01HD092414. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. We would like to thank E. Martin, B. Koebbe, and J. Hoisington-Lopez from the Edison Family Center for Genome Sciences & Systems Biology at Washington University School of Medicine for technical support in highthroughput computing and sequencing. We would like to thank A. J. Gasparrini, B. Wang, and B. Berla for technical assistance in experimental and computational protocol optimization for whole-metagenome shotgun sequencing of fecal samples. We would like to thank I. M. Ndao, N. Shaikh, S. Patel, B. Wang, and S. X. Sun for archival and maintenance of frozen fecal sample inventory. We would like to thank F. S. Cole and members of the Dantas lab for general helpful discussions regarding the research presented in this manuscript, and K. Guilonard for helpful comments on the text.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Agostoni C, 2000, J AM COLL NUTR, V19, P434, DOI 10.1080/07315724.2000.10718943; Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P210, DOI http://10.1097/01.AOG.0000425668.87506.4c; Antony KM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.041; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2015, CELL HOST MICROBE, V17, P852, DOI 10.1016/j.chom.2015.05.012; Badurdeen S, 2015, PEDIATR RES, V77, P290, DOI 10.1038/pr.2014.177; Bauchart-Thevret C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1239, DOI 10.1152/ajpendo.91021.2008; Bhatia J, 2008, PEDIATRICS, V121, P1062, DOI 10.1542/peds.2008-0564; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butteiger DN, 2016, J NUTR, V146, P697, DOI 10.3945/jn.115.224196; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Choe EK, 2012, J KOREAN MED SCI, V27, P777, DOI 10.3346/jkms.2012.27.7.777; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Chu Derrick M, 2016, Genome Med, V8, P77, DOI 10.1186/s13073-016-0330-z; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; de Weerth C, 2013, PEDIATRICS, V131, pE550, DOI 10.1542/peds.2012-1449; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; Dias MF, 2018, WATER RES, V132, P79, DOI 10.1016/j.watres.2017.12.052; Fein SB, 2008, PEDIATRICS, V122, pS28, DOI 10.1542/peds.2008-1315c; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Gurnee EA, 2015, J INFECT DIS, V212, P1862, DOI 10.1093/infdis/jiv278; Haschke-Becher E, 2016, J INHERIT METAB DIS, V39, P25, DOI 10.1007/s10545-015-9870-4; Hu JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078257; Indrio F, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00178; Joo JWJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0903-6; Li ST, 2015, J FOOD SCI, V80, pM2530, DOI 10.1111/1750-3841.13086; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Ma J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4889; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; Moore AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0090-9; Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930; Oozeer R, 2013, AM J CLIN NUTR, V98, p561S, DOI 10.3945/ajcn.112.038893; Piacentini G, 2010, J PEDIATR GASTR NUTR, V51, P71, DOI 10.1097/MPG.0b013e3181dc8b02; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Prince AL, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023051; Robinson A, 2017, J PEDIATR GASTR NUTR, V65, P509, DOI 10.1097/MPG.0000000000001566; Sacchetti R, 2014, INT J HYG ENVIR HEAL, V217, P255, DOI 10.1016/j.ijheh.2013.06.002; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schwarzenberg SJ, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3716; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Singh S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0836-9; Stanislawski MA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0332-0; Vandenplas Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070731; Vazquez L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070727; Vitreschak AG, 2002, NUCLEIC ACIDS RES, V30, P3141, DOI 10.1093/nar/gkf433; Yang B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7592; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang ZY, 2013, NUTRIENTS, V5, P4800, DOI 10.3390/nu5124800; Zhou P, 2015, NUTRIENTS, V7, P7256, DOI 10.3390/nu7095334	55	104	104	5	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1822	+		10.1038/s41591-018-0216-2	http://dx.doi.org/10.1038/s41591-018-0216-2			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30374198	Green Accepted			2022-12-27	WOS:000452392200010
J	Kim, ST; Cristescu, R; Bass, AJ; Kim, KM; Odegaard, JI; Kim, K; Liu, XQ; Sher, XW; Jung, H; Lee, M; Lee, S; Park, SH; Park, JO; Park, YS; Lim, HY; Lee, H; Choi, M; Talasaz, A; Kang, PS; Cheng, J; Loboda, A; Lee, J; Kang, WK				Kim, Seung Tae; Cristescu, Razvan; Bass, Adam J.; Kim, Kyoung-Mee; Odegaard, Justin, I; Kim, Kyung; Liu, Xiao Qiao; Sher, Xinwei; Jung, Hun; Lee, Mijin; Lee, Sujin; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Lee, Hyuk; Choi, Mingew; Talasaz, Amirali; Kang, Peter Soonmo; Cheng, Jonathan; Loboda, Andrey; Lee, Jeeyun; Kang, Won Ki			Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer	NATURE MEDICINE			English	Article							MUTATIONAL PROCESSES; CARCINOMA; SIGNATURES; NIVOLUMAB; RECURRENT	Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifying determinants of response, we performed molecular characterization of tissues and circulating tumor DNA (ctDNA) from 61 patients with mGC who were treated with pembrolizumab as salvage treatment in a prospective phase 2 clinical trial. In patients with microsatellite instability-high and Epstein-Barr virus-positive tumors, which are mutually exclusive, dramatic responses to pembrolizumab were observed (overall response rate (ORR) 85.7% in microsatellite instability-high mGC and ORR 100% in Epstein-Barr virus-positive mGC). For the 55 patients for whom programmed death-ligand 1 (PD-L1) combined positive score positivity was available (combined positive score cut-off value >= 1%), ORR was significantly higher in PD-L1(+) gastric cancer when compared to PD-L1(-) tumors (50.0% versus 0.0%, P value <0.001). Changes in ctDNA levels at six weeks post-treatment predicted response and progression-free survival, and decreased ctDNA was associated with improved outcomes. Our findings provide insight into the molecular features associated with response to pembrolizumab in patients with mGC and provide biomarkers potentially relevant for the selection of patients who may derive greater benefit from PD-1 inhibition.	[Kim, Seung Tae; Kim, Kyung; Lee, Mijin; Lee, Sujin; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Lee, Jeeyun; Kang, Won Ki] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Cristescu, Razvan; Liu, Xiao Qiao; Sher, Xinwei; Jung, Hun; Kang, Peter Soonmo; Cheng, Jonathan; Loboda, Andrey] Merck & Co Inc, Kenilworth, NJ USA; [Bass, Adam J.] Dana Farber Canc Inst, Div Mol & Cellular Oncol, Boston, MA 02115 USA; [Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea; [Odegaard, Justin, I; Talasaz, Amirali] Guardant Hlth, Dept Med Affairs, Redwood City, CA USA; [Lee, Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Gastroenterol,Dept Med, Seoul, South Korea; [Choi, Mingew] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Merck & Company; Harvard University; Dana-Farber Cancer Institute; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J; Kang, WK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea.	jyunlee@skku.edu; wkkang@skku.edu	Park, Se Hoon/GMX-1199-2022; kim, st/O-5928-2014; Lee, Jee Yun/C-9646-2011	Park, Se Hoon/0000-0001-5084-9326; Sher, Xinwei/0000-0003-3977-3695; Cristescu, Razvan/0000-0002-9978-0339; Lee, Su Jin/0000-0003-3405-9935	MISP program at Merck Sharp & Dohme Corp., USA; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI16C1990]	MISP program at Merck Sharp & Dohme Corp., USA; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by the MISP program at Merck Sharp & Dohme Corp., USA, and a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI16C1990) (to J.L. and K.-M.K.). We thank D. Kaufman for drafting the manuscript. We thank J. Park at Samsung Medical Information and Media Servces at Samsung Medical Center for dedicated support with image work.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2018, INTERPRETATION MANUA, V2018; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Cho J, 2017, ONCOTARGET, V8, P13320, DOI 10.18632/oncotarget.14519; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Cristescu R, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.7_suppl.1; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Derks S, 2016, ONCOTARGET, V7, P32925, DOI 10.18632/oncotarget.9076; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fuchs CS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.4037; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuziora M., 2017, J CLIN ONCOL, V36; Kuziora MA, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-582; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Lee J, 2017, ONCOTARGET, V8, P66305, DOI 10.18632/oncotarget.19985; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Muro K, 2016, LANCET ONCOL, V17, P717, DOI 10.1016/S1470-2045(16)00175-3; Nevins JR, 2003, HUM MOL GENET, V12, pR153, DOI 10.1093/hmg/ddg287; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Sherry ST, 1999, GENOME RES, V9, P677; Song HJ, 2010, GASTROENTEROLOGY, V139, P84, DOI 10.1053/j.gastro.2010.04.002; Station W., 2015, KEYTRUDA PEMBROLIZUM; Terry S, 2017, MOL ONCOL, V11, P824, DOI 10.1002/1878-0261.12093; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163	36	689	723	8	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1449	+		10.1038/s41591-018-0101-z	http://dx.doi.org/10.1038/s41591-018-0101-z			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30013197				2022-12-27	WOS:000444174100030
J	Massaro, G; Mattar, CNZ; Wong, AMS; Sirka, E; Buckley, SMK; Herbert, BR; Karlsson, S; Perocheau, DP; Burke, D; Heales, S; Richard-Londt, A; Brandner, S; Huebecker, M; Priestman, DA; Platt, FM; Mills, K; Biswas, A; Cooper, JD; Chan, JKY; Cheng, SH; Waddington, SN; Rahim, AA				Massaro, Giulia; Mattar, Citra N. Z.; Wong, Andrew M. S.; Sirka, Ernestas; Buckley, Suzanne M. K.; Herbert, Bronwen R.; Karlsson, Stefan; Perocheau, Dany P.; Burke, Derek; Heales, Simon; Richard-Londt, Angela; Brandner, Sebastian; Huebecker, Mylene; Priestman, David A.; Platt, Frances M.; Mills, Kevin; Biswas, Arijit; Cooper, Jonathan D.; Chan, Jerry K. Y.; Cheng, Seng H.; Waddington, Simon N.; Rahim, Ahad A.			Fetal gene therapy for neurodegenerative disease of infants	NATURE MEDICINE			English	Article							PRENATAL-DIAGNOSIS; BETA-GLUCOSIDASE; FACTOR-IX; DELIVERY; EXPRESSION; ADULT; MICE; CELL; TRANSDUCTION; WIDESPREAD	For inherited genetic diseases, fetal gene therapy offers the potential of prophylaxis against early, irreversible and lethal pathological change. To explore this, we studied neuronopathic Gaucher disease (nGD), caused by mutations in GBA. In adult patients, the milder form presents with hepatomegaly, splenomegaly and occasional lung and bone disease; this is managed, symptomatically, by enzyme replacement therapy. The acute childhood lethal form of nGD is untreatable since enzyme cannot cross the blood-brain barrier. Patients with nGD exhibit signs consistent with hindbrain neurodegeneration, including neck hyperextension, strabismus and, often, fatal apnea(1). We selected a mouse model of nGD carrying a loxP-flanked neomycin disruption of Gba plus Cre recombinase regulated by the keratinocyte-specific K14 promoter. Exclusive skin expression of Gba prevents fatal neonatal dehydration. Instead, mice develop fatal neurodegeneration within 15 days(2). Using this model, fetal intracranial injection of adeno-associated virus (AAV) vector reconstituted neuronal glucocerebrosidase expression. Mice lived for up to at least 18 weeks, were fertile and fully mobile. Neurodegeneration was abolished and neuroinflammation ameliorated. Neonatal intervention also rescued mice but less effectively. As the next step to clinical translation, we also demonstrated the feasibility of ultrasound-guided global AAV gene transfer to fetal macaque brains.	[Massaro, Giulia; Rahim, Ahad A.] UCL, UCL Sch Pharm, London, England; [Mattar, Citra N. Z.; Biswas, Arijit; Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Wong, Andrew M. S.; Cooper, Jonathan D.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England; [Sirka, Ernestas; Mills, Kevin] UCL, UCL Great Ormond St Inst Child Hlth, London, England; [Buckley, Suzanne M. K.; Perocheau, Dany P.; Waddington, Simon N.] UCL, UCL Inst Womens Hlth, London, England; [Herbert, Bronwen R.] Imperial Coll London, Inst Reprod & Dev Biol, London, England; [Karlsson, Stefan] Lund Univ, Div Mol Med & Gene Therapy, Lund, Sweden; [Burke, Derek; Heales, Simon] Great Ormond St Hosp Sick Children, Paediat Lab Med, London, England; [Burke, Derek; Heales, Simon] UCL Great Ormond St Inst Child Hlth, London, England; [Richard-Londt, Angela; Brandner, Sebastian] UCL, UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Huebecker, Mylene; Priestman, David A.; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Cooper, Jonathan D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles Biomed Res Inst,Harbor UCLA Med Ctr, Torrance, CA USA; [Cooper, Jonathan D.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Med Sch, Canc & Stem Cell Biol, Singapore, Singapore; [Cheng, Seng H.] Sanofi, Framingham, MA USA; [Waddington, Simon N.] Univ Witwatersrand, Fac Hlth Sci, MRC Antiviral Gene Therapy Res Unit, Johannesburg, South Africa	University of London; University College London; National University of Singapore; University of London; King's College London; University of London; University College London; University of London; University College London; Imperial College London; Lund University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lundquist Institute; Washington University (WUSTL); KK Women's & Children's Hospital; National University of Singapore; Sanofi-Aventis; University of Witwatersrand	Waddington, SN (corresponding author), UCL, UCL Inst Womens Hlth, London, England.	s.waddington@ucl.ac.uk	Brandner, Sebastian/J-4562-2014; rahim, abdul/AAC-6745-2021; Cheng, Seng H/AAC-6564-2022; Cooper, Jonathan/V-9962-2019; Waddington, Simon/G-3778-2011	Brandner, Sebastian/0000-0002-9821-0342; rahim, abdul/0000-0002-0269-9156; Cooper, Jonathan/0000-0003-1339-4750; Waddington, Simon/0000-0003-4970-4730; Huebecker, Mylene/0000-0003-3030-7110; Massaro, Giulia/0000-0002-5986-6082; Platt, Frances/0000-0001-7614-0403; Mattar, Citra Nurfarah/0000-0003-0068-6957	UK Medical Research Council [G1000709]; SPARKS [17UCL01]; MRC [MR/R015325/1, MR/N026101/1]; NC3Rs grant [NC/L001780/1]; UK Gauchers Association; European Union's Horizon 2020 research and innovation program [666918]; Action Medical Research [GN2485]; MRC grant [MR/M00676X/1]; Asociacion Niemann Pick de Fuenlabrada; Niemann-Pick UK; Niemann Pick Research Foundation; NBIA Disorders Association; ERC grant 'Somabio' [260862]; Singapore Ministry of Health's National Medical Research Council [NMRC/TA/0003/2012, NMRC/CSA-INV/0012/2016]; Parkinson's UK grant [H-1501]; Royal Society Wolfson Research Merit Award; Mizutani Foundation for Glycoscience; Singapore's Ministry of Health's National Medical Research Council NMRC [CSA/043/2012, CSA(SI)/008/2016, CIRG/1459/2016]; European Union [666918]; Batten Disease Support and Research Association (US); Batten Disease Family Association (UK); Peto Foundation; National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre;  [MR/N019075/1];  [MR/P026494/1]; Medical Research Council [MR/R015325/1, MR/R025134/1, MR/N026101/1] Funding Source: researchfish; Rosetrees Trust [M576-F1] Funding Source: researchfish; MRC [MR/R025134/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SPARKS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NC3Rs grant(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); UK Gauchers Association; European Union's Horizon 2020 research and innovation program; Action Medical Research; MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asociacion Niemann Pick de Fuenlabrada; Niemann-Pick UK; Niemann Pick Research Foundation; NBIA Disorders Association; ERC grant 'Somabio'; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); Parkinson's UK grant; Royal Society Wolfson Research Merit Award(Royal Society of London); Mizutani Foundation for Glycoscience; Singapore's Ministry of Health's National Medical Research Council NMRC(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Batten Disease Support and Research Association (US); Batten Disease Family Association (UK); Peto Foundation; National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre(National Institute for Health Research (NIHR)); ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S.N.W., A.A.R. and J.D.C. received funding from UK Medical Research Council grant G1000709. S.N.W. received funding from MR/N019075/1 and MR/P026494/1 and SPARKS (17UCL01). A.A.R. and S.N.W. received funding from MRC grants MR/R015325/1 and MR/N026101/1 and NC3Rs grant NC/L001780/1. G.M., A.A.R. and S.N.W. received funding from the UK Gauchers Association. A.A.R. received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 666918 (BATCure), Action Medical Research (GN2485), MRC grant MR/M00676X/1, Asociacion Niemann Pick de Fuenlabrada, Niemann-Pick UK, Niemann Pick Research Foundation and the NBIA Disorders Association. S.M.K.B. and S.N.W. received funding from ERC grant 'Somabio' 260862. C.N.Z.M. received salary support from the Singapore Ministry of Health's National Medical Research Council NMRC/TA/0003/2012 and NMRC/CSA-INV/0012/2016. M.H. is supported by Parkinson's UK grant H-1501. F.M.P. is a Royal Society Wolfson Research Merit Award holder and a Wellcome Trust Investigator in Science. F.M.P. and D.A.P. were supported by the Mizutani Foundation for Glycoscience. J.K.Y.C. is funded by Singapore's Ministry of Health's National Medical Research Council NMRC CSA/043/2012, CSA(SI)/008/2016 and CIRG/1459/2016. J.D.C. received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 666918 (BATCure), the Batten Disease Support and Research Association (US) and Batten Disease Family Association (UK). K.M. received funding from the Peto Foundation. S.B. was supported by the National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre. We thank R. Baker, M. Choolani, N. Johana, N. Wen, B. Warburton, S. Richards, T. O'Mahoney, G. Sturges O. Woolmer, E.-H. Davies, T. Collin-Histed, A. Mehta and D. Hughes. Most of all, for guidance, mentorship and inspiration, we thank C. Coutelle.	Auray-Blais C, 2015, CLIN CHIM ACTA, V438, P195, DOI 10.1016/j.cca.2014.08.002; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; BARTON DJ, 1989, METABOLISM, V38, P1238, DOI 10.1016/0026-0495(89)90165-0; Cabrera-Salazar MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043310; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farfel- Becker T., 2013, HUM MOL GENET; Farfel- Becker T., 2011, HUM MOL GENET; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Gupta N, 2011, BLOOD CELL MOL DIS, V46, P75, DOI 10.1016/j.bcmd.2010.08.012; Haddad MR, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.27; Kim JY, 2014, JOVE-J VIS EXP, DOI 10.3791/51863; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mattar Citra N, 2012, Methods Mol Biol, V891, P249, DOI 10.1007/978-1-61779-873-3_12; Mattar CNZ, 2011, MOL THER, V19, P1950, DOI 10.1038/mt.2011.107; McCain L., 2015, BEST PRACT RES CLIN; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Mills K, 2005, RAPID COMMUN MASS SP, V19, P1739, DOI 10.1002/rcm.1977; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Nivsarkar MS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/397879; Passini MA, 2001, J VIROL, V75, P12382, DOI 10.1128/JVI.75.24.12382-12392.2001; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Pearson EG, 2013, SEMIN PEDIATR SURG, V22, P56, DOI 10.1053/j.sempedsurg.2012.10.010; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Rahim AA, 2012, GENE THER, V19, P936, DOI 10.1038/gt.2011.157; Rahim AA, 2009, GENE THER, V16, P509, DOI 10.1038/gt.2008.186; Rahim AA, 2011, FASEB J, V25, P3505, DOI 10.1096/fj.11-182311; Sardi S. P., 2011, P NATL ACAD SCI US; Sehara Y, 2017, HUM GENE THER CL DEV, V28, P74, DOI 10.1089/humc.2017.010; Tai D. S., 2015, GENE THER; Tardieu M., 2014, HUM GENE THER; U.S. National Institutes of Health. Recombinant DNA Advisory Committee, 2000, Hum Gene Ther, V11, P1211; Verma J, 2015, PRENATAL DIAG, V35, P1137, DOI 10.1002/pd.4663; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; WENGER DA, 1978, CLIN GENET, V13, P145; Zeevi DA, 2015, J CLIN INVEST, V125, P3757, DOI 10.1172/JCI79322; Zimmer KP, 1999, J PATHOL, V188, P407	43	87	88	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1317	+		10.1038/s41591-018-0106-7	http://dx.doi.org/10.1038/s41591-018-0106-7			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30013199	Green Submitted, Green Accepted			2022-12-27	WOS:000444174100011
J	Canadas, I; Thummalapalli, R; Kim, JW; Kitajima, S; Jenkins, RW; Christensen, CL; Campisi, M; Kuang, YN; Zhang, YX; Gjini, E; Zhang, G; Tian, T; Sen, DR; Miao, D; Imamura, Y; Thai, T; Piel, B; Terai, H; Aref, AR; Hagan, T; Koyama, S; Watanabe, M; Baba, H; Adeni, AE; Lydon, CA; Tamayo, P; Wei, Z; Herlyn, M; Barbie, TU; Uppaluri, R; Sholl, LM; Sicinska, E; Sands, J; Rodig, S; Wong, KK; Paweletz, CP; Watanabe, H; Barbie, DA				Canadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook; Kitajima, Shunsuke; Jenkins, Russell William; Christensen, Camilla Laulund; Campisi, Marco; Kuang, Yanan; Zhang, Yanxi; Gjini, Evisa; Zhang, Gao; Tian, Tian; Sen, Debattama Rai; Miao, Diana; Imamura, Yu; Tran Thai; Piel, Brandon; Terai, Hideki; Aref, Amir Reza; Hagan, Timothy; Koyama, Shohei; Watanabe, Masayuki; Baba, Hideo; Adeni, Anika Elise; Lydon, Christine Anne; Tamayo, Pablo; Wei, Zhi; Herlyn, Meenhard; Barbie, Thanh Uyen; Uppaluri, Ravindra; Sholl, Lynnette Marie; Sicinska, Ewa; Sands, Jacob; Rodig, Scott; Wong, Kwok Kin; Paweletz, Cloud Peter; Watanabe, Hideo; Barbie, David Allen			Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses	NATURE MEDICINE			English	Article							CANCER; CELLS; REVEALS; TARGET; HETEROGENEITY; TRANSCRIPTS; LANDSCAPE; MELANOMA; AGENTS; SENSE	Mesenchymal tumor subpopulations secrete pro-tumorigenic cytokines and promote treatment resistance(1-4). This phenomenon has been implicated in chemorefractory small cell lung cancer and resistance to targeted therapiess(5-8), but remains incompletely defined. Here, we identify a subclass of endogenous retroviruses (ERVs) that engages innate immune signaling in these cells. Stimulated 3 prime antisense retroviral coding sequences (SPARCS) are oriented inversely in 3' untranslated regions of specific genes enriched for regulation by STAT1 and EZH2. Derepression of these loci results in double-stranded RNA generation following IFN-gamma exposure due to bi-directional transcription from the STAT1-activated gene promoter and the 5' long terminal repeat of the antisense ERV. Engagement of MAVS and STING activates downstream TBK1, IRF3, and STAT1 signaling, sustaining a positive feedback loop. SPARCS induction in human tumors is tightly associated with major histocompatibility complex class 1 expression, mesenchymal markers, and downregulation of chromatin modifying enzymes, including EZH2. Analysis of cell lines with high inducible SPARCS expression reveals strong association with an AXL/MET-positive mesenchymal cell state. While SPARCS-high tumors are immune infiltrated, they also exhibit multiple features of an immune-suppressed microenviroment. Together, these data unveil a subclass of ERVs whose derepression triggers pathologic innate immune signaling in cancer, with important implications for cancer immunotherapy.	[Canadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook; Kitajima, Shunsuke; Jenkins, Russell William; Christensen, Camilla Laulund; Campisi, Marco; Zhang, Yanxi; Miao, Diana; Tran Thai; Piel, Brandon; Terai, Hideki; Adeni, Anika Elise; Lydon, Christine Anne; Barbie, Thanh Uyen; Uppaluri, Ravindra; Sands, Jacob; Wong, Kwok Kin; Barbie, David Allen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Jong Wook; Miao, Diana] Broad Inst Harvard & MIT, Cambridge, MA USA; [Jenkins, Russell William] Harvard Med Sch, Massachusetts Gen Hosp, Div Med Oncol, Canc Ctr, Boston, MA USA; [Kuang, Yanan; Aref, Amir Reza; Paweletz, Cloud Peter] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA; [Gjini, Evisa; Sholl, Lynnette Marie; Rodig, Scott] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Zhang, Gao; Herlyn, Meenhard] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA; [Zhang, Gao; Herlyn, Meenhard] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Tian, Tian; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Sen, Debattama Rai] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Imamura, Yu; Watanabe, Masayuki] Japanese Fdn Canc Res, Gastroenterol Surg, Canc Inst Hosp, Tokyo, Japan; [Imamura, Yu; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan; [Hagan, Timothy; Sicinska, Ewa] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA; [Koyama, Shohei] Osaka Univ, Dept Resp Med Allergy & Rheumat Dis, Grad Sch Med, Osaka, Japan; [Tamayo, Pablo] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Tamayo, Pablo] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Barbie, Thanh Uyen; Uppaluri, Ravindra] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Wong, Kwok Kin] NYU, Perlmutter Canc Ctr, Langone Med Ctr, New York, NY USA; [Watanabe, Hideo] Icahn Sch Med Mt Sinai, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Watanabe, Hideo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; The Wistar Institute; The Wistar Institute; New Jersey Institute of Technology; Harvard University; Dana-Farber Cancer Institute; Japanese Foundation for Cancer Research; Kumamoto University; Harvard University; Dana-Farber Cancer Institute; Osaka University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; New York University; NYU Langone Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Barbie, DA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	dbarbie@partners.org	Sen, Debattama/AAC-5679-2020; , AndyWei/H-4415-2012; Koyama, Shohei/AAU-4113-2021; Rodig, Scott/Y-3889-2019; uppaluri, ravi/AAU-2132-2020	Sen, Debattama/0000-0002-0947-8284; Koyama, Shohei/0000-0002-6897-9417; Thummalapalli, Rohit/0000-0002-8865-0299; CAMPISI, MARCO/0000-0002-9288-5285; Wei, Zhi/0000-0001-6059-4267; Sands, Jacob/0000-0003-4663-7464; Jenkins, Russell/0000-0001-6110-2148	NCI [R01 CA190394-02]; NIH [U01 CA2143A1-01, U01 CA217885, P01 CA114046, P01 CA025874, P30 CA010815, R01 CA047159]; Gloria T. Maheu, Steven J. Schaubert, and Heerwagen Family Funds for Lung Cancer Research; Rising Tide Foundation; NIH/NCI [P01CA120964, 5R01CA163896-04, 5R01CA140594-07, 5R01CA122794-10, 5R01CA166480-04]; Gross-Loh Family Fund for Lung Cancer Research; Susan Spooner Family Lung Cancer Research Fund at Dana-Farber Cancer Institute; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Melanoma Research Foundation; Cancer Center Support Grant [CA010815]; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2CAACR-DT1715]; American Association for Cancer Research, the Scientific Partner of SU2C; NATIONAL CANCER INSTITUTE [P01CA025874, P01CA114046, R01CA140594, U01CA214381, P30CA010815, R01CA047159, R01CA163896, K99CA201618, R01CA166480, P01CA120964, U01CA213333, U01CA217885, R01CA122794, R01CA190394, U24CA194107] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gloria T. Maheu, Steven J. Schaubert, and Heerwagen Family Funds for Lung Cancer Research; Rising Tide Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gross-Loh Family Fund for Lung Cancer Research; Susan Spooner Family Lung Cancer Research Fund at Dana-Farber Cancer Institute; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Melanoma Research Foundation; Cancer Center Support Grant; Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant; American Association for Cancer Research, the Scientific Partner of SU2C; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Albanell, A. Rovira, and E. Arriola (Hospital del Mar Medical Research Institute, Barcelona, Spain) for providing human SCLC cell lines and the H69/H69M cell model. We also thank W.G. Kaelin, Jr. (Dana-Farber Cancer Institute, Boston, MA) for providing human ccRCC cell lines. This work was supported by NCI-R01 CA190394-02 and NIH-U01 CA2143A1-01 (D.A.B.), the Gloria T. Maheu, Steven J. Schaubert, and Heerwagen Family Funds for Lung Cancer Research (D.A.B.), the Rising Tide Foundation (D.A.B.), NIH-U01 CA217885 (J.W.K., P.T.), NIH/NCI P01CA120964 (K.K.W.), 5R01CA163896-04 (K.K.W.), 5R01CA140594-07 (K.K.W.), 5R01CA122794-10 (K.K.W.), 5R01CA166480-04 (K.K.W.), the Gross-Loh Family Fund for Lung Cancer Research (K.K.W., D.A.B.), and the Susan Spooner Family Lung Cancer Research Fund at Dana-Farber Cancer Institute (K.K.W.). Additional funding was provided by NIH grants P01 CA114046, P01 CA025874, P30 CA010815, and R01 CA047159 and by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Melanoma Research Foundation. The support for Shared Resources used in this study was provided by Cancer Center Support Grant CA010815 (to The Wistar Institute). Additional support from a Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2CAACR-DT1715). Stand Up to Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the Scientific Partner of SU2C. R.T. is a Howard Hughes Medical Institute Medical Research Fellow.	Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Canadas I, 2014, CLIN CANCER RES, V20, P938, DOI 10.1158/1078-0432.CCR-13-1330; Carey CD, 2017, BLOOD, V130, P2420, DOI 10.1182/blood-2017-03-770719; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Henke C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0138-8; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Jenkins R. W., 2017, CANCER DISCOV, V8, P1; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kim JW, 2016, NAT BIOTECHNOL, V34, P539, DOI 10.1038/nbt.3527; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Poirier JT, 2015, ONCOGENE, V34, P5869, DOI 10.1038/onc.2015.38; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Rhodes DA, 2016, ANNU REV IMMUNOL, V34, P151, DOI 10.1146/annurev-immunol-041015-055435; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542	38	153	153	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1143	+		10.1038/s41591-018-0116-5	http://dx.doi.org/10.1038/s41591-018-0116-5			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30038220	Green Accepted, Green Submitted			2022-12-27	WOS:000440955500020
J	Ramanathan, DS; Guo, L; Gulati, T; Davidson, G; Hishinuma, AK; Won, SJ; Knight, RT; Chang, EF; Swanson, RA; Ganguly, K				Ramanathan, Dhakshin S.; Guo, Ling; Gulati, Tanuj; Davidson, Gray; Hishinuma, April K.; Won, Seok-Joon; Knight, Robert T.; Chang, Edward F.; Swanson, Raymond A.; Ganguly, Karunesh			Low-frequency cortical activity is a neuromodulatory target that tracks recovery after stroke	NATURE MEDICINE			English	Article							LOCAL-FIELD POTENTIALS; CEREBRAL-ARTERY OCCLUSION; PACED HAND MOVEMENTS; MOTOR CORTEX; ELECTRICAL-STIMULATION; ISCHEMIC INFARCT; LARGE-SCALE; RAT; PLASTICITY; DYNAMICS	Recent work has highlighted the importance of transient low-frequency oscillatory (LFO; <4Hz) activity in the healthy primary motor cortex during skilled upper-limb tasks. These brief bouts of oscillatory activity may establish the timing or sequencing of motor actions. Here, we show that LFOs track motor recovery post-stroke and can be a physiological target for neuromodulation. In rodents, we found that reach-related LFOs, as measured in both the local field potential and the related spiking activity, were diminished after stroke and that spontaneous recovery was closely correlated with their restoration in the perilesional cortex. Sensorimotor LFOs were also diminished in a human subject with chronic disability after stroke in contrast to two non-stroke subjects who demonstrated robust LFOs. Therapeutic delivery of electrical stimulation time-locked to the expected onset of LFOs was found to significantly improve skilled reaching in stroke animals. Together, our results suggest that restoration or modulation of cortical oscillatory dynamics is important for the recovery of upper-limb function and that they may serve as a novel target for clinical neuromodulation.	[Ramanathan, Dhakshin S.; Guo, Ling; Gulati, Tanuj; Davidson, Gray; Hishinuma, April K.; Won, Seok-Joon; Swanson, Raymond A.; Ganguly, Karunesh] San Francisco VA Med Ctr, Neurol Serv, San Francisco, CA 94121 USA; [Ramanathan, Dhakshin S.; Davidson, Gray] San Francisco VA Med Ctr, Mental Hlth Serv, San Francisco, CA USA; [Ramanathan, Dhakshin S.; Davidson, Gray] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Ramanathan, Dhakshin S.] VA San Diego Hlth Syst, Mental Hlth Serv, San Diego, CA USA; [Ramanathan, Dhakshin S.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Guo, Ling] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA; [Gulati, Tanuj; Hishinuma, April K.; Won, Seok-Joon; Swanson, Raymond A.; Ganguly, Karunesh] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Chang, Edward F.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Ganguly, K (corresponding author), San Francisco VA Med Ctr, Neurol Serv, San Francisco, CA 94121 USA.; Ganguly, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	karunesh.ganguly@ucsf.edu	Gulati, Tanuj/AAA-3304-2019	Gulati, Tanuj/0000-0003-3243-7883; Guo, Ling/0000-0001-8394-4338; Ganguly, Karunesh/0000-0002-2570-9943	National Institute of Neurological Disorders and Stroke, NIH [1K99NS097620]; A*STAR; Department of Veterans Affairs, Veterans Health Administration (VA Merit) [1I01RX001640]; Department of Veterans Affairs, Veterans Health Administration (Career Development Award) [7IK2BX003308]; National Institute of Mental Health, NIH [5R01MH111871]; UCSF Department of Neurology; Burroughs Wellcome Fund [1015644, 1009855]; Independent Scientist Award from the National Institute of Neurological Disorders and Stroke, NIH [1K02NS093014]; NIH [R37NS21135]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135, K99NS097620, K02NS093014, R00NS097620, R01NS081149] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001640, IK2BX003308] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); A*STAR(Agency for Science Technology & Research (A*STAR)); Department of Veterans Affairs, Veterans Health Administration (VA Merit)(US Department of Veterans Affairs); Department of Veterans Affairs, Veterans Health Administration (Career Development Award)(US Department of Veterans Affairs); National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCSF Department of Neurology; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Independent Scientist Award from the National Institute of Neurological Disorders and Stroke, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by awards from the National Institute of Neurological Disorders and Stroke, NIH (Pathway to Independence Award to T.G., 1K99NS097620), A*STAR (fellowship to L.G.), Department of Veterans Affairs, Veterans Health Administration (VA Merit: 1I01RX001640 to K.G., Career Development Award: 7IK2BX003308 to D.S.R.) and National Institute of Mental Health, NIH (5R01MH111871 to K.G.); and start-up funds from the UCSF Department of Neurology to K.G.; and a Career Award for Medical Scientists from the Burroughs Wellcome Fund to D.S.R. (1015644). K.G. also holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund (1009855) and an Independent Scientist Award (1K02NS093014) from the National Institute of Neurological Disorders and Stroke, NIH. This human work was also supported by a grant from the NIH (R37NS21135 to R.T.K.).	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Allman C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5651; [Anonymous], 1984, PREPARATORY STATES P; Bansal AK, 2011, J NEUROPHYSIOL, V105, P1603, DOI 10.1152/jn.00532.2010; Berenyi A, 2012, SCIENCE, V337, P735, DOI 10.1126/science.1223154; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chang EF, 2015, NEURON, V86, P68, DOI 10.1016/j.neuron.2015.03.037; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; Cowley BR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066012; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Elsner B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009645.pub3; Flint RD, 2016, J NEUROSCI, V36, P3623, DOI 10.1523/JNEUROSCI.2339-15.2016; Flint RD, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056005; Flint RD, 2012, J NEUROPHYSIOL, V108, P18, DOI 10.1152/jn.00832.2011; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Gharbawie OA, 2005, NEUROSCIENCE, V130, P601, DOI 10.1016/j.neuroscience.2004.10.010; Godlove J, 2016, ANN CLIN TRANSL NEUR, V3, P956, DOI 10.1002/acn3.368; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Gulati T, 2017, NAT NEUROSCI, V20, P1277, DOI 10.1038/nn.4601; Gulati T, 2015, J NEUROSCI, V35, P8653, DOI 10.1523/JNEUROSCI.5007-14.2015; Gulati T, 2014, NAT NEUROSCI, V17, P1107, DOI 10.1038/nn.3759; Hall TM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6462; Hall TM, 2014, NEURON, V83, P1185, DOI 10.1016/j.neuron.2014.07.022; HASHIMOTO S, 1979, EXP NEUROL, V65, P218, DOI 10.1016/0014-4886(79)90262-0; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Kargo WJ, 2004, J NEUROSCI, V24, P5560, DOI 10.1523/JNEUROSCI.0562-04.2004; Kitamura JI, 1996, ELECTROEN CLIN NEURO, V98, P149, DOI 10.1016/0013-4694(95)00218-9; Krasoulis A, 2014, IEEE ENG MED BIO, P1630, DOI 10.1109/EMBC.2014.6943917; Lafon B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01045-x; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Levy RM, 2016, NEUROREHAB NEURAL RE, V30, P107, DOI 10.1177/1545968315575613; Lim DH, 2014, J NEUROSCI, V34, P16455, DOI 10.1523/JNEUROSCI.3384-14.2014; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Mollazadeh M., 2009, 2009 4th International IEEE/EMBS Conference on Neural Engineering (NER 2009), P506, DOI 10.1109/NER.2009.5109344; Mollazadeh M, 2011, J NEUROSCI, V31, P15531, DOI 10.1523/JNEUROSCI.2999-11.2011; Nishibe M, 2015, NEUROREHAB NEURAL RE, V29, P472, DOI 10.1177/1545968314543499; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plautz EJ, 2016, NEUROREHAB NEURAL RE, V30, P159, DOI 10.1177/1545968315619701; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Ramanathan DS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002263; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Rockstroh B., 1989, SLOW CORTICAL POTENT; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; SASAKI K, 1981, EXP NEUROL, V72, P41, DOI 10.1016/0014-4886(81)90125-4; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Taplin AM, 2016, EPILEPSY BEHAV CASE, V5, P46, DOI 10.1016/j.ebcr.2016.03.003; Wallstrom G, 2008, J STAT SOFTW, V26, P1; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; Wong CC, 2015, J NEUROSCI METH, V246, P30, DOI 10.1016/j.jneumeth.2015.03.008; Yilmaz O, 2013, IEEE ENG MED BIO, P2216, DOI 10.1109/EMBC.2013.6609976; Yilmaz O, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01033; Yu B. M, 2009, ADV NEURAL INFORM PR, V21, P1881	70	51	51	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1257	+		10.1038/s41591-018-0058-y	http://dx.doi.org/10.1038/s41591-018-0058-y			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29915259	Green Accepted, Green Submitted			2022-12-27	WOS:000440955500031
J	Stower, H				Stower, Hannah			INFECTIOUS DISEASE An antiviral for smallpox	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1088	1088		10.1038/s41591-018-0152-1	http://dx.doi.org/10.1038/s41591-018-0152-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082865	Bronze			2022-12-27	WOS:000440955500007
J	Ruess, DA; Heynen, GJ; Ciecielski, KJ; Ai, JY; Berninger, A; Kabacaoglu, D; Gorgulu, K; Dantes, Z; Wormann, SM; Diakopoulos, KN; Karpathaki, AF; Kowalska, M; Kaya-Aksoy, E; Song, L; van der Laan, EAZ; Lopez-Alberca, MP; Nazare, M; Reichert, M; Saur, D; Erkan, MM; Hopt, UT; Sainz, B; Birchmeier, W; Schmid, RM; Lesina, M; Algul, H				Ruess, Dietrich A.; Heynen, Guus J.; Ciecielski, Katrin J.; Ai, Jiaoyu; Berninger, Alexandra; Kabacaoglu, Derya; Goerguelue, Kivanc; Dantes, Zahra; Woermann, Sonja M.; Diakopoulos, Kalliope N.; Karpathaki, Angeliki F.; Kowalska, Marlena; Kaya-Aksoy, Ezgi; Song, Liang; van der Laan, Eveline A. Zeeuw; Lopez-Alberca, Maria P.; Nazare, Marc; Reichert, Maximilian; Saur, Dieter; Erkan, Mert M.; Hopt, Ulrich T.; Sainz, Bruno, Jr.; Birchmeier, Walter; Schmid, Roland M.; Lesina, Marina; Alguel, Hana			Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase	NATURE MEDICINE			English	Article							MOUSE MODEL; PHOSPHOTYROSINE PHOSPHATASE; TYROSINE PHOSPHATASES; PANCREATIC-CANCER; COLON-CANCER; LUNG-CANCER; SHP2; INHIBITION; PROGRESSION; MEK	The ubiquitously expressed non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, is involved in signal transduction downstream of multiple growth factor, cytokine and integrin receptors(1). Its requirement for complete RAS-MAPK activation and its role as a negative regulator of JAK-STAT signaling have established SHP2 as an essential player in oncogenic signaling pathways(1-7). Recently, a novel potent allosteric SHP2 inhibitor was presented as a viable therapeutic option for receptor tyrosine kinase-driven cancers, but was shown to be ineffective in KRAS-mutant tumor cell lines in vitro(8). Here, we report a central and indispensable role for SHP2 in oncogenic KRAS-driven tumors. Genetic deletion of Ptpn11 profoundly inhibited tumor development in mutant KRAS-driven murine models of pancreatic ductal adenocarcinoma and non-small-cell lung cancer. We provide evidence for a critical dependence of mutant KRAS on SHP2 during carcinogenesis. Deletion or inhibition of SHP2 in established tumors delayed tumor progression but was not sufficient to achieve tumor regression. However, SHP2 was necessary for resistance mechanisms upon blockade of MEK. Synergy was observed when both SHP2 and MEK were targeted, resulting in sustained tumor growth control in murine and human patient-derived organoids and xenograft models of pancreatic ductal adenocarcinoma and non-small-cell lung cancer. Our data indicate the clinical utility of dual SHP2/MEK inhibition as a targeted therapy approach for KRAS-mutant cancers.	[Ruess, Dietrich A.; Ciecielski, Katrin J.; Ai, Jiaoyu; Berninger, Alexandra; Kabacaoglu, Derya; Goerguelue, Kivanc; Dantes, Zahra; Woermann, Sonja M.; Diakopoulos, Kalliope N.; Karpathaki, Angeliki F.; Kowalska, Marlena; Kaya-Aksoy, Ezgi; Song, Liang; Reichert, Maximilian; Saur, Dieter; Schmid, Roland M.; Lesina, Marina; Alguel, Hana] Tech Univ Munich, Klinikum Rechts Isar, Internal Med 2, Mildred Scheel Chair Tumor Metab, Munich, Germany; [Ruess, Dietrich A.; Hopt, Ulrich T.] Univ Freiburg, Med Ctr, Fac Med, Dept Surg, Freiburg, Germany; [Heynen, Guus J.; van der Laan, Eveline A. Zeeuw; Birchmeier, Walter] Helmholtz Soc, Max Delbruck Ctr Mol Med MDC, Canc Res Program, Berlin, Germany; [Lopez-Alberca, Maria P.; Nazare, Marc] Leibniz Forschungsinst Mol Pharmakol, Med Chem, Berlin, Germany; [Erkan, Mert M.] Koc Univ, Sch Med, Istanbul, Turkey; [Sainz, Bruno, Jr.] Univ Autonoma Madrid, Dept Biochem, Sch Med, Inst Invest Biomed Alberto Sols, Madrid, Spain	Technical University of Munich; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Koc University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Algul, H (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Internal Med 2, Mildred Scheel Chair Tumor Metab, Munich, Germany.	hana.alguel@mri.tum.de	Kabacaoglu, Derya/HDL-8563-2022; Görgülü, Kıvanç/AAV-6525-2020; Anding, Bruno Sainz/ABH-5365-2020; Reichert, Maximilian/GOH-1246-2022; Saur, Dieter/O-8355-2015; Nazare, Marc/AAD-6082-2022; Nazare, Marc/X-4996-2018; Ruess, Dietrich A./J-6983-2019; Lesina, Marina/AAV-3845-2020	Görgülü, Kıvanç/0000-0002-1613-1422; Anding, Bruno Sainz/0000-0003-4829-7651; Saur, Dieter/0000-0001-5874-0210; Nazare, Marc/0000-0002-1602-2330; Nazare, Marc/0000-0002-1602-2330; Ruess, Dietrich A./0000-0003-4371-2246; Kabacaoglu, Derya/0000-0002-3601-0265; Berninger, Alexandra/0000-0002-6494-2369; Diakopoulos, Kalliope/0000-0002-9236-0489; Zeeuw van der Laan, Eveline/0000-0002-2784-5236; Kaya Aksoy, Ezgi/0000-0002-9375-9686; Frank, Katrin Jana/0000-0002-7913-4794	Deutsche Forschungsgemeinschaft [DFG AL1174/5-1, LE3222/1-1]; Deutsche Krebshilfe [111646, 111464, 111273]; Wilhelm Sander Stiftung [2014.052.1]; Fundacion Asociacion Espanola Contra el Cancer	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander Stiftung; Fundacion Asociacion Espanola Contra el Cancer	We thank G.-S. Feng (Department of Pathology, School of Medicine, and Molecular Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA, USA) for sharing the Ptpn11<SUP>fl</SUP> allele. We also thank R. F. Braren and D. C. Karampinos (both Institute of Radiology, Klinikum rechts der Isar, Technische Universitat Munchen) for providing the infrastructure and A. Gupta for help with the setup for MRI studies. This work was supported by grants from Deutsche Forschungsgemeinschaft (DFG AL1174/5-1 to H.A. and LE3222/1-1 to M.L.), Deutsche Krebshilfe (no. 111646 and no. 111464 to H.A.; Max Eder Program no. 111273 to M.R.), the Wilhelm Sander Stiftung (2014.052.1 to H.A.) and the Fundacion Asociacion Espanola Contra el Cancer (to B.S.).	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alagesan B, 2015, CLIN CANCER RES, V21, P396, DOI 10.1158/1078-0432.CCR-14-1591; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Grosskopf S, 2015, CHEMMEDCHEM, V10, P815, DOI 10.1002/cmdc.201500015; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Infante JR, 2014, EUR J CANCER, V50, P2072, DOI 10.1016/j.ejca.2014.04.024; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janne PA, 2017, JAMA-J AM MED ASSOC, V317, P1844, DOI 10.1001/jama.2017.3438; Lan LX, 2015, EMBO J, V34, P1493, DOI 10.15252/embj.201489004; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lu W, 2003, BIOCHEMISTRY-US, V42, P5461, DOI 10.1021/bi0340144; Mainardi S, 2018, NAT MED, V24, P961, DOI 10.1038/s41591-018-0023-9; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Marino S, 2000, GENE DEV, V14, P994; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pergolizzi RG, 2006, BLOOD, V108, P862, DOI 10.1182/blood-2005-06-2330; Pettazzoni P, 2015, CANCER RES, V75, P1091, DOI 10.1158/0008-5472.CAN-14-1854; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Schneeberger VE, 2015, ONCOTARGET, V6, P6191, DOI 10.18632/oncotarget.3356; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu J, 2013, BIOCHEM BIOPH RES CO, V439, P586, DOI 10.1016/j.bbrc.2013.09.028; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zheng J, 2016, NAT GENET, V48, P747, DOI 10.1038/ng.3568	53	205	216	7	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					954	+		10.1038/s41591-018-0024-8	http://dx.doi.org/10.1038/s41591-018-0024-8			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29808009	Green Submitted			2022-12-27	WOS:000438187700023
J	Stower, H				Stower, Hannah			In utero correction of a genetic disorder	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					702	702		10.1038/s41591-018-0077-8	http://dx.doi.org/10.1038/s41591-018-0077-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875458	Bronze			2022-12-27	WOS:000434281300009
J	Arner, P; Bernard, S; Appelsved, L; Fu, KY; Andersson, DP; Salehpour, M; Thorell, A; Ryden, M; Spalding, KL				Arner, P.; Bernard, S.; Appelsved, L.; Fu, K. -Y.; Andersson, D. P.; Salehpour, M.; Thorell, A.; Ryden, M.; Spalding, K. L.			Adipose lipid turnover and long-term changes in body weight	NATURE MEDICINE			English	Article							TRIGLYCERIDE TURNOVER; TISSUE MORPHOLOGY; FATTY-ACIDS; LIPOLYSIS; MEN; MOBILIZATION; RADIOCARBON; OVERWEIGHT; EXERCISE; OBESITY	The worldwide obesity epidemic(1) makes it important to understand how lipid turnover (the capacity to store and remove lipids) regulates adipose tissue mass. Cross-sectional studies have shown that excess body fat is associated with decreased adipose lipid removal rates(2,3). Whether lipid turnover is constant over the life span or changes during long-term weight increase or loss is unknown. We determined the turnover of fat cell lipids in adults followed for up to 16 years, by measuring the incorporation of nuclear bomb test-derived C-14 in adipose tissue triglycerides. Lipid removal rate decreases during aging, with a failure to reciprocally adjust the rate of lipid uptake resulting in weight gain. Substantial weight loss is not driven by changes in lipid removal but by the rate of lipid uptake in adipose tissue. Furthermore, individuals with a low baseline lipid removal rate are more likely to remain weight-stable after weight loss. Therefore, lipid turnover adaptation might be important for maintaining pronounced weight loss. Together these findings identify adipose lipid turnover as an important factor for the long-term development of overweight/obesity and weight loss maintenance in humans.	[Arner, P.; Andersson, D. P.; Ryden, M.] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [Bernard, S.] Univ Lyon, CNRS, UMR5208, Inst Camille Jordan, Villeurbanne, France; [Appelsved, L.; Fu, K. -Y.; Spalding, K. L.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Salehpour, M.] Uppsala Univ, Dept Phys & Astron, Ion Phys, Uppsala, Sweden; [Thorell, A.] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Thorell, A.] Karolinska Inst, Ersta Hosp, Dept Surg, Stockholm, Sweden; [Spalding, K. L.] Integrated Cardio Metab Ctr, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Karolinska Institutet; Uppsala University; Danderyds Hospital; Karolinska Institutet; Ersta Sjukhus; Karolinska Institutet	Arner, P (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Stockholm, Sweden.; Spalding, KL (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Spalding, KL (corresponding author), Integrated Cardio Metab Ctr, Dept Med, Stockholm, Sweden.	peter.arner@ki.se; kirsty.spalding@ki.se	Spalding, Kirsty/CAF-4248-2022; Bernard, Samuel/A-5623-2009; Andersson, Daniel/AAY-6362-2021; Andersson, Daniel Peter/AAN-8648-2020	Spalding, Kirsty/0000-0002-5189-7028; Bernard, Samuel/0000-0002-8442-9968; Andersson, Daniel Peter/0000-0003-4655-4837; Salehpour, Mehran/0000-0003-2787-8801; Thorell, Anders/0000-0001-7238-1728; Ryden, Mikael/0000-0003-4785-1876; Arner, Peter/0000-0002-6208-6220	Stockholm County Council [ALF SLL20160040, K0138-2015]; Stockholm County Council (CIMED project) [3115]; Swedish Research Council [K2014-54x-14510-12-5, K2012-55x-01034-46-5, 542-2013-8358]; Strategic Research Program for Diabetes at Karolinska Institutet [H721309942, H721105932, C5471152]; Novo Nordisk Foundation [120C101637]; Novo Nordisk Foundation (Tripartite Immunometabolism Consortium) [NNF15CC0018486]; Novo Nordisk Foundation (MSAM consortium) [NNF15SA0018346]; Novo Nordisk Foundation (Excellence Project Award) [NNF120 C1016064]; Swedish Diabetes Foundation [DIA2016-097]; Karolinska Institutet/Astra Zeneca Integrated Cardiometabolic Centre [H725701603]; Vallee Foundation Vallee Scholar Award [C5471234]; Swedish Society of Medicine [H721748513]; ErlingPersson Family foundation [140604]; Institut rhonalpin des systemes complexes [12554]; Novo Nordisk Fonden [NNF15OC0015894] Funding Source: researchfish	Stockholm County Council(Stockholm County Council); Stockholm County Council (CIMED project); Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Program for Diabetes at Karolinska Institutet; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation (Tripartite Immunometabolism Consortium); Novo Nordisk Foundation (MSAM consortium); Novo Nordisk Foundation (Excellence Project Award); Swedish Diabetes Foundation; Karolinska Institutet/Astra Zeneca Integrated Cardiometabolic Centre; Vallee Foundation Vallee Scholar Award; Swedish Society of Medicine; ErlingPersson Family foundation; Institut rhonalpin des systemes complexes; Novo Nordisk Fonden(Novo Nordisk Foundation)	We would like to acknowledge the assistance of research nurses, Y. Widlund and K. Hertel, as well as laboratory technician K. Wahlen. This study was supported by grants from the Stockholm County Council (no. ALF SLL20160040 to M.R. and CIMED project code no. 3115 to P.A.), Swedish Research Council (no. K2014-54x-14510-12-5to M.R., no. K2012-55x-01034-46-5 to P.A. and no. 542-2013-8358 to K.S.), the Strategic Research Program for Diabetes at Karolinska Institutet (no. H721309942 to M.R., no. H721105932 to P.A. and no. C5471152 to K.S.), the Novo Nordisk Foundation (no. 120C101637 to P.A., the Tripartite Immunometabolism Consortium no. NNF15CC0018486 and MSAM consortium no. NNF15SA0018346 to M.R. and an Excellence Project Award no. NNF120 C1016064 to K.S.), the Swedish Diabetes Foundation (no. DIA2016-097 to M.R.), Karolinska Institutet/Astra Zeneca Integrated Cardiometabolic Centre (no. H725701603 to KS.) and the Vallee Foundation Vallee Scholar Award (no. C5471234 to KS.). D.P.A. was supported by The Swedish Society of Medicine (no. H721748513) and the Stockholm County Council (no. K0138-2015). A.T. was supported by The ErlingPersson Family foundation (project code no. 140604). S.B. was supported by the Institut rhonalpin des systemes complexes (project code no. 12554).	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Andersson DP, 2017, INT J OBESITY, V41, P1564, DOI 10.1038/ijo.2017.148; Arner E, 2010, NEW ENGL J MED, V362, P1151, DOI 10.1056/NEJMc0910718; Arner P, 2018, CELL METAB, V28, P45, DOI 10.1016/j.cmet.2018.05.004; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bernard S, 2010, NUCL INSTRUM METH B, V268, P1295, DOI 10.1016/j.nimb.2009.10.156; De Glisezinski I, 1998, AM J PHYSIOL-ENDOC M, V275, pE951, DOI 10.1152/ajpendo.1998.275.6.E951; DESPRES JP, 1984, METABOLISM, V33, P235, DOI 10.1016/0026-0495(84)90043-X; Dulloo AG, 2012, OBES REV, V13, P105, DOI 10.1111/j.1467-789X.2012.01041.x; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Frayn K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003467; Guillermier C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90349; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; HENDERSON M, 1987, BRIT J PSYCHIAT, V150, P18, DOI 10.1192/bjp.150.1.18; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Hoffstedt J, 2017, DIABETES CARE, V40, P77, DOI 10.2337/dc16-1072; Jeukendrup JE, 1998, INT J SPORTS MED, V19, P231; KATHER H, 1987, J CLIN INVEST, V80, P566, DOI 10.1172/JCI113105; KLEIN RA, 1980, LIPIDS, V15, P572, DOI 10.1007/BF02534181; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2013, TELLUS B, V65, DOI 10.3402/tellusb.v65i0.20092; Linne Y, 2005, INT J OBESITY, V29, P458, DOI 10.1038/sj.ijo.0802892; Lonnqvist F., 2003, J CLIN INVEST, V85; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; MARIN P, 1990, EUR J CLIN INVEST, V20, P158, DOI 10.1111/j.1365-2362.1990.tb02263.x; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Ravussin E, 2016, OBESITY, V24, P1607, DOI 10.1002/oby.21586; Reimer PJ, 2004, RADIOCARBON, V46, P1299; Rosenbaum M, 2016, OBESITY, V24, P1620, DOI 10.1002/oby.21559; Ryden M, 2013, J LIPID RES, V54, P2909, DOI 10.1194/jlr.M040345; Salehpour M, 2016, NUCL INSTRUM METH B, V371, P360, DOI 10.1016/j.nimb.2015.10.034; Salehpour M, 2013, NUCL INSTRUM METH B, V294, P97, DOI 10.1016/j.nimb.2012.08.054; Santosa S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00103; Seals DR, 2000, J PHYSIOL-LONDON, V528, P407, DOI 10.1111/j.1469-7793.2000.00407.x; Spalding KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15253; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; US Department of Health and Human Services and USDA, 2015, DIET GUID AM 2015 20; Vors C, 2013, AM J CLIN NUTR, V97, P23, DOI 10.3945/ajcn.112.043976; You TJ, 2004, J CLIN ENDOCR METAB, V89, P1739, DOI 10.1210/jc.2003-031310	42	52	52	4	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1385	+		10.1038/s41591-019-0565-5	http://dx.doi.org/10.1038/s41591-019-0565-5			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501613				2022-12-27	WOS:000484832800020
J	Gyorgy, B; Nist-Lund, C; Pan, BF; Asai, Y; Karavitaki, KD; Kleinstiver, BP; Garcia, SP; Zaborowski, MP; Solanes, P; Spataro, S; Schneider, BL; Joung, JK; Geleoc, GSG; Holt, JR; Corey, DP				Gyorgy, Bence; Nist-Lund, Carl; Pan, Bifeng; Asai, Yukako; Karavitaki, K. Domenica; Kleinstiver, Benjamin P.; Garcia, Sara P.; Zaborowski, Mikolaj P.; Solanes, Paola; Spataro, Sofia; Schneider, Bernard L.; Joung, J. Keith; Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.; Corey, David P.			Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss	NATURE MEDICINE			English	Article							EAR HAIR-CELLS; CRISPR-CAS9 NUCLEASES; INNER; MECHANOTRANSDUCTION; TRANSDUCTION; CHANNEL; TMC1	Since most dominant human mutations are single nucleotide substitutions(1,2), we explored gene editing strategies to disrupt dominant mutations efficiently and selectively without affecting wild-type alleles. However, single nucleotide discrimination can be difficult to achieve(3) because commonly used endonucleases, such as Streptococcus pyogenes Cas9 (SpCas9), can tolerate up to seven mismatches between guide RNA (gRNA) and target DNA. Furthermore, the protospacer-adjacent motif (PAM) in some Cas9 enzymes can tolerate mismatches with the target DNA(3,4). To circumvent these limitations, we screened 14 Cas9/gRNA combinations for specific and efficient disruption of a nucleotide substitution that causes the dominant progressive hearing loss, DFNA36. As a model for DFNA36, we used Beethoven mice(5), which harbor a point mutation in Tmc1, a gene required for hearing that encodes a pore-forming subunit of mechanosensory transduction channels in inner-ear hair cells(6). We identified a PAM variant of Staphylococcus aureus Cas9 (SaCas9-KKH) that selectively and efficiently disrupted the mutant allele, but not the wild-type Tmc1/ TMC1 allele, in Beethoven mice and in a DFNA36 human cell line. Adeno-associated virus (AAV)-mediated SaCas9-KKH delivery prevented deafness in Beethoven mice up to one year post injection. Analysis of current ClinVar entries revealed that similar to 21% of dominant human mutations could be targeted using a similar approach.	[Gyorgy, Bence; Karavitaki, K. Domenica; Corey, David P.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Gyorgy, Bence; Zaborowski, Mikolaj P.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gyorgy, Bence] Inst Mol & Clin Ophthalmol Basel, Basel, Switzerland; [Nist-Lund, Carl; Pan, Bifeng; Asai, Yukako; Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.] Boston Childrens Hosp, Dept Otolaryngol, Boston, MA 02115 USA; [Nist-Lund, Carl; Pan, Bifeng; Asai, Yukako; Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Nist-Lund, Carl; Pan, Bifeng; Asai, Yukako; Geleoc, Gwenaelle S. G.; Holt, Jeffrey R.] Harvard Med Sch, Boston, MA 02115 USA; [Kleinstiver, Benjamin P.; Garcia, Sara P.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA USA; [Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kleinstiver, Benjamin P.; Garcia, Sara P.; Joung, J. Keith] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Zaborowski, Mikolaj P.] Poznan Univ Med Sci, Div Gynecol Oncol, Dept Gynecol Obstet & Gynecol Oncol, Poznan, Poland; [Solanes, Paola; Spataro, Sofia; Schneider, Bernard L.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Poznan University of Medical Sciences; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Holt, JR (corresponding author), Boston Childrens Hosp, Dept Otolaryngol, Boston, MA 02115 USA.; Holt, JR (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.; Holt, JR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jeffrey.holt@childrens.harvard.edu	Kleinstiver, Benjamin/K-4498-2014; Spataro, Sofia/AGZ-6545-2022; Schneider, Bernard/H-6168-2011	Kleinstiver, Benjamin/0000-0002-5469-0655; Spataro, Sofia/0000-0002-5030-4470; Schneider, Bernard/0000-0001-5485-8748; Nist-Lund, Carl/0000-0002-0224-7387; Gyorgy, Bence/0000-0003-0766-6246; Zaborowski, Mikolaj/0000-0002-4400-6688; Geleoc, Gwenaelle/0000-0002-2825-6521; Pan, Bifeng/0000-0001-9746-3420; Garcia, Sara/0000-0003-3312-6454	BCH Viral Core (BCH IDDRC) [1U54HD090255]; Jeff and Kimberly Barber Fund; NIH [R01-DC013521, R01-DC05439, R01-DC000304, R01-DC016932, DC008853, K99-CA218870]; Charles A. King Trust; Banting Postdoctoral Fellowship; Kosciuszko Foundation; Bertarelli Foundation; Desmond and Ann Heathwood MGH Research Scholar award; Richard Floor Biorepository Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K99CA218870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013521, R01DC008853, R01DC000304, R01DC005439, R01DC016932] Funding Source: NIH RePORTER	BCH Viral Core (BCH IDDRC); Jeff and Kimberly Barber Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; Banting Postdoctoral Fellowship; Kosciuszko Foundation; Bertarelli Foundation; Desmond and Ann Heathwood MGH Research Scholar award; Richard Floor Biorepository Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank members of Holt/Geleoc and Corey laboratories for many helpful discussions and critical review of the manuscript. We thank the MGH DNA Core for sequencing services and the BCH Viral Core (BCH IDDRC, grant no. 1U54HD090255) for vector production. We also thank L. Pinello for assistance with CRISPResso analysis, V. Dillard for the help with TIDE analysis and A. A. Sousa for technical assistance with the GUIDE-Seq analysis. This work was supported by the Jeff and Kimberly Barber Fund and NIH grant nos. R01-DC013521 and R01-DC05439 (to J.R.H.), R01-DC000304 and R01-DC016932 (to D.P.C.), DC008853 (to G.S.G) and no. K99-CA218870, the Charles A. King Trust, a Banting Postdoctoral Fellowship (to B.P.K.), the Richard Floor Biorepository Fund, the Kosciuszko Foundation (to M.P.Z.) and by the Bertarelli Foundation. J.K.J. is supported by a Desmond and Ann Heathwood MGH Research Scholar award and B.G. was an Edward R. and Anne G. Lefler Center Postdoctoral Fellow.	Askew C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1996; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Christie KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16279-4; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gao X, 2018, NATURE, V553, P217, DOI 10.1038/nature25164; Gyorgy B, 2018, MOL THER-NUCL ACIDS, V11, P429, DOI 10.1016/j.omtn.2018.03.007; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Landegger LD, 2017, NAT BIOTECHNOL, V35, P280, DOI 10.1038/nbt.3781; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Narayan DS, 2016, ACTA OPHTHALMOL, V94, P748, DOI 10.1111/aos.13141; Pan BF, 2018, NEURON, V99, P736, DOI 10.1016/j.neuron.2018.07.033; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Shibata SB, 2016, AM J HUM GENET, V98, P1101, DOI 10.1016/j.ajhg.2016.03.028; Shin JW, 2016, HUM MOL GENET, V25, P4566, DOI 10.1093/hmg/ddw286; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Yoshimura H, 2019, MOL THER, V27, P681, DOI 10.1016/j.ymthe.2018.12.014; Zhao Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090836, 10.1371/journal.pone.0104330]; Zinn E, 2015, CELL REP, V12, P1056, DOI 10.1016/j.celrep.2015.07.019	30	91	94	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1123	+		10.1038/s41591-019-0500-9	http://dx.doi.org/10.1038/s41591-019-0500-9			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270503	Green Accepted			2022-12-27	WOS:000474430400027
J	Kather, JN; Pearson, AT; Halama, N; Jager, D; Krause, J; Loosen, SH; Marx, A; Boor, P; Tacke, F; Neumann, UP; Grabsch, HI; Yoshikawa, T; Brenner, H; Chang-Claude, J; Hoffmeister, M; Trautwein, C; Luedde, T				Kather, Jakob Nikolas; Pearson, Alexander T.; Halama, Niels; Jaeger, Dirk; Krause, Jeremias; Loosen, Sven H.; Marx, Alexander; Boor, Peter; Tacke, Frank; Neumann, Ulf Peter; Grabsch, Heike I.; Yoshikawa, Takaki; Brenner, Hermann; Chang-Claude, Jenny; Hoffmeister, Michael; Trautwein, Christian; Luedde, Tom			Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer	NATURE MEDICINE			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; GASTRIC-CANCER; TUMORS	Microsatellite instability determines whether patients with gastrointestinal cancer respond exceptionally well to immunotherapy. However, in clinical practice, not every patient is tested for MSI, because this requires additional genetic or immunohistochemical tests. Here we show that deep residual learning can predict MSI directly from H&E histology, which is ubiquitously available. This approach has the potential to provide immunotherapy to a much broader subset of patients with gastrointestinal cancer.	[Kather, Jakob Nikolas; Krause, Jeremias; Loosen, Sven H.; Trautwein, Christian; Luedde, Tom] Univ Hosp RWTH Aachen, Dept Med 2, Aachen, Germany; [Kather, Jakob Nikolas; Halama, Niels; Jaeger, Dirk] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Kather, Jakob Nikolas; Jaeger, Dirk] German Canc Res Ctr, Appl Tumor Immun, Heidelberg, Germany; [Kather, Jakob Nikolas; Pearson, Alexander T.] Univ Chicago, Dept Med, Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kather, Jakob Nikolas; Halama, Niels; Jaeger, Dirk] Natl Ctr Tumor Dis NCT, Med Oncol, Heidelberg, Germany; [Halama, Niels] German Canc Res Ctr, Translat Immunotherapy, Heidelberg, Germany; [Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Boor, Peter] Univ Hosp RWTH Aachen, Inst Pathol, Aachen, Germany; [Boor, Peter] Univ Hosp RWTH Aachen, Dept Nephrol, Aachen, Germany; [Tacke, Frank] Charite, Hepatol & Gastroenterol, Berlin, Germany; [Neumann, Ulf Peter] Univ Hosp RWTH Aachen, Visceral & Transplant Surg, Aachen, Germany; [Grabsch, Heike I.] Univ Leeds, Pathol & Data Analyt, Leeds Inst Med Res St Jamess, Leeds, W Yorkshire, England; [Grabsch, Heike I.] Maastricht Univ Med Ctr, Pathol & GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Yoshikawa, Takaki] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan; [Yoshikawa, Takaki] Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan; [Brenner, Hermann; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Canc Epidemiol Grp, Hamburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Chicago; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; RWTH Aachen University Hospital; University of Leeds; Maastricht University; Maastricht University Medical Centre (MUMC); Kanagawa Prefectural Cancer Center; National Cancer Center - Japan; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf	Kather, JN; Luedde, T (corresponding author), Univ Hosp RWTH Aachen, Dept Med 2, Aachen, Germany.; Kather, JN (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.; Kather, JN (corresponding author), German Canc Res Ctr, Appl Tumor Immun, Heidelberg, Germany.; Kather, JN (corresponding author), Univ Chicago, Dept Med, Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Kather, JN (corresponding author), Natl Ctr Tumor Dis NCT, Med Oncol, Heidelberg, Germany.	jkather@ukaachen.de; tluedde@ukaachen.de	Loosen, Sven/AHC-5236-2022; Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/T-7187-2019; Tacke, Frank/ABF-2212-2020; Luedde, Tom/AAE-9135-2022; Hoffmeister, Michael/AAB-2321-2022; Kather, Jakob Nikolas/D-4279-2015; Brenner, Hermann/ABE-6383-2020; Boor, Peter/C-7707-2011	Loosen, Sven/0000-0002-2799-2287; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Luedde, Tom/0000-0002-6288-8821; Hoffmeister, Michael/0000-0002-8307-3197; Kather, Jakob Nikolas/0000-0002-3730-5348; Brenner, Hermann/0000-0002-6129-1572; Halama, Niels/0000-0003-0344-6027; Boor, Peter/0000-0001-9921-4284	RWTH University Aachen [START 2018-691906]; NIH/NIDCR [K08-DE026500]; German Federal Ministry of Education and Research (BMBF) [M2oBITE/13GW0091E]; National Center for Tumor Diseases (NCT), Germany; German Research Council DFG [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, BR 1704/17-1, CH 117/1-1, HO 5117/2-1]; BMBF [01ER0814, 01ER0815, 01ER1505A, 01ER1505B]; DFG [BO 3755/6-1, SFB-TRR57, SFB-TRR219, SFB-TRR57/P06, LU 1360/3-1]; Horizon 2020 through the European Research Council (ERC) Consolidator Grant PhaseControl [771083]; Mildred-Scheel-Endowed Professorship from the German Cancer Aid; Ernst-Jung-Foundation Hamburg; IZKF (Interdisciplinary Center of Clinical Research) at RWTH Aachen	RWTH University Aachen; NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Center for Tumor Diseases (NCT), Germany; German Research Council DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Horizon 2020 through the European Research Council (ERC) Consolidator Grant PhaseControl; Mildred-Scheel-Endowed Professorship from the German Cancer Aid; Ernst-Jung-Foundation Hamburg; IZKF (Interdisciplinary Center of Clinical Research) at RWTH Aachen	The results are in part based on data generated by the TCGA Research Network (http://cancergenome.nih.gov/). J.N.K.was funded by RWTH University Aachen (START 2018-691906). A.T.P. was funded by NIH/NIDCR (K08-DE026500). A.M. was funded by the German Federal Ministry of Education and Research (BMBF) (M2oBITE/13GW0091E). The DACHS study was funded by the Interdisciplinary Research Program of the National Center for Tumor Diseases (NCT), Germany and German Research Council DFG (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, BR 1704/17-1, CH 117/1-1 and HO 5117/2-1), BMBF (01ER0814, 01ER0815, 01ER1505A and 01ER1505B). P. B. was funded by the DFG (BO 3755/6-1, SFB-TRR57 and SFB-TRR219). T.L. was funded by Horizon 2020 through the European Research Council (ERC) Consolidator Grant PhaseControl (771083), Mildred-Scheel-Endowed Professorship from the German Cancer Aid, DFG (SFB-TRR57/P06 and LU 1360/3-1), Ernst-Jung-Foundation Hamburg and IZKF (Interdisciplinary Center of Clinical Research) at RWTH Aachen.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Aoyama T, 2018, CANCER MED-US, V7, P4914, DOI 10.1002/cam4.1744; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Chang P, 2018, AM J NEURORADIOL, V39, P1201, DOI 10.3174/ajnr.A5667; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Darvin P, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0191-1; DiCiccio TJ, 1996, STAT SCI, V11, P189; FRANKE AJ, 2018, J CLIN ONCOL S, V36; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hoffmeister M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv045; Iandola F.N., 2016, PREPRINT; Kather JN, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002730; Kather JN, 2018, SEMIN CANCER BIOL, V52, P189, DOI 10.1016/j.semcancer.2018.02.010; Kather JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27988; Kawakami H, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0348-2; Krizhevsky A., 2012, ADV NEURAL INFORM PR; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Liu Y, 2018, CANCER CELL, V33, P721, DOI 10.1016/j.ccell.2018.03.010; Macenko M, 2009, I S BIOMED IMAGING, P1107, DOI 10.1109/ISBI.2009.5193250; Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Norgeot B, 2019, NAT MED, V25, P14, DOI 10.1038/s41591-018-0320-3; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Schaumberg A. J., 2018, PREPRINT, DOI [10.1101/064279v9, DOI 10.1101/064279V9]; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Zhu L, 2015, MOL CLIN ONCOL, V3, P699, DOI 10.3892/mco.2015.506	31	386	400	12	99	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1054	+		10.1038/s41591-019-0462-y	http://dx.doi.org/10.1038/s41591-019-0462-y			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31160815	Green Accepted			2022-12-27	WOS:000474430400017
J	Stower, H				Stower, Hannah			E-cigarettes to help smoking cessation	NATURE MEDICINE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					358	358		10.1038/s41591-019-0395-5	http://dx.doi.org/10.1038/s41591-019-0395-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842668	Bronze			2022-12-27	WOS:000460643100009
J	Yilmaz, B; Juillerat, P; Oyas, O; Ramon, C; Bravo, FD; Franc, Y; Michetti, P; Mueller, C; Geuking, M; Pittet, VEH; Maillard, MH; Rogler, G; Abdelrahman, K; Ademi, G; Aepli, P; Thomas, A; Anderegg, C; Antonino, AT; Archanioti, E; Arrigoni, E; de Jong, DB; Balsiger, B; Basturk, P; Bauerfeind, P; Becocci, A; Belli, D; Bengoa, JM; Biedermann, L; Binek, J; Blattmann, M; Boehm, S; Boldanova, T; Borovicka, J; Braegger, CP; Brand, S; Brugger, L; Brunner, S; Buhr, P; Burnand, B; Burk, S; Burri, E; Buyse, S; Cao, DT; Carstens, O; Criblez, DH; Cunningham, S; D'Angelo, F; de Saussure, P; Degen, L; Delarive, J; Doerig, C; Dora, B; Drerup, S; Egger, M; El-Wafa, A; Engelmann, M; Ezri, J; Felley, C; Fliegner, M; Fournier, N; Fraga, M; Frei, P; Frei, R; Fried, M; Froehlich, F; Furlano, RI; Garzoni, L; Geyer, M; Girard, L; Girardin, M; Golay, D; Good, I; Bigler, UG; Gysi, B; Haarer, J; Halama, M; Haldemann, J; Heer, P; Heimgartner, B; Helbling, B; Hengstler, P; Herzog, D; Hess, C; Hessler, R; Heyland, K; Hinterleitner, T; Hirschi, C; Hruz, P; Khalid-de Bakker, C; Kayser, S; Keller, C; Knellwolf, C; Knoblauch, C; Kohler, H; Koller, R; Krieger, C; Kunzler, P; Kusche, R; Lehmann, FS; Macpherson, AJ; Manz, M; Marot, A; Meier, R; Meyenberger, C; Meyer, P; Misselwitz, B; Mosler, P; Mottet, C; Mullhaupt, B; Musso, L; Neagu, M; Nichita, C; Niess, J; Nydegger, A; Obialo, N; Ollo, D; Oropesa, C; Peter, U; Peternac, D; Petit, LM; Pohl, D; Porzner, M; Preissler, C; Raschle, N; Rentsch, R; Restellini, A; Restellini, S; Richterich, JP; Ris, F; Risti, B; Ritz, MA; Rohrich, N; Rossel, JB; Rueger, V; Rusticeanu, M; Sagmeister, M; Saner, G; Sauter, B; Sawatzki, M; Scharl, M; Schelling, M; Schibli, S; Schlauri, H; Schluckebier, D; Schmid, D; Schmid, S; Schnegg, JF; Schoepfer, A; Seematter, V; Seibold, F; Seirafi, M; Semadeni, GM; Senning, A; Sokollik, C; Sommer, J; Spalinger, J; Spangenberger, H; Stadler, P; Staub, P; Staudenmann, D; Stenz, V; Steuerwald, M; Straumann, A; Strebel, B; Stulz, A; Sulz, M; Tatu, A; Tempia-Caliera, M; Thorens, J; Truninger, K; Tutuian, R; Urfer, P; Vavricka, S; Viani, F; Vogtlin, J; Von Kanel, R; Vouillamoz, D; Vulliamy, R; Wiesel, P; Wiest, R; Wohrle, S; Zamora, S; Zander, S; Wylie, T; Zeitz, J; Zimmermann, D; Stelling, J; Macpherson, AJ				Yilmaz, Bahtiyar; Juillerat, Pascal; Oyas, Ove; Ramon, Charlotte; Bravo, Francisco Damian; Franc, Yannick; Michetti, Pierre; Mueller, Christoph; Geuking, Markus; Pittet, Valerie E. H.; Maillard, Michel H.; Rogler, Gerhard; Abdelrahman, Karim; Ademi, Gentiana; Aepli, Patrick; Thomas, Amman; Anderegg, Claudia; Antonino, Anca-Teodora; Archanioti, Eva; Arrigoni, Eviano; de Jong, Diana Bakker; Balsiger, Bruno; Bastuerk, Polat; Bauerfeind, Peter; Becocci, Andrea; Belli, Dominique; Bengoa, Jose M.; Biedermann, Luc; Binek, Janek; Blattmann, Mirjam; Boehm, Stephan; Boldanova, Tujana; Borovicka, Jan; Braegger, Christian P.; Brand, Stephan; Brugger, Lukas; Brunner, Simon; Buehr, Patrick; Burnand, Bernard; Burk, Sabine; Burri, Emanuel; Buyse, Sophie; Cao, Dahlia-Thao; Carstens, Ove; Criblez, Dominique H.; Cunningham, Sophie; D'Angelo, Fabrizia; de Saussure, Philippe; Degen, Lukas; Delarive, Joakim; Doerig, Christopher; Dora, Barbara; Drerup, Susan; Egger, Mara; El-Wafa, Ali; Engelmann, Matthias; Ezri, Jessica; Felley, Christian; Fliegner, Markus; Fournier, Nicolas; Fraga, Montserrat; Frei, Pascal; Frei, Remus; Fried, Michael; Froehlich, Florian; Furlano, Raoul Ivano; Garzoni, Luca; Geyer, Martin; Girard, Laurent; Girardin, Marc; Golay, Delphine; Good, Ignaz; Bigler, Ulrike Graf; Gysi, Beat; Haarer, Johannes; Halama, Marcel; Haldemann, Janine; Heer, Pius; Heimgartner, Benjamin; Helbling, Beat; Hengstler, Peter; Herzog, Denise; Hess, Cyrill; Hessler, Roxane; Heyland, Klaas; Hinterleitner, Thomas; Hirschi, Claudia; Hruz, Petr; Khalid-de Bakker, Carolina; Kayser, Stephan; Keller, Celine; Knellwolf (-Grieger), Christina; Knoblauch, Christoph; Koehler, Henrik; Koller, Rebekka; Krieger(-Grubel), Claudia; Kunzler, Patrizia; Kusche, Rachel; Lehmann, Frank Serge; Macpherson, Andrew J.; Manz, Michael; Marot, Astrid; Meier, Remy; Meyenberger, Christa; Meyer, Pamela; Misselwitz, Benjamin; Mosler, Patrick; Mottet, Christian; Muellhaupt, Beat; Musso, Leilla; Neagu, Michaela; Nichita, Cristina; Niess, Jan; Nydegger, Andreas; Obialo, Nicole; Ollo, Diana; Oropesa, Cassandra; Peter, Ulrich; Peternac, Daniel; Petit, Laetitia Marie; Pohl, Daniel; Porzner, Marc; Preissler, Claudia; Raschle, Nadia; Rentsch, Ronald; Restellini, Alexandre; Restellini, Sophie; Richterich, Jean-Pierre; Ris, Frederic; Risti, Branislav; Ritz, Marc Alain; Roehrich, Nina; Rossel, Jean-Benoit; Rueger, Vanessa; Rusticeanu, Monica; Sagmeister, Markus; Saner, Gaby; Sauter, Bernhard; Sawatzki, Mikael; Scharl, Michael; Schelling, Martin; Schibli, Susanne; Schlauri, Hugo; Schluckebier, Dominique; Schmid, Daniela; Schmid(-Uebelhart), Sybille; Schnegg, Jean-Francois; Schoepfer, Alain; Seematter, Vivianne; Seibold, Frank; Seirafi, Mariam; Semadeni, Gian-Marco; Senning, Arne; Sokollik, Christiane; Sommer, Joachim; Spalinger, Johannes; Spangenberger, Holger; Stadler, Philippe; Staub, Peter; Staudenmann, Dominic; Stenz, Volker; Steuerwald, Michael; Straumann, Alex; Strebel, Bruno; Stulz, Andreas; Sulz, Michael; Tatu, Aurora; Tempia-Caliera, Michela; Thorens, Joel; Truninger, Kaspar; Tutuian, Radu; Urfer, Patrick; Vavricka, Stephan; Viani, Francesco; Voegtlin, Jurg; Von Kaenel, Roland; Vouillamoz, Dominique; Vulliamy, Rachel; Wiesel, Paul; Wiest, Reiner; Woehrle, Stefanie; Zamora, Samuel; Zander, Silvan; Wylie, Tina; Zeitz, Jonas; Zimmermann, Dorothee; Stelling, Joerg; Macpherson, Andrew J.		Swiss IBD Cohort Investigators	Microbial network disturbances in relapsing refractory Crohn's disease	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MUCOSA-ASSOCIATED MICROBIOTA; INVASIVE ESCHERICHIA-COLI; MOLECULAR-PHYLOGENETIC CHARACTERIZATION; TOLL-LIKE RECEPTORS; CD4(+) T-CELLS; GUT MICROBIOTA; ULCERATIVE-COLITIS; FAECALIBACTERIUM-PRAUSNITZII; INTESTINAL INFLAMMATION	Inflammatory bowel diseases (IBD) can be broadly divided into Crohn's disease (CD) and ulcerative colitis (UC) from their clinical phenotypes. Over 150 host susceptibility genes have been described, although most overlap between CD, UC and their subtypes, and they do not adequately account for the overall incidence or the highly variable severity of disease. Replicating key findings between two long-term IBD cohorts, we have defined distinct networks of taxa associations within intestinal biopsies of CD and UC patients. Disturbances in an association network containing taxa of the Lachnospiraceae and Ruminococcaceae families, typically producing short chain fatty acids, characterize frequently relapsing disease and poor responses to treatment with anti-TNF-alpha therapeutic antibodies. Alterations of taxa within this network also characterize risk of later disease recurrence of patients in remission after the active inflamed segment of CD has been surgically removed.	[Yilmaz, Bahtiyar; Juillerat, Pascal; Geuking, Markus; Macpherson, Andrew J.] Univ Bern, Dept Biomed Res, Maurice Muller Labs, Bern, Switzerland; [Yilmaz, Bahtiyar; Juillerat, Pascal; Bravo, Francisco Damian; Brugger, Lukas; Carstens, Ove; Bigler, Ulrike Graf; Heimgartner, Benjamin; Macpherson, Andrew J.; Rusticeanu, Monica; Schmid(-Uebelhart), Sybille; Strebel, Bruno; Tatu, Aurora; Tutuian, Radu; Wiest, Reiner; Macpherson, Andrew J.] Univ Bern, Univ Hosp Bern, Dept Visceral Surg & Med, Bern, Switzerland; [Oyas, Ove; Ramon, Charlotte; Stelling, Joerg] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Oyas, Ove; Ramon, Charlotte; Stelling, Joerg] Swiss Fed Inst Technol, SIB, Basel, Switzerland; [Franc, Yannick; Pittet, Valerie E. H.; Burnand, Bernard; Egger, Mara; Fournier, Nicolas; Golay, Delphine; Marot, Astrid; Musso, Leilla; Rossel, Jean-Benoit; Seematter, Vivianne; Sommer, Joachim; Vulliamy, Rachel] Lausanne Univ Hosp, Insti Social & Prevent Med IUMSP, Lausanne, Switzerland; [Michetti, Pierre; Maillard, Michel H.; Keller, Celine; Nydegger, Andreas; Schoepfer, Alain] Gastroenterol La Source Beaulieu, Lausanne, Switzerland; [Archanioti, Eva; Ezri, Jessica; Fraga, Montserrat; Nydegger, Andreas; Schoepfer, Alain] CHU Vaudois, Dept Med, Serv Gastroenterol & Hepatol, Lausanne, Switzerland; [Archanioti, Eva; Ezri, Jessica; Fraga, Montserrat; Nydegger, Andreas; Schoepfer, Alain] Univ Lausanne, Lausanne, Switzerland; [Mueller, Christoph] Univ Bern, Inst Pathol, Div Expt Pathol, Bern, Switzerland; [Rogler, Gerhard; Biedermann, Luc; Blattmann, Mirjam; Burk, Sabine; Dora, Barbara; Fried, Michael; Misselwitz, Benjamin; Muellhaupt, Beat; Obialo, Nicole; Pohl, Daniel; Raschle, Nadia; Scharl, Michael; Vavricka, Stephan; Von Kaenel, Roland; Zeitz, Jonas] Univ Zurich, Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Abdelrahman, Karim] Clin Montchoisi, Lausanne, Switzerland; [Ademi, Gentiana; Borovicka, Jan; Brand, Stephan; Frei, Remus; Haarer, Johannes; Knellwolf (-Grieger), Christina; Krieger(-Grubel), Claudia; Kunzler, Patrizia; Meyenberger, Christa; Meyer, Pamela; Roehrich, Nina; Sawatzki, Mikael; Schelling, Martin; Semadeni, Gian-Marco; Sulz, Michael; Zimmermann, Dorothee] Kantonsspital St Gallen, St Gallen, Switzerland; [Aepli, Patrick; Criblez, Dominique H.; Hess, Cyrill; Richterich, Jean-Pierre; Spalinger, Johannes; Staudenmann, Dominic; Stulz, Andreas; Woehrle, Stefanie] Kantonsspital Luzern, Luzern, Switzerland; [Thomas, Amman; Rentsch, Ronald] GI Private Practice, St Gallen, Switzerland; [Anderegg, Claudia; Koehler, Henrik; Kusche, Rachel] Kantonspital Aarau, Klin Kinder & Jugendliche, Aarau, Switzerland; [Antonino, Anca-Teodora] Hop Riviera Site Samaritain, Vevey, Vaud, Switzerland; [Arrigoni, Eviano; Bengoa, Jose M.; Cunningham, Sophie; de Saussure, Philippe; Girard, Laurent] GI Private Practice, Geneva, Switzerland; [de Jong, Diana Bakker; Bastuerk, Polat; Brunner, Simon; Degen, Lukas; Hruz, Petr; Khalid-de Bakker, Carolina; Niess, Jan] Univ Basel Hosp, Dept Gastroenterol & Hepatol, Basel, Switzerland; [Balsiger, Bruno; Haldemann, Janine; Saner, Gaby; Seibold, Frank] Gastroenterolog Praxis, Bern, Switzerland; [Bauerfeind, Peter] Stadtspital Triemli, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Becocci, Andrea; Belli, Dominique] Geneva Univ Hosp, Dept Pediat, Geneva, Switzerland; [Binek, Janek; Hengstler, Peter] Gastroenterol Rosenberg, St Gallen, Switzerland; [Boehm, Stephan] Spital Bulach, Zurich, Switzerland; [Boldanova, Tujana] Univ Basel, Dept Biomed, Basel, Switzerland; [Braegger, Christian P.; Buehr, Patrick; Koller, Rebekka; Rueger, Vanessa; Senning, Arne] Univ Children Hosp, Zurich, Switzerland; [Burri, Emanuel] Kantonsspital Liestal, Dept Gastroenterol, Liestal, Switzerland; [Buyse, Sophie] GI Private Practice, Yverdon Ies Bains, Switzerland; [Cao, Dahlia-Thao] Hosp Neuchatelois, Neuchatel, Switzerland; [D'Angelo, Fabrizia] Geneva Univ Hosp, Dept Gastroenterol & Hepatol, Geneva, Switzerland; [Delarive, Joakim] GI Private Practice, Lausanne, Switzerland; [Doerig, Christopher; Hessler, Roxane] Clin Cecil, Lausanne, Switzerland; [Drerup, Susan] Schulthess Clin, Zurich, Switzerland; [El-Wafa, Ali] GI Private Practice, La Chaux De Fonds, Switzerland; [Engelmann, Matthias; Hirschi, Claudia] Gastropraxis Luzern, Luzern, Switzerland; [Felley, Christian; Ollo, Diana; Oropesa, Cassandra; Petit, Laetitia Marie; Restellini, Sophie; Ris, Frederic; Schluckebier, Dominique] Ctr Gastroenterol Beaulieu SA, Geneva, Switzerland; [Fliegner, Markus] Med Ctr Sihlc, Zurich, Switzerland; [Frei, Pascal; Helbling, Beat] Gastroenterol Bethanien, Zurich, Switzerland; [Froehlich, Florian] Hosp Canton Jura, Jura, Switzerland; [Furlano, Raoul Ivano] UKBB, Basel, Switzerland; [Garzoni, Luca] Geneva Univ Hosp, Clin Grangettes, Geneva, Switzerland; [Geyer, Martin] GI Private Practice, Wettingen, Aargau, Switzerland; [Girardin, Marc; Restellini, Alexandre; Zamora, Samuel] Grp Med Onex, Onex, Switzerland; [Good, Ignaz] Spital Walenstadt, St Gallen, Switzerland; [Gysi, Beat] GI Private Practice, Reinach, Switzerland; [Halama, Marcel; Manz, Michael] Aerztehaus Fluntern, Zurich, Switzerland; [Heer, Pius; Lehmann, Frank Serge; Straumann, Alex] GI Private Practice, Olten, Switzerland; [Herzog, Denise] HFR Hop Fribourgeois Pediat, Fribourg, Switzerland; [Heyland, Klaas; Peter, Ulrich] KSW Kantonsspital, Winterthur Kinderklin, Winterthur, Switzerland; [Hinterleitner, Thomas] GI Private Practice, Zurich, Switzerland; [Kayser, Stephan] GI Private Practice, Luzern, Switzerland; [Knoblauch, Christoph; Schmid, Daniela] Kantonsspital Nidwalden, Stans, Nidwalden, Switzerland; [Meier, Remy] AMB Arztpraxis MagenDarm Basel, Basel, Switzerland; [Mosler, Patrick] Kantonsspital Graubunden, Chur, Switzerland; [Mottet, Christian] GI Private Practice, Sion, Switzerland; [Neagu, Michaela] Spital Tiefenau, Bern, Switzerland; [Nichita, Cristina; Wiesel, Paul] Ctr Med Epalinges, Epalinges, Switzerland; [Peternac, Daniel] Spital Waid, Zurich, Switzerland; [Porzner, Marc] Spital Lachen, Lachen, Switzerland; [Preissler, Claudia] Kantonsspital Olten, Olten, Switzerland; [Risti, Branislav] GI Practice, Dietikon, Switzerland; [Ritz, Marc Alain; Steuerwald, Michael; Voegtlin, Jurg] GI Practice, Liestal, Switzerland; [Sagmeister, Markus] GI Private Practice, Heerbrugg, Switzerland; [Sauter, Bernhard] Klin Hirslanden Zurich, Zurich, Switzerland; [Schibli, Susanne; Sokollik, Christiane; Spalinger, Johannes] Bern Univ Hosp, Kinderklin Bern, Bern, Switzerland; [Schlauri, Hugo] Derby Ctr, Wil, Switzerland; [Schnegg, Jean-Francois] GI Private Practice, Montreux, Switzerland; [Seirafi, Mariam] Clin La Colline, Geneva, Switzerland; [Spangenberger, Holger] Kantonsspital Wolhusen, Wolhusen, Switzerland; [Stadler, Philippe] GI Private Practice, Payerne, Switzerland; [Staub, Peter] Spital Heiden Appenzell Ausserrhoden, Heiden, Switzerland; [Stenz, Volker] Kantonsspital Munsterlingen, Munsterlingen, Switzerland; [Tempia-Caliera, Michela] Clin Grangettes, Chene Bougeries, Switzerland; [Thorens, Joel] GI Private Practice, Yverdon, Switzerland; [Truninger, Kaspar] GI Private Practice, Langenthal, Switzerland; [Urfer, Patrick] Gastro Zentrum, Hirslanden Klin Aarau, Aarau, Switzerland; [Viani, Francesco] Private Practice, Vevey, Switzerland; [Vouillamoz, Dominique] Private Practice, Pully, Switzerland; [Zander, Silvan] Spital Limmattal, Schlieren, Switzerland; [Wylie, Tina] Lausanne Univ Hosp, Infirmiere Rech Chez CHUV, Lausanne, Switzerland	University of Bern; University of Bern; University Hospital of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Bern; University of Zurich; University Zurich Hospital; Lucerne Cantonal Hospital; Kantonsspital Aarau AG (KSA); University of Basel; Triemli Hospital; University of Geneva; University of Basel; University Children's Hospital Zurich; Kantonsspital Baselland; University of Geneva; Schulthess Clinic; University of Geneva; Kantonsspital Graubunden; Kantonsspital Olten; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Macpherson, AJ (corresponding author), Univ Bern, Dept Biomed Res, Maurice Muller Labs, Bern, Switzerland.; Macpherson, AJ (corresponding author), Univ Bern, Univ Hosp Bern, Dept Visceral Surg & Med, Bern, Switzerland.	andrew.macpherson@dbmr.unibe.ch	von Känel, Roland/B-1811-2019; Mueller, Christoph/F-2233-2014; Yilmaz, Bahtiyar/U-6646-2019; Müller, Christian/AAB-4783-2022; Braegger, Christian Peter/ABC-9884-2021; Ris, Frederic/H-7030-2019; Stelling, Joerg/F-7499-2010; Bauerfeind, Peter/AAV-2069-2020	von Känel, Roland/0000-0002-8929-5129; Mueller, Christoph/0000-0002-3921-8678; Müller, Christian/0000-0002-1120-6405; Ris, Frederic/0000-0001-7421-6101; Stelling, Joerg/0000-0002-1145-891X; Yilmaz, Bahtiyar/0000-0003-1888-9226; Braegger, Christian/0000-0001-8069-9875; Oyas, Ove/0000-0001-6990-0339; Pittet, Valerie/0000-0003-2208-966X; Michetti, Pierre/0000-0003-4982-7327; Juillerat, Pascal/0000-0002-0947-5235	Systems X (GutX); Swiss IBD cohort [33CS30-148422]	Systems X (GutX); Swiss IBD cohort	We thank all patients and the members of the Swiss IBD cohort and Bern cohort for their commitment. We also thank the staff of the University Hospital of Bern, Clinic of Visceral Medicine and Surgery, and the Bern City Hospitals led by F. Seibold and R. Tutuian for obtaining samples in Cohort 2. This research was supported by Systems X (GutX) to A.J.M. and J.S., and the Swiss IBD cohort (grant no. 33CS30-148422) to G.R., A.J.M and C.M. The founding institutions had no role in the study design, analysis or interpretation of the results. We thank G. Rahnavard and C. Huttenhower (Department of Biostatistics, Harvard T.H. Chan School of Public Health, USA) for their help in using the HAllA pipeline. We also thank J. Harrell Rieder, A. Suter, S. Brand, C. Mooser, W. Kwong Chung and J. Hugenschmidt for helping B.Y. during the process of sample preparation. We also thank G. Weingart (Department of Biostatistics, Harvard T.H. Chan School of Public Health, USA) for his enormous help in the optimization of MaAsLin running on the MacOS platform using R.	Abecia L., 2010, International Journal of Probiotics and Prebiotics, V5, P61; Alkadhi S, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-25; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashton JJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007347; Bajer L, 2017, WORLD J GASTROENTERO, V23, P4548, DOI 10.3748/wjg.v23.i25.4548; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bel S, 2014, P NATL ACAD SCI USA, V111, P4964, DOI 10.1073/pnas.1319114111; Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39; Bibiloni R, 2005, LETT APPL MICROBIOL, V41, P45, DOI 10.1111/j.1472-765X.2005.01720.x; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chen J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176583; Chen LP, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000051; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Cummings J. H, 2004, NOVART FDN SYMP, V263, P211; Cummings J. H, 2004, NOVART FDN SYMP, V263; Cummings John H, 2004, Novartis Found Symp, V263, P99; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Engels M, 2018, CLIN EXP GASTROENTER, V11, P1, DOI 10.2147/CEG.S120816; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Ettreiki C, 2012, WORLD J GASTROENTERO, V18, P2619, DOI 10.3748/wjg.v18.i21.2619; Eun CS, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0437-0; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Flint HJ, 2017, CURR OPIN MICROBIOL, V38, P59, DOI 10.1016/j.mib.2017.04.005; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Forbes JD, 2016, INFLAMM BOWEL DIS, V22, P817, DOI 10.1097/MIB.0000000000000684; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gecse KB, 2014, GUT, V63, P1381, DOI 10.1136/gutjnl-2013-306709; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530; Goodman AL, 2010, CELL METAB, V12, P111, DOI 10.1016/j.cmet.2010.07.001; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gupta SN, 2014, AUSTIN J NEUROL DISO, V1, P1, DOI DOI 10.1016/J.ARABJC.2014.08.004; Hakansson A, 2015, CLIN EXP MED, V15, P107, DOI 10.1007/s10238-013-0270-5; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hancock L, 2008, INFLAMM BOWEL DIS, V14, pS68, DOI 10.1002/ibd.20600; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; He Q, 2016, APPL MICROBIOL BIOT, V100, P4485, DOI 10.1007/s00253-015-7205-x; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hoentjen F, 2003, GUT, V52, P1721, DOI 10.1136/gut.52.12.1721; Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; Jacobs JP, 2016, CELL MOL GASTROENTER, V2, P750, DOI 10.1016/j.jcmgh.2016.06.004; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Jergens AE, 2012, J FELINE MED SURG, V14, P445, DOI 10.1177/1098612X12451548; Johnston DGW, 2018, J CROHNS COLITIS, V12, P835, DOI 10.1093/ecco-jcc/jjy038; Jones-Hall YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119441; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaakoush NO, 2012, J CLIN MICROBIOL, V50, P3258, DOI 10.1128/JCM.01396-12; Kabeerdoss J, 2015, INDIAN J MED RES, V142, P23, DOI 10.4103/0971-5916.162091; Kellermayer R, 2012, J PEDIATR GASTR NUTR, V55, P243, DOI 10.1097/MPG.0b013e3182617c16; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Knoll RL, 2017, AM J PHYSIOL-GASTR L, V312, pG327, DOI 10.1152/ajpgi.00293.2016; Kolho KL, 2015, AM J GASTROENTEROL, V110, P921, DOI 10.1038/ajg.2015.149; Kudelka MR, 2016, P NATL ACAD SCI USA, V113, P14787, DOI 10.1073/pnas.1612158114; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Larmonier CB, 2013, AM J PHYSIOL-GASTR L, V305, pG667, DOI 10.1152/ajpgi.00189.2013; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Lee JCW, 1996, GASTROENTEROLOGY, V111, P587, DOI 10.1053/gast.1996.v111.pm8780561; Li M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00824; Liguori G, 2016, J CROHNS COLITIS, V10, P296, DOI 10.1093/ecco-jcc/jjv209; Lopez-Siles M, 2015, APPL ENVIRON MICROB, V81, P7582, DOI 10.1128/AEM.02006-15; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Machiels K, 2017, GUT, V66, P79, DOI 10.1136/gutjnl-2015-309398; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3; Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703; Magnusson MK, 2016, J CROHNS COLITIS, V10, P943, DOI 10.1093/ecco-jcc/jjw051; Maharshak N, 2013, GUT MICROBES, V4, P316, DOI 10.4161/gmic.25486; Mainali KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187132; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manchester AC, 2013, J VET INTERN MED, V27, P56, DOI 10.1111/jvim.12020; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Mitchell J, 2018, INFLAMM BOWEL DIS, V24, P1718, DOI 10.1093/ibd/izy124; Moon C, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700391; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Munyaka PM, 2016, J BASIC MICROB, V56, P986, DOI 10.1002/jobm.201500726; Nagalingam NA, 2011, INFLAMM BOWEL DIS, V17, P917, DOI 10.1002/ibd.21462; Nishino K, 2018, J GASTROENTEROL, V53, P95, DOI 10.1007/s00535-017-1384-4; Nones K, 2009, J APPL MICROBIOL, V107, P557, DOI 10.1111/j.1365-2672.2009.04225.x; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Nunberg M, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00213-17; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Olivera P, 2017, CURR OPIN GASTROEN, V33, P246, DOI 10.1097/MOG.0000000000000361; Omori M, 2017, J VET MED SCI, V79, P1840, DOI 10.1292/jvms.17-0045; Osaka T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121329; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Park SH, 2017, CURR OPIN PHARMACOL, V37, P65, DOI 10.1016/j.coph.2017.09.007; Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235; Patterson AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01166; Pedamallu CS, 2016, CELL MOL GASTROENTER, V2, P563, DOI 10.1016/j.jcmgh.2016.05.011; Perez-Munoz ME, 2014, GUT MICROBES, V5, P286, DOI 10.4161/gmic.28622; Pillai N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185500; Plevinsky JM, 2018, J PEDIATR GASTR NUTR, V66, P79, DOI 10.1097/MPG.0000000000001633; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Rahnavard G. F, 2017, HALLA HIERARCHICAL A; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rehman A, 2010, J MED MICROBIOL, V59, P1114, DOI 10.1099/jmm.0.021170-0; Ren YL, 2018, J NUTR BIOCHEM, V57, P67, DOI 10.1016/j.jnutbio.2018.03.005; Robinson AM, 2017, AM J PHYSIOL-GASTR L, V312, pG85, DOI 10.1152/ajpgi.00210.2016; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Rossi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094699; Roy U, 2017, CELL REP, V21, P994, DOI 10.1016/j.celrep.2017.09.097; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Santoru ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10034-5; Sartor RB, 2017, GASTROENTEROLOGY, V152, P327, DOI 10.1053/j.gastro.2016.10.012; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Schuppler M, 2004, INFECT IMMUN, V72, P1983, DOI 10.1128/IAI.72.4.1983-1990.2004; Schwab C, 2014, ISME J, V8, P1101, DOI 10.1038/ismej.2013.223; Schwiertz A, 2010, J PEDIATR-US, V157, P240, DOI 10.1016/j.jpeds.2010.02.046; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Selvanantham T, 2016, J IMMUNOL, V197, P4464, DOI 10.4049/jimmunol.1601410; Seregin SS, 2017, CELL REP, V19, P2174, DOI 10.1016/j.celrep.2017.05.074; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spalinger MR, 2015, MUCOSAL IMMUNOL, V8, P918, DOI 10.1038/mi.2014.122; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Tong MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080702; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Uhlig HH, 2013, GUT, V62, P1795, DOI 10.1136/gutjnl-2012-303956; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Vazquez-Baeza Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.177, 10.1038/nmicrobiol.2016.177]; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wohlgemuth S, 2009, ENVIRON MICROBIOL, V11, P1562, DOI 10.1111/j.1462-2920.2009.01883.x; Wu FF, 2017, EXP THER MED, V14, P3122, DOI 10.3892/etm.2017.4878; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Xu J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0736-2; Yang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070783; Ye JX, 2008, INFLAMM BOWEL DIS, V14, P1041, DOI 10.1002/ibd.20442; Zachos M, 2007, COCHRANE DATABASE SY, V4; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhang QP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27572; Zhang Z, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070677; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172; Zimmermann J, 2018, EUR J IMMUNOL, V48, P161, DOI 10.1002/eji.201747100; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	176	167	175	6	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					323	+		10.1038/s41591-018-0308-z	http://dx.doi.org/10.1038/s41591-018-0308-z			34	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30664783				2022-12-27	WOS:000457842100030
J	Price, WN; Cohen, IG				Price, W. Nicholson; Cohen, I. Glenn			Privacy in the age of medical big data	NATURE MEDICINE			English	Review							HEALTH; LEGAL; SYSTEM	Big data has become the ubiquitous watch word of medical innovation. The rapid development of machine-learning techniques and artificial intelligence in particular has promised to revolutionize medical practice from the allocation of resources to the diagnosis of complex diseases. But with big data comes big risks and challenges, among them significant questions about patient privacy. Here, we outline the legal and ethical challenges big data brings to patient privacy. We discuss, among other topics, how best to conceive of health privacy; the importance of equity, consent, and patient governance in data collection; discrimination in data uses; and how to handle data breaches. We close by sketching possible ways forward for the regulatory system.	[Price, W. Nicholson] Univ Michigan, Law Sch, Ann Arbor, MI 48109 USA; [Price, W. Nicholson; Cohen, I. Glenn] Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Project Personalized Med Artificial Intelligence, Cambridge, MA 02138 USA; [Price, W. Nicholson; Cohen, I. Glenn] Univ Copenhagen, Ctr Adv Studies Biomed Innovat Law, Copenhagen, Denmark; [Cohen, I. Glenn] Harvard Law Sch, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; University of Copenhagen; Harvard University	Cohen, IG (corresponding author), Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Project Personalized Med Artificial Intelligence, Cambridge, MA 02138 USA.; Cohen, IG (corresponding author), Univ Copenhagen, Ctr Adv Studies Biomed Innovat Law, Copenhagen, Denmark.; Cohen, IG (corresponding author), Harvard Law Sch, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu		Price, Nicholson/0000-0003-0729-290X	NATIONAL CANCER INSTITUTE [R01CA214829] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avati A, 2018, IMPROVING PALLIATIVE; Barocas S, 2016, CALIF LAW REV, V104, P671, DOI 10.15779/Z38BG31; Beaulieu-Jones B. K., 2018, PRIVACY PRESERVING G; Behrman RE, 2011, NEW ENGL J MED, V364, P498, DOI 10.1056/NEJMp1014427; Calo MR, 2011, INDIANA LAW J, V86, P1131; Centers for Medicare and Medicaid Services, BLUE BUTT 2 0 IMPR M; Centers for Medicare & Medicaid Services, 2017, HOSP INP QUAL REP PR; Chen I, 2018, WHY IS MY CLASSIFIER; Cohen IG, 2014, HEALTH AFFAIR, V33, P1139, DOI 10.1377/hlthaff.2014.0048; Cohen I. Glenn, 2018, BIG DATA HLTH LAW BI; Connected Health Cities, 2017, CIT JUR REP; Cook-Deegan R, 2013, EUR J HUM GENET, V21, P585, DOI 10.1038/ejhg.2012.217; Couzin-Frankel J., 2016, SCIENCE; Crawford K., 2014, BOSTON COLL LAW REV, V55, P93; Dwork C, 2013, FOUND TRENDS THEOR C, V9, P211, DOI 10.1561/0400000042; Eisenberg RS, 2017, J LAW BIOSCI, V4, P3, DOI 10.1093/jlb/lsw062; EPSTEIN RA, 1994, BOSTON U LAW REV, V74, P1; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Evans B. J., 2018, BIG DATA HLTH LAW BI; Executive Office of the President, 2014, BIG DAT SEIZ OPP PRE; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Ford RogerAllan, 2016, MICH TELECOMM TECH L, V23, P1; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Goldacre B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001821; Grady C, 2015, AM J BIOETHICS, V15, P34, DOI 10.1080/15265161.2015.1062162; Grande D, 2013, JAMA INTERN MED, V173, P1798, DOI 10.1001/jamainternmed.2013.9166; Greely HT, 2007, ANNU REV GENOM HUM G, V8, P343, DOI 10.1146/annurev.genom.7.080505.115721; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hoffman AK, 2011, U PENN LAW REV, V159, P1873; Hoffman S., 2015, BERKELEY TECHNOLOGY, V30, P1741; Hoffman S., 2018, BIG DATA HLTH LAW BI; Hoffman Sharona, 2016, ELECT HLTH RECORDS M; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Kaye Jane, 2015, Eur J Hum Genet, V23, P141, DOI 10.1038/ejhg.2014.71; Kleinberg Jon, 2016, P 8 INN THEOR COMP S; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Konnoth C, 2017, IOWA LAW REV, V102, P1533; Liu NT, 2014, MED BIOL ENG COMPUT, V52, P193, DOI 10.1007/s11517-013-1130-x; Malanga Sarah E., 2018, BIG DATA HLTH LAW BI, V98, P98, DOI DOI 10.1017/9781108147972.010; Maschke K. J, 2017, SPECIMEN SCI ETHICS; May T, 2018, NEW ENGL J MED, V379, P410, DOI 10.1056/NEJMp1805870; Mayer-Schonberger V, 2018, J INTERN MED, V283, P418, DOI 10.1111/joim.12721; Mello MM, 2018, NEW ENGL J MED, V378, P2202, DOI 10.1056/NEJMsa1713258; Miller FG, 2008, NEW ENGL J MED, V358, P765, DOI 10.1056/NEJMp0800136; Morreim H, 2005, AM J BIOETHICS, V5, P42, DOI 10.1080/15265160590931205; Moussa M, 2017, ADV INF SECUR PRIV, P191, DOI 10.4018/978-1-5225-2486-1.ch009; Narayanan A, 2008, P IEEE S SECUR PRIV, P111, DOI 10.1109/SP.2008.33; Nissenbaum H.F., 2010, PRIVACY CONTEXT TECH; Ohm P, 2010, UCLA LAW REV, V57, P1701; Olsen L. A, 2007, LEARNINGHEALTHCARE S; Philibert RA, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-28; Price II W. N, 2018, DRUG APPROVAL LEARNI; Price W. N., 2016, HARV JL TECH, V28, P419; Price WN, 2017, MICH LAW REV, V116, P421; Price WN, 2016, CARDOZO LAW REV, V37, P1401; Raval Mehul V, 2014, Bull Am Coll Surg, V99, P21; Riley M. F., 2018, BIG DATA HLTH LAW BI; Rockhold F, 2016, NEW ENGL J MED, V375, P1115, DOI 10.1056/NEJMp1608086; Skopek J. M, 2018, BIG DATA HLTH LAW BI; Spector-Bagdady K, 2018, AM J MED GENET C, V178, P81, DOI 10.1002/ajmg.c.31608; Spector-Bagdady K, 2018, OTOLARYNG HEAD NECK, V158, P405, DOI 10.1177/0194599817740522; Spector-Bagdady K, 2016, ANN EPIDEMIOL, V26, P515, DOI 10.1016/j.annepidem.2016.05.007; STONE DA, 1993, J HEALTH POLIT POLIC, V18, P287, DOI 10.1215/03616878-18-2-287; Terry N. P, 2017, ETHICS MED PUB HLTH, V3, P19, DOI DOI 10.1016/J.JEMEP.2017.02.007]; Terry N.P., 2017, YALE J HLTH POLY L E, V17, P143; Terry N. P, 2012, UMKC L REV, V81, P1; Terry N. P, 2018, APPIFICATION AI HEAL; US Department of Health and Human Services, HLTH INF PRIV HIPAA; Winickoff DE, 2003, NEW ENGL J MED, V349, P1180, DOI 10.1056/NEJMsb030036	70	276	283	45	248	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					37	43		10.1038/s41591-018-0272-7	http://dx.doi.org/10.1038/s41591-018-0272-7			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617331	Green Accepted			2022-12-27	WOS:000455027700018
J	Farrell, A				Farrell, Alison			A vaccine for tuberculosis	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1637	1637		10.1038/s41591-018-0258-5	http://dx.doi.org/10.1038/s41591-018-0258-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401862	Bronze			2022-12-27	WOS:000449404200004
J	De Fauw, J; Ledsam, JR; Romera-Paredes, B; Nikolov, S; Tomasev, N; Blackwell, S; Askham, H; Glorot, X; O'Donoghue, B; Visentin, D; van den Driessche, G; Lakshminarayanan, B; Meyer, C; Mackinder, F; Bouton, S; Ayoub, K; Chopra, R; King, D; Karthikesalingam, A; Hughes, CO; Raine, R; Hughes, J; Sim, DA; Egan, C; Tufail, A; Montgomery, H; Hassabis, D; Rees, G; Back, T; Khaw, PT; Suleyman, M; Cornebise, J; Keane, PA; Ronneberger, O				De Fauw, Jeffrey; Ledsam, Joseph R.; Romera-Paredes, Bernardino; Nikolov, Stanislav; Tomasev, Nenad; Blackwell, Sam; Askham, Harry; Glorot, Xavier; O'Donoghue, Brendan; Visentin, Daniel; van den Driessche, George; Lakshminarayanan, Balaji; Meyer, Clemens; Mackinder, Faith; Bouton, Simon; Ayoub, Kareem; Chopra, Reena; King, Dominic; Karthikesalingam, Alan; Hughes, Cian O.; Raine, Rosalind; Hughes, Julian; Sim, Dawn A.; Egan, Catherine; Tufail, Adnan; Montgomery, Hugh; Hassabis, Demis; Rees, Geraint; Back, Trevor; Khaw, Peng T.; Suleyman, Mustafa; Cornebise, Julien; Keane, Pearse A.; Ronneberger, Olaf			Clinically applicable deep learning for diagnosis and referral in retinal disease	NATURE MEDICINE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FULLY AUTOMATED DETECTION; DIABETIC MACULAR EDEMA; DEGENERATION; CLASSIFICATION; SEGMENTATION; IMAGES; DELAY; METAANALYSIS; RETINOPATHY	The volume and complexity of diagnostic imaging is increasing at a pace faster than the availability of human expertise to interpret it. Artificial intelligence has shown great promise in classifying two-dimensional photographs of some common diseases and typically relies on databases of millions of annotated images. Until now, the challenge of reaching the performance of expert clinicians in a real-world clinical pathway with three-dimensional diagnostic scans has remained unsolved. Here, we apply a novel deep learning architecture to a clinically heterogeneous set of three-dimensional optical coherence tomography scans from patients referred to a major eye hospital. We demonstrate performance in making a referral recommendation that reaches or exceeds that of experts on a range of sight-threatening retinal diseases after training on only 14,884 scans. Moreover, we demonstrate that the tissue segmentations produced by our architecture act as a device-independent representation; referral accuracy is maintained when using tissue segmentations from a different type of device. Our work removes previous barriers to wider clinical use without prohibitive training data requirements across multiple pathologies in a real-world setting.	[De Fauw, Jeffrey; Ledsam, Joseph R.; Romera-Paredes, Bernardino; Nikolov, Stanislav; Tomasev, Nenad; Blackwell, Sam; Askham, Harry; Glorot, Xavier; O'Donoghue, Brendan; Visentin, Daniel; van den Driessche, George; Lakshminarayanan, Balaji; Meyer, Clemens; Mackinder, Faith; Bouton, Simon; Ayoub, Kareem; King, Dominic; Karthikesalingam, Alan; Hughes, Cian O.; Hassabis, Demis; Back, Trevor; Suleyman, Mustafa; Cornebise, Julien; Ronneberger, Olaf] DeepMind, London, England; [Chopra, Reena; Hughes, Julian; Sim, Dawn A.; Egan, Catherine; Tufail, Adnan; Khaw, Peng T.; Keane, Pearse A.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Chopra, Reena; Hughes, Julian; Sim, Dawn A.; Egan, Catherine; Tufail, Adnan; Khaw, Peng T.; Keane, Pearse A.] UCL Inst Ophthalmol, London, England; [Hughes, Cian O.; Raine, Rosalind; Montgomery, Hugh; Rees, Geraint; Cornebise, Julien] UCL, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London	Ronneberger, O (corresponding author), DeepMind, London, England.; Keane, PA (corresponding author), Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England.; Keane, PA (corresponding author), UCL Inst Ophthalmol, London, England.	pearse.keane@moorfields.nhs.uk; olafr@deepmind.com	Rees, Geraint/C-1493-2008; Montgomery, Hugh/L-1229-2019; Keane, Pearse/AAE-5709-2019; Montgomery, Hugh/C-2592-2008	Rees, Geraint/0000-0002-9623-7007; Keane, Pearse/0000-0002-9239-745X; Montgomery, Hugh/0000-0001-8797-5019; Tufail, Adnan/0000-0001-6131-7640; Chopra, Reena/0000-0002-4264-8329; Raine, Rosalind/0000-0003-0904-749X; Khaw, Sir Peng Tee/0000-0002-8087-2268; Glorot, Xavier/0000-0002-6729-2189; Egan, Catherine/0000-0001-5593-1169	NIHR Clinician Scientist Award [NIHR-CS-2014-14-023]; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; NIHR Moorfields Clinical Research Facility; College of Optometrists, United Kingdom; Wellcome Trust [100227/Z/12/Z] Funding Source: researchfish	NIHR Clinician Scientist Award; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; NIHR Moorfields Clinical Research Facility; College of Optometrists, United Kingdom; Wellcome Trust(Wellcome TrustEuropean Commission)	We thank K. Kavukcuoglu, A. Zisserman, M. Jaderberg, K. Simonyan for discussions, A. Cain and M. Cant for work on the visuals, D. Mitchell and M. Johnson for infrastructure and systems administration, J. Morgan and OpenEyes for providing the electronic health record records, T. Peto, P. Blows, A. O'Shea and the NIHR Clinical Research Facility for work on the labeling, T. Heeran, M. Lukic, K. Kortum, K. Fasler, S. Wagner and N. Pontikos for work on the labeling, E. Steele, V. Louw, S. Gill and the rest of Moorfields IT team for work on the data collection and deidentification, S. Al-Abed and N. Smith for Moorfields technical advice at project initiation, R. Wood and D. Corder at Softwire for engineering support at Moorfields, R. Ogbe and the Moorfields Information Governance team for support, M. Hassard for Moorfields research and development support, K. Bonstein and the National Institute for Health Research (NIHR) for support at the Moorfields Biomedical Research Centre (BRC), J. Besley for legal assistance, E. Manna for patient engagement and support, and the rest of the DeepMind team for their support, ideas and encouragement. P.A.K. is supported by an NIHR Clinician Scientist Award (NIHR-CS-2014-14-023). D.A.S., A.T., C.E. and P.T.K. are supported by the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology and the NIHR Moorfields Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. R.C. receives studentship support from the College of Optometrists, United Kingdom.	Apostolopoulos S., 2016, RETINET AUTOMATIC AM; Arias L, 2009, EYE, V23, P326, DOI 10.1038/sj.eye.6703053; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Buchan JC, 2017, EYE, V31, P1519, DOI 10.1038/eye.2017.114; Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a; Chopra R, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.16; Cicek O., 2016, LECT NOTES COMPUTER, V9901; De Fauw Jeffrey, 2016, F1000Res, V5, P1573; Duker J.S., 2013, HDB RETINAL OCT OPTI; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fang LY, 2017, BIOMED OPT EXPRESS, V8, P2732, DOI 10.1364/BOE.8.002732; Farsiu S, 2014, OPHTHALMOLOGY, V121, P162, DOI 10.1016/j.ophtha.2013.07.013; Folgar FA, 2014, OPHTHALMOLOGY, V121, P1956, DOI 10.1016/j.ophtha.2014.04.020; Foot B, 2017, EYE, V31, P771, DOI 10.1038/eye.2017.1; Goodfellow I., 2015, TENSORFLOW LARGE SCA; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Karri SPK, 2017, BIOMED OPT EXPRESS, V8, P579, DOI 10.1364/BOE.8.000579; Keane PA, 2011, SAUDI J OPHTHALMOL, V25, P145, DOI 10.1016/j.sjopt.2011.01.003; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Kingama D., 2015, 3 INT C LEARN REPRES; Lakshminarayanan B., 2017, ADV NEURAL INFORM PR, P6405; Lee CS, 2017, OPHTHALMOL RETINA, V1, P322, DOI 10.1016/j.oret.2016.12.009; Lee CS, 2017, BIOMED OPT EXPRESS, V8, P3440, DOI 10.1364/BOE.8.003440; Lu D, 2017, RETINAL FLUID SEGMEN; Muether PS, 2011, GRAEF ARCH CLIN EXP, V249, P633, DOI 10.1007/s00417-010-1520-9; OECD, 2022, MAGNETIC RESONANCE I, DOI [10.1787/1d89353f-en, DOI 10.1787/1D89353F-EN]; OECD, 2020, COMP TOM CT EX IND, DOI [10.1787/3c994537-en, DOI 10.1787/3C994537-EN]; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Ronneberger O, 2015, LECT NOTES COMPUTER, V9351; Roy AG, 2017, BIOMED OPT EXPRESS, V8, P3627, DOI 10.1364/BOE.8.003627; Rudnicka AR, 2015, AM J OPHTHALMOL, V160, P85, DOI 10.1016/j.ajo.2015.04.003; Schaal KB, 2016, OPHTHALMOLOGY, V123, P1060, DOI 10.1016/j.ophtha.2016.01.034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlegl T, 2018, OPHTHALMOLOGY, V125, P549, DOI 10.1016/j.ophtha.2017.10.031; Schmidt-Erfurth U, 2017, EYE, V31, P26, DOI 10.1038/eye.2016.227; Schmidt-Erfurth U, 2018, OPHTHALMOL RETINA, V2, P24, DOI 10.1016/j.oret.2017.03.015; Schmidt-Erfurth U, 2016, PROG RETIN EYE RES, V50, P1, DOI 10.1016/j.preteyeres.2015.07.007; Srinivasan PP, 2014, BIOMED OPT EXPRESS, V5, P3568, DOI 10.1364/BOE.5.003568; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Villani E, 2017, INVEST OPHTH VIS SCI, V58, pBIO76; Whited JD, 2005, TELEMED J E-HEALTH, V11, P641, DOI 10.1089/tmj.2005.11.641	43	954	964	34	322	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1342	+		10.1038/s41591-018-0107-6	http://dx.doi.org/10.1038/s41591-018-0107-6			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30104768	Green Submitted			2022-12-27	WOS:000444174100015
J	Stower, H				Stower, Hannah			DIAGNOSTIC DEVICES Identifying atrial fibrillation	NATURE MEDICINE			English	Editorial Material																			0	0	0	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1088	1088		10.1038/s41591-018-0151-2	http://dx.doi.org/10.1038/s41591-018-0151-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082864	Bronze			2022-12-27	WOS:000440955500005
J	Guo, XY; Zhang, YY; Zheng, LT; Zheng, CH; Song, JT; Zhang, QM; Kang, BX; Liu, ZZR; Jin, L; Xing, R; Gao, RR; Zhang, L; Dong, MH; Hu, XD; Ren, XW; Kirchhoff, D; Roider, HG; Yan, TS; Zhang, ZM				Guo, Xinyi; Zhang, Yuanyuan; Zheng, Liangtao; Zheng, Chunhong; Song, Jintao; Zhang, Qiming; Kang, Boxi; Liu, Zhouzerui; Jin, Liang; Xing, Rui; Gao, Ranran; Zhang, Lei; Dong, Minghui; Hu, Xueda; Ren, Xianwen; Kirchhoff, Dennis; Roider, Helge Gottfried; Yan, Tiansheng; Zhang, Zemin			Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing	NATURE MEDICINE			English	Article							PD-1 BLOCKADE; EXPRESSION PROFILES; CHECKPOINT BLOCKADE; EFFECTOR FUNCTIONS; IMMUNE CHECKPOINT; RNA-SEQ; LANDSCAPE; SUBSETS; LYMPHOCYTES; EXHAUSTION	Cancer immunotherapies have shown sustained clinical responses in treating non-small-cell lung cancer(1-3), but efficacy varies and depends in part on the amount and properties of tumor infiltrating lymphocytes(4-6). To depict the baseline landscape of the composition, lineage and functional states of tumor infiltrating lymphocytes, here we performed deep single-cell RNA sequencing for 12,346 T cells from 14 treatment-naive non-small-cell lung cancer patients. Combined expression and T cell antigen receptor based lineage tracking revealed a significant proportion of inter-tissue effector T cells with a highly migratory nature. As well as tumor-infiltrating CD8(+) T cells undergoing exhaustion, we observed two clusters of cells exhibiting states preceding exhaustion, and a high ratio of "pre-exhausted" to exhausted T cells was associated with better prognosis of lung adenocarcinoma. Additionally, we observed further heterogeneity within the tumor regulatory T cells (Tregs), characterized by the bimodal distribution of TNFRSF9, an activation marker for antigen-specific Tregs. The gene signature of those activated tumor Tregs, which included IL1R2, correlated with poor prognosis in lung adenocarcinoma. Our study provides a new approach for patient stratification and will help further understand the functional states and dynamics of T cells in lung cancer.	[Guo, Xinyi; Zhang, Yuanyuan; Zheng, Chunhong; Zhang, Qiming; Kang, Boxi; Liu, Zhouzerui; Gao, Ranran; Dong, Minghui; Hu, Xueda; Ren, Xianwen; Zhang, Zemin] Peking Univ, Beijing Adv Innovat Ctr Genom, BIOPIC, Beijing, Peoples R China; [Guo, Xinyi; Zhang, Yuanyuan; Zheng, Chunhong; Zhang, Qiming; Kang, Boxi; Liu, Zhouzerui; Gao, Ranran; Dong, Minghui; Hu, Xueda; Ren, Xianwen; Zhang, Zemin] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Zheng, Liangtao; Zhang, Lei; Zhang, Zemin] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Song, Jintao; Jin, Liang; Yan, Tiansheng] Peking Univ, Dept Thorac Surg, Hosp 3, Beijing, Peoples R China; [Xing, Rui] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China; [Kirchhoff, Dennis; Roider, Helge Gottfried] Bayer AG, Berlin, Germany	Peking University; Peking University; Peking University; Peking University; Peking University; Bayer AG	Zhang, ZM (corresponding author), Peking Univ, Beijing Adv Innovat Ctr Genom, BIOPIC, Beijing, Peoples R China.; Zhang, ZM (corresponding author), Peking Univ, Sch Life Sci, Beijing, Peoples R China.; Zhang, ZM (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Yan, TS (corresponding author), Peking Univ, Dept Thorac Surg, Hosp 3, Beijing, Peoples R China.	yts8966@163.com; zemin@pku.edu.cn	Zhang, Yuanyuan/GYE-1266-2022	Zhang, Yuanyuan/0000-0001-6972-5606; Zheng, Liangtao/0000-0001-9795-3198; Liu, Zhouzerui/0000-0001-9282-3327; Kang, Boxi/0000-0002-0276-0519	Beijing Advanced Innovation Centre for Genomics at Peking University; Key Technologies RD Program [2016YFC0900100]; National Natural Science Foundation of China [81573022, 31530036, 91742203]; Bayer AG (Germany); Postdoctoral Foundation of Centre for Life Sciences at Peking University-Tsinghua University	Beijing Advanced Innovation Centre for Genomics at Peking University; Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bayer AG (Germany)(Bayer AG); Postdoctoral Foundation of Centre for Life Sciences at Peking University-Tsinghua University	We thank S. Geng for discussions and members of the BIOPIC high-throughput sequencing facility and the Computing Platform of the Centre for Life Science. We also thank the National Centre for Protein Sciences Beijing (Peking University) and F. Wang, X. Zhang, S. Wang and Z. Fu for assistance with FACS. This project was supported by grants from the Beijing Advanced Innovation Centre for Genomics at Peking University, Key Technologies R&D Program (2016YFC0900100), the National Natural Science Foundation of China (81573022, 31530036, 91742203) and Bayer AG (Germany). C. Zheng and L. Zhang were supported by the Postdoctoral Foundation of Centre for Life Sciences at Peking University-Tsinghua University.	Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Danaher P., 2016, BIORXIV, DOI [10.1101/068940, DOI 10.1101/068940]; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hidalgo LG, 2008, AM J TRANSPLANT, V8, P627, DOI 10.1111/j.1600-6143.2007.02128.x; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Ruitenberg JJ, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-11; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	42	593	615	20	160	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					978	+		10.1038/s41591-018-0045-3	http://dx.doi.org/10.1038/s41591-018-0045-3			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29942094				2022-12-27	WOS:000438187700026
J	Priego, N; Zhu, LC; Monteiro, C; Mulders, M; Wasilewski, D; Bindeman, W; Doglio, L; Martinez, L; Martinez-Saez, E; Cajal, SRY; Megias, D; Hernandez-Encinas, E; Blanco-Aparicio, C; Martinez, L; Zarzuela, E; Munoz, J; Fustero-Torre, C; Pineiro-Yanez, E; Hernandez-Lain, A; Bertero, L; Poli, V; Sanchez-Martinez, M; Menendez, JA; Soffietti, R; Bosch-Barrera, J; Valiente, M				Priego, Neibla; Zhu, Lucia; Monteiro, Catia; Mulders, Manon; Wasilewski, David; Bindeman, Wendy; Doglio, Laura; Martinez, Liliana; Martinez-Saez, Elena; Ramon y Cajal, Santiago; Megias, Diego; Hernandez-Encinas, Elena; Blanco-Aparicio, Carmen; Martinez, Lola; Zarzuela, Eduardo; Munoz, Javier; Fustero-Torre, Coral; Pineiro-Yanez, Elena; Hernandez-Lain, Aurelio; Bertero, Luca; Poli, Valeria; Sanchez-Martinez, Melchor; Menendez, Javier A.; Soffietti, Riccardo; Bosch-Barrera, Joaquim; Valiente, Manuel			STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL SURVIVAL; REVEALS; MICROENVIRONMENT; ACTIVATION; PROMOTE; PATHWAY; INHIBITION; EXPRESSION; MELANOMA	The brain microenvironment imposes a particularly intense selective pressure on metastasis-initiating cells, but successful metastases bypass this control through mechanisms that are poorly understood. Reactive astrocytes are key components of this microenvironment that confine brain metastasis without infiltrating the lesion. Here, we describe that brain metastatic cells induce and maintain the co-option of a pro-metastatic program driven by signal transducer and activator of transcription 3 (STAT3) in a subpopulation of reactive astrocytes surrounding metastatic lesions. These reactive astrocytes benefit metastatic cells by their modulatory effect on the innate and acquired immune system. In patients, active STAT3 in reactive astrocytes correlates with reduced survival from diagnosis of intracranial metastases. Blocking STAT3 signaling in reactive astrocytes reduces experimental brain metastasis from different primary tumor sources, even at advanced stages of colonization. We also show that a safe and orally bioavailable treatment that inhibits STAT3 exhibits significant antitumor effects in patients with advanced systemic disease that included brain metastasis. Responses to this therapy were notable in the central nervous system, where several complete responses were achieved. Given that brain metastasis causes substantial morbidity and mortality, our results identify a novel treatment for increasing survival in patients with secondary brain tumors.	[Priego, Neibla; Zhu, Lucia; Monteiro, Catia; Mulders, Manon; Wasilewski, David; Bindeman, Wendy; Doglio, Laura; Martinez, Liliana; Valiente, Manuel] Spanish Natl Canc Res Ctr CNIO, Brain Metastasis Grp, Madrid, Spain; [Martinez-Saez, Elena; Ramon y Cajal, Santiago] Vall dHebron Hosp, Pathol Dept, Barcelona, Spain; [Martinez-Saez, Elena; Ramon y Cajal, Santiago] Spanish Biomed Res Network Ctr Oncol CIBERONC, Barcelona, Spain; [Megias, Diego] Spanish Natl Canc Res Ctr CNIO, Confocal Microscopy Unit, Madrid, Spain; [Hernandez-Encinas, Elena; Blanco-Aparicio, Carmen] Spanish Natl Canc Ctr CNIO, Expt Therapeut Program, Madrid, Spain; [Martinez, Lola] Spanish Natl Canc Res Ctr CNIO, Flow Cytometry Unit, Madrid, Spain; [Zarzuela, Eduardo; Munoz, Javier] Spanish Natl Canc Res Ctr CNIO, ProteoRed ISCIII Prote Unit, Madrid, Spain; [Fustero-Torre, Coral; Pineiro-Yanez, Elena] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, Madrid, Spain; [Hernandez-Lain, Aurelio] Hosp Univ 12 Octubre, Res Inst, Neuropathol Unit, Madrid, Spain; [Bertero, Luca] Univ Turin, Div Pathol, Med Sci Dept, Turin, Italy; [Bertero, Luca; Soffietti, Riccardo] City Hlth & Sci Univ Hosp Turin, Turin, Italy; [Poli, Valeria] Univ Turin, Mol Biotechnol Ctr, Turin, Italy; [Sanchez-Martinez, Melchor] Mind Byte, Barcelona, Spain; [Menendez, Javier A.] Catalan Inst Oncol, Metab & Canc Grp, Program Canc Therapeut Resistance ProCURE, Girona, Spain; [Menendez, Javier A.; Bosch-Barrera, Joaquim] Girona Biomed Res Inst IDIBGI, Mol Oncol Grp, Girona, Spain; [Soffietti, Riccardo] Univ Turin, Neurooncol Dept, Turin, Italy; [Bosch-Barrera, Joaquim] Univ Girona, Med Sch, Dept Med Sci, Girona, Spain; [Bosch-Barrera, Joaquim] Dr Josep Trueta Univ Hosp, Catalan Inst Oncol ICO, Girona, Spain; [Wasilewski, David] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Doglio, Laura] Kings Coll London, Ctr Dev Neurobiol, London, England	Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario 12 de Octubre; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Turin; Universitat de Girona; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; King's College London	Valiente, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Brain Metastasis Grp, Madrid, Spain.	mvaliente@cnio.es	Martinez, Lola/L-2308-2014; Sanchez-Martinez, Melchor/A-3392-2014; Soffietti, Riccardo/AAA-7965-2022; Monteiro, Cátia/L-5409-2014; MENENDEZ, JAVIER A/C-6148-2016; Piñeiro-Yáñez, Elena/L-1396-2017; Munoz, Javier/I-4891-2012; Lain, Aurelio Hernandez/S-6172-2018; Wasilewski, David/HGB-6012-2022; W., David/GON-7276-2022; Martinez, Lola/ABG-2474-2020; Megías, Diego/L-6008-2014; Hernandez Encinas, Elena/I-4623-2018; Ramon y Cajal, Santiago/H-4955-2016; Bertero, Luca/N-5357-2017; Martinez-Saez, Elena/E-9097-2018; Blanco-Aparicio, Carmen/I-3162-2015; Poli, Valeria/A-9215-2012; Valiente, Manuel/J-9523-2014; Fustero-Torre, Coral/L-2418-2017	Martinez, Lola/0000-0001-6273-6724; Sanchez-Martinez, Melchor/0000-0002-3674-8577; Soffietti, Riccardo/0000-0002-9204-7038; Monteiro, Cátia/0000-0002-0828-4541; MENENDEZ, JAVIER A/0000-0001-8733-4561; Piñeiro-Yáñez, Elena/0000-0003-2773-2343; Munoz, Javier/0000-0003-3288-3496; Lain, Aurelio Hernandez/0000-0003-1642-4505; W., David/0000-0001-6505-0584; Hernandez Encinas, Elena/0000-0003-4984-0302; Ramon y Cajal, Santiago/0000-0002-3867-1390; Bertero, Luca/0000-0001-9887-7668; Martinez-Saez, Elena/0000-0001-6004-5364; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Poli, Valeria/0000-0002-3739-3966; Valiente, Manuel/0000-0002-0647-7542; Bindeman, Wendy/0000-0003-4065-6197; Fustero-Torre, Coral/0000-0001-5504-4164; Bosch-Barrera, Joaquim/0000-0002-0893-7821; Zarzuela, Eduardo/0000-0002-0187-4012; Megias, Diego/0000-0003-0755-0518	MINECO [MINECO-Retos SAF201457243-R]; MINECO-Europa Excelencia [SAF2015-62547-ERC]; FERO Grant for Research in Oncology; Melanoma Research Alliance Young Investigator Award; AECC Coordinated Translational Groups; SEOM; Pfizer [WI190764]; Meda Pharma; Armangue Family Fund; La Caixa-Severo Ochoa International PhD Program Fellowship; FCT PhD Fellowship [SFRH/BD/100089/2014]; Fulbright Program; Ramon y Cajal Investigator [RYC-2013-13365]	MINECO(Spanish Government); MINECO-Europa Excelencia; FERO Grant for Research in Oncology; Melanoma Research Alliance Young Investigator Award; AECC Coordinated Translational Groups; SEOM; Pfizer(Pfizer); Meda Pharma; Armangue Family Fund; La Caixa-Severo Ochoa International PhD Program Fellowship; FCT PhD Fellowship(Portuguese Foundation for Science and Technology); Fulbright Program; Ramon y Cajal Investigator(Spanish Government)	We want to thank the CNIO Core Facilities for their excellent assistance. We also thank F.X. Real, O. Marin, M. Serrano, O. Fernandez-Capetillo and M. Soengas for critically reading the manuscript, P. Bos for advice with CD8<SUP>+</SUP> T cell experiments, J. Massague (MSKCC) for the BrM cell lines, MEDA for Legasil, M. A. Perez (University of Copenhagen), H. Peinado (CNIO), M. Soengas (CNIO) and M. Squatrito (CNIO) for reagents. This work was supported by MINECO grants MINECO-Retos SAF201457243-R (M.V.), MINECO-Europa Excelencia SAF2015-62547-ERC (M.V.), FERO Grant for Research in Oncology (M.V.), Melanoma Research Alliance Young Investigator Award (M.V.), AECC Coordinated Translational Groups (M.V., E.M.-S. and S.R.y.C), SEOM (J.B.-B.), Pfizer WI190764 (J.B.-B.), Meda Pharma (J.B.-B.), Armangue Family Fund (JA.M. and J.B.-B.), La Caixa-Severo Ochoa International PhD Program Fellowship (L.Z.), FCT PhD Fellowship SFRH/BD/100089/2014 (C.M.), the Fulbright Program (W.B.). M.V. is a Ramon y Cajal Investigator (RYC-2013-13365). This work is dedicated to the memory of Maria Jesus Cortes Garin.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Ashraf MI, 2016, AM J TRANSPLANT, V16, P808, DOI 10.1111/ajt.13521; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Berghoff AS, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1057388; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bosch-Barrera J, 2016, ONCOTARGET, V7, P32006, DOI 10.18632/oncotarget.7900; Bosch-Barrera J, 2015, CANCER TREAT REV, V41, P540, DOI 10.1016/j.ctrv.2015.04.008; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Cho JH, 2013, J IMMUNOL, V191, P5559, DOI 10.4049/jimmunol.1302293; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Chuang HN, 2013, GLIA, V61, P1331, DOI 10.1002/glia.22518; Cohen S, 2012, J IMMUNOL, V188, P259, DOI 10.4049/jimmunol.1101468; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Dubeykovskaya Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10517; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Ghoochani A, 2016, ONCOGENE, V35, P6246, DOI 10.1038/onc.2016.160; Gil-Yarom N, 2017, P NATL ACAD SCI USA, V114, P562, DOI 10.1073/pnas.1612195114; Hatiboglu MA, 2012, INT J CANCER, V131, P8, DOI 10.1002/ijc.26307; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jee Y, 2001, J NEUROIMMUNOL, V114, P40, DOI 10.1016/S0165-5728(00)00446-X; Jones LM, 2016, CANCER RES, V76, P1416, DOI 10.1158/0008-5472.CAN-15-2770; Kaur S, 2014, J IMMUNOL, V193, P3914, DOI 10.4049/jimmunol.1303116; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim SJ, 2015, CLIN CANCER RES, V21, P4630, DOI 10.1158/1078-0432.CCR-14-3195; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kumthekar P, 2013, J NEURO-ONCOL, V112, P247, DOI 10.1007/s11060-013-1055-0; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lee HT, 2015, ONCOTARGET, V6, P10016, DOI 10.18632/oncotarget.3540; Lee Y, 2015, J NEUROSCI RES, V93, P755, DOI 10.1002/jnr.23544; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lin NU, 2015, LANCET ONCOL, V16, pE270, DOI 10.1016/S1470-2045(15)70057-4; Louie E, 2013, ONCOGENE, V32, P4064, DOI 10.1038/onc.2012.417; Lyle LT, 2016, CLIN CANCER RES, V22, P5287, DOI 10.1158/1078-0432.CCR-15-1836; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Masgrau R, 2017, TRENDS MOL MED, V23, P486, DOI 10.1016/j.molmed.2017.04.005; Neman J, 2014, P NATL ACAD SCI USA, V111, P984, DOI 10.1073/pnas.1322098111; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Paik PK, 2015, CANCER DISCOV, V5, P610, DOI 10.1158/2159-8290.CD-14-1129; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Schildge Sebastian, 2013, J Vis Exp, DOI 10.3791/50079; Schwartz H, 2016, CANCER RES, V76, P4359, DOI 10.1158/0008-5472.CAN-16-0485; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Singh M, 2015, ONCOTARGET, V6, P27461, DOI 10.18632/oncotarget.4742; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sperduto PW, 2017, JAMA ONCOL, V3, P827, DOI 10.1001/jamaoncol.2016.3834; Steinman RA, 2003, ONCOGENE, V22, P3608, DOI 10.1038/sj.onc.1206523; Thorne M, 2009, J NEUROIMMUNOL, V211, P92, DOI 10.1016/j.jneuroim.2009.04.003; Valiente M, 2018, TRENDS CANCER, V4, P176, DOI 10.1016/j.trecan.2018.01.003; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	67	164	165	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1024	+		10.1038/s41591-018-0044-4	http://dx.doi.org/10.1038/s41591-018-0044-4			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892069	Green Submitted			2022-12-27	WOS:000438187700031
J	Stower, H				Stower, Hannah			A pig model of Huntington's disease	NATURE MEDICINE			English	Editorial Material																			0	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					898	898		10.1038/s41591-018-0119-2	http://dx.doi.org/10.1038/s41591-018-0119-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988131				2022-12-27	WOS:000438187700008
J	Stower, H				Stower, Hannah			Detecting dengue	NATURE MEDICINE			English	Editorial Material																			0	0	0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					898	898		10.1038/s41591-018-0120-9	http://dx.doi.org/10.1038/s41591-018-0120-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988137	Bronze			2022-12-27	WOS:000438187700009
J	Yang, H; Xia, L; Chen, J; Zhang, SQ; Martin, V; Li, QQ; Lin, SQ; Chen, JF; Calmette, J; Lu, M; Fu, LY; Yang, J; Pan, ZZ; Yu, K; He, JJ; Morand, E; Schlecht-Louf, G; Krzysiek, R; Zitvogel, L; Kang, BX; Zhang, ZM; Leader, A; Zhou, PH; Lanfumey, L; Shi, MX; Kroemer, G; Ma, YT				Yang, Heng; Xia, Lin; Chen, Jian; Zhang, Shuqing; Martin, Vincent; Li, Qingqing; Lin, Shangqing; Chen, Jinfeng; Calmette, Joseph; Lu, Min; Fu, Lingyi; Yang, Jie; Pan, Zhizhong; Yu, Kuai; He, Jingjing; Morand, Eric; Schlecht-Louf, Geraldine; Krzysiek, Roman; Zitvogel, Laurence; Kang, Boxi; Zhang, Zeming; Leader, Andrew; Zhou, Penghui; Lanfumey, Laurence; Shi, Minxin; Kroemer, Guido; Ma, Yuting			Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity	NATURE MEDICINE			English	Article							INDUCED LEUCINE-ZIPPER; DEPRESSION-LIKE BEHAVIORS; DENDRITIC CELLS; SOCIAL DEFEAT; CANCER; CHEMOTHERAPY; ACTIVATION; FLUOXETINE; STRESS; GLUCOCORTICOIDS	Psychological distress has long been suspected to influence cancer incidence and mortality. It remains largely unknown whether and how stress affects the efficacy of anticancer therapies. We observed that social defeat caused anxiety-like behaviors in mice and dampened therapeutic responses against carcinogen-induced neoplasias and transplantable tumors. Stress elevated plasma corticosterone and upregulated the expression of glucocorticoid-inducible factor Tsc22d3, which blocked type I interferon (IFN) responses in dendritic cell (DC) and IFN-gamma(+) T cell activation. Similarly, close correlations were discovered among plasma cortisol levels, TSC22D3 expression in circulating leukocytes and negative mood in patients with cancer. In murine models, exogenous glucocorticoid injection, or enforced expression of Tsc22d3 in DC was sufficient to abolish therapeutic control of tumors. Administration of a glucocorticoid receptor antagonist or DC-specific Tsc22d3 deletion reversed the negative impact of stress or glucocorticoid supplementation on therapeutic outcomes. Altogether, these results indicate that stress-induced glucocorticoid surge and Tsc22d3 upregulation can subvert therapy-induced anticancer immunosurveillance.	[Yang, Heng; Xia, Lin; Zhang, Shuqing; Li, Qingqing; Lin, Shangqing; Chen, Jinfeng; Zitvogel, Laurence; Kroemer, Guido; Ma, Yuting] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China; [Yang, Heng; Xia, Lin; Zhang, Shuqing; Li, Qingqing; Lin, Shangqing; Chen, Jinfeng; Zitvogel, Laurence; Kroemer, Guido; Ma, Yuting] Peking Union Med Coll, Beijing, Peoples R China; [Yang, Heng; Xia, Lin; Zhang, Shuqing; Li, Qingqing; Lin, Shangqing; Chen, Jinfeng; Zitvogel, Laurence; Kroemer, Guido; Ma, Yuting] Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China; [Chen, Jian; Shi, Minxin] Nantong Univ, Nantong Tumor Hosp, Affiliated Tumor Hosp, Nantong, Jiangsu, Peoples R China; [Martin, Vincent; Lanfumey, Laurence] Univ Paris 05, INSERM, UMR S894, Ctr Psychiat & Neurosci, Paris, France; [Calmette, Joseph; Schlecht-Louf, Geraldine; Krzysiek, Roman] Univ Paris Saclay, Univ Paris Sud, INSERM, UMR996,Inflammat Chemokines & Immunopathol, Clamart, France; [Lu, Min] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai, Peoples R China; [Fu, Lingyi; Yang, Jie; Pan, Zhizhong; Yu, Kuai; He, Jingjing; Zhou, Penghui] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Morand, Eric] Monash Univ, Monash Med Ctr, Clin Sci, Clayton, Vic, Australia; [Krzysiek, Roman] CHU Kremlin Bicetre, AP HP, Lab Immunol Biol, Paris, France; [Zitvogel, Laurence] Gustave Roussy Canc Campus, U1015, INSERM, Villejuif, France; [Zitvogel, Laurence] Univ Paris Saclay, Villejuif, France; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France; [Kang, Boxi; Zhang, Zeming] Peking Univ, Beijing Adv Innovat Ctr Genom, BIOPIC, Beijing, Peoples R China; [Kang, Boxi; Zhang, Zeming] Peking Univ, Sch Life Sci, Beijing, Peoples R China; [Leader, Andrew] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Kroemer, Guido] Univ Paris, Paris, France; [Kroemer, Guido] Ctr Rech Cordeliers, Equipe 11 Labellisee Ligue Natl Canc, Paris, France; [Kroemer, Guido] INSERM, U1138, Paris, France; [Kroemer, Guido] Sorbonne Univ, Paris, France; [Kroemer, Guido] Gustave Roussy Canc Campus, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nantong University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Sciences; Shanghai Jiao Tong University; State Key Lab Oncology South China; Sun Yat Sen University; Monash University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Peking University; Peking University; Icahn School of Medicine at Mount Sinai; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Kroemer, G; Ma, YT (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.; Kroemer, G; Ma, YT (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Kroemer, G; Ma, YT (corresponding author), Suzhou Inst Syst Med, Suzhou, Jiangsu, Peoples R China.; Kroemer, G (corresponding author), Univ Paris, Paris, France.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe 11 Labellisee Ligue Natl Canc, Paris, France.; Kroemer, G (corresponding author), INSERM, U1138, Paris, France.; Kroemer, G (corresponding author), Sorbonne Univ, Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Canc Campus, Metabol & Cell Biol Platforms, Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden.	kroemer@orange.fr; yuting_ma1984@163.com	Yang, Heng/GWV-0038-2022; Morand, Eric F/I-4718-2013; KROEMER, Guido/B-4263-2013; Morand, Eric/AAT-3259-2021; Géraldine, SCHLECHT-LOUF/H-7490-2013; Kroemer, Guido/AAY-9859-2020	Morand, Eric F/0000-0002-9507-3338; KROEMER, Guido/0000-0002-9334-4405; Morand, Eric/0000-0002-9507-3338; Géraldine, SCHLECHT-LOUF/0000-0002-7924-5371; ZITVOGEL, laurence/0000-0003-1596-0998; zhou, penghui/0000-0003-0519-461X; Kang, Boxi/0000-0002-0276-0519	China Ministry of Science and Technology [2017YFA0506200]; Natural Science Foundation of China (NSFC) [81972701, 81722037, 81671630]; Natural Science Foundation of Jiangsu Province [BK20170006, BK20160379, BK20170407, BK20160378]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-005, 2019-I2M-1-003]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2017NL31004, 2017RC31008]; National Thousand Talents Recruitment Program (China); Innovative and Entrepreneurial Team Program (Jiangsu Province); Recruitment Program of High-end Foreign Experts in China [GDW20171100085, GDW20181100051]; NSFC [81802870, 31600959]; Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); European Union; Fondation Carrefour; Fondation pour la Recherche Medicate (FRM); Institut Gustave Roussy (Odysssea); Institut National du Cancer (INCa); INSEAM (HTE); Institut Universita de France; LabEx Immuno-Oncology [ANR-18-IDEX-0001]; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); 'Innovation Therapeutique du fundamental a l'applique' Doctoral School, LabEX LERMIT [ED 569]	China Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); CAMS Innovation Fund for Medical Sciences (CIFMS); Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; National Thousand Talents Recruitment Program (China); Innovative and Entrepreneurial Team Program (Jiangsu Province); Recruitment Program of High-end Foreign Experts in China; NSFC(National Natural Science Foundation of China (NSFC)); Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Chancelerie des universites de Paris (Legs Poix); European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); European Union(European Commission); Fondation Carrefour; Fondation pour la Recherche Medicate (FRM)(Fondation pour la Recherche Medicale); Institut Gustave Roussy (Odysssea); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); INSEAM (HTE); Institut Universita de France; LabEx Immuno-Oncology; RHU Torino Lumiere; Seerave Foundation; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); 'Innovation Therapeutique du fundamental a l'applique' Doctoral School, LabEX LERMIT	Y.M. is supported by China Ministry of Science and Technology (National key research and development program, Grant 2017YFA0506200), Natural Science Foundation of China (NSFC) Grant 81972701, 81722037 and 81671630), Natural Science Foundation of Jiangsu Province (Grant BK20170006 and BK20160379), CAMS Innovation Fund for Medical Sciences (CIFMS; 2016-I2M-1-005 and 2019-I2M-1-003), Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2017NL31004 and 2017RC31008), National Thousand Talents Recruitment Program (China) and Innovative and Entrepreneurial Team Program (Jiangsu Province). G.K. and L.Z. are supported by the Recruitment Program of High-end Foreign Experts in China (GDW20171100085, GDW20181100051). Y.H. is supported by NSFC Grant 81802870 and Natural Science Foundation of Jiangsu Province Grant BK20170407. Z.S.Q. is supported by NSFC Grant 31600959 and Natural Science Foundation of Jiangsu Province Grant BK20160378. G.K. is supported by the Ligue contre le Cancer (equipe labellisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Chancelerie des universites de Paris (Legs Poix), a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); European Union Horizon 2020 (OncoBiome), Fondation Carrefour; Fondation pour la Recherche Medicate (FRM); Institut Gustave Roussy (Odysssea), Institut National du Cancer (INCa); INSEAM (HTE); Institut Universita de France; the LabEx Immuno-Oncology (ANR-18-IDEX-0001); the RHU Torino Lumiere; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM). J. Calmette was supported by a doctoral fellowship from the 'Innovation Therapeutique du fundamental a l'applique' Doctoral School (ED 569), LabEX LERMIT. We acknowledge C. Sevoz-Couche and C. Brouillard (UMR S 1158, Unite de Neurophysiologie Respiratoire Experimentale et Clinique, Sorbonne Universite), and P. Li and J. Zhu (Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College) for technical assistance. We thank F. Bachelerie for access to an animal facility (UMS/IPSIT, Clamart).	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bai YY, 2016, NEUROPSYCHOPHARMACOL, V41, P2882, DOI 10.1038/npp.2016.100; Baker F, 2002, PSYCHO-ONCOLOGY, V11, P273, DOI 10.1002/pon.564; Batty GD, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j108; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bradt J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006911.pub3; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Calmette J, 2016, J IMMUNOL, V197, P4247, DOI 10.4049/jimmunol.1600561; Calmette J, 2014, J IMMUNOL, V193, P5863, DOI 10.4049/jimmunol.1400758; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; Cheng KKF, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011152.pub2; Cryan JF, 2005, PSYCHOPHARMACOLOGY, V182, P335, DOI 10.1007/s00213-005-0093-5; Cui B, 2019, J CLIN INVEST, V129, P1030, DOI 10.1172/JCI121685; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Ducottet C, 2004, PHYSIOL BEHAV, V81, P417, DOI 10.1016/j.physbeh.2004.01.013; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Futterleib JS, 2014, TRANSFUS APHER SCI, V50, P379, DOI 10.1016/j.transci.2013.10.003; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; GONZALO JA, 1993, J EXP MED, V177, P1239, DOI 10.1084/jem.177.5.1239; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hamdi H, 2007, BLOOD, V110, P211, DOI 10.1182/blood-2006-10-052506; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Li CYC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002269; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Ma YT, 2017, IMMUNOL REV, V280, P194, DOI 10.1111/imr.12586; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Navari RM, 2016, NEW ENGL J MED, V374, P1356, DOI 10.1056/NEJMra1515442; Ngo D, 2013, ARTHRITIS RHEUM-US, V65, P1203, DOI 10.1002/art.37858; Norbiato G, 1996, J CLIN ENDOCR METAB, V81, P2601, DOI 10.1210/jc.81.7.2601; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Papadopoulou A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.72; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Roni MA, 2015, PHARMACOL BIOCHEM BE, V139, P1, DOI 10.1016/j.pbb.2015.10.006; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Schoemaker MJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0733-1; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; SPITZ IM, 1993, NEW ENGL J MED, V329, P404; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Thormann V, 2018, NUCLEIC ACIDS RES, V46, P2868, DOI 10.1093/nar/gky051; Tritos NA, 2012, DISCOV MED, V13, P171; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	60	101	109	6	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1428	+		10.1038/s41591-019-0566-4	http://dx.doi.org/10.1038/s41591-019-0566-4			31	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501614				2022-12-27	WOS:000484832800027
J	Jameson, KG; Hsiao, EY				Jameson, K. G.; Hsiao, E. Y.			A novel pathway for microbial metabolism of levodopa	NATURE MEDICINE			English	Editorial Material								Particular bacteria from the gut microbiota metabolize levodopa (L-dopa), reducing bioavailability of the drug for treating Parkinson's disease.	[Jameson, K. G.; Hsiao, E. Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Jameson, KG (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	kgjameson@ucla.edu		Jameson, Kelly/0000-0002-9972-9138	NIGMS NIH HHS [T32 GM007185] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; Fasano A, 2013, MOVEMENT DISORD, V28, P1241, DOI 10.1002/mds.25522; Hashim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112330; PAPAVASILIOU PS, 1972, NEW ENGL J MED, V286, P8, DOI 10.1056/NEJM197201062860102; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Whitfield AC, 2014, ACS CHEM NEUROSCI, V5, P1192, DOI 10.1021/cn5001759; Zhu HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep27779; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3; Zimmermann M, 2019, SCIENCE, V363, P600, DOI 10.1126/science.aat9931	9	6	6	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1195	1197		10.1038/s41591-019-0544-x	http://dx.doi.org/10.1038/s41591-019-0544-x			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388180	Green Accepted			2022-12-27	WOS:000480414600015
J	Muller, WJ; Mulkey, SB				Muller, William J.; Mulkey, Sarah B.			Lessons about early neurodevelopment in children exposed to ZIKV in utero	NATURE MEDICINE			English	Editorial Material							VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES; INFANTS; STATES	Infants with congenital Zika virus infection are at risk for multiple abnormalities related to impairment in neurodevelopment. Although some findings apparent at birth may resolve with time, infants with no abnormalities apparent at birth may develop problems in early childhood.	[Muller, William J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA; [Mulkey, Sarah B.] Childrens Natl Hlth Syst, Fetal Med Inst, Washington, DC USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; George Washington University; George Washington University; Children's National Health System	Muller, WJ (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA.	wjmuller@northwestern.edu	Mulkey, Sarah/ABI-1363-2020	Mulkey, Sarah/0000-0002-8084-526X; Muller, William J/0000-0001-7690-0695				Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1; Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1	12	5	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1192	1193		10.1038/s41591-019-0540-1	http://dx.doi.org/10.1038/s41591-019-0540-1			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31359000				2022-12-27	WOS:000480414600013
J	Seo, J; Byun, WY; Alisafaei, F; Georgescu, A; Yi, YS; Massaro-Giordano, M; Shenoy, VB; Lee, V; Bunya, VY; Huh, D				Seo, Jeongyun; Byun, Woo Y.; Alisafaei, Farid; Georgescu, Andrei; Yi, Yoon-Suk; Massaro-Giordano, Mina; Shenoy, Vivek B.; Lee, Vivian; Bunya, Vatinee Y.; Huh, Dongeun			Multiscale reverse engineering of the human ocular surface	NATURE MEDICINE			English	Article							EYELID PRESSURE; PROTEOGLYCAN 4; INFLAMMATION; MECHANISM; DYNAMICS; LUBRICIN; LUBRICATION; CONJUNCTIVA; EXPRESSION; OSMOLARITY	Here we present a miniaturized analog of a blinking human eye to reverse engineer the complexity of the interface between the ocular system and the external environment. Our model comprises human cells and provides unique capabilities to replicate multiscale structural organization, biological phenotypes and dynamically regulated environmental homeostasis of the human ocular surface. Using this biomimetic system, we discovered new biological effects of blink-induced mechanical forces. Furthermore, we developed a specialized in vitro model of evaporative dry-eye disease for high-content drug screening. This work advances our ability to emulate how human physiological systems interface with the external world, and may contribute to the future development of novel screening platforms for biopharmaceutical and environmental applications.	[Seo, Jeongyun; Byun, Woo Y.; Georgescu, Andrei; Yi, Yoon-Suk; Huh, Dongeun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Alisafaei, Farid; Shenoy, Vivek B.] Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA; [Massaro-Giordano, Mina; Lee, Vivian; Bunya, Vatinee Y.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Massaro-Giordano, Mina; Bunya, Vatinee Y.] Univ Penn, Penn Dry Eye & Ocular Surface Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shenoy, Vivek B.; Huh, Dongeun] Univ Penn, NSF Sci & Technol Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA; [Huh, Dongeun] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Huh, D (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Huh, D (corresponding author), Univ Penn, NSF Sci & Technol Ctr Engn Mechanobiol, Philadelphia, PA 19104 USA.; Huh, D (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.	huhd@seas.upenn.edu	Shenoy, Vivek/ABD-5075-2021; Alisafaei, Farid/GOK-2900-2022	Byun, Woo Yul/0000-0001-8686-638X; Huh, Dongeun/0000-0002-5718-6884; Georgescu, Andrei/0000-0003-1612-3497; Alisafaei, Farid/0000-0002-9621-9095	National Institutes of Health (NIH) [1DP2HL127720-01, R01EY026972, K08EY025742-01]; National Science Foundation [CMMI: 15-48571]; Research to Prevent Blindness; University of Pennsylvania; NIH Director's New Innovator Award; Cancer Research Institute Technology Impact Award; NATIONAL EYE INSTITUTE [K08EY025742, R01EY026972] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Pennsylvania; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Technology Impact Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank G. Al, R. Dana and P. Argueso for their input to this study; I. Gipson at the Schepens Eye Research Institute for providing immortalized human conjunctival epithelial cells; G. Jay at Brown University for providing human lubricin; K. Kwon for providing data on the kinematics of blinking in the human eye; D. Song, J. Vance, D. Caggiano, M. Henderson and J. DuPont for assistance in OCT, TearLab and keratography; L. Du and M. Allen for assistance in mechanical testing; and P. McClanahan for assistance in fluorescence imaging of tear fluids. This work was supported by the National Institutes of Health (NIH) grant nos. 1DP2HL127720-01 (to D. H.), R01EY026972 (to V. Y. B.) and K08EY025742-01 (to V. L.), the National Science Foundation grant no. CMMI: 15-48571 (to V. B. S. and D. H.), the Research to Prevent Blindness (to V. Y. B.) and the University of Pennsylvania. D. H. is a recipient of the NIH Director's New Innovator Award and the Cancer Research Institute Technology Impact Award.	Abdelfattah NS, 2015, CORNEA, V34, pS48, DOI 10.1097/ICO.0000000000000570; Al-Sharif A, 2015, ARTHRITIS RHEUMATOL, V67, P1503, DOI 10.1002/art.39087; Baudouin C, 2018, ACTA OPHTHALMOL, V96, P111, DOI 10.1111/aos.13436; Belmonte C, 2017, OCUL SURF, V15, P404, DOI 10.1016/j.jtos.2017.05.002; Bron AJ, 2015, PROG RETIN EYE RES, V44, P36, DOI 10.1016/j.preteyeres.2014.10.001; Bron AJ, 2017, OCUL SURF, V15, P438, DOI 10.1016/j.jtos.2017.05.011; Bunya VY, 2017, JAMA OPHTHALMOL, V135, P1078, DOI 10.1001/jamaophthalmol.2017.3346; Bunya VY, 2015, JAMA OPHTHALMOL, V133, P662, DOI 10.1001/jamaophthalmol.2015.0429; Chao W, 2016, OCUL SURF, V14, P264, DOI 10.1016/j.jtos.2015.11.003; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507, DOI 10.1016/0002-9394(80)90058-6; Ehlers N, 2010, ACTA OPHTHALMOL, V88, P858, DOI 10.1111/j.1755-3768.2009.01610.x; FARRIS RL, 1981, OPHTHALMOLOGY, V88, P852; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2007, INVEST OPHTH VIS SCI, V48, P4391, DOI 10.1167/iovs.07-0770; HALL A, 1945, BRIT J OPHTHALMOL, V29, P445, DOI 10.1136/bjo.29.9.445; Iqbal SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18910; Jay G.D., 2004, CURR OPIN ORTHOP, V15, P355, DOI DOI 10.1097/01.BCO.0000136127.00043.A8; Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1; Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008; Jones MB, 2008, B MATH BIOL, V70, P323, DOI 10.1007/s11538-007-9252-7; Koh S, 2016, EYE CONTACT LENS, V42, P250, DOI 10.1097/ICL.0000000000000191; Kwon KA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0227; Lambiase A, 2017, OCUL SURF, V15, P77, DOI 10.1016/j.jtos.2016.08.004; Lee HS, 2012, INVEST OPHTH VIS SCI, V53, P5632, DOI 10.1167/iovs.12-9547; Lu QZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06369-8; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Masterton S, 2018, EXP EYE RES, V177, P122, DOI 10.1016/j.exer.2018.08.001; Meloni M, 2011, MOL VIS, V17, P113; Molladavoodi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178981; Morrison S, 2012, EYE CONTACT LENS, V38, P27, DOI 10.1097/ICL.0b013e31823f7041; NICHOLS B, 1983, INVEST OPHTH VIS SCI, V24, P570; Nowell CS, 2017, J CELL SCI, V130, P1021, DOI 10.1242/jcs.198119; PFISTER RR, 1977, INVEST OPHTH VIS SCI, V16, P614; Pitenis AA, 2017, BIOTRIBOLOGY, V11, P77, DOI DOI 10.1016/j.biotri.2017.04.003; Pitenis AA, 2018, TRIBOL LETT, V66, DOI 10.1007/s11249-018-1029-7; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Regmi SC, 2017, EXP EYE RES, V161, P1, DOI 10.1016/j.exer.2017.05.006; Ren HW, 1997, ACTA OPHTHALMOL SCAN, V75, P383; Rhee MK, 2017, OPHTHALMOLOGY, V124, pS14, DOI 10.1016/j.ophtha.2017.08.029; Sakai E, 2012, EYE CONTACT LENS, V38, P326, DOI 10.1097/ICL.0b013e318268610a; Samsom ML, 2014, EXP EYE RES, V127, P14, DOI 10.1016/j.exer.2014.06.015; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Schmidt TA, 2013, JAMA OPHTHALMOL, V131, P766, DOI 10.1001/jamaophthalmol.2013.2385; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Shaw A.I., 2009, THESIS; Shaw AJ, 2010, INVEST OPHTH VIS SCI, V51, P1911, DOI 10.1167/iovs.09-4090; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; TIAN L, 2016, AM J OPHTHALMOL, V16, DOI DOI 10.1142/S0219455415500303; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Waller KA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061252; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Warren HS, 2015, P NATL ACAD SCI USA, V112, pE345, DOI 10.1073/pnas.1414857111; Willcox MDP, 2017, OCUL SURF, V15, P366, DOI 10.1016/j.jtos.2017.03.006; Yamamoto Y, 2016, CURR EYE RES, V41, P171, DOI 10.3109/02713683.2015.1009636	58	52	52	6	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1310	+		10.1038/s41591-019-0531-2	http://dx.doi.org/10.1038/s41591-019-0531-2			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31384041	Green Accepted			2022-12-27	WOS:000480414600030
J	Wolf, DP; Mitalipov, PA; Mitalipov, SM				Wolf, Don P.; Mitalipov, Paul A.; Mitalipov, Shoukhrat M.			Principles of and strategies for germline gene therapy	NATURE MEDICINE			English	Article							MITOCHONDRIAL REPLACEMENT THERAPY; GENOMIC DNA; HUMAN-CELLS; CRISPR-CAS9; DIAGNOSIS; EMBRYOS; MUTATIONS; NUCLEASES; ATTITUDES; BASE	Monogenic disorders occur at a high frequency in human populations and are commonly inherited through the germline. Unfortunately, once the mutation has been transmitted to a child, only limited treatment options are available in most cases. However, means of correcting disease-causing nuclear and mitochondrial DNA mutations in gametes or preimplantation embryos have now been developed and are commonly referred to as germline gene therapy (GGT). We will discuss these novel strategies and provide a path forward for safe, high-efficiency GGT that may provide a promising new paradigm for preventing the passage of deleterious genes from parent to child.	[Wolf, Don P.; Mitalipov, Paul A.; Mitalipov, Shoukhrat M.] Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97201 USA	Oregon Health & Science University	Mitalipov, SM (corresponding author), Oregon Hlth & Sci Univ, Ctr Embryon Cell & Gene Therapy, Portland, OR 97201 USA.	mitalipo@ohsu.edu			NICHD NIH HHS [R01 HD063276] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adashi EY, 2018, OBSTET GYNECOL, V131, P553, DOI 10.1097/AOG.0000000000002486; Adikusuma F, 2018, NATURE, V560, pE8, DOI 10.1038/s41586-018-0380-z; Alikani M, 2017, REPROD BIOMED ONLINE, V34, P333, DOI 10.1016/j.rbmo.2017.02.004; [Anonymous], 2016, 2016 IVF OUTC PER EG; [Anonymous], 2017, HUMAN GENOME EDITING; Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Carlson LM, 2017, OBSTET GYN CLIN N AM, V44, P245, DOI 10.1016/j.ogc.2017.02.004; Chan S, 2015, AM J BIOETHICS, V15, P42, DOI 10.1080/15265161.2015.1103814; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cohen J., 2018, SCIENCE; Cornu TI, 2017, NAT MED, V23, P415, DOI 10.1038/nm.4313; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; CYRANOSKI D., 2018, NATURE; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Egli D, 2018, NATURE, V560, pE5, DOI 10.1038/s41586-018-0379-5; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Haworth KG, 2017, CYTOTHERAPY, V19, P1325, DOI 10.1016/j.jcyt.2017.05.013; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Ishii T., 2018, EMJ REPRO HLTH, V4, P88; Ishii T, 2017, CURR OPIN ENDOCRINOL, V24, P418, DOI 10.1097/MED.0000000000000369; Jin S, 2019, SCIENCE, V364, P292, DOI 10.1126/science.aaw7166; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kang EJ, 2016, NATURE, V540, P270, DOI 10.1038/nature20592; Kim D, 2016, GENOME RES, V26, P406, DOI 10.1101/gr.199588.115; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Koch L, 2016, NAT REV GENET, V17, DOI 10.1038/nrg.2016.2; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lander E, 2019, NATURE, V567, P165, DOI 10.1038/d41586-019-00726-5; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Lee VCY, 2017, BEST PRACT RES CL OB, V44, P68, DOI 10.1016/j.bpobgyn.2017.04.001; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Ma H, 2018, NATURE, V560, pE10, DOI 10.1038/s41586-018-0381-y; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Ma H, 2017, CELL STEM CELL, V20, P112, DOI 10.1016/j.stem.2016.10.001; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Massaro G, 2018, NAT MED, V24, P1317, DOI 10.1038/s41591-018-0106-7; Matsoukas IG, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00021; McCaughey T, 2016, CELL STEM CELL, V18, P569, DOI 10.1016/j.stem.2016.04.011; Mitalipov S, 2014, CELL REP, V7, P935, DOI 10.1016/j.celrep.2014.05.004; National Eye Institute, 2015, COL BLINDN; National Heart Lung and Blood Institute, 2019, MARF SYNDR; National Institute of Neurological Disorders and Stroke, 2016, HUNT DIS INF PAG; Nuffield Council on Bioethics (NCOB), 2018, GENOME EDITING HUMAN; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ormond KE, 2017, AM J HUM GENET, V101, P167, DOI 10.1016/j.ajhg.2017.06.012; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Petrucelli N, 1998, GENEREVIEWS; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rossidis AC, 2018, NAT MED, V24, P1513, DOI 10.1038/s41591-018-0184-6; Scheufele DA, 2017, SCIENCE, V357, P553, DOI 10.1126/science.aan3708; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Song J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10548; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Steffann J, 2018, CELL STEM CELL, V22, P481, DOI 10.1016/j.stem.2018.01.004; Suzuki K, 2014, CELL STEM CELL, V15, P31, DOI 10.1016/j.stem.2014.06.016; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tang LC, 2017, MOL GENET GENOMICS, V292, P525, DOI 10.1007/s00438-017-1299-z; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tu ZC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42081; U. S. National Library of Medicine, 2015, BET THAL; U. S. National Library of Medicine, 2018, SPIN MUSC ATR; U. S. National Library of Medicine, 2018, LEIGH SYNDR; US National Library of Medicine, 2018, TAY SACHS DIS; Varga T, 2005, DNA REPAIR, V4, P1038, DOI 10.1016/j.dnarep.2005.05.004; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220; WHO. Genomic Resource Centre, GEN HUM DIS; Wilde J. J., 2018, PREPRINT, DOI [10.1101/263699, DOI 10.1101/263699]; Wolf DP, 2017, EMBO J, V36, P2659, DOI 10.15252/embj.201797843; Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	93	28	30	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					890	897		10.1038/s41591-019-0473-8	http://dx.doi.org/10.1038/s41591-019-0473-8			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31160821				2022-12-27	WOS:000470844400018
J	Zappasodi, R; Sirard, C; Li, YY; Budhu, S; Abu-Akeel, M; Liu, CL; Yang, X; Zhong, H; Newman, W; Qi, JJ; Wong, P; Schaer, D; Koon, H; Velcheti, V; Hellmann, MD; Postow, MA; Callahan, MK; Wolchok, JD; Merghoub, T				Zappasodi, Roberta; Sirard, Cynthia; Li, Yanyun; Budhu, Sadna; Abu-Akeel, Mohsen; Liu, Cailian; Yang, Xia; Zhong, Hong; Newman, Walter; Qi, Jingjing; Wong, Phillip; Schaer, David; Koon, Henry; Velcheti, Vamsidhar; Hellmann, Matthew D.; Postow, Michael A.; Callahan, Margaret K.; Wolchok, Jedd D.; Merghoub, Taha			Rational design of anti-GITR-based combination immunotherapy	NATURE MEDICINE			English	Article							CD8(+) T-CELLS; COMBINED NIVOLUMAB; SOLID TUMORS; OPEN-LABEL; MODULATION; IPILIMUMAB; MELANOMA; COSTIMULATION; STIMULATION; MECHANISMS	Modulating T cell homeostatic mechanisms with checkpoint blockade can efficiently promote endogenous anti-tumor T cell responses(1-11). However, many patients still do not benefit from checkpoint blockade(12), highlighting the need for targeting of alternative immune pathways(13). Glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) is an attractive target for immunotherapy, owing to its capacity to promote effector T cell (T-eff) functions(14,15) and hamper regulatory T cell (T-reg) suppression(16-20). On the basis of the potent preclinical anti-tumor activity of agonist anti-GITR antibodies, reported by us and others(16,21,22), we initiated the first in-human phase 1 trial of GITR agonism with the anti-GITR antibody TRX518 (NCT01239134). Here, we report the safety profile and immune effects of TRX518 monotherapy in patients with advanced cancer and provide mechanistic preclinical evidence to rationally combine GITR agonism with checkpoint blockade in future clinical trials. We demonstrate that TRX518 reduces circulating and intratumoral T-reg cells to similar extents, providing an easily assessable biomarker of anti-GITR activity. Despite T-reg reductions and increased T-eff: T-reg ratios, substantial clinical responses were not seen. Similarly, in mice with advanced tumors, GITR agonism was not sufficient to activate cytolytic T cells due to persistent exhaustion. We demonstrate that T cell reinvigoration with PD-1 blockade can overcome resistance of advanced tumors to anti-GITR monotherapy. These findings led us to start investigating TRX518 with PD-1 pathway blockade in patients with advanced refractory tumors (NCT02628574).	[Zappasodi, Roberta; Li, Yanyun; Budhu, Sadna; Abu-Akeel, Mohsen; Liu, Cailian; Yang, Xia; Zhong, Hong; Schaer, David; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat & Swim Amer Lab, 1275 York Ave, New York, NY 10021 USA; [Zappasodi, Roberta; Li, Yanyun; Qi, Jingjing; Wong, Phillip; Hellmann, Matthew D.; Callahan, Margaret K.; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA; [Sirard, Cynthia; Newman, Walter] Leap Therapeut, Cambridge, MA USA; [Qi, Jingjing; Wong, Phillip] Mem Sloan Kettering Canc Ctr, Immune Monitoring Core Facil, 1275 York Ave, New York, NY 10021 USA; [Koon, Henry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Velcheti, Vamsidhar] NYU, Sch Med, Dept Hematol & Oncol, New York, NY USA; [Hellmann, Matthew D.; Postow, Michael A.; Callahan, Margaret K.; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Hellmann, Matthew D.; Postow, Michael A.; Callahan, Margaret K.; Wolchok, Jedd D.] Weill Cornell Med Coll, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; New York University; Memorial Sloan Kettering Cancer Center; Cornell University	Wolchok, JD; Merghoub, T (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Collaborat & Swim Amer Lab, 1275 York Ave, New York, NY 10021 USA.; Wolchok, JD; Merghoub, T (corresponding author), Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10021 USA.; Wolchok, JD; Merghoub, T (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Wolchok, JD (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	wolchokj@mskcc.org; merghout@mskcc.org	Qi, Jingjing/AAL-7378-2021; Merghoub, Taha/ABD-8362-2021; Qi, Jingjing/AAP-8561-2021	Qi, Jingjing/0000-0002-9368-1882	NIH/NCI Cancer Center Support Grant [P30 CA008748]; NIH/NCI [R01 CA056821]; Swim Across America; Ludwig Institute for Cancer Research; Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering; Cancer Research Institute; Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; Parker Institute for Cancer Immunotherapy scholar award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NIH/NCI Cancer Center Support Grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swim Across America; Ludwig Institute for Cancer Research; Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering; Cancer Research Institute; Parker Institute for Cancer Immunotherapy; Breast Cancer Research Foundation; Parker Institute for Cancer Immunotherapy scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Immune Monitoring, Flow Cytometry and Molecular Cytology Core Facilities at Memorial Sloan Kettering Cancer Center for technical assistance. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748, NIH/NCI R01 CA056821, the Swim Across America, Ludwig Institute for Cancer Research, Ludwig Center for Cancer Immunotherapy at Memorial Sloan Kettering, Cancer Research Institute, Parker Institute for Cancer Immunotherapy and Breast Cancer Research Foundation. R.Z. was supported by the Parker Institute for Cancer Immunotherapy scholar award.	Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cohen AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010436; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gonzalez AM, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-3643; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Mahne AE, 2017, CANCER RES, V77, P1108, DOI 10.1158/0008-5472.CAN-16-0797; Mitsui J, 2010, CLIN CANCER RES, V16, P2781, DOI 10.1158/1078-0432.CCR-09-3243; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nishikawa H, 2008, CANCER RES, V68, P5948, DOI 10.1158/0008-5472.CAN-07-5839; Nocentini G, 2012, BRIT J PHARMACOL, V165, P2089, DOI 10.1111/j.1476-5381.2011.01753.x; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; R Core Team, 2021, R LANGUAGE ENV STAT; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Rosenzweig M, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.e13028; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Schaer DA, 2013, CANCER IMMUNOL RES, V1, P320, DOI 10.1158/2326-6066.CIR-13-0086; Schaer DA, 2012, CURR OPIN IMMUNOL, V24, P217, DOI 10.1016/j.coi.2011.12.011; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Sukumar S, 2017, CANCER RES, V77, P4378, DOI 10.1158/0008-5472.CAN-16-1439; Tigue NJ, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1280645; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yarilin D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09534; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; 2018, CANCER CELL, V33, P1017, DOI DOI 10.1016/J.CCELL.2018.05.009	42	115	118	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					759	+		10.1038/s41591-019-0420-8	http://dx.doi.org/10.1038/s41591-019-0420-8			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31036879	Green Accepted			2022-12-27	WOS:000468247800019
J	Klaus, J; Kanton, S; Kyrousi, C; Ayo-Martin, AC; Di Giaimo, R; Riesenberg, S; O'Neill, AC; Camp, JG; Tocco, C; Santel, M; Rusha, E; Drukker, M; Schroeder, M; Gotz, M; Robertson, SP; Treutlein, B; Cappello, S				Klaus, Johannes; Kanton, Sabina; Kyrousi, Christina; Ayo-Martin, Ane Cristina; Di Giaimo, Rossella; Riesenberg, Stephan; O'Neill, Adam C.; Camp, J. Gray; Tocco, Chiara; Santel, Malgorzata; Rusha, Ejona; Drukker, Micha; Schroeder, Mariana; Goetz, Magdalena; Robertson, Stephen P.; Treutlein, Barbara; Cappello, Silvia			Altered neuronal migratory trajectories in human cerebral organoids derived from individuals with neuronal heterotopia	NATURE MEDICINE			English	Article							NODULAR HETEROTOPIA; READ ALIGNMENT; ISOFORM	Malformations of the human cortex represent a major cause of disability1. Mouse models with mutations in known causal genes only partially recapitulate the phenotypes and are therefore not unlimitedly suited for understanding the molecular and cellular mechanisms responsible for these conditions(2). Here we study periventricular heterotopia (PH) by analyzing cerebral organoids derived from induced pluripotent stem cells (iPSCs) of patients with mutations in the cadherin receptor-ligand pair DCHS1 and FAT4 or from isogenic knockout (KO) lines(1,3). Our results show that human cerebral organoids reproduce the cortical heterotopia associated with PH. Mutations in DCHS1 and FAT4 or knockdown of their expression causes changes in the morphology of neural progenitor cells and result in defective neuronal migration dynamics only in a subset of neurons. Single-cell RNA-sequencing (scRNA-seq) data reveal a subpopulation of mutant neurons with dysregulated genes involved in axon guidance, neuronal migration and patterning. We suggest that defective neural progenitor cell (NPC) morphology and an altered navigation system in a subset of neurons underlie this form of PH.	[Klaus, Johannes; Kyrousi, Christina; Ayo-Martin, Ane Cristina; Di Giaimo, Rossella; Tocco, Chiara; Schroeder, Mariana; Cappello, Silvia] Max Planck Inst Psychiat, Munich, Germany; [Kanton, Sabina; Riesenberg, Stephan; Camp, J. Gray; Santel, Malgorzata; Treutlein, Barbara] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Ayo-Martin, Ane Cristina] IMPRS TP, Munich, Germany; [Di Giaimo, Rossella] Univ Naples Federico II, Dept Biol, Naples, Italy; [O'Neill, Adam C.; Robertson, Stephen P.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin, New Zealand; [O'Neill, Adam C.; Goetz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, Munich, Germany; [Rusha, Ejona; Drukker, Micha] Helmholtz Ctr Munich, Inst Stem Cell Res, iPSC Core Facil, Munich, Germany; [Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Munich, Germany; [Treutlein, Barbara] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Treutlein, Barbara] Univ Munich, Dept Biosci, Freising Weihenstephan, Germany	Max Planck Society; Max Planck Society; University of Naples Federico II; University of Otago; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; University of Munich	Cappello, S (corresponding author), Max Planck Inst Psychiat, Munich, Germany.; Treutlein, B (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.; Treutlein, B (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.; Treutlein, B (corresponding author), Univ Munich, Dept Biosci, Freising Weihenstephan, Germany.	barbara_treutlein@eva.mpg.de; silvia_cappello@psych.mpg.de	Di Giaimo, Rossella/A-3521-2014; Cappello, Silvia/AAQ-4590-2021; Schroeder, Mariana/AAA-9216-2020	Di Giaimo, Rossella/0000-0003-3604-3697; Cappello, Silvia/0000-0003-1553-6775; Schroeder, Mariana/0000-0002-9517-4243; Kyrousi, Christina/0000-0002-6234-8382; Treutlein, Barbara/0000-0002-3299-5597; Tocco, Chiara/0000-0002-2616-0198	DFG [CA1205/2-1]; ForIPS; Max Planck Society; Boehringer Ingelheim Fonds; Health Research Council of NZ; ERC Starting Grant; Curekids	DFG(German Research Foundation (DFG)); ForIPS; Max Planck Society(Max Planck SocietyFoundation CELLEX); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Health Research Council of NZ(Health Research Council of New Zealand); ERC Starting Grant(European Research Council (ERC)); Curekids	We thank the families participating in this study for their involvement. We thank Y. Lu for help generating the microRNAs, M. Karow and I. Buchsbaum for helping with experiments and fruitful discussions in the lab, T. Ozturk for excellent technical support, A. Weigert for organoid culture, J. Kageyama for helping with data processing, R. Snabel for helping with Smart-seq2 libraries, the Core Unit Flow Cytometry at the Zentrum fur Infektionsmedizin (veterinary faculty of the University of Leipzig) and the Core Unit Qualitatsmanagement/Technologieplattform at the Sachsischer Inkubator fur Klinische Translation (SIKT) in Leipzig for karyotyping. This work was supported by funding from the DFG CA1205/2-1 (S.C.), ForIPS (M.G.), by the Max Planck Society (S.C., B.T.), by the Boehringer Ingelheim Fonds (S.K.), by the Health Research Council of NZ and Curekids (S.P.R.) and by an ERC Starting Grant (B.T.).	Aghakhani Y, 2005, BRAIN, V128, P641, DOI 10.1093/brain/awh388; Boyer Leah F, 2012, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01h06s22; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Cappello S, 2013, NAT GENET, V45, P1300, DOI 10.1038/ng.2765; Cardoso C, 2009, NEUROLOGY, V72, P784, DOI 10.1212/01.wnl.0000336339.08878.2d; DUBEAU F, 1995, BRAIN, V118, P1273, DOI 10.1093/brain/118.5.1273; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Heinzen EL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007281; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Kang HM, 2018, NAT BIOTECHNOL, V36, P89, DOI 10.1038/nbt.4042; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Mansour S, 2012, EUR J HUM GENET, V20, P1024, DOI 10.1038/ejhg.2012.57; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; O'Neill AC, 2018, CELL REP, V25, P2729, DOI 10.1016/j.celrep.2018.11.029; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pilz GA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3125; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Renaud G, 2015, BIOINFORMATICS, V31, P770, DOI 10.1093/bioinformatics/btu719; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Riesenberg S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04609-7; Romero DM, 2018, SEMIN CELL DEV BIOL, V76, P33, DOI 10.1016/j.semcdb.2017.09.031; Tassi L, 2005, BRAIN, V128, P321, DOI 10.1093/brain/awh357; Topol A, 2015, JOVE-J VIS EXP, DOI 10.3791/52495; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030	35	86	86	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					561	+		10.1038/s41591-019-0371-0	http://dx.doi.org/10.1038/s41591-019-0371-0			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30858616	Green Accepted			2022-12-27	WOS:000463342800016
J	Beyret, E; Liao, HK; Yamamoto, M; Hernandez-Benitez, R; Fu, YP; Erikson, G; Reddy, P; Belmonte, JCI				Beyret, Ergin; Liao, Hsin-Kai; Yamamoto, Mako; Hernandez-Benitez, Reyna; Fu, Yunpeng; Erikson, Galina; Reddy, Pradeep; Belmonte, Juan Carlos Izpisua			Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome	NATURE MEDICINE			English	Article							PREMATURE; LAMINOPATHIES; PRELAMIN	Hutchinson-Gilford progeria syndrome (HGPS) is a rare lethal genetic disorder characterized by symptoms reminiscent of accelerated aging. The major underlying genetic cause is a substitution mutation in the gene coding for lamin A, causing the production of a toxic isoform called progerin. Here we show that reduction of lamin A/progerin by a single-dose systemic administration of adeno-associated virus-delivered CRISPR-Cas9 components suppresses HGPS in a mouse model.	[Beyret, Ergin; Liao, Hsin-Kai; Yamamoto, Mako; Hernandez-Benitez, Reyna; Fu, Yunpeng; Erikson, Galina; Reddy, Pradeep; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Yamamoto, Mako] Univ Catolica San Antonio Murcia, Murcia, Spain	Salk Institute; Universidad Catolica de Murcia	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Liao, Hsin-Kai/H-9608-2015; Reddy, Pradeep/G-1770-2014	Reddy, Pradeep/0000-0002-9173-3845; Erikson, Galina/0000-0001-6041-5652; Hernandez-Benitez, Reyna/0000-0003-2546-8956; BEYRET, ERGIN/0000-0003-1980-532X	Catharina Foundation; Muscular Dystrophy Association; NIH-NCI CCSG [P30 014195]; Helmsley Trust; Progeria Research Foundation; Universidad Catolica San Antonio de Murcia (UCAM); Fundacion Dr. Pedro Guillen; G. Harold and Leila Y. Mathers Charitable Foundation; Glenn Foundation; Moxie Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Catharina Foundation; Muscular Dystrophy Association(Muscular Dystrophy Association); NIH-NCI CCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Helmsley Trust; Progeria Research Foundation; Universidad Catolica San Antonio de Murcia (UCAM); Fundacion Dr. Pedro Guillen; G. Harold and Leila Y. Mathers Charitable Foundation; Glenn Foundation; Moxie Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Ocampo for discussions throughout the study and M. Schwarz for administrative support. We are grateful to G. Sancar and Ronald Evans Lab for providing the running wheel equipment. E.B. was partially funded by the Catharina Foundation. P.R. was partially supported by the Muscular Dystrophy Association. G.E. was partially funded by NIH-NCI CCSG: P30 014195 and by the Helmsley Trust. Work in the laboratory of J.C.I.B. was supported by The Progeria Research Foundation, Universidad Catolica San Antonio de Murcia (UCAM), Fundacion Dr. Pedro Guillen, the G. Harold and Leila Y. Mathers Charitable Foundation, The Glenn Foundation and The Moxie Foundation.	Ahmed MS, 2018, MOL NEUROBIOL, V55, P4417, DOI 10.1007/s12035-017-0610-7; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Buchwalter A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00322-z; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007; Gordon L.B., 2003, GENEREVIEWS; Gordon LB, 2014, CIRCULATION, V130, P27, DOI 10.1161/CIRCULATIONAHA.113.008285; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Kubben N, 2017, NAT REV MOL CELL BIO, V18, P595, DOI 10.1038/nrm.2017.68; Liao HK, 2017, CELL, V171, P1495, DOI 10.1016/j.cell.2017.10.025; Lopez-Mejia IC, 2014, EMBO REP, V15, P529, DOI 10.1002/embr.201338126; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Olaya Santiago-Fernandez F. G. O., NAT MED; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Vidak S, 2016, HISTOCHEM CELL BIOL, V145, P401, DOI 10.1007/s00418-016-1411-1; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2015, HUM MOL GENET, V24, P2826, DOI 10.1093/hmg/ddv043; Young SG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005229	21	65	69	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					419	+		10.1038/s41591-019-0343-4	http://dx.doi.org/10.1038/s41591-019-0343-4			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30778240	Green Accepted			2022-12-27	WOS:000460643100018
J	Gu, Y; Liu, YF; Fu, L; Zhai, LL; Zhu, J; Han, YM; Jiang, YM; Zhang, Y; Zhang, P; Jiang, ZP; Zhang, X; Cao, XT				Gu, Yan; Liu, Yanfang; Fu, Li; Zhai, Lili; Zhu, Jie; Han, Yanmei; Jiang, Yingming; Zhang, Yi; Zhang, Peng; Jiang, Zhengping; Zhang, Xiang; Cao, Xuetao			Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG	NATURE MEDICINE			English	Article							T-CELLS; VEGF-C; LYMPHANGIOGENESIS; INFLAMMATION; PHENOTYPE; MELANOMA; NICHE; IDENTIFICATION; HIF-1-ALPHA; MODULATION	Primary tumors may create the premetastatic niche in secondary organs for subsequent metastasis. Humoral immunity contributes to the progression of certain cancers, but the roles of B cells and their derived antibodies in premetastatic niche formation are poorly defined. Using a mouse model of spontaneous lymph node metastasis of breast cancer, we show that primary tumors induced B cell accumulation in draining lymph nodes. These B cells selectively promoted lymph node metastasis by producing pathogenic IgG that targeted glycosylated membrane protein HSPA4, and activated the HSPA4-binding protein ITGB5 and the downstream Src/NF-kappa B pathway in tumor cells for CXCR4/SDF1 alpha-axis-mediated metastasis. High serum anti-HSPA4 IgG was correlated with high tumor HSPA4 expression and poor prognosis of breast cancer subjects. Our findings identify a key role for tumor-educated B cells and their derived antibodies in lymph node premetastatic niche formation, providing potential targets for cancer intervention.	[Gu, Yan; Liu, Yanfang; Zhu, Jie; Han, Yanmei; Jiang, Yingming; Zhang, Yi; Zhang, Peng; Jiang, Zhengping; Zhang, Xiang; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Gu, Yan; Liu, Yanfang; Zhu, Jie; Han, Yanmei; Jiang, Yingming; Zhang, Yi; Zhang, Peng; Jiang, Zhengping; Zhang, Xiang; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Liu, Yanfang] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China; [Fu, Li; Zhai, Lili] Tianjin Med Univ, Canc Hosp, Dept Breast Canc Pathol & Res Lab, Tianjin, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing, Peoples R China; [Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nankai University	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Ctr Immunotherapy, Beijing, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.	caoxt@immunol.org			National Key R&D Program of China [2018YFA0507400]; National 135 Major Project of China [2017ZX10203206]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]; National Natural Science Foundation of China [81602497, 87188101, 91542000, 31400757, 91542204, 81622023]	National Key R&D Program of China; National 135 Major Project of China; CAMS Innovation Fund for Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Y. Li and X. Zuo for technical assistance and S. Xu, J. Hou, C. Han, Z. Yu, and Y. Bao for helpful discussions. This work was supported by grants from National Key R&D Program of China (2018YFA0507400) to X.C., the National 135 Major Project of China (2017ZX10203206) to X.C., National Natural Science Foundation of China (81602497 to Y.L., 87188101 to X.C., 91542000 to X.C., 31400757 to Y.G., 91542204 to Y.H., and 81622023 to Y.H.), and CAMS Innovation Fund for Medical Sciences (2016-12M-1-003) to X.C.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bianchi-Smiraglia A, 2013, ONCOGENE, V32, P3049, DOI 10.1038/onc.2012.320; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; BRODT P, 1982, CANCER IMMUNOL IMMUN, V13, P125; Carmi Y, 2015, NATURE, V521, P99, DOI 10.1038/nature14424; Casadevall A, 2012, NAT IMMUNOL, V13, P21, DOI 10.1038/ni.2184; Cochran AJ, 2006, NAT REV IMMUNOL, V6, P659, DOI 10.1038/nri1919; Cui K, 2011, J SURG RES, V171, P143, DOI 10.1016/j.jss.2010.03.001; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Dougan SK, 2013, NATURE, V503, P406, DOI 10.1038/nature12637; Du FY, 2010, ANAL CHEM, V82, P9374, DOI 10.1021/ac101983b; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Garmy-Susini B, 2013, P NATL ACAD SCI USA, V110, P9042, DOI 10.1073/pnas.1219603110; Gotoh K, 2004, FEBS LETT, V560, P19, DOI 10.1016/S0014-5793(04)00034-1; Guan GF, 2015, CANCER LETT, V357, P254, DOI 10.1016/j.canlet.2014.11.034; Hagglund P, 2004, J PROTEOME RES, V3, P556, DOI 10.1021/pr034112b; Halama N, 2016, CANCER CELL, V29, P587, DOI 10.1016/j.ccell.2016.03.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang L, 2017, ONCOGENE, V36, P4081, DOI 10.1038/onc.2017.35; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karagiannis P, 2013, CANCER RES, V73, DOI [10.1172/JCI65579, 10.1158/1538-7445.TUMIMM2012-B65]; Kirkegaard T, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9823; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lee-Chang C, 2013, J IMMUNOL, V191, P4141, DOI 10.4049/jimmunol.1300606; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; Liu FF, 2009, HISTOPATHOLOGY, V54, P741, DOI 10.1111/j.1365-2559.2009.03289.x; Liu HD, 2010, ANAT REC, V293, P1838, DOI 10.1002/ar.21240; Liu XG, 2011, ONCOL REP, V25, P1343, DOI 10.3892/or.2011.1202; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Lohmueller J, 2017, PHARMACOL THERAPEUT, V178, P31, DOI 10.1016/j.pharmthera.2017.03.008; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pal SK, 2015, MOL CANCER THER, V14, P2896, DOI 10.1158/1535-7163.MCT-15-0367; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Pucci F, 2016, SCIENCE, V352, P242, DOI 10.1126/science.aaf1328; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Srivastava PK, 2009, EXPERT OPIN BIOL TH, V9, P179, DOI [10.1517/14712590802633918, 10.1517/14712590802633918 ]; Stasinopoulos I, 2009, CANCER BIOL THER, V8, P31, DOI 10.4161/cbt.8.1.7079; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Van den Eynden GG, 2007, CLIN CANCER RES, V13, P5391, DOI 10.1158/1078-0432.CCR-07-1230; Wakisaka N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144056; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zhou D, 2006, P NATL ACAD SCI USA, V103, P19057, DOI 10.1073/pnas.0607242103; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	62	107	117	6	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					312	+		10.1038/s41591-018-0309-y	http://dx.doi.org/10.1038/s41591-018-0309-y			30	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30643287				2022-12-27	WOS:000457842100029
J	Xu, YC; Poggio, M; Jin, HY; Shi, Z; Forester, CM; Wang, Y; Stumpf, CR; Xue, LR; Devericks, E; So, L; Nguyen, HG; Griselin, A; Gordan, JD; Umetsu, SE; Reich, SH; Worland, ST; Asthana, S; Barna, M; Webster, KR; Cunningham, JT; Ruggero, D				Xu, Yichen; Poggio, Mauro; Jin, Hyun Yong; Shi, Zhen; Forester, Craig M.; Wang, Ying; Stumpf, Craig R.; Xue, Lingru; Devericks, Emily; So, Lomon; Nguyen, Hao G.; Griselin, Alice; Gordan, John D.; Umetsu, Sarah E.; Reich, Siegfried H.; Worland, Stephen T.; Asthana, Saurabh; Barna, Maria; Webster, Kevin R.; Cunningham, John T.; Ruggero, Davide			Translation control of the immune checkpoint in cancer and its therapeutic targeting	NATURE MEDICINE			English	Article							T-CELLS; HEPATOCELLULAR-CARCINOMA; READ ALIGNMENT; IN-VIVO; C-MYC; EXPRESSION; TUMOR; INITIATION; PHOSPHORYLATION; PD-L1	Cancer cells develop mechanisms to escape immunosurveillance, among which modulating the expression of immune suppressive messenger RNAs is most well-documented. However, how this is molecularly achieved remains largely unresolved. Here, we develop an in vivo mouse model of liver cancer to study oncogene cooperation in immunosurveillance. We show that MYC overexpression (MYCTg) synergizes with KRAS(G12D) to induce an aggressive liver tumor leading to metastasis formation and reduced mouse survival compared with KRAS(G12D) alone. Genome-wide ribosomal footprinting of MYCTg; KRAS(G12) tumors compared with KRAS(G12D) revealed potential alterations in translation of mRNAs, including programmed-death-ligand 1 (PD-L1). Further analysis revealed that PD-L1 translation is repressed in KRAS(G12D) tumors by functional, non-canonical upstream open reading frames in its 5' untranslated region, which is bypassed in MYCTg; KRAS(G12D) tumors to evade immune attack. We show that this mechanism of PD-L1 translational upregulation was effectively targeted by a potent, clinical compound that inhibits eIF4E phosphorylation, eFT508, which reverses the aggressive and metastatic characteristics of MYCTg; KRAS(G12D) tumors. Together, these studies reveal how immune-checkpoint proteins are manipulated by distinct oncogenes at the level of mRNA translation, which can be exploited for new immunotherapies.	[Xu, Yichen; Poggio, Mauro; Jin, Hyun Yong; Forester, Craig M.; Wang, Ying; Stumpf, Craig R.; Xue, Lingru; Devericks, Emily; So, Lomon; Nguyen, Hao G.; Griselin, Alice; Cunningham, John T.; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Xu, Yichen; Poggio, Mauro; Jin, Hyun Yong; Forester, Craig M.; Wang, Ying; Stumpf, Craig R.; Xue, Lingru; Devericks, Emily; So, Lomon; Nguyen, Hao G.; Griselin, Alice; Gordan, John D.; Asthana, Saurabh; Cunningham, John T.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Shi, Zhen; Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Shi, Zhen; Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Forester, Craig M.] Univ Calif San Francisco, Div Pediat Allergy Immunol & Bone Marrow Transpla, San Francisco, CA 94143 USA; [Wang, Ying] Nanjing Univ, Nanjing Adv Inst Life Sci, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Stumpf, Craig R.; Reich, Siegfried H.; Worland, Stephen T.; Webster, Kevin R.] eFFECTOR Therapeut, San Diego, CA USA; [Umetsu, Sarah E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Cunningham, John T.] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA; [Ruggero, Davide] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Stanford University; Stanford University; University of California System; University of California San Francisco; Nanjing University; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.; Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Ruggero, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	davide.ruggero@ucsf.edu	Cunningham, John T./AAS-5008-2021; Forester, Craig/HCI-4174-2022; Stumpf, Craig/B-8703-2014	Cunningham, John T./0000-0001-6490-4533; Worland, Stephen/0000-0001-8924-253X; Stumpf, Craig/0000-0002-9946-8986	Damon Runyon Postdoctoral Fellowship; AACR-Incyte Corporation Fellowship In Basic Cancer Research [17-40-46-JIN]; Life Science Foundation Postdoctoral Fellowship; Department of Defense Physician training award; Campini Foundation; Leukemia and Lymphoma Foundation; UCSF Department of Pediatrics K12 [5K12HDO72222-05]; American Cancer Society Postdoctoral Fellowship; Conquer Cancer Foundation Young Investigator Award; Pew Scholars Award; NIH [1R01HD086634, R01CA140456, R01CA154916, R01CA184624]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD072222, R01HD086634] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA140456, R01CA184624, R01CA154916] Funding Source: NIH RePORTER	Damon Runyon Postdoctoral Fellowship; AACR-Incyte Corporation Fellowship In Basic Cancer Research; Life Science Foundation Postdoctoral Fellowship; Department of Defense Physician training award; Campini Foundation; Leukemia and Lymphoma Foundation; UCSF Department of Pediatrics K12; American Cancer Society Postdoctoral Fellowship(American Cancer Society); Conquer Cancer Foundation Young Investigator Award; Pew Scholars Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank members of the Ruggero laboratory for discussion and critical reading of the manuscript. We thank C. Her for his help with the mouse HCC cell line generation protocol, D. Wang for the help with hydrodynamic transfection, and K. Fujii and D. Simsek for advice and technique assistance. We thank B. Tiano for the contribution in developing and characterizing the MYC transgenic mice. This work was supported by the Damon Runyon Postdoctoral Fellowship (Y.X.), AACR-Incyte Corporation Fellowship In Basic Cancer Research (grant no. 17-40-46-JIN) (H.Y.J), Life Science Foundation Postdoctoral Fellowship (S.Z.), Department of Defense Physician training award (H.G.N), the Campini Foundation, The Leukemia and Lymphoma Foundation Career Development Grant and UCSF Department of Pediatrics K12 (grant no. 5K12HDO72222-05) (C.M.F.), American Cancer Society Postdoctoral Fellowship and Conquer Cancer Foundation Young Investigator Award (J.D.G), Pew Scholars Award (M.B.), NIH grant no. 1R01HD086634 (M.B.), NIH grants (nos. R01CA140456, R01CA154916, and R01CA184624) (D.R.). M.B. is a New York Stem Cell Foundation Robertson Investigator. D.R. is a Leukemia and Lymphoma Society Scholar.	Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Calkhoven CF, 2000, GENE DEV, V14, P1920; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cerezo M, 2018, NAT MED, V24, P1877, DOI 10.1038/s41591-018-0217-1; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14572; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep36722; Marquardt JU, 2014, J HEPATOL, V60, P346, DOI 10.1016/j.jhep.2013.10.014; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; MIYAZAKI J, 1989, GENE, V79, P269; O'Dell MR, 2012, CANCER RES, V72, P1557, DOI 10.1158/0008-5472.CAN-11-3596; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pulko V, 2011, J IMMUNOL, V187, P5606, DOI 10.4049/jimmunol.1003976; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rees S, 1996, BIOTECHNIQUES, V20, P102; Reich SH, 2018, J MED CHEM, V61, P3516, DOI 10.1021/acs.jmedchem.7b01795; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Stewart B, 2014, WORLD CANC REPORT 20; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Truitt ML, 2017, NAT REV CANCER, V17, P332, DOI 10.1038/nrc.2017.30; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	69	117	120	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					301	+		10.1038/s41591-018-0321-2	http://dx.doi.org/10.1038/s41591-018-0321-2			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30643286	Green Accepted			2022-12-27	WOS:000457842100028
J	Jiang, L; Berraondo, P; Jerico, D; Guey, LT; Sampedro, A; Frassetto, A; Benenato, KE; Burke, K; Santamaria, E; Alegre, M; Pejenaute, A; Kalariya, M; Butcher, W; Park, JS; Zhu, XL; Sabnis, S; Kumarasinghe, ES; Salerno, T; Kenney, M; Lukacs, CM; Avila, MA; Martini, PGV; Fontanellas, A				Jiang, Lei; Berraondo, Pedro; Jerico, Daniel; Guey, Lin T.; Sampedro, Ana; Frassetto, Andrea; Benenato, Kerry E.; Burke, Kristine; Santamaria, Eva; Alegre, Manuel; Pejenaute, Alvaro; Kalariya, Mayur; Butcher, William; Park, Ji-Sun; Zhu, Xuling; Sabnis, Staci; Kumarasinghe, E. Sathyajith; Salerno, Timothy; Kenney, Matthew; Lukacs, Christine M.; Avila, Matias A.; Martini, Paolo G. V.; Fontanellas, Antonio			Systemic messenger RNA as an etiological treatment for acute intermittent porphyria	NATURE MEDICINE			English	Article							HEME-ARGINATE; PORPHOBILINOGEN DEAMINASE; AMINOLEVULINIC-ACID; MITOCHONDRIAL; DEFICIENCY; THERAPY; METABOLISM; EXPRESSION; NEUROPATHY; ATTACKS	Acute intermittent porphyria (AIP) results from haploinsufficiency of porphobilinogen deaminase (PBGD), the third enzyme in the heme biosynthesis pathway. Patients with AIP have neurovisceral attacks associated with increased hepatic heme demand. Phenobarbital-challenged mice with AIP recapitulate the biochemical and clinical characteristics of patients with AIP, including hepatic overproduction of the potentially neurotoxic porphyrin precursors. Here we show that intravenous administration of human PBGD (hPBGD) mRNA (encoded by the gene HMBS) encapsulated in lipid nanoparticles induces dose-dependent protein expression in mouse hepatocytes, rapidly normalizing urine porphyrin precursor excretion in ongoing attacks. Furthermore, hPBGD mRNA protected against mitochondrial dysfunction, hypertension, pain and motor impairment. Repeat dosing in AIP mice showed sustained efficacy and therapeutic improvement without evidence of hepatotoxicity. Finally, multiple administrations to nonhuman primates confirmed safety and translatability. These data provide proof-of-concept for systemic hPBGD mRNA as a potential therapy for AIP.	[Jiang, Lei; Guey, Lin T.; Frassetto, Andrea; Benenato, Kerry E.; Burke, Kristine; Kalariya, Mayur; Butcher, William; Park, Ji-Sun; Zhu, Xuling; Sabnis, Staci; Kumarasinghe, E. Sathyajith; Salerno, Timothy; Kenney, Matthew; Lukacs, Christine M.; Martini, Paolo G. V.] Moderna Therapeut, Cambridge, MA 02139 USA; [Berraondo, Pedro] Univ Navarra, Program Immunol & Immunotherapy, Ctr Appl Med Res CIMA, Pamplona, Spain; [Berraondo, Pedro; Jerico, Daniel; Sampedro, Ana; Santamaria, Eva; Avila, Matias A.; Fontanellas, Antonio] Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Berraondo, Pedro] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Jerico, Daniel; Sampedro, Ana; Santamaria, Eva; Avila, Matias A.; Fontanellas, Antonio] Univ Navarra, Hepatol Program, Ctr Appl Med Res CIMA, Pamplona, Spain; [Santamaria, Eva; Avila, Matias A.; Fontanellas, Antonio] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Alegre, Manuel] Univ Navarra, Dept Clin Neurophysiol, Clin Univ, Pamplona, Spain; [Alegre, Manuel] Univ Navarra, Neurosci Program, Ctr Appl Med Res CIMA, Neurophysiol Lab, Pamplona, Spain; [Pejenaute, Alvaro] Univ Navarra, Dept Biochem & Genet, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; University of Navarra; University of Navarra; University of Navarra	Martini, PGV (corresponding author), Moderna Therapeut, Cambridge, MA 02139 USA.; Fontanellas, A (corresponding author), Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain.; Fontanellas, A (corresponding author), Univ Navarra, Hepatol Program, Ctr Appl Med Res CIMA, Pamplona, Spain.; Fontanellas, A (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.	paolo.martini@modernatx.com; afontanellas@unav.es	Fontanellas, Antonio/AAD-8073-2022; Avila, Matias A/Y-6342-2019; Santa María Monasteri, Eva/Z-4537-2019; Berraondo, Pedro/J-3154-2012; Alegre, Manuel/F-5379-2011	Fontanellas, Antonio/0000-0001-9279-7990; Avila, Matias A/0000-0001-6570-3557; Santa María Monasteri, Eva/0000-0003-0629-6175; Berraondo, Pedro/0000-0001-7410-1865; Alegre, Manuel/0000-0003-4985-9724; Jerico, Daniel/0000-0001-6184-4598; Pejenaute Martinez de Lizarrondo, Alvaro/0000-0002-0260-7848	Spanish Fundacion Mutua Madrilena; Spanish Fundacion Eugenio Rodriguez Pascual; Spanish Institute of Health Carlos III (FIS) - European FEDER funds [PI09/02639, PI12/02785, PI15/01951, PI16/00668]; Miguel Servet II from Instituto de Salud Carlos III [CPII15/00004]	Spanish Fundacion Mutua Madrilena; Spanish Fundacion Eugenio Rodriguez Pascual; Spanish Institute of Health Carlos III (FIS) - European FEDER funds; Miguel Servet II from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	P.B., M.A.A. and A.Fo. thank J. Prieto for his enthusiastic and continuous support of our research on porphyria. We thank S. Arcelus and I. Alkain for technical assistance; J. L. Lanciego, A. Rico, L. Guembe and A. Benito for their helpful technical and scientific support with NHPs; P. Harper and E. Sardh for supplying liver explants from patients with porphyria. T1 and T2 mouse strains were provided by U. A. Meyer (Biozentrum of University of Basel, Basel, Switzerland). This study was supported in part by grants from the Spanish Fundacion Mutua Madrilena, Spanish Fundacion Eugenio Rodriguez Pascual and Spanish Institute of Health Carlos III (FIS) cofinanced by European FEDER funds (grant numbers PI09/02639, PI12/02785, PI15/01951 and PI16/00668 funds). P.B. is supported by a Miguel Servet II (CPII15/00004) contract from Instituto de Salud Carlos III.	An D, 2017, CELL REP, V21, P3548, DOI 10.1016/j.celrep.2017.11.081; Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; ANDERSON PM, 1982, ENZYME, V28, P146, DOI 10.1159/000459098; [Anonymous], 2015, ALN REP POS IN CLIN; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Bissell DM, 2017, NEW ENGL J MED, V377, P862, DOI 10.1056/NEJMra1608634; Bissell DM, 2015, AM J MED, V128, P313, DOI 10.1016/j.amjmed.2014.10.026; Bonkovsky HL, 2014, AM J MED, V127, P1233, DOI 10.1016/j.amjmed.2014.06.036; BONKOWSKY HL, 1975, J LAB CLIN MED, V85, P93; Bylesjo I, 2009, SCAND J CLIN LAB INV, V69, P612, DOI 10.1080/00365510902935979; D'Avola D, 2016, J HEPATOL, V65, P776, DOI 10.1016/j.jhep.2016.05.012; Dowman JK, 2012, LIVER TRANSPLANT, V18, P195, DOI 10.1002/lt.22345; Fratz EJ, 2014, HANDB PORPHYR SCI, V26, P1; GOLDBERG A, 1955, PROC R SOC SER B-BIO, V143, P257, DOI 10.1098/rspb.1955.0009; GOUYA L, 2017, EXPLORE PROSPECTIVE; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Harper P, 2014, EXPERT OPIN ORPHAN D, V2, P349, DOI 10.1517/21678707.2014.891456; HERRICK AL, 1989, LANCET, V1, P1295; Homedan C, 2014, INT J BIOCHEM CELL B, V51, P93, DOI 10.1016/j.biocel.2014.03.032; Innala E, 2010, ACTA OBSTET GYN SCAN, V89, P95, DOI 10.3109/00016340903390729; Kim CY, 2005, J MED PRIMATOL, V34, P96, DOI 10.1111/j.1600-0684.2005.00097.x; KLINGER W, 1980, ACTA BIOL MED GER, V39, P107; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; Marsden JT, 2015, JIMD REP, V22, P57, DOI 10.1007/8904_2015_411; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; MCCOLL KEL, 1987, BRIT J CLIN PHARMACO, V23, P553, DOI 10.1111/j.1365-2125.1987.tb03091.x; Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139; MULLEREBERHARD U, 1983, BIOCHEM PHARMACOL, V32, P3765, DOI 10.1016/0006-2952(83)90147-8; Pallet N, 2015, KIDNEY INT, V88, P386, DOI 10.1038/ki.2015.97; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Sabnis S, 2018, MOL THER, V26, P1509, DOI 10.1016/j.ymthe.2018.03.010; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schmitt C, 2018, J INTERN MED, V284, P78, DOI 10.1111/joim.12750; Sedic M, 2018, VET PATHOL, V55, P341, DOI 10.1177/0300985817738095; Tchernitchko D, 2017, J AM SOC NEPHROL, V28, P1924, DOI 10.1681/ASN.2016080918; TOKOLA O, 1987, PHARMACOL TOXICOL, V61, P75, DOI 10.1111/j.1600-0773.1987.tb01778.x; Unzu C, 2015, GENE THER, V22, P856, DOI 10.1038/gt.2015.64; Unzu C, 2011, MOL THER, V19, P243, DOI 10.1038/mt.2010.210; Vijayasarathy C, 1999, EUR J BIOCHEM, V266, P191, DOI 10.1046/j.1432-1327.1999.00843.x; Willandt B, 2016, JIMD REP, V25, P77, DOI 10.1007/8904_2015_458; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892; Yasuda M, 2014, P NATL ACAD SCI USA, V111, P7777, DOI 10.1073/pnas.1406228111; Yasuda M, 2010, MOL THER, V18, P17, DOI 10.1038/mt.2009.250	46	88	91	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1899	+		10.1038/s41591-018-0199-z	http://dx.doi.org/10.1038/s41591-018-0199-z			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30297912				2022-12-27	WOS:000452392200019
J	Tamburini, FB; Andermann, TM; Tkachenko, E; Senchyna, F; Banaei, N; Bhatt, AS				Tamburini, Fiona B.; Andermann, Tessa M.; Tkachenko, Ekaterina; Senchyna, Fiona; Banaei, Niaz; Bhatt, Ami S.			Precision identification of diverse bloodstream pathogens in the gut microbiome	NATURE MEDICINE			English	Article							TRANSPLANT RECIPIENTS; INFECTION; BACTEREMIA; SURVEILLANCE; ALIGNMENT; TRANSLOCATION; DOMINATION; HEALTH; RATES; RISK	A comprehensive evaluation of every patient with a bloodstream infection includes an attempt to identify the infectious source. Pathogens can originate from various places, such as the gut microbiota, skin and the external environment. Identifying the definitive origin of an infection would enable precise interventions focused on management of the source(1,2). Unfortunately, hospital infection control practices are often informed by assumptions about the source of various specific pathogens; if these assumptions are incorrect, they lead to interventions that do not decrease pathogen exposure(3). Here, we develop and apply a streamlined bio-informatic tool, named StrainSifter, to match bloodstream pathogens precisely to a candidate source. We then leverage this approach to interrogate the gut microbiota as a potential reservoir of bloodstream pathogens in a cohort of hematopoietic cell transplantation recipients. We find that patients with Escherichia coli and Klebsiella pneumoniae bloodstream infections have concomitant gut colonization with these organisms, suggesting that the gut may be a source of these infections. We also find cases where typically nonenteric pathogens, such as Pseudomonas aeruginosa and Staphylococcus epidermidis, are found in the gut microbiota, thereby challenging the existing informal dogma of these infections originating from environmental or skin sources. Thus, we present an approach to distinguish the source of various bloodstream infections, which may facilitate more accurate tracking and prevention of hospital-acquired infections.	[Tamburini, Fiona B.; Bhatt, Ami S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Andermann, Tessa M.; Banaei, Niaz] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Tkachenko, Ekaterina; Bhatt, Ami S.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Senchyna, Fiona; Banaei, Niaz] Stanford Univ, Med Ctr, Clin Microbiol Lab, Stanford, CA 94305 USA; [Banaei, Niaz] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Bhatt, AS (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Bhatt, AS (corresponding author), Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA.	asbhatt@stanford.edu	Andermann, Tessa M./L-6449-2019; Andermann, Tessa/AAB-6139-2020	Andermann, Tessa/0000-0002-0844-7400; Banaei, Niaz/0000-0001-8501-3000; Bhatt, Ami/0000-0001-8099-2975	National Science Foundation Graduate Research Fellowship; National Institutes of Health (NIH); National Center for Advancing Translational Science, Clinical and Translational Science Awards [KL2 TR001083, UL1 TR001085]; American Society of Blood and Marrow Transplantation New Investigator Award; National Cancer Institute NIH K08 award [CA184420]; Damon Runyon Clinical Investigator Award; Amy Strelzer Manasevit Award; NATIONAL CANCER INSTITUTE [K08CA184420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085, KL2TR001083] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Science, Clinical and Translational Science Awards; American Society of Blood and Marrow Transplantation New Investigator Award; National Cancer Institute NIH K08 award; Damon Runyon Clinical Investigator Award; Amy Strelzer Manasevit Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Kang for her assistance with stool sample processing, as well as the other members of the Bhatt laboratory for providing feedback on the study design, bioinformatics pipeline and manuscript revisions. We also thank N. Greenfield and the One Codex team for help with using their platform. We appreciate M. Kelly, C. Severyn and D. Ward for their feedback on the manuscript. We especially thank the patients and nurses on the Blood and Marrow Transplantation service for their enthusiastic participation in this project. This work was supported in part by the National Science Foundation Graduate Research Fellowship (F.B.T.), the National Institutes of Health (NIH), National Center for Advancing Translational Science, Clinical and Translational Science Awards KL2 TR001083 and UL1 TR001085 and the American Society of Blood and Marrow Transplantation New Investigator Award (T.M.A.). A.S.B. was funded in part by the National Cancer Institute NIH K08 award, no. CA184420, the Damon Runyon Clinical Investigator Award and the Amy Strelzer Manasevit Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Blennow O, 2014, TRANSPL INFECT DIS, V16, P106, DOI 10.1111/tid.12175; Brown CT, 2016, NAT BIOTECHNOL, V34, P1256, DOI 10.1038/nbt.3704; Costa SF, 2006, AM J INFECT CONTROL, V34, P36, DOI 10.1016/j.ajic.2005.10.007; Costa SF, 2004, LANCET INFECT DIS, V4, P278, DOI 10.1016/S1473-3099(04)01003-5; Costea PI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182392; Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Gudiol C, 2014, BONE MARROW TRANSPL, V49, P824, DOI 10.1038/bmt.2014.37; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Kaysen A, 2017, TRANSL RES, V186, P79, DOI 10.1016/j.trsl.2017.06.008; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Krueger F., 2017, TRIM GALORE; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Minot S. S., 2015, ONE CODEX SENSITIVE, DOI [10.1101/027607, DOI 10.1101/027607]; Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115; Nesher L, 2015, TRANSPL INFECT DIS, V17, P33, DOI 10.1111/tid.12323; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Petersen K.R., 2015, P 6 ACM C BIOINF COM, P491, DOI [10.1145/2808719.2811568, DOI 10.1145/2808719.2811568]; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roach DJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005413; ROTSTEIN C, 1988, J SURG ONCOL, V39, P154, DOI 10.1002/jso.2930390304; Samet A, 2013, EUR J CLIN MICROBIOL, V32, P1393, DOI 10.1007/s10096-013-1886-9; Satlin MJ, 2013, LEUKEMIA LYMPHOMA, V54, P799, DOI 10.3109/10428194.2012.723210; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; See I, 2017, AM J INFECT CONTROL, V45, P321, DOI 10.1016/j.ajic.2016.10.015; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Steinberg JP, 2013, INFECT CONT HOSP EP, V34, P171, DOI 10.1086/669082; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; WADE JC, 1982, ANN INTERN MED, V97, P503, DOI 10.7326/0003-4819-97-4-503; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wickham H, 2007, J STAT SOFTW, V21, P1; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	49	83	86	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1809	+		10.1038/s41591-018-0202-8	http://dx.doi.org/10.1038/s41591-018-0202-8			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30323331	Green Submitted, Green Accepted			2022-12-27	WOS:000452392200008
J	Zhao, LT; He, R; Long, HX; Guo, B; Jia, QZ; Qin, DY; Liu, SQ; Wang, ZY; Xiang, T; Zhang, J; Tan, YL; Huang, JN; Chen, JY; Wang, F; Xiao, ML; Gao, JB; Yang, XX; Zeng, H; Wang, XX; Hu, CY; Alexander, PB; Symonds, ALJ; Yu, J; Wan, YS; Li, QJ; Ye, LL; Zhu, B				Zhao, Lintao; He, Ran; Long, Haixia; Guo, Bo; Jia, Qingzhu; Qin, Diyuan; Liu, Si-Qi; Wang, Zhongyu; Xiang, Tong; Zhang, Jue; Tan, Yulong; Huang, Jiani; Chen, Junying; Wang, Fang; Xiao, Minglu; Gao, Jianbao; Yang, Xinxin; Zeng, Hao; Wang, Xinxin; Hu, Chunyan; Alexander, Peter B.; Symonds, Alistair L. J.; Yu, Jia; Wan, Yisong; Li, Qi-Jing; Ye, Lilin; Zhu, Bo			Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells	NATURE MEDICINE			English	Article							EPSTEIN-BARR-VIRUS; RECEPTOR STIMULATION; NADPH OXIDASE; SELF-RENEWAL; CANCER; EXPRESSION; INFECTION; SPLEEN; HEMATOPOIESIS; DIFFERENTIATION	Impaired immunity in patients with late-stage cancer is not limited to antitumor responses, as demonstrated by poor vaccination protection and high susceptibility to infection(1-3). This has been largely attributed to chemotherapy-induced impairment of innate immunity, such as neutropenia(2), whereas systemic effects of tumors on hematopoiesis and adoptive immunity remain incompletely understood. Here we observed anemia associated with severe deficiency of CD8(+) T cell responses against pathogens in treatment-naive mice bearing large tumors. Specifically, we identify CD45(+) erythroid progenitor cells (CD71(+)TER119(+); EPCs) as robust immunosuppressors. CD45(+) EPCs, induced by tumor growth-associated extramedullary hematopoiesis, accumulate in the spleen to become a major population, outnumbering regulatory T cells (T(reg)s) and myeloid-derived suppressor cells (MDSCs). The CD45(+) EPC transcriptome closely resembles that of MDSCs, and, like MDSCs, reactive oxygen species production is a major mechanism underlying CD45(+) EPC-mediated immunosuppression. Similarly, an immunosuppressive CD45(+) EPC population was detected in patients with cancer who have anemia. These findings identify a major population of immunosuppressive cells that likely contributes to the impaired T cell responses commonly observed in patients with advanced cancer.	[Zhao, Lintao; Long, Haixia; Jia, Qingzhu; Wang, Zhongyu; Xiang, Tong; Zhang, Jue; Huang, Jiani; Chen, Junying; Gao, Jianbao; Wang, Xinxin; Hu, Chunyan; Zhu, Bo] Third Mil Med Univ, Inst Canc, Xinqiao Hosp, Chongqing, Peoples R China; [He, Ran] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Immunol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Guo, Bo; Tan, Yulong; Xiao, Minglu; Yang, Xinxin; Ye, Lilin] Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China; [Qin, Diyuan; Liu, Si-Qi; Alexander, Peter B.; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA; [Wang, Fang; Yu, Jia] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Wang, Fang; Yu, Jia] PUMC, Beijing, Peoples R China; [Zeng, Hao] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Symonds, Alistair L. J.] Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Wan, Yisong] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Wan, Yisong] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Zhu, Bo] Third Mil Med Univ, Chongqing Key Lab Immunotherapy, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Huazhong University of Science & Technology; Army Medical University; Duke University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Army Medical University; University of London; Queen Mary University London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Army Medical University	Zhu, B (corresponding author), Third Mil Med Univ, Inst Canc, Xinqiao Hosp, Chongqing, Peoples R China.; Ye, LL (corresponding author), Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China.; Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.; Zhu, B (corresponding author), Third Mil Med Univ, Chongqing Key Lab Immunotherapy, Xinqiao Hosp, Chongqing, Peoples R China.	qi-jing.li@duke.edu; yelilinlcmv@163.com; b.davis.zhu@gmail.com	Liu, Siqi/AAL-6891-2020; Wan, Yisong/ABE-1200-2021	Liu, Siqi/0000-0001-9727-9498; Wan, Yisong/0000-0003-4346-9717; Zhu, Bo/0000-0002-5829-9581; Gao, Jianbao/0000-0002-6517-4525; Symonds, Alistair/0000-0002-9461-0816; Yu, Jia/0000-0003-3499-5133; Wang, Xinxin/0000-0001-8238-7832	National Institute of Allergy and Infectious Disease (NIAID) [R01-AI091878]; National Cancer Institute (NCI) [P50-CA190991]; National Institutes of Health (NIH) Beau Biden Cancer Moonshot Initiative [R33CA225328]; National Nature Science Foundation of China [81472648, 81500089, 81620108023, 81222031, 81773041, 31600733]; Research on The Basis and Frontier of Chongqing [cstc2016jcyjA0049]; NATIONAL CANCER INSTITUTE [R33CA225328, P50CA190991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091878] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) Beau Biden Cancer Moonshot Initiative; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research on The Basis and Frontier of Chongqing; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MMTV-PyMT mice were kindly provided by X. Liu (State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai). P14 (CD90.1) TCR transgenic mice were obtained from R. Ahmed at Emory University. Q.-J.L. is a Whitehead Family Foundation Scholar and supported by the National Institute of Allergy and Infectious Disease (NIAID; R01-AI091878), the National Cancer Institute (NCI; P50-CA190991), and the National Institutes of Health (NIH) Beau Biden Cancer Moonshot Initiative (R33CA225328). This work is also supported by the National Nature Science Foundation of China (grant nos. 81472648, 81500089, 81620108023, 81222031, 81773041 and 31600733), by the Research on The Basis and Frontier of Chongqing (grant nos. cstc2016jcyjA0049).	Baden LR, 2012, J NATL COMPR CANC NE, V10, P1412, DOI 10.6004/jnccn.2012.0146; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; BENNETT M, 1968, BLOOD, V32, P908, DOI 10.1182/blood.V32.6.908.908; BODEY GP, 1986, AM J MED, V81, P11, DOI 10.1016/0002-9343(86)90510-3; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; CRAIG W, 1994, BRIT J HAEMATOL, V88, P24, DOI 10.1111/j.1365-2141.1994.tb04972.x; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; FREEDMAN MH, 1981, AM J HEMATOL, V11, P271, DOI 10.1002/ajh.2830110307; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han YM, 2018, CELL, V173, P634, DOI 10.1016/j.cell.2018.02.061; Harashima A, 2002, BLOOD, V100, P4440, DOI 10.1182/blood-2002-03-0864; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Khanna R, 2000, ANNU REV MICROBIOL, V54, P19, DOI 10.1146/annurev.micro.54.1.19; Kosmidis CI, 2012, LEUKEMIA LYMPHOMA, V53, P8, DOI 10.3109/10428194.2011.602770; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Lowell CA, 1996, BLOOD, V87, P1780; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Segal Brahm H, 2008, J Natl Compr Canc Netw, V6, P122; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Vento S, 2008, LANCET ONCOL, V9, P982, DOI 10.1016/S1470-2045(08)70255-9; Zhang BJ, 2016, IMMUNITY, V44, P568, DOI 10.1016/j.immuni.2016.01.007	30	56	64	5	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1536	+		10.1038/s41591-018-0205-5	http://dx.doi.org/10.1038/s41591-018-0205-5			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297899	Green Accepted			2022-12-27	WOS:000446577900016
J	Junqueira, C; Barbosa, CRR; Costa, PAC; Teixeira-Carvalho, A; Castro, G; Sen Santara, S; Barbosa, RP; Dotiwala, F; Pereira, DB; Antonelli, LR; Lieberman, J; Gazzinelli, RT				Junqueira, Caroline; Barbosa, Camila R. R.; Costa, Pedro A. C.; Teixeira-Carvalho, Andrea; Castro, Guilherme; Sen Santara, Sumit; Barbosa, Rafael P.; Dotiwala, Farokh; Pereira, Dhelio B.; Antonelli, Lis R.; Lieberman, Judy; Gazzinelli, Ricardo T.			Cytotoxic CD8(+) T cells recognize and kill Plasmodium vivax-infected reticulocytes	NATURE MEDICINE			English	Article							FLOW-CYTOMETRY; GAMMA-INTERFERON; CLASS-I; MALARIA; FALCIPARUM; LYMPHOCYTES; GRANULYSIN; PROTEIN; SUSCEPTIBILITY; ERYTHROCYTES	Plasmodium vivax causes approximately 100 million clinical malaria cases yearly(1,2). The basis of protective immunity is poorly understood and thought to be mediated by antibodies(3,4). Cytotoxic CD8(+) T cells protect against other intracellular parasites by detecting parasite peptides presented by human leukocyte antigen class I on host cells. Cytotoxic CD8(+) T cells kill parasite-infected mammalian cells and intracellular parasites by releasing their cytotoxic granules(5,6). Perforin delivers the antimicrobial peptide granulysin and death-inducing granzymes into the host cell, and granulysin then delivers granzymes into the parasite. Cytotoxic CD8(+) T cells were thought to have no role against Plasmodium spp. blood stages because red blood cells generally do not express human leukocyte antigen class I-7. However, P. vivax infects reticulocytes that retain the protein translation machinery. Here we show that P. vivax-infected reticulocytes express human leukocyte antigen class I. Infected patient circulating CD8(+) T cells highly express cytotoxic proteins and recognize and form immunological synapses with P. vivax-infected reticulocytes in a human leukocyte antigen-dependent manner, releasing their cytotoxic granules to kill both host cell and intracellular parasite, preventing reinvasion. P. vivax-infected reticulocytes and parasite killing is perforin independent, but depends on granulysin, which generally efficiently forms pores only in microbial membranes(8). We find that P. vivax depletes cholesterol from the P. vivax-infected reticulocyte cell membrane, rendering it granulysin-susceptible. This unexpected T cell defense might be mobilized to improve P. vivax vaccine efficacy.	[Junqueira, Caroline; Barbosa, Camila R. R.; Costa, Pedro A. C.; Teixeira-Carvalho, Andrea; Castro, Guilherme; Antonelli, Lis R.] Fundacao Oswaldo Cruz, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Junqueira, Caroline; Sen Santara, Sumit; Barbosa, Rafael P.; Dotiwala, Farokh; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Junqueira, Caroline; Sen Santara, Sumit; Barbosa, Rafael P.; Dotiwala, Farokh; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Pereira, Dhelio B.] Ctr Pesquisas Med Trop, Porto Velho, Brazil; [Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Plataforma Med Translat, Ribeirao Preto, Brazil; [Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	Fundacao Oswaldo Cruz; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester	Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Gazzinelli, RT (corresponding author), Fundacao Oswaldo Cruz, Plataforma Med Translat, Ribeirao Preto, Brazil.; Gazzinelli, RT (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.; Gazzinelli, RT (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA.	carolinejunqueira@minas.fiocruz.br; judy.lieberman@childrens.harvard.edu; ricardo.gazzinelli@umassmed.edu	Dotiwala, Farokh/S-5367-2019; Costa, Pedro Augusto Carvalho/T-6813-2018; Junqueira, Caroline/GVR-8109-2022; Antonelli, Lis/R-4910-2019; Lieberman, Judy/A-2717-2015; Pereira, Dhelio Batista/F-9312-2017; Polidoro, Rafael Barbosa/A-6385-2016	Dotiwala, Farokh/0000-0002-7387-2219; Costa, Pedro Augusto Carvalho/0000-0002-3240-7513; Antonelli, Lis/0000-0002-4969-8812; Pereira, Dhelio Batista/0000-0002-7761-5498; Polidoro, Rafael Barbosa/0000-0003-2982-0072; Junqueira, Caroline/0000-0003-0545-0986; sen santara, sumit/0000-0003-2881-0825; Castro, Guilherme/0000-0002-7182-1813	National Institutes of Health [1R01NS098747, Amazonian-ICEMR U19 AI089681, 1R01AI116577, R21AI131632-01]; National Institute of Science and Technology for Vaccines/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [465293/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [RED-00012-14, APQ-00653-16]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/23618-8]; CNPq; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089681, R01AI116577, R01AI079293, R21AI131632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS098747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Science and Technology for Vaccines/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Kasturi Haldar and Kenneth Rock for scientific discussions and suggestions during the development of this work. We are grateful to the Program for Technological Development in Tools for Health-PDTIS-FIOCRUZ for use of its facilities, and to the clinic, laboratory and administrative staff, as well as field workers and subjects from Porto Velho who participated in the study. This study was funded by the National Institutes of Health (1R01NS098747 to R.T.G.; the Amazonian-ICEMR U19 AI089681 to C.J., L.R.A., and R.T.G.; 1R01AI116577 and R21AI131632-01 to R.T.G. and J.L.); National Institute of Science and Technology for Vaccines/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (465293/2014-0 to C.J., L.R.A., D.B.P. and R.T.G.) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (RED-00012-14 and APQ-00653-16 to C.J. and R.T.G.); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2016/23618-8 to R.T.G.). C.J., L.R.A., A.T.-C., and R.T.G. are recipients of CNPq fellowships; P.A.C.C. and C.R.R.B. are fellows from FAPEMIG; and C.J. is a fellow from Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior.	Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Antonelli LRV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004393; Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Bassat Q, 2011, NAT MED, V17, P48, DOI 10.1038/nm0111-48; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Burel JG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005031; Chakravarty S, 2008, INFECT IMMUN, V76, P3628, DOI 10.1128/IAI.00471-08; Cho JS, 2016, INT J PARASITOL, V46, P31, DOI 10.1016/j.ijpara.2015.08.003; Costa G, 2011, BLOOD, V118, P6952, DOI 10.1182/blood-2011-08-376111; Costa PAC, 2015, J INFECT DIS, V212, P1999, DOI 10.1093/infdis/jiv306; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Dotiwala F, 2016, NAT MED, V22, P210, DOI 10.1038/nm.4023; Falanga YT, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93814; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Hoffmann JJML, 1999, CLIN LAB HAEMATOL, V21, P257, DOI 10.1046/j.1365-2257.1999.00243.x; Hojo-Souza NS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0762-x; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mueller I, 2015, VACCINE, V33, P7489, DOI 10.1016/j.vaccine.2015.09.060; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Ramsey JM, 2002, J PARASITOL, V88, P59, DOI 10.1645/0022-3395(2002)088[0059:PFAPVG]2.0.CO;2; Rocha BC, 2015, CELL REP, V13, P2829, DOI 10.1016/j.celrep.2015.11.055; Rug M, 2014, BLOOD, V124, P3459, DOI 10.1182/blood-2014-06-583054; Russell B, 2013, ANTIMICROB AGENTS CH, V57, P5170, DOI 10.1128/AAC.00682-13; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Safeukui I, 2015, MBIO, V6, DOI 10.1128/mBio.02493-14; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SEGUIN MC, 1994, J EXP MED, V180, P353, DOI 10.1084/jem.180.1.353; SILVESTR.D, 1970, NATURE, V228, P67, DOI 10.1038/228067a0; Spencer AJ, 2017, J IMMUNOL, V198, P2006, DOI 10.4049/jimmunol.1601209; Thiery J., 2010, CURR PROTOC CELL BIO; Troye-Blomberg M, 1999, SCAND J IMMUNOL, V50, P642, DOI 10.1046/j.1365-3083.1999.00647.x; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; Wilson MC, 2016, MOL CELL PROTEOMICS, V15, P1938, DOI 10.1074/mcp.M115.057315; Wirjanata G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0940-8; Zimmerman PA, 2013, ADV PARASIT, V81, P27, DOI 10.1016/B978-0-12-407826-0.00002-3	47	44	50	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1330	+		10.1038/s41591-018-0117-4	http://dx.doi.org/10.1038/s41591-018-0117-4			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30038217	Green Accepted			2022-12-27	WOS:000444174100013
J	Sun, WF; Dong, H; Becker, AS; Dapito, DH; Modica, S; Grandl, G; Opitz, L; Efthymiou, V; Straub, LG; Sarker, G; Balaz, M; Balazova, L; Perdikari, A; Kiehlmann, E; Bacanovic, S; Zellweger, C; Peleg-Raibstein, D; Pelczar, P; Reik, W; Burger, IA; von Meyenn, F; Wolfrum, C				Sun, Wenfei; Dong, Hua; Becker, Anton S.; Dapito, Dianne H.; Modica, Salvatore; Grandl, Gerald; Opitz, Lennart; Efthymiou, Vissarion; Straub, Leon G.; Sarker, Gitalee; Balaz, Miroslav; Balazova, Lucia; Perdikari, Aliki; Kiehlmann, Elke; Bacanovic, Sara; Zellweger, Caroline; Peleg-Raibstein, Daria; Pelczar, Pawel; Reik, Wolf; Burger, Irene A.; von Meyenn, Ferdinand; Wolfrum, Christian			Cold-induced epigenetic programming of the sperm enhances brown adipose tissue activity in the offspring	NATURE MEDICINE			English	Article							HIGH-FAT DIET; GENE-EXPRESSION; METHYLATION; OBESITY; THERMOGENESIS; INHERITANCE; PREVALENCE; HUMANS; HEALTH; TARGET	Recent research has focused on environmental effects that control tissue functionality and systemic metabolism. However, whether such stimuli affect human thermogenesis and body mass index (BMI) has not been explored. Here we show retrospectively that the presence of brown adipose tissue (BAT) and the season of conception are linked to BMI in humans. In mice, we demonstrate that cold exposure (CE) of males, but not females, before mating results in improved systemic metabolism and protection from diet-induced obesity of the male offspring. Integrated analyses of the DNA methylome and RNA sequencing of the sperm from male mice revealed several clusters of co-regulated differentially methylated regions (DMRs) and differentially expressed genes (DEGs), suggesting that the improved metabolic health of the offspring was due to enhanced BAT formation and increased neurogenesis. The conclusions are supported by cell-autonomous studies in the offspring that demonstrate an enhanced capacity to form mature active brown adipocytes, improved neuronal density and more norepinephrine release in BAT in response to cold stimulation. Taken together, our results indicate that in humans and in mice, seasonal or experimental CE induces an epigenetic programming of the sperm such that the offspring harbor hyperactive BAT and an improved adaptation to overnutrition and hypothermia.	[Sun, Wenfei; Dong, Hua; Becker, Anton S.; Dapito, Dianne H.; Modica, Salvatore; Grandl, Gerald; Opitz, Lennart; Efthymiou, Vissarion; Straub, Leon G.; Sarker, Gitalee; Balaz, Miroslav; Balazova, Lucia; Perdikari, Aliki; Kiehlmann, Elke; Peleg-Raibstein, Daria; Wolfrum, Christian] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland; [Becker, Anton S.] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Becker, Anton S.; Bacanovic, Sara; Zellweger, Caroline; Burger, Irene A.] Univ Hosp Zurich, Clin Nucl Med, Zurich, Switzerland; [Opitz, Lennart] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, Basel, Switzerland; [Reik, Wolf; von Meyenn, Ferdinand] Babraham Inst, Epigenet Program, Cambridge, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton, England; [von Meyenn, Ferdinand] Kings Coll London, Dept Med & Mol Genet, London, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Basel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; University of London; King's College London	Wolfrum, C (corresponding author), Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland.	christian-wolfrum@ethz.ch	von Meyenn, Ferdinand/O-4517-2017; Balaz, Miroslav/E-8034-2018; Peleg-Raibstein, Daria/F-1734-2017; sun, wenfei/S-3513-2019; Becker, Anton S./H-5416-2019; Reik, Wolf/I-6794-2012; Burger, Irene/AAG-1077-2020; Sun, Wenfei/GWV-0960-2022; Balazova, Lucia/Y-6371-2019	von Meyenn, Ferdinand/0000-0001-9920-3075; sun, wenfei/0000-0001-5762-6010; Becker, Anton S./0000-0001-8372-6496; Straub, Leon/0000-0001-6738-0130; Balaz, Miroslav/0000-0002-5740-4896; Wolfrum, Christian/0000-0002-3862-6805; Balazova, Lucia/0000-0001-6765-7486; Efthymiou, Vissarion/0000-0003-4327-7977	Swiss National Science Foundation (SNSF); BBSRC [BBS/E/B/000C0424, BBS/E/B/0000H334] Funding Source: UKRI	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to M. Stoffel, J. Krutzfeldt and members of the Wolfrum lab for helpful discussions, K. Tabbada for assistance with WGBS high-throughput sequencing, and F. Krueger and S. Andrews for help with bioinformatics analysis. We thank K. De Bock and F. Zheng for the IB4 antibody and K. A. Rollins for editing the manuscript. Data produced and analyzed in this paper were generated in collaboration with the Genetic Diversity Center (GDC) and Functional Genomics Center Zurich (FGCZ). The work was supported by the Swiss National Science Foundation (SNSF; C.W. and F.v.M.).	Abreu-Vieira G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8433; Adefuye Anthonio O, 2014, J Mol Signal, V9, P8, DOI 10.1186/1750-2187-9-8; Afonso A., 2004, MEDITERRANEAN Q, V15, P147, DOI [DOI 10.1215/10474552-15-4-147, 10.1215/10474552-15-4-147]; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Becker AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149458; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Haueter S, 2010, GENESIS, V48, P151, DOI 10.1002/dvg.20598; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaufman M. H., 1994, THE ATLAS OF MOUSE D; Kazak L, 2015, CELL, V163, P643, DOI 10.1016/j.cell.2015.09.035; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv J, 2015, J EPIDEMIOL, V25, P221, DOI 10.2188/jea.JE20140154; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ost A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005; Phillips DIW, 2000, INT J OBESITY, V24, P281, DOI 10.1038/sj.ijo.0801125; Pryce CR, 2003, BEHAV NEUROSCI, V117, P883, DOI 10.1037/0735-7044.117.5.883; Rando OJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022988; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shea JM, 2015, DEV CELL, V35, P750, DOI 10.1016/j.devcel.2015.11.024; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Speakman JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30409; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Valdes S, 2014, OBESITY, V22, P2328, DOI 10.1002/oby.20866; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; von Meyenn F, 2016, DEV CELL, V39, P104, DOI 10.1016/j.devcel.2016.09.015; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; World Health Organization, 2017, OB OV; Yang HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141724; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zhang Z, 2004, J ANDROL, V25, P57; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	59	59	61	2	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1372	+		10.1038/s41591-018-0102-y	http://dx.doi.org/10.1038/s41591-018-0102-y			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	29988127	Green Submitted			2022-12-27	WOS:000444174100018
J	Abbink, P; Larocca, RA; Dejnirattisai, W; Peterson, R; Nkolola, JP; Borducchi, EN; Supasa, P; Mongkolsapaya, J; Screaton, GR; Barouch, DH				Abbink, Peter; Larocca, Rafael A.; Dejnirattisai, Wanwisa; Peterson, Rebecca; Nkolola, Joseph P.; Borducchi, Erica N.; Supasa, Piyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.; Barouch, Dan H.			Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys	NATURE MEDICINE			English	Article							VIRUS-INFECTION; CROSS-REACTIVITY; VACCINE; POTENT; ENHANCEMENT; CHALLENGE	Strategies to treat Zika virus (ZIKV) infection in dengue virus (DENV)-endemic areas are urgently needed. Here we show that a DENV-specific antibody against the E-dimer epitope (EDE) potently cross-neutralizes ZIKV and provides robust therapeutic efficacy as well as prophylactic efficacy against ZIKV in rhesus monkeys. Viral escape was not detected, suggesting a relatively high bar to escape. These data demonstrate the potential for antibody-based therapy and prevention of ZIKV.	[Abbink, Peter; Larocca, Rafael A.; Peterson, Rebecca; Nkolola, Joseph P.; Borducchi, Erica N.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Dejnirattisai, Wanwisa; Supasa, Piyada; Mongkolsapaya, Juthathip] Imperial Coll, Div Immunol & Inflammat, Dept Med, Hammersmith Campus, London, England; [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Siriraj Hosp, Bangkok, Thailand; [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Dept Med, Oxford, England; [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Imperial College London; Mahidol University; University of Oxford; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Screaton, GR (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Med, Oxford, England.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	gavin.screaton@medsci.ox.ac.uk; dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019	Screaton, Gavin/0000-0002-3549-4309; Abbink, Peter/0000-0003-1978-088X	US National Institutes of Health [AI124377, AI126603, AI128751, AI129797]; National Institute for Health Research Biomedical Research Centre funding scheme UK; MRC-Newton UK; Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095985] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research Biomedical Research Centre funding scheme UK; MRC-Newton UK; Ragon Institute of MGH, MIT, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Cao-Lormeau (Unit of Emerging Infectious Diseases, Institut Louis Malarde; provided Zika virus strain PF-13), E. Moseley, K. McMahan, M. Boyd, M. Kirilova, O. Nanayakkara, Z. Li, N. Mercado, A. Badamchi-Zadeh, M. Iampietro, C. Bricault, P. Gandhi, S. Khatiwada, S. Mojta, B. Alimonti, A. Chandrashekar, A. Brinkman, M. Ferguson, and W. Rinaldi for generous advice, assistance, and reagents. We acknowledge support from the US National Institutes of Health (AI124377, AI126603, AI128751, AI129797) (D.H.B.), the National Institute for Health Research Biomedical Research Centre funding scheme UK (G.R.S), MRC-Newton UK (J.M.), and the Ragon Institute of MGH, MIT, and Harvard (D.H.B.). G.R.S. is a Wellcome Trust Senior Investigator.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137; Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849; Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002	20	35	36	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					721	+		10.1038/s41591-018-0056-0	http://dx.doi.org/10.1038/s41591-018-0056-0			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29867228	Green Accepted, Green Submitted			2022-12-27	WOS:000434281300016
J	Wirka, RC; Wagh, D; Paik, DT; Pjanic, M; Nguyen, T; Miller, CL; Kundu, R; Nagao, M; Coller, J; Koyano, TK; Fong, R; Woo, YJ; Liu, BX; Montgomery, SB; Wu, JC; Zhu, KX; Chang, R; Alamprese, M; Tallquist, MD; Kim, JB; Quertermous, T				Wirka, Robert C.; Wagh, Dhananjay; Paik, David T.; Pjanic, Milos; Trieu Nguyen; Miller, Clint L.; Kundu, Ramen; Nagao, Manabu; Coller, John; Koyano, Tiffany K.; Fong, Robyn; Woo, Y. Joseph; Liu, Boxiang; Montgomery, Stephen B.; Wu, Joseph C.; Zhu, Kuixi; Chang, Rui; Alamprese, Melissa; Tallquist, Michelle D.; Kim, Juyong B.; Quertermous, Thomas			Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis	NATURE MEDICINE			English	Article							ATHEROSCLEROTIC PLAQUES; MACROPHAGE; TRANSCRIPTION; EXPRESSION; LOCI; RISK	In response to various stimuli, vascular smooth muscle cells (SMCs) can de-differentiate, proliferate and migrate in a process known as phenotypic modulation. However, the phenotype of modulated SMCs in vivo during atherosclerosis and the influence of this process on coronary artery disease (CAD) risk have not been clearly established. Using single-cell RNA sequencing, we comprehensively characterized the transcriptomic phenotype of modulated SMCs in vivo in atherosclerotic lesions of both mouse and human arteries and found that these cells transform into unique fibroblast-like cells, termed 'fibromyocytes', rather than into a classical macrophage phenotype. SMC-specific knockout of TCF21-a causal CAD gene-markedly inhibited SMC phenotypic modulation in mice, leading to the presence of fewer fibromyocytes within lesions as well as within the protective fibrous cap of the lesions. Moreover, TCF21 expression was strongly associated with SMC phenotypic modulation in diseased human coronary arteries, and higher levels of TCF21 expression were associated with decreased CAD risk in human CAD-relevant tissues. These results establish a protective role for both TCF21 and SMC phenotypic modulation in this disease.	[Wirka, Robert C.; Paik, David T.; Pjanic, Milos; Trieu Nguyen; Kundu, Ramen; Nagao, Manabu; Wu, Joseph C.; Kim, Juyong B.; Quertermous, Thomas] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Wirka, Robert C.; Paik, David T.; Pjanic, Milos; Trieu Nguyen; Kundu, Ramen; Nagao, Manabu; Wu, Joseph C.; Kim, Juyong B.; Quertermous, Thomas] Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Wagh, Dhananjay; Coller, John] Stanford Univ, Sch Med, Stanford Funct Genom Facil, Stanford, CA 94305 USA; [Miller, Clint L.] Univ Virginia, Dept Publ Hlth Sci, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Koyano, Tiffany K.; Fong, Robyn; Woo, Y. Joseph] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Liu, Boxiang; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Zhu, Kuixi; Chang, Rui; Alamprese, Melissa] Univ Arizona, Dept Neurol, Tucson, AZ USA; [Zhu, Kuixi; Chang, Rui; Alamprese, Melissa] Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ USA; [Tallquist, Michelle D.] Univ Hawaii Manoa, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA	Stanford University; Stanford University; University of Virginia; Stanford University; Stanford University; University of Arizona; University of Arizona; University of Hawaii System; University of Hawaii Manoa	Quertermous, T (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.; Quertermous, T (corresponding author), Stanford Cardiovasc Inst, Stanford, CA 94305 USA.	tomq1@stanford.edu	Tallquist, Michelle/AAU-5277-2021; Pjanic, Milos/AAH-1262-2019; Miller, Clint/I-4370-2019; Wu, Joseph/H-1067-2013; Paik, David T./L-7619-2016	Tallquist, Michelle/0000-0002-1383-144X; Pjanic, Milos/0000-0001-9746-8838; Wu, Joseph/0000-0002-6068-8041; Kim, Juyong/0000-0002-9675-2607; Paik, David T./0000-0002-7830-312X; Quertermous, Thomas/0000-0002-7645-9067; Liu, Boxiang/0000-0002-2595-4463; Montgomery, Stephen/0000-0002-5200-3903	NIH [F32HL129670, K08HL133375, R00HL125912, R01HL109512, R01HL134817, R33HL120757, R01DK107437, R01HL139478, 1R01HL141371, 17GRNT33660474 AHA, S10OD018220, S10RR025518-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL144067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to G. Owens for providing Tg<SUP>Myh11-Cre</SUP>, ApoE<SUP>-/-</SUP> animals and experimental protocols. The authors are also grateful to L. Roman for assistance with developing the human coronary digestion protocol. This work was supported by NIH grant F32HL129670 and AHA grant 18CDA34110206 (both to R.C.W.), and NIH grants K08HL133375 (to J.B.K.), R00HL125912 (to C.L.M.), R01HL109512 (to T.Q.), R01HL134817 (to T.Q.), R33HL120757 (to T.Q.), R01DK107437 (to T.Q.), R01HL139478 (to T.Q.), 1R01HL141371 (to J.C.W.) and 17GRNT33660474 AHA (to M.D.T.). The sequencing data were generated on an Illumina HiSeq 4000 that was purchased with funds from NIH under award number S10OD018220. Cell sorting was performed on an instrument in the Shared FACS Facility obtained using NIH S10 Shared Instrument Grant S10RR025518-01.	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chappell J, 2016, CIRC RES, V119, P1313, DOI 10.1161/CIRCRESAHA.116.309799; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Dobnikar L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06891-x; Franzen O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Jacobsen K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95890; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kitchen CM, 2013, GENE, V513, P82, DOI 10.1016/j.gene.2012.10.073; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Miller CL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004263; Miller CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003652; Nurnberg ST, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005155; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Rong JX, 2002, ARTERIOSCL THROM VAS, V22, P1617, DOI 10.1161/01.ATV.0000035408.93749.71; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sazonova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005202; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Vengrenyuk Y, 2015, ARTERIOSCL THROM VAS, V35, P535, DOI 10.1161/ATVBAHA.114.304029; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	38	229	233	12	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1280	+		10.1038/s41591-019-0512-5	http://dx.doi.org/10.1038/s41591-019-0512-5			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31359001	Green Accepted			2022-12-27	WOS:000480414600027
J	Aagaard, K; Hohmann, E				Aagaard, Kjersti; Hohmann, Elizabeth			Regulating microbiome manipulation	NATURE MEDICINE			English	Editorial Material									[Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, Kjersti] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Aagaard, Kjersti] Baylor Coll Med, Dept Cell & Mol Biol, Houston, TX 77030 USA; [Aagaard, Kjersti] Texas Childrens Hosp, Houston, TX 77030 USA; [Hohmann, Elizabeth] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital	Aagaard, K (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.; Aagaard, K (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aagaard, K (corresponding author), Baylor Coll Med, Dept Cell & Mol Biol, Houston, TX 77030 USA.; Aagaard, K (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	aagaardt@bcm.edu						Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; [Anonymous], 2016, BACT RISK CONTR STRA; Carlucci C, 2016, EBIOMEDICINE, V13, P37, DOI 10.1016/j.ebiom.2016.09.029; Gupta A, 2018, JAMA-J AM MED ASSOC, V320, P1031, DOI 10.1001/jama.2018.12194; Hoffmann D, 2017, SCIENCE, V358, P1390, DOI 10.1126/science.aaq0034; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Sachs RE, 2015, J LAW BIOSCI, V2, P396, DOI 10.1093/jlb/lsv032; Thomas S, 2017, CANCER RES, V77, P1783, DOI 10.1158/0008-5472.CAN-16-2929; U.S. Food & Drug Administration, 2016, ENF POL REG INV NEW; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Woodworth MH, 2017, NEW BIOETH, V23, P210, DOI 10.1080/20502877.2017.1387386; Woodworth MH, 2017, J CLIN MICROBIOL, V55, P1002, DOI 10.1128/JCM.02327-16	12	6	6	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					874	876		10.1038/s41591-019-0451-1	http://dx.doi.org/10.1038/s41591-019-0451-1			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31133692				2022-12-27	WOS:000470844400008
J	Thomas, AM; Manghi, P; Asnicar, F; Pasolli, E; Armanini, F; Zolfo, M; Beghini, F; Manara, S; Karcher, N; Pozzi, C; Gandini, S; Serrano, D; Tarallo, S; Francavilla, A; Gallo, G; Trompetto, M; Ferrero, G; Mizutani, S; Shiroma, H; Shiba, S; Shibata, T; Yachida, S; Yamada, T; Wirbel, J; Schrotz-King, P; Ulrich, CM; Brenner, H; Arumugam, M; Bork, P; Zeller, G; Cordero, F; Dias-Neto, E; Setubal, JC; Tett, A; Pardini, B; Rescigno, M; Waldron, L; Naccarati, A; Segata, N				Thomas, Andrew Maltez; Manghi, Paolo; Asnicar, Francesco; Pasolli, Edoardo; Armanini, Federica; Zolfo, Moreno; Beghini, Francesco; Manara, Serena; Karcher, Nicolai; Pozzi, Chiara; Gandini, Sara; Serrano, Davide; Tarallo, Sonia; Francavilla, Antonio; Gallo, Gaetano; Trompetto, Mario; Ferrero, Giulio; Mizutani, Sayaka; Shiroma, Hirotsugu; Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi; Yamada, Takuji; Wirbel, Jakob; Schrotz-King, Petra; Ulrich, Cornelia M.; Brenner, Hermann; Arumugam, Manimozhiyan; Bork, Peer; Zeller, Georg; Cordero, Francesca; Dias-Neto, Emmanuel; Setubal, Joao Carlos; Tett, Adrian; Pardini, Barbara; Rescigno, Maria; Waldron, Levi; Naccarati, Alessio; Segata, Nicola			Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation	NATURE MEDICINE			English	Article							HUMAN GUT MICROBIOME; READ ALIGNMENT; RISK; DIVERSITY; TUMORIGENESIS; ASSOCIATION; SEARCH; HEALTH; TOOL	Several studies have investigated links between the gut microbiome and colorectal cancer (CRC), but questions remain about the replicability of biomarkers across cohorts and populations. We performed a meta-analysis of five publicly available datasets and two new cohorts and validated the findings on two additional cohorts, considering in total 969 fecal metagenomes. Unlike microbiome shifts associated with gastrointestinal syndromes, the gut microbiome in CRC showed reproducibly higher richness than controls (P < 0.01), partially due to expansions of species typically derived from the oral cavity. Meta-analysis of the microbiome functional potential identified gluconeogenesis and the putrefaction and fermentation pathways as being associated with CRC, whereas the stachyose and starch degradation pathways were associated with controls. Predictive microbiome signatures for CRC trained on multiple datasets showed consistently high accuracy in datasets not considered for model training and independent validation cohorts (average area under the curve, 0.84). Pooled analysis of raw metagenomes showed that the choline trimethylaminelyase gene was overabundant in CRC (P = 0.001), identifying a relationship between microbiome choline metabolism and CRC. The combined analysis of heterogeneous CRC cohorts thus identified reproducible microbiome biomarkers and accurate disease-predictive models that can form the basis for clinical prognostic tests and hypothesis-driven mechanistic studies.	[Thomas, Andrew Maltez; Manghi, Paolo; Asnicar, Francesco; Pasolli, Edoardo; Armanini, Federica; Zolfo, Moreno; Beghini, Francesco; Manara, Serena; Karcher, Nicolai; Tett, Adrian; Segata, Nicola] Univ Trento, Dept CIBIO, Trento, Italy; [Thomas, Andrew Maltez; Setubal, Joao Carlos] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Thomas, Andrew Maltez; Manghi, Paolo; Dias-Neto, Emmanuel] CIPE AC Camargo Canc Ctr, Med Genom Lab, Sao Paulo, Brazil; [Pozzi, Chiara; Gandini, Sara; Serrano, Davide] European Inst Oncol, Milan, Italy; [Tarallo, Sonia; Francavilla, Antonio; Pardini, Barbara; Naccarati, Alessio] Italian Inst Genom Med, Turin, Italy; [Gallo, Gaetano] Univ Catanzaro, Dept Surg & Med Sci, Catanzaro, Italy; [Gallo, Gaetano; Trompetto, Mario] Clin S Rita, Dept Colorectal Surg, Vercelli, Italy; [Ferrero, Giulio; Cordero, Francesca] Univ Turin, Dept Comp Sci, Turin, Italy; [Mizutani, Sayaka; Shiroma, Hirotsugu; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan; [Mizutani, Sayaka] Japan Soc Promot Sci, Tokyo, Japan; [Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo, Japan; [Yachida, Shinichi] Osaka Univ, Dept Canc Genome Informat, Osaka, Japan; [Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Wirbel, Jakob; Bork, Peer; Zeller, Georg] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Schrotz-King, Petra; Brenner, Hermann] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Schrotz-King, Petra; Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Ulrich, Cornelia M.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Arumugam, Manimozhiyan] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Arumugam, Manimozhiyan] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Bork, Peer] Mol Med Partnership Unit, Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bork, Peer] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany; [Dias-Neto, Emmanuel] Univ Sao Paulo, Inst Psychiat, Lab Neurosci, Sao Paulo, Brazil; [Setubal, Joao Carlos] Virginia Tech, Biocomplex Inst, Blacksburg, VA USA; [Pardini, Barbara] Univ Turin, Dept Med Sci, Turin, Italy; [Rescigno, Maria] Humanitas Res Hosp, Mucosal Immunol & Microbiota Unit, Milan, Italy; [Waldron, Levi] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Waldron, Levi] CUNY, Inst Implementat Sci Populat Hlth, New York, NY 10021 USA; [Naccarati, Alessio] Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic	University of Trento; Universidade de Sao Paulo; A.C.Camargo Cancer Center; IRCCS European Institute of Oncology (IEO); Italian Institute for Genomic Medicine (IIGM); Magna Graecia University of Catanzaro; University of Turin; Tokyo Institute of Technology; Japan Society for the Promotion of Science; National Cancer Center - Japan; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Universidade de Sao Paulo; Virginia Polytechnic Institute & State University; University of Turin; City University of New York (CUNY) System; City University of New York (CUNY) System; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Segata, N (corresponding author), Univ Trento, Dept CIBIO, Trento, Italy.	nicola.segata@unitn.it	Dias-Neto, Emmanuel/A-5869-2008; shiba, satoshi/AAL-4953-2021; Brenner, Hermann/B-4627-2017; Pozzi, Chiara/K-4481-2018; Brenner, Hermann/ABE-6383-2020; Dias-Neto, Emmanuel/AAA-6701-2019; francavilla, antonio/AAB-8783-2022; Arumugam, Manimozhiyan/E-1211-2011; Shiba, Satoshi/AAJ-2157-2021; Cordero, Francesca/AAB-3655-2019; Zolfo, Moreno/Y-4374-2019; Bork, Peer/F-1813-2013; Segata, Nicola/AAB-2980-2019; Asnicar, Francesco/AAB-9255-2020; Gallo, Gaetano/I-6917-2019; Beghini, Francesco/ABE-9981-2021; Dias-Neto, Emmanuel/AAE-9147-2020; Manara, Serena/AAQ-7771-2020; Shibata, Tatsuhiro/AAO-1278-2021; gandini, sara/J-4916-2018; Pardini, Barbara/ABI-2295-2020; Shibata, Tatsuhiro/ABA-8234-2020; Ferrero, Giulio/K-9508-2019; Zolfo, Moreno/Q-4368-2016; Arumugam, Manimozhiyan/AAJ-2394-2020; Waldron, Levi/H-2967-2019; Setubal, Joao Carlos/C-7305-2012; Tarallo, Sonia/AAB-8656-2022; Zeller, Georg/M-6484-2013; Pasolli, Edoardo/K-5156-2016	Dias-Neto, Emmanuel/0000-0001-5670-8559; Brenner, Hermann/0000-0002-6129-1572; Pozzi, Chiara/0000-0003-2153-6130; Brenner, Hermann/0000-0002-6129-1572; Arumugam, Manimozhiyan/0000-0002-0886-9101; Shiba, Satoshi/0000-0001-5159-5719; Cordero, Francesca/0000-0002-3143-3330; Zolfo, Moreno/0000-0001-6661-4046; Bork, Peer/0000-0002-2627-833X; Asnicar, Francesco/0000-0003-3732-1468; Gallo, Gaetano/0000-0003-1066-4671; Beghini, Francesco/0000-0002-8105-9607; Manara, Serena/0000-0001-6371-528X; gandini, sara/0000-0002-1348-4548; Pardini, Barbara/0000-0001-9571-4257; Ferrero, Giulio/0000-0002-4580-0680; Zolfo, Moreno/0000-0001-6661-4046; Arumugam, Manimozhiyan/0000-0002-0886-9101; Waldron, Levi/0000-0003-2725-0694; Setubal, Joao Carlos/0000-0001-9174-2816; Zeller, Georg/0000-0003-1429-7485; Thomas, Andrew Maltez/0000-0001-5789-3354; Manghi, Paolo/0000-0003-0846-6529; Tett, Adrian/0000-0003-3141-3943; Wirbel, Jakob/0000-0002-4073-3562; Serrano, Davide/0000-0002-2945-4108; Tarallo, Sonia/0000-0003-0887-2607; Naccarati, Alessio/0000-0001-5774-0905; Pasolli, Edoardo/0000-0003-0799-3490; francavilla, antonio/0000-0003-1594-2837; Karcher, Nicolai/0000-0001-7894-8182	Lega Italiana per La Lotta contro i Tumori; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [16/23527-2]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq, Brazil); FAPESP [14/26897-0]; Associacao Beneficente Alzira Denise Hertzog Silva (ABADHS, Brazil); PRONON/SIPAR; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) [001]; Italian Institute for Genomic Medicine (IIGM); Compagnia di San Paolo Torino; Fondazione Umberto Veronesi; Grant Agency of the Czech Republic [17-16857S]; Fondazione Umberto Veronesi [FUV-14-SG-GANDINI]; European Union [707345]; European Research Council (ERC-STG project MetaPG); MIUR 'Futuro in Ricerca' [RBFR13EWWI_001]; European Union; National Cancer Institute [U24CA180996, R01 CA189184, R01 CA207371, U01 CA206110, P30 CA042014]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [1R21AI121784-01]; Fulbright Research Scholarship; EMBL; DKFZ; Huntsman Cancer Foundation; Intramural Research Program of the National Cancer Institute; ETH Zurich; European Research Council [ERC-2010-AdG_20100317, ERC-AdG-669830]; Novo Nordisk Foundation [NNF10CC1016515]; Danish Diabetes Academy - Novo Nordisk Foundation; TARGET research initiative (Danish Strategic Research Council) [0603-00484B]; Matthias-Lackas Foundation; BMBF [031A537B]; ERA-NET TRANSCAN project [01KT1503]; Helmut Horten Foundation; National Cancer Center Research and Development Fund [25-A-4, 28-A-4, 29-A-6]; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) [JP18ek0109187]; JST (Japan Science and Technology Agency)-PRESTO [JPMJPR1507]; Japan Society for the Promotion of Science KAKENHI [16J10135, 142558, 221S0002]; Joint Research Project of the Institute of Medical Science; University of Tokyo; Takeda Science Foundation; Suzuken Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	Lega Italiana per La Lotta contro i Tumori; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Associacao Beneficente Alzira Denise Hertzog Silva (ABADHS, Brazil); PRONON/SIPAR; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Italian Institute for Genomic Medicine (IIGM); Compagnia di San Paolo Torino(Compagnia di San Paolo); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); European Union(European Commission); European Research Council (ERC-STG project MetaPG); MIUR 'Futuro in Ricerca'(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fulbright Research Scholarship; EMBL; DKFZ(Helmholtz Association); Huntsman Cancer Foundation; Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Academy - Novo Nordisk Foundation; TARGET research initiative (Danish Strategic Research Council); Matthias-Lackas Foundation; BMBF(Federal Ministry of Education & Research (BMBF)); ERA-NET TRANSCAN project; Helmut Horten Foundation; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JST (Japan Science and Technology Agency)-PRESTO; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Joint Research Project of the Institute of Medical Science; University of Tokyo; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Segata, Naccarati and Waldron groups for insightful discussions, all the volunteers enrolled in the study, the NGS facility at the University of Trento for performing the metagenomic sequencing, and the HPC facility at the University of Trento for supporting the computational experiments. This work was primarily supported by Lega Italiana per La Lotta contro i Tumori to N.S., F.C. and A.N., and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant No. 16/23527-2) to A.M.T. This work was also partially supported by the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq, Brazil) to J.C.S. and E.D.-N.; by FAPESP (grant No. 14/26897-0); by Associacao Beneficente Alzira Denise Hertzog Silva (ABADHS, Brazil) and PRONON/SIPAR to E.D.-N.; by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) (Finance Code No. 001 to J.C.S.; by the Italian Institute for Genomic Medicine (IIGM) and Compagnia di San Paolo Torino to A.N, A.F., B.P. and S.T.; by Fondazione Umberto Veronesi 'Post-doctoral Fellowship Years 2014, 2015, 2016, 2017 and 2018' to B.P. and S.T.; by the Grant Agency of the Czech Republic (grant No. 17-16857S) to A.N.; by Fondazione Umberto Veronesi (grant No. FUV-14-SG-GANDINI) to S.G.; by the European Union H2020 Marie Curie grant (No. 707345) to E.P.; by the European Research Council (ERC-STG project MetaPG) to N.S.; by MIUR 'Futuro in Ricerca' (grant No. RBFR13EWWI_001) to N.S.; by the People Programme (Marie Curie Actions) of the European Union FP7 and H2020 to N.S.; and by the National Cancer Institute (grant No. U24CA180996) and National Institute of Allergy and Infectious Diseases (grant No. 1R21AI121784-01) of the National Institutes of Health to L.W.B.P. is the recipient of a Fulbright Research Scholarship (year 2018). We acknowledge funding from EMBL, DKFZ, the Huntsman Cancer Foundation, the Intramural Research Program of the National Cancer Institute, ETH Zurich and the following external sources: the European Research Council (CancerBiome, grant No. ERC-2010-AdG_20100317) to P.B.; Microbios (No. ERC-AdG-669830) to P.B.; the Novo Nordisk Foundation (grant No. NNF10CC1016515) to M.A.; the Danish Diabetes Academy supported by the Novo Nordisk Foundation and TARGET research initiative (Danish Strategic Research Council, grant No. 0603-00484B) to M.A.; the Matthias-Lackas Foundation (to C.M.U.); the National Cancer Institute (grant Nos. R01 CA189184, R01 CA207371, U01 CA206110 and P30 CA042014 ll to C.M.U.); the BMBF (the de. NBI network, grant No. 031A537B) to P.B.; the ERA-NET TRANSCAN project (No. 01KT1503) to C.M.U.; and the Helmut Horten Foundation (to S.S.). For Validation Cohort2, funding was provided by grants from the National Cancer Center Research and Development Fund (grant Nos. 25-A-4, 28-A-4 and 29-A-6); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED, grant No. JP18ek0109187); JST (Japan Science and Technology Agency)-PRESTO (grant No. JPMJPR1507); Japan Society for the Promotion of Science KAKENHI (grant Nos. 16J10135, 142558 and 221S0002); Joint Research Project of the Institute of Medical Science; the University of Tokyo; the Takeda Science Foundation; and the Suzuken Memorial Foundation.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Bae S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835; Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3; Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927; Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3; Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; Frank C, 2017, INT J CANCER, V140, P1510, DOI 10.1002/ijc.30583; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kalnins G, 2015, J BIOL CHEM, V290, P21732, DOI 10.1074/jbc.M115.670471; Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kummen M, 2017, UNITED EUR GASTROENT, V5, P532, DOI 10.1177/2050640616663453; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANDAL S, 2015, MICROB ECOL HEALTH D, V26, DOI DOI 10.3402/MEHD.V26.27663; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Oellgaard J, 2017, CURR PHARM DESIGN, V23, P3699, DOI 10.2174/1381612823666170622095324; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Pasolli E, 2017, NAT METHODS, V14, P1023, DOI 10.1038/nmeth.4468; Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pollock J, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02627-17; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935; Rath S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0271-9; Riester M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju048; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segata N, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00190-17; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thomas AM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00179; Thomas RM, 2015, TRENDS CANCER, V1, P24, DOI 10.1016/j.trecan.2015.07.005; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362; Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xie YH, 2017, EBIOMEDICINE, V25, P32, DOI 10.1016/j.ebiom.2017.10.005; Xu R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S4; Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645	81	292	298	13	115	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					667	+		10.1038/s41591-019-0405-7	http://dx.doi.org/10.1038/s41591-019-0405-7			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30936548	Green Submitted, Green Accepted			2022-12-27	WOS:000463342800028
J	Helmink, BA; Khan, MAW; Hermann, A; Gopalakrishnan, V; Wargo, JA				Helmink, Beth A.; Khan, M. A. Wadud; Hermann, Amanda; Gopalakrishnan, Vancheswaran; Wargo, Jennifer A.			The microbiome, cancer, and cancer therapy	NATURE MEDICINE			English	Review							CLOSTRIDIUM-DIFFICILE INFECTION; RANDOMIZED DOUBLE-BLIND; HUMAN GUT MICROBIOME; FECAL MICROBIOTA; COLORECTAL-CANCER; FUSOBACTERIUM-NUCLEATUM; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; PROMOTES; TRANSPLANTATION	With the advent of next-generation sequencing, we have an unprecedented ability to study tumor and host genomes as well as those of the vast array of microorganisms that exist within living organisms. Evidence now suggests that these microbes may confer susceptibility to certain cancers and may also influence response to therapeutics. A prime example of this is seen with immunotherapy, for which gut microbes have been implicated in influencing therapeutic responses in preclinical models and patient cohorts. However, these microbes may influence responses to other forms of therapy as well and may also affect treatment-associated toxicity. Based on these influences, there is growing interest in targeting these microbes in the treatment of cancer and other diseases. Yet complexities exist, and a deeper understanding of host-microbiome interactions is critical to realization of the full potential of such approaches. These concepts and the means through which such findings may be translated into the clinic will be discussed herein.	[Helmink, Beth A.; Khan, M. A. Wadud; Hermann, Amanda; Gopalakrishnan, Vancheswaran; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wargo, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.; Wargo, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	jwargo@mdanderson.org	Gopalakrishnan, Vancheswaran/S-9550-2019	Gopalakrishnan, Vancheswaran/0000-0002-8704-035X; Helmink, Beth/0000-0002-8206-0351				Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Alexander JL, 2017, NAT REV GASTRO HEPAT, V14, P356, DOI 10.1038/nrgastro.2017.20; Appleyard CB, 2011, AM J PHYSIOL-GASTR L, V301, pG1004, DOI 10.1152/ajpgi.00167.2011; Arbel LT, 2017, CUREUS, V9, DOI 10.7759/cureus.1599; Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Arthur JC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02868; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Aviles-Jimenez F., 2016, CLIN MICROBIOL INFEC, V22; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bak SH, 2017, INTEST RES, V15, P244, DOI 10.5217/ir.2017.15.2.244; Banerjee S, 2017, ONCOTARGET, V8, P36225, DOI 10.18632/oncotarget.16717; Berer K, 2011, MOL IMMUNOL, V48, P1332, DOI 10.1016/j.molimm.2010.10.025; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Boursi B, 2015, EUR J CANCER, V51, P2655, DOI 10.1016/j.ejca.2015.08.015; Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Camara-Lemarroy CR, 2018, BRAIN, V141, P1900, DOI 10.1093/brain/awy131; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Cieplak T, 2018, GUT MICROBES, V9, P391, DOI 10.1080/19490976.2018.1447291; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Costello SP, 2017, ALIMENT PHARM THER, V46, P213, DOI 10.1111/apt.14173; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59; Czesnikiewicz-Guzik M, 2018, CARDIOVASC RES, V114, pE72, DOI 10.1093/cvr/cvy171; Dalmasso G, 2014, GUT MICROBES, V5, P675, DOI 10.4161/19490976.2014.969989; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Derosa L, 2018, ANN ONCOL, V29, P1437, DOI 10.1093/annonc/mdy103; Di Domenico EG, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091887; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; El Hage R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01889; Ferreira RM, 2018, GUT, V67, P226, DOI 10.1136/gutjnl-2017-314205; Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004; Gaines S, 2018, BRIT J SURG, V105, pE131, DOI 10.1002/bjs.10760; Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020; Garcia-Castillo V, 2016, J MED MICROBIOL, V65, P1347, DOI 10.1099/jmm.0.000371; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Gerassy-Vainberg S, 2018, GUT, V67, P97, DOI 10.1136/gutjnl-2017-313789; Gerding DN, 2015, JAMA-J AM MED ASSOC, V313, P1719, DOI 10.1001/jama.2015.3725; Gianotti L, 2010, WORLD J GASTROENTERO, V16, P167, DOI 10.3748/wjg.v16.i2.167; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Hansen Jonathan J, 2015, Curr Treat Options Gastroenterol, V13, P105, DOI 10.1007/s11938-014-0042-7; He Z, 2019, GUT, V68, P289, DOI 10.1136/gutjnl-2018-317200; Heimann DM, 2003, J IMMUNOTHER, V26, P179, DOI 10.1097/00002371-200303000-00011; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hibberd AA, 2017, BMJ OPEN GASTROENTER, V4, P145, DOI [10.1136/bmjgast-2017-000145, DOI 10.1136/BMJGAST-2017-000145]; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Host KM, 2017, MBIO, V8, DOI 10.1128/mBio.00917-17; Huang Y, 2004, J CLIN PATHOL, V57, P1273, DOI 10.1136/jcp.2004.018556; Huda MN, 2014, PEDIATRICS, V134, pE362, DOI 10.1542/peds.2013-3937; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ishaq Sauid, 2015, Gastroenterol Hepatol Bed Bench, V8, pS6; Jacobsohn DA, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-35; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Juul FE, 2018, NEW ENGL J MED, V378, P2535, DOI 10.1056/NEJMc1803103; Kao D, 2017, JAMA-J AM MED ASSOC, V318, P1985, DOI 10.1001/jama.2017.17077; Karakan T, 2014, TURK J GASTROENTEROL, V25, P346, DOI 10.5152/tjg.2014.0013; Kelly CP, 2013, NEW ENGL J MED, V368, P474, DOI 10.1056/NEJMe1214816; Kelly CR, 2014, AM J GASTROENTEROL, V109, P1065, DOI 10.1038/ajg.2014.133; Khanna S, 2016, ALIMENT PHARM THER, V44, P715, DOI 10.1111/apt.13750; Khanna S, 2016, J INFECT DIS, V214, P173, DOI 10.1093/infdis/jiv766; Kim D, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.24; Kim OY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00729-8; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Kolacek S, 2017, J PEDIATR GASTR NUTR, V65, P117, DOI 10.1097/MPG.0000000000001603; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kouchaki E, 2017, CLIN NUTR, V36, P1245, DOI 10.1016/j.clnu.2016.08.015; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Kwa M, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw029; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lehouritis P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14554; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26337; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Lusiak-Szelachowska M, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0196-7; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Maciejewska B, 2018, APPL MICROBIOL BIOT, V102, P2563, DOI 10.1007/s00253-018-8811-1; MacLellan A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050447; Makkawi S, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000459; Mangerich A, 2012, P NATL ACAD SCI USA, V109, pE1820, DOI 10.1073/pnas.1207829109; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mao QX, 2018, CANCER LETT, V415, P40, DOI 10.1016/j.canlet.2017.11.036; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; Mego M, 2015, COMPLEMENT THER MED, V23, P356, DOI 10.1016/j.ctim.2015.03.008; Mego M, 2013, COMPLEMENT THER MED, V21, P712, DOI 10.1016/j.ctim.2013.08.018; Mima K, 2017, CANCER LETT, V402, P9, DOI 10.1016/j.canlet.2017.05.001; Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001; MOHTY M, 2017, BLOOD S1, V130; Montassier E, 2015, ALIMENT PHARM THER, V42, P515, DOI 10.1111/apt.13302; Morovic W, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01747; Morrissey D, 2010, CURR GENE THER, V10, P3, DOI 10.2174/156652310790945575; Naito S, 2008, J UROLOGY, V179, P485, DOI 10.1016/j.juro.2007.09.031; Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727; Neuman H, 2015, FEMS MICROBIOL REV, V39, P509, DOI 10.1093/femsre/fuu010; O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Ohkusa T, 2002, J GASTROEN HEPATOL, V17, P849, DOI 10.1046/j.1440-1746.2002.02834.x; Orberg ET, 2017, MUCOSAL IMMUNOL, V10, P421, DOI 10.1038/mi.2016.53; Osterlund P, 2007, BRIT J CANCER, V97, P1028, DOI 10.1038/sj.bjc.6603990; Panda Anshuman, 2018, J Natl Cancer Inst, V110, P316, DOI 10.1093/jnci/djx213; Panebianco C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0483-7; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pflug N, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1150399; Podolsky SH, 2012, LANCET, V380, P1810, DOI 10.1016/S0140-6736(12)62018-2; Purcell RV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171602; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Riehl TE, 2018, GUT; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Schubert AM, 2014, MBIO, V5, DOI 10.1128/mBio.01021-14; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Shapira Iuliana, 2013, ISRN Oncol, V2013, P693920, DOI 10.1155/2013/693920; Sharma A, 2012, EUR J CANCER, V48, P875, DOI 10.1016/j.ejca.2011.06.010; Shen SQ, 2017, NAT NEUROSCI, V20, P1213, DOI 10.1038/nn.4606; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smola S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090254; Sokol H, 2018, GUT, V67, P1, DOI 10.1136/gutjnl-2017-314279; Tankou SK, 2018, ANN NEUROL, V83, P1147, DOI 10.1002/ana.25244; Taper HS, 2005, IN VIVO, V19, P201; Theodoropoulos GE, 2016, ANN GASTROENTEROL, V29, P56; Tian Y, 2019, ONCOL LETT, V17, P2836, DOI 10.3892/ol.2019.9906; Tomkovich S, 2017, CANCER RES, V77, P2620, DOI 10.1158/0008-5472.CAN-16-3472; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Tsilimigras MCB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346; Venugopalan V, 2010, EMERG INFECT DIS, V16, P1661, DOI 10.3201/eid1611.100574; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Wang SL, 2012, EXP THER MED, V4, P1051, DOI 10.3892/etm.2012.718; Wang YH, 2018, NAT MED, V24, P1804, DOI 10.1038/s41591-018-0238-9; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Weber D, 2015, BLOOD, V126, P1723, DOI 10.1182/blood-2015-04-638858; Winston JA, 2016, ANAEROBE, V41, P44, DOI 10.1016/j.anaerobe.2016.05.003; Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang Y, 2017, CURR OPIN GASTROEN, V33, P422, DOI 10.1097/MOG.0000000000000399; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yu JH, 2016, INT J CANCER, V139, P1318, DOI 10.1002/ijc.30168; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng JH, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9537; Zhu YM, 2011, CANCER LETT, V309, P119, DOI 10.1016/j.canlet.2011.06.004; Zitvogel L, 2017, NAT REV MICROBIOL, V15, P465, DOI 10.1038/nrmicro.2017.44; Zuo T, 2018, GUT, V67, P634, DOI 10.1136/gutjnl-2017-313952	175	427	436	36	335	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					377	388		10.1038/s41591-019-0377-7	http://dx.doi.org/10.1038/s41591-019-0377-7			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842679				2022-12-27	WOS:000460643100015
J	Stower, H				Stower, Hannah			Depression linked to the microbiome	NATURE MEDICINE			English	Editorial Material																			0	16	17	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					358	358		10.1038/s41591-019-0396-4	http://dx.doi.org/10.1038/s41591-019-0396-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842669	Bronze			2022-12-27	WOS:000460643100005
J	Stower, H				Stower, Hannah			Mosquito deterrent	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					358	358		10.1038/s41591-019-0398-2	http://dx.doi.org/10.1038/s41591-019-0398-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842667	Bronze			2022-12-27	WOS:000460643100008
J	Yamayoshi, S; Kawaoka, Y				Yamayoshi, Seiya; Kawaoka, Yoshihiro			Current and future influenza vaccines	NATURE MEDICINE			English	Review							GAMMA-R INTERACTIONS; HEMAGGLUTININ-STEM; VIRUS HEMAGGLUTININ; A VIRUSES; TEMPERATURE SENSITIVITY; MONOCLONAL-ANTIBODIES; ANTIGENIC STRUCTURE; IMMUNE-RESPONSE; H7N9 INFLUENZA; GLOBULAR HEAD	Although antiviral drugs and vaccines have reduced the economic and healthcare burdens of influenza, influenza epidemics continue to take a toll. Over the past decade, research on influenza viruses has revealed a potential path to improvement. The clues have come from accumulated discoveries from basic and clinical studies. Now, virus surveillance allows researchers to monitor influenza virus epidemic trends and to accumulate virus sequences in public databases, which leads to better selection of candidate viruses for vaccines and early detection of drug-resistant viruses. Here we provide an overview of current vaccine options and describe efforts directed toward the development of next-generation vaccines. Finally, we propose a plan for the development of an optimal influenza vaccine.	[Yamayoshi, Seiya; Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Special Pathogens, Int Res Ctr Infect Dis, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci, Tokyo, Japan.; Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Special Pathogens, Int Res Ctr Infect Dis, Tokyo, Japan.; Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	yoshihiro.kawaoka@wisc.edu	Yamayoshi, Seiya/Y-7430-2019	Yamayoshi, Seiya/0000-0001-7768-5157	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) [JP18fm0108006]; Leading Advanced Projects for medical innovation (LEAP) from AMED [JP18am001007]; Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan [16H06429, 16K21723, 16H06434]; JSPS KAKENHI [18K07141]; Center for Research on Influenza Pathogenesis (CRIP) - National Institute of Allergy and Infectious Disease [HHSN272201400008C]	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Leading Advanced Projects for medical innovation (LEAP) from AMED; Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center for Research on Influenza Pathogenesis (CRIP) - National Institute of Allergy and Infectious Disease	We thank S. Watson for editing the manuscript. Our work described in this review was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Japan Agency for Medical Research and Development (AMED) (JP18fm0108006), by Leading Advanced Projects for medical innovation (LEAP) from AMED (JP18am001007), by Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan (16H06429, 16K21723, and 16H06434), by JSPS KAKENHI Grant Number 18K07141, and by the Center for Research on Influenza Pathogenesis (CRIP) funded by National Institute of Allergy and Infectious Disease contract HHSN272201400008C.	Air GM, 2012, INFLUENZA OTHER RESP, V6, P245, DOI 10.1111/j.1750-2659.2011.00304.x; AIR GM, 1985, VIROLOGY, V145, P237, DOI 10.1016/0042-6822(85)90157-6; AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; Andrews SF, 2015, SCI TRANSL MED, V7, P316; ATASSI MZ, 1983, P NATL ACAD SCI-BIOL, V80, P840, DOI 10.1073/pnas.80.3.840; Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; BOTH GW, 1979, EUR J BIOCHEM, V96, P363, DOI 10.1111/j.1432-1033.1979.tb13048.x; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; Cheung PPH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5794; COLMAN PM, 1985, CURR TOP MICROBIOL, V114, P177; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cox MMJ, 2008, INFLUENZA OTHER RESP, V2, P211, DOI 10.1111/j.1750-2659.2008.00053.x; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; Doyle TM, 2013, ANTIVIR RES, V100, P567, DOI 10.1016/j.antiviral.2013.09.018; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Feng SZ, 2011, APPL MICROBIOL BIOT, V89, P893, DOI 10.1007/s00253-010-2973-9; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; GHENDON YZ, 1984, INFECT IMMUN, V44, P730, DOI 10.1128/IAI.44.3.730-733.1984; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hadfield J, 2017, BIORXIV, DOI [10.1101/224048, DOI 10.1101/224048]; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Hamamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059892; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hegde NR, 2015, HUM VACC IMMUNOTHER, V11, P1223, DOI 10.1080/21645515.2015.1016666; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hoffmann E, 2005, J VIROL, V79, P11014, DOI 10.1128/JVI.79.17.11014-11021.2005; Hoft DF, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/cvi.00414-16, 10.1128/CVI.00414-16]; Hu WB, 2015, VACCINE, V33, P374, DOI 10.1016/j.vaccine.2014.11.007; Imai M, 2017, CELL HOST MICROBE, V22, P615, DOI 10.1016/j.chom.2017.09.008; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025953; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kadam RU, 2018, P NATL ACAD SCI USA, V115, P4240, DOI 10.1073/pnas.1801999115; Kim CU, 1999, ANTIVIR CHEM CHEMOTH, V10, P141, DOI 10.1177/095632029901000401; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kolpe A, 2017, EXPERT REV VACCINES, V16, P123, DOI 10.1080/14760584.2017.1240041; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Li CJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.58, 10.1038/nmicrobiol.2016.58]; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Liu J, 2010, VACCINE, V28, P1285, DOI 10.1016/j.vaccine.2009.11.023; Lu Y, 2014, P NATL ACAD SCI USA, V111, P125, DOI 10.1073/pnas.1308701110; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; McCarthy KR, 2018, IMMUNITY, V48, P174, DOI 10.1016/j.immuni.2017.12.009; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Nachbagauer R, 2014, J VIROL, V88, P13260, DOI 10.1128/JVI.02133-14; Naito T, 2017, J VIROL, V91, DOI 10.1128/JVI.01073-16; Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Nolte N, 2015, NUCLEIC ACIDS RES, V43, pW547, DOI 10.1093/nar/gkv417; Omoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27890-4; Onodera T, 2016, J IMMUNOL, V196, P4172, DOI 10.4049/jimmunol.1600046; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Park JK, 2018, MBIO, V9, DOI [10.1128/mBio.02284-17, 10.1128/mbio.02284-17]; Paules CI, 2017, IMMUNITY, V47, P599, DOI 10.1016/j.immuni.2017.09.007; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Ping JH, 2016, P NATL ACAD SCI USA, V113, pE8296, DOI 10.1073/pnas.1616530113; Ping JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9148; Pleguezuelos O, 2015, CLIN VACCINE IMMUNOL, V22, P828, DOI 10.1128/CVI.00098-15; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rajao DS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00123; Rajendran M, 2017, MBIO, V8, DOI [10.1128/mBio.02281-16, 10.1128/mbio.02281-16]; Raymond DD, 2016, NAT MED, V22, P1465, DOI 10.1038/nm.4223; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Rizzo C, 2018, HUM VACC IMMUNOTHER, V14, P693, DOI 10.1080/21645515.2017.1367463; Russell CA, 2014, ELIFE, V3, DOI 10.7554/eLife.03883; Sakai-Tagawa Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14536-0; Sakala IG, 2016, HUM VACC IMMUNOTHER, V12, P3065, DOI 10.1080/21645515.2016.1215392; Sandbulte MR, 2011, P NATL ACAD SCI USA, V108, P20748, DOI 10.1073/pnas.1113801108; Schaffner W, 2018, AM J MED, V131, P865, DOI 10.1016/j.amjmed.2018.02.019; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stoloff GA, 2007, EUR J IMMUNOL, V37, P2441, DOI 10.1002/eji.200737254; Strauch EM, 2017, NAT BIOTECHNOL, V35, P667, DOI 10.1038/nbt.3907; Strauli NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0314-z; Suzuki T, 2015, P NATL ACAD SCI USA, V112, P7809, DOI 10.1073/pnas.1503885112; Tao WQ, 2017, ANTIVIR RES, V141, P62, DOI 10.1016/j.antiviral.2017.01.021; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tregoning JS, 2018, HUM VACC IMMUNOTHER, V14, P550, DOI 10.1080/21645515.2017.1415684; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Trombetta CM, 2016, EXPERT REV VACCINES, V15, P967, DOI 10.1586/14760584.2016.1164046; Viboud C, 2016, J INFECT DIS, V213, P738, DOI 10.1093/infdis/jiv534; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Watanabe T, 2014, CELL HOST MICROBE, V15, P692, DOI 10.1016/j.chom.2014.05.006; WEBSTER RG, 1980, VIROLOGY, V104, P139, DOI 10.1016/0042-6822(80)90372-4; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu NC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006682; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yamayoshi S, 2018, EMERG INFECT DIS, V24, P746, DOI 10.3201/eid2404.171509; Yamayoshi S, 2017, EBIOMEDICINE, V17, P182, DOI 10.1016/j.ebiom.2017.03.007; Yamayoshi S, 2016, J VIROL, V90, P444, DOI 10.1128/JVI.02175-15; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; YEWDELL JW, 1981, J IMMUNOL, V126, P1814; Young B, 2018, J INFECT DIS, V217, P731, DOI 10.1093/infdis/jix632; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	131	76	86	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					212	220		10.1038/s41591-018-0340-z	http://dx.doi.org/10.1038/s41591-018-0340-z			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30692696	Bronze			2022-12-27	WOS:000457842100015
J	Gurovich, Y; Hanani, Y; Bar, O; Nadav, G; Fleischer, N; Gelbman, D; Basel-Salmon, L; Krawitz, PM; Kamphausen, SB; Zenker, M; Bird, LM; Gripp, KW				Gurovich, Yaron; Hanani, Yair; Bar, Omri; Nadav, Guy; Fleischer, Nicole; Gelbman, Dekel; Basel-Salmon, Lina; Krawitz, Peter M.; Kamphausen, Susanne B.; Zenker, Martin; Bird, Lynne M.; Gripp, Karen W.			Identifying facial phenotypes of genetic disorders using deep learning	NATURE MEDICINE			English	Article							NOONAN SYNDROME; DYSMORPHOLOGY; MUTATIONS; RECOGNITION; GENOTYPE	Syndromic genetic conditions, in aggregate, affect 8% of the population(1). Many syndromes have recognizable facial features(2) that are highly informative to clinical geneticists(3-5). Recent studies show that facial analysis technologies measured up to the capabilities of expert clinicians in syndrome identification(6-9). However, these technologies identified only a few disease phenotypes, limiting their role in clinical settings, where hundreds of diagnoses must be considered. Here we present a facial image analysis framework, DeepGestalt, using computer vision and deep-learning algorithms, that quantifies similarities to hundreds of syndromes. DeepGestalt outperformed clinicians in three initial experiments, two with the goal of distinguishing subjects with a target syndrome from other syndromes, and one of separating different genetic sub-types in Noonan syndrome. On the final experiment reflecting a real clinical setting problem, DeepGestalt achieved 91% top-10 accuracy in identifying the correct syndrome on 502 different images. The model was trained on a dataset of over 17,000 images representing more than 200 syndromes, curated through a community-driven phenotyping platform. DeepGestalt potentially adds considerable value to phenotypic evaluations in clinical genetics, genetic testing, research and precision medicine.	[Gurovich, Yaron; Hanani, Yair; Bar, Omri; Nadav, Guy; Fleischer, Nicole; Gelbman, Dekel] FDNA Inc, Boston, MA 02111 USA; [Basel-Salmon, Lina] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Basel-Salmon, Lina] Rabin Med Ctr, Recanati Genet Inst, Petah Tiqwa, Israel; [Basel-Salmon, Lina] Schneider Childrens Med Ctr, Petah Tiqwa, Israel; [Krawitz, Peter M.] Rheinische Friedrich Wilhelms Univ, Univ Hosp Bonn, Inst Genom Stat & Bioinformat, Bonn, Germany; [Kamphausen, Susanne B.; Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, Magdeburg, Germany; [Bird, Lynne M.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Bird, Lynne M.] Rady Childrens Hosp San Diego, Div Genet Dysmorphol, San Diego, CA USA; [Gripp, Karen W.] AI du Pont Hosp Children Nemours, Div Med Genet, Wilmington, DE USA	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; University of Bonn; University Hospital Magdeburg; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Nemours Alfred I. duPont Hospital for Children	Gurovich, Y (corresponding author), FDNA Inc, Boston, MA 02111 USA.	yaron@fdna.com	Bird, Lynne/AAG-9533-2021; Krawitz, Peter/F-3142-2012	Krawitz, Peter/0000-0002-3194-8625; Bird, Lynne/0000-0003-4833-3747; Bar, Omri/0000-0001-6680-2178; Gurovich, Yaron/0000-0002-9474-3846				Abadi M., 2016, TENSORFLOW LARGE SCA; Allanson JE, 2010, AM J MED GENET A, V152A, P1960, DOI 10.1002/ajmg.a.33518; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Basel-Vanagaite L, 2016, CLIN GENET, V89, P557, DOI 10.1111/cge.12716; Bird L.M, 2014, 35 ANN DW SMITH WORK; Cave H, 2016, EUR J HUM GENET, V24, P1124, DOI 10.1038/ejhg.2015.273; Chollet F., 2015, KERAS; Delgadillo V, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-189; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ferry Q, 2014, ELIFE, V3, DOI 10.7554/eLife.02020; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Gripp KW, 2016, AM J MED GENET A, V170, P1754, DOI 10.1002/ajmg.a.37672; Gulec EY, 2015, INT J CARDIOL, V186, P13, DOI 10.1016/j.ijcard.2015.03.260; Hadj-Rabia S, 2017, AM J MED GENET A, V173, P2408, DOI 10.1002/ajmg.a.38343; Hart TC, 2009, ORTHOD CRANIOFAC RES, V12, P212, DOI 10.1111/j.1601-6343.2009.01455.x; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; Huang G., 2012, ADV NEURAL INFORM PR, P764; Huang G.B, 2008, TECHNICAL REPORT; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Karlinsky L, 2012, LECT NOTES COMPUT SC, V7574, P326, DOI 10.1007/978-3-642-33712-3_24; Kingma DP., 2014, ADAM METHOD STOCHAST; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kole A, 2009, VOICE 12000 PATIENTS; Kouz K, 2016, GENET MED, V18, P1226, DOI 10.1038/gim.2016.32; Liehr T, 2018, CLIN GENET, V93, P378, DOI 10.1111/cge.13087; Lin H., 2015, PROC CVPR IEEE, DOI [10.1109/CVPR.2015.7299170, DOI 10.1109/CVPR.2015.7299170]; Liu J, 2015, TARGETING ULTIMATE A; Rai MCEL, 2015, INT C COMM SIG PROC; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Rohatgi S, 2010, AM J MED GENET A, V152A, P1641, DOI 10.1002/ajmg.a.33441; Rusu C, 2014, ACTA ENDOCRINOL-BUCH, V10, P463, DOI 10.4183/aeb.2014.463; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Shukla P, 2017, 2017 IEEE WINT C APP; Simonyan K., 2013, 13126034 ARXIV, DOI DOI 10.1038/S41591-018-0335-9; Taigman Y, 2015, PROC CVPR IEEE, P2746, DOI 10.1109/CVPR.2015.7298891; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Valentine M, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2028; WINTER RM, 1987, J MED GENET, V24, P509, DOI 10.1136/jmg.24.8.509; Yi D., 2014, ARXIV PREPRINT ARXIV; Yin Q., 2015, NAIVE DEEP FACE RECO; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519; Zarate YA, 2018, AM J MED GENET A, V176, P925, DOI 10.1002/ajmg.a.38630; Zenker M, 2007, J MED GENET, V44, P651, DOI 10.1136/jmg.2007.051276	45	248	255	9	104	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					60	+		10.1038/s41591-018-0279-0	http://dx.doi.org/10.1038/s41591-018-0279-0			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617323				2022-12-27	WOS:000455027700021
J	Liu, HY; Golji, J; Brodeur, LK; Chung, FS; Chen, JT; deBeaumont, RS; Bullock, CP; Jones, MD; Kerr, G; Li, L; Rakiec, DP; Schlabach, MR; Sovath, S; Growney, JD; Pagliarini, RA; Ruddy, DA; MacIsaac, KD; Korn, JM; McDonald, ER				Liu, Huayang; Golji, Javad; Brodeur, Lauren K.; Chung, Franklin S.; Chen, Julie T.; deBeaumont, Rosalie S.; Bullock, Caroline P.; Jones, Michael D.; Kerr, Grainne; Li, Li; Rakiec, Daniel P.; Schlabach, Michael R.; Sovath, Sosathya; Growney, Joseph D.; Pagliarini, Raymond A.; Ruddy, David A.; MacIsaac, Kenzie D.; Korn, Joshua M.; McDonald, E. Robert, III			Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss	NATURE MEDICINE			English	Article							I INTERFERONS; LARGE-SCALE; CANCER; RNA; MECHANISMS; RESISTANCE; MUTATIONS; INDUCTION; DSRNA	Interferons (IFNs) are cytokines that play a critical role in limiting infectious and malignant diseases(1-4). Emerging data suggest that the strength and duration of IFN signaling can differentially impact cancer therapies, including immune checkpoint blockade(5-7). Here, we characterize the output of IFN signaling, specifically IFN-stimulated gene (ISG) signatures, in primary tumors from The Cancer Genome Atlas. While immune infiltration correlates with the ISG signature in some primary tumors, the existence of ISG signature-positive tumors without evident infiltration of IFN-producing immune cells suggests that cancer cells per se can be a source of IFN production. Consistent with this hypothesis, analysis of patient-derived tumor xenografts propagated in immune-deficient mice shows evidence of ISG-positive tumors that correlates with expression of human type I and III IFNs derived from the cancer cells. Mechanistic studies using cell line models from the Cancer Cell Line Encyclopedia that harbor ISG signatures demonstrate that this is a by-product of a STING-dependent pathway resulting in chronic tumor-derived IFN production. This imposes a transcriptional state on the tumor, poising it to respond to the aberrant accumulation of double-stranded RNA (dsRNA) due to increased sensor levels (MDA5, RIG-I and PKR). By interrogating our functional short-hairpin RNA screen dataset across 398 cancer cell lines, we show that this ISG transcriptional state creates a novel genetic vulnerability. ISG signature-positive cancer cells are sensitive to the loss of ADAR, a dsRNA-editing enzyme that is also an ISG. A genome-wide CRISPR genetic suppressor screen reveals that the entire type I IFN pathway and the dsRNA-activated kinase, PKR, are required for the lethality induced by ADAR depletion. Therefore, tumor-derived IFN resulting in chronic signaling creates a cellular state primed to respond to dsRNA accumulation, rendering ISG-positive tumors susceptible to ADAR loss.	[Liu, Huayang; Golji, Javad; Brodeur, Lauren K.; Chung, Franklin S.; Chen, Julie T.; deBeaumont, Rosalie S.; Bullock, Caroline P.; Jones, Michael D.; Li, Li; Rakiec, Daniel P.; Schlabach, Michael R.; Sovath, Sosathya; Growney, Joseph D.; Pagliarini, Raymond A.; Ruddy, David A.; MacIsaac, Kenzie D.; Korn, Joshua M.; McDonald, E. Robert, III] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA; [Kerr, Grainne] Novartis Inst Biomed Res, Oncol Dis Area, Basel, Switzerland	Novartis; Novartis	McDonald, ER (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA.	rob.mcdonald@novartis.com		Jones, Michael/0000-0001-7541-7634				Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Bamborough P, 2006, BIOORG MED CHEM LETT, V16, P6236, DOI 10.1016/j.bmcl.2006.09.018; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Dabo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16089-8; de Weck A, 2017, FIBROBLAST CELL LINE, DOI [10.1101/166199, DOI 10.1101/166199]; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gao J, 2016, CELL, V167; Gray JS, 2008, TOXICOL SCI, V105, P322, DOI 10.1093/toxsci/kfn128; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mostafavi S, 2016, CELL, V164, P564, DOI 10.1016/j.cell.2015.12.032; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845	48	129	131	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					95	+		10.1038/s41591-018-0302-5	http://dx.doi.org/10.1038/s41591-018-0302-5			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30559422				2022-12-27	WOS:000455027700027
J	Shah, KN; Bhatt, R; Rotow, J; Rohrberg, J; Olivas, V; Wang, VE; Hemmati, G; Martins, MM; Maynard, A; Kuhn, J; Galeas, J; Donnella, HJ; Kaushik, S; Ku, A; Dumont, S; Krings, G; Haringsma, HJ; Robillard, L; Simmons, AD; Harding, TC; McCormick, F; Goga, A; Blakely, CM; Bivona, TG; Bandyopadhyay, S				Shah, Khyati N.; Bhatt, Roma; Rotow, Julia; Rohrberg, Julia; Olivas, Victor; Wang, Victoria E.; Hemmati, Golzar; Martins, Maria M.; Maynard, Ashley; Kuhn, Jonathan; Galeas, Jacqueline; Donnella, Hayley J.; Kaushik, Swati; Ku, Angel; Dumont, Sophie; Krings, Gregor; Haringsma, Henry J.; Robillard, Liliane; Simmons, Andrew D.; Harding, Thomas C.; McCormick, Frank; Goga, Andrei; Blakely, Collin M.; Bivona, Trever G.; Bandyopadhyay, Sourav			Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer	NATURE MEDICINE			English	Article							ACQUIRED-RESISTANCE; RESIDUAL DISEASE; BREAST-CANCER; AZD9291; HETEROGENEITY; DEPENDENCE; MECHANISMS; CHECKPOINT; STABILITY; CARCINOMA	Although targeted therapies often elicit profound initial patient responses, these effects are transient due to residual disease leading to acquired resistance. How tumors transition between drug responsiveness, tolerance and resistance, especially in the absence of preexisting subclones, remains unclear. In epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma cells, we demonstrate that residual disease and acquired resistance in response to EGFR inhibitors requires Aurora kinase A (AURKA) activity. Nongenetic resistance through the activation of AURKA by its coactivator TPX2 emerges in response to chronic EGFR inhibition where it mitigates drug-induced apoptosis. Aurora kinase inhibitors suppress this adaptive survival program, increasing the magnitude and duration of EGFR inhibitor response in preclinical models. Treatment-induced activation of AURKA is associated with resistance to EGFR inhibitors in vitro, in vivo and in most individuals with EGFR-mutant lung adenocarcinoma. These findings delineate a molecular path whereby drug resistance emerges from drug-tolerant cells and unveils a synthetic lethal strategy for enhancing responses to EGFR inhibitors by suppressing AURKA-driven residual disease and acquired resistance.	[Shah, Khyati N.; Bhatt, Roma; Donnella, Hayley J.; Kaushik, Swati; Ku, Angel; Bandyopadhyay, Sourav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Shah, Khyati N.; Bhatt, Roma; Rotow, Julia; Rohrberg, Julia; Olivas, Victor; Wang, Victoria E.; Hemmati, Golzar; Martins, Maria M.; Maynard, Ashley; Galeas, Jacqueline; Donnella, Hayley J.; Kaushik, Swati; Ku, Angel; McCormick, Frank; Goga, Andrei; Blakely, Collin M.; Bivona, Trever G.; Bandyopadhyay, Sourav] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Rotow, Julia; Rohrberg, Julia; Olivas, Victor; Hemmati, Golzar; Martins, Maria M.; Maynard, Ashley; Blakely, Collin M.; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kuhn, Jonathan; Dumont, Sophie; Goga, Andrei] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Krings, Gregor] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Haringsma, Henry J.; Robillard, Liliane; Simmons, Andrew D.; Harding, Thomas C.] Clovis Oncol Inc, Boulder, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bandyopadhyay, S (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Bandyopadhyay, S (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	sourav.bandyopadhyay@ucsf.edu	Shah, Khyati/I-1597-2019; Kaushik, Swati/AAR-6954-2020	Shah, Khyati/0000-0002-2510-803X; Kaushik, Swati/0000-0002-3562-8522; Maynard, Ashley/0000-0002-3588-3080; Ku, Angel/0000-0002-3830-2798; Rohrberg, Julia/0000-0001-6965-3905	National Cancer Institute [U01CA168370, NIGMS R01GM107671, R01CA169338, U54CA224081]; NATIONAL CANCER INSTITUTE [U01CA168370, U01CA217882, U54CA224081, R01CA169338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107671] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Bandyopadhyay laboratory for helpful discussions and technical assistance. We also thank J. Gordon from the LCA microscopy core for technical assistance and reagents. This work was supported by National Cancer Institute grant nos. U01CA168370 (S.B.), NIGMS R01GM107671 (S.B.), R01CA169338 (T.G.B) and U54CA224081 (S.B., T.G.B).	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bavetsias V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00278; Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Blakely CM, 2017, NAT GENET, V49, P1693, DOI 10.1038/ng.3990; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chen J, 2015, ONCOL REP, V33, P1860, DOI 10.3892/or.2015.3764; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim TM, 2015, J THORAC ONCOL, V10, P1736, DOI 10.1097/JTO.0000000000000688; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lee CK, 2018, JAMA ONCOL, V4, P210, DOI 10.1001/jamaoncol.2017.4427; Li L, 2017, ONCOTARGET, V8, P18609, DOI 10.18632/oncotarget.14506; Melichar B, 2015, LANCET ONCOL, V16, P395, DOI 10.1016/S1470-2045(15)70051-3; Moustafa-Kamal M, 2013, CELL DEATH DIFFER, V20, P1393, DOI 10.1038/cdd.2013.93; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Ramirez M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10690; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharifnia T, 2014, P NATL ACAD SCI USA, V111, P18661, DOI 10.1073/pnas.1412228112; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Yang Z, 2018, CLIN CANCER RES, V24, P3097, DOI 10.1158/1078-0432.CCR-17-2310; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	42	138	143	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					111	+		10.1038/s41591-018-0264-7	http://dx.doi.org/10.1038/s41591-018-0264-7			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30478424	Green Accepted, Green Submitted			2022-12-27	WOS:000455027700029
J	Swarup, V; Hinz, FI; Rexach, JE; Noguchi, K; Toyoshiba, H; Oda, A; Hirai, K; Sarkar, A; Seyfried, NT; Cheng, CL; Haggarty, SJ; Ferrari, R; Rohrer, JD; Ramasamy, A; Hardy, J; Hernandez, DG; Nalls, MA; Singleton, AB; Kwok, JBJ; Dobson-Stone, C; Brooks, WS; Schofield, PR; Halliday, GM; Hodges, JR; Piguet, O; Bartley, L; Thompson, E; Haan, E; Hernandez, I; Ruiz, A; Boada, M; Borroni, B; Padovani, A; Cairns, NJ; Cruchaga, C; Binetti, G; Ghidoni, R; Benussi, L; Forloni, G; Albani, D; Galimberti, D; Fenoglio, C; Serpente, M; Scarpini, E; Clarimon, J; Lleo, A; Blesa, R; Waldo, ML; Nilsson, K; Nilsson, C; Mackenzie, IRA; Hsiung, GYR; Mann, DMA; Grafman, J; Morris, CM; Attems, J; Griffiths, TD; McKeith, IG; Thomas, AJ; Jaros, E; Pietrini, P; Huey, ED; Wassermann, EM; Tierney, MC; Baborie, A; Pastor, P; Ortega-Cubero, S; Razquin, C; Alonso, E; Perneczky, R; Diehl-Schmid, J; Alexopoulos, P; Kurz, A; Rainero, I; Rubino, E; Pinessi, L; Rogaeva, E; St George-Hyslop, P; Rossi, G; Tagliavini, F; Giaccone, G; Rowe, JB; Schlachetzki, JCM; Uphill, J; Collinge, J; Mead, S; Danek, A; Van Deerlin, VM; Grossman, M; Trojanowski, JQ; Pickering-Brown, S; Momeni, P; van der Zee, J; Cruts, M; Van Broeckhoven, C; Cappa, SF; Leber, I; Brice, A; Hannequin, D; Golfier, V; Vercelletto, M; Nacmias, B; Sorbi, S; Bagnoli, S; Piaceri, I; Nielsen, JE; Hjermind, LE; Riemenschneider, M; Mayhaus, M; Gasparoni, G; Pichler, S; Ibach, B; Rossor, MN; Fox, NC; Warren, JD; Spillantini, MG; Morris, HR; Rizzu, P; Heutink, P; Snowden, JS; Rollinson, S; Gerhard, A; Richardson, A; Bruni, AC; Maletta, R; Frangipane, F; Cupidi, C; Bernardi, L; Anfossi, M; Gallo, M; Conidi, ME; Smirne, N; Rademakers, R; Baker, M; Dickson, DW; Graff-Radford, NR; Petersen, RC; Knopman, D; Josephs, KA; Boeve, BF; Parisi, JE; Miller, BL; Karydas, AM; Rosen, H; Seeley, WW; van Swieten, JC; Dopper, EGP; Seelaar, H; Pijnenburg, YAL; Scheltens, P; Logroscino, G; Capozzo, R; Novelli, V; Puca, AA; Franceschi, M; Postiglione, A; Milan, G; Sorrentino, P; Kristiansen, M; Chiang, HH; Graff, C; Pasquier, F; Rollin, A; Deramecourt, V; Lebouvier, T; Ferrucci, L; Kapogiannis, D; Grossman, M; Van Deerlin, VM; Trojanowski, JQ; Lah, JJ; Levey, AI; Kondou, S; Geschwind, DH				Swarup, Vivek; Hinz, Flora I.; Rexach, Jessica E.; Noguchi, Ken-ichi; Toyoshiba, Hiroyoshi; Oda, Akira; Hirai, Keisuke; Sarkar, Arjun; Seyfried, Nicholas T.; Cheng, Chialin; Haggarty, Stephen J.; Ferrari, Raffaele; Rohrer, Jonathan D.; Ramasamy, Adaikalavan; Hardy, John; Hernandez, Dena G.; Nalls, Michael A.; Singleton, Andrew B.; Kwok, John B. J.; Dobson-Stone, Carol; Brooks, William S.; Schofield, Peter R.; Halliday, Glenda M.; Hodges, John R.; Piguet, Olivier; Bartley, Lauren; Thompson, Elizabeth; Haan, Eric; Hernandez, Isabel; Ruiz, Agustin; Boada, Merce; Borroni, Barbara; Padovani, Alessandro; Cairns, Nigel J.; Cruchaga, Carlos; Binetti, Giuliano; Ghidoni, Roberta; Benussi, Luisa; Forloni, Gianluigi; Albani, Diego; Galimberti, Daniela; Fenoglio, Chiara; Serpente, Maria; Scarpini, Elio; Clarimon, Jordi; Lleo, Alberto; Blesa, Rafael; Waldo, Maria Landqvist; Nilsson, Karin; Nilsson, Christer; Mackenzie, Ian R. A.; Hsiung, Ging-Yuek R.; Mann, David M. A.; Grafman, Jordan; Morris, Christopher M.; Attems, Johannes; Griffiths, Timothy D.; McKeith, Ian G.; Thomas, Alan J.; Jaros, Evelyn; Pietrini, Pietro; Huey, Edward D.; Wassermann, Eric M.; Tierney, Michael C.; Baborie, Atik; Pastor, Pau; Ortega-Cubero, Sara; Razquin, Cristina; Alonso, Elena; Perneczky, Robert; Diehl-Schmid, Janine; Alexopoulos, Panagiotis; Kurz, Alexander; Rainero, Innocenzo; Rubino, Elisa; Pinessi, Lorenzo; Rogaeva, Ekaterina; St George-Hyslop, Peter; Rossi, Giacomina; Tagliavini, Fabrizio; Giaccone, Giorgio; Rowe, James B.; Schlachetzki, Johannes C. M.; Uphill, James; Collinge, John; Mead, Simon; Danek, Adrian; Van Deerlin, Vivianna M.; Grossman, Murray; Trojanowski, John Q.; Pickering-Brown, Stuart; Momeni, Parastoo; van der Zee, Julie; Cruts, Marc; Van Broeckhoven, Christine; Cappa, Stefano F.; Leber, Isabelle; Brice, Alexis; Hannequin, Didier; Golfier, Veronique; Vercelletto, Martine; Nacmias, Benedetta; Sorbi, Sandro; Bagnoli, Silvia; Piaceri, Irene; Nielsen, Jorgen E.; Hjermind, Lena E.; Riemenschneider, Matthias; Mayhaus, Manuel; Gasparoni, Gilles; Pichler, Sabrina; Ibach, Bernd; Rossor, Martin N.; Fox, Nick C.; Warren, Jason D.; Spillantini, Maria Grazia; Morris, Huw R.; Rizzu, Patrizia; Heutink, Peter; Snowden, Julie S.; Rollinson, Sara; Gerhard, Alexander; Richardson, Anna; Bruni, Amalia C.; Maletta, Raffaele; Frangipane, Francesca; Cupidi, Chiara; Bernardi, Livia; Anfossi, Maria; Gallo, Maura; Conidi, Maria Elena; Smirne, Nicoletta; Rademakers, Rosa; Baker, Matt; Dickson, Dennis W.; Graff-Radford, Neill R.; Petersen, Ronald C.; Knopman, David; Josephs, Keith A.; Boeve, Bradley F.; Parisi, Joseph E.; Miller, Bruce L.; Karydas, Anna M.; Rosen, Howard; Seeley, William W.; van Swieten, John C.; Dopper, Elise G. P.; Seelaar, Harro; Pijnenburg, Yolande A. L.; Scheltens, Philip; Logroscino, Giancarlo; Capozzo, Rosa; Novelli, Valeria; Puca, Annibale A.; Franceschi, Massimo; Postiglione, Alfredo; Milan, Graziella; Sorrentino, Paolo; Kristiansen, Mark; Chiang, Huei-Hsin; Graff, Caroline; Pasquier, Florence; Rollin, Adeline; Deramecourt, Vincent; Lebouvier, Thibaud; Ferrucci, Luigi; Kapogiannis, Dimitrios; Grossman, Murray; Van Deerlin, Vivianna M.; Trojanowski, John Q.; Lah, James J.; Levey, Allan I.; Kondou, Shinichi; Geschwind, Daniel H.		Int Frontotemporal Dementia Gen	Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia	NATURE MEDICINE			English	Article							FRONTOTEMPORAL DEMENTIA; EXPRESSION ANALYSIS; COGNITIVE DEFICITS; IMMUNE-RESPONSES; TRANSGENIC MICE; LONG-TERM; BRAIN; TRANSCRIPTOME; NEUROPATHOLOGY; COEXPRESSION	Identifying the mechanisms through which genetic risk causes dementia is an imperative for new therapeutic development. Here, we apply a multistage, systems biology approach to elucidate the disease mechanisms in frontotemporal dementia. We identify two gene coexpression modules that are preserved in mice harboring mutations in MAPT, GRN and other dementia mutations on diverse genetic backgrounds. We bridge the species divide via integration with proteomic and transcriptomic data from the human brain to identify evolutionarily conserved, disease-relevant networks. We find that overexpression of miR-203, a hub of a putative regulatory microRNA (miRNA) module, recapitulates mRNA coexpression patterns associated with disease state and induces neuronal cell death, establishing this miRNA as a regulator of neurodegeneration. Using a database of drug-mediated gene expression changes, we identify small molecules that can normalize the disease-associated modules and validate this experimentally. Our results highlight the utility of an integrative, cross-species network approach to drug discovery.	[Swarup, Vivek; Hinz, Flora I.; Rexach, Jessica E.; Sarkar, Arjun; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Noguchi, Ken-ichi; Toyoshiba, Hiroyoshi; Oda, Akira; Hirai, Keisuke; Kondou, Shinichi] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, CNS, Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Seyfried, Nicholas T.; Lah, James J.; Levey, Allan I.] Emory Univ, Sch Med, Alzheimers Dis Res Ctr, Atlanta, GA USA; [Seyfried, Nicholas T.; Lah, James J.; Levey, Allan I.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Cheng, Chialin; Haggarty, Stephen J.] MIT, Ctr Genom Med, Chem Neurobiol Lab, Boston, MA USA; [Cheng, Chialin; Haggarty, Stephen J.] Harvard Med Sch, Boston, MA USA; [Grossman, Murray] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA USA; [Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Dept Neurol, Perelman Sch Med, Penn FTD Ctr, Philadelphia, PA 19104 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA; [Ferrari, Raffaele; Rohrer, Jonathan D.; Ramasamy, Adaikalavan; Hardy, John] UCL, Dept Mol Neurosci, London, England; [Hernandez, Dena G.; Nalls, Michael A.; Singleton, Andrew B.] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Kwok, John B. J.; Dobson-Stone, Carol; Brooks, William S.; Schofield, Peter R.; Halliday, Glenda M.; Hodges, John R.; Piguet, Olivier; Bartley, Lauren] Neurosci Res Australia, Sydney, NSW, Australia; [Thompson, Elizabeth; Haan, Eric] Womens & Childrens Hosp, South Australian Clin Genet Serv, Adelaide, SA, Australia; [Hernandez, Isabel; Ruiz, Agustin; Boada, Merce] Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin Fundacio ACE, Barcelona, Spain; [Borroni, Barbara; Padovani, Alessandro] Univ Brescia, Neurol Clin, Brescia, Italy; [Cairns, Nigel J.; Cruchaga, Carlos] Washington Univ, Sch Med, Hope Ctr, St Louis, MO USA; [Binetti, Giuliano; Ghidoni, Roberta; Benussi, Luisa] Ist Ctr San Giovanni Dio Fatebenefratelli, IRCCS, Brescia, Italy; [Forloni, Gianluigi; Albani, Diego] Ist Ric Farmacol, IRCCS, Biol Neurodegenerat Disorders, Milan, Italy; [Galimberti, Daniela; Fenoglio, Chiara; Serpente, Maria; Scarpini, Elio] Univ Milan, Milan, Italy; [Galimberti, Daniela; Fenoglio, Chiara; Serpente, Maria; Scarpini, Elio] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Milan, Italy; [Clarimon, Jordi; Lleo, Alberto; Blesa, Rafael] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neurol Dept, Memory Unit, Barcelona, Spain; [Clarimon, Jordi; Lleo, Alberto; Blesa, Rafael] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, St Pau Biomed Res Inst, Barcelona, Spain; [Waldo, Maria Landqvist; Nilsson, Karin; Nilsson, Christer] Lund Univ, Dept Clin Sci, Unit Geriatr Psychiat, Lund, Sweden; [Mackenzie, Ian R. A.; Hsiung, Ging-Yuek R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Mann, David M. A.] Univ Manchester, Salford Royal Hosp, Inst Brain Behav & Mental Hlth, Salford, Lancs, England; [Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Psychiat, Feinberg Sch Med, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Cognit Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Alzheimers Dis Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Morris, Christopher M.; Attems, Johannes; Griffiths, Timothy D.; McKeith, Ian G.; Thomas, Alan J.; Jaros, Evelyn] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Pietrini, Pietro] IMT Sch Adv Studies, Lucca, Italy; [Huey, Edward D.] Columbia Univ, Dept Psychiat, Taub Inst, New York, NY USA; [Huey, Edward D.] Columbia Univ, Dept Neurol, Taub Inst, New York, NY USA; [Wassermann, Eric M.; Tierney, Michael C.] NINDS, Behav Neurol Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Baborie, Atik] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Pastor, Pau; Ortega-Cubero, Sara] Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain; [Razquin, Cristina; Alonso, Elena] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neurogenet Lab, Pamplona, Spain; [Perneczky, Robert] Imperial Coll Sci Technol & Med, Sch Publ Hlth, Neuroepidemiol & Ageing Res Unit, London, England; [Diehl-Schmid, Janine; Alexopoulos, Panagiotis; Kurz, Alexander] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Rainero, Innocenzo; Rubino, Elisa; Pinessi, Lorenzo] Univ Torino, Dept Neurosci, Turin, Italy; [Rogaeva, Ekaterina; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Rossi, Giacomina; Tagliavini, Fabrizio; Giaccone, Giorgio] Fdn IRCCS Ist Neurol Carlo Besta, Div Neurol & Neuropathol 5, Milan, Italy; [Rowe, James B.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Schlachetzki, Johannes C. M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Uphill, James; Collinge, John; Mead, Simon] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London, England; [Danek, Adrian] Ludwig Maximilians Univ Munchen, Neurol Klin & Poliklin, Munich, Germany; [Pickering-Brown, Stuart] Univ Manchester, Fac Med & Human Sci, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Momeni, Parastoo] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lab Neurogenet, Lubbock, TX 79430 USA; [van der Zee, Julie; Cruts, Marc; Van Broeckhoven, Christine] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Antwerp, Belgium; [Cappa, Stefano F.] Univ Vita Salute San Raffaele, Dept Clin Neurosci, Neurorehabilitat Unit, Milan, Italy; [Cappa, Stefano F.] Ist Sci San Raffaele, Milan, Italy; [Leber, Isabelle; Brice, Alexis] CRICM, INSERM, Paris, France; [Hannequin, Didier] Rouen Univ Hosp, Serv Neurol, Rouen, France; [Golfier, Veronique] Serv Neurol, St Brieuc, France; [Vercelletto, Martine] CHU Nantes, Serv Neurol, Nantes, France; [Nacmias, Benedetta; Sorbi, Sandro; Bagnoli, Silvia; Piaceri, Irene] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy; [Nielsen, Jorgen E.; Hjermind, Lena E.] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Dementia Res Ctr,Neurogenet Clin, Copenhagen, Denmark; [Riemenschneider, Matthias; Mayhaus, Manuel; Gasparoni, Gilles; Pichler, Sabrina] Saarland Univ Hosp, Lab Neurogenet, Homburg, Saar, Germany; [Ibach, Bernd] Univ Regensburg, Dept Psychiat Psychotherapy & Psychosomat, Regensburg, Germany; [Rossor, Martin N.; Fox, Nick C.; Warren, Jason D.] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, England; [Spillantini, Maria Grazia] Univ Cambridge, John Van Geest Brain Repair Ctr, Dept Clin Neurosci, Cambridge, England; [Morris, Huw R.] UCL, Dept Mol Neurosci, London, England; [Rizzu, Patrizia; Heutink, Peter] German Ctr Neurodegenerat Diseases Tubingen, Tubingen, Germany; [Snowden, Julie S.; Rollinson, Sara; Gerhard, Alexander] Univ Manchester, Fac Med & Human Sci, Inst Brain Behav & Mental Hlth, Manchester, Lancs, England; [Richardson, Anna; Bruni, Amalia C.; Maletta, Raffaele; Frangipane, Francesca; Cupidi, Chiara; Bernardi, Livia; Anfossi, Maria] Univ Manchester, Fac Med & Human Sci, Salford Royal Fdn Trust, Manchester, Lancs, England; [Gallo, Maura; Conidi, Maria Elena; Smirne, Nicoletta] ASPCZ, Reg Neurogenet Ctr, Lamezia Terme, Italy; [Rademakers, Rosa; Baker, Matt; Dickson, Dennis W.; Graff-Radford, Neill R.] Mayo Clin Jacksonville, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Petersen, Ronald C.; Knopman, David; Josephs, Keith A.; Boeve, Bradley F.] Mayo Clin Rochester, Dept Neurol, Rochester, MN USA; [Parisi, Joseph E.] Mayo Clin Rochester, Dept Pathol, Rochester, MN USA; [Miller, Bruce L.; Karydas, Anna M.; Rosen, Howard] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Seeley, William W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [van Swieten, John C.; Dopper, Elise G. P.; Seelaar, Harro] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Pijnenburg, Yolande A. L.; Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Pijnenburg, Yolande A. L.; Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Logroscino, Giancarlo; Capozzo, Rosa] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Novelli, Valeria] Fdn Policlin Univ Agostino Gemelli, Med Genet Unit, Rome, Italy; [Puca, Annibale A.] IRCCS Multimed, Cardiovasc Res Unit, Milan, Italy; [Puca, Annibale A.] Univ Salerno, Dept Med & Surg, Baronissi, Italy; [Franceschi, Massimo] IRCCS Multimed, Neurol Dept, Milan, Italy; [Postiglione, Alfredo] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Milan, Graziella; Sorrentino, Paolo] ASL Napoli 1 Ctr, Geriatr Ctr Frullone, Naples, Italy; [Kristiansen, Mark] UCL, ICH, UCL Genom, London, England; [Chiang, Huei-Hsin; Graff, Caroline] Karolinska Inst, Alzheimer Res Ctr, Dept NVS, Stockholm, Sweden; [Pasquier, Florence; Rollin, Adeline; Deramecourt, Vincent; Lebouvier, Thibaud] Univ Lille, Lille, France; [Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Kapogiannis, Dimitrios] NIA, Cellular & Mol Neurosci Sect, Baltimore, MD 21224 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Takeda Pharmaceutical Company Ltd; Emory University; Emory University; Emory University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Neuroscience Research Australia; University of Brescia; Washington University (WUSTL); IRCCS Fatebenefratelli; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Lund University; University of British Columbia; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Newcastle University - UK; IMT School for Advanced Studies Lucca; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Alberta; University of Navarra; Imperial College London; Technical University of Munich; University of Munich; University of Turin; University of Toronto; IRCCS Istituto Neurologico Besta; University of Cambridge; University of California System; University of California San Diego; University of London; University College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Manchester; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Flanders Institute for Biotechnology (VIB); Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; Nantes Universite; CHU de Nantes; University of Florence; Rigshospitalet; University of Copenhagen; Universitatsklinikum des Saarlandes; University of Regensburg; University of London; University College London; University of Cambridge; University of London; University College London; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Universita degli Studi di Bari Aldo Moro; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Multimedica; University of Salerno; IRCCS Multimedica; University of Naples Federico II; University of London; University College London; Karolinska Institutet; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Thomas, Alan J/G-4807-2011; Ghidoni, Roberta/K-4507-2016; Borroni, Barbara/AAN-4105-2020; Kapogiannis, Dimitrios/AAW-4934-2020; ANFOSSI, MARIA/AAD-7220-2019; Ruiz, Agustin/G-5677-2012; Smirne, Nicoletta/AAB-9557-2019; Danek, Adrian/G-7339-2011; Rossi, Giacomina/I-2783-2012; Capozzo, Rosa/AAC-2716-2019; Hardy, John/C-2451-2009; Morris, Huw R/B-8527-2008; Hsiung, Robin/AAT-1661-2021; graff, caroline/A-2545-2009; McKeith, Ian/AAH-3382-2021; Lebouvier, Thibaud/G-7053-2018; Tagliavini, Fabrizio/AAO-7891-2021; giaccone, giorgio/AAB-9978-2019; Brice, Alexis/A-2170-2009; Cruchaga, Carlos/ABF-4065-2020; Wassermann, Eric M./AAC-9064-2020; Singleton, Andrew B/C-3010-2009; Cappa, Stefano/B-1874-2014; Razquin, Cristina/H-2366-2017; Padovani, Alessandro/ABI-7312-2020; Fox, Nick C/B-1319-2009; ALBANI, DIEGO/I-5183-2018; Cairns, Nigel/AAB-9713-2020; Pietrini, Pietro/Z-4202-2019; Halliday, Glenda M/E-8555-2011; Forloni, Gianluigi/AAB-2115-2020; BENUSSI, LUISA/K-4409-2016; Scheltens, Philip/AAL-9631-2020; Tick, Beata/ABA-1728-2020; Puca, Annibale Alessandro/K-2099-2018; Lleó, Alberto/K-5783-2019; Binetti, Giuliano/K-4519-2016; brice, alexis/AAE-8275-2019; Nacmias, Benedetta/J-5084-2018; Pastor, Pau/C-9834-2009; Serpente, Maria/K-5792-2016; Levey, Allan/F-2104-2011; Perneczky, Robert/AAJ-2550-2020; Fox, Nick C/AAE-1849-2021; Maletta, Raffaele/AGR-3707-2022; Bruni, Amalia/K-5038-2016; Rowe, James/C-3661-2013; Piguet, Olivier/C-9658-2011	Ghidoni, Roberta/0000-0002-7691-1957; Kapogiannis, Dimitrios/0000-0003-2181-3118; ANFOSSI, MARIA/0000-0001-7810-8634; Smirne, Nicoletta/0000-0003-4645-9960; Danek, Adrian/0000-0001-8857-5383; Rossi, Giacomina/0000-0001-6680-2725; Capozzo, Rosa/0000-0002-7672-8669; Hardy, John/0000-0002-3122-0423; Morris, Huw R/0000-0002-5473-3774; Hsiung, Robin/0000-0002-8017-0856; Lebouvier, Thibaud/0000-0002-4386-6045; Tagliavini, Fabrizio/0000-0003-1039-7315; giaccone, giorgio/0000-0002-4803-0802; Cruchaga, Carlos/0000-0002-0276-2899; Wassermann, Eric M./0000-0003-0628-0210; Cappa, Stefano/0000-0003-1003-3925; Razquin, Cristina/0000-0003-3480-2645; Padovani, Alessandro/0000-0002-0119-3639; Fox, Nick C/0000-0002-6660-657X; ALBANI, DIEGO/0000-0002-7050-6723; Cairns, Nigel/0000-0001-9858-3344; Halliday, Glenda M/0000-0003-0422-8398; Forloni, Gianluigi/0000-0001-5374-3914; BENUSSI, LUISA/0000-0003-2836-8141; Scheltens, Philip/0000-0002-1046-6408; Binetti, Giuliano/0000-0003-2759-5844; brice, alexis/0000-0002-0941-3990; Nacmias, Benedetta/0000-0001-9338-9040; Pastor, Pau/0000-0002-7493-8777; Serpente, Maria/0000-0003-0725-1403; Levey, Allan/0000-0002-3153-502X; Fox, Nick C/0000-0002-6660-657X; ortega-cubero, sara/0000-0003-0520-9439; Thomas, Alan/0000-0002-6667-9533; Diehl-Schmid, Janine/0000-0002-7745-1382; Mead, Simon/0000-0002-4326-1468; Bruni, Amalia/0000-0003-3471-3343; Griffiths, Timothy/0000-0001-8066-4381; Graff, Caroline/0000-0002-9949-2951; Heutink, Peter/0000-0001-5218-1737; Swarup, Vivek/0000-0003-3762-2746; McKeith, Ian/0000-0002-9250-0568; Attems, Johannes/0000-0003-1636-1700; Warren, Jason/0000-0002-5405-0826; Ruiz Laza, Agustin/0000-0003-2633-2495; Rubino, Elisa/0000-0002-7553-7553; Morris, Christopher/0000-0002-3749-0993; novelli, valeria/0000-0002-4859-0826; Rossor, Martin/0000-0001-8215-3120; Miller, Bruce/0000-0002-2152-4220; Dobson-Stone, Carol/0000-0002-2211-0257; Pickering-Brown, Stuart/0000-0003-1561-6054; Rowe, James/0000-0001-7216-8679; Snowden, Julie/0000-0002-3976-4310; sorbi, sandro/0000-0002-0380-6670; St George-Hyslop, Peter/0000-0003-0796-7209; Piguet, Olivier/0000-0002-6696-1440; Brooks, William Seymour/0000-0001-8603-4233; Pietrini, Pietro/0000-0002-6768-5556	Takeda Pharmaceuticals; Rainwater Charitable Foundation/Tau consortium; NIH [5R25 NS065723, 5U01AG046161]; Larry L. Hillblom Foundation Postdoctoral Fellowship; National Institute on Aging (NIA) [P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949]; National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS080820]; CurePSP Foundation; Mayo Foundation; NINDS [U24 NS072026]; NIA [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; MRC [G0900652, MC_UU_00024/7, G0400074, MC_U123192748, MC_UU_00024/1, MC_U105597119, MC_UU_00005/12, G0502157, G0301152, G1100540, MC_G1000734, MR/N012453/1, MR/J009482/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080820, R25NS065723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006786, U01AG046139, P01AG019724, P50AG016574, P01AG003991, P50AG005681, P01AG017586, P30AG019610, U01AG046161, P01AG003949, P30AG010124] Funding Source: NIH RePORTER	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Rainwater Charitable Foundation/Tau consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation Postdoctoral Fellowship; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CurePSP Foundation; Mayo Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this work was provided by Takeda Pharmaceuticals (D.H.G.), Rainwater Charitable Foundation/Tau consortium (D.H.G., S.J.H.), NIH grants to D.H.G., S.J.H., A.L. (5U01AG046161) and J.R. (5R25 NS065723) and Larry L. Hillblom Foundation Postdoctoral Fellowship to V.S. K.N., H.T., A.O., K.H. and S.K. are employees of Takeda Pharmaceuticals. The authors thank M. Hattori, Y. Obayashi and K. Nakamura for their contribution to the TPR50 mouse sample preparation and analysis. The authors thank M. Gearing at the Emory Alzheimer's Disease Research Center brain bank for providing human FTD samples. The authors also thank N. Parikshak for help with network analysis and critical reading of the manuscript. We thank Eli Lilly and Company scientists for generating the Tg4510 microglia RNA-seq data and providing access to them. For the PSP and FTD temporal cortex RNA-seq dataset, study data were provided by the following sources: Mayo Clinic Alzheimer's Disease Genetic Studies, led by N. Taner and S. G. Younkin, Mayo Clinic Jacksonville, using samples from the Mayo Clinic Study of Aging, Mayo Clinic Alzheimer's Disease Research Center, and Mayo Clinic Brain Bank. Data collection was supported through funding by National Institute on Aging (NIA) grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949, National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS080820, the CurePSP Foundation, and support from the Mayo Foundation. Study data include samples collected through the Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the NINDS (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the NIA (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. Tg4510 replication and CRND8 RNA-seq data were provided by the NIH U01 AG046139. We thank J. Lewis, K. Duff, D. Westaway and D. Borchelt for generating these lines of transgenic mice and providing access to them.	Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Almeida S, 2012, CELL REP, V2, P789, DOI 10.1016/j.celrep.2012.09.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas MHU, 2016, STEM CELL REP, V7, P316, DOI 10.1016/j.stemcr.2016.08.006; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chang LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090980; Cheng C, 2017, CURR PROTOC HUM GENE, V92; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469; Gjorlund MD, 2012, FASEB J, V26, P4174, DOI 10.1096/fj.11-202242; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta S, 2015, DRUG DEVELOP RES, V76, P397, DOI 10.1002/ddr.21277; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hardy J, 2016, BIOCHEM SOC T, V44, P659, DOI 10.1042/BST20150287; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hinz FI, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023705; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Huang KP, 2004, J NEUROSCI, V24, P10660, DOI 10.1523/JNEUROSCI.2213-04.2004; Institute of Medicine, 2013, IMPR UT TRANSL AN MO; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jaworski M, 2014, EMBO J, V33, P2765, DOI 10.15252/embj.201488987; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kuhn A, 2011, NAT METHODS, V8, P945, DOI [10.1038/NMETH.1710, 10.1038/nmeth.1710]; LaFerla F. M, 2012, COLD SPRING HARB PER, V2; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Maeda S, 2016, EMBO REP, V17, P530, DOI 10.15252/embr.201541438; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Menkes-Caspi N, 2015, NEURON, V85, P959, DOI 10.1016/j.neuron.2015.01.025; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mullane K, 2013, BIOCHEM PHARMACOL, V85, P289, DOI 10.1016/j.bcp.2012.11.014; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Narayanan M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145304; Ng ASL, 2015, ANN NY ACAD SCI, V1338, P71, DOI 10.1111/nyas.12638; Onishi T, 2014, NEUROSCI RES, V80, P76, DOI 10.1016/j.neures.2013.12.006; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Qosa Hisham, 2016, J Syst Integr Neurosci, V2, P135; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Weitzner DS, 2015, JOVE-J VIS EXP, DOI 10.3791/52706; Wes PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106050; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Young DD, 2010, J AM CHEM SOC, V132, P7976, DOI 10.1021/ja910275u; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	83	55	57	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					152	+		10.1038/s41591-018-0223-3	http://dx.doi.org/10.1038/s41591-018-0223-3			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30510257	Green Submitted, Green Accepted			2022-12-27	WOS:000455027700033
J	Basson, M				Basson, Michael			Personalized tracking of exposure to airborne organisms and chemicals	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1637	1637		10.1038/s41591-018-0259-4	http://dx.doi.org/10.1038/s41591-018-0259-4			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401864	Bronze			2022-12-27	WOS:000449404200006
J	Fish, L; Zhang, S; Yu, JX; Culbertson, B; Zhou, AY; Goga, A; Goodarzi, H				Fish, Lisa; Zhang, Steven; Yu, Johnny X.; Culbertson, Bruce; Zhou, Alicia Y.; Goga, Andrei; Goodarzi, Hani			Cancer cells exploit an orphan RNA to drive metastatic progression	NATURE MEDICINE			English	Article							BREAST-CANCER; MESSENGER-RNA; BINDING-SITES; DISCOVERY; CLIP; EXPRESSION; MICRORNAS; PROTEINS; GROWTH	Here we performed a systematic search to identify breast-cancer-specific small noncoding RNAs, which we have collectively termed orphan noncoding RNAs (oncRNAs). We subsequently discovered that one of these oncRNAs, which originates from the 3' end of TERC, acts as a regulator of gene expression and is a robust promoter of breast cancer metastasis. This oncRNA, which we have named T3p, exerts its prometastatic effects by acting as an inhibitor of RISC complex activity and increasing the expression of the prometastatic genes NUPR1 and PANX2. Furthermore, we have shown that oncRNAs are present in cancer-cell-derived extracellular vesicles, raising the possibility that these circulating oncRNAs may also have a role in non-cell autonomous disease pathogenesis. Additionally, these circulating oncRNAs present a novel avenue for cancer fingerprinting using liquid biopsies.	[Fish, Lisa; Zhang, Steven; Yu, Johnny X.; Culbertson, Bruce; Goodarzi, Hani] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Fish, Lisa; Zhang, Steven; Yu, Johnny X.; Culbertson, Bruce; Goodarzi, Hani] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Fish, Lisa; Zhang, Steven; Yu, Johnny X.; Culbertson, Bruce; Zhou, Alicia Y.; Goga, Andrei; Goodarzi, Hani] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Zhou, Alicia Y.; Goga, Andrei] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Zhou, Alicia Y.; Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Goodarzi, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Goodarzi, H (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.; Goodarzi, H (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	hani.goodarzi@ucst.edu		Fish, Lisa/0000-0001-9184-0512; Culbertson, Bruce/0000-0002-1489-1348; Goodarzi, Hani/0000-0002-9648-8949	NIH [R01GM123977, R00CA194077]; American Cancer Society [130920-RSG-17-114-01-RMC]; Goldberg-Benioff Fund in Translational Research; HHMI Medical Research Fellowship; CDMRP Breast Cancer Research Program [W81XWH-12-1-0272, W81XWH-16-1-0603]; Friends for an Earlier Breast Cancer Test; NATIONAL CANCER INSTITUTE [R00CA194077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Goldberg-Benioff Fund in Translational Research; HHMI Medical Research Fellowship; CDMRP Breast Cancer Research Program; Friends for an Earlier Breast Cancer Test; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Ruggero, D. Erle, F. Feng, S. Tavazoie and S. Tavazoie for reading earlier versions of this manuscript; D. Erle and P. Godoy for providing early access to their serum smRNA profiles; B. Hann and the Preclinical Therapeutics core as well as the Laboratory Animal Resource Center (LARC); S. Kilinc for her assistance with extracellular vesicle size analysis; F. Fattahi for helpful discussions; and J. Massague for providing cell lines. We are also grateful for the genomic data contributed by the TCGA Research Network, including donors and researchers. We acknowledge the UCSF Center for Advanced Technology (CAT) for high-throughput sequencing and other genomic analyses; and support from our colleagues at the Breast Oncology Program (Helen Diller Family Comprehensive Cancer Center). This work was supported by the NIH (R01GM123977 and R00CA194077), Friends for an Earlier Breast Cancer Test, the American Cancer Society (130920-RSG-17-114-01-RMC) and the Goldberg-Benioff Fund in Translational Research. S.Z. was supported through the HHMI Medical Research Fellowship. J.X.Y. is an NSF GRFP fellow. A.G. was supported by the CDMRP Breast Cancer Research Program W81XWH-12-1-0272 and W81XWH-16-1-0603.	Ainsztein AM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27493; Bak RO, 2013, RNA, V19, P280, DOI 10.1261/rna.034850.112; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen LY, 2012, MOL CELL, V47, P1, DOI 10.1016/j.molcel.2012.06.031; COOPER DN, 1994, ANN MED, V26, P9, DOI 10.3109/07853899409147321; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fish L, 2016, GENE DEV, V30, P386, DOI 10.1101/gad.270645.115; Fiskaa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161824; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Huo DZ, 2016, ONCOTARGET, V7, P55231, DOI 10.18632/oncotarget.10485; Kim B, 2017, MOL CELL, V66, P258, DOI 10.1016/j.molcel.2017.03.013; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kodahl AR, 2014, MOL ONCOL, V8, P874, DOI 10.1016/j.molonc.2014.03.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin RK, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-46; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Vanharanta S, 2014, ELIFE, V3, DOI 10.7554/eLife.02734; Wu CI, 2016, ANNU REV GENET, V50, P347, DOI 10.1146/annurev-genet-112414-054842; Wu XW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-42; Yang YCT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1273-2; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	43	19	21	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1743	+		10.1038/s41591-018-0230-4	http://dx.doi.org/10.1038/s41591-018-0230-4			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30397354	Green Submitted, Green Accepted			2022-12-27	WOS:000449404200027
J	Qiu, CX; Huang, SZ; Park, J; Park, Y; Ko, YA; Seasock, MJ; Bryer, JS; Xu, XX; Song, WC; Palmer, M; Hill, J; Guarnieri, P; Hawkins, J; Boustany-Kari, CM; Pullen, SS; Brown, CD; Susztak, K				Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan; Park, YoSon; Ko, Yi-An; Seasock, Matthew J.; Bryer, Joshua S.; Xu, Xiang-Xi; Song, Wen-Chao; Palmer, Matthew; Hill, Jon; Guarnieri, Paolo; Hawkins, Julie; Boustany-Kari, Carine M.; Pullen, Steven S.; Brown, Christopher D.; Susztak, Katalin			Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease	NATURE MEDICINE			English	Article							EPITHELIAL-CELLS; PROXIMAL TUBULE; HUMAN GENOME; EXPRESSION; RISK; VARIANT; GROWTH; BETA; IDENTIFICATION; METAANALYSIS	Chronic kidney disease (CKD), a condition in which the kidneys are unable to clear waste products, affects 700 million people globally. Genome-wide association studies (GWASs) have identified sequence variants for CKD; however, the biological basis of these GWAS results remains poorly understood. To address this issue, we created an expression quantitative trait loci (eQTL) atlas for the glomerular and tubular compartments of the human kidney. Through integrating the CKD GWAS with eQTL, single-cell RNA sequencing and regulatory region maps, we identified novel genes for CKD. Putative causal genes were enriched for proximal tubule expression and endolysosomal function, where DAB2, an adaptor protein in the TGF-beta pathway, formed a central node. Functional experiments confirmed that reducing Dab2 expression in renal tubules protected mice from CKD. In conclusion, compartment-specific eQTL analysis is an important avenue for the identification of novel genes and cellular pathways involved in CKD development and thus potential new opportunities for its treatment.	[Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan; Ko, Yi-An; Seasock, Matthew J.; Bryer, Joshua S.; Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Park, YoSon; Ko, Yi-An; Brown, Christopher D.; Susztak, Katalin] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Dept Cell Biol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Song, Wen-Chao] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Palmer, Matthew] Univ Penn, Pathol & Lab Med Hosp, Philadelphia, PA 19104 USA; [Hill, Jon; Guarnieri, Paolo; Hawkins, Julie; Boustany-Kari, Carine M.; Pullen, Steven S.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Boehringer Ingelheim	Susztak, K (corresponding author), Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.; Susztak, K (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	ksusztak@pennmedicine.upenn.edu	Susztak, Katalin/ABE-7474-2021; Seasock, Matthew J/O-7809-2018; Qiu, Chengxiang/X-5040-2019	Susztak, Katalin/0000-0002-1005-3726; Seasock, Matthew J/0000-0002-5940-5913; Qiu, Chengxiang/0000-0002-6346-8669; Park, Jihwan/0000-0002-5728-912X; , YoSon/0000-0002-0465-4744; sodaei, sara/0000-0002-4546-1324; Brown, Christopher/0000-0002-3785-5008	Diabetes Research Center at the University of Pennsylvania at the University of Pennsylvania [P30-DK19525]; National Institute of Health NIH [R01 DK087635, DK076077, DP3108220]; Boehringer Ingelheim [R01 DK087635, DK076077, DP3108220]; Eli Lilly Co.; Juvenile Diabetes Research Foundation; Molecular Pathology and Imaging Core [P30-DK050306]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635, R01DK105821, DP3DK108220, P30DK019525, P30DK050306, R01DK076077] Funding Source: NIH RePORTER	Diabetes Research Center at the University of Pennsylvania at the University of Pennsylvania; National Institute of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly Co.(Eli Lilly); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Molecular Pathology and Imaging Core; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Molecular Pathology and Imaging Core (P30-DK050306) and Diabetes Research Center (P30-DK19525) at the University of Pennsylvania for their services. This work in the Susztak lab has been supported by the National Institute of Health NIH R01 DK087635, DK076077 and DP3108220, Boehringer Ingelheim, the Eli Lilly Co. and the Juvenile Diabetes Research Foundation.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araki T, 2003, NEPHRON EXP NEPHROL, V93, P117, DOI 10.1159/000069552; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Braun DA, 2016, NAT GENET, V48, P457, DOI 10.1038/ng.3512; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Edeling M, 2016, NAT REV NEPHROL, V12, P426, DOI 10.1038/nrneph.2016.54; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Garrett MR, 2010, J AM SOC NEPHROL, V21, P398, DOI 10.1681/ASN.2009080881; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gillies CE, 2018, AM J HUM GENET, V103, P232, DOI 10.1016/j.ajhg.2018.07.004; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Gupta RM, 2017, CELL, V170, P522, DOI 10.1016/j.cell.2017.06.049; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ishigaki K, 2017, NAT GENET, V49, P1120, DOI 10.1038/ng.3885; Kimura T, 2013, AUTOPHAGY, V9, P1876, DOI 10.4161/auto.25418; Ko YA, 2017, AM J HUM GENET, V100, P940, DOI 10.1016/j.ajhg.2017.05.004; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Korstanje R, 2002, NAT GENET, V31, P235, DOI 10.1038/ng0702-235; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pashos EE, 2017, CELL STEM CELL, V20, P558, DOI 10.1016/j.stem.2017.03.017; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Rhee CM, 2015, NAT REV NEPHROL, V11, DOI 10.1038/nrneph.2015.25; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schiffer M, 2015, NAT MED, V21, P601, DOI 10.1038/nm.3843; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sud M, 2016, NEPHROL DIAL TRANSPL, V31, P1122, DOI 10.1093/ndt/gfv389; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Tao WS, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00129; Tory K, 2014, NAT GENET, V46, P299, DOI 10.1038/ng.2898; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Yeo NC, 2015, GENOME RES, V25, P57, DOI 10.1101/gr.182881.114; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061	80	110	112	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1721	+		10.1038/s41591-018-0194-4	http://dx.doi.org/10.1038/s41591-018-0194-4			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30275566	Green Accepted			2022-12-27	WOS:000449404200025
J	Mehr, AP; Tran, MT; Ralto, KM; Leaf, DE; Washco, V; Messmer, J; Lerner, A; Kher, A; Kim, SH; Khoury, CC; Herzig, SJ; Trovato, ME; Simon-Tillaux, N; Lynch, MR; Thadhani, RI; Clish, CB; Khabbaz, KR; Rhee, EP; Waikar, SS; Berg, AH; Parikh, SM				Mehr, Ali Poyan; Tran, Mei T.; Ralto, Kenneth M.; Leaf, David E.; Washco, Vaughan; Messmer, Joseph; Lerner, Adam; Kher, Ajay; Kim, Steven H.; Khoury, Charbel C.; Herzig, Shoshana J.; Trovato, Mary E.; Simon-Tillaux, Noemie; Lynch, Matthew R.; Thadhani, Ravi, I; Clish, Clary B.; Khabbaz, Kamal R.; Rhee, Eugene P.; Waikar, Sushrut S.; Berg, Anders H.; Parikh, Samir M.			De novo NAD(+) biosynthetic impairment in acute kidney injury in humans	NATURE MEDICINE			English	Article							LIFE-SPAN EXTENSION; NICOTINAMIDE RIBOSIDE; OXIDATIVE-METABOLISM; CALORIE RESTRICTION; MITOCHONDRIAL; TRIAL	Nicotinamide adenine dinucleotide (NAD(+)) extends longevity in experimental organisms, raising interest in its impact on human health. De novo NAD(+) biosynthesis from tryptophan is evolutionarily conserved yet considered supplanted among higher species by biosynthesis from nicotinamide (NAM). Here we show that a bottleneck enzyme in de novo biosynthesis, quinolinate phosphoribosyltransferase (QPRT), defends renal NAD(+) and mediates resistance to acute kidney injury (AKI). Following murine AKI, renal NAD(+) fell, quinolinate rose, and QPRT declined. QPRT(+/-) mice exhibited higher quinolinate, lower NAD(+), and higher AKI susceptibility. Metabolomics suggested an elevated urinary quinolinate/tryptophan ratio (uQ/T) as an indicator of reduced QPRT. Elevated uQ/T predicted AKI and other adverse outcomes in critically ill patients. A phase 1 placebo-controlled study of oral NAM demonstrated a dose-related increase in circulating NAD(+) metabolites. NAM was well tolerated and was associated with less AKI. Therefore, impaired NAD(+) biosynthesis may be a feature of high-risk hospitalizations for which NAD(+) augmentation could be beneficial.	[Mehr, Ali Poyan; Tran, Mei T.; Ralto, Kenneth M.; Washco, Vaughan; Messmer, Joseph; Kher, Ajay; Kim, Steven H.; Simon-Tillaux, Noemie; Lynch, Matthew R.; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Mehr, Ali Poyan; Tran, Mei T.; Ralto, Kenneth M.; Washco, Vaughan; Messmer, Joseph; Kher, Ajay; Kim, Steven H.; Herzig, Shoshana J.; Simon-Tillaux, Noemie; Lynch, Matthew R.; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Mehr, Ali Poyan; Tran, Mei T.; Leaf, David E.; Washco, Vaughan; Messmer, Joseph; Lerner, Adam; Kher, Ajay; Kim, Steven H.; Khoury, Charbel C.; Herzig, Shoshana J.; Trovato, Mary E.; Simon-Tillaux, Noemie; Lynch, Matthew R.; Thadhani, Ravi, I; Khabbaz, Kamal R.; Rhee, Eugene P.; Waikar, Sushrut S.; Berg, Anders H.; Parikh, Samir M.] Harvard Med Sch, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Leaf, David E.; Waikar, Sushrut S.] Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA; [Leaf, David E.; Waikar, Sushrut S.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Lerner, Adam] Beth Israel Deaconess Med Ctr, Dept Anesthesia & Crit Care, Boston, MA 02215 USA; [Khoury, Charbel C.; Thadhani, Ravi, I] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Khoury, Charbel C.; Thadhani, Ravi, I] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Herzig, Shoshana J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care Med, Boston, MA 02215 USA; [Trovato, Mary E.; Khabbaz, Kamal R.] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Trovato, Mary E.; Khabbaz, Kamal R.] Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA; [Clish, Clary B.] Brd Inst Harvard & MIT, Cambridge, MA USA; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Berg, Anders H.] Beth Israel Deaconess Med Ctr, Div Clin Chem, Boston, MA 02215 USA; [Berg, Anders H.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Parikh, SM (corresponding author), Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA.; Parikh, SM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.; Parikh, SM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	sparikh1@bidmc.harvard.edu	Ralto, Kenneth/AAX-8474-2020; Mehr, Ali Poyan/P-9665-2019; Clish, Clary/AAB-7124-2019; Leaf, David/AAO-8977-2021; Simon, Noemie/ADZ-2920-2022; Clish, Clary B/ABB-9374-2021	Mehr, Ali Poyan/0000-0001-5610-2979; Leaf, David/0000-0001-7875-090X; Clish, Clary B/0000-0001-8259-9245; Tran, Mei/0000-0003-1114-0984	BIDMC; Assistance Publique-Hopitaux de Paris;  [T32DK007199];  [K23DK106448];  [T32DK007540];  [K23AG042459];  [K08HL121801];  [R56HL133399];  [R35HL139424];  [R01HL125275,];  [R01DK095072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL133399, R35HL139424, R01HL125275, K08HL121801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095072, T32DK007540, T32DK007199, K23DK106448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG042459] Funding Source: NIH RePORTER	BIDMC; Assistance Publique-Hopitaux de Paris; ; ; ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This randomized clinical trial was funded by an Innovation Grant from the BIDMC awarded to A.P.M. and K.R.K. K.M.R., V.W., A.K., and M.R.L. were supported by T32DK007199; D.E.L. by K23DK106448; C.C.K. and R.I.T. by T32DK007540; S.J.H. by K23AG042459; N.S.-T. by a grant from Assistance Publique-Hopitaux de Paris; and A.H.B. by K08HL121801 and R56HL133399. Work in S.M.P.'s laboratory was supported by R35HL139424, R01HL125275, and R01DK095072.	Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Chen AC, 2015, NEW ENGL J MED, V373, P1618, DOI 10.1056/NEJMoa1506197; CHRISTEN S, 1990, P NATL ACAD SCI USA, V87, P2506, DOI 10.1073/pnas.87.7.2506; COLLINS PB, 1972, J BIOL CHEM, V247, P778; Ebrahimkhani MR, 2014, P NATL ACAD SCI USA, V111, pE4878, DOI 10.1073/pnas.1413582111; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Garg AX, 2014, JAMA-J AM MED ASSOC, V311, P2191, DOI 10.1001/jama.2014.4952; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Kirkland JB, 2012, MUTAT RES-FUND MOL M, V733, P14, DOI 10.1016/j.mrfmmm.2011.11.008; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Langholz B, 1996, STAT SCI, V11, P35; Leaf DE, 2017, J AM SOC NEPHROL, V28, P1877, DOI 10.1681/ASN.2016080836; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; PETLEY A, 1995, DIABETES, V44, P152, DOI 10.2337/diabetes.44.2.152; Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI [10.1056/NEJMoa1616361, 10.1056/nejmoa1616361]; Ternes CM, 2014, GENOME BIOL EVOL, V6, P2335, DOI 10.1093/gbe/evu185; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184; Underwood E, 2015, SCIENCE, V350, P1188, DOI 10.1126/science.350.6265.1188; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693	40	164	165	5	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1351	+		10.1038/s41591-018-0138-z	http://dx.doi.org/10.1038/s41591-018-0138-z			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30127395	Green Accepted			2022-12-27	WOS:000444174100016
J	Stower, H				Stower, Hannah			Modeling tumors and their T cell killers	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1303	1303		10.1038/s41591-018-0189-1	http://dx.doi.org/10.1038/s41591-018-0189-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194408	Bronze			2022-12-27	WOS:000444174100022
J	Janic, A; Valente, LJ; Wakefield, MJ; Di Stefano, L; Milla, L; Wilcox, S; Yang, HY; Tai, L; Vandenberg, CJ; Kueh, AJ; Mizutani, S; Brennan, MS; Schenk, RL; Lindqvist, LM; Papenfuss, AT; O'Connor, L; Strasser, A; Herold, MJ				Janic, Ana; Valente, Liz J.; Wakefield, Matthew J.; Di Stefano, Leon; Milla, Liz; Wilcox, Stephen; Yang, Haoyu; Tai, Lin; Vandenberg, Cassandra J.; Kueh, Andrew J.; Mizutani, Shinsuke; Brennan, Margs S.; Schenk, Robyn L.; Lindqvist, Lisa M.; Papenfuss, Anthony T.; O'Connor, Liam; Strasser, Andreas; Herold, Marco J.			DNA repair processes are critical mediators of p53-dependent tumor suppression	NATURE MEDICINE			English	Article							CELL-CYCLE ARREST; IN-VIVO; MISMATCH REPAIR; P53; MICE; RESPONSES; GENOME; CANCER; GENES; PUMA	It has long been assumed that p53 suppresses tumor development through induction of apoptosis, possibly with contributions by cell cycle arrest and cell senescence(1,2). However, combined deficiency in these three processes does not result in spontaneous tumor formation as observed upon loss of p53, suggesting the existence of additional mechanisms that are critical mediators of p53-dependent tumor suppression function(3-5). To define such mechanisms, we performed in vivo shRNA screens targeting p53-regulated genes in sensitized genetic backgrounds. We found that knockdown of Zmat3, Ctsf and Cav1, promoted lymphoma/leukemia development only when PUMA and p21, the critical effectors of p53-driven apoptosis, cell cycle arrest and senescence, were also absent. Notably, loss of the DNA repair gene Mlh1 caused lymphoma in a wild-type background, and its enforced expression was able to delay tumor development driven by loss of p53. Further examination of direct p53 target genes implicated in DNA repair showed that knockdown of Mlh1, Msh2, Rnf144b, Cav1 and Ddit4 accelerated MYC-driven lymphoma development to a similar extent as knockdown of p53. Collectively, these findings demonstrate that extensive functional overlap of several p53-regulated processes safeguards against cancer and that coordination of DNA repair appears to be an important process by which p53 suppresses tumor development.	[Janic, Ana; Valente, Liz J.; Wakefield, Matthew J.; Di Stefano, Leon; Milla, Liz; Wilcox, Stephen; Yang, Haoyu; Tai, Lin; Vandenberg, Cassandra J.; Kueh, Andrew J.; Mizutani, Shinsuke; Brennan, Margs S.; Schenk, Robyn L.; Lindqvist, Lisa M.; Papenfuss, Anthony T.; O'Connor, Liam; Strasser, Andreas; Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic, Australia; [Janic, Ana; Valente, Liz J.; Milla, Liz; Wilcox, Stephen; Yang, Haoyu; Vandenberg, Cassandra J.; Kueh, Andrew J.; Mizutani, Shinsuke; Brennan, Margs S.; Schenk, Robyn L.; Lindqvist, Lisa M.; Papenfuss, Anthony T.; O'Connor, Liam; Strasser, Andreas; Herold, Marco J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Valente, Liz J.] Stanford Univ, Sch Med, Div Radiat Oncol Radiat & Canc Biol, Stanford, CA 94305 USA; [Wakefield, Matthew J.] Univ Melbourne, Melbourne Bioinformat, Carlton, Vic, Australia; [Yang, Haoyu] Tsinghua Univ, Sch Pharmaceut Sci, Beijing, Peoples R China; [Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Stanford University; University of Melbourne; Tsinghua University; Peter Maccallum Cancer Center	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic, Australia.; Strasser, A (corresponding author), Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia.	strasser@wehi.edu.au	Janic, Ana/AAR-4783-2020; Wakefield, Matthew J/A-7795-2008; Herold, Marco J/C-8039-2013; Strasser, Andreas/C-7581-2013; Wakefield, Matthew/X-7593-2019; Papenfuss, Anthony T/C-6297-2008	Janic, Ana/0000-0002-4200-2560; Wakefield, Matthew J/0000-0001-6624-4698; Herold, Marco J/0000-0001-7539-7581; Strasser, Andreas/0000-0002-5020-4891; Wakefield, Matthew/0000-0001-6624-4698; Papenfuss, Anthony T/0000-0002-1102-8506; Brennan, Margs/0000-0002-8864-4147; Milla, Liz/0000-0002-6139-4336; Valente, Liz J/0000-0002-5591-7700	Leukemia & Lymphoma Society of America; Marie Curie Actions; Beatriu de Pinos; Lady Tata Memorial Trust; Cancer Australia and Cure Cancer Australia Foundation [1067571]; National Health and Medical Research Council (NHMRC) [1016701]; NHMRC Senior Principal Research Fellow (SPRF) [1020363]; Leukemia & Lymphoma Society of America (Specialized Center of Research (SCOR)) [7001-13]; Australian Phenomics Network; CCV Venture Grant	Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Marie Curie Actions(European Commission); Beatriu de Pinos; Lady Tata Memorial Trust; Cancer Australia and Cure Cancer Australia Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellow (SPRF)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia & Lymphoma Society of America (Specialized Center of Research (SCOR)); Australian Phenomics Network; CCV Venture Grant	We thank S. Lowe, A. Lujambio, A. Ventura and C. Concepcion for the p53 target gene shRNA library and for discussions; M. Ritchie, W. Shi, Y. Liao for data analysis, J.M. Adams, P. Bouillet, S. Cory, K. Rajewsky and A. Villunger for gifts of mice and for discussions. This work was supported by postdoctoral fellowships from the Leukemia & Lymphoma Society of America, Marie Curie Actions and Beatriu de Pinos, and Lady Tata Memorial Trust to A.J. and by grants from Cancer Australia and Cure Cancer Australia Foundation (grant no. 1067571), the National Health and Medical Research Council (NHMRC; program grant no. 1016701, NHMRC Senior Principal Research Fellow (SPRF) Fellowship 1020363 to A. S.), and the Leukemia & Lymphoma Society of America (Specialized Center of Research (SCOR) grant no. 7001-13), Australian Phenomics Network and a CCV Venture Grant. This work was made possible by operational infrastructure grants through the Australian Government Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS) and the Victorian State Government Operational Infrastructure Support (OIS).	Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Bersani C, 2014, ONCOGENE, V33, P4407, DOI 10.1038/onc.2013.594; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Broz DK, 2013, GENE DEV, V27, P1016, DOI 10.1101/gad.212282.112; Cameron D. L., 2017, BIORXIV; Cameron DL, 2017, GENOME RES, V27, P2050, DOI 10.1101/gr.222109.117; Chan TA, 2000, GENE DEV, V14, P1584; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Josephidou M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv135; Kueh AJ, 2017, CELL DEATH DIFFER, V24, P1821, DOI 10.1038/cdd.2017.122; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee K, 2016, DNA REPAIR, V38, P140, DOI 10.1016/j.dnarep.2015.11.015; Li H., 2013, CLONE SEQUENCES ASSE; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Malkin D., SCIENCE, V250; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Obenchain V, 2014, BIOINFORMATICS, V30, P2076, DOI 10.1093/bioinformatics/btu168; Razani B, 2001, J BIOL CHEM, V276, P38121; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Schneider K., 1999, LI FRAUMENI SYNDROME; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Valente L. J., 2015, ONCOGENE; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Willems T, 2017, NAT METHODS, V14, P590, DOI [10.1038/NMETH.4267, 10.1038/nmeth.4267]; Williams AB, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026070; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012055	48	82	84	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					947	+		10.1038/s41591-018-0043-5	http://dx.doi.org/10.1038/s41591-018-0043-5			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892060				2022-12-27	WOS:000438187700022
J	Yun, SP; Kam, TI; Panicker, N; Kim, S; Oh, Y; Park, JS; Kwon, SH; Park, YJ; Karuppagounder, SS; Park, H; Kim, S; Oh, N; Kim, NA; Lee, S; Brahmachari, S; Mao, XB; Lee, JH; Kumar, M; An, D; Kang, SU; Lee, Y; Lee, KC; Na, DH; Kim, D; Lee, SH; Roschke, VV; Liddelow, SA; Mari, Z; Barres, B; Dawson, VL; Lee, S; Dawson, TM; Ko, HS				Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Oh, Yumin; Park, Jong-Sung; Kwon, Seung-Hwan; Park, Yong Joo; Karuppagounder, Senthilkumar S.; Park, Hyejin; Kim, Sangjune; Oh, Nayeon; Kim, Nayoung Alice; Lee, Saebom; Brahmachari, Saurav; Mao, Xiaobo; Lee, Jun Hee; Kumar, Manoj; An, Daniel; Kang, Sung-Ung; Lee, Yunjong; Lee, Kang Choon; Na, Dong Hee; Kim, Donghoon; Lee, Sang Hun; Roschke, Viktor V.; Liddelow, Shane A.; Mari, Zoltan; Barres, Ben A.; Dawson, Valina L.; Lee, Seulki; Dawson, Ted M.; Ko, Han Seok			Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease	NATURE MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; TRAUMATIC BRAIN-INJURY; ALPHA-SYNUCLEIN; RECEPTOR AGONIST; DOPAMINERGIC-NEURONS; MOUSE MODEL; EXENDIN-4; ACTIVATION; GLP-1; EXPRESSION	Activation of microglia by classical inflammatory mediators can convert astrocytes into a neurotoxic A1 phenotype in a variety of neurological diseases(1,2). Development of agents that could inhibit the formation of A1 reactive astrocytes could be used to treat these diseases for which there are no disease-modifying therapies. Glucagon-like peptide-1 receptor (GLP1R) agonists have been indicated as potential neuroprotective agents for neurologic disorders such as Alzheimer's disease and Parkinson's disease(3-13). The mechanisms by which GLP1R agonists are neuroprotective are not known. Here we show that a potent, brain-penetrant long-acting GLP1R agonist, NLY01, protects against the loss of dopaminergic neurons and behavioral deficits in the a alpha-synuclein preformed fibril (alpha-syn PFF) mouse model of sporadic Parkinson's disease(14,15). NLY01 also prolongs the life and reduces the behavioral deficits and neuropathological abnormalities in the human A53T alpha-synuclein (hA53T) transgenic mouse model of alpha-synucle-inopathy-induced neurodegeneration(16). We found that NLY01 is a potent GLP1R agonist with favorable properties that is neuroprotective through the direct prevention of microglial-mediated conversion of astrocytes to an A1 neurotoxic phenotype. In light of its favorable properties, NLY01 should be evaluated in the treatment of Parkinson's disease and related neurologic disorders characterized by microglial activation.	[Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Kwon, Seung-Hwan; Karuppagounder, Senthilkumar S.; Park, Hyejin; Kim, Sangjune; Oh, Nayeon; Kim, Nayoung Alice; Lee, Saebom; Brahmachari, Saurav; Mao, Xiaobo; Kumar, Manoj; An, Daniel; Kang, Sung-Ung; Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21218 USA; [Yun, Seung Pil; Kam, Tae-In; Panicker, Nikhil; Kim, SangMin; Kwon, Seung-Hwan; Karuppagounder, Senthilkumar S.; Park, Hyejin; Kim, Sangjune; Oh, Nayeon; Kim, Nayoung Alice; Lee, Saebom; Brahmachari, Saurav; Mao, Xiaobo; Kumar, Manoj; An, Daniel; Kang, Sung-Ung; Kim, Donghoon; Mari, Zoltan; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA; [Yun, Seung Pil; Karuppagounder, Senthilkumar S.; Brahmachari, Saurav; Mao, Xiaobo; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Oh, Yumin; Park, Jong-Sung; Park, Yong Joo; Lee, Seulki] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Oh, Yumin; Park, Jong-Sung; Park, Yong Joo; Lee, Seulki] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Lee, Jun Hee] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham Sch Med, Birmingham, AL USA; [Lee, Yunjong] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol & Cell Biol,Div Pharmacol, Suwon, South Korea; [Lee, Kang Choon] Sungkyunkwan Univ, Coll Pharm, Suwon, South Korea; [Na, Dong Hee] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Kim, Donghoon; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kim, Donghoon; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Lee, Sang Hun] Soonchunhyang Univ, Seoul Hosp, Soonchunhyang Med Sci Res Inst, Seoul, South Korea; [Roschke, Viktor V.] Neuraly Inc, Baltimore, MD USA; [Liddelow, Shane A.; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Dawson, Ted M.; Ko, Han Seok] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Alabama System; University of Alabama Birmingham; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Chung Ang University; Johns Hopkins University; Johns Hopkins University; Soonchunhyang University; Stanford University; Johns Hopkins University	Dawson, TM; Ko, HS (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Inst Cell Engn, Baltimore, MD 21218 USA.; Dawson, TM; Ko, HS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA.; Dawson, TM; Ko, HS (corresponding author), Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA.; Lee, S (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.; Lee, S (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Nanomed, Wilmer Eye Inst, Baltimore, MD 21218 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.; Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.; Dawson, TM; Ko, HS (corresponding author), Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA.	slee343@jhmi.edu; tdawson@jhmi.edu; hko3@jhmi.edu	Karuppagounder, Senthilkumar/I-6752-2013; Oh, Yumin/AAU-1302-2021; Liddelow, Shane/ABE-6456-2020; Mari, Zoltan/ABC-4879-2020; Mao, Xiaobo/A-7362-2010; Kim, Sangjune/AAA-9561-2022; Panicker, Nikhil/A-2770-2019; lee, sang hun/Q-4650-2019; Dawson, Valina/Y-9757-2019	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Oh, Yumin/0000-0003-1456-4045; Liddelow, Shane/0000-0002-0840-1437; Mao, Xiaobo/0000-0001-6587-556X; Panicker, Nikhil/0000-0003-1752-4284; lee, sang hun/0000-0002-9005-5966; Lee, Seulki/0000-0001-7082-154X; Na, Dong Hee/0000-0001-9313-0127; Kwon, Seung-Hwan/0000-0001-7965-5875; Kam, Tae-In/0000-0002-7241-4902; Kim, Sangjune/0000-0003-3052-3163; An, Daniel/0000-0001-5036-0985	NIH/NINDS [NS38377, NS082205, NS098006]; Maryland Stem Cell Research Foundation [2012-MSCRFE-0059]; JPB Foundation; NIH/National Institute on Aging grant [1K01AG056841-01]; American Parkinson Disease Association (APDA); National Research Foundation of Korea [NRF-2016R1D1A1B03934847]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS082205, R21NS098006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG056841] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Maryland Stem Cell Research Foundation; JPB Foundation; NIH/National Institute on Aging grant; American Parkinson Disease Association (APDA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All relevant ethical regulations were followed. This work was supported by grants from the NIH/NINDS NS38377 (H.S.K., V.L.D. and T.M.D.), NIH/NINDS NS082205 and NS098006 (H.S.K.), Maryland Stem Cell Research Foundation 2012-MSCRFE-0059 (H.S.K.), the JPB Foundation (T.M.D.), NIH/National Institute on Aging grant 1K01AG056841-01(X.M.), the American Parkinson Disease Association (APDA) Research Grant Awards (X.M.) and the National Research Foundation of Korea NRF-2016R1D1A1B03934847 (D.H.N.). We acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through their direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs M-1 (T.M.D. and V.L.D.), M-2 (T.M.D. and V.L.D.), H-2014 (T.M.D.), M-2014 (H.S.K., T.M.D. and V.L.D.), H-1 (H.S.K.), H-2013 (H.S.K.). T.M.D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. We thank Neuraly Inc. for providing NLY01.	Allen Reish HE, 2015, J PARKINSON DIS, V5, P1, DOI DOI 10.3233/JPD-140491; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Brahmachari S, 2016, J CLIN INVEST, V126, P2970, DOI 10.1172/JCI85456; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Chen S, 2014, NEUROSCIENCE, V256, P137, DOI 10.1016/j.neuroscience.2013.10.038; Daher JPL, 2012, HUM MOL GENET, V21, P2420, DOI 10.1093/hmg/dds057; Goncalves A, 2016, INVEST OPHTH VIS SCI, V57, P2584, DOI 10.1167/iovs.15-19006; Gray MT, 2015, J CEREBR BLOOD F MET, V35, P747, DOI 10.1038/jcbfm.2015.32; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Harms AS, 2018, EXP NEUROL, V300, P179, DOI 10.1016/j.expneurol.2017.11.010; Ji CH, 2016, BRAIN RES, V1634, P1, DOI 10.1016/j.brainres.2015.09.035; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kim C, 2016, EXP NEUROBIOL, V25, P113, DOI 10.5607/en.2016.25.3.113; Kim S, 2018, P NATL ACAD SCI USA, V115, P798, DOI 10.1073/pnas.1700465115; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Kim TH, 2012, BIOCONJUGATE CHEM, V23, P2214, DOI 10.1021/bc300265n; Kim TH, 2011, BIOCONJUGATE CHEM, V22, P625, DOI 10.1021/bc100404x; Lee CH, 2018, MOL NEUROBIOL, V55, P3007, DOI 10.1007/s12035-017-0550-2; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee Y, 2013, NAT NEUROSCI, V16, P1392, DOI 10.1038/nn.3500; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mao XB, 2016, SCIENCE, V353, DOI 10.1126/science.aah3374; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Polinski NK, 2018, J PARKINSON DIS, V8, P303, DOI 10.3233/JPD-171248; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Ventorp F, 2017, J PARKINSON DIS, V7, P263, DOI 10.3233/JPD-171068; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wu HY, 2018, J NEUROIMMUNOL, V316, P17, DOI 10.1016/j.jneuroim.2017.12.005; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	44	430	441	15	183	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					931	+		10.1038/s41591-018-0051-5	http://dx.doi.org/10.1038/s41591-018-0051-5			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892066	Green Accepted			2022-12-27	WOS:000438187700020
J	Xu, R; Yallowitz, A; Qin, A; Wu, ZH; Shin, DY; Kim, JM; Debnath, S; Ji, G; Bostrom, MP; Yang, X; Zhang, C; Dong, H; Kermani, P; Lalani, S; Li, N; Liu, YF; Poulos, MG; Wach, A; Zhang, Y; Inoue, K; Di Lorenzo, A; Zhao, BH; Butler, JM; Shim, JH; Glimcher, LH; Greenblatt, MB				Xu, Ren; Yallowitz, Alisha; Qin, An; Wu, Zhuhao; Shin, Dong Yeon; Kim, Jung-Min; Debnath, Shawon; Ji, Gang; Bostrom, Mathias P.; Yang, Xu; Zhang, Chao; Dong, Han; Kermani, Pouneh; Lalani, Sarfaraz; Li, Na; Liu, Yifang; Poulos, Michael G.; Wach, Amanda; Zhang, Yi; Inoue, Kazuki; Di Lorenzo, Annarita; Zhao, Baohong; Butler, Jason M.; Shim, Jae-Hyuck; Glimcher, Laurie H.; Greenblatt, Matthew B.			Targeting skeletal endothelium to ameliorate bone loss	NATURE MEDICINE			English	Article							OSTEOBLAST DIFFERENTIATION; VASCULAR NETWORK; ANGIOGENESIS; ROBO; SLIT2; OSTEOGENESIS; MAINTENANCE; EXPRESSION; ROLES; MICE	Recent studies have identified a specialized subset of CD31(hi)endomucin(hi) (CD31(hi)EMCN(hi)) vascular endothelium that positively regulates bone formation. However, it remains unclear how CD31(hi)EMCN(hi) endothelium levels are coupled to anabolic bone formation. Mice with an osteoblast-specific deletion of Shn3, which have markedly elevated bone formation, demonstrated an increase in CD31(hi)EMCN(hi) endothelium. Transcriptomic analysis identified SLIT3 as an osteoblast-derived, SHN3-regulated proangiogenic factor. Genetic deletion of Slit3 reduced skeletal CD31(hi)EMCN(hi) endothelium, resulted in low bone mass because of impaired bone formation and partially reversed the high bone mass phenotype of Shn3(-/-) mice. This coupling between osteo-blasts and CD31(hi)EMCN(hi) endothelium is essential for bone healing, as shown by defective fracture repair in SLIT3-mutant mice and enhanced fracture repair in SHN3-mutant mice. Finally, administration of recombinant SLIT3 both enhanced bone fracture healing and counteracted bone loss in a mouse model of postmenopausal osteoporosis. Thus, drugs that target the SLIT3 pathway may represent a new approach for vascular-targeted osteoanabolic therapy to treat bone loss.	[Xu, Ren; Yallowitz, Alisha; Shin, Dong Yeon; Debnath, Shawon; Lalani, Sarfaraz; Li, Na; Liu, Yifang; Zhang, Yi; Di Lorenzo, Annarita; Greenblatt, Matthew B.] Cornell Univ, Dept Pathol & Lab Med, New York, NY 10021 USA; [Qin, An] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed, Shanghai Key Lab Orthopaed Implant,Sch Med, Shanghai, Peoples R China; [Wu, Zhuhao] Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10021 USA; [Kim, Jung-Min; Shim, Jae-Hyuck] Univ Massachusetts, Dept Med, Med Sch, Div Rheumatol, Worcester, MA USA; [Ji, Gang; Bostrom, Mathias P.; Yang, Xu] Hosp Special Surg, Res Div, 535 E 70th St, New York, NY 10021 USA; [Ji, Gang] Hebei Med Univ, Dept Joint Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Bostrom, Mathias P.] Hosp Special Surg, Div Adult Reconstruct & Joint Replacement, Dept Orthopaed Surg, 535 E 70th St, New York, NY 10021 USA; [Zhang, Chao] Cornell Univ, Inst Computat Biomed, New York, NY 10021 USA; [Dong, Han; Glimcher, Laurie H.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Dong, Han; Glimcher, Laurie H.] Harvard Univ, Med Sch, Boston, MA 02115 USA; [Dong, Han; Glimcher, Laurie H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Dong, Han; Glimcher, Laurie H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kermani, Pouneh; Poulos, Michael G.; Butler, Jason M.] Cornell Univ, Ansary Stem Cell Inst, Dept Med, Div Regenerat Med, New York, NY 10021 USA; [Wach, Amanda] Hosp Special Surg, Dept Biomech, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Hosp Special Surg, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA; [Inoue, Kazuki; Zhao, Baohong] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Shanghai Jiao Tong University; Rockefeller University; University of Massachusetts System; University of Massachusetts Worcester; Hebei Medical University; Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Cornell University; Cornell University	Greenblatt, MB (corresponding author), Cornell Univ, Dept Pathol & Lab Med, New York, NY 10021 USA.; Glimcher, LH (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Univ, Med Sch, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Glimcher, LH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	laurie_glimcher@dfci.harvard.edu; mag3003@med.cornell.edu	Inoue, Kazuki/GRY-3245-2022; Wu, Zhuhao/I-5852-2018; Kim, Jung Min/AAL-8604-2021; JI, Gang/AAG-9877-2020; xu, ren/G-6907-2015; Zhang, Chao/E-6476-2015	Kim, Jung Min/0000-0002-9072-4293; JI, Gang/0000-0002-2415-6275; Wu, Zhuhao/0000-0002-2471-0555; Di Lorenzo, Annarita/0000-0003-1239-4222; Shim, Jae-Hyuck/0000-0002-4947-3293; Lalani, Sarfaraz/0000-0003-3624-9409; xu, ren/0000-0001-6578-4553; Yang, Xu/0000-0001-8377-077X; Zhang, Chao/0000-0001-8019-7998	Career Award for Medical Scientists from the Burroughs Wellcome Foundation; Office of the Director of the NIH [DP5OD021351]; Musculoskeletal Transplant Foundation; March of Dimes Basil O'Connor Award; National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH [R01AR068983]; pilot project program award from UMass Center for Clinical and Translational Science; NIH/National Heart, Lung, and Blood Institute [R01 HL126913]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068970, R01AR068983, R01AR071463] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021351] Funding Source: NIH RePORTER	Career Award for Medical Scientists from the Burroughs Wellcome Foundation; Office of the Director of the NIH; Musculoskeletal Transplant Foundation; March of Dimes Basil O'Connor Award(March of Dimes); National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); pilot project program award from UMass Center for Clinical and Translational Science; NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the many individuals who provided valuable reagents. M.B.G. holds a Career Award for Medical Scientists from the Burroughs Wellcome Foundation and is supported by the Office of the Director of the NIH under award DP5OD021351, a Junior Investigator Award from the Musculoskeletal Transplant Foundation and a March of Dimes Basil O'Connor Award. J.-H.S. is supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH under R01AR068983 and a pilot project program award from UMass Center for Clinical and Translational Science. A.D.L. is supported by NIH/National Heart, Lung, and Blood Institute under R01 HL126913. This content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We thank D. Ballon, B. He, B. - S. Ding and J. McCormick and Citigroup Biomedical Imaging Core, Weill Cornell Microscopy and Image Analysis and Flow Cytometry Core Facilities for technical support.	Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Bradaschia-Correa V, 2017, J BONE MINER RES, V32, P821, DOI 10.1002/jbmr.3045; Buza JA, 2016, CLIN CASES MINER BON, V13, P101, DOI 10.11138/ccmbm/2016.13.2.101; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choi HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7943; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Geutskens SB, 2012, LAB INVEST, V92, P1129, DOI 10.1038/labinvest.2012.81; Geutskens SB, 2010, J IMMUNOL, V185, P7691, DOI 10.4049/jimmunol.0903898; Greenblatt MB, 2016, P NATL ACAD SCI USA, V113, pE1226, DOI 10.1073/pnas.1600813113; Han WQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36330; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaworski A, 2012, NAT NEUROSCI, V15, P367, DOI 10.1038/nn.3037; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Leder BZ, 2015, LANCET, V386, P1147, DOI 10.1016/S0140-6736(15)61120-5; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Naska S, 2010, MOL CELL NEUROSCI, V45, P108, DOI 10.1016/j.mcn.2010.05.015; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Paul JD, 2013, J MOL CELL CARDIOL, V64, P124, DOI 10.1016/j.yjmcc.2013.09.005; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Ramalingam P, 2017, CURR OPIN HEMATOL, V24, P289, DOI 10.1097/MOH.0000000000000350; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sakabe M, 2017, P NATL ACAD SCI USA, V114, P10918, DOI 10.1073/pnas.1704030114; Shim JH, 2013, J CLIN INVEST, V123, P4010, DOI 10.1172/JCI69443; Shin M, 2016, DEVELOPMENT, V143, P3796, DOI 10.1242/dev.137919; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun HL, 2009, CELLS TISSUES ORGANS, V190, P69, DOI 10.1159/000178020; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Vasam G, 2017, DIABETES, V66, P505, DOI 10.2337/db16-1039; Wein MN, 2012, P NATL ACAD SCI USA, V109, P8173, DOI 10.1073/pnas.1205848109; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Xu R, 2017, J BONE MINER RES, V32, P1811, DOI 10.1002/jbmr.3184; Xu R, 2014, CELL ADHES MIGR, V8, P5, DOI 10.4161/cam.27752; Yuan WL, 2003, P NATL ACAD SCI USA, V100, P5217, DOI 10.1073/pnas.0730709100; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang C, 2012, BIOINFORMATICS, V28, P1943, DOI 10.1093/bioinformatics/bts278; Zhang JZ, 2016, J BONE MINER RES, V31, P2001, DOI 10.1002/jbmr.2877; Zhang YF, 2016, NAT MED, V22, P1160, DOI 10.1038/nm.4162; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416	51	124	138	11	90	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					823	+		10.1038/s41591-018-0020-z	http://dx.doi.org/10.1038/s41591-018-0020-z			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29785024	Green Accepted			2022-12-27	WOS:000434281300027
J	Qazi, MA; Bakhshinyan, D; Singh, SK				Qazi, Maleeha A.; Bakhshinyan, David; Singh, Sheila K.			Deciphering brain tumor heterogeneity, one cell at a time	NATURE MEDICINE			English	Editorial Material							GLIOBLASTOMA; EVOLUTION; SUBTYPES		[Qazi, Maleeha A.; Bakhshinyan, David; Singh, Sheila K.] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Qazi, Maleeha A.; Bakhshinyan, David; Singh, Sheila K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Singh, Sheila K.] McMaster Univ, Dept Surg, Fac Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Singh, SK (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON, Canada.; Singh, SK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Singh, SK (corresponding author), McMaster Univ, Dept Surg, Fac Hlth Sci, Hamilton, ON, Canada.	ssingh@mcmaster.ca	Singh, Sheila K/W-2799-2018	Singh, Sheila K/0000-0003-1272-5300; Qazi, Maleeha/0000-0001-8350-1094				Gao RL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00244-w; Hovestadt V, 2019, NATURE, V572, P74, DOI 10.1038/s41586-019-1434-6; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ramaswamy V, 2013, LANCET ONCOL, V14, P1200, DOI 10.1016/S1470-2045(13)70449-2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2019, MOL CELL, V75, P7, DOI 10.1016/j.molcel.2019.05.003; Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003	13	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1474	1476		10.1038/s41591-019-0605-1	http://dx.doi.org/10.1038/s41591-019-0605-1			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31541226				2022-12-27	WOS:000489166700014
J	Reimers, P; Witten, C; Coutsoudis, A				Reimers, Penelope; Witten, Chantell; Coutsoudis, Anna			Local variations in exclusive breastfeeding rates in Africa	NATURE MEDICINE			English	Editorial Material							CHILD UNDERNUTRITION	Large-scale analysis of 49 countries in Africa shows improvements in the prevalence of babies under 6 months of age being fed only breast milk, but there are large disparities in progress across and within countries.	[Reimers, Penelope; Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, South Africa; [Witten, Chantell] North West Univ, Sch Physiol Nutr & Consumer Sci, Potchefstroom, South Africa	University of Kwazulu Natal; North West University - South Africa	Reimers, P (corresponding author), Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, South Africa.	pennyreimers@outlook.com	Reimers, Penelope/S-9568-2019	Reimers, Penelope/0000-0001-6864-8477; Olifant, Bakang/0000-0003-1780-3689				[Anonymous], 2018, BREASTF SCOR 2018 EN; Bhattacharjee NV, 2019, NAT MED, V25, P1205, DOI 10.1038/s41591-019-0525-0; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Nieuwoudt S, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0164-y; Odeny BM, 2016, BREASTFEED MED, V11, P252, DOI 10.1089/bfm.2016.0014; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sinha B, 2017, J NUTR, V147, p2179S, DOI 10.3945/jn.116.242321; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, 2014, WHONMHNHD147; World Health Organization, 2011, COUNTR IMPL INT COD; World Health Organization and the United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN	12	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1190	1191		10.1038/s41591-019-0532-1	http://dx.doi.org/10.1038/s41591-019-0532-1			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31332394				2022-12-27	WOS:000480414600012
J	Li, D; March, ME; Gutierrez-Uzquiza, A; Kao, C; Seiler, C; Pinto, E; Matsuoka, LS; Battig, MR; Bhoj, EJ; Wenger, TL; Tian, LF; Robinson, N; Wang, TC; Liu, YC; Weinstein, BM; Swift, M; Jung, HM; Kaminski, CN; Chiavacci, R; Perkins, JA; Levine, MA; Sleiman, PMA; Hicks, PJ; Strausbaugh, JT; Belasco, JB; Dori, Y; Hakonarson, H				Li, Dong; March, Michael E.; Gutierrez-Uzquiza, Alvaro; Kao, Charlly; Seiler, Christoph; Pinto, Erin; Matsuoka, Leticia S.; Battig, Mark R.; Bhoj, Elizabeth J.; Wenger, Tara L.; Tian, Lifeng; Robinson, Nora; Wang, Tiancheng; Liu, Yichuan; Weinstein, Brant M.; Swift, Matthew; Jung, Hyun Min; Kaminski, Courtney N.; Chiavacci, Rosetta; Perkins, Jonathan A.; Levine, Michael A.; Sleiman, Patrick M. A.; Hicks, Patricia J.; Strausbaugh, Janet T.; Belasco, Jean B.; Dori, Yoav; Hakonarson, Hakon			ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor	NATURE MEDICINE			English	Article							NOONAN SYNDROME; VASCULAR ANOMALIES; CHYLOTHORAX; RAF; PHENOTYPE; VESSELS; HYDROPS; FETUSES; SYSTEM	The treatment of lymphatic anomaly, a rare devastating disease spectrum of mostly unknown etiologies, depends on the patient manifestations(1). Identifying the causal genes will allow for developing affordable therapies in keeping with precision medicine implementation(2). Here we identified a recurrent gain-of-function ARAF mutation (c. 640T> C: p. S214P) in a 12-year-old boy with advanced anomalous lymphatic disease unresponsive to conventional sirolimus therapy and in another, unrelated, adult patient. The mutation led to loss of a conserved phosphorylation site. Cells transduced with ARAF-S214P showed elevated ERK1/ 2 activity, enhanced lymphangiogenic capacity, and disassembly of actin skeleton and VE-cadherin junctions, which were rescued using the MEK inhibitor trametinib. The functional relevance of the mutation was also validated by recreating a lymphatic phenotype in a zebrafish model, with rescue of the anomalous phenotype using a MEK inhibitor. Subsequent therapy of the lead proband with a MEK inhibitor led to dramatic clinical improvement, with remodeling of the patient's lymphatic system with resolution of the lymphatic edema, marked improvement in his pulmonary function tests, cessation of supplemental oxygen requirements and near normalization of daily activities. Our results provide a representative demonstration of how knowledge of genetic classification and mechanistic understanding guides biologically based medical treatments, which in our instance was life-saving.	[Li, Dong; March, Michael E.; Gutierrez-Uzquiza, Alvaro; Kao, Charlly; Matsuoka, Leticia S.; Battig, Mark R.; Bhoj, Elizabeth J.; Tian, Lifeng; Robinson, Nora; Wang, Tiancheng; Liu, Yichuan; Kaminski, Courtney N.; Chiavacci, Rosetta; Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Seiler, Christoph] Childrens Hosp Philadelphia, Res Inst, Zebrafish Core Facil, Philadelphia, PA 19104 USA; [Pinto, Erin; Dori, Yoav] Childrens Hosp Philadelphia, Ctr Lymphat Imaging & Intervent, Philadelphia, PA 19104 USA; [Wenger, Tara L.] Seattle Childrens Hosp, Div Craniofacial Med, Seattle, WA USA; [Weinstein, Brant M.; Jung, Hyun Min] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Dev Biol, NIH, Bethesda, MD USA; [Swift, Matthew] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Perkins, Jonathan A.] Seattle Childrens Hosp, Div Otolaryngol Head & Neck Surg, Seattle, WA USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Levine, Michael A.; Sleiman, Patrick M. A.; Hicks, Patricia J.; Strausbaugh, Janet T.; Belasco, Jean B.; Dori, Yoav; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Belasco, Jean B.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA; [Gutierrez-Uzquiza, Alvaro] Univ Complutense Madrid, Sch Pharm, Dept Biochem & Mol Biol 2, Madrid, Spain	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University; Seattle Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Complutense University of Madrid	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.; Hakonarson, H (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.; Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.; Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu	March, Michael/AAB-6502-2019; Liu, Yichuan/AAF-3893-2021; Uzquiza, Alvaro Gutierrez/E-4073-2012	March, Michael/0000-0001-9173-6862; Uzquiza, Alvaro Gutierrez/0000-0002-0446-4131; Hicks, Patricia/0000-0003-3781-780X; LIU, YICHUAN/0000-0003-2023-072X; Levine, Michael/0000-0003-0036-7809	Roberts Collaborative Functional Genomics Rapid Grant from CHOP; Institutional Development Funds from CHOP; CHOP's Endowed Chair in Genomic Research; Aevi Genomic Medicine Inc.	Roberts Collaborative Functional Genomics Rapid Grant from CHOP; Institutional Development Funds from CHOP; CHOP's Endowed Chair in Genomic Research; Aevi Genomic Medicine Inc.	We thank all of the families involved in this study for their participation. We gratefully acknowledge L. Klepper, T. Ferry and J. Kelly, who helped with the collection of the DNA samples and clinical data on patient P2. Research reported in this publication was supported in part by the Roberts Collaborative Functional Genomics Rapid Grant (to D.L.) from CHOP, Institutional Development Funds (to H.H.) from CHOP, CHOP's Endowed Chair in Genomic Research (H.H) and donation from the Adele and Daniel Kubert family (to H.H. and CAG). The study was also funded in part through a sponsored research agreement from Aevi Genomic Medicine Inc., funding discovery and translation of rare and orphan disease genes at the CAG.	Adams DM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3257; Barclay SF, 2019, GENET MED, V21, P1517, DOI 10.1038/s41436-018-0390-0; Brouillard P, 2014, J CLIN INVEST, V124, P898, DOI 10.1172/JCI71614; Bulow L, 2015, AM J MED GENET A, V167, P394, DOI 10.1002/ajmg.a.36838; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen W, 2013, J PEDIATR SURG, V48, pE9, DOI 10.1016/j.jpedsurg.2013.01.017; Clemens RK, 2015, VASA, V44, P92, DOI 10.1024/0301-1526/a000414; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Coso S, 2014, BLOOD, V123, P2614, DOI 10.1182/blood-2013-12-297317; Croonen EA, 2013, EUR J HUM GENET, V21, P936, DOI 10.1038/ejhg.2012.285; Ebrahimi-Fakhari D, 2017, J PEDIATR-US, V185, P248, DOI 10.1016/j.jpeds.2017.02.042; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gargano G, 2014, AM J MED GENET A, V164, P1015, DOI 10.1002/ajmg.a.36376; Gos M, 2014, AM J MED GENET A, V164, P2310, DOI 10.1002/ajmg.a.36646; Grzegorski SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108475; Hammill AM, 2011, PEDIATR BLOOD CANCER, V57, P1018, DOI 10.1002/pbc.23124; Hanson HL, 2014, AM J MED GENET A, V164, P1003, DOI 10.1002/ajmg.a.36375; HILLIARD RI, 1990, PEDIATRICS, V86, P988; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joyce S, 2016, EUR J HUM GENET, V24, P690, DOI 10.1038/ejhg.2015.175; Jung HM, 2017, DEVELOPMENT, V144, P2070, DOI 10.1242/dev.145755; Karaman S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.151019; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Koenighofer M, 2016, CLIN GENET, V89, P359, DOI 10.1111/cge.12608; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lala S, 2013, SKELETAL RADIOL, V42, P917, DOI 10.1007/s00256-012-1565-4; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lee KA, 2009, CLIN GENET, V75, P190, DOI 10.1111/j.1399-0004.2008.01085.x; LEVINE C, 1989, J PEDIATR SURG, V24, P233, DOI 10.1016/S0022-3468(89)80001-6; Li D, 2018, HUM MOL GENET, V27, P3233, DOI 10.1093/hmg/ddy218; Lo IFM, 2008, J MED GENET, V45, P167, DOI 10.1136/jmg.2007.054411; Manevitz-Mendelson E, 2018, ANGIOGENESIS, V21, P287, DOI 10.1007/s10456-018-9595-8; McCormick A, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2694; Milosavljevic D, 2016, AM J MED GENET A, V170, P1874, DOI 10.1002/ajmg.a.37657; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; Morcaldi G, 2015, LYMPHOLOGY, V48, P121; Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SMELTZER DM, 1986, EUR J PEDIATR, V145, P286, DOI 10.1007/BF00439402; Trenor CC, 2014, SEMIN PEDIATR SURG, V23, P186, DOI 10.1053/j.sempedsurg.2014.07.006; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Wassef M, 2015, PEDIATRICS, V136, pE203, DOI 10.1542/peds.2014-3673; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yaoita M, 2016, HUM GENET, V135, P209, DOI 10.1007/s00439-015-1627-5	46	80	82	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1116	+		10.1038/s41591-019-0479-2	http://dx.doi.org/10.1038/s41591-019-0479-2			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31263281				2022-12-27	WOS:000474430400026
J	Voorwerk, L; Slagter, M; Horlings, HM; Sikorska, K; van de Vijver, KK; de Maaker, M; Nederlof, I; Kluin, RJC; Warren, S; Ong, S; Wiersma, TG; Russell, NS; Lalezari, F; Schouten, PC; Bakker, NAM; Ketelaars, SLC; Peters, D; Lange, CAH; van Werkhoven, E; van Tinteren, H; Mandjes, IAM; Kemper, I; Onderwater, S; Chalabi, M; Wilgenhof, S; Haanen, JBAG; Salgado, R; de Visser, KE; Sonke, GS; Wessels, LFA; Linn, SC; Schumacher, TN; Blank, CU; Kok, M				Voorwerk, Leonie; Slagter, Maarten; Horlings, Hugo M.; Sikorska, Karolina; van de Vijver, Koen K.; de Maaker, Michiel; Nederlof, Iris; Kluin, Roelof J. C.; Warren, Sarah; Ong, Sufey; Wiersma, Terry G.; Russell, Nicola S.; Lalezari, Ferry; Schouten, Philip C.; Bakker, Noor A. M.; Ketelaars, Steven L. C.; Peters, Dennis; Lange, Charlotte A. H.; van Werkhoven, Erik; van Tinteren, Harm; Mandjes, Ingrid A. M.; Kemper, Inge; Onderwater, Suzanne; Chalabi, Myriam; Wilgenhof, Sofie; Haanen, John B. A. G.; Salgado, Roberto; de Visser, Karin E.; Sonke, Gabe S.; Wessels, Lodewyk F. A.; Linn, Sabine C.; Schumacher, Ton N.; Blank, Christian U.; Kok, Marleen			Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial	NATURE MEDICINE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RANDOMIZED PHASE-II; COPY NUMBER; SURVIVAL; PROTEASOME; SIGNATURES; CISPLATIN; CETUXIMAB; PROFILES; EFFICACY	The efficacy of programmed cell death protein 1 (PD-1) blockade in metastatic triple-negative breast cancer (TNBC) is low(1-5), highlighting a need for strategies that render the tumor microenvironment more sensitive to PD-1 blockade. Preclinical research has suggested immunomodulatory properties for chemotherapy and irradiation(6-13). In the first stage of this adaptive, non-comparative phase 2 trial, 67 patients with metastatic TNBC were randomized to nivolumab (1) without induction or with 2-week low-dose induction, or with (2) irradiation (3 x 8 Gy), (3) cyclophosphamide, (4) cisplatin or (5) doxorubicin, all followed by nivolumab. In the overall cohort, the objective response rate (ORR; iRECIST(14)) was 20%. The majority of responses were observed in the cisplatin (ORR 23%) and doxorubicin (ORR 35%) cohorts. After doxorubicin and cisplatin induction, we detected an upregulation of immune-related genes involved in PD-1-PD-L1 (programmed death ligand 1) and T cell cytotoxicity pathways. This was further supported by enrichment among upregulated genes related to inflammation, JAK-STAT and TNF-alpha signaling after doxorubicin. Together, the clinical and translational data of this study indicate that short-term doxorubicin and cisplatin may induce a more favorable tumor microenvironment and increase the likelihood of response to PD-1 blockade in TNBC. These data warrant confirmation in TNBC and exploration of induction treatments prior to PD-1 blockade in other cancer types.	[Voorwerk, Leonie; Slagter, Maarten; Ketelaars, Steven L. C.; Chalabi, Myriam; Haanen, John B. A. G.; Schumacher, Ton N.; Blank, Christian U.; Kok, Marleen] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Slagter, Maarten; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Slagter, Maarten; Bakker, Noor A. M.; de Visser, Karin E.; Wessels, Lodewyk F. A.; Schumacher, Ton N.] Oncode Inst, Utrecht, Netherlands; [Horlings, Hugo M.; van de Vijver, Koen K.] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [Sikorska, Karolina; van Werkhoven, Erik; van Tinteren, Harm; Mandjes, Ingrid A. M.] Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [van de Vijver, Koen K.] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium; [de Maaker, Michiel; Nederlof, Iris; Schouten, Philip C.; Linn, Sabine C.] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Kluin, Roelof J. C.] Netherlands Canc Inst, Genom Core Facil, Amsterdam, Netherlands; [Warren, Sarah; Ong, Sufey] NanoString Technol Inc, Seattle, WA USA; [Wiersma, Terry G.; Russell, Nicola S.] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [Lalezari, Ferry; Lange, Charlotte A. H.] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands; [Bakker, Noor A. M.; de Visser, Karin E.] Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands; [Peters, Dennis] Netherlands Canc Inst, Core Facil Mol Pathol & Biobanking, Amsterdam, Netherlands; [Kemper, Inge; Onderwater, Suzanne; Wilgenhof, Sofie; Haanen, John B. A. G.; Sonke, Gabe S.; Linn, Sabine C.; Blank, Christian U.; Kok, Marleen] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Chalabi, Myriam] Netherlands Canc Inst, Dept Gastrointestinal Oncol, Amsterdam, Netherlands; [Salgado, Roberto] GZA ZNA Ziekenhuizen, Dept Pathol, Antwerp, Belgium; [Salgado, Roberto] Peter Mac Callum Canc Ctr, Div Res, Melbourne, Vic, Australia	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Ghent University; Ghent University Hospital; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Peter Maccallum Cancer Center	Kok, M (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Kok, M (corresponding author), Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands.	m.kok@nki.nl	Van de Vijver, Koen/N-7895-2019; Haanen, John/AAD-8534-2022; Salgado, Roberto/AAG-6677-2020; Haanen, John/AAD-8578-2022; Schumacher, Ton/Y-2432-2019; van Werkhoven, Erik/ABE-8062-2020	Van de Vijver, Koen/0000-0002-2026-9790; Haanen, John/0000-0001-5884-7704; Schumacher, Ton/0000-0003-0517-8804; Kluin, Roel/0000-0002-5133-142X; de Visser, Karin/0000-0002-0293-868X; Horlings, Hugo/0000-0003-4782-8828; Nederlof, Iris/0000-0001-7608-6515; van Tinteren, Harm/0000-0002-4626-8702	BMS/II-ON; Dutch Cancer Society [NKI2015-7710, 10653 ALPE, NKI2015-7542, NKI2016-8214]; Breast Cancer Research Foundation [BCRF-17-188, BCRF-17-194]	BMS/II-ON; Dutch Cancer Society(KWF Kankerbestrijding); Breast Cancer Research Foundation	We thank the patients and their families for participating in the study. We thank J. Foekema, M. Holtkamp, M. Delfos, J. van Zyl-de Jong and K. Kersten for their support in the care for patients. We thank S. Vanhoutvin for legal support. We thank the Core Facility of Molecular Pathology & Biobanking for their support in processing of samples. In addition, we acknowledge the Genomics Core Facility for their support regarding sequencing. We acknowledge J. Lips from Adaptive Biotechnologies for his support. We thank the scientific administration department, in particular L. Ruiter, for data management/monitoring. The Clinical Chemistry Department is thanked for their support in blood withdrawals. We thank H. Garner, M. van der Heijden and J. Stouthard for critical reading of the manuscript. We acknowledge D. Cullen, A. Evans, D. Zardavas and D. Feltquate of Bristol-Myers Squibb (BMS) for scientific input. We thank BMS/II-ON and the Dutch Cancer Society (NKI2015-7710, 10653 ALPE) for funding the study and a fellowship to M. K. (NKI2015-7542). Pink Ribbon (NKI2016-8214), the Breast Cancer Research Foundation (BCRF-17-188) and BMS/II-ON are thanked for the funding of the translational research. R.S. is supported by a grant from the Breast Cancer Research Foundation (BCRF-17-194).	Adams S, 2019, ANN ONCOL, V30, P405, DOI 10.1093/annonc/mdy518; Adams S, 2019, JAMA ONCOL, V5, P334, DOI 10.1001/jamaoncol.2018.5152; Alizadeh D, 2014, CANCER RES, V74, P104, DOI 10.1158/0008-5472.CAN-13-1545; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Baselga J, 2013, J CLIN ONCOL, V31, P2586, DOI 10.1200/JCO.2012.46.2408; Bezzi M, 2018, NAT MED, V24, P165, DOI 10.1038/nm.4463; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DANAHER P, 2018, J CLIN ONCOL S, V36; Danaher P, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0215-8; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; de Biasi AR, 2014, CLIN CANCER RES, V20, P5384, DOI 10.1158/1078-0432.CCR-14-1298; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; den Brok WD, 2017, BREAST CANCER RES TR, V161, P549, DOI 10.1007/s10549-016-4080-9; Dirix LY, 2018, BREAST CANCER RES TR, V167, P671, DOI 10.1007/s10549-017-4537-5; EFRON B, 1976, BIOMETRIKA, V63, P435, DOI 10.1093/biomet/63.3.435; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emens LA, 2019, JAMA ONCOL, V5, P74, DOI 10.1001/jamaoncol.2018.4224; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Greenall S, 2018, ANN ONCOL, V29; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kok M, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00052; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Loibl S, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.104; Love MI, 2016, NAT BIOTECHNOL, V34, P1287, DOI 10.1038/nbt.3682; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MOLINERO L, 2018, CANCER RES S, V78; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; R Core Team, 2018, R LANG ENV STAT COMP; Rimm DL, 2017, JAMA ONCOL, V3, P1051, DOI 10.1001/jamaoncol.2017.0013; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Schmid P, 2019, NEW ENGL J MED, V380, P987, DOI 10.1056/NEJMc1900150; Schouten PC, 2015, MOL ONCOL, V9, P1274, DOI 10.1016/j.molonc.2015.03.002; Scurr M, 2017, CLIN CANCER RES, V23, P6771, DOI 10.1158/1078-0432.CCR-17-0895; Seymour L, 2017, LANCET ONCOL, V18, pE143, DOI 10.1016/S1470-2045(17)30074-8; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Singh JC, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3634; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Wan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032542; Zavalishina L, 2018, VIRCHOWS ARCH, V473, P719, DOI 10.1007/s00428-018-2453-7	60	370	381	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					920	+		10.1038/s41591-019-0432-4	http://dx.doi.org/10.1038/s41591-019-0432-4			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31086347				2022-12-27	WOS:000470844400022
J	Rothwell, DG; Ayub, M; Cook, N; Thistlethwaite, F; Carter, L; Dean, E; Smith, N; Villa, S; Dransfield, J; Clipson, A; White, D; Nessa, K; Ferdous, S; Howell, M; Gupta, A; Kilerci, B; Mohan, S; Frese, K; Gulati, S; Miller, C; Jordan, A; Eaton, H; Hickson, N; O'Brien, C; Graham, D; Kelly, C; Aruketty, S; Metcalf, R; Chiramel, J; Tinsley, N; Vickers, AJ; Kurup, R; Frost, H; Stevenson, J; Southam, S; Landers, D; Wallace, A; Marais, R; Hughes, AM; Brady, G; Dive, C; Krebs, MG				Rothwell, Dominic G.; Ayub, Mahmood; Cook, Natalie; Thistlethwaite, Fiona; Carter, Louise; Dean, Emma; Smith, Nigel; Villa, Shaun; Dransfield, Joanne; Clipson, Alexandra; White, Daniel; Nessa, Kamrun; Ferdous, Saba; Howell, Matthew; Gupta, Avinash; Kilerci, Bedirhan; Mohan, Sumitra; Frese, Kris; Gulati, Sakshi; Miller, Crispin; Jordan, Allan; Eaton, Helen; Hickson, Nicholas; O'Brien, Ciara; Graham, Donna; Kelly, Claire; Aruketty, Sreeja; Metcalf, Robert; Chiramel, Jaseela; Tinsley, Nadina; Vickers, Alexander J.; Kurup, Roopa; Frost, Hannah; Stevenson, Julie; Southam, Siobhan; Landers, Donal; Wallace, Andrew; Marais, Richard; Hughes, Andrew M.; Brady, Ged; Dive, Caroline; Krebs, Matthew G.			Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study	NATURE MEDICINE			English	Article							PRECISION MEDICINE; CANCERS; DNA; EFFICACY; TUMORS	Next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) supports blood-based genomic profiling but is not yet routinely implemented in the setting of a phase I trials clinic. TARGET is a molecular profiling program with the primary aim to match patients with a broad range of advanced cancers to early phase clinical trials on the basis of analysis of both somatic mutations and copy number alterations (CNA) across a 641 cancer-associated-gene panel in a single ctDNA assay. For the first 100 TARGET patients, ctDNA data showed good concordance with matched tumor and results were turned round within a clinically acceptable timeframe for Molecular Tumor Board (MTB) review. When a 2.5% variant allele frequency (VAF) threshold was applied, actionable mutations were identified in 41 of 100 patients, and 11 of these patients received a matched therapy. These data support the application of ctDNA in this early phase trial setting where broad genomic profiling of contemporaneous tumor material enhances patient stratification to novel therapies and provides a practical template for bringing routinely applied blood-based analyses to the clinic.	[Rothwell, Dominic G.; Ayub, Mahmood; Smith, Nigel; Clipson, Alexandra; White, Daniel; Nessa, Kamrun; Ferdous, Saba; Howell, Matthew; Kilerci, Bedirhan; Mohan, Sumitra; Frese, Kris; Gulati, Sakshi; Miller, Crispin; Stevenson, Julie; Southam, Siobhan; Landers, Donal; Brady, Ged; Dive, Caroline] CRUK Manchester Inst, Clin Expt Pharmacol Grp, Manchester, Lancs, England; [Cook, Natalie; Thistlethwaite, Fiona; Carter, Louise; Dean, Emma; Villa, Shaun; Dransfield, Joanne; Gupta, Avinash; O'Brien, Ciara; Graham, Donna; Kelly, Claire; Aruketty, Sreeja; Metcalf, Robert; Chiramel, Jaseela; Tinsley, Nadina; Vickers, Alexander J.; Kurup, Roopa; Frost, Hannah; Krebs, Matthew G.] Christie NHS Fdn Trust, Expt Canc Med Team, Manchester, Lancs, England; [Cook, Natalie; Thistlethwaite, Fiona; Carter, Louise; Dean, Emma; Villa, Shaun; Hughes, Andrew M.; Krebs, Matthew G.] Univ Manchester, Div Canc Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Jordan, Allan] CRUK Manchester Inst, Drug Discovery Unit, Manchester, Lancs, England; [Eaton, Helen; Hickson, Nicholas; Wallace, Andrew] North West Ctr Genom Med, Manchester, Lancs, England; [Landers, Donal] AstraZeneca, Innovat Med Biotech Unit, Cambridge, England; [Marais, Richard] CRUK Manchester Inst, Mol Oncol Grp, Manchester, Lancs, England; [Dive, Caroline] Univ Manchester, Manchester Ctr Canc Biomarker Sci, Manchester, Lancs, England	Christie NHS Foundation Trust; University of Manchester; AstraZeneca; University of Manchester	Dive, C (corresponding author), CRUK Manchester Inst, Clin Expt Pharmacol Grp, Manchester, Lancs, England.; Krebs, MG (corresponding author), Christie NHS Fdn Trust, Expt Canc Med Team, Manchester, Lancs, England.; Krebs, MG (corresponding author), Univ Manchester, Div Canc Sci, Fac Biol Med & Hlth, Manchester, Lancs, England.; Dive, C (corresponding author), Univ Manchester, Manchester Ctr Canc Biomarker Sci, Manchester, Lancs, England.	caroline.dive@manchester.ac.uk; matthew.krebs@manchester.ac.uk	Ferdous, Saba/W-5562-2019; Ayub, Mahmood/V-8792-2019; Thistlethwaite, Fiona/O-8326-2015; Cook, Natalie/O-4871-2015; Dean, Emma/J-1921-2015	Ferdous, Saba/0000-0002-7714-6732; Ayub, Mahmood/0000-0002-2096-2704; Rothwell, Dominic/0000-0002-8757-3893; Thistlethwaite, Fiona/0000-0002-4832-7008; Tinsley, Nadina/0000-0003-1877-658X; Landers, Donal/0000-0001-8376-9779; Dive, Caroline/0000-0002-1726-8850; Cook, Natalie/0000-0003-2606-1082; Howell, Matthew/0000-0003-3241-5529; Dean, Emma/0000-0001-9956-257X; Kurup, Roopa/0000-0001-5572-8507	Christie Charitable Fund; Cancer Research UK (CRUK) [A27412]; CRUK Manchester Centre [A25254]; CRUK Manchester Experimental Cancer Medicines Centre [A25146]; NIHR Manchester Biomedical Research Centre; NIHR Manchester Clinical Research Facility; Manchester Academic Health Science Centre; AstraZeneca iDECIDE Programme [119106]; CRUK Precision Panc grant [C480/A25235]; EU IMI consortium CANCER-ID [115749]; Roche Products, Ltd. through the provision of the Foundation Medicine tumor profiling service; PCRF 2012 Project Grant	Christie Charitable Fund; Cancer Research UK (CRUK)(Cancer Research UK); CRUK Manchester Centre; CRUK Manchester Experimental Cancer Medicines Centre; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Manchester Clinical Research Facility; Manchester Academic Health Science Centre; AstraZeneca iDECIDE Programme; CRUK Precision Panc grant; EU IMI consortium CANCER-ID; Roche Products, Ltd. through the provision of the Foundation Medicine tumor profiling service; PCRF 2012 Project Grant	This research was co-funded by The Christie Charitable Fund, by Cancer Research UK (CRUK) via core-funding to the CRUK Manchester Institute (grant no. A27412, R.M.), the CRUK Manchester Centre (grant no. A25254, R.M.), the CRUK Manchester Experimental Cancer Medicines Centre (grant no. A25146, R.M.) and the NIHR Manchester Biomedical Research Centre (C.D. and M.K.). This research was supported by the NIHR Manchester Clinical Research Facility, the Manchester Academic Health Science Centre, the AstraZeneca iDECIDE Programme (grant no. 119106, C.D.) awarded to Manchester Cancer Research Centre, PCRF 2012 Project Grant (C.D.), CRUK Precision Panc grant (no. C480/A25235, C.D.), the EU IMI consortium CANCER-ID (grant no. 115749-Cancer-ID, C.D.) and Roche Products, Ltd. through the provision of the Foundation Medicine tumor profiling service. The views expressed are those of the authors and not necessarily those of the funders, the NHS, the NIHR or the Department of Health.	Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Belic J, 2015, CLIN CHEM, V61, P838, DOI 10.1373/clinchem.2014.234286; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dominguez-Vigil IG, 2018, ONCOTARGET, V9, P2912, DOI 10.18632/oncotarget.23131; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; ManChon U, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003545; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Merker JD, 2018, J CLIN ONCOL, V36, P1631, DOI 10.1200/JCO.2017.76.8671; Odegaard JI, 2018, CLIN CANCER RES, V24, P3539, DOI 10.1158/1078-0432.CCR-17-3831; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Ritter DI, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0367-z; Rothwell DG, 2016, MOL ONCOL, V10, P566, DOI 10.1016/j.molonc.2015.11.006; Schwaederle M, 2016, JAMA ONCOL, V2, P1452, DOI 10.1001/jamaoncol.2016.2129; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Stockley TL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0364-2; Van Allen EM, 2013, J CLIN ONCOL, V31, P1825, DOI 10.1200/JCO.2013.48.7215; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Zill OA, 2018, CLIN CANCER RES, V24, P3528, DOI 10.1158/1078-0432.CCR-17-3837; 2017, CANCER DISCOV, V7, P400, DOI DOI 10.1158/2159-8290.CD-16-1237	27	145	147	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					738	+		10.1038/s41591-019-0380-z	http://dx.doi.org/10.1038/s41591-019-0380-z			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31011204	Green Submitted, Green Accepted			2022-12-27	WOS:000468247800016
J	Preische, O; Schultz, SA; Apel, A; Kuhle, J; Kaeser, SA; Barro, C; Graber, S; Kuder-Buletta, E; LaFougere, C; Laske, C; Voglein, J; Levin, J; Masters, CL; Martins, R; Schofield, PR; Rossor, MN; Graff-Radford, NR; Salloway, S; Ghetti, B; Ringman, JM; Noble, JM; Chhatwal, J; Goate, AM; Benzinger, TLS; Morris, JC; Bateman, RJ; Wang, GQ; Fagan, AM; McDade, EM; Gordon, BA; Jucker, M; Allegri, R; Amtashar, F; Bateman, R; Benzinger, T; Berman, S; Bodge, C; Brandon, S; Brooks, W; Buck, J; Buckles, V; Chea, S; Chhatwal, J; Chrem, P; Chui, H; Cinco, J; Clifford, J; Cruchaga, C; D'Mello, M; Donahue, T; Douglas, J; Edigo, N; Erekin-Taner, N; Fagan, A; Farlow, M; Farrar, A; Feldman, H; Flynn, G; Fox, N; Franklin, E; Fujii, H; Gant, C; Gardener, S; Ghetti, B; Goate, A; Goldman, J; Gordon, B; Graff-Radford, N; Gray, J; Gurney, J; Hassenstab, J; Hirohara, M; Holtzman, D; Hornbeck, R; DiBari, SH; Ikeuchi, T; Ikonomovic, S; Jerome, G; Jucker, M; Karch, C; Kasuga, K; Kawarabayashi, T; Klunk, W; Koeppe, R; Kuder-Buletta, E; Laske, C; Lee, JH; Levin, J; Marcus, D; Martins, R; Mason, NS; Masters, C; Maue-Dreyfus, D; McDade, E; Montoya, L; Mori, H; Morris, J; Nagamatsu, A; Neimeyer, K; Noble, J; Norton, J; Perrin, R; Raichle, M; Ringman, J; Roh, JH; Salloway, S; Schofield, P; Shimada, H; Shiroto, T; Shoji, M; Sigurdson, W; Sohrabi, H; Sparks, P; Suzuki, K; Swisher, L; Taddei, K; Wang, J; Wang, P; Weiner, M; Wolfsberger, M; Xiong, CJ; Xu, X				Preische, Oliver; Schultz, Stephanie A.; Apel, Anja; Kuhle, Jens; Kaeser, Stephan A.; Barro, Christian; Graeber, Susanne; Kuder-Buletta, Elke; LaFougere, Christian; Laske, Christoph; Voeglein, Jonathan; Levin, Johannes; Masters, Colin L.; Martins, Ralph; Schofield, Peter R.; Rossor, Martin N.; Graff-Radford, Neill R.; Salloway, Stephen; Ghetti, Bernardino; Ringman, John M.; Noble, James M.; Chhatwal, Jasmeer; Goate, Alison M.; Benzinger, Tammie L. S.; Morris, John C.; Bateman, Randall J.; Wang, Guoqiao; Fagan, Anne M.; McDade, Eric M.; Gordon, Brian A.; Jucker, Mathias; Allegri, Ricardo; Amtashar, Fatima; Bateman, Randall; Benzinger, Tammie; Berman, Sarah; Bodge, Courtney; Brandon, Susan; Brooks, William; Buck, Jill; Buckles, Virginia; Chea, Sochenda; Chhatwal, Jasmeer; Chrem, Patricio; Chui, Helena; Cinco, Jake; Clifford, Jack; Cruchaga, Carlos; D'Mello, Mirelle; Donahue, Tamara; Douglas, Jane; Edigo, Noelia; Erekin-Taner, Nilufer; Fagan, Anne; Farlow, Marty; Farrar, Angela; Feldman, Howard; Flynn, Gigi; Fox, Nick; Franklin, Erin; Fujii, Hisako; Gant, Cortaiga; Gardener, Samantha; Ghetti, Bernardino; Goate, Alison; Goldman, Jill; Gordon, Brian; Graff-Radford, Neill; Gray, Julia; Gurney, Jenny; Hassenstab, Jason; Hirohara, Mie; Holtzman, David; Hornbeck, Russ; DiBari, Siri Houeland; Ikeuchi, Takeshi; Ikonomovic, Snezana; Jerome, Gina; Jucker, Mathias; Karch, Celeste; Kasuga, Kensaku; Kawarabayashi, Takeshi; Klunk, William; Koeppe, Robert; Kuder-Buletta, Elke; Laske, Christoph; Lee, Jae-Hong; Levin, Johannes; Marcus, Daniel; Martins, Ralph; Mason, Neal Scott; Masters, Colin; Maue-Dreyfus, Denise; McDade, Eric; Montoya, Lucy; Mori, Hiroshi; Morris, John; Nagamatsu, Akem; Neimeyer, Katie; Noble, James; Norton, Joanne; Perrin, Richard; Raichle, Marc; Ringman, John; Roh, Jee Hoon; Salloway, Stephen; Schofield, Peter; Shimada, Hiroyuki; Shiroto, Tomoyo; Shoji, Mikio; Sigurdson, Wendy; Sohrabi, Hamid; Sparks, Paige; Suzuki, Kazushi; Swisher, Laura; Taddei, Kevin; Wang, Jen; Wang, Peter; Weiner, Mike; Wolfsberger, Mary; Xiong, Chengjie; Xu, Xiong		Dominantly Inherited Alzheimer Net	Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease	NATURE MEDICINE			English	Article							AUTOSOMAL-DOMINANT; LIGHT-CHAIN; NEURONAL DAMAGE; BIOMARKER; PROTEIN; BLOOD; INDIVIDUALS; MARKER; ONSET; CSF	Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly Inherited Alzheimer Network and ultrasensitive immunoassay technology to demonstrate that NfL levels in the cerebrospinal fluid (n = 187) and serum (n = 405) are correlated with one another and are elevated at the presymptomatic stages of familial Alzheimer's disease. Longitudinal, within-person analysis of serum NfL dynamics (n = 196) confirmed this elevation and further revealed that the rate of change of serum NfL could discriminate mutation carriers from non-mutation carriers almost a decade earlier than cross-sectional absolute NfL levels (that is, 16.2 versus 6.8 years before the estimated symptom onset). Serum NfL rate of change peaked in participants converting from the presymptomatic to the symptomatic stage and was associated with cortical thinning assessed by magnetic resonance imaging, but less so with amyloid-beta deposition or glucose metabolism (assessed by positron emission tomography). Serum NfL was predictive for both the rate of cortical thinning and cognitive changes assessed by the Mini-Mental State Examination and Logical Memory test. Thus, NfL dynamics in serum predict disease progression and brain neurodegeneration at the early presymptomatic stages of familial Alzheimer's disease, which supports its potential utility as a clinically useful biomarker.	[Preische, Oliver; Apel, Anja; Kaeser, Stephan A.; Graeber, Susanne; Kuder-Buletta, Elke; LaFougere, Christian; Laske, Christoph; Jucker, Mathias] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Preische, Oliver; Apel, Anja; Kaeser, Stephan A.; Laske, Christoph; Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Preische, Oliver; Apel, Anja; Kaeser, Stephan A.; Laske, Christoph; Jucker, Mathias] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Schultz, Stephanie A.; Benzinger, Tammie L. S.; Morris, John C.; Bateman, Randall J.; Wang, Guoqiao; Fagan, Anne M.; McDade, Eric M.; Gordon, Brian A.] Washington Univ, Sch Med, Dept Radiol, Dept Neurol, St Louis, MO 63110 USA; [Schultz, Stephanie A.; Benzinger, Tammie L. S.; Morris, John C.; Bateman, Randall J.; Wang, Guoqiao; Fagan, Anne M.; McDade, Eric M.; Gordon, Brian A.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Kuhle, Jens; Barro, Christian] Univ Basel, Neurol Clin & Policlin, Dept Med, Univ Hosp Basel, Basel, Switzerland; [Kuhle, Jens; Barro, Christian] Univ Basel, Neurol Clin & Policlin, Dept Biomed & Clin Res, Univ Hosp Basel, Basel, Switzerland; [Voeglein, Jonathan; Levin, Johannes] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Voeglein, Jonathan; Levin, Johannes] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany; [Masters, Colin L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Neurodegenerat Div, Parkville, Vic, Australia; [Martins, Ralph] Edith Cowan Univ, Sch Med Hlth & Sci, Joondalup, WA, Australia; [Martins, Ralph] Macquarie Univ, Dept Biomed Sci, Sydney, NSW, Australia; [Schofield, Peter R.] Neurosci Res Australia, Randwick, NSW, Australia; [Schofield, Peter R.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Rossor, Martin N.] UCL, Queen Sq Inst Neurol, Dept Neurodegenerat, Dementia Res Ctr, London, England; [Graff-Radford, Neill R.] Mayo Clin Jacksonville, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Salloway, Stephen] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Ringman, John M.] USC, Keck Sch Med, Dept Neurol, Los Angeles, CA USA; [Noble, James M.] Columbia Univ, Med Ctr, Dept Neurol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Chhatwal, Jasmeer] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Allegri, Ricardo; Chrem, Patricio; Edigo, Noelia] Inst Neurol Res, FLENI, Fdn Lucha Enfermedades Neurolog Infancia, Buenos Aires, DF, Argentina; [Amtashar, Fatima; Bateman, Randall; Benzinger, Tammie; Brandon, Susan; Buckles, Virginia; Cruchaga, Carlos; Donahue, Tamara; Fagan, Anne; Farrar, Angela; Flynn, Gigi; Franklin, Erin; Gant, Cortaiga; Gordon, Brian; Gray, Julia; Gurney, Jenny; Hassenstab, Jason; Holtzman, David; Hornbeck, Russ; Jerome, Gina; Karch, Celeste; Marcus, Daniel; Maue-Dreyfus, Denise; McDade, Eric; Morris, John; Nagamatsu, Akem; Norton, Joanne; Perrin, Richard; Raichle, Marc; Sigurdson, Wendy; Swisher, Laura; Wang, Peter; Wolfsberger, Mary; Xiong, Chengjie; Xu, Xiong] Washington Univ, Sch Med, St Louis, MO USA; [Berman, Sarah; Ikonomovic, Snezana; Klunk, William] Univ Pittsburgh, Pittsburgh, PA USA; [Bodge, Courtney; Salloway, Stephen] Brown Univ, Butler Hosp, Providence, RI 02912 USA; [Brooks, William; D'Mello, Mirelle; Schofield, Peter] Neurosci Res Australia, Sydney, NSW, Australia; [Buck, Jill; Farlow, Marty; Ghetti, Bernardino] Indiana Univ, Bloomington, IN USA; [Chea, Sochenda; Clifford, Jack; Erekin-Taner, Nilufer; Graff-Radford, Neill] Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA; [Chhatwal, Jasmeer; Sparks, Paige] Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02114 USA; [Chui, Helena; Montoya, Lucy; Ringman, John] Univ Southern Calif, Los Angeles, CA USA; [Cinco, Jake; Douglas, Jane; Fox, Nick] UCL, London, England; [Feldman, Howard] Univ Calif San Diego, San Diego, CA 92103 USA; [Fujii, Hisako; Mori, Hiroshi; Shimada, Hiroyuki] Osaka City Univ, Osaka, Japan; [Gardener, Samantha; Martins, Ralph; Sohrabi, Hamid; Taddei, Kevin] Edith Cowan Univ, Perth, WA, Australia; [Goate, Alison; Wang, Jen] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Goldman, Jill; Neimeyer, Katie; Noble, James] Columbia Univ, New York, NY USA; [Hirohara, Mie; Kawarabayashi, Takeshi; Shiroto, Tomoyo; Shoji, Mikio] Hirosaki Univ, Aomori, Japan; [DiBari, Siri Houeland; Levin, Johannes] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Ikeuchi, Takeshi; Kasuga, Kensaku] Niigata Univ, Niigata, Japan; [Jucker, Mathias; Kuder-Buletta, Elke; Laske, Christoph] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Koeppe, Robert] Univ Michigan, Ann Arbor, MI 48109 USA; [Lee, Jae-Hong; Roh, Jee Hoon] Asan Med Ctr, Seoul, South Korea; [Mason, Neal Scott] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Masters, Colin] Univ Melbourne, Melbourne, Vic, Australia; [Nagamatsu, Akem; Suzuki, Kazushi] Univ Tokyo, Tokyo, Japan; [Weiner, Mike] Univ Calif San Francisco, San Francisco, CA 94143 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Washington University (WUSTL); Washington University (WUSTL); University of Basel; University of Basel; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Edith Cowan University; Macquarie University; Neuroscience Research Australia; University of New South Wales Sydney; University of London; University College London; Mayo Clinic; Brown University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Southern California; University of Southern California Keck Hospital; Columbia University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Butler Hospital Rhode Island; Neuroscience Research Australia; Indiana University System; Indiana University Bloomington; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; University of Southern California; University of London; University College London; University of California System; University of California San Diego; Osaka Metropolitan University; Edith Cowan University; Icahn School of Medicine at Mount Sinai; Columbia University; Hirosaki University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Niigata University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Melbourne; University of Tokyo; University of California System; University of California San Francisco	Jucker, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany.; Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany.; Jucker, M (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	Benzinger, Tammie/L-6104-2013; wang, peter/AAD-5851-2020; Fox, Nick C/B-1319-2009; la Fougère, Christian/AAN-2811-2021; Barro, Christian/AAO-3567-2021; Kasuga, Kensaku/AAQ-6627-2020; Cruchaga, Carlos/ABF-4065-2020; Sohrabi, Hamid/D-2744-2013; Noble, James McCallum/AAA-4218-2020; Levin, Johannes/W-8686-2019; Kuhle, Jens/AGE-3474-2022; ALLEGRI, RICARDO FRANCISCO/AAY-4898-2021; Levin, Johannes/E-4052-2010; Gordon, Brian/U-7794-2019; Sohrabi, Hamid Reza/ABY-5173-2022; Hassenstab, Jason/AAF-2063-2020; la Fougere, Christian/G-6514-2012; JH, Roh/F-4078-2014; Gardener, Samantha/D-1718-2016; Berman, Sarah/I-2792-2014	Benzinger, Tammie/0000-0002-8114-0552; Fox, Nick C/0000-0002-6660-657X; la Fougère, Christian/0000-0001-7519-0417; Barro, Christian/0000-0002-7795-7383; Kasuga, Kensaku/0000-0002-2178-0769; Cruchaga, Carlos/0000-0002-0276-2899; Sohrabi, Hamid/0000-0001-8017-8682; Noble, James McCallum/0000-0003-0648-6702; Levin, Johannes/0000-0001-5092-4306; Levin, Johannes/0000-0001-5092-4306; Gordon, Brian/0000-0003-2109-2955; JH, Roh/0000-0002-3243-0529; Schultz, Stephanie/0000-0001-8460-4415; Feldman, Howard/0000-0002-9258-4538; Klunk, William/0000-0001-5512-0251; Gardener, Samantha/0000-0002-1933-5260; Masters, Colin/0000-0003-3072-7940; Berman, Sarah/0000-0002-5096-4962; Brooks, William Seymour/0000-0001-8603-4233; Martins, Ralph/0000-0002-4828-9363; Allegri, Ricardo Francisco/0000-0001-7166-1234; Morris, John/0000-0001-9820-5618; Rossor, Martin/0000-0001-8215-3120; Bateman, Randall/0000-0002-7729-1702; Shoji, Mikio/0000-0003-1027-1712; Jucker, Mathias/0000-0001-9045-1072	DIAN - National Institute on Aging [UF1AG032438]; German Center for Neurodegenerative Diseases (DZNE); National Institutes of Health [P30NS098577, UL1TR001873]; National Science Foundation [DGE-1745038]; Swiss National Science Foundation [320030-160221]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC Dementias Platform UK [MR/L023784/1, MR/009076/1]; MRC [MR/L023784/1, MR/L023784/2] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS098577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG032438, U24AG021886, K01AG053474, UF1AG032438] Funding Source: NIH RePORTER	DIAN - National Institute on Aging; German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); MRC Dementias Platform UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank M. Staufenbiel and M. Eichner for support and helpful comments and C. Haass and M. Suarez (Munich) for experimental and logistic support. Data collection and sharing for this project was supported by DIAN (grant no. UF1AG032438) funded by the National Institute on Aging and the German Center for Neurodegenerative Diseases (DZNE). Additional support came from the National Institutes of Health-funded NINDS Center Core for Brain Imaging (grant no. P30NS098577), the National Science Foundation (grant no. DGE-1745038), National Institutes of Health (grant no. UL1TR001873 to J.M.N.), the Swiss National Science Foundation (grant no. 320030-160221 to J.K.), the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and the MRC Dementias Platform UK (grant nos. MR/L023784/1 and MR/009076/1). We acknowledge the altruism of the participants and their families and input of the DIAN research and support staff at each of the participating sites for their contributions to this study.	Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Barro C, 2018, BRAIN, V141, P2382, DOI 10.1093/brain/awy154; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Brureau A, 2017, NEUROBIOL DIS, V104, P73, DOI 10.1016/j.nbd.2017.04.007; Burnham SC, 2016, LANCET NEUROL, V15, P1044, DOI 10.1016/S1474-4422(16)30125-9; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Cairns NJ, 2015, NEUROPATHOLOGY, V35, P390, DOI 10.1111/neup.12205; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Fandos Noelia, 2017, Alzheimers Dement (Amst), V8, P179, DOI 10.1016/j.dadm.2017.07.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gelman A, 2015, J EDUC BEHAV STAT, V40, P530, DOI 10.3102/1076998615606113; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; Henriksen K, 2014, ALZHEIMERS DEMENT, V10, P115, DOI 10.1016/j.jalz.2013.01.013; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kinnunen KM, 2018, ALZHEIMERS DEMENT, V14, P43, DOI 10.1016/j.jalz.2017.06.2268; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; McDade E, 2018, NEUROLOGY, V91, pE1295, DOI 10.1212/WNL.0000000000006277; Mielke MM, 2018, ALZHEIMERS DEMENT, V14, P989, DOI 10.1016/j.jalz.2018.02.013; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris John C, 2012, Clin Investig (Lond), V2, P975; Moulder KL, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt213; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Norgren N, 2002, HYBRIDOMA HYBRIDOM, V21, P53, DOI 10.1089/15368590252917647; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Rojas JC, 2016, ANN CLIN TRANSL NEUR, V3, P216, DOI 10.1002/acn3.290; Ryman Davis C, 2014, Neurology, V83, P253, DOI 10.1212/WNL.0000000000000596; SCHLAEPFER WW, 1977, J CELL BIOL, V74, P241, DOI 10.1083/jcb.74.1.241; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Sutphen CL, 2018, ALZHEIMERS DEMENT, V14, P869, DOI 10.1016/j.jalz.2018.01.012; Tang M, 2016, LANCET NEUROL, V15, P1317, DOI 10.1016/S1474-4422(16)30229-0; Thomas JB, 2014, JAMA NEUROL, V71, P1111, DOI 10.1001/jamaneurol.2014.1654; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Zhou WJ, 2017, NEUROSCI LETT, V650, P60, DOI 10.1016/j.neulet.2017.04.027	46	385	390	9	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					277	+		10.1038/s41591-018-0304-3	http://dx.doi.org/10.1038/s41591-018-0304-3			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30664784	Green Submitted, Green Accepted			2022-12-27	WOS:000457842100025
J	Attia, ZI; Kapa, S; Lopez-Jimenez, F; McKie, PM; Ladewig, DJ; Satam, G; Pellikka, PA; Enriquez-Sarano, M; Noseworthy, PA; Munger, TM; Asirvatham, SJ; Scott, CG; Carter, RE; Friedman, PA				Attia, Zachi I.; Kapa, Suraj; Lopez-Jimenez, Francisco; McKie, Paul M.; Ladewig, Dorothy J.; Satam, Gaurav; Pellikka, Patricia A.; Enriquez-Sarano, Maurice; Noseworthy, Peter A.; Munger, Thomas M.; Asirvatham, Samuel J.; Scott, Christopher G.; Carter, Rickey E.; Friedman, Paul A.			Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram	NATURE MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; 2013 ACCF/AHA GUIDELINE; HEART-FAILURE; TASK-FORCE; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; ASSOCIATION; MANAGEMENT; ECHOCARDIOGRAPHY; SOCIETY	Asymptomatic left ventricular dysfunction (ALVD) is present in 3-6% of the general population, is associated with reduced quality of life and longevity, and is treatable when found(1-4). An inexpensive, noninvasive screening tool for ALVD in the doctor's office is not available. We tested the hypothesis that application of artificial intelligence (AI) to the electrocardiogram (ECG), a routine method of measuring the heart's electrical activity, could identify ALVD. Using paired 12-lead ECG and echocardiogram data, including the left ventricular ejection fraction (a measure of contractile function), from 44,959 patients at the Mayo Clinic, we trained a convolutional neural network to identify patients with ventricular dysfunction, defined as ejection fraction <= 35%, using the ECG data alone. When tested on an independent set of 52,870 patients, the network model yielded values for the area under the curve, sensitivity, specificity, and accuracy of 0.93, 86.3%, 85.7%, and 85.7%, respectively. In patients without ventricular dysfunction, those with a positive AI screen were at 4 times the risk (hazard ratio, 4.1; 95% confidence interval, 3.3 to 5.0) of developing future ventricular dysfunction compared with those with a negative screen. Application of AI to the ECG-a ubiquitous, low-cost test-permits the ECG to serve as a powerful screening tool in asymptomatic individuals to identify ALVD.	[Attia, Zachi I.; Kapa, Suraj; Lopez-Jimenez, Francisco; McKie, Paul M.; Pellikka, Patricia A.; Enriquez-Sarano, Maurice; Noseworthy, Peter A.; Munger, Thomas M.; Asirvatham, Samuel J.; Friedman, Paul A.] Mayo Clin, Cardiovasc Med, Rochester, MN 55905 USA; [Ladewig, Dorothy J.; Satam, Gaurav] Mayo Clin, Business Dev, Rochester, MN USA; [Scott, Christopher G.] Mayo Clin, Hlth Sci Res, Rochester, MN USA; [Carter, Rickey E.] Mayo Clin, Hlth Sci Res, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Friedman, PA (corresponding author), Mayo Clin, Cardiovasc Med, Rochester, MN 55905 USA.	attia.itzhak@mayo.edu; friedman.paul@mayo.edu	Pellikka, Patricia A/N-5387-2014; Attia, Zachi Itzhak/AAI-2497-2019	Pellikka, Patricia A/0000-0001-6800-3521; Attia, Zachi/0000-0002-9706-7900; Enriquez-Sarano, Maurice/0000-0003-0910-5450	Mayo Clinic	Mayo Clinic	The study was conceived, funded, and executed entirely by Mayo Clinic. There was no industry support of any kind.	Al-Khatib SM, 2018, CIRCULATION, V138, pE210, DOI [10.1161/CIR.0000000000000548, 10.1161/CIR.0000000000000549]; Salazar-Licea LA, 2017, COMPUT METH PROG BIO, V143, P97, DOI 10.1016/j.cmpb.2017.02.003; Betti I, 2009, J CARD FAIL, V15, P377, DOI 10.1016/j.cardfail.2008.12.002; Bhalla V, 2005, AM J HYPERTENS, V18, p73S, DOI 10.1016/j.amjhyper.2004.11.044; Costello-Boerrigter LC, 2006, J AM COLL CARDIOL, V47, P345, DOI 10.1016/j.jacc.2005.09.025; Couderc JP, 2011, HEART RHYTHM, V8, P1036, DOI 10.1016/j.hrthm.2011.02.005; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Gholam-Hosseini H, 1998, P ANN INT IEEE EMBS, V20, P127, DOI 10.1109/IEMBS.1998.745846; Gruca TS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002909; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Khan GM, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000226; Kim JH, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/434153; Kingma DP., 2014, ADAM METHOD STOCHAST; KRIZHEVSKY A, 2012, NON TRADITIONAL REF, V1097; McDonagh Theresa A, 2008, Congest Heart Fail, V14, P5; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nagi J., 2011, 2011 IEEE International Conference on Signal and Image Processing Applications (ICSIPA 2011), P342, DOI 10.1109/ICSIPA.2011.6144164; Oetgen WJ, 2013, J AM COLL CARDIOL, V61, P1318, DOI 10.1016/j.jacc.2012.12.017; Pasquier M, 2001, NEURAL NETWORKS, V14, P1099, DOI 10.1016/S0893-6080(01)00048-X; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2004, CIRCULATION, V109, P3176, DOI 10.1161/01.CIR.0000130845.38133.8F; Sugrue A, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003830; Van Rossum G., 1995, PYTHON TUTORIAL; Wilson FN, 1944, AM HEART J, V27, P19, DOI 10.1016/S0002-8703(44)90603-4; Wingfield C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005617; Yamani H, 2012, ECHOCARDIOGR-J CARD, V29, P66, DOI 10.1111/j.1540-8175.2011.01526.x; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yasin OZ, 2017, J ELECTROCARDIOL, V50, P620, DOI 10.1016/j.jelectrocard.2017.06.008; Yoshida H, 2018, GASTRIC CANCER, V21, P249, DOI 10.1007/s10120-017-0731-8	34	318	333	23	148	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					70	+		10.1038/s41591-018-0240-2	http://dx.doi.org/10.1038/s41591-018-0240-2			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617318				2022-12-27	WOS:000455027700023
J	Feucht, J; Sun, J; Eyquem, J; Ho, YJ; Zhao, ZG; Leibold, J; Dobrin, A; Cabriolu, A; Hamieh, M; Sadelain, M				Feucht, Judith; Sun, Jie; Eyquem, Justin; Ho, Yu-Jui; Zhao, Zeguo; Leibold, Josef; Dobrin, Anton; Cabriolu, Annalisa; Hamieh, Mohamad; Sadelain, Michel			Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency	NATURE MEDICINE			English	Article							CHIMERIC ANTIGEN RECEPTOR; CD8(+); CD19; ZETA; LYMPHOCYTES; GENERATION; EFFECTOR; DOMAINS; DESIGN	Chimeric antigen receptors (CARs) are synthetic receptors that target and reprogram T cells to acquire augmented antitumor properties(1). CD19-specific CARs that comprise CD28 and CD3 zeta signaling motifs(2) have induced remarkable responses in patients with refractory leukemia(3-5) and lymphoma(6) and were recently approved by the US Food and Drug Administration(7). These CARs program highly performing effector functions that mediate potent tumor elimination(4,8) despite the limited persistence they confer on T cells(3-6,8). Extending their functional persistence without compromising their potency should improve current CAR therapies. Strong T cell activation drives exhaustion(9,10), which may be accentuated by the redundancy of CD28 and CD3 zeta signaling(11,12) as well as the spatiotemporal constraints imparted by the structure of second-generation CARs(2). Thus, we hypothesized that calibrating the activation potential of CD28-based CARs would differentially reprogram T cell function and differentiation. Here, we show that CARs encoding a single immunoreceptor tyrosine-based activation motif direct T cells to different fates by balancing effector and memory programs, thereby yielding CAR designs with enhanced therapeutic profiles.	[Feucht, Judith; Sun, Jie; Eyquem, Justin; Zhao, Zeguo; Dobrin, Anton; Cabriolu, Annalisa; Hamieh, Mohamad; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA; [Feucht, Judith; Sun, Jie; Eyquem, Justin; Zhao, Zeguo; Dobrin, Anton; Cabriolu, Annalisa; Hamieh, Mohamad; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Sun, Jie] Zhejiang Univ, Inst Hematol, Zhejing, Peoples R China; [Sun, Jie] Zhejiang Engn Lab Stem Cell & Immunotherapy, Zhejing, Peoples R China; [Ho, Yu-Jui; Leibold, Josef] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Zhejiang University; Memorial Sloan Kettering Cancer Center	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.	m-sadelain@ski.mskcc.org	Eyquem, Justin/AAW-5753-2020; Hamieh, Mohamad/AAX-3056-2020	Ho, Yu-jui/0000-0002-7540-024X; Sun, Jie/0000-0002-5642-0560; Eyquem, Justin/0000-0001-8262-1190; Zhao, Zeguo/0000-0002-2901-5033; Leibold, Josef/0000-0003-2336-1987	NCI Cancer Center Support Grant [P30 CA08748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Care-for-Rare Foundation; German Research Foundation (DFG); Edythe Griffinger Fellowship; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences; Lake Road Foundation; Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research; Lymphoma and Leukemia Society; MSKCC Support Grant/Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Care-for-Rare Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Edythe Griffinger Fellowship; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences; Lake Road Foundation; Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research; Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); MSKCC Support Grant/Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Mansilla-Soto, S. van der Stegen, F. Perna, and other Sadelain laboratory members (Memorial Sloan Kettering Cancer Center) for helpful and critical discussions and G. Gunset for excellent technical assistance. We thank the following Memorial Sloan Kettering Cancer Center (MSKCC) core facilities for the excellent support: SKI Flow Cytometry core facility; animal facility; bioinformatics core; and integrated genomics operation core, funded by the NCI Cancer Center Support Grant (P30 CA08748), Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. We thank the Care-for-Rare Foundation (J.F.), the German Research Foundation (DFG) (J.F.), the Edythe Griffinger Fellowship (J.S.), and the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences (A.D.) for their support. This work was in part supported by the Lake Road Foundation, the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Lymphoma and Leukemia Society, and the MSKCC Support Grant/Core Grant (P30 CA008748).	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chae WJ, 2004, INT IMMUNOL, V16, P1225, DOI 10.1093/intimm/dxh120; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Daniels MA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00617; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Ghosh A, 2013, J CLIN INVEST, V123, P2654, DOI 10.1172/JCI66301; Gong Michael C., 1999, Neoplasia (New York), V1, P123, DOI 10.1038/sj.neo.7900018; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; James JR, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1088; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Mukhopadhyay H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003004; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Sadelain M, 2017, CELL, V171, P1471, DOI 10.1016/j.cell.2017.12.002; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Youngblood B, 2010, INT IMMUNOL, V22, P797, DOI 10.1093/intimm/dxq437; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150	40	219	226	5	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					82	+		10.1038/s41591-018-0290-5	http://dx.doi.org/10.1038/s41591-018-0290-5			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30559421	Green Accepted			2022-12-27	WOS:000455027700025
J	Gottesman, O; Johansson, F; Komorowski, M; Faisal, A; Sontag, D; Doshi-Velez, F; Celi, LA				Gottesman, Omer; Johansson, Fredrik; Komorowski, Matthieu; Faisal, Aldo; Sontag, David; Doshi-Velez, Finale; Celi, Leo Anthony			Guidelines for reinforcement learning in healthcare	NATURE MEDICINE			English	Editorial Material								In this Comment, we provide guidelines for reinforcement learning for decisions about patient treatment that we hope will accelerate the rate at which observational cohorts can inform healthcare practice in a safe, risk-conscious manner.	[Gottesman, Omer; Doshi-Velez, Finale] Harvard Univ, Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Johansson, Fredrik; Sontag, David] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Komorowski, Matthieu; Celi, Leo Anthony] MIT, Harvard MIT Hlth Sci & Technol, Lab Computat Physiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Komorowski, Matthieu] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England; [Faisal, Aldo] Imperial Coll London, Dept Bioengn, London, England; [Faisal, Aldo] Imperial Coll London, Dept Comp, London, England; [Faisal, Aldo] Data Sci Inst, London, England; [Faisal, Aldo] MRC London Inst Clin Sci, London, England; [Celi, Leo Anthony] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Celi, Leo Anthony] MIT Crit Data, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Imperial College London; Imperial College London; Imperial College London; Harvard University; Beth Israel Deaconess Medical Center	Celi, LA (corresponding author), MIT, Harvard MIT Hlth Sci & Technol, Lab Computat Physiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Celi, LA (corresponding author), Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.; Celi, LA (corresponding author), MIT Crit Data, Cambridge, MA 02139 USA.	lceli@mit.edu		Komorowski, Matthieu/0000-0003-0559-5747; Johansson, Fredrik/0000-0002-4323-3715				[Anonymous], 2008, P 23 AAAI C ARTI INT; Chakraborty B, 2013, STAT METHODS DYNAMIC; Doshi-Velez F., 2017, MACH LEARN, P1; Gottesman O., 2018, EVALUATING REINFORCE; Johansson F, 2016, P 33 INT C MACH LEAR; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Parbhoo Sonali, 2017, AMIA Jt Summits Transl Sci Proc, V2017, P239; Precup D., 2000, INT C MACH LEARN, P759; Simpson N, 2017, CURR OPIN CRIT CARE, V23, P561, DOI 10.1097/MCC.0000000000000460	10	89	90	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					16	18		10.1038/s41591-018-0310-5	http://dx.doi.org/10.1038/s41591-018-0310-5			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617332	Green Submitted			2022-12-27	WOS:000455027700008
J	Cerezo, M; Guemiri, R; Druillennec, S; Girault, I; Malka-Mahieu, H; Shen, SS; Allard, D; Martineau, S; Welsch, C; Agoussi, S; Estrada, C; Adam, J; Libenciuc, C; Routier, E; Roy, S; Desaubry, L; Eggermont, AM; Sonenberg, N; Scoazec, JY; Eychene, A; Vagner, S; Robert, C				Cerezo, Michael; Guemiri, Ramdane; Druillennec, Sabine; Girault, Isabelle; Malka-Mahieu, Helene; Shen, Shensi; Allard, Delphine; Martineau, Sylvain; Welsch, Caroline; Agoussi, Sandrine; Estrada, Charlene; Adam, Julien; Libenciuc, Cristina; Routier, Emilie; Roy, Severine; Desaubry, Laurent; Eggermont, Alexander M.; Sonenberg, Nahum; Scoazec, Jean Yves; Eychene, Alain; Vagner, Stephan; Robert, Caroline			Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma	NATURE MEDICINE			English	Article							INITIATION COMPLEX; ONCOGENIC RAS; RNA HELICASE; MICE LACKING; RESISTANCE; EIF4F; PD-L1; INHIBITOR; BRAF; SENSITIVITY	Preventing the immune escape of tumor cells by blocking inhibitory checkpoints, such as the interaction between programmed death ligand-1 (PD-L1) and programmed death-1 (PD-1) receptor, is a powerful anticancer approach. However, many patients do not respond to checkpoint blockade. Tumor PD-L1 expression is a potential efficacy biomarker, but the complex mechanisms underlying its regulation are not completely understood. Here, we show that the eukaryotic translation initiation complex, eIF4F, which binds the 5' cap of mRNAs, regulates the surface expression of interferon-gamma-induced PD-L1 on cancer cells by regulating translation of the mRNA encoding the signal transducer and activator of transcription 1 (STAT1) transcription factor. eIF4F complex formation correlates with response to immunotherapy in human melanoma. Pharmacological inhibition of eIF4A, the RNA helicase component of eIF4F, elicits powerful antitumor immune-mediated effects via PD-L1 downregulation. Thus, eIF4A inhibitors, in development as anticancer drugs, may also act as cancer immunotherapies.	[Cerezo, Michael; Guemiri, Ramdane; Girault, Isabelle; Shen, Shensi; Allard, Delphine; Welsch, Caroline; Agoussi, Sandrine; Adam, Julien; Robert, Caroline] INSERM, U981, Villejuif, France; [Cerezo, Michael; Guemiri, Ramdane; Girault, Isabelle; Shen, Shensi; Allard, Delphine; Welsch, Caroline; Agoussi, Sandrine; Eggermont, Alexander M.; Robert, Caroline] Univ Paris Saclay, Univ Paris Sud, Le Kremlin Bicetre, France; [Guemiri, Ramdane; Malka-Mahieu, Helene; Martineau, Sylvain; Welsch, Caroline; Vagner, Stephan] PSL Res Univ, CNRS, UMR 3348, Inst Curie, Orsay, France; [Guemiri, Ramdane; Malka-Mahieu, Helene; Martineau, Sylvain; Welsch, Caroline; Vagner, Stephan] Univ Paris Saclay, Univ Paris Sud, CNRS, UMR 3348, Orsay, France; [Guemiri, Ramdane; Druillennec, Sabine; Malka-Mahieu, Helene; Martineau, Sylvain; Welsch, Caroline; Estrada, Charlene; Eychene, Alain; Vagner, Stephan] Equipe Labellisee Ligue Canc, Paris, France; [Druillennec, Sabine; Estrada, Charlene; Eychene, Alain] PSL Res Univ, CNRS, UMR 3347, Inst Curie,INSERM,U1021, Orsay, France; [Druillennec, Sabine; Estrada, Charlene; Eychene, Alain] Univ Paris Saclay, Univ Paris Sud, CNRS, INSERM,U1021,UMR 3347, Orsay, France; [Adam, Julien; Scoazec, Jean Yves] Gustave Roussy Univ Paris Saclay, Dept Pathol & Lab Med BIOpath, Villejuif, France; [Libenciuc, Cristina; Routier, Emilie; Roy, Severine; Eggermont, Alexander M.; Vagner, Stephan; Robert, Caroline] Gustave Roussy Univ Paris Saclay, Oncol Dept, Villejuif, France; [Desaubry, Laurent] Strasbourg Univ, CNRS, UMR7200, Illkirch Graffenstaden, France; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; McGill University	Robert, C (corresponding author), INSERM, U981, Villejuif, France.; Robert, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, Le Kremlin Bicetre, France.; Vagner, S (corresponding author), PSL Res Univ, CNRS, UMR 3348, Inst Curie, Orsay, France.; Vagner, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, UMR 3348, Orsay, France.; Vagner, S (corresponding author), Equipe Labellisee Ligue Canc, Paris, France.; Vagner, S; Robert, C (corresponding author), Gustave Roussy Univ Paris Saclay, Oncol Dept, Villejuif, France.	stephan.vagner@curie.fr; caroline.robert@gustaveroussy.fr	Robert, Caroline/G-6157-2018; Eychene, Alain/M-8838-2017; DRUILLENNEC, Sabine/B-2572-2019; SHEN, Shensi/AAW-2735-2020; Desaubry, Laurent G/R-5446-2017; Cerezo, Michaël/AAW-2971-2020; Vagner, Stephan/G-3664-2013	Robert, Caroline/0000-0002-9493-0238; DRUILLENNEC, Sabine/0000-0003-0237-1465; SHEN, Shensi/0000-0002-5087-8220; Desaubry, Laurent G/0000-0002-1192-2970; Cerezo, Michaël/0000-0002-3687-2009; ALLARD, Delphine/0000-0001-7534-8982; EYCHENE, Alain/0000-0002-6818-7225; GUEMIRI, Ramdane/0000-0002-0012-7197; vagner, stephan/0000-0003-1452-7164; Girault, Isabelle/0000-0002-9587-5197	INSERM; CNRS; Institut Curie; Ligue Nationale Contre le Cancer (Equipe labellisee); Institut National du Cancer [2013-1-MEL-01-ICR-1]; Ensemble contre le melanome; Vaincre le Melanome; Les Sites de recherche Integre sur le Cancer (SIRIC Socrate) label Gustave Roussy; Fondation Bettencourt Schueller; Fondation ARC pour la Recherche sur le Cancer [PJA20161204588]; Association pour la recherche contre le cancer; Fondation pour la Recherche Medicale [FDT2017043739]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Ensemble contre le melanome; Vaincre le Melanome; Les Sites de recherche Integre sur le Cancer (SIRIC Socrate) label Gustave Roussy; Fondation Bettencourt Schueller; Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association pour la recherche contre le cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank M. A. Shipp for the PD-L1 luciferase promoter, J. Wargo for the BRAF/PTEN mouse cell line (BP), S. Rocchi for the CMV beta Gal plasmid and WM793 melanoma cells and M.-P. Teulade-Fichou for the PhenDC3. We thank the Institut Curie Genomics (A. Rapinat and D. Gentien) platform for assistance with the microarray experiments and the animal facility of the Orsay site of the Institut Curie. We thank the Gustave Roussy platform 'Module de developpement en pathologie INSERM U981/SIRI SOCRATE' and 'Plateforme d'evaluation Preclinique'. We thank M. Tichet, M. Khaled and S. Apcher for helpful discussions. This study was supported by INSERM, CNRS, Gustave Roussy and Institut Curie. This study was also funded by grants from Ligue Nationale Contre le Cancer (Equipe labellisee) (to S.V. and A.E.), Institut National du Cancer (grant number 2013-1-MEL-01-ICR-1) (to S.V., A.E. and C.R.), 'Ensemble contre le melanome' (to C.R. and S.V.), 'Vaincre le Melanome' (to M.C. and C.R.), Les Sites de recherche Integre sur le Cancer (SIRIC Socrate) label Gustave Roussy (to C.R.), Fondation Bettencourt Schueller (to C.R.) and Fondation ARC pour la Recherche sur le Cancer (project PJA20161204588) (to S.S.). M.C. was supported by a post-doctoral fellowship from 'Association pour la recherche contre le cancer' and R.G. was supported by a pre-doctoral fellowship from 'Fondation pour la Recherche Medicale, (FDT2017043739).	Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Botton T, 2009, J INVEST DERMATOL, V129, P1208, DOI 10.1038/jid.2008.346; Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Chu J, 2018, CURR OPIN GENET DEV, V48, P89, DOI 10.1016/j.gde.2017.11.002; Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005; Chu J, 2016, CELL REP, V15, P2340, DOI 10.1016/j.celrep.2016.05.005; Chu J, 2015, BBA-GENE REGUL MECH, V1849, P781, DOI 10.1016/j.bbagrm.2014.09.006; Coelho MA, 2017, IMMUNITY, V47, P1083, DOI 10.1016/j.immuni.2017.11.016; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Cooper ZA, 2014, CANCER IMMUNOL RES, V2, P643, DOI 10.1158/2326-6066.CIR-13-0215; de la Parra C, 2018, CURR OPIN GENET DEV, V48, P82, DOI 10.1016/j.gde.2017.11.001; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dorard C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15262; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; GRAFF JR, 1995, INT J CANCER, V60, P255; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Halder K, 2011, CHEMBIOCHEM, V12, P1663, DOI 10.1002/cbic.201100228; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin CJ, 2012, CELL REPORTS, V1, P325, DOI 10.1016/j.celrep.2012.02.010; Malka-Mahieu H, 2017, CLIN CANCER RES, V23, P21, DOI 10.1158/1078-0432.CCR-14-2362; Malka-Mahieu H, 2016, CELL CYCLE, V15, P2405, DOI 10.1080/15384101.2016.1208862; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patton JT, 2015, ONCOTARGET, V6, P2693, DOI 10.18632/oncotarget.2098; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Reading JL, 2016, IMMUNITY, V45, P1181, DOI 10.1016/j.immuni.2016.12.004; Ribas A, 2016, J EXP MED, V213, P2835, DOI 10.1084/jem.20161462; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rubio CA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0476-1; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Steinberger J, 2017, CELL MOL LIFE SCI, V74, P1681, DOI 10.1007/s00018-016-2430-8; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Truitt ML, 2016, NAT REV CANCER, V16, P288, DOI 10.1038/nrc.2016.27; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Yajima I, 2006, GENESIS, V44, P34, DOI 10.1002/gene.20182; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zindy P, 2011, CANCER RES, V71, P4068, DOI 10.1158/0008-5472.CAN-11-0420; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	58	114	117	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1877	+		10.1038/s41591-018-0217-1	http://dx.doi.org/10.1038/s41591-018-0217-1			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30374200				2022-12-27	WOS:000452392200017
J	Tirosh, O; Conlan, S; Deming, C; Lee-Lin, SQ; Huang, X; Su, HC; Freeman, AF; Segre, JA; Kong, HH				Tirosh, Osnat; Conlan, Sean; Deming, Clay; Lee-Lin, Shih-Queen; Huang, Xin; Su, Helen C.; Freeman, Alexandra F.; Segre, Julia A.; Kong, Heidi H.		NISC Comparative Sequencing Progra	Expanded skin virome in DOCK8-deficient patients	NATURE MEDICINE			English	Article							CD-HIT; CLASSIFICATION; ALIGNMENT; COMMUNITIES; PROPOSALS; ALGORITHM; VIRUSES; PROTEIN; FUNGAL; GENOME	Human microbiome studies have revealed the intricate interplay of host immunity and bacterial communities to achieve homeostatic balance. Healthy skin microbial communities are dominated by bacteria with low viral representation(1-3), mainly bacteriophage. Specific eukaryotic viruses have been implicated in both common and rare skin diseases, but cataloging skin viral communities has been limited. Alterations in host immunity provide an opportunity to expand our understanding of microbial-host interactions. Primary immunodeficient patients manifest with various viral, bacterial, fungal, and parasitic infections, including skin infections(4). Dedicator of cytokinesis 8 (DOCK8) deficiency is a rare primary human immunodeficiency characterized by recurrent cutaneous and systemic infections, as well as atopy and cancer susceptibility(5). DOCK8, encoding a guanine nucleotide exchange factor highly expressed in lymphocytes, regulates actin cytoskeleton, which is critical for migration through collagen- dense tissues such as skin(6). Analyzing deep metagenomic sequencing data from DOCK8-deficient skin samples demonstrated a notable increase in eukaryotic viral representation and diversity compared with healthy volunteers. De novo assembly approaches identified hundreds of novel human papillomavirus genomes, illuminating microbial dark matter. Expansion of the skin virome in DOCK8-deficient patients underscores the importance of immune surveillance in controlling eukaryotic viral colonization and infection.	[Tirosh, Osnat; Conlan, Sean; Deming, Clay; Lee-Lin, Shih-Queen; Huang, Xin; Segre, Julia A.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Su, Helen C.; Freeman, Alexandra F.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Kong, Heidi H.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kong, Heidi H.] NIAMSD, Dermatol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Segre, JA (corresponding author), NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA.; Kong, HH (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Kong, HH (corresponding author), NIAMSD, Dermatol Branch, NIH, Bethesda, MD 20892 USA.	jsegre@nhgri.nih.gov; konghe@mail.nih.gov	Kong, Heidi H/L-4856-2018; Conlan, Sean/B-4401-2008	Kong, Heidi H/0000-0003-4424-064X; Conlan, Sean/0000-0001-6848-3465; Segre, Julia/0000-0001-6860-348X; Vemulapalli, Meghana/0000-0003-3687-313X	National Human Genome Research Institute; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL CANCER INSTITUTE [ZIABC011558] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001193, ZIAAI001247] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study utilized the high-performance computational capabilities of the NIH Biowulf Linux cluster (http://hpc.nih.gov).We thank M. Park, P. Thomas, A. Young, S. Phang, A. Pradhan, V. Pillai, J. Fekecs, NIH Patient Photography, and W.-I. Ng for underlying efforts, and the Segre and Kong laboratories for helpful discussions. We appreciate the participation of patients and their families. This work was supported by the National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Institute of Arthritis and Musculoskeletal and Skin Diseases Intramural Research Programs.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Byrd AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-262; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen XY, 2013, LANCET INFECT DIS, V13, P877, DOI 10.1016/S1473-3099(13)70109-9; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; de Jong SJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01222; Pena MJD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030113; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Jiang P, 2010, BIOINFORMATICS, V26, P1105, DOI 10.1093/bioinformatics/btq078; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jo JH, 2016, J INVEST DERMATOL, V136, P2356, DOI 10.1016/j.jid.2016.05.130; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kowarsky M, 2017, P NATL ACAD SCI USA, V114, P9623, DOI 10.1073/pnas.1707009114; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Legoff J, 2017, NAT MED, V23, P1080, DOI 10.1038/nm.4380; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez-Bueno A, 2017, J GEN VIROL, V98, P1073, DOI 10.1099/jgv.0.000759; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Meisel JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0404-9; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Picard C, 2015, J CLIN IMMUNOL, V35, P696, DOI 10.1007/s10875-015-0201-1; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roossinck MJ, 2015, J VIROL, V89, P6532, DOI 10.1128/JVI.02974-14; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Xiang Y, 2003, J VIROL, V77, P2623, DOI 10.1128/JVI.77.4.2623-2630.2003; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	57	53	54	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1815	+		10.1038/s41591-018-0211-7	http://dx.doi.org/10.1038/s41591-018-0211-7			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30397357	Green Published, Green Accepted, Bronze			2022-12-27	WOS:000452392200009
J	Gao, K				Gao, Kate			Analyzing the drug overdose epidemic in the United States	NATURE MEDICINE			English	Editorial Material														Gao, Peng (Kate)/0000-0002-6557-8511					0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1637	1637		10.1038/s41591-018-0261-x	http://dx.doi.org/10.1038/s41591-018-0261-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401865	Bronze			2022-12-27	WOS:000449404200008
J	Gill, ML; Grahn, P; Calvert, JS; Linde, MB; Lavrov, IA; Strommen, JA; Beck, LA; Sayenko, DG; Van Straaten, MG; Drubach, DI; Veith, DD; Thoreson, AR; Lopez, C; Gerasimenko, YP; Edgerton, VR; Lee, KH; Zhao, KD				Gill, Megan L.; Grahn, Peteri; Calvert, Jonathan S.; Linde, Margaux B.; Lavrov, Igor A.; Strommen, Jeffrey A.; Beck, Lisa A.; Sayenko, Dimitry G.; Van Straaten, Meegan G.; Drubach, Dina, I; Veith, Daniel D.; Thoreson, Andrew R.; Lopez, Cesar; Gerasimenko, Yury P.; Edgerton, V. Reggie; Lee, Kendall H.; Zhao, Kristin D.			Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia	NATURE MEDICINE			English	Article							CORD-INJURY; EPIDURAL STIMULATION; ELECTRICAL-STIMULATION; VOLITIONAL CONTROL; HUMANS; WALKING; RATS; MOVEMENTS; RECOVERY; POTENTIALS	Spinal sensorimotor networks that are functionally disconnected from the brain because of spinal cord injury (SCI) can be facilitated via epidural electrical stimulation (EES) to restore robust, coordinated motor activity in humans with paralysis(1-3). Previously, we reported a clinical case of complete sensorimotor paralysis of the lower extremities in which EES restored the ability to stand and the ability to control step-like activity while side-lying or suspended vertically in a body-weight support system (BWS)(4). Since then, dynamic task-specific training in the presence of EES, termed multimodal rehabilitation (MMR), was performed for 43 weeks and resulted in bilateral stepping on a treadmill, independent from trainer assistance or BWS. Additionally, MMR enabled independent stepping over ground while using a front-wheeled walker with trainer assistance at the hips to maintain balance. Furthermore, MMR engaged sensorimotor networks to achieve dynamic performance of standing and stepping. To our knowledge, this is the first report of independent stepping enabled by task-specific training in the presence of EES by a human with complete loss of lower extremity sensorimotor function due to SCI.	[Gill, Megan L.; Linde, Margaux B.; Strommen, Jeffrey A.; Beck, Lisa A.; Van Straaten, Meegan G.; Veith, Daniel D.; Thoreson, Andrew R.; Lopez, Cesar; Lee, Kendall H.; Zhao, Kristin D.] Mayo Clin, Rehabil Med Res Ctr, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Grahn, Peteri; Lavrov, Igor A.; Drubach, Dina, I; Lee, Kendall H.; Zhao, Kristin D.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Calvert, Jonathan S.] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Lavrov, Igor A.] Mayo Clin, Dept Biomed Engn, Rochester, MN USA; [Lavrov, Igor A.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Sayenko, Dimitry G.; Gerasimenko, Yury P.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Sayenko, Dimitry G.] Houston Methodist Res Inst, Ctr Neuroregenerat, Dept Neurosurg, Houston, TX USA; [Gerasimenko, Yury P.] Russian Acad Sci, Pavlov Inst Physiol, St Petersburg, Russia; [Lee, Kendall H.; Zhao, Kristin D.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Kazan Federal University; University of California System; University of California Los Angeles; The Methodist Hospital System; The Methodist Hospital - Houston; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Mayo Clinic	Lee, KH; Zhao, KD (corresponding author), Mayo Clin, Rehabil Med Res Ctr, Dept Phys Med & Rehabil, Rochester, MN 55905 USA.; Lee, KH; Zhao, KD (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.; Lee, KH; Zhao, KD (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	lee.kendall@mayo.edu; zhao.kristin@mayo.edu	Calvert, Jonathan/AAW-3147-2021; Gerasimenko, Yury/A-3655-2017; Sayenko, Dimitry/AAP-4936-2020; Lavrov, Igor/E-4334-2016	Calvert, Jonathan/0000-0001-7197-9082; Sayenko, Dimitry/0000-0002-4154-6873; Lavrov, Igor/0000-0002-3885-4509	Grainger Foundation; Jack Jablonski Bel13ve in Miracles Foundation; Mayo Clinic Rehabilitation Medicine Research Center; Craig H. Neilsen Foundation; Regenerative Medicine Minnesota; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Graduate School of Biomedical Sciences; Dana and Albert R. Broccoli Charitable Foundation; Christopher and Dana Reeve Foundation; Walkabout Foundation; Mayo Clinic Transform the Practice	Grainger Foundation; Jack Jablonski Bel13ve in Miracles Foundation; Mayo Clinic Rehabilitation Medicine Research Center; Craig H. Neilsen Foundation; Regenerative Medicine Minnesota; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Graduate School of Biomedical Sciences; Dana and Albert R. Broccoli Charitable Foundation; Christopher and Dana Reeve Foundation; Walkabout Foundation; Mayo Clinic Transform the Practice	We thank the participant for his time, effort, and continuous feedback throughout the study. We also thank C. Blaha, J. Chen, B. Cloud, T. Gardner, D. Hare, Y. Li, A. Mendez, C. Mitrovich, A. Schmeling, T. Scrabeck, M. Shaft, C. Stoppel, B. Wessel, and L. Zoecklein as well as the surgical team for their support during EES system implantation. K.H.L. received funding from The Grainger Foundation. K.H.L. and K.D.Z. received funding from the Jack Jablonski Bel13ve in Miracles Foundation, Mayo Clinic Rehabilitation Medicine Research Center, Mayo Clinic Transform the Practice, and Craig H. Neilsen Foundation. P.J.G. was supported by Regenerative Medicine Minnesota and the Mayo Clinic Center for Regenerative Medicine. J.S.C. was supported by the Mayo Clinic Graduate School of Biomedical Sciences. V.R.E. received funding from the Dana and Albert R. Broccoli Charitable Foundation, the Christopher and Dana Reeve Foundation, and the Walkabout Foundation.	Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; [Anonymous], 2016, AM J NEUROPROT NEURO, DOI [DOI 10.1166/AJNN.2016.1120, 10.1166/ajnn.2016.1120]; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Courtine G, 2015, NEURON, V86, P29, DOI 10.1016/j.neuron.2015.02.039; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Dimitrijevic M R, 1988, Adv Neurol, V47, P138; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; DIMITRIJEVIC MR, 1983, ELECTROEN CLIN NEURO, V56, pS68; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Forrest GF, 2008, J SPINAL CORD MED, V31, P509, DOI 10.1080/10790268.2008.11753646; Gad P, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00333; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Grahn PJ, 2017, MAYO CLIN PROC, V92, P544, DOI 10.1016/j.mayocp.2017.02.014; Harkema S. J., 2011, LOCOMOTOR TRAINING P, P54; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; Huang H, 2006, IEEE T NEUR SYS REH, V14, P14, DOI 10.1109/TNSRE.2005.862694; Ichiyama RM, 2005, NEUROSCI LETT, V383, P339, DOI 10.1016/j.neulet.2005.04.049; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; Lavrov I, 2008, J NEUROSCI, V28, P7774, DOI 10.1523/JNEUROSCI.1069-08.2008; Lu DC, 2016, NEUROREHAB NEURAL RE, V30, P951, DOI 10.1177/1545968316644344; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K, 2016, CNS NEUROSCI THER, V22, P262, DOI 10.1111/cns.12530; Moritz CT, 2018, NEUROTHERAPEUTICS, V15, P628, DOI 10.1007/s13311-018-0637-0; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rejc E, 2017, J NEUROTRAUM, V34, P1787, DOI 10.1089/neu.2016.4516; Rejc E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133998; Sayenko DG, 2015, NEUROSCI LETT, V609, P229, DOI 10.1016/j.neulet.2015.10.005; Sayenko DG, 2015, J APPL PHYSIOL, V118, P1364, DOI 10.1152/japplphysiol.01128.2014; Sayenko DG, 2014, J NEUROPHYSIOL, V111, P1088, DOI 10.1152/jn.00489.2013; Shah PK, 2017, NEUROSCIENTIST, V23, P664, DOI 10.1177/1073858417699554; Shah PK, 2012, EUR J NEUROSCI, V36, P2054, DOI 10.1111/j.1460-9568.2012.08106.x; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Taccola G, 2018, PROG NEUROBIOL, V160, P64, DOI 10.1016/j.pneurobio.2017.10.004; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Wenger N, 2016, NAT MED, V22, P138, DOI 10.1038/nm.4025; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325	42	230	244	3	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1677	+		10.1038/s41591-018-0175-7	http://dx.doi.org/10.1038/s41591-018-0175-7			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30250140				2022-12-27	WOS:000449404200018
J	Gaulke, CA; Sharpton, TJ				Gaulke, Christopher A.; Sharpton, Thomas J.			The influence of ethnicity and geography on human gut microbiome composition	NATURE MEDICINE			English	Editorial Material									[Gaulke, Christopher A.; Sharpton, Thomas J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Sharpton, Thomas J.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sharpton, TJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.; Sharpton, TJ (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.	thomas.sharpton@oregonstate.edu	Gaulke, Christopher/M-7308-2019	Gaulke, Christopher/0000-0001-7741-7822; Sharpton, Thomas/0000-0002-5996-7764				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11	12	90	95	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1495	1496		10.1038/s41591-018-0210-8	http://dx.doi.org/10.1038/s41591-018-0210-8			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30275567				2022-12-27	WOS:000446577900007
J	Lieb, A; Qiu, YC; Dixon, CL; Heller, JP; Walker, MC; Schorge, S; Kullmann, DM				Lieb, Andreas; Qiu, Yichen; Dixon, Christine L.; Heller, Janosch P.; Walker, Matthew C.; Schorge, Stephanie; Kullmann, Dimitri M.			Biochemical autoregulatory gene therapy for focal epilepsy	NATURE MEDICINE			English	Article							DRUG-RESISTANT EPILEPSY; ANTIEPILEPTIC DRUGS; GLUTAMATE; SEIZURE; CORTEX; HIPPOCAMPUS; RELEASE; CHANNEL; BRAIN; RATS	Despite the introduction of more than one dozen new antiepileptic drugs in the past 20 years, approximately one-third of people who develop epilepsy continue to have seizures on mono-or polytherapy(1). Viral-vector-mediated gene transfer offers the opportunity to design a rational treatment that builds on mechanistic understanding of seizure generation and that can be targeted to specific neuronal populations in epileptogenic foci(2). Several such strategies have shown encouraging results in different animal models, although clinical translation is limited by possible effects on circuits underlying cognitive, mnemonic, sensory or motor function. Here, we describe an autoregulatory antiepileptic gene therapy, which relies on neuronal inhibition in response to elevations in extracellular glutamate. It is effective in a rodent model of focal epilepsy and is well tolerated, thus lowering the barrier to clinical translation.	[Lieb, Andreas; Qiu, Yichen; Dixon, Christine L.; Heller, Janosch P.; Walker, Matthew C.; Schorge, Stephanie; Kullmann, Dimitri M.] UCL, UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England	University of London; University College London	Lieb, A; Kullmann, DM (corresponding author), UCL, UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	a.lieb@ucl.ac.uk; d.kullmann@ucl.ac.uk	Walker, Matthew C/C-1577-2008; Heller, Janosch/GVT-5921-2022; Kullmann, Dimitri M/A-3162-2009; Heller, Janosch/J-7509-2019; Schorge, Stephanie/C-8515-2009	Walker, Matthew C/0000-0002-0812-0352; Kullmann, Dimitri M/0000-0001-6696-3545; Heller, Janosch/0000-0002-8825-3787; Lieb, Andreas/0000-0001-9567-649X; Schorge, Stephanie/0000-0003-1541-5148	European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant [701411]; Medical Research Council [MR/L01095X/1]; Wellcome Trust [095580/Z/11/Z, 104033/Z/14/Z]; MRC [G0802158, MR/L01095X/1, G116/147] Funding Source: UKRI	European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Schiavo (UCL Institute of Neurology) for the gift of tetanus toxin and S. Hart (UCL Institute of Child Health) for the mouse Neuro-2a cell line. We are grateful to J. Cornford for assistance with ECoG analysis and to K. Hashemi for help optimizing wireless-transmitter use. This project was supported by the European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant agreement no. 701411 to A.L.); the Medical Research Council (MR/L01095X/1 to D.M.K., S.S. and M.C.W.); and the Wellcome Trust (095580/Z/11/Z to D.M.K.; 104033/Z/14/Z to D.M.K. and S.S.).	Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Baldassano SN, 2017, BRAIN, V140, P1680, DOI 10.1093/brain/awx098; Barker-Haliski M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022863; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Cavus I, 2016, EPILEPSIA, V57, P288, DOI 10.1111/epi.13269; Chen ZB, 2018, JAMA NEUROL, V75, P279, DOI 10.1001/jamaneurol.2017.3949; Cleeren E, 2015, EPILEPSIA, V56, P1366, DOI 10.1111/epi.13077; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; DURING MJ, 1993, LANCET, V341, P1607; Frazier SJ, 2013, J BIOL CHEM, V288, P21029, DOI 10.1074/jbc.M112.423921; Jaenisch N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26173; Katzel D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4847; Kullmann DM, 2014, NAT REV NEUROL, V10, P300, DOI 10.1038/nrneurol.2014.43; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Mainardi M, 2012, EPILEPSIA, V53, pe132, DOI 10.1111/j.1528-1167.2012.03510.x; Miles R., 2012, JASPERS BASIC MECH E; Perucca P, 2012, LANCET NEUROL, V11, P792, DOI 10.1016/S1474-4422(12)70153-9; Ryvlin P, 2014, LANCET NEUROL, V13, P1114, DOI 10.1016/S1474-4422(14)70156-5; Stephens ML, 2014, EPILEPSIA, V55, P1817, DOI 10.1111/epi.12797; Tang F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00301; Thomas PM, 2004, ACTA NEUROCHIR, V146, P143, DOI 10.1007/s00701-003-0189-9; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Vink CA, 2017, MOL THER, V25, P1790, DOI 10.1016/j.ymthe.2017.04.028; Weir GA, 2017, BRAIN, V140, P2570, DOI 10.1093/brain/awx201; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; Yaguchi M, 2013, HUM GENE THER METHOD, V24, P333, DOI 10.1089/hgtb.2012.238	28	31	31	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1324	+		10.1038/s41591-018-0103-x	http://dx.doi.org/10.1038/s41591-018-0103-x			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	29988123	Green Submitted, Green Accepted			2022-12-27	WOS:000444174100012
J	Naik, S				Naik, Shruti			Wound, heal thyself	NATURE MEDICINE			English	Editorial Material							SKIN		[Naik, Shruti] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Naik, Shruti] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA	New York University; New York University	Naik, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.; Naik, S (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10003 USA.	shruti.naik@nyumc.org						Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kurita M, 2018, NATURE, V561, P243, DOI 10.1038/s41586-018-0477-4; Lincoln K, 2016, WOUNDS, V28, P347; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085	10	7	7	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1311	1312		10.1038/s41591-018-0179-3	http://dx.doi.org/10.1038/s41591-018-0179-3			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194410				2022-12-27	WOS:000444174100009
J	Stower, H				Stower, Hannah			Treating Huntington's with oligonucleotides	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					877	877		10.1038/s41591-019-0491-6	http://dx.doi.org/10.1038/s41591-019-0491-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171870	Bronze			2022-12-27	WOS:000470844400012
J	Wei, XZ; Nielsen, R				Wei, Xinzhu; Nielsen, Rasmus			CCR5-Delta 32 is deleterious in the homozygous state in humans	NATURE MEDICINE			English	Article							RESISTANCE; CCR5	We use the genotyping and death register information of 409,693 individuals of British ancestry to investigate fitness effects of the CCR5-Delta 32 mutation. We estimate a 21% increase in the all-cause mortality rate in individuals who are homozygous for the Delta 32 allele. A deleterious effect of the Delta 32/Delta 32 mutation is also independently supported by a significant deviation from the Hardy-Weinberg equilibrium (HWE) due to a deficiency of Delta 32/Delta 32 individuals at the time of recruitment.	[Wei, Xinzhu; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol & Stat, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Copenhagen, Ctr GeoGenet, Copenhagen, Denmark	University of California System; University of California Berkeley; University of Copenhagen	Wei, XZ (corresponding author), Univ Calif Berkeley, Dept Integrat Biol & Stat, Berkeley, CA 94720 USA.	aprilwei@berkeley.edu; rasmus_nielsen@berkeley.edu	Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Wei, Xinzhu/0000-0001-8184-7016	US National Institutes of Health (NIH) [R01GM116044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116044] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank D. Feehan, M. Slatkin, and P. Wilton for discussions about death rate estimation, and R. Durbin, C. Freeman, and G. McVean for discussions about UK Biobank markers. This work is supported by US National Institutes of Health (NIH) grant R01GM116044 to R.N.	Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cahill ME, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3186-6; Cox D. R., 1984, ANAL SURVIVAL DATA; CYRANOSKI D., 2018, NATURE; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Falcon A, 2015, J GEN VIROL, V96, P2074, DOI 10.1099/vir.0.000165; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Hoover KC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204989; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Lim JK, 2011, EXP CELL RES, V317, P569, DOI 10.1016/j.yexcr.2011.01.009; Mostafavi H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002458; Nash S, 2018, PROGR ENDING HIV EPI; Normile D, 2018, SCIENCE, V362, P978, DOI 10.1126/science.362.6418.978; Pavlicev M, 2012, TRENDS ECOL EVOL, V27, P316, DOI 10.1016/j.tree.2012.01.016; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Wei XZ, 2017, GENETICS, V205, P925, DOI 10.1534/genetics.116.195487	17	44	46	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					909	+		10.1038/s41591-019-0459-6	http://dx.doi.org/10.1038/s41591-019-0459-6			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31160814	Green Submitted, Green Accepted			2022-12-27	WOS:000470844400020
J	Pasca, AM; Park, JY; Shin, HW; Qi, QH; Revah, O; Krasnoff, R; O'Hara, R; Willsey, AJ; Palmer, TD; Pascz, SP				Pasca, Anca M.; Park, Jin-Young; Shin, Hyun-Woo; Qi, Qihao; Revah, Omer; Krasnoff, Rebecca; O'Hara, Ruth; Willsey, A. Jeremy; Palmer, Theo D.; Pascz, Sergiu P.			Human 3D cellular model of hypoxic brain injury of prematurity	NATURE MEDICINE			English	Article							UNFOLDED PROTEIN RESPONSE; DIFFERENTIAL EXPRESSION ANALYSIS; GENE-COEXPRESSION NETWORK; RADIAL GLIA; SUBVENTRICULAR ZONE; ENCEPHALOPATHY; REVEALS; CELLS	Owing to recent medical and technological advances in neonatal care, infants born extremely premature have increased survival rates(1,2). After birth, these infants are at high risk of hypoxic episodes because of lung immaturity, hypotension and lack of cerebral-flow regulation, and can develop a severe condition called encephalopathy of prematurity(3). Over 80% of infants born before post-conception week 25 have moderate-to-severe long-term neurodevelopmental impairments(4). The susceptible cell types in the cerebral cortex and the molecular mechanisms underlying associated gray-matter defects in premature infants remain unknown. Here we used human three-dimensional brain-region-specific organoids to study the effect of oxygen deprivation on corticogenesis. We identified specific defects in intermediate progenitors, a cortical cell type associated with the expansion of the human cerebral cortex, and showed that these are related to the unfolded protein response and changes. Moreover, we verified these findings in human primary cortical tissue and demonstrated that a small-molecule modulator of the unfolded protein response pathway can prevent the reduction in intermediate progenitors following hypoxia. We anticipate that this human cellular platform will be valuable for studying the environmental and genetic factors underlying injury in the developing human brain.	[Pasca, Anca M.] Stanford Univ, Dept Pediat, Div Neonatol, Stanford, CA 94305 USA; [Park, Jin-Young; Shin, Hyun-Woo; Revah, Omer; O'Hara, Ruth; Pascz, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Park, Jin-Young; Shin, Hyun-Woo; Revah, Omer; O'Hara, Ruth; Pascz, Sergiu P.] Stanford Univ, Stanford Human Brain Organogenesis Program, Stanford, CA 94305 USA; [Shin, Hyun-Woo] Seoul Natl Univ, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Qi, Qihao; Krasnoff, Rebecca; Willsey, A. Jeremy] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Qi, Qihao; Krasnoff, Rebecca; Willsey, A. Jeremy] Univ Calif San Francisco, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA USA; [Palmer, Theo D.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Seoul National University (SNU); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Pascz, SP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Pascz, SP (corresponding author), Stanford Univ, Stanford Human Brain Organogenesis Program, Stanford, CA 94305 USA.	spasca@stanford.edu	Palmer, Theo/GSI-6635-2022; Pasca, Sergiu/AAY-3949-2021; Revah, Omer/AAW-4048-2021	Pasca, Sergiu/0000-0002-3216-3248; Revah, Omer/0000-0002-4002-5689; Palmer, Theo/0000-0002-6266-1862; SHIN, HYUN-WOO/0000-0002-4038-9992	US National Institute of Health (NIH) BRAINS Award [MH107800]; MQ Fellow Award; NYSCF Robertson Stem Cell Investigator Award; Stanford Neurosciences Institute's Human Brain Organogenesis Program; Brain Rejuvenation Project; Kwan Research Fund; California Institute of Regenerative Medicine (CIRM); UCSF Weill Institute for Neurosciences; NIH [R01MH108659, K12-HD000850]; Association of Medical School Pediatric Department Chairs (AMSPDC); Stanford Maternal and Child Health Research Institute Fellowship; Stanford Bio-X; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108660, R01MH107800] Funding Source: NIH RePORTER	US National Institute of Health (NIH) BRAINS Award; MQ Fellow Award; NYSCF Robertson Stem Cell Investigator Award; Stanford Neurosciences Institute's Human Brain Organogenesis Program; Brain Rejuvenation Project; Kwan Research Fund; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCSF Weill Institute for Neurosciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association of Medical School Pediatric Department Chairs (AMSPDC); Stanford Maternal and Child Health Research Institute Fellowship; Stanford Bio-X; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank W.E. Benitz, D.K. Stevenson, V.K. Bhutani and U. Francke for valuable scientific advice and discussions. This work was supported by the US National Institute of Health (NIH) BRAINS Award (MH107800), the MQ Fellow Award, the NYSCF Robertson Stem Cell Investigator Award, the Stanford Neurosciences Institute's Human Brain Organogenesis Program and the Brain Rejuvenation Project, Stanford Bio-X, the Kwan Research Fund and the California Institute of Regenerative Medicine (CIRM) (to S.P.P.); the UCSF Weill Institute for Neurosciences (startup funds to A.J.W.); NIH R01MH108659 and R01MH108659 (to T.D.P.); and the NIH K12-HD000850 (Pediatric Scientist Development Program), the Association of Medical School Pediatric Department Chairs (AMSPDC) and Stanford Maternal and Child Health Research Institute Fellowship (to A.M.P.).	Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arshad A, 2016, CEREB CORTEX, V26, P2242, DOI 10.1093/cercor/bhv074; Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Godin JD, 2016, TRENDS NEUROSCI, V39, P394, DOI 10.1016/j.tins.2016.04.002; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Jantzie LL, 2015, DEV NEUROSCI-BASEL, V37, P277, DOI 10.1159/000371721; Jarjour IT, 2015, PEDIATR NEUROL, V52, P143, DOI 10.1016/j.pediatrneurol.2014.10.027; Javaherian A, 2009, CEREB CORTEX, V19, pI70, DOI 10.1093/cercor/bhp029; Lacaille H, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0300-18.2019; Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lui JH, 2014, NATURE, V515, P264, DOI 10.1038/nature13973; Malik S, 2013, J NEUROSCI, V33, P411, DOI 10.1523/JNEUROSCI.4445-12.2013; Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Ortega JA, 2017, CEREB CORTEX, V27, P3736, DOI 10.1093/cercor/bhw194; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Penn AA, 2016, NEUROBIOL DIS, V92, P90, DOI 10.1016/j.nbd.2015.10.012; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson S, 2006, J NEUROSURG, V104, P396, DOI 10.3171/ped.2006.104.6.396; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; SOOTHILL PW, 1986, OBSTET GYNECOL, V68, P173; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wagenfuhr L, 2015, DEVELOPMENT, V142, P2904, DOI 10.1242/dev.121939; Wang HP, 2015, TOXICOL APPL PHARM, V283, P157, DOI 10.1016/j.taap.2014.12.019; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zyryanova AF, 2018, SCIENCE, V359, P1533, DOI 10.1126/science.aar5129; 2011, NAT MED, V17, P1657, DOI DOI 10.1038/NM.2576	50	75	75	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					784	+		10.1038/s41591-019-0436-0	http://dx.doi.org/10.1038/s41591-019-0436-0			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31061540	Green Accepted, Green Submitted			2022-12-27	WOS:000468247800022
J	Caskey, M; Klein, F; Nussenzweig, MC				Caskey, Marina; Klein, Florian; Nussenzweig, Michel C.			Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic	NATURE MEDICINE			English	Review							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; MUCOSAL SHIV CHALLENGE; PASSIVE TRANSFER; IN-VITRO; IMPROVES PROTECTION; IMMUNE-RESPONSES; LATENT RESERVOIR; HIV-1 INFECTION; DURABLE CONTROL; PHASE-I	Combination anti-retroviral therapy (ART) has revolutionized the treatment and prevention of HIV-1 infection. Taken daily, ART prevents and suppresses the infection. However, ART interruption almost invariably leads to rebound viremia in infected individuals due to a long-lived latent reservoir of integrated proviruses. Therefore, ART must be administered on a life-long basis. Here we review recent preclinical and clinical studies suggesting that immunotherapy may be an alternative or an adjuvant to ART because, in addition to preventing new infections, anti-HIV-1 antibodies clear the virus, directly kill infected cells and produce immune complexes that can enhance host immunity to the virus.	[Caskey, Marina; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Klein, Florian] Univ Cologne, Inst Virol, Fac Med, Expt Immunol Lab, Cologne, Germany; [Klein, Florian] Univ Hosp Cologne, Cologne, Germany; [Klein, Florian] Univ Cologne, CMMC, Fac Med, Cologne, Germany; [Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; University of Cologne; University of Cologne; University of Cologne; German Center for Infection Research; University of Cologne; Howard Hughes Medical Institute; Rockefeller University	Caskey, M; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.; Klein, F (corresponding author), Univ Cologne, Inst Virol, Fac Med, Expt Immunol Lab, Cologne, Germany.; Klein, F (corresponding author), Univ Hosp Cologne, Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, CMMC, Fac Med, Cologne, Germany.; Klein, F (corresponding author), German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	mcaskey@rockefeller.edu; florian.klein@uk-koeln.de; nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019		NIH/National Institute of Allergy and Infectious Diseases Grant [U01AI129825]; Einstein-Rockefeller-CUNY Center for AIDS Research [1P30AI124414-01A1]; BEAT-HIV Delaney grant [UM1 AI126620]; Heisenberg-Program of the DFG [KL 2389/2-1]; European Research Council [ERC-StG639961]; German Center for Infection Research (DZIF); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grants [OPP1092074, OPP1124068]; NIH [1UM1 AI100663, R01AI-129795]; Robertson fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126620, R01AI129795] Funding Source: NIH RePORTER	NIH/National Institute of Allergy and Infectious Diseases Grant; Einstein-Rockefeller-CUNY Center for AIDS Research; BEAT-HIV Delaney grant; Heisenberg-Program of the DFG(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Infection Research (DZIF); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Klein and Nussenzweig laboratories for discussion. This work was supported by the NIH/National Institute of Allergy and Infectious Diseases Grant (U01AI129825), the Einstein-Rockefeller-CUNY Center for AIDS Research (1P30AI124414-01A1) and the BEAT-HIV Delaney grant UM1 AI126620 (M.C.); the Heisenberg-Program of the DFG (KL 2389/2-1), the European Research Council (ERC-StG639961) and the German Center for Infection Research (DZIF) (F.K.); the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1092074 and OPP1124068 and the NIH grants 1UM1 AI100663 and R01AI-129795 (M.C.N.); and the Robertson fund.	Armbruster C, 2002, AIDS, V16, P227, DOI 10.1097/00002030-200201250-00012; Armbruster C, 2004, J ANTIMICROB CHEMOTH, V54, P915, DOI 10.1093/jac/dkh428; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Bournazos S, 2017, ANNU REV IMMUNOL, V35, P285, DOI 10.1146/annurev-immunol-051116-052433; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cavacini LA, 1998, AIDS RES HUM RETROV, V14, P545, DOI 10.1089/aid.1998.14.545; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cockerham LR, 2016, CURR HIV-AIDS REP, V13, P1, DOI 10.1007/s11904-016-0296-x; Cohen YZ, 2018, J EXP MED, V215, P2311, DOI 10.1084/jem.20180936; Cohen YZ, 2018, J VIROL, V92, DOI 10.1128/JVI.01883-17; Cohn LB, 2018, NAT MED, V24, P604, DOI 10.1038/s41591-018-0017-7; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Freund NT, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2144; Gama L, 2018, ANNU REV MED, V69, P409, DOI 10.1146/annurev-med-061016-041032; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Gilbert Peter B, 2017, Stat Commun Infect Dis, V9, DOI 10.1515/scid-2016-0001; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang YD, 2018, HUM VACC IMMUNOTHER, V14, P2116, DOI 10.1080/21645515.2018.1462640; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1321; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kwon YD, 2016, J VIROL, V90, P5899, DOI 10.1128/JVI.03246-15; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; LI J, 1992, J ACQ IMMUN DEF SYND, V5, P639; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Margolis DM, 2017, J INFECT DIS, V215, pS111, DOI 10.1093/infdis/jiw618; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moldt B, 2012, J VIROL, V86, P6189, DOI 10.1128/JVI.00491-12; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Namazi G, 2018, J INFECT DIS, V218, P1954, DOI 10.1093/infdis/jiy479; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; Pal R, 2003, JAIDS-J ACQ IMM DEF, V33, P300, DOI 10.1097/00126334-200307010-00003; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Scott-Algaram D., 2015, C RETR OPP INF; Sengupta S, 2018, IMMUNITY, V48, P872, DOI 10.1016/j.immuni.2018.04.030; Shan L, 2017, IMMUNITY, V47, P766, DOI 10.1016/j.immuni.2017.09.014; SHIBATA R, 1991, J VIROL, V65, P3514, DOI 10.1128/JVI.65.7.3514-3520.1991; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; VITTECOQ D, 1992, J INFECT DIS, V165, P364, DOI 10.1093/infdis/165.2.364; Wagh K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006860; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang Z, 2018, P NATL ACAD SCI USA, V115, pE2575, DOI 10.1073/pnas.1720665115; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	99	135	139	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					547	553		10.1038/s41591-019-0412-8	http://dx.doi.org/10.1038/s41591-019-0412-8			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30936546	Green Accepted			2022-12-27	WOS:000463342800014
J	Wirbel, J; Pyl, PT; Kartal, E; Zych, K; Kashani, A; Milanese, A; Fleck, JS; Voigt, AY; Palleja, A; Ponnudurai, R; Sunagawa, S; Coelho, LP; Schrotz-King, P; Vogtmann, E; Habermann, N; Nimeus, E; Thomas, AM; Manghi, P; Gandini, S; Serrano, D; Mizutani, S; Shiroma, H; Shiba, S; Shibata, T; Yachida, S; Yamada, T; Waldron, L; Naccarati, A; Segata, N; Sinha, R; Ulrich, CM; Brenner, H; Arumugam, M; Bork, P; Zeller, G				Wirbel, Jakob; Pyl, Paul Theodor; Kartal, Ece; Zych, Konrad; Kashani, Alireza; Milanese, Alessio; Fleck, Jonas S.; Voigt, Anita Y.; Palleja, Albert; Ponnudurai, Ruby; Sunagawa, Shinichi; Coelho, Luis Pedro; Schrotz-King, Petra; Vogtmann, Emily; Habermann, Nina; Nimeus, Emma; Thomas, Andrew M.; Manghi, Paolo; Gandini, Sara; Serrano, Davide; Mizutani, Sayaka; Shiroma, Hirotsugu; Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi; Yamada, Takuji; Waldron, Levi; Naccarati, Alessio; Segata, Nicola; Sinha, Rashmi; Ulrich, Cornelia M.; Brenner, Hermann; Arumugam, Manimozhiyan; Bork, Peer; Zeller, Georg			Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer	NATURE MEDICINE			English	Article							GUT METAGENOME; COLON; ASSOCIATION; TUMORIGENESIS; METABOLOMICS; INFORMATION; DISCOVERY; SELECTION; ALIGNMENT; ACCURATE	Association studies have linked microbiome alterations with many human diseases. However, they have not always reported consistent results, thereby necessitating cross-study comparisons. Here, a meta-analysis of eight geographically and technically diverse fecal shotgun metagenomic studies of colorectal cancer (CRC, n = 768), which was controlled for several confounders, identified a core set of 29 species significantly enriched in CRC metagenomes (false discovery rate (FDR) <1 x 10(-5)). CRC signatures derived from single studies maintained their accuracy in other studies. By training on multiple studies, we improved detection accuracy and disease specificity for CRC. Functional analysis of CRC metagenomes revealed enriched protein and mucin catabolism genes and depleted carbohydrate degradation genes. Moreover, we inferred elevated production of secondary bile acids from CRC metagenomes, suggesting a metabolic link between cancer-associated gut microbes and a fat-and meat-rich diet. Through extensive validations, this meta-analysis firmly establishes globally generalizable, predictive taxonomic and functional microbiome CRC signatures as a basis for future diagnostics.	[Wirbel, Jakob; Kartal, Ece; Zych, Konrad; Milanese, Alessio; Fleck, Jonas S.; Voigt, Anita Y.; Ponnudurai, Ruby; Sunagawa, Shinichi; Coelho, Luis Pedro; Bork, Peer; Zeller, Georg] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Pyl, Paul Theodor; Kashani, Alireza; Palleja, Albert; Arumugam, Manimozhiyan] Univ Copenhagen, Fac Hlth & Med, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Pyl, Paul Theodor; Nimeus, Emma] Lund Univ, Dept Clin Sci Lund, Fac Med, Div Surg Oncol & Pathol, Lund, Sweden; [Kartal, Ece; Bork, Peer] Mol Med Partnership Unit, Heidelberg, Germany; [Voigt, Anita Y.] Jackson Lab Genom Med, Farmington, CT USA; [Sunagawa, Shinichi] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Schrotz-King, Petra; Brenner, Hermann] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Schrotz-King, Petra; Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Vogtmann, Emily; Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Habermann, Nina] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Nimeus, Emma] Skane Univ Hosp, Dept Clin Sci Lund, Fac Med, Div Surg, Lund, Sweden; [Thomas, Andrew M.; Manghi, Paolo; Segata, Nicola] Univ Trento, Dept CIBIO, Trento, Italy; [Thomas, Andrew M.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Gandini, Sara; Serrano, Davide] European Inst Oncol IRCCS, IEO, Milan, Italy; [Mizutani, Sayaka; Shiroma, Hirotsugu; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan; [Mizutani, Sayaka] Japan Soc Promot Sci, Tokyo, Japan; [Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Lab Mol Med, Human Genome Ctr, Tokyo, Japan; [Yachida, Shinichi] Osaka Univ, Fac Med, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan; [Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Waldron, Levi] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Waldron, Levi] CUNY, Inst Implementat Sci Populat Hlth, New York, NY 10021 USA; [Naccarati, Alessio] Italian Inst Genom Med, Turin, Italy; [Naccarati, Alessio] Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic; [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Ulrich, Cornelia M.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Arumugam, Manimozhiyan] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bork, Peer] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany; [Coelho, Luis Pedro] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China	European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation; University of Copenhagen; Lund University; Jackson Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); European Molecular Biology Laboratory (EMBL); Lund University; Skane University Hospital; University of Trento; Universidade de Sao Paulo; IRCCS European Institute of Oncology (IEO); Tokyo Institute of Technology; Japan Society for the Promotion of Science; National Cancer Center - Japan; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); City University of New York (CUNY) System; City University of New York (CUNY) System; Italian Institute for Genomic Medicine (IIGM); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern Denmark; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Fudan University	Bork, P; Zeller, G (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.; Arumugam, M (corresponding author), Univ Copenhagen, Fac Hlth & Med, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.; Bork, P (corresponding author), Mol Med Partnership Unit, Heidelberg, Germany.; Arumugam, M (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.; Bork, P (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.; Bork, P (corresponding author), Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany.	arumugam@sund.ku.dk; bork@embl.de; zeller@embl.de	Vogtmann, Emily/O-9125-2017; Brenner, Hermann/ABE-6383-2020; Arumugam, Manimozhiyan/E-1211-2011; Coelho, Luis Pedro/D-1260-2009; Shiba, Satoshi/AAJ-2157-2021; Bork, Peer/F-1813-2013; Brenner, Hermann/B-4627-2017; gandini, sara/J-4916-2018; Sunagawa, Shinichi/Q-5950-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Waldron, Levi/H-2967-2019; Shibata, Tatsuhiro/ABA-8234-2020; shiba, satoshi/AAL-4953-2021; Shibata, Tatsuhiro/AAO-1278-2021; Segata, Nicola/AAB-2980-2019; Zeller, Georg/M-6484-2013; Pyl, Paul Theodor/K-5034-2015	Vogtmann, Emily/0000-0003-1355-5593; Brenner, Hermann/0000-0002-6129-1572; Arumugam, Manimozhiyan/0000-0002-0886-9101; Coelho, Luis Pedro/0000-0002-9280-7885; Shiba, Satoshi/0000-0001-5159-5719; Bork, Peer/0000-0002-2627-833X; Brenner, Hermann/0000-0002-6129-1572; gandini, sara/0000-0002-1348-4548; Sunagawa, Shinichi/0000-0003-3065-0314; Arumugam, Manimozhiyan/0000-0002-0886-9101; Waldron, Levi/0000-0003-2725-0694; Zeller, Georg/0000-0003-1429-7485; Thomas, Andrew Maltez/0000-0001-5789-3354; Serrano, Davide/0000-0002-2945-4108; Pyl, Paul Theodor/0000-0002-7651-883X; Naccarati, Alessio/0000-0001-5774-0905; Manghi, Paolo/0000-0003-0846-6529; Wirbel, Jakob/0000-0002-4073-3562; Nimeus, Emma/0000-0003-0262-9083; Fleck, Jonas Simon/0000-0002-4686-7254; Palleja, Albert/0000-0001-5388-4063; Milanese, Alessio/0000-0002-7050-2239; Kartal, Ece/0000-0002-7720-455X	EMBL; German Cancer Research Center; Huntsman Cancer Foundation; Intramural Research Program of the National Cancer Institute; ETH Zurich; European Research Council [ERC-2010-AdG_20100317, ERC-AdG-669830, ERC-2016-STG-716575]; Novo Nordisk Foundation [NNF10CC1016515]; Danish Diabetes Academy - Novo Nordisk Foundation; TARGET Research Initiative (Danish Strategic Research Council) [0603-00484B]; Matthias-Lackas Foundation; National Cancer Institute [R01 CA189184, R01 CA207371, U01 CA206110, P30 CA042014]; Federal Ministry of Education and Research (BMBF) [031A537B, 01KT1503]; Helmut Horten Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [16/23527-2]; Lega Italiana per La Lotta contro i Tumori; National Cancer Center Research and Development Fund [25-A-4, 28-A-4, 29-A-6]; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development [JP18ek0109187]; Japan Science and Technology Agency-PRESTO [JPMJPR1507]; Japan Society for the Promotion of Science KAKENHI [16J10135, 142558, 221S0002]; Joint Research Project of the Institute of Medical Science, University of Tokyo; Takeda Science Foundation; Suzuken Memorial Foundation; NATIONAL CANCER INSTITUTE [U01CA206110, ZIACP010198, R01CA207371, P30CA042014] Funding Source: NIH RePORTER	EMBL; German Cancer Research Center; Huntsman Cancer Foundation; Intramural Research Program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ETH Zurich(ETH Zurich); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Academy - Novo Nordisk Foundation; TARGET Research Initiative (Danish Strategic Research Council); Matthias-Lackas Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmut Horten Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Lega Italiana per La Lotta contro i Tumori; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Science and Technology Agency-PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Joint Research Project of the Institute of Medical Science, University of Tokyo; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are thankful to members of the Zeller, Bork, and Arumugam groups for inspiring discussions. Additionally, we thank Y.P. Yuan and the EMBL Information Technology Core Facility for support with high-performance computing, and the EMBL Genomics Core Facility for their sequencing support. We are also grateful for the advice provided by B. Klaus, EMBL Centre for Statistical Data Analysis. We acknowledge funding from EMBL, the German Cancer Research Center, the Huntsman Cancer Foundation, the Intramural Research Program of the National Cancer Institute, ETH Zurich, and the following external sources: the European Research Council (CancerBiome grant no. ERC-2010-AdG_20100317 to P.B., Microbios grant no. ERC-AdG-669830 to P.B., and Meta-PG grant no. ERC-2016-STG-716575 to N.S.); the Novo Nordisk Foundation (grant no. NNF10CC1016515 to M.A.); the Danish Diabetes Academy supported by the Novo Nordisk Foundation and TARGET Research Initiative (Danish Strategic Research Council grant no. 0603-00484B to M.A.); the Matthias-Lackas Foundation (to C.M.U.); the National Cancer Institute (grant nos. R01 CA189184, R01 CA207371, U01 CA206110, and P30 CA042014 to C.M.U.); the Federal Ministry of Education and Research (BMBF; the de. NBI network no. 031A537B to P.B. and the ERA-NET TRANSCAN project no. 01KT1503 to C.M.U.); the Helmut Horten Foundation (to S. Sunagawa); and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant no. 16/23527-2 to A.M.T.). For the Italy validation cohorts, funding was provided by the Lega Italiana per La Lotta contro i Tumori. For the Japan validation cohort, funding was provided to T.Y. and S.Y. by the National Cancer Center Research and Development Fund (grant nos. 25-A-4,28-A-4, and 29-A-6); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (grant no. JP18ek0109187); Japan Science and Technology Agency-PRESTO (grant no. JPMJPR1507); Japan Society for the Promotion of Science KAKENHI (grant nos. 16J10135, 142558, and 221S0002); Joint Research Project of the Institute of Medical Science, University of Tokyo; and the Takeda Science and Suzuken Memorial Foundations.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2018, DIET NUTR PHYS ACT C; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Aykan Nuri Faruk, 2015, Oncol Rev, V9, P288, DOI 10.4081/oncol.2015.288; Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohm J, 2017, SURGERY, V161, P808, DOI 10.1016/j.surg.2016.08.025; Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; Costea PI, 2014, NAT METHODS, V11, P359, DOI 10.1038/nmeth.2897; Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dutilh BE, 2013, BEST PRACT RES CL GA, V27, P85, DOI 10.1016/j.bpg.2013.03.008; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goedert JJ, 2014, CARCINOGENESIS, V35, P2089, DOI 10.1093/carcin/bgu131; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18; Hastie T., 2009, UNSUPERVISED LEARNIN; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kultima JR, 2016, BIOINFORMATICS, V32, P2520, DOI 10.1093/bioinformatics/btw183; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liesenfeld DB, 2015, AM J CLIN NUTR, V102, P433, DOI 10.3945/ajcn.114.103804; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Mal M, 2012, ANAL BIOANAL CHEM, V403, P483, DOI 10.1007/s00216-012-5870-5; MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Milanese A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08844-4; Ocvirk Soren, 2017, Curr Nutr Rep, V6, P315, DOI 10.1007/s13668-017-0219-5; Ogino S, 2018, GUT, V67, P1168, DOI 10.1136/gutjnl-2017-315537; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; REDDY BS, 1981, CANCER RES, V41, P3766; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Ridlon JM, 2010, ANAEROBE, V16, P137, DOI 10.1016/j.anaerobe.2009.05.004; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189; Shkoporov AN, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0446-z; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.88, 10.1038/NMICROBIOL.2016.88]; Viennot S, 2009, GASTROEN CLIN BIOL, V33, pS190, DOI 10.1016/S0399-8320(09)73154-9; Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645; zur Hausen H, 2012, INT J CANCER, V130, P2475, DOI 10.1002/ijc.27413	80	368	383	22	192	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					679	+		10.1038/s41591-019-0406-6	http://dx.doi.org/10.1038/s41591-019-0406-6			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30936547	Green Submitted, Green Accepted			2022-12-27	WOS:000463342800029
J	Santiago-Fernandez, O; Osorio, FG; Quesada, V; Rodriguez, F; Basso, S; Maeso, D; Rolas, L; Barkaway, A; Nourshargh, S; Folgueras, AR; Freije, JMP; Lopez-Otin, C				Santiago-Fernandez, Olaya; Osorio, Fernando G.; Quesada, Victor; Rodriguez, Francisco; Basso, Sammy; Maeso, Daniel; Rolas, Loic; Barkaway, Anna; Nourshargh, Sussan; Folgueras, Alicia R.; Freije, Jose M. P.; Lopez-Otin, Carlos			Development of a CRISPR/Cas9-based therapy for Hutchinson-Gilford progeria syndrome	NATURE MEDICINE			English	Article							READ ALIGNMENT; DISEASE	CRISPR/Cas9-based therapies hold considerable promise for the treatment of genetic diseases. Among these, Hutchinson-Gilford progeria syndrome, caused by a point mutation in the LMNA gene, stands out as a potential candidate. Here, we explore the efficacy of a CRISPR/Cas9-based approach that reverts several alterations in Hutchinson-Gilford progeria syndrome cells and mice by introducing frameshift mutations in the LMNA gene.	[Santiago-Fernandez, Olaya; Osorio, Fernando G.; Quesada, Victor; Rodriguez, Francisco; Basso, Sammy; Maeso, Daniel; Folgueras, Alicia R.; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Oncol Principado Asturias, Oviedo, Spain; [Quesada, Victor; Freije, Jose M. P.; Lopez-Otin, Carlos] Ctr Invest Biomed Red Canc, Madrid, Spain; [Rolas, Loic; Barkaway, Anna; Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of London; Queen Mary University London	Freije, JMP; Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Oncol Principado Asturias, Oviedo, Spain.; Freije, JMP; Lopez-Otin, C (corresponding author), Ctr Invest Biomed Red Canc, Madrid, Spain.	jmpf@uniovi.es; clo@uniovi.es	López-Otín, Carlos/AAB-2106-2020; Quesada, Víctor/B-6557-2014; Freije, José M.P./A-6535-2008; Santiago-Fernández, Olaya/AAP-4039-2021; Rolas, Loic/AAA-6717-2022; Folgueras, Alicia/B-3281-2017	López-Otín, Carlos/0000-0001-6964-1904; Quesada, Víctor/0000-0002-8398-3457; Freije, José M.P./0000-0002-4688-8266; Santiago-Fernández, Olaya/0000-0002-5933-3104; Folgueras, Alicia/0000-0003-3426-9502; Barkaway, Anna/0000-0003-4366-0378; Maeso Miguel, Daniel/0000-0003-0086-6157; Rolas, Loic/0000-0001-7617-0768; Nourshargh, Sussan/0000-0001-5677-1806	Fundacion Bancaria Caja de Ahorros de Asturias; Ministerio de Economia y Competitividad (MINECO/FEDER) [SAF2014-52413-R, SAF2017-87655-R, SAF2015-64157-R]; Gobierno del Principado de Asturias; European Research Council (ERC-2016-ADG); Instituto de Salud Carlos III (RTICC); Progeria Research Foundation [PRF2016-66]; FPU fellowship; Ramon y Cajal fellowship; Wellcome Trust [098291/Z/12/Z]	Fundacion Bancaria Caja de Ahorros de Asturias; Ministerio de Economia y Competitividad (MINECO/FEDER)(Spanish Government); Gobierno del Principado de Asturias(Principality of Asturias); European Research Council (ERC-2016-ADG); Instituto de Salud Carlos III (RTICC)(Instituto de Salud Carlos III); Progeria Research Foundation; FPU fellowship(Spanish Government); Ramon y Cajal fellowship(Spanish Government); Wellcome Trust(Wellcome Trust)	We thank G. Velasco, R. Villa-Bellosta, C. Barcena, A.P. Ugalde and X.M. Caravia for helpful comments and advice, and R. Feijoo, A. Moyano, D.A. Puente and S.A. Miranda for excellent technical assistance. We also acknowledge the generous support by J.I. Cabrera and Associazione Italiana Progeria Sammy Basso and the contribution of Dr. Matthew Golding to the generation of the anti-murine progerin antibody. The Instituto Universitario de Oncologia del Principado de Asturias is supported by Fundacion Bancaria Caja de Ahorros de Asturias. J.M.P.F. is supported by Ministerio de Economia y Competitividad (MINECO/FEDER: No. SAF2015-64157-R) and Gobierno del Principado de Asturias. C.L.-O. is supported by grants from the European Research Council (ERC-2016-ADG, DeAge), Ministerio de Economia y Competitividad (MINECO/FEDER: Nos. SAF2014-52413-R and SAF2017-87655-R), Instituto de Salud Carlos III (RTICC) and Progeria Research Foundation (No. PRF2016-66). O.S.-F. is recipient of an FPU fellowship. A.R.F. is recipient of a Ramon y Cajal fellowship. The generation of progerin antibody was funded by the Wellcome Trust (No. 098291/Z/12/Z to S.N.).	Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081; Bar DZ, 2017, J MED GENET, V54, P212, DOI 10.1136/jmedgenet-2016-104295; Beyret E, 2019, NAT MED, V25, P419, DOI 10.1038/s41591-019-0343-4; de la Rosa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3268; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Gao X, 2018, NATURE, V553, P217, DOI 10.1038/nature25164; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2018, JAMA-J AM MED ASSOC, V319, P1687, DOI 10.1001/jama.2018.3264; Gordon LB, 2014, CIRCULATION, V130, P27, DOI 10.1161/CIRCULATIONAHA.113.008285; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469	21	68	72	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					423	+		10.1038/s41591-018-0338-6	http://dx.doi.org/10.1038/s41591-018-0338-6			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30778239	Green Accepted			2022-12-27	WOS:000460643100019
J	Stower, H				Stower, Hannah			Detecting opioid overdoses with smartphones	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					197	197		10.1038/s41591-019-0362-1	http://dx.doi.org/10.1038/s41591-019-0362-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728530	Bronze			2022-12-27	WOS:000457842100009
J	Minchole, A; Rodriguez, B				Minchole, Ana; Rodriguez, Blanca			Artificial intelligence for the electrocardiogram	NATURE MEDICINE			English	Editorial Material							RESOURCE	Deep-learning algorithms can be applied to large datasets of electrocardiograms, are capable of identifying abnormal heart rhythms and mechanical dysfunction, and could aid healthcare decisions.	[Minchole, Ana; Rodriguez, Blanca] Univ Oxford, British Heart Fdn, Ctr Res Excellence, Dept Comp Sci, Oxford, England	University of Oxford	Rodriguez, B (corresponding author), Univ Oxford, British Heart Fdn, Ctr Res Excellence, Dept Comp Sci, Oxford, England.	blanca@cs.ox.ac.uk	Minchole, Ana/B-7609-2019	Minchole, Ana/0000-0003-3183-4107; Rodriguez, Blanca/0000-0001-6361-3339	National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/P001076/1] Funding Source: Medline	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))		Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2; Bai WJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0471-x; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Camps J, 2018, P 3 INT WORKSH BIOM; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Kiranyaz S, 2016, IEEE T BIO-MED ENG, V63, P664, DOI 10.1109/TBME.2015.2468589; Lau JK, 2013, INT J CARDIOL, V165, P193, DOI 10.1016/j.ijcard.2013.01.220; Lyon A, 2018, EUROPACE, V20, P102, DOI 10.1093/europace/euy226; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724	12	49	52	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					22	23		10.1038/s41591-018-0306-1	http://dx.doi.org/10.1038/s41591-018-0306-1			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617324				2022-12-27	WOS:000455027700015
J	Stower, H				Stower, Hannah			Full dairy ahead!	NATURE MEDICINE			English	Editorial Material																			0	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					19	19		10.1038/s41591-018-0331-0	http://dx.doi.org/10.1038/s41591-018-0331-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617329	Bronze			2022-12-27	WOS:000455027700009
J	Gandara, DR; Paul, SM; Kowanetz, M; Schleifman, E; Zou, W; Li, Y; Rittmeyer, A; Fehrenbacher, L; Otto, G; Malboeuf, C; Lieber, DS; Lipson, D; Silterra, J; Amler, L; Riehl, T; Cummings, CA; Hegde, PS; Sandler, A; Ballinger, M; Fabrizio, D; Mok, T; Shames, DS				Gandara, David R.; Paul, Sarah M.; Kowanetz, Marcin; Schleifman, Erica; Zou, Wei; Li, Yan; Rittmeyer, Achim; Fehrenbacher, Louis; Otto, Geoff; Malboeuf, Christine; Lieber, Daniel S.; Lipson, Doron; Silterra, Jacob; Amler, Lukas; Riehl, Todd; Cummings, Craig A.; Hegde, Priti S.; Sandler, Alan; Ballinger, Marcus; Fabrizio, David; Mok, Tony; Shames, David S.			Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab	NATURE MEDICINE			English	Article							LIQUID BIOPSIES; PD-1 BLOCKADE; OPEN-LABEL; DOCETAXEL; DNA; NIVOLUMAB; PEMBROLIZUMAB; MULTICENTER; LANDSCAPE; EVOLUTION	Although programmed death-ligand 1-programmed death 1 (PD-L1-PD-1) inhibitors are broadly efficacious, improved outcomes have been observed in patients with high PD-L1 expression or high tumor mutational burden (TMB). PD-L1 testing is required for checkpoint inhibitor monotherapy in front-line non-small-cell lung cancer (NSCLC). However, obtaining adequate tumor tissue for molecular testing in patients with advanced disease can be challenging. Thus, an unmet medical need exists for diagnostic approaches that do not require tissue to identify patients who may benefit from immunotherapy. Here, we describe a novel, technically robust, blood-based assay to measure TMB in plasma (bTMB) that is distinct from tissue-based approaches. Using a retrospective analysis of two large randomized trials as test and validation studies, we show that bTMB reproducibly identifies patients who derive clinically significant improvements in progression-free survival from atezolizumab (an anti-PDL1) in second-line and higher NSCLC. Collectively, our data show that high bTMB is a clinically actionable biomarker for atezolizumab in NSCLC.	[Gandara, David R.] UC Davis Comprehens Canc Ctr, Sacramento, CA USA; [Paul, Sarah M.; Kowanetz, Marcin; Schleifman, Erica; Zou, Wei; Li, Yan; Amler, Lukas; Riehl, Todd; Cummings, Craig A.; Hegde, Priti S.; Sandler, Alan; Ballinger, Marcus; Shames, David S.] Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Rittmeyer, Achim] Lungenfachklin Immenhausen, Immenhausen, Germany; [Fehrenbacher, Louis] Kaiser Permanente Med Ctr, Vallejo, CA USA; [Otto, Geoff; Malboeuf, Christine; Lieber, Daniel S.; Lipson, Doron; Silterra, Jacob; Fabrizio, David] Fdn Med Inc, Cambridge, MA USA; [Mok, Tony] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Southern China, Hong Kong, Hong Kong, Peoples R China	Roche Holding; Genentech; Kaiser Permanente; Foundation Medicine; Chinese University of Hong Kong	Shames, DS (corresponding author), Genentech Inc, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.; Mok, T (corresponding author), Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Southern China, Hong Kong, Hong Kong, Peoples R China.	drgandara@ucdavis.edu; tony@clo.cuhk.edu.hk; shames.david@gene.com	Rittmeyer, Achim/W-2405-2019; Mok, Tony Shu Kam/B-2310-2019	Mok, Tony Shu Kam/0000-0002-8251-0551; Silterra, Jacob/0000-0001-9159-5836; Rittmeyer, Achim/0000-0002-5280-6052	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	We thank the patients, their families and the clinical study-site investigators and staff for their contributions to the study. In addition, we acknowledge E. White, M. Coyne, T. Brennan, M. Kennedy, J. He, S. Zhong, G. Young, J. Ma, M. Zhao and G. Frampton for their contributions. This study was funded by F. Hoffmann-La Roche. Editorial support for this manuscript was provided by M. Balbas of Health Interactions and funded by F. Hoffmann-La Roche.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Campesato LF, 2015, ONCOTARGET, V6, P34221, DOI 10.18632/oncotarget.5950; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chaudhuri AA, 2017, CANCER DISCOV, V7, P1394, DOI 10.1158/2159-8290.CD-17-0716; Chen LX, 2017, SCIENCE, V355, P752, DOI 10.1126/science.aai8690; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Fabrizio D, 2017, ANN ONCOL, V28; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Friedman J H, 1995, Stat Methods Med Res, V4, P197, DOI 10.1177/096228029500400303; Garon EB, 2017, NEW ENGL J MED, V376, P2483, DOI 10.1056/NEJMe1705692; Green M. R., 2014, J CLIN ONCOL, V26; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Hui R, 2017, ANN ONCOL, V28, P874, DOI 10.1093/annonc/mdx008; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Johnson DB, 2016, CANCER IMMUNOL RES, V4, P959, DOI 10.1158/2326-6066.CIR-16-0143; Kowanetz M, 2017, J THORAC ONCOL, V12, pS321, DOI 10.1016/j.jtho.2016.11.343; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lim C, 2015, ANN ONCOL, V26, P1415, DOI 10.1093/annonc/mdv208; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Sun JX, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005965; Sun JX, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-1893; Tischer B, 2017, J THORAC ONCOL, V12, pS1199, DOI 10.1016/j.jtho.2016.11.1690; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7	37	638	690	8	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1441	+		10.1038/s41591-018-0134-3	http://dx.doi.org/10.1038/s41591-018-0134-3			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30082870				2022-12-27	WOS:000444174100029
J	Xu, M; Pirtskhalava, T; Farr, JN; Weigand, BM; Palmer, AK; Weivoda, MM; Inman, CL; Ogrodnik, MB; Hachfeld, CM; Fraser, DG; Onken, JL; Johnson, KO; Verzosa, GC; Langhi, LGP; Weigl, M; Giorgadze, N; LeBrasseur, NK; Miller, JD; Jurk, D; Singh, RJ; Allison, DB; Ejima, K; Hubbard, GB; Ikeno, Y; Cubro, H; Garovic, VD; Hou, XN; Weroha, SJ; Robbins, PD; Niedernhofer, LJ; Khosla, S; Tchkonia, T; Kirkland, JL				Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N.; Weigand, Bettina M.; Palmer, Allyson K.; Weivoda, Megan M.; Inman, Christina L.; Ogrodnik, Mikolaj B.; Hachfeld, Christine M.; Fraser, Daniel G.; Onken, Jennifer L.; Johnson, Kurt O.; Verzosa, Grace C.; Langhi, Larissa G. P.; Weigl, Moritz; Giorgadze, Nino; LeBrasseur, Nathan K.; Miller, Jordan D.; Jurk, Diana; Singh, Ravinder J.; Allison, David B.; Ejima, Keisuke; Hubbard, Gene B.; Ikeno, Yuji; Cubro, Hajrunisa; Garovic, Vesna D.; Hou, Xiaonan; Weroha, S. John; Robbins, Paul D.; Niedernhofer, Laura J.; Khosla, Sundeep; Tchkonia, Tamara; Kirkland, James L.			Senolytics improve physical function and increase lifespan in old age	NATURE MEDICINE			English	Article							SENESCENT SECRETORY PHENOTYPE; CELLULAR SENESCENCE; FRAILTY; CELLS; DYSFUNCTION; PREVALENCE; CLEARANCE; PROGRAM; TISSUE; ADULTS	Physical function declines in old age, portending disability, increased health expenditures, and mortality. Cellular senescence, leading to tissue dysfunction, may contribute to these consequences of aging, but whether senescence can directly drive age-related pathology and be therapeutically targeted is still unclear. Here we demonstrate that transplanting relatively small numbers of senescent cells into young mice is sufficient to cause persistent physical dysfunction, as well as to spread cellular senescence to host tissues. Transplanting even fewer senescent cells had the same effect in older recipients and was accompanied by reduced survival, indicating the potency of senescent cells in shortening health- and lifespan. The senolytic cocktail, dasatinib plus quercetin, which causes selective elimination of senescent cells, decreased the number of naturally occurring senescent cells and their secretion of frailty-related proinflammatory cytokines in explants of human adipose tissue. Moreover, intermittent oral administration of senolytics to both senescent cell-transplanted young mice and naturally aged mice alleviated physical dysfunction and increased post-treatment survival by 36% while reducing mortality hazard to 65%. Our study provides proof-of-concept evidence that senescent cells can cause physical dysfunction and decreased survival even in young mice, while senolytics can enhance remaining health- and lifespan in old mice.	[Xu, Ming; Pirtskhalava, Tamar; Farr, Joshua N.; Weigand, Bettina M.; Palmer, Allyson K.; Weivoda, Megan M.; Inman, Christina L.; Ogrodnik, Mikolaj B.; Hachfeld, Christine M.; Fraser, Daniel G.; Onken, Jennifer L.; Johnson, Kurt O.; Verzosa, Grace C.; Langhi, Larissa G. P.; Weigl, Moritz; Giorgadze, Nino; LeBrasseur, Nathan K.; Miller, Jordan D.; Khosla, Sundeep; Tchkonia, Tamara; Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA; [Xu, Ming] Univ Connecticut, Ctr Aging, Univ Connecticut Hlth, Farmington, CT 06030 USA; [Weigand, Bettina M.; Ogrodnik, Mikolaj B.; Jurk, Diana] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Weigand, Bettina M.; Ogrodnik, Mikolaj B.; Jurk, Diana] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Singh, Ravinder J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Allison, David B.; Ejima, Keisuke] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Allison, David B.; Ejima, Keisuke] Univ Alabama Birmingham, Nathan Shock Ctr Comparat Energet & Aging, Birmingham, AL USA; [Hubbard, Gene B.; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Hubbard, Gene B.; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ikeno, Yuji] South Texas Vet Healthcare Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA; [Cubro, Hajrunisa; Garovic, Vesna D.] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA; [Hou, Xiaonan; Weroha, S. John] Mayo Clin, Dept Oncol, Rochester, MN USA; [Robbins, Paul D.; Niedernhofer, Laura J.] Scripps Res Inst, Ctr Aging, Dept Mol Med, Jupiter, FL USA	Mayo Clinic; University of Connecticut; Newcastle University - UK; Newcastle University - UK; Mayo Clinic; Indiana University System; Indiana University Bloomington; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; Mayo Clinic; Mayo Clinic; Scripps Research Institute	Xu, M; Tchkonia, T; Kirkland, JL (corresponding author), Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA.; Xu, M (corresponding author), Univ Connecticut, Ctr Aging, Univ Connecticut Hlth, Farmington, CT 06030 USA.	mixu@uchc.edu; tchkonia.tamar@mayo.edu; kirkland.james@mayo.edu	Ogrodnik, Mikolaj/GSI-9480-2022; Xu, Ming/L-4044-2019; Palmer, Allyson/ABA-5926-2020; Xu, Ming/AAR-1681-2021; Khosla, Sundeep/AAE-6170-2020	Xu, Ming/0000-0002-4477-939X; Khosla, Sundeep/0000-0002-2936-4372; Ogrodnik, Mikolaj/0000-0003-3137-2037; Weigl, Moritz/0000-0002-3941-5671; Miller, Jordan/0000-0002-9868-4097; Tchkonia, Tamar/0000-0003-4623-7145; Langhi Prata, Larissa/0000-0001-9617-8089; Niedernhofer, Laura/0000-0002-1074-1385; Jurk, Diana/0000-0003-4486-0857; Robbins, Paul/0000-0003-1068-7099; Palmer, Allyson/0000-0001-7505-3455	Connor Group; National Institutes of Health (NIH) [AG13925, AG49182, DK50456, AG46061, AG13319, AG050886, AG043376, AG056278, AG044376]; Glenn/American Federation for Aging Research (AFAR) BIG Award; Glenn Foundation; Ted Nash Long Life Foundation; Noaber Foundation; Glenn/AFAR Postdoctoral Fellowship for Translational Research on Aging; Irene Diamond Fund/AFAR Postdoctoral Transition Award in Aging; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002377] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR070281, K01AR070241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG056278, R21AG049182, R01AG044376, P01AG004875, P30AG050886, F30AG046061, R01AG048792, P01AG043376, R01AG013925, P30AG013319, R37AG013925] Funding Source: NIH RePORTER	Connor Group; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn/American Federation for Aging Research (AFAR) BIG Award; Glenn Foundation; Ted Nash Long Life Foundation; Noaber Foundation; Glenn/AFAR Postdoctoral Fellowship for Translational Research on Aging; Irene Diamond Fund/AFAR Postdoctoral Transition Award in Aging; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to J. L. Armstrong and L. Thesing for administrative assistance, M. Mahlman for obtaining human adipose tissue samples, Z. Aversa for help with muscle analysis, the Pathology Research Core Lab at Mayo Clinic-Rochester for histology studies, and C. Guo for overall support. This work was supported by the Connor Group (J.L.K.) and Robert J. and Theresa W. Ryan (J.L.K.); the National Institutes of Health (NIH) grants AG13925 (J.L.K.), AG49182 (J.L.K), DK50456 (Adipocyte Subcore, J.L.K.), AG46061 (A.K.P.), AG46061 (S.K.), AG46061 (S.K.), AG46061 (J.N.F.), AG46061 (M.M.W.), AG13319 (Y.I. and G.B.H.), AG050886 (D.B.A.), AG043376 (P.D.R., and L.J.N.), AG056278 (P.D.R. and L.J.N.), and AG044376 (L.J.N.); a Glenn/American Federation for Aging Research (AFAR) BIG Award (J.L.K.); the Glenn Foundation (L.J.N.); and the Ted Nash Long Life and Noaber Foundations (J.L.K.). M.X. received the Glenn/AFAR Postdoctoral Fellowship for Translational Research on Aging and an Irene Diamond Fund/AFAR Postdoctoral Transition Award in Aging.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beyer I, 2012, EXP GERONTOL, V47, P52, DOI 10.1016/j.exger.2011.10.005; Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Costa LG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2986796; Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385; Farr JN, 2016, J BONE MINER RES, V31, P1920, DOI 10.1002/jbmr.2892; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268; Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Justice JN, 2018, J GERONTOL A-BIOL, V73, P939, DOI 10.1093/gerona/glx134; Kane AE, 2016, CLIN INTERV AGING, V11, P1519, DOI 10.2147/CIA.S105714; Kao TW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31905; Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969; Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013; Lu YX, 2016, ONCOTARGET, V7, P28783, DOI 10.18632/oncotarget.8939; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x; Montani D, 2012, CIRCULATION, V125, P2128, DOI 10.1161/CIRCULATIONAHA.111.079921; MOSIER DE, 1993, J EXP MED, V177, P191, DOI 10.1084/jem.177.1.191; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Palmer AK, 2015, DIABETES, V64, P2289, DOI 10.2337/db14-1820; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Srinivas-Shankar U, 2009, FRONT HORM RES, V37, P133, DOI 10.1159/000176050; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V293, pE1810, DOI 10.1152/ajpendo.00295.2007; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Xu M, 2017, J GERONTOL A-BIOL, V72, P780, DOI 10.1093/gerona/glw154; Xu M, 2016, PHARMACOL RES, V111, P152, DOI 10.1016/j.phrs.2016.05.015; Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997; Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344; Zhu Y, 2014, CURR OPIN CLIN NUTR, V17, P324, DOI 10.1097/MCO.0000000000000065	63	818	838	24	239	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1246	+		10.1038/s41591-018-0092-9	http://dx.doi.org/10.1038/s41591-018-0092-9			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29988130	Green Accepted			2022-12-27	WOS:000440955500030
J	Tao, RY; Wang, CX; Stohr, O; Qiu, W; Hu, Y; Miao, J; Dong, XC; Leng, S; Stefater, M; Stylopoulos, N; Lin, L; Copps, KD; White, MF				Tao, Rongya; Wang, Caixia; Stohr, Oliver; Qiu, Wei; Hu, Yue; Miao, Ji; Dong, X. Charles; Leng, Sining; Stefater, Margaret; Stylopoulos, Nicholas; Lin, Lin; Copps, Kyle D.; White, Morris F.			Inactivating hepatic follistatin alleviates hyperglycemia	NATURE MEDICINE			English	Article							RECEPTOR SUBSTRATE 1; TGF-BETA FAMILY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CIRCULATING FOLLISTATIN; NUTRIENT HOMEOSTASIS; GLUCOSE-UTILIZATION; IN-VIVO; METABOLISM; LIVER	Unsuppressed hepatic glucose production (HGP) contributes substantially to glucose intolerance and diabetes, which can be modeled by the genetic inactivation of hepatic insulin receptor substrate 1 (Irs1) and Irs2 (LDKO mice). We previously showed that glucose intolerance in LDKO mice is resolved by hepatic inactivation of the transcription factor FoxO1 (that is, LTKO mice)-even though the liver remains insensitive to insulin. Here, we report that insulin sensitivity in the white adipose tissue of LDKO mice is also impaired but is restored in LTKO mice in conjunction with normal suppression of HGP by insulin. To establish the mechanism by which white adipose tissue insulin signaling and HGP was regulated by hepatic FoxO1, we identified putative hepatokines-including excess follistatin (Fst)-that were dysregulated in LDKO mice but normalized in LTKO mice. Knockdown of hepatic Fst in the LDKO mouse liver restored glucose tolerance, white adipose tissue insulin signaling and the suppression of HGP by insulin; however, the expression of Fst in the liver of healthy LTKO mice had the opposite effect. Of potential clinical significance, knockdown of Fst also improved glucose tolerance in high-fat-fed obese mice, and the level of serum Fst was reduced in parallel with glycated hemoglobin in obese individuals with diabetes who underwent therapeutic gastric bypass surgery. We conclude that Fst is a pathological hepatokine that might be targeted for diabetes therapy during hepatic insulin resistance.	[Tao, Rongya; Wang, Caixia; Stohr, Oliver; Qiu, Wei; Hu, Yue; Miao, Ji; Leng, Sining; Stefater, Margaret; Stylopoulos, Nicholas; Lin, Lin; Copps, Kyle D.; White, Morris F.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Dong, X. Charles] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Indiana University System; Indiana University Bloomington	White, MF (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA.	morris.white@childrens.harvard.edu	Stylopoulos, Nicholas/V-1377-2019; Miao, Ji/F-9398-2015	Stylopoulos, Nicholas/0000-0002-5025-7854; Miao, Ji/0000-0003-0869-4492; Dong, X Charlie/0000-0001-5452-6882	NIH [DK098655, 2 GM021700, DK108642, DK091592, DK107682, AA024550]; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091592, R00DK100539, R01DK098655, R56DK091592, R01DK108642, R01DK107682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA024550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Biddinger's lab for providing the cDNA from the LIRKO liver. We thank E. Rosen's lab for providing the 3T3-L1 cells. We thank U. Ozcan's lab for providing the pAAV2. TBG. PI vector. We thank R. DePinho's lab for providing the floxed FoxO1 mice. This work was supported by NIH grants DK098655 and project 2 GM021700 (M.F.W.); DK108642 (N.S.); and DK091592, DK107682 and AA024550 (X.C.D.).	Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brown ML, 2011, OBESITY, V19, P1940, DOI 10.1038/oby.2011.97; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Copps KD, 2016, ENDOCRINOLOGY ADULT, P556; Copps KD, 2016, J BIOL CHEM, V291, P8602, DOI 10.1074/jbc.M116.714915; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Edgerton DS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91863; El Ouaamari A, 2016, CELL METAB, V23, P194, DOI 10.1016/j.cmet.2015.12.001; FERRE P, 1985, BIOCHEM J, V228, P103, DOI 10.1042/bj2280103; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Guo TQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03245; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hansen J, 2013, DIABETES-METAB RES, V29, P463, DOI 10.1002/dmrr.2415; Hansen JS, 2016, J CLIN ENDOCR METAB, V101, P550, DOI 10.1210/jc.2015-3668; Hansen JS, 2016, MOL CELL ENDOCRINOL, V433, P87, DOI 10.1016/j.mce.2016.06.002; Hansen JS, 2016, J CLIN ENDOCR METAB, V101, P2816, DOI 10.1210/jc.2016-1681; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kucejova B, 2016, CELL REP, V16, P508, DOI 10.1016/j.celrep.2016.06.006; Lambert-Messerlian GM, 2004, MOL CELL ENDOCRINOL, V225, P101, DOI 10.1016/j.mce.2004.02.019; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE428, DOI 10.1152/ajpendo.00116.2001; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Modica S, 2016, CELL REP, V16, P2243, DOI 10.1016/j.celrep.2016.07.048; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Myburgh R, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.58; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Samanta D, 2012, FRONT BIOSCI-LANDMRK, V17, P1281, DOI 10.2741/3986; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Schneyer AL, 2004, J CLIN ENDOCR METAB, V89, P5067, DOI 10.1210/jc.2004-0162; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shearin AL, 2016, MOL METAB, V5, P472, DOI 10.1016/j.molmet.2016.05.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Walton RG, 2015, J BIOL CHEM, V290, P11547, DOI 10.1074/jbc.M114.628487; Wang Q, 2015, INT J BIOL SCI, V11, P199, DOI 10.7150/ijbs.10430; Wang ZW, 2012, DIABETES, V61, P2134, DOI 10.2337/db11-1763; Xiong XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074340; Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	54	48	51	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1058	+		10.1038/s41591-018-0048-0	http://dx.doi.org/10.1038/s41591-018-0048-0			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29867232	Green Accepted, Green Submitted			2022-12-27	WOS:000438187700034
J	Nielsen-Saines, K; Brasil, P; Kerin, T; Vasconcelos, Z; Gabaglia, CR; Damasceno, L; Pone, M; de Carvalho, LMA; Pone, SM; Zin, AA; Tsui, I; Salles, TRS; da Cunha, DC; Costa, RP; Malacarne, J; Reis, AB; Hasue, RH; Aizawa, CYP; Genovesi, FF; Einspieler, C; Marschik, PB; Pereira, JP; Gaw, SL; Adachi, K; Cherry, JD; Xu, ZH; Cheng, GH; Moreira, ME				Nielsen-Saines, Karin; Brasil, Patricia; Kerin, Tara; Vasconcelos, Zilton; Gabaglia, Claudia Raja; Damasceno, Luana; Pone, Marcos; Abreu de Carvalho, Liege M.; Pone, Sheila M.; Zin, Andrea A.; Tsui, Irena; Salles, Tania Regina S.; da Cunha, Denise Cotrim; Costa, Roozemerie Pereira; Malacarne, Jociele; Reis, Ana Beatriz; Hasue, Renata Hydee; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.; Einspieler, Christa; Marschik, Peter B.; Pereira, Jose Paulo; Gaw, Stephanie L.; Adachi, Kristina; Cherry, James D.; Xu, Zhiheng; Cheng, Genhong; Moreira, Maria Elisabeth			Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children	NATURE MEDICINE			English	Article							INFANT NEUROLOGICAL EXAMINATION; VIRUS-INFECTION; OPHTHALMIC MANIFESTATIONS; CEREBRAL-PALSY; BIRTH-DEFECTS; BAYLEY-III; EPIDEMIC; OUTCOMES; SEX	We report neurodevelopmental outcomes in 216 infants followed since the time of PCR-confirmed maternal Zika virus (ZIKV) infection in pregnancy during the Rio de Janeiro epidemic of 2015-2016 (refs. (1,2)). Neurodevelopment was assessed by Bayley Scales of Infant and Toddler Development, third edition (Bayley-III; cognitive, language and motor domains) in 146 children and through neurodevelopment questionnaires/neurological examinations in 70 remaining children. Complete eye exams (n = 137) and hearing assessments (n = 114) were also performed. Below-average neurodevelopment and/or abnormal eye or hearing assessments were noted in 31.5% of children between 7 and 32 months of age. Among children assessed by Bayley-III, 12% scored below -2 s.d. (score < 70; a score of 100 +/- 2 s.d. is the range) in at least one domain; and 28% scored between -1 and -2 s.d. in any domain (scores < 85-70). Language function was most affected, with 35% of 146 children below average. Improved neurodevelopmental outcomes were noted in female children, term babies, children with normal eye exams and maternal infection later in pregnancy (P = 0.01). We noted resolution of microcephaly with normal neurodevelopment in two of eight children, development of secondary microcephaly in two other children and autism spectrum disorder in three previously healthy children in the second year of life.	[Nielsen-Saines, Karin; Kerin, Tara; Tsui, Irena; Adachi, Kristina; Cherry, James D.; Cheng, Genhong] David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA; [Brasil, Patricia; Vasconcelos, Zilton; Damasceno, Luana; Pone, Marcos; Abreu de Carvalho, Liege M.; Pone, Sheila M.; Zin, Andrea A.; Salles, Tania Regina S.; da Cunha, Denise Cotrim; Costa, Roozemerie Pereira; Malacarne, Jociele; Reis, Ana Beatriz; Pereira, Jose Paulo; Moreira, Maria Elisabeth] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA; [Hasue, Renata Hydee; Aizawa, Carolina Y. P.; Genovesi, Fernanda F.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Graz, Austria; [Marschik, Peter B.] Univ Med Ctr, Gottingen, Germany; [Gaw, Stephanie L.] UCSF Sch Med, San Francisco, CA USA; [Xu, Zhiheng] Chinese Acad Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Medical University of Graz; University of Gottingen; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Los Angeles, CA 90095 USA.; Moreira, ME (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.	knielsen@mednet.ucla.edu; bebethiff@gmail.com	de Lima, Antonio Marcos Oliveira/AAT-2148-2021; Moreira, Maria Elisabeth Lopes/AAA-3775-2020; de Carvalho, Liege Maria/AAV-8922-2021; Brasil, Patricia/P-3536-2014; Hasue, Renata Hydee/B-2328-2013; Einspieler, Christa/HHS-6481-2022; Pone, Marcos/ABF-2743-2022	Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Hasue, Renata Hydee/0000-0002-7717-6042; Pone, Marcos/0000-0002-5152-2242; Vasconcelos, Zilton/0000-0002-2193-2224; Brasil, Patricia/0000-0001-9555-7976; Reis, AlessanRSS/0000-0001-8486-7469; Moura Pone, Sheila/0000-0002-6246-8915	Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil [DECIT/25000.072811/2016-19]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001/88887.116627/2016-01]; Brazilian National Council for Scientific and Technological Development [CNPq/441098/2016-9, CNPq307282/2017-1]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-18/2015TXB, 239224/E-032018, E-26/202.862/2018]; Fondation Christophe e Rodolphe Merieux [734548]; Thrasher Research Fund [20164370]; Bill and Melinda gates Foundation Grand Challenges Explorations [OPP112887]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health [AI28697, AI1259534-01, AI140718-01]; National Eye Institute (NEI) of the National Institutes of Health [AI129847-01]; United Kingdom's Department for International Development; ZikaPlan (Preparedness Latin American Network); NATIONAL EYE INSTITUTE [R21EY028318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI140718, K08AI141728, R21AI129534, P30AI028697] Funding Source: NIH RePORTER	Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fondation Christophe e Rodolphe Merieux; Thrasher Research Fund; Bill and Melinda gates Foundation Grand Challenges Explorations(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Eye Institute (NEI) of the National Institutes of Health; United Kingdom's Department for International Development; ZikaPlan (Preparedness Latin American Network); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Departamento de Ciencia e Tecnologia do Ministerio da Saude do Brasil (DECIT/25000.072811/2016-19, to P.B. and M.E.M.); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES 001/88887.116627/2016-01 to PB); Brazilian National Council for Scientific and Technological Development (CNPq/441098/2016-9 to M.E.M. and CNPq307282/2017-1 to P.B.); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, No. E-18/2015TXB to M.E.M., No. 239224/E-032018 to M.E.M. and No. E-26/202.862/2018 to P.B.); Fondation Christophe e Rodolphe Merieux to P.B.; ZikAlliance, 734548 to P.B.; the Thrasher Research Fund (No. 20164370 to K.N.S. and K.A.); the Bill and Melinda gates Foundation Grand Challenges Explorations (No. OPP112887 to P.B.M.); the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (No. AI28697 to K.N.S., No. AI1259534-01 to K.N.S. and G.C., No. AI140718-01 to K.N.S. and P.B.); the National Eye Institute (NEI) of the National Institutes of Health (No. AI129847-01 to K.N.S., I.T. and P.B.); the United Kingdom's Department for International Development (to M.E.M.); and the ZikaPlan (Preparedness Latin American Network, to M.E.M.). We thank the women who enrolled in this study, the Fiocruz Zika Field Team who rendered our work possible, and P.F. Augusto and C.B. de Souza (Federal University of Sao Paulo), who assisted with neurodevelopmental assessments.	Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Ballot Daynia E, 2017, Int Sch Res Notices, V2017, P1631760, DOI 10.1155/2017/1631760; Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901; BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.2307/1126464; Bayley N., 2019, BAYLEY SCALES INFANT; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cherry J, 2018, FEIGIN CHERRYS TXB P, V8; da Cunha RDES, 2016, J PEDIAT-BRAZIL, V92, P136, DOI 10.1016/j.jped.2015.04.004; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098; Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8; Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037; Johnson S, 2014, PEDIATR RES, V75, P670, DOI 10.1038/pr.2014.10; Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606; Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004; Pacheco O, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMoa1604037; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1; Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876; Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006; Rossetto J. D., 2018, J AAPOS, V22, pe60; Souza CT, 2010, BRAZ J PHYS THER, V14, P309; Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; Ventura C. V, 2016, ARQ BRAS OFTALMOL, V79; Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784; Vianna P, 2018, NEUROIMMUNOMODULAT, V25, P320, DOI 10.1159/000495660; Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561; Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474	39	124	125	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1213	+		10.1038/s41591-019-0496-1	http://dx.doi.org/10.1038/s41591-019-0496-1			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31285631	Green Accepted			2022-12-27	WOS:000480414600018
J	Yost, KE; Satpathy, AT; Wells, DK; Qi, YY; Wang, CL; Kageyama, R; McNamara, KL; Granja, JM; Sarin, KY; Brown, RA; Gupta, RK; Curtis, C; Bucktrout, SL; Davis, MM; Chang, ALS; Chang, HY				Yost, Kathryn E.; Satpathy, Ansuman T.; Wells, Daniel K.; Qi, Yanyan; Wang, Chunlin; Kageyama, Robin; McNamara, Katherine L.; Granja, Jeffrey M.; Sarin, Kavita Y.; Brown, Ryanne A.; Gupta, Rohit K.; Curtis, Christina; Bucktrout, Samantha L.; Davis, Mark M.; Chang, Anne Lynn S.; Chang, Howard Y.			Clonal replacement of tumor-specific T cells following PD-1 blockade	NATURE MEDICINE			English	Article							INFERENCE; EXPRESSION; CARCINOMA; PATHWAYS	Immunotherapies that block inhibitory checkpoint receptors on T cells have transformed the clinical care of patients with cancer(1). However, whether the T cell response to checkpoint blockade relies on reinvigoration of pre-existing tumor-infiltrating lymphocytes or on recruitment of novel T cells remains unclear(2-4). Here we performed paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy. Tracking T cell receptor clones and transcriptional phenotypes revealed coupling of tumor recognition, clonal expansion and T cell dysfunction marked by clonal expansion of CD8(+)CD39(+) T cells, which co-expressed markers of chronic T cell activation and exhaustion. However, the expansion of T cell clones did not derive from pre-existing tumor-infiltrating T lymphocytes; instead, the expanded clones consisted of novel clonotypes that had not previously been observed in the same tumor. Clonal replacement of T cells was preferentially observed in exhausted CD8(+) T cells and evident in patients with basal or squamous cell carcinoma. These results demonstrate that pre-existing tumor-specific T cells may have limited reinvigoration capacity, and that the T cell response to checkpoint blockade derives from a distinct repertoire of T cell clones that may have just recently entered the tumor.	[Yost, Kathryn E.; Satpathy, Ansuman T.; Qi, Yanyan; Granja, Jeffrey M.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Satpathy, Ansuman T.; Brown, Ryanne A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Satpathy, Ansuman T.; Wells, Daniel K.; Kageyama, Robin; Bucktrout, Samantha L.; Davis, Mark M.; Chang, Howard Y.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Wang, Chunlin] iRepertoire Inc, Huntsville, AL USA; [McNamara, Katherine L.; Curtis, Christina] Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA; [McNamara, Katherine L.; Granja, Jeffrey M.; Curtis, Christina; Chang, Howard Y.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [McNamara, Katherine L.; Curtis, Christina] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Granja, Jeffrey M.] Stanford Univ, Sch Med, Program Biophys, Stanford, CA 94305 USA; [Sarin, Kavita Y.; Brown, Ryanne A.; Chang, Anne Lynn S.; Chang, Howard Y.] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA; [Gupta, Rohit K.] Stanford Univ, Sch Med, Stanford Biobank, Palo Alto, CA 94304 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Davis, Mark M.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Satpathy, AT; Chang, HY (corresponding author), Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA.; Satpathy, AT (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Satpathy, AT; Chang, HY (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Chang, HY (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Chang, ALS; Chang, HY (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA.; Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	satpathy@stanford.edu; alschang@stanford.edu; howchang@stanford.edu	Yost, Kathryn/X-2171-2019; Wells, Daniel K./AAH-4015-2020	Yost, Kathryn/0000-0001-6807-950X; Davis, Mark/0000-0001-6868-657X; Satpathy, Ansuman/0000-0002-5167-537X; Sarin, Kavita/0000-0001-5363-3053; McNamara, Katherine/0000-0002-3717-6494; Gupta, Rohit/0000-0002-6897-7083; Brown, Ryanne/0000-0001-9099-7227	Parker Institute for Cancer Immunotherapy; Michelson Foundation; National Institutes of Health (NIH) [P50HG007735, R35CA209919, K08CA230188, K23CA211793, R01CA182514, DP1-CA238296, 5U19AI057229]; National Science Foundation Graduate Research Fellowship Program (NSF) [DGE-1656518]; Stanford Graduate Fellowship; Bridge Scholar Award from Parker Institute for Cancer Immunotherapy; Burroughs Wellcome Fund; NIH [S10OD018220]; NATIONAL CANCER INSTITUTE [R35CA209919, K23CA211793, P30CA124435] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG007735, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	Parker Institute for Cancer Immunotherapy; Michelson Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program (NSF); Stanford Graduate Fellowship(Stanford University); Bridge Scholar Award from Parker Institute for Cancer Immunotherapy; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Chang laboratory for discussions; X. Ji, D. Wagh and J. Coller at the Stanford Functional Genomics Facility, J. Sung and S. Fitch at the Stanford Clinical and Translational Research Unit Biobank and D. D. Hiraki at the Stanford Blood Center Histocompatibility, Immunogenetics, and Disease Profiling Laboratory; A. D. Colevas, S. Reddy, L. Van Der Bokke and R. Patel for clinical collaboration; A. Pague and A. Valencia for assistance with clinical specimens; K. Quema-Yee at the Parker Institute for Cancer Immunotherapy for assistance with illustrations. This work was supported by the Parker Institute for Cancer Immunotherapy (A.T.S., D.K.W., R. K., S.L.B., M.M.D. and H.Y.C.), the Michelson Foundation (A.T.S.) and the National Institutes of Health (NIH) (P50HG007735, R35CA209919 (H.Y.C.), K08CA230188 (A.T.S.), K23CA211793 (K.Y.S.), R01CA182514, DP1-CA238296 (C.C.) and 5U19AI057229 (M.M.D.)). K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship. A.T.S. was supported by a Bridge Scholar Award from the Parker Institute for Cancer Immunotherapy, a Career Award for Medical Scientists from the Burroughs Wellcome Fund and the Human Vaccines Project Michelson Prize for Human Immunology and Vaccine Research. Cell sorting for this project was done on instruments in the Stanford Shared FACS Facility. Sequencing was performed by the Stanford Functional Genomics Facility (supported by NIH grant S10OD018220). M.M.D. and H.Y.C. are investigators of the Howard Hughes Medical Institute.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bernemann TM, 2000, J CUTAN PATHOL, V27, P108, DOI 10.1034/j.1600-0560.2000.027003108.x; Bircan S, 2006, J CUTAN PATHOL, V33, P293, DOI 10.1111/j.0303-6987.2006.00436.x; Birger C., 2017, PREPRINT, DOI [10.1101/209494v1, DOI 10.1101/209494V1]; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Calderon D., 2018, PREPRINT, DOI [10.1101/409722v1, DOI 10.1101/409722V1]; Chang ALS, 2019, J AM ACAD DERMATOL, V80, P564, DOI 10.1016/j.jaad.2018.08.017; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fan J, 2018, GENOME RES, V28, P1217, DOI 10.1101/gr.228080.117; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Hoang VLT, 2017, PEERJ, V5, DOI 10.7717/peerj.3631; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0473-4; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2018, IMMUNITY, V48, P185, DOI 10.1016/j.immuni.2018.02.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McInnes L., 2018, UMAP UNIFORM MANIFOL; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Ransohoff KJ, 2015, NEW ENGL J MED, V373, P1079, DOI 10.1056/NEJMc1504261; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Skidmore ZL, 2016, BIOINFORMATICS, V32, P3012, DOI 10.1093/bioinformatics/btw325; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Sun RP, 2017, NAT GENET, V49, P1015, DOI 10.1038/ng.3891; TELLECHEA O, 1993, AM J DERMATOPATH, V15, P452, DOI 10.1097/00000372-199310000-00007; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Thorstenson YR, 2018, HUM IMMUNOL, V79, P839, DOI 10.1016/j.humimm.2018.09.004; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xie C, 2017, P NATL ACAD SCI USA, V114, P8059, DOI 10.1073/pnas.1707945114; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	62	526	542	16	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1251	+		10.1038/s41591-019-0522-3	http://dx.doi.org/10.1038/s41591-019-0522-3			29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31359002	Green Submitted, Green Accepted			2022-12-27	WOS:000480414600023
J	Stower, H				Stower, Hannah			Testing for repeat adverse events	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1029	1029		10.1038/s41591-019-0528-x	http://dx.doi.org/10.1038/s41591-019-0528-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270498	Bronze			2022-12-27	WOS:000474430400007
J	Rozeman, EA; Blank, CU				Rozeman, Elisa A.; Blank, Christian U.			Combining checkpoint inhibition and targeted therapy in melanoma	NATURE MEDICINE			English	Editorial Material							BRAF; VEMURAFENIB; COMBINATION; DABRAFENIB		[Blank, Christian U.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Pathol & Immunol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Blank, CU (corresponding author), Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands.	c.blank@nki.nl						Ascierto PA, 2019, NAT MED, V25, P941, DOI 10.1038/s41591-019-0448-9; Casebeer AW, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.30_suppl.46; Deken MA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238557; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Hodi FS, 2018, LANCET ONCOL, V19, P1480, DOI 10.1016/S1470-2045(18)30700-9; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2018, J CLIN ONCOL, V36, P667, DOI 10.1200/JCO.2017.74.1025; Minor DR, 2015, PIGM CELL MELANOMA R, V28, P611, DOI 10.1111/pcmr.12383; Ribas A, 2019, NAT MED, V25, P936, DOI 10.1038/s41591-019-0476-5; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Robert L, 2016, SEMIN IMMUNOL, V28, P73, DOI 10.1016/j.smim.2016.01.001; Rozeman E. A., 2018, ANN ONCOL, V29; Sullivan RJ, 2019, NAT MED, V25, P929, DOI 10.1038/s41591-019-0474-7; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479	15	9	9	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					879	882		10.1038/s41591-019-0482-7	http://dx.doi.org/10.1038/s41591-019-0482-7			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171877				2022-12-27	WOS:000470844400015
J	Stower, H				Stower, Hannah			Lymph removal not tied to positive outcomes	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					541	541		10.1038/s41591-019-0426-2	http://dx.doi.org/10.1038/s41591-019-0426-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30948850	Bronze			2022-12-27	WOS:000463342800007
J	Stower, H				Stower, Hannah			Linking Alzheimer's disease and frailty	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					358	358		10.1038/s41591-019-0399-1	http://dx.doi.org/10.1038/s41591-019-0399-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842666	Bronze			2022-12-27	WOS:000460643100007
J	Caielli, S; Veiga, DT; Balasubramanian, P; Athale, S; Domic, B; Murat, E; Banchereau, R; Xu, ZH; Chandra, M; Chung, CH; Walters, L; Baisch, J; Wright, T; Punaro, M; Nassi, L; Stewart, K; Fuller, J; Ucar, D; Ueno, H; Zhou, J; Banchereau, J; Pascual, V				Caielli, Simone; Veiga, Diogo Troggian; Balasubramanian, Preetha; Athale, Shruti; Domic, Bojana; Murat, Elise; Banchereau, Romain; Xu, Zhaohui; Chandra, Manjari; Chung, Cheng-Han; Walters, Lynnette; Baisch, Jeanine; Wright, Tracey; Punaro, Marilynn; Nassi, Lorien; Stewart, Katie; Fuller, Julie; Ucar, Duygu; Ueno, Hideki; Zhou, Joseph; Banchereau, Jacques; Pascual, Virginia			A CD4(+) T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate	NATURE MEDICINE			English	Article							PLASMACYTOID DENDRITIC CELLS; DISEASE-ACTIVITY; NUCLEIC-ACIDS; I INTERFERON; DIFFERENTIATION; CLASSIFICATION; MITOCHONDRIA; EXPRESSION; PROMOTE; ANTIGEN	Understanding the mechanisms underlying autoantibody development will accelerate therapeutic target identification in autoimmune diseases such as systemic lupus erythematosus (SLE)(1). Follicular helper T cells (T-FH cells) have long been implicated in SLE pathogenesis. Yet a fraction of autoantibodies in individuals with SLE are unmutated, supporting that autoreactive B cells also differentiate outside germinal centers(2). Here, we describe a CXCR5(-)CXCR3(+) programmed death 1 (PD1)(hi)CD4(+) helper T cell population distinct from T-FH cells and expanded in both SLE blood and the tubulointerstitial areas of individuals with proliferative lupus nephritis. These cells produce interleukin-10 (IL-10) and accumulate mitochondrial reactive oxygen species as the result of reverse electron transport fueled by succinate. Furthermore, they provide B cell help, independently of IL-21, through IL-10 and succinate. Similar cells are generated in vitro upon priming naive CD4(+) T cells with plasmacytoid dendritic cells activated with oxidized mitochondrial DNA, a distinct class of interferogenic toll-like receptor 9 ligand(3). Targeting this pathway might blunt the initiation and/or perpetuation of extrafollicular humoral responses in SLE.	[Caielli, Simone; Athale, Shruti; Domic, Bojana; Murat, Elise; Banchereau, Romain; Xu, Zhaohui; Chandra, Manjari; Walters, Lynnette; Baisch, Jeanine; Ueno, Hideki; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Caielli, Simone; Balasubramanian, Preetha; Murat, Elise; Baisch, Jeanine; Pascual, Virginia] Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY 10065 USA; [Caielli, Simone; Balasubramanian, Preetha; Murat, Elise; Baisch, Jeanine; Pascual, Virginia] Weill Cornell Med, Dept Pediat, New York, NY 10065 USA; [Veiga, Diogo Troggian; Chung, Cheng-Han; Ucar, Duygu; Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Walters, Lynnette; Wright, Tracey; Punaro, Marilynn; Nassi, Lorien; Stewart, Katie; Fuller, Julie; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Wright, Tracey; Punaro, Marilynn; Nassi, Lorien; Stewart, Katie; Fuller, Julie] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Ueno, Hideki] Mt Sinai Sch Med, New York, NY USA; [Zhou, Joseph] Pathol Biomed Labs, Lewisville, TX USA	Baylor Scott & White Health; Cornell University; Cornell University; Jackson Laboratory; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; Icahn School of Medicine at Mount Sinai	Pascual, V (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.; Pascual, V (corresponding author), Weill Cornell Med, Drukier Inst Childrens Hlth, New York, NY 10065 USA.; Pascual, V (corresponding author), Weill Cornell Med, Dept Pediat, New York, NY 10065 USA.; Pascual, V (corresponding author), Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA.	vip2021@med.cornell.edu	Veiga, Diogo Troggian/J-9279-2019; Pascual, Virginia/ABD-3099-2020; Ueno, Hideki/L-1237-2016	Veiga, Diogo Troggian/0000-0002-4018-5375; Banchereau, Romain/0000-0001-6916-6445; Ueno, Hideki/0000-0001-7747-0738; Xu, Zhaohui/0000-0003-0645-1737	NIH [P50 AR054083-01, U19 AIO82715]; Baylor Scott & White Health Care Research Foundation; Drukier Institute for Children's Health at Weill Cornell Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR070594] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Scott & White Health Care Research Foundation; Drukier Institute for Children's Health at Weill Cornell Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank C. Kusminski and R. Gordillo for helping with the metabolic Seahorse experiments. We also thank N. Baldwin, R. Marches and especially our study subjects, healthy donors and their parents. This work was supported by NIH grants P50 AR054083-01 and U19 AIO82715 (V.P.), by the Baylor Scott & White Health Care Research Foundation and by the Drukier Institute for Children's Health at Weill Cornell Medicine.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Anoopkumar-Dukie S, 2005, BRIT J RADIOL, V78, P945, DOI 10.1259/bjr/54004230; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Chang A, 2011, J IMMUNOL, V186, P1849, DOI 10.4049/jimmunol.1001983; Dorner T, 2004, LUPUS, V13, P283, DOI 10.1191/0961203304lu1014oa; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Gilliet M, 2002, HUM IMMUNOL, V63, P1149, DOI 10.1016/S0198-8859(02)00753-X; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glimcher LH, 2000, GENE DEV, V14, P1693; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Jackson SK, 2002, IMMUNOLOGY, V106, P486, DOI 10.1046/j.1365-2567.2002.01457.x; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nag S, 2001, LAB INVEST, V81, P41, DOI 10.1038/labinvest.3780210; Oaks Z, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0622-8; Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Peti-Peterdi J, 2010, KIDNEY INT, V78, P1214, DOI 10.1038/ki.2010.333; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145	48	114	116	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					75	+		10.1038/s41591-018-0254-9	http://dx.doi.org/10.1038/s41591-018-0254-9			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30478422	Green Accepted			2022-12-27	WOS:000455027700024
J	Lourenco, MV; Frozza, RL; de Freitas, GB; Zhang, H; Kincheski, GC; Ribeiro, FC; Goncalves, RA; Clarke, JR; Beckman, D; Staniszewski, A; Berman, H; Guerra, LA; Forny-Germano, L; Meier, S; Wilcock, DM; de Souza, JM; Alves-Leon, S; Prado, VF; Prado, MAM; Abisambra, JF; Tovar-Moll, F; Mattos, P; Arancio, O; Ferreira, ST; De Felice, FG				Lourenco, Mychael V.; Frozza, Rudimar L.; de Freitas, Guilherme B.; Zhang, Hong; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Goncalves, Rafaella A.; Clarke, Julia R.; Beckman, Danielle; Staniszewski, Agnieszka; Berman, Hanna; Guerra, Lorena A.; Forny-Germano, Leticia; Meier, Shelby; Wilcock, Donna M.; de Souza, Jorge M.; Alves-Leon, Soniza; Prado, Vania F.; Prado, Marco A. M.; Abisambra, Jose F.; Tovar-Moll, Fernanda; Mattos, Paulo; Arancio, Ottavio; Ferreira, Sergio T.; De Felice, Fernanda G.			Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models	NATURE MEDICINE			English	Article							DEPRESSIVE-LIKE BEHAVIOR; AMYLOID-BETA OLIGOMERS; HIPPOCAMPAL INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MOUSE MODEL; EIF2-ALPHA KINASES; GENE-EXPRESSION; ENERGY-INTAKE; BRAIN; DISEASE	Defective brain hormonal signaling has been associated with Alzheimer's disease (AD), a disorder characterized by synapse and memory failure. Irisin is an exercise-induced myokine released on cleavage of the membrane-bound precursor protein fibronectin type III domain-containing protein 5 (FNDC5), also expressed in the hippocampus. Here we show that FNDC5/irisin levels are reduced in AD hippocampi and cerebrospinal fluid, and in experimental AD models. Knockdown of brain FNDC5/irisin impairs long-term potentiation and novel object recognition memory in mice. Conversely, boosting brain levels of FNDC5/irisin rescues synaptic plasticity and memory in AD mouse models. Peripheral overexpression of FNDC5/irisin rescues memory impairment, whereas blockade of either peripheral or brain FNDC5/irisin attenuates the neuroprotective actions of physical exercise on synaptic plasticity and memory in AD mice. By showing that FNDC5/irisin is an important mediator of the beneficial effects of exercise in AD models, our findings place FNDC5/irisin as a novel agent capable of opposing synapse failure and memory impairment in AD.	[Lourenco, Mychael V.; Frozza, Rudimar L.; de Freitas, Guilherme B.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Clarke, Julia R.; Beckman, Danielle; Guerra, Lorena A.; Forny-Germano, Leticia; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil; [Lourenco, Mychael V.; Kincheski, Grasielle C.; Ribeiro, Felipe C.; Guerra, Lorena A.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil; [Lourenco, Mychael V.; Zhang, Hong; Staniszewski, Agnieszka; Berman, Hanna; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Frozza, Rudimar L.] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Rio De Janeiro, Brazil; [de Freitas, Guilherme B.; Goncalves, Rafaella A.; De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, Rio De Janeiro, Brazil; [Meier, Shelby; Wilcock, Donna M.; Abisambra, Jose F.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurosurg, Rio De Janeiro, Brazil; [de Souza, Jorge M.; Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Epilepsy Program, Div Neurol, Rio De Janeiro, Brazil; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Prado, Vania F.; Prado, Marco A. M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Tovar-Moll, Fernanda; Mattos, Paulo] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil; [Mattos, Paulo] Univ Fed Rio de Janeiro, Inst Psychiat, Rio De Janeiro, Brazil; [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Arancio, Ottavio] Columbia Univ, Dept Med, New York, NY 10027 USA; [De Felice, Fernanda G.] Queens Univ, Dept Psychiat, Kingston, ON, Canada	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Columbia University; Fundacao Oswaldo Cruz; Queens University - Canada; Universidade Federal do Rio de Janeiro; University of Kentucky; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Columbia University; Columbia University; Queens University - Canada	Ferreira, ST; De Felice, FG (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, Brazil.; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.; Arancio, O (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Arancio, O (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Arancio, O (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.; De Felice, FG (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON, Canada.	oa1@cumc.columbia.edu; ferreira@biof.ufrj.br; fernanda.defelice@queensu.ca	Abisambra, Joe/AAP-3269-2020; Forny-Germano, Leticia/L-6639-2019; Lourenco, Mychael/G-2614-2014; Ferreira, Sergio/AAZ-1576-2020; De Felice, Fernanda G/M-1074-2017; Prado, Vania Ferreira/K-7630-2013; Leon, Soniza V Alves/J-7786-2012; Moll, Fernanda Tovar/N-3320-2018; arancio, ottavio/AAB-7959-2019; Forny-Germano, Leticia/D-1342-2017; Prado, Marco Antonio Maximo/K-7638-2013; Abisambra, Jose/V-6860-2019; Ribeiro, Felipe Campos/W-9758-2019; Clarke, Julia/AAF-9434-2019; de Mattos, Paulo Eduardo Luiz/D-2328-2014; Beckman, Danielle/B-4656-2015; Moll, Fernanda Tovar/AAF-8477-2021	Forny-Germano, Leticia/0000-0001-8301-0711; Lourenco, Mychael/0000-0002-1078-0296; Ferreira, Sergio/0000-0001-7160-9866; Prado, Vania Ferreira/0000-0003-4994-6393; Moll, Fernanda Tovar/0000-0002-0292-5985; Forny-Germano, Leticia/0000-0001-8301-0711; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Abisambra, Jose/0000-0001-6341-679X; Ribeiro, Felipe Campos/0000-0003-3028-3307; de Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783; Beckman, Danielle/0000-0002-9584-4411; Moll, Fernanda Tovar/0000-0002-0292-5985; Berman, Hanna/0000-0002-8616-8167; De Freitas, Guilherme/0000-0003-4614-4280; Frozza, Rudimar Luiz/0000-0003-0918-4128; Araujo Goncalves da Silva, Rafaella/0000-0001-5334-0816; Meier, Shelby/0000-0003-1946-9004	Alzheimer Society of Canada; Weston Brain Institute; National Institute for Translational Neuroscience (INNT/Brazil) [465346/2014-6]; Human Frontier Science Program; International Society for Neurochemistry (CAEN 1B); National Institutes of Health [NIH-R01NS049442]; Canadian Institutes of Health Research [CIHR MOP 136940, MOP 89919]; Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [451195/2017-5, 406436/2016-9, 473324/2013-0]; Brazilian funding agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [202.817/2016, 201.432/2014, 202.944/2015]; FAPERJ; CNPq; Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil) [001]; NIH T32 grant [AG057461]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG057461, P30AG028383] Funding Source: NIH RePORTER	Alzheimer Society of Canada; Weston Brain Institute; National Institute for Translational Neuroscience (INNT/Brazil); Human Frontier Science Program(Human Frontier Science Program); International Society for Neurochemistry (CAEN 1B); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Alzheimer Society of Canada (to F.G.D.F.) and the Weston Brain Institute (to F.G.D.F.), National Institute for Translational Neuroscience (INNT/Brazil) (465346/2014-6 to S.T.F. and F.G.F.), Human Frontier Science Program (to F.G.D.F.), International Society for Neurochemistry (CAEN 1B to M.V.L.), National Institutes of Health (NIH-R01NS049442 to O.A.), Canadian Institutes of Health Research (CIHR MOP 136940 and MOP 89919 to V.F.P. and M.A.M.P.), and from the Brazilian funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (451195/2017-5 to M.V.L., 406436/2016-9 to S.T.F., and 473324/2013-0 to F.G.D.F.) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (202.817/2016 to M.V.L., 201.432/2014 to S.T.F., and 202.944/2015 to F.G.D.F.). R.L.F, G.B.d.F., G.C.K., F.C.R., J.R.C., D.B., and L.F.-G. were supported by fellowships granted by FAPERJ, CNPq, or Comissao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil; financial code 001). S.M. was supported by an NIH T32 grant (AG057461). We acknowledge the University of Kentucky Alzheimer's Disease Center and its Neuropathology Core, which is supported by NIH/NIA P30 AG028383, for brain samples. We thank W.L. Klein (Northwestern University) for the kind gift of oligomer-specific NU4 antibodies, B.M. Spiegelman (Harvard University) for sharing AdGFP and AdFNDC5 adenoviral constructs, and J. Wang (Queen's University, Canada) for help with mass spectrometry analyses. We also thank A. Lepelley, M. Oliveira, M. Melo, A.C. Rangel, and the CENABIO team for technical and/or administrative assistance.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Beckman D, 2015, J BIOL CHEM, V290, P20488, DOI 10.1074/jbc.M115.666156; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Chen K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao6298; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2014, ALZHEIMERS DEMENT, V10, pS26, DOI 10.1016/j.jalz.2013.12.004; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; Drummond C, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00096; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Figueiredo CP, 2013, J NEUROSCI, V33, P9626, DOI 10.1523/JNEUROSCI.0482-13.2013; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Grillo CA, 2015, DIABETES, V64, P3927, DOI 10.2337/db15-0596; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Irving AJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0155; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Katsnelson A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aal2074; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco MV, 2015, PROG NEUROBIOL, V129, P37, DOI 10.1016/j.pneurobio.2015.03.003; Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Madeira C, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.52; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; McEwen BS, 2015, P NATL ACAD SCI USA, V112, P15544, DOI 10.1073/pnas.1521416112; Mendes ND, 2018, J NEUROSCI METH, V307, P203, DOI 10.1016/j.jneumeth.2018.05.021; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Mucke L, 2012, COLD SPRING HARB PER, V2; Muller S, 2018, ALZHEIMERS DEMENT, V14, P1427, DOI 10.1016/j.jalz.2018.06.3059; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Okonkwo OC, 2014, NEUROLOGY, V83, P1753, DOI 10.1212/WNL.0000000000000964; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Schaefer N, 2017, J NEUROCHEM, V142, P790, DOI 10.1111/jnc.14107; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schumacher MA, 2013, J BIOL CHEM, V288, P33738, DOI 10.1074/jbc.M113.516641; Sebollela A, 2012, J BIOL CHEM, V287, P7436, DOI 10.1074/jbc.M111.298471; da Silva GSS, 2017, J BIOL CHEM, V292, P7395, DOI 10.1074/jbc.M116.753525; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092; Smith RW, 2007, PROTEOMICS, V7, P4171, DOI 10.1002/pmic.200700573; Suwabe K, 2018, P NATL ACAD SCI USA, V115, P10487, DOI 10.1073/pnas.1805668115; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013; van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wadman M, 2012, NATURE, V485, P426, DOI 10.1038/485426a; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Yang WZ, 2016, NEUROBIOL AGING, V41, P19, DOI 10.1016/j.neurobiolaging.2016.02.005; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	70	320	340	22	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					165	+		10.1038/s41591-018-0275-4	http://dx.doi.org/10.1038/s41591-018-0275-4			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617325	Green Accepted			2022-12-27	WOS:000455027700034
J	Topol, EJ				Topol, Eric J.			High-performance medicine: the convergence of human and artificial intelligence	NATURE MEDICINE			English	Review							DEEP-LEARNING ALGORITHM; RISK-FACTORS; DIABETIC-RETINOPATHY; PREDICTION; HEALTH; CANCER; CLASSIFICATION; METAANALYSIS; MORTALITY; FUTURE	The use of artificial intelligence, and the deep-learning subtype in particular, has been enabled by the use of labeled big data, along with markedly enhanced computing power and cloud storage, across all sectors. In medicine, this is beginning to have an impact at three levels: for clinicians, predominantly via rapid, accurate image interpretation; for health systems, by improving workflow and the potential for reducing medical errors; and for patients, by enabling them to process their own data to promote health. The current limitations, including bias, privacy and security, and lack of transparency, along with the future directions of these applications will be discussed in this article. Over time, marked improvements in accuracy, productivity, and workflow will likely be actualized, but whether that will be used to improve the patient-doctor relationship or facilitate its erosion remains to be seen.	[Topol, Eric J.] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute	Topol, EJ (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729	Clinical and Translational Science Award (CTSA) from the National Institute of Health (NIH) [UL1TR002550]	Clinical and Translational Science Award (CTSA) from the National Institute of Health (NIH)	Funding was provided by the Clinical and Translational Science Award (CTSA) from the National Institute of Health (NIH) grant number UL1TR002550.	Abramoff MD, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0040-6; Acs B, 2018, JAMA ONCOL, V4, P403, DOI 10.1001/jamaoncol.2017.5449; Adam GC, 2018, NATURE, V558, P39, DOI 10.1038/d41586-018-05297-5; Alaa AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29523-2; Albers DJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005232; AlQuraishi M., 2018, END TO END DIFFERENT, DOI 10.1101/265231; Angermueller C, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1189-z; [Anonymous], 2018, NAT BIOTECHNOL, V36, P290, DOI 10.1038/nbt0418-290; [Anonymous], 2014, NATURE, V515, P163, DOI 10.1038/515163a; [Anonymous], 2015, U CAMBRIDGE RES; [Anonymous], 2018, NAT BIOMED ENG, V2, P139; Arbabshirani MR, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0015-z; Avati A., 2017, IMPROVING PALLIATIVE; Bahl M, 2018, RADIOLOGY, V286, P810, DOI 10.1148/radiol.2017170549; Bally L, 2018, NEW ENGL J MED, V379, P547, DOI 10.1056/NEJMoa1805233; Banino A, 2018, NATURE, V557, P429, DOI 10.1038/s41586-018-0102-6; Bar A., 2017, COMPRESSION FRACTURE; Barrett PM, 2017, LANCET, V389, P1877, DOI 10.1016/S0140-6736(17)31218-7; Baur C., 2018, GENERATING HIGHLY RE; Beam AL, 2016, JAMA-J AM MED ASSOC, V316, P2368, DOI 10.1001/jama.2016.17217; Behravan H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31573-5; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bennington-Castro J., 2018, NBC NEWS; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bhagwat N, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006376; Bilsland E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19549-x; Brown JM, 2018, JAMA OPHTHALMOL, V136, P803, DOI 10.1001/jamaophthalmol.2018.1934; Buhr S., 2017, TECHCRUNCH; Burlina PM, 2017, JAMA OPHTHALMOL, V135, P1170, DOI 10.1001/jamaophthalmol.2017.3782; Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015; Cao B., 2018, DEEPMOOD MODELING MO; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Caravagna G, 2018, NAT METHODS, V15, P707, DOI 10.1038/s41592-018-0108-x; Carroll A. E., 2018, NY TIMES; Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a; Chakradhar S, 2017, NAT MED, V23, P1244, DOI 10.1038/nm1117-1244; Chekroud AM, 2016, LANCET PSYCHIAT, V3, P243, DOI 10.1016/S2215-0366(15)00471-X; Chilamkurthy S., 2018, DEV VALIDATION DEEP; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Christiansen EM, 2018, CELL, V173, P792, DOI 10.1016/j.cell.2018.03.040; Chung Y, 2018, JAMA PSYCHIAT, V75, P960, DOI 10.1001/jamapsychiatry.2018.1543; Coiera E, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0066-9; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Culliton Phil, 2017, PREDICTING SEVERE SE; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; De Graaf M., 2018, DAILY MAIL; de Langavant LC, 2018, J MED INTERNET RES, V20, DOI 10.2196/10493; Eichstaedt JC, 2018, P NATL ACAD SCI USA, V115, P11203, DOI 10.1073/pnas.1802331115; Elfiky AA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0926; Espinoza JL, 2018, J INTERN MED, V284, P189, DOI 10.1111/joim.12746; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fingas R., 2018, APPLEINSIDER; Finlayson SG, 2018, ARXIV180405296CSCR; Firth J, 2017, WORLD PSYCHIATRY, V16, P287, DOI 10.1002/wps.20472; Fitzpatrick KK, 2017, JMIR MENT HEALTH, V4, DOI 10.2196/mental.7785; Frankel J., 2016, ATLANTIC; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Gale W, 2017, DETECTING HIP FRACTU; Gehlbach PL, 2018, NAT BIOMED ENG, V2, P627, DOI 10.1038/s41551-018-0289-8; Golden JA, 2017, JAMA-J AM MED ASSOC, V318, P2184, DOI 10.1001/jama.2017.14580; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gurovich Y., 2017, DEEPGESTALT IDENTIFY; Gut G, 2018, SCIENCE, V361, DOI 10.1126/science.aar7042; Haenssle HA, 2018, ANN ONCOL, V29, P1836, DOI 10.1093/annonc/mdy166; Hall H, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005143; Han Q., 2018, A HYBRID RECOMMENDER; Han SS, 2018, J INVEST DERMATOL, V138, P1529, DOI 10.1016/j.jid.2018.01.028; Haque A., 2017, VISION BASED SMART H; Harvey H., 2018, TOWARDS DATA SCI; Harvey H., 2018, TOWARDS DATA SCIENCE; Hassabis D, 2017, NEURON, V95, P245, DOI 10.1016/j.neuron.2017.06.011; Haun K., 2017, NY TIMES; Heller N., 2017, NEW YORKER; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Hie B, 2018, SCIENCE, V362, P347, DOI 10.1126/science.aat4807; Holme O, 2018, ANN INTERN MED, V169, P409, DOI 10.7326/M18-1901; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Hsu J., 2018, ATLANTIC; Hu J., 2017, ARXIV170901507; Hulman A, 2018, DIABETOLOGIA, V61, P101, DOI 10.1007/s00125-017-4468-z; Hung AJ, 2018, JAMA SURG, V153, P770, DOI 10.1001/jamasurg.2018.1512; Januszewski M, 2018, NAT METHODS, V15, P605, DOI 10.1038/s41592-018-0049-4; Just MA, 2017, NAT HUM BEHAV, V1, P911, DOI 10.1038/s41562-017-0234-y; Kanagasingam Y, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2665; Kazeminia S., 2018, GANS MED IMAGE ANAL; Keane PA, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0048-y; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Kim HK, 2018, NAT BIOTECHNOL, V36, P239, DOI 10.1038/nbt.4061; Kish LJ, 2015, NAT BIOTECHNOL, V33, P921, DOI 10.1038/nbt.3340; Knight W, 2017, TECHNOL REV, V120, P54; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Korem T, 2017, CELL METAB, V25, P1243, DOI 10.1016/j.cmet.2017.05.002; Korkinof D., 2018, HIGH RESOLUTION MAMM; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kuang C., 2017, NEW YORK TIMES MAGAZ; Kwolek B, 2014, COMPUT METH PROG BIO, V117, P489, DOI 10.1016/j.cmpb.2014.09.005; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lehman CD, 2019, RADIOLOGY, V290, P52, DOI 10.1148/radiol.2018180694; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Levine B., 2018, ONDUO DELIVERS DIABE; Li Z., 2017, THORACIC DIS IDENTIF; Lieman-Sifry J, 2017, FASTVENTRICLE CARDIA; Lin C, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx681; Lindsey R, 2018, P NATL ACAD SCI USA, V115, P11591, DOI 10.1073/pnas.1806905115; Listgarten J, 2018, NAT BIOMED ENG, V2, P38, DOI 10.1038/s41551-017-0178-6; Liu F., 2018, JOINT SHAPE REPRESEN; Liu Y, 2019, ARCH PATHOL LAB MED, V143, P859, DOI 10.5858/arpa.2018-0147-OA; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Long EP, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0024; Lowe D, 2018, NATURE, V555, P592, DOI 10.1038/d41586-018-03774-5; Luechtefeld T, 2018, TOXICOL SCI, V165, P198, DOI 10.1093/toxsci/kfy152; Lundberg SM, 2018, NAT BIOMED ENG, V2, P749, DOI 10.1038/s41551-018-0304-0; Luo R, 2018, CLAIRVOYANTE MULTITA; Madani A, 2018, NPJ DIGIT MED, V1, DOI [10.1038/s41746-018-0065-x, 10.1038/s41746-017-0013-1]; Maier-Hein L, 2017, NAT BIOMED ENG, V1, P691, DOI 10.1038/s41551-017-0132-7; Manak MS, 2018, NAT BIOMED ENG, V2, P761, DOI 10.1038/s41551-018-0285-z; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mathotaarachchi S, 2017, NEUROBIOL AGING, V59, P80, DOI 10.1016/j.neurobiolaging.2017.06.027; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Miliard M., 2018, HLTHCARE IT NEWS; Miller A. P., 2018, HARVARD BUSINESS REV; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Mohr DC, 2018, JAMA PSYCHIAT, V75, P113, DOI 10.1001/jamapsychiatry.2017.3838; Mori Y, 2018, ANN INTERN MED, V169, P357, DOI 10.7326/M18-0249; Mutlu U, 2018, JAMA NEUROL, V75, P1256, DOI 10.1001/jamaneurol.2018.1563; Nam JG, 2019, RADIOLOGY, V290, P218, DOI 10.1148/radiol.2018180237; Nikolov S., 2018, DEEP LEARNING ACHIEV; Nitta N, 2018, CELL, V175, P266, DOI 10.1016/j.cell.2018.08.028; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Ota S, 2018, SCIENCE, V360, P1246, DOI 10.1126/science.aan0096; Ounkomol C, 2018, NAT METHODS, V15, P917, DOI 10.1038/s41592-018-0111-2; Patel NM, 2018, ONCOLOGIST, V23, P179, DOI 10.1634/theoncologist.2017-0170; Peters A, 2018, FAST CO; Poplin R, 2016, CREATING UNIVERSAL S; Poplin R, 2018, NAT BIOTECHNOL, V36, P983, DOI 10.1038/nbt.4235; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Prasad N, 2018, REINFORCEMENT LEARNI; Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Rajpurkar Pranav, 2017, CARDIOLOGIST LEVEL A; Rampasek L, 2018, CELL, V172, P893, DOI 10.1016/j.cell.2018.02.013; Razavian N., 2016, JMLR WORKSHOP C P, V56, P73; Reece AG, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0110-z; Ridley E. L., 2017, DEEP LEARNING ALGORI; Ridley E. L., 2018, ARTIFICIAL INTELLIGE; Ridley E. L, 2017, DEEP LEARNING SHOWS; Riesselman AJ, 2018, NAT METHODS, V15, P816, DOI 10.1038/s41592-018-0138-4; Robie AA, 2017, CELL, V170, P393, DOI 10.1016/j.cell.2017.06.032; Rose S, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1404; Roser M., 2020, OUR WORLD DATA; Ross C., 2018, STAT-US, V25; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Savelli F, 2018, NATURE, V557, P313, DOI 10.1038/d41586-018-04992-7; Schneider G, 2018, NAT REV DRUG DISCOV, V17, P97, DOI 10.1038/nrd.2017.232; Schnyer DM, 2017, PSYCHIAT RES-NEUROIM, V264, P1, DOI 10.1016/j.pscychresns.2017.03.003; Shadmi R., 2018, 2018 IEEE 15 INT S B; Shameer K, 2017, BIOCOMPUTING, P276, DOI 10.1142/9789813207813_0027; Shladover SE, 2016, SCI AM, V314, P53, DOI 10.1038/scientificamerican0616-52; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; Steiner DF, 2018, AM J SURG PATHOL, V42, P1636, DOI 10.1097/PAS.0000000000001151; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Strodthoff N, 2018, DETECTING INTERPRETI; Sullivan DP, 2018, NAT BIOTECHNOL, V36, P820, DOI 10.1038/nbt.4225; Sullivan DP, 2018, CELL, V173, P546, DOI 10.1016/j.cell.2018.04.003; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; Suresh H., 2017, CLIN INTERVENTION PR, P322; Tarassenko L, 2018, JAMA-J AM MED ASSOC, V320, P2309, DOI 10.1001/jama.2018.16558; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Thakrar AP, 2018, HEALTH AFFAIR, V37, P140, DOI 10.1377/hlthaff.2017.0767; Ting DSW, 2018, NAT MED, V24, P539, DOI 10.1038/s41591-018-0029-3; Titano JJ, 2018, NAT MED, V24, P1337, DOI 10.1038/s41591-018-0147-y; Tuegel E.J., 2011, INT J AEROSP ENG, V2011, P154798, DOI [10.1155/2011/154798, DOI 10.1155/2011/154798]; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Victory J., 2018, HEALTHNEWSREVIEW; Wager TD, 2017, NAT MED, V23, P16, DOI 10.1038/nm.4264; Walsh CG, 2017, CLIN PSYCHOL SCI, V5, P457, DOI 10.1177/2167702617691560; Wang P, 2018, NAT BIOMED ENG, V2, P741, DOI 10.1038/s41551-018-0301-3; Wang ZC, 2017, J BIOMED INFORM, V76, P59, DOI 10.1016/j.jbi.2017.11.003; Wapner J., 2018, NEWSWEEK; Weigert M., 2017, CONTENT AWARE IMAGE, DOI 10.1101/236463; Weinberger D., 2017, BACKCHANNEL; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503; Wong A, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1018; Wong D, 2018, NATURE, V555, P446, DOI 10.1038/d41586-018-02881-7; Wong TY, 2016, JAMA-J AM MED ASSOC, V316, P2366, DOI 10.1001/jama.2016.17563; Wood DE, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar7939; Wright CD, 2016, NAT NANOTECHNOL, V11, P655, DOI 10.1038/nnano.2016.90; Wu D, 2018, NATURE, V559, P637, DOI 10.1038/s41586-018-0350-5; Yang SJ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2087-4; Yang ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24389-w; Yasaka K, 2018, RADIOLOGY, V286, P899, DOI 10.1148/radiol.2017170706; Yee K. M., 2017, AI ALGORITHM MATCHES; Yoon J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194985; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Zaidi D., 2017, VENTURE BEAT; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhang J, 2018, CIRCULATION, V138, P1623, DOI 10.1161/CIRCULATIONAHA.118.034338; Zhou J, 2018, NAT GENET, V50, P1171, DOI 10.1038/s41588-018-0160-6; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]; Zhu B, 2018, NATURE, V555, P487, DOI 10.1038/nature25988; Zitnik M., 2018, MACHINE LEARNING INT, DOI [10.1111/joim.12746, DOI 10.1111/JOIM.12746]; Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016	213	1485	1534	148	1240	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					44	56		10.1038/s41591-018-0300-7	http://dx.doi.org/10.1038/s41591-018-0300-7			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617339				2022-12-27	WOS:000455027700019
J	Graham, DB; Luo, CW; O'Connell, DJ; Lefkovith, A; Brown, EM; Yassour, M; Varma, M; Abelin, JG; Conway, KL; Jasso, GJ; Matar, CG; Carr, SA; Xavier, RJ				Graham, Daniel B.; Luo, Chengwei; O'Connell, Daniel J.; Lefkovith, Ariel; Brown, Eric M.; Yassour, Moran; Varma, Mukund; Abelin, Jennifer G.; Conway, Kara L.; Jasso, Guadalupe J.; Matar, Caline G.; Carr, Steven A.; Xavier, Ramnik J.			Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes	NATURE MEDICINE			English	Article							CLASS-II PRESENTATION; T-CELLS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; PEPTIDES; MOLECULES; BINDING; MICROBIOTA; IDENTIFICATION; PREDICTION	Identifying immunodominant T cell epitopes remains a significant challenge in the context of infectious disease, autoimmunity, and immuno-oncology. To address the challenge of antigen discovery, we developed a quantitative proteomic approach that enabled unbiased identification of major histocompatibility complex class II (MHCII)-associated peptide epitopes and biochemical features of antigenicity. On the basis of these data, we trained a deep neural network model for genome-scale predictions of immunodominant MHCII-restricted epitopes. We named this model bacteria originated T cell antigen (BOTA) predictor. In validation studies, BOTA accurately predicted novel CD4 T cell epitopes derived from the model pathogen Listeria monocytogenes and the commensal microorganism Muribaculum intestinale. To conclusively define immunodominant T cell epitopes predicted by BOTA, we developed a high-throughput approach to screen DNA-encoded peptide-MHCII libraries for functional recognition by T cell receptors identified from single-cell RNA sequencing. Collectively, these studies provide a framework for defining the immunodominance landscape across a broad range of immune pathologies.	[Graham, Daniel B.; Luo, Chengwei; O'Connell, Daniel J.; Lefkovith, Ariel; Brown, Eric M.; Yassour, Moran; Varma, Mukund; Abelin, Jennifer G.; Jasso, Guadalupe J.; Matar, Caline G.; Carr, Steven A.; Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Graham, Daniel B.; Luo, Chengwei; Conway, Kara L.; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Graham, Daniel B.; Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02115 USA; [Graham, Daniel B.; Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Luo, Chengwei; Conway, Kara L.; Xavier, Ramnik J.] Harvard Med Sch, Ctr Computat & Integrat Biol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Jasso, Guadalupe J.] Harvard Med Sch, Immunol Program, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Graham, DB; Xavier, RJ (corresponding author), Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA.; Graham, DB; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA.; Graham, DB; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA.; Graham, DB; Xavier, RJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02115 USA.; Graham, DB; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Xavier, RJ (corresponding author), Harvard Med Sch, Ctr Computat & Integrat Biol, Massachusetts Gen Hosp, Boston, MA 02115 USA.	dgraham@broadinstitute.org; xavier@molbio.mgh.harvard.edu	Jasso, Guadalupe/AAM-8574-2021; Yassour, Moran/ABE-7415-2020; Carr, Steven A./AAH-8366-2019	Yassour, Moran/0000-0002-7344-5188; Jasso, Guadalupe/0000-0002-7254-3296; Abelin, Jennifer/0000-0001-5262-7241	Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health [DK043351, AI109725, AT009708, DK092405]; Juvenile Diabetes Research Fund; National Center for Complementary & Integrative Health [R01AT009708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097485, P30DK043351, R01DK092405] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Fund(Juvenile Diabetes Research Foundation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Vlamakis, T. Reimels, and I. Latorre for scientific input, J. Gracias for technical assistance, and P. Rogers for the FACS work. This work was supported by funding from The Leona M. and Harry B. Helmsley Charitable Trust, National Institutes of Health grants DK043351, AI109725, AT009708, and DK092405, and the Juvenile Diabetes Research Fund to R.J.X.	Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Andreatta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026781; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandwein SL, 1997, J IMMUNOL, V159, P44; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Christmann BS, 2015, J ALLERGY CLIN IMMUN, V136, P1378, DOI 10.1016/j.jaci.2015.03.036; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Depontieu FR, 2009, P NATL ACAD SCI USA, V106, P12073, DOI 10.1073/pnas.0903852106; Dongre AR, 2001, EUR J IMMUNOL, V31, P1485, DOI 10.1002/1521-4141(200105)31:5<1485::AID-IMMU1485>3.0.CO;2-A; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Kim A, 2015, CURR OPIN IMMUNOL, V34, P9, DOI 10.1016/j.coi.2014.12.005; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lippolis JD, 2002, J IMMUNOL, V169, P5089, DOI 10.4049/jimmunol.169.9.5089; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; McDavid A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003696; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mommen GPM, 2016, MOL CELL PROTEOMICS, V15, P1412, DOI 10.1074/mcp.M115.055780; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Palm NW, 2015, CLIN IMMUNOL, V159, P122, DOI 10.1016/j.clim.2015.05.014; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sofron A, 2016, EUR J IMMUNOL, V46, P319, DOI 10.1002/eji.201545930; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Stoll ML, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0486-0; Suri A, 2008, J IMMUNOL, V180, P3849, DOI 10.4049/jimmunol.180.6.3849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Xu C, 2015, BIOINFORMATICS, V31, P1974, DOI 10.1093/bioinformatics/btv088; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	60	34	35	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1762	+		10.1038/s41591-018-0203-7	http://dx.doi.org/10.1038/s41591-018-0203-7			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30349087	Green Accepted			2022-12-27	WOS:000449404200029
J	Deschasaux, M; Bouter, KE; Prodan, A; Levin, E; Groen, AK; Herrema, H; Tremaroli, V; Bakker, GJ; Attaye, I; Pinto-Sietsma, SJ; van Raalte, DH; Snijder, MB; Nicolaou, M; Peters, R; Zwinderman, AH; Backhed, F; Nieuwdorp, M				Deschasaux, Melanie; Bouter, Kristien E.; Prodan, Andrei; Levin, Evgeni; Groen, Albert K.; Herrema, Hilde; Tremaroli, Valentina; Bakker, Guido J.; Attaye, Ilias; Pinto-Sietsma, Sara-Joan; van Raalte, Daniel H.; Snijder, Marieke B.; Nicolaou, Mary; Peters, Ron; Zwinderman, Aeilko H.; Backhed, Fredrik; Nieuwdorp, Max			Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography	NATURE MEDICINE			English	Article							GLUCOSE-METABOLISM; HEALTH; DIVERSITY; GENETICS; DIET; AGE	Trillions of microorganisms inhabit the human gut and are regarded as potential key factors for health(1,2). Characteristics such as diet, lifestyle, or genetics can shape the composition of the gut microbiota(2-6) and are usually shared by individuals from comparable ethnic origin. So far, most studies assessing how ethnicity relates to the intestinal microbiota compared small groups living at separate geographical locations(7-10). Using fecal 16S ribosomal RNA gene sequencing in 2,084 participants of the Healthy Life in an Urban Setting (HELIUS) study(11,12), we show that individuals living in the same city tend to share similar gut microbiota characteristics with others of their ethnic background. Ethnicity contributed to explain the interindividual dissimilarities in gut microbiota composition, with three main poles primarily characterized by operational taxonomic units (OTUs) classified as Prevotella (Moroccans, Turks, Ghanaians), Bacteroides (African Surinamese, South-Asian Surinamese), and Clostridiales (Dutch). The Dutch exhibited the greatest gut microbiota alpha-diversity and the South-Asian Surinamese the smallest, with corresponding enrichment or depletion in numerous OTUs. Ethnic differences in alpha-diversity and interindividual dissimilarities were independent of metabolic health and only partly explained by ethnic-related characteristics including sociodemographic, lifestyle, or diet factors. Hence, the ethnic origin of individuals may be an important factor to consider in microbiome research and its potential future applications in ethnic-diverse societies.	[Deschasaux, Melanie; Pinto-Sietsma, Sara-Joan; Snijder, Marieke B.; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinform, Amsterdam, Netherlands; [Bouter, Kristien E.; Prodan, Andrei; Levin, Evgeni; Groen, Albert K.; Herrema, Hilde; van Raalte, Daniel H.; Nieuwdorp, Max] Vrije Univ Amsterdam, Amsterdam Diabet Ctr, Acad Med Ctr, Dept Internal Med,Med Ctr, Amsterdam, Netherlands; [Tremaroli, Valentina; Backhed, Fredrik; Nieuwdorp, Max] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Gothenburg, Sweden; [Bakker, Guido J.; Attaye, Ilias; Pinto-Sietsma, Sara-Joan; Nieuwdorp, Max] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Snijder, Marieke B.; Nicolaou, Mary] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Peters, Ron] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Backhed, Fredrik] Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Gothenburg; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Novo Nordisk Foundation; University of Copenhagen	Deschasaux, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinform, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Vrije Univ Amsterdam, Amsterdam Diabet Ctr, Acad Med Ctr, Dept Internal Med,Med Ctr, Amsterdam, Netherlands.; Nieuwdorp, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Gothenburg, Sweden.; Nieuwdorp, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	m.c.deschasaux@amc.uva.nl; m.b.snijder@amc.uva.nl; m.nieuwdorp@amc.uva.nl	Tremaroli, Valentina/AAE-8001-2019; SJ, Pinto-Sietsma/AAI-3207-2021; Bakker, Guido J./AAE-2743-2020; Backhed, Fredrik/ABE-6613-2020; Deschasaux, Mélanie/AAK-9116-2020	Tremaroli, Valentina/0000-0002-9150-4233; Bakker, Guido J./0000-0002-2819-9395; Backhed, Fredrik/0000-0002-4871-8818; Deschasaux, Mélanie/0000-0002-3359-420X; van Raalte, Daniel/0000-0003-2894-6124; Prodan, Andrei/0000-0003-2789-7789; Herrema, Hilde/0000-0002-0112-6348				Andrews S., 2010, FASTQC QUALITY CONTR; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7; Beukers MH, 2015, EUR J CLIN NUTR, V69, P579, DOI 10.1038/ejcn.2014.180; Borgdorff H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181135; Bouter KE, 2017, GASTROENTEROLOGY, V152, P1671, DOI 10.1053/j.gastro.2016.12.048; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979; Dekker LH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-441; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Findley K, 2016, TRENDS MICROBIOL, V24, P847, DOI 10.1016/j.tim.2016.08.001; Fortenberry JD, 2013, TRENDS MICROBIOL, V21, P165, DOI 10.1016/j.tim.2013.01.001; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lippert K, 2017, BENEF MICROBES, V8, P545, DOI 10.3920/BM2016.0184; Luthold RV, 2017, METABOLISM, V69, P76, DOI 10.1016/j.metabol.2017.01.007; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller GE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148952; Mobini R, 2017, DIABETES OBES METAB, V19, P579, DOI 10.1111/dom.12861; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Oki K, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0898-x; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prideaux L, 2013, INFLAMM BOWEL DIS, V19, P2906, DOI 10.1097/01.MIB.0000435759.05577.12; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Snijder MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017873; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Stenman LK, 2016, BENEF MICROBES, V7, P11, DOI 10.3920/BM2015.0069; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	51	271	278	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1526	+		10.1038/s41591-018-0160-1	http://dx.doi.org/10.1038/s41591-018-0160-1			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30150717	Green Submitted			2022-12-27	WOS:000446577900014
J	Delzenne, NM; Bindels, LB				Delzenne, Nathalie M.; Bindels, Laure B.			Microbiome metabolomics reveals new drivers of human liver steatosis	NATURE MEDICINE			English	Editorial Material							HUMAN GUT; METABOLITES		[Delzenne, Nathalie M.; Bindels, Laure B.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium	Universite Catholique Louvain	Delzenne, NM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; Bindels, Laure/T-7846-2019	Delzenne, Nathalie/0000-0003-2115-6082; Bindels, Laure/0000-0003-3747-3234				Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; Delzenne N. M, 2017, NAT REV GASTRO HEPAT, V15, P69; Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3; Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594	6	18	19	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					906	907		10.1038/s41591-018-0126-3	http://dx.doi.org/10.1038/s41591-018-0126-3			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988145				2022-12-27	WOS:000438187700016
J	Maryanovich, M; Zahalka, AH; Pierce, H; Pinho, S; Nakahara, F; Asada, N; Wei, QZ; Wang, XZ; Ciero, P; Xu, JN; Leftin, A; Frenette, PS				Maryanovich, Maria; Zahalka, Ali H.; Pierce, Halley; Pinho, Sandra; Nakahara, Fumio; Asada, Noboru; Wei, Qiaozhi; Wang, Xizhe; Ciero, Paul; Xu, Jianing; Leftin, Avigdor; Frenette, Paul S.			Adrenergic nerve degeneration in bone marrow drives aging of the hematopoietic stem cell niche	NATURE MEDICINE			English	Article							PROGENITOR CELLS; DNA-DAMAGE; REGENERATION; AGE; MOBILIZATION; QUIESCENCE; DISTINCT; REJUVENATION; MAINTENANCE; MECHANISMS	Aging of hematopoietic stem cells (HSCs) is associated with a decline in their regenerative capacity and multilineage differentiation potential, contributing to the development of blood disorders. The bone marrow microenvironment has recently been suggested to influence HSC aging, but the underlying mechanisms remain largely unknown. Here we show that HSC aging critically depends on bone marrow innervation by the sympathetic nervous system (SNS), as loss of SNS nerves or adrenoreceptor beta 3 signaling in the bone marrow microenvironment of young mice led to premature HSC aging, as evidenced by appearance of HSC phenotypes reminiscent of physiological aging. Strikingly, supplementation of a sympathomimetic acting selectively on adrenoreceptor beta 3 to old mice significantly rejuvenated the in vivo function of aged HSCs, suggesting that the preservation or restitution of bone marrow SNS innervation during aging may hold the potential for new HSC rejuvenation strategies.	[Maryanovich, Maria; Zahalka, Ali H.; Pierce, Halley; Pinho, Sandra; Nakahara, Fumio; Asada, Noboru; Wei, Qiaozhi; Wang, Xizhe; Ciero, Paul; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY 10461 USA; [Maryanovich, Maria; Zahalka, Ali H.; Pierce, Halley; Pinho, Sandra; Nakahara, Fumio; Asada, Noboru; Wei, Qiaozhi; Wang, Xizhe; Ciero, Paul; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Pinho, Sandra; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Xu, Jianing] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Leftin, Avigdor] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Asada, Noboru] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Okayama University	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012; Pinho, Sandra/GWC-8029-2022; xu, jia/GSD-6347-2022	Frenette, Paul S/0000-0003-0862-9922; Pinho, Sandra/0000-0002-5241-7364; Nakahara, Fumio/0000-0003-1515-8284	New York State Department of Health (NYSTEM Program) [C029154, N13G-262]; Leukemia and Lymphoma Society's Translational Research Program; National Institutes of Health (NIH) [DK112976, DK056638, HL116340, HL097819, DK116312]; New York Stem Cell Foundation (NYSCF); EMBO European Commission FP7 (Marie Curie Actions; EMBOCOFUND2012) [GA-2012-600394, ALTF 447-2014]; NIH Training Grant [T32 NS007098]; National Cancer Institute (NCI) predoctoral M.D./Ph.D. fellowship [F30 CA203446]; Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS); NCI Individual Postdoctoral Fellowship (F32); Ruth L. Kirschstein National Research Service Award [NCI 1F32CA20277]; NATIONAL CANCER INSTITUTE [F30CA203446] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819, R01HL116340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112976, U01DK116312, R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098] Funding Source: NIH RePORTER	New York State Department of Health (NYSTEM Program); Leukemia and Lymphoma Society's Translational Research Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation (NYSCF); EMBO European Commission FP7 (Marie Curie Actions; EMBOCOFUND2012); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI) predoctoral M.D./Ph.D. fellowship; Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS); NCI Individual Postdoctoral Fellowship (F32); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Vijg (Department of Genetics, Albert Einstein College of Medicine) for advice on experiment design and for providing old C57BL/6 mice for initial experiments. We also thank C. Prophete for technical assistance, M. Lee for assistance with old mice, and D. Sun and L. Tesfa for assistance with cell sorting and S. Maqbool for RNA sequencing. We are also grateful to the New York State Department of Health (NYSTEM Program) for shared facility (C029154) and research support (N13G-262) and the Leukemia and Lymphoma Society's Translational Research Program. This work was supported by R01 or U01 grants from the National Institutes of Health (NIH) (DK112976, DK056638, HL116340, HL097819, and DK116312 to P.S.F.) and by the New York Stem Cell Foundation (NYSCF). M. M. is a New York Stem Cell Foundation (NYSCF) Druckenmiller fellow and was previously supported by the EMBO European Commission FP7 (Marie Curie Actions; EMBOCOFUND2012, GA-2012-600394, ALTF 447-2014). A.H.Z was supported by NIH Training Grant (T32 NS007098) and by a National Cancer Institute (NCI) predoctoral M.D./Ph.D. fellowship (F30 CA203446). F.N. and N.A. were supported by the Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (JSPS). A.L is supported by NCI Individual Postdoctoral Fellowship (F32), Ruth L. Kirschstein National Research Service Award (NCI 1F32CA20277).	Afan AM, 1997, BRIT J HAEMATOL, V98, P569, DOI 10.1046/j.1365-2141.1997.2733092.x; Ambrosi TH, 2017, CELL STEM CELL, V20, P771, DOI 10.1016/j.stem.2017.02.009; Arranz L, 2014, NATURE, V512, P78, DOI 10.1038/nature13383; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Beerman I, 2014, EXP CELL RES, V329, P192, DOI 10.1016/j.yexcr.2014.09.013; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bellinger D. L., 2008, HDB NEUROCHEMISTRY M, P61; Benestad HB, 1998, BLOOD, V91, P1280, DOI 10.1182/blood.V91.4.1280; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Geiger H, 2007, CELL CYCLE, V6, P884, DOI 10.4161/cc.6.8.4131; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Guidi N, 2017, EMBO J, V36, P840, DOI 10.15252/embj.201694969; Guidi N, 2017, SEMIN HEMATOL, V54, P51, DOI 10.1053/j.seminhematol.2016.10.005; Hanoun M, 2014, CELL STEM CELL, V15, P365, DOI 10.1016/j.stem.2014.06.020; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Miyan JA, 1998, BLOOD, V92, P2971, DOI 10.1182/blood.V92.8.2971b.splL2_2971_2972; Moehrle BM, 2015, CELL REP, V13, P2412, DOI 10.1016/j.celrep.2015.11.030; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pierce H, 2017, CELL STEM CELL, V20, P648, DOI 10.1016/j.stem.2017.01.002; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Poulos MG, 2017, J CLIN INVEST, V127, P4163, DOI 10.1172/JCI93940; Rinkevich Y, 2014, P NATL ACAD SCI USA, V111, P9846, DOI 10.1073/pnas.1410097111; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tuljapurkar SR, 2011, J ANAT, V219, P574, DOI 10.1111/j.1469-7580.2011.01423.x; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Young K, 2016, J EXP MED, V213, P2259, DOI 10.1084/jem.20160168; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	63	175	176	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					782	+		10.1038/s41591-018-0030-x	http://dx.doi.org/10.1038/s41591-018-0030-x			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29736022	Green Accepted			2022-12-27	WOS:000434281300023
J	Sanchez-Mut, JV; Heyn, H; Silva, BA; Dixsaut, L; Garcia-Esparcia, P; Vidal, E; Sayols, S; Glauser, L; Monteagudo-Sanchez, A; Perez-Tur, J; Ferrer, I; Monk, D; Schneider, B; Esteller, M; Graff, J				Sanchez-Mut, Jose V.; Heyn, Holger; Silva, Bianca A.; Dixsaut, Lucie; Garcia-Esparcia, Paula; Vidal, Enrique; Sayols, Sergi; Glauser, Liliane; Monteagudo-Sanchez, Ana; Perez-Tur, Jordi; Ferrer, Isidre; Monk, David; Schneider, Bernard; Esteller, Manel; Graeff, Johannes			PM20D1 is a quantitative trait locus associated with Alzheimer's disease	NATURE MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; NEURODEGENERATIVE DISEASES; BRAIN; ENHANCERS; EXPRESSION; METHYLOMES; PATTERNS; FEATURES; CORTEX	The chances to develop Alzheimer's disease (AD) result from a combination of genetic and non-genetic risk factors(1), the latter likely being mediated by epigenetic mechanisms(2). In the past, genome-wide association studies (GWAS) have identified an important number of risk loci associated with AD pathology(3), but a causal relationship remains difficult to establish. In contrast, locus-specific or epigenome-wide association studies (EWAS) have revealed site-specific epigenetic alterations, which provide mechanistic insights for a particular risk gene but often lack the statistical power of GWAS(4). Here, combining both approaches, we report a previously unidentified association of the peptidase M20-domain-containing protein 1 (PM20D1) with AD. We find that PM20D1 is a methylation and expression quantitative trait locus coupled to an AD-risk associated haplotype, which displays enhancer-like characteristics and contacts the PM20D1 promoter via a haplotype-dependent, CCCTC-binding-factor-mediated chromatin loop. Furthermore, PM20D1 is increased following AD-related neurotoxic insults at symptomatic stages in the APP/PS1 mouse model of AD and in human patients with AD who are carriers of the non-risk haplotype. In line, genetically increasing or decreasing the expression of PM20D1 reduces and aggravates AD-related pathologies, respectively. These findings suggest that in a particular genetic background, PM20D1 contributes to neuroprotection against AD.	[Silva, Bianca A.; Dixsaut, Lucie; Glauser, Liliane; Graeff, Johannes] Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Neuroepigenet, Lausanne, Switzerland; [Heyn, Holger] BIST, CNAG, Ctr Genom Regulat CRG, Barcelona, Spain; [Heyn, Holger] UPF, Barcelona, Spain; [Garcia-Esparcia, Paula; Ferrer, Isidre] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Vidal, Enrique] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain; [Sayols, Sergi] Inst Mol Biol, Bioinformat Core Facil, Mainz, Germany; [Monteagudo-Sanchez, Ana; Monk, David] Inst Invest Biomed Bellvitge, Genom Imprinting & Canc Grp, Canc Epigenet & Biol Program, Barcelona, Spain; [Perez-Tur, Jordi] Inst Invest Sanitaria La Fe, CSIC, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Biomed Valencia, Valencia, Spain; [Schneider, Bernard] Ecole Polytech Fed Lausanne, Brain Mind Inst, Fac Life Sci, Neurodegenerat Studies Lab, Lausanne, Switzerland; [Esteller, Manel] Inst Invest Biomed Bellvitge, Canc Epigenet Grp, Canc Epigenet & Biol Program, Barcelona, Spain	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institute of Molecular Biology (IMB); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Graff, J (corresponding author), Ecole Polytech Fed Lausanne, Fac Life Sci, Brain Mind Inst, Lab Neuroepigenet, Lausanne, Switzerland.	johannes.graeff@epfl.ch	Sanchez-Mut, Jose V./A-8651-2019; Vidal, Enrique/R-5593-2019; Esteller, Manel/L-5956-2014; Perez-Tur, Jordi/A-2143-2010; Schneider, Bernard/H-6168-2011; Silva, Bianca Ambrogina/AAE-3354-2020	Sanchez-Mut, Jose V./0000-0002-9292-8521; Vidal, Enrique/0000-0002-4217-1807; Esteller, Manel/0000-0003-4490-6093; Perez-Tur, Jordi/0000-0002-9111-1712; Schneider, Bernard/0000-0001-5485-8748; Silva, Bianca Ambrogina/0000-0003-3877-1356; Monteagudo Sanchez, Ana/0000-0002-1432-1185; Garcia Esparcia, Paula/0000-0002-6045-4472; Heyn, Holger/0000-0002-3276-1889; Sayols, Sergi/0000-0002-3877-4170; Graff, Johannes/0000-0002-3219-3578	SYNAPSIS Foundation; Beatrice Ederer-Weber Stiftung; Floshield Foundation; Alzheimer's Association [NIRG-15-363964]; Foundation Jerome Lejeune, Spanish Ministerio de Educacion y Competitividad [BFU2014-53093]; Spanish Ministerio de Economia, Industria y Competitividad; FEDER programme from the EU [SAF2014-59469-R]; CIBERNED; SYNAPSIS Foundation Fellowship for Advanced PostDocs; Heidi Seiler-Stiftung foundation; Spanish Institute of Health Carlos III (ISCIII) [CP14/00229]; FPI PhD studentship from MINECO	SYNAPSIS Foundation; Beatrice Ederer-Weber Stiftung; Floshield Foundation; Alzheimer's Association(Alzheimer's Association); Foundation Jerome Lejeune, Spanish Ministerio de Educacion y Competitividad; Spanish Ministerio de Economia, Industria y Competitividad; FEDER programme from the EU; CIBERNED(Instituto de Salud Carlos III); SYNAPSIS Foundation Fellowship for Advanced PostDocs; Heidi Seiler-Stiftung foundation; Spanish Institute of Health Carlos III (ISCIII)(Instituto de Salud Carlos III); FPI PhD studentship from MINECO	The work in the laboratory of J.G. is supported by the SYNAPSIS Foundation, the Beatrice Ederer-Weber Stiftung, the Floshield Foundation and the Alzheimer's Association (grant no. NIRG-15-363964). The laboratory of D.M. is supported by the Foundation Jerome Lejeune, Spanish Ministerio de Educacion y Competitividad (grant no. BFU2014-53093). The laboratory of J.P.-T. is supported by the Spanish Ministerio de Economia, Industria y Competitividad and the FEDER programme from the EU (grant no. SAF2014-59469-R) and the CIBERNED. J.V.S.-M. is supported by a SYNAPSIS Foundation Fellowship for Advanced PostDocs and the Heidi Seiler-Stiftung foundation. H.H. is a Miguel Servet (CP14/00229) researcher funded by the Spanish Institute of Health Carlos III (ISCIII). B.A.S. is an EMBO long-term fellow (ALTF 1605-2014, Marie Curie Actions, LTFCOFUND2013, GA-2013-609409). A.M.-S. is a recipient of a FPI PhD studentship from MINECO. M.E. is an ICREA Research Professor. J.G. is an MQ fellow and a NARSAD Independent Investigator.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ashoor H, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav085; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Court F, 2011, NUCLEIC ACIDS RES, V39, P5893, DOI 10.1093/nar/gkr209; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; D'Addario C, 2017, J NEUROL SCI, V372, P211, DOI 10.1016/j.jns.2016.11.052; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guedj M, 2006, HUM HERED, V61, P210, DOI 10.1159/000094776; Hannon E, 2016, NAT NEUROSCI, V19, P48, DOI 10.1038/nn.4182; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hokama M, 2014, CEREB CORTEX, V24, P2476, DOI 10.1093/cercor/bht101; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kivipelto M, 2014, NAT REV NEUROL, V10, P552, DOI 10.1038/nrneurol.2014.170; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Larrick JW, 2016, REJUV RES, V19, P337, DOI 10.1089/rej.2016.1859; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li HH, 2015, MOVEMENT DISORD, V30, P1335, DOI 10.1002/mds.26176; Long JZ, 2016, CELL, V166, P424, DOI 10.1016/j.cell.2016.05.071; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Maltby VE, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0371-1; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Narayanan M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145304; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanchez-Mut JV, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.214; Sanchez-Mut JV, 2013, BRAIN, V136, P3018, DOI 10.1093/brain/awt237; Sanchez-Mut J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00347; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Sanchez-Mut JV, 2014, HIPPOCAMPUS, V24, P363, DOI 10.1002/hipo.22245; Watson CT, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0258-8; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011	54	47	49	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					598	+		10.1038/s41591-018-0013-y	http://dx.doi.org/10.1038/s41591-018-0013-y			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736028	Green Submitted			2022-12-27	WOS:000432126800016
J	Galli, E; Hartmann, FJ; Schreiner, B; Ingelfinger, F; Arvaniti, E; Diebold, M; Mrdjen, D; van der Meer, F; Krieg, C; Al Nimer, F; Sanderson, N; Stadelmann, C; Khademi, M; Piehl, F; Claassen, M; Derfuss, T; Olsson, T; Becher, B				Galli, Edoardo; Hartmann, Felix J.; Schreiner, Bettina; Ingelfinger, Florian; Arvaniti, Eirini; Diebold, Martin; Mrdjen, Dunja; van der Meer, Franziska; Krieg, Carsten; Al Nimer, Faiez; Sanderson, Nicholas; Stadelmann, Christine; Khademi, Mohsen; Piehl, Fredrik; Claassen, Manfred; Derfuss, Tobias; Olsson, Tomas; Becher, Burkhard			GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis	NATURE MEDICINE			English	Article							PLACEBO-CONTROLLED PHASE-3; BLOOD MONONUCLEAR-CELLS; CEREBROSPINAL-FLUID; CYTOMETRY DATA; BRAIN-BARRIER; MYELOID CELLS; ORAL BG-12; B-CELLS; EXPRESSION; CXCL12	Cytokine dysregulation is a central driver of chronic inflammatory diseases such as multiple sclerosis (MS). Here, we sought to determine the characteristic cellular and cytokine polarization profile in patients with relapsing-remitting multiple sclerosis (RRMS) by high-dimensional single-cell mass cytometry (CyTOF). Using a combination of neural network-based representation learning algorithms, we identified an expanded T helper cell subset in patients with MS, characterized by the expression of granulocyte-macrophage colony-stimulating factor and the C-X-C chemokine receptor type 4. This cellular signature, which includes expression of very late antigen 4 in peripheral blood, was also enriched in the central nervous system of patients with relapsing-remitting multiple sclerosis. In independent validation cohorts, we confirmed that this cell population is increased in patients with MS compared with other inflammatory and non-inflammatory conditions. Lastly, we also found the population to be reduced under effective disease-modifying therapy, suggesting that the identified T cell profile represents a specific therapeutic target in MS.	[Galli, Edoardo; Hartmann, Felix J.; Schreiner, Bettina; Ingelfinger, Florian; Mrdjen, Dunja; Krieg, Carsten; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Schreiner, Bettina] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Arvaniti, Eirini; Claassen, Manfred] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, Zurich, Switzerland; [Diebold, Martin; Sanderson, Nicholas; Derfuss, Tobias] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [van der Meer, Franziska; Stadelmann, Christine] Univ Med Gottingen, Neurol Klin, Inst Neuropathol, Gottingen, Germany; [Al Nimer, Faiez; Khademi, Mohsen; Piehl, Fredrik; Olsson, Tomas] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Al Nimer, Faiez] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Hartmann, Felix J.] Med Univ South Carolina, Dept Dermatol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Krieg, Carsten] Med Univ South Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA	University of Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Gottingen; Karolinska Institutet; Stanford University; Medical University of South Carolina; Medical University of South Carolina	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	sanderson, nicholas/GQH-2848-2022; Galli, Edoardo/AAZ-6959-2021; Becher, Burkhard/ABE-4225-2020; Krieg, Carsten/ABA-6734-2020; Nimer, Faiez Al/ABB-9465-2020	sanderson, nicholas/0000-0003-1711-7275; Galli, Edoardo/0000-0002-9760-2643; Becher, Burkhard/0000-0002-1541-7867; Krieg, Carsten/0000-0002-5145-7591; Al Nimer, Faiez/0000-0003-0937-5995; Claassen, Manfred/0000-0002-4583-9083; Mrdjen, Dunja/0000-0001-9269-2806; Olsson, Tomas/0000-0002-2938-1877; Stadelmann, Christine/0000-0003-1766-5458; Hartmann, Felix/0000-0002-4174-2276; Derfuss, Tobias/0000-0001-8656-4250; Diebold, Martin/0000-0001-9636-6936; Ingelfinger, Florian/0000-0001-6890-9753	Swiss National Science Foundation [310030_170320, 316030_150768, CRSII5_183478]; European Union; Swiss Multiple Sclerosis Society; Van Riemsdijk PhD fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Swiss Multiple Sclerosis Society; Van Riemsdijk PhD fellowship	This work was supported by grants from the Swiss National Science Foundation (310030_170320, 316030_150768 and CRSII5_183478; all to B.B.), European Union FP7 projects NeuroKine (to B.B.) and the Swiss Multiple Sclerosis Society (to B.B.). F.J.H. received a Van Riemsdijk PhD fellowship. Lymph node cryosections for establishing histological staining conditions were provided by the tissue bank of the Institute of Pathology and Molecular Pathology of the University Hospital Zurich.	Andreakos ET, 2002, CYTOKINE GROWTH F R, V13, P299, DOI 10.1016/S1359-6101(02)00018-7; Arvaniti E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14825; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Chanvillard C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00063; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Constantinescu CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000117; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Diebold M, 2018, J AUTOIMMUN, V86, P39, DOI 10.1016/j.jaut.2017.09.009; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Galli E, 2019, EUR J IMMUNOL, V49, P212, DOI 10.1002/eji.201847758; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Gross CC, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000183; Hartmann FJ, 2016, J EXP MED, V213, P2621, DOI 10.1084/jem.20160897; Hartmann FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6056; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser Stephen L, 2008, N Engl J Med, V358, P676, DOI 10.1056/NEJMoa0706383; Herndler-Brandstetter D, 2014, CELL RES, V24, P1379, DOI 10.1038/cr.2014.155; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Imitola J, 2018, J NEUROIMMUNOL, V317, P45, DOI 10.1016/j.jneuroim.2017.12.017; Jelcic I, 2018, CELL, V175, P85, DOI 10.1016/j.cell.2018.08.011; Kleinewietfeld M, 2014, IMMUNOL REV, V259, P231, DOI 10.1111/imr.12169; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kowarik MC, 2014, J NEUROL, V261, P130, DOI 10.1007/s00415-013-7145-2; Kowarik MC, 2011, NEUROLOGY, V76, P1214, DOI 10.1212/WNL.0b013e3182143564; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li R, 2017, J IMMUNOL, V198, P691, DOI 10.4049/jimmunol.1601649; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; McDonald J.H., 2014, HDB BIOL STAT; Mei HE, 2015, J IMMUNOL, V194, P2022, DOI 10.4049/jimmunol.1402661; Mishra MK, 2016, NAT REV NEUROL, V12, P539, DOI 10.1038/nrneurol.2016.110; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; O'Gorman WE, 2015, J ALLERGY CLIN IMMUN, V136, P1326, DOI 10.1016/j.jaci.2015.04.008; OLSSON T, 1990, J CLIN INVEST, V86, P981, DOI 10.1172/JCI114800; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; PANITCH HS, 1987, LANCET, V1, P893; Pietschmann P, 2003, EXP GERONTOL, V38, P1119, DOI 10.1016/S0531-5565(03)00189-X; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Poznansky MC, 2000, NAT MED, V6, P543, DOI 10.1038/75022; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; R Core Team, 2021, R LANGUAGE ENV STAT; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; Restorick SM, 2017, BRAIN BEHAV IMMUN, V64, P71, DOI 10.1016/j.bbi.2017.03.008; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Spath S, 2017, IMMUNITY, V46, P245, DOI 10.1016/j.immuni.2017.01.007; Spencer CM, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000076; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; Wu Q, 2017, J IMMUNOL, V198, P3069, DOI 10.4049/jimmunol.1601532; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	71	96	96	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1290	+		10.1038/s41591-019-0521-4	http://dx.doi.org/10.1038/s41591-019-0521-4			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31332391	Green Accepted			2022-12-27	WOS:000480414600028
J	Ardila, D; Kiraly, AP; Bharadwaj, S; Choi, B; Reicher, JJ; Peng, L; Tse, D; Etemadi, M; Ye, WX; Corrado, G; Naidich, DP; Shetty, S				Ardila, Diego; Kiraly, Atilla P.; Bharadwaj, Sujeeth; Choi, Bokyung; Reicher, Joshua J.; Peng, Lily; Tse, Daniel; Etemadi, Mozziyar; Ye, Wenxing; Corrado, Greg; Naidich, David P.; Shetty, Shravya			End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography	NATURE MEDICINE			English	Article							NODULE DETECTION; COST-EFFECTIVENESS; AIDED DETECTION; PULMONARY NODULES; CT; PERFORMANCE; SYSTEM; VALIDATION; IMAGES; TRIAL	With an estimated 160,000 deaths in 2018, lung cancer is the most common cause of cancer death in the United States(1). Lung cancer screening using low-dose computed tomography has been shown to reduce mortality by 20-43% and is now included in US screening guidelines(1-6). Existing challenges include inter-grader variability and high false-positive and false-negative rates(7-10). We propose a deep learning algorithm that uses a patient's current and prior computed tomography volumes to predict the risk of lung cancer. Our model achieves a state-of-the-art performance (94.4% area under the curve) on 6,716 National Lung Cancer Screening Trial cases, and performs similarly on an independent clinical validation set of 1,139 cases. We conducted two reader studies. When prior computed tomography imaging was not available, our model outperformed all six radiologists with absolute reductions of 11% in false positives and 5% in false negatives. Where prior computed tomography imaging was available, the model performance was on-par with the same radiologists. This creates an opportunity to optimize the screening process via computer assistance and automation. While the vast majority of patients remain unscreened, we show the potential for deep learning models to increase the accuracy, consistency and adoption of lung cancer screening worldwide.	[Ardila, Diego; Kiraly, Atilla P.; Bharadwaj, Sujeeth; Choi, Bokyung; Peng, Lily; Tse, Daniel; Ye, Wenxing; Corrado, Greg; Shetty, Shravya] Google AI, Mountain View, CA 94043 USA; [Reicher, Joshua J.] Stanford Hlth Care, Palo Alto, CA USA; [Reicher, Joshua J.] Palo Alto Vet Affairs, Palo Alto, CA USA; [Etemadi, Mozziyar] Northwestern Med, Chicago, IL USA; [Naidich, David P.] NYU, Ctr Biol Imaging, Langone Med Ctr, New York, NY USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Northwestern University; Feinberg School of Medicine; New York University; NYU Langone Medical Center	Tse, D (corresponding author), Google AI, Mountain View, CA 94043 USA.	tsed@google.com		Tse, Daniel/0000-0001-5315-8539; naidich, david/0000-0003-3751-5836				Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Armato SG, 2007, ACAD RADIOL, V14, P1409, DOI 10.1016/j.acra.2007.07.008; Armato SG, 2002, RADIOLOGY, V225, P685, DOI 10.1148/radiol.2253011376; Bellotti R, 2007, MED PHYS, V34, P4901, DOI 10.1118/1.2804720; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Bogoni L, 2012, J DIGIT IMAGING, V25, P771, DOI 10.1007/s10278-012-9496-0; Carreira J, 2017, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2017.502; CHEN CW, 2018, IEEE T PATTERN ANAL, DOI DOI 10.1109/TPAMI.2018.2858826; Chihara L.M., 2014, MATH STAT RESAMPLING; Ciompi F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46479; Das M, 2008, BRIT J RADIOL, V81, P841, DOI 10.1259/bjr/50635688; De Koning H, 2018, J THORAC ONCOL, V13, pS185, DOI 10.1016/j.jtho.2018.08.012; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Field JK, 2016, THORAX, V71, P161, DOI 10.1136/thoraxjnl-2015-207140; Firmino M, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-015-0120-7; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goffin JR, 2015, JAMA ONCOL, V1, P807, DOI 10.1001/jamaoncol.2015.2472; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He K., 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, DOI 10.1109/ICCV.2017.322]; Huang J, 2017, PROC CVPR IEEE, P3296, DOI 10.1109/CVPR.2017.351; Jemal A, 2017, JAMA ONCOL, V3, P1278, DOI 10.1001/jamaoncol.2016.6416; Kazerooni EA, 2014, J THORAC IMAG, V29, P310, DOI 10.1097/RTI.0000000000000097; Liao F., 2017, PREPRINT; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Manos D, 2014, CAN ASSOC RADIOL J, V65, P121, DOI 10.1016/j.carj.2014.03.004; Martin MD, 2017, RADIOGRAPHICS, V37, P1975, DOI 10.1148/rg.2017170051; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; Mehta HJ, 2017, CHEST, V151, P539, DOI 10.1016/j.chest.2016.07.028; National Cancer Institute, 2018, NAT LUNG SCREEN TRIA; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Pinsky PF, 2013, RADIOLOGY, V268, P865, DOI 10.1148/radiol.13121530; Quantitative Insights, 2018, QUANT INS GAINS IND; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sahiner B, 2009, ACAD RADIOL, V16, P1518, DOI 10.1016/j.acra.2009.08.006; Setio AAA, 2017, MED IMAGE ANAL, V42, P1, DOI 10.1016/j.media.2017.06.015; Singh S, 2011, RADIOLOGY, V259, P263, DOI 10.1148/radiol.10101254; Sun Y., 2011, P 12 ACM C EL COMM, P177, DOI [DOI 10.1145/1993574.1993601, 10.1145/1993574.1993601]; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; The American College of Radiology, 2014, AD LUNG CANC SCREEN; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Trajanovski S., 2019, PREPRINT; US Preventive Services Task Force, 2018, FIN UPD SUMM LUNG CA; Valente IRS, 2016, COMPUT METH PROG BIO, V124, P91, DOI 10.1016/j.cmpb.2015.10.006; van Riel SJ, 2019, EUR RADIOL, V29, P924, DOI 10.1007/s00330-018-5599-4; Varela C, 2005, EUR J RADIOL, V56, P248, DOI 10.1016/j.ejrad.2005.04.007; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Wille MMW, 2015, EUR RADIOL, V25, P3093, DOI 10.1007/s00330-015-3689-0; Ye XJ, 2009, IEEE T BIO-MED ENG, V56, P1810, DOI 10.1109/TBME.2009.2017027	50	640	668	29	194	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					954	+		10.1038/s41591-019-0447-x	http://dx.doi.org/10.1038/s41591-019-0447-x			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31110349				2022-12-27	WOS:000470844400027
J	Shan, Y; Segre, JA; Chang, EB				Shan, Yue; Segre, Julia A.; Chang, Eugene B.			Responsible stewardship for communicating microbiome research to the press and public	NATURE MEDICINE			English	Editorial Material							TRIAL		[Shan, Yue; Chang, Eugene B.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Segre, Julia A.] NHGRI, NIH, Bethesda, MD 20892 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chang, EB (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu	Shan, Yue/R-2196-2018	Segre, Julia/0000-0001-6860-348X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2016, FEC MICR TRANSP NAT; Freedman SB, 2018, NEW ENGL J MED, V379, P2015, DOI [10.1056/NEJMoa1802597, 10.1056/nejmoa1802597]; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Panigrahi P, 2008, J PEDIATR GASTR NUTR, V47, P45, DOI 10.1097/MPG.0b013e31815a5f2c; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Schnadower D, 2018, NEW ENGL J MED, V379, P2002, DOI [10.1056/nejmoa1802598, 10.1056/NEJMoa1802598]; van Nood E, 2013, NEW ENGL J MED, V368, P2145, DOI 10.1056/NEJMc1303919	8	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					872	874		10.1038/s41591-019-0470-y	http://dx.doi.org/10.1038/s41591-019-0470-y			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31133694				2022-12-27	WOS:000470844400007
J	Steinhubl, SR				Steinhubl, Steven R.			The future of individualized health maintenance	NATURE MEDICINE			English	Editorial Material								Multi-omics longitudinal profiling of individuals can detect subtle changes in health status at the earliest possible time point, allowing preemptive initiation of mechanism-appropriate disease-prevention strategies.	[Steinhubl, Steven R.] Scripps Res Translat Inst, La Jolla, CA 92037 USA		Steinhubl, SR (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.	steinhub@scripps.edu		Steinhubl, Steve/0000-0002-9256-7914				Catala A, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1395-z; Gigerenzer G, 2017, PSYCHOL REV, V124, P179, DOI 10.1037/rev0000055; Hall H, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005143; Hollands GJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1102; Huffaker MF, 2018, AM J RESP CRIT CARE, V198, P320, DOI 10.1164/rccm.201712-2606OC; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Parikh RB, 2017, NEW ENGL J MED, V376, P1609, DOI 10.1056/NEJMp1613224; Schussler-Fiorenza Rose S. M., 2019, NAT MED, DOI [10.1038/s41591-019-0414-6, DOI 10.1038/S41591-019-0414-6]; Shilaih M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01433-9; Turnwald BP, 2019, NAT HUM BEHAV, V3, P48, DOI 10.1038/s41562-018-0483-4; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	11	6	6	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					712	714		10.1038/s41591-019-0443-1	http://dx.doi.org/10.1038/s41591-019-0443-1			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068704				2022-12-27	WOS:000468247800011
J	Wang, J; Sun, JW; Liu, LN; Flies, DB; Nie, XX; Toki, M; Zhang, JP; Song, C; Zarr, M; Zhou, X; Han, X; Archer, KA; O'Neill, T; Herbst, RS; Boto, AN; Sanmamed, MF; Langermann, S; Rimm, DL; Chen, LP				Wang, Jun; Sun, Jingwei; Liu, Linda N.; Flies, Dallas B.; Nie, Xinxin; Toki, Maria; Zhang, Jianping; Song, Chang; Zarr, Melissa; Zhou, Xu; Han, Xue; Archer, Kristina A.; O'Neill, Thomas; Herbst, Roy S.; Boto, Agedi N.; Sanmamed, Miguel F.; Langermann, Solomon; Rimm, David L.; Chen, Lieping			Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy	NATURE MEDICINE			English	Article							T-CELL-ACTIVATION; B7 FAMILY; MONOCLONAL-ANTIBODIES; ANTITUMOR IMMUNITY; OSTEOCLAST DIFFERENTIATION; QUANTITATIVE-ANALYSIS; PROTEIN EXPRESSION; PD-1; B7-H1; MOLECULE	Overexpression of the B7-H1 (PD-L1) molecule in the tumor microenvironment (TME) is a major immune evasion mechanism in some patients with cancer, and antibody blockade of the B7-H1/PD-1 interaction can normalize compromised immunity without excessive side-effects. Using a genome-scale T cell activity array, we identified Siglec-15 as a critical immune suppressor. While only expressed on some myeloid cells normally, Siglec-15 is broadly upregulated on human cancer cells and tumor-infiltrating myeloid cells, and its expression is mutually exclusive to B7-H1, partially due to its induction by macrophage colony-stimulating factor and downregulation by IFN-gamma. We demonstrate that Siglec-15 suppresses antigen-specific T cell responses in vitro and in vivo. Genetic ablation or antibody blockade of Siglec-15 amplifies anti-tumor immunity in the TME and inhibits tumor growth in some mouse models. Taken together, our results support Siglec-15 as a potential target for normalization cancer immunotherapy.	[Wang, Jun; Sun, Jingwei; Nie, Xinxin; Zhang, Jianping; Zhou, Xu; Han, Xue; Boto, Agedi N.; Sanmamed, Miguel F.; Chen, Lieping] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Liu, Linda N.; Flies, Dallas B.; Song, Chang; Zarr, Melissa; Archer, Kristina A.; O'Neill, Thomas; Langermann, Solomon] NextCure Inc, Beltsville, MD USA; [Toki, Maria; Boto, Agedi N.; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Herbst, Roy S.; Rimm, David L.; Chen, Lieping] Yale Univ, Sch Med, Dept Med Med Oncol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Chen, LP (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA.; Chen, LP (corresponding author), Yale Univ, Sch Med, Dept Med Med Oncol, New Haven, CT 06510 USA.	lieping.chen@yale.edu	Zhou, Xu/AAI-9269-2020; Nie, Xinxin/AAV-9668-2021; Toki, Maria/M-5582-2019; Liu, Linda/GVS-9417-2022; F Sanmamed, Miguel/I-5572-2017	Toki, Maria/0000-0002-7074-7148; Zhou, Xu/0000-0002-1692-6823; Wang, Jun/0000-0002-6346-2929; F Sanmamed, Miguel/0000-0002-7295-6074; Han, Xue/0000-0001-5016-2356; Rimm, David/0000-0001-5820-4397	National Institutes of Health [P30 CA16359, P50 CA196530]; NextCure Inc.; United Technologies Corporation Endowed Chair; NATIONAL CANCER INSTITUTE [P50CA196530, P30CA016359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NextCure Inc.; United Technologies Corporation Endowed Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Cadugan for editing the manuscript; other members in the laboratories of Yale and NextCure for helpful discussions and technical assistance; and D. Pardoll and J. Fu at Johns Hopkins University for the B16-GMCSF cell line. This research was supported partially by the National Institutes of Health grants nos. P30 CA16359 and P50 CA196530, sponsored research funding from NextCure Inc. and the United Technologies Corporation Endowed Chair.	Altan M., 2012, CLIN CANCER RES, V23, pE514; Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Briard JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03245-5; Brown JR, 2014, CLIN CANCER RES, V20, P5995, DOI 10.1158/1078-0432.CCR-14-1622; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chang LY, 2017, J PROTEOME RES, V16, P3929, DOI 10.1021/acs.jproteome.7b00625; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; CHEN LP, 1994, J EXP MED, V179, P523, DOI 10.1084/jem.179.2.523; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Flies DB, 2014, J CLIN INVEST, V124, P1966, DOI 10.1172/JCI74589; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gangadhar TC, 2014, NAT REV CLIN ONCOL, V11, P91, DOI 10.1038/nrclinonc.2013.245; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hirano F, 2005, CANCER RES, V65, P1089; Hiruma Y, 2013, BONE, V53, P87, DOI 10.1016/j.bone.2012.11.036; Hiruma Y, 2011, BIOCHEM BIOPH RES CO, V409, P424, DOI 10.1016/j.bbrc.2011.05.015; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Kim TK, 2018, TRENDS IMMUNOL, V39, P624, DOI 10.1016/j.it.2018.05.001; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lipson EJ, 2015, SEMIN ONCOL, V42, P587, DOI 10.1053/j.seminoncol.2015.05.013; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mosely SIS, 2017, CANCER IMMUNOL RES, V5, P29, DOI 10.1158/2326-6066.CIR-16-0114; Peper JK, 2014, J IMMUNOL METHODS, V405, P192, DOI 10.1016/j.jim.2014.01.012; Ricard C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26381; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; Shimizu T, 2015, BONE, V79, P65, DOI 10.1016/j.bone.2015.05.029; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Stuible M, 2014, J BIOL CHEM, V289, P6498, DOI 10.1074/jbc.M113.494542; Sznol M, 2013, CLIN CANCER RES, V19, P5542, DOI 10.1158/1078-0432.CCR-13-2234; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Yao S, 2011, IMMUNITY, V34, P729, DOI 10.1016/j.immuni.2011.03.014; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Zhang Y, 2016, JAMA ONCOL, V2, P1403, DOI 10.1001/jamaoncol.2016.2450; Zhu YW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3043; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	56	281	301	17	214	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					656	+		10.1038/s41591-019-0374-x	http://dx.doi.org/10.1038/s41591-019-0374-x			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30833750	Green Accepted			2022-12-27	WOS:000463342800027
J	D'Angelo, F; Ceccarelli, M; Tala; Garofano, L; Zhang, J; Frattini, V; Caruso, FP; Lewis, G; Alfaro, KD; Bauchet, L; Berzero, G; Cachia, D; Cangiano, M; Capelle, L; de Groot, J; DiMeco, F; Ducray, F; Farah, W; Finocchiaro, G; Goutagny, S; Kamiya-Matsuoka, C; Lavarino, C; Loiseau, H; Lorgis, V; Marras, CE; McCutcheon, I; Nam, DH; Ronchi, S; Saletti, V; Seizeur, R; Slopis, J; Sunol, M; Vandenbos, F; Varlet, P; Vidaud, D; Watts, C; Tabar, V; Reuss, DE; Kim, SK; Meyronet, D; Mokhtari, K; Salvador, H; Bhat, KP; Eoli, M; Sanson, M; Lasorella, A; Iavarone, A				D'Angelo, Fulvio; Ceccarelli, Michele; Tala; Garofano, Luciano; Zhang, Jing; Frattini, Veronique; Caruso, Francesca P.; Lewis, Genevieve; Alfaro, Kristin D.; Bauchet, Luc; Berzero, Giulia; Cachia, David; Cangiano, Mario; Capelle, Laurent; de Groot, John; DiMeco, Francesco; Ducray, Francois; Farah, Walid; Finocchiaro, Gaetano; Goutagny, Stephane; Kamiya-Matsuoka, Carlos; Lavarino, Cinzia; Loiseau, Hugues; Lorgis, Veronique; Marras, Carlo E.; McCutcheon, Ian; Nam, Do-Hyun; Ronchi, Susanna; Saletti, Veronica; Seizeur, Romuald; Slopis, John; Sunol, Mariona; Vandenbos, Fanny; Varlet, Pascale; Vidaud, Dominique; Watts, Colin; Tabar, Viviane; Reuss, David E.; Kim, Seung-Ki; Meyronet, David; Mokhtari, Karima; Salvador, Hector; Bhat, Krishna P.; Eoli, Marica; Sanson, Marc; Lasorella, Anna; Iavarone, Antonio			The molecular landscape of glioma in patients with Neurofibromatosis 1	NATURE MEDICINE			English	Article							MUTATIONAL SPECTRUM; NF1 GENE; PROFILING REVEALS; SOMATIC MUTATION; CANCER; TUMORS; TELOMERES; TYPE-1; CELLS; DISCOVERY	Neurofibromatosis type 1 (NF1) is a common tumor predisposition syndrome in which glioma is one of the prevalent tumors. Gliomagenesis in NF1 results in a heterogeneous spectrum of low-to high-grade neoplasms occurring during the entire lifespan of patients. The pattern of genetic and epigenetic alterations of glioma that develops in NF1 patients and the similarities with sporadic glioma remain unknown. Here, we present the molecular landscape of low- and high-grade gliomas in patients affected by NF1 (NF1-glioma). We found that the predisposing germline mutation of the NF1 gene was frequently converted to homozygosity and the somatic mutational load of NF1-glioma was influenced by age and grade. High-grade tumors harbored genetic alterations of TP53 and CDKN2A, frequent mutations of ATRX associated with Alternative Lengthening of Telomere, and were enriched in genetic alterations of transcription/chromatin regulation and PI3 kinase pathways. Low-grade tumors exhibited fewer mutations that were over-represented in genes of the MAP kinase pathway. Approximately 50% of low-grade NF1-gliomas displayed an immune signature, T lymphocyte infiltrates, and increased neo-antigen load. DNA methylation assigned NF1-glioma to LGm6, a poorly defined Isocitrate Dehydrogenase 1 wild-type subgroup enriched with ATRX mutations. Thus, the profiling of NF1-glioma defined a distinct landscape that recapitulates a subset of sporadic tumors.	[D'Angelo, Fulvio; Tala; Garofano, Luciano; Zhang, Jing; Frattini, Veronique; Lewis, Genevieve; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA; [D'Angelo, Fulvio; Ceccarelli, Michele; Garofano, Luciano; Caruso, Francesca P.; Cangiano, Mario] BIOGEM Ist Ric Genet G Salvatore, Ariano Irpino, Italy; [Ceccarelli, Michele; Caruso, Francesca P.] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Alfaro, Kristin D.] Univ Texas MD Anderson Canc Ctr, John Mendelsohn Fac, Ctr FC7 3025 Neurooncol, Unit 0431, Houston, TX 77030 USA; [Bauchet, Luc] Montpellier Univ, Med Ctr, Gui Chauliac Hosp, Dept Neurosurg, Montpellier, France; [Berzero, Giulia; Ronchi, Susanna; Mokhtari, Karima; Sanson, Marc] UPMC Univ Paris 06, Sorbonne Univ, AP HP, UMR S 1127,INSERM,U1127,CNRS,UMR 7225,ICM, Paris, France; [Cachia, David] Med Univ South Carolina, Dept Neurooncol, Charleston, SC 29425 USA; [Cachia, David] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [Capelle, Laurent] Hop La Pitie Salpetriere, AP HP, Serv Neurochirurg, Paris, France; [de Groot, John; Kamiya-Matsuoka, Carlos; McCutcheon, Ian; Slopis, John; Bhat, Krishna P.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [DiMeco, Francesco] Ist Nazl Neurol Carlo Besta, Dept Neurol Surg, Milan, Italy; [DiMeco, Francesco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [DiMeco, Francesco] Hunterian Brain Tumor Res Lab, CRB2 2M41, Baltimore, MD USA; [Ducray, Francois] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Canc Res Ctr Lyon,CNRS,UMR 5286, Serv Neurooncol,Dept Canc Cell Plast,INSERM,U1052, Lyon, France; [Farah, Walid] CHU Dijon, Dept Neurosurg, Dijon, France; [Finocchiaro, Gaetano; Eoli, Marica] Ist Nazl Neurol Carlo Besta, IRCCS Fdn, Unit Mol Neurooncol, Milan, Italy; [Goutagny, Stephane] Hop Beaujon, AP HP, Serv Neurochirurg, Clichy, France; [Lavarino, Cinzia] Fdn St Joan Deu, Dev Tumor Lab, Barcelona, Spain; [Loiseau, Hugues] Bordeaux Univ, Bordeaux Univ Hospital, Dept Neurosurg, Labex TRAIL ANR 10 LABX 57 IMOTION EA 7435, Bordeaux, France; [Lorgis, Veronique] Ctr GF Leclerc, Dept Med Oncol, Dijon, France; [Marras, Carlo E.] Bambino Gesu Pediat Hosp, Dept Neurosci & Neurorehabilitat, Pediat Neurosurg Unit, Rome, Italy; [Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Nam, Do-Hyun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Saletti, Veronica] Ist Nazl Neurol Carlo Besta, IRCCS Fdn, Dev Neurol Unit, Milan, Italy; [Seizeur, Romuald] Univ Brest, CHRU Brest, Hop Cavale Blanche, Serv Neurochirurg, Brest, France; [Sunol, Mariona] Hosp St Joan Deu, Dept Pathol, Barcelona, Spain; [Vandenbos, Fanny] Pasteur I Univ Hosp, Cent Lab Pathol, Nice, France; [Varlet, Pascale] St Anna Hosp, Dept Neuropathol, Paris, France; [Varlet, Pascale] Inst Psychiat & Neurosci Paris, INSERM, IMA Brain, U894, Paris, France; [Vidaud, Dominique] Univ Paris 05, EA 7331, Paris, France; [Vidaud, Dominique] Hop Cochin, AP HP, Serv Genet & Biol Mol, Paris, France; [Watts, Colin] Univ Birmingham Edgbaston, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA; [Reuss, David E.] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, Heidelberg, Germany; [Reuss, David E.] Heidelberg Univ Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Kim, Seung-Ki] Seoul Natl Univ, Coll Med, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea; [Meyronet, David] Est Hosp Civils Lyon, Ctr Pathol & Neuropathol, Lyon, France; [Salvador, Hector] Hosp St Joan Deu, Pediat Oncol Unit, Barcelona, Spain; [Lasorella, Anna] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA	Columbia University; University of Sannio; University of Texas System; UTMD Anderson Cancer Center; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Medical University of South Carolina; Medical University of South Carolina; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; UTMD Anderson Cancer Center; IRCCS Istituto Neurologico Besta; University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Dijon Bourgogne; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; UNICANCER; Centre Georges-Francois Leclerc; IRCCS Bambino Gesu; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; CHU Brest; Universite de Bretagne Occidentale; University of Barcelona; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Birmingham; Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Seoul National University (SNU); Seoul National University Hospital; University of Barcelona; Columbia University; Columbia University; Columbia University	Lasorella, A; Iavarone, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA.; Lasorella, A (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA.; Lasorella, A; Iavarone, A (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.; Iavarone, A (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10027 USA.	al2179@cumc.columbia.edu; ai2102@cumc.columbia.edu	McCutcheon, Ian E./AGV-2293-2022; Ceccarelli, Michele/AGP-1739-2022; Eoli, Marica/K-7748-2016; Kamiya-Matsuoka, Carlos/AAU-4393-2020; DiMeco, Francesco/Z-5431-2019; Saletti, Veronica/K-3458-2018; Garofano, Luciano/ABI-7602-2022; D'Angelo, Fulvio/AAG-9788-2020; Berzero, Giulia/AAA-4424-2019; Finocchiaro, Gaetano/AAG-6791-2020; Marras, Carlo Efisio/AAA-4964-2020	Eoli, Marica/0000-0003-4744-9377; Saletti, Veronica/0000-0003-4830-6204; Garofano, Luciano/0000-0001-8582-0865; D'Angelo, Fulvio/0000-0002-4940-4693; Berzero, Giulia/0000-0001-8798-9058; Marras, Carlo Efisio/0000-0003-0790-8903; Ceccarelli, Michele/0000-0002-4702-6617; Caruso, Francesca Pia/0000-0002-2206-1459; Ducray, Francois/0000-0002-8150-5785; Alfaro, Kristin/0000-0002-9870-8415; Cangiano, Mario/0000-0003-0858-8286; Finocchiaro, Gaetano/0000-0003-3583-4040; Salvador, Hector/0000-0002-2515-0019; Zhang, Jing/0000-0001-8549-3286; Goutagny, Stephane/0000-0001-6975-9945	Children's Tumor Foundation Synodos Glioma Consortium [2015-04-007]; NIH [R01CA101644, U54CA193313, R01CA131126, R01CA178546, R01CA179044, R01CA190891, R01NS061776]; Chemotherapy Foundation; NATIONAL CANCER INSTITUTE [U54CA193313, R01CA239698, R01CA179044, R01CA178546, R01CA190891] Funding Source: NIH RePORTER	Children's Tumor Foundation Synodos Glioma Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemotherapy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Children's Tumor Foundation Synodos Glioma Consortium (2015-04-007); NIH R01CA101644, U54CA193313, and R01CA131126 to A.L.; and R01CA178546, U54CA193313, R01CA179044, R01CA190891, R01NS061776, and The Chemotherapy Foundation to A. I. This work benefited from the facilities and expertise of the Onconeurotek Tumor Bank (Pitie-Salpetriere, Paris, France), the CCBH-M Collection Neurology (University Hospital, Montpellier, France, www.chu-montpellier.fr), the NeuroBioTec Collection (Groupement Hospitalier Est, Bron France), the biobank Tissutheque Beaujon BB-0033-00078 (Pathology Department, Beaujon hospital, Clichy, France), the Centre de Ressource Plurithematique Bordeaux Biotheque Sante, and the TUCERA network (Bordeaux, France). We are particularly grateful to P. Polisi for technical support with the mutation calls on high-performance clusters; to A. Rahimian and I. Detrait for technical support; and to V. Rigau, C. Goze, A. Vital, S. Elmer, and I. Quintin-Roue for histological analyses.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Aran D., 2018, REFERENCE BASED ANNO, DOI [10.1101/284604, DOI 10.1101/284604]; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Babadi M, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-3580; Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-47; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Blanchard G, 2016, EUR J PAEDIATR NEURO, V20, P275, DOI 10.1016/j.ejpn.2015.12.002; Boegel S, 2012, GENOME MED, V4, DOI 10.1186/gm403; Braendstrup P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094892; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douville C, 2016, HUM MUTAT, V37, P28, DOI 10.1002/humu.22911; Eisenbarth I, 2000, AM J HUM GENET, V66, P393, DOI 10.1086/302747; Evans DG, 2016, EBIOMEDICINE, V7, P212, DOI 10.1016/j.ebiom.2016.04.005; Evans DG, 2010, AM J MED GENET A, V152A, P327, DOI 10.1002/ajmg.a.33139; Ferlaino M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1862-y; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; Frattini V, 2018, NATURE, V553, P222, DOI 10.1038/nature25171; Friedman JM, 2022, GENEREVIEWS, P1993; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Gutmann DH, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.4; Gutmann DH, 2002, NEUROLOGY, V59, P759, DOI 10.1212/WNL.59.5.759; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Helfferich J, 2016, CRIT REV ONCOL HEMAT, V104, P30, DOI 10.1016/j.critrevonc.2016.05.008; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Hiltemann S, 2015, GENOME RES, V25, P1382, DOI 10.1101/gr.183053.114; Hong E, 2016, J BIOL CHEM, V291, P8931, DOI 10.1074/jbc.M115.695304; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077940; Hutter S, 2016, HUM GENET, V135, P469, DOI 10.1007/s00439-016-1646-x; Isserlin Ruth, 2014, F1000Res, V3, P141, DOI 10.12688/f1000research.4536.1; Jeschke J, 2017, J CLIN INVEST, V127, P3090, DOI 10.1172/JCI91095; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koschmann C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac8228; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Laycock-van Spyk Sebastian, 2011, Human Genomics, V5, P623; Lee S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx193; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mall R, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky015; Mayakonda A., 2016, BIORXIV, P052662; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pemov A, 2017, ONCOGENE, V36, P3168, DOI 10.1038/onc.2016.464; Philpott C, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0109-3; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Rodriguez FJ, 2008, J NEUROPATH EXP NEUR, V67, P240, DOI 10.1097/NEN.0b013e318165eb75; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sellmer L, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0588-2; Seminog O O, 2013, Br J Cancer, V108, P193, DOI 10.1038/bjc.2012.535; Shukla SA, 2017, GYNECOL ONCOL REP, V19, P42, DOI 10.1016/j.gore.2016.12.009; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Solga AC, 2015, NEOPLASIA, V17, P776, DOI 10.1016/j.neo.2015.10.002; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Thomas L, 2012, EUR J HUM GENET, V20, P411, DOI 10.1038/ejhg.2011.207; Upadhyaya M, 2008, HUM MUTAT, V29, P74, DOI [10.1002/humu.20601, 10.1002/humu.20793]; Uusitalo E, 2016, J CLIN ONCOL, V34, P1978, DOI 10.1200/JCO.2015.65.3576; Uusitalo E, 2015, J INVEST DERMATOL, V135, P904, DOI 10.1038/jid.2014.465; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yuan JZ, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0567-9; Zhang YW, 2017, J COMPUT GRAPH STAT, V26, P1, DOI [10.1080/10618600.2016.1154063, 10.1080/10618600.2016.114036]	86	102	102	2	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					176	+		10.1038/s41591-018-0263-8	http://dx.doi.org/10.1038/s41591-018-0263-8			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30531922	Green Accepted, Green Submitted			2022-12-27	WOS:000455027700035
J	Stower, H				Stower, Hannah			Towards poliovirus eradication	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1491	1491		10.1038/s41591-018-0228-y	http://dx.doi.org/10.1038/s41591-018-0228-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297892	Bronze			2022-12-27	WOS:000446577900004
J	Stower, H				Stower, Hannah			Early immune development	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1491	1491		10.1038/s41591-018-0226-0	http://dx.doi.org/10.1038/s41591-018-0226-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297890	Bronze			2022-12-27	WOS:000446577900034
J	Hunter, RW; Hughey, CC; Lantier, L; Sundelin, EI; Peggie, M; Zeqiraj, E; Sicheri, F; Jessen, N; Wasserman, DH; Sakamoto, K				Hunter, Roger W.; Hughey, Curtis C.; Lantier, Louise; Sundelin, Elias, I; Peggie, Mark; Zeqiraj, Elton; Sicheri, Frank; Jessen, Niels; Wasserman, David H.; Sakamoto, Kei			Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; PYRUVATE-KINASE; FRUCTOSE-1,6-BISPHOSPHATASE INHIBITORS; HEPATIC GLUCONEOGENESIS; PLASMA-GLUCOSE; ASSAY; INSULIN; TISSUE; AMP; PHOSPHORYLATION	Metformin is a first-line drug for the treatment of individuals with type 2 diabetes, yet its precise mechanism of action remains unclear. Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP). This suppression is thought to be mediated through inhibition of mitochondrial respiratory complex I, and thus elevation of 5'-adenosine monophosphate (AMP) levels and the activation of AMP-activated protein kinase (AMPK), though this proposition has been challenged given results in mice lacking hepatic AMPK. Here we report that the AMP-inhibited enzyme fructose-1,6-bisphosphatase-1 (FBP1), a rate-controlling enzyme in gluconeogenesis, functions as a major contributor to the therapeutic action of metformin. We identified a point mutation in FBP1 that renders it insensitive to AMP while sparing regulation by fructose2,6-bisphosphate (F-2,6-P-2), and knock-in (KI) of this mutant in mice significantly reduces their response to metformin treatment. We observe this during a metformin tolerance test and in a metformin-euglycemic clamp that we have developed. The antihyperglycemic effect of metformin in high-fat diet-fed diabetic FBP1-KI mice was also significantly blunted compared to wild-type controls. Collectively, we show a new mechanism of action for metformin and provide further evidence that molecular targeting of FBP1 can have antihyperglycemic effects.	[Hunter, Roger W.; Sakamoto, Kei] Nestle Inst Hlth Sci SA, Lausanne, Switzerland; [Hughey, Curtis C.; Lantier, Louise; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Hughey, Curtis C.; Lantier, Louise; Wasserman, David H.] Vanderbilt Univ, Vanderbilt Mouse Metab Phenotyping Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Sundelin, Elias, I; Jessen, Niels] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Sundelin, Elias, I; Jessen, Niels] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Peggie, Mark] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee, Scotland; [Zeqiraj, Elton; Sicheri, Frank] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Sicheri, Frank] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hunter, Roger W.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Zeqiraj, Elton] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England	Nestle SA; Vanderbilt University; Vanderbilt University; Aarhus University; Aarhus University; University of Dundee; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Bristol; University of Leeds	Sakamoto, K (corresponding author), Nestle Inst Hlth Sci SA, Lausanne, Switzerland.	kei.sakamoto@rd.nestle.com	sakamoto, kei/C-8806-2019; Jessen, Niels/E-1731-2011	sakamoto, kei/0000-0001-8839-5980; Zeqiraj, Elton/0000-0003-0239-5926; Jessen, Niels/0000-0001-5613-7274; Sundelin, Elias/0000-0001-6485-082X; Hunter, Roger/0000-0003-0177-1512; Lantier, Louise/0000-0002-6620-4976	Vanderbilt Mouse Metabolic Phenotyping Center Grant [DK059637, R37 DK050277]; Foundation Grant from the Canadian Institutes of Health Research [FND 143277]; Danish Council for Independent Research [DFF-4183-00384]; Novo Nordisk Foundation [NNF130C0003882]; Sir Henry Wellcome postdoctoral fellowship; Canadian Diabetes Association postdoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050277, U24DK059637, U2CDK059637, P30DK058404] Funding Source: NIH RePORTER	Vanderbilt Mouse Metabolic Phenotyping Center Grant; Foundation Grant from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sir Henry Wellcome postdoctoral fellowship; Canadian Diabetes Association postdoctoral fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Deak for molecular biology assistance and S. Jakobsen and J. Frokiaer for support in method development of the [<SUP>11</SUP>C]metformin-uptake study. We also thank E. Heikkila for performing islet isolation, S. Ducommun for performing the pTBC1D1 blot, and S. Cotting for constructing Wollenberger tongs.GLUT2 antibody was provided by B. Thorens, GCK/HXK4 antibody was provided by M. Magnuson, GCKR antibody was provided by M. Shiota, G6PC antibody was provided by G. Mithieux, PFKFB1 antibody was provided by S. Baltrusch, pS33 PFKFB1 antibody was provided by J. Xie and pS8 GYS2 antibody was provided by J. Guinovart. This study was supported by Vanderbilt Mouse Metabolic Phenotyping Center Grant DK059637 (D.H.W.) and R37 DK050277 (D.H.W.), a Foundation Grant (FND 143277) from the Canadian Institutes of Health Research (F.S.), the Danish Council for Independent Research DFF-4183-00384 (N.J.) and the Novo Nordisk Foundation NNF130C0003882 (N.J.). E.Z. was supported by a Sir Henry Wellcome postdoctoral fellowship. C.C.H. was supported by a Canadian Diabetes Association postdoctoral fellowship.	Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; BLAIR JB, 1976, J BIOL CHEM, V251, P3756; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; Bosselaar M, 2011, J CLIN PHARMACOL, V51, P1449, DOI 10.1177/0091270010382912; Bouskila M, 2010, CELL METAB, V12, P456, DOI 10.1016/j.cmet.2010.10.006; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; CASTANO JG, 1979, J BIOL CHEM, V254, P5576; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Chomczynski P, 2006, BIOTECHNIQUES, V40, P454, DOI 10.2144/000112149; Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Dang Q, 2007, J AM CHEM SOC, V129, P15491, DOI 10.1021/ja074871l; DAVIDSON AL, 1987, ARCH BIOCHEM BIOPHYS, V253, P156, DOI 10.1016/0003-9861(87)90648-5; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Erion MD, 2005, P NATL ACAD SCI USA, V102, P7970, DOI 10.1073/pnas.0502983102; FAUPEL RP, 1972, ARCH BIOCHEM BIOPHYS, V148, P509, DOI 10.1016/0003-9861(72)90170-1; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; GIDHJAIN M, 1994, J BIOL CHEM, V269, P27732; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; GIROUX E, 1994, J BIOL CHEM, V269, P31404; Gormsen LC, 2016, J NUCL MED, V57, P1920, DOI 10.2967/jnumed.116.177774; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; HAN P, 1982, ANAL BIOCHEM, V122, P269, DOI 10.1016/0003-2697(82)90280-9; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jakobsen S, 2016, J NUCL MED, V57, P615, DOI 10.2967/jnumed.115.169292; Jensen JB, 2016, DIABETES, V65, P1724, DOI 10.2337/db16-0032; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Kjobsted R, 2015, DIABETES, V64, P2042, DOI 10.2337/db14-1402; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; McCarty MF, 1999, MED HYPOTHESES, V52, P89, DOI 10.1054/mehy.1997.0597; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; NAKAMURA K, 1987, ANAL BIOCHEM, V165, P28, DOI 10.1016/0003-2697(87)90196-5; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; Noll F, 1984, METHOD ENZYMAT AN, V6, P582; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PAGLIARA AS, 1972, J CLIN INVEST, V51, P2115, DOI 10.1172/JCI107018; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7; Racker E., 1965, METHOD ENZYMAT AN, P160; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; RYLL T, 1991, J CHROMATOGR-BIOMED, V570, P77, DOI 10.1016/0378-4347(91)80202-N; SAHEKI S, 1985, ANAL BIOCHEM, V148, P277, DOI 10.1016/0003-2697(85)90229-5; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SMILEY KL, 1967, J BIOL CHEM, V242, P2502; STALMANS W, 1975, EUR J BIOCHEM, V54, P341, DOI 10.1111/j.1432-1033.1975.tb04144.x; Stepensky D, 2002, DRUG METAB DISPOS, V30, P861, DOI 10.1124/dmd.30.8.861; Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; TASHIMA Y, 1979, J BIOCHEM, V86, P1089, DOI 10.1093/oxfordjournals.jbchem.a132603; Terada T, 2006, PHARM RES, V23, P1696, DOI 10.1007/s11095-006-9016-3; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; van Poelje PD, 2007, CURR OPIN DRUG DISC, V10, P430; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; Vincent MF, 1996, BIOCHEM PHARMACOL, V52, P999, DOI 10.1016/0006-2952(96)00413-3; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yoshida T, 2009, EUR J PHARMACOL, V623, P141, DOI 10.1016/j.ejphar.2009.09.003; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zarghi A, 2003, J PHARMACEUT BIOMED, V31, P197, DOI 10.1016/S0731-7085(02)00608-8; Zhang Y, 2010, ENDOCRINOLOGY, V151, P4688, DOI 10.1210/en.2009-1185; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	83	126	129	6	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1395	+		10.1038/s41591-018-0159-7	http://dx.doi.org/10.1038/s41591-018-0159-7			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30150719	Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000444174100020
J	Madiraju, AK; Qiu, Y; Perry, RJ; Rahimi, Y; Zhang, XM; Zhang, DY; Camporez, JPG; Cline, GW; Butrico, GM; Kemp, BE; Casals, G; Steinberg, GR; Vatner, DF; Petersen, KF; Shulman, GI				Madiraju, Anila K.; Qiu, Yang; Perry, Rachel J.; Rahimi, Yasmeen; Zhang, Xian-Man; Zhang, Dongyan; Camporez, Joao-Paulo G.; Cline, Gary W.; Butrico, Gina M.; Kemp, Bruce E.; Casals, Gregori; Steinberg, Gregory R.; Vatner, Daniel F.; Petersen, Kitt F.; Shulman, Gerald, I			Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY LIVER-DISEASE; PERFUSED-RAT-LIVER; CITRIC-ACID CYCLE; GLUCOSE-PRODUCTION; HEPATIC GLUCONEOGENESIS; DIABETES-MELLITUS; INSULIN-RESISTANCE; RESPIRATORY-CHAIN; COMPLEX I	Metformin, the universal first-line treatment for type 2 diabetes, exerts its therapeutic glucose-lowering effects by inhibiting hepatic gluconeogenesis. However, the primary molecular mechanism of this biguanide remains unclear, though it has been suggested to act, at least partially, by mitochondrial complex I inhibition. Here we show that clinically relevant concentrations of plasma metformin achieved by acute intravenous, acute intraportal or chronic oral administration in awake normal and diabetic rats inhibit gluconeogenesis from lactate and glycerol but not from pyruvate and alanine, implicating an increased cytosolic redox state in mediating metformin's antihyperglycemic effect. All of these effects occurred independently of complex I inhibition, evidenced by unaltered hepatic energy charge and citrate synthase flux. Normalizing the cytosolic redox state by infusion of methylene blue or substrates that contribute to gluconeogenesis independently of the cytosolic redox state abrogated metformin-mediated inhibition of gluconeogenesis in vivo. Additionally, in mice expressing constitutively active acetylCoA carboxylase, metformin acutely decreased hepatic glucose production and increased the hepatic cytosolic redox state without altering hepatic triglyceride content or gluconeogenic enzyme expression. These studies demonstrate that metformin, at clinically relevant plasma concentrations, inhibits hepatic gluconeogenesis in a redox-dependent manner independently of reductions in citrate synthase flux, hepatic nucleotide concentrations, acetyl-CoA carboxylase activity, or gluconeogenic enzyme protein expression.	[Madiraju, Anila K.; Qiu, Yang; Perry, Rachel J.; Rahimi, Yasmeen; Zhang, Xian-Man; Zhang, Dongyan; Camporez, Joao-Paulo G.; Cline, Gary W.; Butrico, Gina M.; Casals, Gregori; Vatner, Daniel F.; Petersen, Kitt F.; Shulman, Gerald, I] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Madiraju, Anila K.; Shulman, Gerald, I] Yale Univ, Sch Med, Cellular & Mol Physiol, New Haven, CT 06520 USA; [Madiraju, Anila K.; Shulman, Gerald, I] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Qiu, Yang] China Med Univ, Dept Endocrinol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Melbourne, Vic, Australia; [Kemp, Bruce E.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Kemp, Bruce E.] Australian Catholic Univ Fitzroy, Mary MacKillop Inst Hlth Res, Fitzroy, Vic, Australia; [Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; China Medical University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; Australian Catholic University; McMaster University; McMaster University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Cellular & Mol Physiol, New Haven, CT 06520 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019; Casals, Gregori/F-6506-2012; Kemp, Bruce/G-9602-2019	Shulman, Gerald I./0000-0003-1529-5668; Casals, Gregori/0000-0002-3271-1371; Kemp, Bruce/0000-0001-6735-5082; Camporez, Joao Paulo/0000-0003-3486-4301; Steinberg, Gregory/0000-0001-5425-8275; Perry, Rachel/0000-0003-0748-8064	US Department of Health and Human Services [R01 DK113984, P30 DK45735, P30 DK034989, K99 CA215315, R01 DK114793]; Canada Research Chair in Metabolism and Obesity; J. Bruce Duncan Endowed Chair in Metabolic Diseases at McMaster University; Diabetes Canada; National Health and Medical Research Council [1068813, 1085460]; Victorian Government Operational Infrastructure Support Scheme; NATIONAL CANCER INSTITUTE [K99CA215315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049230, P30DK034989, R01DK113984, P30DK045735, P01DK068229, R01DK114793] Funding Source: NIH RePORTER	US Department of Health and Human Services; Canada Research Chair in Metabolism and Obesity; J. Bruce Duncan Endowed Chair in Metabolic Diseases at McMaster University; Diabetes Canada; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to thank J. Dong, M. Kahn, S. Dufour, J. Stack, Y. Kosover, A. Nasiri, X. Ma, W. Zhu, and K. Harry for their technical support and V. Samuel, S. Caprio, and D. Kibbey for helpful discussions. This publication was supported by grants from the US Department of Health and Human Services: R01 DK113984, P30 DK45735, P30 DK034989, K99 CA215315 and R01 DK114793. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or the NIH. G.R.S. is supported by grants and fellowships from a Canada Research Chair in Metabolism and Obesity, the J. Bruce Duncan Endowed Chair in Metabolic Diseases at McMaster University and Diabetes Canada. B.E.K. is supported by grants and a Fellowship (BEK) from the National Health and Medical Research Council (1068813 and 1085460) and the Victorian Government Operational Infrastructure Support Scheme.	Alves TC, 2011, HEPATOLOGY, V53, P1175, DOI 10.1002/hep.24170; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Baur JA, 2014, CELL METAB, V20, P197, DOI 10.1016/j.cmet.2014.07.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bronden A. A. A., 2017, J CLIN ENDOCRINOL ME; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; Chu CA, 2000, METABOLISM, V49, P1619, DOI 10.1053/meta.2000.18561; COMTE B, 1990, METABOLISM, V39, P259, DOI 10.1016/0026-0495(90)90044-D; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Drahota Z, 2014, PHYSIOL RES, V63, P1, DOI 10.33549/physiolres.932600; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Goodman L. S., 2011, GOODMAN GILMANS PHAR, P1906; Gormsen LC, 2018, DIABETES OBES METAB, V20, P1435, DOI 10.1111/dom.13244; Gormsen LC, 2016, J NUCL MED, V57, P1920, DOI 10.2967/jnumed.116.177774; GREGORY RB, 1992, BIOCHIM BIOPHYS ACTA, V1137, P34, DOI 10.1016/0167-4889(92)90096-T; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2016, EXPERIENTIA SUPPL, V107, P327, DOI 10.1007/978-3-319-43589-3_13; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; HUSSEY EK, 2013, BMC PHARMACOL TOXICO, V14; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Johanns M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10856; JOMAINBAUM M, 1975, J BIOL CHEM, V250, P8978; Kim CW, 2017, CELL METAB, V26, P576, DOI 10.1016/j.cmet.2017.08.011; Kneer N, 2000, ARCH BIOCHEM BIOPHYS, V375, P145, DOI 10.1006/abbi.1999.1668; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Konopka AR, 2016, CELL REP, V15, P1394, DOI 10.1016/j.celrep.2016.04.024; LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Lavine JE, 2011, JAMA-J AM MED ASSOC, V305, P1659, DOI 10.1001/jama.2011.520; Lewis AJM, 2016, DIABETES, V65, P3544, DOI 10.2337/db16-0804; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; NATTRASS M, 1977, DIABETOLOGIA, V13, P145, DOI 10.1007/BF00745143; NURJHAN N, 1992, J CLIN INVEST, V89, P169, DOI 10.1172/JCI115558; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Perry RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01143-w; Perry RJ, 2017, J CLIN INVEST, V127, P657, DOI 10.1172/JCI88477; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789; Qi HY, 2018, DIABETOLOGIA, V61, P445, DOI 10.1007/s00125-017-4445-6; Rakoski MO, 2010, ALIMENT PHARM THER, V32, P1211, DOI 10.1111/j.1365-2036.2010.04467.x; Reed MJ, 1999, DIABETOLOGIA, V42, P102, DOI 10.1007/s001250051121; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; RYLE PR, 1985, BIOCHEM J, V232, P877, DOI 10.1042/bj2320877; Said A, 2017, ANN HEPATOL, V16, P538, DOI 10.5604/01.3001.0010.0284; Sawangjit R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004529; SCHLIENGER JL, 1979, DIABETES METAB, V5, P5; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shields William W, 2009, Therap Adv Gastroenterol, V2, P157, DOI 10.1177/1756283X09105462; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; SUGANO T, 1980, J BIOCHEM-TOKYO, V87, P153, DOI 10.1093/oxfordjournals.jbchem.a132721; Timmins P, 2005, CLIN PHARMACOKINET, V44, P721, DOI 10.2165/00003088-200544070-00004; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P5044; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	68	135	138	10	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1384	+		10.1038/s41591-018-0125-4	http://dx.doi.org/10.1038/s41591-018-0125-4			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30038219	Green Submitted, Green Accepted			2022-12-27	WOS:000444174100019
J	Skinner, MK				Skinner, Michael K.			Preconception cold-induced epigenetic inheritance	NATURE MEDICINE			English	Editorial Material							PLASTICITY		[Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA.	skinner@wsu.edu			National Institutes of Health (NIH) [ES012974]; John Templeton Foundation [50183]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	I thank H. Johnson for assistance in preparation of this manuscript. This work was supported by grants from the National Institutes of Health (NIH; ES012974) and the John Templeton Foundation (50183) to M.K.S.	Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Kress A, 2017, J INSECT PHYSIOL, V99, P113, DOI 10.1016/j.jinsphys.2017.04.003; Lu JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25076; Nilsson EE, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy016; Roth O, 2017, EVOL APPL, V10, P514, DOI 10.1111/eva.12473; Skinner MK, 2015, GENOME BIOL EVOL, V7, P1296, DOI 10.1093/gbe/evv073; Sun WF, 2018, NAT MED, V24, P1372, DOI 10.1038/s41591-018-0102-y; Symonds ME, 2018, J ENDOCRINOL, V238, pR53, DOI 10.1530/JOE-18-0084; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747	11	2	2	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1308	1309		10.1038/s41591-018-0187-3	http://dx.doi.org/10.1038/s41591-018-0187-3			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194411	Green Accepted			2022-12-27	WOS:000444174100007
J	Stower, H				Stower, Hannah			Bringing polygenic risk scores to the clinic	NATURE MEDICINE			English	Editorial Material																			0	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1303	1303		10.1038/s41591-018-0190-8	http://dx.doi.org/10.1038/s41591-018-0190-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194405				2022-12-27	WOS:000444174100025
J	Titano, JJ; Badgeley, M; Schefflein, J; Pain, M; Su, A; Cai, M; Swinburne, N; Zech, J; Kim, J; Bederson, J; Mocco, J; Drayer, B; Lehar, J; Cho, S; Costa, A; Oermann, EK				Titano, Joseph J.; Badgeley, Marcus; Schefflein, Javin; Pain, Margaret; Su, Andres; Cai, Michael; Swinburne, Nathaniel; Zech, John; Kim, Jun; Bederson, Joshua; Mocco, J.; Drayer, Burton; Lehar, Joseph; Cho, Samuel; Costa, Anthony; Oermann, Eric K.			Automated deep-neural-network surveillance of cranial images for acute neurologic events	NATURE MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; TIME; CLASSIFICATION; VALIDATION; DIAGNOSIS; THROMBUS; MODELS; BRAIN; CNN	Rapid diagnosis and treatment of acute neurological illnesses such as stroke, hemorrhage, and hydrocephalus are critical to achieving positive outcomes and preserving neurologic function-'time is brain'(1-5). Although these disorders are often recognizable by their symptoms, the critical means of their diagnosis is rapid imaging(6-10). Computer-aided surveillance of acute neurologic events in cranial imaging has the potential to triage radiology workflow, thus decreasing time to treatment and improving outcomes. Substantial clinical work has focused on computer-assisted diagnosis (CAD), whereas technical work in volumetric image analysis has focused primarily on segmentation. 3D convolutional neural networks (3D-CNNs) have primarily been used for supervised classification on 3D modeling and light detection and ranging (LiDAR) data(11-15). Here, we demonstrate a 3D-CNN architecture that performs weakly supervised classification to screen head CT images for acute neurologic events. Features were automatically learned from a clinical radiology dataset comprising 37,236 head CTs and were annotated with a semisupervised natural-language processing (NLP) framework(16). We demonstrate the effectiveness of our approach to triage radiology workflow and accelerate the time to diagnosis from minutes to seconds through a randomized, double-blinded, prospective trial in a simulated clinical environment.	[Titano, Joseph J.; Schefflein, Javin; Su, Andres; Cai, Michael; Swinburne, Nathaniel; Zech, John; Drayer, Burton] Icahn Sch Med, Dept Radiol, New York, NY USA; [Badgeley, Marcus; Pain, Margaret; Bederson, Joshua; Mocco, J.; Cho, Samuel; Costa, Anthony; Oermann, Eric K.] Icahn Sch Med, Dept Neurol Surg, New York, NY 10029 USA; [Kim, Jun; Cho, Samuel] Icahn Sch Med, Dept Orthoped Surg, New York, NY USA; [Lehar, Joseph] Boston Univ, Bioengn & Bioinformat, Boston, MA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boston University	Oermann, EK (corresponding author), Icahn Sch Med, Dept Neurol Surg, New York, NY 10029 USA.	eric.oermann@mountsinai.org	Oermann, Eric/AAD-9729-2020; Kim, Jun Sup/ABB-5046-2021; Costa, Anthony/C-5471-2009	Oermann, Eric/0000-0002-1876-5963; Kim, Jun Sup/0000-0002-6114-2673; Swinburne, Nathaniel/0000-0001-5831-7287; Cho, Samuel/0000-0001-7511-2486; Costa, Anthony/0000-0002-2202-6450				Agarwal V, 2016, J AM MED INFORM ASSN, V23, P1166, DOI 10.1093/jamia/ocw028; [Anonymous], 2017, IEEE C COMP VIS PATT; Brock A., 2016, GENERATIVE DISCRIMIN; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Brosch T, 2016, IEEE T MED IMAGING, V35, P1229, DOI 10.1109/TMI.2016.2528821; Bush K, 2013, CRANIOMAX TRAUM REC, V6, P237, DOI 10.1055/s-0033-1349214; Chen PH, 2016, PROC SPIE, V9789, DOI 10.1117/12.2216574; Cicek O, 2016, 3D U NET LEARNING DE; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Ferro JM, 1998, STROKE, V29, P1106, DOI 10.1161/01.STR.29.6.1106; Furlan AJ, 2006, STROKE, V37, P2863, DOI 10.1161/01.STR.0000251852.07152.63; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Halpern Yoni, 2014, AMIA Annu Symp Proc, V2014, P606; He K., 2016, CVPR, DOI 10.1109/cvpr.2016.90; HEGDE V., 2016, FUSIONNET 3D OBJECT; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kim EY, 2005, STROKE, V36, P2745, DOI 10.1161/01.STR.0000185720.03803.41; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lehman CD, 2015, JAMA INTERN MED, V175, P1828, DOI 10.1001/jamainternmed.2015.5231; Li X., 2017, H DENSEUNET HYBRID D; Liu Y., 2017, DETECTING CANCER MET; Maturana D, 2015, IEEE INT C INT ROBOT, P922, DOI 10.1109/IROS.2015.7353481; Merkow J., 2017, DEEPRADIOLOGYNET RAD; Mullins ME, 2002, RADIOLOGY, V224, P353, DOI 10.1148/radiol.2242010873; National Collaborating Centre for Chronic Conditions (UK), 2011, STROK NAT CLIN GUID; Navi BB, 2013, NEUROHOSPITALIST, V3, P7, DOI 10.1177/1941874412458677; Oktay O., 2017, IEEE T MED IMAGING, V37, P384, DOI DOI 10.1109/TMI.2017.2743464; Riedel CH, 2010, STROKE, V41, P1659, DOI 10.1161/STROKEAHA.110.580662; Rubinstein D, 1996, J TRAUMA, V40, P204, DOI 10.1097/00005373-199602000-00006; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Sedaghat N, 2016, ORIENTATION BOOSTED; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Sinha A, 2016, LECT NOTES COMPUT SC, V9910, P223, DOI 10.1007/978-3-319-46466-4_14; Spinoulas L, 2015, IEEE COMPUT SOC CONF; Viertel VG, 2013, AM J ROENTGENOL, V200, P1132, DOI 10.2214/AJR.12.9041; Wen W., 2016, LEARNING STRUCTURED; Zech J, 2018, RADIOLOGY, V287, P570, DOI 10.1148/radiol.2018171093	42	190	194	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1337	+		10.1038/s41591-018-0147-y	http://dx.doi.org/10.1038/s41591-018-0147-y			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30104767				2022-12-27	WOS:000444174100014
J	Iorgulescu, JB; Reardon, DA; Chiocca, EA; Wu, CJ				Iorgulescu, J. Bryan; Reardon, David A.; Chiocca, E. Antonio; Wu, Catherine J.			Immunotherapy for glioblastoma: going viral	NATURE MEDICINE			English	Editorial Material							GENE		[Iorgulescu, J. Bryan; Reardon, David A.; Wu, Catherine J.] Dana Farber Canc Ctr, Dept Med Oncol, Boston, MA 02215 USA; [Iorgulescu, J. Bryan; Reardon, David A.; Chiocca, E. Antonio; Wu, Catherine J.] Harvard Med Sch, Boston, MA 02115 USA; [Iorgulescu, J. Bryan] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Reardon, David A.; Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Chiocca, E. Antonio] Brigham & Womens Hosp, Dana Farber Canc Ctr, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute	Wu, CJ (corresponding author), Dana Farber Canc Ctr, Dept Med Oncol, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Wu, CJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	cwu@partners.org		Iorgulescu, J. Bryan/0000-0003-1405-3667	Abbvie; Agenus; Bristol-Myers Squibb; Celldex; EMD Serono; Genentech/Roche; Inovio; Merck; Merck KGaA; Monteris; Novocure; Oncorus; Oxigene; Regeneron; Stemline; Taiho Oncology, Inc.; Advantagene; Dnatrix; NATIONAL CANCER INSTITUTE [P01CA163205] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	Abbvie(AbbVie); Agenus; Bristol-Myers Squibb(Bristol-Myers Squibb); Celldex; EMD Serono; Genentech/Roche(Roche HoldingGenentech); Inovio; Merck(Merck & Company); Merck KGaA; Monteris; Novocure(Novocure Limited); Oncorus; Oxigene; Regeneron(Regeneron); Stemline; Taiho Oncology, Inc.; Advantagene; Dnatrix; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	D.A.R. reports receiving honoraria, advisory, and consultant fees from Abbvie; Agenus; Bristol-Myers Squibb; Celldex; EMD Serono; Genentech/Roche; Inovio; Merck; Merck KGaA; Monteris; Novocure; Oncorus; Oxigene; Regeneron; Stemline; and Taiho Oncology, Inc. E.A.C. reports receiving consultant and advisory fees from Advantagene and Dnatrix. C.J.W. is cofounder of Neon Therapeutics and a member of its scientific advisory board. All other authors declare that they have no competing interests.	Brown MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan4220; Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435; Grob JJ, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.9534; Gromeier M, 1996, P NATL ACAD SCI USA, V93, P2370, DOI 10.1073/pnas.93.6.2370; Keskin D. B, 2018, CANC RES, V78; Lawler SE, 2017, JAMA ONCOL, V3, P841, DOI 10.1001/jamaoncol.2016.2064; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Reardon D. A, 2017, NEUROONCOL, V19; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Trask TW, 2000, MOL THER, V1, P195, DOI 10.1006/mthe.2000.0030; Wheeler LA, 2016, NEURO-ONCOLOGY, V18, P1137, DOI 10.1093/neuonc/now002	12	17	18	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1094	1096		10.1038/s41591-018-0142-3	http://dx.doi.org/10.1038/s41591-018-0142-3			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082860	Green Accepted			2022-12-27	WOS:000440955500012
J	Haapaniemi, E; Botla, S; Persson, J; Schmierer, B; Taipale, J				Haapaniemi, Emma; Botla, Sandeep; Persson, Jenna; Schmierer, Bernhard; Taipale, Jussi			CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response	NATURE MEDICINE			English	Article							CELLS; INHIBITION; EFFICIENCY; REPAIR; GENES	Here, we report that genome editing by CRISPR-Cas9 induces a p53-mediated DNA damage response and cell cycle arrest in immortalized human retinal pigment epithelial cells, leading to a selection against cells with a functional p53 pathway. Inhibition of p53 prevents the damage response and increases the rate of homologous recombination from a donor template. These results suggest that p53 inhibition may improve the efficiency of genome editing of untransformed cells and that p53 function should be monitored when developing cell-based therapies utilizing CRISPR-Cas9.	[Haapaniemi, Emma; Botla, Sandeep; Persson, Jenna; Schmierer, Bernhard; Taipale, Jussi] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Haapaniemi, Emma; Taipale, Jussi] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland; [Taipale, Jussi] Univ Cambridge, Dept Biochem, Cambridge, England	Karolinska Institutet; University of Helsinki; University of Cambridge	Schmierer, B; Taipale, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.; Taipale, J (corresponding author), Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland.; Taipale, J (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	bernhard.schmierer@ki.se; ajt208@cam.ac.uk	Schmierer, Bernhard/P-4208-2019; Spence, Brea/GYR-1210-2022; Schmierer, Bernhard/C-1416-2009	Schmierer, Bernhard/0000-0002-9082-7022; Schmierer, Bernhard/0000-0002-9082-7022; Haapaniemi, Emma/0000-0002-6693-8208; Persson, Jenna/0000-0002-0208-8080; Botla, Sandeep/0000-0001-9937-0455	Science for Life Laboratory (Scilifelab); Knut and Alice Wallenberg Foundation; Cancerfonden; Barncancerfonden; Academy of Finland	Science for Life Laboratory (Scilifelab); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Cancerfonden(Swedish Cancer Society); Barncancerfonden; Academy of Finland(Academy of Finland)	Part of this work was carried out at the High Throughput Genome Engineering Facility and the Swedish National Genomics Infrastructure funded by Science for Life Laboratory (Scilifelab). The Knut and Alice Wallenberg Foundation, Cancerfonden, Barncancerfonden and the Academy of Finland supported this work. We thank H. Han and Y. Bryceson for providing equipment, the Protein Science Facility at Karolinska Institutet, as well as I. Sur and T. Kivioja for their comments on the manuscript.	Canny MD, 2018, NAT BIOTECHNOL, V36, P95, DOI 10.1038/nbt.4021; Cuella-Martin R, 2016, MOL CELL, V64, P51, DOI 10.1016/j.molcel.2016.08.002; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; HOHMANN S, 1988, MOL GEN GENET, V211, P446, DOI 10.1007/BF00425699; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Lee K, 2017, ELIFE, V6, DOI 10.7554/eLife.25312; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Luo MY, 2018, INT J OPHTHALMOL-CHI, V11, P150, DOI 10.18240/ijo.2018.01.23; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Muerdter F, 2018, NAT METHODS, V15, P141, DOI 10.1038/nmeth.4534; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Schmierer B, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177834; Sokolova M, 2017, CELL CYCLE, V16, P189, DOI 10.1080/15384101.2016.1261765; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	20	548	579	18	389	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					927	+		10.1038/s41591-018-0049-z	http://dx.doi.org/10.1038/s41591-018-0049-z			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892067	Green Published, Green Submitted			2022-12-27	WOS:000438187700019
J	Stower, H				Stower, Hannah			Understanding genetic disease with electronic medical records	NATURE MEDICINE			English	Editorial Material																			0	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					898	898		10.1038/s41591-018-0121-8	http://dx.doi.org/10.1038/s41591-018-0121-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988133	Bronze			2022-12-27	WOS:000438187700007
J	Wong, GS; Zhou, J; Liu, JB; Wu, Z; Xu, XS; Li, TX; Xu, D; Schumacher, SE; Puschhof, J; McFarland, J; Zou, C; Dulak, A; Henderson, L; Xu, P; O'Day, E; Rendak, R; Liao, WL; Cecchi, F; Hembrough, T; Schwartz, S; Szeto, C; Rustgi, AK; Wong, KK; Diehl, JA; Jensen, K; Graziano, F; Ruzzo, A; Fereshetian, S; Mertins, P; Carr, SA; Beroukhim, R; Nakamura, K; Oki, E; Watanabe, M; Baba, H; Imamura, Y; Catenacci, D; Bass, AJ				Wong, Gabrielle S.; Zhou, Jin; Liu, Jie Bin; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Xu, David; Schumacher, Steven E.; Puschhof, Jens; McFarland, James; Zou, Charles; Dulak, Austin; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Liao, Wei-li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher; Rustgi, Anil K.; Wong, Kwok-Kin; Diehl, J. Alan; Jensen, Karin; Graziano, Francesco; Ruzzo, Annamaria; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A.; Beroukhim, Rameen; Nakamura, Kenichi; Oki, Eiji; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu; Catenacci, Daniel; Bass, Adam J.			Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition	NATURE MEDICINE			English	Article							ACQUIRED-RESISTANCE; GENE AMPLIFICATION; COLORECTAL-CANCER; GASTRIC-CANCER; MUTANT LUNG; RAS; ACTIVATION; PHOSPHORYLATION; GROWTH; THERAPY	The role of KRAS, when activated through canonical mutations, has been well established in cancer(1). Here we explore a secondary means of KRAS activation in cancer: focal high-level amplification of the KRAS gene in the absence of coding mutations. These amplifications occur most commonly in esophageal, gastric and ovarian adenocarcinomas(2-4). KRAS-amplified gastric cancer models show marked overexpression of the KRAS protein and are insensitive to MAPK blockade owing to their capacity to adaptively respond by rapidly increasing KRAS-GTP levels. Here we demonstrate that inhibition of the guanine-exchange factors SOS1 and SOS2 or the protein tyrosine phosphatase SHP2 can attenuate this adaptive process and that targeting these factors, both genetically and pharmacologically, can enhance the sensitivity of KRAS-amplified models to MEK inhibition in both in vitro and in vivo settings. These data demonstrate the relevance of copy-number amplification as a mechanism of KRAS activation, and uncover the therapeutic potential for targeting of these tumors through combined SHP2 and MEK inhibition.	[Wong, Gabrielle S.; Zhou, Jin; Liu, Jie Bin; Wu, Zhong; Xu, Xinsen; Li, Tianxia; Puschhof, Jens; McFarland, James; Zou, Charles; Dulak, Austin; Beroukhim, Rameen; Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wong, Gabrielle S.] Novartis Inst Biomed Res Inc, Cambridge, MA USA; [Xu, David; Henderson, Les; Xu, Peng; O'Day, Emily; Rendak, Rachel; Catenacci, Daniel] Univ Chicago, Dept Med, Hematol Oncol Sect, Med Ctr & Biol Sci, Chicago, IL 60637 USA; [Schumacher, Steven E.; McFarland, James; Fereshetian, Shaunt; Mertins, Philipp; Carr, Steven A.; Beroukhim, Rameen; Bass, Adam J.] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Dulak, Austin] Surface Oncol, Cambridge, MA USA; [Liao, Wei-li; Cecchi, Fabiola; Hembrough, Todd; Schwartz, Sarit; Szeto, Christopher] OncoPlex Diagnost NantOm, Rockville, MD USA; [Rustgi, Anil K.] Univ Penn, Dept Med, Div Gastroenterol, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Dept Genet, Div Gastroenterol, Abramson Canc Ctr,Perelman Sch Med, Philadelphia, PA 19104 USA; [Wong, Kwok-Kin; Beroukhim, Rameen; Bass, Adam J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Wong, Kwok-Kin] NYU Langone Hlth, New York, NY USA; [Diehl, J. Alan] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Jensen, Karin] Sanofi Oncol, Cambridge, MA USA; [Jensen, Karin] Univ Illinois, Chicago, IL USA; [Graziano, Francesco; Ruzzo, Annamaria] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Mertins, Philipp] Max Delbruck Ctr Mol Med, Berlin, Germany; [Beroukhim, Rameen; Bass, Adam J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Nakamura, Kenichi; Watanabe, Masayuki; Baba, Hideo; Imamura, Yu] Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan; [Oki, Eiji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Watanabe, Masayuki; Imamura, Yu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan	Harvard University; Dana-Farber Cancer Institute; Novartis; University of Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; NYU Langone Medical Center; Medical University of South Carolina; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Urbino; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Kumamoto University; Kyushu University; Japanese Foundation for Cancer Research	Bass, AJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Catenacci, D (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Med Ctr & Biol Sci, Chicago, IL 60637 USA.; Bass, AJ (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA.; Bass, AJ (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Bass, AJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	dcatenac@bsd.uchicago.edu; adam_bass@dfci.harvard.edu	Catenacci, Daniel/K-4177-2019; Carr, Steven A./AAH-8366-2019; Xu, Xinsen/ABF-2110-2021	wong, kwok kin/0000-0001-6323-235X	Target Cancer Foundation, Sanofi Oncology; Twomey Family Fellowship in Esophageal Cancer Research; American Cancer Society; NIH [P01 CA098101, K23 CA178203-01A1]; JSPS Kakenhi [JP16H06259]; Kobayashi Foundation for Cancer Research; Live Like Katie (LLK) Fund; Sal Ferrara II Fund for PANGEA; University of Chicago Comprehensive Cancer Center (UCCCC) Precision Oncology-Cancer Center [P30 CA014599]; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA014599, P01CA098101, K23CA178203] Funding Source: NIH RePORTER	Target Cancer Foundation, Sanofi Oncology; Twomey Family Fellowship in Esophageal Cancer Research; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Live Like Katie (LLK) Fund; Sal Ferrara II Fund for PANGEA; University of Chicago Comprehensive Cancer Center (UCCCC) Precision Oncology-Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by funding from Target Cancer Foundation, Sanofi Oncology (A.J.B., G.S.W. and K.J.), Twomey Family Fellowship in Esophageal Cancer Research (G.S.W. and J.Z.), a Research Scholar Grant from the American Cancer Society to A.J.B. and NIH grants P50 CA127003 (A.J.B.). A.J.B., K.-K.W., J.A.D. and A.K.R. were supported by NIH grant P01 CA098101. JSPS Kakenhi grant JP16H06259 and Kobayashi Foundation for Cancer Research supported Y.I. D.C. was supported by the Live Like Katie (LLK) Fund, Sal Ferrara II Fund for PANGEA, NIH K23 CA178203-01A1, University of Chicago Comprehensive Cancer Center (UCCCC) Precision Oncology-Cancer Center Support Grant P30 CA014599.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Ahronian LG, 2015, CANCER DISCOV, V5, P358, DOI 10.1158/2159-8290.CD-14-1518; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Birkeland E, 2012, BRIT J CANCER, V107, P1997, DOI 10.1038/bjc.2012.477; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; BUDAY L, 1995, ONCOGENE, V11, P1327; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Cargnelutti M, 2015, ONCOTARGET, V6, P5182, DOI 10.18632/oncotarget.3311; Catenacci DVT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100586; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Das K, 2014, CANCER LETT, V353, P167, DOI 10.1016/j.canlet.2014.07.021; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dulak AM, 2012, CANCER RES, V72, P4383, DOI 10.1158/0008-5472.CAN-11-3893; Evelyn CR, 2014, CHEM BIOL, V21, P1618, DOI 10.1016/j.chembiol.2014.09.018; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Hembrough T, 2013, J MOL DIAGN, V15, P454, DOI 10.1016/j.jmoldx.2013.03.002; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Jokinen E, 2015, THER ADV MED ONCOL, V7, P170, DOI 10.1177/1758834015571111; Kamioka Y, 2010, J BIOL CHEM, V285, P33540, DOI 10.1074/jbc.M110.135517; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Maron SB, 2018, CANCER DISCOV, V8, P696, DOI 10.1158/2159-8290.CD-17-1260; McNeill RS, 2017, NEURO-ONCOLOGY, V19, P1469, DOI 10.1093/neuonc/nox044; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Oddo D, 2016, CANCER RES, V76, P4504, DOI 10.1158/0008-5472.CAN-16-0396; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; Ross JS, 2013, GYNECOL ONCOL, V130, P554, DOI 10.1016/j.ygyno.2013.06.019; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Tokunaga R, 2016, ONCOTARGET, V7, P19748, DOI 10.18632/oncotarget.7782; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang WR, 2012, BIOORG MED CHEM LETT, V22, P5766, DOI 10.1016/j.bmcl.2012.07.082; Winter JJG, 2015, J MED CHEM, V58, P2265, DOI 10.1021/jm501660t; Zawistowski JS, 2017, CANCER DISCOV, V7, P302, DOI 10.1158/2159-8290.CD-16-0653; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	47	138	143	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					968	+		10.1038/s41591-018-0022-x	http://dx.doi.org/10.1038/s41591-018-0022-x			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29808010	Green Accepted			2022-12-27	WOS:000438187700025
J	Stower, H				Stower, Hannah			Zika virus shedding in semen	NATURE MEDICINE			English	Editorial Material																			0	4	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					702	702		10.1038/s41591-018-0075-x	http://dx.doi.org/10.1038/s41591-018-0075-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875461	Bronze			2022-12-27	WOS:000434281300007
J	Cassotta, A; Mikol, V; Bertrand, T; Pouzieux, S; Le Parc, J; Ferrari, P; Dumas, J; Auer, M; Deisenhammer, F; Gastaldi, M; Franciotta, D; Silacci-Fregni, C; Rodriguez, BF; Giacchetto-Sasselli, I; Foglierini, M; Jarrossay, D; Geiger, R; Sallusto, F; Lanzavecchia, A; Piccoli, L				Cassotta, Antonino; Mikol, Vincent; Bertrand, Thomas; Pouzieux, Stephanie; Le Parc, Josiane; Ferrari, Paul; Dumas, Jacques; Auer, Michael; Deisenhammer, Florian; Gastaldi, Matteo; Franciotta, Diego; Silacci-Fregni, Chiara; Rodriguez, Blanca Fernandez; Giacchetto-Sasselli, Isabella; Foglierini, Mathilde; Jarrossay, David; Geiger, Roger; Sallusto, Federica; Lanzavecchia, Antonio; Piccoli, Luca			A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; INTERFERON-BETA; B-CELLS; IMMUNOGENICITY	Natalizumab (NZM), a humanized monoclonal IgG4 antibody to alpha 4 integrins, is used to treat patients with relapsing-remitting multiple sclerosis (MS)(1,2), but in about 6% of the cases persistent neutralizing anti-drug antibodies (ADAs) are induced leading to therapy discontinuation(3,4). To understand the basis of the ADA response and the mechanism of ADA-mediated neutralization, we performed an in-depth analysis of the B and T cell responses in two patients. By characterizing a large panel of NZM-specific monoclonal antibodies, we found that, in both patients, the response was polyclonal and targeted different epitopes of the NZM idiotype. The neutralizing activity was acquired through somatic mutations and correlated with a slow dissociation rate, a finding that was supported by structural data. Interestingly, in both patients, the analysis of the CD4(+) T cell response, combined with mass spectrometry-based peptidomics, revealed a single immunodominant T cell epitope spanning the FR2-CDR2 region of the NZM light chain. Moreover, a CDR2-modified version of NZM was not recognized by T cells, while retaining binding to alpha 4 integrins. Collectively, our integrated analysis identifies the basis of T-B collaboration that leads to ADA-mediated therapeutic resistance and delineates an approach to design novel deimmunized antibodies for autoimmune disease and cancer treatment.	[Cassotta, Antonino; Silacci-Fregni, Chiara; Rodriguez, Blanca Fernandez; Giacchetto-Sasselli, Isabella; Foglierini, Mathilde; Jarrossay, David; Geiger, Roger; Sallusto, Federica; Lanzavecchia, Antonio; Piccoli, Luca] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Cassotta, Antonino; Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Mikol, Vincent; Bertrand, Thomas; Pouzieux, Stephanie; Le Parc, Josiane; Ferrari, Paul; Dumas, Jacques] Sanofi R&D, Res Platform, Vitry Sur Seine, France; [Auer, Michael; Deisenhammer, Florian] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Gastaldi, Matteo; Franciotta, Diego] IRCCS Mondino Fdn, Lab Neuroimmunol, Pavia, Italy; [Foglierini, Mathilde] Swiss Inst Bioinformat, Lausanne, Switzerland	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Sanofi-Aventis; Sanofi France; Medical University of Innsbruck; IRCCS Fondazione Casimiro Mondino; Swiss Institute of Bioinformatics	Piccoli, L (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland.	luca.piccoli@irb.usi.ch	Franciotta, Diego/K-8262-2016; Franciotta, Diego/ABE-0957-2022; Cassotta, Antonino/AAW-2529-2021; Gastaldi, Matteo/K-8398-2016	Franciotta, Diego/0000-0002-3014-3913; Franciotta, Diego/0000-0002-3014-3913; Cassotta, Antonino/0000-0001-8674-4294; BERTRAND, Thomas/0000-0002-9188-6673; Foglierini, Mathilde/0000-0001-7538-4262; Geiger, Roger/0000-0002-8016-1669	Swiss National Science Foundation [176165]; Innovative Medicines Initiative Joint Undertaking ABIRISK [115303]; European Union; EFPIA Companies; Helmut Horten Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Innovative Medicines Initiative Joint Undertaking ABIRISK; European Union(European Commission); EFPIA Companies; Helmut Horten Foundation	The authors would like to thank the patients for their participation in the study. We would like to thank M. Nussenzweig (Rockefeller University) for providing reagents for antibody cloning and expression, and Servizio Tipizzazione of the IRCCS San Matteo Hospital Foundation, Pavia, Italy, for HLA typing. This work was supported by the Swiss National Science Foundation (grant no. 176165 to A.L.) and by the Innovative Medicines Initiative Joint Undertaking ABIRISK (Anti -Biopharmaceutical Immunization: Prediction and analysis of clinical relevance to minimize the risk) project under grant agreement no. 115303, resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and EFPIA Companies. A.L. and F.S. are supported by the Helmut Horten Foundation.	Bachelet D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162752; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bricogne G., 2017, BUSTER VERSION 2 10; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Chataway J, 2013, NEUROTHERAPEUTICS, V10, P19, DOI 10.1007/s13311-012-0171-4; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; de la Hera B, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000047; Dunn N, 2018, MULT SCLER J, V24, P1224, DOI 10.1177/1352458517720044; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hamze M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00500; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Jensen PEH, 2019, J NEUROIMMUNOL, V326, P19, DOI 10.1016/j.jneuroim.2018.11.002; Latorre D, 2018, NATURE, V562, P63, DOI 10.1038/s41586-018-0540-1; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li H, 2018, CURR DRUG METAB, V19, P1213, DOI 10.2174/1389200219666180427165841; Link J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170395; Murdaca G, 2016, EXPERT OPIN DRUG SAF, V15, P43, DOI 10.1517/14740338.2016.1112375; PAN Y, 1995, FASEB J, V9, P43, DOI 10.1096/fasebj.9.1.7821758; Paul S, 2015, J IMMUNOL METHODS, V422, P28, DOI 10.1016/j.jim.2015.03.022; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Quistrebert J, 2019, SEMIN ARTHRITIS RHEU, V48, P967, DOI 10.1016/j.semarthrit.2018.10.006; Rup B, 2015, CLIN EXP IMMUNOL, V181, P385, DOI 10.1111/cei.12652; SPITS H, 1983, HYBRIDOMA, V2, P423, DOI 10.1089/hyb.1983.2.423; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Schie KA, 2017, J ALLERGY CLIN IMMUN, V139, P1035, DOI 10.1016/j.jaci.2016.09.014; WATSON AJ, 1983, NATURE, V304, P358, DOI 10.1038/304358a0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457; Yu YM, 2013, J BIOL CHEM, V288, P32314, DOI 10.1074/jbc.M113.501668; Zare N, 2013, J KOREAN MED SCI, V28, P1801, DOI 10.3346/jkms.2013.28.12.1801	34	29	31	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1402	+		10.1038/s41591-019-0568-2	http://dx.doi.org/10.1038/s41591-019-0568-2			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501610	Green Accepted			2022-12-27	WOS:000484832800023
J	Ghorashian, S; Kramer, AM; Onuoha, S; Wright, G; Bartram, J; Richardson, R; Albon, SJ; Casanovas-Company, J; Castro, F; Popova, B; Villanueva, K; Yeung, J; Vetharoy, W; Guvenel, A; Wawrzyniecka, PA; Mekkaoui, L; Cheung, GWK; Pinner, D; Chu, J; Lucchini, G; Silva, J; Ciocarlie, O; Lazareva, A; Inglott, S; Gilmour, KC; Ahsan, G; Ferrari, M; Manzoor, S; Champion, K; Brooks, T; Lopes, A; Hackshaw, A; Farzaneh, F; Chiesa, R; Rao, K; Bonney, D; Samarasinghe, S; Goulden, N; Vora, A; Veys, P; Hough, R; Wynn, R; Pule, MA; Amrolia, PJ				Ghorashian, Sara; Kramer, Anne Marijn; Onuoha, Shimobi; Wright, Gary; Bartram, Jack; Richardson, Rachel; Albon, Sarah J.; Casanovas-Company, Joan; Castro, Fernanda; Popova, Bilyana; Villanueva, Krystle; Yeung, Jenny; Vetharoy, Winston; Guvenel, Aleks; Wawrzyniecka, Patrycja A.; Mekkaoui, Leila; Cheung, Gordon Weng-Kit; Pinner, Danielle; Chu, Jan; Lucchini, Giovanna; Silva, Juliana; Ciocarlie, Oana; Lazareva, Arina; Inglott, Sarah; Gilmour, Kimberly C.; Ahsan, Gulrukh; Ferrari, Mathieu; Manzoor, Somayya; Champion, Kim; Brooks, Tony; Lopes, Andre; Hackshaw, Allan; Farzaneh, Farzin; Chiesa, Robert; Rao, Kanchan; Bonney, Denise; Samarasinghe, Sujith; Goulden, Nicholas; Vora, Ajay; Veys, Paul; Hough, Rachael; Wynn, Robert; Pule, Martin A.; Amrolia, Persis J.			Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR	NATURE MEDICINE			English	Article								Chimeric antigen receptor (CAR)-modified T cells targeting CD19 demonstrate unparalleled responses in relapsed/refractory acute lymphoblastic leukemia (ALL)(1-5), but toxicity, including cytokine-release syndrome (CRS) and neurotoxicity, limits broader application. Moreover, 40-60% of patients relapse owing to poor CAR T cell persistence or emergence of CD19(-) clones. Some factors, including the choice of single-chain spacer(6) and extracellular(7) and costimulatory domains(8), have a profound effect on CAR T cell function and persistence. However, little is known about the impact of CAR binding affinity. There is evidence of a ceiling above which increased immunoreceptor affinity may adversely affect T cell responses(9-11). We generated a novel CD19 CAR (CAT) with a lower affinity than FMC63, the high-affinity binder used in many clinical studies(1-4). CAT CAR T cells showed increased proliferation and cytotoxicity in vitro and had enhanced proliferative and in vivo antitumor activity compared with FMC63 CAR T cells. In a clinical study (CARPALL, NCT02443831), 12/14 patients with relapsed/refractory pediatric B cell acute lymphoblastic leukemia treated with CAT CAR T cells achieved molecular remission. Persistence was demonstrated in 11 of 14 patients at last follow-up, with enhanced CAR T cell expansion compared with published data. Toxicity was low, with no severe CRS. One-year overall and event-free survival were 63% and 46%, respectively.	[Ghorashian, Sara; Kramer, Anne Marijn; Richardson, Rachel; Albon, Sarah J.; Casanovas-Company, Joan; Yeung, Jenny; Vetharoy, Winston; Guvenel, Aleks; Amrolia, Persis J.] UCL, Great Ormond St Inst Child Hlth, Mol & Cellular Immunol Sect, London, England; [Onuoha, Shimobi; Mekkaoui, Leila; Ferrari, Mathieu; Manzoor, Somayya] Autolus Ltd, London, England; [Wright, Gary; Bartram, Jack; Pinner, Danielle; Chu, Jan; Lucchini, Giovanna; Silva, Juliana; Ciocarlie, Oana; Lazareva, Arina; Inglott, Sarah; Chiesa, Robert; Rao, Kanchan; Samarasinghe, Sujith; Goulden, Nicholas; Vora, Ajay; Veys, Paul; Amrolia, Persis J.] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London, England; [Wright, Gary; Bartram, Jack; Pinner, Danielle; Chu, Jan; Lucchini, Giovanna; Silva, Juliana; Ciocarlie, Oana; Lazareva, Arina; Inglott, Sarah; Chiesa, Robert; Rao, Kanchan; Samarasinghe, Sujith; Goulden, Nicholas; Vora, Ajay; Veys, Paul; Amrolia, Persis J.] Great Ormond St Hosp Sick Children, Dept Haematol, London, England; [Castro, Fernanda; Popova, Bilyana; Villanueva, Krystle; Champion, Kim; Lopes, Andre; Hackshaw, Allan] Canc Res UK, London, England; [Castro, Fernanda; Popova, Bilyana; Villanueva, Krystle; Champion, Kim; Lopes, Andre; Hackshaw, Allan] UCL, Canc Trials Ctr, London, England; [Wawrzyniecka, Patrycja A.; Cheung, Gordon Weng-Kit; Pule, Martin A.] UCL, Inst Canc, London, England; [Gilmour, Kimberly C.; Ahsan, Gulrukh] Great Ormond St Hosp Sick Children, Cell Therapy & Immunol Labs, London, England; [Brooks, Tony] UCL, Genom, London, England; [Farzaneh, Farzin] Kings Coll London, Dept Haematol Med, London, England; [Bonney, Denise; Wynn, Robert] Royal Manchester Childrens Hosp, Dept Blood & Marrow Transplant, Manchester, Lancs, England; [Hough, Rachael] Univ Coll London Hosp NHS Trust, Dept Haematol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; King's College London; Royal Manchester Children's Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London	Amrolia, PJ (corresponding author), UCL, Great Ormond St Inst Child Hlth, Mol & Cellular Immunol Sect, London, England.; Amrolia, PJ (corresponding author), Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London, England.	Persis.Amrolia@gosh.nhs.uk	; Kramer, Anne Marijn/G-3128-2014	Yeung, Jenny/0000-0002-1452-1056; Pule, Martin/0000-0002-8347-9867; Lopes, Andre/0000-0002-1405-7337; Manzoor, Somayya/0000-0002-4188-8232; Bartram, Jack/0000-0003-1573-2506; Mekkaoui, Leila/0000-0001-8640-840X; Ferrari, Mathieu/0000-0001-8535-7348; Kramer, Anne Marijn/0000-0001-5239-7343	Children with Cancer UK; Great Ormond St Children's Charity; JP Moulton Foundation; National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospital; King's Health Partners; University College London; NIHR [514413]; GOSH-CC [543539]; Stylian Petrov Foundation; UK National Institute of Health Research University College London Hospital Biomedical Research Centre; CRUK [C604/A25135]; Experimental Cancer Medicine Centre [C30122/A25150]; NIHR Biomedical Research Centres (BRC) based at King's Health Partners; JP Moulton Foundation [522356]; European Union FP7 consortium ATECT [602239]	Children with Cancer UK; Great Ormond St Children's Charity; JP Moulton Foundation; National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospital; King's Health Partners; University College London(General Electric); NIHR(National Institute for Health Research (NIHR)); GOSH-CC; Stylian Petrov Foundation; UK National Institute of Health Research University College London Hospital Biomedical Research Centre; CRUK(Cancer Research UK); Experimental Cancer Medicine Centre; NIHR Biomedical Research Centres (BRC) based at King's Health Partners; JP Moulton Foundation; European Union FP7 consortium ATECT	This work was supported by Children with Cancer UK, Great Ormond St Children's Charity, the JP Moulton Foundation and the National Institute for Health Research Biomedical Research Centres at Great Ormond Street Hospital for Children NHS Foundation Trust, University College London Hospital, and King's Health Partners, as well as University College London. P.J.A. is a recipient of an NIHR Research Professorship, which also supported S.G. (grant code 514413). R.R. was supported by GOSH-CC (grant code 543539). F.C. was supported by the Stylian Petrov Foundation. M.P. is supported by the UK National Institute of Health Research University College London Hospital Biomedical Research Centre. F.F:s group at King's is supported by CRUK (grant code C604/A25135), the Experimental Cancer Medicine Centre (grant code C30122/A25150), and the NIHR Biomedical Research Centres (BRC) based at King's Health Partners. The work carried out by S.G., A-M.K., A.R., S.J.A., J.C-C., F.C., B.P., K.V., J.Y., W.V., A.G., K.C., T.B., A.L. and A.H. was supported by Children with Cancer UK, Great Ormond St Children's Charity and the JP Moulton Foundation (grant code 522356). P.W., L.M. and G.W-K.C. were supported by the European Union FP7 consortium ATECT (grant code 602239). We thank M. Brenner, J. Moppett and W. Qian for providing oversight of the study as the Independent Data Monitoring Committee, W Qasim for technical support in GMP CAR T cell manufacture and M. Al-hajj and L. Stanczuk for multiplex cytokine analysis.	Almasbak H, 2015, GENE THER, V22, P391, DOI 10.1038/gt.2015.4; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Lugthart G, 2012, J IMMUNOTHER, V35, P42, DOI 10.1097/CJI.0b013e31823569e2; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ricciardelli I, 2014, BLOOD, V124, P2514, DOI 10.1182/blood-2014-01-553362; ZOLA H, 1991, IMMUNOL CELL BIOL, V69, P411, DOI 10.1038/icb.1991.58	9	245	254	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1408	+		10.1038/s41591-019-0549-5	http://dx.doi.org/10.1038/s41591-019-0549-5			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31477906	Green Submitted			2022-12-27	WOS:000484832800024
J	Rio, P; Navarro, S; Wang, W; Sanchez-Dominguez, R; Pujol, RM; Segovia, JC; Bogliolo, M; Merino, E; Wu, N; Salgado, R; Lamana, ML; Yanez, RM; Casado, JA; Gimenez, Y; Roman-Rodriguez, FJ; Alvarez, L; Alberquilla, O; Raimbault, A; Guenechea, G; Lozano, ML; Cerrato, L; Hernando, M; Galvez, E; Hladun, R; Giralt, I; Barquinero, J; Galy, A; de Andoin, NG; Lopez, R; Catala, A; Schwartz, JD; Surralles, J; Soulier, J; Schmidt, M; de Heredia, CD; Sevilla, J; Bueren, JA				Rio, Paula; Navarro, Susana; Wang, Wei; Sanchez-Dominguez, Rebeca; Pujol, Roser M.; Segovia, Jose C.; Bogliolo, Massimo; Merino, Eva; Wu, Ning; Salgado, Rocio; Lamana, Maria L.; Yanez, Rosa M.; Casado, Jose A.; Gimenez, Yari; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Alberquilla, Omaira; Raimbault, Anna; Guenechea, Guillermo; Luz Lozano, M.; Cerrato, Laura; Hernando, Miriam; Galvez, Eva; Hladun, Raquel; Giralt, Irina; Barquinero, Jordi; Galy, Anne; Garcia de Andoin, Nagore; Lopez, Ricardo; Catala, Albert; Schwartz, Jonathan D.; Surralles, Jordi; Soulier, Jean; Schmidt, Manfred; Diaz de Heredia, Cristina; Sevilla, Julian; Bueren, Juan A.			Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia	NATURE MEDICINE			English	Article							BONE-MARROW FAILURE; PHENOTYPIC CORRECTION; CD34(+) CELLS; THERAPY; INTEGRATION; COLLECTION; MOSAICISM; VECTOR; PCR	Fanconi anemia (FA) is a DNA repair syndrome generated by mutations in any of the 22 FA genes discovered to date(1,2). Mutations in FANCA account for more than 60% of FA cases worldwide(3,4). Clinically, FA is associated with congenital abnormalities and cancer predisposition. However, bone marrow failure is the primary pathological feature of FA that becomes evident in 70-80% of patients with FA during the first decade of life(5,6). In this clinical study (ClinicalTrials. gov, NCT03157804; European Clinical Trials Database, 2011-006100-12), we demonstrate that lentiviral-mediated hematopoietic gene therapy reproducibly confers engraftment and proliferation advantages of gene-corrected hematopoietic stem cells (HSCs) in non-conditioned patients with FA subtype A. Insertion-site analyses revealed the multipotent nature of corrected HSCs and showed that the repopulation advantage of these cells was not due to genotoxic integrations of the therapeutic provirus. Phenotypic correction of blood and bone marrow cells was shown by the acquired resistance of hematopoietic progenitors and T lymphocytes to DNA cross-linking agents. Additionally, an arrest of bone marrow failure progression was observed in patients with the highest levels of gene marking. The progressive engraftment of corrected HSCs in non-conditioned patients with FA supports that gene therapy should constitute an innovative low-toxicity therapeutic option for this life-threatening disorder.	[Rio, Paula; Navarro, Susana; Sanchez-Dominguez, Rebeca; Segovia, Jose C.; Lamana, Maria L.; Yanez, Rosa M.; Casado, Jose A.; Gimenez, Yari; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Alberquilla, Omaira; Guenechea, Guillermo; Luz Lozano, M.; Cerrato, Laura; Hernando, Miriam; Bueren, Juan A.] Ctr Invest Energet Medioambientales & Tecnol, Hematopoiet Innovat Therapies Div, Madrid, Spain; [Rio, Paula; Navarro, Susana; Sanchez-Dominguez, Rebeca; Pujol, Roser M.; Segovia, Jose C.; Bogliolo, Massimo; Merino, Eva; Lamana, Maria L.; Yanez, Rosa M.; Casado, Jose A.; Gimenez, Yari; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Alberquilla, Omaira; Guenechea, Guillermo; Luz Lozano, M.; Cerrato, Laura; Hernando, Miriam; Galvez, Eva; Catala, Albert; Surralles, Jordi; Sevilla, Julian; Bueren, Juan A.] Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain; [Rio, Paula; Navarro, Susana; Sanchez-Dominguez, Rebeca; Segovia, Jose C.; Lamana, Maria L.; Yanez, Rosa M.; Casado, Jose A.; Gimenez, Yari; Roman-Rodriguez, Francisco J.; Alvarez, Lara; Alberquilla, Omaira; Guenechea, Guillermo; Luz Lozano, M.; Cerrato, Laura; Hernando, Miriam; Bueren, Juan A.] Fdn Jimenez Diaz, Inst Invest Sanitarias, Madrid, Spain; [Wang, Wei; Wu, Ning; Schmidt, Manfred] German Canc Res Ctr, Div Translat Oncol, Heidelberg, Germany; [Wang, Wei; Wu, Ning; Schmidt, Manfred] Natl Ctr Tumor Dis, Heidelberg, Germany; [Wang, Wei; Schmidt, Manfred] GeneWerk, Heidelberg, Germany; [Pujol, Roser M.; Bogliolo, Massimo; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Barcelona, Spain; [Pujol, Roser M.; Bogliolo, Massimo; Surralles, Jordi] Hosp Santa Creu & Sant Pau, Serv Genet, Barcelona, Spain; [Pujol, Roser M.; Bogliolo, Massimo; Surralles, Jordi] Hosp Santa Creu & Sant Pau, Inst Invest Biomed, Barcelona, Spain; [Merino, Eva; Galvez, Eva; Sevilla, Julian] Hosp Infantil Univ Nino Jesus, Fdn Invest Biomed, Serv Hematol & Oncol Pediat, Madrid, Spain; [Salgado, Rocio] Fdn Jimenez Diaz, Inst Invest Sanitarias, Hosp Univ Fdn Jimenez Diaz, Serv Hematol, Madrid, Spain; [Raimbault, Anna; Soulier, Jean] Univ Paris, IRSL, INSERM, CNRS, Paris, France; [Raimbault, Anna; Soulier, Jean] Hop St Louis, Paris, France; [Hladun, Raquel; Diaz de Heredia, Cristina] Hosp Univ Vall dHebron, Serv Oncol & Hematol Pediat, Barcelona, Spain; [Hladun, Raquel; Giralt, Irina; Barquinero, Jordi; Diaz de Heredia, Cristina] Vall dHebron Inst Recerca, Barcelona, Spain; [Galy, Anne] Genethon, Evry, France; [Garcia de Andoin, Nagore] Hosp Univ Donostia, San Sebastian, Spain; [Lopez, Ricardo] Cruces Univ Hosp, Pediat Oncol & Hematol Unit, Osakidetza Basque Hlth Serv, Baracaldo, Spain; [Catala, Albert] Hosp San Juan Dios, Serv Hematol & Oncol, Barcelona, Spain; [Schwartz, Jonathan D.] Rocket Pharma, New York, NY USA	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Fundacion Jimenez Diaz; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitario Cruces; University of Barcelona	Bueren, JA (corresponding author), Ctr Invest Energet Medioambientales & Tecnol, Hematopoiet Innovat Therapies Div, Madrid, Spain.; Bueren, JA (corresponding author), Ctr Invest Biomed Red Enfermedades Raras, Madrid, Spain.; Bueren, JA (corresponding author), Fdn Jimenez Diaz, Inst Invest Sanitarias, Madrid, Spain.	juan.bueren@ciemat.es	Yanez, Rosa M/Q-8877-2017; Navarro, Susana/L-9300-2014; Segovia, Jose Carlos/L-2922-2014; Guenechea, Guillermo/L-6119-2014; Rio, Paula/G-8681-2015; Sanchez, Rebeca/L-7138-2014; Surrallés, Jordi/AAE-7667-2020; Bueren, Juan/L-6112-2014; Barquinero, Jordi/F-6979-2011; Sevilla, Julian/L-9270-2014; Sanchez, Rebeca/GXH-6596-2022; Alberquilla, Omaira/L-7107-2014; Roman, Francisco J/H-5861-2015; Casado, Jose A/H-5077-2015; Diaz de Heredia, Cristina/G-4016-2016; GALY, Anne/J-4439-2013	Yanez, Rosa M/0000-0003-0132-3402; Navarro, Susana/0000-0002-0764-5384; Segovia, Jose Carlos/0000-0003-4101-6124; Guenechea, Guillermo/0000-0001-7679-0895; Rio, Paula/0000-0002-5424-5543; Sanchez, Rebeca/0000-0002-2073-2810; Bueren, Juan/0000-0002-3228-7013; Barquinero, Jordi/0000-0002-1677-9851; Sevilla, Julian/0000-0002-6852-1860; Sanchez, Rebeca/0000-0002-2073-2810; CATALA, ALBERT/0000-0003-0133-1752; Bogliolo, Massimo/0000-0001-8240-7784; Lopez Almaraz, Ricardo/0000-0001-5521-9892; Alberquilla, Omaira/0000-0002-0301-8340; Alvarez Ramos, Lara/0000-0001-6170-2549; Giralt, Irina/0000-0002-9094-4325; Roman, Francisco J/0000-0002-9331-6770; Casado, Jose A/0000-0003-2479-1508; Diaz de Heredia, Cristina/0000-0001-8086-296X; GALY, Anne/0000-0002-0153-4392	European Commission [HEALTH -F5-2012-305421]; Ministerio de Sanidad, Servicios Sociales e Igualdad [EC11/060, EC11/550]; Ministerio de Economia, Comercio y Competitividad; Fondo Europeo de Desarrollo Regional [SAF2015-68073-R, RTI2018-097125-B-I00]; Fondo de Investigaciones Sanitarias at the Instituto de Salud Carlos III [RD12/0019/0023]; ERC [CEVAL-311660]; ICREA Academia;  [SAF2015-64152-R]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government); Ministerio de Economia, Comercio y Competitividad; Fondo Europeo de Desarrollo Regional(European Commission); Fondo de Investigaciones Sanitarias at the Instituto de Salud Carlos III; ERC(European Research Council (ERC)European Commission); ICREA Academia(ICREA); 	The authors thank F. Mavilio, A. Thrasher, C. Booth and M. Cavazzana for collaboration in the EUROFANCOLEN Consortium, and D. A. Williams, H. Hanenberg, J. Tolar, G. P. Rizzardi and G. Shah for helpful discussions. The authors also thank A. de la Cal for coordinating the delivery of BM and PB samples from patients with FA. The authors are also indebted to the patients with FA, their families and clinicians from the Fundacion Anemia de Fanconi. This work was supported by grants from the European Commission's Seventh Framework Program (HEALTH -F5-2012-305421 to the EUROFANCOLEN Consortium J.B., J.Surralles, C.D.H., J.Soulier, M.S., A.G. and J.Sevilla), Ministerio de Sanidad, Servicios Sociales e Igualdad (EC11/060 and EC11/550 to C.D.H., J.Sevilla, J.B. and J.Surralles), Ministerio de Economia, Comercio y Competitividad and Fondo Europeo de Desarrollo Regional (SAF2015-68073-R and RTI2018-097125-B-I00 to P.R. and G.G.) and Fondo de Investigaciones Sanitarias at the Instituto de Salud Carlos III (RD12/0019/0023 to J.C.S.). The authors also thank the Fundacion Botin for promoting translational research at the Hematopoietic Innovative Therapies division of the CIEMAT. CIBERER is an initiative of the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional. J.Soulier is supported by the ERC Candidator grant CEVAL-311660, and J.Surralles is supported by ICREA Academia and SAF2015-64152-R.	Adair JE, 2016, CURR GENE THER, V16, P338, DOI 10.2174/1566523217666170119113029; Afzal S, 2017, MOL THER-NUCL ACIDS, V6, P133, DOI 10.1016/j.omtn.2016.12.001; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Alter BP, 2018, HAEMATOLOGICA, V103, P30, DOI 10.3324/haematol.2017.178111; Bagby Grover, 2018, F1000Res, V7, P105, DOI 10.12688/f1000research.13213.1; Battaile KP, 1999, BLOOD, V94, P2151; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Castella M, 2011, J MED GENET, V48, P242, DOI 10.1136/jmg.2010.084210; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Charrier S, 2011, GENE THER, V18, P479, DOI 10.1038/gt.2010.163; Croop JM, 2001, BLOOD, V98, P2917, DOI 10.1182/blood.V98.10.2917; Eichler F, 2017, NEW ENGL J MED, V377, P1630, DOI 10.1056/NEJMoa1700554; Gabriel R, 2009, NAT MED, V15, P1431, DOI 10.1038/nm.2057; Galimi F, 2002, BLOOD, V100, P2732, DOI 10.1182/blood-2002-04-1245; Gonzalez-Murillo A, 2010, HUM GENE THER, V21, P623, DOI 10.1089/hum.2009.141; Gross M, 2002, CYTOGENET GENOME RES, V98, P126, DOI 10.1159/000069805; Gush KA, 2000, BLOOD, V95, P700, DOI 10.1182/blood.V95.2.700; Hamanoue S, 2006, BRIT J HAEMATOL, V132, P630, DOI 10.1111/j.1365-2141.2005.05916.x; Haneline LS, 2003, BLOOD, V101, P1299, DOI 10.1182/blood-2002-08-2404; Molina-Estevez FJ, 2015, CURR GENE THER, V15, P550, DOI 10.2174/1566523215666150929110903; Kelly PF, 2007, MOL THER, V15, P211, DOI 10.1038/sj.mt.6300033; Knies K, 2017, J CLIN INVEST, V127, P3013, DOI 10.1172/JCI92069; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liu JM, 1999, HUM GENE THER, V10, P2337, DOI 10.1089/10430349950016988; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mankad A, 2006, BLOOD, V107, P3084, DOI 10.1182/blood-2005-07-2638; Masserot C, 2008, CANCER-AM CANCER SOC, V113, P3315, DOI 10.1002/cncr.23954; Meyer S, 2012, ANEMIA, V2012, DOI 10.1155/2012/349837; Muller LUW, 2008, MOL THER, V16, P1154, DOI 10.1038/mt.2008.67; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Quentin S, 2011, BLOOD, V117, pE161, DOI 10.1182/blood-2010-09-308726; Rio P, 2002, BLOOD, V100, P2032; Rio P, 2017, BLOOD, V130, P1535, DOI 10.1182/blood-2017-03-774174; Soulier J, 2005, BLOOD, V105, P1329, DOI 10.1182/blood-2004-05-1852; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342	40	69	70	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1396	+		10.1038/s41591-019-0550-z	http://dx.doi.org/10.1038/s41591-019-0550-z			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501599				2022-12-27	WOS:000484832800022
J	Stower, H				Stower, Hannah			An unexpected response	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1189	1189		10.1038/s41591-019-0551-y	http://dx.doi.org/10.1038/s41591-019-0551-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388176	Bronze			2022-12-27	WOS:000480414600007
J	Anhe, FF; Schertzer, JD; Marette, A				Anhe, Fernando F.; Schertzer, Jonathan D.; Marette, Andre			Bacteria to alleviate metabolic syndrome	NATURE MEDICINE			English	Editorial Material							MICROBIOTA; OBESITY; GUT	Heat-inactivated Akkermansia muciniphila helps alleviate features of metabolic syndrome in overweight and obese subjects.	[Anhe, Fernando F.; Schertzer, Jonathan D.] McMaster Univ, Dept Biochem & Biomed Sci, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Anhe, Fernando F.; Schertzer, Jonathan D.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Marette, Andre] Laval Univ, Fac Med, Dept Med, Cardiol Axis Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada	McMaster University; McMaster University; Laval University; Quebec Heart & Lung Institute; Laval University	Marette, A (corresponding author), Laval Univ, Fac Med, Dept Med, Cardiol Axis Quebec Heart & Lung Inst, Quebec City, PQ, Canada.; Marette, A (corresponding author), Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada.	andre.marette@criucpq.ulaval.ca	Anhê, Fernando Forato/ABD-3859-2020; Schertzer, Jonathan/P-3395-2017	Marette, Andre/0000-0003-3950-5973; Forato Anhe, Fernando/0000-0003-1543-4154; Schertzer, Jonathan/0000-0002-1547-5856				Anhe FF, 2017, CAN J DIABETES, V41, P439, DOI 10.1016/j.jcjd.2017.02.002; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Cavallari JF, 2017, CELL METAB, V25, P1063, DOI 10.1016/j.cmet.2017.03.021; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Gu YQ, 2018, DIABETES RES CLIN PR, V141, P140, DOI 10.1016/j.diabres.2018.04.041; Kootte RS, 2017, CELL METAB, V26, P611, DOI 10.1016/j.cmet.2017.09.008; McPhee JB, 2015, CLIN SCI, V129, P1083, DOI 10.1042/CS20150431; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Sakai T, 2013, J NUTR SCI VITAMINOL, V59, P144, DOI 10.3177/jnsv.59.144; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839	12	13	14	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1031	1033		10.1038/s41591-019-0516-1	http://dx.doi.org/10.1038/s41591-019-0516-1			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31263287				2022-12-27	WOS:000474430400012
J	Stower, H				Stower, Hannah			Translating thoughts into speech	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					877	877		10.1038/s41591-019-0488-1	http://dx.doi.org/10.1038/s41591-019-0488-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171874	Bronze			2022-12-27	WOS:000470844400009
J	Stower, H				Stower, Hannah			Rapid neonatal diagnosis	NATURE MEDICINE			English	Editorial Material																			0	0	0	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					877	877		10.1038/s41591-019-0487-2	http://dx.doi.org/10.1038/s41591-019-0487-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171871	Bronze			2022-12-27	WOS:000470844400010
J	Sun, LL; Clarke, R; Bennett, D; Guo, Y; Walters, RG; Hill, M; Parish, S; Millwood, IY; Bian, Z; Chen, YP; Yu, CQ; Lv, J; Collins, R; Chen, JS; Peto, R; Li, LM; Chen, ZM; Avery, D; Bennett, D; Boxall, R; Bragg, F; Chang, YM; Chen, YP; Clarke, R; Du, HD; Gilbert, S; Hacker, A; Holmes, M; Kartsonaki, C; Kerosi, R; Lancaster, G; Lin, K; McDonnell, J; Millwood, I; Nie, QH; Radhakrishnan, J; Ryder, P; Sansome, S; Schmidt, D; Sohoni, R; Turnbull, I; Wang, J; Wang, L; Wright, N; Yang, L; Yang, XM; Bian, Z; Guo, Y; Han, X; Hou, C; Jing, B; Liu, C; Lv, J; Pei, P; Tan, YL; Yu, CQ; Pang, ZC; Gao, RQ; Li, SP; Wang, SJ; Liu, YM; Du, RR; Zang, YJ; Cheng, L; Tian, XC; Zhang, H; Zhai, YM; Ning, F; Sun, XH; Li, FF; Lv, SL; Wang, JZ; Hou, W; Zeng, MY; Jiang, G; Zhou, X; Yang, LQ; He, H; Yu, B; Li, YJ; Xu, QN; Kang, Q; Guo, ZY; Wang, D; Hu, XM; Wang, HM; Chen, JY; Fu, Y; Fu, ZW; Wang, XH; Weng, M; Guo, ZD; Wu, SK; Li, YL; Li, HM; Fu, ZF; Wu, M; Zhou, YL; Zhou, JY; Tao, R; Yang, J; Su, J; Liu, F; Zhang, J; Hu, YH; Lu, Y; Ma, LC; Tang, AY; Zhang, S; Jin, JR; Liu, JC; Tang, ZZ; Chen, NY; Huang, Y; Li, MQ; Meng, JH; Pan, R; Jiang, QL; Lan, J; Liu, Y; Wei, LP; Zhou, LY; Chen, NY; Wang, P; Meng, FW; Qin, YL; Wang, SS; Wu, XP; Zhang, NM; Chen, XF; Zhou, WW; Luo, GJ; Li, JG; Chen, XF; Zhong, XF; Liu, JQ; Sun, Q; Ge, PF; Ren, XL; Dong, CX; Zhang, H; Mao, EK; Wang, XP; Wang, T; Zhang, X; Zhang, D; Zhou, G; Feng, SX; Chang, L; Fan, L; Gao, YL; He, TY; Sun, HR; He, P; Hu, C; Zhang, XK; Wu, HF; Yu, M; Hu, RY; Wang, H; Qian, YJ; Wang, CM; Xie, KX; Chen, LL; Zhang, YD; Pan, DX; Gu, QJ; Huang, YL; Chen, BY; Yin, L; Liu, HL; Fu, ZX; Xu, QH; Xu, X; Zhang, H; Long, HJ; Li, XZ; Zhang, LB; Qiu, Z				Sun, Luanluan; Clarke, Robert; Bennett, Derrick; Guo, Yu; Walters, Robin G.; Hill, Michael; Parish, Sarah; Millwood, Iona Y.; Bian, Zheng; Chen, Yiping; Yu, Canqing; Lv, Jun; Collins, Rory; Chen, Junshi; Peto, Richard; Li, Liming; Chen, Zhengming; Avery, Daniel; Bennett, Derrick; Boxall, Ruth; Bragg, Fiona; Chang, Yumei; Chen, Yiping; Clarke, Robert; Du, Huaidong; Gilbert, Simon; Hacker, Alex; Holmes, Michael; Kartsonaki, Christiana; Kerosi, Rene; Lancaster, Garry; Lin, Kuang; McDonnell, John; Millwood, Iona; Nie, Qunhua; Radhakrishnan, Jayakrishnan; Ryder, Paul; Sansome, Sam; Schmidt, Dan; Sohoni, Rajani; Turnbull, Iain; Wang, Jenny; Wang, Lin; Wright, Neil; Yang, Ling; Yang, Xiaoming; Bian, Zheng; Guo, Yu; Han, Xiao; Hou, Can; Jing, Biao; Liu, Chao; Lv, Jun; Pei, Pei; Tan, Yunlong; Yu, Canqing; Pang, Zengchang; Gao, Ruqin; Li, Shanpeng; Wang, Shaojie; Liu, Yongmei; Du, Ranran; Zang, Yajing; Cheng, Liang; Tian, Xiaocao; Zhang, Hua; Zhai, Yaoming; Ning, Feng; Sun, Xiaohui; Li, Feifei; Lv, Silu; Wang, Junzheng; Hou, Wei; Zeng, Mingyuan; Jiang, Ge; Zhou, Xue; Yang, Liqiu; He, Hui; Yu, Bo; Li, Yanjie; Xu, Qinai; Kang, Quan; Guo, Ziyan; Wang, Dan; Hu, Ximin; Wang, Hongmei; Chen, Jinyan; Fu, Yan; Fu, Zhenwang; Wang, Xiaohuan; Weng, Min; Guo, Zhendong; Wu, Shukuan; Li, Yilei; Li, Huimei; Fu, Zhifang; Wu, Ming; Zhou, Yonglin; Zhou, Jinyi; Tao, Ran; Yang, Jie; Su, Jian; Liu, Fang; Zhang, Jun; Hu, Yihe; Lu, Yan; Ma, Liangcai; Tang, Aiyu; Zhang, Shuo; Jin, Jianrong; Liu, Jingchao; Tang, Zhenzhu; Chen, Naying; Huang, Ying; Li, Mingqiang; Meng, Jinhuai; Pan, Rong; Jiang, Qilian; Lan, Jian; Liu, Yun; Wei, Liuping; Zhou, Liyuan; Chen, Ningyu; Wang, Ping; Meng, Fanwen; Qin, Yulu; Wang, Sisi; Wu, Xianping; Zhang, Ningmei; Chen, Xiaofang; Zhou, Weiwei; Luo, Guojin; Li, Jianguo; Chen, Xiaofang; Zhong, Xunfu; Liu, Jiaqiu; Sun, Qiang; Ge, Pengfei; Ren, Xiaolan; Dong, Caixia; Zhang, Hui; Mao, Enke; Wang, Xiaoping; Wang, Tao; Zhang, Xi; Zhang, Ding; Zhou, Gang; Feng, Shixian; Chang, Liang; Fan, Lei; Gao, Yulian; He, Tianyou; Sun, Huarong; He, Pan; Hu, Chen; Zhang, Xukui; Wu, Huifang; Yu, Min; Hu, Ruying; Wang, Hao; Qian, Yijian; Wang, Chunmei; Xie, Kaixu; Chen, Lingli; Zhang, Yidan; Pan, Dongxia; Gu, Qijun; Huang, Yuelong; Chen, Biyun; Yin, Li; Liu, Huilin; Fu, Zhongxi; Xu, Qiaohua; Xu, Xin; Zhang, Hao; Long, Huajun; Li, Xianzhi; Zhang, Libo; Qiu, Zhe		China Kadoorie Biobank	Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults	NATURE MEDICINE			English	Article							CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LDL CHOLESTEROL; INDIVIDUAL DATA; MORTALITY; ATORVASTATIN; METAANALYSIS; PREVENTION	Stroke is the second leading cause of death worldwide and accounts for >2 million deaths annually in China(1,2). Ischemic stroke (IS) and intracerebral hemorrhage (ICH) account for an equal number of deaths in China, despite a fourfold greater incidence of IS1,2. Stroke incidence and ICH proportion are higher in China than in Western populations(3-5), despite having a lower mean low-density lipoprotein cholesterol (LDL-C) concentration. Observational studies reported weaker positive associations of LDL-C with IS than with coronary heart disease (CHD)(6,7), but LDL-C-lowering trials demonstrated similar risk reductions for IS and CHD8-10. Mendelian randomization studies of LDL-C and IS have reported conflicting results(11-13), and concerns about the excess risks of ICH associated with lowering LDL-C-14,C-15 may have prevented the more widespread use of statins in China. We examined the associations of biochemically measured lipids with stroke in a nested case-control study in the China Kadoorie Biobank (CKB) and compared the risks for both stroke types associated with equivalent differences in LDL-C in Mendelian randomization analyses. The results demonstrated positive associations of LDL-C with IS and equally strong inverse associations with ICH, which were confirmed by genetic analyses and LDL-C-lowering trials. Lowering LDL-C is still likely to have net benefit for the prevention of overall stroke and cardiovascular disease in China.	[Sun, Luanluan; Clarke, Robert; Bennett, Derrick; Collins, Rory; Peto, Richard; Chen, Zhengming; Avery, Daniel; Bennett, Derrick; Boxall, Ruth; Bragg, Fiona; Chang, Yumei; Chen, Yiping; Clarke, Robert; Du, Huaidong; Gilbert, Simon; Hacker, Alex; Holmes, Michael; Kartsonaki, Christiana; Kerosi, Rene; Lancaster, Garry; Lin, Kuang; McDonnell, John; Millwood, Iona; Nie, Qunhua; Radhakrishnan, Jayakrishnan; Ryder, Paul; Sansome, Sam; Schmidt, Dan; Sohoni, Rajani; Turnbull, Iain; Wang, Jenny; Wang, Lin; Wright, Neil; Yang, Ling; Yang, Xiaoming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Sun, Luanluan; Clarke, Robert; Bennett, Derrick; Collins, Rory; Peto, Richard; Chen, Zhengming; Avery, Daniel; Bennett, Derrick; Boxall, Ruth; Bragg, Fiona; Chang, Yumei; Chen, Yiping; Clarke, Robert; Du, Huaidong; Gilbert, Simon; Hacker, Alex; Holmes, Michael; Kartsonaki, Christiana; Kerosi, Rene; Lancaster, Garry; Lin, Kuang; McDonnell, John; Millwood, Iona; Nie, Qunhua; Radhakrishnan, Jayakrishnan; Ryder, Paul; Sansome, Sam; Schmidt, Dan; Sohoni, Rajani; Turnbull, Iain; Wang, Jenny; Wang, Lin; Wright, Neil; Yang, Ling; Yang, Xiaoming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Guo, Yu; Bian, Zheng; Bian, Zheng; Guo, Yu; Han, Xiao; Hou, Can; Jing, Biao; Liu, Chao; Pei, Pei; Tan, Yunlong] Chinese Acad Med Sci, Beijing, Peoples R China; [Walters, Robin G.; Hill, Michael; Parish, Sarah; Millwood, Iona Y.; Chen, Yiping] Univ Oxford, Nuffield Dept Populat Hlth, MRC Populat Hlth Res Unit, Oxford, England; [Yu, Canqing; Lv, Jun; Li, Liming; Lv, Jun; Yu, Canqing] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Chen, Junshi] China Natl Ctr Food Safety Risk Assessment, Beijing, Peoples R China; [Pang, Zengchang; Gao, Ruqin; Li, Shanpeng; Wang, Shaojie; Liu, Yongmei; Du, Ranran; Zang, Yajing; Cheng, Liang; Tian, Xiaocao; Zhang, Hua; Zhai, Yaoming; Ning, Feng; Sun, Xiaohui; Li, Feifei] Qingdao CDC, NCD Prevent & Control Dept, Qingdao, Shandong, Peoples R China; [Lv, Silu; Wang, Junzheng; Hou, Wei] Licang CDC, NCD Prevent & Control Dept, Qingdao, Shandong, Peoples R China; [Zeng, Mingyuan; Jiang, Ge; Zhou, Xue] Heilongjiang CDC, NCD Prevent & Control Dept, Harbin, Heilongjiang, Peoples R China; [Yang, Liqiu; He, Hui; Yu, Bo; Li, Yanjie; Xu, Qinai; Kang, Quan; Guo, Ziyan] Nangang CDC, NCD Prevent & Control Dept, Harbin, Heilongjiang, Peoples R China; [Wang, Dan; Hu, Ximin; Wang, Hongmei; Chen, Jinyan; Fu, Yan; Fu, Zhenwang; Wang, Xiaohuan] Hainan Prov CDC, NCD Prevent & Control Dept, Haikou, Hainan, Peoples R China; [Weng, Min; Guo, Zhendong; Wu, Shukuan; Li, Yilei; Li, Huimei; Fu, Zhifang] Meilan CDC, NCD Prevent & Control Dept, Haikou, Hainan, Peoples R China; [Wu, Ming; Zhou, Yonglin; Zhou, Jinyi; Tao, Ran; Yang, Jie; Su, Jian] Jiangsu Prov CDC, NCD Prevent & Control Dept, Nanjing, Jiangsu, Peoples R China; [Liu, Fang; Zhang, Jun; Hu, Yihe; Lu, Yan; Ma, Liangcai; Tang, Aiyu; Zhang, Shuo; Jin, Jianrong; Liu, Jingchao] Wuzhong CDC, NCD Prevent & Control Dept, Suzhou, Peoples R China; [Tang, Zhenzhu; Chen, Naying; Huang, Ying] Guangxi Prov CDC, NCD Prevent & Control Dept, Nanning, Peoples R China; [Li, Mingqiang; Meng, Jinhuai; Pan, Rong; Jiang, Qilian; Lan, Jian; Liu, Yun; Wei, Liuping; Zhou, Liyuan; Chen, Ningyu; Wang, Ping; Meng, Fanwen; Qin, Yulu; Wang, Sisi] Liuzhou CDC, NCD Prevent & Control Dept, Liubei, Liuzhou, Peoples R China; [Wu, Xianping; Zhang, Ningmei; Chen, Xiaofang; Zhou, Weiwei] Sichuan Prov CDC, NCD Prevent & Control Dept, Chengdu, Sichuan, Peoples R China; [Luo, Guojin; Li, Jianguo; Chen, Xiaofang; Zhong, Xunfu; Liu, Jiaqiu; Sun, Qiang] Pengzhou CDC, NCD Prevent & Control Dept, Chengdu, Sichuan, Peoples R China; [Ge, Pengfei; Ren, Xiaolan; Dong, Caixia] Gansu Prov CDC, NCD Prevent & Control Dept, Lanzhou, Gansu, Peoples R China; [Zhang, Hui; Mao, Enke; Wang, Xiaoping; Wang, Tao; Zhang, Xi] Maijixiang CDC, NCD Prevent & Control Dept, Maijixiang, Tianshui, Peoples R China; [Zhang, Ding; Zhou, Gang; Feng, Shixian; Chang, Liang; Fan, Lei] Henan Prov CDC, NCD Prevent & Control Dept, Zhengzhou, Henan, Peoples R China; [Gao, Yulian; He, Tianyou; Sun, Huarong; He, Pan; Hu, Chen; Zhang, Xukui; Wu, Huifang] Huixian CDC, NCD Prevent & Control Dept, Huixian, Peoples R China; [Yu, Min; Hu, Ruying; Wang, Hao] Zhejiang Prov CDC, NCD Prevent & Control Dept, Hangzhou, Zhejiang, Peoples R China; [Qian, Yijian; Wang, Chunmei; Xie, Kaixu; Chen, Lingli; Zhang, Yidan; Pan, Dongxia; Gu, Qijun] Tongxiang CDC, NCD Prevent & Control Dept, Tongxiang, Peoples R China; [Huang, Yuelong; Chen, Biyun; Yin, Li; Liu, Huilin; Fu, Zhongxi; Xu, Qiaohua] Hunan Prov CDC, NCD Prevent & Control Dept, Changsha, Hunan, Peoples R China; [Xu, Xin; Zhang, Hao; Long, Huajun; Li, Xianzhi; Zhang, Libo; Qiu, Zhe] Liuyang CDC, NCD Prevent & Control Dept, Liuyang, Peoples R China	University of Oxford; University of Oxford; Chinese Academy of Medical Sciences - Peking Union Medical College; University of Oxford; Peking University	Clarke, R; Chen, ZM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.; Clarke, R; Chen, ZM (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England.	robert.clarke@ndph.ox.ac.uk; zhengming.chen@ndph.ox.ac.uk	Ning, Feng/AAF-2042-2019; Collins, Rory/ABA-8487-2020; , Bennett/O-7998-2019; Walters, Robin G/E-6069-2010; Lv, Jun/O-4746-2019; Keskin, Kudret/AAB-8198-2019	Walters, Robin G/0000-0002-9179-0321; Lv, Jun/0000-0001-7916-3870; Keskin, Kudret/0000-0002-9049-1530; Bennett, Derrick/0000-0002-9170-8447; Du, Huaidong/0000-0002-9814-0049	Wellcome Trust [202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z]; National Natural Science Foundation of China [81390540, 81390541, 81390544]; National Key Research and Development Program of China [2016YFC0900500, 2016YFC0900501, 2016YFC0900504, 2016YFC1303904]; British Heart Foundation; UK Medical Research Council; Cancer Research UK; University of Oxford; Kadoorie Charitable Foundation, Hong Kong, China; MRC [MC_PC_13049, MC_U137686855, MC_U137686851, MC_UU_12026/2, MC_PC_14135] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); University of Oxford; Kadoorie Charitable Foundation, Hong Kong, China; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We wish to thank the participants, project staff, and staff of the China Center for Disease Control and its regional offices for access to death and disease registries. The Chinese National Health Insurance scheme provided electronic linkage to all hospitalization data. The CKB study is jointly coordinated by the University of Oxford and the Chinese Academy of Medical Sciences. The funding body for the baseline survey was the Kadoorie Charitable Foundation, Hong Kong, China. Z.C. was funded for the long-term continuation of the study by Wellcome Trust grants (nos. 202922/Z/16/Z, 104085/Z/14/Z, and 088158/Z/09/Z). L.L. was funded by the National Natural Science Foundation of China (grant nos. 81390540, 81390541, and 81390544) and the National Key Research and Development Program of China (grant nos. 2016YFC0900500, 2016YFC0900501, 2016YFC0900504, and 2016YFC1303904). Core funding was also provided to the Clinical Trial Service Unit, University of Oxford, by the British Heart Foundation, the UK Medical Research Council, and Cancer Research UK. L.S. received a Clarendon Scholarship from the University of Oxford. The funders played no role in the design or conduct of the study, including data collection, management, analysis, or interpretation of the results; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ebrahim S, 2006, BMJ-BRIT MED J, V333, P22, DOI 10.1136/bmj.38855.610324.80; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Hindy G, 2018, STROKE, V49, P820, DOI 10.1161/STROKEAHA.117.019653; HOPEWELL JC, 2012, CIRCULATION S, V126; Hopewell JC, 2018, EUR HEART J, V39, P354, DOI 10.1093/eurheartj/ehx373; Institute for Health Metrics and Evaluation, 2016, GLOBAL BURDEN DIS ST; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; KONISHI M, 1993, STROKE, V24, P954, DOI 10.1161/01.STR.24.7.954; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewington S, 2016, JAMA INTERN MED, V176, P524, DOI 10.1001/jamainternmed.2016.0190; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; MacKenzie JM, 1996, J CLIN PATHOL, V49, P360, DOI 10.1136/jcp.49.5.360; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; OONEDA G, 1978, BLOOD VESSELS, V15, P148; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; PETO R, 1983, CANCER SURV, V2, P327; Peto R, 2011, BRIT J CANCER, V104, P1057, DOI 10.1038/bjc.2011.79; Rao AS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002162; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Wald A, 1940, ANN MATH STAT, V11, P284, DOI 10.1214/aoms/1177731868; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6	48	119	130	11	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					569	+		10.1038/s41591-019-0366-x	http://dx.doi.org/10.1038/s41591-019-0366-x			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30858617	Green Submitted, Green Accepted			2022-12-27	WOS:000463342800017
J	Cloughesy, TF; Mochizuki, AY; Orpilla, JR; Hugo, W; Lee, AH; Davidson, TB; Wang, AC; Ellingson, BM; Rytlewski, JA; Sanders, CM; Kawaguchi, ES; Du, L; Li, G; Yong, WH; Gaffey, SC; Cohen,AL; Mellinghoff, IK; Lee, EQ; Reardon, DA; O'Brien, BJ; Butowski, NA; Nghiemphu, PL; Clarke, JL; Arrillaga-Romany, IC; Colman, H; Kaley, TJ; De Groot, JF; Liau, LM; Wen, PY; Prins, RM				Cloughesy, Timothy F.; Mochizuki, Aaron Y.; Orpilla, Joey R.; Hugo, Willy; Lee, Alexander H.; Davidson, Tom B.; Wang, Anthony C.; Ellingson, Benjamin M.; Rytlewski, Julie A.; Sanders, Catherine M.; Kawaguchi, Eric S.; Du, Lin; Li, Gang; Yong, William H.; Gaffey, Sarah C.; Cohen, Adam L.; Mellinghoff, Ingo K.; Lee, Eudocia Q.; Reardon, David A.; O'Brien, Barbara J.; Butowski, Nicholas A.; Nghiemphu, Phioanh L.; Clarke, Jennifer L.; Arrillaga-Romany, Isabel C.; Colman, Howard; Kaley, Thomas J.; De Groot, John F.; Liau, Linda M.; Wen, Patrick Y.; Prins, Robert M.			Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma	NATURE MEDICINE			English	Article							PROGRESSION-FREE SURVIVAL; CHECKPOINT BLOCKADE; PEMBROLIZUMAB; EXPRESSION; SAFETY; BEVACIZUMAB; NIVOLUMAB; INTERFERON; THERAPY; BRAIN	Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. The Ivy Foundation Early Phase Clinical Trials Consortium conducted a randomized, multi-institution clinical trial to evaluate immune responses and survival following neoadjuvant and/or adjuvant therapy with pembrolizumab in 35 patients with recurrent, surgically resectable glioblastoma. Patients who were randomized to receive neoadjuvant pembrolizumab, with continued adjuvant therapy following surgery, had significantly extended overall survival compared to patients that were randomized to receive adjuvant, post-surgical programmed cell death protein 1 (PD-1) blockade alone. Neoadjuvant PD-1 blockade was associated with upregulation of T cell-and interferon-gamma-related gene expression, but downregulation of cell-cycle-related gene expression within the tumor, which was not seen in patients that received adjuvant therapy alone. Focal induction of programmed death-ligand 1 in the tumor microenvironment, enhanced clonal expansion of T cells, decreased PD-1 expression on peripheral blood T cells and a decreasing monocytic population was observed more frequently in the neoadjuvant group than in patients treated only in the adjuvant setting. These findings suggest that the neoadjuvant administration of PD-1 blockade enhances both the local and systemic antitumor immune response and may represent a more efficacious approach to the treatment of this uniformly lethal brain tumor.	[Cloughesy, Timothy F.; Nghiemphu, Phioanh L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.; Lee, Alexander H.; Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.; Davidson, Tom B.; Ellingson, Benjamin M.; Li, Gang; Liau, Linda M.; Prins, Robert M.] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Mochizuki, Aaron Y.; Davidson, Tom B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Orpilla, Joey R.; Lee, Alexander H.; Wang, Anthony C.; Liau, Linda M.; Prins, Robert M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hugo, Willy] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Rytlewski, Julie A.; Sanders, Catherine M.] Adapt Biotechnol, Seattle, WA USA; [Kawaguchi, Eric S.; Du, Lin; Li, Gang] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Yong, William H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Gaffey, Sarah C.; Lee, Eudocia Q.; Reardon, David A.; Wen, Patrick Y.] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA; [Cohen, Adam L.; Colman, Howard] Univ Utah, Dept Neurosurg, Huntsman Canc Inst, Salt Lake City, UT USA; [Mellinghoff, Ingo K.; Kaley, Thomas J.] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [O'Brien, Barbara J.; De Groot, John F.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Butowski, Nicholas A.; Clarke, Jennifer L.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Arrillaga-Romany, Isabel C.] Massachusetts Gen Hosp, Dept Neurol, Canc Ctr, Boston, MA 02114 USA; [Prins, Robert M.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Dana-Farber Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital	Cloughesy, TF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.; Cloughesy, TF; Prins, RM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA.; Cloughesy, TF; Prins, RM (corresponding author), Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Prins, RM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.; Prins, RM (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.	tcloughesy@mednet.ucla.edu; rprins@mednet.ucla.edu	Wang, Anthony/GPP-5594-2022; Cloughesy, Timothy Francis/AGV-1013-2022; Rytlewski, Julie/O-6811-2019; Wang, Anthony/GSD-5456-2022; Prins, Robert/AAX-1155-2021; Wen, Patrick/AAE-3776-2022	Rytlewski, Julie/0000-0001-5244-6790; Lee, Alexander/0000-0002-4583-0740; Orpilla, Joey/0000-0002-6679-9463; Mochizuki, Aaron/0000-0003-1073-916X; Prins, Robert/0000-0002-6282-6583; Liau, Linda/0000-0002-4053-0052; Hugo, Willy/0000-0002-1426-7190; Reynoso, Jeremy G./0000-0002-4376-0101; Cloughesy, Timothy/0000-0002-8656-7483	National Institutes of Health SPORE in Brain Cancer [P50CA211015]; Parker Institute for Cancer Immunotherapy [20163828]; Cancer Research Institute; Musella Foundation; Ben and Catherine Ivy Foundation; Uncle Kory Foundation; Defeat GBM Program of the National Brain Tumor Society; Ziering Family Foundation; Merck Co., Inc.; Adaptive Biotechnologies; NATIONAL CANCER INSTITUTE [P50CA211015, R21CA186004, T32CA009120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Institutes of Health SPORE in Brain Cancer; Parker Institute for Cancer Immunotherapy; Cancer Research Institute; Musella Foundation; Ben and Catherine Ivy Foundation; Uncle Kory Foundation; Defeat GBM Program of the National Brain Tumor Society; Ziering Family Foundation; Merck Co., Inc.(Merck & Company); Adaptive Biotechnologies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded in part by the National Institutes of Health SPORE in Brain Cancer (grant no. P50CA211015), the Parker Institute for Cancer Immunotherapy (grant no. 20163828), the Cancer Research Institute, the Musella Foundation, the Ben and Catherine Ivy Foundation, the Uncle Kory Foundation, the Defeat GBM Program of the National Brain Tumor Society, the Ziering Family Foundation and by Merck & Co., Inc. Research and/or financial support was also provided by Adaptive Biotechnologies. The authors also thank A. Garcia, N. Akkad, M. Attiah, S. Khattab, J. Reynoso, M. Wong and M. Guemes for their contributions to the experiments. ImmunoSEQ assays are for research use only and not for use in diagnostic procedures.	Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antonios JP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87059; Antonios JP, 2017, NEURO-ONCOLOGY, V19, P796, DOI 10.1093/neuonc/now287; Arbour KC, 2018, J CLIN ONCOL, V36, P2872, DOI 10.1200/JCO.2018.79.0006; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Bloch O, 2013, CLIN CANCER RES, V19, P3165, DOI 10.1158/1078-0432.CCR-12-3314; Blumenthal DT, 2016, J NEURO-ONCOL, V129, P453, DOI 10.1007/s11060-016-2190-1; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Burki TK, 2015, LANCET ONCOL, V16, pE264, DOI 10.1016/S1470-2045(15)70193-2; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chen J, 2012, IMMUNOBIOLOGY, V217, P385, DOI 10.1016/j.imbio.2011.10.016; Clarke JL, 2011, NEURO-ONCOLOGY, V13, P1118, DOI 10.1093/neuonc/nor110; Daley T, 2013, NAT METHODS, V10, P325, DOI 10.1038/nmeth.2375; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; Ellingson BM, 2018, NEURO-ONCOLOGY, V20, P1411, DOI 10.1093/neuonc/noy054; Ellingson BM, 2018, NEURO-ONCOLOGY, V20, P1240, DOI 10.1093/neuonc/noy053; Ellingson BM, 2017, NEURO-ONCOLOGY, V19, P89, DOI 10.1093/neuonc/now187; Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095; Ellingson BM, 2014, RADIOLOGY, V271, P200, DOI 10.1148/radiol.13131305; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hamza MA, 2014, J NEURO-ONCOL, V119, P135, DOI 10.1007/s11060-014-1460-z; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Johanns TM, 2016, CANCER DISCOV, V6, P1230, DOI 10.1158/2159-8290.CD-16-0575; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; Li G, 2019, J AM STAT ASSOC, V114, P1815, DOI 10.1080/01621459.2018.1515079; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Okada Hideho, 2015, Lancet Oncol, V16, pe534, DOI 10.1016/S1470-2045(15)00088-1; Omuro A, 2018, NEURO-ONCOLOGY, V20, P674, DOI 10.1093/neuonc/nox208; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Pollack IF, 2014, J CLIN ONCOL, V32, P2050, DOI 10.1200/JCO.2013.54.0526; Prins RM, 2011, CLIN CANCER RES, V17, P1603, DOI 10.1158/1078-0432.CCR-10-2563; Reardon DA, 2016, CANCER IMMUNOL RES, V4, P124, DOI 10.1158/2326-6066.CIR-15-0151; Reardona DA, 2017, NEURO-ONCOLOGY, V19, P21, DOI 10.1093/neuonc/nox036.071; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Redman JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0571-0; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robert L, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29244; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; SHEARER M, 1987, CANCER METAST REV, V6, P199, DOI 10.1007/BF00144264; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Urup T, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3251-3; Wainwright DA, 2014, CLIN CANCER RES, V20, P5290, DOI 10.1158/1078-0432.CCR-14-0514; Weber JS, 2017, J CLIN ONCOL, V35, P785, DOI 10.1200/JCO.2015.66.1389; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wu WT, 2010, NEURO-ONCOLOGY, V12, P164, DOI 10.1093/neuonc/nop019; YUNG WKA, 1987, J NEURO-ONCOL, V5, P323; Zeng J, 2013, INT J RADIAT ONCOL, V86, P343, DOI 10.1016/j.ijrobp.2012.12.025; Zhao KY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r74	73	554	573	4	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					477	+		10.1038/s41591-018-0337-7	http://dx.doi.org/10.1038/s41591-018-0337-7			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30742122	Green Accepted, Green Submitted			2022-12-27	WOS:000460643100027
J	Stower, H				Stower, Hannah			Local immune monitoring	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					19	19		10.1038/s41591-018-0332-z	http://dx.doi.org/10.1038/s41591-018-0332-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617330	Bronze			2022-12-27	WOS:000455027700011
J	Sepulcre, J; Grothe, MJ; Uquillas, FD; Ortiz-Teran, L; Diez, I; Yang, HS; Jacobs, HIL; Hanseeuw, BJ; Li, QZ; El-Fakhri, G; Sperling, RA; Johnson, KA				Sepulcre, Jorge; Grothe, Michel J.; Uquillas, Federico d'Oleire; Ortiz-Teran, Laura; Diez, Ibai; Yang, Hyun-Sik; Jacobs, Heidi I. L.; Hanseeuw, Bernard J.; Li, Quanzheng; El-Fakhri, Georges; Sperling, Reisa A.; Johnson, Keith A.			Neurogenetic contributions to amyloid beta and tau spreading in the human cortex	NATURE MEDICINE			English	Article							ALZHEIMERS-DISEASE; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; CEREBRAL-CORTEX; MOUSE MODEL; PATHOLOGY; ATLAS; NEURODEGENERATION; VULNERABILITY; INDIVIDUALS	Tau and amyloid beta (A beta) proteins accumulate along neuronal circuits in Alzheimer's disease. Unraveling the genetic background for the regional vulnerability of these proteinopathies can help in understanding the mechanisms of pathology progression. To that end, we developed a novel graph theory approach and used it to investigate the intersection of longitudinal A beta and tau positron emission tomography imaging of healthy adult individuals and the genetic transcriptome of the Allen Human Brain Atlas. We identified distinctive pathways for tau and A beta accumulation, of which the tau pathways correlated with cognitive levels. We found that tau propagation and A beta propagation patterns were associated with a common genetic profile related to lipid metabolism, in which APOE played a central role, whereas the tau-specific genetic profile was classified as 'axon related' and the A beta profile as 'dendrite related'. This study reveals distinct genetic profiles that may confer vulnerability to tau and A beta in vivo propagation in the human brain.	[Sepulcre, Jorge; Ortiz-Teran, Laura; Diez, Ibai; Jacobs, Heidi I. L.; Hanseeuw, Bernard J.; Li, Quanzheng; El-Fakhri, Georges; Johnson, Keith A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Gordon Ctr Med Imaging, Boston, MA 02115 USA; [Sepulcre, Jorge; Hanseeuw, Bernard J.; Sperling, Reisa A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Grothe, Michel J.] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany; [Uquillas, Federico d'Oleire; Yang, Hyun-Sik; Sperling, Reisa A.; Johnson, Keith A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Diez, Ibai] Tecnalia Hlth Dept, Neurotechnol Lab, Derio, Spain; [Yang, Hyun-Sik; Sperling, Reisa A.; Johnson, Keith A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, Boston, MA USA; [Hanseeuw, Bernard J.] Univ Louvain, St Luc Univ Hosp, Inst Neurosci, Dept Neurol, Brussels, Belgium	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Sepulcre, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Gordon Ctr Med Imaging, Boston, MA 02115 USA.; Sepulcre, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	sepulcre@nmr.mgh.harvard.edu	Grothe, Michel J./S-7374-2018; Sepulcre, Jorge/ABE-6375-2020; Jacobs, Heidi/E-9550-2011; Hanseeuw, Bernard/J-8410-2014	Grothe, Michel J./0000-0003-2600-9022; Jacobs, Heidi/0000-0001-7620-3822; Hanseeuw, Bernard/0000-0002-3102-6778; d'Oleire Uquillas, Federico/0000-0001-9078-9452; Diez, Ibai/0000-0001-5769-0178	National Institutes of Health (NIH) [K23-EB019023, T32EB013180, R01HL137230, P41-EB022544, R01-AG027435-S1, P50-AG00513421, R01AG046396, P01-AG036694, RF1AG052653]; Massachusetts ADRC; Alzheimer's Association [NIRG-11-205690, IIRG-06-32444, ZEN-10-174210]; Alzheimer ForschungInitiative e.V.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB022544, K23EB019023, T32EB013180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027435, R01AG046396, P01AG036694, RF1AG052653] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts ADRC; Alzheimer's Association(Alzheimer's Association); Alzheimer ForschungInitiative e.V.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the investigators and staff of the Harvard Aging Brain Study, Massachusetts Alzheimer's Disease Research Center, the individual research participants, and their families and caregivers. We also thank the PET Core of the MGH, the Harvard Center for Brain Science Neuroimaging Core and the Athinoula A. Martinos Center for biomedical imaging support. This research was supported by grants from the National Institutes of Health (NIH) (K23-EB019023 to J.S.; T32EB013180 to L.O.-T.; R01HL137230 and P41-EB022544 to G.E.-F.; R01-AG027435-S1 to R.A.S. and K.A.J.; P50-AG00513421 and R01AG046396 to K.A.J. and R.A.S.; P01-AG036694 to R.A.S. and K.A.J.; and RF1AG052653 to Q.L.); Massachusetts ADRC; Alzheimer's Association (NIRG-11-205690 to J.S.; IIRG-06-32444 to R.A.S. and K.A.J.; and ZEN-10-174210 to K.A.J.); and the Alzheimer ForschungInitiative e.V. (to M.J.G.). The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.	Allen M, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt268; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beecham GW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004606; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Braak H, 2000, ANN NY ACAD SCI, V924, P53; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Chhatwal JP, 2016, NEUROLOGY, V87, P920, DOI 10.1212/WNL.0000000000003050; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Cho H, 2016, ANN NEUROL, V80, P247, DOI 10.1002/ana.24711; Dagley A, 2017, NEUROIMAGE, V144, P255, DOI 10.1016/j.neuroimage.2015.03.069; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7; Freer R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600947; French L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00323; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; Grothe MJ, 2017, NEUROLOGY, V89, P2031, DOI 10.1212/WNL.0000000000004643; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hanseeuw BJ, 2017, ANN NEUROL, V81, P583, DOI 10.1002/ana.24910; Hansson O, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00167; Hedden T, 2012, J NEUROSCI, V32, P16233, DOI 10.1523/JNEUROSCI.2462-12.2012; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Jacobs HIL, 2018, NAT NEUROSCI, V21, P424, DOI 10.1038/s41593-018-0070-z; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; KALUS P, 1989, BRAIN RES, V494, P198, DOI 10.1016/0006-8993(89)90164-9; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Marioni RE, 2017, J ALZHEIMERS DIS, V57, P275, DOI 10.3233/JAD-161070; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Meyer FG, 2014, APPL COMPUT HARMON A, V36, P326, DOI 10.1016/j.acha.2013.06.004; Mormino EC, 2017, ALZHEIMERS DEMENT, V13, P1004, DOI 10.1016/j.jalz.2017.01.018; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Roussotte FF, 2014, J NEUROSCI, V34, P6537, DOI 10.1523/JNEUROSCI.5236-13.2014; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sepulcre J, 2017, ALZHEIMERS DEMENT, V13, P1261, DOI 10.1016/j.jalz.2017.02.011; Sepulcre J, 2017, JAMA NEUROL, V74, P813, DOI 10.1001/jamaneurol.2017.0263; Sepulcre J, 2016, J NEUROSCI, V36, P7364, DOI 10.1523/JNEUROSCI.0639-16.2016; Sepulcre J, 2013, BRAIN, V136, P2239, DOI 10.1093/brain/awt146; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Theendakara V, 2016, J NEUROSCI, V36, P685, DOI 10.1523/JNEUROSCI.3562-15.2016; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Zhang F, 2008, PATTERN RECOGN, V41, P3328, DOI 10.1016/j.patcog.2008.05.007; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	67	79	79	3	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1910	+		10.1038/s41591-018-0206-4	http://dx.doi.org/10.1038/s41591-018-0206-4			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30374196	Green Accepted			2022-12-27	WOS:000452392200020
J	Ovalle, F; Grimes, T; Xu, GL; Patel, AJ; Grayson, TB; Thielen, LA; Li, P; Shalev, A				Ovalle, Fernando; Grimes, Tiffany; Xu, Guanlan; Patel, Anish J.; Grayson, Truman B.; Thielen, Lance A.; Li, Peng; Shalev, Anath			Verapamil and beta cell function in adults with recent-onset type 1 diabetes	NATURE MEDICINE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; ANTI-CD3 MONOCLONAL-ANTIBODY; C-PEPTIDE; MELLITUS; GLUCOSE; DIAGNOSIS; CARDIOMYOPATHY; EXPRESSION; APOPTOSIS; INVEST	Pancreatic beta cell loss is a key factor in the pathogenesis of type 1 diabetes (T1D), but therapies to halt this process are lacking. We previously reported that the approved antihypertensive calcium-channel blocker verapamil, by decreasing the expression of thioredoxin-interacting protein, promotes the survival of insulin-producing beta cells and reverses diabetes in mouse models(1). To translate these findings into humans, we conducted a randomized double-blind placebo-controlled phase 2 clinical trial (NCT02372253) to assess the efficacy and safety of oral verapamil added for 12 months to a standard insulin regimen in adult subjects with recent-onset T1D. Verapamil treatment, compared with placebo was well tolerated and associated with an improved mixed-meal-stimulated C-peptide area under the curve, a measure of endogenous beta cell function, at 3 and 12 months (prespecified primary endpoint), as well as with a lower increase in insulin requirements, fewer hypoglycemic events and on-target glycemic control (secondary endpoints). Thus, addition of once-daily oral verapamil may be a safe and effective novel approach to promote endogenous beta cell function and reduce insulin requirements and hypoglycemic episodes in adult individuals with recent-onset T1D.	[Ovalle, Fernando; Grimes, Tiffany; Xu, Guanlan; Patel, Anish J.; Grayson, Truman B.; Thielen, Lance A.; Shalev, Anath] Univ Alabama Birmingham, Dept Med, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Li, Peng] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shalev, A (corresponding author), Univ Alabama Birmingham, Dept Med, Comprehens Diabet Ctr, Birmingham, AL 35294 USA.	shalev@uab.edu	Ovalle, Fernando/Q-6647-2019	Ovalle, Fernando/0000-0002-6711-071X; Li, Peng/0000-0002-9026-9999	JDRF grant [3-SRA-2014-302-M-R]; DRC [P30DK079626];  [UL1TR001417]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752, P30DK079626] Funding Source: NIH RePORTER	JDRF grant; DRC; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by JDRF grant 3-SRA-2014-302-M-R to A.S. The UAB Physiology Core was supported by DRC P30DK079626, and the UAB Center for Clinical and Translational Science was supported by UL1TR001417. We thank M. Preuss for excellent administrative support during the study.	AFZAL N, 1988, DIABETES, V37, P936, DOI 10.2337/diabetes.37.7.936; Ali MA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf7779; Aronson R, 2014, DIABETES CARE, V37, P2746, DOI 10.2337/dc13-0327; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1133, DOI 10.1152/ajpendo.90944.2008; Cohn RD, 2001, J CLIN INVEST, V107, pR1, DOI 10.1172/JCI11642; Cooper-DeHoff R, 2006, AM J CARDIOL, V98, P890, DOI 10.1016/j.amjcard.2006.04.030; Cooper-DeHoff RM, 2006, AM HEART J, V151, P1072, DOI 10.1016/j.ahj.2005.05.024; Davis AK, 2015, DIABETES CARE, V38, P476, DOI 10.2337/dc14-1952; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Greenbaum CJ, 2012, DIABETES, V61, P2066, DOI 10.2337/db11-1538; Hao W, 2016, DIABETES CARE, V39, P1664, DOI 10.2337/dc16-0360; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Jo S, 2018, DIABETES, V67, P256, DOI 10.2337/db17-0506; Khodneva Y, 2016, DIABETES RES CLIN PR, V115, P115, DOI 10.1016/j.diabres.2016.01.021; Lachin JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026471; Li P, 2015, JAMA-J AM MED ASSOC, V314, P1966, DOI 10.1001/jama.2015.15281; Liu EH, 2009, DIABETOLOGIA, V52, P1369, DOI 10.1007/s00125-009-1342-7; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Moore CG, 2011, CTS-CLIN TRANSL SCI, V4, P332, DOI 10.1111/j.1752-8062.2011.00347.x; Nambam B, 2017, DIABETES TECHNOL THE, V19, pS74, DOI 10.1089/dia.2017.2507; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pozzilli P, 2015, NAT REV ENDOCRINOL, V11, P289, DOI 10.1038/nrendo.2015.8; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; SORENSEN MB, 1991, EUR J CLIN PHARMACOL, V41, P401, DOI 10.1007/BF00626359; Sosenko JM, 2004, DIABETES, V53, pA425; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Yin T, 2017, J CLIN ENDOCR METAB, V102, P2604, DOI 10.1210/jc.2016-3778; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	33	80	81	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1108	+		10.1038/s41591-018-0089-4	http://dx.doi.org/10.1038/s41591-018-0089-4			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29988125	Green Accepted			2022-12-27	WOS:000440955500015
J	Friedman, SL; Neuschwander-Tetri, BA; Rinella, M; Sanyal, AJ				Friedman, Scott L.; Neuschwander-Tetri, Brent A.; Rinella, Mary; Sanyal, Arun J.			Mechanisms of NAFLD development and therapeutic strategies	NATURE MEDICINE			English	Review							NONALCOHOLIC FATTY LIVER; TISSUE INSULIN-RESISTANCE; DE-NOVO LIPOGENESIS; TERM-FOLLOW-UP; ADIPOSE-TISSUE; HEPATIC STEATOSIS; CARDIOVASCULAR-DISEASE; DIETARY FRUCTOSE; MOUSE MODEL; WEIGHT-LOSS	There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase in diabetes and metabolic syndrome. NAFLD, a continuum of liver abnormalities from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), has a variable course but can lead to cirrhosis and liver cancer. Here we review the pathogenic and clinical features of NAFLD, its major comorbidities, clinical progression and risk of complications and in vitro and animal models of NAFLD enabling refinement of therapeutic targets that can accelerate drug development. We also discuss evolving principles of clinical trial design to evaluate drug efficacy and the emerging targets for drug development that involve either single agents or combination therapies intended to arrest or reverse disease progression.	[Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA; [Neuschwander-Tetri, Brent A.] St Louis Univ Sch Med, Div Gastroenterol & Hepatol, St Louis, MO USA; [Rinella, Mary] Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Div Gastroenterol, Richmond, VA USA	Icahn School of Medicine at Mount Sinai; Saint Louis University; Northwestern University; Feinberg School of Medicine; Virginia Commonwealth University	Friedman, SL (corresponding author), Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA.	scott.friedman@mssm.edu	rinella, mary/AAJ-4065-2021	rinella, mary/0000-0003-0620-9705; Friedman, Scott/0000-0003-1178-6195	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056621] Funding Source: NIH RePORTER; NIAAA NIH HHS [P20 AA017067, R01 AA020709] Funding Source: Medline; NIDDK NIH HHS [R01 DK056621, R56 DK056621] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdelmalek M. F., 2017, J HEPATOL, V67, P1265; Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Ahmadian M, 2018, CELL REP, V22, P2849, DOI 10.1016/j.celrep.2018.02.061; Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Allen AM, 2018, HEPATOLOGY, V67, P1726, DOI 10.1002/hep.29546; Alonso C, 2017, GASTROENTEROLOGY, V152, P1449, DOI 10.1053/j.gastro.2017.01.015; Alvarado Tamara Feliciano, 2016, Gene Expression, V17, P19, DOI 10.3727/105221616X691631; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Anstee QM, 2011, BBA-MOL BASIS DIS, V1812, P1557, DOI 10.1016/j.bbadis.2011.07.017; Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Armstrong MJ, 2016, LANCET, V387, P679, DOI 10.1016/S0140-6736(15)00803-X; Arsov T, 2006, BIOCHEM BIOPH RES CO, V342, P1152, DOI 10.1016/j.bbrc.2006.02.032; Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570; Bashiardes S, 2016, MOL METAB, V5, P782, DOI 10.1016/j.molmet.2016.06.003; BasuRay S, 2017, HEPATOLOGY, V66, P1111, DOI 10.1002/hep.29273; Bazick J, 2015, DIABETES CARE, V38, P1347, DOI 10.2337/dc14-1239; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Betrapally NS, 2016, GASTROENTEROLOGY, V150, P1745, DOI 10.1053/j.gastro.2016.02.073; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Boyle A, 2017, J HEPATOL, V66, pS282, DOI 10.1016/S0168-8278(17)30881-4; Brandl K, 2017, CURR OPIN GASTROEN, V33, P128, DOI 10.1097/MOG.0000000000000349; Bril F, 2017, HEPATOLOGY, V65, P1132, DOI [10.1002/hep.28985, 10.1002/hep.2]; Bruschi FV, 2017, HEPATOLOGY, V65, P1875, DOI 10.1002/hep.29041; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Carino A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42801; Caussy C, 2017, J CLIN INVEST, V127, P2697, DOI 10.1172/JCI93465; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Choudhury Jayanta, 2004, Clin Liver Dis, V8, P575, DOI 10.1016/j.cld.2004.04.006; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Drew L, 2017, NATURE, V551, pS86, DOI 10.1038/d41586-017-06926-1; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Feaver RE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90954; Friedman SL, 2018, HEPATOLOGY, V67, P1754, DOI 10.1002/hep.29477; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116; Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138; Giles DA, 2017, NAT MED, V23, P829, DOI 10.1038/nm.4346; Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003; Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559; Haflidadottir S, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-166; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Harrison SA, 2018, LANCET, V391, P1174, DOI 10.1016/S0140-6736(18)30474-4; Hartmann P, 2018, HEPATOLOGY, V67, P2150, DOI 10.1002/hep.29676; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hirsova P, 2016, J LIPID RES, V57, P1758, DOI 10.1194/jlr.R066357; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Horwath JA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90170; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ioannou GN, 2016, TRENDS ENDOCRIN MET, V27, P84, DOI 10.1016/j.tem.2015.11.008; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jinnouchi H, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/706416; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Karajamaki AJ, 2017, METABOLISM, V66, P55, DOI 10.1016/j.metabol.2016.06.009; Kim CW, 2017, CELL METAB, V26, P394, DOI 10.1016/j.cmet.2017.07.009; Konerman MA, 2018, J HEPATOL, V68, P362, DOI 10.1016/j.jhep.2017.10.015; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Krishnan A, 2017, AM J PHYSIOL-GASTR L, V312, pG666, DOI 10.1152/ajpgi.00213.2016; Kwok R, 2016, GUT, V65, P1359, DOI 10.1136/gutjnl-2015-309265; Lade A, 2014, CURR OPIN ONCOL, V26, P100, DOI 10.1097/CCO.0000000000000042; Lai CY, 2018, BBA-MOL CELL BIOL L, V1863, P844, DOI 10.1016/j.bbalip.2018.04.009; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Lindenmeyer CC, 2018, CLIN LIVER DIS, V22, P11, DOI 10.1016/j.cld.2017.08.003; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Loomba R., ASK1 INHIBITOR SELON; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; Loomba R, 2015, GASTROENTEROLOGY, V149, P1784, DOI 10.1053/j.gastro.2015.08.011; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Loomba R, 2012, HEPATOLOGY, V56, P943, DOI 10.1002/hep.25772; Lorbeer R, 2017, J HYPERTENS, V35, P737, DOI 10.1097/HJH.0000000000001245; Luukkonen PK, 2016, J HEPATOL, V64, P1167, DOI 10.1016/j.jhep.2016.01.002; Magkos F, 2016, CELL METAB, V23, P591, DOI 10.1016/j.cmet.2016.02.005; Mahady SE, 2011, J HEPATOL, V55, P1383, DOI 10.1016/j.jhep.2011.03.016; Mantovani A, 2016, DIGEST DIS SCI, V61, P1246, DOI 10.1007/s10620-016-4040-6; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; Mauer AS, 2017, AM J PHYSIOL-GASTR L, V312, pG300, DOI 10.1152/ajpgi.00222.2016; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Mittal S, 2016, CLIN GASTROENTEROL H, V14, P124, DOI 10.1016/j.cgh.2015.07.019; Mota M, 2016, METABOLISM, V65, P1049, DOI 10.1016/j.metabol.2016.02.014; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Musselman LP, 2013, J BIOL CHEM, V288, P8028, DOI 10.1074/jbc.M112.371047; Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004; Nakayama H, 2007, METABOLISM, V56, P470, DOI 10.1016/j.metabol.2006.11.004; Namisaki T, 2016, J GASTROENTEROL, V51, P162, DOI 10.1007/s00535-015-1104-x; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Nguyen DG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158674; Nies VJM, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00193; Noguchi R, 2010, INT J MOL MED, V26, P407, DOI 10.3892/ijmm_00000480; Oana F, 2005, METABOLISM, V54, P995, DOI 10.1016/j.metabol.2005.02.016; Oseini AM, 2018, HEPATOL INT, V12, P6, DOI 10.1007/s12072-017-9838-6; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Pal M, 2016, J PHYSIOL-LONDON, V594, P267, DOI 10.1113/JP271457; Patel YA, 2017, GASTROENTEROLOGY, V153, P621, DOI 10.1053/j.gastro.2017.07.024; Pelusi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163069; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Piscaglia F, 2016, HEPATOLOGY, V63, P827, DOI 10.1002/hep.28368; Portillo-Sanchez P, 2015, J CLIN ENDOCR METAB, V100, P2231, DOI 10.1210/jc.2015-1966; Pouladi N, 2016, TRANSL RES, V168, P22, DOI 10.1016/j.trsl.2015.04.016; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Puri P, 2018, CLIN LIVER DIS, V22, P121, DOI 10.1016/j.cld.2017.08.009; Rao SSC, 2007, CLIN GASTROENTEROL H, V5, P959, DOI 10.1016/j.cgh.2007.04.008; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Ratziu V, 2016, GASTROENTEROLOGY, V150, P1147, DOI 10.1053/j.gastro.2016.01.038; Ratziu V, 2010, HEPATOLOGY, V51, P445, DOI 10.1002/hep.23270; Rinella ME, 2016, NAT REV GASTRO HEPAT, V13, P196, DOI 10.1038/nrgastro.2016.3; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Safadi R, 2014, CLIN GASTROENTEROL H, V12, P2085, DOI 10.1016/j.cgh.2014.04.038; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal Arun J, 2015, Trans Am Clin Climatol Assoc, V126, P271; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schubert K, 2017, IMMUNOL REV, V279, P23, DOI 10.1111/imr.12579; Schwarz JM, 2017, GASTROENTEROLOGY, V153, P743, DOI 10.1053/j.gastro.2017.05.043; Siddiqui MS, 2018, HEPATOLOGY, V67, P2001, DOI 10.1002/hep.29607; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0; Sookoian S, 2017, CLIN MOL HEPATOL, V23, P1, DOI 10.3350/cmh.2016.0109; Sookoian S, 2013, OBES SURG, V23, P1815, DOI 10.1007/s11695-013-0981-4; Sorrentino P, 2010, AM J GASTROENTEROL, V105, P336, DOI 10.1038/ajg.2009.587; Staiger H, 2017, ENDOCR REV, V38, P468, DOI 10.1210/er.2017-00016; Stender S, 2017, NAT GENET, V49, P842, DOI 10.1038/ng.3855; Sternson SM, 2017, ANNU REV PHYSIOL, V79, P401, DOI 10.1146/annurev-physiol-021115-104948; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Taub R, 2013, ATHEROSCLEROSIS, V230, P373, DOI 10.1016/j.atherosclerosis.2013.07.056; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; TRUSWELL AS, 1988, AM J CLIN NUTR, V48, P1424, DOI 10.1093/ajcn/48.6.1424; Tsuchida T, 2018, J HEPATOL, V69, P385, DOI 10.1016/j.jhep.2018.03.011; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Valbusa F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173398; Valenti L, 2017, HEPATOLOGY, V66, P1026, DOI 10.1002/hep.29298; van Nierop FS, 2017, LANCET DIABETES ENDO, V5, P224, DOI 10.1016/S2213-8587(16)30155-3; VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Weltman MD, 1996, GASTROENTEROLOGY, V111, P1645, DOI 10.1016/S0016-5085(96)70028-8; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Woodcock J, 2011, NEW ENGL J MED, V364, P985, DOI 10.1056/NEJMp1101548; Wooden B, 2017, GASTROENTEROLOGY, V152, P53, DOI 10.1053/j.gastro.2016.09.065; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	179	1360	1427	86	514	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					908	922		10.1038/s41591-018-0104-9	http://dx.doi.org/10.1038/s41591-018-0104-9			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29967350	Green Accepted			2022-12-27	WOS:000438187700017
J	Hsia, DS; Heymsfield, SB				Hsia, Daniel S.; Heymsfield, Steven B.			METABOLISM Reducing diabetes risk at an early age	NATURE MEDICINE			English	Editorial Material							LIFE-STYLE; CHILDHOOD; OVERWEIGHT; ADULTHOOD	A large retrospective study involving 62,565 Danish men shows that those who have been overweight in childhood have a lower risk of having type 2 diabetes in adulthood if they had remission of overweight before 13 years of age.	[Hsia, Daniel S.; Heymsfield, Steven B.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Hsia, DS (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	daniel.hsia@pbrc.edu	Heymsfield, Steven B/N-1968-2017; Hsia, Daniel/N-1970-2017; Hsia, Daniel/AAJ-6247-2020	Heymsfield, Steven B/0000-0003-1127-9425; Hsia, Daniel/0000-0003-2832-3429; Hsia, Daniel/0000-0003-2832-3429				Bjerregaard LG, 2018, NEW ENGL J MED, V378, P1302, DOI [10.1056/NEJMoa1713231, 10.1056/nejmoa1713231]; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Glavin K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-160; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Leitner DR, 2017, OBESITY FACTS, V10, P483, DOI 10.1159/000480525; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yang WY, 2018, DIABETES CARE, V41, P917, DOI 10.2337/dci18-0007; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	11	2	2	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					708	710		10.1038/s41591-018-0067-x	http://dx.doi.org/10.1038/s41591-018-0067-x			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875462				2022-12-27	WOS:000434281300014
J	Nahrendorf, M				Nahrendorf, Matthias			Myeloid cell contributions to cardiovascular health and disease	NATURE MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; RESIDENT CARDIAC MACROPHAGES; HEMATOPOIETIC STEM-CELLS; BLOOD MONOCYTE SUBSETS; CLONAL HEMATOPOIESIS; STEADY-STATE; LY-6C(HIGH) MONOCYTES; DIABETES-MELLITUS; TYROSINE KINASE; WESTERN DIET	Recent advances in cell tracing and sequencing technologies have expanded our knowledge on leukocyte behavior. As a consequence, inflammatory cells, such as monocyte-derived macrophages, and their actions and products are increasingly being considered as potential drug targets for treatment of atherosclerosis, myocardial infarction and heart failure. Particularly promising developments are the identification of harmful arterial and cardiac macrophage subsets, the cells' altered, sometimes even clonal production in hematopoietic organs, and epigenetically entrained memories of myeloid progenitors and macrophages in the setting of cardiovascular disease. Given the roles of monocytes and macrophages in host defense, intricately understanding the involved cellular subsets, sources and functions is essential for the design of precision therapeutics that preserve protective innate immunity. Here I review how new clinical and preclinical data, often linking the cardiovascular, immune and other organ systems, propel conceptual advances to a point where cardiovascular immunotherapy appears within reach.	[Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Nahrendorf, Matthias] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Nahrendorf, Matthias] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Nahrendorf, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mnahrendorf@mgh.harvard.edu			National Institutes of Health [NS084863, HL139598, HL128264, HL117829, HL096576, HL131495]; European Union's Horizon 2020 research and innovation program [667837]; Global Research Lab (GRL) program of the National Research Foundation by the Korean government [NRF-2015K1A1A2028228]; MGH Research Scholar Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL139598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union's Horizon 2020 research and innovation program; Global Research Lab (GRL) program of the National Research Foundation by the Korean government; MGH Research Scholar Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by federal funds from the National Institutes of Health NS084863, HL139598, HL128264, HL117829, HL096576 and HL131495; the European Union's Horizon 2020 research and innovation program under grant agreement no. 667837; the Global Research Lab (GRL) program (NRF-2015K1A1A2028228) of the National Research Foundation by the Korean government and the MGH Research Scholar Program.	A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Anzai A, 2017, J EXP MED, V214, P3293, DOI 10.1084/jem.20170689; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bajpai G., 2018, NAT MED; Bekkering S, 2016, ATHEROSCLEROSIS, V254, P228, DOI 10.1016/j.atherosclerosis.2016.10.019; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Brindle K, 2008, NAT REV CANCER, V8, P94, DOI 10.1038/nrc2289; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Courties G, 2015, CIRC RES, V116, P407, DOI 10.1161/CIRCRESAHA.116.305207; DeBerge M, 2017, CIRC RES, V121, P930, DOI 10.1161/CIRCRESAHA.117.311327; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dutta P, 2015, CELL STEM CELL, V16, P477, DOI 10.1016/j.stem.2015.04.008; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Emami H, 2015, JACC-CARDIOVASC IMAG, V8, P121, DOI 10.1016/j.jcmg.2014.10.009; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Frangogiannis NG, 1998, CIRCULATION, V98, P699, DOI 10.1161/01.CIR.98.7.699; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Haubner BJ, 2016, CIRC RES, V118, P216, DOI 10.1161/CIRCRESAHA.115.307017; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Howangyin KY, 2016, CIRCULATION, V133, P826, DOI 10.1161/CIRCULATIONAHA.115.020857; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2017, SEMIN HEMATOL, V54, P43, DOI 10.1053/j.seminhematol.2016.10.002; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Li WJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87315; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luo YL, 2018, ACS NANO, V12, P994, DOI 10.1021/acsnano.7b07874; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116; McArdle S, 2016, J EXP MED, V213, P1117, DOI 10.1084/jem.20151885; McArdle S, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.2.026005; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Oikawa A, 2010, ARTERIOSCL THROM VAS, V30, P498, DOI 10.1161/ATVBAHA.109.200154; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pinto AR, 2014, AGING-US, V6, P399, DOI 10.18632/aging.100669; Quintar A, 2017, CIRC RES, V120, P1789, DOI 10.1161/CIRCRESAHA.117.310739; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2016, EUR HEART J, V37, P1720, DOI 10.1093/eurheartj/ehw024; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Roufaiel M, 2016, NAT IMMUNOL, V17, P1263, DOI 10.1038/ni.3564; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sager HB, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1435; Sager HB, 2015, CIRCULATION, V132, P1880, DOI 10.1161/CIRCULATIONAHA.115.016160; Sano S, 2018, J AM COLL CARDIOL, V71, P875, DOI 10.1016/j.jacc.2017.12.037; Saxena A, 2014, AM J PHYSIOL-HEART C, V307, pH1233, DOI 10.1152/ajpheart.00328.2014; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tawakol A, 2017, LANCET, V389, P834, DOI 10.1016/S0140-6736(16)31714-7; Thomas GD, 2017, ARTERIOSCL THROM VAS, V37, P1548, DOI 10.1161/ATVBAHA.117.309145; Tothova Z, 2017, CELL STEM CELL, V21, P547, DOI 10.1016/j.stem.2017.07.015; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Vandoorne K, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005613; Walter W, 2018, CELL REP, V23, P622, DOI 10.1016/j.celrep.2018.03.029; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Wang Y, 2017, CELL, V171, P331, DOI 10.1016/j.cell.2017.08.041; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Winkels H, 2018, CIRC RES, V122, P1675, DOI 10.1161/CIRCRESAHA.117.312513; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yin H, 2017, NAT BIOTECHNOL, V35, P1179, DOI 10.1038/nbt.4005; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Ziegler KA, 2018, CARDIOVASC RES, V114, P291, DOI 10.1093/cvr/cvx227; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	113	128	131	3	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					711	720		10.1038/s41591-018-0064-0	http://dx.doi.org/10.1038/s41591-018-0064-0			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29867229	Green Accepted			2022-12-27	WOS:000434281300015
J	Stower, H				Stower, Hannah			Tracing clear cell renal carcinoma evolution	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					702	702		10.1038/s41591-018-0074-y	http://dx.doi.org/10.1038/s41591-018-0074-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875457	Bronze			2022-12-27	WOS:000434281300010
J	Razavian, N				Razavian, Narges			Augmented reality microscopes for cancer histopathology	NATURE MEDICINE			English	Editorial Material									[Razavian, Narges] NYU Langone Med Ctr, Ctr Healthcare Innovat & Delivery Sci, Dept Radiol, New York, NY 10016 USA; [Razavian, Narges] NYU Langone Med Ctr, Ctr Healthcare Innovat & Delivery Sci, Dept Populat Hlth, New York, NY 10016 USA	NYU Langone Medical Center; NYU Langone Medical Center	Razavian, N (corresponding author), NYU Langone Med Ctr, Ctr Healthcare Innovat & Delivery Sci, Dept Radiol, New York, NY 10016 USA.; Razavian, N (corresponding author), NYU Langone Med Ctr, Ctr Healthcare Innovat & Delivery Sci, Dept Populat Hlth, New York, NY 10016 USA.	narges.razavian@nyulangone.org		Razavian, Narges/0000-0002-9922-6370				Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bui MM, 2019, J PATHOL INFORM, V10; Campanella G, 2019, NAT MED, V25, P1301, DOI 10.1038/s41591-019-0508-1; Chen PHC, 2019, NAT MED, V25, P1453, DOI 10.1038/s41591-019-0539-7; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Hekler A, 2019, EUR J CANCER, V115, P79, DOI 10.1016/j.ejca.2019.04.021; Khosravi P, 2018, EBIOMEDICINE, V27, P317, DOI 10.1016/j.ebiom.2017.12.026	8	6	6	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1334	1336		10.1038/s41591-019-0574-4	http://dx.doi.org/10.1038/s41591-019-0574-4			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501608				2022-12-27	WOS:000484832800013
J	Stower, H				Stower, Hannah			A microbiome tool for deriving the universal blood donor	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1029	1029		10.1038/s41591-019-0529-9	http://dx.doi.org/10.1038/s41591-019-0529-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270500	Bronze			2022-12-27	WOS:000474430400006
J	Gilbert, JA; Lynch, SV				Gilbert, Jack A.; Lynch, Susan V.			Community ecology as a framework for human microbiome research	NATURE MEDICINE			English	Article							HUMAN GUT MICROBIOME; COLONIZATION RESISTANCE; CLOSTRIDIUM-DIFFICILE; HOST; PROBIOTICS; EVOLUTION; INFECTION; ECOSYSTEM; IMPACTS; INFANTS	The field of human microbiome research has revealed the intimate co-association of humans with diverse communities of microbes in various habitats in the human body, and the necessity of these microbes for the maintenance of human health. Microbial heterogeneity between humans and across spatial and temporal gradients requires multidimensional datasets and a unifying set of theories and statistical tools to analyze the human microbiome and fully realize the potential of this field. Here we consider the utility of community ecology as a framework for the interrogation and interpretation of the human microbiome.	[Gilbert, Jack A.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Gilbert, Jack A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Lynch, Susan V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Francisco	Gilbert, JA (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Gilbert, JA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.; Lynch, SV (corresponding author), Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA.	gilbertjack@gmail.com; susan.lynch@ucsf.edu	Gilbert, Jack/AAF-3270-2019	Lynch, Susan/0000-0001-5695-7336; Gilbert, Jack/0000-0001-7920-7001	National Institutes of Health [AI089473, AI113916, AI133765, PO515267, DH082147, DA040532]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI089473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank a number of colleagues for suggestions on articles to include in this review. Specifically, L. P. Coelho; B. Prithiviraj; E. Jasarevic; J. Pickard; M. Yassour; and E. Weinstein. S.V.L. is supported by awards from the National Institutes of Health (AI089473, AI113916, AI133765, PO515267, DH082147, DA040532) and the Crohn's and Colitis Foundation of America.	Abisado R. G, 2018, MBIO, V9; Aijo T, 2018, BIOINFORMATICS, V34, P372, DOI 10.1093/bioinformatics/btx549; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bucci V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0980-6; Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753; Cope EK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0266-6; Cussotto S, 2019, PSYCHOPHARMACOLOGY, V236, P1671, DOI 10.1007/s00213-018-5006-5; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Durack J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03157-4; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Fukuyama J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005706; Garcia-Gutierrez E, 2019, GUT MICROBES, V10, P1, DOI 10.1080/19490976.2018.1455790; Gerber GK, 2014, FEBS LETT, V588, P4131, DOI 10.1016/j.febslet.2014.02.037; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Gilbert JA, 2018, ENVIRON MICROBIOL, V20, P1917, DOI 10.1111/1462-2920.14115; Haiser HJ, 2014, GUT MICROBES, V5, P233, DOI 10.4161/gmic.27915; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Halkjaer SI, 2018, GUT, V67, P2107, DOI 10.1136/gutjnl-2018-316434; Hannigan GD, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006099; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kang DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0225-7; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Larsson PG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-223; Lederberg J., 2001, SCIENTIST; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Shenhav L, 2017, MODELING TEMPORAL DY, DOI [10.1101/362822, DOI 10.1101/362822]; Silverman J, 2018, STAT CONSIDERATIONS, DOI [10.1101/448332v1, DOI 10.1101/448332V1]; Silverman JD, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0584-3; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Thaiss CA, 2016, NATURE, V540, P544, DOI 10.1038/nature20796; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Winston JA, 2016, ANAEROBE, V41, P44, DOI 10.1016/j.anaerobe.2016.05.003; Yang L, 2018, CURR OPIN MICROBIOL, V45, P8, DOI 10.1016/j.mib.2018.01.002; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363	53	56	58	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					884	889		10.1038/s41591-019-0464-9	http://dx.doi.org/10.1038/s41591-019-0464-9			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31133693	Green Accepted			2022-12-27	WOS:000470844400017
J	Serrano, MG; Parikh, HI; Brooks, JP; Edwards, DJ; Arodz, TJ; Edupuganti, L; Huang, B; Girerd, PH; Bokhari, YA; Bradley, SP; Brooks, JL; Dickinson, MR; Drake, JI; Duckworth, RA; Fong, SS; Glascock, AL; Jean, S; Jimenez, NR; Khoury, J; Koparde, VN; Lara, AM; Lee, V; Matveyev, AV; Milton, SH; Mistry, SD; Rozycki, SK; Sheth, NU; Smirnova, E; Vivadelli, SC; Wijesooriya, NR; Xu, J; Xu, P; Chaffin, DO; Sexton, AL; Gravett, MG; Rubens, CE; Hendricks-Munoz, KD; Jefferson, KK; Strauss, JF; Fettweis, JM; Buck, GA				Serrano, Myrna G.; Parikh, Hardik I.; Brooks, J. Paul; Edwards, David J.; Arodz, Tom J.; Edupuganti, Laahirie; Huang, Bernice; Girerd, Philippe H.; Bokhari, Yahya A.; Bradley, Steven P.; Brooks, Jamie L.; Dickinson, Molly R.; Drake, Jennifer I.; Duckworth, Robert A., III; Fong, Stephen S.; Glascock, Abigail L.; Jean, Sophonie; Jimenez, Nicole R.; Khoury, Joseph; Koparde, Vishal N.; Lara, Ana M.; Lee, Vladimir; Matveyev, Andrey V.; Milton, Sarah H.; Mistry, Shreni D.; Rozycki, Sarah K.; Sheth, Nihar U.; Smirnova, Ekaterina; Vivadelli, Stephany C.; Wijesooriya, N. Romesh; Xu, Jie; Xu, Ping; Chaffin, Donald O.; Sexton, Amber L.; Gravett, Michael G.; Rubens, Craig E.; Hendricks-Munoz, Karen D.; Jefferson, Kimberly K.; Strauss, Jerome F., III; Fettweis, Jennifer M.; Buck, Gregory A.			Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy	NATURE MEDICINE			English	Article							FALSE DISCOVERY RATE; GARDNERELLA-VAGINALIS; BACTERIAL VAGINOSIS; PRETERM BIRTH; WOMEN; PREVALENCE; HEALTH; RISK	The microbiome of the female reproductive tract has implications for women's reproductive health. We examined the vaginal microbiome in two cohorts of women who experienced normal term births: a cross-sectionally sampled cohort of 613 pregnant and 1,969 non-pregnant women, focusing on 300 pregnant and 300 non-pregnant women of African, Hispanic or European ancestry case-matched for race, gestational age and household income; and a longitudinally sampled cohort of 90 pregnant women of African or non-African ancestry. In these women, the vaginal microbiome shifted during pregnancy toward Lactobacillus-dominated profiles at the expense of taxa often associated with vaginal dysbiosis. The shifts occurred early in pregnancy, followed predictable patterns, were associated with simplification of the metabolic capacity of the microbiome and were significant only in women of African or Hispanic ancestry. Both genomic and environmental factors are likely contributors to these trends, with socioeconomic status as a likely environmental influence.	[Serrano, Myrna G.; Parikh, Hardik I.; Edupuganti, Laahirie; Huang, Bernice; Bradley, Steven P.; Brooks, Jamie L.; Dickinson, Molly R.; Drake, Jennifer I.; Duckworth, Robert A., III; Jean, Sophonie; Jimenez, Nicole R.; Koparde, Vishal N.; Lara, Ana M.; Lee, Vladimir; Matveyev, Andrey V.; Mistry, Shreni D.; Rozycki, Sarah K.; Vivadelli, Stephany C.; Xu, Ping; Jefferson, Kimberly K.; Fettweis, Jennifer M.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23284 USA; [Serrano, Myrna G.; Brooks, J. Paul; Edwards, David J.; Arodz, Tom J.; Edupuganti, Laahirie; Girerd, Philippe H.; Fong, Stephen S.; Jimenez, Nicole R.; Lee, Vladimir; Matveyev, Andrey V.; Vivadelli, Stephany C.; Xu, Jie; Xu, Ping; Hendricks-Munoz, Karen D.; Jefferson, Kimberly K.; Strauss, Jerome F., III; Fettweis, Jennifer M.; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Microbiome Engn & Data Anal, Richmond, VA 23284 USA; [Brooks, J. Paul] Virginia Commonwealth Univ, Sch Business, Supply Chain Management & Analyt, Richmond, VA USA; [Edwards, David J.] Virginia Commonwealth Univ, Coll Humanities & Sci, Dept Stat Sci & Operat Res, Richmond, VA USA; [Arodz, Tom J.; Bokhari, Yahya A.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Comp Sci, Coll Engn, Richmond, VA 23284 USA; [Girerd, Philippe H.; Milton, Sarah H.; Strauss, Jerome F., III; Fettweis, Jennifer M.] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA; [Fong, Stephen S.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Coll Engn, Richmond, VA USA; [Glascock, Abigail L.; Sheth, Nihar U.; Xu, Ping] Virginia Commonwealth Univ, VCU Life Sci, Richmond, VA USA; [Khoury, Joseph; Wijesooriya, N. Romesh; Xu, Jie; Hendricks-Munoz, Karen D.] Virginia Commonwealth Univ, Dept Pediat, Div Gen Pediat, Sch Med,Childrens Hosp Richmond, Richmond, VA USA; [Khoury, Joseph; Xu, Jie; Hendricks-Munoz, Karen D.] Virginia Commonwealth Univ, Dept Pediat, Div Neonatal Med, Sch Med,Childrens Hosp Richmond, Richmond, VA USA; [Smirnova, Ekaterina] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Xu, Ping] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Richmond, VA USA; [Chaffin, Donald O.; Sexton, Amber L.; Gravett, Michael G.; Rubens, Craig E.] Global Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Gravett, Michael G.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Washington; University of Washington Seattle	Buck, GA (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23284 USA.; Buck, GA (corresponding author), Virginia Commonwealth Univ, Ctr Microbiome Engn & Data Anal, Richmond, VA 23284 USA.; Buck, GA (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Coll Engn, Richmond, VA 23284 USA.	gregory.buck@vcuhealth.org	Jean, Sophonie/AAR-8204-2020; Parikh, Hardik/AAG-4963-2021; Edupuganti, Laahirie/AAC-9115-2022	Jean, Sophonie/0000-0001-9372-3491; Koparde, Vishal/0000-0001-8978-8495; Santos Jimenez, Nicole Renea/0000-0001-9755-0022; Brooks, Jamie/0000-0003-0756-1831; Parikh, Hardik/0000-0002-5621-7343; BOKHARI, YAHYA/0000-0002-2352-1701	NIH [UH3AI083263, U54HD080784, R21HD092965, 1R01HD092415]; Common Fund; National Center for Complementary and Integrative Health; Office of Research on Women's Health; Eunice Kenedy Shriver National Institute of Child Heatlh and Human Development; National Institute of Allergy and Infectious Disease at NIH; GAPPS BMGF PPB grant;  [R25GM090084]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092415, R21HD092965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Common Fund; National Center for Complementary and Integrative Health; Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Eunice Kenedy Shriver National Institute of Child Heatlh and Human Development; National Institute of Allergy and Infectious Disease at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GAPPS BMGF PPB grant; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study team would like to gratefully acknowledge the participants who contributed specimens and data to the study. The authors would also like to acknowledge other members of the Vaginal Microbiome Consortium whose contributions made the study possible, including the team of research coordinators, the team of sample processors and the team of clinicians and nurses who assisted with sample collection. This study was funded by NIH grants UH3AI083263 and U54HD080784 to G.A.B., K.K.J. and J.F.S. We would also like to thank the Common Fund, the National Center for Complementary and Integrative Health, the Office of Research on Women's Health, the Eunice Kenedy Shriver National Institute of Child Heatlh and Human Development, and the National Institute of Allergy and Infectious Disease at NIH for their generous support of this project. Other grants that provided partial support include a GAPPS BMGF PPB grant to G.A.B. and J.M.F. and NIH grant R21HD092965 to J.M.F. and E.P. Wickham and 1R01HD092415 to G.A.B. and T.J.A. N.R.J. was supported by grant R25GM090084 for the VCU Initiative For Maximizing Student Development (IMSD) programme. All sequence analysis reported herein was performed in the Nucleic Acids Research Facilities at VCU, and all informatics analysis was performed in servers provided by the Center for High Performance Computing at VCU.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beamer MA, 2017, ANAEROBE, V45, P40, DOI 10.1016/j.anaerobe.2017.02.020; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brooks JP, 2013, COMPUT STAT DATA AN, V61, P83, DOI 10.1016/j.csda.2012.11.007; Brooks J Paul, 2017, IISE Trans Healthc Syst Eng, V7, P121, DOI 10.1080/24725579.2017.1339148; Brooks JP, 2017, CONTRACEPTION, V95, P405, DOI 10.1016/j.contraception.2016.11.006; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Callahan BJ, 2017, P NATL ACAD SCI USA, V114, P9966, DOI 10.1073/pnas.1705899114; Cauci S, 2002, J CLIN MICROBIOL, V40, P2147, DOI 10.1128/JCM.40.6.2147-2152.2002; de Mendoza VB, 2017, BIOL RES NURS, V19, P308, DOI 10.1177/1099800416669049; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Eastment MC, 2018, AIDS, V32, P687, DOI 10.1097/QAD.0000000000001768; Fettweis JM, 2019, NAT MED, V25, P1012, DOI 10.1038/s41591-019-0450-2; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Freitas AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07790-9; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Goltsman DSA, 2018, GENOME RES, V28, P1467, DOI 10.1101/gr.236000.118; Hahsler M, 2011, J MACH LEARN RES, V12, P2021; Hickey RJ, 2012, TRANSL RES, V160, P267, DOI 10.1016/j.trsl.2012.02.008; Hillier SL, 1997, CLIN INFECT DIS, V25, pS123, DOI 10.1086/516221; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Ingianni A, 1997, FEMS IMMUNOL MED MIC, V18, P61, DOI 10.1111/j.1574-695X.1997.tb01028.x; Janulaitiene M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2501-y; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; Modi BP, 2017, MOL GENET GENOM MED, V5, P720, DOI 10.1002/mgg3.330; Muhleisen AL, 2016, MATURITAS, V91, P42, DOI 10.1016/j.maturitas.2016.05.015; Nelson DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/ppe.12106; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2; Pabich WL, 2003, J INFECT DIS, V188, P1054, DOI 10.1086/378203; Parikh HI, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1358-1; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Ravel J, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-29; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shah R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-112; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Stout MJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.018; Tielsch JM, 2015, NESTLE NUTR WORKS SE, V81, P9, DOI 10.1159/000365798; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; York TP, 2014, AM J OBSTET GYNECOL, V210, P398, DOI 10.1016/j.ajog.2013.10.001; Younes JA, 2018, TRENDS MICROBIOL, V26, P16, DOI 10.1016/j.tim.2017.07.008; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	66	110	114	4	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					1001	+		10.1038/s41591-019-0465-8	http://dx.doi.org/10.1038/s41591-019-0465-8			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31142850	Green Accepted			2022-12-27	WOS:000470844400032
J	Toffalori, C; Zito, L; Gambacorta, V; Riba, M; Oliveira, G; Bucci, G; Barcella, M; Spinelli, O; Greco, R; Crucitti, L; Cieri, N; Noviello, M; Manfredi, F; Montaldo, E; Ostuni, R; Naldini, MM; Gentner, B; Waterhouse, M; Zeiser, R; Finke, J; Hanoun, M; Beelen, DW; Gojo, I; Luznik, L; Onozawa, M; Teshima, T; Devillier, R; Blaise, D; Halkes, CJM; Griffioen, M; Carrabba, MG; Bernardi, M; Peccatori, J; Barlassina, C; Stupka, E; Lazarevic, D; Tonon, G; Rambaldi, A; Cittaro, D; Bonini, C; Fleischhauer, K; Ciceri, F; Vago, L				Toffalori, Cristina; Zito, Laura; Gambacorta, Valentina; Riba, Michela; Oliveira, Giacomo; Bucci, Gabriele; Barcella, Matteo; Spinelli, Orietta; Greco, Raffaella; Crucitti, Lara; Cieri, Nicoletta; Noviello, Maddalena; Manfredi, Francesco; Montaldo, Elisa; Ostuni, Renato; Naldini, Matteo M.; Gentner, Bernhard; Waterhouse, Miguel; Zeiser, Robert; Finke, Jurgen; Hanoun, Maher; Beelen, Dietrich W.; Gojo, Ivana; Luznik, Leo; Onozawa, Masahiro; Teshima, Takanori; Devillier, Raynier; Blaise, Didier; Halkes, Constantijn J. M.; Griffioen, Marieke; Carrabba, Matteo G.; Bernardi, Massimo; Peccatori, Jacopo; Barlassina, Cristina; Stupka, Elia; Lazarevic, Dejan; Tonon, Giovanni; Rambaldi, Alessandro; Cittaro, Davide; Bonini, Chiara; Fleischhauer, Katharina; Ciceri, Fabio; Vago, Luca			Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; REGULATORY T-CELLS; DIFFERENTIAL EXPRESSION; UNIPARENTAL DISOMY; GENE-EXPRESSION; IFN-GAMMA; HLA; AZACITIDINE; BLOCKADE; ANTIGEN	Transplantation of hematopoietic cells from a healthy individual (allogeneic hematopoietic cell transplantation (allo-HCT)) demonstrates that adoptive immunotherapy can cure blood cancers: still, post-transplantation relapses remain frequent. To explain their drivers, we analyzed the genomic and gene expression profiles of acute myeloid leukemia (AML) blasts purified from patients at serial time-points during their disease history. We identified a transcriptional signature specific for post-transplantation relapses and highly enriched in immune-related processes, including T cell costimulation and antigen presentation. In two independent patient cohorts we confirmed the deregulation of multiple costimulatory ligands on AML blasts at post-transplantation relapse (PD-L1, B7-H3, CD80, PVRL2), mirrored by concomitant changes in circulating donor T cells. Likewise, we documented the frequent loss of surface expression of HLA-DR, -DQ and -DP on leukemia cells, due to downregulation of the HLA class II regulator CIITA. We show that loss of HLA class II expression and upregulation of inhibitory checkpoint molecules represent alternative modalities to abolish AML recognition from donor-derived T cells, and can be counteracted by interferon-gamma or checkpoint blockade, respectively. Our results demonstrate that the deregulation of pathways involved in T cell-mediated allorecognition is a distinctive feature and driver of AML relapses after allo-HCT, which can be rapidly translated into personalized therapies.	[Toffalori, Cristina; Zito, Laura; Gambacorta, Valentina; Oliveira, Giacomo; Bucci, Gabriele; Fleischhauer, Katharina; Vago, Luca] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Unit Immunogenet Leukemia Genom & Immunobiol, Milan, Italy; [Gambacorta, Valentina] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Unit Senescence Stem Cell Aging Differentiat & Ca, Milan, Italy; [Riba, Michela; Bucci, Gabriele; Stupka, Elia; Lazarevic, Dejan; Tonon, Giovanni; Cittaro, Davide] IRCCS San Raffaele Sci Inst, Ctr Translat Genom & Bioinformat, Milan, Italy; [Oliveira, Giacomo; Cieri, Nicoletta; Noviello, Maddalena; Manfredi, Francesco; Bonini, Chiara] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Expt Hematol Unit, Milan, Italy; [Barcella, Matteo; Barlassina, Cristina] Univ Milan, Dept Hlth Sci, Genom & Bioinformat Unit, Milan, Italy; [Spinelli, Orietta; Rambaldi, Alessandro] ASST Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy; [Greco, Raffaella; Crucitti, Lara; Cieri, Nicoletta; Gentner, Bernhard; Carrabba, Matteo G.; Bernardi, Massimo; Peccatori, Jacopo; Ciceri, Fabio; Vago, Luca] IRCCS San Raffaele Sci Inst, Unit Hematol & Bone Marrow Transplantat, Milan, Italy; [Montaldo, Elisa; Ostuni, Renato] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Genom Innate Immune Syst Unit, Milan, Italy; [Naldini, Matteo M.; Gentner, Bernhard] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy, Translat Stem Cell & Leukemia Unit, Milan, Italy; [Waterhouse, Miguel; Zeiser, Robert; Finke, Jurgen] Univ Klinikum Freiburg, Dept Hematol Oncol & Stem Cell Transplant, Freiburg, Germany; [Hanoun, Maher; Beelen, Dietrich W.] Univ Klinikum Essen, Dept Bone Marrow Transplantat, Essen, Germany; [Gojo, Ivana; Luznik, Leo] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Onozawa, Masahiro; Teshima, Takanori] Hokkaido Univ, Fac Med, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Devillier, Raynier; Blaise, Didier] Inst Paoli Calmettes, Dept Haematol, Marseille, France; [Halkes, Constantijn J. M.; Griffioen, Marieke] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; [Rambaldi, Alessandro] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Bonini, Chiara; Ciceri, Fabio] San Raffaele Vita Salute Univ, Milan, Italy; [Fleischhauer, Katharina] Univ Klinikum Essen, Inst Expt Cellular Therapy, Essen, Germany; [Oliveira, Giacomo; Stupka, Elia] Dana Farber Canc Inst, Boston, MA 02115 USA; [Crucitti, Lara; Cieri, Nicoletta] Univ Milan, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; ASST Papa Giovanni XXIII; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Freiburg; University of Duisburg Essen; Johns Hopkins University; Johns Hopkins Medicine; Hokkaido University; UNICANCER; Institut Paoli-Calmette (IPC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Milan; Vita-Salute San Raffaele University; University of Duisburg Essen; Harvard University; Dana-Farber Cancer Institute; University of Milan	Vago, L (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Unit Immunogenet Leukemia Genom & Immunobiol, Milan, Italy.; Vago, L (corresponding author), IRCCS San Raffaele Sci Inst, Unit Hematol & Bone Marrow Transplantat, Milan, Italy.	vago.luca@hsr.it	Gambacorta, Valentina/AAN-3090-2020; Montaldo, Elisa/AAN-1889-2020; Rambaldi, Alessandro/M-6172-2019; Greco, Raffaella/K-9499-2016; Blaise, Didier/R-2483-2016; Lazarevic, Dejan/AAN-1861-2020; Toffalori, Cristina/AAN-5136-2020; Riba, Michela/AAG-8955-2019; Griffioen, Marieke/ABA-1561-2021; Manfredi, Francesco/AAN-4378-2020; Montaldo, Elisa/AAB-9353-2022; Noviello, Maddalena/AAA-7648-2019; Peccatori, Iacopo/AAB-7506-2019; Cittaro, Davide/K-2405-2018; Spinelli, Orietta/AAC-6200-2022; bernardi, massimo/ABG-4445-2020; Tonon, Giovanni/J-9804-2018; Rambaldi, Alessandro/P-2603-2018; Carrabba, Matteo G/ABB-5345-2021; Barcella, Matteo/E-1998-2014; Bucci, Gabriele/H-3002-2014	Gambacorta, Valentina/0000-0003-2302-4083; Montaldo, Elisa/0000-0001-9293-0683; Rambaldi, Alessandro/0000-0002-3739-7502; Greco, Raffaella/0000-0002-6117-5328; Blaise, Didier/0000-0002-5684-9447; Toffalori, Cristina/0000-0002-8313-3057; Griffioen, Marieke/0000-0002-3001-4441; Manfredi, Francesco/0000-0003-2409-944X; Noviello, Maddalena/0000-0002-3252-8876; Peccatori, Iacopo/0000-0003-4639-1716; Cittaro, Davide/0000-0003-0384-3700; Spinelli, Orietta/0000-0003-0374-1536; bernardi, massimo/0000-0002-1334-0851; Tonon, Giovanni/0000-0003-2973-5038; Rambaldi, Alessandro/0000-0002-3739-7502; Carrabba, Matteo G/0000-0001-7015-4839; Zeiser, Robert/0000-0001-6565-3393; Beelen, Dietrich/0000-0001-5050-220X; Gentner, Bernhard/0000-0001-6024-4718; Naldini, Matteo Maria/0000-0002-9542-2884; Cieri, Nicoletta/0000-0003-1340-6272; Oliveira, Giacomo/0000-0001-7435-5603; lazarevic, dejan/0000-0003-4527-290X; Barcella, Matteo/0000-0002-2353-3999; BONINI, Maria Chiara/0000-0002-0772-1674; riba, michela/0000-0003-4857-2027; Bucci, Gabriele/0000-0001-9838-7204	Italian Ministry of Health [RF-FSR-2008-1202648, RF-2011-02351998, RF-2011-02348034]; Italian Ministry of University and Research [MIUR-2015NZWSEC-001]; CARIPLO Foundation [2009-2665]; Associazione Italiana per la Ricerca sul Cancro [18458, 12042, 14162]; ASCO Conquer Cancer Foundation; EU-FP7; Deutsche Jose Carreras Leukamie Stiftung [DJCLS R 15-02, DJCLS 01 R/2017]; DKMS Mechtild Harf Foundation (DKMS Mechtild Harf Research Grant 2015); Associazione Italiana per la Ricerca sul Cancro postdoctoral fellowship; Fondazione Matarelli fellowship from the Associazione Italiana Leucemie; Fondazione Umberto Veronesi fellowship	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); CARIPLO Foundation(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); ASCO Conquer Cancer Foundation; EU-FP7(European Commission); Deutsche Jose Carreras Leukamie Stiftung; DKMS Mechtild Harf Foundation (DKMS Mechtild Harf Research Grant 2015); Associazione Italiana per la Ricerca sul Cancro postdoctoral fellowship(Fondazione AIRC per la ricerca sul cancro); Fondazione Matarelli fellowship from the Associazione Italiana Leucemie; Fondazione Umberto Veronesi fellowship(Fondazione Umberto Veronesi)	This work was supported by the Italian Ministry of Health (no. RF-FSR-2008-1202648 to K.F., F.C. and C. Barlassina, no. RF-2011-02351998 to F.C. and L.V., no. RF-2011-02348034 to L.V. and TRANSCAN HLALOSS to L.V. and K.F.), by the Italian Ministry of University and Research (no. MIUR-2015NZWSEC-001 to C. Bonini), by the CARIPLO Foundation (no. 2009-2665 to K.F., A.R. and C. Barlassina), by the Associazione Italiana per la Ricerca sul Cancro (IG no. 18458 to C. Bonini, IG no. 12042 to K.F. and F.C. and Start-Up Grant no. 14162 to L.V.), by the ASCO Conquer Cancer Foundation (2014 Young Investigator Award to L.V.), EU-FP7 (SUPERSIST to C. Bonini), the Deutsche Jose Carreras Leukamie Stiftung (grant nos. DJCLS R 15-02 and DJCLS 01 R/2017 to K.F.) and by the DKMS Mechtild Harf Foundation (DKMS Mechtild Harf Research Grant 2015 to L.V.). C.T. was supported by an Associazione Italiana per la Ricerca sul Cancro postdoctoral fellowship. G.O. was supported by a Fondazione Matarelli fellowship from the Associazione Italiana Leucemie and by a Fondazione Umberto Veronesi fellowship.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bashey A, 2009, BLOOD, V113, P1581, DOI 10.1182/blood-2008-07-168468; Garcia-Ruano AB, 2010, IMMUNOGENETICS, V62, P711, DOI 10.1007/s00251-010-0470-z; Berthon C, 2010, CANCER IMMUNOL IMMUN, V59, P1839, DOI 10.1007/s00262-010-0909-y; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blazar BR, 2003, J IMMUNOL, V171, P1272, DOI 10.4049/jimmunol.171.3.1272; Brambati C, 2016, HAEMATOLOGICA, V101, DOI 10.3324/haematol.2015.135467; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Crucitti L, 2015, LEUKEMIA, V29, P1143, DOI 10.1038/leu.2014.314; Davids MS, 2016, NEW ENGL J MED, V375, P143, DOI 10.1056/NEJMoa1601202; de Lima M, 2010, CANCER-AM CANCER SOC, V116, P5420, DOI 10.1002/cncr.25500; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fleischhauer K, 2017, BLOOD, V130, P1089, DOI 10.1182/blood-2017-03-742346; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Goodyear OC, 2012, BLOOD, V119, P3361, DOI 10.1182/blood-2011-09-377044; Gupta M, 2008, GENE CHROMOSOME CANC, V47, P729, DOI 10.1002/gcc.20573; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Haverkos BM, 2017, BLOOD, V130, P221, DOI 10.1182/blood-2017-01-761346; Hobo W, 2018, BRIT J HAEMATOL, V181, P38, DOI 10.1111/bjh.15078; Horowitz M, 2018, BONE MARROW TRANSPL, V53, P1379, DOI 10.1038/s41409-018-0171-z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imus PH, 2017, BIOL BLOOD MARROW TR, V23, P1887, DOI 10.1016/j.bbmt.2017.07.014; Jilani I, 2003, LEUKEMIA, V17, P114, DOI 10.1038/sj.leu.2402743; Knaus HA, 2017, CURR DRUG TARGETS, V18, P315, DOI 10.2174/1389450116666150518095346; Kolb HJ, 2008, BLOOD, V112, P4371, DOI 10.1182/blood-2008-03-077974; Kolde R., 2013, PHEATMAP PRETTY HEAT; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Mathew NR, 2018, NAT MED, V24, P282, DOI 10.1038/nm.4484; Norde WJ, 2011, CANCER RES, V71, P5111, DOI 10.1158/0008-5472.CAN-11-0108; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paulsson K, 2011, LEUKEMIA, V25, P1358, DOI 10.1038/leu.2011.79; Platzbecker U, 2012, LEUKEMIA, V26, P381, DOI 10.1038/leu.2011.234; Raghavan M, 2008, BLOOD, V112, P814, DOI 10.1182/blood-2008-01-132431; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shlush LI, 2017, NATURE, V547, P104, DOI 10.1038/nature22993; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stevanovic S, 2013, LEUKEMIA, V27, P985, DOI 10.1038/leu.2012.270; Ulbricht T, 2012, J CELL BIOL, V199, P49, DOI 10.1083/jcb.201112015; Vago L, 2017, BIOL BLOOD MARROW TR, V23, P1813, DOI 10.1016/j.bbmt.2017.09.009; Vago L, 2012, SEMIN ONCOL, V39, P707, DOI 10.1053/j.seminoncol.2012.09.009; Vago L, 2009, NEW ENGL J MED, V361, P478, DOI 10.1056/NEJMoa0811036; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang JH, 2007, J IMMUNOL, V179, P45, DOI 10.4049/jimmunol.179.1.45; Waterhouse M, 2011, BIOL BLOOD MARROW TR, V17, P1450, DOI 10.1016/j.bbmt.2011.07.012; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446	55	169	172	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					603	+		10.1038/s41591-019-0400-z	http://dx.doi.org/10.1038/s41591-019-0400-z			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30911134				2022-12-27	WOS:000463342800022
J	Patten, DK; Corleone, G; Gyorffy, B; Perone, Y; Slaven, N; Barozzi, I; Erdos, E; Saiakhova, A; Goddard, K; Vingiani, A; Shousha, S; Pongor, LS; Hadjiminas, DJ; Schiavon, G; Barry, P; Palmieri, C; Coombes, RC; Scacheri, P; Pruneri, G; Magnani, L				Patten, Darren K.; Corleone, Giacomo; Gyorffy, Balazs; Perone, Ylenia; Slaven, Neil; Barozzi, Iros; Erdos, Edina; Saiakhova, Alina; Goddard, Kate; Vingiani, Andrea; Shousha, Sami; Pongor, Lorinc Sandor; Hadjiminas, Dimitri J.; Schiavon, Gaia; Barry, Peter; Palmieri, Carlo; Coombes, Raul C.; Scacheri, Peter; Pruneri, Giancarlo; Magnani, Luca			Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer	NATURE MEDICINE			English	Article							ESTROGEN-RECEPTOR BINDING; GENE-EXPRESSION; HUMAN GENOME; TRANSCRIPTION FACTORS; MOLECULAR PORTRAITS; SUPER-ENHANCERS; PIONEER FACTORS; CHROMATIN; CELL; REVEALS	The degree of intrinsic and interpatient phenotypic heterogeneity and its role in tumor evolution is poorly understood. Phenotypic drifts can be transmitted via inheritable transcriptional programs. Cell-type specific transcription is maintained through the activation of epigenetically defined regulatory regions including promoters and enhancers. Here we have annotated the epigenome of 47 primary and metastatic estrogen-receptor (ER alpha)-positive breast cancer clinical specimens and inferred phenotypic heterogeneity from the regulatory landscape, identifying key regulatory elements commonly shared across patients. Shared regions contain a unique set of regulatory information including the motif for transcription factor YY1. We identify YY1 as a critical determinant of ER alpha transcriptional activity promoting tumor growth in most luminal patients. YY1 also contributes to the expression of genes mediating resistance to endocrine treatment. Finally, we used H3K27ac levels at active enhancer elements as a surrogate of intra-tumor phenotypic heterogeneity to track the expansion and contraction of phenotypic subpopulations throughout breast cancer progression. By tracking the clonality of SLC9A3R1-positive cells, a bona fide YY1-ER alpha-regulated gene, we show that endocrine therapies select for phenotypic clones under-represented at diagnosis. Collectively, our data show that epigenetic mechanisms significantly contribute to phenotypic heterogeneity and evolution in systemically treated breast cancer patients.	[Patten, Darren K.; Corleone, Giacomo; Perone, Ylenia; Slaven, Neil; Barozzi, Iros; Coombes, Raul C.; Magnani, Luca] Imperial Coll London, Imperial Ctr Translat & Expt Med, Dept Surg & Canc, London, England; [Gyorffy, Balazs; Pongor, Lorinc Sandor] Hungarian Acad Sci, Inst Enzymol, MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Erdos, Edina] Univ Debrecen, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Debrecen, Hungary; [Saiakhova, Alina; Scacheri, Peter] Case Western Reserve Univ, Case Comprehens Canc Ctr, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Goddard, Kate] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Breast & Gen Surg, London, England; [Vingiani, Andrea] European Inst Oncol, Dept Pathol, Milan, Italy; [Shousha, Sami; Hadjiminas, Dimitri J.] Imperial Coll London, Ctr Pathol, Dept Med, London, England; [Schiavon, Gaia] AstraZeneca, IMED Biotech Unit, Cambridge, England; [Barry, Peter] Royal Marsden NHS Fdn Trust, Dept Breast Surg, Sutton, Surrey, England; [Palmieri, Carlo] Univ Liverpool, Inst Translat Med, Clatterbridge Canc Ctr NHS, NHS Fdn Trust, Liverpool, Merseyside, England; [Palmieri, Carlo] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England; [Pruneri, Giancarlo] Fdn IRCCS Ist Nazl Tumori, Pathol Dept, Milan, Italy; [Pruneri, Giancarlo] Univ Milan, Sch Med, Milan, Italy	Imperial College London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; University of Debrecen; Case Western Reserve University; Imperial College London; IRCCS European Institute of Oncology (IEO); Imperial College London; AstraZeneca; Royal Marsden NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Magnani, L (corresponding author), Imperial Coll London, Imperial Ctr Translat & Expt Med, Dept Surg & Canc, London, England.	l.magnani@imperial.ac.uk	Pongor, Lorinc/AAA-9835-2021; Vingiani, Andrea/AAC-1297-2019; Corleone, Giacomo/ABH-6432-2020; Gyorffy, Balazs/AAA-9135-2021; Corleone, Giacomo/W-7131-2019; Barozzi, Iros/GLQ-8907-2022; Vingiani, Andrea/AAB-7874-2022; Pruneri, Giancarlo/AAC-7767-2022; magnani, luca/N-1094-2015	Pongor, Lorinc/0000-0001-5917-4628; Vingiani, Andrea/0000-0002-9827-3976; Corleone, Giacomo/0000-0002-6170-9780; Gyorffy, Balazs/0000-0002-5772-3766; Barozzi, Iros/0000-0003-0690-3473; Vingiani, Andrea/0000-0002-9827-3976; Pruneri, Giancarlo/0000-0002-7963-7172; magnani, luca/0000-0002-7534-0785; Erdos, Edina/0000-0001-7223-0946; Coombes, Raoul Charles/0000-0002-4811-1100	Breast Cancer Now Tissue Bank [TR0121]; CRUK fellowship [C46704/A23110]; Imperial Junior Fellowship [G53019]; Wellcome Trust PhD studentship [103034/Z/13/Z]; Marie Sklodowska Curie Training Grant (EpiPredict) [642691]; AIRC [IG 2016-18696]; NATIONAL CANCER INSTITUTE [R01CA160356, R01CA193677, R01CA204279] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000121] Funding Source: NIH RePORTER	Breast Cancer Now Tissue Bank; CRUK fellowship; Imperial Junior Fellowship; Wellcome Trust PhD studentship(Wellcome Trust); Marie Sklodowska Curie Training Grant (EpiPredict); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors acknowledge and thanks all patients and their families for support and for donating research samples. The authors thank the Breast Cancer Now Tissue Bank (project TR0121), Imperial Tissue Bank and the LEGACY study for contributing tissues. The authors acknowledge infrastructure support from the Cancer Research UK Imperial Centre, the Imperial Experimental Cancer Medicine Centre and the National Institute for Health Research Imperial Biomedical Research Centre. L.M. was supported by a CRUK fellowship (C46704/A23110) and an Imperial Junior Fellowship (G53019). D.P. was supported by a Wellcome Trust PhD studentship (103034/Z/13/Z). G.C. was supported by a Marie Sklodowska Curie Training Grant (642691, EpiPredict). G.P. was supported by AIRC IG 2016-18696. The authors thank J.A. Buendia, L. Watson and J. Carrol for constructive comments on the manuscript.	Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Arduino S., 1996, European Journal of Gynaecological Oncology, V17, P535; Beagan JA, 2017, GENOME RES, V27, P1139, DOI 10.1101/gr.215160.116; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cohen AJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14400; Coleman RT, 2017, SCIENCE, V356, DOI 10.1126/science.aai8236; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Falahi F, 2013, MOL CANCER RES, V11, P1029, DOI 10.1158/1541-7786.MCR-12-0567; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Genestie C, 1998, ANTICANCER RES, V18, P571; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lan XY, 2017, NATURE, V549, P227, DOI 10.1038/nature23666; Laprell F, 2017, SCIENCE, V356, P85, DOI 10.1126/science.aai8266; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Magnani L, 2017, NAT GENET, V49, P444, DOI 10.1038/ng.3773; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nguyen VTM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10044; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Paakinaho V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15896; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150; Wang XY, 2017, SCIENCE, V356, P88, DOI 10.1126/science.aaj2114; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Whalen S, 2016, NAT GENET, V48, P488, DOI 10.1038/ng.3539; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	58	62	62	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1469	+		10.1038/s41591-018-0091-x	http://dx.doi.org/10.1038/s41591-018-0091-x			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30038216	Green Submitted, Green Accepted			2022-12-27	WOS:000444174100032
J	Quek, L; David, MD; Kennedy, A; Metzner, M; Amatangelo, M; Shih, A; Stoilova, B; Quivoron, C; Heiblig, M; Willekens, C; Saada, V; Alsafadi, S; Vijayabaskar, MS; Peniket, A; Bernard, OA; Agresta, S; Yen, K; MacBeth, K; Stein, E; Vassiliou, GS; Levine, R; De Botton, S; Thakurte, A; Penard-Lacronique, V; Vyas, P				Quek, Lynn; David, Muriel D.; Kennedy, Alison; Metzner, Marlen; Amatangelo, Michael; Shih, Alan; Stoilova, Bilyana; Quivoron, Cyril; Heiblig, Mael; Willekens, Christophe; Saada, Veronique; Alsafadi, Samar; Vijayabaskar, M. S.; Peniket, Andy; Bernard, Oliver A.; Agresta, Sam; Yen, Katharine; MacBeth, Kyle; Stein, Eytan; Vassiliou, George S.; Levine, Ross; De Botton, Stephane; Thakurte, Anjan; Penard-Lacronique, Virginie; Vyas, Paresh			Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib	NATURE MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL LUNG-CANCER; STEM-CELLS; MUTANT IDH2; KINASE DOMAIN; MUTATIONS; RESISTANCE; DIFFERENTIATION; EVOLUTION; PROGNOSIS	Mutations in the gene encoding isocitrate dehydrogenase 2 (IDH2) occur in several types of cancer, including acute myeloid leukemia (AML). In model systems, mutant IDH2 causes hematopoietic differentiation arrest. Enasidenib, a selective smallmolecule inhibitor of mutant IDH2, produces a clinical response in 40% of treated patients with relapsed/refractory AML by promoting leukemic cell differentiation. Here, we studied the clonal basis of response and acquired resistance to enasidenib treatment. Using sequential patient samples, we determined the clonal structure of hematopoietic cell populations at different stages of differentiation. Before therapy, IDH2-mutant clones showed variable differentiation arrest. Enasidenib treatment promoted hematopoietic differentiation from either terminal or ancestral mutant clones; less frequently, treatment promoted differentiation of nonmutant cells. Analysis of paired diagnosis/relapse samples did not identify second-site mutations in IDH2 at relapse. Instead, relapse arose by clonal evolution or selection of terminal or ancestral clones, thus highlighting multiple bypass pathways that could potentially be targeted to restore differentiation arrest. These results show how mapping of clonal structure in cell populations at different stages of differentiation can reveal the response and evolution of clones during treatment response and relapse.	[Quek, Lynn; Kennedy, Alison; Metzner, Marlen; Stoilova, Bilyana; Vyas, Paresh] Univ Oxford, MRC, WIMM, Mol Hematol Unit, Oxford, England; [Quek, Lynn; Kennedy, Alison; Metzner, Marlen; Stoilova, Bilyana; Vyas, Paresh] Oxford Univ Hosp NHS Fdn Trust, Oxford Biomed Res Ctr, Haematol Theme, Oxford, England; [Quek, Lynn; Peniket, Andy; Vyas, Paresh] Oxford Univ Hosp NHS Fdn Trust, Dept Hematol, Oxford, England; [David, Muriel D.; Quivoron, Cyril; Heiblig, Mael; Willekens, Christophe; Saada, Veronique; Bernard, Oliver A.; De Botton, Stephane; Penard-Lacronique, Virginie] Univ Paris Saclay, Equipe Labellisee Ligue Natl Canc, Gustave Roussy, INSERM,U1170, Villejuif, France; [Amatangelo, Michael; MacBeth, Kyle; Thakurte, Anjan] Celgene Corp, Summit, NJ USA; [Shih, Alan; Stein, Eytan; Levine, Ross] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Willekens, Christophe; Saada, Veronique; De Botton, Stephane] Univ Paris Saclay, Dept Hematol, Gustave Roussy, Villejuif, France; [Alsafadi, Samar] Univ Paris Sci & Lettres, Inst Curie, INSERM, Dept Rech Translat,U830, Paris, France; [Vijayabaskar, M. S.; Vassiliou, George S.] Wellcome Trust Sanger Inst, Haematol Canc Genet, Cambridge, England; [Agresta, Sam; Yen, Katharine] Agios Pharmaceut Inc, Cambridge, MA USA; [Vassiliou, George S.] Univ Cambridge, Dept Haematol, Cambridge, England; [Vassiliou, George S.] Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge, England; [Vassiliou, George S.] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge, England; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Levine, Ross] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Oxford University Hospitals NHS Foundation Trust; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Bristol-Myers Squibb; Celgene Corporation; Memorial Sloan Kettering Cancer Center; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Wellcome Trust Sanger Institute; Agios Pharmaceuticals; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Quek, L; Vyas, P (corresponding author), Univ Oxford, MRC, WIMM, Mol Hematol Unit, Oxford, England.; Quek, L; Vyas, P (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Oxford Biomed Res Ctr, Haematol Theme, Oxford, England.; Quek, L; Vyas, P (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Dept Hematol, Oxford, England.; De Botton, S; Penard-Lacronique, V (corresponding author), Univ Paris Saclay, Equipe Labellisee Ligue Natl Canc, Gustave Roussy, INSERM,U1170, Villejuif, France.; Thakurte, A (corresponding author), Celgene Corp, Summit, NJ USA.; De Botton, S (corresponding author), Univ Paris Saclay, Dept Hematol, Gustave Roussy, Villejuif, France.	lynn.quek@imm.ox.ac.uk; stephane.debotton@gustaveroussy.fr; athakurta@celgene.com; virginie.penard-lacronique@inserm.fr; paresh.vyas@imm.ox.ac.uk	Penard-Lacronique, Virginie/E-5729-2016; Alsafadi, Samar/C-4659-2017; Penard-Lacronique, Virginie/R-1938-2019; Bernard, Olivier A./E-5721-2016; David, Muriel/F-9592-2012; levine, ross/AAE-7658-2019	Penard-Lacronique, Virginie/0000-0001-9435-7331; Alsafadi, Samar/0000-0002-0060-1346; Penard-Lacronique, Virginie/0000-0001-9435-7331; David, Muriel/0000-0003-1392-2701; Willekens, Christophe/0000-0001-9814-8537; Vassiliou, George/0000-0003-4337-8022; Vijayabaskar, MS/0000-0002-5559-9394; Kennedy, Alison/0000-0001-6681-3256; Stoilova, Bilyana/0000-0001-6192-9145; DE BOTTON, stephane/0000-0002-8126-4942; Heiblig, Mael/0000-0003-1682-8657; Quivoron, Cyril/0000-0002-9871-0187; Bernard, Olivier/0000-0002-0463-9747	Oxford-Celgene Fellowship; MRC [G1000729/94931, MR/L008963/1]; MRC Molecular Haematology Unit; Oxford Partnership Comprehensive Biomedical Research Centre (NIHR BRC Funding scheme) [oxfbrc-2012-1]; French National Institute of Health (INSERM-AVIESAN); National Cancer Institute [INCa-DGOS-Inserm_6043, INCa 2012-1-RT-09]; SIRIC-SOCRATE 2.0; Fondation Association pour la Recherche sur le Cancer (ARC, Programme); Institut National du Cancer [INCa-DGOS_5733]; NIH [R35 CA197594-01A1]; Memorial Sloan Kettering Cancer Center Support Grant [NIH P30 CA008748]; NATIONAL CANCER INSTITUTE [R01CA173636, P30CA008748, R01CA169784, R35CA197594] Funding Source: NIH RePORTER; MRC [MC_UU_12009/11, G1000729, MR/R007608/1, MC_U137961146, MC_UU_00016/11] Funding Source: UKRI	Oxford-Celgene Fellowship(Bristol-Myers SquibbCelgene Corporation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Molecular Haematology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Partnership Comprehensive Biomedical Research Centre (NIHR BRC Funding scheme); French National Institute of Health (INSERM-AVIESAN); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SIRIC-SOCRATE 2.0; Fondation Association pour la Recherche sur le Cancer (ARC, Programme); Institut National du Cancer(Institut National du Cancer (INCA) France); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the patients and clinical staff for the samples studied. L.Q. was supported by an Oxford-Celgene Fellowship; P.V. acknowledges funding from the MRC Disease Team Awards (G1000729/94931 and MR/L008963/1), MRC Molecular Haematology Unit and the Oxford Partnership Comprehensive Biomedical Research Centre (NIHR BRC Funding scheme. oxfbrc-2012-1). V.P.-L. and S.D.B. acknowledge funding from the French National Institute of Health (INSERM-AVIESAN), the National Cancer Institute (INCa-DGOS-Inserm_6043 and INCa 2012-1-RT-09), SIRIC-SOCRATE 2.0 and the Fondation Association pour la Recherche sur le Cancer (ARC, Programme). M.D.D. is funded by a fellowship from the Institut National du Cancer (INCa-DGOS_5733). M.H. is supported as a fellow of the Fondation Philanthropia, Ecole des Sciences du Cancer, Gustave Roussy, Villejuif, France. We acknowledge the Core Flow Cytometry and Next Generation Sequencing Facilities at the WIMM; the Imaging, Cytometry and Integrated Biology platforms at Gustave Roussy (P. Rameau, Y. Lecluse, N. Droin, M. K. Diop and UMS AMMICa); the clinical departments at Gustave Roussy (J.-B. Micol for clinical specimens; N. Auger for cytogenetic analyses; and C. Marzac and E. Leclercq for FLT3 genotyping) and Memorial Sloan Kettering. R.L.L. is supported by grants from the NIH, including R35 CA197594-01A1 and a Memorial Sloan Kettering Cancer Center Support Grant (NIH P30 CA008748, including a supplement to R.L.L.). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Amatangelo MD, 2017, BLOOD, V130, P732, DOI 10.1182/blood-2017-04-779447; Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Craddock CF, 2017, CLIN CANCER RES, V23, P6430, DOI 10.1158/1078-0432.CCR-17-1423; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Farrar JE, 2016, CANCER RES, V76, P2197, DOI 10.1158/0008-5472.CAN-15-1015; Fasan A, 2013, LEUKEMIA, V27, P482, DOI 10.1038/leu.2012.174; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Gaidzik VI, 2011, J CLIN ONCOL, V29, P1364, DOI 10.1200/JCO.2010.30.7926; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Green CL, 2011, BLOOD, V118, P409, DOI 10.1182/blood-2010-12-322479; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li M, 2011, BLOOD, V118, P5914, DOI 10.1182/blood-2011-05-356204; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mason CC, 2016, LEUKEMIA, V30, P906, DOI 10.1038/leu.2015.337; Maxson JE, 2013, NEW ENGL J MED, V368, P1781, DOI 10.1056/NEJMoa1214514; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Murakami K, 2017, ACTA CRYSTALLOGR F, V73, P347, DOI 10.1107/S2053230X17007336; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Quek L, 2016, J EXP MED, V213, P1513, DOI 10.1084/jem.20151775; Raffel S, 2017, NATURE, V551, P384, DOI 10.1038/nature24294; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shih AH, 2017, CANCER DISCOV, V7, P494, DOI 10.1158/2159-8290.CD-16-1049; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Tauchert MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21510; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034	56	111	111	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1167	+		10.1038/s41591-018-0115-6	http://dx.doi.org/10.1038/s41591-018-0115-6			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30013198	Green Submitted, Green Accepted			2022-12-27	WOS:000440955500023
J	Vinci, M; Burford, A; Molinari, V; Kessler, K; Popov, S; Clarke, M; Taylor, KR; Pemberton, HN; Lord, CJ; Gutteridge, A; Forshew, T; Carvalho, D; Marshall, LV; Qin, EY; Ingram, WJ; Moore, AS; Ng, HK; Trabelsi, S; Hmida-Ben Brahim, D; Entz-Werle, N; Zacharoulis, S; Vaidya, S; Mandeville, HC; Bridges, LR; Martin, AJ; Al-Sarraj, S; Chandler, C; Sunol, M; Mora, J; de Torres, C; Cruz, O; Carcaboso, AM; Monje, M; Mackay, A; Jones, C				Vinci, Mara; Burford, Anna; Molinari, Valeria; Kessler, Ketty; Popov, Sergey; Clarke, Matthew; Taylor, Kathryn R.; Pemberton, Helen N.; Lord, Christopher J.; Gutteridge, Alice; Forshew, Tim; Carvalho, Diana; Marshall, Lynley, V; Qin, Elizabeth Y.; Ingram, Wendy J.; Moore, Andrew S.; Ng, Ho-Keung; Trabelsi, Saoussen; Hmida-Ben Brahim, Dorra; Entz-Werle, Natacha; Zacharoulis, Stergios; Vaidya, Sucheta; Mandeville, Henry C.; Bridges, Leslie R.; Martin, Andrew J.; Al-Sarraj, Safa; Chandler, Christopher; Sunol, Mariona; Mora, Jaume; de Torres, Carmen; Cruz, Ofelia; Carcaboso, Angel M.; Monje, Michelle; Mackay, Alan; Jones, Chris			Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells	NATURE MEDICINE			English	Article							RECEPTOR TYROSINE KINASES; HIGH-GRADE; INTRATUMOR HETEROGENEITY; EVOLUTION; GENES; MUTATIONS; THERAPY; ACVR1; SUBPOPULATIONS; AMPLIFICATION	The failure to develop effective therapies for pediatric glioblastoma (pGBM) and diffuse intrinsic pontine glioma (DIPG) is in part due to their intrinsic heterogeneity. We aimed to quantitatively assess the extent to which this was present in these tumors through subclonal genomic analyses and to determine whether distinct tumor subpopulations may interact to promote tumorigenesis by generating subclonal patient-derived models in vitro and in vivo. Analysis of 142 sequenced tumors revealed multiple tumor subclones, spatially and temporally coexisting in a stable manner as observed by multiple sampling strategies. We isolated genotypically and phenotypically distinct subpopulations that we propose cooperate to enhance tumorigenicity and resistance to therapy. Inactivating mutations in the H4K20 histone methyltransferase KMT5B (SUV420H1), present in <1% of cells, abrogate DNA repair and confer increased invasion and migration on neighboring cells, in vitro and in vivo, through chemokine signaling and modulation of integrins. These data indicate that even rare tumor subpopulations may exert profound effects on tumorigenesis as a whole and may represent a new avenue for therapeutic development. Unraveling the mechanisms of subclonal diversity and communication in pGBM and DIPG will be an important step toward overcoming barriers to effective treatments.	[Vinci, Mara; Burford, Anna; Molinari, Valeria; Kessler, Ketty; Popov, Sergey; Clarke, Matthew; Taylor, Kathryn R.; Carvalho, Diana; Mackay, Alan; Jones, Chris] Inst Canc Res, Ctr Evolut & Canc, London, England; [Vinci, Mara; Burford, Anna; Molinari, Valeria; Kessler, Ketty; Popov, Sergey; Clarke, Matthew; Taylor, Kathryn R.; Carvalho, Diana; Mackay, Alan; Jones, Chris] Inst Canc Res, Div Mol Pathol, London, England; [Vinci, Mara; Burford, Anna; Molinari, Valeria; Kessler, Ketty; Popov, Sergey; Clarke, Matthew; Taylor, Kathryn R.; Carvalho, Diana; Mackay, Alan; Jones, Chris] Inst Canc Res, Div Canc Therapeut, London, England; [Popov, Sergey] Univ Hosp Wales, Dept Cellular Pathol, Cardiff, S Glam, Wales; [Taylor, Kathryn R.; Qin, Elizabeth Y.] Stanford Univ, Sch Med, Stanford, CA USA; [Pemberton, Helen N.; Lord, Christopher J.] Inst Canc Res, CRUK Gene Funct Lab, London, England; [Pemberton, Helen N.; Lord, Christopher J.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England; [Gutteridge, Alice; Forshew, Tim] UCL, UCL Canc Inst, London, England; [Marshall, Lynley, V; Zacharoulis, Stergios; Vaidya, Sucheta] Royal Marsden Hosp, Children & Young Peoples Unit, Paediat Oncol Drug Dev Team, Sutton, Surrey, England; [Ingram, Wendy J.; Moore, Andrew S.] Univ Queensland, UQ Child Hlth Res Ctr, Brisbane, Qld, Australia; [Ingram, Wendy J.; Moore, Andrew S.] Childrens Hlth Queensland Hosp & Hlth Serv, Oncol Serv Grp, Brisbane, Qld, Australia; [Moore, Andrew S.] Univ Queensland, Brisbane, Qld, Australia; [Moore, Andrew S.] Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Ng, Ho-Keung] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Trabelsi, Saoussen; Hmida-Ben Brahim, Dorra] Farhat HACHED Hosp, Dept Cytogenet & Reprod Biol, Sousse, Tunisia; [Hmida-Ben Brahim, Dorra] Fac Med, Sousse, Tunisia; [Entz-Werle, Natacha] Ctr Hosp Reg & Univ Hautepierre, Strasbourg, France; [Mandeville, Henry C.] Royal Marsden Hosp, Dept Radiotherapy, Sutton, Surrey, England; [Bridges, Leslie R.] St Georges Hosp NHS Trust, Dept Cellular Pathol, London, England; [Martin, Andrew J.] St Georges Hosp NHS Trust, Dept Neurosurg, London, England; [Al-Sarraj, Safa] Kings Coll Hosp London, Dept Neuropathol, London, England; [Chandler, Christopher] Kings Coll Hosp London, Dept Neurosurg, London, England; [Sunol, Mariona; Mora, Jaume; de Torres, Carmen; Cruz, Ofelia; Carcaboso, Angel M.] Hosp St Joan de Deu, Barcelona, Spain; [Monje, Michelle] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA USA; [Vinci, Mara] IRCCS, Bambino Gesu Childrens Hosp, Rome, Italy; [Zacharoulis, Stergios] Columbia Univ, Med Ctr, Dept Pediat Hematol Oncol, New York, NY USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cardiff University; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Royal Marsden NHS Foundation Trust; University of Queensland; University of Queensland; University of Queensland; Chinese University of Hong Kong; Universite de Sousse; Hopital Farhat Hached; Universite de Sousse; CHU Strasbourg; Royal Marsden NHS Foundation Trust; St Georges University London; St Georges University London; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Barcelona; Stanford University; IRCCS Bambino Gesu; Columbia University	Jones, C (corresponding author), Inst Canc Res, Ctr Evolut & Canc, London, England.; Jones, C (corresponding author), Inst Canc Res, Div Mol Pathol, London, England.; Jones, C (corresponding author), Inst Canc Res, Div Canc Therapeut, London, England.	chris.jones@icr.ac.uk	vinci, maria/AAI-1092-2019; Cruz, Ofelia/AAE-7058-2020; Ng, Ho Keung/I-3952-2015; Lord, Christopher/AAX-7130-2021; Jones, Chris/ABE-6059-2021; Moore, Andrew S/I-6275-2012; Vaidya, Sucheta/AAG-3490-2021; Lord, Christopher/B-3295-2012	vinci, maria/0000-0002-7952-6771; Cruz, Ofelia/0000-0001-7102-3283; Jones, Chris/0000-0001-8118-2296; Moore, Andrew S/0000-0001-8062-1779; trabelsi, saoussen/0000-0002-2789-7167; Carvalho, Diana/0000-0001-6881-6151; Carcaboso, Angel/0000-0002-8485-426X; Mandeville, Henry/0000-0001-6820-8578; Lord, Christopher/0000-0002-3226-0515; Vaidya, Sucheta/0000-0003-2980-9316	Cancer Research UK [C13468/A13982, C13468/A23536]; Abbie's Army and the DIPG Collaborative; INSTINCT network - Brain Tumour Charity; Great Ormond Street Children's Charity; Children with Cancer UK; Brainchild Foundation (Australia); Children's Hospital Foundation Queensland; Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya; ISCIII-FEDER [CP13/00189]; McKenna Claire Foundation; US National Institutes of Health [K08NS070926, R01NS092597]; Children's Hospital Foundation (Queensland); Brainchild Foundation; NHS; Experimental Cancer Medicines Centre (ECMC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Abbie's Army and the DIPG Collaborative; INSTINCT network - Brain Tumour Charity; Great Ormond Street Children's Charity; Children with Cancer UK; Brainchild Foundation (Australia); Children's Hospital Foundation Queensland; Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya; ISCIII-FEDER; McKenna Claire Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Foundation (Queensland); Brainchild Foundation; NHS; Experimental Cancer Medicines Centre (ECMC); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank L. Howell for confocal microcopy expertise, M. Lambros for technical advice, and H. Vogel for neuropathology expertise and assistance with autopsies at Stanford University. We are indebted to the multidisciplinary teams at the Royal Marsden Hospital, St George's Hospital and Kings College Hospital for their continued assistance with prospective sample collection. Finally we thank the many children and families who contributed to this study through the donation of tumor tissue. This study makes use of data generated by the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project, C. Hawkins and the Hospital for Sick Children, and the McGill University-DKFZ Pediatric Brain Tumour Consortium. This work was supported by Cancer Research UK (grants C13468/A13982 and C13468/A23536), Abbie's Army and the DIPG Collaborative, and the INSTINCT network funded by The Brain Tumour Charity, Great Ormond Street Children's Charity and Children with Cancer UK. We further acknowledge funding from the Brainchild Foundation (Australia), Children's Hospital Foundation Queensland, the Xarxa de Bancs de Tumors de Catalunya (XBTC) sponsored by Pla Director d'Oncologia de Catalunya, ISCIII-FEDER (CP13/00189), McKenna Claire Foundation, and the US National Institutes of Health (grants K08NS070926 and R01NS092597). We acknowledge the support of the Queensland Children's Tumour Bank (QCTB) for provision of samples and clinical data. The QCTB is supported by the Children's Hospital Foundation (Queensland) and the Brainchild Foundation. The authors acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and the ICR and Experimental Cancer Medicines Centre (ECMC) funding.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Bender S, 2016, NAT MED, V22, P1314, DOI 10.1038/nm.4204; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Caretti V, 2014, ACTA NEUROPATHOL, V128, P605, DOI 10.1007/s00401-014-1307-x; Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gajjar A, 2015, J CLIN ONCOL, V33, P2986, DOI 10.1200/JCO.2014.59.9217; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hoffman LM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-015-0269-0; Jamal-Hanjani M, 2015, CLIN CANCER RES, V21, P1258, DOI 10.1158/1078-0432.CCR-14-1429; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Mackay A, 2017, CANCER CELL, V32, P520, DOI 10.1016/j.ccell.2017.08.017; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Moniz S, 2013, HUM MOL GENET, V22, P84, DOI 10.1093/hmg/dds405; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Morrissy AS, 2017, NAT GENET, V49, P780, DOI 10.1038/ng.3838; Nikbakht H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11185; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Postel-Vinay S, 2013, ONCOGENE, V32, P5377, DOI 10.1038/onc.2013.311; Prados MD, 2015, NEURO-ONCOLOGY, V17, P1051, DOI 10.1093/neuonc/nov031; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Salloum R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0479-8; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vinci M, 2015, JOVE-J VIS EXP, DOI 10.3791/52686; Vinci Maria, 2013, Methods Mol Biol, V986, P253, DOI 10.1007/978-1-62703-311-4_16; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102	57	86	88	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1204	+		10.1038/s41591-018-0086-7	http://dx.doi.org/10.1038/s41591-018-0086-7			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29967352	Green Accepted, Green Submitted			2022-12-27	WOS:000440955500026
J	Mai, TT; Lito, P				Mai, Trang T.; Lito, Piro			A treatment strategy for KRAS-driven tumors	NATURE MEDICINE			English	Editorial Material							INHIBITION; SHP2; CANCER		[Mai, Trang T.; Lito, Piro] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Lito, Piro] Cornell Univ, Weill Cornell Med Coll, New York, NY 14850 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Lito, P (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Lito, P (corresponding author), Cornell Univ, Weill Cornell Med Coll, New York, NY 14850 USA.	litop@mskcc.org			National Institutes of Health [K08 CA191082-01A1]; Damon Runyon Cancer Research Foundation (Clinical Investigator Award); LUNGevity Foundation (Career Development Award); V Foundation (Translational Grant)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation (Clinical Investigator Award); LUNGevity Foundation (Career Development Award); V Foundation (Translational Grant)	P.L. is supported by the National Institutes of Health (K08 CA191082-01A1), the Damon Runyon Cancer Research Foundation (Clinical Investigator Award), the LUNGevity Foundation (Career Development Award) and the V Foundation (Translational Grant).	Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Dardaei L, 2018, NAT MED, V24, P512, DOI 10.1038/nm.4497; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Mainardi S, 2018, NAT MED, V24, P961, DOI 10.1038/s41591-018-0023-9; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Ran H, 2016, CANCER CELL, V30, P194, DOI 10.1016/j.ccell.2016.07.010; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x	12	18	20	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					902	904		10.1038/s41591-018-0111-x	http://dx.doi.org/10.1038/s41591-018-0111-x			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988139				2022-12-27	WOS:000438187700014
J	Stower, H				Stower, Hannah			CRISPR-based diagnostics	NATURE MEDICINE			English	Editorial Material																			0	2	2	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					702	702		10.1038/s41591-018-0073-z	http://dx.doi.org/10.1038/s41591-018-0073-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875459	Bronze			2022-12-27	WOS:000434281300006
J	[Anonymous]				[Anonymous]			Redefining Medicine	NATURE MEDICINE			English	Editorial Material																		Lambrechts Diether, 2018, NAT MED, V24, P1277, DOI [10.1038/s41591-018-0096-5, DOI 10.1038/S41591-018-0136-1]; Teixeira Vitor H., 2019, NAT MED, V25, P517, DOI [10.1038/s41591-018-0323-0, DOI 10.1038/S41591-018-0092-9]; 2018, NAT MED, DOI DOI 10.1038/S41591-018-0009-7	3	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					527	527		10.1038/s41591-018-0037-3	http://dx.doi.org/10.1038/s41591-018-0037-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736019	Bronze			2022-12-27	WOS:000432126800002
J	Bhutta, ZA				Bhutta, Zulfiqar A.			The benefits and risks of mass antibiotic use for reducing child mortality	NATURE MEDICINE			English	Editorial Material							AZITHROMYCIN; TRACHOMA		[Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Global Child Hlth & Policy, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University	Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, Global Child Hlth & Policy, Toronto, ON, Canada.; Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@sickkids.ca	Bhutta, Zulfiqar/L-7822-2015	Bhutta, Zulfiqar/0000-0003-0637-599X				Arzika AM, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002835; Chandramohan D, 2019, NEW ENGL J MED, V380, P2197, DOI 10.1056/NEJMoa1811400; Doan T, 2019, NAT MED, V25, P1370, DOI 10.1038/s41591-019-0533-0; Doan T, 2019, NEW ENGL J MED, V380, P2271, DOI 10.1056/NEJMc1901535; Keenan JD, 2018, NEW ENGL J MED, V378, P1583, DOI [10.1056/nejmoa1715474, 10.1056/NEJMoa1715474]; Keenan JD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007442; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Oldenburg CE, 2019, AM J TROP MED HYG, V100, P691, DOI 10.4269/ajtmh.18-0846; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Rogawski ET, 2018, LANCET GLOB HEALTH, V6, pE1319, DOI [10.1016/s2214-109x(18)30351-6, 10.1016/S2214-109X(18)30351-6]; Doan T, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy182; Whitty CJM, 1999, PEDIATR INFECT DIS J, V18, P955, DOI 10.1097/00006454-199911000-00003	12	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1332	1334		10.1038/s41591-019-0576-2	http://dx.doi.org/10.1038/s41591-019-0576-2			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501607				2022-12-27	WOS:000484832800012
J	Rockwood, K; Wallace, LMK; Davis, DH				Rockwood, Kenneth; Wallace, Lindsay M. K.; Davis, Daniel H.			Genetic predisposition and modifiable risks for late-life dementia	NATURE MEDICINE			English	Editorial Material							DELIRIUM		[Rockwood, Kenneth; Wallace, Lindsay M. K.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Rockwood, Kenneth; Davis, Daniel H.] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England	Dalhousie University; University of London; University College London	Rockwood, K (corresponding author), Dalhousie Univ, Dept Med, Halifax, NS, Canada.; Rockwood, K (corresponding author), UCL, MRC, Unit Lifelong Hlth & Ageing, London, England.	kenneth.rockwood@dal.ca	Rockwood, Kenneth/AAD-8951-2019; Davis, Daniel/F-9995-2012	Davis, Daniel/0000-0002-1560-1955; Rockwood, Kenneth/0000-0002-6674-995X	Canadian Institutes of Health Research [CAN-137794]; Alzheimer Society of Canada; Pfizer Canada; Sanofi Canada; Canadian Institutes of Health Research; Canadian Frailty Network; Nova Scotia Health Research Foundation; Nova Scotia Health Authority Research Fund; Fountain Family Innovation Fund of the QEII Health Science Centre Foundation; Baxter; Baxalta; Biogen; Shire; Hollister; Nutricia; Roche; Otsuka	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Pfizer Canada(Pfizer); Sanofi Canada(Sanofi-Aventis); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Frailty Network; Nova Scotia Health Research Foundation; Nova Scotia Health Authority Research Fund; Fountain Family Innovation Fund of the QEII Health Science Centre Foundation; Baxter; Baxalta; Biogen(Biogen); Shire; Hollister; Nutricia(Danone Nutricia); Roche(Roche Holding); Otsuka(Otsuka Pharmaceutical)	In addition to academic and hospital appointments, K.R. is President and Chief Science Officer of DGI Clinical, which in the past 5 years has contracts with pharma and device manufacturers (Baxter, Baxalta, Biogen, Shire, Hollister, Nutricia, Roche, Otsuka) on individualized outcome measurement. In 2017, he attended an advisory board meeting with Lundbeck. Otherwise, any personal fees are for invited guest lectures, rounds and academic symposia, received directly from event organizers, for presentations on frailty. He is Associate Director of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes of Health Research (CAN-137794), with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada (in Phase 1, 2014-2019). He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support through grants from the Canadian Institutes of Health Research, the Canadian Frailty Network, the Nova Scotia Health Research Foundation, the Nova Scotia Health Authority Research Fund and the Fountain Family Innovation Fund of the QEII Health Science Centre Foundation.	Adamis D, 2015, AGE AGEING, V44, P318, DOI 10.1093/ageing/afu152; Canevelli M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00628; Davis DHJ, 2017, JAMA PSYCHIAT, V74, P244, DOI 10.1001/jamapsychiatry.2016.3423; Dekhtyar S, 2019, ANN NEUROL, V86, P68, DOI 10.1002/ana.25501; Licher S, 2019, NAT MED, V25, P1364, DOI 10.1038/s41591-019-0547-7; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lourida I, 2019, JAMA-J AM MED ASSOC, V322, P430, DOI 10.1001/jama.2019.9879; Lyall DM, 2019, NEUROLOGY, V92, pE2691, DOI 10.1212/WNL.0000000000007551; MacLullich AMJ, 2009, INT REV PSYCHIATR, V21, P30, DOI 10.1080/09540260802675031; Persico I, 2018, J AM GERIATR SOC, V66, P2022, DOI 10.1111/jgs.15503; Rogers NT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16104-y; Wallace LMK, 2019, LANCET NEUROL, V18, P177, DOI 10.1016/S1474-4422(18)30371-5	12	5	5	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1331	1332		10.1038/s41591-019-0575-3	http://dx.doi.org/10.1038/s41591-019-0575-3			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31451783	Green Submitted			2022-12-27	WOS:000484832800011
J	Stower, H				Stower, Hannah			Diet influence on cancer therapy	NATURE MEDICINE			English	Editorial Material																		2019, NATURE, V572, P397	1	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1330	1330		10.1038/s41591-019-0588-y	http://dx.doi.org/10.1038/s41591-019-0588-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501605	Bronze			2022-12-27	WOS:000484832800010
J	Johnson, DB; McDonnell, WJ; Gonzalez-Ericsson, PI; Al-Rohil, RN; Mobley, BC; Salem, JE; Wang, DY; Sanchez, V; Wang, Y; Chastain, CA; Barker, K; Liang, Y; Warren, S; Beechem, JM; Menzies, AM; Tio, M; Long, GV; Cohen, JV; Guidon, AC; O'Hare, M; Chandra, S; Chowdhary, A; Lebrun-Vignes, B; Goldinger, SM; Rushing, EJ; Buchbinder, EI; Mallal, SA; Shi, CJ; Xu, YM; Moslehi, JJ; Sanders, ME; Sosman, JA; Balko, JM				Johnson, Douglas B.; McDonnell, Wyatt J.; Gonzalez-Ericsson, Paula I.; Al-Rohil, Rami N.; Mobley, Bret C.; Salem, Joe-Elie; Wang, Daniel Y.; Sanchez, Violeta; Wang, Yu; Chastain, Cody A.; Barker, Kristi; Liang, Yan; Warren, Sarah; Beechem, Joseph M.; Menzies, Alexander M.; Tio, Martin; Long, Georgina V.; Cohen, Justine V.; Guidon, Amanda C.; O'Hare, Meabh; Chandra, Sunandana; Chowdhary, Akansha; Lebrun-Vignes, Benedicte; Goldinger, Simone M.; Rushing, Elisabeth J.; Buchbinder, Elizabeth I.; Mallal, Simon A.; Shi, Chanjuan; Xu, Yaomin; Moslehi, Javid J.; Sanders, Melinda E.; Sosman, Jeffrey A.; Balko, Justin M.			A case report of clonal EBV-like memory CD4(+) T cell activation in fatal checkpoint inhibitor-induced encephalitis	NATURE MEDICINE			English	Article							CLASS-I; TCR REPERTOIRES; CASE SERIES; IPILIMUMAB; EXPRESSION; RESPONSES; MELANOMA; FEATURES; DISTINCT; EPITOPE	Checkpoint inhibitors produce durable responses in numerous metastatic cancers, but immune-related adverse events (irAEs) complicate and limit their benefit. IrAEs can affect organ systems idiosyncratically; presentations range from mild and self-limited to fulminant and fatal. The molecular mechanisms underlying irAEs are poorly understood. Here, we report a fatal case of encephalitis arising during anti-programmed cell death receptor 1 therapy in a patient with metastatic melanoma. Histologic analyses revealed robust T cell infiltration and prominent programmed death ligand 1 expression. We identified 209 reported cases in global pharmacovigilance databases (across multiple cancer types) of encephalitis associated with checkpoint inhibitor regimens, with a 19% fatality rate. We performed further analyses from the index case and two additional cases to shed light on this recurrent and fulminant irAE. Spatial and multi-omic analyses pinpointed activated memory CD4(+) T cells as highly enriched in the inflamed, affected region. We identified a highly oligoclonal T cell receptor repertoire, which we localized to activated memory cytotoxic (CD45RO(+)GZMB(+)Ki67(+)) CD4 cells. We also identified Epstein-Barr virus-specific T cell receptors and EBV+ lymphocytes in the affected region, which we speculate contributed to neural inflammation in the index case. Collectively, the three cases studied here identify CD4(+) and CD8(+) T cells as culprits of checkpoint inhibitor-associated immune encephalitis.	[Johnson, Douglas B.; McDonnell, Wyatt J.; Salem, Joe-Elie; Wang, Daniel Y.; Chastain, Cody A.; Mallal, Simon A.; Moslehi, Javid J.; Balko, Justin M.] Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Johnson, Douglas B.; McDonnell, Wyatt J.; Mallal, Simon A.; Balko, Justin M.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA; [McDonnell, Wyatt J.; Al-Rohil, Rami N.; Mobley, Bret C.; Sanchez, Violeta; Mallal, Simon A.; Shi, Chanjuan; Sanders, Melinda E.; Balko, Justin M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [McDonnell, Wyatt J.; Mallal, Simon A.] Vanderbilt Univ, Med Ctr, Ctr Translat Immunol & Infect Dis, 221 Kirkland Hall, Nashville, TN 37235 USA; [McDonnell, Wyatt J.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gonzalez-Ericsson, Paula I.; Balko, Justin M.] Vanderbilt Univ, Med Ctr, Breast Canc Res Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Al-Rohil, Rami N.] Duke Univ, Med Ctr, Dept Pathol & Dermatol, Durham, NC USA; [Salem, Joe-Elie; Lebrun-Vignes, Benedicte] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP,Dept Pharmacol, INSERM CIC Paris Est,ICAN,Reg Pharmacovigilance C, Paris, France; [Wang, Yu; Xu, Yaomin] Vanderbilt Univ, Med Ctr, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Barker, Kristi; Liang, Yan; Warren, Sarah; Beechem, Joseph M.] NanoString Technol, Seattle, WA USA; [Menzies, Alexander M.; Tio, Martin; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Menzies, Alexander M.; Long, Georgina V.] Univ Sydney, Sydney, NSW, Australia; [Menzies, Alexander M.; Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Menzies, Alexander M.; Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia; [Cohen, Justine V.; Guidon, Amanda C.; O'Hare, Meabh] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chandra, Sunandana; Chowdhary, Akansha] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Goldinger, Simone M.] Univ Hosp, Dept Dermatol, Zurich, Switzerland; [Rushing, Elisabeth J.] Univ Hosp, Inst Neuropathol, Zurich, Switzerland; [Buchbinder, Elizabeth I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Mallal, Simon A.] Inst Immunol & Infect Dis, Perth, WA, Australia; [Sosman, Jeffrey A.] Northwestern Feinberg Sch Med, Chicago, IL USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Vanderbilt University; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital; Harvard University; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Harvard University; Dana-Farber Cancer Institute; Northwestern University; Feinberg School of Medicine	Johnson, DB; Balko, JM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA.; Johnson, DB; Balko, JM (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, 221 Kirkland Hall, Nashville, TN 37235 USA.; Balko, JM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Balko, JM (corresponding author), Vanderbilt Univ, Med Ctr, Breast Canc Res Program, 221 Kirkland Hall, Nashville, TN 37235 USA.	douglas.b.johnson@vumc.org; justin.balko@vumc.org	Mallal, Simon Alexander/HDM-9561-2022; Long, Georgina V/C-1771-2013	Mallal, Simon Alexander/0000-0002-7036-1309; Long, Georgina V/0000-0001-8894-3545; Salem, Joe-Elie/0000-0002-0331-3307; Al-Rohil, Rami/0000-0002-9431-0530; Wang, Yu/0000-0002-2819-4551; Mobley, Bret/0000-0002-8138-5330; McDonnell, Wyatt/0000-0003-3859-2067; Gonzalez Ericsson, Paula/0000-0002-6292-6963	NHBLI [T32HL069765]; NIDDK [R01DK112262, R56DK108352]; NHLBI [K12HL143956]; NIAID [P30AI110527]; NIH/NCI [K23 CA204726, R00CA181491]; James C. Bradford Jr. Melanoma Fund; Cancer ITMO of the French National Alliance for Life and Health Sciences (AVIESAN); Department of Defense Era of Hope Award [BC170037]; NCI/NIH Cancer Center [5P30 CA68485-19]; Vanderbilt Mouse Metabolic Phenotyping Center [2 U24 DK059637-16]; NATIONAL CANCER INSTITUTE [K23CA204726, P30CA068485, R01CA227481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765, K12HL143956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI110527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112262] Funding Source: NIH RePORTER	NHBLI; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James C. Bradford Jr. Melanoma Fund; Cancer ITMO of the French National Alliance for Life and Health Sciences (AVIESAN); Department of Defense Era of Hope Award; NCI/NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Mouse Metabolic Phenotyping Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the patients and their families for participating in this study. W.J.M. was supported by NHBLI grant no. T32HL069765, NIDDK grant nos. R01DK112262 and R56DK108352 and NHLBI grant no. K12HL143956. S.A.M. was supported by NIAID grant no. P30AI110527. D.B.J. is supported by NIH/NCI grant no. K23 CA204726 and the James C. Bradford Jr. Melanoma Fund. J.E.S. was supported by the Cancer ITMO of the French National Alliance for Life and Health Sciences (AVIESAN): 'Plan Cancer 2014-2019'. J.M.B. was supported by the Department of Defense Era of Hope Award no. BC170037 and NIH/NCI grant no. R00CA181491. In addition, we acknowledge the Translational Pathology Shared Resource supported by NCI/NIH Cancer Center Support Grant no. 5P30 CA68485-19 and the Vanderbilt Mouse Metabolic Phenotyping Center Grant no. 2 U24 DK059637-16. The supplied data from VigiBase come from a variety of sources. The probability that a reported adverse event is related to a drug response is not equal in all cases; the information in VigiBase and these analyses does not represent the opinion of the World Health Organization or the Uppsala Monitoring Centre.	Andrews S., 2010, FASTQC QUALITY CONTR; Annels NE, 2000, J IMMUNOL, V165, P4831, DOI 10.4049/jimmunol.165.9.4831; Bossart S, 2017, ONCOLOGIST, V22, P749, DOI 10.1634/theoncologist.2016-0366; Boyle LH, 2004, IMMUNOLOGY, V112, P54, DOI 10.1111/j.1365-2567.2004.01857.x; Chen G, 2017, CELL REP, V19, P569, DOI 10.1016/j.celrep.2017.03.072; Cohen GB, 2002, VIROLOGY, V304, P474, DOI 10.1006/viro.2002.1743; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Darvin P, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0191-1; Das R, 2018, J CLIN INVEST, V128, P715, DOI 10.1172/JCI96798; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Gielis S., 2018, TCREX WEBTOOL PREDIC, DOI [10.1101/373472., DOI 10.1101/373472, 10.1101/373472]; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Gonzalez RS, 2017, HISTOPATHOLOGY, V70, P558, DOI 10.1111/his.13118; Grant EJ, 2016, J BIOL CHEM, V291, P24335, DOI 10.1074/jbc.M116.753988; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Iwama S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008002; Johnson DB, 2018, JAMA-J AM MED ASSOC, V320, P1702, DOI 10.1001/jama.2018.13995; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Koning D, 2014, J IMMUNOL METHODS, V405, P199, DOI 10.1016/j.jim.2014.01.013; Larkin J, 2017, ONCOLOGIST, V22, P709, DOI 10.1634/theoncologist.2016-0487; Legoux F, 2013, EUR J IMMUNOL, V43, P3244, DOI 10.1002/eji.201343726; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Mathew JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19621-6; Moslehi JJ, 2018, LANCET, V391, P933, DOI 10.1016/S0140-6736(18)30533-6; Naidoo J, 2017, J CLIN ONCOL, V35, P709, DOI 10.1200/JCO.2016.68.2005; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Osorio JC, 2017, ANN ONCOL, V28, P583, DOI 10.1093/annonc/mdw640; Peeters LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01160; Penaloza-MacMaster P, 2015, SCIENCE, V347, P278, DOI 10.1126/science.aaa2148; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Ranasinghe S, 2016, IMMUNITY, V45, P917, DOI 10.1016/j.immuni.2016.09.015; Rustenhoven J, 2017, TRENDS PHARMACOL SCI, V38, P291, DOI 10.1016/j.tips.2016.12.001; Shugay M, 2018, NUCLEIC ACIDS RES, V46, pD419, DOI 10.1093/nar/gkx760; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Takeuchi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00194; Tickotsky N, 2017, BIOINFORMATICS, V33, P2924, DOI 10.1093/bioinformatics/btx286; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Verschuren EC, 2016, CLIN GASTROENTEROL H, V14, P836, DOI 10.1016/j.cgh.2015.12.028; Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang M, 2009, CLIN EXP IMMUNOL, V155, P441, DOI 10.1111/j.1365-2249.2008.03856.x	45	88	90	4	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1243	+		10.1038/s41591-019-0523-2	http://dx.doi.org/10.1038/s41591-019-0523-2			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31332390	Green Accepted			2022-12-27	WOS:000480414600022
J	Didelot, X; Pouwels, KB				Didelot, Xavier; Pouwels, Koen B.			Machine-learning-assisted selection of antibiotic prescription	NATURE MEDICINE			English	Editorial Material							MECHANISMS	Machine learning can use patients' demographic information and previous clinical history to help physicians select the antibiotics most likely to successfully treat urinary tract infections, despite growing levels of resistance.	[Didelot, Xavier] Univ Warwick, Sch Life Sci, Warwick, England; [Didelot, Xavier] Univ Warwick, Dept Stat, Warwick, England; [Pouwels, Koen B.] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England	University of Warwick; University of Warwick; University of Oxford	Didelot, X (corresponding author), Univ Warwick, Sch Life Sci, Warwick, England.; Didelot, X (corresponding author), Univ Warwick, Dept Stat, Warwick, England.	xavier.didelot@warwick.ac.uk	Pouwels, Koen B./F-2081-2013; Didelot, Xavier/H-1608-2013	Pouwels, Koen B./0000-0001-7097-8950; Didelot, Xavier/0000-0003-1885-500X	MRC [MR/R015600/1] Funding Source: UKRI; Medical Research Council [MR/R015600/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190521; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Didelot X, 2016, NAT REV MICROBIOL, V14, P150, DOI 10.1038/nrmicro.2015.13; Dolk FCK, 2018, J ANTIMICROB CHEMOTH, V73, P2, DOI 10.1093/jac/dkx504; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; McAdams D, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000250; Oonsivilai Mathupanee, 2018, Wellcome Open Res, V3, P131, DOI 10.12688/wellcomeopenres.14847.1; Pouwels KB, 2018, J ANTIMICROB CHEMOTH, V73, P1700, DOI 10.1093/jac/dky031; Roope LSJ, 2019, SCIENCE, V364, P41, DOI 10.1126/science.aau4679; Whittles LK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002416; Yelin I, 2019, NAT MED, V25, P1143, DOI 10.1038/s41591-019-0503-6	12	3	4	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1033	1034		10.1038/s41591-019-0517-0	http://dx.doi.org/10.1038/s41591-019-0517-0			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31273329	Green Accepted, Green Submitted			2022-12-27	WOS:000474430400013
J	Dougan, M; Dougan, SK				Dougan, Michael; Dougan, Stephanie K.			Programmable bacteria as cancer therapy	NATURE MEDICINE			English	Editorial Material							CD47 BLOCKADE; IMMUNOTHERAPY; CELLS	Quorum-sensing bacteria can deliver a nanobody targeting the 'don't eat me' ligand CD47 to tumors that results in systemic anti-tumor immunity-induced regression in mice.	[Dougan, Michael] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA; [Dougan, Michael] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Dougan, Stephanie K.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Dougan, Stephanie K.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Dougan, SK (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA.; Dougan, SK (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	stephanie_dougan@dfci.harvard.edu						Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Chowdhury S, 2019, NAT MED, V25, P1057, DOI 10.1038/s41591-019-0498-z; Ingram JR, 2018, ANNU REV IMMUNOL, V36, P695, DOI 10.1146/annurev-immunol-042617-053327; Ingram JR, 2017, P NATL ACAD SCI USA, V114, P10184, DOI 10.1073/pnas.1710776114; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; STARNES CO, 1992, NATURE, V357, P11, DOI 10.1038/357011a0; Weiskopf K, 2017, EUR J CANCER, V76, P100, DOI 10.1016/j.ejca.2017.02.013; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Xu MM, 2017, IMMUNITY, V47, P363, DOI 10.1016/j.immuni.2017.07.016	12	16	16	6	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1030	1031		10.1038/s41591-019-0513-4	http://dx.doi.org/10.1038/s41591-019-0513-4			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270505				2022-12-27	WOS:000474430400011
J	Stower, H				Stower, Hannah			Maintaining and expanding HSCs	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1029	1029		10.1038/s41591-019-0530-3	http://dx.doi.org/10.1038/s41591-019-0530-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270496	Bronze			2022-12-27	WOS:000474430400008
J	Raychaudhuri, S; Gupta, RM				Raychaudhuri, Soumya; Gupta, Rajat M.			Immunoprofiling comes of age	NATURE MEDICINE			English	Editorial Material							IMMUNE		[Raychaudhuri, Soumya] Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol & Genet, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Gupta, Rajat M.] Broad Inst Massachusetts Inst & Technol & Harvar, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Div Rheumatol Immunol Allergy, Brookline, MA USA; [Raychaudhuri, Soumya] Harvard Med Sch, Brookline, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Ctr Musculoskeletal Res, Arthrit Res UK Ctr Genet & Genom, Oxford Rd, Manchester, Lancs, England; [Gupta, Rajat M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Gupta, Rajat M.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of Manchester; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Ctr Data Sci, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol & Genet, 75 Francis St, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.; Raychaudhuri, S (corresponding author), Broad Inst Massachusetts Inst & Technol & Harvar, Cambridge, MA 02142 USA.; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol Allergy, Brookline, MA USA.; Raychaudhuri, S (corresponding author), Harvard Med Sch, Brookline, MA USA.; Raychaudhuri, S (corresponding author), Univ Manchester, Ctr Musculoskeletal Res, Arthrit Res UK Ctr Genet & Genom, Oxford Rd, Manchester, Lancs, England.	soumya@broadinstitute.org		Raychaudhuri, Soumya/0000-0002-1901-8265	NHGRI NIH HHS [U01 HG009379] Funding Source: Medline; NIAMS NIH HHS [R01 AR063759, UH2 AR067677] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Fonseka CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0305; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]	9	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					362	364		10.1038/s41591-019-0387-5	http://dx.doi.org/10.1038/s41591-019-0387-5			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842672	Green Accepted			2022-12-27	WOS:000460643100012
J	Nation, DA; Sweeney, MD; Montagne, A; Sagare, AP; D'Orazio, LM; Pachicano, M; Sepehrband, F; Nelson, AR; Buennagel, DP; Harrington, MG; Benzinger, TLS; Fagan, AM; Ringman, JM; Schneider, LS; Morris, JC; Chui, HC; Law, M; Toga, AW; Zlokovic, BV				Nation, Daniel A.; Sweeney, Melanie D.; Montagne, Axel; Sagare, Abhay P.; D'Orazio, Lina M.; Pachicano, Maricarmen; Sepehrband, Farshid; Nelson, Amy R.; Buennagel, David P.; Harrington, Michael G.; Benzinger, Tammie L. S.; Fagan, Anne M.; Ringman, John M.; Schneider, Lon S.; Morris, John C.; Chui, Helena C.; Law, Meng; Toga, Arthur W.; Zlokovic, Berislav V.			Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction	NATURE MEDICINE			English	Article							EARLY ALZHEIMERS-DISEASE; HUMAN CEREBRAL-CORTEX; VASCULAR RISK-FACTORS; FACTOR RECEPTOR-BETA; CEREBROSPINAL-FLUID; NEUROVASCULAR DYSFUNCTION; CEREBROVASCULAR-DISEASE; VESSEL DISEASE; PERICYTES; TAU	Vascular contributions to cognitive impairment are increasingly recognized1-5 as shown by neuropathological(6,7), neuroimaging(4,8-11), and cerebrospinal fluid biomarker(4,12) studies. Moreover, small vessel disease of the brain has been estimated to contribute to approximately 50% of all dementias worldwide, including those caused by Alzheimer's disease (AD)(3,4,13). Vascular changes in AD have been typically attributed to the vasoactive and/or vasculotoxic effects of amyloid-beta (A beta)(3,11,14), and more recently tau(15). Animal studies suggest that A beta and tau lead to blood vessel abnormalities and blood-brain barrier (BBB) breakdown(14-16). Although neurovascular dysfunction(3,11) and BBB breakdown develop early in AD(1,4,5,8-10,12,13), how they relate to changes in the AD classical biomarkers A beta and tau, which also develop before dementia(17), remains unknown. To address this question, we studied brain capillary damage using a novel cerebrospinal fluid biomarker of BBB-associated capillary mural cell pericyte, soluble platelet-derived growth factor receptor-beta(8,18), and regional BBB permeability using dynamic contrast-enhanced magnetic resonance imaging(8-10). Our data show that individuals with early cognitive dysfunction develop brain capillary damage and BBB breakdown in the hippocampus irrespective of Alzheimer's A beta and/or tau biomarker changes, suggesting that BBB breakdown is an early biomarker of human cognitive dysfunction independent of A beta and tau.	[Nation, Daniel A.; Sweeney, Melanie D.; Montagne, Axel; Sagare, Abhay P.; Pachicano, Maricarmen; Nelson, Amy R.; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA; [Nation, Daniel A.; D'Orazio, Lina M.; Ringman, John M.; Schneider, Lon S.; Chui, Helena C.; Law, Meng; Toga, Arthur W.; Zlokovic, Berislav V.] Univ Southern Calif, Keck Sch Med, Alzheimers Dis Res Ctr, Los Angeles, CA 90033 USA; [Nation, Daniel A.] Univ Southern Calif, Dept Psychol, Los Angeles, CA 90089 USA; [D'Orazio, Lina M.; Ringman, John M.; Schneider, Lon S.; Chui, Helena C.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Sepehrband, Farshid; Law, Meng; Toga, Arthur W.] Univ Southern Calif, Keck Sch Med, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90033 USA; [Buennagel, David P.; Harrington, Michael G.] Huntington Med Res Inst, Pasadena, CA USA; [Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Benzinger, Tammie L. S.; Fagan, Anne M.; Morris, John C.] Washington Univ, Sch Med, Hope Ctr Neurodegenerat Disorders, St Louis, MO USA; [Fagan, Anne M.; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Fagan, Anne M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA; [Schneider, Lon S.] Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [Law, Meng] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Huntington Medical Research Institutes; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA.; Zlokovic, BV (corresponding author), Univ Southern Calif, Keck Sch Med, Alzheimers Dis Res Ctr, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Benzinger, Tammie/L-6104-2013; Sagare, Abhay/Y-3273-2019; Nelson, Amy R./HCH-3772-2022; Montagne, Axel/AAV-4343-2020; Nation, Daniel/AAD-1019-2019	Benzinger, Tammie/0000-0002-8114-0552; Sagare, Abhay/0000-0002-8178-3785; Nelson, Amy R./0000-0003-2025-1408; Montagne, Axel/0000-0001-5564-985X; Harrington, Michael/0000-0002-7923-8032; Sweeney, Melanie/0000-0001-9009-6488; Morris, John/0000-0001-9820-5618; Sepehrband, Farshid/0000-0002-4483-5961	National Institutes of Health (NIH) [R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, 5P50AG005142, 509279]; Cure Alzheimer's Fund; Foundation Leducq Transatlantic Network of Excellence [16 CVD 05]; L.K. Whittier Foundation [P01AG052350, RO1AG054434, R01AG055770]; NIH [5P50AG005142, R21AG055034, P50AG05681, P01AG03991, P01AG026276]; Alzheimer's Association [AARG-17-532905]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100459, R01NS090904, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, P50AG005142, R21AG055034, R01AG055770, P01AG026276, R01AG023084, P01AG003991, P01AG052350, R01AG054434, K99AG058780] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; Foundation Leducq Transatlantic Network of Excellence; L.K. Whittier Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work of B.V.Z. is supported by the National Institutes of Health (NIH) grant nos. R01AG023084, R01NS090904, R01NS034467, R01AG039452, 1R01NS100459, 5P01AG052350, and 5P50AG005142 in addition to the Alzheimer's Association strategic 509279 grant, Cure Alzheimer's Fund, and the Foundation Leducq Transatlantic Network of Excellence for the Study of Perivascular Spaces in Small Vessel Disease reference no. 16 CVD 05. D.B and M.G.H. are supported by the L.K. Whittier Foundation, grant nos. P01AG052350, RO1AG054434, and R01AG055770. D.N. is supported by the NIH grant no. R21AG055034 and Alzheimer's Association grant no. AARG-17-532905. Enrollment of participants into the Washington University Knight ADRC is supported by NIH grant nos. P50AG05681 (J.C.M.), P01AG03991 (J.C.M.), and P01AG026276 (J.C.M.). Enrollment of participants into the USC ADRC is supported by NIH grant no. 5P50AG005142 (H.C.C.).	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Bangen KJ, 2015, ALZHEIMERS DEMENT, V11, P394, DOI 10.1016/j.jalz.2013.12.025; Barnes SR, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0062-3; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; Bondi MW, 2014, J ALZHEIMERS DIS, V42, P275, DOI 10.3233/JAD-140276; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Drachman DA, 2014, ALZHEIMERS DEMENT, V10, P372, DOI 10.1016/j.jalz.2013.11.003; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Glikmann-Johnston Y, 2015, NEUROPSYCHOLOGIA, V69, P39, DOI 10.1016/j.neuropsychologia.2015.01.031; Gordon BA, 2016, JAMA NEUROL, V73, P1192, DOI 10.1001/jamaneurol.2016.2642; Gottesman RF, 2017, JAMA-J AM MED ASSOC, V317, P1443, DOI 10.1001/jama.2017.3090; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jak AJ, 2016, J INT NEUROPSYCH SOC, V22, P937, DOI 10.1017/S1355617716000199; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Mendelson K, 2010, J BIOL CHEM, V285, P25024, DOI 10.1074/jbc.M110.102566; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nation DA, 2012, J ALZHEIMERS DIS, V30, P595, DOI 10.3233/JAD-2012-111697; O'Shea A, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00298; Pan C, 2015, J ALZHEIMERS DIS, V45, P709, DOI 10.3233/JAD-143099; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Provost JS, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00140; Rodriguez-Aranda C, 2016, BRAIN LANG, V155, P24, DOI 10.1016/j.bandl.2016.03.001; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Sagare AP, 2015, NEUROSCI LETT, V607, P97, DOI 10.1016/j.neulet.2015.09.025; Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382; Sepehrband F, 2018, NEUROIMAGE, V172, P217, DOI 10.1016/j.neuroimage.2018.01.065; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073377; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Sweeney MD, 2015, J CEREBR BLOOD F MET, V35, P1055, DOI 10.1038/jcbfm.2015.76; Tan ZB, 2018, NEURON, V98, P380, DOI 10.1016/j.neuron.2018.03.018; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Trost A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00020; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van de Haar HJ, 2016, NEUROBIOL AGING, V45, P190, DOI 10.1016/j.neurobiolaging.2016.06.006; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; VERBEEK MM, 1994, AM J PATHOL, V144, P372; Wallin A, 1999, ALZ DIS ASSOC DIS, V13, pS102, DOI 10.1097/00002093-199912003-00015; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	60	569	585	37	301	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					270	+		10.1038/s41591-018-0297-y	http://dx.doi.org/10.1038/s41591-018-0297-y			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30643288	Green Accepted, Green Submitted			2022-12-27	WOS:000457842100024
J	Sun, LL; Xie, C; Wang, G; Wu, Y; Wu, Q; Wang, XM; Liu, J; Deng, YY; Xia, JL; Chen, B; Zhang, SY; Yun, CY; Lian, G; Zhang, XJ; Zhang, H; Bisson, WH; Shi, JM; Gao, XX; Ge, PP; Liu, CH; Krausz, KW; Nichols, RG; Cai, JW; Rimal, B; Patterson, AD; Wang, X; Gonzalez, FJ; Jiang, CT				Sun, Lulu; Xie, Cen; Wang, Guang; Wu, Yue; Wu, Qing; Wang, Xuemei; Liu, Jia; Deng, Yangyang; Xia, Jialin; Chen, Bo; Zhang, Songyang; Yun, Chuyu; Lian, Guan; Zhang, Xiujuan; Zhang, Heng; Bisson, William H.; Shi, Jingmin; Gao, Xiaoxia; Ge, Pupu; Liu, Cuihua; Krausz, Kristopher W.; Nichols, Robert G.; Cai, Jingwei; Rimal, Bipin; Patterson, Andrew D.; Wang, Xian; Gonzalez, Frank J.; Jiang, Changtao			Gut microbiota and intestinal FXR mediate the clinical benefits of metformin	NATURE MEDICINE			English	Article							FARNESOID-X-RECEPTOR; BILE-ACID SYNTHESIS; BETA-MURICHOLIC ACID; METABOLISM; LIVER; AXIS; GLUCONEOGENESIS; HOMEOSTASIS; PROBIOTICS; MECHANISM	The anti-hyperglycemic effect of metformin is believed to be caused by its direct action on signaling processes in hepatocytes, leading to lower hepatic gluconeogenesis. Recently, metformin was reported to alter the gut microbiota community in humans, suggesting that the hyperglycemia-lowering action of the drug could be the result of modulating the population of gut microbiota. However, the critical microbial signaling metabolites and the host targets associated with the metabolic benefits of metformin remained elusive. Here, we performed metagenomic and metabolomic analysis of samples from individuals with newly diagnosed type 2 diabetes (T2D) naively treated with metformin for 3 d, which revealed that Bacteroides fragilis was decreased and the bile acid glycoursodeoxycholic acid (GUDCA) was increased in the gut. These changes were accompanied by inhibition of intestinal farnesoid X receptor (FXR) signaling. We further found that high-fat-diet (HFD)-fed mice colonized with B. fragilis were predisposed to more severe glucose intolerance, and the metabolic benefits of metformin treatment on glucose intolerance were abrogated. GUDCA was further identified as an intestinal FXR antagonist that improved various metabolic endpoints in mice with established obesity. Thus, we conclude that metformin acts in part through a B. fragilis-GUDCA-intestinal FXR axis to improve metabolic dysfunction, including hyperglycemia.	[Sun, Lulu; Wu, Qing; Wang, Xuemei; Xia, Jialin; Chen, Bo; Zhang, Songyang; Yun, Chuyu; Lian, Guan; Zhang, Xiujuan; Jiang, Changtao] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Sun, Lulu; Wu, Qing; Wang, Xuemei; Xia, Jialin; Chen, Bo; Zhang, Songyang; Yun, Chuyu; Lian, Guan; Zhang, Xiujuan; Jiang, Changtao] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Xie, Cen; Shi, Jingmin; Gao, Xiaoxia; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wang, Guang; Liu, Jia; Zhang, Heng] Capital Med Univ, Beijing Chao Yang Hosp, Dept Endocrinol, Beijing, Peoples R China; [Wu, Yue; Deng, Yangyang] Xi An Jiao Tong Univ, Dept Cardiol, Key Lab Environm & Genes Related Dis, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Bisson, William H.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Ge, Pupu; Liu, Cuihua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Nichols, Robert G.; Cai, Jingwei; Rimal, Bipin; Patterson, Andrew D.] Penn State Univ, Dept Mol Toxicol, University Pk, PA 16802 USA	Peking University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Capital Medical University; Xi'an Jiaotong University; Oregon State University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Jiang, CT (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.; Jiang, CT (corresponding author), Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China.	jiangchangtao@bjmu.edu.cn	Rimal, Bipin/HHN-1529-2022; Patterson, Andrew/ABF-1575-2020; Wang, Xuemei/GXF-3702-2022; Shi, Jing/HHS-6413-2022	Patterson, Andrew/0000-0003-2073-0070; Cai, Jingwei/0000-0002-3626-3350; Nichols, Robert/0000-0002-5415-7877; Deng, Yang-Yang/0000-0002-6470-2891; Song-Yang, Zhang/0000-0002-4356-897X; Sun, Lulu/0000-0001-8876-5099; Bo, Chen/0000-0003-4346-0755; Jiang, Changtao/0000-0002-5206-2372	National Key Research and Development Program of China [2016YFC0903100, 2016YFC0903102]; National Natural Science Foundation of China [91439206, 91739303, 81522007, 81470554, 31401011]; National Program for Support of Top-notch Young Professionals [82008Y0005]; Fundamental Research Funds for the Central Universities: Clinical Medicine Plus X-Young Scholars Project of Peking University [PKU2018LCXQ013]; National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012415] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for Support of Top-notch Young Professionals; Fundamental Research Funds for the Central Universities: Clinical Medicine Plus X-Young Scholars Project of Peking University; National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Key Research and Development Program of China (2016YFC0903100 and 2016YFC0903102) to C.J., the National Natural Science Foundation of China (91439206 and 91739303 to X.W., and 81522007, 81470554 and 31401011 to C.J.), the National Program for Support of Top-notch Young Professionals (82008Y0005) to C.J., the Fundamental Research Funds for the Central Universities: Clinical Medicine Plus X-Young Scholars Project of Peking University (PKU2018LCXQ013) to C.J., and the National Cancer Institute Intramural Research Program to F.J.G.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; Bauer PV, 2018, CELL METAB, V27, P572, DOI 10.1016/j.cmet.2018.01.013; Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Fujita K, 2017, LIPIDS, V52, P335, DOI 10.1007/s11745-017-4242-5; Geach T, 2017, NAT REV ENDOCRINOL, V13, P66, DOI 10.1038/nrendo.2016.201; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Gu YY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01682-2; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Lien F, 2014, J CLIN INVEST, V124, P1037, DOI 10.1172/JCI68815; Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; Mueller M, 2015, J HEPATOL, V62, P1398, DOI 10.1016/j.jhep.2014.12.034; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Olgun A, 2017, MED HYPOTHESES, V106, P33, DOI [10.1016/j.mehy.2017.07.009, 10.1016]; Parseus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Pathak P, 2017, J BIOL CHEM, V292, P11055, DOI 10.1074/jbc.M117.784322; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schaeffer L, 2017, BIOINFORMATICS, V33, P2082, DOI 10.1093/bioinformatics/btx106; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Singhal A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009885; STELLWAG EJ, 1976, BIOCHIM BIOPHYS ACTA, V452, P165, DOI 10.1016/0005-2744(76)90068-1; Takahashi S, 2016, J LIPID RES, V57, P2130, DOI 10.1194/jlr.M071183; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Tsuchida T, 2012, METABOLISM, V61, P944, DOI 10.1016/j.metabol.2011.10.023; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Xie C, 2017, DIABETES, V66, P613, DOI 10.2337/db16-0663; Zhang LC, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0294-5; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	49	372	408	41	363	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1919	+		10.1038/s41591-018-0222-4	http://dx.doi.org/10.1038/s41591-018-0222-4			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30397356	Green Accepted			2022-12-27	WOS:000452392200021
J	Coudray, N; Ocampo, PS; Sakellaropoulos, T; Narula, N; Snuderl, M; Fenyo, D; Moreira, AL; Razavian, N; Tsirigos, A				Coudray, Nicolas; Ocampo, Paolo Santiago; Sakellaropoulos, Theodore; Narula, Navneet; Snuderl, Matija; Fenyo, David; Moreira, Andre L.; Razavian, Narges; Tsirigos, Aristotelis			Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning	NATURE MEDICINE			English	Article							TARGETED THERAPY; NEURAL-NETWORKS; EGFR MUTATION; LKB1; ADENOCARCINOMAS; INACTIVATION; SOCIETY; PROMISE; KRAS	Visual inspection of histopathology slides is one of the main methods used by pathologists to assess the stage, type and subtype of lung tumors. Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most prevalent subtypes of lung cancer, and their distinction requires visual inspection by an experienced pathologist. In this study, we trained a deep convolutional neural network (inception v3) on whole-slide images obtained from The Cancer Genome Atlas to accurately and automatically classify them into LUAD, LUSC or normal lung tissue. The performance of our method is comparable to that of pathologists, with an average area under the curve (AUC) of 0.97. Our model was validated on independent datasets of frozen tissues, formalin-fixed paraffin-embedded tissues and biopsies. Furthermore, we trained the network to predict the ten most commonly mutated genes in LUAD. We found that six of them-STK11, EGFR, FAT1, SETBP1, KRAS and TP53-can be predicted from pathology images, with AUCs from 0.733 to 0.856 as measured on a held-out population. These findings suggest that deep-learning models can assist pathologists in the detection of cancer subtype or gene mutations. Our approach can be applied to any cancer type, and the code is available at https://github.com/ncoudray/DeepPATH.	[Coudray, Nicolas; Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY 10003 USA; [Coudray, Nicolas] NYU, Sch Med, Dept Cell Biol, Skirball Inst, New York, NY 10016 USA; [Ocampo, Paolo Santiago; Narula, Navneet; Snuderl, Matija; Moreira, Andre L.; Tsirigos, Aristotelis] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Sakellaropoulos, Theodore] Natl Tech Univ Athens, Sch Mech Engn, Zografos, Greece; [Fenyo, David] NYU, Sch Med, Inst Syst Genet, New York, NY USA; [Fenyo, David] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Moreira, Andre L.] NYU, Ctr Biospecimen Res & Dev, New York, NY USA; [Razavian, Narges] NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA; [Razavian, Narges] NYU, Sch Med, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10003 USA	New York University; New York University; New York University; National Technical University of Athens; New York University; New York University; New York University; New York University; New York University	Tsirigos, A (corresponding author), NYU, Sch Med, Appl Bioinformat Labs, New York, NY 10003 USA.; Tsirigos, A (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.; Razavian, N (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY 10003 USA.; Razavian, N (corresponding author), NYU, Sch Med, Ctr Healthcare Innovat & Delivery Sci, New York, NY 10003 USA.	narges.razavian@nyumc.org; aristotelis.tsirigos@nyumc.org	Sakellaropoulos, Theodore/AAJ-7256-2021; Coudray, Nicolas/O-5935-2015	Sakellaropoulos, Theodore/0000-0001-9946-9498; Coudray, Nicolas/0000-0002-6050-2219; Snuderl, Matija/0000-0003-0752-0917; Tsirigos, Aristotelis/0000-0002-7512-8477; Ocampo, Paolo Santiago/0000-0003-4876-0861; Razavian, Narges/0000-0002-9922-6370	Laura and Isaac Perlmutter Cancer Center [P30CA016087]	Laura and Isaac Perlmutter Cancer Center	We would like to thank the Applied Bioinformatics Laboratories (ABL) at the NYU School of Medicine for providing bioinformatics support and helping with the analysis and interpretation of the data. The Applied Bioinformatics Laboratories are a Shared Resource, partially supported by the Cancer Center Support Grant, P30CA016087 (A.T.), at the Laura and Isaac Perlmutter Cancer Center (A.T.). For this work, we used computing resources at the High -Performance Computing Facility (HPC) at NYU Langone Medical Center. The slide images and the corresponding cancer information were uploaded from the Genomic Data Commons portal (haps:Pgdo portal.nci.nih.gov) and are in whole or in part based upon data generated by the TCGA Research Network (httin(cancergenome. nil-11;ov'). These data were publicly available without restriction, authentication or authorization necessary. We thank the GDC help desk for providing assistance and information regarding the TCGA dataset. For the independent cohorts, we only used whole-slide images; the NYU dataset we used consists of slide images without identifiable information and therefore does not require approval according to both federal regulations and the NYU School of Medicine Institutional Review Board. For this same reason, written informed consent was not necessary. We thank C. Dickerson, from the Center for Biospecimen Research and Development (CBRD), for scanning the whole-slide images from the NYU Langone Medical Center. We also thank T. Papagiannakopoulos, H. Pass and K.-K. Wong or their valuable and constructive suggestions.	Abels Esther, 2017, J Pathol Inform, V8, P23, DOI 10.4103/jpi.jpi_11_17; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Blumenthal GM, 2017, ONCOLOGIST, V22, P762, DOI 10.1634/theoncologist.2017-0152; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bulten W, 2018, PROC SPIE, V10581, DOI 10.1117/12.2292872; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Cheng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21808; Chiang S, 2016, CANCER RES, V76, P7118, DOI 10.1158/0008-5472.CAN-16-0298; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; de Bel T, 2018, PROC SPIE, V10581, DOI 10.1117/12.2293717; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Dimou A, 2011, AM J PATHOL, V179, P580, DOI 10.1016/j.ajpath.2011.04.031; Donovan MJ, 2009, EUR J CANCER, V45, P1518, DOI 10.1016/j.ejca.2009.02.004; Efron B, 1994, INTRO BOOTSTRAP; Ertosun Mehmet Gunhan, 2015, AMIA Annu Symp Proc, V2015, P1899; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gloushankova N, 1997, ONCOGENE, V15, P2985, DOI 10.1038/sj.onc.1201483; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hanna N, 2017, J CLIN ONCOL, V35, P3484, DOI 10.1200/JCO.2017.74.6065; Hershey S, 2017, INT CONF ACOUST SPEE, P131, DOI 10.1109/ICASSP.2017.7952132; Houang M, 2014, PATHOLOGY, V46, P501, DOI 10.1097/PAT.0000000000000141; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khosravi P, 2018, EBIOMEDICINE, V27, P317, DOI 10.1016/j.ebiom.2017.12.026; Luo X, 2017, J THORAC ONCOL, V12, P501, DOI 10.1016/j.jtho.2016.10.017; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Mishra R, 2018, INT S BIOINF RES APP, P12; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Ninomiya H, 2009, LUNG CANCER, V63, P235, DOI 10.1016/j.lungcan.2008.04.017; Parums DV, 2014, DRUG TODAY, V50, P503, DOI [10.1358/dot.2014.50.07.2185913, 10.1358/dot.2014.50.7.2185913]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Qaiser T, 2018, MED IMAGE UNDERSTAND, P320; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schaumberg A.J., 2017, H E STAINED WHOLE SL, DOI [10.1101/064279, DOI 10.1101/064279]; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Simon O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20453-7; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Terra SBSP, 2016, MODERN PATHOL, V29, P824, DOI 10.1038/modpathol.2016.89; Terry J, 2010, AM J SURG PATHOL, V34, P1805, DOI 10.1097/PAS.0b013e3181f7dae3; Thunnissen E, 2014, VIRCHOWS ARCH, V464, P347, DOI 10.1007/s00428-014-1535-4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Warth A, 2014, EUR RESPIR J, V43, P872, DOI 10.1183/09031936.00018013; Xing FY, 2016, IEEE T MED IMAGING, V35, P550, DOI 10.1109/TMI.2015.2481436; Yatabe Y, 2005, AM J SURG PATHOL, V29, P633, DOI 10.1097/01.pas.0000157935.28066.35; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Zachara-Szczakowski S, 2015, HUM PATHOL, V46, P776, DOI 10.1016/j.humpath.2015.02.001; Zeiler M.D., 2015, EUR C COMP VIS, P818	67	957	1003	54	448	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1559	+		10.1038/s41591-018-0177-5	http://dx.doi.org/10.1038/s41591-018-0177-5			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30224757	Green Submitted			2022-12-27	WOS:000446577900019
J	Rossidis, AC; Stratigis, JD; Chadwick, AC; Hartman, HA; Ahn, NJ; Li, HY; Singh, K; Coons, BE; Li, L; Lv, WJ; Zoltick, PW; Alapati, D; Zacharias, W; Jain, R; Morrisey, EE; Musunuru, K; Peranteau, WH				Rossidis, Avery C.; Stratigis, John D.; Chadwick, Alexandra C.; Hartman, Heather A.; Ahn, Nicholas J.; Li, Haiying; Singh, Kshitiz; Coons, Barbara E.; Li, Li; Lv, Wenjian; Zoltick, Philip W.; Alapati, Deepthi; Zacharias, William; Jain, Rajan; Morrisey, Edward E.; Musunuru, Kiran; Peranteau, William H.			In utero CRISPR-mediated therapeutic editing of metabolic genes	NATURE MEDICINE			English	Article							HEREDITARY TYROSINEMIA TYPE-1; ADENOVIRAL VECTOR; HUMAN HEPATOCYTES; VIVO; MICE; PCSK9; TARGET; BASE; EXPRESSION; TOLERANCE	In utero gene editing has the potential to prenatally treat genetic diseases that result in significant morbidity and mortality before or shortly after birth. We assessed the viral vector-mediated delivery of CRISPR-Cas9 or base editor 3 in utero, seeking therapeutic modification of Pcsk9 or Hpd in wild-type mice or the murine model of hereditary tyrosinemia type 1, respectively. We observed long-term postnatal persistence of edited cells in both models, with reduction of plasma PCSK9 and cholesterol levels following in utero Pcsk9 targeting and rescue of the lethal phenotype of hereditary tyrosinemia type 1 following in utero Hpd targeting. The results of this proof-of-concept work demonstrate the possibility of efficiently performing gene editing before birth, pointing to a potential new therapeutic approach for selected congenital genetic disorders.	[Rossidis, Avery C.; Stratigis, John D.; Hartman, Heather A.; Ahn, Nicholas J.; Li, Haiying; Singh, Kshitiz; Coons, Barbara E.; Zoltick, Philip W.; Peranteau, William H.] Childrens Hosp Philadelphia, Ctr Fetal Res, Div Pediat Gen Thorac & Fetal Surg, Philadelphia, PA 19104 USA; [Chadwick, Alexandra C.; Li, Li; Lv, Wenjian; Alapati, Deepthi; Zacharias, William; Jain, Rajan; Morrisey, Edward E.; Musunuru, Kiran] Univ Penn, Dept Med, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chadwick, Alexandra C.; Li, Li; Lv, Wenjian; Musunuru, Kiran] Univ Penn, Dept Genet, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Alapati, Deepthi; Zacharias, William; Jain, Rajan; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Peranteau, WH (corresponding author), Childrens Hosp Philadelphia, Ctr Fetal Res, Div Pediat Gen Thorac & Fetal Surg, Philadelphia, PA 19104 USA.; Musunuru, K (corresponding author), Univ Penn, Dept Med, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Musunuru, K (corresponding author), Univ Penn, Dept Genet, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	kiranmusunuru@gmail.com; peranteauw@email.chop.edu	Singh, Kshitiz/AAT-2094-2020; Ahn, Nicholas/AAQ-8236-2021	Singh, Kshitiz/0000-0003-1331-1951; Zacharias, William/0000-0002-2643-0610; Coons, Barbara/0000-0003-1810-9533; Hartman, Heather/0000-0002-0164-4575	National Institutes of Health [T32-HL007843, R01-HL118744, R01-HL126875]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1-TR001878]; Institute for Translational Medicine and Therapeutics at the University of Pennsylvania; University of Pennsylvania Orphan Disease Center [GE-16-001-IU]; Winkelman Family Fund in Cardiovascular Innovation; Burroughs Wellcome Fund Career Award for Medical Scientists; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126875, R01HL118744, T32HL007843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Institute for Translational Medicine and Therapeutics at the University of Pennsylvania; University of Pennsylvania Orphan Disease Center; Winkelman Family Fund in Cardiovascular Innovation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants T32-HL007843 (A.C.W.), R01-HL118744 and R01-HL126875 (K.M.) from the National Institutes of Health; grant UL1-TR001878 from the National Center for Advancing Translational Sciences of the National Institutes of Health and the Institute for Translational Medicine and Therapeutics at the University of Pennsylvania (W.H.P. and K.M.); grant GE-16-001-IU from the University of Pennsylvania Orphan Disease Center (W.H.P.); the Winkelman Family Fund in Cardiovascular Innovation (K.M.); the Burroughs Wellcome Fund Career Award for Medical Scientists (R.J.); and generous family gifts to the Children's Hospital of Philadelphia (CHOP) (W.H.P.). We thank A. Weilerstein and L. Ma for their help with animal care, the Translational Core Laboratory at CHOP for assistance with liver function tests, and A. Radu, the Pathology Core at CHOP and the Histology Core at the Cardiovascular Institute at the University of Pennsylvania for their assistance with histology.	Ahi YS, 2011, CURR GENE THER, V11, P307; Aponte JL, 2001, P NATL ACAD SCI USA, V98, P641, DOI 10.1073/pnas.98.2.641; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Boelig MM, 2016, BIOL BLOOD MARROW TR, V22, P991, DOI 10.1016/j.bbmt.2016.01.017; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Daer RM, 2017, ACS SYNTH BIOL, V6, P428, DOI 10.1021/acssynbio.5b00299; Davey MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171132; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Endo M, 2010, GENE THER, V17, P61, DOI 10.1038/gt.2009.115; Finn JD, 2018, CELL REP, V22, P2227, DOI 10.1016/j.celrep.2018.02.014; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Kim D, 2017, NAT BIOTECHNOL, V35, P475, DOI 10.1038/nbt.3852; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lipshutz GS, 2000, MOL THER, V2, P374, DOI 10.1006/mthe.2000.0136; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Morrow G, 2017, ADV EXP MED BIOL, V959, P9, DOI 10.1007/978-3-319-55780-9_2; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Pankowicz FP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12642; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Rafati M, 2016, FETAL PEDIATR PATHOL, V35, P282, DOI 10.3109/15513815.2016.1167149; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sabatino DE, 2007, MOL THER, V15, P1677, DOI 10.1038/sj.mt.6300219; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang X, 2016, ARTERIOSCL THROM VAS, V36, P783, DOI 10.1161/ATVBAHA.116.307227; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2017, NAT BIOTECHNOL, V35, P1179, DOI 10.1038/nbt.4005; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	31	117	127	3	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1513	+		10.1038/s41591-018-0184-6	http://dx.doi.org/10.1038/s41591-018-0184-6			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297903	Green Accepted			2022-12-27	WOS:000446577900012
J	Ruella, M; Xu, J; Barrett, DM; Fraietta, JA; Reich, TJ; Ambrose, DE; Klichinsky, M; Shestova, O; Patel, PR; Kulikovskaya, I; Nazimuddin, F; Bhoj, VG; Orlando, EJ; Fry, TJ; Bitter, H; Maude, SL; Levine, BL; Nobles, CL; Bushman, FD; Young, RM; Scholler, J; Gill, SI; June, CH; Grupp, SA; Lacey, SF; Melenhorst, JJ				Ruella, Marco; Xu, Jun; Barrett, David M.; Fraietta, Joseph A.; Reich, Tyler J.; Ambrose, David E.; Klichinsky, Michael; Shestova, Olga; Patel, Prachi R.; Kulikovskaya, Irina; Nazimuddin, Farzana; Bhoj, Vijay G.; Orlando, Elena J.; Fry, Terry J.; Bitter, Hans; Maude, Shannon L.; Levine, Bruce L.; Nobles, Christopher L.; Bushman, Frederic D.; Young, Regina M.; Scholler, John; Gill, Saar I.; June, Carl H.; Grupp, Stephan A.; Lacey, Simon F.; Melenhorst, J. Joseph			Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-SEQUENCING DATA; TUMOR-CELLS; IMMUNOTHERAPY; FRAMEWORK	We report a patient relapsing 9 months after CD19-targeted CAR T cell (CTLO19) infusion with CD19(-) leukemia that aberrantly expressed the anti-CD19 CAR. The CAR gene was unintentionally introduced into a single leukemic B cell during T cell manufacturing, and its product bound in cis to the CD19 epitope on the surface of leukemic cells, masking it from recognition by and conferring resistance to CTLO19.	[Ruella, Marco; Xu, Jun; Fraietta, Joseph A.; Reich, Tyler J.; Ambrose, David E.; Klichinsky, Michael; Shestova, Olga; Patel, Prachi R.; Kulikovskaya, Irina; Nazimuddin, Farzana; Bhoj, Vijay G.; Levine, Bruce L.; Young, Regina M.; Scholler, John; Gill, Saar I.; June, Carl H.; Lacey, Simon F.; Melenhorst, J. Joseph] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Ruella, Marco; Xu, Jun; Fraietta, Joseph A.; Bhoj, Vijay G.; Levine, Bruce L.; June, Carl H.; Lacey, Simon F.; Melenhorst, J. Joseph] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ruella, Marco; Xu, Jun; Fraietta, Joseph A.; Bhoj, Vijay G.; Levine, Bruce L.; Gill, Saar I.; June, Carl H.; Lacey, Simon F.; Melenhorst, J. Joseph] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Ruella, Marco; Fraietta, Joseph A.; June, Carl H.] Univ Penn, Parker Inst Cellular Immunotherapy, Philadelphia, PA 19104 USA; [Ruella, Marco; Gill, Saar I.] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barrett, David M.; Maude, Shannon L.; Grupp, Stephan A.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Klichinsky, Michael] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Orlando, Elena J.; Bitter, Hans] Novartis Inst Biomed Res, Cambridge, MA USA; [Fry, Terry J.] Univ Colorado, Childrens Hosp Colorado, Denver, CO 80202 USA; [Nobles, Christopher L.; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Novartis; Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; University of Pennsylvania; Pennsylvania Medicine	June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; June, CH; Melenhorst, JJ (corresponding author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; June, CH (corresponding author), Univ Penn, Parker Inst Cellular Immunotherapy, Philadelphia, PA 19104 USA.	cjune@upenn.edu; mej@upenn.edu	Melenhorst, Jan/AAW-2546-2020; Ruella, Marco/GQP-8473-2022; patel, prachi/GRY-0386-2022	Melenhorst, Jan/0000-0001-7677-537X; Ruella, Marco/0000-0003-4301-5811; Reich, Tyler/0000-0003-0178-1411	NATIONAL CANCER INSTITUTE [R00CA212302, K99CA212302, T32CA009140, P01CA214278, R01CA120409] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA120409, T32 CA009140, K99 CA212302, P01 CA214278, R00 CA212302] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett DM, 2011, BLOOD, V118, pE112, DOI 10.1182/blood-2011-04-346528; Berry CC, 2012, BIOINFORMATICS, V28, P755, DOI 10.1093/bioinformatics/bts004; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Friederike Braig A. B, 2016, BLOOD, DOI [10.1182/blood-2016-05-718395, DOI 10.1182/BLOOD-2016-05-718395]; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jena B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057838; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcucci KT, 2018, MOL THER, V26, P269, DOI 10.1016/j.ymthe.2017.10.012; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyerson HJ, 2012, AM J CLIN PATHOL, V137, P39, DOI 10.1309/AJCP6VDBL4BRXRQA; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Mueller KT, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.220.220; Ruella M, 2017, BLOOD S1, V130; Ruella M, 2016, COMPUT STRUCT BIOTEC, V14, P357, DOI 10.1016/j.csbj.2016.09.003; Ruella M, 2016, J CLIN INVEST, V126, P3814, DOI 10.1172/JCI87366; Ruella M, 2016, CLIN CANCER RES, V22, P2684, DOI 10.1158/1078-0432.CCR-15-1527; Salvatore G, 2002, CLIN CANCER RES, V8, P995; Sherman E, 2016, MOL THER-METH CLIN D, V4, P39; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Swennenhuis JF, 2013, GENOME MED, V5, DOI 10.1186/gm510; TEDDER TF, 1989, J IMMUNOL, V143, P712; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Xiao XD, 2009, MABS-AUSTIN, V1, P297, DOI 10.4161/mabs.1.3.8113; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	36	288	318	5	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1499	+		10.1038/s41591-018-0201-9	http://dx.doi.org/10.1038/s41591-018-0201-9			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30275568	Green Accepted			2022-12-27	WOS:000446577900009
J	Chen, PHC; Gadepalli, K; MacDonald, R; Liu, Y; Kadowaki, S; Nagpal, K; Kohlberger, T; Dean, J; Corrado, GS; Hipp, JD; Mermel, CH; Stumpe, MC				Chen, Po-Hsuan Cameron; Gadepalli, Krishna; MacDonald, Robert; Liu, Yun; Kadowaki, Shiro; Nagpal, Kunal; Kohlberger, Timo; Dean, Jeffrey; Corrado, Greg S.; Hipp, Jason D.; Mermel, Craig H.; Stumpe, Martin C.			An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis	NATURE MEDICINE			English	Article								The microscopic assessment of tissue samples is instrumental for the diagnosis and staging of cancer, and thus guides therapy. However, these assessments demonstrate considerable variability and many regions of the world lack access to trained pathologists. Though artificial intelligence (AI) promises to improve the access and quality of healthcare, the costs of image digitization in pathology and difficulties in deploying AI solutions remain as barriers to real-world use. Here we propose a cost-effective solution: the augmented reality microscope (ARM). The ARM overlays AI-based information onto the current view of the sample in real time, enabling seamless integration of AI into routine workflows. We demonstrate the utility of ARM in the detection of metastatic breast cancer and the identification of prostate cancer, with latency compatible with real-time use. We anticipate that the ARM will remove barriers towards the use of AI designed to improve the accuracy and efficiency of cancer diagnosis.	[Chen, Po-Hsuan Cameron; Gadepalli, Krishna; MacDonald, Robert; Liu, Yun; Kadowaki, Shiro; Nagpal, Kunal; Kohlberger, Timo; Dean, Jeffrey; Corrado, Greg S.; Hipp, Jason D.; Mermel, Craig H.; Stumpe, Martin C.] Google Hlth, Mountain View, CA USA; [Hipp, Jason D.] AstraZeneca, Gaithersburg, MD USA; [Mermel, Craig H.] Tempus Labs Inc, Chicago, IL 60654 USA	AstraZeneca	Mermel, CH (corresponding author), Google Hlth, Mountain View, CA USA.; Mermel, CH (corresponding author), Tempus Labs Inc, Chicago, IL 60654 USA.	cmermel@google.com	Mermel, Craig/AAZ-7322-2020	Mermel, Craig/0000-0002-0816-3395; Chen, Po-Hsuan Cameron/0000-0002-0083-4991; Liu, Yun/0000-0003-4079-8275				Abadi Martin, 2016, arXiv; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Brimo F, 2010, J UROLOGY, V184, P126, DOI 10.1016/j.juro.2010.03.021; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; ELMORE JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI DOI 10.1001/JAMA.2015.1405; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gutman DA, 2013, J AM MED INFORM ASSN, V20, P1091, DOI 10.1136/amiajnl-2012-001469; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hegde N, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0131-z; Kather JN, 2019, NAT MED, V25, P1054, DOI 10.1038/s41591-019-0462-y; Kohlberger T., 2019, WHOLESLIDE IMAGE FOC; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu Y, 2017, COMMUN MATH BIOL NEU, DOI 10.1080/10408398.2017.1329704; Liu Y, 2019, ARCH PATHOL LAB MED, V143, P859, DOI 10.5858/arpa.2018-0147-OA; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Nagpal K, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0112-2; Pirnstill CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13368; Quinn J.A., 2016, P MACHINE LEARNING H, P271; Russ JC, 2012, WOODHEAD PUBL FOOD S, P233; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Steiner DF, 2018, AM J SURG PATHOL, V42, P1636, DOI 10.1097/PAS.0000000000001151; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; van der Laak JAWM, 2000, CYTOMETRY, V39, P275; Vanderplanck M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43058; Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]; Xie WD, 2018, COMP M BIO BIO E-IV, V6, P283, DOI 10.1080/21681163.2016.1149104	32	91	97	3	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1453	+		10.1038/s41591-019-0539-7	http://dx.doi.org/10.1038/s41591-019-0539-7			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31406351	Green Submitted			2022-12-27	WOS:000484832800029
J	Wiens, J; Saria, S; Sendak, M; Ghassemi, M; Liu, VX; Doshi-Velez, F; Jung, K; Heller, K; Kale, D; Saeed, M; Ossorio, PN; Thadaney-Israni, S; Goldenberg, A				Wiens, Jenna; Saria, Suchi; Sendak, Mark; Ghassemi, Marzyeh; Liu, Vincent X.; Doshi-Velez, Finale; Jung, Kenneth; Heller, Katherine; Kale, David; Saeed, Mohammed; Ossorio, Pilar N.; Thadaney-Israni, Sonoo; Goldenberg, Anna			Do no harm: a roadmap for responsible machine learning for health care	NATURE MEDICINE			English	Article								Interest in machine-learning applications within medicine has been growing, but few studies have progressed to deployment in patient care. We present a framework, context and ultimately guidelines for accelerating the translation of machine-learning-based interventions in health care. To be successful, translation will require a team of engaged stakeholders and a systematic process from beginning (problem formulation) to end (widespread deployment).	[Wiens, Jenna] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Saria, Suchi] Johns Hopkins Univ, Dept Comp Sci, Whiting Sch Engn, Baltimore, MD 21218 USA; [Saria, Suchi] Johns Hopkins Univ, Dept Stat, Whiting Sch Engn, Baltimore, MD 21218 USA; [Saria, Suchi] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Saria, Suchi] Bayesian Hlth, New York, NY USA; [Sendak, Mark] Duke Univ, Sch Med, Duke Inst Hlth Innovat, Durham, NC USA; [Ghassemi, Marzyeh; Goldenberg, Anna] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Ghassemi, Marzyeh] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ghassemi, Marzyeh; Goldenberg, Anna] Vector Inst, Toronto, ON, Canada; [Liu, Vincent X.] Kaiser Permanente, Div Res, Oakland, CA USA; [Doshi-Velez, Finale] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jung, Kenneth] Stanford Univ, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Heller, Katherine] Google Inc, Mountain View, CA USA; [Heller, Katherine] Duke Univ, Dept Stat Sci, Durham, NC USA; [Kale, David] Univ Southern Calif, Inst Informat Sci, Los Angeles, CA USA; [Saeed, Mohammed] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ossorio, Pilar N.] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Thadaney-Israni, Sonoo] Stanford Univ, Presence & Program Bedside Med, Stanford, CA 94305 USA; [Goldenberg, Anna] SickKids Res Inst, Toronto, ON, Canada	University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duke University; University of Toronto; University of Toronto; Kaiser Permanente; Harvard University; Stanford University; Google Incorporated; Duke University; University of Southern California; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wiens, J (corresponding author), Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA.	wiensj@umich.edu; anna.goldenberg@utoronto.ca						[Anonymous], 2019, PROPOSED REGULATORY; Chen Irene Y, 2019, AMA J Ethics, V21, pE167, DOI 10.1001/amajethics.2019.167; Chien S, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aan4831; Evans B, 2018, AM J LAW MED, V44, P237, DOI 10.1177/0098858818789418; He JX, 2019, NAT MED, V25, P30, DOI 10.1038/s41591-018-0307-0; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Henderson P, 2018, 32 AAAI C ART INT AA; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Hutson M., 2017, SCIENCE, DOI [10.1126/science.aal1053, DOI 10.1126/SCIENCE.AAL1053]; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Liu VX, 2019, J AM MED INFORM ASSN, V26, P1655, DOI 10.1093/jamia/ocz088; Luo Y., 2018, P 32 INT C NEUR INF, P1603; Massachusetts Institute of Technology, 2019, SCIENCEDAILY; Nestor B., 2018, RETHINKING CLIN PRED; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Okoro AGO, 2018, AM J LAW MED, V44, P155, DOI 10.1177/0098858818793388; Rajpurkar P, 2017, RADIOLOGIST LEVEL PN; Saria S, 2019, TUTORIAL SAFE RELIAB; Schulam P., 2019, 22 INT C ART INT STA, V89, P1022; Schulam P, 2017, ADV NEUR IN, V30; Silva I, 2012, COMPUT CARDIOL CONF, V39, P245; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x	24	194	194	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1337	1340		10.1038/s41591-019-0548-6	http://dx.doi.org/10.1038/s41591-019-0548-6			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31427808				2022-12-27	WOS:000484832800014
J	Scheiman, J; Luber, JM; Chavkin, TA; MacDonald, T; Tung, A; Pham, LD; Wibowo, MC; Wurth, RC; Punthambaker, S; Tierney, BT; Yang, Z; Hattab, MW; Avila-Pacheco, J; Clish, CB; Lessard, S; Church, GM; Kostic, AD				Scheiman, Jonathan; Luber, Jacob M.; Chavkin, Theodore A.; MacDonald, Tara; Tung, Angela; Loc-Duyen Pham; Wibowo, Marsha C.; Wurth, Renee C.; Punthambaker, Sukanya; Tierney, Braden T.; Yang, Zhen; Hattab, Mohammad W.; Avila-Pacheco, Julian; Clish, Clary B.; Lessard, Sarah; Church, George M.; Kostic, Aleksandar D.			Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism	NATURE MEDICINE			English	Article							READ ALIGNMENT; GUT MICROBIOTA; RECEPTOR; GENETICS	The human gut microbiome is linked to many states of human health and disease(1). The metabolic repertoire of the gut microbiome is vast, but the health implications of these bacterial pathways are poorly understood. In this study, we identify a link between members of the genus Veillonella and exercise performance. We observed an increase in Veillonella relative abundance in marathon runners postmarathon and isolated a strain of Veillonella atypica from stool samples. Inoculation of this strain into mice significantly increased exhaustive treadmill run time. Veillonella utilize lactate as their sole carbon source, which prompted us to perform a shotgun metagenomic analysis in a cohort of elite athletes, finding that every gene in a major pathway metabolizing lactate to propionate is at higher relative abundance postexercise. Using C-13(3)-labeled lactate in mice, we demonstrate that serum lactate crosses the epithelial barrier into the lumen of the gut. We also show that intrarectal instillation of propionate is sufficient to reproduce the increased treadmill run time performance observed with V. atypica gavage. Taken together, these studies reveal that V. atypica improves run time via its metabolic conversion of exercise-induced lactate into propionate, thereby identifying a natural, microbiome-encoded enzymatic process that enhances athletic performance.	[Scheiman, Jonathan; Tung, Angela; Punthambaker, Sukanya; Church, George M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Scheiman, Jonathan; Tung, Angela; Punthambaker, Sukanya; Hattab, Mohammad W.; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Scheiman, Jonathan; Wurth, Renee C.] Fitbiomics, New York, NY USA; [Luber, Jacob M.; Chavkin, Theodore A.; Loc-Duyen Pham; Wibowo, Marsha C.; Tierney, Braden T.; Yang, Zhen; Kostic, Aleksandar D.] Joslin Diabet Ctr, Sect Pathophysiol & Mol Pharmacol, Boston, MA 02215 USA; [Luber, Jacob M.; Chavkin, Theodore A.; Loc-Duyen Pham; Wibowo, Marsha C.; Tierney, Braden T.; Yang, Zhen; Kostic, Aleksandar D.] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Luber, Jacob M.; Tierney, Braden T.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Luber, Jacob M.; Chavkin, Theodore A.; Wibowo, Marsha C.; Tierney, Braden T.; Kostic, Aleksandar D.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Luber, Jacob M.; Avila-Pacheco, Julian; Clish, Clary B.] Broad Inst MIT & Harvard, Cambridge, MA USA; [MacDonald, Tara; Lessard, Sarah] Joslin Diabet Ctr, Sect Clin Behav & Outcomes Res, Boston, MA 02215 USA; [MacDonald, Tara; Lessard, Sarah] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Wurth, Renee C.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Yang, Zhen] Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Waterloo	Church, GM (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Church, GM (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Kostic, AD (corresponding author), Joslin Diabet Ctr, Sect Pathophysiol & Mol Pharmacol, Boston, MA 02215 USA.; Kostic, AD (corresponding author), Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA.; Kostic, AD (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	gc@hms.harvard.edu; aleksandar.kostic@joslin.harvard.edu	Punthambaker, Sukanya/AAR-9166-2020; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Kostic, Aleksandar/0000-0002-0837-4360; Tierney, Braden/0000-0002-7533-8802; church, george/0000-0001-6232-9969; Luber, Jacob/0000-0001-5268-5732; Chavkin, Theodore/0000-0002-9443-9529; Avila, Julian/0000-0001-9388-3946; Tung, Angela/0000-0003-3612-2934	Synthetic Biology platform at the Wyss Institute for Biologically Inspired Engineering at Harvard University; National Institutes of Health (NIH)/National Human Genome Research Institute [T32 HG002295]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [T32 DK007260]; National Science Foundation Graduate Research Fellowship Program fellowship; National Library of Medicine BIRT [T15LM007092]; AWS Research Credits for Education Grant; Smith Family Foundation Award for Excellence in Biomedical Research; American Diabetes Association Pathway to Stop Diabetes Initiator Award; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Research Center [P30DK036836-30]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	Synthetic Biology platform at the Wyss Institute for Biologically Inspired Engineering at Harvard University; National Institutes of Health (NIH)/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation Graduate Research Fellowship Program fellowship; National Library of Medicine BIRT; AWS Research Credits for Education Grant; Smith Family Foundation Award for Excellence in Biomedical Research; American Diabetes Association Pathway to Stop Diabetes Initiator Award; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Research Center; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the Synthetic Biology platform at the Wyss Institute for Biologically Inspired Engineering at Harvard University; National Institutes of Health (NIH)/National Human Genome Research Institute grant T32 HG002295 (to J.M.L.; principal investigator: P. J. Park); NIH/National Institute of Diabetes and Digestive and Kidney Diseases grant T32 DK007260 (to T.A.C.; principal investigator: T.K. Blackwell); a National Science Foundation Graduate Research Fellowship Program fellowship (to J.M.L.); National Library of Medicine BIRT grant T15LM007092 (to B.T.T.); an AWS Research Credits for Education Grant (to J.M.L. and A.D.K.); a Smith Family Foundation Award for Excellence in Biomedical Research (to A.D.K.); an American Diabetes Association Pathway to Stop Diabetes Initiator Award (to A.D.K.) and NIH/National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Research Center grant P30DK036836-30 (to J.M.L., T.A.C., T.M., B.T.T., L.-D.P., Z.Y., M.C.W., S.L. and A.D.K.; principal investigator: G. L. King). We acknowledge C. J. Patel and S. R. Stein for statistical advice, and S. Softic for assistance with tail vein injections.	Araghizadeh F., 2012, COLORECTAL SURG, P3; Bolker B. M., 2012, COEFPLOT2 COEFFICIEN; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chambers ES, 2018, DIABETES OBES METAB, V20, P1034, DOI 10.1111/dom.13159; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Ehrlich SD, 2011, METAGENOMICS OF THE HUMAN BODY, P307, DOI 10.1007/978-1-4419-7089-3_15; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujisaka S, 2018, CELL REP, V22, P3072, DOI 10.1016/j.celrep.2018.02.060; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Jones E., 2001, SCIPY OPEN SOURCE SC; JURKOWSKI JEH, 1981, J APPL PHYSIOL, V51, P1493, DOI 10.1152/jappl.1981.51.6.1493; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kolde R., 2013, PHEATMAP PRETTY HEAT; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luber JM, 2018, BIOINFORMATICS, V34, P1565, DOI 10.1093/bioinformatics/btx787; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Murrell P., 2002, R NEWS, V2, P14; NG SKC, 1973, CAN J MICROBIOL, V19, P715, DOI 10.1139/m73-116; Petersen LM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0320-4; Phypers B, 2006, BJA EDUC, V6, P128, DOI 10.1093/bjaceaccp/mkl018; Pimentel G, 2017, BRIT J NUTR, V118, P1070, DOI 10.1017/S0007114517003245; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Pluznick JL, 2014, GUT MICROBES, V5, P202, DOI 10.4161/gmic.27492; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson O, 2016, MOL BIOL EVOL, V33, P2163, DOI 10.1093/molbev/msw080; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; van den Bogert B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01013-13; Wickham H., 2012, RESHAPE2 FLEXIBLY RE; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156	38	272	288	29	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1104	+		10.1038/s41591-019-0485-4	http://dx.doi.org/10.1038/s41591-019-0485-4			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31235964	Green Accepted			2022-12-27	WOS:000474430400024
J	Fettweis, JM; Serrano, MG; Brooks, JP; Edwards, DJ; Girerd, PH; Parikh, HI; Huang, B; Arodz, TJ; Edupuganti, L; Glascock, AL; Xu, J; Jimenez, NR; Vivadelli, SC; Fong, SS; Sheth, NU; Jean, S; Lee, V; Bokhari, YA; Lara, AM; Mistry, SD; Duckworth, RA; Bradley, SP; Koparde, VN; Orenda, XV; Milton, SH; Rozycki, SK; Matveyev, AV; Wright, ML; Huzurbazar, SV; Jackson, EM; Smirnova, E; Korlach, J; Tsai, YC; Dickinson, MR; Brooks, JL; Drake, JI; Chaffin, DO; Sexton, AL; Gravett, MG; Rubens, CE; Wijesooriya, NR; Hendricks-Munoz, KD; Jefferson, KK; Strauss, JF; Buck, GA				Fettweis, Jennifer M.; Serrano, Myrna G.; Brooks, J. Paul; Edwards, David J.; Girerd, Philippe H.; Parikh, Hardik I.; Huang, Bernice; Arodz, Tom J.; Edupuganti, Laahirie; Glascock, Abigail L.; Xu, Jie; Jimenez, Nicole R.; Vivadelli, Stephany C.; Fong, Stephen S.; Sheth, Nihar U.; Jean, Sophonie; Lee, Vladimir; Bokhari, Yahya A.; Lara, Ana M.; Mistry, Shreni D.; Duckworth, Robert A., III; Bradley, Steven P.; Koparde, Vishal N.; Orenda, X. Valentine; Milton, Sarah H.; Rozycki, Sarah K.; Matveyev, Andrey V.; Wright, Michelle L.; Huzurbazar, Snehalata V.; Jackson, Eugenie M.; Smirnova, Ekaterina; Korlach, Jonas; Tsai, Yu-Chih; Dickinson, Molly R.; Brooks, Jamie L.; Drake, Jennifer I.; Chaffin, Donald O.; Sexton, Amber L.; Gravett, Michael G.; Rubens, Craig E.; Wijesooriya, N. Romesh; Hendricks-Munoz, Karen D.; Jefferson, Kimberly K.; Strauss, Jerome F., III; Buck, Gregory A.			The vaginal microbiome and preterm birth	NATURE MEDICINE			English	Article							BACTERIAL VAGINOSIS; SYSTEMATIC ANALYSIS; WOMEN; HEALTH; LABOR; FLORA	The incidence of preterm birth exceeds 10% worldwide. There are significant disparities in the frequency of preterm birth among populations within countries, and women of African ancestry disproportionately bear the burden of risk in the United States. In the present study, we report a community resource that includes 'omics' data from approximately 12,000 samples as part of the integrative Human Microbiome Project. Longitudinal analyses of 16S ribosomal RNA, metagenomic, metatranscriptomic and cytokine profiles from 45 preterm and 90 term birth controls identified harbingers of preterm birth in this cohort of women predominantly of African ancestry. Women who delivered preterm exhibited significantly lower vaginal levels of Lactobacillus crispatus and higher levels of BVAB1, Sneathia amnii, TM7-H1, a group of Prevotella species and nine additional taxa. The first representative genomes of BVAB1 and TM7-H1 are described. Preterm-birth-associated taxa were correlated with proinflammatory cytokines in vaginal fluid. These findings highlight new opportunities for assessment of the risk of preterm birth.	[Fettweis, Jennifer M.; Serrano, Myrna G.; Parikh, Hardik I.; Huang, Bernice; Edupuganti, Laahirie; Jimenez, Nicole R.; Vivadelli, Stephany C.; Jean, Sophonie; Lee, Vladimir; Lara, Ana M.; Mistry, Shreni D.; Duckworth, Robert A., III; Bradley, Steven P.; Orenda, X. Valentine; Matveyev, Andrey V.; Dickinson, Molly R.; Brooks, Jamie L.; Drake, Jennifer I.; Jefferson, Kimberly K.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23284 USA; [Fettweis, Jennifer M.; Girerd, Philippe H.; Milton, Sarah H.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA; [Fettweis, Jennifer M.; Serrano, Myrna G.; Brooks, J. Paul; Edwards, David J.; Girerd, Philippe H.; Arodz, Tom J.; Edupuganti, Laahirie; Xu, Jie; Jimenez, Nicole R.; Vivadelli, Stephany C.; Fong, Stephen S.; Lee, Vladimir; Hendricks-Munoz, Karen D.; Jefferson, Kimberly K.; Strauss, Jerome F., III; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Microbiome Engn & Data Anal, Richmond, VA 23284 USA; [Brooks, J. Paul] Virginia Commonwealth Univ, Sch Business, Supply Chain Management & Analyt Sch Business, Richmond, VA USA; [Edwards, David J.] Virginia Commonwealth Univ, Coll Humanities & Sci, Department Stat Sci & Operat Res, Richmond, VA USA; [Arodz, Tom J.; Bokhari, Yahya A.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Comp Sci, Coll Engn, Richmond, VA 23284 USA; [Glascock, Abigail L.] Virginia Commonwealth Univ, VCU Life Sci, Richmond, VA USA; [Xu, Jie; Hendricks-Munoz, Karen D.] Virginia Commonwealth Univ, Sch Med, Div Neonatal Med, Richmond, VA USA; [Xu, Jie; Wijesooriya, N. Romesh; Hendricks-Munoz, Karen D.] Virginia Commonwealth Univ, Childrens Hosp Richmond, Sch Med, Dept Pediat, Richmond, VA USA; [Fong, Stephen S.] Virginia Commonwealth Univ, Coll Engn, Dept Chem & Life Sci Engn, Richmond, VA USA; [Sheth, Nihar U.; Koparde, Vishal N.] Virginia Commonwealth Univ, Ctr Study Biol Complex, VCU Life Sci, Richmond, VA USA; [Rozycki, Sarah K.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Wright, Michelle L.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Wright, Michelle L.] Univ Texas Austin, Dept Womens Hlth, Dell Sch Med, Austin, TX 78712 USA; [Wright, Michelle L.] Univ Texas Austin, Sch Nursing, Austin, TX 78712 USA; [Huzurbazar, Snehalata V.; Jackson, Eugenie M.] West Virginia Univ, Dept Biostat, Sch Publ Hlth, Morgantown, WV 26506 USA; [Smirnova, Ekaterina] Univ Montana, Dept Math Sci, Missoula, MT 59812 USA; [Smirnova, Ekaterina] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Korlach, Jonas; Tsai, Yu-Chih] Pacific Biosci, Menlo Pk, CA USA; [Chaffin, Donald O.; Sexton, Amber L.; Gravett, Michael G.; Rubens, Craig E.] Global Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [Gravett, Michael G.] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Emory University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; West Virginia University; University of Montana System; University of Montana; Virginia Commonwealth University; University of Washington; University of Washington Seattle	Buck, GA (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23284 USA.; Buck, GA (corresponding author), Virginia Commonwealth Univ, Ctr Microbiome Engn & Data Anal, Richmond, VA 23284 USA.; Buck, GA (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Coll Engn, Richmond, VA 23284 USA.	gregory.buck@vcuhealth.org	Jean, Sophonie/AAR-8204-2020; Edupuganti, Laahirie/AAC-9115-2022; Parikh, Hardik/AAG-4963-2021; Wright, Michelle Lynn/L-4885-2019	Jean, Sophonie/0000-0001-9372-3491; Wright, Michelle Lynn/0000-0002-9348-8740; Parikh, Hardik/0000-0002-5621-7343; BOKHARI, YAHYA/0000-0002-2352-1701; Brooks, Jamie/0000-0003-0756-1831; Orenda, X. Valentine/0000-0002-2168-5825; Santos Jimenez, Nicole Renea/0000-0001-9755-0022; Tsai, Yu-Chih/0000-0002-2958-0278; Koparde, Vishal/0000-0001-8978-8495; Huzurbazar, Snehalata/0000-0001-9637-5445	NIH [UH3AI083263, U54HD080784, R21HD092965, 1R01HD092415]; Common Fund; National Center for Complementary and Integrative Health; Office of Research on Women's Health; GAPPS BMGF PPB grant; NSF [1453658];  [R25GM090084]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD092965, R01HD092415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090084] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Common Fund; National Center for Complementary and Integrative Health; Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); GAPPS BMGF PPB grant; NSF(National Science Foundation (NSF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge participants who contributed to the study and the teams of research coordinators, the sample processors and clinicians and nurses who assisted with sample collection. This study was funded by NIH grant nos. UH3AI083263 and U54HD080784 to G.A.B., K.K.J. and J.F.S. and was supported with funds from the Common Fund, the National Center for Complementary and Integrative Health, and the Office of Research on Women's Health. Other grants that provided partial support include a GAPPS BMGF PPB grant to G.A.B. and J.M.F., and NIH grants R21HD092965 to J.M.F. and E. Wickham, and 1R01HD092415 to G.A.B. T.A. was supported by NSF grant 1453658. N.R.J. was supported by grant no. R25GM090084 for the VCU Initiative for Maximizing Student Development program. Sequence analysis, with the exception of the TM7-H1 sequencing, was performed in the Nucleic Acids Research Facilities at VCU and analysis was performed with servers provided by the Center for High Performance Computing at VCU.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Aldunate M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00164; Alves JMP, 2007, CHEM BIODIVERS, V4, P2593, DOI 10.1002/cbdv.200790212; Baldwin EA, 2015, PEERJ, V3, DOI 10.7717/peerj.1398; Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Borgdorff H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181135; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Bradshaw CS, 2016, J INFECT DIS, V214, pS14, DOI 10.1093/infdis/jiw159; Brooks J. Paul, 2017, Microbial Ecology in Health and Disease, V28, P1303265, DOI 10.1080/16512235.2017.1303265; Brown RG, 2019, BJOG-INT J OBSTET GY, V126, P916, DOI 10.1111/1471-0528.15600; Brown RG, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0999-x; Butler AS., 2007, SOC COSTS PRETERM BI; Callahan BJ, 2017, P NATL ACAD SCI USA, V114, P9966, DOI 10.1073/pnas.1705899114; Chavoustie SE, 2017, INT J GYNECOL OBSTET, V137, P107, DOI 10.1002/ijgo.12114; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Fong SS, 2014, COMPUT STRUCT BIOTEC, V11, P28, DOI 10.1016/j.csbj.2014.08.005; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Freitas AC, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0502-8; Freitas AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07790-9; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Haque MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16352-y; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; Harwich MD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S4; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jayaprakash TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166794; Jefferson KK, 2019, J PERINATOL, V39, P824, DOI 10.1038/s41372-019-0343-8; Jespers V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12198-6; Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557; Kindinger LM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0223-9; Koparde Vishal N., 2017, International Journal of Computational Biology and Drug Design, V10, P237, DOI 10.1504/IJCBDD.2017.085409; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leal MD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017789; Lin HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24175; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lockwood CJ, 2002, NEW ENGL J MED, V346, P282, DOI 10.1056/NEJM200201243460412; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Marret S, 2007, OBSTET GYNECOL, V110, P72, DOI 10.1097/01.AOG.0000267498.95402.bd; Martin DH, 2016, J INFECT DIS, V214, pS36, DOI 10.1093/infdis/jiw184; Murray Sarah R, 2017, Wellcome Open Res, V2, P101, DOI 10.12688/wellcomeopenres.12783.1; Nelson DB, 2016, AM J PERINAT, V33, P887, DOI 10.1055/s-0036-1581057; Nelson DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/ppe.12106; Ng A. Y., 2004, P 21 INT C MACH LEAR, DOI [10.1145/1015330.1015435, DOI 10.1145/1015330.1015435]; Parikh HI, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1358-1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Serrano MG, 2019, NAT MED, V25, P1001, DOI 10.1038/s41591-019-0465-8; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Sobel JD, 2000, ANNU REV MED, V51, P349, DOI 10.1146/annurev.med.51.1.349; Son Kyung-A, 2018, Obstet Gynecol Sci, V61, P38, DOI 10.5468/ogs.2018.61.1.38; Stafford GP, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00615; Stout MJ, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.05.030; Strauss JF, 2018, AM J OBSTET GYNECOL, V218, P294, DOI 10.1016/j.ajog.2017.12.009; Subramaniam A, 2016, AM J PERINAT, V33, P401, DOI 10.1055/s-0035-1565919; Tabatabaei N, 2019, BJOG-INT J OBSTET GY, V126, P349, DOI 10.1111/1471-0528.15299; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wolke D, 2014, ARCH DIS CHILD-FETAL, V99, pF70, DOI 10.1136/archdischild-2013-303788; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	81	331	344	14	84	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					1012	+		10.1038/s41591-019-0450-2	http://dx.doi.org/10.1038/s41591-019-0450-2			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31142849	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000470844400033
J	Long, GV				Long, Georgina V.			Making a difference to many	NATURE MEDICINE			English	Editorial Material									[Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Long, Georgina V.] Univ Sydney, Royal North Shore Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia	Melanoma Institute Australia; Royal North Shore Hospital; University of Sydney	Long, GV (corresponding author), Melanoma Inst Australia, Sydney, NSW, Australia.; Long, GV (corresponding author), Univ Sydney, Royal North Shore Hosp, Sydney, NSW, Australia.; Long, GV (corresponding author), Mater Hosp, Sydney, NSW, Australia.	georgina.long@melanoma.org.au	Long, Georgina V/C-1771-2013	Long, Georgina V/0000-0001-8894-3545					0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					356	356		10.1038/s41591-019-0390-x	http://dx.doi.org/10.1038/s41591-019-0390-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842664	Bronze			2022-12-27	WOS:000460643100003
J	Yin, CJ; Ackermann, S; Ma, Z; Mohanta, SK; Zhang, CK; Li, YF; Nietzsche, S; Westermann, M; Peng, L; Hu, DS; Bontha, SV; Srikakulapu, P; Beer, M; Megens, RTA; Steffens, S; Hildner, M; Halder, LD; Eckstein, HH; Pelisek, J; Herms, J; Roeber, S; Arzberger, T; Borodovsky, A; Habenicht, L; Binder, CJ; Weber, C; Zipfel, PF; Skerka, C; Habenicht, AJR				Yin, Changjun; Ackermann, Susanne; Ma, Zhe; Mohanta, Sarajo K.; Zhang, Chuankai; Li, Yuanfang; Nietzsche, Sandor; Westermann, Martin; Peng, Li; Hu, Desheng; Bontha, Sai Vineela; Srikakulapu, Prasad; Beer, Michael; Megens, Remco T. A.; Steffens, Sabine; Hildner, Markus; Halder, Luke D.; Eckstein, Hans-Henning; Pelisek, Jaroslav; Herms, Jochen; Roeber, Sigrun; Arzberger, Thomas; Borodovsky, Anna; Habenicht, Livia; Binder, Christoph J.; Weber, Christian; Zipfel, Peter F.; Skerka, Christine; Habenicht, Andreas J. R.			ApoE attenuates unresolvable inflammation by complex formation with activated C1q	NATURE MEDICINE			English	Article							LASER-CAPTURE MICRODISSECTION; FACTOR-H BINDS; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; A-BETA; NEUROFIBRILLARY PATHOLOGY; ATHEROSCLEROSIS; IMMUNE; MICE; NEURODEGENERATION	Apolipoprotein-E (ApoE) has been implicated in Alzheimer's disease, atherosclerosis, and other unresolvable inflammatory conditions but a common mechanism of action remains elusive. We found in ApoE-deficient mice that oxidized lipids activated the classical complement cascade (CCC), resulting in leukocyte infiltration of the choroid plexus (ChP). All human ApoE iso-forms attenuated CCC activity via high-affinity binding to the activated CCC-initiating C1q protein (K-D similar to 140-580 pM) in vitro, and C1q-ApoE complexes emerged as markers for ongoing complement activity of diseased ChPs, A beta plaques, and atherosclerosis in vivo. C1q-ApoE complexes in human ChPs, A beta plaques, and arteries correlated with cognitive decline and atherosclerosis, respectively. Treatment with small interfering RNA (siRNA) against C5, which is formed by all complement pathways, attenuated murine ChP inflammation, A beta-associated microglia accumulation, and atherosclerosis. Thus, ApoE is a direct checkpoint inhibitor of unresolvable inflammation, and reducing C5 attenuates disease burden.	[Yin, Changjun; Ma, Zhe; Mohanta, Sarajo K.; Zhang, Chuankai; Li, Yuanfang; Megens, Remco T. A.; Steffens, Sabine; Weber, Christian; Habenicht, Andreas J. R.] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Yin, Changjun; Steffens, Sabine; Weber, Christian] Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Partner Site, Munich, Germany; [Ackermann, Susanne; Halder, Luke D.; Zipfel, Peter F.; Skerka, Christine] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Nietzsche, Sandor; Westermann, Martin] Friedrich Schiller Univ Jena, Jena Univ Hosp, Ctr Electron Microscopy, Jena, Germany; [Peng, Li] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Cardiovasc Med, Guiyang, Guizhou, Peoples R China; [Hu, Desheng] Huazhong Univ Sci & Technol, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan, Hubei, Peoples R China; [Bontha, Sai Vineela] Univ Tennessee, Dept Surg, Memphis, TN USA; [Srikakulapu, Prasad] Univ Virginia, Cardiovasc Res Ctr CVRC, Charlottesville, VA USA; [Beer, Michael] Univ Clin Jena, Dept Informat Technol, Jena, Germany; [Megens, Remco T. A.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Hildner, Markus] Univ Clin Jena, Inst Anat 2, Jena, Germany; [Eckstein, Hans-Henning; Pelisek, Jaroslav] Tech Univ Munich, Dept Vasc & Endovasc Surg, Klinikum Rechts Isar, Munich, Germany; [Herms, Jochen; Roeber, Sigrun; Arzberger, Thomas] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Herms, Jochen] Ludwig Maximilians Univ Munchen, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Arzberger, Thomas] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany; [Borodovsky, Anna] Alnylam Pharmaceut Cambridge, Cambridge, MA USA; [Habenicht, Livia] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med CeMM, Vienna, Austria; [Zipfel, Peter F.] Friedrich Schiller Univ, Fac Biol Sci, Jena, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Guizhou University of Traditional Chinese Medicine; Huazhong University of Science & Technology; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; Friedrich Schiller University of Jena; Maastricht University; Friedrich Schiller University of Jena; Technical University of Munich; University of Munich; University of Munich; University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Friedrich Schiller University of Jena	Yin, CJ (corresponding author), Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany.; Yin, CJ (corresponding author), Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Partner Site, Munich, Germany.; Skerka, C (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	changjun.yin@med.uni-muenchen.de; christine.skerka@hki-jena.de	Mohanta, Sarajo/L-1355-2019; Yin, Changjun/ABI-7117-2020; Habenicht, Andreas/HGA-2184-2022; Mohanta, Sarajo K/J-5441-2015; Srikakulapu, Prasad/AAK-3185-2020; Weber, Christian/AAW-2153-2020; ZHANG, CHUANKAI/AAL-4561-2021; Eckstein, Hans-Henning/AAF-9200-2022; Steffens, Sabine/AAV-4551-2020; Eckstein, Hans-Henning/AFK-1881-2022	Mohanta, Sarajo/0000-0001-6144-4092; Mohanta, Sarajo K/0000-0001-6144-4092; Srikakulapu, Prasad/0000-0003-3428-4518; Weber, Christian/0000-0003-4610-8714; Steffens, Sabine/0000-0002-6892-9751; Li, Yuanfang/0000-0002-2646-3260; megens, remco/0000-0001-9871-6696; Halder, Luke Donald/0000-0002-8155-1458; Habenicht, Livia/0000-0002-6582-6458; Binder, Christoph J./0000-0001-8313-7050; bontha, sai vineela/0000-0001-8914-1966; Yin, Changjun/0000-0002-1913-4477; Ackermann, Susanne/0000-0001-8179-5201; habenicht, andreas/0000-0003-2901-3027; Peng, Li/0000-0003-0646-8117	Deutsche Forschungsgemeinschaft (DFG) [YI 133/2-1, HA 1083/15-4, MO 3054/1-1]; German Collaborative Research Center [CRC124/2-C4, SK46/2, CRC124/2-C6]; DFG [TR 1992, SFB 1123/A1, SFB 1123/Z3]; German Centre for Cardiovascular Research [DZHK MHA VD1.2]; European Research Council (ERC) [AdG 692511, SFB1123/Z01, INST409/150-1 FUGG]; Chinese National Natural Science Foundation [31770983]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Collaborative Research Center; DFG(German Research Foundation (DFG)); German Centre for Cardiovascular Research; European Research Council (ERC)(European Research Council (ERC)European Commission); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank W. Schneider, Medical University of Vienna, Austria, for advice; T. Hallstrom, Y. Lin, and S. Halbich, Leibniz Institute for Natural Product Research and Infection Biology, Jena, for performing complement assays; W. Wilfert, Institute of Laboratory Medicine, University of Munich for lipid analyses; S. Schmidt, Institute for Experimental Neurology, Jena, for advice; and N. Buresch, Center for Neuropathology and Prion Research, Munich, for technical assistance; M. Jucker, Hertie Institute for Clinical Brain Research, University of Tubingen, for experimental support. This work was funded by the Deutsche Forschungsgemeinschaft (DFG): YI 133/2-1 to C.Y.; HA 1083/15-4 to A.J.R.H.; MO 3054/1-1 to S.M.; The German Collaborative Research Center (CRC124/2-C4), SK46/2 to C.S.; CRC124/2-C6 and DFG TR 1992 to P.F.Z.; the German Centre for Cardiovascular Research (DZHK MHA VD1.2), DFG SFB 1123/A1 and Z3, the European Research Council (ERC AdG 692511) to C.W.; SFB1123/Z01, INST409/150-1 FUGG to R.T.A.M.; Chinese National Natural Science Foundation (31770983) to D.H.; S.A. and L.D.H. are doctoral researchers at the International Leibniz Research School (ILRS) in Jena.	Abbott AL, 2015, STROKE, V46, P3288, DOI 10.1161/STROKEAHA.115.003390; Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P309, DOI 10.1007/s00401-009-0485-4; Arlaud GJ, 2011, J LIPIDS, V2011, DOI 10.1155/2011/376092; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Beer M, 2011, METHODS MOL BIOL, V755, P417, DOI 10.1007/978-1-61779-163-5_35; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Franklin K., 2007, MOUSE BRAIN STEREOTA; Girija UV, 2013, P NATL ACAD SCI USA, V110, P13916, DOI 10.1073/pnas.1311113110; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Greissel A, 2015, THROMB HAEMOSTASIS, V114, P390, DOI 10.1160/TH14-10-0852; Haapasalo K, 2015, J BIOL CHEM, V290, P28977, DOI 10.1074/jbc.M115.669226; Haege S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042814; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hu DS, 2015, IMMUNITY, V42, P1100, DOI 10.1016/j.immuni.2015.05.015; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Huynh TPV, 2017, NEURON, V96, P1013, DOI 10.1016/j.neuron.2017.11.014; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Liu CC, 2017, NEURON, V96, P1024, DOI 10.1016/j.neuron.2017.11.013; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Macedo ACL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00055; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Moore GRW, 2016, J NEUROPATH EXP NEUR, V75, P415, DOI 10.1093/jnen/nlw017; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tenner AJ, 2018, MOL IMMUNOL, V102, P3, DOI 10.1016/j.molimm.2018.06.264; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Timaran CH, 2011, J VASC SURG, V53, P1679, DOI 10.1016/j.jvs.2010.11.122; Ulrich JD, 2018, J EXP MED, V215, P1047, DOI 10.1084/jem.20171265; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wang CZ, 2018, NAT MED, V24, P647, DOI 10.1038/s41591-018-0004-z; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Wendorff C, 2015, STROKE, V46, P3213, DOI 10.1161/STROKEAHA.115.010558; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yin CJ, 2015, METHODS MOL BIOL, V1339, P297, DOI 10.1007/978-1-4939-2929-0_20; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	65	125	129	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					496	+		10.1038/s41591-018-0336-8	http://dx.doi.org/10.1038/s41591-018-0336-8			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30692699	Green Accepted			2022-12-27	WOS:000460643100029
J	Charlesworth, CT; Deshpande, PS; Dever, DP; Camarena, J; Lemgart, VT; Cromer, MK; Vakulskas, CA; Collingwood, MA; Zhang, LY; Bode, NM; Behlke, MA; Dejene, B; Cieniewicz, B; Romano, R; Lesch, BJ; Gomez-Ospina, N; Mantri, S; Pavel-Dinu, M; Weinberg, KI; Porteus, MH				Charlesworth, Carsten T.; Deshpande, Priyanka S.; Dever, Daniel P.; Camarena, Joab; Lemgart, Viktor T.; Cromer, M. Kyle; Vakulskas, Christopher A.; Collingwood, Michael A.; Zhang, Liyang; Bode, Nicole M.; Behlke, Mark A.; Dejene, Beruh; Cieniewicz, Brandon; Romano, Rosa; Lesch, Benjamin J.; Gomez-Ospina, Natalia; Mantri, Sruthi; Pavel-Dinu, Mara; Weinberg, Kenneth I.; Porteus, Matthew H.			Identification of preexisting adaptive immunity to Cas9 proteins in humans	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; STAPHYLOCOCCUS-AUREUS; IFN-GAMMA; CRISPR/CAS9; RESPONSES; ANTIBODY; STREPTOCOCCUS; ANTIGENS; MUSCLE; LIVER	The CRISPR-Cas9 system is a powerful tool for genome editing, which allows the precise modification of specific DNA sequences. Many efforts are underway to use the CRISPR-Cas9 system to therapeutically correct human genetic diseases(1-6). The most widely used orthologs of Cas9 are derived from Staphylococcus aureus and Streptococcus pyogenes(5,7). Given that these two bacterial species infect the human population at high frequencies(8,9), we hypothesized that humans may harbor preexisting adaptive immune responses to the Cas9 orthologs derived from these bacterial species, SaCas9 (S. aureus) and SpCas9 (S. pyogenes). By probing human serum for the presence of anti-Cas9 antibodies using an enzyme-linked immunosorbent assay, we detected antibodies against both SaCas9 and SpCas9 in 78% and 58% of donors, respectively. We also found anti-SaCas9 T cells in 78% and anti-SpCas9 T cells in 67% of donors, which demonstrates a high prevalence of antigen-specific T cells against both orthologs. We confirmed that these T cells were Cas9-specific by demonstrating a Cas9-specific cytokine response following isolation, expansion, and antigen restimulation. Together, these data demonstrate that there are preexisting humoral and cell-mediated adaptive immune responses to Cas9 in humans, a finding that should be taken into account as the CRISPR-Cas9 system moves toward clinical trials.	[Charlesworth, Carsten T.; Deshpande, Priyanka S.; Dever, Daniel P.; Camarena, Joab; Lemgart, Viktor T.; Cromer, M. Kyle; Dejene, Beruh; Cieniewicz, Brandon; Romano, Rosa; Lesch, Benjamin J.; Gomez-Ospina, Natalia; Mantri, Sruthi; Pavel-Dinu, Mara; Weinberg, Kenneth I.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Vakulskas, Christopher A.; Collingwood, Michael A.; Zhang, Liyang; Bode, Nicole M.; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA USA	Stanford University	Weinberg, KI; Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	kw1@stanford.edu; mporteus@stanford.edu		Camarena, Joab/0000-0002-3102-5820; Bode, Nicole/0000-0001-7209-303X; Collingwood, Michael/0000-0002-8849-4038; Cromer, Kyle/0000-0002-8198-5010; Behlke, Mark/0000-0002-4218-857X; Vakulskas, Christopher/0000-0001-8510-4332; Gomez-Ospina, Natalia/0000-0002-6740-1154; Romano, Rosa/0000-0002-1206-5165	Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; Stanford Child Health Research Institute; CIRM Bridges to Stem Cell Research Program [CIRM TB1-01190]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM119995] Funding Source: NIH RePORTER	Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; Stanford Child Health Research Institute; CIRM Bridges to Stem Cell Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.H.P. gratefully thanks the support of the Amon Carter Foundation and the Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research for this work. D.P.D. thanks the Stanford Child Health Research Institute Grant and Postdoctoral Award for supporting his work. C.T.C. was supported by the CIRM Bridges to Stem Cell Research Program (CIRM TB1-01190). We thank the Binns Family Program for Cord Blood Research (Stanford University) for providing the cord blood sera used in this work. We thank the other members of the Porteus laboratory for their helpful comments and suggestions.	Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Charlesworth C., 2018, IDENTIFICATION PREEX; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Colque-Navarro P, 2010, CLIN VACCINE IMMUNOL, V17, P1117, DOI 10.1128/CVI.00506-09; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; DePolo NJ, 2000, MOL THER, V2, P218, DOI 10.1006/mthe.2000.0116; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Finn JD, 2018, CELL REP, V22, P2227, DOI 10.1016/j.celrep.2018.02.014; Ford T, 2017, VACCINE, V35, P1898, DOI 10.1016/j.vaccine.2017.02.038; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gupta S, 2015, BIOPROTOCOL, V5, pe1442; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kolata JB, 2015, J INFECT DIS, V212, P830, DOI 10.1093/infdis/jiv128; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lovelace P, 2011, METHODS MOL BIOL, V699, P165, DOI 10.1007/978-1-61737-950-5_8; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mortensen R, 2015, J IMMUNOL, V195, P1657, DOI 10.4049/jimmunol.1500804; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; PUKELSHEIM F, 1994, AM STAT, V48, P88, DOI 10.2307/2684253; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Simhadri VL, 2018, MOL THER-METH CLIN D, V10, P105, DOI 10.1016/j.omtm.2018.06.006; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Wagner DL, 2019, NAT MED, V25, P242, DOI 10.1038/s41591-018-0204-6; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wilson JM, 2009, MOL GENET METAB, V96, P151, DOI 10.1016/j.ymgme.2008.12.016; YANG YP, 1995, J IMMUNOL, V155, P2564; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	41	398	407	11	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					249	+		10.1038/s41591-018-0326-x	http://dx.doi.org/10.1038/s41591-018-0326-x			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30692695	Green Submitted, Green Accepted			2022-12-27	WOS:000457842100021
J	Ledergor, G; Weiner, A; Zada, M; Wang, SY; Cohen, YC; Gatt, ME; Snir, N; Magen, H; Koren-Michowitz, M; Herzog-Tzarfati, K; Keren-Shaul, H; Bornstein, C; Rotkopf, R; Yofe, I; David, E; Yellapantula, V; Kay, S; Salai, M; Ben Yehuda, D; Nagler, A; Shvidel, L; Orr-Urtreger, A; Halpern, KB; Itzkovitz, S; Landgren, O; San-Miguel, J; Paiva, B; Keats, JJ; Papaemmanuil, E; Avivi, I; Barbash, GI; Tanay, A; Amit, I				Ledergor, Guy; Weiner, Assaf; Zada, Mor; Wang, Shuang-Yin; Cohen, Yael C.; Gatt, Moshe E.; Snir, Nimrod; Magen, Hila; Koren-Michowitz, Maya; Herzog-Tzarfati, Katrin; Keren-Shaul, Hadas; Bornstein, Chamutal; Rotkopf, Ron; Yofe, Ido; David, Eyal; Yellapantula, Venkata; Kay, Sigalit; Salai, Moshe; Ben Yehuda, Dina; Nagler, Arnon; Shvidel, Lev; Orr-Urtreger, Avi; Halpern, Keren Bahar; Itzkovitz, Shalev; Landgren, Ola; San-Miguel, Jesus; Paiva, Bruno; Keats, Jonathan J.; Papaemmanuil, Elli; Avivi, Irit; Barbash, Gabriel I.; Tanay, Amos; Amit, Ido			Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma	NATURE MEDICINE			English	Article							MULTIPLE-MYELOMA; RNA-SEQ; MUTATIONS; PROTEIN; PROGRESSION; EXPRESSION; GAMMOPATHY; DIAGNOSIS; BIOMARKER; MGUS	Multiple myeloma, a plasma cell malignancy, is the second most common blood cancer. Despite extensive research, disease heterogeneity is poorly characterized, hampering efforts for early diagnosis and improved treatments. Here, we apply single cell RNA sequencing to study the heterogeneity of 40 individuals along the multiple myeloma progression spectrum, including 11 healthy controls, demonstrating high interindividual variability that can be explained by expression of known multiple myeloma drivers and additional putative factors. We identify extensive subclonal structures for 10 of 29 individuals with multiple myeloma. In asymptomatic individuals with early disease and in those with minimal residual disease post-treatment, we detect rare tumor plasma cells with molecular characteristics similar to those of active myeloma, with possible implications for personalized therapies. Single cell analysis of rare circulating tumor cells allows for accurate liquid biopsy and detection of malignant plasma cells, which reflect bone marrow disease. Our work establishes single cell RNA sequencing for dissecting blood malignancies and devising detailed molecular characterization of tumor cells in symptomatic and asymptomatic patients.	[Ledergor, Guy; Weiner, Assaf; Zada, Mor; Wang, Shuang-Yin; Keren-Shaul, Hadas; Bornstein, Chamutal; Yofe, Ido; David, Eyal; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Ledergor, Guy] Tel Aviv Sourasky Med Ctr, Dept Internal Med, Tel Aviv, Israel; [Cohen, Yael C.; Kay, Sigalit; Avivi, Irit] Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel; [Cohen, Yael C.; Snir, Nimrod; Magen, Hila; Koren-Michowitz, Maya; Herzog-Tzarfati, Katrin; Salai, Moshe; Nagler, Arnon; Orr-Urtreger, Avi; Avivi, Irit] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Gatt, Moshe E.; Ben Yehuda, Dina] Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel; [Gatt, Moshe E.; Ben Yehuda, Dina; Shvidel, Lev] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Snir, Nimrod; Salai, Moshe] Tel Aviv Sourasky Med Ctr, Dept Orthoped, Tel Aviv, Israel; [Magen, Hila] Chaim Sheba Med Ctr, Hematol Div, Ramat Gan, Israel; [Koren-Michowitz, Maya; Herzog-Tzarfati, Katrin] Assaf Harofeh Med Ctr, Dept Hematol, Zerifin, Israel; [Keren-Shaul, Hadas; Rotkopf, Ron] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel; [Yellapantula, Venkata] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Yellapantula, Venkata; Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Shvidel, Lev] Kaplan Med Ctr, Hematol Inst, Rehovot, Israel; [Orr-Urtreger, Avi] Tel Aviv Sourasky Med Ctr, Genet Inst, Tel Aviv, Israel; [Halpern, Keren Bahar; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Landgren, Ola] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA; [San-Miguel, Jesus; Paiva, Bruno] Clin Univ Navarra, CIMA, CIBER ONC CB16 12 00369, Pamplona, Spain; [Keats, Jonathan J.] Translat Genom Res Inst, Integrated Canc Genom, Phoenix, AZ USA; [Barbash, Gabriel I.] Weizmann Inst Sci, Bench Bedside Program, Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Chaim Sheba Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Weizmann Institute of Science; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Memorial Sloan Kettering Cancer Center; University of Navarra; Translational Genomics Research Institute; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	ido.amit@weizmann.ac.il	San-Miguel, Jesús F./V-8977-2018; Paiva, Bruno/AAB-8881-2021; Yellapantula, Venkata/AAM-3996-2021	San-Miguel, Jesús F./0000-0002-9183-4857; Paiva, Bruno/0000-0003-1977-3815; Koren-Michowitz, Maya/0000-0002-7223-328X; Ledergor, Guy/0000-0003-0443-6066; Rotkopf, Ron/0000-0001-9503-7348; Orr-Urtreger, Avi/0000-0001-9305-6203; Keats, Jonathan/0000-0003-4375-7399; Wang, Shuang-Yin/0000-0001-9683-4103	Benoziyo Family Fund, Clalit Health Care Services; Chan Zuckerberg Initiative (CZI); Howard Hughes Medical Institute International Scholar award; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; Melanoma Research Alliance (MRA) Established Investigator Award [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; NeuroMac DFG/Transregional Collaborative Research Center Grant; Abramson Family Center for Young Scientists; European Research Council (ERC) (scAssembly); Flight Attendant Medical Research Institute; CZI; ERC 2015 Starting Grant (MYELOMANEXT); NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Benoziyo Family Fund, Clalit Health Care Services; Chan Zuckerberg Initiative (CZI); Howard Hughes Medical Institute International Scholar award(Howard Hughes Medical Institute); European Research Council Consolidator Grant (ERC-COG); Melanoma Research Alliance (MRA) Established Investigator Award; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; NeuroMac DFG/Transregional Collaborative Research Center Grant; Abramson Family Center for Young Scientists; European Research Council (ERC) (scAssembly); Flight Attendant Medical Research Institute; CZI; ERC 2015 Starting Grant (MYELOMANEXT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the participants and their families; clinical coordinators D. Yaish, I. Maman and S. Levy; N. Voskoboinik for iFISH analysis; K. Kogan for help with REDCap installation and A. Giladi for review of the manuscript. We thank Brian Fritz and Tarjei Mikkelsen from 10x Genomics for help and support with the Chromium single cell 5' and V(D) J kits. This study was partly supported by the Benoziyo Family Fund, Clalit Health Care Services and Mrs. and Mr. Barry Lang. I.A. is supported by the Chan Zuckerberg Initiative (CZI); the Howard Hughes Medical Institute International Scholar award; the European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0; Melanoma Research Alliance (MRA) Established Investigator Award (509044); the Israel Science Foundation (703/15); the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; the Helen and Martin Kimmel award for innovative investigation; a Minerva Stiftung research grant; the Israeli Ministry of Science, Technology, and Space; the David and Fela Shapell Family Foundation; the NeuroMac DFG/Transregional Collaborative Research Center Grant,; and the Abramson Family Center for Young Scientists. A.T. is supported by the European Research Council (ERC) (scAssembly), the CZI, and the Flight Attendant Medical Research Institute. B.P. is supported by an ERC 2015 Starting Grant (MYELOMANEXT).	Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baran Y., 2018, BIORXIV, DOI [10.1101/437665, DOI 10.1101/437665]; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bolli N, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.72; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen X, 2017, ONCOTARGET, V8; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Combes A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00695-1; Defays A, 2011, BLOOD, V118, P609, DOI 10.1182/blood-2010-11-319699; Dhodapkar MV, 2016, BLOOD, V128, P2599, DOI 10.1182/blood-2016-09-692954; Dubovsky JA, 2013, BLOOD, V122, P3308, DOI 10.1182/blood-2013-05-504597; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; Flores-Montero J, 2017, LEUKEMIA, V31, P2094, DOI 10.1038/leu.2017.29; Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hellstrom I, 2003, CANCER RES, V63, P3695; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Juneja SC, 2016, BONE MARROW RES, DOI 10.1155/2016/3152065; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Kumar SK, 2018, NAT REV CLIN ONCOL, V15, P409, DOI 10.1038/s41571-018-0018-y; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Lagana A, 2018, LEUKEMIA, V32, P120, DOI 10.1038/leu.2017.197; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Leidi M, 2009, CELL MOL LIFE SCI, V66, P2733, DOI 10.1007/s00018-009-0069-4; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lohr JG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7037; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Manier S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04001-5; Mishima Y, 2017, CELL REP, V19, P218, DOI 10.1016/j.celrep.2017.03.025; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Paiva B, 2017, LEUKEMIA, V31, P382, DOI 10.1038/leu.2016.211; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pawlyn C, 2017, NAT REV CANCER, V17, P543, DOI 10.1038/nrc.2017.63; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Puig N, 2015, LEUKEMIA, V29, P1435, DOI 10.1038/leu.2015.7; Rajan AM, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.92; Rajkumar SV, 2016, AM J HEMATOL, V91, P720, DOI 10.1002/ajh.24402; Rasche L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00296-y; Shah V, 2018, LEUKEMIA, V32, P102, DOI 10.1038/leu.2017.179; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Walker BA, 2012, BLOOD, V120, P1077, DOI 10.1182/blood-2012-03-412981; Zhao XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05383-2	52	118	119	5	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1867	+		10.1038/s41591-018-0269-2	http://dx.doi.org/10.1038/s41591-018-0269-2			29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30523328	Green Submitted			2022-12-27	WOS:000452392200016
J	Saria, S				Saria, Suchi			Individualized sepsis treatment using reinforcement learning	NATURE MEDICINE			English	Editorial Material							FLUID THERAPY	Reinforcement learning is applied to two large databases of electronic health records for patients admitted to an intensive care unit to identify individualized treatment strategies for correcting hypotension in sepsis.	[Saria, Suchi] Johns Hopkins Univ, Dept Comp Sci & Appl Math & Stat, Whiting Sch Engn, Baltimore, MD 21218 USA; [Saria, Suchi] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Saria, Suchi] Johns Hopkins Univ, Armstrong Inst Patient Safety & Qual, Johns Hopkins Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Saria, S (corresponding author), Johns Hopkins Univ, Dept Comp Sci & Appl Math & Stat, Whiting Sch Engn, Baltimore, MD 21218 USA.; Saria, S (corresponding author), Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.; Saria, S (corresponding author), Johns Hopkins Univ, Armstrong Inst Patient Safety & Qual, Johns Hopkins Sch Med, Baltimore, MD 21218 USA.	ssaria@cs.jhu.edu			American Heart Association (Dallas)	American Heart Association (Dallas)(American Heart Association)	S.S. has received research support from the American Heart Association (Dallas) and an honorarium from AbbVie (Chicago) and has an ownership interest in Patient Ping (Boston) and Bayesian Health (Baltimore).	Bai XW, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0532-y; Jaehne AK, 2016, CRIT CARE MED, V44, P2263, DOI 10.1097/CCM.0000000000002145; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Malbrain MLNG, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0402-x; Marik P, 2016, BRIT J ANAESTH, V116, P339, DOI 10.1093/bja/aev349; Nemati S., 2016, 2016 IEEE 38 ANN INT; Prasad N., 2017, PREPRINT; Schulam P., 2018, PREPRINT; Self WH, 2018, ANN EMERG MED, V72, P457, DOI 10.1016/j.annemergmed.2018.03.039; Xu Y, 2016, MACH LEARN HEALTHC C, V56, P282	11	17	17	4	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1641	1642		10.1038/s41591-018-0253-x	http://dx.doi.org/10.1038/s41591-018-0253-x			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30397359				2022-12-27	WOS:000449404200011
J	Veit, G; Xu, HJ; Dreano, E; Avramescu, RG; Bagdany, M; Beitel, LK; Roldan, A; Hancock, M; Lay, C; Li, W; Morin, K; Gao, S; Mak, PA; Ainscow, E; Orth, AP; McNamara, P; Edelman, A; Frenkiel, S; Matouk, E; Sermet-Gaudelus, I; Barnes, WG; Lukacs, GL				Veit, Guido; Xu, Haijin; Dreano, Elise; Avramescu, Radu G.; Bagdany, Miklos; Beitel, Lenore K.; Roldan, Ariel; Hancock, Marka; Lay, Cecilia; Li, Wei; Morin, Katelin; Gao, Sandra; Mak, Puiying A.; Ainscow, Edward; Orth, Anthony P.; McNamara, Peter; Edelman, Aleksander; Frenkiel, Saul; Matouk, Elias; Sermet-Gaudelus, Isabelle; Barnes, William G.; Lukacs, Gergely L.			Structure-guided combination therapy to potently improve the function of mutant CFTRs	NATURE MEDICINE			English	Article							SMALL-MOLECULE CORRECTORS; PROTEIN-QUALITY CONTROL; CHANNEL ACTIVITY; IN-VITRO; DOMAIN; DELTA-F508-CFTR; MUTATION; RESCUE; DEFECT; CELLS	Available corrector drugs are unable to effectively rescue the folding defects of CFTR-Delta F508 (or CFTR-F508del), the most common disease-causing mutation of the cystic fibrosis transmembrane conductance regulator, a plasma membrane (PM) anion channel, and thus to substantially ameliorate clinical phenotypes of cystic fibrosis (CF). To overcome the corrector efficacy ceiling, here we show that compounds targeting distinct structural defects of CFTR can synergistically rescue mutant expression and function at the PM. High-throughput cell-based screens and mechanistic analysis identified three small-molecule series that target defects at nucleotide-binding domain (NBD1), NBD2 and their membrane-spanning domain (MSD) interfaces. Although individually these compounds marginally improve Delta F508-CFTR folding efficiency, function and stability, their combinations lead to similar to 50-100% of wild-type-level correction in immortalized and primary human airway epithelia and in mouse nasal epithelia. Likewise, corrector combinations were effective against rare missense mutations in various CFTR domains, probably acting via structural allostery, suggesting a mechanistic framework for their broad application.	[Veit, Guido; Xu, Haijin; Avramescu, Radu G.; Bagdany, Miklos; Beitel, Lenore K.; Roldan, Ariel; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Dreano, Elise; Edelman, Aleksander; Sermet-Gaudelus, Isabelle] INEM, INSERM U1151, Paris, France; [Hancock, Marka] McGill Univ, SPR MS Facil, Montreal, PQ, Canada; [Lay, Cecilia; Li, Wei; Morin, Katelin; Gao, Sandra; Mak, Puiying A.; Ainscow, Edward; Orth, Anthony P.; McNamara, Peter; Barnes, William G.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Frenkiel, Saul] McGill Univ, Dept Otolaryngol Head & Neck Surg, Montreal, PQ, Canada; [Matouk, Elias] McGill Univ, Montreal Chest Inst, Adult Cyst Fibrosis Clin, Montreal, PQ, Canada; [Lukacs, Gergely L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ, Canada	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Novartis; McGill University; McGill University; McGill University; McGill University	Veit, G; Lukacs, GL (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.; Lukacs, GL (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Lukacs, GL (corresponding author), McGill Univ, GRASP, Montreal, PQ, Canada.	guido.veit@mcgill.ca; gergely.lukacs@mcgill.ca	Veit, Guido/C-9596-2009	Veit, Guido/0000-0002-6758-2696; Lukacs, Gergely/0000-0003-0900-0675; Hancock, Mark/0000-0001-7427-7449; Roldan, Ariel/0000-0002-8159-5450; Beitel, Lenore K./0000-0002-2836-5568	Vaincre La Mucoviscidose; Canadian Institutes of Health Research [MOP-142221, PJT-153095]; National Institute of Diabetes AMP; Digestive AMP; Kidney Diseases [5R01DK075302]; Cystic Fibrosis Foundation Therapeutics; Cystic Fibrosis Canada; Canada Foundation for Innovation [32616, 228340]; Fonds de Recherche du Quebec Sante (FRQS) Doctoral Training Scholarship; BIACORE T200 SPR system [228340]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075302] Funding Source: NIH RePORTER	Vaincre La Mucoviscidose; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Diabetes AMP; Digestive AMP; Kidney Diseases; Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de Recherche du Quebec Sante (FRQS) Doctoral Training Scholarship; BIACORE T200 SPR system; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to the individuals who volunteered to participate in this study. We thank D. C. Gruenert for the parental CFBE41o-cell line; W. E. Finkbeiner for supplying HBE cells, J. Riordan and the Cystic Fibrosis Foundation for the 660 antibody, P. Thomas for providing vectors encoding some of the CFTR2 mutants and members of the Cystic Fibrosis Folding Consortium for advice. This work was supported by Vaincre La Mucoviscidose to A.E. and I.S.-G., the Canadian Institutes of Health Research (MOP-142221 to G.L.L. and PJT-153095 to G.V., E.M., and G.L.L.), National Institute of Diabetes & Digestive & Kidney Diseases (5R01DK075302 to G.L.L.) and the Cystic Fibrosis Foundation Therapeutics to G.L.L. as well as Cystic Fibrosis Canada to G.L.L. We acknowledge the Canada Foundation for Innovation for infrastructure support: Bruker UltrafleXtreme MALDI-TOF/TOF system (grant no. 32616, awarded to G. Multhaup and G.L.L.); BIACORE T200 SPR system (grant no. 228340 awarded to G. Multhaup). R.G.A. is a recipient of the Fonds de Recherche du Quebec Sante (FRQS) Doctoral Training Scholarship. G.L.L. is a Canada Research Chair.	Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Avramescu RG, 2017, HUM MOL GENET, V26, P4873, DOI 10.1093/hmg/ddx367; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Chong PA, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009522; Coffman KC, 2014, J MED CHEM, V57, P6729, DOI 10.1021/jm5007885; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; da Cunha MF, 2016, INT J BIOCHEM CELL B, V80, P87, DOI 10.1016/j.biocel.2016.10.001; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Duarri A, 2008, HUM MOL GENET, V17, P3728, DOI 10.1093/hmg/ddn269; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Griesenbach U, 1999, THORAX, V54, pS19, DOI 10.1136/thx.54.2008.S19; Hall JD, 2016, PROTEIN SCI, V25, P360, DOI 10.1002/pro.2821; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; Hegde RN, 2015, ELIFE, V4, DOI 10.7554/eLife.10365; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hunt JF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009514; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liu XF, 2017, NAT PROTOC, V12, P439, DOI 10.1038/nprot.2016.174; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Lopes-Pacheco M, 2015, J BIOL CHEM, V290, P25636, DOI 10.1074/jbc.M115.671925; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Muller L, 2013, JOVE-J VIS EXP, DOI 10.3791/50646; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Pranke IM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07504-1; Phuan PW, 2014, MOL PHARMACOL, V86, P42, DOI 10.1124/mol.114.092478; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Saussereau EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057317; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Trzcinska-Daneluti AM, 2015, MOL CELL PROTEOMICS, V14, P1569, DOI 10.1074/mcp.M114.046375; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Vernon RM, 2017, J BIOL CHEM, V292, P14147, DOI 10.1074/jbc.M116.772335; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	68	80	80	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1732	+		10.1038/s41591-018-0200-x	http://dx.doi.org/10.1038/s41591-018-0200-x			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30297908	Green Accepted			2022-12-27	WOS:000449404200026
J	Orlando, EJ; Han, X; Tribouley, C; Wood, PA; Leary, RJ; Riester, M; Levine, JE; Qayed, M; Grupp, SA; Boyer, M; De Moerloose, B; Nemecek, ER; Bittencourt, H; Hiramatsu, H; Buechner, J; Davies, SM; Verneris, MR; Nguyen, K; Brogdon, JL; Bitter, H; Morrissey, M; Pierog, P; Pantano, S; Engelman, JA; Winckler, W				Orlando, Elena J.; Han, Xia; Tribouley, Catherine; Wood, Patricia A.; Leary, Rebecca J.; Riester, Markus; Levine, John E.; Qayed, Muna; Grupp, Stephan A.; Boyer, Michael; De Moerloose, Barbara; Nemecek, Eneida R.; Bittencourt, Henrique; Hiramatsu, Hidefumi; Buechner, Jochen; Davies, Stella M.; Verneris, Michael R.; Nguyen, Kevin; Brogdon, Jennifer L.; Bitter, Hans; Morrissey, Michael; Pierog, Piotr; Pantano, Serafino; Engelman, Jeffrey A.; Winckler, Wendy			Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							DNA-SEQUENCING DATA; T-CELL THERAPY; MUTATIONS; FRAMEWORK; ESCAPE	We identified genetic mutations in CD19 and loss of heterozygosity at the time of CD19(-) relapse to chimeric antigen receptor (CAR) therapy. The mutations are present in the vast majority of resistant tumor cells and are predicted to lead to a truncated protein with a nonfunctional or absent transmembrane domain and consequently to a loss of surface antigen. This irreversible loss of CD19 advocates for an alternative targeting or combination CAR approach.	[Orlando, Elena J.; Leary, Rebecca J.; Riester, Markus; Brogdon, Jennifer L.; Bitter, Hans; Morrissey, Michael; Engelman, Jeffrey A.; Winckler, Wendy] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Han, Xia; Tribouley, Catherine; Wood, Patricia A.; Pierog, Piotr] Novartis Pharmaceut, E Hanover, NJ USA; [Levine, John E.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Qayed, Muna] Emory Univ, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Grupp, Stephan A.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Boyer, Michael] Univ Utah, Salt Lake City, UT USA; [De Moerloose, Barbara] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium; [Nemecek, Eneida R.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Bittencourt, Henrique] St Justine Univ, Hlth Ctr, Montreal, PQ, Canada; [Hiramatsu, Hidefumi] Kyoto Univ, Dept Pediat, Kyoto, Japan; [Buechner, Jochen] Oslo Univ Hosp, Dept Pediat Hematol & Oncol, Oslo, Norway; [Davies, Stella M.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplantat & Immune Deficiency, Cincinnati, OH 45229 USA; [Verneris, Michael R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Nguyen, Kevin] Navigate BioPharma Serv Inc, Carlsbad, CA USA; [Pantano, Serafino] Novartis Pharma AG, Basel, Switzerland	Novartis; Novartis; Icahn School of Medicine at Mount Sinai; Emory University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utah System of Higher Education; University of Utah; Ghent University; Ghent University Hospital; Oregon Health & Science University; Universite de Montreal; Kyoto University; University of Oslo; Cincinnati Children's Hospital Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Novartis	Orlando, EJ (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	elena.orlando@novartis.com	De+Moerloose, Barbara/AAN-3298-2020	Levine, John/0000-0002-5611-7828; Buechner, Jochen/0000-0001-5848-4501; De Moerloose, Barbara/0000-0002-2449-539X; Riester, Markus/0000-0002-4759-8332				Buechner J., 2017, EHA, V17; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Grupp SA, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.67.67; Jacoby E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12320; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; MAUDE SL, 2016, BLOOD, V128; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Riester M, 2016, SOURCE CODE BIOL MED, V11, DOI 10.1186/s13029-016-0060-z; Ruella M, 2016, COMPUT STRUCT BIOTEC, V14, P357, DOI 10.1016/j.csbj.2016.09.003; Shah NP, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1895.1895; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sommermeyer D, 2017, LEUKEMIA, V31, P2191, DOI 10.1038/leu.2017.57; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; Wang ZG, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0423-1; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zugmaier G, 2015, BLOOD, V126, P2578, DOI 10.1182/blood-2015-06-649111	22	265	271	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1504	+		10.1038/s41591-018-0146-z	http://dx.doi.org/10.1038/s41591-018-0146-z			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30275569				2022-12-27	WOS:000446577900010
J	Huang, CC; Yang, WS; Guo, CX; Jiang, HW; Li, FX; Xiao, ML; Davidson, S; Yu, G; Duan, B; Huang, TW; Huang, AJW; Liu, Q				Huang, Cheng-Chiu; Yang, Weishan; Guo, Changxiong; Jiang, Haowu; Li, Fengxian; Xiao, Maolei; Davidson, Steve; Yu, Guang; Duan, Bo; Huang, Tianwen; Huang, Andrew J. W.; Liu, Qin			Anatomical and functional dichotomy of ocular itch and pain	NATURE MEDICINE			English	Article							ALLERGIC CONJUNCTIVITIS; SENSORY NEURONS; MAST-CELLS; HISTAMINE; NOCICEPTORS; SUBPOPULATION; SENSITIVITY; ACTIVATION; RECEPTORS; RESPONSES	Itch and pain are refractory symptoms of many ocular conditions. Ocular itch is generated mainly in the conjunctiva and is absent from the cornea. In contrast, most ocular pain arises from the cornea. However, the underlying mechanisms remain unknown. Using genetic axonal tracing approaches, we discover distinct sensory innervation patterns between the conjunctiva and cornea. Further genetic and functional analyses in rodent models show that a subset of conjunctival-selective sensory fibers marked by Mrgpr A3 expression, rather than corneal sensory fibers, mediates ocular itch. Importantly, the actions of both histamine and nonhistamine pruritogens converge onto this unique subset of conjunctiva sensory fibers and enable them to play a key role in mediating itch associated with allergic conjunctivitis. This is distinct from skin itch, in which discrete populations of sensory neurons cooperate to carry itch. Finally, we provide proof of concept that selective silencing of conjunctiva itch-sensing fibers by pruritogen-mediated entry of sodium channel blocker QX-314 is a feasible therapeutic strategy to treat ocular itch in mice. Itch-sensing fibers also innervate the human conjunctiva and allow pharmacological silencing using QX-314. Our results cast new light on the neural mechanisms of ocular itch and open a new avenue for developing therapeutic strategies.	[Huang, Cheng-Chiu; Yang, Weishan; Guo, Changxiong; Jiang, Haowu; Li, Fengxian; Xiao, Maolei; Liu, Qin] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Huang, Cheng-Chiu; Yang, Weishan; Guo, Changxiong; Jiang, Haowu; Li, Fengxian; Xiao, Maolei; Liu, Qin] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63130 USA; [Li, Fengxian] Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Davidson, Steve] Univ Cincinnati, Coll Med, Dept Anesthesiol, Cincinnati, OH USA; [Davidson, Steve] Univ Cincinnati, Coll Med, Pain Res Ctr, Cincinnati, OH USA; [Yu, Guang] Nanjing Univ Chinese Med, Sch Med & Life Sci, Nanjing, Jiangsu, Peoples R China; [Duan, Bo; Huang, Tianwen] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; [Duan, Bo; Huang, Tianwen] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Huang, Andrew J. W.; Liu, Qin] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Huang, Cheng-Chiu] Merck Res Labs, San Francisco, CA USA; [Duan, Bo] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); Southern Medical University - China; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Nanjing University of Chinese Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL); Merck & Company; University of Michigan System; University of Michigan	Liu, Q (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Liu, Q (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63130 USA.; Liu, Q (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	qinliu@wustl.edu	Huang, Tianwen/HGC-4346-2022; Huang, Tianwen/AAI-1038-2020	Yu, Guang/0000-0001-7918-0160; Davidson, Steve/0000-0003-2944-1144; Huang, Andrew JW/0000-0003-1939-9149; Jiang, Haowu/0000-0003-2477-5970; LI, FENGXIAN/0000-0002-3307-1468	"Research to Prevent Blindness" (RPB); National Institutes of Health [R01EY024704, 1R01AI125743]; Pew Scholar Award; NATIONAL EYE INSTITUTE [R01EY024704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068012] Funding Source: NIH RePORTER	"Research to Prevent Blindness" (RPB)(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to M. W. Panneton, H. Hu, B. Kim, Z. F. Chen, T. P. Margolis and X. Dong for insightful discussions and comments on the manuscript, and we thank A. S. Yoo and Y. Liu for technical support. Mrgpra3<SUP>GFP-cre</SUP>, Pirt<SUP>GCaMP3/+</SUP> and MRGPRX1;Mrgpr-cluster Delta<SUP>-/-</SUP> mice were generous gifts from X. Dong of Johns Hopkins University. Mrgprd<SUP>eGFP/+</SUP> mice were from D. J. Anderson of the California Institute of Technology. Trpm8<SUP>GFP/+</SUP> mice were from G. Story. Nav1.8<SUP>cre</SUP>, Nmb<SUP>-/-</SUP>, Nmbr<SUP>-/-</SUP> and Nmbr<SUP>GFP</SUP> transgenic mice were from Z. -F. Chen of Washington University in St. Louis. Slc17a8<SUP>Cre/+</SUP> tissues were from Q. Ma of Dana-Farber Cancer Institute. This work was supported by the "Research to Prevent Blindness" (RPB) unrestricted grant to the Department of Ophthalmology (A.J.W.H. and Q.L.), and the National Institutes of Health (R01EY024704 and 1R01AI125743; Q.L.) and the Pew Scholar Award (Q.L.).	Abelson Mark B, 2003, Ocul Surf, V1, P127; Abila B, 1994, Afr J Med Med Sci, V23, P139; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Belmonte C, 1999, INVEST OPHTH VIS SCI, V40, P513; Belmonte Carlos, 2004, Ocul Surf, V2, P248; BEUERMAN RW, 1979, PAIN, V7, P1, DOI 10.1016/0304-3959(79)90102-7; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; BONINI S, 1989, INT ARCH ALLER A IMM, V88, P144, DOI 10.1159/000234769; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; CIPRANDI G, 1992, DRUGS, V43, P154, DOI 10.2165/00003495-199243020-00003; Cursiefen Claus, 2007, Chem Immunol Allergy, V92, P50, DOI 10.1159/000099253; Dell Ralph B, 2002, ILAR J, V43, P207; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Huang CC, 2016, J ALLERGY CLIN IMMUN, V137, P1267, DOI 10.1016/j.jaci.2015.08.047; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Knop E, 2010, DEV OPHTHALMOL, V45, P108, DOI 10.1159/000315024; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Lee MG, 2008, J IMMUNOL, V180, P2251, DOI 10.4049/jimmunol.180.4.2251; Leonardi Andrea, 2002, Curr Allergy Asthma Rep, V2, P325, DOI 10.1007/s11882-002-0061-7; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Liu Q, 2012, J NEUROSCI, V32, P14532, DOI 10.1523/JNEUROSCI.3509-12.2012; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; MACIVER MB, 1993, J NEUROSCI, V13, P4511; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Mishra SK, 2012, J NEUROSCI, V32, P8686, DOI 10.1523/JNEUROSCI.1533-12.2012; Morita T, 2015, NEURON, V87, P124, DOI 10.1016/j.neuron.2015.05.044; MOUSLI M, 1989, J PHARMACOL EXP THER, V250, P329; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nagaki Y, 1999, J CATARACT REFR SURG, V25, P96, DOI 10.1016/S0886-3350(99)80018-2; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Ono SJ, 2005, J ALLERGY CLIN IMMUN, V115, P118, DOI 10.1016/j.jaci.2004.10.042; OTSUKI JA, 1976, IMMUNOL COMMUN, V5, P27, DOI 10.3109/08820137609020610; Panneton WM, 2010, EXP EYE RES, V90, P388, DOI 10.1016/j.exer.2009.11.018; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; Reddy VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8864; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Stantcheva KK, 2016, EMBO REP, V17, P585, DOI 10.15252/embr.201540983; TANELIAN DL, 1984, EXP NEUROL, V84, P165, DOI 10.1016/0014-4886(84)90013-X; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Wong AHC, 2009, RECENT PATENTS INFLA, V3, P118, DOI 10.2174/187221309788489733; Yeniad B, 2009, CORNEA, V28, P477, DOI 10.1097/ICO.0b013e31818d37fa; Zhao Z. Q., 2010, J NEUROSCI, V34, P108; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	54	32	32	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1268	+		10.1038/s41591-018-0083-x	http://dx.doi.org/10.1038/s41591-018-0083-x			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29988128	Green Accepted			2022-12-27	WOS:000440955500032
J	Lam, TKT; Cherney, DZI				Lam, Tony K. T.; Cherney, David Z. I.			CLINICAL TRIALS Beta cell preservation in patients with type 1 diabetes	NATURE MEDICINE			English	Editorial Material							THIOREDOXIN-INTERACTING PROTEIN; REDUCTION; EXENATIDE; APOPTOSIS; RATS		[Lam, Tony K. T.; Cherney, David Z. I.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Lam, Tony K. T.; Cherney, David Z. I.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lam, Tony K. T.; Cherney, David Z. I.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lam, Tony K. T.; Cherney, David Z. I.] Banting & Best Diabet Ctr, Toronto, ON, Canada; [Cherney, David Z. I.] Univ Hlth Network, Div Nephrol, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Cherney, DZI (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Cherney, DZI (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Cherney, DZI (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Cherney, DZI (corresponding author), Banting & Best Diabet Ctr, Toronto, ON, Canada.; Cherney, DZI (corresponding author), Univ Hlth Network, Div Nephrol, Dept Med, Toronto, ON, Canada.	david.cherney@uhn.ca			Juvenile Diabetes Research Foundation (JDRF) [17-2013-312]; Canadian Diabetes Association; CIHR-JDRF SPOR operating grant; Banting and Best Diabetes Centre; University of Toronto Department of Medicine Merit Award; Canadian Institutes of Health Research (CIHR) Foundation Grant [FDN-143204]; Canadian Diabetes Association Operating Grant [OG-3-15-4901-TL]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Diabetes Association; CIHR-JDRF SPOR operating grant; Banting and Best Diabetes Centre; University of Toronto Department of Medicine Merit Award; Canadian Institutes of Health Research (CIHR) Foundation Grant(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association Operating Grant	D.Z.I.C. receives funding from by the Juvenile Diabetes Research Foundation (JDRF) (The Canadian Study of Longevity in Diabetes, Operating Grant No. 17-2013-312), the Canadian Diabetes Association and the CIHR-JDRF SPOR operating grant and the Banting and Best Diabetes Centre. He is also the recipient of a University of Toronto Department of Medicine Merit Award. T.K.T.L. is funded by a Canadian Institutes of Health Research (CIHR) Foundation Grant (FDN-143204) and a Canadian Diabetes Association Operating Grant (OG-3-15-4901-TL). T.K.T.L holds the John Kitson McIvor (1915-1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Diabetes and Obesity.	Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Kaneto H, 2017, J DIABETES, V9, P219, DOI 10.1111/1753-0407.12494; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; Kuriyama C, 2014, J PHARMACOL EXP THER, V351, P423, DOI 10.1124/jpet.114.217992; Lotfy M, 2014, J ENDOCRINOL, V220, P291, DOI 10.1530/JOE-13-0426; Ovalle F, 2018, NAT MED, V24, P1108, DOI 10.1038/s41591-018-0089-4; Retnakaran R, 2014, DIABETES CARE, V37, P3270, DOI 10.2337/dc14-0893; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Shimo N, 2015, BIOCHEM BIOPH RES CO, V467, P948, DOI 10.1016/j.bbrc.2015.10.038; Yin T, 2017, J CLIN ENDOCR METAB, V102, P2604, DOI 10.1210/jc.2016-3778	12	3	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1089	1090		10.1038/s41591-018-0144-1	http://dx.doi.org/10.1038/s41591-018-0144-1			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082859				2022-12-27	WOS:000440955500009
J	Stower, H				Stower, Hannah			PREGNANCY OUTCOME Predicting preterm birth	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1088	1088		10.1038/s41591-018-0154-z	http://dx.doi.org/10.1038/s41591-018-0154-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082868	Bronze			2022-12-27	WOS:000440955500006
J	Shen, JF; Ju, ZL; Zhao, W; Wang, LL; Peng, Y; Ge, ZQ; Nagel, ZD; Zou, J; Wang, C; Kapoor, P; Ma, XY; Ma, D; Liang, JY; Song, SM; Liu, JS; Samson, LD; Ajani, JA; Li, GM; Liang, H; Shen, XT; Mills, GB; Peng, G				Shen, Jianfeng; Ju, Zhenlin; Zhao, Wei; Wang, Lulu; Peng, Yang; Ge, Zhongqi; Nagel, Zachary D.; Zou, Jun; Wang, Chen; Kapoor, Prabodh; Ma, Xiangyi; Ma, Ding; Liang, Jiyong; Song, Shumei; Liu, Jinsong; Samson, Leona D.; Ajani, Jaffer A.; Li, Guo-Min; Liang, Han; Shen, Xuetong; Mills, Gordon B.; Peng, Guang			ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade	NATURE MEDICINE			English	Article							MISMATCH-REPAIR DEFICIENCY; HUMAN SWI/SNF COMPLEXES; CANCER-TREATMENT; PD-1 BLOCKADE; COLON-CANCER; CELL-LINES; EXPRESSION; IMMUNOTHERAPY; TUMORS; MUTATIONS	ARID1A (the AT-rich interaction domain 1A, also known as BAF250a) is one of the most commonly mutated genes in cancer(1,2). The majority of ARID1A mutations are inactivating mutations and lead to loss of ARID1A expression(3), which makes ARID1A a poor therapeutic target. Therefore, it is of clinical importance to identify molecular consequences of ARID1A deficiency that create therapeutic vulnerabilities in ARID1A-mutant tumors. In a proteomic screen, we found that ARID1A interacts with mismatch repair (MMR) protein MSH2. ARID1A recruited MSH2 to chromatin during DNA replication and promoted MMR. Conversely, ARID1A inactivation compromised MMR and increased mutagenesis. ARID1A deficiency correlated with microsatellite instability genomic signature and a predominant C>T mutation pattern and increased mutation load across multiple human cancer types. Tumors formed by an ARID1A-deficient ovarian cancer cell line in syngeneic mice displayed increased mutation load, elevated numbers of tumor-infiltrating lymphocytes, and PD-L1 expression. Notably, treatment with anti-PD-L1 antibody reduced tumor burden and prolonged survival of mice bearing ARID1A-deficient but not ARID1A-wild-type ovarian tumors. Together, these results suggest ARID1A deficiency contributes to impaired MMR and mutator phenotype in cancer, and may cooperate with immune checkpoint blockade therapy.	[Shen, Jianfeng; Wang, Lulu; Peng, Yang; Peng, Guang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Ju, Zhenlin; Zhao, Wei; Liang, Jiyong; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Ge, Zhongqi; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Nagel, Zachary D.; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, Dept Biol Engn, Cambridge, MA 02139 USA; [Zou, Jun; Wang, Chen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Hubei, Peoples R China; [Kapoor, Prabodh; Shen, Xuetong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX USA; [Ma, Xiangyi; Ma, Ding] Canc Biol Res Ctr, Wuhan, Hubei, Peoples R China; [Ma, Xiangyi; Ma, Ding] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Song, Shumei; Ajani, Jaffer A.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Li, Guo-Min] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Peng, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA.	gpeng@mdanderson.org	Classen, Scott/AAY-8176-2020; Shen, Jianfeng/G-6644-2014	Mills, Gordon/0000-0002-0144-9614; Ajani, Jaffer A/0000-0001-9946-0629; Shen, Jianfeng/0000-0001-9779-6225	NCI Cancer Center Support Grant [CA016672]; Department of Defense grant [OC140431]; NIH R01 grant [CA181663, GM093104]; Cancer Prevention and Research Institute of Texas grant [RP160242]; NIH P01 grant [CA092584]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA181663, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093104] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant(United States Department of Defense); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas grant; NIH P01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NCI Cancer Center Support Grant CA016672 to The University of Texas MD Anderson Cancer Center, Department of Defense grant OC140431, NIH R01 grant CA181663 to G.P., Cancer Prevention and Research Institute of Texas grant RP160242 to X.S. and G.P., NIH R01 grant GM093104 to X.S, and NIH P01 grant CA092584 to Z.D.N.	Allo G, 2014, MODERN PATHOL, V27, P255, DOI 10.1038/modpathol.2013.144; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Chou A, 2014, HUM PATHOL, V45, P1697, DOI 10.1016/j.humpath.2014.04.009; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kane MF, 1997, CANCER RES, V57, P808; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kim MS, 2012, APMIS, V120, P1020, DOI 10.1111/j.1600-0463.2012.02930.x; Koster BD, 2015, CURR OPIN ONCOL, V27, P482, DOI 10.1097/CCO.0000000000000221; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tscharke DC, 2015, NAT REV IMMUNOL, V15, P705, DOI 10.1038/nri3905; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Wu RC, 2014, CANCER BIOL THER, V15, P655, DOI 10.4161/cbt.28411; Zhao H, 2014, ELIFE, V3, DOI 10.7554/eLife.02725	35	255	258	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					556	+		10.1038/s41591-018-0012-z	http://dx.doi.org/10.1038/s41591-018-0012-z			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736026	Green Accepted			2022-12-27	WOS:000432126800011
J	Kellmeyer, P; Biller-Andorno, N; Meynen, G				Kellmeyer, Philipp; Biller-Andorno, Nikola; Meynen, Gerben			Ethical tensions of virtual reality treatment in vulnerable patients	NATURE MEDICINE			English	Editorial Material							THERAPY	Emerging virtual reality systems offer intriguing therapeutic possibilities, but their development and use should be guided by ethical priorities that account for the specific vulnerabilities of patients.	[Kellmeyer, Philipp] Univ Freiburg, Med Ctr, Dept Neurosurg, Neuromed Artificial Intelligence Lab, Freiburg, Germany; [Kellmeyer, Philipp] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Freiburg, Germany; [Kellmeyer, Philipp] Univ Freiburg, Cluster Excellence BrainLinks BrainTools, Freiburg, Germany; [Kellmeyer, Philipp; Biller-Andorno, Nikola] Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland; [Meynen, Gerben] Vrije Univ Amsterdam, Fac Humanities, Amsterdam, Netherlands; [Meynen, Gerben] Univ Utrecht, Willem Pompe Inst Criminal Law & Criminol, Utrecht, Netherlands; [Meynen, Gerben] Univ Utrecht, UCALL, Utrecht, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; University of Zurich; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University	Kellmeyer, P (corresponding author), Univ Freiburg, Med Ctr, Dept Neurosurg, Neuromed Artificial Intelligence Lab, Freiburg, Germany.; Kellmeyer, P (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Freiburg, Germany.; Kellmeyer, P (corresponding author), Univ Freiburg, Cluster Excellence BrainLinks BrainTools, Freiburg, Germany.; Kellmeyer, P (corresponding author), Univ Zurich, Inst Biomed Eth & Hist Med, Zurich, Switzerland.	philipp.kellmeyer@uniklinik-freiburg.de	Kellmeyer, Philipp/ABI-6392-2020	Kellmeyer, Philipp/0000-0001-5538-373X; Meynen, Gerben/0000-0001-7298-8407; Biller-Andorno, Nikola/0000-0001-7661-1324	German Ministry of Education and Research (BMBF) [13GW0053D]; German Research Foundation (DFG) [EXC1086]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was partly supported by the German Ministry of Education and Research (BMBF) grant no. 13GW0053D to the University of Freiburg -Medical Center; and by the German Research Foundation (DFG) grant no. EXC1086 (BrainLinks-BrainTools) to the University of Freiburg. Author P.K. wishes to thank his friend Dr. med. Lorenz Lehmann (University of Heidelberg - Medical Center) for valuable inspiration in designing the figure.	Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Dascal Julieta, 2017, Innov Clin Neurosci, V14, P14; Fogg B. J., 2003, PERSUASIVE TECHNOLOG, P89; Freeman D, 2018, LANCET PSYCHIAT, V5, P625, DOI 10.1016/S2215-0366(18)30226-8; Ganguli-Mitra A., 2011, SAGE HDB HLTH CARE E, P239, DOI https://doi.org/10.4135/9781446200971.n21; Howard MC, 2017, COMPUT HUM BEHAV, V70, P317, DOI 10.1016/j.chb.2017.01.013; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Kellmeyer P, 2018, CAMB Q HEALTHC ETHIC, V27, P610, DOI 10.1017/S0963180118000129; Mackenzie C., 2013, VULNERABILITY NEW ES; Morozov Evgeny, 2014, SAVE EVERYTHING CLIC; Orji R, 2018, HEALTH INFORM J, V24, P66, DOI 10.1177/1460458216650979; Pot-Kolder RMCA, 2018, LANCET PSYCHIAT, V5, P217, DOI 10.1016/S2215-0366(18)30053-1; Timmer Jelte, 2015, Persuasive Technology. 10th International Conference, PERSUASIVE 2015. Proceedings: LNCS 9072, P196, DOI 10.1007/978-3-319-20306-5_18; Tuente SK, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1830-8	14	13	13	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1185	1188		10.1038/s41591-019-0543-y	http://dx.doi.org/10.1038/s41591-019-0543-y			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31359003				2022-12-27	WOS:000480414600006
J	Depommier, C; Everard, A; Druart, C; Plovier, H; Van Hul, M; Vieira-Silva, S; Falony, G; Raes, J; Maiter, D; Delzenne, NM; de Barsy, M; Loumaye, A; Hermans, MP; Thissen, JP; de Vos, WM; Cani, PD				Depommier, Clara; Everard, Amandine; Druart, Celine; Plovier, Hubert; Van Hul, Matthias; Vieira-Silva, Sara; Falony, Gwen; Raes, Jeroen; Maiter, Dominique; Delzenne, Nathalie M.; de Barsy, Marie; Loumaye, Audrey; Hermans, Michel P.; Thissen, Jean-Paul; de Vos, Willem M.; Cani, Patrice D.			Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study	NATURE MEDICINE			English	Article							ASSAY-DEPENDENT VARIABILITY; GAMMA-GLUTAMYL-TRANSFERASE; SERUM-INSULIN LEVELS; WHITE BLOOD-CELLS; GUT MICROBIOME; WEIGHT-LOSS; TYPE-2; GLUCOSE; RISK; METAANALYSIS	Metabolic syndrome is characterized by a constellation of comorbidities that predispose individuals to an increased risk of developing cardiovascular pathologies as well as type 2 diabetes mellitus(1). The gut microbiota is a new key contributor involved in the onset of obesity-related disorders(2). In humans, studies have provided evidence for a negative correlation between Akkermansia muciniphila abundance and overweight, obesity, untreated type 2 diabetes mellitus or hypertension(3-8). Since the administration of A. muciniphila has never been investigated in humans, we conducted a randomized, double-blind, placebo-controlled pilot study in overweight/ obese insulin-resistant volunteers; 40 were enrolled and 32 completed the trial. The primary end points were safety, tolerability and metabolic parameters (that is, insulin resistance, circulating lipids, visceral adiposity and body mass). Secondary outcomes were gut barrier function (that is, plasma lipopolysaccharides) and gut microbiota composition. In this single-center study, we demonstrated that daily oral supplementation of 10(10) A. muciniphila bacteria either live or pasteurized for three months was safe and well tolerated. Compared to placebo, pasteurized A. muciniphila improved insulin sensitivity (+ 28.62 +/- 7.02%, P = 0.002), and reduced insulinemia (-34.08 +/- 7.12%, P = 0.006) and plasma total cholesterol (-8.68 +/- 2.38%, P = 0.02). Pasteurized A. muciniphila supplementation slightly decreased body weight (-2.27 +/- 0.92 kg, P = 0.091) compared to the placebo group, and fat mass (-1.37 +/- 0.82 kg, P = 0.092) and hip circumference (-2.63 +/- 1.14 cm, P = 0.091) compared to baseline. After three months of supplementation, A. muciniphila reduced the levels of the relevant blood markers for liver dysfunction and inflammation while the overall gut microbiome structure was unaffected. In conclusion, this proof-of-concept study (clinical trial no. NCT02637115) shows that the intervention was safe and well tolerated and that supplementation with A. muciniphila improves several metabolic parameters.	[Depommier, Clara; Everard, Amandine; Druart, Celine; Plovier, Hubert; Van Hul, Matthias; Cani, Patrice D.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, WELBIO,Walloon Excellence Life Sci & BIOtechnol, Brussels, Belgium; [Vieira-Silva, Sara; Falony, Gwen; Raes, Jeroen] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Mol Bacteriol, Leuven, Belgium; [Vieira-Silva, Sara; Falony, Gwen; Raes, Jeroen] VIB, Ctr Microbiol, Leuven, Belgium; [Maiter, Dominique; de Barsy, Marie; Loumaye, Audrey; Hermans, Michel P.; Thissen, Jean-Paul] Catholic Univ Louvain, UCLouvain, Inst Rech Expt & Clin, Pole EDIN, Louvain La Neuve, Belgium; [Maiter, Dominique; de Barsy, Marie; Loumaye, Audrey; Hermans, Michel P.; Thissen, Jean-Paul] Clin Univ St Luc, Div Endocrinol & Nutr, Brussels, Belgium; [Delzenne, Nathalie M.] Catholic Univ Louvain, UCLouvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, Brussels, Belgium; [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [de Vos, Willem M.] Univ Helsinki, Human Microbiome Res Program, Fac Med, Helsinki, Finland	Universite Catholique Louvain; WELBIO; KU Leuven; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Wageningen University & Research; University of Helsinki	Cani, PD (corresponding author), Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, WELBIO,Walloon Excellence Life Sci & BIOtechnol, Brussels, Belgium.	Patrice.cani@uclouvain.be	D., Cani Patrice/M-8055-2016; Falony, Gwen/AAN-5011-2020; Delzenne, Nathalie/AAC-4628-2019; Vieira-Silva, Sara/ABE-1247-2021; Plovier, Hubert/AAG-1533-2021; raes, jeroen/D-7835-2018	D., Cani Patrice/0000-0003-2040-2448; Falony, Gwen/0000-0003-2450-0782; Delzenne, Nathalie/0000-0003-2115-6082; Vieira-Silva, Sara/0000-0002-4616-7602; raes, jeroen/0000-0002-1337-041X; Van Hul, Matthias/0000-0002-5503-107X; Everard, Amandine/0000-0001-8925-8144; Druart, Celine/0000-0002-7786-9172	FIRST Spin-Off grant from the Walloon Region [1410053]; European Research Council (ERC) [250172]; Spinoza Award of the Netherlands Organization for Scientific Research; FNRS [J.0084.15, 3.4579.11]; Projet de Recherche [T.0138.14]; FRFS-WELBIO [WELBIO-CR-2017C-02]; Funds Baillet Latour (Grant for Medical Research 2015); Banque Transatlantique Belgium; PoC ERC [Microbes4U_713547]; ERC [336452-ENIGMO]; FWO [30770923]; SIAM Gravity Grant [024.002.002]; Walloon Region [1410053]	FIRST Spin-Off grant from the Walloon Region; European Research Council (ERC)(European Research Council (ERC)European Commission); Spinoza Award of the Netherlands Organization for Scientific Research; FNRS(Fonds de la Recherche Scientifique - FNRS); Projet de Recherche; FRFS-WELBIO(WELBIO); Funds Baillet Latour (Grant for Medical Research 2015); Banque Transatlantique Belgium; PoC ERC; ERC(European Research Council (ERC)European Commission); FWO(FWO); SIAM Gravity Grant; Walloon Region	We thank A. Barrois for the excellent technical assistance. We are very grateful to M. Buysschaert for his continuous support and helpful criticism during the preparation of this project. We also thank the volunteers who participated in this study. P.D.C. is a senior research associate at Fonds de la Recherche Scientifique (FRS-FNRS). A.E. is a research associated at FRS-FNRS. C. Druart was supported by a FIRST Spin-Off grant from the Walloon Region (no. 1410053). Research in the Wageningen laboratory of W.M.d.V. was partially supported by a European Research Council (ERC) Advanced Grant no. 250172 (Microbes Inside), the SIAM Gravity Grant no. 024.002.002 and the Spinoza Award of the Netherlands Organization for Scientific Research. P.D.C. is the recipient of grants from the FNRS (nos. J.0084.15 and 3.4579.11) and Projet de Recherche (no. T.0138.14) and FRFS-WELBIO grants (no. WELBIO-CR-2017C-02). This work was supported by the Funds Baillet Latour (Grant for Medical Research 2015), a prize of the Banque Transatlantique Belgium and a FIRST Spin-Off grant from the Walloon Region (no. 1410053). P.D.C. is a recipient of the PoC ERC grant 2016 (no. Microbes4U_713547) and ERC Starting Grant 2013 (no. 336452-ENIGMO). P.D.C. and J.R. are recipients of a grant from the FNRS and FWO (EOS program no. 30770923).	Akoumianakis I, 2017, VASC PHARMACOL, V96-98, P1, DOI 10.1016/j.vph.2017.07.001; Allin KH, 2018, DIABETOLOGIA, V61, P810, DOI 10.1007/s00125-018-4550-1; Atkin SL, 2017, J DIABETES COMPLICAT, V31, P1458, DOI 10.1016/j.jdiacomp.2017.05.016; Borza D, 2008, CLIN CHEM LAB MED, V46, P1655, DOI 10.1515/CCLM.2008.315; Brahe LK, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2019, NAT METAB, V1, P34, DOI 10.1038/s42255-018-0017-4; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Dennis JM, 2018, DIABETES CARE, V41, P705, DOI 10.2337/dc17-1827; Everard A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08051-7; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Grander C, 2018, GUT, V67, P892, DOI 10.1136/gutjnl-2016-313432; Gu YQ, 2018, DIABETES RES CLIN PR, V141, P140, DOI 10.1016/j.diabres.2018.04.041; Hanninen A, 2018, GUT, V67, P1445, DOI 10.1136/gutjnl-2017-314508; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Kim SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092843; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Lim JS, 2007, CLIN CHEM, V53, P1092, DOI 10.1373/clinchem.2006.079814; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ohshita K, 2004, DIABETES CARE, V27, P491, DOI 10.2337/diacare.27.2.491; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olivares M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01900; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Rantala AO, 2000, J INTERN MED, V248, P230, DOI 10.1046/j.1365-2796.2000.00723.x; Ras RT, 2013, ATHEROSCLEROSIS, V230, P336, DOI 10.1016/j.atherosclerosis.2013.08.012; Rosenstock J, 2014, HORM METAB RES, V46, P348, DOI 10.1055/s-0033-1358759; Scherbaum WA, 2008, DIABETES OBES METAB, V10, P675, DOI 10.1111/j.1463-1326.2008.00850.x; Shen J, 2016, ARTERIOSCL THROM VAS, V36, P1448, DOI 10.1161/ATVBAHA.116.307597; Twig G, 2013, DIABETES CARE, V36, P276, DOI 10.2337/dc11-2298; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Veronelli A, 2004, DIABETES CARE, V27, P2501, DOI 10.2337/diacare.27.10.2501; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Werner M, 2008, CLIN CHEM LAB MED, V46, P240, DOI 10.1515/CCLM.2008.020; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu WR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01804; Yassour M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0271-6; Zhang HM, 2017, J DIABETES COMPLICAT, V31, P31, DOI 10.1016/j.jdiacomp.2016.10.029; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	48	753	784	44	412	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1096	+		10.1038/s41591-019-0495-2	http://dx.doi.org/10.1038/s41591-019-0495-2			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31263284	Green Accepted			2022-12-27	WOS:000474430400023
J	Courtine, G; Sofroniew, MV				Courtine, Gregoire; Sofroniew, Michael V.			Spinal cord repair: advances in biology and technology	NATURE MEDICINE			English	Review							NEURAL STEM-CELLS; EPIDURAL ELECTRICAL-STIMULATION; REPETITIVE INTERMITTENT HYPOXIA; ASTROCYTE-SECRETED PROTEINS; A ANTIBODY TREATMENT; AXON REGENERATION; FUNCTIONAL RECOVERY; MOTOR CORTEX; CORTICOSPINAL TRACT; CIRCUIT REORGANIZATION	Individuals with spinal cord injury (SCI) can face decades with permanent disabilities. Advances in clinical management have decreased morbidity and improved outcomes, but no randomized clinical trial has demonstrated the efficacy of a repair strategy for improving recovery from SCI. Here, we summarize recent advances in biological and engineering strategies to augment neuroplasticity and/or functional recovery in animal models of SCI that are pushing toward clinical translation.	[Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Geneva, Switzerland; [Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Geneva, Switzerland; [Courtine, Gregoire] Univ Hosp Lausanne CHUV, Dept Neurosurg, Lausanne, Switzerland; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Ctr Neuroprosthet, Geneva, Switzerland.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Geneva, Switzerland.; Courtine, G (corresponding author), Univ Hosp Lausanne CHUV, Dept Neurosurg, Lausanne, Switzerland.	gregoire.courtine@epfl.ch	Sofroniew, Michael/ABE-8857-2020	Sofroniew, Michael/0000-0001-6075-0178; courtine, gregoire/0000-0002-5744-4142	Consolidator Grant from the European Research Council [ERC-2015-CoG HOW2WALKAGAIN 682999]; Swiss National Science Foundation; bonus of Excellence [310030B_166674]; National Center of Competence in Research (NCCR) Robotics; US National Institutes of Health [R01NS084030]; Dr Miriam and Sheldon G. Adelson Medical Foundation; Wings for Life	Consolidator Grant from the European Research Council; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); bonus of Excellence; National Center of Competence in Research (NCCR) Robotics(Swiss National Science Foundation (SNSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr Miriam and Sheldon G. Adelson Medical Foundation; Wings for Life	The authors kindly thank J. B. Mignardot for drafting the figures. This work was supported by a Consolidator Grant from the European Research Council (ERC-2015-CoG HOW2WALKAGAIN 682999 to G.G.), the Swiss National Science Foundation including a bonus of Excellence (310030B_166674) and the National Center of Competence in Research (NCCR) Robotics (to G.C.), the US National Institutes of Health R01NS084030 (to M.S.), the Dr Miriam and Sheldon G. Adelson Medical Foundation (to M.S.) and Wings for Life (to G.C. and M.S.).	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Anderson KD, 2017, J NEUROTRAUM, V34, P2950, DOI 10.1089/neu.2016.4895; Anderson MA, 2018, NATURE, V561, P396, DOI 10.1038/s41586-018-0467-6; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Angeli C, 2015, BRAIN, V138, DOI 10.1093/brain/awu376; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; [Anonymous], 2016, SPIN CORD INJ SCI FA; Arber S, 2018, SCIENCE, V360, P1403, DOI 10.1126/science.aat5994; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Bachmann LC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005972; BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; Baker SN, 2017, J NEUROSCI, V37, P9778, DOI 10.1523/JNEUROSCI.3368-16.2017; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Baraban M, 2018, NAT NEUROSCI, V21, P19, DOI 10.1038/s41593-017-0040-x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BAROLAT G, 1986, APPL NEUROPHYSIOL, V49, P307; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Bonizzato M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05282-6; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Borton D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005968; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Carmel JB, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00051; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chen B, 2018, CELL, V174, P521, DOI 10.1016/j.cell.2018.06.005; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; ChenKinon, 2017, EXP NEUROL, V292, P135, DOI 10.1016/j.expneurol.2017.03.012; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cote MP, 2017, J NEUROTRAUM, V34, P1841, DOI 10.1089/neu.2016.4577; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dietz V, 2010, NAT REV NEUROL, V6, P167, DOI 10.1038/nrneurol.2009.227; Dixon L, 2016, J NEUROPHYSIOL, V116, P904, DOI 10.1152/jn.00259.2016; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040; Donati ARC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30383; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; Edwards TJ, 2014, CELL REP, V8, P272, DOI 10.1016/j.celrep.2014.06.008; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, 2017, GLOB SPINE J, V7, p84S, DOI 10.1177/2192568217703387; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Formento E, 2018, NAT NEUROSCI, V21, P1728, DOI 10.1038/s41593-018-0262-6; Fouad K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00187; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Gaunt RA, 2006, J NEUROPHYSIOL, V96, P2995, DOI 10.1152/jn.00061.2006; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Gilja V, 2015, NAT MED, V21, P1142, DOI 10.1038/nm.3953; Gill ML, 2018, NAT MED, V24, P1677, DOI 10.1038/s41591-018-0175-7; Gomez-Pinilla F, 2004, J NEUROPHYSIOL, V92, P3423, DOI 10.1152/jn.00432.2004; Gorgey AS, 2018, WORLD J ORTHOP, V9, P112, DOI 10.5312/wjo.v9.i9.112; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grahn PJ, 2017, MAYO CLIN PROC, V92, P544, DOI 10.1016/j.mayocp.2017.02.014; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hachmann JT, 2017, MAYO CLIN PROC, V92, P1401, DOI 10.1016/j.mayocp.2017.04.011; Harkema SJ, 2008, BRAIN RES REV, V57, P255, DOI 10.1016/j.brainresrev.2007.07.012; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Herman R, 2002, SPINAL CORD, V40, P65, DOI 10.1038/sj.sc.3101263; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Holinski BJ, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/5/056016; Hollis ER, 2016, NAT NEUROSCI, V19, P697, DOI 10.1038/nn.4282; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hutson TH, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2064; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Jarosiewicz B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7328; Jiang YQ, 2016, J NEUROSCI, V36, P193, DOI 10.1523/JNEUROSCI.3441-15.2016; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kasten MR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/044001; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lacour SP, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.63; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Long JY, 2017, BRAIN, V140, P1619, DOI 10.1093/brain/awx102; Lopez-Alvarez VM, 2015, PAIN, V156, P1812, DOI 10.1097/j.pain.0000000000000268; Lovett-Barr MR, 2012, J NEUROSCI, V32, P3591, DOI 10.1523/JNEUROSCI.2908-11.2012; Lu DC, 2016, NEUROREHAB NEURAL RE, V30, P951, DOI 10.1177/1545968316644344; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; MASON CA, 1988, J NEUROSCI, V8, P3124; Masu M, 2016, J NEUROCHEM, V139, P58, DOI 10.1111/jnc.13508; McPherson JG, 2015, P NATL ACAD SCI USA, V112, P12193, DOI 10.1073/pnas.1505383112; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Minassian K, 2016, NEUROTHERAPEUTICS, V13, P284, DOI 10.1007/s13311-016-0421-y; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Mironova YA, 2013, TRENDS NEUROSCI, V36, P363, DOI 10.1016/j.tins.2013.04.003; Mishra AM, 2017, J PHYSIOL-LONDON, V595, P6953, DOI 10.1113/JP274663; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Moraud EM, 2016, NEURON, V89, P814, DOI 10.1016/j.neuron.2016.01.009; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Mullner A, 2008, EUR J NEUROSCI, V27, P326, DOI 10.1111/j.1460-9568.2007.06006.x; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Navarrete-Opazo A, 2017, J NEUROTRAUM, V34, P1803, DOI 10.1089/neu.2016.4478; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nishimura Y, 2013, NEURON, V80, P1301, DOI 10.1016/j.neuron.2013.08.028; Nishimura Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00057; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; NUDO RJ, 1988, J COMP NEUROL, V277, P53, DOI 10.1002/cne.902770105; O'Shea TM, 2017, RSC SMART MATER, V25, P529; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Onishi K, 2014, CURR OPIN NEUROBIOL, V27, P232, DOI 10.1016/j.conb.2014.05.005; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Overman JJ, 2014, NEUROSCIENTIST, V20, P15, DOI 10.1177/1073858413491146; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Phillips AA, 2018, J NEUROTRAUM, V35, P446, DOI 10.1089/neu.2017.5082; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Radhakrishna M, 2017, CURR PHARM DESIGN, V23, P1789, DOI 10.2174/1381612822666161227152200; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Rejc E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14003-w; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Ruder L, 2016, NEURON, V92, P1063, DOI 10.1016/j.neuron.2016.10.032; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; Sofroniew MV, 2018, NATURE, V557, P343, DOI 10.1038/s41586-018-0068-4; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Takeoka A, 2014, CELL, V159, P1626, DOI 10.1016/j.cell.2014.11.019; Tazoe T, 2015, ARCH PHYS MED REHAB, V96, pS145, DOI 10.1016/j.apmr.2014.07.418; Torres-Espin A, 2018, J NEUROTRAUM, V35, P1970, DOI 10.1089/neu.2018.5906; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Tselnicker IF, 2014, BIOCHEM SOC T, V42, P1263, DOI 10.1042/BST20140166; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wenger N, 2016, NAT MED, V22, P138, DOI 10.1038/nm.4025; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Yoon C, 2016, NEURON, V89, P881, DOI 10.1016/j.neuron.2016.02.022; Zareen N, 2017, EXP NEUROL, V297, P179, DOI 10.1016/j.expneurol.2017.08.004; Zhang SS, 2015, BIOMACROMOLECULES, V16, P1331, DOI 10.1021/acs.biomac.5b00124; Zhu Y, 2015, NEUROBIOL DIS, V74, P114, DOI 10.1016/j.nbd.2014.10.024; Zimmermann JB, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/054001; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013; 2013, INT PERSP SPIN CORD, P1	174	187	195	24	178	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					898	908		10.1038/s41591-019-0475-6	http://dx.doi.org/10.1038/s41591-019-0475-6			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31160817				2022-12-27	WOS:000470844400019
J	Ying, ZT; Huang, XF; Xiang, XY; Liu, YL; Kang, X; Song, YQ; Guo, XK; Liu, HZ; Ding, N; Zhang, TT; Duan, PP; Lin, YF; Zheng, W; Wang, XP; Lin, NJ; Tu, MF; Xie, Y; Zhang, C; Liu, WP; Deng, LJ; Gao, SY; Ping, LY; Wang, XJ; Zhou, NN; Zhang, JQ; Wang, YL; Lin, SF; Mamuti, M; Yu, XY; Fang, LZ; Wang, S; Song, HF; Wang, G; Jones, L; Zhu, J; Chen, SY				Ying, Zhitao; Huang, Xue F.; Xiang, Xiaoyu; Liu, Yanling; Kang, Xi; Song, Yuqin; Guo, Xiaokai; Liu, Hanzhi; Ding, Ning; Zhang, Tingting; Duan, Panpan; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Gao, Shunyu; Ping, Lingyan; Wang, Xuejuan; Zhou, Nina; Zhang, Junqing; Wang, Yulong; Lin, Songfeng; Mamuti, Mierzhati; Yu, Xueyun; Fang, Lizhu; Wang, Shuai; Song, Haifeng; Wang, Guan; Jones, Lindsey; Zhu, Jun; Chen, Si-Yi			A safe and potent anti-CD19 CAR T cell therapy	NATURE MEDICINE			English	Article							CHIMERIC ANTIGEN RECEPTORS; B-CELL; REMISSIONS; MANAGEMENT; DOMAINS	Anti-CD19 chimeric antigen receptor (CAR) T cell therapies can cause severe cytokine-release syndrome (CRS) and neurotoxicity, impeding their therapeutic application. Here we generated a new anti-CD19 CAR molecule (CD19-BBz(86)) derived from the CD19-BBz prototype bearing co-stimulatory 4-1BB and CD3 zeta domains. We found that CD19-BBz(86) CAR T cells produced lower levels of cytokines, expressed higher levels of antiapoptotic molecules and proliferated more slowly than the prototype CD19-BBz CAR T cells, although they retained potent cytolytic activity. We performed a phase 1 trial of CD19-BBz(86) CAR T cell therapy in patients with B cell lymphoma (ClinicalTrials. gov identifier NCT02842138). Complete remission occurred in 6 of 11 patients (54.5%) who each received a dose of 2 x 10(8)-4 x 10(8) CD19-BBz(86) CAR T cells. Notably, no neurological toxicity or CRS (greater than grade 1) occurred in any of the 25 patients treated. No significant elevation in serum cytokine levels after CAR T cell infusion was detected in the patients treated, including in those who achieved complete remission. CD19-BBz(86) CAR T cells persistently proliferated and differentiated into memory cells in vivo. Thus, therapy with the new CD19-BBz(86) CAR T cells produces a potent and durable antilymphoma response without causing neurotoxicity or severe CRS, representing a safe and potent anti-CD19 CAR T cell therapy.	[Ying, Zhitao; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Gao, Shunyu; Ping, Lingyan; Wang, Xuejuan; Zhou, Nina; Zhu, Jun] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Lymphoma, Beijing, Peoples R China; [Ying, Zhitao; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Gao, Shunyu; Ping, Lingyan; Wang, Xuejuan; Zhou, Nina; Zhu, Jun] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Radiol, Beijing, Peoples R China; [Ying, Zhitao; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Gao, Shunyu; Ping, Lingyan; Wang, Xuejuan; Zhou, Nina; Zhu, Jun] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Nucl Med, Beijing, Peoples R China; [Huang, Xue F.; Kang, Xi; Wang, Guan; Jones, Lindsey; Chen, Si-Yi] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Xiang, Xiaoyu; Liu, Yanling; Guo, Xiaokai; Liu, Hanzhi; Zhang, Tingting; Duan, Panpan; Zhang, Junqing; Wang, Yulong; Lin, Songfeng; Mamuti, Mierzhati; Yu, Xueyun; Fang, Lizhu; Wang, Shuai; Song, Haifeng] Marino Biotechnol Corp, Beijing, Peoples R China	University of Southern California	Zhu, J (corresponding author), Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Lymphoma, Beijing, Peoples R China.; Zhu, J (corresponding author), Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Radiol, Beijing, Peoples R China.; Zhu, J (corresponding author), Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Nucl Med, Beijing, Peoples R China.; Chen, SY (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	zhujun@csco.org.cn; siyichen@usc.edu	Ying, Zhitao/AAY-6293-2020	Song, Yuqin/0000-0001-5451-6481	National Natural Science Foundation of China [81600164, 81870154]; Beijing Natural Science Foundation [7172046]; Beijing Municipal Administration of Hospitals Incubating Program [PX2017001]; Capital's Funds for Health Improvement and Research [2018-1-2151]; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20151001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Municipal Administration of Hospitals Incubating Program; Capital's Funds for Health Improvement and Research; Beijing Municipal Administration of Hospitals' Ascent Plan	We would like to thank S. Yan, X. Wu, Y. Yan and members of the GMP-compliant CAR vector and CAR T cell manufacturing teams and the immunological monitoring team of Marino Biotechnology Corp. for their technical assistance. We would also like to thank Y. Wei and T. Liu for their valuable suggestions and help. This study was supported financially by the National Natural Science Foundation of China (No. 81600164, No. 81870154), Beijing Natural Science Foundation (No. 7172046), Beijing Municipal Administration of Hospitals Incubating Program (PX2017001), Capital's Funds for Health Improvement and Research (No. 2018-1-2151), Beijing Municipal Administration of Hospitals' Ascent Plan (No. DFL20151001), a generous donation from Y. L. Zhu and the Marino Biotechnology Corp.	Alabanza L, 2017, MOL THER, V25, P2452, DOI 10.1016/j.ymthe.2017.07.013; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brudno JN, 2018, NAT REV CLIN ONCOL, V15, P31, DOI 10.1038/nrclinonc.2017.128; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Campana D, 2014, CANCER J, V20, P134, DOI 10.1097/PPO.0000000000000028; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jiang XX, 2011, IMMUNITY, V35, P883, DOI 10.1016/j.immuni.2011.11.010; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; MARASCO WA, 1993, P NATL ACAD SCI USA, V90, P7889, DOI 10.1073/pnas.90.16.7889; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; MAUDE SL, 2016, BLOOD, V128; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Salter AI, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat6753; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Wang AR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004306; Wang DH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98368; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360	40	199	217	13	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					947	+		10.1038/s41591-019-0421-7	http://dx.doi.org/10.1038/s41591-019-0421-7			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31011207	Green Accepted			2022-12-27	WOS:000470844400026
J	Kopper, O; de Witte, CJ; Lohmussaar, K; Valle-Inclan, JE; Hami, N; Kester, L; Balgobind, AV; Korving, J; Proost, N; Begthel, H; van Wijk, LM; Revilla, SA; Theeuwsen, R; van de Ven, M; van Roosmalen, MJ; Ponsioen, B; Ho, VWH; Neel, BG; Bosse, T; Gaarenstroom, KN; Vrieling, H; Vreeswijk, MPG; van Diest, PJ; Witteveen, PO; Jonges, T; Bos, JL; van Oudenaarden, A; Zweemer, RP; Snippert, HJG; Kloosterman, WP; Clevers, H				Kopper, Oded; de Witte, Chris J.; Lohmussaar, Kadi; Valle-Inclan, Jose Espejo; Hami, Nizar; Kester, Lennart; Balgobind, Anjali Vanita; Korving, Jeroen; Proost, Natalie; Begthel, Harry; van Wijk, Lise M.; Revilla, Sonia Aristin; Theeuwsen, Rebecca; van de Ven, Marieke; van Roosmalen, Markus J.; Ponsioen, Bas; Ho, Victor W. H.; Neel, Benjamin G.; Bosse, Tjalling; Gaarenstroom, Katja N.; Vrieling, Harry; Vreeswijk, Maaike P. G.; van Diest, Paul J.; Witteveen, Petronella O.; Jonges, Trudy; Bos, Johannes L.; van Oudenaarden, Alexander; Zweemer, Ronald P.; Snippert, Hugo J. G.; Kloosterman, Wigard P.; Clevers, Hans			An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity	NATURE MEDICINE			English	Article							GRADE SEROUS CARCINOMA; COPY NUMBER; GENOME; MUTATIONS; BREAST; TUMORS; ORIGIN; PATHOGENESIS; SIGNATURES; CULTURES	Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage. Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of OC are limited and hard to establish. We present a protocol that enables efficient derivation and long-term expansion of OC organoids. Utilizing this protocol, we have established 56 organoid lines from 32 patients, representing all main subtypes of OC. OC organoids recapitulate histological and genomic features of the pertinent lesion from which they were derived, illustrating intra-and interpatient heterogeneity, and can be genetically modified. We show that OC organoids can be used for drug-screening assays and capture different tumor subtype responses to the gold standard platinum-based chemotherapy, including acquisition of chemoresistance in recurrent disease. Finally, OC organoids can be xenografted, enabling in vivo drug-sensitivity assays. Taken together, this demonstrates their potential application for research and personalized medicine.	[Kopper, Oded; Lohmussaar, Kadi; Kester, Lennart; Balgobind, Anjali Vanita; Korving, Jeroen; Begthel, Harry; Revilla, Sonia Aristin; van Oudenaarden, Alexander; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Kopper, Oded; Lohmussaar, Kadi; Hami, Nizar; Kester, Lennart; Balgobind, Anjali Vanita; Korving, Jeroen; Begthel, Harry; Revilla, Sonia Aristin; Ponsioen, Bas; Bos, Johannes L.; van Oudenaarden, Alexander; Snippert, Hugo J. G.; Clevers, Hans] UMC Utrecht, Utrecht, Netherlands; [Kopper, Oded; Lohmussaar, Kadi; Hami, Nizar; Kester, Lennart; Balgobind, Anjali Vanita; Korving, Jeroen; Begthel, Harry; Revilla, Sonia Aristin; Ponsioen, Bas; Bos, Johannes L.; van Oudenaarden, Alexander; Snippert, Hugo J. G.; Clevers, Hans] Oncode Inst, Utrecht, Netherlands; [de Witte, Chris J.; Valle-Inclan, Jose Espejo; van Roosmalen, Markus J.; Kloosterman, Wigard P.] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Hami, Nizar; Ponsioen, Bas; Bos, Johannes L.; Snippert, Hugo J. G.] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands; [Proost, Natalie; Theeuwsen, Rebecca; van de Ven, Marieke] Mouse Clin Canc & Ageing MCCA NKI, Preclin Intervent Unit, Amsterdam, Netherlands; [van Wijk, Lise M.; Vrieling, Harry; Vreeswijk, Maaike P. G.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Ho, Victor W. H.; Neel, Benjamin G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Neel, Benjamin G.] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA; [Bosse, Tjalling] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Gaarenstroom, Katja N.] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands; [van Diest, Paul J.; Jonges, Trudy] Univ Utrecht, Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Witteveen, Petronella O.] Univ Utrecht, Univ Med Ctr Utrecht, Canc Ctr, Dept Med Oncol, Utrecht, Netherlands; [Zweemer, Ronald P.] Univ Utrecht, Univ Med Ctr Utrecht, Canc Ctr, Dept Gynaecol Oncol, Utrecht, Netherlands; [Clevers, Hans] Netherlands Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; NYU Langone Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands.; Clevers, H (corresponding author), UMC Utrecht, Utrecht, Netherlands.; Clevers, H (corresponding author), Oncode Inst, Utrecht, Netherlands.; Kloosterman, WP (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.; Clevers, H (corresponding author), Netherlands Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.	w.kloosterman@umcutrecht.nl; h.clevers@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Bosse, Tjalling/AFX-6970-2022; Vrieling, Harry/ABC-8068-2020; Lõhmussaar, Kadi/AAJ-3175-2021	Bosse, Tjalling/0000-0002-6881-8437; Zweemer, Ronald/0000-0003-1829-7773; Gaarenstroom, Katja/0000-0002-4702-1680; Vrieling, Harry/0000-0002-3034-2664; de Witte, Chris Jenske/0000-0003-3785-1047; Vreeswijk, Maaike P.G./0000-0003-4068-9271; Kester, Lennart/0000-0002-8259-9971; Espejo Valle-Inclan, Jose/0000-0002-4857-5984	Marie Sklodowska-Curie IF grant [658933 - HGSOC]; gravitation program CancerGenomiCs. nl from the Netherlands Organisation for Scientific Research (NWO); MKMD grant from Netherlands Organization for Scientific Research (NWO-ZonMw) [114021012]; Stand Up to Cancer International Translational Cancer Research Grant; program of the Entertainment Industry Foundation; Dutch Cancer Society (KWF) grant [UU2015-7743]; Dutch Cancer Society (Alpe d'HuZes) grant [EMCR 2014-7048]; Gieskes Strijbis Foundation [1816199]; Dutch Cancer Society	Marie Sklodowska-Curie IF grant; gravitation program CancerGenomiCs. nl from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); MKMD grant from Netherlands Organization for Scientific Research (NWO-ZonMw)(Netherlands Organization for Scientific Research (NWO)); Stand Up to Cancer International Translational Cancer Research Grant; program of the Entertainment Industry Foundation; Dutch Cancer Society (KWF) grant; Dutch Cancer Society (Alpe d'HuZes) grant; Gieskes Strijbis Foundation; Dutch Cancer Society(KWF Kankerbestrijding)	We thank T. Bayram for supporting of ethical regulatory affairs. We acknowledge A. Brousali, P. van der Groep, A. Constantinides, A. Snelting and O. Kranenburg of the Utrecht Platform for Organoid Technology (U-PORT; UMC Utrecht) for patient inclusion and tissue acquisition. We thank the Integraal Kankercentrum Nederland (IKNL) and M. van der Aa for supplying clinical data, and I. Renkens for help with DNA isolations. We acknowledge E. Stelloo for her help with culturing organoids. We thank the people from the Preclinical Intervention Unit of the Mouse Clinic for Cancer and Ageing (MCCA) at the NKI for performing the intervention studies. We thank B. Artegiani and T. Dayton for critically reading the manuscript. O.K. was supported by Marie Sklodowska-Curie IF grant 658933 - HGSOC. This work was funded by the gravitation program CancerGenomiCs. nl from the Netherlands Organisation for Scientific Research (NWO), MKMD grant (114021012) from Netherlands Organization for Scientific Research (NWO-ZonMw), Stand Up to Cancer International Translational Cancer Research Grant, a program of the Entertainment Industry Foundation administered by the AACR, Dutch Cancer Society (KWF) grant UU2015-7743, Dutch Cancer Society (Alpe d'HuZes) grant EMCR 2014-7048, and a grant from the Gieskes Strijbis Foundation (1816199). The Oncode Institute is supported by the Dutch Cancer Society.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Aune G, 2011, GYNECOL ONCOL, V121, P402, DOI 10.1016/j.ygyno.2010.12.355; Ben-David U, 2017, NAT GENET, V49, P1567, DOI 10.1038/ng.3967; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bourgeois DL, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0263-4; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Brown J, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0389-x; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fischerova D, 2012, ONCOLOGIST, V17, P1515, DOI 10.1634/theoncologist.2012-0139; Fleury Hubert, 2015, Genes Cancer, V6, P378; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Fumagalli A, 2017, P NATL ACAD SCI USA, V114, pE2357, DOI 10.1073/pnas.1701219114; Gabai-Kapara E, 2014, P NATL ACAD SCI USA, V111, P14205, DOI 10.1073/pnas.1415979111; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gershenson DM, 2009, GYNECOL ONCOL, V114, P48, DOI 10.1016/j.ygyno.2009.03.001; Gilmour LMR, 2002, CLIN CANCER RES, V8, P3933; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Hill SJ, 2018, CANCER DISCOV, V8, P1404, DOI 10.1158/2159-8290.CD-18-0474; Hunter SM, 2012, CLIN CANCER RES, V18, P5267, DOI 10.1158/1078-0432.CCR-12-1103; Ince TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8419; Jones PM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00217; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Koshiyama M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934261; Kreuzinger C, 2015, CANCER LETT, V362, P218, DOI 10.1016/j.canlet.2015.03.040; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Letourneau IJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-379; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meijer TG, 2018, CLIN CANCER RES, V24, P6277, DOI 10.1158/1078-0432.CCR-18-0063; Murai J, 2017, INT J CLIN ONCOL, V22, P619, DOI 10.1007/s10147-017-1145-7; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Pectasides D, 2005, GYNECOL ONCOL, V97, P436, DOI 10.1016/j.ygyno.2004.12.056; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Priestley P., 2019, PAN CANC WHOLE GENOM, DOI [10.1101/415133, DOI 10.1101/415133]; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Romero I, 2013, GYNECOL ONCOL, V130, P660, DOI 10.1016/j.ygyno.2013.05.021; Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010; Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; Seidman JD, 2008, ARCH PATHOL LAB MED, V132, P1753, DOI 10.1043/1543-2165-132.11.1753; Seidman JD, 2011, INT J GYNECOL PATHOL, V30, P4, DOI 10.1097/PGP.0b013e3181f29d2a; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thu KL, 2017, ONCOTARGET, V8, P50489, DOI 10.18632/oncotarget.9929; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Wang M, 2015, APPL IMMUNOHISTO M M, V23, P280, DOI 10.1097/PAI.0000000000000065; Yadav B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05193	78	286	306	29	132	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					838	+		10.1038/s41591-019-0422-6	http://dx.doi.org/10.1038/s41591-019-0422-6			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31011202				2022-12-27	WOS:000468247800027
J	Filbin, M; Monje, M				Filbin, Mariella; Monje, Michelle			Developmental origins and emerging therapeutic opportunities for childhood cancer	NATURE MEDICINE			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; CENTRAL-NERVOUS-SYSTEM; ATYPICAL TERATOID/RHABDOID TUMOR; PEDIATRIC HIGH-GRADE; STEM-CELLS; NEURONAL-ACTIVITY; HIPPOCAMPAL NEUROGENESIS; DRIVER MUTATIONS; PROGENITOR CELLS; PRENATAL ORIGIN	Cancer is the leading disease-related cause of death in children in developed countries. Arising in the context of actively growing tissues, childhood cancers are fundamentally diseases of dysregulated development. Childhood cancers exhibit a lower overall mutational burden than adult cancers, and recent sequencing studies have revealed that the genomic events central to childhood oncogenesis include mutations resulting in broad epigenetic changes or translocations that result in fusion oncoproteins. Here, we will review the developmental origins of childhood cancers, epigenetic dysregulation in tissue stem/precursor cells in numerous examples of childhood cancer oncogenesis and emerging therapeutic opportunities aimed at both cell-intrinsic and microenvironmental targets together with new insights into the mechanisms underlying long-term sequelae of childhood cancer therapy.	[Filbin, Mariella] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA USA; [Filbin, Mariella] Harvard Med Sch, Boston, MA 02115 USA; [Monje, Michelle] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Stanford University	Monje, M (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.	mmonje@stanford.edu		Monje, Michelle/0000-0002-3547-237X	Career Award for Medical Scientist from Burroughs Wellcome Fund; Solving Kids' Cancer; Cure Starts Now Foundation; DIPG Collaborative; National Institutes of Neurological Disorders and Stroke [R01NS092597]; National Institutes of Health [DP1NS111132]; Abbie's Army; McKenna Claire Foundation; Unravel Pediatric Cancer Foundation; Alex's Lemonade Stand Foundation; Maternal and Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092597] Funding Source: NIH RePORTER	Career Award for Medical Scientist from Burroughs Wellcome Fund; Solving Kids' Cancer; Cure Starts Now Foundation; DIPG Collaborative; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbie's Army; McKenna Claire Foundation; Unravel Pediatric Cancer Foundation; Alex's Lemonade Stand Foundation; Maternal and Child Health Research Institute at Stanford; Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors extend special thanks to S. Knemeyer for illustrations, to A. Groves for help with Supplementary Table 1 and to K.E. Warren for helpful input on Box 2, Challenges in clinical trials in childhood cancer. The authors acknowledge funding from the Career Award for Medical Scientist from Burroughs Wellcome Fund (M.G.F.), Solving Kids' Cancer (M.G.F.), The Cure Starts Now Foundation and DIPG Collaborative (M.G.F. and M.M.), National Institutes of Neurological Disorders and Stroke (R01NS092597 to M.M.), National Institutes of Health (DP1NS111132 to M.M.), Abbie's Army (M.M.), McKenna Claire Foundation (M.M.), Unravel Pediatric Cancer Foundation (M.M.), Alex's Lemonade Stand Foundation (M.G.F. and M.M.), Maternal and Child Health Research Institute at Stanford (M.M.) and the Anne T. and Robert M. Bass Endowed Faculty Scholarship in Pediatric Cancer and Blood Diseases (M. M.).	Acharya MM, 2015, CANCER RES, V75, P676, DOI 10.1158/0008-5472.CAN-14-2237; Andersson AK, 2011, LEUKEMIA, V25, P1570, DOI 10.1038/leu.2011.133; Andres AL, 2014, EXP NEUROL, V255, P137, DOI 10.1016/j.expneurol.2014.02.020; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Banerjee A, 2017, NEURO-ONCOLOGY, V19, P1135, DOI 10.1093/neuonc/now282; Baraban M, 2016, BRAIN RES, V1641, P149, DOI 10.1016/j.brainres.2015.10.026; Bayliss J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah6904; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Boiers C, 2018, DEV CELL, V44, P362, DOI 10.1016/j.devcel.2017.12.005; Brown ZZ, 2014, J AM CHEM SOC, V136, P13498, DOI 10.1021/ja5060934; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P410, DOI 10.1093/neuonc/noq205; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Crispino JD, 2005, PEDIATR BLOOD CANCER, V44, P40, DOI 10.1002/pbc.20066; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Dietrich J, 2018, J CLIN INVEST, V128, P281, DOI 10.1172/JCI90647; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Dubuc AM, 2013, ACTA NEUROPATHOL, V125, P373, DOI 10.1007/s00401-012-1070-9; Edelmann MN, 2014, BRAIN, V137, P2973, DOI 10.1093/brain/awu230; Ellenberg L, 2009, NEUROPSYCHOLOGY, V23, P705, DOI 10.1037/a0016674; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng X, 2018, ELIFE, V7, DOI 10.7554/eLife.38865; Feng X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0671-y; Filbin MG, 2018, SCIENCE, V360, P331, DOI 10.1126/science.aao4750; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Gawade PL, 2014, CURR PEDIATR REV, V10, P249, DOI 10.2174/1573400510666141114223827; Gibson EM, 2019, CELL, V176, P43, DOI 10.1016/j.cell.2018.10.049; Gibson EM, 2018, DEV NEUROBIOL, V78, P123, DOI 10.1002/dneu.22541; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Green JL, 2013, PEDIATR BLOOD CANCER, V60, P1261, DOI 10.1002/pbc.24537; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Han Ruolan, 2008, J Biol, V7, P12, DOI 10.1186/jbiol69; Han ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10421; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Hjalgrim LL, 2002, BRIT J CANCER, V87, P994, DOI 10.1038/sj.bjc.6600601; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jalali R, 2010, INT J RADIAT ONCOL, V77, P113, DOI 10.1016/j.ijrobp.2009.04.031; Judkins AR, 2005, J NEUROPATH EXP NEUR, V64, P391, DOI 10.1093/jnen/64.5.391; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Koelsche C, 2018, MODERN PATHOL, V31, P1246, DOI 10.1038/s41379-018-0045-3; Kondyli M, 2018, J NEURO-ONCOL, V140, P435, DOI 10.1007/s11060-018-2971-9; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Larson JD, 2019, CANCER CELL, V35, P140, DOI 10.1016/j.ccell.2018.11.015; Lashford LS, 2002, J CLIN ONCOL, V20, P4684, DOI 10.1200/JCO.2002.08.141; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lehnertz B, 2017, BLOOD, V130, P2204, DOI 10.1182/blood-2017-03-774653; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SRA, 2015, CANCER CELL, V28, P429, DOI 10.1016/j.ccell.2015.09.007; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mack SC, 2018, NATURE, V553, P101, DOI 10.1038/nature25169; Mackay A, 2017, CANCER CELL, V32, P520, DOI 10.1016/j.ccell.2017.08.017; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Maris JM, 2002, CANCER CELL, V2, P447, DOI 10.1016/S1535-6108(02)00206-4; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; McHale CM, 2003, GENE CHROMOSOME CANC, V37, P36, DOI 10.1002/gcc.10199; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Morioka S, 2013, NEURORADIOLOGY, V55, P1251, DOI 10.1007/s00234-013-1245-7; Mount CW, 2018, NAT MED, V24, P572, DOI 10.1038/s41591-018-0006-x; Mount CW, 2017, NEURON, V95, P743, DOI 10.1016/j.neuron.2017.07.009; Murgai M, 2017, NAT MED, V23, P1176, DOI 10.1038/nm.4400; Nagaraja S, 2017, CANCER CELL, V31, P635, DOI 10.1016/j.ccell.2017.03.011; Ng JMY, 2015, CANCER RES, V75, P4629, DOI 10.1158/0008-5472.CAN-15-0874; Pajtler KW, 2018, ACTA NEUROPATHOL, V136, P211, DOI 10.1007/s00401-018-1877-0; Parent JM, 1999, J NEUROSCI, V19, P4508; Pathania M, 2017, CANCER CELL, V32, P684, DOI 10.1016/j.ccell.2017.09.014; Peterson SC, 2015, CELL STEM CELL, V16, P400, DOI 10.1016/j.stem.2015.02.006; Pierson C, 2016, PEDIATR BLOOD CANCER, V63, P1998, DOI 10.1002/pbc.26117; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Qaddoumi I, 2009, CANCER, V115, P5761, DOI 10.1002/cncr.24663; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sevenet N, 1999, HUM MOL GENET, V8, P2359, DOI 10.1093/hmg/8.13.2359; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stopczynski RE, 2014, CANCER RES, V74, P1718, DOI 10.1158/0008-5472.CAN-13-2050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Tate MC, 2015, J COMP NEUROL, V523, P449, DOI 10.1002/cne.23690; Venkatesh H, 2017, TRENDS CANCER, V3, P89, DOI 10.1016/j.trecan.2016.12.008; Venkatesh HS, 2017, NATURE, V549, P533, DOI 10.1038/nature24014; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vitte J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00346-5; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wiemels JL, 2002, BLOOD, V99, P3801, DOI 10.1182/blood.V99.10.3801; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Zollner SK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam8429	123	53	53	4	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					367	376		10.1038/s41591-019-0383-9	http://dx.doi.org/10.1038/s41591-019-0383-9			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842674	Green Accepted			2022-12-27	WOS:000460643100014
J	Koffler, J; Zhu, W; Qu, X; Platoshyn, O; Dulin, JN; Brock, J; Graham, L; Lu, P; Sakamoto, J; Marsala, M; Chen, SC; Tuszynski, MH				Koffler, Jacob; Zhu, Wei; Qu, Xin; Platoshyn, Oleksandr; Dulin, Jennifer N.; Brock, John; Graham, Lori; Lu, Paul; Sakamoto, Jeff; Marsala, Martin; Chen, Shaochen; Tuszynski, Mark H.			Biomimetic 3D-printed scaffolds for spinal cord injury repair	NATURE MEDICINE			English	Article							NEURAL STEM-CELL; TEMPLATED AGAROSE SCAFFOLDS; AXONAL GROWTH; FUNCTIONAL RECOVERY; TRACT AXONS; REGENERATION; SUPPORT; SITES; TRANSPLANTATION	Current methods for bioprinting functional tissue lack appropriate biofabrication techniques to build complex 3D micro-architectures essential for guiding cell growth and promoting tissue maturation(1). 3D printing of central nervous system (CNS) structures has not been accomplished, possibly owing to the complexity of CNS architecture. Here, we report the use of a microscale continuous projection printing method (mu CPP) to create a complex CNS structure for regenerative medicine applications in the spinal cord. mu CPP can print 3D biomimetic hydrogel scaffolds tailored to the dimensions of the rodent spinal cord in 1.6 s and is scalable to human spinal cord sizes and lesion geometries. We tested the ability of mu CPP 3D-printed scaffolds loaded with neural progenitor cells (NPCs) to support axon regeneration and form new 'neural relays' across sites of complete spinal cord injury in vivo in rodents(1,2). We find that injured host axons regenerate into 3D biomimetic scaffolds and synapse onto NPCs implanted into the device and that implanted NPCs in turn extend axons out of the scaffold and into the host spinal cord below the injury to restore synaptic transmission and significantly improve functional outcomes. Thus, 3D biomimetic scaffolds offer a means of enhancing CNS regeneration through precision medicine.	[Koffler, Jacob; Dulin, Jennifer N.; Brock, John; Graham, Lori; Lu, Paul; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Zhu, Wei; Qu, Xin; Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Platoshyn, Oleksandr; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Sakamoto, Jeff] Univ Michigan, Mech Engn Dept, Ann Arbor, MI 48109 USA; [Tuszynski, Mark H.] Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Koffler, J; Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Chen, SC (corresponding author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.; Tuszynski, MH (corresponding author), Vet Affairs Med Ctr, San Diego, CA 92161 USA.	ykoffler@ucsd.edu; chen168@eng.ucsd.edu; mtuszynski@ucsd.edu		koffler, jacob/0000-0002-8415-2938	NIH [R01EB021857, R21HD090662]; NSF [1547005, 1644967]; California Institute for Regenerative Medicine [RT3-07899]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health [S10OD023527]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD090662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB021857] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank J. Liu for materials synthesis, J. Li, D. Xue and S. You for helpful discussion and CAD design, and R. Anderson for assistance in scanning electron microscopy. This work was supported in part by the NIH (R01EB021857, R21HD090662), the NSF (1547005, 1644967), the California Institute for Regenerative Medicine (RT3-07899) and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The electron micrographs were taken in the Cellular and Molecular Medicine Electron microscopy core facility, which is supported in part by National Institutes of Health Award number S10OD023527.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; [Anonymous], 2014, NSCISC ANN STAT REP; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Ciranna L, 2006, CURR NEUROPHARMACOL, V4, P101, DOI 10.2174/157015906776359540; Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Fehlings MG, 2001, SPINE, V26, pS101, DOI 10.1097/00007632-200112151-00017; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070; Grill R, 1997, J NEUROSCI, V17, P5560; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; HUNG TK, 1981, J BIOMECH, V14, P269, DOI 10.1016/0021-9290(81)90072-5; Iyer S, 2010, J NEUROSCI METH, V193, P210, DOI 10.1016/j.jneumeth.2010.08.017; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Koffler J, 2014, METHODS MOL BIOL, V1162, P157, DOI 10.1007/978-1-4939-0777-9_13; Le W, 2014, BRAIN RES, V1575, P87, DOI 10.1016/j.brainres.2014.05.038; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/786475; Lu P, 2017, J CLIN INVEST, V127, P3293, DOI 10.1172/JCI92955; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Okada S, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0026-1; Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364; Park SS, 2011, CELL TRANSPLANT, V20, P1867, DOI 10.3727/096368911X566163; Pawar K, 2015, BIOMATERIALS, V65, P1, DOI 10.1016/j.biomaterials.2015.05.032; Peron S, 2017, J NEUROSCI, V37, P1820, DOI 10.1523/JNEUROSCI.2936-16.2017; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Soman P, 2013, BIOTECHNOL BIOENG, V110, P3038, DOI 10.1002/bit.24957; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041; Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777; Tator CH, 1999, J NEUROSURG, V91, P12, DOI 10.3171/spi.1999.91.1.0012; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473; Yu CG, 2008, J NEUROTRAUM, V25, P833, DOI 10.1089/neu.2007.0490; Yu D, 2009, STEM CELLS, V27, P1212, DOI 10.1002/stem.26; Zhu YC, 2018, DEV DYNAM, V247, P75, DOI 10.1002/dvdy.24558	42	290	298	83	665	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					263	+		10.1038/s41591-018-0296-z	http://dx.doi.org/10.1038/s41591-018-0296-z			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30643285	Green Accepted			2022-12-27	WOS:000457842100023
J	Marktel, S; Scaramuzza, S; Cicalese, MP; Giglio, F; Galimberti, S; Lidonnici, MR; Calbi, V; Assanelli, A; Bernardo, ME; Rossi, C; Calabria, A; Milani, R; Gattillo, S; Benedicenti, F; Spinozzi, G; Aprile, A; Bergami, A; Casiraghi, M; Consiglieri, G; Masera, N; D'Angelo, E; Mirra, N; Origa, R; Tartaglione, I; Perrotta, S; Winter, R; Coppola, M; Viarengo, G; Santoleri, L; Graziadei, G; Gabaldo, M; Valsecchi, MG; Montini, E; Naldini, L; Cappellini, MD; Ciceri, F; Aiuti, A; Ferrari, G				Marktel, Sarah; Scaramuzza, Samantha; Cicalese, Maria Pia; Giglio, Fabio; Galimberti, Stefania; Lidonnici, Maria Rosa; Calbi, Valeria; Assanelli, Andrea; Bernardo, Maria Ester; Rossi, Claudia; Calabria, Andrea; Milani, Raffaella; Gattillo, Salvatore; Benedicenti, Fabrizio; Spinozzi, Giulio; Aprile, Annamaria; Bergami, Alessandra; Casiraghi, Miriam; Consiglieri, Giulia; Masera, Nicoletta; D'Angelo, Emanuela; Mirra, Nadia; Origa, Raffaella; Tartaglione, Immacolata; Perrotta, Silverio; Winter, Robert; Coppola, Milena; Viarengo, Gianluca; Santoleri, Luca; Graziadei, Giovanna; Gabaldo, Michela; Valsecchi, Maria Grazia; Montini, Eugenio; Naldini, Luigi; Cappellini, Maria Domenica; Ciceri, Fabio; Aiuti, Alessandro; Ferrari, Giuliana			Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent beta-thalassemia	NATURE MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; INTRAVENOUS-INJECTION; EUROPEAN-SOCIETY; LONG-TERM; PROGENITORS; CHILDREN	beta-thalassemia is caused by beta-globin gene mutations resulting in reduced (beta(+)) or absent (beta(0)) hemoglobin production. Patient life expectancy has recently increased, but the need for chronic transfusions in transfusion-dependent thalassemia (TDT) and iron chelation impairs quality of life(1). Allogeneic hematopoietic stem cell (HSC) transplantation represents the curative treatment, with thalassemia-free survival exceeding 80%. However, it is available to a minority of patients and is associated with morbidity, rejection and graft-versus-host disease(2). Gene therapy with autologous HSCs modified to express beta-globin represents a potential therapeutic option. We treated three adults and six children with beta(0) or severe beta(+) mutations in a phase 1/2 trial (NCT02453477) with an intrabone administration of HSCs transduced with the lentiviral vector GLOBE. Rapid hematopoietic recovery with polyclonal multilineage engraftment of vector-marked cells was achieved, with a median of 37.5% (range 12.6-76.4%) in hematopoietic progenitors and a vector copy number per cell (VCN) of 0.58 (range 0.10-1.97) in erythroid precursors at 1 year, in absence of clonal dominance. Transfusion requirement was reduced in the adults. Three out of four evaluable pediatric participants discontinued transfusions after gene therapy and were transfusion independent at the last followup. Younger age and persistence of higher VCN in the repopulating hematopoietic cells are associated with better outcome.	[Marktel, Sarah; Scaramuzza, Samantha; Cicalese, Maria Pia; Lidonnici, Maria Rosa; Calbi, Valeria; Bernardo, Maria Ester; Rossi, Claudia; Calabria, Andrea; Benedicenti, Fabrizio; Spinozzi, Giulio; Aprile, Annamaria; Bergami, Alessandra; Casiraghi, Miriam; Consiglieri, Giulia; Gabaldo, Michela; Montini, Eugenio; Naldini, Luigi; Ciceri, Fabio; Aiuti, Alessandro; Ferrari, Giuliana] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR TIGET, Milan, Italy; [Marktel, Sarah; Giglio, Fabio; Assanelli, Andrea; Ciceri, Fabio] IRCCS San Raffaele Sci Inst, Haematol & BMT Unit, Milan, Italy; [Cicalese, Maria Pia; Calbi, Valeria; Bernardo, Maria Ester; Casiraghi, Miriam; Consiglieri, Giulia; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, Pediat Immunohematol, Milan, Italy; [Galimberti, Stefania; Valsecchi, Maria Grazia] Univ Milano Bicocca, Sch Med & Surg, Ctr Biostat Clin Epidemiol, Milan, Italy; [Milani, Raffaella; Gattillo, Salvatore; Coppola, Milena; Santoleri, Luca] IRCCS San Raffaele Sci Inst, Blood Transfus Serv, Milan, Italy; [Masera, Nicoletta] Univ Milano Bicocca, San Gerardo Hosp, Pediat Dept, Monza, Italy; [D'Angelo, Emanuela; Mirra, Nadia] Fdn IRCCS Ca Granda, Pediat Clin DH, Milan, Italy; [Origa, Raffaella] AO G Brotzu, Osped Pediat Microcitem A Cao, Cagliari, Italy; [Tartaglione, Immacolata; Perrotta, Silverio] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialist Surg, Naples, Italy; [Winter, Robert] Great Ormond St Hosp NHS Fdn Trust, Dept Chem Pathol, London, England; [Viarengo, Gianluca] Fdn IRCCS Policlin S Matteo, Immunohematol & Transfus Med Serv, Pavia, Italy; [Graziadei, Giovanna; Cappellini, Maria Domenica] Univ Milan, Fdn IRCCS Ca Granda, Rare Dis Ctr, Milan, Italy; [Naldini, Luigi; Ciceri, Fabio; Aiuti, Alessandro; Ferrari, Giuliana] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; Universita della Campania Vanvitelli; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University	Ferrari, G (corresponding author), IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR TIGET, Milan, Italy.; Ferrari, G (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	ferrari.giuliana@hsr.it	Ferrari, Giuliana/AAB-5546-2019; Tartaglione, Immacolata/AAY-9511-2020; Montini, Eugenio/L-1152-2016; galimberti, stefania/H-2594-2012; Valsecchi, Maria Grazia/K-8891-2016; Santoleri, Luca/AAN-3885-2020; marktel, sarah/ABH-5549-2020; Calbi, Valeria/K-4102-2018; Lidonnici, Maria Rosa/AAN-2208-2020; Spinozzi, Giulio/T-8085-2019; Scaramuzza, Samantha/AAN-2204-2020; Calabria, Andrea/AAA-3349-2019	Ferrari, Giuliana/0000-0003-0790-3133; Montini, Eugenio/0000-0003-1771-6067; Valsecchi, Maria Grazia/0000-0001-5574-3504; Calbi, Valeria/0000-0003-3514-666X; Lidonnici, Maria Rosa/0000-0003-3413-8414; Spinozzi, Giulio/0000-0002-4220-2474; Scaramuzza, Samantha/0000-0003-2903-3650; Calabria, Andrea/0000-0003-3515-3384; marktel, sarah/0000-0002-3768-4288; NALDINI, Luigi/0000-0002-7835-527X; Aprile, Annamaria/0000-0001-6019-1345; tartaglione, immacolata/0000-0003-1278-2372; GALIMBERTI, STEFANIA/0000-0003-1504-7242; Giglio, Fabio/0000-0003-4755-9533; Rossi, Claudia/0000-0002-3810-7247; Graziadei, Giovanna/0000-0002-6801-5730; Perrotta, Silverio/0000-0001-6149-6845	Fondazione Telethon; GlaxoSmithKline (GSK)	Fondazione Telethon(Fondazione TelethonEuropean Commission); GlaxoSmithKline (GSK)(GlaxoSmithKline)	The clinical trial was supported initially by Fondazione Telethon and by GlaxoSmithKline (GSK). We wish to acknowledge Fondazione Telethon for continuous support and strategic guidance. GSK has licensed the thalassemia HSC gene therapy in August 2017 and transferred to Orchard Therapeutics in April 2018. We thank the patients and families who are participating in this study; The Association of Patients with Thalassaemia and Drepanocytosis in Lombardy, Italy, for facilitating communication between patients, families and health care operators. We thank all physicians that have referred patients for participation, the clinical and laboratory staff of the Ospedale San Raffaele Stem Cell Program for patient care and data collection, the Paediatric Clinical Research Unit, S. Zancan and the personnel of SR-TIGET Clinical Trial Office for regulatory support. We thank A. Spinelli of the Ospedale San Raffaele Experimental Imaging Centre for bioluminescence acquisition and analysis. We are grateful to H. Prunty and R. Chiesa for supervision and interpretation of the treosulfan pharmacokinetics analysis (Great Ormond Street Hospital, London, UK).	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Andreani M, 2011, HAEMATOL-HEMATOL J, V96, P128, DOI 10.3324/haematol.2010.031013; Baronciani D, 2016, BONE MARROW TRANSPL, V51, P536, DOI 10.1038/bmt.2015.293; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Bonifazi F, 2019, BONE MARROW TRANSPL, V54, P717, DOI 10.1038/s41409-018-0335-x; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chiesa R, 2017, BMJ-BRIT MED J, V102, pA23; Dalle JH, 2017, BONE MARROW TRANSPL, V52, P1029, DOI 10.1038/bmt.2017.21; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Eichler F, 2017, NEW ENGL J MED, V377, P1630, DOI 10.1056/NEJMoa1700554; Feng Q, 2008, EXP HEMATOL, V36, P1556, DOI 10.1016/j.exphem.2008.06.010; Frassoni F, 2008, LANCET ONCOL, V9, P831, DOI 10.1016/S1470-2045(08)70180-3; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Lidonnici MR, 2018, MOL THER-METH CLIN D, V11, P9, DOI 10.1016/j.omtm.2018.09.001; Lidonnici MR, 2017, HAEMATOLOGICA, V102, pE120, DOI 10.3324/haematol.2016.154740; Mansilla-Soto J, 2016, HUM GENE THER, V27, P295, DOI 10.1089/hum.2016.037; Marktel S, 2010, PEDIATR TRANSPLANT, V14, P393, DOI 10.1111/j.1399-3046.2009.01282.x; Mathews V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061637; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; Miccio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027955; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Murata M, 2017, CANCER SCI, V108, P1634, DOI 10.1111/cas.13291; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Okada M, 2018, EUR J HAEMATOL, V100, P335, DOI 10.1111/ejh.12999; Pantin JM, 2015, AM J TRANSPLANT, V15, P606, DOI 10.1111/ajt.13007; Remberger M, 2017, INT J HEMATOL, V106, P471, DOI 10.1007/s12185-017-2320-3; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Rocha V, 2013, TRANSPLANTATION, V95, P1284, DOI 10.1097/TP.0b013e318288ca4d; Roselli EA, 2010, EMBO MOL MED, V2, P315, DOI 10.1002/emmm.201000083; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Taher AT, 2018, LANCET, V391, P155, DOI 10.1016/S0140-6736(17)31822-6; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; Wiebking V, 2017, ANN HEMATOL, V96, P1373, DOI 10.1007/s00277-017-3030-x; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995	36	126	133	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					234	+		10.1038/s41591-018-0301-6	http://dx.doi.org/10.1038/s41591-018-0301-6			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30664781				2022-12-27	WOS:000457842100019
J	Stower, H				Stower, Hannah			Accumulating mutations	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					19	19		10.1038/s41591-018-0329-7	http://dx.doi.org/10.1038/s41591-018-0329-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617327	Bronze			2022-12-27	WOS:000455027700010
J	[Anonymous]				[Anonymous]			Medicine in the digital age	NATURE MEDICINE			English	Editorial Material								As Nature Medicine celebrates its 25th anniversary, we bring you a special Focus on Digital Medicine that highlights the new technologies transforming medicine and healthcare, as well as the related regulatory challenges ahead.											0	19	20	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					1	1		10.1038/s41591-018-0322-1	http://dx.doi.org/10.1038/s41591-018-0322-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617338	Bronze			2022-12-27	WOS:000455027700001
J	Gopalakrishnan, V; Jenq, RR				Gopalakrishnan, Vancheswaran; Jenq, Robert R.			Implicating or exonerating the gut microbiome in blood-borne infection	NATURE MEDICINE			English	Editorial Material									[Gopalakrishnan, Vancheswaran] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Jenq, Robert R.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Jenq, RR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.; Jenq, RR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	RRJenq@mdanderson.org	Gopalakrishnan, Vancheswaran/S-9550-2019	Gopalakrishnan, Vancheswaran/0000-0002-8704-035X				Bodey GP, 2009, J ANTIMICROB CHEMOTH, V63, pI3, DOI 10.1093/jac/dkp074; BODEY GP, 1970, AM J MED SCI, V260, P82, DOI 10.1097/00000441-197008000-00002; Costea PI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182392; Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115; SLEIJFER DT, 1980, EUR J CANCER, V16, P859, DOI 10.1016/0014-2964(80)90140-1; Tamburini FB, 2018, NAT MED, V24, P1809, DOI 10.1038/s41591-018-0202-8; TANCREDE CH, 1985, J INFECT DIS, V152, P99, DOI 10.1093/infdis/152.1.99; Taur Y, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0306-z; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918	11	4	4	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1788	1789		10.1038/s41591-018-0270-9	http://dx.doi.org/10.1038/s41591-018-0270-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30510253				2022-12-27	WOS:000452392200002
J	Blank, CU; Rozeman, EA; Fanchi, LF; Sikorska, K; van de Wiel, B; Kvistborg, P; Krijgsman, O; van den Braber, M; Philips, D; Broeks, A; van Thienen, JV; Mallo, HA; Adriaansz, S; ter Meulens, S; Pronk, LM; Grijpink-Ongering, LG; Bruining, A; Gittelman, RM; Warren, S; van Tinteren, H; Peeper, DS; Haanen, JBAG; van Akkooi, ACJ; Schumacher, TN				Blank, Christian U.; Rozeman, Elisa A.; Fanchi, Lorenzo F.; Sikorska, Karolina; van de Wiel, Bart; Kvistborg, Pia; Krijgsman, Oscar; van den Braber, Marlous; Philips, Daisy; Broeks, Annegien; van Thienen, Johannes, V; Mallo, Henk A.; Adriaansz, Sandra; ter Meulens, Sylvia; Pronk, Loes M.; Grijpink-Ongering, Lindsay G.; Bruining, Annemarie; Gittelman, Rachel M.; Warren, Sarah; van Tinteren, Harm; Peeper, Daniel S.; Haanen, John B. A. G.; van Akkooi, Alexander C. J.; Schumacher, Ton N.			Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma	NATURE MEDICINE			English	Article							PD-1 BLOCKADE; BREAST-CANCER; IMMUNOTHERAPY; RESISTANCE; RESPONSES; SURVIVAL; THERAPY; DISEASE; CLONES; PHASE	Adjuvant ipilimumab (anti-CTLA-4) and nivolumab (antiPD-1) both improve relapse-free survival of stage III melanoma patients(1,2). In stage IV disease, the combination of ipilimumab + nivolumab is superior to ipilimumab alone and also appears to be more effective than nivolumab monotherapy(3). Preclinical work suggests that neoadjuvant application of checkpoint inhibitors may be superior to adjuvant therapy(4). To address this question and to test feasibility, 20 patients with palpable stage III melanoma were 1:1 randomized to receive ipilimumab 3 mg kg(-1) and nivolumab 1 mg kg(-1), as either four courses after surgery (adjuvant arm) or two courses before surgery and two courses postsurgery (neoadjuvant arm). Neoadjuvant therapy was feasible, with all patients undergoing surgery at the preplanned time point. However in both arms, 9/10 patients experienced one or more grade 3/4 adverse events. Pathological responses were achieved in 7/9 (78%) patients treated in the neoadjuvant arm. None of these patients have relapsed so far (median follow-up, 25.6months). We found that neoadjuvant ipilimumab + nivolumab expand more tumor-resident T cell clones than adjuvant application. While neoadjuvant therapy appears promising, with the current regimen it induced high toxicity rates; therefore, it needs further investigation to preserve efficacy but reduce toxicity.	[Blank, Christian U.; Rozeman, Elisa A.; van Thienen, Johannes, V; Mallo, Henk A.; Adriaansz, Sandra; Haanen, John B. A. G.] Netherlands Canc Inst, Med Oncol Dept, Amsterdam, Netherlands; [Blank, Christian U.; Rozeman, Elisa A.; Fanchi, Lorenzo F.; Kvistborg, Pia; Krijgsman, Oscar; van den Braber, Marlous; Philips, Daisy; Peeper, Daniel S.; Haanen, John B. A. G.; Schumacher, Ton N.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Sikorska, Karolina; Pronk, Loes M.; Grijpink-Ongering, Lindsay G.; van Tinteren, Harm] Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [van de Wiel, Bart; Broeks, Annegien] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [ter Meulens, Sylvia; van Akkooi, Alexander C. J.] Netherlands Canc Inst, Surg Oncol Dept, Amsterdam, Netherlands; [Bruining, Annemarie] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands; [Gittelman, Rachel M.] Adapt Biotechnol, Seattle, WA USA; [Warren, Sarah] NanoString Technol Inc, Seattle, WA USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Blank, CU (corresponding author), Netherlands Canc Inst, Med Oncol Dept, Amsterdam, Netherlands.; Blank, CU; Schumacher, TN (corresponding author), Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.	c.blank@nki.nl; t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019; Haanen, John/AAD-8578-2022; Peeper, Daniel/AAA-2430-2020; Haanen, John/AAD-8534-2022	Schumacher, Ton/0000-0003-0517-8804; Haanen, John/0000-0001-5884-7704; van Akkooi, Alexander Christopher Jonathan/0000-0002-3262-6935; Gittelman, Rachel/0000-0003-3202-6582; van Tinteren, Harm/0000-0002-4626-8702				Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Burmeister BH, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70138-9; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Eggermont A. M., 2014, J CLIN ONCOL, V32; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Eroglu Z., 2017, ANN M SOC MEL RES SM; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Larkin J, 2017, ONCOLOGIST, V22, P709, DOI 10.1634/theoncologist.2016-0487; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Long GV, 2017, LANCET ONCOL, V18, P1202, DOI 10.1016/S1470-2045(17)30428-X; LUI VK, 1975, BRIT J CANCER, V32, P323, DOI 10.1038/bjc.1975.230; Meerveld-Eggink A, 2017, ANN ONCOL, V28, P862, DOI 10.1093/annonc/mdw692; Memarnejadian A, 2017, J IMMUNOL, V199, P3348, DOI 10.4049/jimmunol.1700643; Reddy S. M., 2017, 32 SITC ANN M NAT HA; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Steenbruggen TG, 2017, DRUGS, V77, P1313, DOI 10.1007/s40265-017-0774-5; Straver ME, 2010, BRIT J SURG, V97, P1226, DOI 10.1002/bjs.7073; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	32	370	377	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1655	+		10.1038/s41591-018-0198-0	http://dx.doi.org/10.1038/s41591-018-0198-0			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30297911				2022-12-27	WOS:000449404200015
J	Blair, JD; Hockemeyer, D; Bateup, HS				Blair, John D.; Hockemeyer, Dirk; Bateup, Helen S.			Genetically engineered human cortical spheroid models of tuberous sclerosis	NATURE MEDICINE			English	Article							PLURIPOTENT STEM-CELLS; TSC1-TSC2 COMPLEX; GENE INACTIVATION; MTOR PATHWAY; GIANT-CELLS; MOUSE MODEL; TSC2; NEURONS; MUTATIONS; LEADS	Tuberous sclerosis complex (TSC) is a multisystem developmental disorder caused by mutations in the TSC1 or TSC2 genes, whose protein products are negative regulators of mechanistic target of rapamycin complex 1 signaling. Hallmark pathologies of TSC are cortical tubers-regions of dysmorphic, disorganized neurons and glia in the cortex that are linked to epileptogenesis. To determine the developmental origin of tuber cells, we established human cellular models of TSC by CRISPR-Cas9-mediated gene editing of TSC1 or TSC2 in human pluripotent stem cells (hPSCs). Using heterozygous TSC2 hPSCs with a conditional mutation in the functional allele, we show that mosaic biallelic inactivation during neural progenitor expansion is necessary for the formation of dysplastic cells and increased glia production in three-dimensional cortical spheroids. Our findings provide support for the second-hit model of cortical tuber formation and suggest that variable developmental timing of somatic mutations could contribute to the heterogeneity in the neurological presentation of TSC.	[Blair, John D.; Hockemeyer, Dirk; Bateup, Helen S.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bateup, Helen S.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bateup, HS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Bateup, HS (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	bateup@berkeley.edu			American Epilepsy Society; Canadian Institutes for Health Research [356733]; Brain Research Foundation Seed Grant [BRFSG-2014-02]; Hellman Family Faculty Fund Award; NINDS R01 [R01NS097823]; Sloan Research Fellowship in Neuroscience [FR-2015-65790]; NCI R01 [R01CA196884]; Pew Charitable Trusts; Alexander and Margaret Stewart Trust; Siebel Stem Cell Institute; NATIONAL CANCER INSTITUTE [R01CA196884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097823] Funding Source: NIH RePORTER	American Epilepsy Society; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Brain Research Foundation Seed Grant; Hellman Family Faculty Fund Award; NINDS R01; Sloan Research Fellowship in Neuroscience; NCI R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Charitable Trusts; Alexander and Margaret Stewart Trust; Siebel Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Lorbeer for her help with the teratoma formation assay. This work was supported by a Predoctoral Award from the American Epilepsy Society (to J.D.B.), Frederick Banting and Charles Best Canada Graduate Scholarship from Canadian Institutes for Health Research (no. 356733 to J.D.B.), Brain Research Foundation Seed Grant (no. BRFSG-2014-02 to H.S.B.), Hellman Family Faculty Fund Award (to H.S.B.), NINDS R01 (no. R01NS097823 to H.S.B.), Sloan Research Fellowship in Neuroscience (no. FR-2015-65790 to H.S.B.), and NCI R01 (no. R01CA196884 to D.H.). D.H. is a Pew-Stewart Scholar for Cancer Research supported by the Pew Charitable Trusts and the Alexander and Margaret Stewart Trust. Seed funding was provided by the Siebel Stem Cell Institute.	An KS, 2007, GENET MED, V9, P88, DOI 10.1097/GIM.0b013e31803068c7; Au KS, 1999, AM J HUM GENET, V65, P1790, DOI 10.1086/302648; Blair JD, 2017, CELL REP, V21, P2005, DOI 10.1016/j.celrep.2017.10.095; Blair JD, 2016, JOVE-J VIS EXP, DOI 10.3791/53583; Boer K, 2008, EPILEPSY RES, V78, P7, DOI 10.1016/j.eplepsyres.2007.10.002; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chambers SM, 2011, METHODS MOL BIOL, V793, P87, DOI 10.1007/978-1-61779-328-8_6; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan JA, 2004, J NEUROPATH EXP NEUR, V63, P1236, DOI 10.1093/jnen/63.12.1236; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa V, 2016, CELL REP, V15, P86, DOI 10.1016/j.celrep.2016.02.090; Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81; Crino PB, 2013, ACTA NEUROPATHOL, V125, P317, DOI 10.1007/s00401-013-1085-x; Crino PB, 2010, NEUROLOGY, V74, P1716, DOI 10.1212/WNL.0b013e3181e04325; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2015, LANCET NEUROL, V14, P733, DOI 10.1016/S1474-4422(15)00069-1; D'Gama AM, 2017, CELL REP, V21, P3754, DOI 10.1016/j.celrep.2017.11.106; de Vries PJ, 2007, TRENDS MOL MED, V13, P319, DOI 10.1016/j.molmed.2007.06.003; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Grabole N, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0347-3; Henske EP, 1996, AM J HUM GENET, V59, P400; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jansen FE, 2008, NEUROLOGY, V70, P916, DOI 10.1212/01.wnl.0000280579.04974.c0; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li YQ, 2017, STEM CELL REP, V8, P883, DOI 10.1016/j.stemcr.2017.02.020; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magri L, 2013, CELL MOL LIFE SCI, V70, P2887, DOI 10.1007/s00018-012-1196-x; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Martin KR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15816; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mizuguchi M, 2001, BRAIN DEV-JPN, V23, P508, DOI 10.1016/S0387-7604(01)00304-7; Mohamed AR, 2012, NEUROLOGY, V79, P2249, DOI 10.1212/WNL.0b013e3182768923; NELLIST M, 1993, CELL, V75, P1305; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Qin W, 2010, BRAIN PATHOL, V20, P1096, DOI 10.1111/j.1750-3639.2010.00416.x; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Sosunov AA, 2008, EPILEPSIA, V49, P53, DOI 10.1111/j.1528-1167.2008.01493.x; Sosunov AA, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0191-5; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Thiele EA, 2010, EPILEPSIA, V51, P90, DOI 10.1111/j.1528-1167.2009.02458.x; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tsai PT, 2013, BEHAV GENET, V43, P51, DOI 10.1007/s10519-012-9571-9; Tyburczy ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005637; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Zeng LH, 2011, HUM MOL GENET, V20, P445, DOI 10.1093/hmg/ddq491	65	95	96	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1568	+		10.1038/s41591-018-0139-y	http://dx.doi.org/10.1038/s41591-018-0139-y			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30127391	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000446577900020
J	Seo, H; Kim, JS				Seo, Huiyun; Kim, Jin-Soo			Towards therapeutic base editing	NATURE MEDICINE			English	Editorial Material							DNA CLEAVAGE; GENOMIC DNA		[Seo, Huiyun; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Daejon, South Korea; [Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Kim, JS (corresponding author), Inst for Basic Sci Korea, Ctr Genome Engn, Daejon, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Dept Chem, Seoul, South Korea.	jskim01@snu.ac.kr	KIM, Jin-Soo/M-6918-2013	KIM, Jin-Soo/0000-0003-4847-1306				Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Kim K, 2017, NAT BIOTECHNOL, V35, P435, DOI 10.1038/nbt.3816; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li XS, 2018, NAT BIOTECHNOL, V36, P324, DOI 10.1038/nbt.4102; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Rossidis AC, 2018, NAT MED, V24, P1513, DOI 10.1038/s41591-018-0184-6; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Villiger L, 2018, NAT MED, DOI [10.1038/s41591-018-209-1, DOI 10.1038/S41591-018-209-1]; Zafra MP, 2018, NAT BIOTECHNOL, V36, P888, DOI 10.1038/nbt.4194	12	3	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1493	1495		10.1038/s41591-018-0215-3	http://dx.doi.org/10.1038/s41591-018-0215-3			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297902				2022-12-27	WOS:000446577900006
J	Bulluck, H; Hausenloy, DJ				Bulluck, Heerajnarain; Hausenloy, Derek J.			Modulating NAD(+) metabolism to prevent acute kidney injury	NATURE MEDICINE			English	Editorial Material							METAANALYSIS; SURGERY		[Bulluck, Heerajnarain] Norfolk & Norwich Univ Hosp, Norfolk, England; [Hausenloy, Derek J.] UCL, Hatter Cardiovasc Inst, London, England; [Hausenloy, Derek J.] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Hausenloy, Derek J.] Natl Heart Ctr, Singapore, Singapore; [Hausenloy, Derek J.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Hausenloy, Derek J.] Duke Natl Univ Singapore, Cardiovasc & Metab Disorders Program, Med Sch, Singapore, Singapore; [Hausenloy, Derek J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; National Heart Centre Singapore; University of London; Queen Mary University London; National University of Singapore; National University of Singapore	Hausenloy, DJ (corresponding author), UCL, Hatter Cardiovasc Inst, London, England.; Hausenloy, DJ (corresponding author), Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England.; Hausenloy, DJ (corresponding author), Natl Heart Ctr, Singapore, Singapore.; Hausenloy, DJ (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, London, England.; Hausenloy, DJ (corresponding author), Duke Natl Univ Singapore, Cardiovasc & Metab Disorders Program, Med Sch, Singapore, Singapore.; Hausenloy, DJ (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.	derek.hausenloy@duke-nus.edu.sg	Bulluck, Heeraj/H-7425-2019; Bulluck, Heeraj/AAB-7669-2022	Bulluck, Heeraj/0000-0002-1985-1783; Hausenloy, Derek/0000-0003-0729-4956	British Heart Foundation [FS/10/039/28270]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Duke-National University Singapore Medical School; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist-Senior Investigator scheme [NMRC/CSA-SI/0011/2017]; Collaborative Centre Grant scheme [NMRC/CGAug16C006]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2016-T2-2-021]; COST (European Cooperation in Science and Technology) [CA16225]	British Heart Foundation(British Heart Foundation); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Duke-National University Singapore Medical School; Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist-Senior Investigator scheme(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Collaborative Centre Grant scheme; Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	D.J.H. was supported by the British Heart Foundation (FS/10/039/28270), the National Institute for Health Research University College London Hospitals Biomedical Research Centre, Duke-National University Singapore Medical School, Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist-Senior Investigator scheme (NMRC/CSA-SI/0011/2017) and Collaborative Centre Grant scheme (NMRC/CGAug16C006) and the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2016-T2-2-021). This article is based upon work from COST Action EU-CARDIOPROTECTION CA16225 supported by COST (European Cooperation in Science and Technology).	Bhatt GC, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0486-9; Bulluck H, 2018, HEART, V104, P313, DOI 10.1136/heartjnl-2017-311760; Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001; Hershberger KA, 2017, NAT REV NEPHROL, V13, P213, DOI 10.1038/nrneph.2017.5; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lok CE, 2004, AM HEART J, V148, P430, DOI 10.1016/j.ahj.2003.12.042; Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113	8	7	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1306	1307		10.1038/s41591-018-0181-9	http://dx.doi.org/10.1038/s41591-018-0181-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30177824	Green Submitted			2022-12-27	WOS:000444174100006
J	Okoye, AA; Hansen, SG; Vaidya, M; Fukazawa, Y; Park, H; Duell, DM; Lum, R; Hughes, CM; Ventura, AB; Ainslie, E; Ford, JC; Morrow, D; Gilbride, RM; Legasse, AW; Hesselgesser, J; Geleziunas, R; Li, Y; Oswald, K; Shoemaker, R; Fast, R; Bosche, WJ; Borate, BR; Edlefsen, PT; Axthelm, MK; Picker, LJ; Lifson, JD				Okoye, Afam A.; Hansen, Scott G.; Vaidya, Mukta; Fukazawa, Yoshinori; Park, Haesun; Duell, Derick M.; Lum, Richard; Hughes, Colette M.; Ventura, Abigail B.; Ainslie, Emily; Ford, Julia C.; Morrow, David; Gilbride, Roxanne M.; Legasse, Alfred W.; Hesselgesser, Joseph; Geleziunas, Romas; Li, Yuan; Oswald, Kelli; Shoemaker, Rebecca; Fast, Randy; Bosche, William J.; Borate, Bhavesh R.; Edlefsen, Paul T.; Axthelm, Michael K.; Picker, Louis J.; Lifson, Jeffrey D.			Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound	NATURE MEDICINE			English	Article							T-CELL RESPONSES; IMMUNODEFICIENCY VIRUS-INFECTION; HIGHLY PATHOGENIC SIV; LATENT RESERVOIR; CLONAL EXPANSION; HIV-1; REPLICATION; VIREMIA; PROTECTION; MEMORY	Prophylactic vaccination of rhesus macaques with rhesus cytomegalovirus (RhCMV) vectors expressing simian immunodeficiency virus (SIV) antigens (RhCMV/SIV) elicits immune responses that stringently control highly pathogenic SIV infection, with subsequent apparent clearance of the infection, in -50% of vaccinees. In contrast, here, we show that therapeutic RhCMV/SIV vaccination of rhesus macaques previously infected with SIV and given continuous combination antiretroviral therapy (cART) beginning 4-9 d post-SIV infection does not mediate measurable SIV reservoir clearance during over 600 d of follow-up on cART relative to RhCMV/control vaccination. However, none of the six animals started on cART on day four or five, across both RhCMV/SIV- and RhCMV/control-vaccinated groups, those rhesus macaques with SIV reservoirs most closely resembling those of prophylactically RhCMV/SIV-vaccinated and protected animals early in their course, showed post-cART viral rebound with up to nine months of follow-up. Moreover, at necropsy, these rhesus macaques showed little to no evidence of replication-competent SIV. These results suggest that the early SIV reservoir is limited in durability and that effective blockade of viral replication and spread in this critical time window by either pharmacologic or immunologic suppression may result in reduction, and potentially loss, of rebound-competent virus over a period of -two years.	[Okoye, Afam A.; Hansen, Scott G.; Vaidya, Mukta; Fukazawa, Yoshinori; Park, Haesun; Duell, Derick M.; Lum, Richard; Hughes, Colette M.; Ventura, Abigail B.; Ainslie, Emily; Ford, Julia C.; Morrow, David; Gilbride, Roxanne M.; Legasse, Alfred W.; Axthelm, Michael K.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Okoye, Afam A.; Hansen, Scott G.; Vaidya, Mukta; Fukazawa, Yoshinori; Park, Haesun; Duell, Derick M.; Lum, Richard; Hughes, Colette M.; Ventura, Abigail B.; Ainslie, Emily; Ford, Julia C.; Morrow, David; Gilbride, Roxanne M.; Legasse, Alfred W.; Axthelm, Michael K.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Hesselgesser, Joseph; Geleziunas, Romas] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Li, Yuan; Oswald, Kelli; Shoemaker, Rebecca; Fast, Randy; Bosche, William J.; Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21701 USA; [Borate, Bhavesh R.; Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Gilead Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.; Lifson, JD (corresponding author), Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21701 USA.	pickerl@ohsu.edu; lifsonj@mail.nih.gov			US National Institutes of Health [U19AI096109, U19AI095985, UM1AI126611, UM1AI124377, R37AI054292, P51OD011092]; Bill and Melinda Gates Foundation [OPP1094567]; federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095985, UM1AI126611, UM1AI124377, U19AI096109, R37AI054292] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health (grants U19AI096109, U19AI095985, UM1AI126611, UM1AI124377, R37AI054292, and P51OD011092, L.J.P.), by the Bill and Melinda Gates Foundation (grant OPP1094567, L.J.P.), and supported in part with federal funds from the National Cancer Institute, National Institutes of Health (Contract No. HHSN261200800001E, J.D.L.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The authors thank B. Keele (Leidos Biomedical Research, Inc.) for providing SIVmac239X and Janssen Pharmaceuticals for providing Darunavir. The CD8<SUP>+</SUP> lymphocyte-depleting monoclonal antibody, M-T807R1, was provided by the National Institutes of Health's Nonhuman Primate Reagent Resource Program. We thank A. Sylwester, S. Hagen, T. Swanson, M. Fischer, S. Planer, C. Kahl, D. Siess, M. Reyes, J. Clock, A. Konfe, C. Abana, C. Pexton, E. McDonald, K. Jeffries, M. Grey, C. Xu, W. Brantley, A. Maxwell, M. Lidell, D. Malouli, M. Marenco, A. Townsend, and L. Boshears for technical or administrative assistance.	[Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P458, DOI 10.15585/mmwr.mm6517a5; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Churchill MJ, 2016, NAT REV MICROBIOL, V14, P55, DOI 10.1038/nrmicro.2015.5; Cline AN, 2005, J MED PRIMATOL, V34, P303; Colby DJ, 2018, NAT MED, V24, P923, DOI 10.1038/s41591-018-0026-6; Del Prete GQ, 2016, AIDS RES HUM RETROV, V32, P163, DOI [10.1089/AID.2015.0130, 10.1089/aid.2015.0130]; Del Prete GQ, 2014, J VIROL, V88, P8077, DOI 10.1128/JVI.01026-14; Del Prete GQ, 2013, CURR OPIN HIV AIDS, V8, P262, DOI 10.1097/COH.0b013e328361cf40; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Hansen SG, 2017, NATURE, V547, P123, DOI 10.1038/nature22984; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Henrich TJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002417; Henrich TJ, 2013, J INFECT DIS, V207, P1694, DOI 10.1093/infdis/jit086; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Kim M, 2016, P NATL ACAD SCI USA, V113, P1692, DOI 10.1073/pnas.1600097113; Kim WK, 2015, AIDS RES HUM RETROV, V31, P696, DOI [10.1089/aid.2015.0003, 10.1089/AID.2015.0003]; Kwon KJ, 2017, J CLIN INVEST, V127, P2536, DOI 10.1172/JCI95329; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Luzuriaga K, 2013, 20 C RETR OPP INF MA; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Miles B, 2016, TRENDS MICROBIOL, V24, P338, DOI 10.1016/j.tim.2016.02.006; Murray AJ, 2016, J IMMUNOL, V197, P407, DOI 10.4049/jimmunol.1600343; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; van der Kuyl AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000257; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	43	60	60	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1430	+		10.1038/s41591-018-0130-7	http://dx.doi.org/10.1038/s41591-018-0130-7			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30082858	Green Accepted, Bronze			2022-12-27	WOS:000444174100028
J	Deribe, YL; Sun, YT; Terranova, C; Khan, F; Martinez-Ledesma, J; Gay, J; Gao, G; Mullinax, RA; Khor, T; Feng, NP; Lin, YH; Wu, CC; Reyes, C; Peng, Q; Robinson, F; Inoue, A; Kochat, V; Liu, CG; Asara, JM; Moran, C; Muller, F; Wang, J; Fang, BL; Papadimitrakopoulou, V; Wistuba, II; Rai, K; Marszalek, J; Futreal, PA				Deribe, Yonathan Lissanu; Sun, Yuting; Terranova, Christopher; Khan, Fatima; Martinez-Ledesma, Juan; Gay, Jason; Gao, Guang; Mullinax, Robert A.; Khor, Tin; Feng, Ningping; Lin, Yu-Hsi; Wu, Chia-Chin; Reyes, Claudia; Peng, Qian; Robinson, Frederick; Inoue, Akira; Kochat, Veena; Liu, Chang-Gong; Asara, John M.; Moran, Cesar; Muller, Florian; Wang, Jing; Fang, Bingliang; Papadimitrakopoulou, Vali; Wistuba, Ignacio I.; Rai, Kunal; Marszalek, Joseph; Futreal, P. Andrew			Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer	NATURE MEDICINE			English	Article							CHROMATIN-REMODELING FACTOR; TUMOR-SUPPRESSOR; CELL-LINES; METABOLISM; BRG1; MYC; INHIBITORS; POLYCOMB; RECEPTOR; SURVIVAL	Lung cancer is a devastating disease that remains a top cause of cancer mortality. Despite improvements with targeted and immunotherapies, the majority of patients with lung cancer lack effective therapies, underscoring the need for additional treatment approaches. Genomic studies have identified frequent alterations in components of the SWI/SNF chromatin remodeling complex including SMARCA4 and ARID1A. To understand the mechanisms of tumorigenesis driven by mutations in this complex, we developed a genetically engineered mouse model of lung adenocarcinoma by ablating Smarca4 in the lung epithelium. We demonstrate that Smarca4 acts as a bona fide tumor suppressor and cooperates with p53 loss and Kras activation. Gene expression analyses revealed the signature of enhanced oxidative phosphorylation (OXPHOS) in SMARCA4 mutant tumors. We further show that SMARCA4 mutant cells have enhanced oxygen consumption and increased respiratory capacity. Importantly, SMARCA4 mutant lung cancer cell lines and xenograft tumors have marked sensitivity to inhibition of OXPHOS by a novel small molecule, IACS-010759, that is under clinical development. Mechanistically, we show that SMARCA4-deficient cells have a blunted transcriptional response to energy stress creating a therapeutically exploitable synthetic lethal interaction. These findings provide the mechanistic basis for further development of OXPHOS inhibitors as therapeutics against SWI/SNF mutant tumors.	[Deribe, Yonathan Lissanu; Terranova, Christopher; Khan, Fatima; Martinez-Ledesma, Juan; Wu, Chia-Chin; Reyes, Claudia; Peng, Qian; Inoue, Akira; Rai, Kunal; Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Sun, Yuting; Gay, Jason; Gao, Guang; Mullinax, Robert A.; Khor, Tin; Feng, Ningping; Robinson, Frederick; Marszalek, Joseph] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Lin, Yu-Hsi; Muller, Florian] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Kochat, Veena] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA USA; [Asara, John M.] Harvard Med Sch, Boston, MA USA; [Moran, Cesar] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Fang, Bingliang; Papadimitrakopoulou, Vali] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Deribe, YL; Futreal, PA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	ylissanu@mdanderson.org; Afutreal@mdanderson.org	Wu, Chia-Chin/ABD-5516-2021; Kochat, Veena/AAX-1915-2021	Wu, Chia-Chin/0000-0002-5208-6016; Inoue, Akira/0000-0002-5000-9084; Muller, Florian/0000-0001-7568-2948; Robinson, Frederick/0000-0003-1188-0376; Martinez Ledesma, Juan Emmanuel/0000-0003-1191-7917; Terranova, Christopher/0000-0002-3674-7013; Rai, Kunal/0000-0003-2321-6894	Cancer Prevention Research Institute [R120501]; Welch Foundation's Robert A. Welch Distinguished University Chair Award [G-0040]; ACS grant [RSG1514501CDD]; CPRIT grant [RP140612]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Cancer Prevention Research Institute; Welch Foundation's Robert A. Welch Distinguished University Chair Award; ACS grant; CPRIT grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Tieu for vector cloning; the MD Anderson core facilities, including the Sequencing and Microarray Facility (SMF), the Non-coding RNA and Sequencing Facility, the Genetically Engineered Mouse Facility (GEMF), S. Jiang and K. Zhao for assistance in maintenance of mouse colonies; T. Gutschner for discussion; and D. Spring for editing. This study was supported by the Cancer Prevention Research Institute (R120501 to P.A.F.) and the Welch Foundation's Robert A. Welch Distinguished University Chair Award (G-0040 to P.A.F.). F.M. is supported by ACS grant RSG1514501CDD and CPRIT grant RP140612. The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; CARLSON M, 1981, GENETICS, V98, P25; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Errico Alessia, 2014, Nat Rev Clin Oncol, V11, P302, DOI 10.1038/nrclinonc.2014.63; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; HA J, 1994, J BIOL CHEM, V269, P22162; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Johnson BE, 2016, NEW ENGL J MED, V375, P1892, DOI 10.1056/NEJMe1611003; Jones SF, 2015, CLIN CANCER RES, V21, P5434, DOI 10.1158/1078-0432.CCR-15-0126; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kottakis F, 2016, NATURE, V539, P390, DOI 10.1038/nature20132; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Medina PP, 2004, GENE CHROMOSOME CANC, V41, P170, DOI 10.1002/gcc.20068; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; NEIGEBORN L, 1984, GENETICS, V108, P845; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Rivkin A, 2006, BIOORG MED CHEM LETT, V16, P4620, DOI 10.1016/j.bmcl.2006.06.014; Rodriguez-Nieto S, 2009, CARCINOGENESIS, V30, P547, DOI 10.1093/carcin/bgp035; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Samur MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106397; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Stanton BZ, 2017, NAT GENET, V49, P282, DOI 10.1038/ng.3735; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Tagal V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14098; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang XF, 2017, NAT GENET, V49, P289, DOI 10.1038/ng.3746; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong AKC, 2000, CANCER RES, V60, P6171; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.565	61	109	110	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1047	+		10.1038/s41591-018-0019-5	http://dx.doi.org/10.1038/s41591-018-0019-5			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892061	Green Accepted			2022-12-27	WOS:000438187700033
J	Ihry, RJ; Worringer, KA; Salick, MR; Frias, E; Ho, D; Theriault, K; Kommineni, S; Chen, J; Sondey, M; Ye, CY; Randhawa, R; Kulkarni, T; Yang, Z; McAllister, G; Russ, C; Reece-Hoyes, J; Forrester, W; Hoffman, GR; Dolmetsch, R; Kaykas, A				Ihry, Robert J.; Worringer, Kathleen A.; Salick, Max R.; Frias, Elizabeth; Ho, Daniel; Theriault, Kraig; Kommineni, Sravya; Chen, Julie; Sondey, Marie; Ye, Chaoyang; Randhawa, Ranjit; Kulkarni, Tripti; Yang, Zinger; McAllister, Gregory; Russ, Carsten; Reece-Hoyes, John; Forrester, William; Hoffman, Gregory R.; Dolmetsch, Ricardo; Kaykas, Ajamete			p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells	NATURE MEDICINE			English	Article							HOMOLOGOUS RECOMBINATION; HUMAN ESCS; CAS9; ACTIVATION; GENERATION; NUCLEASES; NETWORKS; PATHWAY; DISEASE; CANCER	CRISPR/Cas9 has revolutionized our ability to engineer genomes and conduct genome-wide screens in human cells(1-3). Whereas some cell types are amenable to genome engineering, genomes of human pluripotent stem cells (hPSCs) have been difficult to engineer, with reduced efficiencies relative to tumour cell lines or mouse embryonic stem cells(3-13). Here, using hPSC lines with stable integration of Cas9 or transient delivery of Cas9-ribonucleoproteins (RNPs), we achieved an average insertion or deletion (indel) efficiency greater than 80%. This high efficiency of indel generation revealed that double-strand breaks (DSBs) induced by Cas9 are toxic and kill most hPSCs. In previous studies, the toxicity of Cas9 in hPSCs was less apparent because of low transfection efficiency and subsequently low DSB induction(3). The toxic response to DSBs was P53/TP53-dependent, such that the efficiency of precise genome engineering in hPSCs with a wild-type P53 gene was severely reduced. Our results indicate that Cas9 toxicity creates an obstacle to the high-throughput use of CRISPR/Cas9 for genome engineering and screening in hPSCs. Moreover, as hPSCs can acquire P53 mutations(14), cell replacement therapies using CRISPR/Cas9-enginereed hPSCs should proceed with caution, and such engineered hPSCs should be monitored for P53 function.	[Ihry, Robert J.; Worringer, Kathleen A.; Salick, Max R.; Ho, Daniel; Theriault, Kraig; Kommineni, Sravya; Randhawa, Ranjit; Kulkarni, Tripti; Dolmetsch, Ricardo; Kaykas, Ajamete] Novartis Inst Biomed Res, Dept Neurosci, Cambridge, MA 02139 USA; [Frias, Elizabeth; Yang, Zinger; McAllister, Gregory; Russ, Carsten; Reece-Hoyes, John; Forrester, William; Hoffman, Gregory R.] Novartis Inst Biomed Res, Dept Chem Biol & Therapeut, Cambridge, MA USA; [Chen, Julie] Novartis Inst Biomed Res, Dept Oncol, Cambridge, MA USA; [Sondey, Marie] Abbvie, Cambridge, MA USA; [Ye, Chaoyang] Blueprint Med, Cambridge, MA USA	Novartis; Novartis; Novartis; AbbVie	Kaykas, A (corresponding author), Novartis Inst Biomed Res, Dept Neurosci, Cambridge, MA 02139 USA.	ajamete.kaykas@novartis.com		Randhawa, Ranjit/0000-0003-1516-7674; Reece-Hoyes, John/0000-0001-5251-5813; Yang Loureiro, Zinger/0000-0001-8543-4841				Aguirre A.J., 2016, CANCER DISCOV, V2641, P617; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bidinosti M, 2016, SCIENCE, V351, P1199, DOI 10.1126/science.aad5487; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; Hagiyama H, 1999, ONCOGENE, V18, P4091, DOI 10.1038/sj.onc.1202772; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jaeger S, 2014, J BIOMOL SCREEN, V19, P791, DOI 10.1177/1087057114522690; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Liu Y, 2011, METHODS MOL BIOL, V767, P355, DOI 10.1007/978-1-61779-201-4_26; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Merkle FT, 2015, CELL REP, V11, P875, DOI 10.1016/j.celrep.2015.04.007; Munoz DM, 2016, CANCER DISCOV, V6, P900, DOI 10.1158/2159-8290.CD-16-0178; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	48	464	491	15	282	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					939	+		10.1038/s41591-018-0050-6	http://dx.doi.org/10.1038/s41591-018-0050-6			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892062	Green Submitted			2022-12-27	WOS:000438187700021
J	Stower, H				Stower, Hannah			Predicting colon cancer recurrence	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					898	898		10.1038/s41591-018-0123-6	http://dx.doi.org/10.1038/s41591-018-0123-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988135				2022-12-27	WOS:000438187700010
J	Stower, H				Stower, Hannah			A microbiome aid for malnutrition	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1189	1189		10.1038/s41591-019-0553-9	http://dx.doi.org/10.1038/s41591-019-0553-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388177	Bronze			2022-12-27	WOS:000480414600009
J	Abdel-Gadir, A; Stephen-Victor, E; Gerber, GK; Rivas, MN; Wang, S; Harb, H; Wang, L; Li, N; Crestani, E; Spielman, S; Secor, W; Biehl, H; Dibendetto, N; Dong, XX; Umetsu, DT; Bry, L; Rachid, R; Chatila, TA				Abdel-Gadir, Azza; Stephen-Victor, Emmanuel; Gerber, Georg K.; Rivas, Magali Noval; Wang, Sen; Harb, Hani; Wang, Leighanne; Li, Ning; Crestani, Elena; Spielman, Sara; Secor, William; Biehl, Heather; Dibendetto, Nicholas; Dong, Xiaoxi; Umetsu, Dale T.; Bry, Lynn; Rachid, Rima; Chatila, Talal A.			Microbiota therapy acts via a regulatory T cell MyD88/ROR gamma t pathway to suppress food allergy	NATURE MEDICINE			English	Article							GUT MICROBIOTA; ORAL TOLERANCE; COMMENSAL; SENSITIZATION; INFLAMMATION; INDUCTION; IMMUNITY; DISEASE; COLONIZATION; METABOLITES	The role of dysbiosis in food allergy (FA) remains unclear. We found that dysbiotic fecal microbiota in FA infants evolved compositionally over time and failed to protect against FA in mice. Infants and mice with FA had decreased IgA and increased IgE binding to fecal bacteria, indicative of a broader breakdown of oral tolerance than hitherto appreciated. Therapy with Clostridiales species impacted by dysbiosis, either as a consortium or as monotherapy with Subdoligranulum variabile, suppressed FA in mice as did a separate immunomodulatory Bacteroidales consortium. Bacteriotherapy induced expression by regulatory T (Treg) cells of the transcription factor ROR-gamma t in a MyD88-dependent manner, which was deficient in FA infants and mice and ineffectively induced by their microbiota. Deletion of Myd88 or Rorc in Treg cells abrogated protection by bacteriotherapy. Thus, commensals activate a MyD88/ROR-gamma t pathway in nascent Treg cells to protect against FA, while dysbiosis impairs this regulatory response to promote disease.	[Abdel-Gadir, Azza; Stephen-Victor, Emmanuel; Wang, Sen; Harb, Hani; Wang, Leighanne; Crestani, Elena; Spielman, Sara; Secor, William; Biehl, Heather; Rachid, Rima; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Abdel-Gadir, Azza; Stephen-Victor, Emmanuel; Wang, Sen; Harb, Hani; Crestani, Elena; Rachid, Rima; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Gerber, Georg K.; Li, Ning; Dibendetto, Nicholas; Dong, Xiaoxi; Bry, Lynn] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Massachusetts Host Microbiome Ctr, Boston, MA 02115 USA; [Rivas, Magali Noval] Cedars Sinai Med Ctr, Dept Pediat, Infect & Immunol Dis Res Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Umetsu, Dale T.] Genentech Inc, San Francisco, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cedars Sinai Medical Center; Roche Holding; Genentech	Rachid, R; Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Rachid, R; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	Rima.Rachid@childrens.harvard.edu; Talal.chatila@childrens.harvard.edu	Harb, Hani/J-6517-2019; SEO, GOO-YOUNG/R-2267-2018; Stephen Victor, Emmanuel/HDN-0252-2022; Harb, Hani/HGB-7333-2022; Noval Rivas, Magali/R-4987-2016	Harb, Hani/0000-0001-8218-2538; SEO, GOO-YOUNG/0000-0001-5517-724X; Stephen Victor, Emmanuel/0000-0001-5049-7017; Harb, Hani/0000-0001-8218-2538; DiBenedetto, Nicholas/0000-0002-4043-9881; Noval Rivas, Magali/0000-0001-5570-8928; Abdel-Gadir, Azza/0000-0003-4210-9445; Spielman, Sara/0000-0003-2830-2361; Bry, Lynn/0000-0002-8792-8527	NIH NIAID [1R56AI117983, 1R01AI126915]; NIDDK [P30DK056338]; Clinical and Translational Science Center/Harvard Catalyst; Bunning Food Allergy Fund; Jasmine and Paul Mashikian Fund; Massachusetts Life Sciences Center; Partners Healthcare Innovations Development grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical and Translational Science Center/Harvard Catalyst; Bunning Food Allergy Fund; Jasmine and Paul Mashikian Fund; Massachusetts Life Sciences Center; Partners Healthcare Innovations Development grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Oettgen for the provision of Igh7<SUP>-/-</SUP> Il4ra<SUP>F709</SUP> mice, L.-M. Charbonnier for critical review of the manuscript and M. Delaney for support with microbiology. This work was supported by NIH NIAID grants Nos. 1R56AI117983 and 1R01AI126915 (to T.A.C.), NIDDK grant No. P30DK056338 (to L.B.), the Clinical and Translational Science Center/Harvard Catalyst, the Bunning Food Allergy Fund, the Jasmine and Paul Mashikian Fund, the Massachusetts Life Sciences Center and a Partners Healthcare Innovations Development grant.	Abdel-Gadir A, 2018, CLIN EXP ALLERGY, V48, P825, DOI 10.1111/cea.13161; Abdel-Gadir Azza, 2018, F1000Res, V7, P38, DOI 10.12688/f1000research.12650.1; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bjorksten B, 2009, CURR OPIN ALLERGY CL, V9, P185, DOI 10.1097/ACI.0b013e32832abfc2; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Britton GJ, 2019, IMMUNITY, V50, P212, DOI 10.1016/j.immuni.2018.12.015; Bucci V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0980-6; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; EXCOFFIER L, 1992, GENETICS, V131, P479; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gerber GK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002624; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Kalia VC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-18; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Koplin J, 2008, PEDIAT ALLERG IMM-UK, V19, P682, DOI 10.1111/j.1399-3038.2008.00731.x; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; Mangalam A, 2017, CELL REP, V20, P1269, DOI 10.1016/j.celrep.2017.07.031; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; Mathias CB, 2011, J ALLERGY CLIN IMMUN, V127, P795, DOI 10.1016/j.jaci.2010.11.009; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Narushima S, 2014, GUT MICROBES, V5, P333, DOI 10.4161/gmic.28572; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Pinciroli R, 2016, RESP CARE, V61, P1431, DOI 10.4187/respcare.04363; Rachid R, 2016, CURR OPIN PEDIATR, V28, P748, DOI 10.1097/MOP.0000000000000427; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Rios-Covian D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00376; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P801, DOI 10.1016/j.jaci.2016.02.030; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Russler-Germain EV, 2017, MUCOSAL IMMUNOL, V10, P1375, DOI 10.1038/mi.2017.65; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Sudo N, 1997, J IMMUNOL, V159, P1739; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wesemann DR, 2016, IMMUNITY, V44, P728, DOI 10.1016/j.immuni.2016.02.002; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822	69	145	149	12	69	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1164	+		10.1038/s41591-019-0461-z	http://dx.doi.org/10.1038/s41591-019-0461-z			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31235962	Green Accepted			2022-12-27	WOS:000474430400031
J	Wang, ZX; Yip, LY; Lee, JHJ; Wu, ZW; Chew, HY; Chong, PKW; Teo, CC; Ang, HYK; Peh, KLE; Yuan, J; Ma, SM; Choo, LSK; Basri, N; Jiang, X; Yu, Q; Hillmer, AM; Lim, WT; Lim, TKH; Takano, A; Tan, EH; Tan, DSW; Ho, YS; Lim, B; Tam, WL				Wang, Zhenxun; Yip, Lian Yee; Lee, Jia Hui Jane; Wu, Zhengwei; Chew, Hui Yi; Chong, Pooi Kiat William; Teo, Chin Chye; Ang, Heather Yin-Kuan; Peh, Kai Lay Esther; Yuan, Ju; Ma, Siming; Choo, Li Shi Kimberly; Basri, Nurhidayah; Jiang, Xia; Yu, Qiang; Hillmer, Axel M.; Lim, Wan Teck; Lim, Tony Kiat Hon; Takano, Angela; Tan, Eng Huat; Tan, Daniel Shao Weng; Ho, Ying Swan; Lim, Bing; Tam, Wai Leong			Methionine is a metabolic dependency of tumor-initiating cells	NATURE MEDICINE			English	Article							AMINO ACID REQUIREMENTS; CANCER STEM-CELLS; S-ADENOSYLMETHIONINE; PANCREATIC-CANCER; EXPRESSION; GENE; HISTONE; METHYLATION; SURVIVAL; GLYCINE	Understanding cellular metabolism holds immense potential for developing new classes of therapeutics that target metabolic pathways in cancer. Metabolic pathways are altered in bulk neoplastic cells in comparison to normal tissues. However, carcinoma cells within tumors are heterogeneous, and tumor-initiating cells (TICs) are important therapeutic targets that have remained metabolically uncharacterized. To understand their metabolic alterations, we performed metabolomics and metabolite tracing analyses, which revealed that TICs have highly elevated methionine cycle activity and transmethylation rates that are driven by MAT2A. High methionine cycle activity causes methionine consumption to far outstrip its regeneration, leading to addiction to exogenous methionine. Pharmacological inhibition of the methionine cycle, even transiently, is sufficient to cripple the tumor-initiating capability of these cells. Methionine cycle flux specifically influences the epigenetic state of cancer cells and drives tumor initiation. Methionine cycle enzymes are also enriched in other tumor types, and MAT2A expression impinges upon the sensitivity of certain cancer cells to therapeutic inhibition.	[Wang, Zhenxun; Lee, Jia Hui Jane; Wu, Zhengwei; Chew, Hui Yi; Ang, Heather Yin-Kuan; Yuan, Ju; Ma, Siming; Choo, Li Shi Kimberly; Jiang, Xia; Yu, Qiang; Hillmer, Axel M.; Tan, Daniel Shao Weng; Tam, Wai Leong] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Yip, Lian Yee; Chong, Pooi Kiat William; Teo, Chin Chye; Peh, Kai Lay Esther; Basri, Nurhidayah; Ho, Ying Swan] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Lee, Jia Hui Jane; Tam, Wai Leong] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Wu, Zhengwei; Tam, Wai Leong] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Lim, Wan Teck; Tan, Eng Huat; Tan, Daniel Shao Weng] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Lim, Wan Teck] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Lim, Wan Teck] Duke NUS Med Sch, Singapore, Singapore; [Lim, Tony Kiat Hon; Takano, Angela] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore; [Lim, Bing] Merck Sharp & Dohme Translat Med Res Ctr, Singapore, Singapore; [Tam, Wai Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Singapore General Hospital; National University of Singapore	Tam, WL (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.; Tam, WL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.; Tam, WL (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore.; Lim, B (corresponding author), Merck Sharp & Dohme Translat Med Res Ctr, Singapore, Singapore.; Tam, WL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.	bing.lim@merck.com; tamwl@gis.a-star.edu.sg	Lim, Darren Wan Teck/L-2007-2016; Lim, Darren Wan-Teck/V-8435-2019; Tam, Wai Leong/P-1497-2019	Lim, Darren Wan Teck/0000-0002-4655-0206; Lim, Darren Wan-Teck/0000-0002-4655-0206; Tam, Wai Leong/0000-0003-2365-5264; Yu, Qiang/0000-0003-2132-8278; Chew, Hui Yi/0000-0001-7186-9895; Ho, Ying Swan/0000-0002-9292-3106; Wang, Zhenxun/0000-0002-7862-4636; Ma, Siming/0000-0002-1810-8357; Wu, Zhengwei/0000-0001-9229-6176	National Research Foundation, Singapore [NRF-NRFF2015-04]; National Medical Research Council, Singapore [LCG17MAY004, NMRC/OFIRG/0064/2017, NMRC/TCR/007-NCC/2013, OFYIRG16nov013]; Agency for Science, Research and Technology, Singapore [1331AEG071, 334I00053, SPF 2012/001]; Singapore Ministry of Education under its Research Centers of Excellence initiative	National Research Foundation, Singapore(National Research Foundation, Singapore); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agency for Science, Research and Technology, Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education under its Research Centers of Excellence initiative(Ministry of Education, Singapore)	We thank SingHealth Advanced Molecular Pathology Laboratory for their assistance in generating tumor microarray data, M.Y. Lee, K.H.E. Lim, X.H. Yeo, G.S. Tan, M. Nichane, L. Chen, W.A. Zaw, S.L. Khaw, M.S. Noghabi and R. Ettikan for technical assistance, and S.-C. Ng for critical comments. This research is supported by the National Research Foundation, Singapore (NRF-NRFF2015-04), the National Medical Research Council, Singapore (LCG17MAY004; NMRC/OFIRG/0064/2017; NMRC/TCR/007-NCC/2013; OFYIRG16nov013), the Agency for Science, Research and Technology, Singapore (1331AEG071; 334I00053; SPF 2012/001), and the Singapore Ministry of Education under its Research Centers of Excellence initiative. Z. Wang dedicates this manuscript to the memory of Joseph P. Calarco, a wonderful friend and scientist.	Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen X, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0035-6; Cooper S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13661; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; Davis MA, 2019, P NATL ACAD SCI USA, V116, P5061, DOI 10.1073/pnas.1818598116; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DELAHABA G, 1959, J BIOL CHEM, V234, P603; EAGLE H, 1955, J EXP MED, V102, P37, DOI 10.1084/jem.102.1.37; EAGLE H, 1957, ARCH BIOCHEM BIOPHYS, V67, P432, DOI 10.1016/0003-9861(57)90298-9; Fang D, 2017, CELL CYCLE, V16, P1781, DOI 10.1080/15384101.2017.1281483; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fofou-Caillierez MB, 2013, HUM MOL GENET, V22, P4591, DOI 10.1093/hmg/ddt308; Freeman TJ, 2019, CANCERS, V11, DOI 10.3390/cancers11010102; Garcia-Lopez S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206534; Gerhart SV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28002-y; GUO HY, 1993, CANCER RES, V53, P2479; GUO HY, 1993, CANCER RES, V53, P5676; HALPERN BC, 1974, P NATL ACAD SCI USA, V71, P1133, DOI 10.1073/pnas.71.4.1133; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; HOFFMAN RM, 1976, P NATL ACAD SCI USA, V73, P1523, DOI 10.1073/pnas.73.5.1523; Ikeda S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04003-1; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122983; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kera Y, 2013, J BIOL CHEM, V288, P13592, DOI 10.1074/jbc.M112.429738; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Lee YA, 2018, ANGEW CHEM INT EDIT, V57, P2851, DOI 10.1002/anie.201712920; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Li YY, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1390-8; Limm K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160348; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Martinez-Chantar ML, 2003, J BIOL CHEM, V278, P19885, DOI 10.1074/jbc.M211554200; Mayers JR, 2016, SCIENCE, V353, P1161, DOI 10.1126/science.aaf5171; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Papal S, 2019, J NEUROSCI RES, V97, P16, DOI 10.1002/jnr.24329; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Quinlan CL, 2017, NAT CHEM BIOL, V13, P785, DOI 10.1038/nchembio.2384; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; STERN PH, 1984, J CELL PHYSIOL, V119, P29, DOI 10.1002/jcp.1041190106; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tan WL, 2016, LANCET ONCOL, V17, pE347, DOI 10.1016/S1470-2045(16)30123-1; Tsuyama T, 2016, METHODS MOL BIOL, V1341, P173, DOI 10.1007/7651_2015_272; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang LJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006522; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yano S, 2014, ONCOTARGET, V5, P8729, DOI 10.18632/oncotarget.2369; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang W, 2013, ACS CHEM BIOL, V8, P796, DOI 10.1021/cb3005353; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhang X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14799; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zhu B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02687-7; Zizza P, 2019, NUCLEIC ACIDS RES, V47, P3365, DOI 10.1093/nar/gkz041; 2012, NATURE, V491, P458, DOI DOI 10.1038/NATURE11540; 2017, CELL, V169, P824, DOI DOI 10.1016/J.CELL.2017.05.003	88	155	161	5	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					825	+		10.1038/s41591-019-0423-5	http://dx.doi.org/10.1038/s41591-019-0423-5			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31061538				2022-12-27	WOS:000468247800026
J	Stower, H				Stower, Hannah			Modeling kidney disease with organoids	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					541	541		10.1038/s41591-019-0428-0	http://dx.doi.org/10.1038/s41591-019-0428-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30948848	Bronze			2022-12-27	WOS:000463342800008
J	Liang, HY; Tsui, BY; Ni, H; Valentim, CCS; Baxter, SL; Liu, G; Cai, WJ; Kermany, DS; Sun, X; Chen, JC; He, LY; Zhu, J; Tian, P; Shao, H; Zheng, LH; Hou, R; Hewett, S; Li, G; Liang, P; Zang, X; Zhang, ZQ; Pan, LY; Cai, HM; Ling, RJ; Li, SH; Cui, YW; Tang, SS; Ye, H; Huang, XY; He, W; Liang, WQ; Zhang, Q; Jiang, J; Yu, W; Gao, JQ; Ou, WX; Deng, YM; Hou, QZ; Wang, B; Yao, CC; Liang, Y; Zhang, S; Duan, Y; Zhang, RZ; Gibson, S; Zhang, CL; Li, OL; Zhang, ED; Karin, G; Nguyen, N; Wu, XK; Wen, C; Xu, J; Xu, W; Wang, BC; Wang, W; Li, J; Pizzato, B; Bao, C; Xiang, DM; He, WT; He, SQ; Zhou, YG; Haw, W; Goldbaum, M; Tremoulet, A; Hsu, CN; Carter, H; Zhu, L; Zhang, K; Xia, HM				Liang, Huiying; Tsui, Brian Y.; Ni, Hao; Valentim, Carolina C. S.; Baxter, Sally L.; Liu, Guangjian; Cai, Wenjia; Kermany, Daniel S.; Sun, Xin; Chen, Jiancong; He, Liya; Zhu, Jie; Tian, Pin; Shao, Hua; Zheng, Lianghong; Hou, Rui; Hewett, Sierra; Li, Gen; Liang, Ping; Zang, Xuan; Zhang, Zhiqi; Pan, Liyan; Cai, Huimin; Ling, Rujuan; Li, Shuhua; Cui, Yongwang; Tang, Shusheng; Ye, Hong; Huang, Xiaoyan; He, Waner; Liang, Wenqing; Zhang, Qing; Jiang, Jianmin; Yu, Wei; Gao, Jianqun; Ou, Wanxing; Deng, Yingmin; Hou, Qiaozhen; Wang, Bei; Yao, Cuichan; Liang, Yan; Zhang, Shu; Duan, Yaou; Zhang, Runze; Gibson, Sarah; Zhang, Charlotte L.; Li, Oulan; Zhang, Edward D.; Karin, Gabriel; Nguyen, Nathan; Wu, Xiaokang; Wen, Cindy; Xu, Jie; Xu, Wenqin; Wang, Bochu; Wang, Winston; Li, Jing; Pizzato, Bianca; Bao, Caroline; Xiang, Daoman; He, Wanting; He, Suiqin; Zhou, Yugui; Haw, Weldon; Goldbaum, Michael; Tremoulet, Adriana; Hsu, Chun-Nan; Carter, Hannah; Zhu, Long; Zhang, Kang; Xia, Huimin			Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence	NATURE MEDICINE			English	Article							CLASSIFICATION	Artificial intelligence (AI)-based methods have emerged as powerful tools to transform medical care. Although machine learning classifiers (MLCs) have already demonstrated strong performance in image-based diagnoses, analysis of diverse and massive electronic health record (EHR) data remains challenging. Here, we show that MLCs can query EHRs in a manner similar to the hypothetico-deductive reasoning used by physicians and unearth associations that previous statistical methods have not found. Our model applies an automated natural language processing system using deep learning techniques to extract clinically relevant information from EHRs. In total, 101.6 million data points from 1,362,559 pediatric patient visits presenting to a major referral center were analyzed to train and validate the framework. Our model demonstrates high diagnostic accuracy across multiple organ systems and is comparable to experienced pediatricians in diagnosing common childhood diseases. Our study provides a proof of concept for implementing an AI-based system as a means to aid physicians in tackling large amounts of data, augmenting diagnostic evaluations, and to provide clinical decision support in cases of diagnostic uncertainty or complexity. Although this impact may be most evident in areas where healthcare providers are in relative shortage, the benefits of such an AI system are likely to be universal.	[Liang, Huiying; Liu, Guangjian; Kermany, Daniel S.; Sun, Xin; He, Liya; Zhu, Jie; Hewett, Sierra; Li, Gen; Pan, Liyan; Ling, Rujuan; Li, Shuhua; Cui, Yongwang; Tang, Shusheng; Ye, Hong; Huang, Xiaoyan; He, Waner; Liang, Wenqing; Zhang, Qing; Jiang, Jianmin; Yu, Wei; Gao, Jianqun; Ou, Wanxing; Deng, Yingmin; Hou, Qiaozhen; Wang, Bei; Yao, Cuichan; Liang, Yan; Zhang, Shu; Wu, Xiaokang; Li, Jing; Xiang, Daoman; He, Wanting; Zhou, Yugui; Zhang, Kang; Xia, Huimin] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Tsui, Brian Y.; Baxter, Sally L.; Cai, Wenjia; Kermany, Daniel S.; Chen, Jiancong; Tian, Pin; Shao, Hua; Hewett, Sierra; Li, Gen; Duan, Yaou; Zhang, Runze; Gibson, Sarah; Zhang, Charlotte L.; Li, Oulan; Zhang, Edward D.; Karin, Gabriel; Nguyen, Nathan; Wu, Xiaokang; Wen, Cindy; Xu, Jie; Xu, Wenqin; Wang, Bochu; Wang, Winston; Li, Jing; Pizzato, Bianca; Bao, Caroline; He, Wanting; He, Suiqin; Zhou, Yugui; Haw, Weldon; Goldbaum, Michael; Tremoulet, Adriana; Hsu, Chun-Nan; Carter, Hannah; Zhang, Kang] Univ Calif San Diego, Inst Engn Med, Inst Genom Med, La Jolla, CA 92093 USA; [Tsui, Brian Y.; Baxter, Sally L.; Cai, Wenjia; Kermany, Daniel S.; Chen, Jiancong; Tian, Pin; Shao, Hua; Hewett, Sierra; Li, Gen; Duan, Yaou; Zhang, Runze; Gibson, Sarah; Zhang, Charlotte L.; Li, Oulan; Zhang, Edward D.; Karin, Gabriel; Nguyen, Nathan; Wu, Xiaokang; Wen, Cindy; Xu, Jie; Xu, Wenqin; Wang, Bochu; Wang, Winston; Li, Jing; Pizzato, Bianca; Bao, Caroline; He, Wanting; He, Suiqin; Zhou, Yugui; Haw, Weldon; Goldbaum, Michael; Tremoulet, Adriana; Hsu, Chun-Nan; Carter, Hannah; Zhang, Kang] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Ni, Hao; Liang, Ping; Zang, Xuan; Zhang, Zhiqi; Zhu, Long] Hangzhou YITU Healthcare Technol Co Ltd, Hangzhou, Zhejiang, Peoples R China; [Valentim, Carolina C. S.] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg Oncol, China State Key Lab, Guangzhou, Guangdong, Peoples R China; [Valentim, Carolina C. S.] Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zheng, Lianghong; Hou, Rui; Cai, Huimin] Guangzhou Kangrui Co Ltd, Guangzhou, Guangdong, Peoples R China; [Zheng, Lianghong; Hou, Rui; Cai, Huimin] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Guangdong, Peoples R China; [Haw, Weldon; Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92161 USA	Guangzhou Medical University; University of California System; University of California San Diego; University of California System; University of California San Diego; Guangzhou Medical University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Zhang, K; Xia, HM (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China.; Zhang, K (corresponding author), Univ Calif San Diego, Inst Engn Med, Inst Genom Med, La Jolla, CA 92093 USA.; Zhang, K (corresponding author), Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA.; Zhang, K (corresponding author), Vet Adm Healthcare Syst, San Diego, CA 92161 USA.	kang.zhang@gmail.com; xiahumin@hotmail.com	Zhang, Kang/Y-2740-2019; Zhu, Jie/AAD-1330-2022; Goldbaum, Michael/AAG-4258-2020; Wang, Bo/AAU-1329-2021; xu, jie/GQR-1913-2022; Xu, Jie/AIE-0524-2022; Cai, Wenjia/AAE-4402-2020	Zhang, Kang/0000-0002-4549-1697; Zhu, Jie/0000-0001-6862-9022; Goldbaum, Michael/0000-0002-7721-2736; Wang, Bo/0000-0001-8947-8526; xu, jie/0000-0002-2039-7055; Cai, Wenjia/0000-0003-2398-1449; Hewett, Sierra/0000-0002-9997-0730; Carvalho Soares Valentim, Carolina/0000-0003-4203-6856; Gibson, Sarah/0000-0002-7337-800X; Baxter, Sally/0000-0002-5271-7690; Wu, Xiaokang/0000-0003-1020-6232; Wang, Winston/0000-0003-4442-174X; Pizzato, Bianca/0000-0002-2711-867X	National Key Research and Development Program of China [2017YFC1104600]; National Natural Science Foundation of China [81771629, 81700882]; Guangzhou Women and Children's Medical Center; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (Innovation and Startup Talents Program) [2018GZR031001]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Women and Children's Medical Center; Guangzhou Regenerative Medicine and Health Guangdong Laboratory (Innovation and Startup Talents Program)	This study was funded by the National Key Research and Development Program of China (2017YFC1104600 to H.L.), National Natural Science Foundation of China (81771629 to H.X. and 81700882 to J.X.), Guangzhou Women and Children's Medical Center, Guangzhou Regenerative Medicine and Health Guangdong Laboratory (Innovation and Startup Talents Program 2018GZR031001 to L.Z. and R.H.).	[Anonymous], 2015, ENGLISH CHINESE MED; Banko M, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P26, DOI 10.3115/1073012.1073017; Erickson BJ, 2017, RADIOGRAPHICS, V37, P505, DOI 10.1148/rg.2017160130; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Hornberger J, 2009, JAMA-J AM MED ASSOC, V301, P110, DOI [10.1001/jama.2008.910, DOI 10.1001/JAMA.2008.910]; Hu J., 2016, HEALTHCARE INFORM MA; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Liang Y., 2013, CHIN MED J, V1, P414; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lipton ZC., 2015, PREPRINT, V1506, P00019; Manning C. D., 2015, PREPRINT; Nezhad M. Z., 2017, 2017 16 IEEE INT C M; Peng XB, 2018, IEEE INT CONF ROBOT, P3803, DOI 10.1109/ICCABS.2018.8541936; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Tsui B. Y., 2018, PREPRINT; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Tweedie FJ, 1996, COMPUT HUMANITIES, V30, P1, DOI 10.1007/BF00054024; Wang F, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P145, DOI 10.1145/2623330.2623755; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; World Health Organization, 2004, INT STAT CLASS DIS R; Yeung K. Y., 2011, DETAILS ADJUSTED RAN	24	219	242	25	292	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					433	+		10.1038/s41591-018-0335-9	http://dx.doi.org/10.1038/s41591-018-0335-9			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30742121				2022-12-27	WOS:000460643100021
J	Stower, H				Stower, Hannah			Transmission of A beta seeds	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					197	197		10.1038/s41591-019-0364-z	http://dx.doi.org/10.1038/s41591-019-0364-z			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728534	Bronze			2022-12-27	WOS:000457842100007
J	Chen, X; Gan, L				Chen, Xu; Gan, Li			An exercise-induced messenger boosts memory in Alzheimer's disease	NATURE MEDICINE			English	Editorial Material							IRISIN	An exercise-linked hormone, FNDC5/irisin, mediates the benefit of exercise in Alzheimer's disease models by enhancing synaptic plasticity and memory.	[Chen, Xu; Gan, Li] Univ Calif San Francisco, Dept Neurol, Gladstone Inst, San Francisco, CA 94143 USA; [Gan, Li] Weill Cornell Med, Brain & Mind Res Inst, Helen & Robert Appel Alzheimers Dis Res Inst, New York, NY 10065 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Cornell University	Gan, L (corresponding author), Univ Calif San Francisco, Dept Neurol, Gladstone Inst, San Francisco, CA 94143 USA.; Gan, L (corresponding author), Weill Cornell Med, Brain & Mind Res Inst, Helen & Robert Appel Alzheimers Dis Res Inst, New York, NY 10065 USA.	lig2033@med.cornell.edu		Gan, Li/0000-0003-4600-275X; Chen, Xu/0000-0001-8926-3090				Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4; Maliszewska-Cyna E, 2017, CURR ALZHEIMER RES, V14, P47, DOI 10.2174/1567205013666160819125400; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Polyzos SA, 2018, ENDOCRINE, V59, P260, DOI 10.1007/s12020-017-1476-1; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Zhang Jing, 2016, BioMolecular Concepts, V7, P253, DOI 10.1515/bmc-2016-0012	12	8	9	4	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					20	21		10.1038/s41591-018-0311-4	http://dx.doi.org/10.1038/s41591-018-0311-4			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617321				2022-12-27	WOS:000455027700014
J	Ravizza, S; Huschto, T; Adamov, A; Bohm, L; Busser, A; Flother, FF; Hinzmann, R; Konig, H; McAhren, SM; Robertson, DH; Schleyer, T; Schneidinger, B; Petrich, W				Ravizza, Stefan; Huschto, Tony; Adamov, Anja; Boehm, Lars; Buesser, Alexander; Floether, Frederik F.; Hinzmann, Rolf; Konig, Helena; McAhren, Scott M.; Robertson, Daniel H.; Schleyer, Titus; Schneidinger, Bernd; Petrich, Wolfgang			Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data	NATURE MEDICINE			English	Article							BIG DATA; HEALTH; PROGRESSION; OUTCOMES; CARE	Diagnostic procedures, therapeutic recommendations, and medical risk stratifications are based on dedicated, strictly controlled clinical trials. However, a plethora of real-world medical data exists, whereupon the increase in data volume comes at the expense of completeness, uniformity, and control. Here, a case-by-case comparison shows that the predictive power of our real world data-based model for diabetes-related chronic kidney disease outperforms published algorithms, which were derived from clinical study data.	[Ravizza, Stefan; Adamov, Anja; Boehm, Lars; Buesser, Alexander; Floether, Frederik F.] IBM Switzerland Ltd, Zurich, Switzerland; [Huschto, Tony; Hinzmann, Rolf; Konig, Helena; Schneidinger, Bernd; Petrich, Wolfgang] Roche Diabet Care GmbH, Mannheim, Germany; [McAhren, Scott M.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Robertson, Daniel H.] Indiana Biosci Res Inst, Indianapolis, IN USA; [Schleyer, Titus] Regenstrief Inst Inc, Indianapolis, IN USA	Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Petrich, W (corresponding author), Roche Diabet Care GmbH, Mannheim, Germany.	wolfgang.petrich@roche.com	Robertson, Daniel H/W-1996-2018	Robertson, Daniel H/0000-0002-8774-0890; Adamov, Anja/0000-0002-7506-1583; Schleyer, Titus/0000-0003-1829-971X	Roche Diabetes Care GmbH	Roche Diabetes Care GmbH	The authors thank O. Quarder, C. Ringemann, P. Stephan (Roche Diabetes Care GmbH, Germany), and H. Mikulski (Roche Diabetes Care Spain, S.L.) for their continuing contributions to this work. We are grateful to T. Beck, S. Chittajallu, and S. Weinert (Roche Diabetes Care, Inc., USA) for their consultancy in the early phase of the investigation. The support from U. Gunzel as well as H. Rincker and team (Roche Diabetes Care Deutschland, Germany) is highly appreciated. We are indebted to R. Daikeler, K. Kusterer, S. Waibel, and S. Zink (Germany) for their medical advice concerning our initial results. The research described in this manuscript was funded by Roche Diabetes Care GmbH and supplemented with in-kind contributions from Eli Lilly and Company (S.M.), Indiana Biosciences Research Institute (D.R.), and Regenstrief Institute, Inc. (T.S.).	[Anonymous], 2013, DIABETES MANAGEMENT; Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Bender E, 2015, NATURE, V527, pS19, DOI 10.1038/527S19a; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Dunkler D, 2015, CLIN J AM SOC NEPHRO, V10, P1371, DOI 10.2215/CJN.10321014; Fioretto P, 2010, NAT REV ENDOCRINOL, V6, P19, DOI 10.1038/nrendo.2009.213; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Glassock RJ, 2017, NAT REV NEPHROL, V13, P104, DOI [10.1038/nmeph.2016.163, 10.1038/nrneph.2016.163]; Hastie T., 2009, UNSUPERVISED LEARNIN; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jardine MJ, 2012, AM J KIDNEY DIS, V60, P770, DOI 10.1053/j.ajkd.2012.04.025; Kaelber DC, 2012, J AM MED INFORM ASSN, V19, P965, DOI 10.1136/amiajnl-2011-000782; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; McDonald CJ, 2005, HEALTH AFFAIR, V24, P1214, DOI 10.1377/hlthaff.24.5.1214; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Platinga L. C, 2010, ADV CHRON KIDN DIS, V17, P225; Razavian N, 2015, BIG DATA, V3, P277, DOI 10.1089/big.2015.0020; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Trojano M, 2017, NAT REV NEUROL, V13, P105, DOI 10.1038/nrneurol.2016.188; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Vergouwe Y, 2010, DIABETOLOGIA, V53, P254, DOI 10.1007/s00125-009-1585-3; Voosen P, 2017, SCIENCE, V357, P22, DOI 10.1126/science.357.6346.22; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Wu XD, 2014, IEEE T KNOWL DATA EN, V26, P97, DOI 10.1109/TKDE.2013.109	33	75	81	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					57	+		10.1038/s41591-018-0239-8	http://dx.doi.org/10.1038/s41591-018-0239-8			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617317				2022-12-27	WOS:000455027700020
J	Amaria, RN; Reddy, SM; Tawbi, HA; Davies, MA; Ross, MI; Glitza, IC; Cormier, JN; Lewis, C; Hwu, WJ; Hanna, E; Diab, A; Wong, MK; Royal, R; Gross, N; Weber, R; Lai, SY; Ehlers, R; Blando, J; Milton, DR; Woodman, S; Kageyama, R; Wells, DK; Hwu, P; Patel, SP; Lucci, A; Hessel, A; Lee, JE; Gershenwald, J; Simpson, L; Burton, EM; Posada, L; Haydu, L; Wang, LH; Zhang, SJ; Lazar, A; Hudgens, CW; Gopalakrishnan, V; Reuben, A; Andrews, MC; Spencer, CN; Prieto, V; Sharma, P; Allison, J; Tetzlaff, MT; Wargo, JA				Amaria, Rodabe N.; Reddy, Sangeetha M.; Tawbi, Hussein A.; Davies, Michael A.; Ross, Merrick, I; Glitza, Isabella C.; Cormier, Janice N.; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong, Michael K.; Royal, Richard; Gross, Neil; Weber, Randal; Lai, Stephen Y.; Ehlers, Richard; Blando, Jorge; Milton, Denai R.; Woodman, Scott; Kageyama, Robin; Wells, Daniel K.; Hwu, Patrick; Patel, Sapna P.; Lucci, Anthony; Hessel, Amy; Lee, Jeffrey E.; Gershenwald, Jeffrey; Simpson, Lauren; Burton, Elizabeth M.; Posada, Liberty; Haydu, Lauren; Wang, Linghua; Zhang, Shaojun; Lazar, Alexanderj; Hudgens, Courtney W.; Gopalakrishnan, Vancheswaran; Reuben, Alexandre; Andrews, Miles C.; Spencer, Christine N.; Prieto, Victor; Sharma, Padmanee; Allison, James; Tetzlaff, Michael T.; Wargo, Jennifer A.			Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma	NATURE MEDICINE			English	Article							STAGE-III; ADJUVANT DABRAFENIB; COMBINED NIVOLUMAB; IPILIMUMAB; TRAMETINIB; SURVIVAL	Preclinical studies suggest that treatment with neoadjuvant immune checkpoint blockade is associated with enhanced survival and antigen-specific T cell responses compared with adjuvant treatment(1); however, optimal regimens have not been defined. Here we report results from a randomized phase 2 study of neoadjuvant nivolumab versus combined ipilimumab with nivolumab in 23 patients with high-risk resectable melanoma (NCT02519322). RECIST overall response rates (ORR), pathologic complete response rates (pCR), treatment-related adverse events (trAEs) and immune correlates of response were assessed. Treatment with combined ipilimumab and nivolumab yielded high response rates (RECIST ORR 73%, pCR 45%) but substantial toxicity (73% grade 3 trAEs), whereas treatment with nivolumab monotherapy yielded modest responses (ORR 25%, pCR 25%) and low toxicity (8% grade 3 trAEs). Immune correlates of response were identified, demonstrating higher lymphoid infiltrates in responders to both therapies and a more clonal and diverse T cell infiltrate in responders to nivolumab monotherapy. These results describe the feasibility of neoadjuvant immune checkpoint blockade in melanoma and emphasize the need for additional studies to optimize treatment regimens and to validate putative biomarkers.	[Amaria, Rodabe N.; Tawbi, Hussein A.; Davies, Michael A.; Glitza, Isabella C.; Hwu, Wen-Jen; Diab, Adi; Wong, Michael K.; Woodman, Scott; Hwu, Patrick; Patel, Sapna P.; Simpson, Lauren; Posada, Liberty] MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX USA; [Reddy, Sangeetha M.] MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX USA; [Ross, Merrick, I; Cormier, Janice N.; Royal, Richard; Ehlers, Richard; Lucci, Anthony; Lee, Jeffrey E.; Gershenwald, Jeffrey; Burton, Elizabeth M.; Haydu, Lauren; Gopalakrishnan, Vancheswaran; Reuben, Alexandre; Andrews, Miles C.; Wargo, Jennifer A.] MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Lewis, Carol; Hanna, Ehab; Gross, Neil; Weber, Randal; Lai, Stephen Y.; Hessel, Amy] MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX USA; [Blando, Jorge; Sharma, Padmanee; Allison, James] MD Anderson Canc Ctr, Dept Immunol, Houston, TX USA; [Milton, Denai R.] MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA; [Kageyama, Robin; Wells, Daniel K.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Wang, Linghua; Zhang, Shaojun; Spencer, Christine N.; Wargo, Jennifer A.] MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Lazar, Alexanderj; Hudgens, Courtney W.; Prieto, Victor; Tetzlaff, Michael T.] MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA; [Sharma, Padmanee] MD Anderson Canc Ctr, Dept Genitourinary Canc, Houston, TX USA; [Tetzlaff, Michael T.] MD Anderson Canc Ctr, Dept Translat & Mol Pathol, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wargo, JA (corresponding author), MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.; Wargo, JA (corresponding author), MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	jwargo@mdanderson.org	Hanna, Ehab Y/B-1593-2017; Davies, Michael/GWV-2527-2022; Burton, Elizabeth/AAB-9393-2021; Reddy, Sangeetha/GNZ-8658-2022; Gershenwald, Jeff/AAX-4367-2020; Gopalakrishnan, Vancheswaran/S-9550-2019; Wells, Daniel K./AAH-4015-2020	Hanna, Ehab Y/0000-0003-3241-2440; Burton, Elizabeth/0000-0002-3424-4922; Gershenwald, Jeff/0000-0003-4519-5369; Gopalakrishnan, Vancheswaran/0000-0002-8704-035X; Wang, Linghua/0000-0001-9380-0266; Reddy, Sangeetha/0000-0002-8401-1481; Andrews, Miles/0000-0003-1231-8641; Lucci, Anthony/0000-0003-4039-174X; Zhang, Shaojun/0000-0001-5760-5797; Lai, Stephen/0000-0001-8301-7286; Hudgens, Courtney/0000-0001-8312-7485; Lazar, Alexander/0000-0002-6395-4499	Bristol-Myers Squibb; US Department of Defense Grant [CA150619]; NATIONAL CANCER INSTITUTE [T32CA009666] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); US Department of Defense Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the patients and their families for participating in this clinical trial. The clinical aspects of this study were funded by Bristol-Myers Squibb. The correlative research was supported by the philanthropic contributions to The University of Texas MD Anderson Cancer Center Melanoma Moon Shot Program, The Parker Institute for Cancer Immunotherapy and US Department of Defense Grant CA150619.	Amaria RN, 2018, LANCET ONCOL, V19, P181, DOI 10.1016/S1470-2045(18)30015-9; [Anonymous], 2009, NAT CANC I COMM TERM; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Edge SB, 2010, AJCC CANC STAGING MA; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Eggermont AMM, 2017, NEW ENGL J MED, V376, P399, DOI 10.1056/NEJMc1615564; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Huang AC, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-CT181; Inoue H, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1204507; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Provenzano E, 2015, MODERN PATHOL, V28, P1185, DOI 10.1038/modpathol.2015.74; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	28	397	401	4	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1649	+		10.1038/s41591-018-0197-1	http://dx.doi.org/10.1038/s41591-018-0197-1			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30297909	Green Accepted			2022-12-27	WOS:000449404200014
J	Chongsathidkiet, P; Jackson, C; Koyama, S; Loebel, F; Cui, XY; Farber, SH; Woroniecka, K; Elsamadicy, AA; Dechant, CA; Kemeny, HR; Sanchez-Perez, L; Cheema, TA; Souders, NC; Herndon, JE; Coumans, JV; Everitt, JI; Nahed, BV; Sampson, JH; Gunn, MD; Martuza, RL; Dranoff, G; Curry, WT; Fecci, PE				Chongsathidkiet, Pakawat; Jackson, Christina; Koyama, Shohei; Loebel, Franziska; Cui, Xiuyu; Farber, S. Harrison; Woroniecka, Karolina; Elsamadicy, Aladine A.; Dechant, Cosette A.; Kemeny, Hanna R.; Sanchez-Perez, Luis; Cheema, Tooba A.; Souders, Nicholas C.; Herndon, James E.; Coumans, Jean-Valery; Everitt, Jeffrey, I; Nahed, Brian, V; Sampson, John H.; Gunn, Michael D.; Martuza, Robert L.; Dranoff, Glenn; Curry, William T.; Fecci, Peter E.			Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors	NATURE MEDICINE			English	Article							PRIMARY BRAIN-TUMORS; S1P(1) RECEPTOR AGONIST; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE RECEPTOR-1; MALIGNANT GLIOMA; LYMPHOID ORGANS; IMMUNE DEFECTS; IMMUNOBIOLOGY; S1PR1; NEUROINFLAMMATION	T cell dysfunction contributes to tumor immune escape in patients with cancer and is particularly severe amidst glioblastoma (GBM). Among other defects, T cell lymphopenia is characteristic, yet often attributed to treatment. We reveal that even treatment-naive subjects and mice with GBM can harbor AIDS-level CD4 counts, as well as contracted, T cell-deficient lymphoid organs. Missing naive T cells are instead found sequestered in large numbers in the bone marrow. This phenomenon characterizes not only GBM but a variety of other cancers, although only when tumors are introduced into the intracranial compartment. T cell sequestration is accompanied by tumor-imposed loss of S1P1 from the T cell surface and is reversible upon precluding S1P1 internalization. In murine models of GBM, hindering S1P1 internalization and reversing sequestration licenses T cell-activating therapies that were previously ineffective. Sequestration of T cells in bone marrow is therefore a tumor-adaptive mode of T cell dysfunction, whose reversal may constitute a promising immunotherapeutic adjunct.	[Chongsathidkiet, Pakawat; Cui, Xiuyu; Farber, S. Harrison; Woroniecka, Karolina; Elsamadicy, Aladine A.; Dechant, Cosette A.; Kemeny, Hanna R.; Sanchez-Perez, Luis; Sampson, John H.; Fecci, Peter E.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27708 USA; [Chongsathidkiet, Pakawat; Cui, Xiuyu; Farber, S. Harrison; Woroniecka, Karolina; Elsamadicy, Aladine A.; Dechant, Cosette A.; Kemeny, Hanna R.; Sanchez-Perez, Luis; Sampson, John H.; Fecci, Peter E.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA; [Chongsathidkiet, Pakawat; Woroniecka, Karolina; Everitt, Jeffrey, I; Sampson, John H.; Gunn, Michael D.; Fecci, Peter E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27708 USA; [Jackson, Christina] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Koyama, Shohei] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Suita, Osaka, Japan; [Loebel, Franziska] Charite Med Univ, Dept Neurosurg, Berlin, Germany; [Farber, S. Harrison] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA; [Cheema, Tooba A.] Unum Therapeut, Cambridge, MA USA; [Souders, Nicholas C.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Herndon, James E.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Coumans, Jean-Valery; Nahed, Brian, V; Martuza, Robert L.; Curry, William T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Coumans, Jean-Valery; Nahed, Brian, V; Martuza, Robert L.; Curry, William T.] Harvard Med Sch, Boston, MA USA; [Sampson, John H.] Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC USA; [Sampson, John H.; Gunn, Michael D.] Duke Univ, Dept Immunol, Med Ctr, Durham, NC USA; [Gunn, Michael D.] Duke Univ, Dept Med, Div Cardiol, Med Ctr, Durham, NC USA; [Dranoff, Glenn] Novartis Inst Biomed Res, Cambridge, MA USA	Duke University; Duke University; Duke University; Johns Hopkins University; Osaka University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Harvard University; Dana-Farber Cancer Institute; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; Duke University; Duke University; Novartis	Fecci, PE (corresponding author), Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27708 USA.; Fecci, PE (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA.; Fecci, PE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27708 USA.	peter.fecci@duke.edu	Chongsathidkiet, Pakawat/AAG-9681-2020; Koyama, Shohei/AAU-4113-2021; Woroniecka, Karolina/K-9044-2019; Nahed, Brian/E-4239-2014	Chongsathidkiet, Pakawat/0000-0001-5363-3061; Koyama, Shohei/0000-0002-6897-9417; Everitt, Jeffrey/0000-0003-0273-6284; Nahed, Brian/0000-0001-8537-106X; Woroniecka, Karolina/0000-0001-9217-0733; Champion, Cosette/0000-0001-5140-5196; Sampson, John/0000-0002-0104-7658; Farber, S. Harrison/0000-0002-0171-6516; Fecci, Peter/0000-0002-2912-8695	institutional start-up funds from Duke University Medical Center; Sontag Foundation Distinguished Scientist Award; National Institutes of Health [R01NS099096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099096, R01NS032677] Funding Source: NIH RePORTER	institutional start-up funds from Duke University Medical Center; Sontag Foundation Distinguished Scientist Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank G.E. Archer, K.A. Batich, T.A. Chewning, K.L. Congdon, K.A. Keith, R.J. Lefkowitz, P.K. Norberg, E.A. Reap, L.A.M. Rein, K.E. Rhodin, A. Seas, S.H. Shen, R.J. Schmittling, D.J. Snyder, C.M. Suryadevara, A.M. Swartz, W.H. Tomaszewski, D.S. Wilkinson, W Xie, H. Yang, and members of the Duke Brain Tumor Immunotherapy Program for their insights throughout the study. We would like to thank M. Foster and J.W. Thompson from the Proteomics and Metabolomics Shared Resource, Duke Center for Genomic and Computational Biology for help with liquid chromatography-tandem mass spectrometry analyses. We would like to thank M.R. Llewellyn for the preparation of medical illustrations. This work was supported by institutional start-up funds from Duke University Medical Center, The Sontag Foundation Distinguished Scientist Award, and the National Institutes of Health R01NS099096 to P.E.F.	Abuhusain HJ, 2013, J BIOL CHEM, V288, P37355, DOI 10.1074/jbc.M113.494740; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Blaho VA, 2015, NATURE, V523, P342, DOI 10.1038/nature14462; BROOKS WH, 1977, CLIN EXP IMMUNOL, V29, P61; BROOKS WH, 1981, J NEUROSURG, V54, P331, DOI 10.3171/jns.1981.54.3.0331; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Deng HF, 2013, ACS MED CHEM LETT, V4, P942, DOI 10.1021/ml400194r; Dix AR, 1999, J NEUROIMMUNOL, V100, P216, DOI 10.1016/S0165-5728(99)00203-9; Drouillard A, 2018, J IMMUNOL, V200, P551, DOI 10.4049/jimmunol.1701278; Dunn GP, 2012, NEUROSURGERY, V71, P201, DOI 10.1227/NEU.0b013e31824f840d; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Fecci PE, 2014, CLIN CANCER RES, V20, P5620, DOI 10.1158/1078-0432.CCR-14-0832; Frej C, 2015, ANAL BIOANAL CHEM, V407, P8533, DOI 10.1007/s00216-015-9008-4; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Garris CS, 2013, NAT IMMUNOL, V14, P1166, DOI 10.1038/ni.2730; Grossman SA, 2011, CLIN CANCER RES, V17, P5473, DOI 10.1158/1078-0432.CCR-11-0774; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Hughes MA, 2005, INT J RADIAT ONCOL, V62, P1423, DOI 10.1016/j.ijrobp.2004.12.085; Jackson CM, 2016, CLIN CANCER RES, V22, P1161, DOI 10.1158/1078-0432.CCR-15-1516; Jin J, 2014, BIOCHEM PHARMACOL, V90, P50, DOI 10.1016/j.bcp.2014.04.010; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maeda Y, 2010, INT IMMUNOL, V22, P515, DOI 10.1093/intimm/dxq036; MAHALEY MS, 1977, J NEUROSURG, V46, P467, DOI 10.3171/jns.1977.46.4.0467; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Morford LA, 1999, J NEUROSURG, V91, P935, DOI 10.3171/jns.1999.91.6.0935; Omuro A, 2018, NEURO-ONCOLOGY, V20, P674, DOI 10.1093/neuonc/nox208; Ostrom Q.T., 2014, NEURO-ONCOLOGY, V16, DOI DOI 10.1093/NEU0NC/N0U223; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Reeves PM, 2016, TRAFFIC, V17, P40, DOI 10.1111/tra.12343; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Wakim LM, 2012, J IMMUNOL, V189, P3462, DOI 10.4049/jimmunol.1201305; Woroniecka K. I., 2018, CLIN CANCER RES, V24, P1; Yamamoto R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110819; Zajac AJ, 2014, CELL MOL IMMUNOL, V11, P221, DOI 10.1038/cmi.2014.7	45	266	270	6	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1459	+		10.1038/s41591-018-0135-2	http://dx.doi.org/10.1038/s41591-018-0135-2			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30104766	Green Accepted			2022-12-27	WOS:000444174100031
J	Stower, H				Stower, Hannah			Restoring sight with native cell reprogramming	NATURE MEDICINE			English	Editorial Material																			0	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1303	1303		10.1038/s41591-018-0192-6	http://dx.doi.org/10.1038/s41591-018-0192-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194409				2022-12-27	WOS:000444174100024
J	Hiebert, P; Werner, S				Hiebert, Paul; Werner, Sabine			Targeting metabolism to treat psoriasis	NATURE MEDICINE			English	Editorial Material							GLUCOSE; PROLIFERATION		[Hiebert, Paul; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Werner, S (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland.	sabine.werner@biol.ethz.ch	Hiebert, Paul/AAY-2278-2021	Hiebert, Paul/0000-0001-8179-4217; Werner, Sabine/0000-0001-7397-8710				Andrisse S, 2014, REDOX BIOL, V2, P764, DOI 10.1016/j.redox.2014.03.004; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Tao J, 2008, J DERMATOL SCI, V51, P203, DOI 10.1016/j.jdermsci.2008.04.012; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tochio T, 2013, INT J DERMATOL, V52, P300, DOI 10.1111/j.1365-4632.2011.05299.x; Wang J, 2017, ONCOTARGET, V8, P16875, DOI 10.18632/oncotarget.15171; Zhang ZZ, 2018, NAT MED, V24, P617, DOI 10.1038/s41591-018-0003-0	9	9	9	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					537	539		10.1038/s41591-018-0027-5	http://dx.doi.org/10.1038/s41591-018-0027-5			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736020				2022-12-27	WOS:000432126800007
J	Klarin, D; Lynch, J; Aragam, K; Chaffin, M; Assimes, TL; Huang, J; Lee, KM; Shao, Q; Huffman, JE; Natarajan, P; Arya, S; Small, A; Sun, YV; Vujkovic, M; Freiberg, MS; Wang, L; Chen, JB; Saleheen, D; Lee, JS; Miller, DR; Reaven, P; Alba, PR; Patterson, OV; DuVall, SL; Boden, WE; Beckman, JA; Gaziano, JM; Concato, J; Rader, DJ; Cho, K; Chang, KM; Wilson, PWF; O'Donnell, CJ; Kathiresan, S; Program, VAMV; Tsao, PS; Damrauer, SM				Klarin, Derek; Lynch, Julie; Aragam, Krishna; Chaffin, Mark; Assimes, Themistocles L.; Huang, Jie; Lee, Kyung Min; Shao, Qing; Huffman, Jennifer E.; Natarajan, Pradeep; Arya, Shipra; Small, Aeron; Sun, Yan V.; Vujkovic, Marijana; Freiberg, Matthew S.; Wang, Lu; Chen, Jinbo; Saleheen, Danish; Lee, Jennifer S.; Miller, Donald R.; Reaven, Peter; Alba, Patrick R.; Patterson, Olga V.; DuVall, Scott L.; Boden, William E.; Beckman, Joshua A.; Gaziano, J. Michael; Concato, John; Rader, Daniel J.; Cho, Kelly; Chang, Kyong-Mi; Wilson, Peter W. F.; O'Donnell, Christopher J.; Kathiresan, Sekar; Program, V. A. Million Veteran; Tsao, Philip S.; Damrauer, Scott M.			Genome-wide association study of peripheral artery disease in the Million Veteran Program	NATURE MEDICINE			English	Article							BIOBANK; MUTATION; LOCI; SUSCEPTIBILITY; METAANALYSIS; RESISTANCE; ANGPTL3; ATLAS; RISK; GENE	Peripheral artery disease (PAD) is a leading cause of cardiovascular morbidity and mortality; however, the extent to which genetic factors increase risk for PAD is largely unknown. Using electronic health record data, we performed a genome-wide association study in the Million Veteran Program testing similar to 32 million DNA sequence variants with PAD (31,307 cases and 211,753 controls) across veterans of European, African and Hispanic ancestry. The results were replicated in an independent sample of 5,117 PAD cases and 389,291 controls from the UK Biobank. We identified 19 PAD loci, 18 of which have not been previously reported. Eleven of the 19 loci were associated with disease in three vascular beds (coronary, cerebral, peripheral), including LDLR, LPL and LPA, suggesting that therapeutic modulation of low-density lipoprotein cholesterol, the lipoprotein lipase pathway or circulating lipoprotein(a) may be efficacious for multiple atherosclerotic disease phenotypes. Conversely, four of the variants appeared to be specific for PAD, including F5 p.R506Q, highlighting the pathogenic role of thrombosis in the peripheral vascular bed and providing genetic support for Factor Xa inhibition as a therapeutic strategy for PAD. Our results highlight mechanistic similarities and differences among coronary, cerebral and peripheral atherosclerosis and provide therapeutic insights.	[Klarin, Derek; Natarajan, Pradeep; Boden, William E.; Gaziano, J. Michael; Cho, Kelly; O'Donnell, Christopher J.] Boston VA Healthcare Syst, Boston, MA USA; [Klarin, Derek; Aragam, Krishna; Natarajan, Pradeep; Kathiresan, Sekar] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02115 USA; [Klarin, Derek; Aragam, Krishna; Chaffin, Mark; Kathiresan, Sekar] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Klarin, Derek] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Lynch, Julie; Lee, Kyung Min; Alba, Patrick R.; Patterson, Olga V.; DuVall, Scott L.] Salt Lake City Hlth Care Syst, Dept Vet Affairs, VA Informat & Comp Infrastruct, Salt Lake City, CT USA; [Lynch, Julie] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Lynch, Julie; Lee, Kyung Min; Shao, Qing; Miller, Donald R.] Edith Nourse Rogers Mem VA Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Assimes, Themistocles L.; Arya, Shipra; Tsao, Philip S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Assimes, Themistocles L.; Lee, Jennifer S.; Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Huang, Jie; Huffman, Jennifer E.; Lee, Jennifer S.; Boden, William E.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Lee, Kyung Min] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA 02215 USA; [Natarajan, Pradeep] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Arya, Shipra] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Small, Aeron; Vujkovic, Marijana; Saleheen, Danish; Chang, Kyong-Mi; Damrauer, Scott M.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA; [Small, Aeron; Concato, John] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Sun, Yan V.; Wilson, Peter W. F.] Atlanta VA Hlth Care Syst, Decatur, GA USA; [Sun, Yan V.] Emory Univ, Sch Med, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Sun, Yan V.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA; [Vujkovic, Marijana; Wang, Lu; Chen, Jinbo; Saleheen, Danish] Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA; [Freiberg, Matthew S.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA; [Freiberg, Matthew S.] Vanderbilt Univ, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Miller, Donald R.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Reaven, Peter] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA; [Alba, Patrick R.; Patterson, Olga V.; DuVall, Scott L.] Univ Utah, Sch Med, Div Epidemiol, Dept Internal Med, Salt Lake City, UT USA; [Beckman, Joshua A.] Vanderbilt Univ, Med Ctr, Div Cardiovasc, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gaziano, J. Michael] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; [Rader, Daniel J.; Chang, Kyong-Mi] Univ Penn, Dept Med, Perlman Sch Med, Philadelphia, PA 19104 USA; [Wilson, Peter W. F.] Emory Clin, Cardiovasc Res Inst, Atlanta, GA 30322 USA; [O'Donnell, Christopher J.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Med Div, Boston, MA 02115 USA; [Damrauer, Scott M.] Univ Penn, Dept Surg, Perlman Sch Med, Philadelphia, PA 19104 USA; [Concato, John] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Boston; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Massachusetts General Hospital; Stanford University; Yale University; Emory University; Rollins School Public Health; Emory University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Boston University; Utah System of Higher Education; University of Utah; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Pennsylvania; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pennsylvania; US Food & Drug Administration (FDA)	Damrauer, SM (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA.; Damrauer, SM (corresponding author), Univ Penn, Dept Surg, Perlman Sch Med, Philadelphia, PA 19104 USA.	damrauer@upenn.edu	Assimes, Themistocles Leonard/D-9696-2015; Vujković, Marijana/S-9414-2019; Natarajan, Pradeep/H-9764-2019; Beckman, Joshua/A-7537-2016	Assimes, Themistocles Leonard/0000-0003-2349-0009; Vujković, Marijana/0000-0003-4924-5714; Natarajan, Pradeep/0000-0001-8402-7435; Chang, Kyong-Mi/0000-0001-6811-9364; Beckman, Joshua/0000-0001-8332-8439; Lynch, Julie/0000-0003-0108-2127; Klarin, Derek/0000-0002-4636-5780; Chaffin, Mark/0000-0002-1234-5562; Arya, Shipra/0000-0002-0404-9325; DuVall, Scott/0000-0002-4898-3865; Lee, Kyung Min/0000-0001-8995-0448; Alba, Patrick/0000-0002-5176-5447	Department of Veterans Affairs [I01-BX03340, I01-BX003362, IK2-CX001780]; VA Informatics and Computing Infrastructure (VINCI) VA [HSR RES 130457]; National Institutes of Health [R01-HL131977, R03-AG050930, R01-HL138306, R01-HL127564, K08-HL140203]; American Heart Association [18SFRN33960373, 17IFUNP33840012, 15MCPRP25580005];  [MVP000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131977, R01HL142711, R01HL138306, K08HL140203, R01HL127564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG050930] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003340, IK2CX001780, I01BX003362] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); VA Informatics and Computing Infrastructure (VINCI) VA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This research is based on data from the MVP, Office of Research and Development, Veterans Health Administration and was supported by award no. MVP000. This publication does not represent the views of the Department of Veterans Affairs, the US Food and Drug Administration, or the US Government. This research was also supported by funding from: the Department of Veterans Affairs awards nos. I01-BX03340 (K.C. and P.W.F.W.), I01-BX003362 (P.S.T. and K.M.C) and IK2-CX001780 (S.M.D.) and the VA Informatics and Computing Infrastructure (VINCI) VA HSR RES 130457 (P.A., O.V.P. and S.L.D.); the National Institutes of Health grants nos. R01-HL131977 (J.A.B.), R03-AG050930 (S.A.), R01-HL138306 (J. Chen), R01-HL127564 (S.K.) and K08-HL140203 (P.N.); and the American Heart Association grant no. 18SFRN33960373 (J.A.B. and M.S.F.), 17IFUNP33840012 (K.A.) and 15MCPRP25580005 (S.A.). Data on CAD have been contributed by the CARDIoGRAMplusC4D investigators. Data on large artery stroke have been contributed by the MEGASTROKE investigators. The MEGASTROKE project received funding from sources specified at http://www.megastroke.org/acknowledgements.html.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Alba P. R, 2018, AMIA ANN S P; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; [Anonymous], 2015, NAT GENET, V47, P1121, DOI [DOI 10.1038/ng.3396, DOI 10.1038/NG.3396, 10.1038/ng.3396]; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; Arya S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007425; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Cheng YJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001515; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Conte MS, 2015, J VASC SURG, V61, p1S, DOI 10.1016/j.jvs.2014.12.006; Cornia R, 2014, AMIA ANN S P, V1356; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Emdin CA, 2016, J AM COLL CARDIOL, V68, P2761, DOI 10.1016/j.jacc.2016.10.033; Fan J, 2013, J AM MED INFORM ASSN, V20, pE349, DOI 10.1136/amiajnl-2013-001827; Ferrucci D., 2004, Natural Language Engineering, V10, P327, DOI 10.1017/S1351324904003523; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; GREENGARD JS, 1994, NEW ENGL J MED, V331, P1559, DOI 10.1056/NEJM199412083312305; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Klarin D, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001643; Kullo IJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00166; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Matsukura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139262; Murabito JM, 2012, CIRC-CARDIOVASC GENE, V5, P100, DOI 10.1161/CIRCGENETICS.111.961292; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Myocardial IG, 2016, NEW ENGL J MED, V374, P1134, DOI DOI 10.1056/NEJM0A1507652; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; SONG RJ, 2016, CIRCULATION, V134; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Sun BB, 2018, NATURE, V558, P73, DOI 10.1038/s41586-018-0175-2; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wahlgren CM, 2011, ARTERIOSCL THROM VAS, V31, P678, DOI 10.1161/ATVBAHA.110.210385; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Willey J, 2018, J VASC SURG, V68, P527, DOI 10.1016/j.jvs.2017.11.083; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	57	83	85	2	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1274	+		10.1038/s41591-019-0492-5	http://dx.doi.org/10.1038/s41591-019-0492-5			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31285632	Green Accepted			2022-12-27	WOS:000480414600026
J	Christophersen, A; Lund, EG; Snir, O; Sola, E; Kanduri, C; Dahal-Koirala, S; Zuhlke, S; Molberg, O; Utz, PJ; Rohani-Pichavant, M; Simard, JF; Dekker, CL; Lundin, KEA; Sollid, LM; Davis, MM				Christophersen, Asbjorn; Lund, Eivind G.; Snir, Omri; Sola, Elsa; Kanduri, Chakravarthi; Dahal-Koirala, Shiva; Zuhlke, Stephanie; Molberg, Oyvind; Utz, Paul J.; Rohani-Pichavant, Mina; Simard, Julia F.; Dekker, Cornelia L.; Lundin, Knut E. A.; Sollid, Ludvig M.; Davis, Mark M.			Distinct phenotype of CD4(+) T cells driving celiac disease identified in multiple autoimmune conditions	NATURE MEDICINE			English	Article							PERIPHERAL-BLOOD; AMERICAN-COLLEGE; TRANSGLUTAMINASE; CLASSIFICATION; AUTOANTIBODIES; EXPRESSION; CYTOMETRY; CRITERIA; TIME	Combining HLA-DQ-gluten tetramers with mass cytometry and RNA sequencing analysis, we find that gluten-specific CD4(+) T cells in the blood and intestines of patients with celiac disease display a surprisingly rare phenotype. Cells with this phenotype are also elevated in patients with systemic sclerosis and systemic lupus erythematosus, suggesting a way to characterize CD4(+) T cells specific for disease-driving antigens in multiple autoimmune conditions.	[Christophersen, Asbjorn; Lund, Eivind G.; Snir, Omri; Kanduri, Chakravarthi; Dahal-Koirala, Shiva; Zuhlke, Stephanie; Lundin, Knut E. A.; Sollid, Ludvig M.] Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway; [Christophersen, Asbjorn; Lund, Eivind G.; Snir, Omri; Dahal-Koirala, Shiva; Zuhlke, Stephanie; Molberg, Oyvind; Lundin, Knut E. A.; Sollid, Ludvig M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Christophersen, Asbjorn; Lund, Eivind G.; Snir, Omri; Dahal-Koirala, Shiva; Zuhlke, Stephanie; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, Oslo, Norway; [Christophersen, Asbjorn; Sola, Elsa; Utz, Paul J.; Rohani-Pichavant, Mina; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Sola, Elsa] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain; [Kanduri, Chakravarthi] Univ Oslo, Dept Informat, Oslo, Norway; [Molberg, Oyvind] Oslo Univ Hosp, Dept Rheumatol Dermatol & Infect Dis, Oslo, Norway; [Simard, Julia F.] Stanford Sch Med, Epidemiol Hlth Res & Policy, Stanford, CA 94305 USA; [Dekker, Cornelia L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Lundin, Knut E. A.] Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway; [Sollid, Ludvig M.] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	University of Oslo; University of Oslo; University of Oslo; Stanford University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oslo; University of Oslo; Stanford University; Stanford University; University of Oslo; University of Oslo; Stanford University; Howard Hughes Medical Institute; Stanford University	Sollid, LM (corresponding author), Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway.; Sollid, LM (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Sollid, LM (corresponding author), Univ Oslo, Dept Immunol, Oslo, Norway.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Sollid, LM (corresponding author), Oslo Univ Hosp, Dept Immunol, Oslo, Norway.; Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	l.m.sollid@medisin.uio.no; mmdavis@stanford.edu	Lundin, Knut E. A./AAW-9519-2021; Kanduri, Chakravarthi/AAL-1021-2020	Lundin, Knut E. A./0000-0003-1713-5545; Kanduri, Chakravarthi/0000-0002-4783-9060; Davis, Mark/0000-0001-6868-657X	University of Oslo - University of Oslo World-leading research program on human immunology (WL-IMMUNOLOGY); EC FP7 Maria Sklodowska-Curie COFUND Programme [GA 609020]; Stiftelsen KG Jebsen [SKGJ-MED-017]; Unger-Vetlesen Medical Fund; U.S.-Norwegian Fulbright Foundation for educational exchange; Fondsstiftelsen (Oslo University Hospital); Howard Hughes Medical Institute; Simons Foundation; National Institutes of Health; Donald E. and Delia B. Baxter Foundation; Henry Gustav Floren Trust;  [U19-AI057229];  [U19-AI110491];  [UL1 TR001085];  [R01 AI125197-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R01AI125197, U19AI110491] Funding Source: NIH RePORTER	University of Oslo - University of Oslo World-leading research program on human immunology (WL-IMMUNOLOGY); EC FP7 Maria Sklodowska-Curie COFUND Programme; Stiftelsen KG Jebsen; Unger-Vetlesen Medical Fund; U.S.-Norwegian Fulbright Foundation for educational exchange; Fondsstiftelsen (Oslo University Hospital); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald E. and Delia B. Baxter Foundation; Henry Gustav Floren Trust; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the patients participating in this study, S. Furholm, C. Hinrichs and M. H. Bakke for collecting patient material at the Endoscopy Unit (Oslo University Hospital-Rikshospitalet), the Stanford-LPCH Vaccine Program with S. Swope and S. Mackey for the study of patients with influenza virus infection, A. Nau (Davis group), M. Leipold (The Human Immune Monitoring Center, Stanford University) and Brith Bergum (Flow Cytometry Core Facility, University of Bergen) for technical assistance with the Helios mass cytometers, B. Simonsen and S. R. Lund (Sollid group) for producing the biotinylated HLA-DQ2.5:gluten molecules, M. K. Johannesen (Sollid group) for laboratory technical assistance, K. J. Rolfsen (University of Oslo) for producing the cookies for gluten challenge, G. K. Sandve (University of Oslo) for critical inputs on RNA-seq data analysis in addition to V. K. Sarna (University of Oslo) and L. Chung (Stanford Medicine) for help with the clinical assessment of patients. We also thank the Flow Cytometry Core Facility (Oslo University Hospital-Rikshospitalet and Radiumhospitalet) and the Stanford Shared FACS Facility for technical assistance. We express our gratitude to the funding bodies of this research: The University of Oslo Scientia Fellows program, co-funded by the University of Oslo World-leading research program on human immunology (WL-IMMUNOLOGY) (L. M. S.) and by the EC FP7 Maria Sklodowska-Curie COFUND Programme (GA 609020) (A. C. and L. M. S.); Stiftelsen KG Jebsen (project SKGJ-MED-017) (L. M. S. and K.E.A.L.); The Unger-Vetlesen Medical Fund (A. C.); The U.S.-Norwegian Fulbright Foundation for educational exchange (A. C.); Fondsstiftelsen (Oslo University Hospital) (A. C.); The Howard Hughes Medical Institute (M.M.D.); The Simons Foundation (M.M.D.); The National Institutes of Health; U19-AI057229 (M.M.D.), U19-AI110491 (P.J.U.), UL1 TR001085 (C.L.D.) and R01 AI125197-01 (P.J.U.); The Donald E. and Delia B. Baxter Foundation (P.J.U.); The Henry Gustav Floren Trust (P.J.U.); and a gift from Elizabeth F. Adler (P.J.U.).	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Bodd M, 2013, EUR J IMMUNOL, V43, P2605, DOI 10.1002/eji.201343382; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Christophersen A, 2014, UNITED EUR GASTROENT, V2, P268, DOI 10.1177/2050640614540154; Cook L, 2017, J ALLERGY CLIN IMMUN, V140, P1592, DOI 10.1016/j.jaci.2017.02.015; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; du Pre MF, 2011, AM J GASTROENTEROL, V106, P1147, DOI 10.1038/ajg.2011.24; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoydahl LS, 2019, GASTROENTEROLOGY, V156, P1428, DOI 10.1053/j.gastro.2018.12.013; Kooy-Winkelaar YMC, 2017, P NATL ACAD SCI USA, V114, pE980, DOI 10.1073/pnas.1620036114; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Mei HE, 2015, J IMMUNOL, V194, P2022, DOI 10.4049/jimmunol.1402661; Moens L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00065; Molberg O, 2000, METH MOLEC MED, V41, P105, DOI 10.1385/1-59259-082-9:105; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nowicka Malgorzata, 2017, F1000Res, V6, P748, DOI 10.12688/f1000research.11622.3; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Raki M, 2007, P NATL ACAD SCI USA, V104, P2831, DOI 10.1073/pnas.0608610104; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Risnes LF, 2018, J CLIN INVEST, V128, P2642, DOI 10.1172/JCI98819; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Steinsbo O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5041; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; 2016, J IMMUNOL, V196, P2819, DOI DOI 10.4049/JIMMUNOL.1501152	35	78	79	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					734	+		10.1038/s41591-019-0403-9	http://dx.doi.org/10.1038/s41591-019-0403-9			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	30911136	Green Accepted			2022-12-27	WOS:000468247800015
J	Grigelioniene, G; Suzuki, HI; Taylan, F; Mirzamohammadi, F; Borochowitz, ZU; Ayturk, UM; Tzur, S; Horemuzova, E; Lindstrand, A; Weis, MA; Grigelionis, G; Hammarsjo, A; Marsk, E; Nordgren, A; Nordenskjold, M; Eyre, DR; Warman, ML; Nishimura, G; Sharp, PA; Kobayashi, T				Grigelioniene, Giedre; Suzuki, Hiroshi I.; Taylan, Fulya; Mirzamohammadi, Fatemeh; Borochowitz, Zvi U.; Ayturk, Ugur M.; Tzur, Shay; Horemuzova, Eva; Lindstrand, Anna; Weis, Mary Ann; Grigelionis, Gintautas; Hammarsjo, Anna; Marsk, Elin; Nordgren, Ann; Nordenskjold, Magnus; Eyre, David R.; Warman, Matthew L.; Nishimura, Gen; Sharp, Phillip A.; Kobayashi, Tatsuya			Gain-of-function mutation of microRNA-140 in human skeletal dysplasia	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTORS; SEED REGION; CHONDROCYTE DIFFERENTIATION; SUPER-ENHANCERS; BINDING-SITES; CELL IDENTITY; HEARING-LOSS; RNA; EXPRESSION; YB-1	MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression. Heterozygous loss-of-function point mutations of miRNA genes are associated with several human congenital disorders(1-5), but neomorphic (gain-of-new-function) mutations in miRNAs due to nucleotide substitutions have not been reported. Here we describe a neomorphic seed region mutation in the chondrocyte-specific, super-enhancer-associated MIR140 gene encoding microRNA-140 (miR-140) in a novel autosomal dominant human skeletal dysplasia. Mice with the corresponding single nucleotide substitution show skeletal abnormalities similar to those of the patients but distinct from those of miR-140-null mice(6). This mutant miRNA gene yields abundant mutant miR-140-5p expression without miRNA-processing defects. In chondrocytes, the mutation causes widespread derepression of wild-type miR-140-5p targets and repression of mutant miR-140-5p targets, indicating that the mutation produces both loss-of-function and gain-of-function effects. Furthermore, the mutant miR-140-5p seed competes with the conserved RNA-binding protein Ybx1 for overlapping binding sites. This finding may explain the potent target repression and robust in vivo effect by this mutant miRNA even in the absence of evolutionary selection of miRNA-target RNA interactions, which contributes to the strong regulatory effects of conserved miRNAs(7,8). Our study presents the first case of a pathogenic gain-of-function miRNA mutation and provides molecular insight into neomorphic actions of emerging and/or mutant miRNAs.	[Grigelioniene, Giedre; Mirzamohammadi, Fatemeh; Kobayashi, Tatsuya] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Grigelioniene, Giedre; Mirzamohammadi, Fatemeh; Kobayashi, Tatsuya] Harvard Med Sch, Boston, MA 02115 USA; [Grigelioniene, Giedre; Taylan, Fulya; Lindstrand, Anna; Grigelionis, Gintautas; Hammarsjo, Anna; Nordgren, Ann; Nordenskjold, Magnus] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Grigelioniene, Giedre; Taylan, Fulya; Lindstrand, Anna; Grigelionis, Gintautas; Hammarsjo, Anna; Nordgren, Ann; Nordenskjold, Magnus] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Grigelioniene, Giedre; Lindstrand, Anna; Hammarsjo, Anna; Nordgren, Ann; Nordenskjold, Magnus] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden; [Suzuki, Hiroshi I.; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Borochowitz, Zvi U.] Technion Israel Inst Technol, Med Genet Clin, Rappaport Fac Med, Assuta Med Ctr, Haifa, Israel; [Ayturk, Ugur M.; Warman, Matthew L.] Boston Childrens Hosp, Dept Orthopaed Surg, Orthopaed Res Labs, Boston, MA USA; [Tzur, Shay] Rambam Hlth Care Campus, Lab Mol Med, Haifa, Israel; [Tzur, Shay] Emedgene Technol, Genom Res Dept, Tel Aviv, Israel; [Horemuzova, Eva] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Horemuzova, Eva] Karolinska Univ Hosp, Pediat Endocrinol Unit, Stockholm, Sweden; [Weis, Mary Ann; Eyre, David R.] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98195 USA; [Marsk, Elin] Karolinska Univ Hosp, Dept Otorhinolaryngol, Stockholm, Sweden; [Nishimura, Gen] Saitama Med Univ Hosp, Ctr Intractable Dis, Saitama, Japan; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Massachusetts Institute of Technology (MIT); Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Harvard University; Boston Children's Hospital; Rambam Health Care Campus; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Saitama Medical University; Massachusetts Institute of Technology (MIT)	Kobayashi, T (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.; Kobayashi, T (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	tkobayashi1@mgh.harvard.edu	Taylan, Fulya/V-7121-2019; Lindstrand, Anna/J-3566-2012; Grigelioniene, Giedre/AAH-8408-2020; Nordgren, Ann/AAQ-9142-2021; Nordgren, Ann C/N-4057-2013; Lindstrand, Anna/AAT-9969-2021; Grigelionis, Gintautas/AAA-1028-2021	Taylan, Fulya/0000-0002-2907-0235; Lindstrand, Anna/0000-0003-0806-5602; Grigelioniene, Giedre/0000-0001-9601-3137; Nordgren, Ann/0000-0003-3285-4281; Nordgren, Ann C/0000-0003-3285-4281; Lindstrand, Anna/0000-0003-0806-5602; Grigelionis, Gintautas/0000-0003-4939-2319; Kobayashi, Tatsuya/0000-0003-4264-5117; Nordenskjold, Magnus/0000-0002-4974-425X; Suzuki, Hiroshi/0000-0003-4682-5086	Science for Life Laboratory, the National Genomics Infrastructure (NGI), Sweden, SNIC through UPPMAX [b2014231]; NIH [P30 AR066261]; Stockholm County Council [20150143, 20130315]; National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [R01-AR056645]; National Institutes of Health (National Institute of General Medical Sciences) [R01-GM034277]; National Institutes of Health (National Cancer Institute) [R01-CA133404, P30-CA14051]; Eli Lilly International Corporation; Fernstrom Foundation; Karolinska Institutet; Swedish Society of Medicine; Stiftelsen Samariten, Stockholm, Sweden; Promobilia and Frimurare Barnhuset Stockholm; Swedish Research Council [2018-03046]; Uehara Memorial Foundation Research Fellowship; Osamu Hayaishi Memorial Scholarship for Study Abroad; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261, R01AR056645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	Science for Life Laboratory, the National Genomics Infrastructure (NGI), Sweden, SNIC through UPPMAX; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stockholm County Council(Stockholm County Council); National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eli Lilly International Corporation(Eli Lilly); Fernstrom Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Society of Medicine; Stiftelsen Samariten, Stockholm, Sweden; Promobilia and Frimurare Barnhuset Stockholm; Swedish Research Council(Swedish Research CouncilEuropean Commission); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); Osamu Hayaishi Memorial Scholarship for Study Abroad; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank patients and their family members for their participation in the study, M. Mannstadt, K. Leuter, M. Wein, H. Kronenberg, H. Jueppner, G. Bjork, and A. Merker for advice and chemicals, J. Lundin for assistance with the human comparative genomic hybridization array databases, and Science for Life Laboratory, the National Genomics Infrastructure (NGI), Sweden, SNIC through UPPMAX under project b2014231 for providing assistance in massive parallel DNA sequencing and computational infrastructure. We also thank Center for Skeletal Research Core (NIH P30 AR066261) for access to histological analysis equipment; Harvard GMF for generation of knock-in mice; and DFCI and MGH Sequencing Cores for assistance with RNA and Sanger sequencing; the Robert A. Swanson (1969) Biotechnology Center at the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology for technical support, specifically S. Levine and the staff of the BioMicro Center/KI Genomic Core Facility and G. Paradis, M. Jennings, and M. Saturno-Condon of the Flow Cytometry Core Facility. This project was supported by grants provided by the Stockholm County Council (ALF projects 20150143 and 20130315 to G. Grigelioniene. and A.N.) and by the National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01-AR056645 to T.K., National Institute of General Medical Sciences grant R01-GM034277 and National Cancer Institute grant R01-CA133404 to P.A.S., and National Cancer Institute grant P30-CA14051 to the Koch Institute Core Facility). G. Grigelioniene was supported by a grant of the Sabbatical Leave Programme of the European Society for Paediatric Endocrinology through an educational grant from Eli Lilly International Corporation, travel grants from Fernstrom Foundation, Karolinska Institutet and Swedish Society of Medicine, scholarship from Stiftelsen Samariten, Stockholm, Sweden, Research Funds from Promobilia and Frimurare Barnhuset Stockholm, and project grant from Swedish Research Council 2018-03046. H. I. S. is supported by the Uehara Memorial Foundation Research Fellowship and the Osamu Hayaishi Memorial Scholarship for Study Abroad.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henrion-Caude A, 2012, CURR GENE THER, V12, P292, DOI 10.2174/156652312802083602; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kvarnung M, 2018, CLIN GENET, V94, P528, DOI 10.1111/cge.13448; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lechner J, 2013, INVEST OPHTH VIS SCI, V54, P5266, DOI 10.1167/iovs.13-12035; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindstrand A, 2010, CLIN GENET, V77, P552, DOI 10.1111/j.1399-0004.2009.01341.x; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Napierala D, 2008, HUM MOL GENET, V17, P2244, DOI 10.1093/hmg/ddn125; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Papaioannou G, 2015, J BONE MINER RES, V30, P1044, DOI 10.1002/jbmr.2438; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Solda G, 2012, HUM MOL GENET, V21, P577, DOI 10.1093/hmg/ddr493; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki HI, 2018, NAT GENET, V50, P657, DOI 10.1038/s41588-018-0104-1; Suzuki HI, 2017, CELL, V168, P1000, DOI 10.1016/j.cell.2017.02.015; Suzuki HI, 2015, NAT STRUCT MOL BIOL, V22, P512, DOI 10.1038/nsmb.3050; Tijchon E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131481; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Van Nostrand EL, 2017, METHODS MOL BIOL, V1648, pE1, DOI 10.1007/978-1-4939-7204-3_19; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wei WJ, 2012, NUCLEIC ACIDS RES, V40, P8622, DOI 10.1093/nar/gks579; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu SL, 2015, NUCLEIC ACIDS RES, V43, P8516, DOI 10.1093/nar/gkv779; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zhang J, 2015, HUM MOL GENET, V24, P6174, DOI 10.1093/hmg/ddv333; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	47	49	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					583	+		10.1038/s41591-019-0353-2	http://dx.doi.org/10.1038/s41591-019-0353-2			29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30804514	Green Published, Green Accepted			2022-12-27	WOS:000463342800019
J	Kinsey, CG; Camolotto, SA; Boespflug, AM; Guillen, KP; Foth, M; Truong, A; Schuman, SS; Shea, JE; Seipp, MT; Yap, JT; Burrell, LD; Lum, DH; Whisenant, JR; Gilcrease, GW; Cavalieri, CC; Rehbein, KM; Cutler, SL; Affolter, KE; Welm, AL; Welm, BE; Scaife, CL; Snyder, EL; McMahon, M				Kinsey, Conan G.; Camolotto, Soledad A.; Boespflug, Amelie M.; Guillen, Katrin P.; Foth, Mona; Truong, Amanda; Schuman, Sophia S.; Shea, Jill E.; Seipp, Michael T.; Yap, Jeffrey T.; Burrell, Lance D.; Lum, David H.; Whisenant, Jonathan R.; Gilcrease, G. Weldon, III; Cavalieri, Courtney C.; Rehbein, Kaitrin M.; Cutler, Stephanie L.; Affolter, Kajsa E.; Welm, Alana L.; Welm, Bryan E.; Scaife, Courtney L.; Snyder, Eric L.; McMahon, Martin			Protective autophagy elicited by RAF -> MEK -> ERK inhibition suggests a treatment strategy for RAS-driven cancers	NATURE MEDICINE			English	Article							GROWTH; CELLS; BRAF; PHOSPHORYLATION; GEMCITABINE; COMBINATION; TRAMETINIB; RESISTANCE; PLATFORM; PROTEIN	Pancreatic ductal adenocarcinoma (PDA) was responsible for similar to 44,000 deaths in the United States in 2018 and is the epitome of a recalcitrant cancer driven by a pharmacologically intractable oncoprotein, KRAS(1-4). Downstream of KRAS, the RAF. MEK. ERK signaling pathway plays a central role in pancreatic carcinogenesis(5). However, paradoxically, inhibition of this pathway has provided no clinical benefit to patients with PDA(6). Here we show that inhibition of KRAS -> RAF -> MEK -> ERK signaling elicits autophagy, a process of cellular recycling that protects PDA cells from the cytotoxic effects of KRAS pathway inhibition. Mechanistically, inhibition of MEK1/2 leads to activation of the LKB1 -> AMPK -> ULK1 signaling axis, a key regulator of autophagy. Furthermore, combined inhibition of MEK1/2 plus autophagy displays synergistic anti-proliferative effects against PDA cell lines in vitro and promotes regression of xenografted patient-derived PDA tumors in mice. The observed effect of combination trametinib plus chloroquine was not restricted to PDA as other tumors, including patient-derived xenografts (PDX) of NRAS-mutated melanoma and BRAF-mutated colorectal cancer displayed similar responses. Finally, treatment of a patient with PDA with the combination of trametinib plus hydroxychloroquine resulted in a partial, but nonetheless striking disease response. These data suggest that this combination therapy may represent a novel strategy to target RAS-driven cancers.	[Kinsey, Conan G.; Camolotto, Soledad A.; Boespflug, Amelie M.; Guillen, Katrin P.; Foth, Mona; Truong, Amanda; Schuman, Sophia S.; Yap, Jeffrey T.; Burrell, Lance D.; Lum, David H.; Whisenant, Jonathan R.; Gilcrease, G. Weldon, III; Cavalieri, Courtney C.; Rehbein, Kaitrin M.; Cutler, Stephanie L.; Affolter, Kajsa E.; Welm, Alana L.; Welm, Bryan E.; Scaife, Courtney L.; Snyder, Eric L.; McMahon, Martin] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Kinsey, Conan G.; Whisenant, Jonathan R.; Gilcrease, G. Weldon, III] Univ Utah, Sch Med, Dept Internal Med, Div Oncol, Salt Lake City, UT USA; [Boespflug, Amelie M.] Ctr Hosp Lyon Sud, Dept Dermatol, Pierre Benite, France; [Boespflug, Amelie M.] Claude Bernard Lyon 1 Univ, Canc Res Ctr Lyon, INSERM 1052, CNRS 5286, Villeurbanne, France; [Shea, Jill E.; Seipp, Michael T.; Welm, Bryan E.; Scaife, Courtney L.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT USA; [Yap, Jeffrey T.] Univ Utah, Sch Med, Dept Radiol & Imaging Serv, Salt Lake City, UT USA; [Cavalieri, Courtney C.] Univ Utah, Huntsman Canc Inst, Dept Pharm Serv, Salt Lake City, UT USA; [Affolter, Kajsa E.; Snyder, Eric L.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Welm, Alana L.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT USA; [McMahon, Martin] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	McMahon, M (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; McMahon, M (corresponding author), Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84132 USA.	martin.mcmahon@hci.utah.edu	Foth, Mona/AAU-5336-2021	Yap, Jeffrey/0000-0001-5306-2860; Foth, Mona/0000-0001-6507-8114; Shea, Jill/0000-0002-8644-7772; Boespflug, Amelie/0000-0002-2656-5144	National Cancer Institute [R01-CA176839, R01-CA131261, P30-CA042014]; Pancreatic Cancer Collective; Melanoma Research Alliance; Five for the Fight; Huntsman Cancer Foundation; Career Award for Medical Scientists from the Burroughs Wellcome Fund; V Scholar Award; NIH [R01CA212415]; National Cancer Institute; DoD [U54CA224076, W81XWH1410417]; Fondation pour la Recherche Medicale [FDM20150633361]; Societe Francaise de Dermatologie; NATIONAL CANCER INSTITUTE [F30CA235964, U54CA224076, R01CA212415, R01CA176839, P30CA042014, R01CA131261] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer Collective; Melanoma Research Alliance; Five for the Fight; Huntsman Cancer Foundation; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); V Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe Francaise de Dermatologie; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this work to the memory of our patient and his family, whose courage continues to inspire us to further improve the diagnosis and treatment of pancreatic cancer. We thank the members of the McMahon Lab for their support, advice, guidance, comments and discussions during the course of this work. Additionally we thank I. Garrido-Laguna (HCI/Univ. of Utah), M. Tempero, E. Collisson and F. McCormick (U.C. San Francisco), E. White (Rutgers University), D. Tuveson (Cold Spring Harbor), and K. Olive (Columbia) for advice and guidance, J. Mulcahy-Levy and A. Thorburn (U.C. Denver) for inspiration, advice, guidance and reagents, H. Land (University of Rochester Medical Center) and K. Shokat (UCSF) for providing reagents, NCI Patient-Derived Models Repository for supplying the NCI-516677 NRAS-mutated melanoma PDX, K. Owings, D. Lum and the HCI Preclinical Research Resource for assistance with tumor xenografts and drug treatments and M. Silvis for assistance with drug dosing. C.K. & M.M. wish to acknowledge the collegiality of K. Bryant and C. Der (University of North Carolina, Chapel Hill) for ongoing discussions and for sharing data in advance of publication. M. M. acknowledges financial support from the National Cancer Institute (R01-CA176839, R01-CA131261 & P30-CA042014), the Pancreatic Cancer Collective, Melanoma Research Alliance, Five for the Fight, and the Huntsman Cancer Foundation. E.L.S. was supported in part by a Career Award for Medical Scientists from the Burroughs Wellcome Fund, a V Scholar Award, the Huntsman Cancer Foundation, and the NIH (R01CA212415). B.E.W. acknowledges support from the National Cancer Institute and DoD (U54CA224076 and W81XWH1410417). A.L.W. acknowledges support from the Huntsman Cancer Foundation. C.G.K acknowledges support from the Huntsman Cancer Foundation. A.M.B. acknowledges support from Fondation pour la Recherche Medicale (FDM20150633361) and Societe Francaise de Dermatologie.	Awasthi N, 2013, CARCINOGENESIS, V34, P2361, DOI 10.1093/carcin/bgt227; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Bryant KL, 2019, NAT MED, V25, P628, DOI 10.1038/s41591-019-0368-8; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eng CH, 2016, P NATL ACAD SCI USA, V113, P182, DOI 10.1073/pnas.1515617113; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Gump JM, 2014, AUTOPHAGY, V10, P1327, DOI 10.4161/auto.29394; Honda A, 2016, ACS MED CHEM LETT, V7, P72, DOI 10.1021/acsmedchemlett.5b00335; Infante JR, 2014, EUR J CANCER, V50, P2072, DOI 10.1016/j.ejca.2014.04.024; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KB, 2013, J CLIN ONCOL, V31, P482, DOI 10.1200/JCO.2012.43.5966; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Levy JMM, 2017, ELIFE, V6, DOI 10.7554/eLife.19671; Levy JMM, 2014, CANCER DISCOV, V4, P773, DOI 10.1158/2159-8290.CD-14-0049; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Poillet-Perez L, 2018, NATURE, V563, P569, DOI 10.1038/s41586-018-0697-7; Rice KD, 2012, ACS MED CHEM LETT, V3, P416, DOI 10.1021/ml300049d; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Vessoni AT, 2016, FREE RADICAL BIO MED, V90, P91, DOI 10.1016/j.freeradbiomed.2015.11.008; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; Yang AN, 2018, CANCER DISCOV, V8, P276, DOI 10.1158/2159-8290.CD-17-0952; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	41	321	330	10	134	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					620	+		10.1038/s41591-019-0367-9	http://dx.doi.org/10.1038/s41591-019-0367-9			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30833748	Green Accepted			2022-12-27	WOS:000463342800024
J	Ito, H; Nakashima, H; Chiocca, EA				Ito, Hirotaka; Nakashima, Hiroshi; Chiocca, E. Antonio			Molecular responses to immune checkpoint blockade in glioblastoma	NATURE MEDICINE			English	Editorial Material									[Ito, Hirotaka; Nakashima, Hiroshi; Chiocca, E. Antonio] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chiocca, EA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA.	eachiocca@bwh.harvard.edu		Ito, Hirotaka/0000-0001-8223-0229	NATIONAL CANCER INSTITUTE [P01CA163205, P01CA069246] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA069246, P01 CA163205] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chiocca EA, 2019, NEURO-ONCOLOGY, V21, P14, DOI 10.1093/neuonc/noy170; Cloughesy TF, 2019, NAT MED, V25, P477, DOI 10.1038/s41591-018-0337-7; Dyck L, 2017, EUR J IMMUNOL, V47, P765, DOI 10.1002/eji.201646875; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kamiya-Matsuoka Carlos, 2015, CNS Oncol, V4, P91, DOI 10.2217/cns.14.55; Keskin DB, 2019, NATURE, V565, P234, DOI 10.1038/s41586-018-0792-9; Kurz SC, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0499-0; Mooney KL, 2016, J CLIN NEUROSCI, V34, P1, DOI 10.1016/j.jocn.2016.05.012; Nam JY, 2017, J ONCOL PRACT, V13, P629, DOI 10.1200/JOP.2017.025536; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Schalper KA, 2019, NAT MED, V25, P470, DOI 10.1038/s41591-018-0339-5; Thomas AA, 2017, CANCER IMMUNOL IMMUN, V66, P379, DOI 10.1007/s00262-016-1941-3; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao, 2019, J NAT MED, DOI [10.1038/s41591-019-0349-y, DOI 10.1038/S41591-019-0349-Y]	14	27	27	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					359	361		10.1038/s41591-019-0385-7	http://dx.doi.org/10.1038/s41591-019-0385-7			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842671	Green Accepted			2022-12-27	WOS:000460643100010
J	Stower, H				Stower, Hannah			Personalizing metabolic disease therapies	NATURE MEDICINE			English	Editorial Material																			0	0	0	2	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					197	197		10.1038/s41591-019-0365-y	http://dx.doi.org/10.1038/s41591-019-0365-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728533	Bronze			2022-12-27	WOS:000457842100008
J	Boja, E; Tezak, Z; Zhang, B; Wang, P; Johanson, E; Hinton, D; Rodriguez, H				Boja, Emily; Tezak, Zivana; Zhang, Bing; Wang, Pei; Johanson, Elaine; Hinton, Denise; Rodriguez, Henry			Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge	NATURE MEDICINE			English	Editorial Material							PROTEOGENOMIC CHARACTERIZATION; CANCER		[Boja, Emily; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, Bethesda, MD 20892 USA; [Tezak, Zivana] US FDA, Off In Vitro Diagnost & Radiol Hlth, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Zhang, Bing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wang, Pei] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Johanson, Elaine] US FDA, Off Hlth Informat, Off Chief Scientist, Off Commissioner, Silver Spring, MD USA; [Hinton, Denise] US FDA, Off Chief Scientist, Off Commissioner, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Food & Drug Administration (FDA); Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Boja, E (corresponding author), NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, Bethesda, MD 20892 USA.	emily.boja@nih.gov; zivana.tezak@fda.hhs.gov		Hinton, Denise/0000-0002-9597-0012; Wang, Pei/0000-0002-6890-6453	NCI NIH HHS [U24 CA210993] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Fiore LD, 2017, CLIN PHARMACOL THER, V101, P619, DOI 10.1002/cpt.658; Hawker C. D., 2014, FIXING PROBLEM MISLA; Martin H., 2015, ONLINE J NURS INFORM, V19; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Regnier FE, 2010, CLIN CHEM, V56, P165, DOI 10.1373/clinchem.2009.140087; Rodriguez H, 2018, CELL, V173, P533, DOI 10.1016/j.cell.2018.04.008; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069; Zych K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171324	11	9	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1301	1302		10.1038/s41591-018-0180-x	http://dx.doi.org/10.1038/s41591-018-0180-x			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194412	Green Published			2022-12-27	WOS:000444174100004
J	Bajpai, G; Schneider, C; Wong, N; Bredemeyer, A; Hulsmans, M; Nahrendorf, M; Epelman, S; Kreisel, D; Liu, YJ; Itoh, A; Shankar, TS; Selzman, CH; Drakos, SG; Lavine, KJ				Bajpai, Geetika; Schneider, Caralin; Wong, Nicole; Bredemeyer, Andrea; Hulsmans, Maarten; Nahrendorf, Matthias; Epelman, Slava; Kreisel, Daniel; Liu, Yongjian; Itoh, Akinobu; Shankar, Thirupura S.; Selzman, Craig H.; Drakos, Stavros G.; Lavine, Kory J.			The human heart contains distinct macrophage subsets with divergent origins and functions	NATURE MEDICINE			English	Article							TISSUE-RESIDENT MACROPHAGES; HEMATOPOIETIC STEM-CELLS; STEADY-STATE; CARDIAC MACROPHAGES; LANGERHANS CELLS; ANALYSIS REVEALS; DENDRITIC CELLS; LYMPH-NODES; MONOCYTES; EXPRESSION	Paradigm-shifting studies in the mouse have identified tissue macrophage heterogeneity as a critical determinant of immune responses. In contrast, surprisingly little is known regarding macrophage heterogeneity in humans. Macrophages within the mouse heart are partitioned into CCR2- and CCR2+ subsets with divergent origins, repopulation mechanisms, and functions. Here, we demonstrate that the human myocardium also contains distinct subsets of CCR2- and CCR2+ macrophages. Analysis of sex-mismatched heart transplant recipients revealed that CCR2- macrophages are a tissue-resident population exclusively replenished through local proliferation, whereas CCR2+ macrophages are maintained through monocyte recruitment and proliferation. Moreover, CCR2- and CCR2+ macrophages have distinct functional properties, analogous to reparative CCR2- and inflammatory CCR2+ macrophages in the mouse heart. Clinically, CCR2+ macrophage abundance is associated with left ventricular remodeling and systolic function in heart failure patients. Collectively, these observations provide initial evidence for the functional importance of macrophage heterogeneity in the human heart.	[Bajpai, Geetika; Schneider, Caralin; Wong, Nicole; Bredemeyer, Andrea; Lavine, Kory J.] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA; [Hulsmans, Maarten; Nahrendorf, Matthias] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA USA; [Epelman, Slava] Univ Toronto, Toronto Gen Hosp, Peter Munk Cardiac Ctr, Ted Rogers Ctr Heart Failure Res, Toronto, ON, Canada; [Kreisel, Daniel; Itoh, Akinobu] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Liu, Yongjian] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Shankar, Thirupura S.; Selzman, Craig H.; Drakos, Stavros G.] Univ Utah, Sch Med, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT USA; [Selzman, Craig H.] Univ Utah, Sch Med, Div Cardiothorac Surg, Salt Lake City, UT USA; [Drakos, Stavros G.] Univ Utah, Sch Med, Div Cardiovasc Med, Salt Lake City, UT USA; [Lavine, Kory J.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA; [Lavine, Kory J.] Washington Univ, Sch Med, Dept Immunol & Pathol, St Louis, MO 63130 USA	Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Washington University (WUSTL); Washington University (WUSTL); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Washington University (WUSTL); Washington University (WUSTL)	Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Res,Div Cardiol, St Louis, MO 63110 USA.; Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA.; Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Immunol & Pathol, St Louis, MO 63130 USA.	klavine@wustl.edu	bajpai, geetika/ABH-1952-2020; Epelman, Slava/AAO-1728-2020	Epelman, Slava/0000-0003-3400-4475; Bredemeyer, Andrea/0000-0003-2970-5998; Hulsmans, Maarten/0000-0003-1009-658X; Wong, Nicole/0000-0003-4590-8306	Children's Discovery Institute of Washington University and St. Louis Children's Hospital [CH-II-2015-462, CH-II-2017-628]; Foundation for Barnes-Jewish Hospital [8038-88]; NHLBI [R01 HL138466, R01 HL139714, R01 HL135121-01]; National Institutes of Health (NIH) [K08 HL123519]; Burroughs Welcome Fund [1014782]; NCI [P30 CA91842]; ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of the NIH [UL1TR000448]; NIH Roadmap for Medical Research; AHA [HF 16SFRN29020000]; Nora Eccles Treadwell Foundation; NIH [HL139598, R01HL131908, R01HL125655, P01AI116501, R01 HL094601]; MGH Research Scholar Program; Veterans Administration Merit Review grant [1I01BX002730]; Foundation for Barnes-Jewish Hospital; MGH ECOR Tosteson; Fund for Medical Discovery Fellowship [2017A052660];  [P30 DK52574]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL135121, R01HL139714, R01HL125655, K08HL123519, R01HL131908, R01HL138466, R35HL139598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER	Children's Discovery Institute of Washington University and St. Louis Children's Hospital; Foundation for Barnes-Jewish Hospital; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA Grant from the National Center for Research Resources (NCRR), a component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Nora Eccles Treadwell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH Research Scholar Program; Veterans Administration Merit Review grant(US Department of Veterans Affairs); Foundation for Barnes-Jewish Hospital; MGH ECOR Tosteson; Fund for Medical Discovery Fellowship; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the Translational Cardiovascular Biorepository at Washington University for providing cardiac tissue specimens. This project was made possible by funding provided from the Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CH-II-2015-462, CH-II-2017-628), the Foundation for Barnes-Jewish Hospital (8038-88), and the NHLBI (R01 HL138466, R01 HL139714). K.J.L. is supported by National Institutes of Health (NIH) K08 HL123519 and Burroughs Welcome Fund (1014782). Histology was performed in the DDRCC advanced imaging and tissue analysis core supported by Grant #P30 DK52574. The Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant #UL1TR000448 from the National Center for Research Resources (NCRR), a component of the NIH, and NIH Roadmap for Medical Research. S.G.D. is supported by NHLBI R01 HL135121-01, AHA HF 16SFRN29020000-Project 1, and the Nora Eccles Treadwell Foundation. M.N. is supported by NIH HL139598 and the MGH Research Scholar Program. Y.L. is supported by NIH R01HL131908 and R01HL125655. D.K. is supported by NIH P01AI116501 and R01 HL094601, Veterans Administration Merit Review grant 1I01BX002730 and the Foundation for Barnes-Jewish Hospital. M.H. was supported by an MGH ECOR Tosteson and Fund for Medical Discovery Fellowship (2017A052660).	Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bittmann I, 2001, AM J CLIN PATHOL, V115, P525; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Brandenburger M, 2012, CARDIOVASC RES, V93, P50, DOI 10.1093/cvr/cvr259; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Diakos NA, 2014, J AM COLL CARDIOL, V64, P1602, DOI 10.1016/j.jacc.2014.05.073; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Drakos SG, 2013, J AM COLL CARDIOL, V61, P1985, DOI 10.1016/j.jacc.2013.01.072; Eguiluz-Gracia I, 2016, THORAX, V71, P1006, DOI 10.1136/thoraxjnl-2016-208292; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fujiu K, 2017, NAT MED, V23, P611, DOI 10.1038/nm.4326; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Haniff M, 2009, J EXP MED, V206, P371, DOI 10.1084/jem.20081633; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Kanitakis J, 2004, NEW ENGL J MED, V351, P2661, DOI 10.1056/NEJM200412163512523; Kaufmann A, 2001, J LEUKOCYTE BIOL, V69, P248; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Li WJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87315; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; SAWYER RT, 1982, LAB INVEST, V46, P165; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Vickers AEM, 2004, TOXICOL SCI, V82, P534, DOI 10.1093/toxsci/kfh285; VOLKMAN A, 1983, LAB INVEST, V49, P291; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zarif JC, 2016, BIOTECHNIQUES, V61, P33, DOI 10.2144/000114435	46	254	256	12	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1234	+		10.1038/s41591-018-0059-x	http://dx.doi.org/10.1038/s41591-018-0059-x			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29892064	Green Accepted			2022-12-27	WOS:000440955500029
J	Kourtis, N; Lazaris, C; Hockemeyerl, K; Balandran, JC; Jimenez, AR; Mullenders, J; Gong, Y; Trimarchi, T; Bhatt, K; Hu, H; Shrestha, L; Ambesi-Impiombato, A; Kelliher, M; Paietta, E; Chiosiss, G; Guzman, ML; Ferrando, AA; Tsirigos, A; Aifantis, I				Kourtis, Nikos; Lazaris, Charalampos; Hockemeyerl, Kathryn; Balandran, Juan Carlos; Jimenez, Alejandra R.; Mullenders, Jasper; Gong, Yixiao; Trimarchi, Thomas; Bhatt, Kamala; Hu, Hai; Shrestha, Liza; Ambesi-Impiombato, Alberto; Kelliher, Michelle; Paietta, Elisabeth; Chiosiss, Gabriela; Guzman, Monica L.; Ferrando, Adolfo A.; Tsirigos, Aristotelis; Aifantis, Iannis			Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia	NATURE MEDICINE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; C-MYC; NOTCH1 ACTIVATION; GENE-EXPRESSION; HSP90 CHAPERONE; REVEALS; MUTATIONS; PROTEIN; TARGET	Cellular transformation is accompanied by extensive rewiring of many biological processes leading to augmented levels of distinct types of cellular stress, including proteotoxic stress. Cancer cells critically depend on stress-relief pathways for their survival. However, the mechanisms underlying the transcriptional initiation and maintenance of the oncogenic stress response remain elusive. Here, we show that the expression of heat shock transcription factor 1 (HSF1) and the downstream mediators of the heat shock response is transcriptionally upregulated in T cell acute lymphoblastic leukemia (T-ALL). Hsf1 ablation suppresses the growth of human T-ALL and eradicates leukemia in mouse models of T-ALL, while sparing normal hematopoiesis. HSF1 drives a compact transcriptional program and among the direct HSF1 targets, specific chaperones and co-chaperones mediate its critical role in T-ALL. Notably, we demonstrate that the central T-ALL oncogene NOTCH1 hijacks the cellular stress response machinery by inducing the expression of HSF1 and its downstream effectors. The NOTCH1 signaling status controls the levels of chaperone/co-chaperone complexes and predicts the response of T-ALL patient samples to HSP90 inhibition. Our data demonstrate an integral crosstalk between mediators of oncogene and non-oncogene addiction and reveal critical nodes of the heat shock response pathway that can be targeted therapeutically.	[Kourtis, Nikos; Lazaris, Charalampos; Hockemeyerl, Kathryn; Mullenders, Jasper; Gong, Yixiao; Trimarchi, Thomas; Bhatt, Kamala; Hu, Hai; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Kourtis, Nikos; Lazaris, Charalampos; Hockemeyerl, Kathryn; Mullenders, Jasper; Gong, Yixiao; Trimarchi, Thomas; Bhatt, Kamala; Hu, Hai; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Isaac Perlmutter Canc Ctr, New York, NY 10003 USA; [Balandran, Juan Carlos] CINVESTAV, Mol Biomed Program, IPN, Mexico City, DF, Mexico; [Balandran, Juan Carlos] CONACYT Ctr Invest Biomed Oriente, IMSS Delegac Puebla, Atlixco, Mexico; [Balandran, Juan Carlos; Jimenez, Alejandra R.; Guzman, Monica L.] Weill Cornell Med Coll, Dept Med, Haematol & Med Oncol, New York, NY USA; [Shrestha, Liza; Chiosiss, Gabriela] Sloan Kettering Inst, Program Chem Biol, New York, NY USA; [Ambesi-Impiombato, Alberto; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Inst Canc Genet, New York, NY USA; [Ambesi-Impiombato, Alberto; Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Kelliher, Michelle] Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Paietta, Elisabeth] Montefiore Med Ctr, New York, NY USA; [Tsirigos, Aristotelis] NYU, Sch Med, Appl Bioinformat Labs, New York, NY USA; [Mullenders, Jasper] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [Mullenders, Jasper] UMC, Utrecht, Netherlands; [Ambesi-Impiombato, Alberto] PsychoGenics Inc, New York, NY USA	New York University; New York University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Cornell University; Memorial Sloan Kettering Cancer Center; Columbia University; Columbia University; University of Massachusetts System; University of Massachusetts Worcester; Montefiore Medical Center; New York University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Kourtis, N; Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.; Kourtis, N; Aifantis, I (corresponding author), NYU, Sch Med, Isaac Perlmutter Canc Ctr, New York, NY 10003 USA.	Nikolaos.Kourtis@nyumc.org; Iannis.Aifantis@nyumc.org	Balandrán, Juan Carlos/AAM-3818-2020; Lazaris, Charalampos/J-9230-2015	Balandrán, Juan Carlos/0000-0003-1978-248X; Lazaris, Charalampos/0000-0002-7345-8288; Tsirigos, Aristotelis/0000-0002-7512-8477	National Institutes of Health (NIH)/National Cancer Institute (NCI) [P30CA016087-30]; NYU Histology Core [5P30CA16087-31]; American Cancer Society [RSG-15-189-01-RMC]; Leukemia AMP; Lymphoma Society New Idea Award [8007-17]; NIH [R01CA133379, R01CA105129, R01CA149655, 5R01CA173636, 1R01CA194923]; NYSTEM program of the New York State Health Department [NYSTEM-N11G-255]; Leukemia AMP; Lymphoma Society (LLS) Translational Research Program (TRP); CONACyT [FOSISSS 2015-1-261848]; IMSS [FIS/IMSS/PROT/G14/1289]; KWF [BUIT2012-5358]; Human Frontiers Science Program (HFSP) Long Term Fellowship [LT000150/2013-L]; Charles H. Revson Senior Fellowship in Biomedical Science [15-31]; European Molecular Biology Organization (EMBO) Long Term Fellowship [ALTF 850-2012]; NATIONAL CANCER INSTITUTE [P01CA186866, P50CA192937, U24CA196172, P30CA016087, R01CA133379, R01CA096899, R01CA149655, R01CA105129, R01CA194923, R01CA202027, R35CA210065, R01CA202025, R01CA173636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Histology Core; American Cancer Society(American Cancer Society); Leukemia AMP; Lymphoma Society New Idea Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM program of the New York State Health Department; Leukemia AMP; Lymphoma Society (LLS) Translational Research Program (TRP); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IMSS; KWF; Human Frontiers Science Program (HFSP) Long Term Fellowship(Human Frontier Science Program); Charles H. Revson Senior Fellowship in Biomedical Science; European Molecular Biology Organization (EMBO) Long Term Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Aifantis laboratory for discussions throughout the duration of this project; T. Papagiannakopoulos and P. Ntziachristos for critical assessment of this work; E. Christians (UPMC Univ. Paris 06, CNRS) for the Hsf1<SUP>f/f</SUP> mice; A. Heguy and the NYU Genome Technology Center (supported in part by National Institutes of Health (NIH)/National Cancer Institute (NCI) grant P30CA016087-30) for expertise with sequencing experiments; the NYU Histology Core (5P30CA16087-31) for assistance; C. Loomis and L. Chiriboga for immunohistochemistry experiments; C. Jamieson (UCSD) for human LICs; The ECOG-ACRIN Cancer Research Group for clinical specimens. This work has used computing resources at the High Performance Computing Facility at the NYU Medical Center. A. T. is supported by a Research Scholar Grant (RSG-15-189-01-RMC) from the American Cancer Society and a Leukemia & Lymphoma Society New Idea Award (8007-17). I. A. is supported by the NIH (R01CA133379, R01CA105129, R01CA149655, 5R01CA173636, 1R01CA194923), the NYSTEM program of the New York State Health Department (NYSTEM-N11G-255) and the Leukemia & Lymphoma Society (LLS) Translational Research Program (TRP). J.C.B. was supported by CONACyT (FOSISSS 2015-1-261848) and IMSS (FIS/IMSS/PROT/G14/1289). J.M. was supported by KWF BUIT2012-5358. N.K. is supported by a Human Frontiers Science Program (HFSP) Long Term Fellowship (LT000150/2013-L) and previously by a Charles H. Revson Senior Fellowship in Biomedical Science (15-31) and a European Molecular Biology Organization (EMBO) Long Term Fellowship (ALTF 850-2012).	Akahane K, 2016, LEUKEMIA, V30, P219, DOI 10.1038/leu.2015.222; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Aster JC, 1997, J BIOL CHEM, V272, P11336; Belver L, 2016, NAT REV CANCER, V16, P494, DOI 10.1038/nrc.2016.63; BENBASSAT H, 1990, CANCER GENET CYTOGEN, V49, P241, DOI 10.1016/0165-4608(90)90148-4; Brandvold KR, 2015, J MOL BIOL, V427, P2931, DOI 10.1016/j.jmb.2015.05.010; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai CK, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0525; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; de Jonge HJM, 2011, LEUKEMIA, V25, P1825, DOI 10.1038/leu.2011.172; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fabbri G, 2017, P NATL ACAD SCI USA, V114, pE2911, DOI 10.1073/pnas.1702564114; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Gomez-Pastor R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14405; Gong YX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3817-0; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herranz D, 2015, NAT MED, V21, P1182, DOI 10.1038/nm.3955; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Holmes R, 2009, COLD SPRING HARB PRO, V2009; Hu YZ, 2011, J BIOL CHEM, V286, P31397, DOI 10.1074/jbc.M111.255851; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kourtis N, 2015, NAT CELL BIOL, V17, P322, DOI 10.1038/ncb3121; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Masson F, 2011, MOL CELL BIOL, V31, P3410, DOI 10.1128/MCB.05237-11; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Morimoto R. I., 2017, TRENDS CELL BIOL; Moulick K, 2011, NAT CHEM BIOL, V7, P818, DOI 10.1038/nchembio.670; Nagel R, 2016, EMBO REP, V17, P1516, DOI 10.15252/embr.201643030; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Roderick JE, 2014, BLOOD, V123, P1040, DOI 10.1182/blood-2013-08-522698; Rodina A, 2016, NATURE, V538, P397, DOI 10.1038/nature19807; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Shrestha L, 2016, CELL CHEM BIOL, V23, P158, DOI 10.1016/j.chembiol.2015.12.006; Solis EJ, 2016, MOL CELL, V63, P60, DOI 10.1016/j.molcel.2016.05.014; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taldone T, 2014, J MED CHEM, V57, P1208, DOI 10.1021/jm401552y; Taldone T, 2011, BIOORG MED CHEM LETT, V21, P5347, DOI 10.1016/j.bmcl.2011.07.026; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Tatarek J, 2011, BLOOD, V118, P1579, DOI 10.1182/blood-2010-08-300343; Tsirigos A, 2012, BIOINFORMATICS, V28, P282, DOI 10.1093/bioinformatics/btr646; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Wang ZJ, 2017, CLIN CANCER RES, V23, P3834, DOI 10.1158/1078-0432.CCR-16-2880; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xi CX, 2012, J BIOL CHEM, V287, P35646, DOI 10.1074/jbc.M112.377481; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	80	46	47	1	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1157	+		10.1038/s41591-018-0105-8	http://dx.doi.org/10.1038/s41591-018-0105-8			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30038221	Green Accepted			2022-12-27	WOS:000440955500022
J	Mainardi, S; Mulero-Sanchez, A; Prahallad, A; Germano, G; Bosma, A; Krimpenfort, P; Lieftink, C; Steinberg, JD; de Wit, N; Goncalves-Ribeiro, S; Nadal, E; Bardelli, A; Villanueva, A; Bernards, R				Mainardi, Sara; Mulero-Sanchez, Antonio; Prahallad, Anirudh; Germano, Giovanni; Bosma, Astrid; Krimpenfort, Paul; Lieftink, Cor; Steinberg, Jeffrey D.; de Wit, Niels; Goncalves-Ribeiro, Samuel; Nadal, Ernest; Bardelli, Alberto; Villanueva, Alberto; Bernards, Rene			SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo	NATURE MEDICINE			English	Article							PHOSPHOTYROSINE PHOSPHATASE; TYROSINE PHOSPHORYLATION; INDUCED SENESCENCE; MEK INHIBITORS; K-RAS; EXPRESSION; MUTATIONS; PROGRESSION; RESISTANCE; THERAPY	RAS mutations are frequent in human cancer, especially in pancreatic, colorectal and non-small-cell lung cancers (NSCLCs)(1-3). Inhibition of the RAS oncoproteins has proven difficult(4), and attempts to target downstream effectors(5-7) have been hampered by the activation of compensatory resistance mechanisms(8). It is also well established that KRAS-mutant tumors are insensitive to inhibition of upstream growth factor receptor signaling. Thus, epidermal growth factor receptor antibody therapy is only effective in KRAS wild-type colon cancers(9,10). Consistently, inhibition of SHP2 (also known as PTPN11), which links receptor tyrosine kinase signaling to the RAS-RAF-MEK-ERK pathway(11,12), was shown to be ineffective in KRAS-mutant or BRAF-mutant cancer cell lines(13). Our data also indicate that SHP2 inhibition in KRAS-mutant NSCLC cells under normal cell culture conditions has little effect. By contrast, SHP2 inhibition under growth factor-limiting conditions in vitro results in a senescence response. In vivo, inhibition of SHP2 in KRAS-mutant NSCLC also provokes a senescence response, which is exacerbated by MEK inhibition. Our data identify SHP2 inhibition as an unexpected vulnerability of KRAS-mutant NSCLC cells that remains undetected in cell culture and can be exploited therapeutically.	[Mainardi, Sara; Mulero-Sanchez, Antonio; Prahallad, Anirudh; Bosma, Astrid; Lieftink, Cor; Bernards, Rene] Netherlands Canc Inst, Oncode Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Germano, Giovanni; Bardelli, Alberto] IRCCS, Candiolo Canc Inst FPO, Turin, Italy; [Germano, Giovanni; Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy; [Krimpenfort, Paul] Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands; [Steinberg, Jeffrey D.; de Wit, Niels] Netherlands Canc Inst, Mouse Clin Canc & Aging MCCA Imaging Unit, Amsterdam, Netherlands; [Goncalves-Ribeiro, Samuel; Villanueva, Alberto] IDIBELL, Grp Chemoresistance & Predict Factors, Subprogram Canc Therapeut Resistance ProCURE, ICO,Oncobell Program, Barcelona, Spain; [Nadal, Ernest] Catalan Inst Oncol ICO, Dept Med Oncol, Thorac Oncol Unit, Barcelona, Spain; [Villanueva, Alberto] Business Bioincubator, Xenopat SL, Bellvitge Hlth Sci Campus, Barcelona, Spain; [Prahallad, Anirudh] Novartis Pharma AG, BioMed Res, Basel, Switzerland	Netherlands Cancer Institute; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Netherlands Cancer Institute; Netherlands Cancer Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Novartis	Bernards, R (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands.	r.bernards@nki.nl	Gonçalves-Ribeiro, Samuel/ABI-2149-2020; Germano, Giovanni/AAB-6672-2020; BARDELLI, Alberto/J-9721-2018; Steinberg, Jeffrey/H-3540-2013	Germano, Giovanni/0000-0003-1688-8684; BARDELLI, Alberto/0000-0003-1647-5070; Steinberg, Jeffrey/0000-0003-4110-3586; Goncalves-Ribeiro, Samuel/0000-0002-0261-3965; Nadal, Ernest/0000-0002-9674-5554; Mulero Sanchez, Antonio/0000-0003-1668-7022	Center for Cancer Genomics (CGC.NL); Dutch Cancer Society (KWF); EMBO Long-Term Fellowship [ALTF 1184-2014]; European Commission (Marie Curie Actions, LTFCOFUND2013) [GA-2013-609409]; Associazione Italiana per la Ricerca sul Cancro (AIRC); European Union; European Community's Seventh Framework Programme [602901]; Horizon 2020 grant [635342-2]; IMI [115749 CANCER-ID]; AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille [9970]; AIRC IG [16788]; Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille Ministero della Salute; Fondo de Investigaciones Sanitarias, FIS [PI16-01898, PI14-01109]; Spanish Association Against Cancer, AECC [CGB14142035THOM]	Center for Cancer Genomics (CGC.NL); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); European Commission (Marie Curie Actions, LTFCOFUND2013); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Union(European Commission); European Community's Seventh Framework Programme(European Commission); Horizon 2020 grant; IMI; AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille(Fondazione AIRC per la ricerca sul cancro); AIRC IG(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille Ministero della Salute; Fondo de Investigaciones Sanitarias, FIS(Instituto de Salud Carlos III); Spanish Association Against Cancer, AECC	We thank the Intervention Unit of the Mouse Clinic for Cancer and Aging (MCCA) of the Netherlands Cancer Institute, in particular, M. v. d. Ven and N. Proost, for the technical support with in vivo studies. We are grateful to pathologist H. Horlings for evaluation and scoring of in vivo samples. We are grateful to the NCI RAS Initiative for the kind gift of the panel of Rasless cells reconstituted with mutant KRAS alleles. This work was supported by grants from the Center for Cancer Genomics (CGC.NL) and the Dutch Cancer Society (KWF). S.M. was financially supported by an EMBO Long-Term Fellowship (ALTF 1184-2014) co-funded by the European Commission FP7 (Marie Curie Actions, LTFCOFUND2013, GA-2013-609409). G.G. was supported by an iCare fellowship by the Associazione Italiana per la Ricerca sul Cancro (AIRC) co-funded by the European Union. A. Bardelli was supported by the European Community's Seventh Framework Programme under grant agreement no. 602901 MErCuRIC, Horizon 2020 grant agreement no. 635342-2 MoTriColor, IMI contract no. 115749 CANCER-ID, AIRC 2010 Special Program Molecular Clinical Oncology 5 per mille, Project no. 9970 Extension program, AIRC IG no. 16788, Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per mille 2011 e 2014 Ministero della Salute. A.V. and E.N. were supported by the Fondo de Investigaciones Sanitarias, FIS (PI16-01898 (to A.V.) and PI14-01109 (to E.N.)), and by the Spanish Association Against Cancer, AECC (CGB14142035THOM) (to A.V.).	Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Bernards R, 2012, CELL, V151, P465, DOI 10.1016/j.cell.2012.10.014; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lan LX, 2015, EMBO J, V34, P1493, DOI 10.15252/embj.201489004; Lu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21949; Lu W, 2003, BIOCHEMISTRY-US, V42, P5461, DOI 10.1021/bi0340144; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Purcell M, 2014, CELL CYCLE, V13, P3927, DOI 10.4161/15384101.2014.973327; Ruess DA, 2018, NAT MED, V24, P954, DOI 10.1038/s41591-018-0024-8; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Waters AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao3332; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	37	175	187	5	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					961	+		10.1038/s41591-018-0023-9	http://dx.doi.org/10.1038/s41591-018-0023-9			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29808006	Green Submitted			2022-12-27	WOS:000438187700024
J	Shioda, N; Yabuki, Y; Yamaguchi, K; Onozato, M; Li, Y; Kurosawa, K; Tanabe, H; Okamoto, N; Era, T; Sugiyama, H; Wada, T; Fukunaga, K				Shioda, Norifumi; Yabuki, Yasushi; Yamaguchi, Kouya; Onozato, Misaki; Li, Yue; Kurosawa, Kenji; Tanabe, Hideyuki; Okamoto, Nobuhiko; Era, Takumi; Sugiyama, Hiroshi; Wada, Takahito; Fukunaga, Kohji			Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome	NATURE MEDICINE			English	Article							PROTEIN-KINASE-II; THALASSEMIA-MENTAL-RETARDATION; LONG-TERM POTENTIATION; 5-AMINOLEVULINIC ACID; ADD DOMAIN; HISTONE CHAPERONE; IMPRINTED GENES; MESSENGER-RNA; MUTATIONS; METHYLATION	Alpha-thalassemia X-linked intellectual disability (ATR-X) syndrome is caused by mutations in ATRX, which encodes a chromatin-remodeling protein. Genome-wide analyses in mouse and human cells indicate that ATRX tends to bind to G-rich sequences with a high potential to form G-quadruplexes. Here, we report that Atrx mutation induces aberrant upregulation of Xlr3b expression in the mouse brain, an outcome associated with neuronal pathogenesis displayed by ATR-X model mice. We show that ATRX normally binds to G-quadruplexes in CpG islands of the imprinted Xlr3b gene, regulating its expression by recruiting DNA methyltransferases. Xlr3b binds to dendritic mRNAs, and its overexpression inhibits dendritic transport of the mRNA encoding CaMKII-alpha, promoting synaptic dysfunction. Notably, treatment with 5-ALA, which is converted into G-quadruplex-binding metabolites, reduces RNA polymerase II recruitment and represses Xlr3b transcription in ATR-X model mice. 5-ALA treatment also rescues decreased synaptic plasticity and cognitive deficits seen in ATR-X model mice. Our findings suggest a potential therapeutic strategy to target G-quadruplexes and decrease cognitive impairment associated with ATR-X syndrome.	[Shioda, Norifumi] Gifu Pharmaceut Univ, Dept Biofunct Anal, Lab Mol Biol, Gifu, Japan; [Yabuki, Yasushi; Yamaguchi, Kouya; Onozato, Misaki; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan; [Li, Yue; Sugiyama, Hiroshi] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Genet, Yokohama, Kanagawa, Japan; [Tanabe, Hideyuki] SOKENDAI Grad Univ Adv Studies, Sch Adv Sci, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Okamoto, Nobuhiko] Osaka Womens & Childrens Hosp, Dept Med Genet, Osaka, Japan; [Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto, Japan; [Wada, Takahito] Kyoto Univ, Grad Sch Med, Dept Med Eth & Med Genet, Kyoto, Japan	Gifu Pharmaceutical University; Tohoku University; Kyoto University; Graduate University for Advanced Studies - Japan; Kumamoto University; Kyoto University	Shioda, N (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Anal, Lab Mol Biol, Gifu, Japan.; Fukunaga, K (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan.; Wada, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Eth & Med Genet, Kyoto, Japan.	shioda@gifu-pu.ac.jp; wadataka@kuhp.kyoto-u.ac.jp; kfukunaga@m.tohoku.ac.jp	WADA, Takahito/GYR-3028-2022; Sugiyama, Hiroshi/C-7687-2011; Yabuki, Yasushi/AAF-7931-2021; Fukunaga, Kohji/AAI-8811-2021	Sugiyama, Hiroshi/0000-0001-8923-5946; Fukunaga, Kohji/0000-0001-8526-2824	Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED); MEXT/JSPS KAKENHI [16K08265, 25110705]	Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank I. Kitajima for kindly providing Atrx<SUP>Delta E2</SUP> mice, deposited in the RIKEN BioResource Center (RBRC04937), H. Shimbo for kindly assisting in cell culture, D. Picketts for kindly providing the Atrx cDNA (pEGFP-C2-ATRX-HA) plasmid, N. Berube for kindly providing the ATRX shRNA (pSUPER-shATRX1) plasmid and K. Kosik for kindly providing the GFP-MS2-nls and MS2-binding site-CaMKII-alpha 3' UTR plasmids. This research was supported by the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED; N.S., K.K., H.T., N.O., H.S., K.F. and T.W.). This work was also supported by MEXT/JSPS KAKENHI (grant numbers 16K08265 and 25110705) to N.S.	Abidi FE, 2005, EUR J HUM GENET, V13, P176, DOI 10.1038/sj.ejhg.5201303; Al-Saber F, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8294805; Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; BERGSAGEL PL, 1994, GENE, V150, P345, DOI 10.1016/0378-1119(94)90450-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Butler MG, 2009, J ASSIST REPROD GEN, V26, P477, DOI 10.1007/s10815-009-9353-3; Clynes D, 2013, CURR OPIN GENET DEV, V23, P289, DOI 10.1016/j.gde.2013.01.005; Dalton JT, 2002, J PHARMACOL EXP THER, V301, P507, DOI 10.1124/jpet.301.2.507; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Howard MT, 2004, J MED GENET, V41, P951, DOI 10.1136/jmg.2004.020248; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Kernohan KD, 2014, NUCLEIC ACIDS RES, V42, P8356, DOI 10.1093/nar/gku564; Kernohan KD, 2010, DEV CELL, V18, P191, DOI 10.1016/j.devcel.2009.12.017; Kikin O, 2008, NUCLEIC ACIDS RES, V36, pD141, DOI 10.1093/nar/gkm982; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Levy MA, 2015, HUM MOL GENET, V24, P1824, DOI 10.1093/hmg/ddu596; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li Y, 2016, CHEMBIOCHEM, V17, P928, DOI 10.1002/cbic.201500655; Martinez-Garay I, 2002, GENOMICS, V80, P259, DOI 10.1006/geno.2002.6834; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Nogami T, 2011, HIPPOCAMPUS, V21, P678, DOI 10.1002/hipo.20782; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Perotti C, 2002, BRIT J CANCER, V87, P790, DOI 10.1038/sj.bjc.6600559; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Roberts DW, 2012, NEUROSURG CLIN N AM, V23, P371, DOI 10.1016/j.nec.2012.04.001; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Shioda N, 2017, MOL PSYCHIATR, V22, P1205, DOI 10.1038/mp.2016.200; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Skalska L, 2017, NAT REV MOL CELL BIO, V18, P1, DOI 10.1038/nrm.2017.12; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017; VILLANUEVA A, 1993, CANCER LETT, V73, P59, DOI 10.1016/0304-3835(93)90188-F; Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036	57	45	47	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					802	+		10.1038/s41591-018-0018-6	http://dx.doi.org/10.1038/s41591-018-0018-6			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29785027	Green Accepted			2022-12-27	WOS:000434281300025
J	Yant, SR; Mulato, A; Hansen, D; Tse, WC; Niedziela-Majka, A; Zhang, JR; Stepan, GJ; Jin, DB; Wong, MH; Perreira, JM; Singer, E; Papalia, GA; Hu, EY; Zheng, J; Lu, B; Schroeder, SD; Chou, K; Ahmadyar, S; Liclican, A; Yu, H; Novikov, N; Paoli, E; Gonik, D; Ram, RR; Hung, M; McDougall, WM; Brass, AL; Sundquist, WI; Cihlar, T; Link, JO				Yant, Stephen R.; Mulato, Andrew; Hansen, Derek; Tse, Winston C.; Niedziela-Majka, Anita; Zhang, Jennifer R.; Stepan, George J.; Jin, Debi; Wong, Melanie H.; Perreira, Jill M.; Singer, Eric; Papalia, Giuseppe A.; Hu, Eric Y.; Zheng, Jim; Lu, Bing; Schroeder, Scott D.; Chou, Kevin; Ahmadyar, Shekeba; Liclican, Albert; Yu, Helen; Novikov, Nikolai; Paoli, Eric; Gonik, Daniel; Ram, Renee R.; Hung, Magdeleine; McDougall, William M.; Brass, Abraham L.; Sundquist, Wesley I.; Cihlar, Tomas; Link, John O.			A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model	NATURE MEDICINE			English	Article							NONADHERENCE; ASSAYS; LEVEL	People living with HIV (PLWH) have expressed concern about the life-long burden and stigma associated with taking pills daily and can experience medication fatigue that might lead to suboptimal treatment adherence and the emergence of drug-resistant viral variants, thereby limiting future treatment options(1)(-3). As such, there is strong interest in long-acting antiretroviral (ARV) agents that can be administered less frequently(4). Herein, we report GS-CA1, a new archetypal small-molecule HIV capsid inhibitor with exceptional potency against HIV-2 and all major HIV-1 types, including viral variants resistant to the ARVs currently in clinical use. Mechanism-of-action studies indicate that GS-CA1 binds directly to the HIV-1 capsid and interferes with capsid-mediated nuclear import of viral DNA, HIV particle production and ordered capsid assembly. GS-CA1 selects in vitro for unfit GS-CAI-resistant capsid variants that remain fully susceptible to other classes of ARVs. Its high metabolic stability and low solubility enabled sustained drug release in mice following a single subcutaneous dosing. GS-CA1 showed high antiviral efficacy as a long-acting injectable monotherapy in a humanized mouse model of HIV-1 infection, outperforming long-acting rilpivirine. Collectively, these results demonstrate the potential of ultrapotent capsid inhibitors as new long-acting agents for the treatment of HIV-1 infection.	[Yant, Stephen R.; Mulato, Andrew; Hansen, Derek; Tse, Winston C.; Niedziela-Majka, Anita; Zhang, Jennifer R.; Stepan, George J.; Jin, Debi; Wong, Melanie H.; Singer, Eric; Papalia, Giuseppe A.; Hu, Eric Y.; Zheng, Jim; Lu, Bing; Schroeder, Scott D.; Chou, Kevin; Ahmadyar, Shekeba; Liclican, Albert; Yu, Helen; Novikov, Nikolai; Paoli, Eric; Gonik, Daniel; Ram, Renee R.; Hung, Magdeleine; Cihlar, Tomas; Link, John O.] Gilead Sci, Foster City, CA 94404 USA; [Perreira, Jill M.; McDougall, William M.; Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA USA; [Brass, Abraham L.] Peak Gastroenterol Associates, Colorado Springs, CO USA; [Sundquist, Wesley I.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT USA; [Tse, Winston C.] Vir Biotechnol Inc, San Francisco, CA USA	Gilead Sciences; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Utah System of Higher Education; University of Utah	Yant, SR (corresponding author), Gilead Sci, Foster City, CA 94404 USA.	stephen.yant@gilead.com			Gilead Sciences, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI150464] Funding Source: NIH RePORTER	Gilead Sciences, Inc.(Gilead Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to A. Irrinki for assisting with the FACS portion of the entry studies, and K. Stray for supplying the pLAI-RenLuc vector. We appreciate the expertise provided by J. Wong at the Gladstone Institute Electron Microscopy Core facility, C. Lackman-Smith at Southern Research and C. Verhaeghe at TransCure bioServices as part of the work each performed under contracted research agreements. This study was funded by Gilead Sciences, Inc. The anti-HIV-1 p24 AG3.0 monoclonal antibody was obtained from J. Allan through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH.	Alberti MO, 2015, AIDS RES HUM RETROV, V31, P1278, DOI 10.1089/aid.2015.0074; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Balasubramaniam M, 2019, J VIROL, V93, DOI 10.1128/JVI.01741-18; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Boretzki J, 2017, PATIENT PREFER ADHER, V11, P1897, DOI 10.2147/PPA.S141762; Carnes SK, 2018, CURR OPIN HIV AIDS, V13, P359, DOI 10.1097/COH.0000000000000472; Chen NY, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0262-0; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Claborn K. R., 2015, PSYCHOL HEALTH MED, V20, P1; Corneli A, 2016, JAIDS-J ACQ IMM DEF, V71, P452, DOI 10.1097/QAI.0000000000000880; Daar E. S., 2019, IAS C HIV SCI; De Clercq E, 2010, CURR OPIN PHARMACOL, V10, P507, DOI 10.1016/j.coph.2010.04.011; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ferretti F, 2018, CURR OPIN HIV AIDS, V13, P300, DOI 10.1097/COH.0000000000000474; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Hulme AE, 2015, J VIROL, V89, P5350, DOI 10.1128/JVI.00476-15; Hung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058035; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Margot NA, 2010, ANTIMICROB AGENTS CH, V54, P2345, DOI 10.1128/AAC.01784-09; Matreyek KA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003693; Nyaku AN, 2017, CURR HIV-AIDS REP, V14, P63, DOI 10.1007/s11904-017-0353-0; Peng K, 2014, ELIFE, V3, DOI 10.7554/eLife.04114; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Sager J, 2019, C RETR OPP INF CROI; Spenlehauer C, 2001, VIROLOGY, V280, P292, DOI 10.1006/viro.2000.0780; Thenin-Houssier S, 2016, CURR HIV RES, V14, P270, DOI 10.2174/1570162X14999160224103555; Tsiang M, 2016, ANTIMICROB AGENTS CH, V60, P7086, DOI 10.1128/AAC.01474-16; Yamashita M, 2017, TRENDS MICROBIOL, V25, P741, DOI 10.1016/j.tim.2017.04.004; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194	37	66	67	3	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1377	+		10.1038/s41591-019-0560-x	http://dx.doi.org/10.1038/s41591-019-0560-x			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501601	Green Accepted			2022-12-27	WOS:000484832800019
J	Campanella, G; Hanna, MG; Geneslaw, L; Miraflor, A; Silva, VWK; Busam, KJ; Brogi, E; Reuter, VE; Klimstra, DS; Fuchs, TJ				Campanella, Gabriele; Hanna, Matthew G.; Geneslaw, Luke; Miraflor, Allen; Silva, Vitor Werneck Krauss; Busam, Klaus J.; Brogi, Edi; Reuter, Victor E.; Klimstra, David S.; Fuchs, Thomas J.			Clinical-grade computational pathology using weakly supervised deep learning on whole slide images	NATURE MEDICINE			English	Article							SKIN-CANCER	The development of decision support systems for pathology and their deployment in clinical practice have been hindered by the need for large manually annotated datasets. To overcome this problem, we present a multiple instance learning-based deep learning system that uses only the reported diagnoses as labels for training, thereby avoiding expensive and time-consuming pixel-wise manual annotations. We evaluated this framework at scale on a dataset of 44,732 whole slide images from 15,187 patients without any form of data curation. Tests on prostate cancer, basal cell carcinoma and breast cancer metastases to axillary lymph nodes resulted in areas under the curve above 0.98 for all cancer types. Its clinical application would allow pathologists to exclude 65-75% of slides while retaining 100% sensitivity. Our results show that this system has the ability to train accurate classification models at unprecedented scale, laying the foundation for the deployment of computational decision support systems in clinical practice.	[Campanella, Gabriele; Hanna, Matthew G.; Geneslaw, Luke; Miraflor, Allen; Silva, Vitor Werneck Krauss; Busam, Klaus J.; Brogi, Edi; Reuter, Victor E.; Klimstra, David S.; Fuchs, Thomas J.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Campanella, Gabriele; Fuchs, Thomas J.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Fuchs, TJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.; Fuchs, TJ (corresponding author), Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA.	fuchst@mskcc.org		Campanella, Gabriele/0000-0001-6299-1311; Geneslaw, Luke/0000-0001-6862-9102	NIH/NCI Cancer Center [P30 CA008748]	NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank The Warren Alpert Center for Digital and Computational Pathology and MSK's high-performance computing team for their support. We also thank J. Samboy for leading the digital scanning initative and E. Stamelos and F. Cao, from the pathology informatics team at MSK, for their invaluable help querying the digital slide and LIS databases. We are in debt to P. Schueffler for extending the digital whole slide viewer specifically for this study and for supporting its use by the whole research team. Finally, we thank C. Virgo for managing the project, D.V.K. Yarlagadda for development support and D. Schnau for help editing the manuscript. This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Andrews S, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P943; BALL CLARA SUE, 1966, BIOS, V37, P51; Bejnordi BE, 2018, MODERN PATHOL, V31, P1502, DOI 10.1038/s41379-018-0073-z; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Bychkov D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21758-3; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Coudray N, 2018, NAT MED, V24, P1559, DOI 10.1038/s41591-018-0177-5; Das K, 2017, I S BIOMED IMAGING, P1024, DOI 10.1109/ISBI.2017.7950690; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dietterich TG, 1997, ARTIF INTELL, V89, P31, DOI 10.1016/S0004-3702(96)00034-3; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fuchs TJ, 2011, COMPUT MED IMAG GRAP, V35, P515, DOI 10.1016/j.compmedimag.2011.02.006; Fuchs TJ, 2008, LECT NOTES COMPUT SC, V5242, P1, DOI 10.1007/978-3-540-85990-1_1; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; Hajdu SI, 2011, ANN CLIN LAB SCI, V41, P201; He K., 2016, CVPR, P770; Hou L, 2016, PROC CVPR IEEE, P2424, DOI 10.1109/CVPR.2016.266; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Kraus OZ, 2016, BIOINFORMATICS, V32, P52, DOI 10.1093/bioinformatics/btw252; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeBoit P.E., 2006, PATHOLOGY GENETICS S; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Liu Y, 2017, COMMUN MATH BIOL NEU, DOI 10.1080/10408398.2017.1329704; Louis DN, 2016, ARCH PATHOL LAB MED, V140, P41, DOI 10.5858/arpa.2015-0093-SA; Mobadersany P, 2018, P NATL ACAD SCI USA, V115, pE2970, DOI 10.1073/pnas.1717139115; Nakul V, 2012, LEARNING DATA LOW IN; Olsen Thomas George, 2018, J Pathol Inform, V9, P32, DOI 10.4103/jpi.jpi_31_18; Ozdamar S. O., 1996, International Urology and Nephrology, V28, P73, DOI 10.1007/BF02550141; Paszke Adam, 2017, NIPS W; R Core Team, 2021, R LANGUAGE ENV STAT; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SVANHOLM H, 1985, ACTA PATH MICRO IM A, V93, P67; Valkonen M, 2017, CYTOM PART A, V91A, P555, DOI 10.1002/cyto.a.23089; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang D., 2016, ARXIV PREPRINT ARXIV; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Yu Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2829-5; Zhang C., 2006, ADV NEURAL INFORM PR, P1417; Zhang Q, 2002, ADV NEUR IN, V14, P1073	46	606	641	20	169	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1301	+		10.1038/s41591-019-0508-1	http://dx.doi.org/10.1038/s41591-019-0508-1			19	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31308507	Green Accepted			2022-12-27	WOS:000480414600029
J	Chapuis, AG; Egan, DN; Bar, M; Schmitt, TM; McAfee, MS; Paulson, KG; Voillet, V; Gottardo, R; Ragnarsson, GB; Bleakley, M; Yeung, CC; Muhlhauser, P; Nguyen, HN; Kropp, LA; Castelli, L; Wagener, F; Hunter, D; Lindberg, M; Cohen, K; Seese, A; McElrath, MJ; Duerkopp, N; Gooley, TA; Greenberg, PD				Chapuis, Aude G.; Egan, Daniel N.; Bar, Merav; Schmitt, Thomas M.; McAfee, Megan S.; Paulson, Kelly G.; Voillet, Valentin; Gottardo, Raphael; Ragnarsson, Gunnar B.; Bleakley, Marie; Yeung, Cecilia C.; Muhlhauser, Petri; Nguyen, Hieu N.; Kropp, Lara A.; Castelli, Luca; Wagener, Felecia; Hunter, Daniel; Lindberg, Marcus; Cohen, Kristen; Seese, Aaron; McElrath, M. Juliana; Duerkopp, Natalie; Gooley, Ted A.; Greenberg, Philip D.			T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant	NATURE MEDICINE			English	Article							MEASURABLE RESIDUAL DISEASE; VERSUS-HOST-DISEASE; ADOPTIVE IMMUNOTHERAPY; MEMORY; EXPRESSION; ANTIGEN; TRANSPLANTATION; LYMPHOCYTES; IMMUNITY; SURVIVAL	Relapse after allogeneic hematopoietic cell transplantation (HCT) is the leading cause of death in patients with acute myeloid leukemia (AML) entering HCT with poor-risk features(1-3). When HCT does produce prolonged relapse-free survival, it commonly reflects graft-versus-leukemia effects mediated by donor T cells reactive with antigens on leukemic cells(4). As graft T cells have not been selected for leukemia specificity and frequently recognize proteins expressed by many normal host tissues, graft-versus-leukemia effects are often accompanied by morbidity and mortality from graft-versushost disease(5). Thus, AML relapse risk might be more effectively reduced with T cells expressing receptors (TCRs) that target selected AML antigens(6). We therefore isolated a high-affinity Wilms' Tumor Antigen 1-specific TCR (TCRC4) from HLA-A2(+) normal donor repertoires, inserted TCRC4 into Epstein-Bar virus-specific donor CD8(+) T cells (TTCR-C4) to minimize graftversus-host disease risk and enhance transferred T cell survival(7,8), and infused these cells prophylactically post-HCT into 12 patients (NCT01640301). Relapse-free survival was 100% at a median of 44 months following infusion, while a concurrent comparative group of 88 patients with similar risk AML had 54% relapse-free survival (P = 0.002). TTCR-C4 maintained TCRC4 expression, persisted long-term and were polyfunctional. This strategy appears promising for preventing AML recurrence in individuals at increased risk of post-HCT relapse.	[Chapuis, Aude G.; Schmitt, Thomas M.; McAfee, Megan S.; Paulson, Kelly G.; Ragnarsson, Gunnar B.; Bleakley, Marie; Nguyen, Hieu N.; Kropp, Lara A.; Castelli, Luca; Wagener, Felecia; Hunter, Daniel; Lindberg, Marcus; Duerkopp, Natalie; Greenberg, Philip D.] Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA; [Chapuis, Aude G.; Egan, Daniel N.; Bar, Merav; Schmitt, Thomas M.; McAfee, Megan S.; Paulson, Kelly G.; Ragnarsson, Gunnar B.; Bleakley, Marie; Yeung, Cecilia C.; Kropp, Lara A.; Castelli, Luca; Wagener, Felecia; Hunter, Daniel; Lindberg, Marcus; McElrath, M. Juliana; Duerkopp, Natalie; Gooley, Ted A.; Greenberg, Philip D.] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA; [Chapuis, Aude G.; Egan, Daniel N.; Bar, Merav; Paulson, Kelly G.; Bleakley, Marie; Yeung, Cecilia C.; Muhlhauser, Petri; McElrath, M. Juliana; Greenberg, Philip D.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Voillet, Valentin; Gottardo, Raphael; Cohen, Kristen; Seese, Aaron; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Gottardo, Raphael; Gooley, Ted A.; Greenberg, Philip D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Greenberg, Philip D.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Greenberg, Philip D.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ragnarsson, Gunnar B.] Landspitali Haskolasjukrahus, Reykjavik, Iceland; [Nguyen, Hieu N.] Alpine Biotech, Seattle, WA USA; [Kropp, Lara A.; Castelli, Luca] Fred Hutchinson Canc Res Ctr, Therapeut Prod Program, 1124 Columbia St, Seattle, WA 98104 USA; [Lindberg, Marcus] Univ Edinburgh, Sch Informat, Edinburgh, Midlothian, Scotland	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Edinburgh	Greenberg, PD (corresponding author), Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA.; Greenberg, PD (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.; Greenberg, PD (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Greenberg, PD (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	pgreen@u.washington.edu	Paulson, Kelly G/E-5761-2010; Paulson, Kelly/HHC-3903-2022; Gottardo, Raphael/HCH-3169-2022; Schmitt, Tom/AAG-9941-2020	Paulson, Kelly G/0000-0002-0033-3708; Gottardo, Raphael/0000-0002-3867-0232; Lindberg, Marcus/0000-0002-4339-9408	Juno Therapeutics; Immunotherapy Integrated Research Center at the Fred Hutchinson Cancer Research Center; Damon Runyon; Guillot Family ZachAttacksLeukemia Foundation;  [P01CA18029-41];  [NIH-5K08CA169485]; NATIONAL CANCER INSTITUTE [K08CA169485, P01CA018029] Funding Source: NIH RePORTER	Juno Therapeutics; Immunotherapy Integrated Research Center at the Fred Hutchinson Cancer Research Center; Damon Runyon; Guillot Family ZachAttacksLeukemia Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Estey and F. Milano for their contribution to the manuscript; the Fred Hutchinson Cancer Research Center Good Manufacturing Practice Cell Processing Facility for generating TTCR-C4; the Immune Monitoring Laboratory for generating tetramers; the Flow Cytometry Facility for providing instruments and assistance in flow cytometry assays; and the Program in Immunology, Immunotherapy Integrated Research Center, Seattle Cancer Care Alliance Immunotherapy Clinic staff and K.-T. Bui for supporting the clinical protocol implementation. We received funding from grant no. P01CA18029-41 (P.G.), grant no. NIH-5K08CA169485 (A.G.C.), the Immunotherapy Integrated Research Center at the Fred Hutchinson Cancer Research Center (A.G.C.), Damon Runyon (A.G.C.), the Guillot Family ZachAttacksLeukemia Foundation and Juno Therapeutics.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Araki D, 2016, J CLIN ONCOL, V34, P329, DOI 10.1200/JCO.2015.63.3826; Ariyaratana Suzie, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000336; Armand P, 2014, BLOOD, V123, P3664, DOI 10.1182/blood-2014-01-552984; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Boeckh M, 2004, J CLIN MICROBIOL, V42, P1142, DOI 10.1128/JCM.42.3.1142-1148.2004; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Busch DH, 2016, SEMIN IMMUNOL, V28, P28, DOI 10.1016/j.smim.2016.02.001; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chapuis AG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2568; Chapuis AG, 2016, J CLIN ONCOL, V34, P3787, DOI 10.1200/JCO.2015.65.5142; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Chapuis AG, 2011, BLOOD, V117, P5391, DOI 10.1182/blood-2010-11-320226; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Deeg HJ, 2018, BIOL BLOOD MARROW TR, V24, P956, DOI 10.1016/j.bbmt.2017.12.785; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dossett ML, 2009, MOL THER, V17, P742, DOI 10.1038/mt.2008.300; Fang M, 2012, CANCER-AM CANCER SOC, V118, P2411, DOI 10.1002/cncr.26539; Festuccia M, 2016, BIOL BLOOD MARROW TR, V22, P1227, DOI 10.1016/j.bbmt.2016.03.029; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Freeman SD, 2018, J CLIN ONCOL, V36, P1486, DOI 10.1200/JCO.2017.76.3425; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gill S, 2016, BEST PRACT RES CL HA, V29, P329, DOI 10.1016/j.beha.2016.10.004; Harris DT, 2016, TRENDS PHARMACOL SCI, V37, P220, DOI 10.1016/j.tips.2015.11.004; Hemmati PG, 2017, EUR J HAEMATOL, V98, P160, DOI 10.1111/ejh.12815; Horowitz MM, 2009, BEST PRACT RES CL HA, V22, P537, DOI 10.1016/j.beha.2009.09.006; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Jones S, 2009, HUM GENE THER, V20, P630, DOI 10.1089/hum.2008.048; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kimura MY, 2013, NAT IMMUNOL, V14, P143, DOI 10.1038/ni.2494; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Legat A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00455; Limaye AP, 1999, J CLIN MICROBIOL, V37, P1113, DOI 10.1128/JCM.37.4.1113-1116.1999; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Ochsenreither S, 2012, BLOOD, V119, P5492, DOI 10.1182/blood-2011-07-365890; Parmar S, 2011, CURR OPIN HEMATOL, V18, P98, DOI 10.1097/MOH.0b013e328343b858; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; RIDDELL SR, 1992, SCIENCE, V257, P238; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Scholten KBJ, 2006, CLIN IMMUNOL, V119, P135, DOI 10.1016/j.clim.2005.12.009; Stone JD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00244; Storb R, 2013, J CLIN ONCOL, V31, P1530, DOI 10.1200/JCO.2012.45.0247; Stromnes IM, 2014, IMMUNOL REV, V257, P145, DOI 10.1111/imr.12141; Styczynski J, 2016, J CLIN ONCOL, V34, P2212, DOI 10.1200/JCO.2015.64.2405; Sugiyama H, 2010, JPN J CLIN ONCOL, V40, P377, DOI 10.1093/jjco/hyp194; Tauro S, 2005, J CLIN ONCOL, V23, P9387, DOI 10.1200/JCO.2005.02.0057; Topp MS, 2003, J EXP MED, V198, P947, DOI 10.1084/jem.20021288; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou Y, 2017, CURR HEMATOL MALIG R, V12, P557, DOI 10.1007/s11899-017-0419-5	60	145	146	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1064	+		10.1038/s41591-019-0472-9	http://dx.doi.org/10.1038/s41591-019-0472-9			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31235963	Green Accepted			2022-12-27	WOS:000474430400019
J	Ascierto, PA; Ferrucci, PF; Fisher, R; Del Vecchio, M; Atkinson, V; Schmidt, H; Schachter, J; Queirolo, P; Long, GV; Di Giacomo, AM; Svane, IM; Lotem, M; Bar-Sela, G; Couture, F; Mookerjee, B; Ghori, R; Ibrahim, N; Moreno, BH; Ribas, A				Ascierto, Paolo Antonio; Ferrucci, Pier Francesco; Fisher, Rosalie; Del Vecchio, Michele; Atkinson, Victoria; Schmidt, Henrik; Schachter, Jacob; Queirolo, Paola; Long, Georgina V.; Di Giacomo, Anna Maria; Svane, Inge Marie; Lotem, Michal; Bar-Sela, Gil; Couture, Felix; Mookerjee, Bijoyesh; Ghori, Razi; Ibrahim, Nageatte; Moreno, Blanca Homet; Ribas, Antoni			Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma	NATURE MEDICINE			English	Article							MEK INHIBITION; POOLED ANALYSIS; T-CELL; COMBINATION; SURVIVAL; VEMURAFENIB; PROGRESSION; IPILIMUMAB; NIVOLUMAB; OUTCOMES	Blocking programmed death 1 (PD-1) may enhance the durability of anti-tumor responses that are induced by the combined inhibition of BRAF and MEK1. Here we performed a randomized phase 2 trial (NCT02130466), in which patients with treatment-naive BRAF(V600E/K)-mutant, advanced melanoma received the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib together with the PD-1-blocking antibody pembrolizumab (triplet; n = 60) or placebo (doublet; n = 60). The primary end point of progression-free survival was numerically improved in the triplet group-16.0 months-compared with 10.3 months in the doublet group (hazard ratio, 0.66; P = 0.043); however, the trial did not reach the planned benefit for a statistically significant improvement. Median duration of response was 18.7 months (95% confidence interval, 10.1-22.1) and 12.5 months (95% confidence interval, 6.0-14.1); 59.8 and 27.8% of responses were estimated to have lasted for more than 18 months for triplet and doublet treatment, respectively. Grade 3-5 treatment-related adverse events occurred in 58.3 and 26.7% of patients treated with triplet and doublet therapies, respectively, which were most commonly fever, increased transaminase levels and rash. One patient who received triplet therapy died of pneumonitis. In summary, triplet therapy with dabrafenib, trametinib and pembrolizumab conferred numerically longer progressionfree survival and duration of response with a higher rate of grade 3/4 adverse events compared with the doublet therapy of dabrafenib, trametinib and placebo.	[Ascierto, Paolo Antonio] Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy; [Ferrucci, Pier Francesco] European Inst Oncol IRCCS, Milan, Italy; [Fisher, Rosalie] Auckland City Hosp, Auckland, New Zealand; [Del Vecchio, Michele] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Atkinson, Victoria] Greenslopes Private Hosp, Gallipoli Med Res Fdn, Brisbane, Qld, Australia; [Schmidt, Henrik] Aarhus Univ Hosp, Aarhus, Denmark; [Schachter, Jacob] Sheba Med Ctr Tel HaShomer, Ella Lemelbaum Inst Melanoma, Canc Ctr Oncol Inst, Ramat Gan, Israel; [Queirolo, Paola] IRCCS San Martino IST, Genoa, Italy; [Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Long, Georgina V.] Univ Sydney, Mater Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Univ Sydney, Royal North Shore Hosp, Sydney, NSW, Australia; [Di Giacomo, Anna Maria] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy; [Svane, Inge Marie] Univ Copenhagen, Herlev Hosp, Herlev, Denmark; [Lotem, Michal] Hadassah Hebrew Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Bar-Sela, Gil] Rambam Hlth Care Campus, Haifa, Israel; [Couture, Felix] Laval Univ, Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Mookerjee, Bijoyesh] Novartis, E Hanover, NJ USA; [Ghori, Razi; Ibrahim, Nageatte; Moreno, Blanca Homet] Merck & Co Inc, Kenilworth, NJ USA; [Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA USA; [Ribas, Antoni] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	IRCCS Fondazione Pascale; IRCCS European Institute of Oncology (IEO); Auckland City Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; Aarhus University; Chaim Sheba Medical Center; University of Genoa; IRCCS AOU San Martino IST; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Siena; University Hospital of Siena; University of Copenhagen; Herlev & Gentofte Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Rambam Health Care Campus; Laval University; Novartis; Merck & Company; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center	Ascierto, PA (corresponding author), Ist Nazl Tumori IRCCS Fdn G Pascale, Naples, Italy.; Ferrucci, PF (corresponding author), European Inst Oncol IRCCS, Milan, Italy.	paolo.ascierto@gmail.com; pier.ferrucci@ieo.it; aribas@mednet.ucla.edu	Long, Georgina V/C-1771-2013; Di Giacomo, Anna Maria/AAY-5625-2020; Ferrucci, Pier Francesco/AAQ-9002-2020; Ascierto, Paolo A/J-9106-2016; Schmidt, Henrik/A-1753-2008	Long, Georgina V/0000-0001-8894-3545; Ascierto, Paolo A/0000-0002-8322-475X; Ferrucci, Pier Francesco/0000-0001-6255-5851; Svane, Inge Marie/0000-0002-9451-6037; Bar-Sela, Gil/0000-0001-6579-1841; Melucci, Maria Teresa/0000-0002-1677-3345	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA; Parker Institute for Cancer Immunotherapy; NIH [R35 CA197633, P01 CA168585]	Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA; Parker Institute for Cancer Immunotherapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the patients and their families; S. Ebbinghaus for clinical study design, oversight and initiation of this collaborative study with Novartis; S. Diede for clinical study design and oversight; M. Bucci, J. Siegel and N. Cote for data acquisition; J. Anderson for statistical analysis and study oversight; and R. Yadav Baddula for data analysis. Medical writing and/or editorial assistance was provided by D. Mitra of the ApotheCom pembrolizumab team. This assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Funding for this research was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Study drug was provided by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and Novartis. A.R. is supported by the Parker Institute for Cancer Immunotherapy and NIH grants R35 CA197633 and P01 CA168585. The sponsor collaborated with academic advisors to design the study, acquire and analyze data, and interpret the results. All authors had access to all study data and reviewed and approved the final version of the manuscript for publication.	Ascierto PA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468955; Deken MA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238557; DUMMER R, 2018, J CLIN ONCOL S, V36; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long G. V., 2018, P 2018 C SOC MEL RES; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Moreno BH, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1052212; National Comprehensive Cancer Network (NCCN), 2018, NCCN CLIN PRACT GUID; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Ribas A., NAT MED; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Robert C, 2015, EUR J CANCER, V51, pS663, DOI 10.1016/S0959-8049(16)31820-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Rozeman E. A., 2018, ANN ONCOL, V29; Schadendorf D, 2017, EUR J CANCER, V82, P45, DOI 10.1016/j.ejca.2017.05.033; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Vella LJ, 2014, CANCER IMMUNOL RES, V2, P351, DOI 10.1158/2326-6066.CIR-13-0181; Weide B, 2016, CLIN CANCER RES, V22, P5487, DOI 10.1158/1078-0432.CCR-16-0127; Wilmott JS, 2012, CLIN CANCER RES, V18, P1386, DOI 10.1158/1078-0432.CCR-11-2479; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684	31	162	161	5	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					941	+		10.1038/s41591-019-0448-9	http://dx.doi.org/10.1038/s41591-019-0448-9			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171878				2022-12-27	WOS:000470844400025
J	Rose, SMSF; Contrepois, K; Moneghetti, KJ; Zhou, WY; Mishra, T; Mataraso, S; Dagan-Rosenfeld, O; Ganz, AB; Dunn, J; Hornburg, D; Rego, S; Perelman, D; Ahadi, S; Sailani, MR; Zhou, YJ; Leopold, SR; Chen, JM; Ashland, M; Christle, JW; Avina, M; Limcaoco, P; Ruiz, C; Tan, M; Butte, AJ; Weinstock, GM; Slavich, GM; Sodergren, E; McLaughlin, TL; Haddad, F; Snyder, MP				Rose, Sophia Miryam Schussler-Fiorenza; Contrepois, Kevin; Moneghetti, Kegan J.; Zhou, Wenyu; Mishra, Tejaswini; Mataraso, Samson; Dagan-Rosenfeld, Orit; Ganz, Ariel B.; Dunn, Jessilyn; Hornburg, Daniel; Rego, Shannon; Perelman, Dalia; Ahadi, Sara; Sailani, M. Reza; Zhou, Yanjiao; Leopold, Shana R.; Chen, Jieming; Ashland, Melanie; Christle, Jeffrey W.; Avina, Monika; Limcaoco, Patricia; Ruiz, Camilo; Tan, Marilyn; Butte, Atul J.; Weinstock, George M.; Slavich, George M.; Sodergren, Erica; McLaughlin, Tracey L.; Haddad, Francois; Snyder, Michael P.			A longitudinal big data approach for precision health	NATURE MEDICINE			English	Article							CORONARY-HEART-DISEASE; BETA-CELL FUNCTION; INSULIN-RESISTANCE; AMERICAN-COLLEGE; UNDETERMINED SIGNIFICANCE; CARDIOVASCULAR-DISEASE; MONOCLONAL GAMMOPATHY; GLUCOSE-TOLERANCE; RISK PREDICTION; ARTERY CALCIUM	Precision health relies on the ability to assess disease risk at an individual level, detect early preclinical conditions and initiate preventive strategies. Recent technological advances in omics and wearable monitoring enable deep molecular and physiological profiling and may provide important tools for precision health. We explored the ability of deep longitudinal profiling to make health-related discoveries, identify clinically relevant molecular pathways and affect behavior in a prospective longitudinal cohort (n = 109) enriched for risk of type 2 diabetes mellitus. The cohort underwent integrative personalized omics profiling from samples collected quarterly for up to 8 years (median, 2.8 years) using clinical measures and emerging technologies including genome, immunome, transcriptome, proteome, metabolome, microbiome and wearable monitoring. We discovered more than 67 clinically actionable health discoveries and identified multiple molecular pathways associated with metabolic, cardiovascular and oncologic pathophysiology. We developed prediction models for insulin resistance by using omics measurements, illustrating their potential to replace burdensome tests. Finally, study participation led the majority of participants to implement diet and exercise changes. Altogether, we conclude that deep longitudinal profiling can lead to actionable health discoveries and provide relevant information for precision health.	[Rose, Sophia Miryam Schussler-Fiorenza; Contrepois, Kevin; Zhou, Wenyu; Mishra, Tejaswini; Dagan-Rosenfeld, Orit; Ganz, Ariel B.; Dunn, Jessilyn; Hornburg, Daniel; Rego, Shannon; Perelman, Dalia; Ahadi, Sara; Sailani, M. Reza; Ashland, Melanie; Avina, Monika; Limcaoco, Patricia; Snyder, Michael P.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Rose, Sophia Miryam Schussler-Fiorenza] Vet Affairs Palo Alto Hlth Care Syst, Spinal Cord Injury Serv, Palo Alto, CA USA; [Rose, Sophia Miryam Schussler-Fiorenza] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA USA; [Moneghetti, Kegan J.; Christle, Jeffrey W.; Haddad, Francois; Snyder, Michael P.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Moneghetti, Kegan J.; Christle, Jeffrey W.; Haddad, Francois] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Moneghetti, Kegan J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Mataraso, Samson] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Mataraso, Samson] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dunn, Jessilyn] Stanford Univ, Mobilize Ctr, Stanford, CA 94305 USA; [Zhou, Yanjiao; Leopold, Shana R.; Weinstock, George M.; Sodergren, Erica] Jackson Lab Genom Med, Farmington, CT USA; [Zhou, Yanjiao] Univ Connecticut Hlth, Dept Med, Farmington, CT USA; [Chen, Jieming; Butte, Atul J.] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA; [Chen, Jieming; Butte, Atul J.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Ruiz, Camilo] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tan, Marilyn; McLaughlin, Tracey L.] Stanford Univ, Sch Med, Div Endocrinol, Stanford, CA USA; [Slavich, George M.] Univ Calif Los Angeles, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA USA; [Slavich, George M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; St Vincent's Hospital Melbourne; University of Melbourne; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Jackson Laboratory; University of Connecticut; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Snyder, MP (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Haddad, F; Snyder, MP (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Haddad, F (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	fhaddad@stanford.edu; mpsnyder@stanford.edu	Leopold, Shana/ABA-2797-2020; Mishra, Tejaswini/D-3528-2018; Slavich, George/ABD-5450-2021; Slavich, George M/C-6208-2008; Schussler-Fiorenza Rose, Sophia Miryam/E-6411-2013	Leopold, Shana/0000-0001-5830-1955; Mishra, Tejaswini/0000-0001-9931-1260; Slavich, George M/0000-0001-5710-3818; Snyder, Michael/0000-0003-0784-7987; Schussler-Fiorenza Rose, Sophia Miryam/0000-0002-6311-6671; Mataraso, Samson/0000-0003-3146-2243; Ashland, Melanie/0000-0002-3340-3573; Moneghetti, Kegan/0000-0001-9503-6660; Tan, Marilyn/0000-0002-6651-4691; Zhou, Wenyu/0000-0002-8447-8815	National Institutes of Health (NIH) Human Microbiome Project (HMP) [1U54DE02378901]; NIH [R01 DK110186-03, S10OD020141, P30DK116074, K08 MH103443]; NIH National Center for Advancing Translational Science Clinical and Translational Science Award [UL1TR001085]; Stanford Center for Genomics and Personalized Medicine Sequencing Center; Diabetes Genomics Analysis Core; Clinical and Translational Core of the Stanford Diabetes Research Center (NIH) [P30DK116074]; Department of Veteran Affairs Office of Academic Affiliations Advanced Fellowship in Spinal Cord Injury Medicine; NIH Career Development Award [K08 ES028825]; Stanford School of Medicine Dean's Postdoctoral Fellowship; Stanford Center for Computational, Evolutionary and Human Genomics Fellowship [P300PA_161005, P2GEP3_151825]; Swiss National Science Foundation (SNSF); SNSF; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK116074, R01DK110186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K08ES028825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH103443] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Human Microbiome Project (HMP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Advancing Translational Science Clinical and Translational Science Award; Stanford Center for Genomics and Personalized Medicine Sequencing Center; Diabetes Genomics Analysis Core; Clinical and Translational Core of the Stanford Diabetes Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs Office of Academic Affiliations Advanced Fellowship in Spinal Cord Injury Medicine; NIH Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford School of Medicine Dean's Postdoctoral Fellowship; Stanford Center for Computational, Evolutionary and Human Genomics Fellowship; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Our work was supported by grants from the National Institutes of Health (NIH) Human Microbiome Project (HMP) 1U54DE02378901 (G.M.W. and M.P.S.), an NIH grant no. R01 DK110186-03 (T.L.M.), a NIH National Center for Advancing Translational Science Clinical and Translational Science Award (no. UL1TR001085). This work used the Genome Sequencing Service Center by the Stanford Center for Genomics and Personalized Medicine Sequencing Center (supported by NIH grant no. S10OD020141), the Diabetes Genomics Analysis Core and the Clinical and Translational Core of the Stanford Diabetes Research Center (NIH grant no. P30DK116074). S.M.S.-F.R. was supported by a Department of Veteran Affairs Office of Academic Affiliations Advanced Fellowship in Spinal Cord Injury Medicine and a NIH Career Development Award no. K08 ES028825. G.M.S. was supported by NIH grant no. K08 MH103443. D.H. was supported by a Stanford School of Medicine Dean's Postdoctoral Fellowship and a Stanford Center for Computational, Evolutionary and Human Genomics Fellowship. M.R.S. was supported by grant nos. P300PA_161005 and P2GEP3_151825 from the Swiss National Science Foundation (SNSF). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, the Department of Veteran Affairs, or the SNSF. We thank S. Chen and B. Lee for their work in metabolomics data production. A. Breschi generously shared her code for the ISR calculations. Finally, we thank the iPOP participants who generously gave their time and biological samples.	Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2018, LUMINEX MULTIPLEX AN; Apostolopoulou M, 2018, DIABETES CARE, V41, P1235, DOI 10.2337/dc17-1318; Arena R, 2003, CHEST, V124, P720, DOI 10.1378/chest.124.2.720; Bell EJ, 2016, STROKE, V47, P2689, DOI 10.1161/STROKEAHA.116.014172; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Buhr S., 2018, APPLES WATCH ISNT 1; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cauwenberghs N, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008315; Cersosimo E, 2014, CURR DIABETES REV, V10, P2, DOI 10.2174/1573399810666140214093600; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Charbonneau B, 2012, CYTOKINE, V60, P882, DOI 10.1016/j.cyto.2012.08.028; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Chen XP, 2014, METAB SYNDR RELAT D, V12, P362, DOI 10.1089/met.2014.0017; COHEN S, 1988, CLAR SYMP, P31; Contrepois K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35807-4; Contrepois K, 2015, MOL CELL PROTEOMICS, V14, P1684, DOI 10.1074/mcp.M114.046508; Cross DS, 2012, CURR MED RES OPIN, V28, P1819, DOI 10.1185/03007995.2012.742878; Ding Q, 2016, CANCER MED-US, V5, P3246, DOI 10.1002/cam4.934; DINNEEN S, 1992, NEW ENGL J MED, V327, P707, DOI 10.1056/NEJM199209033271007; Douglas PS, 2016, JACC-CARDIOVASC IMAG, V9, P1211, DOI 10.1016/j.jcmg.2016.02.027; Elkind MS, 2005, ATHEROSCLEROSIS, V180, P181, DOI 10.1016/j.atherosclerosis.2004.11.015; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Go RS, 2015, CL LYMPH MYELOM LEUK, V15, P177, DOI 10.1016/j.clml.2014.09.004; Godsland IF, 2004, DIABETOLOGIA, V47, P1157, DOI 10.1007/s00125-004-1454-z; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gomez-Arango LF, 2016, DIABETES, V65, P2214, DOI 10.2337/db16-0278; Guasch-Ferre M, 2016, DIABETES CARE, V39, P833, DOI 10.2337/dc15-2251; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Hall H, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005143; Hall KT, 2014, ARTERIOSCL THROM VAS, V34, P2160, DOI 10.1161/ATVBAHA.114.303845; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hovorka R, 1996, COMPUT METH PROG BIO, V50, P253, DOI 10.1016/0169-2607(96)01755-5; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Iikuni Noriko, 2008, Current Immunology Reviews, V4, P70, DOI 10.2174/157339508784325046; Johnson LDS, 2014, ANTICANCER RES, V34, P593; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kaminsky LA, 2017, MAYO CLIN PROC, V92, P228, DOI 10.1016/j.mayocp.2016.10.003; Kanat M, 2011, DIABETES CARE, V34, P1006, DOI 10.2337/dc10-1352; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kuznetsova T, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004661; Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517; Lagani V., 2017, J STAT SOFTWARE ARTI, V80, P1; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Li JJ, 2018, CELL, V174, P1361, DOI 10.1016/j.cell.2018.07.021; Li X, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001402; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma H, 2002, ATHEROSCLEROSIS, V164, P79, DOI 10.1016/S0021-9150(02)00062-X; Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McClelland RL, 2015, J AM COLL CARDIOL, V66, P1643, DOI 10.1016/j.jacc.2015.08.035; McConnell MV, 2017, JAMA CARDIOL, V2, P67, DOI 10.1001/jamacardio.2016.4395; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Moneghetti KJ, 2018, INT J CARDIOL, V263, P75, DOI 10.1016/j.ijcard.2018.02.102; Montagna P. A., 2014, S CENTR SAS US GROUP; Mothe-Satney I, 2012, DIABETES, V61, P2311, DOI 10.2337/db11-1455; Myers J, 2001, AM HEART J, V142, P1041, DOI 10.1067/mhj.2001.118740; National Research Council (US), 2012, PREC MED BUILD KNOWL; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; Oliveira AG, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00503; Omer W, 2016, GENET TEST MOL BIOMA, V20, P685, DOI 10.1089/gtmb.2016.0108; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; PEI D, 1994, DIABETOLOGIA, V37, P843, DOI 10.1007/BF00404344; Perkins BA, 2018, P NATL ACAD SCI USA, V115, P3686, DOI 10.1073/pnas.1706096114; Piening BD, 2018, CELL SYST, V6, P157, DOI 10.1016/j.cels.2017.12.013; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Price ND, 2017, NAT BIOTECHNOL, V35, P747, DOI 10.1038/nbt.3870; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Przewoznik M, 2012, J IMMUNOTHER, V35, P217, DOI 10.1097/CJI.0b013e318247440a; Rego S, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a003178; Reidy SP, 2000, COMP BIOCHEM PHYS A, V125, P285, DOI 10.1016/S1095-6433(00)00159-8; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slavich GM, 2018, PSYCHOSOM MED, V80, P17, DOI 10.1097/PSY.0000000000000534; Smith DA, 2016, ANN INTERN MED, V164, pJC35, DOI 10.7326/ACPJC-2016-164-6-035; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Turesson I, 2014, BLOOD, V123, P338, DOI 10.1182/blood-2013-05-505487; Twig G, 2013, DIABETES CARE, V36, P276, DOI 10.2337/dc11-2298; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Varghese RT, 2016, J CLIN ENDOCR METAB, V101, P4816, DOI 10.1210/jc.2016-1998; Wang TJ, 2003, CIRCULATION, V108, P572, DOI 10.1161/01.CIR.0000081764.35431.DE; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wollert KC, 2017, CLIN CHEM, V63, P140, DOI 10.1373/clinchem.2016.255174; Zhou W, NATURE	97	165	164	10	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					792	+		10.1038/s41591-019-0414-6	http://dx.doi.org/10.1038/s41591-019-0414-6			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068711	Green Submitted, Green Accepted			2022-12-27	WOS:000468247800023
J	Teixeira, VH; Pipinikas, CP; Pennycuick, A; Lee-Six, H; Chandrasekharan, D; Beane, J; Morris, TJ; Karpathakis, A; Feber, A; Breeze, CE; Ntolios, P; Hynds, RE; Falzon, M; Capitanio, A; Carroll, B; Durrenberger, PF; Hardavella, G; Brown, JM; Lynch, AG; Farmery, H; Paul, DS; Chambers, RC; McGranahan, N; Navani, N; Thakrar, RM; Swanton, C; Beck, S; George, PJ; Spira, A; Campbell, PJ; Thirlwell, C; Janes, SM				Teixeira, Vitor H.; Pipinikas, Christodoulos P.; Pennycuick, Adam; Lee-Six, Henry; Chandrasekharan, Deepak; Beane, Jennifer; Morris, Tiffany J.; Karpathakis, Anna; Feber, Andrew; Breeze, Charles E.; Ntolios, Paschalis; Hynds, Robert E.; Falzon, Mary; Capitanio, Arrigo; Carroll, Bernadette; Durrenberger, Pascal F.; Hardavella, Georgia; Brown, James M.; Lynch, Andy G.; Farmery, Henry; Paul, Dirk S.; Chambers, Rachel C.; McGranahan, Nicholas; Navani, Neal; Thakrar, Ricky M.; Swanton, Charles; Beck, Stephan; George, Phillip Jeremy; Spira, Avrum; Campbell, Peter J.; Thirlwell, Christina; Janes, Sam M.			Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions	NATURE MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; COPY NUMBER ANALYSIS; CHROMOSOMAL IMBALANCES; HYBRIDIZATION ANALYSIS; MUTATIONAL PROCESSES; GENE-EXPRESSION; PROFILES; PATTERNS; KEGG; ADENOCARCINOMA	The molecular alterations that occur in cells before cancer is manifest are largely uncharted. Lung carcinoma in situ (CIS) lesions are the pre-invasive precursor to squamous cell carcinoma. Although microscopically identical, their future is in equipoise, with half progressing to invasive cancer and half regressing or remaining static. The cellular basis of this clinical observation is unknown. Here, we profile the genomic, transcriptomic, and epigenomic landscape of CIS in a unique patient cohort with longitudinally monitored pre-invasive disease. Predictive modeling identifies which lesions will progress with remarkable accuracy. We identify progression-specific methylation changes on a background of widespread heterogeneity, alongside a strong chromosomal instability signature. We observed mutations and copy number changes characteristic of cancer and chart their emergence, offering a window into early carcinogenesis. We anticipate that this new understanding of cancer precursor biology will improve early detection, reduce overtreatment, and foster preventative therapies targeting early clonal events in lung cancer.	[Teixeira, Vitor H.; Pipinikas, Christodoulos P.; Pennycuick, Adam; Chandrasekharan, Deepak; Ntolios, Paschalis; Hynds, Robert E.; Brown, James M.; Navani, Neal; Thakrar, Ricky M.; Janes, Sam M.] UCL, Lungs Living Res Ctr, UCL Resp, London, England; [Pipinikas, Christodoulos P.; Morris, Tiffany J.; Karpathakis, Anna; Feber, Andrew; Breeze, Charles E.; Paul, Dirk S.; Beck, Stephan; Thirlwell, Christina] UCL, UCL Canc Inst, Res Dept Canc Biol, London, England; [Pipinikas, Christodoulos P.; Morris, Tiffany J.; Karpathakis, Anna; Feber, Andrew; Breeze, Charles E.; Paul, Dirk S.; Beck, Stephan; Thirlwell, Christina] UCL, UCL Canc Inst, Med Genom Lab, London, England; [Lee-Six, Henry; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Beane, Jennifer; Spira, Avrum] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Hynds, Robert E.; McGranahan, Nicholas; Swanton, Charles] UCL Canc Inst, CRUK Lung Canc Ctr Excellence, London, England; [Hynds, Robert E.; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Falzon, Mary; Capitanio, Arrigo] Univ Coll London Hosp NHS Trust, Dept Pathol, London, England; [Carroll, Bernadette; Hardavella, Georgia; Navani, Neal; Thakrar, Ricky M.; George, Phillip Jeremy; Janes, Sam M.] Univ Coll London Hosp, Dept Thorac Med, London, England; [Durrenberger, Pascal F.; Chambers, Rachel C.] UCL, UCL Resp, Ctr Inflammat & Tissue Repair, London, England; [Lynch, Andy G.; Farmery, Henry] Canc Res UK Cambridge Inst, Computat Biol & Stat Lab, Cambridge, England; [Lynch, Andy G.] Univ St Andrews, Sch Math & Stat, Sch Med, St Andrews, Fife, Scotland; [Spira, Avrum] Johnson & Johnson Innovat, Cambridge, MA USA	University of London; University College London; University of London; University College London; University of London; University College London; Wellcome Trust Sanger Institute; Boston University; University of London; University College London; Francis Crick Institute; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Cancer Research UK; CRUK Cambridge Institute; University of St Andrews	Janes, SM (corresponding author), UCL, Lungs Living Res Ctr, UCL Resp, London, England.; Janes, SM (corresponding author), Univ Coll London Hosp, Dept Thorac Med, London, England.	s.janes@ucl.ac.uk	McGranahan, Nicholas/ABD-6561-2021; Ntolios, Paschalis/AAB-8455-2021; Paul, Dirk S./H-3469-2019; Hynds, Robert E/F-9516-2012	McGranahan, Nicholas/0000-0001-9537-4045; Paul, Dirk S./0000-0002-8230-0116; Hynds, Robert E/0000-0002-2170-8791; Navani, Neal/0000-0002-6412-7516; Thakrar, Ricky/0000-0001-9793-2223; Lynch, Andy/0000-0002-7876-7338; Janes, Sam/0000-0002-6634-5939; Pennycuick, Adam/0000-0001-5836-0250; Teixeira, Vitor/0000-0003-0090-861X; Beane-Ebel, Jennifer/0000-0002-6699-2132; Feber, Andrew/0000-0001-5282-0498	Wellcome Trust fellowships; Rosetrees Trust; Welton Trust; Garfield Weston Trust; Stoneygate Trust; UCLH Charitable Foundation; Roy Castle Lung Cancer Foundation; Wellcome Trust clinical PhD training fellowship; Wellcome Trust Sanger Institute non-clinical PhD studentship; Department of Health's NIHR Biomedical Research Centre; Stand Up to Cancer; MRC [G108/596] Funding Source: UKRI	Wellcome Trust fellowships(Wellcome Trust); Rosetrees Trust(Rosetrees Trust); Welton Trust; Garfield Weston Trust; Stoneygate Trust; UCLH Charitable Foundation; Roy Castle Lung Cancer Foundation; Wellcome Trust clinical PhD training fellowship(Wellcome Trust); Wellcome Trust Sanger Institute non-clinical PhD studentship; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Stand Up to Cancer; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all of the patients who participated in this study and K. Pearce, G. Chennel, D. Chambers, P. Mercer and K. Gowers for technical help and proofreading. We thank P. Rabbitts, A. Banerjee and C. Read for their early development of the study. The results published here are in part based on data generated by a TCGA pilot project established by the National Cancer Institute and National Human Genome Research Institute. Information about TCGA and the investigators and institutions that constitute the TCGA research network can be found at http://cancergenome.nih.gov. R.E.H., N.M., P.J.C., and S.M.J. are supported by the Wellcome Trust fellowships. S.M.J. is also supported by the Rosetrees Trust, the Welton Trust, the Garfield Weston Trust, the Stoneygate Trust and UCLH Charitable Foundation. V.T., C.P., R.E.H. and S.M.J. have been funded by the Roy Castle Lung Cancer Foundation. A. P. is funded by a Wellcome Trust clinical PhD training fellowship. H.L.-S. is funded by the Wellcome Trust Sanger Institute non-clinical PhD studentship. C.T. was a CRUK Clinician Scientist. This work was partially undertaken at UCLH/UCL, who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centre's funding scheme (S.M.J. and N.N.). R.E.H., N.M., C.S., and S.M.J. are part of the CRUK Lung Cancer Centre of Excellence. A.S., C.S., and S.M.J. are supported by Stand Up to Cancer. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Blackburn A, 2015, EUR J HUM GENET, V23, P1229, DOI 10.1038/ejhg.2014.280; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chujo M, 2002, LUNG CANCER-J IASLC, V38, P23, DOI 10.1016/S0169-5002(02)00151-4; Endesfelder D, 2014, CANCER RES, V74, P4853, DOI 10.1158/0008-5472.CAN-13-2664; Feber A, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r30; Feng J, 2004, NEOPLASIA, V6, P623, DOI 10.1593/neo.04142; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; George PJ, 2007, THORAX, V62, P43, DOI 10.1136/thx.2005.052191; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones D, 2016, CURR PROTOC BIOINFOR, V56; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Keilwagen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092209; Kolde R, 2012, R PACKAGE VERSION, V61, P1; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee K, 2015, MOL CELLS, V38, P789, DOI 10.14348/molcells.2015.0109; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Massion PP, 2002, CANCER RES, V62, P3636; Matsubara D, 2017, CANCER SCI, V108, P1888, DOI 10.1111/cas.13313; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mileyko Y, 2008, P NATL ACAD SCI USA, V105, P16659, DOI 10.1073/pnas.0806239105; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Nicholson AG, 2001, HISTOPATHOLOGY, V38, P202, DOI 10.1046/j.1365-2559.2001.01078.x; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petersen I, 1997, CANCER RES, V57, P2331; Pipinikas CP, 2014, THORAX, V69, P548, DOI 10.1136/thoraxjnl-2013-204198; Raine K. M., 2015, CURR PROTOC BIOINFOR, V52, P15, DOI [10.1002/0471250953.bi1507s52Medline, DOI 10.1002/0471250953.BI1507S52MEDLINE]; Raine Keiran M, 2016, Curr Protoc Bioinformatics, V56, DOI 10.1002/cpbi.17; RIED T, 1994, CANCER RES, V54, P1801; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Rodrigues MFSD, 2016, GENOMICS, V108, P185, DOI 10.1016/j.ygeno.2016.11.001; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Tata PR, 2018, DEV CELL, V44, P679, DOI 10.1016/j.devcel.2018.02.024; Teschendorff AE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10478; Thakrar RM, 2017, CANCER TREAT REV, V58, P77, DOI 10.1016/j.ctrv.2017.05.009; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; van Boerdonk RAA, 2014, THORAX, V69, P464, DOI 10.1136/thoraxjnl-2013-203821; van Boerdonk RAA, 2011, AM J RESP CRIT CARE, V184, P948, DOI 10.1164/rccm.201102-0218OC; van der Heijden EHFM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0193-7; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	70	110	111	2	41	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					517	+		10.1038/s41591-018-0323-0	http://dx.doi.org/10.1038/s41591-018-0323-0			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30664780	Green Submitted, Green Accepted			2022-12-27	WOS:000460643100031
J	Hannun, AY; Rajpurkar, P; Haghpanahi, M; Tison, GH; Bourn, C; Turakhia, MP; Ng, AY				Hannun, Awni Y.; Rajpurkar, Pranav; Haghpanahi, Masoumeh; Tison, Geoffrey H.; Bourn, Codie; Turakhia, Mintu P.; Ng, Andrew Y.			Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network	NATURE MEDICINE			English	Article							ATRIAL-FIBRILLATION; SYSTEM; ERRORS; RHYTHM	Computerized electrocardiogram (ECG) interpretation plays a critical role in the clinical ECG workflow(1). Widely available digital ECG data and the algorithmic paradigm of deep learning(2) present an opportunity to substantially improve the accuracy and scalability of automated ECG analysis. However, a comprehensive evaluation of an end-to-end deep learning approach for ECG analysis across a wide variety of diagnostic classes has not been previously reported. Here, we develop a deep neural network (DNN) to classify 12 rhythm classes using 91,232 single-lead ECGs from 53,549 patients who used a single-lead ambulatory ECG monitoring device. When validated against an independent test dataset annotated by a consensus committee of board-certified practicing cardiologists, the DNN achieved an average area under the receiver operating characteristic curve (ROC) of 0.97. The average F-1 score, which is the harmonic mean of the positive predictive value and sensitivity, for the DNN (0.837) exceeded that of average cardiologists (0.780). With specificity fixed at the average specificity achieved by cardiologists, the sensitivity of the DNN exceeded the average cardiologist sensitivity for all rhythm classes. These findings demonstrate that an end-to-end deep learning approach can classify a broad range of distinct arrhythmias from single-lead ECGs with high diagnostic performance similar to that of cardiologists. If confirmed in clinical settings, this approach could reduce the rate of misdiagnosed computerized ECG interpretations and improve the efficiency of expert human ECG interpretation by accurately triaging or prioritizing the most urgent conditions.	[Hannun, Awni Y.; Rajpurkar, Pranav; Ng, Andrew Y.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Haghpanahi, Masoumeh; Bourn, Codie] iRhythm Technol Inc, San Francisco, CA USA; [Tison, Geoffrey H.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Turakhia, Mintu P.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Turakhia, Mintu P.] Stanford Univ, Sch Med, Ctr Digital Hlth, Stanford, CA 94305 USA; [Turakhia, Mintu P.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; University of California System; University of California San Francisco; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Hannun, AY (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	awni@cs.stanford.edu		Tison, Geoffrey H/0000-0002-0310-3326; Hannun, Awni/0000-0003-3080-4002; Rajpurkar, Pranav/0000-0002-8030-3727; Turakhia, Minang/0000-0001-8025-0904	iRhythm Technologies, Inc.; NVIDIA fellowship; National Institutes of Health [K23 HL135274]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL135274] Funding Source: NIH RePORTER	iRhythm Technologies, Inc.; NVIDIA fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	iRhythm Technologies, Inc. provided financial support for the data annotation in this work. M.H. and C.B. are employees of iRhythm Technologies, Inc. A.Y.H. was funded by an NVIDIA fellowship. G.H.T. received support from the National Institutes of Health (K23 HL135274). The only financial support provided by iRhythm Technologies, Inc. for this study was for the data annotation. Data analysis and interpretation was performed independently from the sponsor. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Acharya UR, 2017, COMPUT BIOL MED, V89, P389, DOI 10.1016/j.compbiomed.2017.08.022; Acharya UR, 2017, INFORM SCIENCES, V405, P81, DOI 10.1016/j.ins.2017.04.012; Al Rahhal MM, 2016, INFORM SCIENCES, V345, P340, DOI 10.1016/j.ins.2016.01.082; Amodei D, 2016, PR MACH LEARN RES, V48; Andreotti F, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.360-239; Banupriya C. V., 2014, INT J COMPUT APPL IJ, V1, P31; Carrara M, 2015, PHYSIOL MEAS, V36, P1873, DOI 10.1088/0967-3334/36/9/1873; Clifford GD, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.065-469; CUBANSKI D, 1994, J CARDIOVASC ELECTR, V5, P602, DOI 10.1111/j.1540-8167.1994.tb01301.x; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guglin ME, 2006, INT J CARDIOL, V106, P232, DOI 10.1016/j.ijcard.2005.02.007; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Holst H, 1999, CLIN PHYSIOL, V19, P410, DOI 10.1046/j.1365-2281.1999.00195.x; Hong SD, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.178-245; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Javadi M, 2013, BIOMED SIGNAL PROCES, V8, P289, DOI 10.1016/j.bspc.2012.10.005; Kingma DP., 2014, ADAM METHOD STOCHAST; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; Mateo J., 2012, Journal of Medical Engineering & Technology, V36, P90, DOI 10.3109/03091902.2011.636859; Nahar J, 2013, EXPERT SYST APPL, V40, P96, DOI 10.1016/j.eswa.2012.07.032; Ochoa A., 2017, P INT C COMPUTE DATA, P277, DOI DOI 10.1145/3093241.3093269; Oh SL, 2018, COMPUT BIOL MED, V102, P278, DOI 10.1016/j.compbiomed.2018.06.002; Poon K, 2005, J ELECTROCARDIOL, V38, P235, DOI 10.1016/j.jelectrocard.2005.01.008; Poungponsri S, 2013, NEUROCOMPUTING, V117, P206, DOI 10.1016/j.neucom.2013.02.010; Pourbabaee B, 2018, IEEE T SYST MAN CY-S, V48, P2095, DOI 10.1109/TSMC.2017.2705582; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; SCHLANT RC, 1992, J AM COLL CARDIOL, V19, P473; Schlapfer J, 2017, J AM COLL CARDIOL, V70, P1183, DOI 10.1016/j.jacc.2017.07.723; Shah AP, 2007, J ELECTROCARDIOL, V40, P385, DOI 10.1016/j.jelectrocard.2007.03.008; Shashikumar SP, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P715, DOI 10.1145/3219819.3219912; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Smith M, 2012, BEST CARE LOWER COST; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Teijeiro T, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.166-054; Turakhia MP, 2013, AM J CARDIOL, V112, P520, DOI 10.1016/j.amjcard.2013.04.017; Xia Y, 2018, COMPUT BIOL MED, V93, P84, DOI 10.1016/j.compbiomed.2017.12.007; Xiong ZH, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.066-138; Xu SSS, 2019, IEEE J BIOMED HEALTH, V23, P1574, DOI 10.1109/JBHI.2018.2871510; Zhou XL, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-18; Zihlmann M, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.070-060	49	921	947	76	522	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					65	+		10.1038/s41591-018-0268-3	http://dx.doi.org/10.1038/s41591-018-0268-3			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617320	Green Accepted			2022-12-27	WOS:000455027700022
J	Norgeot, B; Glicksberg, BS; Butte, AJ				Norgeot, Beau; Glicksberg, Benjamin S.; Butte, Atul J.			A call for deep-learning healthcare	NATURE MEDICINE			English	Editorial Material								Here we argue that now is the time to create smarter healthcare systems in which the best treatment decisions are computationally learned from electronic health record data by deep-learning methodologies.	[Norgeot, Beau; Glicksberg, Benjamin S.; Butte, Atul J.] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA; [Butte, Atul J.] Univ Calif Hlth, Ctr Data Driven Insights & Innovat, Oakland, CA 94607 USA	University of California System; University of California San Francisco	Butte, AJ (corresponding author), Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, San Francisco, CA 94143 USA.; Butte, AJ (corresponding author), Univ Calif Hlth, Ctr Data Driven Insights & Innovat, Oakland, CA 94607 USA.	atul.butte@ucsf.edu	Glicksberg, Benjamin/I-9500-2019	Glicksberg, Benjamin/0000-0003-4515-8090				Etheredge LM, 2007, HEALTH AFFAIR, V26, pW107, DOI 10.1377/hlthaff.26.2.w107; Fogel AL, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0012-2; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Howe JL, 2018, JAMA-J AM MED ASSOC, V319, P1276, DOI 10.1001/jama.2018.1171; Surescripts, 2017, 2017 NAT PROGR REP; Wang MD, 2017, JAMA INTERN MED, V177, P1212, DOI 10.1001/jamainternmed.2017.1548	6	95	96	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					14	15		10.1038/s41591-018-0320-3	http://dx.doi.org/10.1038/s41591-018-0320-3			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617337				2022-12-27	WOS:000455027700007
J	Masri, S; Sassone-Corsi, P				Masri, Selma; Sassone-Corsi, Paolo			The emerging link between cancer, metabolism, and circadian rhythms	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; TUMOR MACROENVIRONMENT; CLOCK GENES; DNA-DAMAGE; STEM-CELLS; MELATONIN; TRANSCRIPTION; LIVER; TIME	The circadian clock is a complex cellular mechanism that, through the control of diverse metabolic and gene expression pathways, governs a large array of cyclic physiological processes. Epidemiological and clinical data reveal a connection between the disruption of circadian rhythms and cancer that is supported by recent preclinical data. In addition, results from animal models and molecular studies underscore emerging links between cancer metabolism and the circadian clock. This has implications for therapeutic approaches, and we discuss the possible design of chronopharmacological strategies.	[Masri, Selma] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Chao Family Comprehens Canc Ctr, Irvine, CA 92717 USA; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, INSERM,U1233, Irvine, CA 92717 USA	University of California System; University of California Irvine; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California Irvine	Masri, S (corresponding author), Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Chao Family Comprehens Canc Ctr, Irvine, CA 92717 USA.; Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, INSERM,U1233, Irvine, CA 92717 USA.	smasri@uci.edu; psc@uci.edu		Masri, Selma/0000-0002-8619-8331	K22 Transition Career Development Award through the National Cancer Institute (NCI); Concern Foundation; V Foundation for Cancer Research; NIH (National Institutes of Health); INSERM (Institut National de la Sante et la Recherche Medicale, France); KAUST (King Abdullah University of Science and Technology, Saudi Arabia); NATIONAL CANCER INSTITUTE [K22CA212045] Funding Source: NIH RePORTER	K22 Transition Career Development Award through the National Cancer Institute (NCI); Concern Foundation; V Foundation for Cancer Research; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM (Institut National de la Sante et la Recherche Medicale, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); KAUST (King Abdullah University of Science and Technology, Saudi Arabia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Masri laboratory is supported by a K22 Transition Career Development Award through the National Cancer Institute (NCI), the Concern Foundation, and the V Foundation for Cancer Research. Work in the Sassone-Corsi laboratory is supported by NIH (National Institutes of Health), INSERM (Institut National de la Sante et la Recherche Medicale, France), and KAUST (King Abdullah University of Science and Technology, Saudi Arabia).	Abbondante S, 2016, J BIOL CHEM, V291, P2812, DOI 10.1074/jbc.M115.681130; Adamovich Y, 2017, CELL METAB, V25, P93, DOI 10.1016/j.cmet.2016.09.014; Aguilar-Arnal L, 2015, NAT STRUCT MOL BIOL, V22, P312, DOI 10.1038/nsmb.2990; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Al-Zhoughbi W, 2014, SEMIN ONCOL, V41, P281, DOI 10.1053/j.seminoncol.2014.02.005; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; ARENDT J, 1985, J CLIN ENDOCR METAB, V60, P1166, DOI 10.1210/jcem-60-6-1166; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Aviram R, 2016, MOL CELL, V62, P636, DOI 10.1016/j.molcel.2016.04.002; Barberino RS, 2017, BIOL REPROD, V96, P1244, DOI 10.1093/biolre/iox053; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bhatti P, 2017, OCCUP ENVIRON MED, V74, P680, DOI 10.1136/oemed-2017-104414; Brady JJ, 2016, CANCER CELL, V29, P697, DOI 10.1016/j.ccell.2016.03.003; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Dallmann R, 2016, TRENDS MOL MED, V22, P430, DOI 10.1016/j.molmed.2016.03.004; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Del Fabbro E, 2013, J CLIN ONCOL, V31, P1271, DOI 10.1200/JCO.2012.43.6766; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Dyar KA, 2018, CELL, V174, P1571, DOI 10.1016/j.cell.2018.08.042; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Fang MZ, 2015, ONCOTARGET, V6, P42879, DOI 10.18632/oncotarget.6002; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gao Y, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12380; Gaucher J, 2018, TRENDS CELL BIOL, V28, P368, DOI 10.1016/j.tcb.2018.01.006; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Goncalves ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150407; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hoffman AE, 2010, CANCER PREV RES, V3, P539, DOI 10.1158/1940-6207.CAPR-09-0127; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Hojo H, 2017, ONCOTARGET, V8, P34128, DOI 10.18632/oncotarget.16699; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Huber AL, 2016, MOL CELL, V64, P774, DOI 10.1016/j.molcel.2016.10.012; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Hung HC, 2007, J BIOL CHEM, V282, P31349, DOI 10.1074/jbc.M702319200; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jobard E, 2014, CANCER LETT, V343, P33, DOI 10.1016/j.canlet.2013.09.011; Kakizaki M, 2008, BRIT J CANCER, V99, P176, DOI 10.1038/sj.bjc.6604425; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Knutsson A, 2013, SCAND J WORK ENV HEA, V39, P170, DOI 10.5271/sjweh.3323; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Lee YM, 2016, J CELL MOL MED, V20, P1076, DOI 10.1111/jcmm.12794; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2; Lissoni P, 2003, J PINEAL RES, V35, P12, DOI 10.1034/j.1600-079X.2003.00032.x; Mao LL, 2012, MOL ENDOCRINOL, V26, P1808, DOI 10.1210/me.2012-1071; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Martin M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x; Masri S, 2016, CELL, V165, P896, DOI 10.1016/j.cell.2016.04.039; Masri S, 2015, CURR OPIN ONCOL, V27, P50, DOI 10.1097/CCO.0000000000000153; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nahimana A, 2009, BLOOD, V113, P3276, DOI 10.1182/blood-2008-08-173369; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459; Oishi K, 2012, CHRONOBIOL INT, V29, P799, DOI 10.3109/07420528.2012.699127; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Papantoniou K, 2015, INT J CANCER, V137, P1147, DOI 10.1002/ijc.29400; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Peek CB, 2017, CELL METAB, V25, P86, DOI 10.1016/j.cmet.2016.09.010; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Proietti S, 2017, CELL MOL LIFE SCI, V74, P4015, DOI 10.1007/s00018-017-2612-z; Puram RV, 2016, CELL, V165, P303, DOI 10.1016/j.cell.2016.03.015; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x; Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutkowski MR, 2015, ADV CANCER RES, V128, P235, DOI 10.1016/bs.acr.2015.04.011; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato S, 2018, MOL METAB, V16, P1, DOI 10.1016/j.molmet.2018.06.008; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Shostak A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11807; Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Srour B, 2018, INT J CANCER, V143, P2369, DOI 10.1002/ijc.31584; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Sulli G, 2018, NATURE, V553, P351, DOI 10.1038/nature25170; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Taniguchi H, 2009, CANCER RES, V69, P8447, DOI 10.1158/0008-5472.CAN-09-0551; Thakur BK, 2013, INT J CANCER, V132, P766, DOI 10.1002/ijc.27726; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tognini P, 2017, CELL METAB, V26, P523, DOI 10.1016/j.cmet.2017.08.015; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Walhout AJM, 1997, NUCLEIC ACIDS RES, V25, P1493, DOI 10.1093/nar/25.8.1493; Wei SW, 2013, MOL ONCOL, V7, P297, DOI 10.1016/j.molonc.2012.10.003; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu YL, 2017, CELL METAB, V25, P73, DOI 10.1016/j.cmet.2016.09.009; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zawilska JB, 2009, PHARMACOL REP, V61, P383, DOI 10.1016/S1734-1140(09)70081-7; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896	134	161	173	7	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1795	1803		10.1038/s41591-018-0271-8	http://dx.doi.org/10.1038/s41591-018-0271-8			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30523327	Green Accepted			2022-12-27	WOS:000452392200006
J	Komorowski, M; Celi, L; Badawi, O; Gordon, AC; Faisal, AA				Komorowski, Matthieu; Celi, Leoa; Badawi, Omar; Gordon, Anthony C.; Faisal, A. Aldo			The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care	NATURE MEDICINE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; SEPTIC SHOCK; MORTALITY; MEDICINE; CRITERIA; THERAPY; ADULTS	Sepsis is the third leading cause of death worldwide and the main cause of mortality in hospitals(1-3), but the best treatment strategy remains uncertain. In particular, evidence suggests that current practices in the administration of intravenous fluids and vasopressors are suboptimal and likely induce harm in a proportion of patients(1,4-6). To tackle this sequential decision-making problem, we developed a reinforcement learning agent, the Artificial Intelligence (AI) Clinician, which extracted implicit knowledge from an amount of patient data that exceeds by many-fold the life-time experience of human clinicians and learned optimal treatment by analyzing a myriad of (mostly suboptimal) treatment decisions. We demonstrate that the value of the AI Clinician's selected treatment is on average reliably higher than human clinicians. In a large validation cohort independent of the training data, mortality was lowest in patients for whom clinicians' actual doses matched the AI decisions. Our model provides individualized and clinically interpretable treatment decisions for sepsis that could improve patient outcomes.	[Komorowski, Matthieu; Gordon, Anthony C.] Imperial Coll London, Dept Surg & Canc, London, England; [Komorowski, Matthieu; Faisal, A. Aldo] Imperial Coll London, Dept Bioengn, London, England; [Komorowski, Matthieu; Celi, Leoa; Badawi, Omar] Harvard MIT Div Hlth Sci & Technol, Lab Computat Physiol, Cambridge, MA USA; [Celi, Leoa] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Badawi, Omar] Philips Healthcare, Dept eICU Res & Dev, Baltimore, MD USA; [Badawi, Omar] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA; [Faisal, A. Aldo] Imperial Coll London, Dept Comp Sci, London, England; [Faisal, A. Aldo] MRC, London Inst Med Sci, London, England; [Faisal, A. Aldo] Data Sci Inst, Behav Analyt Lab, London, England	Imperial College London; Imperial College London; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Philips; Philips Healthcare; University System of Maryland; University of Maryland Baltimore; Imperial College London	Gordon, AC (corresponding author), Imperial Coll London, Dept Surg & Canc, London, England.; Faisal, AA (corresponding author), Imperial Coll London, Dept Bioengn, London, England.; Faisal, AA (corresponding author), Imperial Coll London, Dept Comp Sci, London, England.; Faisal, AA (corresponding author), MRC, London Inst Med Sci, London, England.; Faisal, AA (corresponding author), Data Sci Inst, Behav Analyt Lab, London, England.	anthony.gordon@imperial.ac.uk; a.faisal@imperial.ac.uk	Badawi, Omar/A-6738-2009; Gordon, Anthony/A-3472-2012; Faisal, Aldo/A-2367-2009	Badawi, Omar/0000-0001-8518-9006; Gordon, Anthony/0000-0002-0419-547X; Faisal, Aldo/0000-0003-0813-7207; Komorowski, Matthieu/0000-0003-0559-5747	National Institute of Health Research (NIHR) Comprehensive Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Engineering and Physical Sciences Research Council; Imperial College President's PhD Scholarship; NIHR Research Professorship award [RP-2015-06-018]	National Institute of Health Research (NIHR) Comprehensive Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Imperial College President's PhD Scholarship; NIHR Research Professorship award	We are grateful to F. Doshi-Velez and O. Gottesman for their assistance with the methodology. We are grateful for support from the National Institute of Health Research (NIHR) Comprehensive Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. We are thankful to the Laboratory of Computational Physiology at the Massachusetts Institute of Technology and the eICU Research Institute for providing the data used in this research. M.K. and this project are funded by the Engineering and Physical Sciences Research Council and an Imperial College President's PhD Scholarship. A.C.G. is funded by an NIHR Research Professorship award (RP-2015-06-018). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Acheampong A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0970-1; [Anonymous], 2009, THESIS; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bai XW, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0532-y; Bennett CC, 2013, ARTIF INTELL MED, V57, P9, DOI 10.1016/j.artmed.2012.12.003; Bothe MK, 2013, EXPERT REV MED DEVIC, V10, P661, DOI 10.1586/17434440.2013.827515; Brown SM, 2013, CHEST, V143, P664, DOI 10.1378/chest.12-1106; Byrne L, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-016-0231-8; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Doina Precup, 2000, P 17 INT C MACH LEAR, P80; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gordon AC, 2016, NEW ENGL J MED, V375, P1638, DOI 10.1056/NEJMoa1609409; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hanna J. P., 2016, PREPRINT; Jiang N., 2015, PREPRINT; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson AEW, 2016, P IEEE, V104, P444, DOI 10.1109/JPROC.2015.2501978; Jones RH, 2011, STAT MED, V30, P3050, DOI 10.1002/sim.4323; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Lowery C, 2013, I IEEE EMBS C NEUR E, P1414, DOI 10.1109/NER.2013.6696208; Marik P, 2016, BRIT J ANAESTH, V116, P339, DOI 10.1093/bja/aev349; Marik PE, 2015, ACTA ANAESTH SCAND, V59, P561, DOI 10.1111/aas.12479; Marik PE, 2017, INTENS CARE MED, V43, P625, DOI 10.1007/s00134-016-4675-y; Munos R., 2016, PREPRINT; Prasad N., 2017, PREPRINT; Puterman ML., 2014, MARKOV DECISION PROC; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Schaefer AJ, 2005, INT SER OPER RES MAN, V70, P593, DOI 10.1007/1-4020-8066-2_23; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Thomas P. S., 2015, 29 AAAI C ART INT AA; Thomas P. S., 2016, PREPRINT; Tutz G, 2015, COMPUT STAT DATA AN, V90, P84, DOI 10.1016/j.csda.2015.04.009; Vincent JL, 2016, CRIT CARE MED, V44, P386, DOI 10.1097/CCM.0000000000001530; Waechter J, 2014, CRIT CARE MED, V42, P2158, DOI 10.1097/CCM.0000000000000520	41	340	352	17	152	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1716	+		10.1038/s41591-018-0213-5	http://dx.doi.org/10.1038/s41591-018-0213-5			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30349085	Green Submitted			2022-12-27	WOS:000449404200024
J	Roberts, AB; Gu, XD; Buffa, JA; Hurd, AG; Wang, ZN; Zhu, WF; Gupta, N; Skye, SM; Cody, DB; Levison, BS; Barrington, WT; Russell, MW; Reed, JM; Duzan, A; Lang, JM; Fu, XM; Li, L; Myers, AJ; Rachakonda, S; Didonato, JA; Brown, JM; Gogonea, V; Lusis, AJ; Garcia-Garcia, JC; Hazen, SL				Roberts, Adam B.; Gu, Xiaodong; Buffa, Jennifer A.; Hurd, Alex G.; Wang, Zeneng; Zhu, Weifei; Gupta, Nilaksh; Skye, Sarah M.; Cody, David B.; Levison, Bruce S.; Barrington, William T.; Russell, Matthew W.; Reed, Jodie M.; Duzan, Ashraf; Lang, Jennifer M.; Fu, Xiaoming; Li, Lin; Myers, Alex J.; Rachakonda, Suguna; Didonato, Joseph A.; Brown, J. Mark; Gogonea, Valentin; Lusis, Aldons J.; Garcia-Garcia, Jose Carlos; Hazen, Stanley L.			Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential	NATURE MEDICINE			English	Article							TRIMETHYLAMINE-N-OXIDE; GLYCYL RADICAL ENZYME; ANTIPLATELET THERAPY; CARDIOVASCULAR-DISEASE; PROGNOSTIC VALUE; MONOOXYGENASE 3; HEART-FAILURE; HUMAN HEALTH; L-CARNITINE; CHOLINE	Trimethylamine N-oxide (TMAO) is a gut microbiota-derived metabolite that enhances both platelet responsiveness and in vivo thrombosis potential in animal models, and TMAO plasma levels predict incident atherothrombotic event risks in human clinical studies. TMAO is formed by gut microbe-dependent metabolism of trimethylamine (TMA) moiety-containing nutrients, which are abundant in a Western diet. Here, using a mechanism-based inhibitor approach targeting a major microbial TMA-generating enzyme pair, CutC and CutD (CutC/D), we developed inhibitors that are potent, time-dependent, and irreversible and that do not affect commensal viability. In animal models, a single oral dose of a CutC/D inhibitor significantly reduced plasma TMAO levels for up to 3 d and rescued diet-induced enhanced platelet responsiveness and thrombus formation, without observable toxicity or increased bleeding risk. The inhibitor selectively accumulated within intestinal microbes to millimolar levels, a concentration over 1-million-fold higher than needed for a therapeutic effect. These studies reveal that mechanism-based inhibition of gut microbial TMA and TMAO production reduces thrombosis potential, a critical adverse complication in heart disease. They also offer a generalizable approach for the selective nonlethal targeting of gut microbial enzymes linked to host disease limiting systemic exposure of the inhibitor in the host.	[Roberts, Adam B.; Gu, Xiaodong; Buffa, Jennifer A.; Hurd, Alex G.; Wang, Zeneng; Zhu, Weifei; Gupta, Nilaksh; Skye, Sarah M.; Levison, Bruce S.; Russell, Matthew W.; Fu, Xiaoming; Li, Lin; Myers, Alex J.; Rachakonda, Suguna; Didonato, Joseph A.; Brown, J. Mark; Gogonea, Valentin; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Roberts, Adam B.; Gu, Xiaodong; Buffa, Jennifer A.; Hurd, Alex G.; Wang, Zeneng; Zhu, Weifei; Gupta, Nilaksh; Skye, Sarah M.; Russell, Matthew W.; Duzan, Ashraf; Fu, Xiaoming; Li, Lin; Rachakonda, Suguna; Didonato, Joseph A.; Brown, J. Mark; Gogonea, Valentin; Hazen, Stanley L.] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44106 USA; [Cody, David B.; Reed, Jodie M.; Garcia-Garcia, Jose Carlos] Procter & Gamble, Life Sci Transformat Platform Technol, Cincinnati, OH USA; [Barrington, William T.; Lang, Jennifer M.; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Barrington, William T.; Lang, Jennifer M.; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Duzan, Ashraf; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Hazen, Stanley L.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Hurd, Alex G.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Myers, Alex J.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Procter & Gamble; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio University	Hazen, SL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.; Hazen, SL (corresponding author), Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44106 USA.; Hazen, SL (corresponding author), Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Gupta, Nilaksh/AAC-5005-2020; Hazen, Stanley L/ABD-5845-2021	Gupta, Nilaksh/0000-0002-9449-2610; Levison, Bruce/0000-0002-1816-368X; Roberts, Adam/0000-0003-3539-804X; Garcia-Garcia, Jose Carlos/0000-0002-0272-9722	National Institutes of Health (NIH); Office of Dietary Supplements [HL103866, HL126827, DK106000, HL122283, AA024333, HL28481, HL30568]; Leducq Foundation; Faculty Research Development Award from Cleveland State University; American Heart Association [15POST25750053]; AHA Scientist Development Grant; NIH StrokeNet Clinical Research and Training Grant; training grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the NIH [T32DK007470]; Shimadzu Center of Excellence award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126827, P01HL028481, P01HL030568, R01HL122283, R01HL103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106000, T32DK007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Faculty Research Development Award from Cleveland State University; American Heart Association(American Heart Association); AHA Scientist Development Grant(American Heart Association); NIH StrokeNet Clinical Research and Training Grant; training grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the NIH; Shimadzu Center of Excellence award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We appreciate the aid of J. A. Drazba and G. Deshpande of the Lerner Research Institute Imaging Core in studies using the Cellix microfluidic system. This research was supported by grants from the National Institutes of Health (NIH) and the Office of Dietary Supplements (HL103866, HL126827 and DK106000 (to S.L.H.), HL122283 and AA024333 (to J.M.B.), and HL28481 and HL30568 (to A.J.L.)). S.L.H. reports being supported in part by a grant from the Leducq Foundation. V.G. acknowledges a Faculty Research Development Award from Cleveland State University. A.B.R. was supported in part by a grant from the American Heart Association (15POST25750053). W.Z. was supported in part by an AHA Scientist Development Grant and an NIH StrokeNet Clinical Research and Training Grant. S.M.S. was supported in part by training grant T32DK007470 from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the NIH. Some of the toxicology and safety studies were performed by Pharmaron. Mass spectrometry studies were performed on instrumentation housed in a facility supported in part through a Shimadzu Center of Excellence award. Computational resources were provided by the Extreme Science and Engineering Discovery Environment (National Science Foundation).	Aron-Wisnewsky J, 2016, NAT REV NEPHROL, V12, P169, DOI 10.1038/nrneph.2015.191; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Bobadilla RV, 2016, CRIT CARE NURSE, V36, P15, DOI 10.4037/ccn2016497; Bodea S, 2016, CELL CHEM BIOL, V23, P1206, DOI 10.1016/j.chembiol.2016.07.020; Brown JM, 2017, J BIOL CHEM, V292, P8560, DOI 10.1074/jbc.R116.765388; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850; Cohen M, 2009, MAYO CLIN PROC, V84, P149, DOI 10.1016/S0025-6196(11)60823-9; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Fischbach MA, 2016, CELL, V164, P1288, DOI 10.1016/j.cell.2016.02.037; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Fusaro M, 2017, CLIN CHEM LAB MED, V55, P789, DOI 10.1515/cclm-2016-0783; Gachet C, 2015, J THROMB HAEMOST, V13, pS313, DOI 10.1111/jth.12947; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Heianza Y, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004947; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jackel S, 2017, BLOOD, V130, P542, DOI 10.1182/blood-2016-11-754416; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koopen AM, 2016, CURR OPIN LIPIDOL, V27, P615, DOI 10.1097/MOL.0000000000000357; Levine GN, 2016, J THORAC CARDIOV SUR, V152, P1243, DOI 10.1016/j.jtcvs.2016.07.044; Li TJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00350; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pSE261; Martinez-del Campo A, 2015, MBIO, V6, DOI 10.1128/mBio.00042-15; Nemzek JA, 2001, INFLAMM RES, V50, P523, DOI 10.1007/PL00000229; Organ CL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002314; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; PHILLIPS GB, 1960, BIOCHIM BIOPHYS ACTA, V41, P361, DOI 10.1016/0006-3002(60)90026-3; Qi JQ, 2018, J CELL MOL MED, V22, P185, DOI 10.1111/jcmm.13307; Rath S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0271-9; Rogers MAM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.003; Romano KA, 2017, CELL HOST MICROBE, V22, P279, DOI 10.1016/j.chom.2017.07.021; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; SANDHU SS, 1986, CAN J MICROBIOL, V32, P743, DOI 10.1139/m86-135; Schiattarella GG, 2017, EUR HEART J, V38, P2948, DOI 10.1093/eurheartj/ehx342; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Seldin MM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002767; Senthong V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002816; Tang WHW, 2015, J CARD FAIL, V21, P91, DOI 10.1016/j.cardfail.2014.11.006; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; WALSH CT, 1984, ANNU REV BIOCHEM, V53, P493, DOI 10.1146/annurev.bi.53.070184.002425; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warrier M, 2015, CELL REP, V10, P326, DOI 10.1016/j.celrep.2014.12.036; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yue CC, 2017, BIOCHEM BIOPH RES CO, V490, P541, DOI 10.1016/j.bbrc.2017.06.075; Zhu WF, 2017, CIRCULATION, V135, P1671, DOI 10.1161/CIRCULATIONAHA.116.025338; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	62	252	266	10	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1407	+		10.1038/s41591-018-0128-1	http://dx.doi.org/10.1038/s41591-018-0128-1			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30082863	Green Accepted			2022-12-27	WOS:000444174100026
J	Sellar, RS; Jaiswal, S; Ebert, BL				Sellar, Rob S.; Jaiswal, Siddhartha; Ebert, Benjamin L.			Predicting progression to AML	NATURE MEDICINE			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; CLONAL HEMATOPOIESIS; CANCER; RISK	The number, identity, and burden of mutations in clonal hematopoiesis are associated with the risk and timing of progression to acute myeloid leukemia.	[Sellar, Rob S.; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Sellar, Rob S.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sellar, Rob S.] UCL, UCL Canc Inst, London, England; [Jaiswal, Siddhartha] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Ebert, Benjamin L.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; University College London; Stanford University; Harvard University; Dana-Farber Cancer Institute	Ebert, BL (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Ebert, BL (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	bebert@partners.org			NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA066996] Funding Source: Medline; NHLBI NIH HHS [R01 HL082945] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Amatangelo MD, 2017, BLOOD, V130, P732, DOI 10.1182/blood-2017-04-779447; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484	12	16	17	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					904	906		10.1038/s41591-018-0114-7	http://dx.doi.org/10.1038/s41591-018-0114-7			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988142				2022-12-27	WOS:000438187700015
J	Urnov, FD				Urnov, Fyodor D.			A path to efficient gene editing	NATURE MEDICINE			English	Editorial Material							CELLS		[Urnov, Fyodor D.] Altius Inst Biomed Sci, Seattle, WA 98121 USA		Urnov, FD (corresponding author), Altius Inst Biomed Sci, Seattle, WA 98121 USA.	urnov@altius.org						da Cruz L, 2018, NAT BIOTECHNOL, V36, P1, DOI 10.1038/nbt.4114; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunbar CE, 2018, SCIENCE, V359, P175, DOI 10.1126/science.aan4672; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2018, CRISPR J, V1, P34, DOI 10.1089/crispr.2018.29007.fyu; Urnov FD, 2018, CURR OPIN GENET DEV, V52, P48, DOI 10.1016/j.gde.2018.05.005	12	4	5	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					899	900		10.1038/s41591-018-0110-y	http://dx.doi.org/10.1038/s41591-018-0110-y			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988144				2022-12-27	WOS:000438187700012
J	Parikh, AR; Leshchiner, I; Elagina, L; Goyal, L; Levovitz, C; Siravegna, G; Livitz, D; Rhrissorrakrai, K; Martin, EE; Van Seventer, EE; Hanna, M; Slowik, K; Utro, F; Pinto, CJ; Wong, A; Danysh, BP; de la Cruz, FF; Fetter, IJ; Nadres, B; Shahzade, HA; Allen, JN; Blaszkowsky, LS; Clark, JW; Giantonio, B; Murphy, JE; Nipp, RD; Roeland, E; Ryan, DP; Weekes, CD; Kwak, EL; Faris, JE; Wo, JY; Aguet, F; Dey-Guha, I; Hazar-Rethinam, M; Dias-Santagata, D; Ting, DT; Zhu, AX; Hong, TS; Golub, TR; Iafrate, AJ; Adalsteinsson, VA; Bardelli, A; Parida, L; Juric, D; Getz, G; Corcoran, RB				Parikh, Aparna R.; Leshchiner, Ignaty; Elagina, Liudmila; Goyal, Lipika; Levovitz, Chaya; Siravegna, Giulia; Livitz, Dimitri; Rhrissorrakrai, Kahn; Martin, Elizabeth E.; Van Seventer, Emily E.; Hanna, Megan; Slowik, Kara; Utro, Filippo; Pinto, Christopher J.; Wong, Alicia; Danysh, Brian P.; de la Cruz, Ferran Fece; Fetter, Isobel J.; Nadres, Brandon; Shahzade, Heather A.; Allen, Jill N.; Blaszkowsky, Lawrence S.; Clark, Jeffrey W.; Giantonio, Bruce; Murphy, Janet E.; Nipp, Ryan D.; Roeland, Eric; Ryan, David P.; Weekes, Colin D.; Kwak, Eunice L.; Faris, Jason E.; Wo, Jennifer Y.; Aguet, Francois; Dey-Guha, Ipsita; Hazar-Rethinam, Mehlika; Dias-Santagata, Dora; Ting, David T.; Zhu, Andrew X.; Hong, Theodore S.; Golub, Todd R.; Iafrate, A. John; Adalsteinsson, Viktor A.; Bardelli, Alberto; Parida, Laxmi; Juric, Dejan; Getz, Gad; Corcoran, Ryan B.			Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers	NATURE MEDICINE			English	Article							ANTI-EGFR THERAPY; COLORECTAL-CANCER; TARGETED THERAPY; INTRATUMOR HETEROGENEITY; GENOMIC LANDSCAPE; EVOLUTION; BLOCKADE; DNA; INHIBITION; MUTATIONS	During cancer therapy, tumor heterogeneity can drive the evolution of multiple tumor subclones harboring unique resistance mechanisms in an individual patient(1-3). Previous case reports and small case series have suggested that liquid biopsy (specifically, cell-free DNA (cfDNA)) may better capture the heterogeneity of acquired resistance(4-8). However, the effectiveness of cfDNA versus standard single-lesion tumor biopsies has not been directly compared in larger-scale prospective cohorts of patients following progression on targeted therapy. Here, in a prospective cohort of 42 patients with molecularly defined gastrointestinal cancers and acquired resistance to targeted therapy, direct comparison of post-progression cfDNA versus tumor biopsy revealed that cfDNA more frequently identified clinically relevant resistance alterations and multiple resistance mechanisms, detecting resistance alterations not found in the matched tumor biopsy in 78% of cases. Whole-exome sequencing of serial cfDNA, tumor biopsies and rapid autopsy specimens elucidated substantial geographic and evolutionary differences across lesions. Our data suggest that acquired resistance is frequently characterized by profound tumor heterogeneity, and that the emergence of multiple resistance alterations in an individual patient may represent the 'rule' rather than the 'exception'. These findings have profound therapeutic implications and highlight the potential advantages of cfDNA over tissue biopsy in the setting of acquired resistance.	[Parikh, Aparna R.; Goyal, Lipika; Van Seventer, Emily E.; Pinto, Christopher J.; de la Cruz, Ferran Fece; Fetter, Isobel J.; Nadres, Brandon; Shahzade, Heather A.; Allen, Jill N.; Blaszkowsky, Lawrence S.; Clark, Jeffrey W.; Giantonio, Bruce; Murphy, Janet E.; Nipp, Ryan D.; Roeland, Eric; Ryan, David P.; Weekes, Colin D.; Kwak, Eunice L.; Faris, Jason E.; Wo, Jennifer Y.; Dey-Guha, Ipsita; Hazar-Rethinam, Mehlika; Dias-Santagata, Dora; Ting, David T.; Zhu, Andrew X.; Hong, Theodore S.; Iafrate, A. John; Juric, Dejan; Getz, Gad; Corcoran, Ryan B.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Parikh, Aparna R.; Goyal, Lipika; Van Seventer, Emily E.; Pinto, Christopher J.; de la Cruz, Ferran Fece; Fetter, Isobel J.; Nadres, Brandon; Shahzade, Heather A.; Allen, Jill N.; Blaszkowsky, Lawrence S.; Clark, Jeffrey W.; Giantonio, Bruce; Murphy, Janet E.; Nipp, Ryan D.; Roeland, Eric; Ryan, David P.; Weekes, Colin D.; Kwak, Eunice L.; Faris, Jason E.; Wo, Jennifer Y.; Dey-Guha, Ipsita; Hazar-Rethinam, Mehlika; Dias-Santagata, Dora; Ting, David T.; Zhu, Andrew X.; Hong, Theodore S.; Iafrate, A. John; Juric, Dejan; Getz, Gad; Corcoran, Ryan B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Leshchiner, Ignaty; Elagina, Liudmila; Livitz, Dimitri; Martin, Elizabeth E.; Hanna, Megan; Slowik, Kara; Wong, Alicia; Danysh, Brian P.; Aguet, Francois; Golub, Todd R.; Adalsteinsson, Viktor A.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Levovitz, Chaya; Rhrissorrakrai, Kahn; Utro, Filippo; Parida, Laxmi] IBM Res, Yorktown Hts, NY USA; [Siravegna, Giulia; Bardelli, Alberto] Candiolo Canc Inst, Turin, Italy; [Siravegna, Giulia; Bardelli, Alberto] Univ Torino, Dept Oncol, Turin, Italy; [Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; International Business Machines (IBM); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Getz, G; Corcoran, RB (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.; Getz, G; Corcoran, RB (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Getz, G (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	gadgetz@broadinstitute.org; rbcorcoran@partners.org	Roeland, Eric J/N-4229-2019; BARDELLI, Alberto/J-9721-2018; Ting, David/F-4389-2017	Roeland, Eric J/0000-0002-3674-3573; BARDELLI, Alberto/0000-0003-1647-5070; Fetter, Isobel/0000-0002-6021-2713; Ting, David/0000-0002-3261-2322; Danysh, Brian/0000-0001-6839-6337; Livitz, Dimitri/0000-0003-2528-1446; Leshchiner, Ignaty/0000-0001-8942-9265; Fece de la Cruz, Ferran/0000-0003-2694-4838	NIH/NCI [CA127003, R01CA208437, K08CA166510, U54CA224068]; Damon Runyon Clinical Investigator Award; Stand Up To Cancer Colorectal Dream Team Translational Research Grant [SU2C-AACR-DT22-17]; Broad/IBM Cancer Resistance Research Project; Susan Eid Tumor Heterogeneity Initiative; FONDAZIONE AIRC [21091, 16788]; AIRC [21923]; AIRC-CRUK-FC AECC Accelerator Award [22795]; European Community [602901 MErCuRIC, 635342-2 MoTriColor, 115749 CANCER-ID]; Ministero della Salute [NET-2011-02352137]; Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per Mille 2014; 2015 Ministero della Salute; Roche; AIRC; NATIONAL CANCER INSTITUTE [K08CA166510, K12CA087723, U54CA224068, R01CA208437, P50CA127003] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Clinical Investigator Award; Stand Up To Cancer Colorectal Dream Team Translational Research Grant; Broad/IBM Cancer Resistance Research Project; Susan Eid Tumor Heterogeneity Initiative; FONDAZIONE AIRC(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); AIRC-CRUK-FC AECC Accelerator Award; European Community(European Commission); Ministero della Salute(Ministry of Health, Italy); Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per Mille 2014; 2015 Ministero della Salute; Roche(Roche Holding); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is partially supported by the NIH/NCI Gastrointestinal Cancer Specialized Program of Research Excellence P50 (CA127003, R01CA208437, K08CA166510 and U54CA224068), a Damon Runyon Clinical Investigator Award and a Stand Up To Cancer Colorectal Dream Team Translational Research Grant (grant number SU2C-AACR-DT22-17 to R.B.C.). Research grants are administered by the American Association of Cancer Research, the scientific partners of Stand Up To Cancer. The work is partially supported by the Broad/IBM Cancer Resistance Research Project (G.G. and L.P.) and the Susan Eid Tumor Heterogeneity Initiative (D.J.). The research leading to these results has received funding from FONDAZIONE AIRC under 5 per Mille 2018 ID. 21091 program - P. I. Bardelli Alberto. The research leading to these results has received funding from FONDAZIONE AIRC: AIRC Investigator Grant 2015 - ID. 16788; AIRC Investigator Grant 2018 - ID. 21923; AIRC-CRUK-FC AECC Accelerator Award - contract 22795. This work was also supported by the European Community's Seventh Framework Programme (grant agreement number 602901 MErCuRIC), H2020 (grant agreement number 635342-2 MoTriColor), IMI (contract number 115749 CANCER-ID), Ministero della Salute (project NET-2011-02352137) and Fondazione Piemontese per la Ricerca sul Cancro-ONLUS 5 per Mille 2014 and 2015 Ministero della Salute. G.S. was funded by a Roche per la Ricerca grant (2017) and AIRC three-year fellowship (2017).	Ahronian LG, 2015, CANCER DISCOV, V5, P358, DOI 10.1158/2159-8290.CD-14-1518; Arena S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5640; Bahcall M, 2016, CANCER DISCOV, V6, P1334, DOI 10.1158/2159-8290.CD-16-0686; Bertotti A, 2015, NATURE, V526, P263, DOI 10.1038/nature14969; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Blakely CM, 2017, NAT GENET, V49, P1693, DOI 10.1038/ng.3990; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goyal L, 2017, CANCER DISCOV, V7, P252, DOI 10.1158/2159-8290.CD-16-1000; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Hazar-Rethinam M, 2018, CANCER DISCOV, V8, P417, DOI 10.1158/2159-8290.CD-17-1227; Heist RS, 2016, J THORAC ONCOL, V11, P1242, DOI 10.1016/j.jtho.2016.06.013; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Janjigian YY, 2018, CANCER DISCOV, V8, P49, DOI 10.1158/2159-8290.CD-17-0787; Kim ST, 2018, ANN ONCOL, V29, P1037, DOI 10.1093/annonc/mdy034; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Kwak EL, 2015, CANCER DISCOV, V5, P1271, DOI 10.1158/2159-8290.CD-15-0748; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Leshchiner I., 2018, COMPREHENSIVE ANAL T; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Morelli MP, 2015, ANN ONCOL, V26, P731, DOI 10.1093/annonc/mdv005; Oddo D, 2016, CANCER RES, V76, P4504, DOI 10.1158/0008-5472.CAN-16-0396; Pectasides E, 2018, CANCER DISCOV, V8, P37, DOI 10.1158/2159-8290.CD-17-0395; Piotrowska Z, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00263; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Rothwell DG, 2019, NAT MED, V25, P738, DOI 10.1038/s41591-019-0380-z; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Siravegna G, 2018, CANCER CELL, V34, P148, DOI 10.1016/j.ccell.2018.06.004; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Strickler JH, 2018, CANCER DISCOV, V8, P164, DOI 10.1158/2159-8290.CD-17-1009; Tan L, 2014, P NATL ACAD SCI USA, V111, pE4869, DOI 10.1073/pnas.1403438111; Taylor-Weiner A, 2018, NAT METHODS, V15, P531, DOI 10.1038/s41592-018-0036-9; Thierry AR, 2017, CLIN CANCER RES, V23, P4578, DOI 10.1158/1078-0432.CCR-17-0232; Turajlic S, 2018, CELL, V173, P595, DOI 10.1016/j.cell.2018.03.043; Yaeger R, 2017, CANCER RES, V77, P6513, DOI 10.1158/0008-5472.CAN-17-0768	47	212	215	10	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1415	+		10.1038/s41591-019-0561-9	http://dx.doi.org/10.1038/s41591-019-0561-9			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501609	Green Accepted			2022-12-27	WOS:000484832800025
J	Yelin, I; Snitser, O; Novich, G; Katz, R; Tal, O; Parizade, M; Chodick, G; Koren, G; Shalev, V; Kishony, R				Yelin, Idan; Snitser, Olga; Novich, Gal; Katz, Rachel; Tal, Ofir; Parizade, Miriam; Chodick, Gabriel; Koren, Gideon; Shalev, Varda; Kishony, Roy			Personal clinical history predicts antibiotic resistance of urinary tract infections	NATURE MEDICINE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANCE; ACUTE UNCOMPLICATED CYSTITIS; RISK-FACTORS; ANTIMICROBIAL SUSCEPTIBILITY; EPIDEMIOLOGY; PREVALENCE; PATHOGENS; THERAPY; CARE; MICROBIOLOGY	Antibiotic resistance is prevalent among the bacterial pathogens causing urinary tract infections. However, antimicrobial treatment is often prescribed 'empirically', in the absence of antibiotic susceptibility testing, risking mismatched and therefore ineffective treatment. Here, linking a 10-year longitudinal data set of over 700,000 community-acquired urinary tract infections with over 5,000,000 individually resolved records of antibiotic purchases, we identify strong associations of antibiotic resistance with the demographics, records of past urine cultures and history of drug purchases of the patients. When combined together, these associations allow for machine-learning-based personalized drug-specific predictions of antibiotic resistance, thereby enabling drug-prescribing algorithms that match an antibiotic treatment recommendation to the expected resistance of each sample. Applying these algorithms retrospectively, over a 1-year test period, we find that they greatly reduce the risk of mismatched treatment compared with the current standard of care. The clinical application of such algorithms may help improve the effectiveness of antimicrobial treatments.	[Yelin, Idan; Snitser, Olga; Kishony, Roy] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Novich, Gal; Kishony, Roy] Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel; [Katz, Rachel; Chodick, Gabriel; Koren, Gideon; Shalev, Varda] Maccabi Healthcare Serv, Maccabitech, Tel Aviv, Israel; [Tal, Ofir; Kishony, Roy] Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Haifa, Israel; [Parizade, Miriam] Natl Lab, Maccabi Healthcare Serv, Rehovot, Israel; [Chodick, Gabriel; Koren, Gideon; Shalev, Varda] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine	Kishony, R (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.; Kishony, R (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel.; Kishony, R (corresponding author), Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Haifa, Israel.	rkishony@technion.ac.il	Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875; Yelin, Idan/0000-0003-2515-4113; /0000-0002-5189-8995; Snitser, Olga/0000-0001-6067-1912	US National Institutes of Health [R01 GM081617]; European Research Council FP7 ERC [281891]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081617] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council FP7 ERC; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Datta, A. McAdam, G. Priebe and P. Ramesh for thorough reading of the manuscript and important comments. This work was supported in part by US National Institutes of Health grant no. R01 GM081617 (to R.K.) and European Research Council FP7 ERC grant no. 281891 (to R.K.) as well as The Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine (to R.K.).	Arslan H, 2005, J ANTIMICROB CHEMOTH, V56, P914, DOI 10.1093/jac/dki344; ASHKENAZI S, 1991, PEDIATR INFECT DIS J, V10, P742, DOI 10.1097/00006454-199110000-00005; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Bronzwaer SLAM, 2002, EMERG INFECT DIS, V8, P278, DOI 10.3201/eid0803.010192; Brown PD, 2002, CLIN INFECT DIS, V34, P1061, DOI 10.1086/339491; Burman WJ, 2003, AM J MED, V115, P358, DOI 10.1016/S0002-9343(03)00372-3; Colgan R, 2008, ANTIMICROB AGENTS CH, V52, P846, DOI 10.1128/AAC.01200-07; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Edlin RS, 2013, J UROLOGY, V190, P222, DOI 10.1016/j.juro.2013.01.069; ENA J, 1995, J UROLOGY, V153, P117, DOI 10.1097/00005392-199501000-00040; Engel JD, 1998, UROL CLIN N AM, V25, P685, DOI 10.1016/S0094-0143(05)70057-4; Farrell DJ, 2003, J INFECTION, V46, P94, DOI 10.1053/jinf.2002.1091; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Foxman B, 2002, AM J MED, V113, p5S; Fridkin SK, 2001, ANN INTERN MED, V135, P175, DOI 10.7326/0003-4819-135-3-200108070-00009; Geerlings SE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0002-2012; GINSBURG CM, 1982, PEDIATRICS, V69, P409; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grad YH, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0538-4; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hooton TM, 2004, CLIN INFECT DIS, V39, P75, DOI 10.1086/422145; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Ikram R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0974-0; Johnson L, 2008, AM J MED, V121, P876, DOI 10.1016/j.amjmed.2008.04.039; Kahan NR, 2006, ANN PHARMACOTHER, V40, P2223, DOI 10.1345/aph.1H396; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P128, DOI 10.1093/jac/dkg280; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Kang MS, 2015, ANN REHABIL MED-ARM, V39, P686, DOI 10.5535/arm.2015.39.5.686; Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Lee G, 2010, J KOREAN MED SCI, V25, P1205, DOI 10.3346/jkms.2010.25.8.1205; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; LIPSKY BA, 1989, ANN INTERN MED, V110, P138, DOI 10.7326/0003-4819-110-2-138; Low M, 2019, LANCET INFECT DIS, V19, P419, DOI 10.1016/S1473-3099(18)30676-5; Low M, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0278-5; MacFadden DR, 2014, CLIN INFECT DIS, V59, P1265, DOI 10.1093/cid/ciu588; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Metlay JP, 2003, J ANTIMICROB CHEMOTH, V51, P963, DOI 10.1093/jac/dkg146; Olesen SW, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3155; Paul M, 2006, J ANTIMICROB CHEMOTH, V58, P1238, DOI 10.1093/jac/dkl372; Pouwels KB, 2018, J ANTIMICROB CHEMOTH, V73, P1700, DOI 10.1093/jac/dky031; Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006; Sandora TJ, 2014, CLIN CHEM, V60, P586, DOI 10.1373/clinchem.2013.217141; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Tenney J, 2018, SAUDI PHARM J, V26, P678, DOI 10.1016/j.jsps.2018.02.023; Ventola C Lee, 2015, P T, V40, P277; Wang A, 2017, INFECT CONT HOSP EP, V38, P1457, DOI 10.1017/ice.2017.222	53	58	61	1	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1143	+		10.1038/s41591-019-0503-6	http://dx.doi.org/10.1038/s41591-019-0503-6			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31273328	Green Submitted, Green Accepted			2022-12-27	WOS:000474430400029
J	Zeitler, B; Froelich, S; Marlen, K; Shivak, DA; Yu, Q; Li, D; Pearl, JR; Miller, JC; Zhang, L; Paschon, DE; Hinkley, SJ; Ankoudinova, I; Lam, S; Guschin, D; Kopan, L; Cherone, JM; Nguyen, HOB; Qiao, GJ; Ataei, Y; Mendel, MC; Amora, R; Surosky, R; Laganiere, J; Vu, BJ; Narayanan, A; Sedaghat, Y; Tillack, K; Thiede, C; Gartner, A; Kwak, S; Bard, J; Mrzljak, L; Park, L; Heikkinen, T; Lehtimaki, KK; Svedberg, MM; Haggkvist, J; Tari, L; Toth, M; Varrone, A; Halldin, C; Kudwa, AE; Ramboz, S; Day, M; Kondapalli, J; Surmeier, DJ; Urnov, FD; Gregory, PD; Rebar, EJ; Munoz-Sanjuan, I; Zhang, HS				Zeitler, Bryan; Froelich, Steven; Marlen, Kimberly; Shivak, David A.; Yu, Qi; Li, Davis; Pearl, Jocelynn R.; Miller, Jeffrey C.; Zhang, Lei; Paschon, David E.; Hinkley, Sarah J.; Ankoudinova, Irina; Lam, Stephen; Guschin, Dmitry; Kopan, Lexi; Cherone, Jennifer M.; Nguyen, Hoang-Oanh B.; Qiao, Guijuan; Ataei, Yasaman; Mendel, Matthew C.; Amora, Rainier; Surosky, Richard; Laganiere, Josee; Vu, B. Joseph; Narayanan, Anand; Sedaghat, Yalda; Tillack, Karsten; Thiede, Christina; Gaertner, Annette; Kwak, Seung; Bard, Jonathan; Mrzljak, Ladislav; Park, Larry; Heikkinen, Taneli; Lehtimaki, Kimmo K.; Svedberg, Marie M.; Haggkvist, Jenny; Tari, Lenke; Toth, Miklos; Varrone, Andrea; Halldin, Christer; Kudwa, Andrea E.; Ramboz, Sylvie; Day, Michelle; Kondapalli, Jyothisri; Surmeier, D. James; Urnov, Fyodor D.; Gregory, Philip D.; Rebar, Edward J.; Munoz-Sanjuan, Ignacio; Zhang, H. Steve			Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease	NATURE MEDICINE			English	Article							ZINC-FINGER PROTEINS; MOUSE MODEL; PERFORMANCE EVALUATION; HD GENE; EXPRESSION; SUPPRESSION; BRAIN; DNA; INACTIVATION; DYNAMICS	Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by a CAG trinucleotide expansion in the huntingtin gene (HTT), which codes for the pathologic mutant HTT (mHTT) protein. Since normal HTT is thought to be important for brain function, we engineered zinc finger protein transcription factors (ZFP-TFs) to target the pathogenic CAG repeat and selectively lower mHTT as a therapeutic strategy. Using patient-derived fibroblasts and neurons, we demonstrate that ZFP-TFs selectively repress > 99% of HD-causing alleles over a wide dose range while preserving expression of > 86% of normal alleles. Other CAG-containing genes are minimally affected, and virally delivered ZFP-TFs are active and well tolerated in HD neurons beyond 100 days in culture and for at least nine months in the mouse brain. Using three HD mouse models, we demonstrate improvements in a range of molecular, histopathological, electrophysiological and functional endpoints. Our findings support the continued development of an allele-selective ZFP-TF for the treatment of HD.	[Zeitler, Bryan; Froelich, Steven; Marlen, Kimberly; Shivak, David A.; Yu, Qi; Li, Davis; Pearl, Jocelynn R.; Miller, Jeffrey C.; Zhang, Lei; Paschon, David E.; Hinkley, Sarah J.; Ankoudinova, Irina; Lam, Stephen; Guschin, Dmitry; Kopan, Lexi; Cherone, Jennifer M.; Nguyen, Hoang-Oanh B.; Qiao, Guijuan; Ataei, Yasaman; Mendel, Matthew C.; Amora, Rainier; Surosky, Richard; Laganiere, Josee; Vu, B. Joseph; Narayanan, Anand; Urnov, Fyodor D.; Gregory, Philip D.; Rebar, Edward J.; Zhang, H. Steve] Sangamo Therapeut Inc, Richmond, CA 94804 USA; [Sedaghat, Yalda; Tillack, Karsten; Thiede, Christina; Gaertner, Annette] Evotec AG, Hamburg, Germany; [Kwak, Seung; Bard, Jonathan; Mrzljak, Ladislav; Park, Larry; Munoz-Sanjuan, Ignacio] CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA; [Heikkinen, Taneli; Lehtimaki, Kimmo K.] Charles River Discovery Serv, Kuopio, Finland; [Svedberg, Marie M.; Haggkvist, Jenny; Tari, Lenke; Toth, Miklos; Varrone, Andrea; Halldin, Christer] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Svedberg, Marie M.; Haggkvist, Jenny; Tari, Lenke; Toth, Miklos; Varrone, Andrea; Halldin, Christer] Stockholm Cty Council, Stockholm, Sweden; [Kudwa, Andrea E.; Ramboz, Sylvie] Psychogenics Inc, Paramus, NJ USA; [Day, Michelle; Kondapalli, Jyothisri; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Guschin, Dmitry] Moscow Inst Phys & Technol, Lab Intracellular Signalling, Dolgoprudnyi, Russia; [Laganiere, Josee] Hema Quebec, Med Affairs & Innovat, Quebec City, PQ, Canada; [Urnov, Fyodor D.] Innovat Genom Inst, Berkeley, CA USA; [Zhang, H. Steve] Appl StemCell Inc, Milpitas, CA USA	Evotec; Karolinska Institutet; Stockholm County Council; Northwestern University; Feinberg School of Medicine; Moscow Institute of Physics & Technology; Hema-Quebec	Zeitler, B (corresponding author), Sangamo Therapeut Inc, Richmond, CA 94804 USA.; Munoz-Sanjuan, I (corresponding author), CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA.	bzeitler@sangamo.com; ignacio.munoz@chdifoundation.org	Gaertner, Annette/B-5393-2013; Guschin, Dmitry/U-3731-2019; Lehtimäki, Kimmo K/A-6018-2009	Guschin, Dmitry/0000-0002-4184-0001; Lehtimäki, Kimmo K/0000-0003-2750-8229	CHDI Foundation; Shire Human Genetic Therapies, Inc., a subsidiary of Shire PLC	CHDI Foundation; Shire Human Genetic Therapies, Inc., a subsidiary of Shire PLC	We thank A. Goodwin, C. Schmidt and I. Cardaun for AAV production. We thank J. Fitzpatrick, W. Arias and T. Schwagarus for stereotaxic injections. We thank J. Weidner for IHC of brain sections. We thank J. Babiarz and E. Leung for bioinformatics analysis. We thank I. Cardaun and S. Kanamkudam for zQ175 primary neuron culture and qPCR. We thank G. Nichol, D. Ando, K. Meyer, A. Manning-Bog and V. Beaumont for discussions. We thank M. Chiocco, D. Klatte, V. Choi, D. Howland, S. Noble, J. Zeitler, M. Stilwell, S. Abrahamson, B. Riley and M. Holmes for reviewing the manuscript. This work was funded by CHDI Foundation and Shire Human Genetic Therapies, Inc., a subsidiary of Shire PLC.	Agustin-Pavon C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0128-x; Arteaga-Bracho EE, 2016, NEUROBIOL DIS, V96, P144, DOI 10.1016/j.nbd.2016.09.006; Banez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038; Bankiewicz KS, 2016, J CONTROL RELEASE, V240, P434, DOI 10.1016/j.jconrel.2016.02.034; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Capelli P, 2017, NATURE, V551, P373, DOI 10.1038/nature24064; Carty N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123527; Datson NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171127; Dietrich P, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006846; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109; Gersbach CA, 2014, EXPERT OPIN THER TAR, V18, P835, DOI 10.1517/14728222.2014.913572; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Haggkvist J, 2017, J NUCL MED, V58, P617, DOI 10.2967/jnumed.116.180497; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hinde E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12001; Indersmitten T, 2015, J NEUROPHYSIOL, V113, P2953, DOI 10.1152/jn.01056.2014; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Landwehrmeyer GB, 2017, MOV DISORD CLIN PRAC, V4, P212, DOI 10.1002/mdc3.12388; Langer O, 1999, J LABELLED COMPD RAD, V42, P1183; Latorra D, 2003, HUM MUTAT, V22, P79, DOI 10.1002/humu.10228; Lim RG, 2017, NAT NEUROSCI, V20, P648, DOI 10.1038/nn.4532; Lopes F, 2016, J MED GENET, V53, P190, DOI 10.1136/jmedgenet-2015-103568; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marti E, 2016, BRAIN PATHOL, V26, P779, DOI 10.1111/bpa.12427; Mattis VB, 2015, HUM MOL GENET, V24, P3257, DOI 10.1093/hmg/ddv080; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Minderer M, 2012, J PHYSIOL-LONDON, V590, P99, DOI 10.1113/jphysiol.2011.219014; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Monteys AM, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.7; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Nagy K, 2013, J NUCL MED, V54, P1825, DOI 10.2967/jnumed.112.119065; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NEKLUDOVA L, 1994, P NATL ACAD SCI USA, V91, P6948, DOI 10.1073/pnas.91.15.6948; Niccolini F, 2018, J NEUROL NEUROSUR PS, V89, P185, DOI 10.1136/jnnp-2017-316633; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Plautz SA, 2011, MOL THER, V19, P2144, DOI 10.1038/mt.2011.161; Plotkin JL, 2015, CURR OPIN NEUROBIOL, V33, P53, DOI 10.1016/j.conb.2015.01.020; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Russell DS, 2016, NEUROLOGY, V86, P748, DOI 10.1212/WNL.0000000000002391; Russell DS, 2014, JAMA NEUROL, V71, P1520, DOI 10.1001/jamaneurol.2014.1954; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Southwell AL, 2014, MOL THER, V22, P2093, DOI 10.1038/mt.2014.153; Stanek LM, 2014, HUM GENE THER, V25, P461, DOI 10.1089/hum.2013.200; Stiles DK, 2012, EXP NEUROL, V233, P463, DOI 10.1016/j.expneurol.2011.11.020; Szanda I, 2011, J NUCL MED, V52, P1741, DOI 10.2967/jnumed.111.088260; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/nmeth.3733, 10.1038/NMETH.3733]; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Waldvogel HJ, 2015, CURR TOP BEHAV NEURO, V22, P33, DOI 10.1007/7854_2014_354; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Wang N, 2014, NAT MED, V20, P540, DOI 10.1038/nm.3514; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wilson H, 2016, J NEUROL SCI, V368, P243, DOI 10.1016/j.jns.2016.07.033; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	75	74	77	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1131	+		10.1038/s41591-019-0478-3	http://dx.doi.org/10.1038/s41591-019-0478-3			33	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31263285				2022-12-27	WOS:000474430400028
J	Fresard, L; Smail, C; Ferraro, NM; Teran, NA; Li, X; Smith, KS; Bonner, D; Kernohan, KD; Marwaha, S; Zappala, Z; Balliu, B; Davis, JR; Liu, BX; Prybol, CJ; Kohler, JN; Zastrow, DB; Reuter, CM; Fisk, DG; Grove, ME; Davidson, JM; Hartley, T; Joshi, R; Strober, BJ; Utiramerur, S; Lind, L; Ingelsson, E; Battle, A; Bejerano, G; Bernstein, JA; Ashley, EA; Boycott, KM; Merker, JD; Wheeler, MT; Montgomery, SB; Adams, DR; Aday, A; Alejandro, ME; Allard, P; Ashley, EA; Azamian, MS; Bacino, CA; Baker, E; Balasubramanyam, A; Barseghyan, H; Batzli, GF; Beggs, AH; Behnam, B; Bellen, HJ; Bernstein, JA; Berry, GT; Bican, A; Bick, DP; Birch, CL; Bonner, D; Boone, BE; Bostwick, BL; Briere, LC; Brokamp, E; Brown, DM; Brush, M; Burke, EA; Burrage, LC; Butte, MJ; Chen, S; Clark, GD; Coakley, TR; Cogan, JD; Colley, HA; Cooper, CM; Cope, H; Craigen, WJ; D'Souza, P; Davids, M; Davidson, JM; Dayal, JG; Dell'Angelica, EC; Dhar, SU; Dipple, KM; Donnell-Fink, LA; Dorrani, N; Dorset, DC; Douine, ED; Draper, DD; Dries, AM; Duncan, L; Eckstein, DJ; Emrick, LT; Eng, CM; Enns, GM; Eskin, A; Esteves, C; Estwick, T; Fernandez, L; Ferreira, C; Fieg, EL; Fisher, PG; Fogel, BL; Friedman, ND; Gahl, WA; Glanton, E; Godfrey, RA; Goldman, AM; Goldstein, DB; Gould, SE; Gourdine, JPF; Groden, CA; Gropman, AL; Haendel, M; Hamid, R; Hanchard, NA; High, F; Holm, IA; Hom, J; Howerton, EM; Huang, Y; Jamal, F; Jiang, YH; Johnston, JM; Jones, AL; Karaviti, L; Koeller, DM; Kohane, IS; Kohler, JN; Krasnewich, DM; Korrick, S; Koziura, M; Krier, JB; Kyle, JE; Lalani, SR; Lau, CC; Lazar, J; LeBlanc, K; Lee, BH; Lee, H; Levy, SE; Lewis, RA; Lincoln, SA; Loo, SK; Loscalzo, J; Maas, RL; Macnamara, EF; MacRae, CA; Maduro, VV; Majcherska, MM; Malicdan, MCV; Mamounas, LA; Manolio, TA; Markello, TC; Marom, R; Martin, MG; Martinez-Agosto, JA; Marwaha, S; May, T; McConkie-Rosell, A; McCormack, CE; McCray, AT; Merker, JD; Metz, TO; Might, M; Moretti, PM; Morimoto, M; Mulvihill, JJ; Murdock, DR; Murphy, JL; Muzny, DM; Nehrebecky, ME; Nelson, SF; Newberry, JS; Newman, JH; Nicholas, SK; Novacic, D; Orange, JS; Orengo, JP; Pallais, JC; Palmer, CGS; Papp, JC; Parker, NH; Pena, LDM; Phillips, JA; Posey, JE; Postlethwait, JH; Potocki, L; Pusey, BN; Renteria, G; Reuter, CM; Rives, L; Robertson, AK; Rodan, LH; Rosenfeld, JA; Sampson, JB; Samson, SL; Schoch, K; Scott, DA; Shakachite, L; Sharma, P; Shashi, V; Signer, R; Silverman, EK; Sinsheimer, JS; Smith, KS; Spillmann, RC; Stoler, JM; Stong, N; Sullivan, JA; Sweetser, DA; Tan, QKG; Tifft, CJ; Toro, C; Tran, AA; Urv, TK; Vilain, E; Vogel, TP; Waggott, DM; Wahl, CE; Walley, NM; Walsh, CA; Walker, M; Wan, JJ; Wangler, MF; Ward, PA; Waters, KM; Webb-Robertson, BJM; Westerfield, M; Wheeler, MT; Wise, AL; Wolfe, LA; Worthey, EA; Yamamoto, S; Yang, J; Yang, YP; Yoon, AJ; Yu, GY; Zastrow, DB; Zhao, CL; Zheng, A; Boycott, K; MacKenzie, A; Majewski, J; Brudno, M; Bulman, D; Dyment, D				Fresard, Laure; Smail, Craig; Ferraro, Nicole M.; Teran, Nicole A.; Li, Xin; Smith, Kevin S.; Bonner, Devon; Kernohan, Kristin D.; Marwaha, Shruti; Zappala, Zachary; Balliu, Brunilda; Davis, Joe R.; Liu, Boxiang; Prybol, Cameron J.; Kohler, Jennefer N.; Zastrow, Diane B.; Reuter, Chloe M.; Fisk, Dianna G.; Grove, Megan E.; Davidson, Jean M.; Hartley, Taila; Joshi, Ruchi; Strober, Benjamin J.; Utiramerur, Sowmithri; Lind, Lars; Ingelsson, Erik; Battle, Alexis; Bejerano, Gill; Bernstein, Jonathan A.; Ashley, Euan A.; Boycott, Kym M.; Merker, Jason D.; Wheeler, Matthew T.; Montgomery, Stephen B.; Adams, David R.; Aday, Aaron; Alejandro, Mercedes E.; Allard, Patrick; Ashley, Euan A.; Azamian, Mahshid S.; Bacino, Carlos A.; Baker, Eva; Balasubramanyam, Ashok; Barseghyan, Hayk; Batzli, Gabriel F.; Beggs, Alan H.; Behnam, Babak; Bellen, Hugo J.; Bernstein, Jonathan A.; Berry, Gerard T.; Bican, Anna; Bick, David P.; Birch, Camille L.; Bonner, Devon; Boone, Braden E.; Bostwick, Bret L.; Briere, Lauren C.; Brokamp, Elly; Brown, Donna M.; Brush, Matthew; Burke, Elizabeth A.; Burrage, Lindsay C.; Butte, Manish J.; Chen, Shan; Clark, Gary D.; Coakley, Terra R.; Cogan, Joy D.; Colley, Heather A.; Cooper, Cynthia M.; Cope, Heidi; Craigen, William J.; D'Souza, Precilla; Davids, Mariska; Davidson, Jean M.; Dayal, Jyoti G.; Dell'Angelica, Esteban C.; Dhar, Shweta U.; Dipple, Katrina M.; Donnell-Fink, Laurel A.; Dorrani, Naghmeh; Dorset, Daniel C.; Douine, Emilie D.; Draper, David D.; Dries, Annika M.; Duncan, Laura; Eckstein, David J.; Emrick, Lisa T.; Eng, Christine M.; Enns, Gregory M.; Eskin, Ascia; Esteves, Cecilia; Estwick, Tyra; Fernandez, Liliana; Ferreira, Carlos; Fieg, Elizabeth L.; Fisher, Paul G.; Fogel, Brent L.; Friedman, Noah D.; Gahl, William A.; Glanton, Emily; Godfrey, Rena A.; Goldman, Alica M.; Goldstein, David B.; Gould, Sarah E.; Gourdine, Jean-Philippe F.; Groden, Catherine A.; Gropman, Andrea L.; Haendel, Melissa; Hamid, Rizwan; Hanchard, Neil A.; High, Frances; Holm, Ingrid A.; Hom, Jason; Howerton, Ellen M.; Huang, Yong; Jamal, Fariha; Jiang, Yong-hui; Johnston, Jean M.; Jones, Angela L.; Karaviti, Lefkothea; Koeller, David M.; Kohane, Isaac S.; Kohler, Jennefer N.; Krasnewich, Donna M.; Korrick, Susan; Koziura, Mary; Krier, Joel B.; Kyle, Jennifer E.; Lalani, Seema R.; Lau, C. Christopher; Lazar, Jozef; LeBlanc, Kimberly; Lee, Brendan H.; Lee, Hane; Levy, Shawn E.; Lewis, Richard A.; Lincoln, Sharyn A.; Loo, Sandra K.; Loscalzo, Joseph; Maas, Richard L.; Macnamara, Ellen F.; MacRae, Calum A.; Maduro, Valerie V.; Majcherska, Marta M.; Malicdan, May Christine V.; Mamounas, Laura A.; Manolio, Teri A.; Markello, Thomas C.; Marom, Ronit; Martin, G. Martin; Martinez-Agosto, Julian A.; Marwaha, Shruti; May, Thomas; McConkie-Rosell, Allyn; McCormack, Colleen E.; McCray, Alexa T.; Merker, Jason D.; Metz, Thomas O.; Might, Matthew; Moretti, Paolo M.; Morimoto, Marie; Mulvihill, John J.; Murdock, David R.; Murphy, Jennifer L.; Muzny, Donna M.; Nehrebecky, Michele E.; Nelson, Stan F.; Newberry, J. Scott; Newman, John H.; Nicholas, Sarah K.; Novacic, Donna; Orange, Jordan S.; Orengo, James P.; Pallais, J. Carl; Palmer, Christina G. S.; Papp, Jeanette C.; Parker, Neil H.; Pena, Loren D. M.; Phillips, John A., III; Posey, Jennifer E.; Postlethwait, John H.; Potocki, Lorraine; Pusey, Barbara N.; Renteria, Genecee; Reuter, Chloe M.; Rives, Lynette; Robertson, Amy K.; Rodan, Lance H.; Rosenfeld, Jill A.; Sampson, Jacinda B.; Samson, Susan L.; Schoch, Kelly; Scott, Daryl A.; Shakachite, Lisa; Sharma, Prashant; Shashi, Vandana; Signer, Rebecca; Silverman, Edwin K.; Sinsheimer, Janet S.; Smith, Kevin S.; Spillmann, Rebecca C.; Stoler, Joan M.; Stong, Nicholas; Sullivan, Jennifer A.; Sweetser, David A.; Tan, Queenie K. -G.; Tifft, Cynthia J.; Toro, Camilo; Tran, Alyssa A.; Urv, Tiina K.; Vilain, Eric; Vogel, Tiphanie P.; Waggott, Daryl M.; Wahl, Colleen E.; Walley, Nicole M.; Walsh, Chris A.; Walker, Melissa; Wan, Jijun; Wangler, Michael F.; Ward, Patricia A.; Waters, Katrina M.; Webb-Robertson, Bobbie-Jo M.; Westerfield, Monte; Wheeler, Matthew T.; Wise, Anastasia L.; Wolfe, Lynne A.; Worthey, Elizabeth A.; Yamamoto, Shinya; Yang, John; Yang, Yaping; Yoon, Amanda J.; Yu, Guoyun; Zastrow, Diane B.; Zhao, Chunli; Zheng, Allison; Boycott, Kym; MacKenzie, Alex; Majewski, Jacek; Brudno, Michael; Bulman, Dennis; Dyment, David		Undiagnosed Dis Network; Care4Rare Canada Consortium	Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts	NATURE MEDICINE			English	Article							ONLINE MENDELIAN INHERITANCE; EXPRESSION; DIAGNOSIS; FRAMEWORK; VARIANTS; PATHOGENICITY; SWIPROSIN-1; DISCOVERY; ATROPHY; DECAY	It is estimated that 350 million individuals worldwide suffer from rare diseases, which are predominantly caused by mutation in a single gene(1). The current molecular diagnostic rate is estimated at 50%, with whole-exome sequencing (WES) among the most successful approaches(2-5). For patients in whom WES is uninformative, RNA sequencing (RNA-seq) has shown diagnostic utility in specific tissues and diseases(6-8). This includes muscle biopsies from patients with undiagnosed rare muscle disorders(6,9), and cultured fibroblasts from patients with mitochondrial disorders(7). However, for many individuals, biopsies are not performed for clinical care, and tissues are difficult to access. We sought to assess the utility of RNA-seq from blood as a diagnostic tool for rare diseases of different pathophysiologies. We generated whole-blood RNA-seq from 94 individuals with undiagnosed rare diseases spanning 16 diverse disease categories. We developed a robust approach to compare data from these individuals with large sets of RNA-seq data for controls (n = 1,594 unrelated controls and n = 49 family members) and demonstrated the impacts of expression, splicing, gene and variant filtering strategies on disease gene identification. Across our cohort, we observed that RNA-seq yields a 7.5% diagnostic rate, and an additional 16.7% with improved candidate gene resolution.	[Fresard, Laure; Li, Xin; Smith, Kevin S.; Balliu, Brunilda; Merker, Jason D.; Montgomery, Stephen B.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Smail, Craig; Ferraro, Nicole M.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Teran, Nicole A.; Zappala, Zachary; Davis, Joe R.; Prybol, Cameron J.; Ashley, Euan A.; Montgomery, Stephen B.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bonner, Devon; Marwaha, Shruti; Kohler, Jennefer N.; Zastrow, Diane B.; Reuter, Chloe M.; Davidson, Jean M.; Ashley, Euan A.; Wheeler, Matthew T.] Stanford Univ, Stanford Ctr Undiagnosed Dis, Stanford, CA USA; [Kernohan, Kristin D.] Childrens Hosp Eastern Ontario, NSO, Ottawa, ON, Canada; [Marwaha, Shruti; Ingelsson, Erik; Wheeler, Matthew T.] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA; [Liu, Boxiang] Stanford Univ, Sch Humanities & Sci, Dept Biol, Stanford, CA 94305 USA; [Fisk, Dianna G.; Grove, Megan E.; Joshi, Ruchi; Utiramerur, Sowmithri; Merker, Jason D.] Stanford Univ, Sch Med, Stanford Med Clin Genom Program, Stanford, CA 94305 USA; [Hartley, Taila; Boycott, Kym M.; Boycott, Kym; MacKenzie, Alex; Bulman, Dennis; Dyment, David] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Strober, Benjamin J.; Battle, Alexis] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Lind, Lars] Uppsala Univ, Cardiovasc Epidemiol, Dept Med Sci, Uppsala, Sweden; [Ingelsson, Erik; Ashley, Euan A.] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Bejerano, Gill; Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Bejerano, Gill] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Bejerano, Gill] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Merker, Jason D.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Merker, Jason D.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27515 USA; [Adams, David R.; Aday, Aaron; Alejandro, Mercedes E.; Allard, Patrick; Ashley, Euan A.; Azamian, Mahshid S.; Bacino, Carlos A.; Baker, Eva; Balasubramanyam, Ashok; Barseghyan, Hayk; Batzli, Gabriel F.; Beggs, Alan H.; Behnam, Babak; Bellen, Hugo J.; Bernstein, Jonathan A.; Berry, Gerard T.; Bican, Anna; Bick, David P.; Birch, Camille L.; Bonner, Devon; Boone, Braden E.; Bostwick, Bret L.; Briere, Lauren C.; Brokamp, Elly; Brown, Donna M.; Brush, Matthew; Burke, Elizabeth A.; Burrage, Lindsay C.; Butte, Manish J.; Chen, Shan; Clark, Gary D.; Coakley, Terra R.; Cogan, Joy D.; Colley, Heather A.; Cooper, Cynthia M.; Cope, Heidi; Craigen, William J.; D'Souza, Precilla; Davids, Mariska; Davidson, Jean M.; Dayal, Jyoti G.; Dell'Angelica, Esteban C.; Dhar, Shweta U.; Dipple, Katrina M.; Donnell-Fink, Laurel A.; Dorrani, Naghmeh; Dorset, Daniel C.; Douine, Emilie D.; Draper, David D.; Dries, Annika M.; Duncan, Laura; Eckstein, David J.; Emrick, Lisa T.; Eng, Christine M.; Enns, Gregory M.; Eskin, Ascia; Esteves, Cecilia; Estwick, Tyra; Fernandez, Liliana; Ferreira, Carlos; Fieg, Elizabeth L.; Fisher, Paul G.; Fogel, Brent L.; Friedman, Noah D.; Gahl, William A.; Glanton, Emily; Godfrey, Rena A.; Goldman, Alica M.; Goldstein, David B.; Gould, Sarah E.; Gourdine, Jean-Philippe F.; Groden, Catherine A.; Gropman, Andrea L.; Haendel, Melissa; Hamid, Rizwan; Hanchard, Neil A.; High, Frances; Holm, Ingrid A.; Hom, Jason; Howerton, Ellen M.; Huang, Yong; Jamal, Fariha; Jiang, Yong-hui; Johnston, Jean M.; Jones, Angela L.; Karaviti, Lefkothea; Koeller, David M.; Kohane, Isaac S.; Kohler, Jennefer N.; Krasnewich, Donna M.; Korrick, Susan; Koziura, Mary; Krier, Joel B.; Kyle, Jennifer E.; Lalani, Seema R.; Lau, C. Christopher; Lazar, Jozef; LeBlanc, Kimberly; Lee, Brendan H.; Lee, Hane; Levy, Shawn E.; Lewis, Richard A.; Lincoln, Sharyn A.; Loo, Sandra K.; Loscalzo, Joseph; Maas, Richard L.; Macnamara, Ellen F.; MacRae, Calum A.; Maduro, Valerie V.; Majcherska, Marta M.; Malicdan, May Christine V.; Mamounas, Laura A.; Manolio, Teri A.; Markello, Thomas C.; Marom, Ronit; Martin, G. Martin; Martinez-Agosto, Julian A.; Marwaha, Shruti; May, Thomas; McConkie-Rosell, Allyn; McCormack, Colleen E.; McCray, Alexa T.; Merker, Jason D.; Metz, Thomas O.; Might, Matthew; Moretti, Paolo M.; Morimoto, Marie; Mulvihill, John J.; Murdock, David R.; Murphy, Jennifer L.; Muzny, Donna M.; Nehrebecky, Michele E.; Nelson, Stan F.; Newberry, J. Scott; Newman, John H.; Nicholas, Sarah K.; Novacic, Donna; Orange, Jordan S.; Orengo, James P.; Pallais, J. Carl; Palmer, Christina G. S.; Papp, Jeanette C.; Parker, Neil H.; Pena, Loren D. M.; Phillips, John A., III; Posey, Jennifer E.; Postlethwait, John H.; Potocki, Lorraine; Pusey, Barbara N.; Renteria, Genecee; Reuter, Chloe M.; Rives, Lynette; Robertson, Amy K.; Rodan, Lance H.; Rosenfeld, Jill A.; Sampson, Jacinda B.; Samson, Susan L.; Schoch, Kelly; Scott, Daryl A.; Shakachite, Lisa; Sharma, Prashant; Shashi, Vandana; Signer, Rebecca; Silverman, Edwin K.; Sinsheimer, Janet S.; Smith, Kevin S.; Spillmann, Rebecca C.; Stoler, Joan M.; Stong, Nicholas; Sullivan, Jennifer A.; Sweetser, David A.; Tan, Queenie K. -G.; Tifft, Cynthia J.; Toro, Camilo; Tran, Alyssa A.; Urv, Tiina K.; Vilain, Eric; Vogel, Tiphanie P.; Waggott, Daryl M.; Wahl, Colleen E.; Walley, Nicole M.; Walsh, Chris A.; Walker, Melissa; Wan, Jijun; Wangler, Michael F.; Ward, Patricia A.; Waters, Katrina M.; Webb-Robertson, Bobbie-Jo M.; Westerfield, Monte; Wheeler, Matthew T.; Wise, Anastasia L.; Wolfe, Lynne A.; Worthey, Elizabeth A.; Yamamoto, Shinya; Yang, John; Yang, Yaping; Yoon, Amanda J.; Yu, Guoyun; Zastrow, Diane B.; Zhao, Chunli; Zheng, Allison] NIH, Undiagnosed Dis Network, Bldg 10, Bethesda, MD 20892 USA; [Majewski, Jacek] McGill Univ, Montreal, PQ, Canada; [Brudno, Michael] Univ Toronto, Toronto, ON, Canada	Stanford University; Stanford University; Stanford University; Stanford University; University of Ottawa; Children's Hospital of Eastern Ontario; Stanford University; Stanford University; Stanford University; University of Ottawa; Children's Hospital of Eastern Ontario; Johns Hopkins University; Uppsala University; Stanford University; Johns Hopkins University; Stanford University; Stanford University; Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; McGill University; University of Toronto	Fresard, L; Montgomery, SB (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Montgomery, SB (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	lfresard@stanford.edu; smontgom@stanford.edu	Sharma, Prashant/ABH-2407-2021; Lalani, Seema/AAI-5090-2020; Stong, Nicholas/ABB-7516-2021; Urv, Tiina/AAW-9336-2021; Malicdan, May Christine/AAK-7422-2021; Hanchard, Neil/AAY-9075-2021; Butte, Manish/AAM-8604-2020; Orengo, James/AAF-1667-2021; Sweetser, David/ABB-9347-2021; Loscalzo, Joseph/ABD-8980-2021; Butte, Manish/T-8860-2019; Goldstein, David/AAY-8125-2020; Nelson, Stanley F/D-4771-2009; Yamamoto, Shinya/ABB-2837-2021; Marwaha, Shruti/ABF-5360-2020	Hanchard, Neil/0000-0003-1925-2665; Butte, Manish/0000-0002-4490-5595; Sweetser, David/0000-0002-1621-3284; Butte, Manish/0000-0002-4490-5595; Nelson, Stanley F/0000-0002-2082-3114; Yamamoto, Shinya/0000-0003-2172-8036; Marwaha, Shruti/0000-0002-1877-2629; Douine, Emilie/0000-0002-6048-2887; Stong, Nicholas/0000-0002-0678-637X; Azamian, Mahshid/0000-0002-8543-8284; Montgomery, Stephen/0000-0002-5200-3903; Allard, Patrick/0000-0001-7765-1547; Wheeler, Matthew/0000-0001-8721-3022; Reuter, Chloe/0000-0002-0429-9922; Li, Xin/0000-0002-2122-7461; Fresard, Laure/0000-0001-8154-6328; Liu, Boxiang/0000-0002-2595-4463; Fisher, Paul/0000-0002-1196-1590; Brown, Donna/0000-0002-8805-7225; Behnam, Babak/0000-0002-1266-1602; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; orange, jordan/0000-0001-7117-7725	NIH [R01HG008150, U01HG009080]; Glenn Center for Aging at Stanford; Stanford Center for Computational, Evolutionary, and Human Genomics Fellowship; BD2K Training Grant [T32 LM012409]; National Science Foundation Graduate Research Fellowship; Stanford Genome Training Program [2T32HG000044-21, NIH/NHGRI T32HG000044]; Stanford Computational, Evolutionary, and Human Genomics Fellowship; National Key R&D Program of China [2016YFD0400800]; CIHR Foundation grant [FDN-154279]; CEHG Fellowship; National Science Foundation GRFP [DGE-114747]; Stanford Genome Training Program; Dean's Postdoctoral Fellowship; Lucille P. Markey Biomedical Research 688 Stanford Graduate Fellowship; Stanford Genome Training Program 689 [NIH/NHGRI T32HG000044]; NIST/JIMB [70NANB15H268]; Searle Scholar Fund; Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute; Ontario Research Fund; Children's Hospital of Eastern Ontario Foundation; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director [U01HG007708]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, U01HG010218, U01HG007708, U01HG009080, R01HG008150] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012409] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Center for Aging at Stanford; Stanford Center for Computational, Evolutionary, and Human Genomics Fellowship; BD2K Training Grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Genome Training Program; Stanford Computational, Evolutionary, and Human Genomics Fellowship; National Key R&D Program of China; CIHR Foundation grant(Canadian Institutes of Health Research (CIHR)); CEHG Fellowship; National Science Foundation GRFP(National Science Foundation (NSF)); Stanford Genome Training Program; Dean's Postdoctoral Fellowship; Lucille P. Markey Biomedical Research 688 Stanford Graduate Fellowship; Stanford Genome Training Program 689; NIST/JIMB; Searle Scholar Fund; Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Ontario Research Fund; Children's Hospital of Eastern Ontario Foundation; NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank the patients and their families for their participation in this study. S.B.M. is supported by NIH grants nos. R01HG008150 (NoVa) and U01HG009080 (GSPAC) and the Glenn Center for Aging at Stanford. L.F. was supported by the Stanford Center for Computational, Evolutionary, and Human Genomics Fellowship. C.S. is supported by a BD2K Training Grant (T32 LM012409). N.M.F. is supported by a National Science Foundation Graduate Research Fellowship. N.A.T. is supported by the Stanford Genome Training Program (2T32HG000044-21). B.L. was supported by the Stanford Computational, Evolutionary, and Human Genomics Fellowship and the National Key R&D Program of China (2016YFD0400800). K.M.B. is supported by a CIHR Foundation grant (FDN-154279). Z.Z. was supported by the CEHG Fellowship, the National Science Foundation GRFP (DGE-114747) and the Stanford Genome Training Program (NIH/NHGRI T32HG000044). B.B. was supported by the Stanford Genome Training Program and Dean's Postdoctoral Fellowship. J.R.D. was supported by a Lucille P. Markey Biomedical Research 688 Stanford Graduate Fellowship. J.R.D. acknowledges the Stanford Genome Training Program 689 (NIH/NHGRI T32HG000044). C.J.P. is supported by NIST/JIMB grant no. 70NANB15H268. A.B. is supported by NIH grant no. R01HG008150 (NoVa) and the Searle Scholar Fund. Clinical sample collection was supported, in part, by the Care4Rare Canada Consortium funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, the Ontario Research Fund and the Children's Hospital of Eastern Ontario Foundation. Research reported in this manuscript was in part supported by the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director under Award Number U01HG007708. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Avramidou A, 2007, CELL DEATH DIFFER, V14, P1936, DOI 10.1038/sj.cdd.4402206; Barbosa M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04540-x; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003; Cao D, 2003, CELL, V113, P533, DOI 10.1016/S0092-8674(03)00353-2; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Estivill X, 2015, NAT BIOTECHNOL, V33, P357, DOI 10.1038/nbt.3195; Ewans LJ, 2018, GENET MED, V20, P1564, DOI 10.1038/gim.2018.39; Ganna A, 2018, AM J HUM GENET, V102, P1204, DOI 10.1016/j.ajhg.2018.05.002; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Hamanaka K, 2019, GENET MED, V21, P1629, DOI 10.1038/s41436-018-0360-6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heimer G, 2016, AM J HUM GENET, V99, P1229, DOI 10.1016/j.ajhg.2016.09.021; Kernohan KD, 2017, HUM MUTAT, V38, P611, DOI 10.1002/humu.23211; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Kroczek C, 2010, J IMMUNOL, V184, P3665, DOI 10.4049/jimmunol.0903642; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Nickless A, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0153-7; Pala M, 2017, NAT GENET, V49, P700, DOI 10.1038/ng.3840; Pedersen BS, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0973-5; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao AR, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0371-9; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Soens ZT, 2017, HUM MUTAT, V38, P1521, DOI 10.1002/humu.23294; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Tange O., 2018, USENIX MAGAZINE, V36, P42; Thylur RP, 2018, J CELL BIOCHEM, V119, P150, DOI 10.1002/jcb.26199; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wright CF, 2018, GENET MED, V20, P1216, DOI 10.1038/gim.2017.246; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zeng Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004942; Zhao J, 2016, AM J HUM GENET, V98, P299, DOI 10.1016/j.ajhg.2015.12.023	56	114	116	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					911	+		10.1038/s41591-019-0457-8	http://dx.doi.org/10.1038/s41591-019-0457-8			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31160820	Green Accepted, Green Submitted			2022-12-27	WOS:000470844400021
J	Yousef, H; Czupalla, CJ; Lee, D; Chen, MB; Burke, AN; Zera, KA; Zandstra, J; Berber, E; Lehallier, B; Mathur, V; Nair, RV; Bonanno, LN; Yang, AC; Peterson, T; Hadeiba, H; Merkel, T; Korbelin, J; Schwaninger, M; Buckwalter, MS; Quake, SR; Butcher, EC; Wyss-Coray, T				Yousef, Hanadie; Czupalla, Cathrin J.; Lee, Davis; Chen, Michelle B.; Burke, Ashley N.; Zera, Kristy A.; Zandstra, Judith; Berber, Elisabeth; Lehallier, Benoit; Mathur, Vidhu; Nair, Ramesh V.; Bonanno, Liana N.; Yang, Andrew C.; Peterson, Todd; Hadeiba, Husein; Merkel, Taylor; Koerbelin, Jakob; Schwaninger, Markus; Buckwalter, Marion S.; Quake, Stephen R.; Butcher, Eugene C.; Wyss-Coray, Tony			Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1	NATURE MEDICINE			English	Article							ADHESION MOLECULE-1 VCAM-1; ALZHEIMERS-DISEASE; BARRIER; EXPRESSION; MODELS; NEUROGENESIS; ICAM-1; MICE; INFLAMMATION; MAINTENANCE	An aged circulatory environment can activate microglia, reduce neural precursor cell activity and impair cognition in mice. We hypothesized that brain endothelial cells (BECs) mediate at least some of these effects. We observe that BECs in the aged mouse hippocampus express an inflammatory transcriptional profile with focal upregulation of vascular cell adhesion molecule 1 (VCAM1), a protein that facilitates vascular-immune cell interactions. Concomitantly, levels of the shed, soluble form of VCAM1 are prominently increased in the plasma of aged humans and mice, and their plasma is sufficient to increase VCAM1 expression in cultured BECs and the hippocampi of young mice. Systemic administration of anti-VCAM1 antibody or genetic ablation of Vcam1 in BECs counteracts the detrimental effects of plasma from aged individuals on young brains and reverses aging aspects, including microglial reactivity and cognitive deficits, in the brains of aged mice. Together, these findings establish brain endothelial VCAM1 at the blood-brain barrier as a possible target to treat age-related neurodegeneration.	[Yousef, Hanadie; Lee, Davis; Burke, Ashley N.; Zera, Kristy A.; Zandstra, Judith; Berber, Elisabeth; Lehallier, Benoit; Mathur, Vidhu; Bonanno, Liana N.; Yang, Andrew C.; Peterson, Todd; Merkel, Taylor; Buckwalter, Marion S.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Yousef, Hanadie; Czupalla, Cathrin J.; Lee, Davis; Burke, Ashley N.; Zandstra, Judith; Berber, Elisabeth; Lehallier, Benoit; Mathur, Vidhu; Bonanno, Liana N.; Merkel, Taylor; Butcher, Eugene C.; Wyss-Coray, Tony] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Czupalla, Cathrin J.; Hadeiba, Husein; Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Czupalla, Cathrin J.; Hadeiba, Husein; Butcher, Eugene C.; Wyss-Coray, Tony] Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA; [Chen, Michelle B.; Yang, Andrew C.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chen, Michelle B.; Yang, Andrew C.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Nair, Ramesh V.] Stanford Univ, Sch Med, Stanford Ctr Genom & Personalized Med, Stanford, CA 94305 USA; [Koerbelin, Jakob] Univ Med Ctr Hamburg Eppendorf, Sect Pneumol, Dept Oncol Hematol & Stem Cell Transplantat, Hamburg, Germany; [Schwaninger, Markus] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Lubeck, Germany; [Buckwalter, Marion S.; Wyss-Coray, Tony] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Quake, Stephen R.] Chan Zuckerberg Biohub, Stanford, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; Stanford University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Stanford University	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Wyss-Coray, T (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.; Wyss-Coray, T (corresponding author), Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA.; Wyss-Coray, T (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019; Körbelin, Jakob/ABG-2863-2020	Wyss-Coray, Tony/0000-0001-5893-0831; Körbelin, Jakob/0000-0002-5435-7182; Merkel, Taylor/0000-0002-6427-8488; Burke, Ashley/0000-0002-2170-3819; Buckwalter, Marion/0000-0003-2807-2447; Zera, Kristy/0000-0001-9178-6907; Bonanno, Liana/0000-0002-0840-956X	Department of Veterans Affairs; National Institute on Aging [F32-AG051330, R01-AG045034, DP1-AG053015]; NOMIS Foundation; D.H. Chen Foundation; Glenn Foundation for Aging Research; SPARK grant through the Stanford Clinical and Translational Science Award (CTSA) [UL1-TR001085]; National Institutes of Health [R01-GM37734, R37-AI047822, RO1-AI109452]; Wu Tsai Neurosciences Institute; Stanford Institute for Immunity, Transplantation and Infection; Edinger Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047822, R01AI109452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045034, F32AG051330, DP1AG053015] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NOMIS Foundation; D.H. Chen Foundation; Glenn Foundation for Aging Research; SPARK grant through the Stanford Clinical and Translational Science Award (CTSA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wu Tsai Neurosciences Institute; Stanford Institute for Immunity, Transplantation and Infection; Edinger Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Sutherland and C. Cain for managing the core flow cytometry facility at the VA in Palo Alto and providing H.Y. and C.J.C. training on the instruments, as well as C. Cain for his experimental advice, assistance with flow cytometry and analysis of PBMCs, and thoughtful discussion. We thank O. Leyva for assistance in staining and microscopy analysis for the experiment shown in Extended Data Fig. 4a-d. We would also like to thank R. Watts and N. Bien-Ly for sharing a BEC isolation protocol used in modified form for RNA-seq. This work was funded by the Department of Veterans Affairs (T.W.-C.), the National Institute on Aging (F32-AG051330 to H.Y., R01-AG045034 and DP1-AG053015 to T.W.-C.), the NOMIS Foundation (T.W.-C.), the D.H. Chen Foundation (T.W.-C.), the Glenn Foundation for Aging Research (T.W.-C.), a SPARK grant to H. Y. through the Stanford Clinical and Translational Science Award (CTSA) to Spectrum (UL1-TR001085), the National Institutes of Health (R01-GM37734 and R37-AI047822 to E.C.B., RO1-AI109452 to H.H.), the Wu Tsai Neurosciences Institute (T.W.-C.), the Stanford Institute for Immunity, Transplantation and Infection (C.J.C.) and the Edinger Institute (C.J.C.). The CTSA program is led by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health.	Ballantyne CM, 2002, CIRCULATION, V106, P766, DOI 10.1161/01.CIR.0000028397.68936.12; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bien-Ly N, 2015, NEURON, V88, P289, DOI 10.1016/j.neuron.2015.09.036; Britschgi M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008862; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Calvo CF, 2011, GENE DEV, V25, P831, DOI 10.1101/gad.615311; Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067; Chin JE, 1997, AM J PHYSIOL-LUNG C, V272, pL219, DOI 10.1152/ajplung.1997.272.2.L219; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; Czupalla CJ, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3092; Czupalla CJ, 2014, METHODS MOL BIOL, V1135, P415, DOI 10.1007/978-1-4939-0320-7_34; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Engelhardt B, 2014, CELL TISSUE RES, V355, P687, DOI 10.1007/s00441-014-1811-2; Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420; Ewers M, 2010, EXP GERONTOL, V45, P75, DOI 10.1016/j.exger.2009.09.005; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Gragnano F, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5620314; Han J, 2015, CELL REP, V10, P1158, DOI 10.1016/j.celrep.2015.01.049; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hoffmann A, 2011, TRANSL STROKE RES, V2, P106, DOI 10.1007/s12975-010-0049-x; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V144, P494, DOI 10.1111/j.1365-2249.2006.03064.x; Hu XL, 2017, NEURON, V95, P309, DOI 10.1016/j.neuron.2017.06.047; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kijanka G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085281; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; MATSUDA M, 1995, J NEUROIMMUNOL, V59, P35, DOI 10.1016/0165-5728(95)00023-U; Merat S, 2000, J GERONTOL A-BIOL, V55, pB85; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Muggeo V.M., 2008, R NEWS, V8, P20; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Murakami M, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/293641; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Okugawa Y, 2010, EXP THER MED, V1, P463, DOI 10.3892/etm_00000072; Pan JL, 2016, BLOOD, V128, P104, DOI 10.1182/blood-2015-12-684688; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Polman Chris H, 2006, N Engl J Med, V354, P899; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363; Richter V, 2003, GERONTOLOGY, V49, P293, DOI 10.1159/000071710; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Schlesinger M, 2015, INT J CANCER, V136, P2504, DOI 10.1002/ijc.28927; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; Steffen BJ, 1996, AM J PATHOL, V148, P1819; Sun B. B, 2017, BIORXIV, DOI [10.1101/134551v1, DOI 10.1101/134551V1]; Tchalla AE, 2017, J GERONTOL A-BIOL, V72, P560, DOI 10.1093/gerona/glw099; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vanmeer P, 2005, BIOCHEM J, V389, P593, DOI 10.1042/BJ20042023; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vivash L, 2016, J NUCL MED, V57, P165, DOI 10.2967/jnumed.114.141713; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wolf A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147733; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Yousef H, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3091; Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525	80	141	146	6	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					988	+		10.1038/s41591-019-0440-4	http://dx.doi.org/10.1038/s41591-019-0440-4			43	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31086348	Green Accepted			2022-12-27	WOS:000470844400031
J	Stower, H				Stower, Hannah			Improving cognition	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					710	710		10.1038/s41591-019-0454-y	http://dx.doi.org/10.1038/s41591-019-0454-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068706	Bronze			2022-12-27	WOS:000468247800009
J	Graham, WV; He, WQ; Marchiando, AM; Zha, JM; Singh, G; Li, HS; Biswas, A; Ong, MLDM; Jiang, ZH; Choi, WS; Zuccola, H; Wang, YT; Griffith, J; Wu, JS; Rosenberg, HJ; Wang, YM; Snapper, SB; Ostrov, D; Meredith, SC; Miller, LW; Turner, JR				Graham, W. Vallen; He, Weiqi; Marchiando, Amanda M.; Zha, Juanmin; Singh, Gurminder; Li, Hua-Shan; Biswas, Amlan; Ong, Ma. Lora Drizella M.; Jiang, Zhi-Hui; Choi, Wangsun; Zuccola, Harmon; Wang, Yitang; Griffith, James; Wu, Jingshing; Rosenberg, Harry J.; Wang, Yingmin; Snapper, Scott B.; Ostrov, David; Meredith, Stephen C.; Miller, Lawrence W.; Turner, Jerrold R.			Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis	NATURE MEDICINE			English	Article							LIGHT-CHAIN KINASE; MEMBRANE-PERMEANT PEPTIDE; INTESTINAL PERMEABILITY; INTERLEUKIN-10-DEFICIENT MICE; CROHNS-DISEASE; DYSFUNCTION; DOMAIN; CONTRACTION; ACTIVATION; INHIBITION	Epithelial barrier loss is a driver of intestinal and systemic diseases. Myosin light chain kinase (MLCK) is a key effector of barrier dysfunction and a potential therapeutic target, but enzymatic inhibition has unacceptable toxicity. Here, we show that a unique domain within the MLCK splice variant MLCK1 directs perijunctional actomyosin ring (PAMR) recruitment. Using the domain structure and multiple screens, we identify a domain-binding small molecule (divertin) that blocks MLCK1 recruitment without inhibiting enzymatic function. Divertin blocks acute, tumor necrosis factor (TNF)-induced MLCK1 recruitment as well as downstream myosin light chain (MLC) phosphorylation, barrier loss, and diarrhea in vitro and in vivo. Divertin corrects barrier dysfunction and prevents disease development and progression in experimental inflammatory bowel disease. Beyond applications of divertin in gastrointestinal disease, this general approach to enzymatic inhibition by preventing access to specific subcellular sites provides a new paradigm for safely and precisely targeting individual properties of enzymes with multiple functions.	[Graham, W. Vallen; He, Weiqi; Marchiando, Amanda M.; Zha, Juanmin; Singh, Gurminder; Wang, Yitang; Wu, Jingshing; Rosenberg, Harry J.; Wang, Yingmin; Meredith, Stephen C.; Turner, Jerrold R.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Graham, W. Vallen] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA; [He, Weiqi; Zha, Juanmin; Li, Hua-Shan; Jiang, Zhi-Hui] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [He, Weiqi; Zha, Juanmin; Li, Hua-Shan; Jiang, Zhi-Hui] Soochow Univ, Cambridge Suda Genom Resource Ctr, Suzhou, Peoples R China; [He, Weiqi; Zha, Juanmin; Li, Hua-Shan; Jiang, Zhi-Hui] Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou, Peoples R China; [Singh, Gurminder; Ong, Ma. Lora Drizella M.; Choi, Wangsun; Turner, Jerrold R.] Brigham & Womens Hosp, Dept Pathol, Lab Mucosal Barrier Pathobiol, 75 Francis St, Boston, MA 02115 USA; [Singh, Gurminder; Biswas, Amlan; Ong, Ma. Lora Drizella M.; Choi, Wangsun; Snapper, Scott B.; Turner, Jerrold R.] Harvard Med Sch, Boston, MA 02115 USA; [Biswas, Amlan; Snapper, Scott B.] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Zuccola, Harmon; Griffith, James] Vertex Pharmaceut, Boston, MA USA; [Ostrov, David] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Miller, Lawrence W.] Univ Illinois, Dept Chem, Chicago, IL USA	University of Chicago; Rockefeller University; Soochow University - China; Soochow University - China; Soochow University - China; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Vertex Pharmaceuticals; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Turner, JR (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Turner, JR (corresponding author), Brigham & Womens Hosp, Dept Pathol, Lab Mucosal Barrier Pathobiol, 75 Francis St, Boston, MA 02115 USA.; Turner, JR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jrturner@bwh.harvard.edu	Miller, Lawrence W/C-4586-2013; wang, yingying/GRS-3058-2022; Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yin/HCI-9352-2022; Turner, Jerrold/H-1502-2019; He, Weiqi/L-2502-2019; Wang, Yuan/HHC-1520-2022; wang, yan/GSE-6489-2022; Graham, W/C-4315-2019	Miller, Lawrence W/0000-0003-4501-9357; He, Weiqi/0000-0003-3137-8420; Zuccola, Harmon/0000-0002-2454-784X; Zha, Juanmin/0000-0002-1653-0845; Graham, W/0000-0003-3815-7532	National Institutes of Health (NIH) [R01DK61931, R01DK068271, R24DK099803, R01GM081030, R01AG048793, P30CA014599, P30DK034854, T32HL007237]; Broad Medical Research Program [IBD-022]; Department of Defense [W81XWH-09-1-0341]; Chicago Biomedical Consortium; National Natural Science Foundation of China [81470804, 31401229]; NIH, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK068271, R24DK099803, R01DK061931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048793] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Research Program; Department of Defense(United States Department of Defense); Chicago Biomedical Consortium; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) grant nos. R01DK61931 (J.R.T.), R01DK068271 (J.R.T.), R24DK099803 (J.R.T.), R01GM081030 (L.W.M.), R01AG048793 (S.C.M.), P30CA014599 (University of Chicago Comprehensive Cancer Center), P30DK034854 (the Harvard Digestive Disease Center), and T32HL007237 (W.V.G., A.M.M.). Work was also supported by the Broad Medical Research Program (IBD-022, to J.R.T.), the Department of Defense (W81XWH-09-1-0341, to J.R.T.), a Catalyst Award from the Chicago Biomedical Consortium (J.R.T., L.W.M.), the National Natural Science Foundation of China (81470804 and 31401229 to W.H.). The Berkeley Center for Structural Biology is supported in part by the NIH, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under contract no. DE-AC02-05CH11231.	Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Badri KR, 2013, J CLIN INVEST, V123, P4502, DOI 10.1172/JCI69884; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Berglund JJ, 2001, AM J PHYSIOL-GASTR L, V281, pG1487; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Bricogne G., 2017, BUSTER VERSION 2 10; Brown GR, 1999, GASTROENTEROLOGY, V116, P593, DOI 10.1016/S0016-5085(99)70181-2; Buhner S, 2006, GUT, V55, P342, DOI 10.1136/gut.2005.065557; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Clayburgh DR, 2004, J BIOL CHEM, V279, P55506, DOI 10.1074/jbc.M408822200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Gruber R, 2015, AM J PATHOL, V185, P2777, DOI 10.1016/j.ajpath.2015.06.021; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; Lin HB, 2012, J PROTEOMICS, V75, P5386, DOI 10.1016/j.jprot.2012.06.016; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; NCI Developmental Therapeutics Program, 2004, DAT IND RES; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Oishi K, 2000, AM J PHYSIOL-CELL PH, V279, pC1432, DOI 10.1152/ajpcell.2000.279.5.C1432; Owens SE, 2005, PHARM RES-DORDR, V22, P703, DOI 10.1007/s11095-005-2584-9; PEARSON ADJ, 1982, BMJ-BRIT MED J, V285, P20, DOI 10.1136/bmj.285.6334.20; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Prager M, 2014, SCAND J GASTROENTERO, V49, P1191, DOI 10.3109/00365521.2014.928903; Russo JM, 2005, GASTROENTEROLOGY, V128, P987, DOI 10.1053/j.gastro.2005.01.004; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Somlyo AV, 2004, J MUSCLE RES CELL M, V25, P241, DOI 10.1023/B:JURE.0000038362.84697.c0; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Turner JR, 2001, AM J PHYSIOL-CELL PH, V281, pC1533, DOI 10.1152/ajpcell.2001.281.5.C1533; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Vetrano S, 2008, GASTROENTEROLOGY, V135, P173, DOI 10.1053/j.gastro.2008.04.002; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Webb BA, 2016, J BIOL CHEM, V291, P24096, DOI 10.1074/jbc.M116.736215; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	57	69	70	4	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					690	+		10.1038/s41591-019-0393-7	http://dx.doi.org/10.1038/s41591-019-0393-7			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30936544	Green Accepted, Green Submitted			2022-12-27	WOS:000463342800030
J	Spinner, NB; Krantz, ID				Spinner, Nancy B.; Krantz, Ian D.			Expanded non-invasive prenatal diagnostics	NATURE MEDICINE			English	Editorial Material							DNA; ANEUPLOIDY		[Spinner, Nancy B.] Childrens Hosp Philadelphia, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Spinner, Nancy B.] Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Krantz, Ian D.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Krantz, ID (corresponding author), Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA.; Krantz, ID (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	krantz@email.chop.edu		Spinner, Nancy/0000-0001-8109-3648				Bianchi DW, 2018, GENET MED, V20, P910, DOI 10.1038/gim.2017.219; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Henkel M, 1919, ZENTRALBL GYNAK, V43, P841; Vermeesch JR, 2016, NAT REV GENET, V17, P643, DOI 10.1038/nrg.2016.97; Wapner RJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.041; Zhang JL, 2019, NAT MED, V25, P439, DOI 10.1038/s41591-018-0334-x	7	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					361	362		10.1038/s41591-019-0386-6	http://dx.doi.org/10.1038/s41591-019-0386-6			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30804517				2022-12-27	WOS:000460643100011
J	Stower, H				Stower, Hannah			Direct-to-stomach delivery	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					358	358		10.1038/s41591-019-0397-3	http://dx.doi.org/10.1038/s41591-019-0397-3			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842670	Bronze			2022-12-27	WOS:000460643100006
J	Cideciyan, AV; Jacobson, SG; Drack, AV; Ho, AC; Charng, J; Garafalo, AV; Roman, AJ; Sumaroka, A; Han, IC; Hochstedler, MD; Pfeifer, WL; Sohn, EH; Taiel, M; Schwartz, MR; Biasutto, P; de Wit, W; Cheetham, ME; Adamson, P; Rodman, DM; Platenburg, G; Tome, MD; Balikova, I; Nerinckx, F; De Zaeytijd, J; Van Cauwenbergh, C; Leroy, BP; Russell, SR				Cideciyan, Artur V.; Jacobson, Samuel G.; Drack, Arlene V.; Ho, Allen C.; Charng, Jason; Garafalo, Alexandra V.; Roman, Alejandro J.; Sumaroka, Alexander; Han, Ian C.; Hochstedler, Maria D.; Pfeifer, Wanda L.; Sohn, Elliott H.; Taiel, Magali; Schwartz, Michael R.; Biasutto, Patricia; de Wit, Wilma; Cheetham, Michael E.; Adamson, Peter; Rodman, David M.; Platenburg, Gerard; Tome, Maria D.; Balikova, Irina; Nerinckx, Fanny; De Zaeytijd, Julie; Van Cauwenbergh, Caroline; Leroy, Bart P.; Russell, Stephen R.			Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect	NATURE MEDICINE			English	Article							GENE-THERAPY	Photoreceptor ciliopathies constitute the most common molecular mechanism of the childhood blindness Leber congenital amaurosis. Ten patients with Leber congenital amaurosis carrying the c.2991+1655A>G allele in the ciliopathy gene centrosomal protein 290 (CEP290) were treated (ClinicalTrials. gov no. NCT03140969) with intravitreal injections of an antisense oligonucleotide to restore correct splicing. There were no serious adverse events, and vision improved at 3 months. The visual acuity of one exceptional responder improved from light perception to 20/400.	[Cideciyan, Artur V.; Jacobson, Samuel G.; Charng, Jason; Garafalo, Alexandra V.; Roman, Alejandro J.; Sumaroka, Alexander] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Drack, Arlene V.; Han, Ian C.; Hochstedler, Maria D.; Pfeifer, Wanda L.; Sohn, Elliott H.; Russell, Stephen R.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA USA; [Ho, Allen C.] Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA; [Taiel, Magali; Schwartz, Michael R.; Biasutto, Patricia; de Wit, Wilma; Adamson, Peter; Rodman, David M.; Platenburg, Gerard; Tome, Maria D.] ProQR Therapeut, Leiden, Netherlands; [Cheetham, Michael E.; Adamson, Peter] UCL Inst Ophthalmol, London, England; [Balikova, Irina; Nerinckx, Fanny; De Zaeytijd, Julie; Van Cauwenbergh, Caroline; Leroy, Bart P.] Univ Ghent, Dept Ophthalmol, Ghent, Belgium; [Balikova, Irina; Nerinckx, Fanny; De Zaeytijd, Julie; Van Cauwenbergh, Caroline; Leroy, Bart P.] Ghent Univ Hosp, Ghent, Belgium	University of Pennsylvania; Pennsylvania Medicine; University of Iowa; Jefferson University; University of London; University College London; Ghent University; Ghent University; Ghent University Hospital	Cideciyan, AV; Jacobson, SG (corresponding author), Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA.	cideciya@pennmedicine.upenn.edu; jacobsos@pennmedicine.upenn.edu	Pfeifer, Wanda/T-6868-2019; De Zaeytijd, Julie/GXA-3099-2022	Drack, Arlene/0000-0002-8195-8426; Charng, Jason/0000-0002-5778-6310; Ho, Allen/0000-0003-3921-608X; De Zaeytijd, Julie/0000-0003-4035-6389; Cheetham, Michael/0000-0001-6429-654X; Han, Ian/0000-0002-2371-727X; Russell, Stephen/0000-0003-3776-1367; Jacobson, Samuel/0000-0003-2122-169X; Sohn, Elliott/0000-0002-3778-9362	ProQR Therapeutics	ProQR Therapeutics	This work was supported by clinical trial contracts from ProQR Therapeutics to site principal investigators A.V.C., B.P.L., and S.R.R.	Bailey IL, 2012, OPTOMETRY VISION SCI, V89, P1257, DOI 10.1097/OPX.0b013e318264e85a; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Chew EY, 2010, OPHTHALMOLOGY, V117, P2112, DOI 10.1016/j.ophtha.2010.02.033; Cideciyan AV, 2007, J OPT SOC AM A, V24, P1457, DOI 10.1364/JOSAA.24.001457; Cideciyan AV, 2016, INVEST OPHTH VIS SCI, V57, P3211, DOI 10.1167/iovs.16-19586; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Collison FT, 2014, RETINA-J RET VIT DIS, V34, P1888, DOI 10.1097/IAE.0000000000000144; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dulla K, 2018, MOL THER-NUCL ACIDS, V12, P730, DOI 10.1016/j.omtn.2018.07.010; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jacobson SG, 2017, INVEST OPHTH VIS SCI, V58, P2609, DOI 10.1167/iovs.17-21560; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Klein M, 2009, DOC OPHTHALMOL, V119, P217, DOI 10.1007/s10633-009-9204-7; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Roman AJ, 2007, PHYSIOL MEAS, V28, pN51, DOI 10.1088/0967-3334/28/8/N02; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Shapiro A., 2017, INVEST OPHTHALMOL VI, V58	19	125	128	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					225	+		10.1038/s41591-018-0295-0	http://dx.doi.org/10.1038/s41591-018-0295-0			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30559420	Green Submitted			2022-12-27	WOS:000457842100017
J	Trucco, LD; Mundra, PA; Hogan, K; Garcia-Martinez, P; Viros, A; Mandal, AK; Macagno, N; Gaudy-Marqueste, C; Allan, D; Baenke, F; Cook, M; McManus, C; Sanchez-Laorden, B; Dhomen, N; Marais, R				Trucco, Lucas D.; Mundra, Piyushkumar A.; Hogan, Kate; Garcia-Martinez, Pablo; Viros, Amaya; Mandal, Amit K.; Macagno, Nicolas; Gaudy-Marqueste, Caroline; Allan, Donald; Baenke, Franziska; Cook, Martin; McManus, Clare; Sanchez-Laorden, Berta; Dhomen, Nathalie; Marais, Richard			Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma	NATURE MEDICINE			English	Article							MUTATIONAL PROCESSES	The melanoma genome is dominated by ultraviolet radiation (UVR)-induced mutations. Their relevance in disease progression is unknown. Here we classify melanomas by mutation signatures and identify ten recurrently mutated UVR signature genes that predict patient survival. We validate these findings in primary human melanomas; in mice we show that this signature is imprinted by short-wavelength UVR and that four exposures to UVR are sufficient to accelerate melanomagenesis.	[Trucco, Lucas D.; Mundra, Piyushkumar A.; Hogan, Kate; Garcia-Martinez, Pablo; Viros, Amaya; Mandal, Amit K.; Baenke, Franziska; Cook, Martin; McManus, Clare; Sanchez-Laorden, Berta; Dhomen, Nathalie; Marais, Richard] Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester, Lancs, England; [Macagno, Nicolas] Aix Marseille Univ, Hop Timone, APHM, Dept Pathol, Marseille, France; [Gaudy-Marqueste, Caroline] Aix Marseille Univ, Hop Timone, APHM, Dermatol & Skin Canc Dept, Marseille, France; [Allan, Donald] Univ Manchester, Med Phys Dept, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Allan, Donald] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England	Cancer Research UK; University of Manchester; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Salford Royal NHS Foundation Trust; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester	Marais, R (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester, Lancs, England.	richard.marais@cruk.manchester.ac.uk	Allan, Donald/ABG-7103-2022; Garcia, Pablo/GQQ-3533-2022; Gaudy-Marqueste, caroline/AAN-1402-2021; Mandal, Amit Kumar/AGK-5358-2022; Sanchez-Laorden, Berta/T-2177-2017	Allan, Donald/0000-0002-4256-1629; Gaudy-Marqueste, caroline/0000-0001-6955-5117; Mandal, Amit Kumar/0000-0002-2530-8103; Viros, Amaya/0000-0001-5177-5015; Sanchez-Laorden, Berta/0000-0002-6499-6332; Dhomen, Nathalie/0000-0003-1961-2173; Mundra, Piyushkumar/0000-0001-7769-2939; Macagno, Nicolas/0000-0002-9882-2162; Baenke, Franziska/0000-0001-9389-4688; Garcia-Martinez, Pablo/0000-0003-0074-2672	CRUK-MI [A27412, A22902]; European Research Council (ERC) [671262]; French Society of Dermatology; UNICANCER; CEDEF	CRUK-MI; European Research Council (ERC)(European Research Council (ERC)); French Society of Dermatology; UNICANCER; CEDEF	This work was supported by CRUK-MI (A27412 and A22902) and the European Research Council (ERC Advanced Grant agreement No. 671262) to R.M. C.G-M. was supported by the French Society of Dermatology, UNICANCER and CEDEF. We acknowledge the contribution of the CRUK-MI core facilities and the contribution of the melanoma specimen donors.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Day CP, 2017, LAB INVEST, V97, P698, DOI 10.1038/labinvest.2016.155; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Viros A, 2014, NATURE, V511, P478, DOI 10.1038/nature13298; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	23	46	46	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					221	+		10.1038/s41591-018-0265-6	http://dx.doi.org/10.1038/s41591-018-0265-6			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30510256				2022-12-27	WOS:000457842100016
J	Stower, H				Stower, Hannah			Combination therapy	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					19	19		10.1038/s41591-018-0328-8	http://dx.doi.org/10.1038/s41591-018-0328-8			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617328	Bronze			2022-12-27	WOS:000455027700012
J	Chen, R; Xia, L; Tu, KL; Duan, MX; Kukurba, K; Li-Pook-Than, J; Xie, D; Snyder, M				Chen, Rui; Xia, Lin; Tu, Kailing; Duan, Meixue; Kukurba, Kimberly; Li-Pook-Than, Jennifer; Xie, Dan; Snyder, Michael			Longitudinal personal DNA methylome dynamics in a human with a chronic condition	NATURE MEDICINE			English	Article							METHYLATION; EPIGENOME; EXERCISE; HEALTH	Epigenomics regulates gene expression and is as important as genomics in precision personal health, as it is heavily influenced by environment and lifestyle. We profiled whole-genome DNA methylation and the corresponding transcriptome of peripheral blood mononuclear cells collected from a human volunteer over a period of 36 months, generating 28 methylome and 57 transcriptome datasets. We found that DNA methylomic changes are associated with infrequent glucose level alteration, whereas the transcriptome underwent dynamic changes during events such as viral infections. Most DNA meta-methylome changes occurred 80-90 days before clinically detectable glucose elevation. Analysis of the deep personal methylome dataset revealed an unprecedented number of allelic differentially methylated regions that remain stable longitudinally and are preferentially associated with allele-specific gene regulation. Our results revealed that changes in different types of 'omics' data associate with different physiological aspects of this individual: DNA methylation with chronic conditions and transcriptome with acute events.	[Chen, Rui; Kukurba, Kimberly; Li-Pook-Than, Jennifer; Xie, Dan; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Xia, Lin; Tu, Kailing; Duan, Meixue; Xie, Dan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Ctr Precis Med, Chengdu, Sichuan, Peoples R China; [Chen, Rui] Roche Sequencing Solut, Pleasanton, CA USA	Stanford University; Sichuan University	Xie, D; Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Xie, D (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Ctr Precis Med, Chengdu, Sichuan, Peoples R China.	danxie@scu.edu.cn; mpsnyder@stanford.edu	xia, Lin/GXW-0422-2022	Snyder, Michael/0000-0003-0784-7987; Xia, Lin/0000-0001-6446-542X; Chen, Rui/0000-0002-1956-6499; Xie, Dan/0000-0001-5388-5541	National Institutes of Health [5U54DK10255603, 5P50HG00773503]; Chinese National Natural Science Foundation [91631111, 31571327, 31771426]; Stanford University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Stanford University(Stanford University)	This work is supported by the following grants from the National Institutes of Health: 5U54DK10255603 and 5P50HG00773503 (M.S.); by grants 91631111, 31571327 and 31771426 from Chinese National Natural Science Foundation (D.X.); as well as by funding from Stanford University. M.S. is a cofounder and member of the scientific advisory board of Personalis and Q-bio.	Ball MP, 2014, GENOME MED, V6, DOI 10.1186/gm527; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gertz J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002228; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Kanzleiter T, 2015, AM J PHYSIOL-ENDOC M, V308, pE912, DOI 10.1152/ajpendo.00289.2014; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Li-Pock-Than J, 2013, CHEM BIOL, V20, P660, DOI 10.1016/j.chembiol.2013.05.001; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mias George I, 2013, Quant Biol, V1, P71; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Panda K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1032-y; Rowlands DS, 2014, PHYSIOL GENOMICS, V46, P747, DOI 10.1152/physiolgenomics.00024.2014; Snyder M, 2010, GENE DEV, V24, P423, DOI 10.1101/gad.1864110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Xi Y, 2009, BMC BIOINFORMATICS, V10, P232, DOI DOI 10.1186/1471-2105-10-232	29	28	28	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1930	+		10.1038/s41591-018-0237-x	http://dx.doi.org/10.1038/s41591-018-0237-x			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30397358	Green Accepted			2022-12-27	WOS:000452392200022
J	Stower, H				Stower, Hannah			An option for treatment of multidrug-resistant HIV	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1303	1303		10.1038/s41591-018-0191-7	http://dx.doi.org/10.1038/s41591-018-0191-7			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194407	Bronze			2022-12-27	WOS:000444174100023
J	Stower, H				Stower, Hannah			Revising salt consumption	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1303	1303		10.1038/s41591-018-0193-5	http://dx.doi.org/10.1038/s41591-018-0193-5			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30194406	Bronze			2022-12-27	WOS:000444174100021
J	Stower, H				Stower, Hannah			Training neuropathology	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					702	702		10.1038/s41591-018-0076-9	http://dx.doi.org/10.1038/s41591-018-0076-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29875460	Bronze			2022-12-27	WOS:000434281300008
J	Stower, H				Stower, Hannah			The worldwide burden of childhood cancer	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1330	1330		10.1038/s41591-019-0586-0	http://dx.doi.org/10.1038/s41591-019-0586-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501603	Bronze			2022-12-27	WOS:000484832800007
J	Pan, HZ; Reilly, MP				Pan, Huize; Reilly, Muredach P.			A protective smooth muscle cell transition in atherosclerosis	NATURE MEDICINE			English	Editorial Material								TCF21, a gene associated with coronary heart disease, promotes plaque stability and reduces clinical events by enhancing smooth muscle cell phenotype modulation into "fibromyocytes" in atherosclerosis.	[Pan, Huize; Reilly, Muredach P.] Columbia Univ, Dept Med, Div Cardiol, Irving Med Ctr, New York, NY 10027 USA; [Reilly, Muredach P.] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University	Reilly, MP (corresponding author), Columbia Univ, Dept Med, Div Cardiol, Irving Med Ctr, New York, NY 10027 USA.; Reilly, MP (corresponding author), Columbia Univ, Irving Inst Clin & Translat Res, New York, NY 10027 USA.	mpr2144@cumc.columbia.edu	Pan, Huize/ACM-3473-2022	Pan, Huize/0000-0002-3478-6799	NHLBI NIH HHS [K24 HL107643, R01 HL132561, R01 HL113147] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Chappell J, 2016, CIRC RES, V119, P1313, DOI 10.1161/CIRCRESAHA.116.309799; Daugherty A, 2017, ARTERIOSCL THROM VAS, V37, pE131, DOI 10.1161/ATV.0000000000000062; Dobnikar L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06891-x; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Wirka RC, 2019, NAT MED, V25, P1280, DOI 10.1038/s41591-019-0512-5; Wong D, 2019, ARTERIOSCL THROM VAS, V39, P1006, DOI 10.1161/ATVBAHA.119.312141; Zhang HR, 2018, CIRC RES, V123, P1106, DOI 10.1161/CIRCRESAHA.118.314006	12	10	11	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1194	1195		10.1038/s41591-019-0541-0	http://dx.doi.org/10.1038/s41591-019-0541-0			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31359004	Green Accepted			2022-12-27	WOS:000480414600014
J	Kirjavainen, PV; Karvonen, AM; Adams, RI; Taubel, M; Roponen, M; Tuoresmaki, P; Loss, G; Jayaprakash, B; Depner, M; Ege, MJ; Renz, H; Pfefferle, PI; Schaub, B; Lauener, R; Hyvarinen, A; Knight, R; Heederik, DJJ; von Mutius, E; Pekkanen, J				Kirjavainen, Pirkka V.; Karvonen, Anne M.; Adams, Rachel I.; Taubel, Martin; Roponen, Marjut; Tuoresmaki, Pauli; Loss, Georg; Jayaprakash, Balamuralikrishna; Depner, Martin; Ege, Markus Johannes; Renz, Harald; Pfefferle, Petra Ina; Schaub, Bianca; Lauener, Roger; Hyvarinen, Anne; Knight, Rob; Heederik, Dick J. J.; von Mutius, Erika; Pekkanen, Juha			Farm-like indoor microbiota in non-farm homes protects children from asthma development	NATURE MEDICINE			English	Article							EARLY-LIFE; ANALYTICAL PERFORMANCE; CHILDHOOD ASTHMA; MOISTURE DAMAGE; BACTERIAL; EXPOSURE; ALLERGY; DIVERSITY; ENDOTOXIN; DUST	Asthma prevalence has increased in epidemic proportions with urbanization, but growing up on traditional farms offers protection even today(1). The asthma-protective effect of farms appears to be associated with rich home dust microbiota(2,3), which could be used to model a health-promoting indoor microbiome. Here we show by modeling differences in house dust microbiota composition between farm and non-farm homes of Finnish birth cohorts(4) that in children who grow up in non-farm homes, asthma risk decreases as the similarity of their home bacterial microbiota composition to that of farm homes increases. The protective microbiota had a low abundance of Streptococcaceae relative to outdoor-associated bacterial taxa. The protective effect was independent of richness and total bacterial load and was associated with reduced proinflammatory cytokine responses against bacterial cell wall components ex vivo. We were able to reproduce these findings in a study among rural German children(2) and showed that children living in German non-farm homes with an indoor microbiota more similar to Finnish farm homes have decreased asthma risk. The indoor dust microbiota composition appears to be a definable, reproducible predictor of asthma risk and a potential modifiable target for asthma prevention.	[Kirjavainen, Pirkka V.; Karvonen, Anne M.; Taubel, Martin; Tuoresmaki, Pauli; Jayaprakash, Balamuralikrishna; Hyvarinen, Anne; Pekkanen, Juha] Natl Inst Hlth & Welf, Environm Hlth Unit, Kuopio, Finland; [Kirjavainen, Pirkka V.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Adams, Rachel I.] Calif Dept Publ Hlth, Richmond, CA USA; [Roponen, Marjut] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Tuoresmaki, Pauli; Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Loss, Georg] Univ Calif San Diego, Dept Pediat, Sch Med, San Diego, CA 92103 USA; [Depner, Martin; von Mutius, Erika] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Asthma & Allergy Prevent, Neuherberg, Germany; [Ege, Markus Johannes; Schaub, Bianca; von Mutius, Erika] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany; [Ege, Markus Johannes; Schaub, Bianca; von Mutius, Erika] German Ctr Lung Res, Comprehens Pneumol Ctr Munich, Munich, Germany; [Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Marburg, Germany; [Pfefferle, Petra Ina] Philipps Univ Marburg, German Ctr Lung Res, Comprehens Biomat Bank Marburg CBBMR, Marburg, Germany; [Lauener, Roger] Childrens Hosp Eastern Switzerland, St Gallen, Switzerland; [Lauener, Roger] Univ Zurich, Zurich, Switzerland; [Lauener, Roger] Univ St Gallen, Sch Med, St Gallen, Switzerland; [Lauener, Roger] CK CARE, Christine Kuhne Ctr Allergy Care & Educ, Davos, Switzerland; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, San Diego, CA 92103 USA; [Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Heederik, Dick J. J.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands	Finland National Institute for Health & Welfare; University of Eastern Finland; California Department of Public Health; University of Eastern Finland; University of Helsinki; University of California System; University of California San Diego; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Philipps University Marburg; Philipps University Marburg; University of Zurich; University of St Gallen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Utrecht University	Kirjavainen, PV (corresponding author), Natl Inst Hlth & Welf, Environm Hlth Unit, Kuopio, Finland.; Kirjavainen, PV (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	pirkka.kirjavainen@thl.fi	Kirjavainen, Pirkka/AAW-6833-2021; Ege, Markus/C-1962-2012; Täubel, Martin/P-7059-2019; Schaub, Bianca/B-9935-2019; Kirjavainen, Pirkka/AAX-8069-2020; Loss, Georg/AAE-7296-2019	Kirjavainen, Pirkka/0000-0001-6119-8768; Ege, Markus/0000-0001-6643-3923; Täubel, Martin/0000-0001-8082-1041; Schaub, Bianca/0000-0003-1652-8873; Loss, Georg/0000-0003-1090-812X; Hyvarinen, Anne/0000-0002-2823-0866; Heederik, Dick/0000-0002-4550-1437; Knight, Rob/0000-0002-0975-9019	Academy of Finland [139021, 256375, 287675, 296814, 296817, 308254]; Juho Vainio Foundation; Paivikki and Sakari Sohlberg Foundation; Finnish Cultural Foundation; Yrjo Jahnsson Foundation; Kuopion seudun hengityssaatio; European Union [QLK4-CT-2001-00250]; National Institute for Health and Welfare, Finland; Alfred P. Sloan Foundation [G-2016-7076]; Deutsche Zentrum fur Lungenforschung; Deutsche Forschungsgemeinschaft (DFG) [SFB 1021]; SCHA [997/8-1]; GILKUJ-39; Kuhne Foundation, Schindellegi, Switzerland; German Research Foundation [MU 891/5-1];  [82DZL00502];  [ERC2009-AdG_20090506_250268];  [LSHB-CT-2006-018996]	Academy of Finland(Academy of Finland); Juho Vainio Foundation; Paivikki and Sakari Sohlberg Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Yrjo Jahnsson Foundation; Kuopion seudun hengityssaatio; European Union(European Commission); National Institute for Health and Welfare, Finland; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Deutsche Zentrum fur Lungenforschung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); SCHA; GILKUJ-39; Kuhne Foundation, Schindellegi, Switzerland; German Research Foundation(German Research Foundation (DFG)); ; ; 	We thank J. Kauttio for the processing of LUKAS dust samples and P. Tiittanen and T. Kauppila for LUKAS data management; G. Humphrey and J. Gaffney for the processing of GABRIELA samples; A. Amir for assistance in bioinformatics; U. Naukkarinen and R. Tiihonen for cytokine stimulations; S. Illi for cytokine data processing; M. Martikainen for dendritic cell analyses; the participating families of the LUKAS and GABRIELA studies; the field workers in the LUKAS and GABRIELA studies; and the LUKAS and GABRIELA study groups. We acknowledge funding by the Academy of Finland grants 139021 (J.P.), 256375 (M.R.), 287675 (A.M.K.), 296814 (J.P.), 296817 (M.T.) and 308254 (P.V.K.); the Juho Vainio Foundation (P.V.K., M.T.); the Paivikki and Sakari Sohlberg Foundation (P.V.K., J.P.); The Finnish Cultural Foundation (J.P.); the Yrjo Jahnsson Foundation (P.V.K., J.P.); Kuopion seudun hengityssaatio (B.J.); European Union QLK4-CT-2001-00250 (J.P., H.R., P.I.P., R.L., E.v.M); the National Institute for Health and Welfare, Finland (P.V.K., A.M.K., M.T., B.J., A.H., J.P.); Alfred P. Sloan Foundation G-2016-7076 R.A.; Deutsche Zentrum fur Lungenforschung grants (M.J.E.) and 82DZL00502 (H.R.); Deutsche Forschungsgemeinschaft (DFG) funded SFB 1021 (H.R.); SCHA 997/8-1 (B.S.); GILKUJ-39 (B.S.); Kuhne Foundation, Schindellegi, Switzerland (R.L.); MU 891/5-1 Leibniz Prize, German Research Foundation (E.v.M.); ERC2009-AdG_20090506_250268 (E.v.M.); and LSHB-CT-2006-018996 (E.v.M.).	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0108-3; Amir A., 2017, MSYSTEMS, V2, DOI [DOI 10.1128/MSYSTEMS.00191-16, 10.1128/mSystems.00191-16]; [Anonymous], 2008, CHILD SPEC EXP FACT; Bakowski MA, 2007, CELL MICROBIOL, V9, P2839, DOI 10.1111/j.1462-5822.2007.01000.x; Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112; Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bomert M, 2011, CLIN CHEM LAB MED, V49, P1691, DOI 10.1515/CCLM.2011.631; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cohen R. A., 2006, 20731 SAS I INC; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Eren AM, 2014, P NATL ACAD SCI USA, V111, pE2875, DOI 10.1073/pnas.1409644111; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Genuneit J, 2011, PAEDIATR PERINAT EP, V25, P436, DOI 10.1111/j.1365-3016.2011.01223.x; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Herzum I, 2005, CLIN CHEM LAB MED, V43, P963, DOI 10.1515/CCLM.2005.165; Hyytiainen HK, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0405-8; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Karvonen AM, 2014, ALLERGY, V69, P1092, DOI 10.1111/all.12439; Karvonen AM, 2009, PEDIATRICS, V124, pE329, DOI 10.1542/peds.2008-1590; Kumar S, 2017, INNATE IMMUN-LONDON, V23, P249, DOI 10.1177/1753425917690443; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Leppanen HK, 2018, J EXPO SCI ENV EPID, V28, P231, DOI 10.1038/jes.2017.24; Liu AH, 2015, J ALLERGY CLIN IMMUN, V136, P860, DOI 10.1016/j.jaci.2015.08.012; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MANDAL S, 2015, MICROB ECOL HEALTH D, V26, DOI DOI 10.3402/MEHD.V26.27663; Martikainen MV, 2015, ALLERGY, V70, P1278, DOI 10.1111/all.12682; Mustonen K, 2016, INDOOR AIR, V26, P439, DOI 10.1111/ina.12216; Natarajan S, 2012, INT ARCH ALLERGY IMM, V158, P120, DOI 10.1159/000330896; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ottman N., 2018, J ALLERGY CLIN IMMUN, V143; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Reynolds LA, 2017, NAT REV IMMUNOL, V17, P518, DOI 10.1038/nri.2017.39; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Rochat MK, 2010, CLIN EXP ALLERGY, V40, P786, DOI 10.1111/j.1365-2222.2009.03428.x; Rosenblueth M, 2011, DNA CELL BIOL, V30, P633, DOI 10.1089/dna.2011.1231; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Shan L, 2007, CELL HOST MICROBE, V1, P167, DOI 10.1016/j.chom.2007.04.008; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shrivastava R, 2009, CURR OPIN MICROBIOL, V12, P88, DOI 10.1016/j.mib.2009.01.001; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; Valkonen M, 2018, INDOOR AIR, V28, P16, DOI 10.1111/ina.12427; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu J, 2009, HUM IMMUNOL, V70, P353, DOI 10.1016/j.humimm.2009.01.024	62	130	131	3	39	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1089	+		10.1038/s41591-019-0469-4	http://dx.doi.org/10.1038/s41591-019-0469-4			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31209334	Green Accepted, Green Submitted			2022-12-27	WOS:000474430400022
J	Dominguez-Bello, MG				Dominguez-Bello, Maria Gloria			Gestational shaping of the maternal vaginal microbiome	NATURE MEDICINE			English	Editorial Material									[Dominguez-Bello, Maria Gloria] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Dominguez-Bello, MG (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA.	mg.dominguez-bello@rutgers.edu						Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Boskey ER, 2001, HUM REPROD, V16, P1809, DOI 10.1093/humrep/16.9.1809; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Fettweis JM, 2019, NAT MED, V25, P1012, DOI 10.1038/s41591-019-0450-2; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Forney LJ, 2006, J INFECT DIS, V194, P1468, DOI 10.1086/508497; Klebanoff MA, 2018, LANCET, V392, P2141, DOI 10.1016/S0140-6736(18)32115-9; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Serrano MG, 2019, NAT MED, V25, P1001, DOI 10.1038/s41591-019-0465-8; Tyssen D, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00055-18	12	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					882	883		10.1038/s41591-019-0483-6	http://dx.doi.org/10.1038/s41591-019-0483-6			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31142848				2022-12-27	WOS:000470844400016
J	Bryant, KL; Stalnecker, CA; Zeitouni, D; Klomp, JE; Peng, S; Tikunov, AP; Gunda, V; Pierobon, M; Waters, AM; George, SD; Tomar, G; Papke, B; Hobbs, GA; Yan, L; Hayes, TK; Diehl, JN; Goode, GD; Chaika, NV; Wang, YX; Zhang, GF; Witkiewicz, AK; Knudsen, ES; Petricoin, EF; Singh, PK; Macdonald, JM; Tran, NL; Lyssiotis, CA; Ying, HQ; Kimmelman, AC; Cox, AD; Der, CJ				Bryant, Kirsten L.; Stalnecker, Clint A.; Zeitouni, Daniel; Klomp, Jennifer E.; Peng, Sen; Tikunov, Andrey P.; Gunda, Venugopal; Pierobon, Mariaelena; Waters, Andrew M.; George, Samuel D.; Tomar, Garima; Papke, Bjorn; Hobbs, G. Aaron; Yan, Liang; Hayes, Tikvah K.; Diehl, J. Nathaniel; Goode, Gennifer D.; Chaika, Nina V.; Wang, Yingxue; Zhang, Guo-Fang; Witkiewicz, Agnieszka K.; Knudsen, Erik S.; Petricoin, Emanuel F., III; Singh, Pankaj K.; Macdonald, Jeffrey M.; Tran, Nhan L.; Lyssiotis, Costas A.; Ying, Haoqiang; Kimmelman, Alec C.; Cox, Adrienne D.; Der, Channing J.			Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer	NATURE MEDICINE			English	Article							PATHWAY ACTIVATION; REGULATE AUTOPHAGY; ONCOGENIC KRAS; POOR SURVIVAL; RESISTANCE; BRAF; GEMCITABINE; ENRICHMENT; PROTEIN; TUMORS	Pancreatic ductal adenocarcinoma (PDAC) is characterized by KRAS-and autophagy-dependent tumorigenic growth, but the role of KRAS in supporting autophagy has not been established. We show that, to our surprise, suppression of KRAS increased autophagic flux, as did pharmacological inhibition of its effector ERK MAPK. Furthermore, we demonstrate that either KRAS suppression or ERK inhibition decreased both glycolytic and mitochondrial functions. We speculated that ERK inhibition might thus enhance PDAC dependence on autophagy, in part by impairing other KRAS- or ERK-driven metabolic processes. Accordingly, we found that the autophagy inhibitor chloroquine and genetic or pharmacologic inhibition of specific autophagy regulators synergistically enhanced the ability of ERK inhibitors to mediate antitumor activity in KRAS-driven PDAC. We conclude that combinations of pharmacologic inhibitors that concurrently block both ERK MAPK and autophagic processes that are upregulated in response to ERK inhibition may be effective treatments for PDAC.	[Bryant, Kirsten L.; Stalnecker, Clint A.; Zeitouni, Daniel; Klomp, Jennifer E.; Waters, Andrew M.; George, Samuel D.; Tomar, Garima; Papke, Bjorn; Hobbs, G. Aaron; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Peng, Sen] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ USA; [Tikunov, Andrey P.; Macdonald, Jeffrey M.] Univ N Carolina, Biomed Engn, Chapel Hill, NC 27515 USA; [Gunda, Venugopal; Goode, Gennifer D.; Chaika, Nina V.; Singh, Pankaj K.] Univ Nebraska Med Ctr, Eppley Inst Canc Res, Omaha, NE USA; [Pierobon, Mariaelena; Petricoin, Emanuel F., III] George Mason Univ, Ctr Appl Prote & Mol Med, Fairfax, VA 22030 USA; [Yan, Liang; Ying, Haoqiang] Univ Texas MD Anderson Canc Ctr, Div Basic Sci Res, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hayes, Tikvah K.; Diehl, J. Nathaniel; Der, Channing J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Wang, Yingxue; Zhang, Guo-Fang] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Wang, Yingxue; Zhang, Guo-Fang] Duke Univ, Dept Med, Duke Mol Physiol, Durham, NC USA; [Witkiewicz, Agnieszka K.] Roswell Pk Canc Ctr, Ctr Personalized Med, Buffalo, NY USA; [Knudsen, Erik S.] Roswell Pk Canc Ctr, Dept Mol & Cell Biol, Buffalo, NY USA; [Tran, Nhan L.] Mayo Clin, Dept Canc Biol, Phoenix, AZ USA; [Lyssiotis, Costas A.] Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Lyssiotis, Costas A.] Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [Lyssiotis, Costas A.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Kimmelman, Alec C.] NYU, Perlmutter Canc Ctr, Langone Med Ctr, New York, NY USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA; [Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; Translational Genomics Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Nebraska System; University of Nebraska Medical Center; George Mason University; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Mayo Clinic; Mayo Clinic Phoenix; University of Michigan System; University of Michigan; New York University; NYU Langone Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Der, CJ (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.; Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	cjder@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022; Pierobon, Mariaelena/GXA-0544-2022; Lyssiotis, Costas A/AAI-1923-2019; Ying, Haoqiang/AAK-4325-2020; Ariel, Pablo/AGJ-4118-2022; gunda, venugopal/A-5658-2018; Yan, Liang/AFE-8595-2022; Yan, Liang/AAF-6382-2022	Lyssiotis, Costas A/0000-0001-9309-6141; gunda, venugopal/0000-0002-9156-2580; Yan, Liang/0000-0002-3002-5431; Yan, Liang/0000-0002-3002-5431; Papke, Bjoern/0000-0001-8156-7508; Bryant, Kirsten/0000-0003-4026-0942; Waters, Andrew/0000-0002-6058-5878; Zeitouni, Daniel/0000-0003-3856-1623; Der, Channing/0000-0002-7751-2747; Diehl, John/0000-0002-7309-0903; Singh, Pankaj/0000-0001-8903-0131; Cox, Adrienne D./0000-0002-4901-2454; Klomp, Jennifer/0000-0003-1781-648X; Stalnecker, Clint/0000-0002-0570-4416	National Cancer Institute (NCI) [R01CA42978, R01CA175747, U01CA199235, P50CA196510, P01CA203657, R35CA232113]; Department of Defense [W81XWH-15-1-0611]; Lustgarten Foundation [P30 CA016086, 388222]; Pancreatic Cancer Action Network/American Association for Cancer Research (AACR) [15-90-25-DER]; NCI [R01CA157490, R01CA188048, P01CA117969, T32CA009156, F32CA232529, F32 CA239328, F32CA200313, T32CA071341, F3180693, R01 CA163649, R01 CA210439, R01 CA216853, P30CA036727]; Pancreatic Cancer Action Network/AACR [15-70-25-BRYA]; American Cancer Society fellowship [PF-18-061]; Deutsche Forschungsgemeinschaft [DFG PA 3051/1-1]; American Cancer Society Research Scholar Grant [RSG-13-298-01-TBG]; National Institutes of Health [R01GM095567]; Lustgarten Foundation; Cancer Center Core Support grant [P30 CA016086]; NIH [P30CA016672]; NATIONAL CANCER INSTITUTE [R01CA157490, T32CA009156, T32CA071341, R35CA232113, F32CA232529, P50CA196510, P01CA117969, R01CA188048, P30CA016672, R35CA232124, P30CA016086, R01CA042978, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095567] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Lustgarten Foundation; Pancreatic Cancer Action Network/American Association for Cancer Research (AACR); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pancreatic Cancer Action Network/AACR; American Cancer Society fellowship(American Cancer Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); American Cancer Society Research Scholar Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; Cancer Center Core Support grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Maitra (MD Anderson Cancer Center) for PDAC cell lines, D. Tuveson (Cold Spring Harbor Laboratory) for patient-derived organoids, and C. Kinsey and M. McMahon (Huntsman Cancer Center) for helpful discussions and communication of data before publication. K.L.B. is thankful to B. Elzer Jr. for continued inspiration. Support was provided by grants from the National Cancer Institute (NCI) (R01CA42978, R01CA175747, U01CA199235, P50CA196510, P01CA203657 and R35CA232113), the Department of Defense (W81XWH-15-1-0611), the Lustgarten Foundation (388222) and the Pancreatic Cancer Action Network/American Association for Cancer Research (AACR) (15-90-25-DER) (C.J.D. and A. D. C.). K.L.B. was supported by NCI T32CA009156 and a grant from the Pancreatic Cancer Action Network/AACR (15-70-25-BRYA). C.A.S. was supported by NCI T32CA009156 and F32CA232529. J.E.K. was supported by NCI T32CA009156 and F32 CA239328. A.M.W. was supported by American Cancer Society fellowship PF-18-061. B.P. was supported by the Deutsche Forschungsgemeinschaft (DFG PA 3051/1-1). G.A.H. was supported by NCI T32CA009156 and F32CA200313. T.K.H. was supported by NCI T32CA071341 and NCI F3180693. J.N.D. was supported by NCI T32CA071341. P.K.S. was supported by NCI grants R01 CA163649, R01 CA210439, R01 CA216853, and P30CA036727. A.C.K. was supported by NCI grants R01CA157490, R01CA188048 and P01CA117969, American Cancer Society Research Scholar Grant RSG-13-298-01-TBG, National Institutes of Health grant R01GM095567 and a grant from the Lustgarten Foundation. The Microscopy Services Laboratory, the UNC Flow Cytometry Core Facility and the Lenti-shRNA Core Facility (UNC) are supported in part by P30 CA016086 Cancer Center Core Support grant to the UNC Lineberger Comprehensive Cancer Center. Transmission electron microscopy was conducted in the High-Resolution Electron Microscopy Facility of the MD Anderson Cancer Center (supported by NIH P30CA016672).	Baldelli E, 2017, METHODS MOL BIOL, V1606, P149, DOI 10.1007/978-1-4939-6990-6_11; Baldelli E, 2015, ONCOTARGET, V6, P32368, DOI 10.18632/oncotarget.5941; Boone BA, 2015, ANN SURG ONCOL, V22, P4402, DOI 10.1245/s10434-015-4566-4; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Commisso C, 2014, NAT PROTOC, V9, P182, DOI 10.1038/nprot.2014.004; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Federici G, 2013, MOL CANCER RES, V11, P676, DOI 10.1158/1541-7786.MCR-12-0690; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gunda V, 2018, METHODS MOL BIOL, V1742, P95, DOI 10.1007/978-1-4939-7665-2_9; Guo JYX, 2016, COLD SH Q B, V81, P73, DOI 10.1101/sqb.2016.81.030981; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Janes MR, 2018, CELL, V172, P578, DOI 10.1016/j.cell.2018.01.006; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimmelman AC, 2015, CLIN CANCER RES, V21, P1828, DOI 10.1158/1078-0432.CCR-14-2425; Kinsey CG, 2019, NAT MED, V25, P620, DOI 10.1038/s41591-019-0367-9; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Moschos SJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.92352; Mukai S, 2017, ANN SURG ONCOL, V24, P594, DOI 10.1245/s10434-016-5100-z; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]; Pierobon M, 2017, CLIN CANCER RES, V23, P4919, DOI 10.1158/1078-0432.CCR-16-2656; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Sanduja S, 2016, ONCOGENE, V35, P5295, DOI 10.1038/onc.2016.70; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shestov AA, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00135; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Signore M, 2012, METHODS MOL BIOL, V823, P139, DOI 10.1007/978-1-60327-216-2_10; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Tech K, 2017, CANCER RES, V77, P3217, DOI 10.1158/0008-5472.CAN-16-3304; Tiriac H, 2018, CANCER DISCOV, V8, P1112, DOI 10.1158/2159-8290.CD-18-0349; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; Vaseva AV, 2018, CANCER CELL, V34, P807, DOI 10.1016/j.ccell.2018.10.001; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Waters AM, 2017, COLD SPRING HARB PER, V8; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; Wolpin BM, 2014, ONCOLOGIST, V19, P637, DOI 10.1634/theoncologist.2014-0086; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	60	314	326	15	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					628	+		10.1038/s41591-019-0368-8	http://dx.doi.org/10.1038/s41591-019-0368-8			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30833752	Green Accepted			2022-12-27	WOS:000463342800025
J	Agarwal, R; Chan, YC; Tam, CS; Hunter, T; Vassiliadis, D; Teh, CE; Thijssen, R; Yeh, P; Wong, SQ; Ftouni, S; Lam, EYN; Anderson, MA; Pott, C; Gilan, O; Bell, CC; Knezevic, K; Blombery, P; Rayeroux, K; Zordan, A; Li, J; Huang, DCS; Wall, M; Seymour, JF; Gray, DHD; Roberts, AW; Dawson, MA; Dawson, SJ				Agarwal, Rishu; Chan, Yih-Chih; Tam, Constantine S.; Hunter, Tane; Vassiliadis, Dane; Teh, Charis E.; Thijssen, Rachel; Yeh, Paul; Wong, Stephen Q.; Ftouni, Sarah; Lam, Enid Y. N.; Anderson, Mary Ann; Pott, Christiane; Gilan, Omer; Bell, Charles C.; Knezevic, Kathy; Blombery, Piers; Rayeroux, Kathleen; Zordan, Adrian; Li, Jason; Huang, David C. S.; Wall, Meaghan; Seymour, John F.; Gray, Daniel H. D.; Roberts, Andrew W.; Dawson, Mark A.; Dawson, Sarah-Jane			Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma	NATURE MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; BRUTONS TYROSINE KINASE; CIRCULATING TUMOR DNA; GENE-EXPRESSION; PROGNOSTIC INFORMATION; CLONAL EVOLUTION; INHIBITOR; CANCER; BTK; ACTIVATION	Ibrutinib plus venetoclax is a highly effective combination in mantle cell lymphoma. However, strategies to enable the evaluation of therapeutic response are required. Our prospective analyses of patients within the AIM study revealed genomic profiles that clearly dichotomized responders and nonresponders. Mutations in ATM were present in most patients who achieved a complete response, while chromosome 9p21.1-p24.3 loss and/or mutations in components of the SWI-SNF chromatin-remodeling complex were present in all patients with primary resistance and two-thirds of patients with relapsed disease. Circulating tumor DNA analysis revealed that these alterations could be dynamically monitored, providing concurrent information on treatment response and tumor evolution. Functional modeling demonstrated that compromise of the SWI-SNF complex facilitated transcriptional upregulation of BCL2L1 (Bcl-xL) providing a selective advantage against ibrutinib plus venetoclax. Together these data highlight important insights into the molecular basis of therapeutic response and provide a model for real-time assessment of innovative targeted therapies.	[Agarwal, Rishu; Chan, Yih-Chih; Tam, Constantine S.; Hunter, Tane; Vassiliadis, Dane; Yeh, Paul; Wong, Stephen Q.; Ftouni, Sarah; Lam, Enid Y. N.; Anderson, Mary Ann; Gilan, Omer; Bell, Charles C.; Knezevic, Kathy; Blombery, Piers; Li, Jason; Seymour, John F.; Roberts, Andrew W.; Dawson, Mark A.; Dawson, Sarah-Jane] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Agarwal, Rishu; Chan, Yih-Chih; Hunter, Tane; Vassiliadis, Dane; Yeh, Paul; Lam, Enid Y. N.; Gilan, Omer; Bell, Charles C.; Li, Jason; Seymour, John F.; Dawson, Mark A.; Dawson, Sarah-Jane] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Tam, Constantine S.; Yeh, Paul; Anderson, Mary Ann; Blombery, Piers; Seymour, John F.; Roberts, Andrew W.; Dawson, Mark A.] Royal Melbourne Hosp, Dept Haematol, Melbourne, Vic, Australia; [Tam, Constantine S.] St Vincents Hosp, Dept Haematol, Melbourne, Vic, Australia; [Tam, Constantine S.; Wall, Meaghan] St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Teh, Charis E.; Thijssen, Rachel; Anderson, Mary Ann; Huang, David C. S.; Gray, Daniel H. D.; Roberts, Andrew W.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Teh, Charis E.; Thijssen, Rachel; Anderson, Mary Ann; Huang, David C. S.; Gray, Daniel H. D.; Roberts, Andrew W.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Pott, Christiane] Univ Hosp Schleswig Holstein, Kiel, Germany; [Rayeroux, Kathleen; Zordan, Adrian; Wall, Meaghan] Victorian Canc Cytogenet Serv, Melbourne, Vic, Australia; [Wall, Meaghan] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Roberts, Andrew W.; Dawson, Mark A.; Dawson, Sarah-Jane] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Royal Melbourne Hospital; St Vincent's Hospital Melbourne; St Vincent's Hospital Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Kiel; Schleswig Holstein University Hospital; St. Vincent's Institute of Medical Research; University of Melbourne	Dawson, MA; Dawson, SJ (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.; Dawson, MA; Dawson, SJ (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Royal Melbourne Hosp, Dept Haematol, Melbourne, Vic, Australia.; Dawson, MA; Dawson, SJ (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.	mark.dawson@petermac.org; sarah-jane.dawson@petermac.org	Thijssen, Rachel/AAE-7599-2022; Roberts, Andrew W./C-6736-2012; Dawson, Mark A/B-9317-2017; Huang, David C. S./C-7586-2013; Seymour, John/K-7326-2019; Gray, Daniel/A-3293-2013	Thijssen, Rachel/0000-0002-4493-306X; Roberts, Andrew W./0000-0002-7341-5720; Dawson, Mark A/0000-0002-5464-5029; Huang, David C. S./0000-0002-3101-4873; Seymour, John/0000-0003-2188-6835; Wong, Stephen Q./0000-0002-7335-2168; Anderson, Mary Ann/0000-0002-3515-0215; Vassiliadis, Dane/0000-0002-7814-4851; Gray, Daniel/0000-0002-8457-8242; Dawson, Sarah-Jane/0000-0002-8276-0374; Lam, Enid Yi Ni/0000-0001-5843-7836; Bell, Charles/0000-0003-2194-8311; YEH, PAUL/0000-0002-4172-3614	Abbvie; Janssen; Leukemia and Lymphoma Society [0862-15]; SCOR [11283-17]; CSL Centenary fellowship; Leukaemia Foundation Australia senior fellowship; Howard Hughes Medical Institute international research scholarship [55008729]; NHMRC postgraduate scholarship [1114242]; HSANZ new investigator fellowship; NHMRC fellowships [1089072, 1090236, 1079560]; NHMRC [1104549, 1113577, 1016701]; Leukemia and Lymphoma Society Independent Research Institutes Infrastructure Support Scheme [9000220]; Snowdome Foundation; Maddie Riewoldt's Vision [064728]; Victorian State Government Operational Infrastructure Support grant [1146518, 1102104]; Cancer Council Victoria grant [1146518, 1102104]; Peter MacCallum Cancer Foundation; Victorian Comprehensive Cancer Centre	Abbvie(AbbVie); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); SCOR; CSL Centenary fellowship; Leukaemia Foundation Australia senior fellowship; Howard Hughes Medical Institute international research scholarship; NHMRC postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); HSANZ new investigator fellowship; NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society Independent Research Institutes Infrastructure Support Scheme; Snowdome Foundation; Maddie Riewoldt's Vision; Victorian State Government Operational Infrastructure Support grant; Cancer Council Victoria grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Peter MacCallum Cancer Foundation; Victorian Comprehensive Cancer Centre	The clinical study was funded by Abbvie and Janssen. The work included in this manuscript was funded by the Leukemia and Lymphoma Society (grant no. 0862-15 (S.-J.D., M.A.D., C.S.T., J.F.S.) and SCOR grant no. 11283-17 (A.W.R., D.C.S.H.)). We thank K. Doig, G. Arnau, T. Semple, T. Holloway and J. Carmody for advice and assistance with genomic sequencing, G. Lessene for providing A-1331852 and the following funders for fellowship, scholarship and grant support: CSL Centenary fellowship (S.-J.D.), Leukaemia Foundation Australia senior fellowship and Howard Hughes Medical Institute international research scholarship 55008729 (M.A.D.), NHMRC postgraduate scholarship 1114242 (R.A.) and HSANZ new investigator fellowship (R.A.), NHMRC fellowships (1089072 (C.E.T.), 1090236 (D.H.D.G.) and 1079560 (A.W.R.), NHMRC grant no. 1104549 (S.-J.D., M.A.D., C.S.T., J.F.S.) and programs 1113577, 1016701 (A.W.R., D.C.S.H.) and Leukemia and Lymphoma Society Independent Research Institutes Infrastructure Support Scheme grant no. 9000220 (R.T.), Snowdome Foundation (M.A.A.), Maddie Riewoldt's Vision 064728 (Y.-C.C.), Victorian State Government Operational Infrastructure Support grant and Cancer Council Victoria grant (nos. 1146518, 1102104) and the Peter MacCallum Cancer Foundation. Mass cytometry was performed in part at the Materials Characterization and Fabrication Platform at the University of Melbourne and the Victorian Node of the Australian National Fabrication Facility, with support from the Victorian Comprehensive Cancer Centre.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson MA, 2016, BLOOD, V127, P3215, DOI 10.1182/blood-2016-01-688796; Aukema SM, 2018, BLOOD, V131, P417, DOI 10.1182/blood-2017-07-797019; Axelrod M, 2014, LEUKEMIA, V28, P407, DOI 10.1038/leu.2013.249; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Cheah CY, 2016, J CLIN ONCOL, V34, P1256, DOI 10.1200/JCO.2015.63.5904; Cheminant M, 2016, HAEMATOLOGICA, V101, P336, DOI 10.3324/haematol.2015.134957; Chueh AC, 2017, CLIN CANCER RES, V23, P5573, DOI 10.1158/1078-0432.CCR-17-0466; Davids MS, 2017, J CLIN ONCOL, V35, P826, DOI 10.1200/JCO.2016.70.4320; Dawson MA, 2017, SCIENCE, V355, P1147, DOI 10.1126/science.aam7304; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Delfau-Larue MH, 2015, BLOOD, V126, P604, DOI 10.1182/blood-2015-02-628792; Doig KD, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0427-z; Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4; Dreyling MH, 1997, CANCER RES, V57, P4608; Eskelund CW, 2017, BLOOD, V130, P1903, DOI 10.1182/blood-2017-04-779736; Ferrero S, 2017, HAEMATOLOGICA, V102, P1133, DOI 10.3324/haematol.2017.167627; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Greiner TC, 2006, P NATL ACAD SCI USA, V103, P2352, DOI 10.1073/pnas.0510441103; Halldorsdottir AM, 2011, LEUKEMIA, V25, P1904, DOI 10.1038/leu.2011.162; Hartmann EM, 2010, BLOOD, V116, P953, DOI 10.1182/blood-2010-01-263806; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Herling CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03170-7; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kridel R, 2012, BLOOD, V119, P1963, DOI 10.1182/blood-2011-11-391474; Le Gouill S, 2017, NEW ENGL J MED, V377, P1250, DOI 10.1056/NEJMoa1701769; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2016, ONCOGENE, V35, P6223, DOI 10.1038/onc.2016.155; Martin P, 2017, BLOOD, V130, P1881, DOI 10.1182/blood-2017-05-737510; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nordstrom L, 2014, BRIT J HAEMATOL, V166, P98, DOI 10.1111/bjh.12854; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahal R, 2014, NAT MED, V20, P87, DOI 10.1038/nm.3435; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saba NS, 2016, BLOOD, V128, P82, DOI 10.1182/blood-2015-11-681460; Salaverria I, 2007, J CLIN ONCOL, V25, P1216, DOI 10.1200/JCO.2006.08.4251; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tahir SK, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3383-5; Tam CS, 2018, NEW ENGL J MED, V378, P1211, DOI 10.1056/NEJMoa1715519; van der Velden VHJ, 2007, LEUKEMIA, V21, P604, DOI 10.1038/sj.leu.2404586; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wong SQ, 2015, BRIT J CANCER, V112, P1411, DOI 10.1038/bjc.2015.80; Wong SQ, 2015, CANCER RES, V75, P5228, DOI 10.1158/0008-5472.CAN-15-1877; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Wu CL, 2016, ONCOTARGET, V7, P38180, DOI 10.18632/oncotarget.9500; Yeh P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14756; Zhang J, 2014, BLOOD, V123, P2988, DOI 10.1182/blood-2013-07-517177; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14920; Zhao XX, 2015, BRIT J HAEMATOL, V168, P765, DOI 10.1111/bjh.13149	58	98	101	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					119	+		10.1038/s41591-018-0243-z	http://dx.doi.org/10.1038/s41591-018-0243-z			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30455436				2022-12-27	WOS:000455027700030
J	Menotti, M; Ambrogio, C; Cheong, TC; Pighi, C; Mota, I; Cassel, SH; Compagno, M; Wang, Q; Dall'Olio, R; Minero, VG; Poggio, T; Sharma, GG; Patrucco, E; Mastini, C; Choudhari, R; Pich, A; Zamo, A; Piva, R; Giliani, S; Mologni, L; Collings, CK; Kadoch, C; Gambacorti-Passerini, C; Notarangelo, LD; Anton, IM; Voena, C; Chiarle, R				Menotti, Matteo; Ambrogio, Chiara; Cheong, Taek-Chin; Pighi, Chiara; Mota, Ines; Cassel, Seth H.; Compagno, Mara; Wang, Qi; Dall'Olio, Riccardo; Minero, Valerio G.; Poggio, Teresa; Sharma, Geeta Geeta; Patrucco, Enrico; Mastini, Cristina; Choudhari, Ramesh; Pich, Achille; Zamo, Alberto; Piva, Roberto; Giliani, Silvia; Mologni, Luca; Collings, Clayton K.; Kadoch, Cigall; Gambacorti-Passerini, Carlo; Notarangelo, Luigi D.; Anton, Ines M.; Voena, Claudia; Chiarle, Roberto			Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma	NATURE MEDICINE			English	Article							ACTIN POLYMERIZATION; ALK; KINASE; CDC42; RHOA; WIP; DEFICIENCY; ACTIVATION; MUTATIONS; RAC1	In T lymphocytes, the Wiskott-Aldrich Syndrome protein (WASP) and WASP-interacting-protein (WIP) regulate T cell antigen receptor (TCR) signaling, but their role in lymphoma is largely unknown. Here we show that the expression of WASP and WIP is frequently low or absent in anaplastic large cell lymphoma (ALCL) compared to other T cell lymphomas. In anaplastic lymphoma kinase-positive (ALK+) ALCL, WASP and WIP expression is regulated by ALK oncogenic activity via its downstream mediators STAT3 and C/EBP-beta. ALK+ lymphomas were accelerated in WASP- and WIP-deficient mice. In the absence of WASP, active GTP-bound CDC42 was increased and the genetic deletion of one CDC42 allele was sufficient to impair lymphoma growth. WASP-deficient lymphoma showed increased mitogen-activated protein kinase (MAPK) pathway activation that could be exploited as a therapeutic vulnerability. Our findings demonstrate that WASP and WIP are tumor suppressors in T cell lymphoma and suggest that MAP-kinase kinase (MEK) inhibitors combined with ALK inhibitors could achieve a more potent therapeutic effect in ALK+ ALCL.	[Menotti, Matteo; Pighi, Chiara; Mota, Ines; Compagno, Mara; Dall'Olio, Riccardo; Minero, Valerio G.; Poggio, Teresa; Patrucco, Enrico; Mastini, Cristina; Choudhari, Ramesh; Pich, Achille; Piva, Roberto; Voena, Claudia; Chiarle, Roberto] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Ambrogio, Chiara] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cheong, Taek-Chin; Pighi, Chiara; Compagno, Mara; Wang, Qi; Chiarle, Roberto] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Cheong, Taek-Chin; Pighi, Chiara; Cassel, Seth H.; Compagno, Mara; Wang, Qi; Collings, Clayton K.; Kadoch, Cigall; Chiarle, Roberto] Harvard Med Sch, Boston, MA 02115 USA; [Cassel, Seth H.; Collings, Clayton K.; Kadoch, Cigall] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Cassel, Seth H.; Collings, Clayton K.; Kadoch, Cigall] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Cassel, Seth H.] Harvard Med Sch, Biomed & Biol Sci Program, Boston, MA USA; [Cassel, Seth H.] Harvard Med Sch, Med Scientist Training Program, Boston, MA USA; [Sharma, Geeta Geeta; Mologni, Luca; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Zamo, Alberto] Univ Torino, Dept Oncol, Turin, Italy; [Giliani, Silvia] Univ Brescia, Dept Mol & Translat Med, Nocivelli Inst Mol Med, Brescia, Italy; [Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Anton, Ines M.] CSIC, CNB, Dept Mol & Cellular Biol, Madrid, Spain; [Menotti, Matteo] Univ Manchester, Canc Res UK Manchester Inst, Cell Signalling Grp, Manchester, Lancs, England; [Choudhari, Ramesh] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Emphasis Canc,Paul L Foster Sch Med, El Paso, TX USA	University of Turin; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Milano-Bicocca; University of Turin; University of Brescia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Cancer Research UK; University of Manchester; Texas Tech University System; Texas Tech University	Voena, C; Chiarle, R (corresponding author), Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.; Chiarle, R (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.; Chiarle, R (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	claudia.voena@unito.it; roberto.chiarle@childrens.harvard.edu	PICH, achille/AAJ-5795-2021; Menotti, Matteo/AAA-9312-2022; Giliani, Silvia/AAX-8843-2020; Zamò, Alberto/ABF-4436-2020; VOENA, Claudia/ADJ-6244-2022; Sharma, Geeta G./AAM-6130-2020; Choudhari, Ramesh/AAI-6418-2021; Mologni, Luca/AAC-1065-2022; Pich, Achille/AAJ-8164-2021	PICH, achille/0000-0003-3175-7797; Giliani, Silvia/0000-0001-8137-4642; Sharma, Geeta G./0000-0003-4144-2799; Choudhari, Ramesh/0000-0001-7361-1652; Mologni, Luca/0000-0002-6365-5149; Mota, Ines/0000-0003-1523-7134; Patrucco, Enrico/0000-0001-8060-5058; Wang, Qi/0000-0002-4306-3293; Voena, Claudia/0000-0002-1324-1431; Menotti, Matteo/0000-0002-1260-2389; Poggio, Teresa/0000-0003-2560-8488; Ambrogio, Chiara/0000-0003-4122-701X	AIRC [MFAG]; National Research Foundation of Korea (NRF) fellowship [2016R1A6A3A03006840]; Bando Giovani Ricercatori [2009-GR 1603126]; MINECO/FEDER [SAF2015-70368-R]; Fundacion Ramon Areces; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institute of General Medical Sciences [T32GM007753]; National Institutes of Health DP2 New Innovator award [1DP2CA195762-01]; American Cancer Society Research Scholar award [RSG-14-051-01-DMC]; Pew-Stewart Scholars in Cancer Research Grant; European Union Horizon 2020 Marie Sklodowska-Curie Innovative Training Network Grant [675712];  [FP7 ERC-2009-StG];  [242965-'Lunely'];  [R01 CA196703-01]; NATIONAL CANCER INSTITUTE [R01CA196703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); National Research Foundation of Korea (NRF) fellowship; Bando Giovani Ricercatori; MINECO/FEDER; Fundacion Ramon Areces; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health DP2 New Innovator award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar award(American Cancer Society); Pew-Stewart Scholars in Cancer Research Grant; European Union Horizon 2020 Marie Sklodowska-Curie Innovative Training Network Grant; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M.S. Scalzo and D. Corino for technical assistance, and B. Castella for providing purified human T cells. The work has been supported by grant no. FP7 ERC-2009-StG (Proposal No. 242965-'Lunely') (R.C.) grant no. R01 CA196703-01 (R.C.); AIRC grant no. MFAG (C.A. and M.C.); National Research Foundation of Korea (NRF) fellowship 2016R1A6A3A03006840 (T-C.C.); Bando Giovani Ricercatori grant no. 2009-GR 1603126 (M.C.); MINECO/FEDER grant no. SAF2015-70368-R and Fundacion Ramon Areces (I.M.A.); the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (L.D.N.); and award no. T32GM007753 from the National Institute of General Medical Sciences (S.H.C.) (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health); and in part by awards from the National Institutes of Health DP2 New Innovator award no. 1DP2CA195762-01 (C.K.); the American Cancer Society Research Scholar award no. RSG-14-051-01-DMC and the Pew-Stewart Scholars in Cancer Research Grant (C.K.); and the European Union Horizon 2020 Marie Sklodowska-Curie Innovative Training Network Grant award no. 675712 for the European Research Initiative for ALK-Related Malignancies (G.G.S., I.M., C.GP. and R.C.).	Abate F, 2017, P NATL ACAD SCI USA, V114, P764, DOI 10.1073/pnas.1608839114; Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Al-Mousa H, 2017, J ALLERGY CLIN IMMUN, V139, P1039, DOI 10.1016/j.jaci.2016.08.036; Ambrogio C, 2008, CANCER RES, V68, P8899, DOI 10.1158/0008-5472.CAN-08-2568; Ambrogio C, 2018, CELL, V172, P857, DOI 10.1016/j.cell.2017.12.020; Ambrogio C, 2009, CANCER RES, V69, P8611, DOI 10.1158/0008-5472.CAN-09-2655; Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6; Boddicker Rebecca L, 2019, Small GTPases, V10, P33, DOI 10.1080/21541248.2016.1263718; Castellar ERP, 2014, BLOOD, V124, P1473, DOI 10.1182/blood-2014-04-571091; Ceccon M, 2016, ONCOGENE, V35, P3854, DOI 10.1038/onc.2015.456; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Choudhari R, 2016, BLOOD, V127, P1297, DOI 10.1182/blood-2015-11-683052; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; Crescenzo R, 2015, CANCER CELL, V27, P516, DOI 10.1016/j.ccell.2015.03.006; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; Facchetti F, 1998, J PATHOL, V185, P99, DOI 10.1002/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L; Hassler MR, 2016, CELL REP, V17, P596, DOI 10.1016/j.celrep.2016.09.018; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanzi G, 2012, J EXP MED, V209, P29, DOI 10.1084/jem.20110896; Manser M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43345; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Martinengo C, 2014, CANCER RES, V74, P6094, DOI 10.1158/0008-5472.CAN-14-0268; Massaad MJ, 2013, ANN NY ACAD SCI, V1285, P26, DOI 10.1111/nyas.12049; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Murga-Zamalloa CA, 2017, ONCOGENE, V36, P2085, DOI 10.1038/onc.2016.366; Notarangelo LD, 2005, CURR OPIN ALLERGY CL, V5, P485, DOI 10.1097/01.all.0000191243.25757.ce; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Passerini CG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt378; Piva R, 2006, BLOOD, V107, P689, DOI 10.1182/blood-2005-05-2125; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Ramesh N, 2009, IMMUNOL RES, V44, P99, DOI 10.1007/s12026-008-8086-1; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; Rivers E, 2017, EUR J IMMUNOL, V47, P1857, DOI 10.1002/eji.201646715; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Scarfo I, 2016, BLOOD, V127, P221, DOI 10.1182/blood-2014-12-614503; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Watanabe Y, 2013, J ALLERGY CLIN IMMUN, V132, P648, DOI 10.1016/j.jaci.2013.03.046; Werner MT, 2017, BLOOD, V129, P823, DOI 10.1182/blood-2016-05-717793; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Zhang JQ, 2017, FASEB J, V31, P4277, DOI 10.1096/fj.201700179R; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	35	37	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					130	+		10.1038/s41591-018-0262-9	http://dx.doi.org/10.1038/s41591-018-0262-9			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30510251	Green Submitted, Green Accepted			2022-12-27	WOS:000455027700031
J	Manolio, TA				Manolio, Teri A.			UK Biobank debuts as a powerful resource for genomic research	NATURE MEDICINE			English	Editorial Material									[Manolio, Teri A.] NHGRI, Div Genom Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Manolio, TA (corresponding author), NHGRI, Div Genom Med, Bethesda, MD 20892 USA.	manolio@nih.gov						Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Littlejohns TJ, 2019, EUR HEART J, V40, P1158, DOI 10.1093/eurheartj/ehx254; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	8	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1792	1794		10.1038/s41591-018-0276-3	http://dx.doi.org/10.1038/s41591-018-0276-3			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30510254				2022-12-27	WOS:000452392200005
J	Ossenkoppele, R; Hansson, O				Ossenkoppele, Rik; Hansson, Oskar			Genetic characterization of amyloid-beta and tau network spread	NATURE MEDICINE			English	Editorial Material							HUMAN BRAIN; DEPOSITION; DISEASE		[Ossenkoppele, Rik; Hansson, Oskar] Lund Univ, Clin Memory Res Unit, Lund, Sweden; [Ossenkoppele, Rik] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Ossenkoppele, Rik] Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam Neurosci, Amsterdam, Netherlands; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Lund University; Skane University Hospital	Ossenkoppele, R; Hansson, O (corresponding author), Lund Univ, Clin Memory Res Unit, Lund, Sweden.; Ossenkoppele, R (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands.; Ossenkoppele, R (corresponding author), Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam Neurosci, Amsterdam, Netherlands.; Hansson, O (corresponding author), Skane Univ Hosp, Memory Clin, Malmo, Sweden.	r.ossenkoppele@vumc.nl; oskar.hansson@med.lu.se	Hansson, Oskar/A-7134-2013; Ossenkoppele, Rik/J-5826-2013	Hansson, Oskar/0000-0001-8467-7286; Ossenkoppele, Rik/0000-0003-1584-7477				BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Gordon BA, 2018, LANCET NEUROL, V17, P241, DOI 10.1016/S1474-4422(18)30028-0; Grothe MJ, 2018, BRAIN, V141, P2755, DOI 10.1093/brain/awy189; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Palmqvist S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01150-x; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Sepulcre J, 2018, NAT MED, V24, P1910, DOI 10.1038/s41591-018-0206-4; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; van der Lee SJ, 2018, LANCET NEUROL, V17, P434, DOI [10.1016/s1474-4422(18)30053-X, 10.1016/S1474-4422(18)30053-X]; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1	12	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1790	1792		10.1038/s41591-018-0277-2	http://dx.doi.org/10.1038/s41591-018-0277-2			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30510252				2022-12-27	WOS:000452392200004
J	Stower, H				Stower, Hannah			PANCREATIC CANCER A wasted early warning	NATURE MEDICINE			English	Editorial Material																			0	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1088	1088		10.1038/s41591-018-0153-0	http://dx.doi.org/10.1038/s41591-018-0153-0			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082866	Bronze			2022-12-27	WOS:000440955500004
J	Jun, H; Yu, H; Gong, JK; Jiang, J; Qiao, XN; Perkey, E; Kim, DI; Emont, MP; Zestos, AG; Cho, JS; Liu, JF; Kennedy, RT; Maillard, I; Xu, XZS; Wu, J				Jun, Heejin; Yu, Hui; Gong, Jianke; Jiang, Juan; Qiao, Xiaona; Perkey, Eric; Kim, Dong-Il; Emont, Margo P.; Zestos, Alexander G.; Cho, Jung-Sun; Liu, Jianfeng; Kennedy, Robert T.; Maillard, Ivan; Xu, X. Z. Shawn; Wu, Jun			An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; ALTERNATIVELY ACTIVATED MACROPHAGES; INSULIN SENSITIVITY; ADAPTIVE THERMOGENESIS; UNCOUPLING PROTEIN-1; PPAR-GAMMA; WHITE FAT; MICE; OBESITY; HUMANS	Beige adipocytes have recently been shown to regulate energy dissipation when activated and help organisms defend against hypothermia and obesity. Prior reports indicate that beige-like adipocytes exist in adult humans and that they may present novel opportunities to curb the global epidemic in obesity and metabolic illnesses. In an effort to identify unique features of activated beige adipocytes, we found that expression of the cholinergic receptor nicotinic alpha 2 subunit (Chrna2) was induced in subcutaneous fat during the activation of these cells and that acetylcholine-producing immune cells within this tissue regulated this signaling pathway via paracrine mechanisms. CHRNA2 functioned selectively in uncoupling protein 1 (Ucp1)-positive beige adipocytes, increasing thermogenesis through a cAMP-and protein kinase A-dependent pathway. Furthermore, this signaling via CHRNA2 was conserved and present in human subcutaneous adipocytes. Inactivation of Chrna2 in mice compromised the cold-induced thermogenic response selectively in subcutaneous fat and exacerbated high-fat diet-induced obesity and associated metabolic disorders, indicating that even partial loss of beige fat regulation in vivo had detrimental consequences. Our results reveal a beige-selective immune-adipose interaction mediated through CHRNA2 and identify a novel function of nicotinic acetylcholine receptors in energy metabolism. These findings may lead to identification of therapeutic targets to counteract human obesity.	[Jun, Heejin; Yu, Hui; Gong, Jianke; Jiang, Juan; Qiao, Xiaona; Kim, Dong-Il; Emont, Margo P.; Cho, Jung-Sun; Maillard, Ivan; Xu, X. Z. Shawn; Wu, Jun] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Jun, Heejin; Emont, Margo P.; Xu, X. Z. Shawn; Wu, Jun] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Gong, Jianke; Liu, Jianfeng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Int Res Ctr Sensory Biol & Technol MOST, Key Lab Mol Biophys MOE, Wuhan, Hubei, Peoples R China; [Jiang, Juan] Cent S Univ, Xiangya Hosp, Dept Resp Med, Key Site Natl Clin Res Ctr Resp Dis, Changsha, Hunan, Peoples R China; [Qiao, Xiaona] Fudan Univ, Huashan Hosp, Shanghai, Peoples R China; [Perkey, Eric] Univ Michigan, Ctr Stem Cell Biol, Life Sci Inst, Ann Arbor, MI 48109 USA; [Perkey, Eric; Maillard, Ivan] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Perkey, Eric] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Zestos, Alexander G.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Maillard, Ivan] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Zestos, Alexander G.] Amer Univ, Dept Chem, Ctr Behav Neurosci, Washington, DC 20016 USA; [Maillard, Ivan] Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Maillard, Ivan] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Huazhong University of Science & Technology; Central South University; Fudan University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; American University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wu, J (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.; Wu, J (corresponding author), Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	wujunz@umich.edu	Yu, Hui/AAR-3692-2021; Zestos, Alexander G./E-4649-2018	Zestos, Alexander G./0000-0002-4804-4278; Perkey, Eric/0000-0003-3275-3181; Emont, Margo/0000-0001-9873-2784; Maillard, Ivan/0000-0003-1312-6748	Human Frontier Science Program [RGY0082/14]; Edward Mallinckrodt Jr. Foundation; American Diabetes Association [1-18-IBS-281]; US National Institutes of Health [R01DK107583, P30-DK020572, P30-DK089503, F31DK112625, R37EB003320, DK046960, R01-AI091627, T32DA007268]; American Heart Association [17POST33060001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB003320, R01EB003320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960, P30DK089503, R01DK107583, P30DK020572, R37DK046960, F31DK112625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007268] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Edward Mallinckrodt Jr. Foundation; American Diabetes Association(American Diabetes Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. M. Spiegelman and J. D. Lin for their advice and discussion throughout this work, B. Lowell (Beth Israel Deaconess Medical Center) for the beta-less mice, J. M. Gimble (Tulane University) for human subcutaneous adipose precursor cells and W. Rainey (University of Michigan) for human perirenal adipose precursor cells. The work was supported by the Human Frontier Science Program (grant no. RGY0082/14; J.W.), the Edward Mallinckrodt Jr. Foundation (J.W.), the American Diabetes Association (grant no. 1-18-IBS-281; J. W.), the US National Institutes of Health (grant no. R01DK107583 (J.W.), P30-DK020572 (J.W.), P30-DK089503 (J.W.), F31DK112625 (M.P.E.), R37EB003320 (R.T.K.) and DK046960 (R.T.K.), R01-AI091627 (I.M.) and T32DA007268 (A.G.Z.)) and a postdoctoral fellowship from the American Heart Association (17POST33060001; D.K.).	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bartesaghi S, 2015, MOL ENDOCRINOL, V29, P130, DOI 10.1210/me.2014-1295; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Hanssen MJW, 2015, NAT MED, V21, P863, DOI 10.1038/nm.3891; Jiang HC, 2017, CELL METAB, V26, P686, DOI 10.1016/j.cmet.2017.08.016; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nagano G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122584; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Reardon C, 2013, P NATL ACAD SCI USA, V110, P1410, DOI 10.1073/pnas.1221655110; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Song P, 2012, ANAL CHEM, V84, P412, DOI 10.1021/ac202794q; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Svensson PA, 2014, OBESITY, V22, P1830, DOI 10.1002/oby.20765; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; WEIR JBD, 1990, NUTRITION, V6, P213; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870	45	42	42	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					814	+		10.1038/s41591-018-0032-8	http://dx.doi.org/10.1038/s41591-018-0032-8			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29785025	Green Accepted			2022-12-27	WOS:000434281300026
J	Garrido-Castro, AC; Winer, EP				Garrido-Castro, Ana C.; Winer, Eric P.			Predicting breast cancer therapeutic response	NATURE MEDICINE			English	Editorial Material							SUSCEPTIBILITY GENE BRCA1; DNA-REPAIR		[Garrido-Castro, Ana C.; Winer, Eric P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Winer, EP (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	eric_winer@dfci.harvard.edu						Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Perou CM, 2010, ONCOLOGIST, V15, P39, DOI 10.1634/theoncologist.2010-S5-39; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2018, NAT MED, V24, P628, DOI 10.1038/s41591-018-0009-7; Wong-Brown MW, 2015, BREAST CANCER RES TR, V150, P71, DOI 10.1007/s10549-015-3293-7; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	12	5	5	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					535	537		10.1038/s41591-018-0033-7	http://dx.doi.org/10.1038/s41591-018-0033-7			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736021				2022-12-27	WOS:000432126800006
J	Stower, H				Stower, Hannah			Bioprinting a human heart	NATURE MEDICINE			English	Editorial Material																		2019, SCIENCE, V365, P482	1	2	2	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1330	1330		10.1038/s41591-019-0585-1	http://dx.doi.org/10.1038/s41591-019-0585-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501602	Bronze			2022-12-27	WOS:000484832800006
J	Dietz, WH				Dietz, William H.			Global shifts in the patterns of urban and rural weight increase	NATURE MEDICINE			English	Editorial Material								The prevalence of excess weight gain is increasing more rapidly in rural than in urban environments. Increased intake of ultra-processed foods has been associated with obesity, and the rise of supermarkets and marketing strategies may have contributed to the greater weight increases in rural areas.	[Dietz, William H.] George Washington Univ, Redstone Global Ctr Prevent & Wellness, Washington, DC 20052 USA	George Washington University	Dietz, WH (corresponding author), George Washington Univ, Redstone Global Ctr Prevent & Wellness, Washington, DC 20052 USA.	bdietz@gwu.edu						Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Giles-Corti B, 2016, LANCET, V388, P2912, DOI 10.1016/S0140-6736(16)30066-6; Hall KD, 2019, CELL METAB, V30, P67, DOI 10.1016/j.cmet.2019.05.008; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P18, DOI 10.1017/S1368980017001379; NCD Risk Factor Collaboration (NCD-RisC), 2019, NATURE, V569, P260; PAHO, 2015, ULTRA PROCESSED FOOD; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Tzioumis E, 2016, PUBLIC HEALTH NUTR, V19, P1375, DOI 10.1017/S1368980016000276; Vandevijvere S., 2019, OBES REV, V19, P931	11	3	3	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1035	1036		10.1038/s41591-019-0518-z	http://dx.doi.org/10.1038/s41591-019-0518-z			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31263282				2022-12-27	WOS:000474430400014
J	Wu, YX; Zeng, J; Roscoe, BP; Liu, PP; Yao, QM; Lazzarotto, CR; Clement, K; Cole, MA; Luk, K; Baricordi, C; Shen, AH; Ren, CY; Esrick, EB; Manis, JP; Dorfman, DM; Williams, DA; Biffi, A; Brugnara, C; Biasco, L; Brendel, C; Pinello, L; Tsai, SQ; Wolfe, SA; Bauer, DE				Wu, Yuxuan; Zeng, Jing; Roscoe, Benjamin P.; Liu, Pengpeng; Yao, Qiuming; Lazzarotto, Cicera R.; Clement, Kendell; Cole, Mitchel A.; Luk, Kevin; Baricordi, Cristina; Shen, Anne H.; Ren, Chunyan; Esrick, Erica B.; Manis, John P.; Dorfman, David M.; Williams, David A.; Biffi, Alessandra; Brugnara, Carlo; Biasco, Luca; Brendel, Christian; Pinello, Luca; Tsai, Shengdar Q.; Wolfe, Scot A.; Bauer, Daniel E.			Highly efficient therapeutic gene editing of human hematopoietic stem cells	NATURE MEDICINE			English	Article							FETAL-HEMOGLOBIN; PROGENITOR CELLS; DISEASE; MOBILIZATION; ENGRAFTMENT; PLERIXAFOR; MUTATION; ENHANCER; LINEAGE; MURINE	Re-expression of the paralogous gamma-globin genes (HBG1/2) could be a universal strategy to ameliorate the severe beta-globin disorders sickle cell disease (SCD) and beta-thalassemia by induction of fetal hemoglobin (HbF, alpha(2)gamma(2))(1). Previously, we and others have shown that core sequences at the BCL11A erythroid enhancer are required for repression of HbF in adult-stage erythroid cells but are dispensable in non-erythroid cells(2-6). CRISPR-Cas9-mediated gene modification has demonstrated variable efficiency, specificity, and persistence in hematopoietic stem cells (HSCs). Here, we demonstrate that Cas9:sgRNA ribonucleoprotein (RNP)-mediated cleavage within a GATA1 binding site at the +58 BCL11A erythroid enhancer results in highly penetrant disruption of this motif, reduction of BCL11A expression, and induction of fetal gamma-globin. We optimize conditions for selection-free on-target editing in patient-derived HSCs as a nearly complete reaction lacking detectable genotoxicity or deleterious impact on stem cell function. HSCs preferentially undergo non-homologous compared with microhomology-mediated end joining repair. Erythroid progeny of edited engrafting SCD HSCs express therapeutic levels of HbF and resist sickling, while those from patients with beta-thalassemia show restored globin chain balance. Non-homologous end joining repair-based BCL11A enhancer editing approaching complete allelic disruption in HSCs is a practicable therapeutic strategy to produce durable HbF induction.	[Wu, Yuxuan; Zeng, Jing; Yao, Qiuming; Cole, Mitchel A.; Baricordi, Cristina; Shen, Anne H.; Ren, Chunyan; Esrick, Erica B.; Manis, John P.; Williams, David A.; Biffi, Alessandra; Brugnara, Carlo; Biasco, Luca; Brendel, Christian; Bauer, Daniel E.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Wu, Yuxuan; Zeng, Jing; Yao, Qiuming; Cole, Mitchel A.; Baricordi, Cristina; Shen, Anne H.; Ren, Chunyan; Esrick, Erica B.; Manis, John P.; Williams, David A.; Biffi, Alessandra; Brugnara, Carlo; Biasco, Luca; Brendel, Christian; Bauer, Daniel E.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wu, Yuxuan; Zeng, Jing; Yao, Qiuming; Cole, Mitchel A.; Baricordi, Cristina; Shen, Anne H.; Ren, Chunyan; Esrick, Erica B.; Manis, John P.; Williams, David A.; Biffi, Alessandra; Brugnara, Carlo; Biasco, Luca; Brendel, Christian; Bauer, Daniel E.] Harvard Med Sch, Broad Inst Harvard & MIT, Harvard Stem Cell Inst, Dept Pediat, Boston, MA 02115 USA; [Wu, Yuxuan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Wu, Yuxuan] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Roscoe, Benjamin P.; Liu, Pengpeng; Luk, Kevin; Wolfe, Scot A.] Univ Massachusetts, Med Sch, Li Weibo Inst Rare Dis Res, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Yao, Qiuming; Clement, Kendell; Pinello, Luca] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Boston, MA 02114 USA; [Yao, Qiuming; Clement, Kendell; Pinello, Luca] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Yao, Qiuming; Clement, Kendell; Pinello, Luca] Harvard Med Sch, Broad Inst Harvard & MIT, Dept Pathol, Boston, MA 02115 USA; [Lazzarotto, Cicera R.; Tsai, Shengdar Q.] St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Baricordi, Cristina; Biffi, Alessandra; Biasco, Luca; Brendel, Christian] Dana Farber Boston Childrens Canc & Blood Disorde, Gene Therapy Program, Boston, MA USA; [Dorfman, David M.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Dorfman, David M.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Biasco, Luca] UCL, Great Ormond St Inst Child Hlth, Fac Populat Hlth Sci, London, England	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; East China Normal University; East China Normal University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; St Jude Children's Research Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of London; University College London	Bauer, DE (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Bauer, DE (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Bauer, DE (corresponding author), Harvard Med Sch, Broad Inst Harvard & MIT, Harvard Stem Cell Inst, Dept Pediat, Boston, MA 02115 USA.	daniel.bauer@childrens.harvard.edu	Clement, Kendell/AAZ-6854-2021; liu, pengpeng/AGH-4826-2022; Brugnara, Carlo/A-8041-2010; Lazzarotto, Cicera/AAG-4259-2020; Brendel, Christian/HDN-6077-2022; Biffi, Alessandra/AAA-8890-2019; REN, CHUNYAN/F-1880-2017	liu, pengpeng/0000-0002-4891-8780; Brugnara, Carlo/0000-0001-8192-8713; Tsai, Shengdar/0000-0001-9161-3993; Cole, Mitchel/0000-0003-0708-3542; REN, CHUNYAN/0000-0002-3913-2479; Brendel, Christian/0000-0003-4081-4351	Translational Research Program at BCH; NHLBI [U01HL11772, R01HL137848, DP2OD022716, P01HL053749, P01HL032262]; NHGRI [R00HG008399]; NIAID [R01AI117839]; NIGMS [R01GM115911]; NIDDK [K08DK093705, R03DK109232]; Harvard Stem Cell Institute Seed Grant; St. Jude Children's Research Hospital Collaborative Research Consortium; Burroughs Wellcome Fund; American Society of Hematology; Doris Duke Charitable Foundation; Charles H. Hood Foundation; Cooley's Anemia Foundation; bluebird bio; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL117720, P01HL032262, R01HL137848, P01HL053749, R21HL145636, DP2HL137300] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG008399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK109232, U54DK106829, K08DK093705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115911] Funding Source: NIH RePORTER	Translational Research Program at BCH; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Stem Cell Institute Seed Grant; St. Jude Children's Research Hospital Collaborative Research Consortium; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Society of Hematology; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Charles H. Hood Foundation; Cooley's Anemia Foundation; bluebird bio; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Chui for genetic analyses, N. Barteneva for imaging flow cytometry analysis, R. Mathieu for flow cytometry assistance, Z. Herbert for deep sequencing, and G. Menard and R. Rosales for help with hemoglobin HPLC. We appreciate useful discussions with J. Hsu, B. Croker, C. Lindsley, K. Holden, M. Hoban, M. Canver, and S. Orkin. This project was funded in part by the Translational Research Program at BCH. D.A.W. and C. Brendel were supported by NHLBI (grant no. U01HL11772) and D.A.W. and E.B.E. by NHLBI (grant no. R01HL137848). The trial for SCD HSPC procurement was supported by research funding from bluebird bio to A.B. L.P. was supported by NHGRI (grant no. R00HG008399). S.A.W. was supported by NIAID (grant no. R01AI117839) and NIGMS (grant no. R01GM115911). D.E.B. was supported by NIDDK (grant nos. K08DK093705 and R03DK109232), NHLBI (grant nos. DP2OD022716, P01HL053749 and P01HL032262), Harvard Stem Cell Institute Seed Grant, St. Jude Children's Research Hospital Collaborative Research Consortium, Burroughs Wellcome Fund, American Society of Hematology, and the Doris Duke Charitable, Charles H. Hood, and Cooley's Anemia Foundations.	An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Boulad F, 2018, HAEMATOLOGICA, V103, P770, DOI 10.3324/haematol.2017.187047; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chang KH, 2017, MOL THER-METH CLIN D, V4, P137, DOI 10.1016/j.omtm.2016.12.009; De Ravin S.S., 2017, SCI TRANSL MED, V9, P1; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Diez B, 2017, EMBO MOL MED, V9, P1574, DOI 10.15252/emmm.201707540; Eddaoudi A, 2018, METHODS MOL BIOL, V1686, P49, DOI 10.1007/978-1-4939-7371-2_3; Esrick EB, 2018, BLOOD ADV, V2, P2505, DOI 10.1182/bloodadvances.2018016725; Estcourt LJ, 2017, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003146.PUB3; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Guda S, 2015, MOL THER, V23, P1465, DOI 10.1038/mt.2015.113; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kluk MJ, 2016, J MOL DIAGN, V18, P507, DOI 10.1016/j.jmoldx.2016.02.003; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Lagresle-Peyrou C, 2018, HAEMATOLOGICA, V103, P778, DOI 10.3324/haematol.2017.184788; Lettre G, 2016, LANCET, V387, P2554, DOI 10.1016/S0140-6736(15)01341-0; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Lu XR, 2016, BIOPHYS J, V110, P2751, DOI 10.1016/j.bpj.2016.04.050; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Martyn GE, 2018, NAT GENET, V50, P498, DOI 10.1038/s41588-018-0085-0; McIntosh BE, 2015, STEM CELL REP, V4, P171, DOI 10.1016/j.stemcr.2014.12.005; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Smith EC, 2016, BLOOD, V128, P2338, DOI 10.1182/blood-2016-08-736249; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsai SQ, 2017, NAT METHODS, V14, P607, DOI [10.1038/NMETH.4278, 10.1038/nmeth.4278]; Vakulskas CA, 2018, NAT MED, V24, P1216, DOI 10.1038/s41591-018-0137-0; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Xu S, 2019, BLOOD, DOI [10.1182/blood-2019-01-8950-94, DOI 10.1182/BLOOD-2019-01-8950-94]	44	197	208	8	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					776	+		10.1038/s41591-019-0401-y	http://dx.doi.org/10.1038/s41591-019-0401-y			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	30911135	Green Accepted			2022-12-27	WOS:000468247800021
J	Alpert, A; Pickman, Y; Leipold, M; Rosenberg-Hasson, Y; Ji, XH; Gaujoux, R; Rabani, H; Starosvetsky, E; Kveler, K; Schaffert, S; Furman, D; Caspi, O; Rosenschein, U; Khatri, P; Dekker, CL; Maecker, HT; Davis, MM; Shen-Orr, SS				Alpert, Ayelet; Pickman, Yishai; Leipold, Michael; Rosenberg-Hasson, Yael; Ji, Xuhuai; Gaujoux, Renaud; Rabani, Hadas; Starosvetsky, Elina; Kveler, Ksenya; Schaffert, Steven; Furman, David; Caspi, Oren; Rosenschein, Uri; Khatri, Purvesh; Dekker, Cornelia L.; Maecker, Holden T.; Davis, Mark M.; Shen-Orr, Shai S.			A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring	NATURE MEDICINE			English	Article							SYSTEMS-ANALYSIS; CARDIOVASCULAR RISK; REVEALS; IMMUNOSENESCENCE; VACCINATION; EXPRESSION; MORTALITY; RESPONSES; DRIVEN; CELLS	Immune responses generally decline with age. However, the dynamics of this process at the individual level have not been characterized, hindering quantification of an individual's immune age. Here, we use multiple 'omics' technologies to capture population-and individual-level changes in the human immune system of 135 healthy adult individuals of different ages sampled longitudinally over a nine-year period. We observed high inter-individual variability in the rates of change of cellular frequencies that was dictated by their baseline values, allowing identification of steady-state levels toward which a cell subset converged and the ordered convergence of multiple cell subsets toward an older adult homeostasis. These data form a high-dimensional trajectory of immune aging (IMM-AGE) that describes a person's immune status better than chronological age. We show that the IMM-AGE score predicted all-cause mortality beyond well-established risk factors in the Framingham Heart Study, establishing its potential use in clinics for identification of patients at risk.	[Alpert, Ayelet; Pickman, Yishai; Gaujoux, Renaud; Rabani, Hadas; Starosvetsky, Elina; Kveler, Ksenya; Caspi, Oren; Rosenschein, Uri; Shen-Orr, Shai S.] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Leipold, Michael; Rosenberg-Hasson, Yael; Ji, Xuhuai; Schaffert, Steven; Furman, David; Khatri, Purvesh; Dekker, Cornelia L.; Maecker, Holden T.; Davis, Mark M.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Gaujoux, Renaud] CytoReason, Tel Aviv, Israel; [Schaffert, Steven; Khatri, Purvesh] Stanford Univ, Dept Med, Biomed Informat Res, Sch Med, Stanford, CA 94305 USA; [Caspi, Oren] Rambam Hlth Care Campus, Dept Cardiol, Haifa, Israel; [Rosenschein, Uri] Bnai Zion Med Ctr, Dept Cardiol, Haifa, Israel; [Dekker, Cornelia L.] Stanford Univ, Sch Med, Div Pediat Infect Dis, Stanford, CA 94305 USA; [Maecker, Holden T.; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Davis, Mark M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Stanford University; Stanford University; Rambam Health Care Campus; Bnai Zion Medical Center; Stanford University; Stanford University; Howard Hughes Medical Institute	Shen-Orr, SS (corresponding author), Technion Israel Inst Technol, Fac Med, Haifa, Israel.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	mmdavis@stanford.edu; shenorr@technion.ac.il	Leipold, Michael/A-9452-2013	Leipold, Michael/0000-0001-5389-0906; Davis, Mark/0000-0001-6868-657X; Khatri, Purvesh/0000-0002-4143-4708; Schaffert, Steven/0000-0001-8842-0218; Shen-Orr, Shai/0000-0002-6991-7736	Ellison Medical Foundation; Howard Hughes Medical Institute; National Institute of Allergy and Infectious Diseases [U19 AI057229, U19 AI090019]; Israeli Science Foundation [1365/12]; Rappaport Institute; National Institutes of Health (NIH)/National Center for Research Resources Clinical and Translational Science Awards [UL1 RR025744]; Kolk family awards; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Israeli Science Foundation(Israel Science Foundation); Rappaport Institute; National Institutes of Health (NIH)/National Center for Research Resources Clinical and Translational Science Awards; Kolk family awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. G'Sell for statistical analysis advice, O. Barak, B. Kidd, F. Haddad and members of the Shen-Orr lab for illuminating discussions; the clinical and administrative staff at the Stanford-Lucille Packard Children's Hospital Vaccine Program; members of the Stanford Human Immune Monitoring Center for help with assay measurements; and D. Cohen for computational support. This work was supported in part by grants from the Ellison Medical Foundation, Howard Hughes Medical Institute, and National Institute of Allergy and Infectious Diseases (U19 AI057229 and U19 AI090019) to M.M.D.; and from the Israeli Science Foundation (grant 1365/12), Rappaport Institute and Kolk family awards to S.S.S.-O. The project was supported by National Institutes of Health (NIH)/National Center for Research Resources Clinical and Translational Science Awards to Stanford University (UL1 RR025744). This trial is registered at http://www.clinicaltrials.gov as NCT01827462. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afzali B, 2013, EUR J IMMUNOL, V43, P2043, DOI 10.1002/eji.201243296; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015; Blazkova J, 2017, J IMMUNOL, V198, P2479, DOI 10.4049/jimmunol.1601855; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dai HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00032; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Kaczorowski KJ, 2017, P NATL ACAD SCI USA, V114, pE6097, DOI 10.1073/pnas.1705065114; Lin Y, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0079-7; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; Merino J, 1998, CLIN EXP IMMUNOL, V112, P48; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Patin E, 2018, NAT IMMUNOL, V19, P302, DOI 10.1038/s41590-018-0049-7; Pawelec G, 2018, BIOGERONTOLOGY, V19, P537, DOI 10.1007/s10522-017-9739-z; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Shen-Orr SS, 2016, CELL SYST, V3, P374, DOI 10.1016/j.cels.2016.09.009; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P542, DOI 10.1016/j.coi.2013.07.009; Strogatz SH., 1994, NONLINEAR DYNAMICS C, V1; Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005; Waddington C H, 1957, STRATEGY GENES DISCU	41	182	188	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					487	+		10.1038/s41591-019-0381-y	http://dx.doi.org/10.1038/s41591-019-0381-y			29	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30842675	Green Accepted			2022-12-27	WOS:000460643100028
J	Huang, AC; Orlowski, RJ; Xu, XW; Mick, R; George, SM; Yan, PK; Manne, S; Kraya, AA; Wubbenhorst, B; Dorfman, L; D'Andrea, K; Wenz, BM; Liu, SJ; Chilukuri, L; Kozlov, A; Carberry, M; Giles, L; Kier, MW; Quagliarello, F; McGettigan, S; Kreider, K; Annamalai, L; Zhao, Q; Mogg, R; Xu, W; Blumenschein, WM; Yearley, JH; Linette, GP; Amaravadi, RK; Schuchter, LM; Herati, RS; Bengsch, B; Nathanson, KL; Farwell, MD; Karakousis, GC; Wherry, EJ; Mitchell, TC				Huang, Alexander C.; Orlowski, Robert J.; Xu, Xiaowei; Mick, Rosemarie; George, Sangeeth M.; Yan, Patrick K.; Manne, Sasikanth; Kraya, Adam A.; Wubbenhorst, Bradley; Dorfman, Liza; D'Andrea, Kurt; Wenz, Brandon M.; Liu, Shujing; Chilukuri, Lakshmi; Kozlov, Andrew; Carberry, Mary; Giles, Lydia; Kier, Melanie W.; Quagliarello, Felix; McGettigan, Suzanne; Kreider, Kristin; Annamalai, Lakshmanan; Zhao, Qing; Mogg, Robin; Xu, Wei; Blumenschein, Wendy M.; Yearley, Jennifer H.; Linette, Gerald P.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Herati, Ramin S.; Bengsch, Bertram; Nathanson, Katherine L.; Farwell, Michael D.; Karakousis, Giorgos C.; Wherry, E. John; Mitchell, Tara C.			A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma	NATURE MEDICINE			English	Article							T-CELL EXHAUSTION; EXPRESSION; RESISTANCE; METASTASES; MUTATIONS; IMMUNITY; THERAPY; GENES	Immunologic responses to anti-PD-1 therapy in melanoma patients occur rapidly with pharmacodynamic T cell responses detectable in blood by 3 weeks. It is unclear, however, whether these early blood-based observations translate to the tumor microenvironment. We conducted a study of neoadjuvant/adjuvant anti-PD-1 therapy in stage III/IV melanoma. We hypothesized that immune reinvigoration in the tumor would be detectable at 3 weeks and that this response would correlate with disease-free survival. We identified a rapid and potent anti-tumor response, with 8 of 27 patients experiencing a complete or major pathological response after a single dose of anti-PD-1, all of whom remain disease free. These rapid pathologic and clinical responses were associated with accumulation of exhausted CD8 T cells in the tumor at 3 weeks, with reinvigoration in the blood observed as early as 1 week. Transcriptional analysis demonstrated a pretreatment immune signature (neoadjuvant response signature) that was associated with clinical benefit. In contrast, patients with disease recurrence displayed mechanisms of resistance including immune suppression, mutational escape, and/or tumor evolution. Neoadjuvant anti-PD-1 treatment is effective in high-risk resectable stage III/IV melanoma. Pathological response and immunological analyses after a single neoadjuvant dose can be used to predict clinical outcome and to dissect underlying mechanisms in checkpoint blockade.	[Huang, Alexander C.; Orlowski, Robert J.; Kraya, Adam A.; Wubbenhorst, Bradley; Dorfman, Liza; D'Andrea, Kurt; Wenz, Brandon M.; Carberry, Mary; Giles, Lydia; Kier, Melanie W.; McGettigan, Suzanne; Kreider, Kristin; Xu, Wei; Linette, Gerald P.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Herati, Ramin S.; Nathanson, Katherine L.; Mitchell, Tara C.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Huang, Alexander C.; Yan, Patrick K.; Manne, Sasikanth; Chilukuri, Lakshmi; Quagliarello, Felix; Linette, Gerald P.; Herati, Ramin S.; Bengsch, Bertram; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Huang, Alexander C.; Mick, Rosemarie; Linette, Gerald P.; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Huang, Alexander C.; Xu, Xiaowei; Mick, Rosemarie; Kraya, Adam A.; Wubbenhorst, Bradley; Dorfman, Liza; D'Andrea, Kurt; Wenz, Brandon M.; Liu, Shujing; Kozlov, Andrew; Carberry, Mary; Giles, Lydia; McGettigan, Suzanne; Kreider, Kristin; Xu, Wei; Linette, Gerald P.; Amaravadi, Ravi K.; Schuchter, Lynn M.; Nathanson, Katherine L.; Farwell, Michael D.; Karakousis, Giorgos C.; Wherry, E. John; Mitchell, Tara C.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xu, Xiaowei; Liu, Shujing] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Mick, Rosemarie] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [George, Sangeeth M.; Yan, Patrick K.; Manne, Sasikanth; Chilukuri, Lakshmi; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kozlov, Andrew; Farwell, Michael D.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Annamalai, Lakshmanan; Zhao, Qing; Mogg, Robin; Blumenschein, Wendy M.; Yearley, Jennifer H.] Merck Res Labs, Kenilworth, NJ USA; [Karakousis, Giorgos C.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Orlowski, Robert J.] Merck & Co Inc, Kenilworth, NJ USA; [George, Sangeeth M.] Bristol Myers Squibb, Lawrenceville, NJ USA; [Quagliarello, Felix] Stem Cell Technol, Vancouver, BC, Canada; [Mogg, Robin] Bill & Melinda Gates Med Res Inst, Cambridge, MA USA; [Bengsch, Bertram] Univ Med Ctr Freiburg, Dept Med Gastroenterol Hepatol Endocrinol & Infec, Freiburg, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Merck & Company; University of Pennsylvania; Pennsylvania Medicine; Merck & Company; Bristol-Myers Squibb; University of Freiburg	Huang, AC; Mitchell, TC (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Huang, AC; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Huang, AC; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.; Huang, AC; Wherry, EJ; Mitchell, TC (corresponding author), Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	alexander.huang@uphs.upenn.edu; wherry@pennmedicine.upenn.edu; tara.mitchell@uphs.upenn.edu	Bengsch, Bertram/ABF-2142-2020; Wherry, John/ABI-1280-2020	Bengsch, Bertram/0000-0003-2552-740X; Kozlov, Andrew/0000-0002-3181-6470; Herati, Ramin/0000-0003-2613-4050; Liu, Shujing/0000-0002-2958-093X; Yan, Patrick/0000-0001-6124-1615	SPORE in Skin Cancer [P50-CA174523, P01-CA114046, T32-2T32CA009615]; NIH/NCI Cancer Center [P30-CA016520]; NIH [AI105343, AI108545, AI117950, AI082630, CA210944, AI114852]; Tara Miller Foundation; Melanoma Research Alliance; David and Hallee Adelman Immunotherapy Research Fund; DFG [BE5496/2-1]; Parker Institute for Cancer Immunotherapy Bridge Scholar Award; Merck, Inc.; NATIONAL CANCER INSTITUTE [P50CA174523, P01CA114046, P01CA210944, T32CA009615, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117950, U19AI082630, K08AI114852, P01AI108545, R01AI105343] Funding Source: NIH RePORTER	SPORE in Skin Cancer; NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tara Miller Foundation; Melanoma Research Alliance; David and Hallee Adelman Immunotherapy Research Fund; DFG(German Research Foundation (DFG)); Parker Institute for Cancer Immunotherapy Bridge Scholar Award; Merck, Inc.(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Clinical and correlative studies were supported in part by the SPORE in Skin Cancer: P50-CA174523 (X.X., K.L.N., L.M.S., R.K.A., R.M., G.C.K.), P01-CA114046 (X.X.), T32-2T32CA009615 (A.C.H.); the NIH/NCI Cancer Center Support Grant P30-CA016520 (R.K.A., K.L.N., L.M.S., R.M.), and NIH grants AI105343, AI108545, AI117950, AI082630, CA210944 (E.J.W.), and AI114852 (R.S.H.); the Tara Miller Foundation (A.C.H.); the Melanoma Research Alliance (E.J.W.); the David and Hallee Adelman Immunotherapy Research Fund (E.J.W.); the Heisenberg program BE5496/2-1 of the DFG (B.B.); and the Parker Institute for Cancer Immunotherapy Bridge Scholar Award (A.C.H.). Merck, Inc. supplied drugs and supported clinical and translational aspects of this study. The Human Immunology Core and the Tumor Tissue and Biospecimen Bank of the University of Pennsylvania (supported by P30-CA016520) assisted in tissue collection, processing, and storage.	Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chen MX, 2017, MODERN PATHOL, V30, P1516, DOI 10.1038/modpathol.2017.86; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Daud AI, 2016, J CLIN INVEST, V126, P3447, DOI 10.1172/JCI87324; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Guo G, 2017, CANCER RES, V77, P2292, DOI 10.1158/0008-5472.CAN-16-2832; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Hellmann MD, 2014, LANCET ONCOL, V15, pE42, DOI 10.1016/S1470-2045(13)70334-6; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Luksza M, 2017, NATURE, V551, P517, DOI 10.1038/nature24473; Mihm MC, 1996, LAB INVEST, V74, P43; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sucker A, 2014, CLIN CANCER RES, V20, P6593, DOI 10.1158/1078-0432.CCR-14-0567; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Zappasodi R, 2018, CANCER CELL, V33, P581, DOI 10.1016/j.ccell.2018.03.005; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	42	315	318	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					454	+		10.1038/s41591-019-0357-y	http://dx.doi.org/10.1038/s41591-019-0357-y			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30804515	Green Accepted			2022-12-27	WOS:000460643100024
J	Zhao, J; Chen, AX; Gartrell, RD; Silverman, AM; Aparicio, L; Chu, T; Bordbar, D; Shan, D; Samanamud, J; Mahajan, A; Filip, I; Orenbuch, R; Goetz, M; Yamaguchi, JT; Cloney, M; Horbinski, C; Lukas, RV; Raizer, J; Rae, AI; Yuan, JZ; Canoll, P; Bruce, JN; Saenger, YM; Sims, P; Iwamoto, FM; Sonabend, AM; Rabadan, R				Zhao, Junfei; Chen, Andrew X.; Gartrell, Robyn D.; Silverman, Andrew M.; Aparicio, Luis; Chu, Tim; Bordbar, Darius; Shan, David; Samanamud, Jorge; Mahajan, Aayushi; Filip, Ioan; Orenbuch, Rose; Goetz, Morgan; Yamaguchi, Jonathan T.; Cloney, Michael; Horbinski, Craig; Lukas, Rimas V.; Raizer, Jeffrey; Rae, Ali I.; Yuan, Jinzhou; Canoll, Peter; Bruce, Jeffrey N.; Saenger, Yvonne M.; Sims, Peter; Iwamoto, Fabio M.; Sonabend, Adam M.; Rabadan, Raul			Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma	NATURE MEDICINE			English	Article							PD-1 BLOCKADE; T-CELL; SOMATIC MUTATIONS; EXPRESSION; RESISTANCE; PTEN; SEQ; ACTIVATION; LANDSCAPE; MECHANISM	Immune checkpoint inhibitors have been successful across several tumor types; however, their efficacy has been uncommon and unpredictable in glioblastomas (GBM), where < 10% of patients show long-term responses. To understand the molecular determinants of immunotherapeutic response in GBM, we longitudinally profiled 66 patients, including 17 long-term responders, during standard therapy and after treatment with PD-1 inhibitors (nivolumab or pembrolizumab). Genomic and transcriptomic analysis revealed a significant enrichment of PTEN mutations associated with immunosuppressive expression signatures in non-responders, and an enrichment of MAPK pathway alterations (PTPN11, BRAF) in responders. Responsive tumors were also associated with branched patterns of evolution from the elimination of neoepitopes as well as with differences in T cell clonal diversity and tumor microenvironment profiles. Our study shows that clinical response to anti-PD-1 immunotherapy in GBM is associated with specific molecular alterations, immune expression signatures, and immune infiltration that reflect the tumor's clonal evolution during treatment.	[Zhao, Junfei; Chen, Andrew X.; Aparicio, Luis; Chu, Tim; Filip, Ioan; Orenbuch, Rose; Rabadan, Raul] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Zhao, Junfei; Aparicio, Luis; Chu, Tim; Yuan, Jinzhou; Sims, Peter; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Gartrell, Robyn D.; Silverman, Andrew M.; Bordbar, Darius; Shan, David] Columbia Univ, Dept Pediat, Irving Med Ctr, Pediat Hematol,Oncol,SCT, New York, NY 10027 USA; [Samanamud, Jorge; Mahajan, Aayushi; Bruce, Jeffrey N.] Columbia Univ, Dept Neurosurg, New York, NY USA; [Goetz, Morgan] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Yamaguchi, Jonathan T.; Cloney, Michael; Horbinski, Craig; Sonabend, Adam M.] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Horbinski, Craig] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lukas, Rimas V.; Raizer, Jeffrey] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Rae, Ali I.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Saenger, Yvonne M.] Columbia Univ, Dept Med, Irving Med Ctr, Hematol,Oncol, New York, NY USA; [Iwamoto, Fabio M.] Columbia Univ, Dept Neurol, Irving Med Ctr, Coll Phys & Surg, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Oregon Health & Science University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Rabadan, R (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Rabadan, R (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.; Sonabend, AM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA.; Iwamoto, FM (corresponding author), Columbia Univ, Dept Neurol, Irving Med Ctr, Coll Phys & Surg, New York, NY 10027 USA.	fi2146@cumc.columbia.edu; Adam.Sonabend@nm.org; rr2579@cumc.columbia.edu	Mahajan, Aayushi/ABC-1481-2021; Rabadan, Raul/AAZ-7367-2020; Gartrell, Robyn Denise/GRR-9882-2022; Bruce, Jeffrey N/AAC-5307-2022; Aparicio, Luis/ABI-2660-2020	Mahajan, Aayushi/0000-0003-3966-2936; Gartrell, Robyn Denise/0000-0003-3287-4223; Aparicio, Luis/0000-0002-8859-0839; Orenbuch, Rose/0000-0002-4678-0837; Shan, David/0000-0002-3177-221X; Chen, Andrew/0000-0001-5303-3285; Rabadan, Raul/0000-0001-7946-9255; Yuan, Jinzhou/0000-0002-0001-6008; Cloney, Michael/0000-0002-5085-3103	NIH [R01 CA185486, R01 CA179044, U54 209997, R01 NS103473, U54 CA193313]; NSF/SU2C/V-Foundation Ideas Lab Multidisciplinary Team [PHY-1545805]; 2018 Stand Up To Cancer Phillip A. Sharp Innovation in Collaboration Awards; Keep Punching Foundation; SPORE for Translational Approaches to Brain Cancer [P50CA221747]; Robert H Lurie NCI Cancer Center Support Grant [P30CA060553]; Medical Scientist Training Program [T32GM007367]; CUIMC CTSA [1TL1TR001875-01]; Swim Across America;  [5DP5OD021356-04]; NATIONAL CANCER INSTITUTE [R01CA185486, P50CA221747, P30CA060553, U54CA193313, R01CA179044] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001873, TL1TR001875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS103473, R01NS102669] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021356] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/SU2C/V-Foundation Ideas Lab Multidisciplinary Team; 2018 Stand Up To Cancer Phillip A. Sharp Innovation in Collaboration Awards; Keep Punching Foundation; SPORE for Translational Approaches to Brain Cancer; Robert H Lurie NCI Cancer Center Support Grant; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CUIMC CTSA; Swim Across America; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been funded by NIH grants R01 CA185486 (R.R.), R01 CA179044 (R.R.), U54 CA193313, U54 209997 (R.R.), R01 NS103473 (P.C., J.N.B., P.S.), NSF/SU2C/V-Foundation Ideas Lab Multidisciplinary Team (PHY-1545805) (R.R.), 2018 Stand Up To Cancer Phillip A. Sharp Innovation in Collaboration Awards (R.R.) and Keep Punching Foundation (F.M.I.). Funding support from Northwestern 5DP5OD021356-04 (A.M. Sonabend), P50CA221747 SPORE for Translational Approaches to Brain Cancer (A.M. Sonabend, R.V.L., C.H.). Developmental funds from The Robert H Lurie NCI Cancer Center Support Grant no. P30CA060553 (A.M. Sonabend). A.X.C. is funded by the Medical Scientist Training Program (T32GM007367). R.D.G. is funded by CUIMC CTSA as TL1 Precision Medicine Fellow (1TL1TR001875-01) and Swim Across America.	Abate F, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0097-z; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Arrieta VA, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1445458; Baddeley A, 2015, SPATIAL POINT PATTER; Bedognetti D, 2017, EMERG TOP LIFE SCI, V1, P429, DOI 10.1042/ETLS20170142; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; Deken MA, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238557; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ebert PJR, 2016, IMMUNITY, V44, P609, DOI 10.1016/j.immuni.2016.01.024; Filley AC, 2017, ONCOTARGET, V8, P91779, DOI 10.18632/oncotarget.21586; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gartrell RD, 2018, CANCER IMMUNOL RES, V6, P481, DOI 10.1158/2326-6066.CIR-17-0360; George S, 2017, IMMUNITY, V46, P197, DOI 10.1016/j.immuni.2017.02.001; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin KY, 2007, CANCER RES, V67, P1832, DOI 10.1158/0008-5472.CAN-06-3014; Mooney KL, 2016, J CLIN NEUROSCI, V34, P1, DOI 10.1016/j.jocn.2016.05.012; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Rizvi AH, 2017, NAT BIOTECHNOL, V35, P551, DOI 10.1038/nbt.3854; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S2; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang JG, 2016, NAT GENET, V48, P768, DOI 10.1038/ng.3590; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yao X, 2012, BLOOD, V119, P5688, DOI 10.1182/blood-2011-10-386482; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yuan JZ, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0567-9; Zhang CB, 2017, CLIN CANCER RES, V23, P6279, DOI 10.1158/1078-0432.CCR-16-2598	57	367	371	6	99	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					462	+		10.1038/s41591-019-0349-y	http://dx.doi.org/10.1038/s41591-019-0349-y			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30742119	Green Accepted			2022-12-27	WOS:000460643100025
J	Sahel, JA; Dalkara, D				Sahel, Jose Alain; Dalkara, Deniz			Gene therapy for retinal dystrophy	NATURE MEDICINE			English	Editorial Material									[Sahel, Jose Alain] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Sahel, Jose Alain] Sorbonne Univ, INSERM, CNRS, Inst Vis, Paris, France; [Sahel, Jose Alain] INSERM, DGOS CIC 1423, CHNO Quinze Vingts, DHU Sight Restore, Paris, France; [Dalkara, Deniz] Sorbonne Univ, INSERM, CNRS, Inst Vis, Paris, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Sahel, JA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.; Sahel, JA (corresponding author), Sorbonne Univ, INSERM, CNRS, Inst Vis, Paris, France.; Sahel, JA (corresponding author), INSERM, DGOS CIC 1423, CHNO Quinze Vingts, DHU Sight Restore, Paris, France.	sahelja@upmc.edu	Dalkara, Deniz/D-5057-2017	Dalkara, Deniz/0000-0003-4112-9321				Cideciyan AV, 2019, NAT MED, V25, P225, DOI 10.1038/s41591-018-0295-0; Gao X, 2018, NATURE, V553, P217, DOI 10.1038/nature25164; Maeder ML, 2019, NAT MED, V25, P229, DOI 10.1038/s41591-018-0327-9; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8	5	7	7	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					198	199		10.1038/s41591-019-0346-1	http://dx.doi.org/10.1038/s41591-019-0346-1			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30718907	Green Submitted			2022-12-27	WOS:000457842100010
J	Sharifnia, T; Wawer, MJ; Chen, T; Huang, QY; Weir, BA; Sizemore, A; Lawlor, MA; Goodale, A; Cowley, GS; Vazquez, F; Ott, CJ; Francis, JM; Sassi, S; Cogswell, P; Sheppard, HE; Zhang, TH; Gray, NS; Clarke, PA; Blagg, J; Workman, P; Sommer, J; Hornicek, F; Root, DE; Hahn, WC; Bradner, JE; Wong, KK; Clemons, PA; Lin, CY; Kotz, JD; Schreiber, SL				Sharifnia, Tanaz; Wawer, Mathias J.; Chen, Ting; Huang, Qing-Yuan; Weir, Barbara A.; Sizemore, Ann; Lawlor, Matthew A.; Goodale, Amy; Cowley, Glenn S.; Vazquez, Francisca; Ott, Christopher J.; Francis, Joshua M.; Sassi, Slim; Cogswell, Patricia; Sheppard, Hadley E.; Zhang, Tinghu; Gray, Nathanael S.; Clarke, Paul A.; Blagg, Julian; Workman, Paul; Sommer, Josh; Hornicek, Francis; Root, David E.; Hahn, William C.; Bradner, James E.; Wong, Kwok K.; Clemons, Paul A.; Lin, Charles Y.; Kotz, Joanne D.; Schreiber, Stuart L.			Small-molecule targeting of brachyury transcription factor addiction in chordoma	NATURE MEDICINE			English	Article							READ ALIGNMENT; CANCER; INHIBITION; GROWTH; GENERATION; REGULATOR; ENHANCERS; ONCOGENES; PROFILE; GENES	Chordoma is a primary bone cancer with no approved therapy(1). The identification of therapeutic targets in this disease has been challenging due to the infrequent occurrence of clinically actionable somatic mutations in chordoma tumors(2,3). Here we describe the discovery of therapeutically targetable chordoma dependencies via genome-scale CRISPR-Cas9 screening and focused small-molecule sensitivity profiling. These systematic approaches reveal that the developmental transcription factor T (brachyury; TBXT) is the top selectively essential gene in chordoma, and that transcriptional cyclin-dependent kinase (CDK) inhibitors targeting CDK7/12/13 and CDK9 potently suppress chordoma cell proliferation. In other cancer types, transcriptional CDK inhibitors have been observed to downregulate highly expressed, enhancer-associated oncogenic transcription factors(4,5). In chordoma, we find that T is associated with a 1.5-Mb region containing 'superenhancers' and is the most highly expressed super-enhancer-associated transcription factor. Notably, transcriptional CDK inhibition leads to preferential and concentration-dependent downregulation of cellular brachyury protein levels in all models tested. In vivo, CDK7/12/13-inhibitor treatment substantially reduces tumor growth. Together, these data demonstrate small-molecule targeting of brachyury transcription factor addiction in chordoma, identify a mechanism of T gene regulation that underlies this therapeutic strategy, and provide a blueprint for applying systematic genetic and chemical screening approaches to discover vulnerabilities in genomically quiet cancers.	[Sharifnia, Tanaz; Wawer, Mathias J.; Weir, Barbara A.; Sizemore, Ann; Goodale, Amy; Vazquez, Francisca; Francis, Joshua M.; Root, David E.; Hahn, William C.; Clemons, Paul A.; Kotz, Joanne D.; Schreiber, Stuart L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Chen, Ting; Huang, Qing-Yuan; Wong, Kwok K.] NYU, Langone Med Ctr, New York, NY USA; [Lawlor, Matthew A.; Ott, Christopher J.; Zhang, Tinghu; Gray, Nathanael S.; Hahn, William C.; Bradner, James E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sassi, Slim; Hornicek, Francis] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Sassi, Slim] Harvard Med Sch, Boston, MA USA; [Cogswell, Patricia; Sommer, Josh] Chordoma Fdn, Durham, NC USA; [Sheppard, Hadley E.; Lin, Charles Y.] Baylor Coll Med, Houston, TX 77030 USA; [Clarke, Paul A.; Blagg, Julian; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London, England; [Schreiber, Stuart L.] Harvard Univ, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Huang, Qing-Yuan] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China; [Weir, Barbara A.] Janssen R&D, Cambridge, MA USA; [Sizemore, Ann] Univ Penn, Philadelphia, PA 19104 USA; [Lawlor, Matthew A.; Ott, Christopher J.] Massachusetts Gen Hosp, Charlestown, MA USA; [Cowley, Glenn S.] Janssen R&D, Spring House, PA USA; [Francis, Joshua M.] Gritstone Oncol, Cambridge, MA USA; [Hornicek, Francis] Univ Calif Los Angeles, Med Ctr, Santa Monica, CA USA; [Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA USA; [Kotz, Joanne D.] Jnana Therapeut, Boston, MA 02210 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; NYU Langone Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Howard Hughes Medical Institute; Shanghai Jiao Tong University; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Johnson & Johnson; Janssen Pharmaceuticals; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Novartis	Sharifnia, T; Kotz, JD; Schreiber, SL (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Lin, CY (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Schreiber, SL (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.; Schreiber, SL (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Kotz, JD (corresponding author), Jnana Therapeut, Boston, MA 02210 USA.	tanaz@broadinstitute.org; Charles.Y.Lin@bcm.edu; jkotz@jnanatx.com; stuart_schreiber@harvard.edu	Sommer, Josh/HGA-8789-2022; Vazquez, Francisca/ABC-4620-2020; Huang, Qingyuan/AAC-7164-2019; Vazquez, Francisca/AAA-3751-2020	Vazquez, Francisca/0000-0002-2857-4685; chen, ting/0000-0001-8414-6346; Clarke, Paul/0000-0001-9342-1290; Cowley, Glenn/0000-0002-0526-0616; Chen, Ting/0000-0003-1725-7956; Lawlor, Matthew/0000-0003-0700-5763	Chordoma Foundation; Roye family; Fuchs family; NCI's Cancer Target Discovery and Development (CTD2) Network [U01CA176152/U01CA217848, U01CA176058]; Cancer Prevention Research Institute of Texas [RR150093]; NIH; NCI [1R01CA215452-01]; Cancer Research UK [C2739/A22897]; NATIONAL CANCER INSTITUTE [U01CA176152, U01CA176058, U01CA217848, R01CA215452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Chordoma Foundation; Roye family; Fuchs family; NCI's Cancer Target Discovery and Development (CTD2) Network; Cancer Prevention Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. Vrcic, K. Hartland, S. Figueroa-Lazu, C. Biasetti and J. Santos for assistance with small-molecule sensitivity experiments; members of the Broad Institute Genetic Perturbation Platform for sgRNA library construction and technical assistance with DNA processing after pooled screening; the Histology Core Facility at Ohio State University for immunohistochemistry studies; X. Zhang for guidance with RNA sequencing; L. Gechijian and P. Veeraraghavan for technical and analytical assistance; R. Meyers and A. Cherniack for guidance with copy-number analysis and R. Belizaire, Y. Zou, N. Kwiatkowski, J. Dempster, S. Gill and T. Sundberg for helpful discussions. This work was generously supported by the Chordoma Foundation, the Roye family, the Fuchs family and the NCI's Cancer Target Discovery and Development (CTD<SUP>2</SUP>) Network (grant number U01CA176152/U01CA217848 awarded to S.L.S. and U01CA176058 awarded to W.C.H.). In addition to being supported by the Chordoma Foundation, C.Y.L is supported by the Cancer Prevention Research Institute of Texas (RR150093) and by the NIH and NCI (1R01CA215452-01), and is a Pew-Stewart Scholar for Cancer Research (Alexander and Margaret Stewart Trust). The Institute of Cancer Research authors were funded by Cancer Research UK (Program Grant number C2739/A22897). P.W. is a Cancer Research UK Life Fellow. S.L.S. is an investigator at the Howard Hughes Medical Institute. This paper is dedicated to the memory of Todd Fuchs, whose spirit and perseverance were an inspiration for all involved.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrionuevo F, 2006, DEV BIOL, V295, P128, DOI 10.1016/j.ydbio.2006.03.014; Barry JJ, 2011, NEUROSURGERY, V68, P231, DOI 10.1227/NEU.0b013e3181fd2ac5; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Choy E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101283; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dale T, 2015, NAT CHEM BIOL, V11, P973, DOI 10.1038/nchembio.1952; Dancik V, 2014, J BIOMOL SCREEN, V19, P771, DOI 10.1177/1087057113520226; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Galli GG, 2015, MOL CELL, V60, P328, DOI 10.1016/j.molcel.2015.09.001; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hsu W, 2011, J NEUROSURG, V115, P760, DOI 10.3171/2011.5.JNS11185; Jager D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02174-5; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johannessen L, 2017, NAT CHEM BIOL, V13, P1102, DOI [10.1038/NCHEMBIO.2458, 10.1038/nchembio.2458]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Liu XZ, 2012, J ORTHOP RES, V30, P1666, DOI 10.1002/jor.22113; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Modjtahedi H, 2014, N-S ARCH PHARMACOL, V387, P505, DOI 10.1007/s00210-014-0967-3; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nelson AC, 2012, J PATHOL, V228, P274, DOI 10.1002/path.4082; Palena C, 2007, CLIN CANCER RES, V13, P2471, DOI 10.1158/1078-0432.CCR-06-2353; Pillay N, 2012, NAT GENET, V44, P1185, DOI 10.1038/ng.2419; Presneau N, 2011, J PATHOL, V223, P327, DOI 10.1002/path.2816; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SALISBURY JR, 1993, J PATHOL, V171, P253, DOI 10.1002/path.1711710404; Scheipl S, 2016, J PATHOL, V239, P320, DOI 10.1002/path.4729; Schwab JH, 2009, CANCER IMMUNOL IMMUN, V58, P339, DOI 10.1007/s00262-008-0557-7; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Shah SR, 2017, CELL REP, V21, P495, DOI 10.1016/j.celrep.2017.09.057; Shalaby A, 2011, J PATHOL, V223, P336, DOI 10.1002/path.2818; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharifnia T, 2017, CELL CHEM BIOL, V24, P1075, DOI 10.1016/j.chembiol.2017.08.002; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Stacchiotti S, 2015, LANCET ONCOL, V16, pE71, DOI 10.1016/S1470-2045(14)71190-8; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarpey PS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01026-0; TRASK DK, 1988, P NATL ACAD SCI USA, V85, P1417, DOI 10.1073/pnas.85.5.1417; Tripathy D, 2017, CLIN CANCER RES, V23, P3251, DOI 10.1158/1078-0432.CCR-16-3157; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Yang XHR, 2009, NAT GENET, V41, P1176, DOI 10.1038/ng.454; Zhang TH, 2016, NAT CHEM BIOL, V12, P876, DOI 10.1038/nchembio.2166; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	60	79	84	11	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					292	+		10.1038/s41591-018-0312-3	http://dx.doi.org/10.1038/s41591-018-0312-3			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30664779	Green Accepted			2022-12-27	WOS:000457842100027
J	Brabetz, S; Leary, SES; Grobner, SN; Nakamoto, MW; Seker-Cin, H; Girard, EJ; Cole, B; Strand, AD; Bloom, KL; Hovestadt, V; Mack, NL; Pakiam, F; Schwalm, B; Korshunov, A; Balasubramanian, GP; Northcott, PA; Pedro, KD; Dey, J; Hansen, S; Ditzler, S; Lichter, P; Chavez, L; Jones, DTW; Koster, J; Pfister, SM; Kool, M; Olson, JM				Brabetz, Sebastian; Leary, Sarah E. S.; Groebner, Susanne N.; Nakamoto, Madison W.; Seker-Cin, Huriye; Girard, Emily J.; Cole, Bonnie; Strand, Andrew D.; Bloom, Karina L.; Hovestadt, Volker; Mack, Norman L.; Pakiam, Fiona; Schwalm, Benjamin; Korshunov, Andrey; Balasubramanian, Gnana Prakash; Northcott, Paul A.; Pedro, Kyle D.; Dey, Joyoti; Hansen, Stacey; Ditzler, Sally; Lichter, Peter; Chavez, Lukas; Jones, David T. W.; Koster, Jan; Pfister, Stefan M.; Kool, Marcel; Olson, James M.			A biobank of patient-derived pediatric brain tumor models	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; DNA METHYLATION; MOLECULAR CLASSIFICATION; CELL-LINES; STEM-CELLS; MEDULLOBLASTOMA; SUBGROUPS; TRIAL; XENOGRAFTS; MUTATIONS	Brain tumors are the leading cause of cancer-related death in children. Genomic studies have provided insights into molecular subgroups and oncogenic drivers of pediatric brain tumors that may lead to novel therapeutic strategies. To evaluate new treatments, better preclinical models adequately reflecting the biological heterogeneity are needed. Through the Children's Oncology Group ACNS02B3 study, we have generated and comprehensively characterized 30 patient-derived orthotopic xenograft models and seven cell lines representing 14 molecular subgroups of pediatric brain tumors. Patient-derived orthotopic xenograft models were found to be representative of the human tumors they were derived from in terms of histology, immunohistochemistry, gene expression, DNA methylation, copy number, and mutational profiles. In vivo drug sensitivity of targeted therapeutics was associated with distinct molecular tumor subgroups and specific genetic alterations. These models and their molecular characterization provide an unprecedented resource for the cancer community to study key oncogenic drivers and to evaluate novel treatment strategies.	[Brabetz, Sebastian; Groebner, Susanne N.; Mack, Norman L.; Schwalm, Benjamin; Balasubramanian, Gnana Prakash; Chavez, Lukas; Jones, David T. W.; Pfister, Stefan M.; Kool, Marcel] NCT Heidelberg KiTZ, Hopp Childrens Canc Ctr, Heidelberg, Germany; [Brabetz, Sebastian; Groebner, Susanne N.; Seker-Cin, Huriye; Mack, Norman L.; Schwalm, Benjamin; Balasubramanian, Gnana Prakash; Northcott, Paul A.; Chavez, Lukas; Jones, David T. W.; Pfister, Stefan M.; Kool, Marcel] German Canc Res Ctr, Div Pediat Neurooncol, German Canc Consortium DKTK, Heidelberg, Germany; [Brabetz, Sebastian] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Leary, Sarah E. S.; Cole, Bonnie; Olson, James M.] Seattle Childrens, Seattle, WA 98105 USA; [Leary, Sarah E. S.; Cole, Bonnie; Olson, James M.] Univ Washington, Seattle, WA 98195 USA; [Leary, Sarah E. S.; Nakamoto, Madison W.; Girard, Emily J.; Strand, Andrew D.; Bloom, Karina L.; Pakiam, Fiona; Pedro, Kyle D.; Dey, Joyoti; Hansen, Stacey; Ditzler, Sally; Olson, James M.] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA; [Hovestadt, Volker; Mack, Norman L.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, German Canc Consortium DKTK, Heidelberg, Germany; [Hovestadt, Volker] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hovestadt, Volker] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Hovestadt, Volker] Harvard Med Sch, Boston, MA USA; [Hovestadt, Volker] Broad Inst MIT & Harvard, Cambridge, MA USA; [Korshunov, Andrey] German Canc Res Ctr, CCU Neuropathol, Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, Heidelberg, Germany; [Northcott, Paul A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Koster, Jan] Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands; [Pfister, Stefan M.] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Dey, Joyoti] Presage Biosci, Seattle, WA USA; [Chavez, Lukas] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet, La Jolla, CA 92093 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; St Jude Children's Research Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Ruprecht Karls University Heidelberg; University of California System; University of California San Diego	Pfister, SM; Kool, M (corresponding author), NCT Heidelberg KiTZ, Hopp Childrens Canc Ctr, Heidelberg, Germany.; Pfister, SM; Kool, M (corresponding author), German Canc Res Ctr, Div Pediat Neurooncol, German Canc Consortium DKTK, Heidelberg, Germany.; Olson, JM (corresponding author), Seattle Childrens, Seattle, WA 98105 USA.; Olson, JM (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Olson, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA.; Pfister, SM (corresponding author), Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany.	s.pfister@kitz-heidelberg.de; m.kool@kitz-heidelberg.de; jolson@fredhutch.org	Northcott, Paul A/N-4022-2018; Hovestadt, Volker/ABG-2076-2021; Koster, Jan/C-5934-2008; Jones, David T. W./Z-1963-2019; Pfister, Stefan M/F-6860-2013	Northcott, Paul A/0000-0002-1220-5252; Hovestadt, Volker/0000-0002-3480-6649; Koster, Jan/0000-0002-0890-7585; Pfister, Stefan M/0000-0002-5447-5322; Chavez, Lukas/0000-0002-8718-8848; Girard, Emily/0000-0003-1857-0194; Korshunov, Andrey/0000-0002-5257-3623; Pedro, Kyle/0000-0001-6799-671X	NIH [1U10CA180886-01, 1R01CA155360, R01 CA114567]; Seattle Run of Hope; Seattle Children's Brain Tumor Research Endowment; Dutch Cancer Foundation KWF [2010-4713]; Dutch Cancer Foundation KIKA [90]; Deutsche Krebshilfe [111537]; BMBF [01KT1605]; Helmholtz International Graduate School for Cancer Research; IMI-JUITCC-P4 [116064]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seattle Run of Hope; Seattle Children's Brain Tumor Research Endowment; Dutch Cancer Foundation KWF(KWF Kankerbestrijding); Dutch Cancer Foundation KIKA; Deutsche Krebshilfe(Deutsche Krebshilfe); BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz International Graduate School for Cancer Research; IMI-JUITCC-P4	We are grateful to the patients and families who consented to provide tissue to generate these resources. We thank A. Richards, M. Merrill, D. Acorn, M. Biery, A. Wittmann, and L. Sieber for experimental contributions. We thank the DKFZ Genomics and Proteomics Core Facility, DKFZ Heidelberg, Germany, and the AMC Department of Oncogenomics, Amsterdam, The Netherlands, for performing high-throughput sequencing and microarray analyses to a very high standard. We also thank the DKFZ data management group, especially I. Scholz, for their excellent support in processing the sequencing data, and Z. Gu for the defuse pipeline. We thank X.-N. Li, R. J. Wechsler-Reya, and T. Milde for allowing us to list their PDOX lines on our websites. This work was supported by NIH 1U10CA180886-01 (J.M.O.), NIH 1R01CA155360 (J.M.O.), NIH R01 CA114567 (J.M.O.), the Seattle Run of Hope, the Seattle Children's Brain Tumor Research Endowment, the Dutch Cancer Foundations KWF (2010-4713) (M.K.) and KIKA (90) (M.K.), Deutsche Krebshilfe (111537) (S.M.P., M.K.), BMBF (01KT1605) (S.M.P., M.K.), IMI-JUITCC-P4 (116064) (D.T.W.J., J.K., S.M.P., M.K.), and the Helmholtz International Graduate School for Cancer Research (S.B.).	Biegel Jaclyn A, 2006, Neurosurg Focus, V20, pE11; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Callari M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4414-y; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gajjar A, 2014, CLIN CANCER RES, V20, P5630, DOI 10.1158/1078-0432.CCR-14-0833; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gilbertson RJ, 2006, CELL CYCLE, V5, P135, DOI 10.4161/cc.5.2.2319; GOLDENBERG DM, 1982, P NATL ACAD SCI-BIOL, V79, P2389, DOI 10.1073/pnas.79.7.2389; Goodspeed A, 2016, MOL CANCER RES, V14, P3, DOI 10.1158/1541-7786.MCR-15-0189; Grasso CS, 2015, NAT MED, V21, P827, DOI 10.1038/nm0715-827a; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hovestadt V, 2013, ACTA NEUROPATHOL, V125, P913, DOI 10.1007/s00401-013-1126-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johann PD, 2016, CANCER CELL, V29, P379, DOI 10.1016/j.ccell.2016.02.001; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kilday JP, 2012, CLIN CANCER RES, V18, P2001, DOI 10.1158/1078-0432.CCR-11-2489; Korshunov A, 2017, ACTA NEUROPATHOL, V134, P507, DOI 10.1007/s00401-017-1710-1; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057708; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mackay A, 2017, CANCER CELL, V32, P520, DOI 10.1016/j.ccell.2017.08.017; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Pajtler KW, 2018, ACTA NEUROPATHOL, V136, P211, DOI 10.1007/s00401-018-1877-0; Pajtler KW, 2017, ACTA NEUROPATHOL, V133, P5, DOI 10.1007/s00401-016-1643-0; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Peereboom DM, 2010, J NEURO-ONCOL, V98, P93, DOI 10.1007/s11060-009-0067-2; Pei YX, 2016, CANCER CELL, V29, P311, DOI 10.1016/j.ccell.2016.02.011; Raizer JJ, 2016, J NEURO-ONCOL, V126, P185, DOI 10.1007/s11060-015-1958-z; Ramaswamy V, 2016, NEURO-ONCOLOGY, V18, P291, DOI 10.1093/neuonc/nou357; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sangar MLC, 2017, CLIN CANCER RES, V23, P5802, DOI 10.1158/1078-0432.CCR-16-2943; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Shih DJH, 2014, J CLIN ONCOL, V32, P886, DOI 10.1200/JCO.2013.50.9539; Shou Y, 2015, CLIN CANCER RES, V21, P585, DOI 10.1158/1078-0432.CCR-13-1711; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spiller SE, 2008, J NEURO-ONCOL, V87, P133, DOI 10.1007/s11060-007-9505-1; Stewart E, 2017, NATURE, V549, P96, DOI 10.1038/nature23647; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Torchia J, 2016, CANCER CELL, V30, P891, DOI 10.1016/j.ccell.2016.11.003; Townsend EC, 2016, CANCER CELL, V30, P183, DOI 10.1016/j.ccell.2016.06.008; Triviai I, 2014, P NATL ACAD SCI USA, V111, P8595, DOI 10.1073/pnas.1401215111; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; WANG K, 2010, NUCLEIC ACIDS RES, V38; Wen PY, 2014, NEURO-ONCOLOGY, V16, P567, DOI 10.1093/neuonc/not247; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zhao XM, 2012, NEURO-ONCOLOGY, V14, P574, DOI 10.1093/neuonc/nos061	66	73	73	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1752	+		10.1038/s41591-018-0207-3	http://dx.doi.org/10.1038/s41591-018-0207-3			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30349086				2022-12-27	WOS:000449404200028
J	Johnson, DC; Taabazuing, CY; Okondo, MC; Chui, AJ; Rao, SD; Brown, FC; Reed, C; Peguero, E; de Stanchina, E; Kentsis, A; Bachovchin, DA				Johnson, Darren C.; Taabazuing, Cornelius Y.; Okondo, Marian C.; Chui, Ashley J.; Rao, Sahana D.; Brown, Fiona C.; Reed, Casie; Peguero, Elizabeth; de Stanchina, Elisa; Kentsis, Alex; Bachovchin, Daniel A.			DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia	NATURE MEDICINE			English	Article							DIPEPTIDYL PEPTIDASE-IV; CASPASE-1 AUTOPROTEOLYSIS; POTENT; INFLAMMASOME; CANCER; HEMATOPOIESIS; ISOINDOLINE; TALABOSTAT; EXPRESSION; APOPTOSIS	Small-molecule inhibitors of the serine dipeptidases DPP8 and DPP9 (DPP8/9) induce a lytic form of cell death called pyroptosis in mouse and human monocytes and macrophages(1,2). In mouse myeloid cells, Dpp8/9 inhibition activates the inflammasome sensor NIrp1b, which in turn activates pro-caspase-1 to mediate cell death(3) , but the mechanism of DPP8/9 inhibitor-induced pyroptosis in human myeloid cells is not yet known. Here we show that the CARD-containing protein CARD8 mediates DPP8/9 inhibitor-induced procaspase-1-dependent pyroptosis in human myeloid cells. We further show that DPP8/9 inhibitors induce pyroptosis in the majority of human acute myeloid leukemia (AML) cell lines and primary AML samples, but not in cells from many other lineages, and that these inhibitors inhibit human AML progression in mouse models. Overall, this work identifies an activator of CARD8 in human cells and indicates that its activation by small-molecule DPP8/9 inhibitors represents a new potential therapeutic strategy for AML.	[Johnson, Darren C.; Chui, Ashley J.; Rao, Sahana D.; Kentsis, Alex; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA; [Taabazuing, Cornelius Y.; Okondo, Marian C.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA; [Brown, Fiona C.; Reed, Casie; Kentsis, Alex] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Peguero, Elizabeth; de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Facil, 1275 York Ave, New York, NY 10021 USA; [Kentsis, Alex] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Kentsis, Alex; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Pharmacol Program, Weill Cornell Grad Sch Med Sci, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Pharmacol Program, Weill Cornell Grad Sch Med Sci, 1275 York Ave, New York, NY 10021 USA.	bachovcd@mskcc.org		Okondo, Marian/0000-0003-0065-8155; Chui, Ashley/0000-0003-0037-5761; Rao, Sahana/0000-0003-4592-8921; Kentsis, Alex/0000-0002-8063-9191; Johnson, Darren/0000-0002-0858-6152	Josie Robertson Foundation; Stand Up to Cancer-Innovative Research Grant (American Association for Cancer Research, the scientific partner of SU2C) [SU2C-AACR-IRG11-17]; Pew Charitable Trusts; NIH [R01 AI137168, R21 CA188881, R01 CA204396, T32 GM115327]; NIH (MSKCC Core Grant) [P30 CA008748]; American Cancer Society [PF-17-224-01 - CCG]; Borroughs Wellcome Fund; Alex's Lemonade Stand Foundation; Gabrielle's Angel Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA204396, R21CA188881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM115327] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	Josie Robertson Foundation; Stand Up to Cancer-Innovative Research Grant (American Association for Cancer Research, the scientific partner of SU2C); Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (MSKCC Core Grant); American Cancer Society(American Cancer Society); Borroughs Wellcome Fund; Alex's Lemonade Stand Foundation; Gabrielle's Angel Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Monette for histology advice, and W. Bachovchin, W. Wu and J. Lai (Tufts University, USA) for Val-boroPro, 1G244, 8j and L-allo-Ile-isoindoline. This work was supported by the Josie Robertson Foundation (D.A.B. and A.K.), a Stand Up to Cancer-Innovative Research Grant (grant number SU2C-AACR-IRG11-17 to D.A.B.; Stand Up to Cancer is a program of the Entertainment Industry Foundation; research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C), the Pew Charitable Trusts (D.A.B. is a Pew-Stewart Scholar in Cancer Research), the NIH (R01 AI137168 to D.A.B.; R21 CA188881 and R01 CA204396 to A.K.; T32 GM115327-Tan to D.C.J.; the MSKCC Core Grant P30 CA008748), the American Cancer Society (Postdoctoral Fellowship PF-17-224-01 - CCG to C.Y.T.), Borroughs Wellcome Fund (A.K.), Alex's Lemonade Stand Foundation (A.K.), Gabrielle's Angel Foundation (A.K.) and the Damon Runyon Cancer Research Foundation (A.K. is the Damon Runyon-Richard Lumsden Foundation Clinical Investigator).	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]; Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coutts SJ, 1996, J MED CHEM, V39, P2087, DOI 10.1021/jm950732f; Cunningham CC, 2007, EXPERT OPIN INV DRUG, V16, P1459, DOI 10.1517/13543784.16.9.1459; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Eager RM, 2009, CLIN ONCOL-UK, V21, P464, DOI 10.1016/j.clon.2009.04.007; Eager RM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-263; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guey B, 2014, P NATL ACAD SCI USA, V111, P17254, DOI 10.1073/pnas.1415756111; Jiaang WT, 2005, BIOORG MED CHEM LETT, V15, P687, DOI 10.1016/j.bmcl.2004.11.023; Khwaja A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.10; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Spagnuolo PA, 2013, LEUKEMIA, V27, P1236, DOI 10.1038/leu.2013.9; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Van Goethem S, 2008, BIOORG MED CHEM LETT, V18, P4159, DOI 10.1016/j.bmcl.2008.05.079; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Wagner L, 2016, CLIN EXP IMMUNOL, V184, P265, DOI 10.1111/cei.12757; Walsh MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058860; Wang K, 2017, LEUKEMIA, V31, P151, DOI 10.1038/leu.2016.166; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Zhang H, 2013, MOL CANCER RES, V11, P1487, DOI 10.1158/1541-7786.MCR-13-0272	37	150	155	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1151	+		10.1038/s41591-018-0082-y	http://dx.doi.org/10.1038/s41591-018-0082-y			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29967349	Green Accepted			2022-12-27	WOS:000440955500021
J	Vakulskas, CA; Dever, DP; Rettig, GR; Turk, R; Jacobi, AM; Collingwood, MA; Bode, NM; McNeill, MS; Yan, SQ; Camarena, J; Lee, CM; Parka, SH; Wiebking, V; Bak, RO; Gomez-Ospina, N; Pavel-Dinu, M; Sun, WC; Bao, G; Porteus, MH; Behlke, MA				Vakulskas, Christopher A.; Dever, Daniel P.; Rettig, Garrett R.; Turk, Rolf; Jacobi, Ashley M.; Collingwood, Michael A.; Bode, Nicole M.; McNeill, Matthew S.; Yan, Shuqi; Camarena, Joab; Lee, Ciaran M.; Parka, So Hyun; Wiebking, Volker; Bak, Rasmus O.; Gomez-Ospina, Natalia; Pavel-Dinu, Mara; Sun, Wenchao; Bao, Gang; Porteus, Matthew H.; Behlke, Mark A.			A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells	NATURE MEDICINE			English	Article							OFF-TARGET; MARROW TRANSPLANTATION; CRISPR-CAS9 NUCLEASES; MESSENGER-RNA; BONE-MARROW; T-CELLS; GENOME; CRISPR/CAS9; INTEGRATION; MUTATION	Translation of the CRISPR-Cas9 system to human therapeutics holds high promise. However, specificity remains a concern especially when modifying stem cell populations. We show that existing rationally engineered Cas9 high-fidelity variants have reduced on-target activity when using the therapeutically relevant ribonucleoprotein (RNP) delivery method. Therefore, we devised an unbiased bacterial screen to isolate variants that retain activity in the RNP format. Introduction of a single point mutation, p.R691A, in Cas9 (high-fidelity (HiFi) Cas9) retained the high on-target activity of Cas9 while reducing off-target editing. HiFi Cas9 induces robust AAV6-mediated gene targeting at five therapeutically relevant loci (HBB,IL2RG, CCRS, HEXB, and TRAC) in human CD34(+) hematopoietic stem and progenitor cells (HSPCs) as well as primary T cells. We also show that HiFi Cas9 mediates high-level correction of the sickle cell disease (SCD)-causing p.E6V mutation in HSPCs derived from patients with SCD. We anticipate that HiFi Cas9 will have wide utility for both basic science and therapeutic genome-editing applications.	[Vakulskas, Christopher A.; Rettig, Garrett R.; Turk, Rolf; Jacobi, Ashley M.; Collingwood, Michael A.; Bode, Nicole M.; McNeill, Matthew S.; Yan, Shuqi; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA 52241 USA; [Dever, Daniel P.; Camarena, Joab; Wiebking, Volker; Gomez-Ospina, Natalia; Pavel-Dinu, Mara; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Lee, Ciaran M.; Parka, So Hyun; Bao, Gang] Rice Univ, Dept Bioengn, Houston, TX USA; [Bak, Rasmus O.] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Bak, Rasmus O.] Aarhus Univ, AIAS, Aarhus, Denmark; [Sun, Wenchao] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Palo Alto, CA 94304 USA	Stanford University; Rice University; Aarhus University; Aarhus University; Stanford University	Behlke, MA (corresponding author), Integrated DNA Technol Inc, Coralville, IA 52241 USA.; Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	mporteus@stanford.edu; mbehlke@idtdna.com	Bak, Rasmus O./AAH-9748-2021; Sun, Wenchao/H-7738-2017; Lee, Ciaran Michael/AAV-4690-2020; Turk, Rolf/E-7832-2010	Bak, Rasmus O./0000-0002-7383-0297; Sun, Wenchao/0000-0003-4306-2896; Lee, Ciaran Michael/0000-0002-0789-9149; Turk, Rolf/0000-0003-1283-9594; Jacobi, Ashley/0000-0002-9364-6518; Vakulskas, Christopher/0000-0001-8510-4332; Yan, Shuqi/0000-0002-6537-4906; Behlke, Mark/0000-0002-4218-857X; Collingwood, Michael/0000-0002-8849-4038; Camarena, Joab/0000-0002-3102-5820; Gomez-Ospina, Natalia/0000-0002-6740-1154; Wiebking, Volker/0000-0002-9429-5254; Bode, Nicole/0000-0001-7209-303X; Rettig, Garrett/0000-0003-4634-5787	Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; NIH [R01-AI097320, R01-AI120766]; Cancer Prevention and Research Institute of Texas [RR14008, RP170721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097320, R01AI120766] Funding Source: NIH RePORTER	Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Mantri for collecting and purifying the HSPCs. We thank K. Lennox for critical review of the manuscript. The Band3 APC antibody was a kind gift from A. Narla and M. Narla (Stanford University). M.H.P. gratefully acknowledges the support of the Amon Carter Foundation, the Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research and NIH grant support R01-AI097320 and R01-AI120766. G.B. acknowledges support from the Cancer Prevention and Research Institute of Texas (RR14008 and RP170721). We thank the Binns Program for Cord Blood Research at Stanford University for cord-blood-derived CD34<SUP>+</SUP> HSPCs and also for SCD-HSPCs. Patients with SCD consented to the use of CD34<SUP>+</SUP> HSPCs for research with the accompanying IRB approval.	Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Bak RO, 2017, ELIFE, V6, DOI 10.7554/eLife.27873.001; Bak RO, 2017, CELL REP, V20, P750, DOI 10.1016/j.celrep.2017.06.064; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cameron P, 2017, NAT METHODS, V14, P600, DOI [10.1038/nmeth.4284, 10.1038/NMETH.4284]; Casini A, 2018, NAT BIOTECHNOL, V36, P265, DOI 10.1038/nbt.4066; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Chen ZL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni148; Chicaybam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060298; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.64; Dagdas YS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao0027; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2017, CURR OPIN HEMATOL, V24, P481, DOI 10.1097/MOH.0000000000000385; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dulmovits BM, 2016, BLOOD, V127, P1481, DOI 10.1182/blood-2015-09-667923; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; GATTI RA, 1968, LANCET, V2, P1366; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Gundry MC, 2017, EXP HEMATOL, V54, P4, DOI 10.1016/j.exphem.2017.07.006; Gundry MC, 2016, CELL REP, V17, P1453, DOI 10.1016/j.celrep.2016.09.092; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Haldimann A, 1998, J BACTERIOL, V180, P1277, DOI 10.1128/JB.180.5.1277-1286.1998; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, MOL THER, V24, P1561, DOI 10.1038/mt.2016.148; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jacobi AM, 2017, METHODS, V121, P16, DOI 10.1016/j.ymeth.2017.03.021; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JOHNSON FL, 1984, NEW ENGL J MED, V311, P780, DOI 10.1056/NEJM198409203111207; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lennox KA, 2017, METHODS MOL BIOL, V1517, P51, DOI 10.1007/978-1-4939-6563-2_3; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; LUCARELLI G, 1984, EXP HEMATOL, V12, P676; MacLeod DT, 2017, MOL THER, V25, P949, DOI 10.1016/j.ymthe.2017.02.005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Miller JB, 2017, ANGEW CHEM INT EDIT, V56, P1059, DOI 10.1002/anie.201610209; Munteanu B, 2012, J ZHEJIANG UNIV-SC B, V13, P244, DOI 10.1631/jzus.B1100180; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Osborn MJ, 2016, MOL THER, V24, P570, DOI 10.1038/mt.2015.197; Packer MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01055-9; Porteus MH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0859-y; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schiroli G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0820; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang M, 2016, P NATL ACAD SCI USA, V113, P2868, DOI 10.1073/pnas.1520244113; Williams M, 2002, ENVIRON MOL MUTAGEN, V39, P22, DOI 10.1002/em.10040; Yin H, 2017, NAT BIOTECHNOL, V35, P1179, DOI 10.1038/nbt.4005	73	346	356	7	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1216	+		10.1038/s41591-018-0137-0	http://dx.doi.org/10.1038/s41591-018-0137-0			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082871	Green Accepted, Green Submitted			2022-12-27	WOS:000440955500027
J	Molina, JR; Sun, YT; Protopopova, M; Gera, S; Bandi, M; Bristow, C; McAfoos, T; Morlacchi, P; Ackroyd, J; Agip, ANA; Al-Atrash, G; Asara, J; Bardenhagen, J; Carrillo, CC; Carroll, C; Chang, E; Ciurea, S; Cross, JB; Czako, B; Deem, A; Daver, N; de Groot, JF; Dong, JW; Feng, NP; Gao, G; Gay, J; Do, MG; Greer, J; Giuliani, V; Han, J; Han, LN; Henry, VK; Hirst, J; Huang, S; Jiang, YY; Kang, ZJ; Khor, T; Konoplev, S; Lin, YH; Liu, G; Lodi, A; Lofton, T; Ma, H; Mahendra, M; Matre, P; Mullinax, R; Peoples, M; Petrocchi, A; Rodriguez-Canale, J; Serreli, R; Shi, T; Smith, M; Tabe, Y; Theroff, J; Tiziani, S; Xu, QY; Zhang, Q; Muller, F; DePinho, RA; Toniatti, C; Draetta, GF; Heffernan, TP; Konopleva, M; Jones, P; Di Francesco, ME; Marszalek, JR				Molina, Jennifer R.; Sun, Yuting; Protopopova, Marina; Gera, Sonal; Bandi, Madhavi; Bristow, Christopher; McAfoos, Timothy; Morlacchi, Pietro; Ackroyd, Jeffrey; Agip, Ahmed-Noor A.; Al-Atrash, Gheath; Asara, John; Bardenhagen, Jennifer; Carrillo, Caroline C.; Carroll, Christopher; Chang, Edward; Ciurea, Stefan; Cross, Jason B.; Czako, Barbara; Deem, Angela; Daver, Naval; de Groot, John Frederick; Dong, Jian-Wen; Feng, Ningping; Gao, Guang; Gay, Jason; Do, Mary Geck; Greer, Jennifer; Giuliani, Virginia; Han, Jing; Han, Lina; Henry, Verlene K.; Hirst, Judy; Huang, Sha; Jiang, Yongying; Kang, Zhijun; Khor, Tin; Konoplev, Sergej; Lin, Yu-Hsi; Liu, Gang; Lodi, Alessia; Lofton, Timothy; Ma, Helen; Mahendra, Mikhila; Matre, Polina; Mullinax, Robert; Peoples, Michael; Petrocchi, Alessia; Rodriguez-Canale, Jaime; Serreli, Riccardo; Shi, Thomas; Smith, Melinda; Tabe, Yoko; Theroff, Jay; Tiziani, Stefano; Xu, Quanyun; Zhang, Qi; Muller, Florian; DePinho, Ronald A.; Toniatti, Carlo; Draetta, Giulio F.; Heffernan, Timothy P.; Konopleva, Marina; Jones, Philip; Di Francesco, M. Emilia; Marszalek, Joseph R.			An inhibitor of oxidative phosphorylation exploits cancer vulnerability	NATURE MEDICINE			English	Article							AFFECTED PATIENT FIBROBLASTS; NADH-QUINONE OXIDOREDUCTASE; MITOCHONDRIAL COMPLEX I; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; PHOSPHOGLUCOSE ISOMERASE; RESPIRATORY-CHAIN; GALACTOSE MEDIUM; SCREENING-TEST; BAY 87-2243	Metabolic reprograming is an emerging hallmark of tumor biology and an actively pursued opportunity in discovery of oncology drugs. Extensive efforts have focused on therapeutic targeting of glycolysis, whereas drugging mitochondrial oxidative phosphorylation (OXPHOS) has remained largely unexplored, partly owing to an incomplete understanding of tumor contexts in which OXPHOS is essential. Here, we report the discovery of IACS-010759, a clinical-grade small-molecule inhibitor of complex I of the mitochondrial electron transport chain. Treatment with IACS-010759 robustly inhibited proliferation and induced apoptosis in models of brain cancer and acute myeloid leukemia (AML) reliant on OXPHOS, likely owing to a combination of energy depletion and reduced aspartate production that leads to impaired nucleotide biosynthesis. In models of brain cancer and AML, tumor growth was potently inhibited in vivo following IACS-010759 treatment at well-tolerated doses. IACS-010759 is currently being evaluated in phase 1 clinical trials in relapsed/refractory AML and solid tumors.	[Molina, Jennifer R.; Sun, Yuting; Protopopova, Marina; Gera, Sonal; Bandi, Madhavi; Bristow, Christopher; McAfoos, Timothy; Morlacchi, Pietro; Bardenhagen, Jennifer; Carroll, Christopher; Chang, Edward; Cross, Jason B.; Czako, Barbara; Deem, Angela; Feng, Ningping; Gao, Guang; Gay, Jason; Do, Mary Geck; Greer, Jennifer; Giuliani, Virginia; Han, Jing; Huang, Sha; Jiang, Yongying; Kang, Zhijun; Khor, Tin; Liu, Gang; Lofton, Timothy; Mahendra, Mikhila; Mullinax, Robert; Peoples, Michael; Petrocchi, Alessia; Shi, Thomas; Smith, Melinda; Theroff, Jay; Xu, Quanyun; Toniatti, Carlo; Draetta, Giulio F.; Heffernan, Timothy P.; Jones, Philip; Di Francesco, M. Emilia; Marszalek, Joseph R.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Molina, Jennifer R.; Sun, Yuting; Protopopova, Marina; Gera, Sonal; Bandi, Madhavi; Bristow, Christopher; Chang, Edward; Deem, Angela; Feng, Ningping; Gao, Guang; Gay, Jason; Giuliani, Virginia; Khor, Tin; Mahendra, Mikhila; Mullinax, Robert; Peoples, Michael; Shi, Thomas; Smith, Melinda; Toniatti, Carlo; Draetta, Giulio F.; Heffernan, Timothy P.; Marszalek, Joseph R.] Univ Texas MD Anderson Canc Ctr, Ctr Coclin Trials, Houston, TX 77030 USA; [Ackroyd, Jeffrey; Lin, Yu-Hsi; Muller, Florian] Univ Texas MD Canc Ctr, Dept Canc Imaging Syst, Houston, TX USA; [Agip, Ahmed-Noor A.; Hirst, Judy; Serreli, Riccardo] Univ Cambridge, Mitochondrial Biol Unit, MRC, Wellcome Trust MRC Bldg,Cambridge Biomed Campus, Cambridge, England; [Al-Atrash, Gheath; Ciurea, Stefan] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Asara, John] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Carrillo, Caroline C.; de Groot, John Frederick; Dong, Jian-Wen; Henry, Verlene K.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Daver, Naval; Han, Lina; Ma, Helen; Matre, Polina; Tabe, Yoko; Zhang, Qi; Konopleva, Marina] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Konoplev, Sergej] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Lodi, Alessia; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Rodriguez-Canale, Jaime] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Tabe, Yoko] Juntendo Univ, Sch Med, Dept Lab Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Morlacchi, Pietro] Agilent Technol, Lexington, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; Juntendo University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Agilent Technologies	Marszalek, JR (corresponding author), Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA.; Marszalek, JR (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Coclin Trials, Houston, TX 77030 USA.	jrmarszalek@mdanderson.org	Mahendra, Mikhila/AEC-6580-2022; Gera, Sonal/ABC-6528-2021; Cross, Jason/AAW-6491-2021; Hirst, Judy/F-4803-2011	Mahendra, Mikhila/0000-0001-6670-6792; Hirst, Judy/0000-0001-8667-6797; Toniatti, Carlo/0000-0001-9493-344X; Gera, Sonal/0000-0003-4210-8311; DePinho, Ronald/0000-0002-5625-577X; Alatrash, Gheath/0000-0002-7648-4377; Muller, Florian/0000-0001-7568-2948	Center for Co-Clinical Trials, Institute for Applied Cancer Science; Glioblastoma (GBM); AML/MDS Moon Shots; Agilent Technologies Thought Leader Award; Medical Research Council [MC U105663141, MC UU 00015/2]; CPRIT grant [RP140218, RP140612]; National Institutes of Health (NIH) Brain SPORE [P50CA127001]; American Association for Cancer Research (AACR) [14-90-25]; Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Grant; Leukemia & Lymphoma Society through its Therapy Acceleration Program (TAP); MD Anderson Moon Shots program;  [RSG1514501CDD]; MRC [MC_U105663141, MC_UU_00015/2] Funding Source: UKRI	Center for Co-Clinical Trials, Institute for Applied Cancer Science; Glioblastoma (GBM); AML/MDS Moon Shots; Agilent Technologies Thought Leader Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CPRIT grant; National Institutes of Health (NIH) Brain SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research (AACR); Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Grant; Leukemia & Lymphoma Society through its Therapy Acceleration Program (TAP); MD Anderson Moon Shots program; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the Center for Co-Clinical Trials, Institute for Applied Cancer Science, the Glioblastoma (GBM) and AML/MDS Moon Shots for intellectual and financial support. We would especially like to express our gratitude and appreciation to C. Vellano for his help editing and assembling this manuscript; F. F. Lang and J. Gumin for providing GSC models; C. Kingsley and the MDACC Small Animals Imaging Facility; and N. Satani and E. Lin for validation of antibodies and preparation of samples for analysis, D. Bigner for D423 cells and D. N. Louis for Gli56 cells. P.Mo. was supported by The Agilent Technologies Thought Leader Award. R.A.D., A.-N.A.A., R.S., and J.Hi. were supported by The Medical Research Council (MC U105663141 and MC UU 00015/2 to J.Hi.). M.K., S.T., A.L., P.Ma., H.M., and Q.Z. were supported by CPRIT grant RP140218. F.L.M. was supported by the CPRIT RP140612 and National Institutes of Health (NIH) Brain SPORE P50CA127001, and A.C.S. was supported by the Research Scholar Grant RSG1514501CDD. G.F.D. was supported by the American Association for Cancer Research (AACR) 14-90-25 and by the Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Grant. This work was supported in part by the Leukemia & Lymphoma Society through its Therapy Acceleration Program (TAP) and by the MD Anderson Moon Shots program.	Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boultwood J, 1996, BRIT J HAEMATOL, V95, P426, DOI 10.1046/j.1365-2141.1996.d01-1922.x; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chang E, 2015, CLIN CANCER RES, V21, P335, DOI 10.1158/1078-0432.CCR-14-0217; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; Ellinghaus P, 2013, CANCER MED-US, V2, P611, DOI 10.1002/cam4.112; FDA, 2005, GUID IND EST MAX SAF; GAITONDE MK, 1989, J NEUROCHEM, V52, P1348, DOI 10.1111/j.1471-4159.1989.tb09178.x; Goto M, 2014, CANCER INVEST, V32, P241, DOI 10.3109/07357907.2014.907419; Goto M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-76; Griss T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002309; Hao WS, 2010, J BIOL CHEM, V285, P12647, DOI 10.1074/jbc.M109.084194; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Jeffery CJ, 2001, BIOCHEMISTRY-US, V40, P1560, DOI 10.1021/bi0018483; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krebs H A, 1972, Essays Biochem, V8, P1; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonard PG, 2016, NAT CHEM BIOL, V12, P1053, DOI [10.1038/NCHEMBIO.2195, 10.1038/nchembio.2195]; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li SH, 2008, MOL CANCER THER, V7, P3729, DOI 10.1158/1535-7163.MCT-08-0074; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; PETROVABENEDICT R, 1992, J INHERIT METAB DIS, V15, P943, DOI 10.1007/BF01800243; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Sanchez M, 2008, TOXICOL SCI, V104, P352, DOI 10.1093/toxsci/kfn092; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Schockel L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0138-0; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408; Sukhatme VP, 2012, FEBS LETT, V586, P2389, DOI 10.1016/j.febslet.2012.05.052; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun Y, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-20; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	56	384	394	11	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1036	+		10.1038/s41591-018-0052-4	http://dx.doi.org/10.1038/s41591-018-0052-4			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892070	Green Submitted			2022-12-27	WOS:000438187700032
J	Sanders, SJ; Sahin, M; Hostyk, J; Thurm, A; Jacquemont, S; Avillach, P; Douard, E; Martin, CL; Modi, ME; Moreno-De-Luca, A; Raznahan, A; Anticevic, A; Dolmetsch, R; Feng, GP; Geschwind, DH; Glahn, DC; Goldstein, DB; Ledbetter, DH; Mulle, JG; Pasca, SP; Samaco, R; Sebat, J; Pariser, A; Lehner, T; Gur, RE; Bearden, CE				Sanders, Stephan J.; Sahin, Mustafa; Hostyk, Joseph; Thurm, Audrey; Jacquemont, Sebastien; Avillach, Paul; Douard, Elise; Martin, Christa L.; Modi, Meera E.; Moreno-De-Luca, Andres; Raznahan, Armin; Anticevic, Alan; Dolmetsch, Ricardo; Feng, Guoping; Geschwind, Daniel H.; Glahn, David C.; Goldstein, David B.; Ledbetter, David H.; Mulle, Jennifer G.; Pasca, Sergiu P.; Samaco, Rodney; Sebat, Jonathan; Pariser, Anne; Lehner, Thomas; Gur, Raquel E.; Bearden, Carrie E.			A framework for the investigation of rare genetic disorders in neuropsychiatry	NATURE MEDICINE			English	Article							DE-NOVO MUTATIONS; AUTISM SPECTRUM DISORDER; RESEARCH DOMAIN CRITERIA; COPY NUMBER VARIATIONS; PSYCHIATRIC-DISORDERS; ANIMAL-MODELS; DOWN-SYNDROME; MOUSE MODEL; VARIANTS; SCHIZOPHRENIA	De novo and inherited rare genetic disorders (RGDs) are a major cause of human morbidity, frequently involving neuropsychiatric symptoms. Recent advances in genomic technologies and data sharing have revolutionized the identification and diagnosis of RGDs, presenting an opportunity to elucidate the mechanisms underlying neuropsychiatric disorders by investigating the pathophysiology of high-penetrance genetic risk factors. Here we seek out the best path forward for achieving these goals. We think future research will require consistent approaches across multiple RGDs and developmental stages, involving both the characterization of shared neuropsychiatric dimensions in humans and the identification of neurobiological commonalities in model systems. A coordinated and concerted effort across patients, families, researchers, clinicians and institutions, including rapid and broad sharing of data, is now needed to translate these discoveries into urgently needed therapies.	[Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, UCSF Weill Inst Neurosci, San Francisco, CA USA; [Sahin, Mustafa; Modi, Meera E.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Sahin, Mustafa; Modi, Meera E.] Harvard Med Sch, Boston, MA 02115 USA; [Hostyk, Joseph; Goldstein, David B.] Columbia Univ, Med Ctr, Hammer Hlth Sci, Inst Genom Med, New York, NY USA; [Thurm, Audrey; Raznahan, Armin; Lehner, Thomas] NIMH, Bethesda, MD 20892 USA; [Jacquemont, Sebastien; Douard, Elise] Univ Montreal, CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Avillach, Paul] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Martin, Christa L.; Moreno-De-Luca, Andres; Ledbetter, David H.] Geisinger Autism & Dev Med Inst, Danville, PA USA; [Anticevic, Alan; Glahn, David C.] Boston Childrens Hosp, Tommy Fuss Ctr Neuropsychiat Dis Res, Boston, MA USA; [Anticevic, Alan] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Dolmetsch, Ricardo] Novartis Inst BioMed Res, Dept Neurosci, Cambridge, MA USA; [Feng, Guoping] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Feng, Guoping] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Feng, Guoping] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Mulle, Jennifer G.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Samaco, Rodney] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA; [Pariser, Anne] Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Gur, Raquel E.] Univ Penn, Dept Psychiat, Neuropsychiat Sect, Philadelphia, PA 19104 USA; [Gur, Raquel E.] Univ Penn, Perelman Sch Med, Lifespan Brain Inst, Philadelphia, PA 19104 USA; [Gur, Raquel E.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA 90024 USA; [Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Biobehav Sci & Psychol, Los Angeles, CA 90024 USA	University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Novartis; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Stanford University; Baylor College of Medicine; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gur, RE (corresponding author), Univ Penn, Dept Psychiat, Neuropsychiat Sect, Philadelphia, PA 19104 USA.; Gur, RE (corresponding author), Univ Penn, Perelman Sch Med, Lifespan Brain Inst, Philadelphia, PA 19104 USA.; Gur, RE (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.; Bearden, CE (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA 90024 USA.; Bearden, CE (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Biobehav Sci & Psychol, Los Angeles, CA 90024 USA.	raquel@pennmedicine.upenn.edu; cbearden@mednet.ucla.edu	Jacquemont, Sebastien/AAS-5060-2021; Pasca, Sergiu/AAY-3949-2021; De Luca, Andres Moreno/AAB-3570-2021; SAHIN, MUSTAFA/I-8653-2019; Goldstein, David/AAY-8125-2020	Jacquemont, Sebastien/0000-0001-6838-8767; Pasca, Sergiu/0000-0002-3216-3248; De Luca, Andres Moreno/0000-0002-2732-4043; SAHIN, MUSTAFA/0000-0001-7044-2953; Sanders, Stephan/0000-0001-9112-5148; Bearden, Carrie/0000-0002-8516-923X	NIMH; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH116473, R01MH085953] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This paper offers a synthesis of the ideas generated at the NIMH-sponsored workshop "Rare Genetic Disease Workshop: Window into Genomic Risk and Resilience of Mental Disorders," held in September 2017, with the goal of discussing research and clinical opportunities presented by recent discoveries of RGDs with high risk for developmental neuropsychiatric disorders. Analyses utilize data generated by the Saguenay Youth Study, OMIM (https://www.omim.org), ExAC (http://exac.broadinstitute.org/) and the DECIPHER Consortium, including the Developmental Disorders Genotype-Phenotype Database (DDG2P, https://decipher.sanger.ac.uk/info/ddg2p). A full list of centers that contributed to the generation of the DECIPHER data is available at http://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. We also thank G. Senthil for helpful feedback on the manuscript.	Ahn K, 2014, MOL PSYCHIATR, V19, P568, DOI 10.1038/mp.2013.59; Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007; An JY, 2017, BIOL PSYCHIAT, V82, P78, DOI 10.1016/j.biopsych.2017.05.010; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Anticevic A, 2015, JAMA PSYCHIAT, V72, P882, DOI 10.1001/jamapsychiatry.2015.0566; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Bastarache L, 2018, SCIENCE, V359, P1233, DOI 10.1126/science.aal4043; Bearden CE, 2017, NEURON, V94, P232, DOI 10.1016/j.neuron.2017.03.033; Ben-Shalom R, 2017, BIOL PSYCHIAT, V82, P224, DOI 10.1016/j.biopsych.2017.01.009; Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109; Berry-Kravis EM, 2018, NAT REV DRUG DISCOV, V17, P280, DOI 10.1038/nrd.2017.221; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bredenoord AL, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9414; Bruno JL, 2017, P NATL ACAD SCI USA, V114, P10767, DOI 10.1073/pnas.1620994114; Cao H., 2018, CEREB CORTEX; Cargnin F, 2018, NEURON, V100, P1083, DOI 10.1016/j.neuron.2018.10.016; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Chakravarti A, 2013, CELL, V155, P21, DOI 10.1016/j.cell.2013.09.001; Chen YC, 2017, CELL, V169, P945, DOI 10.1016/j.cell.2017.04.035; Cheng HY, 2019, HUM MOL GENET, V28, P2900, DOI 10.1093/hmg/ddz111; Clarke HF, 2014, J NEUROSCI, V34, P7663, DOI 10.1523/JNEUROSCI.0718-14.2014; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Cuthbert BN, 2015, DIALOGUES CLIN NEURO, V17, P89; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; D'Angelo D, 2016, JAMA PSYCHIAT, V73, P20, DOI 10.1001/jamapsychiatry.2015.2123; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deisseroth K, 2015, JAMA-J AM MED ASSOC, V313, P2019, DOI 10.1001/jama.2015.2544; Demkow U, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.106; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Donaldson ZR, 2015, BIOL PSYCHIAT, V77, P15, DOI 10.1016/j.biopsych.2014.02.004; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finucane B. M, 2016, GENE REV; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Galvao-Coelho NL, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00175; Gandal MJ, 2016, NAT NEUROSCI, V19, P1397, DOI 10.1038/nn.4409; Ganna A, 2016, NAT NEUROSCI, V19, P1563, DOI 10.1038/nn.4404; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Guerrini R, 2011, DEV MED CHILD NEUROL, V53, P11, DOI 10.1111/j.1469-8749.2011.03966.x; Guloksuz S, 2017, PSYCHOL MED, V47, P2743, DOI 10.1017/S0033291717001350; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hazlett HC, 2017, NATURE, V542, P348, DOI 10.1038/nature21369; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Heyne HO, 2018, NAT GENET, V50, P1048, DOI 10.1038/s41588-018-0143-7; Huguet G, 2018, JAMA PSYCHIAT, V75, P447, DOI 10.1001/jamapsychiatry.2018.0039; Insel TR, 2014, AM J PSYCHIAT, V171, P395, DOI 10.1176/appi.ajp.2014.14020138; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Joseph L, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9248-7; Kelly E, 2018, NEUROPSYCHOPHARMACOL, V43, P1457, DOI 10.1038/npp.2017.295; Kendall KM, 2017, BIOL PSYCHIAT, V82, P103, DOI 10.1016/j.biopsych.2016.08.014; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Kotani M, 2016, BEHAV BRAIN RES, V305, P212, DOI 10.1016/j.bbr.2016.02.031; Kothari C, 2018, AM J MED GENET B, V177, P613, DOI 10.1002/ajmg.b.32579; Krueger DA, 2017, ANN CLIN TRANSL NEUR, V4, P877, DOI 10.1002/acn3.494; LeBlanc JJ, 2015, ANN NEUROL, V78, P775, DOI 10.1002/ana.24513; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; Lovelace JW, 2018, NEUROBIOL DIS, V115, P39, DOI 10.1016/j.nbd.2018.03.012; Lukowski AF, 2019, ADV CHILD DEV BEHAV, V56, P257, DOI 10.1016/bs.acdb.2019.01.002; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mannik K, 2015, JAMA-J AM MED ASSOC, V313, P2044, DOI 10.1001/jama.2015.4845; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Mao P, 2015, NEUROSCI BULL, V31, P235, DOI 10.1007/s12264-014-1506-4; Marshall CR, 2017, NAT GENET, V49, P27, DOI 10.1038/ng.3725; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Mighell TL, 2018, AM J HUM GENET, V102, P943, DOI 10.1016/j.ajhg.2018.03.018; Miller I. O, 2007, GENE REV; Moreno-De-Luca A, 2015, JAMA PSYCHIAT, V72, P119, DOI 10.1001/jamapsychiatry.2014.2147; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; National Advisory Mental Health Council Workgroup on Genomics, 2018, OPP CHALL PSYCH GEN; Niemi MEK, 2018, NATURE, V562, P268, DOI 10.1038/s41586-018-0566-4; O'Leary HM, 2018, ANN CLIN TRANSL NEUR, V5, P323, DOI 10.1002/acn3.533; Oikonomidis L, 2017, DEV NEUROBIOL, V77, P328, DOI 10.1002/dneu.22446; Olsen L, 2018, LANCET PSYCHIAT, V5, P573, DOI 10.1016/S2215-0366(18)30168-8; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Pedersen CB, 2018, MOL PSYCHIATR, V23, P6, DOI 10.1038/mp.2017.196; Pidcock FS, 2016, BRAIN DEV-JPN, V38, P76, DOI 10.1016/j.braindev.2015.06.005; Pietri T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00118; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rees E, 2014, MOL PSYCHIATR, V19, P37, DOI 10.1038/mp.2013.156; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Reuter MS, 2017, JAMA PSYCHIAT, V74, P293, DOI 10.1001/jamapsychiatry.2016.3798; Rusk N, 2018, NAT METHODS, V15, P1001, DOI 10.1038/s41592-018-0245-2; Sahin M, 2019, NAT REV DRUG DISCOV, V18, P235, DOI 10.1038/d41573-018-00010-7; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2014, CURR GENET MED REP, V2, P151, DOI DOI 10.1007/S40142-014-0045-7; Sanders SJ, 2018, TRENDS NEUROSCI, V41, P442, DOI 10.1016/j.tins.2018.03.011; Sanders SJ, 2017, NAT NEUROSCI, V20, P1661, DOI 10.1038/s41593-017-0017-9; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Satterstrom F. K, 2018, PREPRINT, DOI [10.1101/484113v3, DOI 10.1101/484113V3]; Sawyer SL, 2016, CLIN GENET, V89, P275, DOI 10.1111/cge.12654; Schaefer GB, 2010, J CHILD NEUROL, V25, P1498, DOI 10.1177/0883073810370479; Scheldeman C, 2017, NEUROBIOL DIS, V108, P225, DOI 10.1016/j.nbd.2017.09.004; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Senthil G, 2017, MOL PSYCHIATR, V22, P1659, DOI 10.1038/mp.2017.29; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffield JM, 2017, JAMA PSYCHIAT, V74, P605, DOI 10.1001/jamapsychiatry.2017.0669; Shukla G, 2017, J CHILD NEUROL, V32, P981, DOI 10.1177/0883073817724903; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Singh T, 2017, NAT GENET, V49, P1167, DOI 10.1038/ng.3903; Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Stewart AM, 2015, BEHAV BRAIN RES, V276, P28, DOI 10.1016/j.bbr.2013.12.024; Stoodley CJ, 2018, NAT NEUROSCI, V21, P1016, DOI 10.1038/s41593-018-0096-2; Sun YS, 2016, ELIFE, V5, DOI 10.7554/eLife.13073; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Thompson PM, 2017, NEUROIMAGE, V145, P389, DOI 10.1016/j.neuroimage.2015.11.057; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2019, RAR DIS COMM ISS DRU; van der Vaart T, 2015, JAMA NEUROL, V72, P1052, DOI 10.1001/jamaneurol.2015.0443; van Os J, 2016, WORLD PSYCHIATRY, V15, P118, DOI 10.1002/wps.20310; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Vockley J, 2014, GENET MED, V16, P188, DOI 10.1038/gim.2013.157; Wang J, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9191-z; Weiner DJ, 2017, NAT GENET, V49, P978, DOI 10.1038/ng.3863; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Willsey AJ, 2017, NEURON, V94, P486, DOI 10.1016/j.neuron.2017.04.024; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wolff M, 2017, BRAIN, V140, P1316, DOI 10.1093/brain/awx054; Wu Y, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9156-7; Zhou Y, 2019, NATURE, V570, P326, DOI 10.1038/s41586-019-1278-0	136	45	45	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2019	25	10					1477	+		10.1038/s41591-019-0581-5	http://dx.doi.org/10.1038/s41591-019-0581-5			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	JC3GJ	31548702	Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000489166700015
J	Belisle-Pipon, JC; Vayena, E; Green, RC; Cohen, IG				Belisle-Pipon, Jean-Christophe; Vayena, Effy; Green, Robert C.; Cohen, I. Glenn			Genetic testing, insurance discrimination and medical research: what the United States can learn from peer countries	NATURE MEDICINE			English	Article							NONDISCRIMINATION ACT; HEALTH; GENOME; PERSPECTIVES; GINA	While genetic testing may be the gateway to the future of medicine, it also poses challenges for individuals, especially in terms of differentiated treatments on the basis of their genetic characteristics. The fear of unwanted disclosure to insurers and the possibility of genetic discrimination can hamper the recruitment of individuals for clinical research that involves genetic testing. Precision medicine initiatives, such as All of Us, are proliferating in the United States. In order to succeed, however, they must ensure that the millions of Americans recruited to share their genetic data are not penalized with regard to life, disability and long-term insurance coverage. In this Perspective, we discuss several initiatives adopted by countries around the world, such as the United Kingdom and France, that better balance the interests of insurers and research subjects, and explain how the United States might learn from them. We call for regulatory and industry leadership to come together to establish a voluntary moratorium on insurance pricing with the aim of protecting research participants.	[Belisle-Pipon, Jean-Christophe; Cohen, I. Glenn] Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Vayena, Effy] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Green, Robert C.] Brigham & Womens Hosp, Broad Inst, 75 Francis St, Boston, MA 02115 USA; [Green, Robert C.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Cohen, IG (corresponding author), Harvard Law Sch, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.	igcohen@law.harvard.edu	Vayena, Effy/ABD-8272-2021; Belisle-Pipon, Jean-Christophe/P-3132-2017	Vayena, Effy/0000-0003-1303-5467; Belisle-Pipon, Jean-Christophe/0000-0002-8965-8153	Canadian Institutes of Health Research (CIHR); Quebec Health Research Fund (FRQS); Quebec SPOR-SUPPORT Unit; National Institutes of Health; Franca Sozzani Fund	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Health Research Fund (FRQS); Quebec SPOR-SUPPORT Unit; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franca Sozzani Fund	The authors would like to thank E. Baird for comments in revising the paper. J.C.B.P. is funded by postdoctoral fellowships from the Canadian Institutes of Health Research (CIHR), the Quebec Health Research Fund (FRQS) and the Quebec SPOR-SUPPORT Unit. R.C.G. is supported by grant funding from the National Institutes of Health and the Franca Sozzani Fund.	[Anonymous], 2008, REUTERS; [Anonymous], PREC MED PREV HLTH D; Arenas M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006960; Barlyn S., 2018, STRAP FITBIT J HANCO; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Bombard Y, 2017, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0005203.pub3, DOI 10.1002/9780470015902.A0005203.PUB3]; Bombard Y, 2018, CAN MED ASSOC J, V190, pE579, DOI 10.1503/cmaj.180298; Brennan P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005522; Canadian Life and Health Insurance Association, 2017, GEN TEST LIF INS OUR; Chen A., 2018, VERGE; Coalition for Genetic Fairness, 2004, FAC GEN DISCR; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Dalpe G, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00128; EPSTEIN RA, 1994, BOSTON U LAW REV, V74, P1; Financial Services Council (Australia), 2016, 11 FSC; Geelen E, 2012, EUR J HUM GENET, V20, P1018, DOI 10.1038/ejhg.2012.53; *GEN PUBL POL CTR, 2007, US PUBL OP US GEN IN; Genetti CA, 2019, GENET MED, V21, P622, DOI 10.1038/s41436-018-0105-6; Gold K., 2016, GLOBE MAIL; Government of the United Kingdom & Association of British Insurers, 2014, CONC MOR GEN INS; Government of the United Kingdom & Association of British Insurers, 2018, COD GEN TEST INS; Green RC, 2015, NEW ENGL J MED, V372, P397, DOI 10.1056/NEJMp1404776; Hancock John, 2018, VITALITY PROGRAM; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Joly Y, 2017, TRENDS GENET, V33, P299, DOI 10.1016/j.tig.2017.02.002; Joly Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-25; Klein Ronald., 2017, GENETICS LIFE INSURA; Minari J, 2018, HUM GENOMICS, V12, DOI 10.1186/s40246-018-0151-9; Moreno PG, 2017, J LAW BIOSCI, V4, P250, DOI 10.1093/jlb/lsx012; Newson AJ, 2017, PUBLIC HEALTH GENOM, V20, P247, DOI 10.1159/000481450; Nys H., 2002, GENETIC TESTING PATI; Otlowski M, 2012, ANNU REV GENOM HUM G, V13, P433, DOI 10.1146/annurev-genom-090711-163800; Reich D, 2018, WHO WE ARE WE GOT HE; Robinson JO, 2016, J EMPIR RES HUM RES, V11, P21, DOI 10.1177/1556264615624078; Rothstein MA, 2008, GENET MED, V10, P655, DOI 10.1097GIM.0b013e31818337bd; Rothstein MA, 2018, HASTINGS CENT REP, V48, P5, DOI 10.1002/hast.847; Sabour L, 2017, PATHOL ONCOL RES, V23, P225, DOI 10.1007/s12253-016-0124-z; Smart A, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-016-0240-3; Tiller J., 2017, CONVERSATION; Tiller J, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00330; Torkamani A, 2018, NAT REV GENET, V19, P581, DOI 10.1038/s41576-018-0018-x; UNESCO, 1997, UN DECL HUM GEN HUM; Vassy JL, 2017, ANN INTERN MED, V167, P159, DOI 10.7326/M17-0188	44	28	29	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1198	1204		10.1038/s41591-019-0534-z	http://dx.doi.org/10.1038/s41591-019-0534-z			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31388181				2022-12-27	WOS:000480414600016
J	Gibani, MM; Jones, E; Barton, A; Jin, C; Meek, J; Camara, S; Galal, U; Heinz, E; Rosenberg-Hasson, Y; Obermoser, G; Jones, C; Campbell, D; Black, C; Thomaides-Brears, H; Darlow, C; Dold, C; Silva-Reyes, L; Blackwell, L; Lara-Tejero, M; Jiao, XY; Stack, G; Blohmke, CJ; Hill, J; Angus, B; Dougan, G; Galan, J; Pollard, AJ				Gibani, Malick M.; Jones, Elizabeth; Barton, Amber; Jin, Celina; Meek, Juliette; Camara, Susana; Galal, Ushma; Heinz, Eva; Rosenberg-Hasson, Yael; Obermoser, Gerlinde; Jones, Claire; Campbell, Danielle; Black, Charlotte; Thomaides-Brears, Helena; Darlow, Christopher; Dold, Christina; Silva-Reyes, Laura; Blackwell, Luke; Lara-Tejero, Maria; Jiao, Xuyao; Stack, Gabrielle; Blohmke, Christoph J.; Hill, Jennifer; Angus, Brian; Dougan, Gordon; Galan, Jorge; Pollard, Andrew J.			Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model	NATURE MEDICINE			English	Article							ENTERICA SEROVAR TYPHI; HUMAN INFECTION MODEL; SALMONELLA-TYPHI; PARATYPHI; CELLS	Salmonella Typhi is a human host-restricted pathogen that is responsible for typhoid fever in approximately 10.9 million people annually(1). The typhoid toxin is postulated to have a central role in disease pathogenesis, the establishment of chronic infection and human host restriction(2-6). However, its precise role in typhoid disease in humans is not fully defined. We studied the role of typhoid toxin in acute infection using a randomized, double-blind S. Typhi human challenge model(7). Forty healthy volunteers were randomized (1:1) to oral challenge with 10(4) colony-forming units of wild-type or an isogenic typhoid toxin deletion mutant (TN) of S. Typhi. We observed no significant difference in the rate of typhoid infection (fever >= 38 degrees C for >= 12 h and/or S. Typhi bacteremia) between participants challenged with wild-type or TN S. Typhi (15 out of 21 (71%) versus 15 out of 19 (79%); P = 0.58). The duration of bacteremia was significantly longer in participants challenged with the TN strain compared with wild-type (47.6 hours (28.9-97.0) versus 30.3(3.6-49.4); P <= 0.001). The clinical syndrome was otherwise indistinguishable between wild-type and TN groups. These data suggest that the typhoid toxin is not required for infection and the development of early typhoid fever symptoms within the context of a human challenge model. Further clinical data are required to assess the role of typhoid toxin in severe disease or the establishment of bacterial carriage.	[Gibani, Malick M.; Jones, Elizabeth; Barton, Amber; Jin, Celina; Meek, Juliette; Camara, Susana; Jones, Claire; Campbell, Danielle; Black, Charlotte; Thomaides-Brears, Helena; Darlow, Christopher; Dold, Christina; Silva-Reyes, Laura; Blackwell, Luke; Blohmke, Christoph J.; Hill, Jennifer; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Gibani, Malick M.; Jones, Elizabeth; Barton, Amber; Jin, Celina; Meek, Juliette; Camara, Susana; Jones, Claire; Campbell, Danielle; Black, Charlotte; Thomaides-Brears, Helena; Darlow, Christopher; Dold, Christina; Silva-Reyes, Laura; Blackwell, Luke; Blohmke, Christoph J.; Hill, Jennifer; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Gibani, Malick M.] Imperial Coll London, Dept Med, London, England; [Galal, Ushma] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Clin Trials Unit, Oxford, England; [Heinz, Eva; Dougan, Gordon] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Heinz, Eva] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Rosenberg-Hasson, Yael; Obermoser, Gerlinde] Stanford Univ, Inst Immun Transplantat & Infect, Human Immune Monitoring Ctr, Stanford, CA 94305 USA; [Lara-Tejero, Maria; Jiao, Xuyao; Stack, Gabrielle; Galan, Jorge] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA; [Angus, Brian] Univ Oxford, Nuffield Dept Med, Oxford, England; [Dougan, Gordon] Univ Cambridge, Dept Med, Hinxton, England	University of Oxford; University of Oxford; Imperial College London; University of Oxford; Wellcome Trust Sanger Institute; Liverpool School of Tropical Medicine; Stanford University; Yale University; University of Oxford; University of Cambridge	Gibani, MM (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.; Gibani, MM (corresponding author), NIHR Oxford Biomed Res Ctr, Oxford, England.; Gibani, MM (corresponding author), Imperial Coll London, Dept Med, London, England.	malick.gibani@paediatrics.ox.ac.uk	Heinz, Eva/I-2053-2014; Dold, Christina/ABA-4237-2021; Darlow, Christopher/GXH-9987-2022	Heinz, Eva/0000-0003-4413-3756; Darlow, Christopher/0000-0002-5400-3413; Silva-Reyes, Laura/0000-0002-3678-1836; dold, christina/0000-0003-2314-507X; Thomaides-Brears, Helena/0000-0003-0774-6983; Jones, Elizabeth/0000-0001-5821-1001; Barton, Amber/0000-0001-8313-8643; Gibani, Malick/0000-0003-1781-0053	Wellcome Trust (Wellcome Trust Strategic Translational Award) [092661]; NIHR Oxford Biomedical Research Centre; Bill & Melinda Gates Foundation: Global Health Vaccine Accelerator Platform grant [OPP1113682]; NIHR Imperial Biomedical Research Centre; Bill & Melinda Gates Foundation [OPP1126235]; MRC [MR/N025989/1] Funding Source: UKRI	Wellcome Trust (Wellcome Trust Strategic Translational Award); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Bill & Melinda Gates Foundation: Global Health Vaccine Accelerator Platform grant; NIHR Imperial Biomedical Research Centre; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to acknowledge the contribution of all study participants. The authors acknowledge the support of the Wellcome Trust (Wellcome Trust Strategic Translational Award grant no. 092661) in the development of the typhoid human challenge model that was used for this study, and the support of the NIHR Oxford Biomedical Research Centre. Cytokine studies were supported by the Bill & Melinda Gates Foundation: Global Health Vaccine Accelerator Platform grant to the Center for Human Systems Immunology at Stanford (no. OPP1113682). M.M.G. is supported in part by the NIHR Imperial Biomedical Research Centre. In addition, the authors wish to thank the following persons: R. Milward and the Walter Reed Army Institute of Research Pilot BioProduction Facility, who manufactured the GMP challenge lots; the Data Safety Monitoring Committee (D. Lalloo, D. Hill, P. Monk); M. Morgan and the microbiology laboratory at the Oxford University Hospital NHS foundation Trust; M. McClure; M. Raymond; T. Darton; C. Waddington; M. M. Levine; and the University of Maryland for provision of the original S. Typhi Quailes challenge strain. The study was funded by the Bill & Melinda Gates Foundation (no. OPP1126235). The study funders had no role in study design, data collection or analysis.	Akinyemi KO, 2000, Z NATURFORSCH C, V55, P489; [Anonymous], 2016, GEN MOD ORG OXF VACC; Baker S, 2005, J CLIN MICROBIOL, V43, P4418, DOI 10.1128/JCM.43.9.4418-4425.2005; Belluz Del Bel L, 2016, PLOS PATHOG, V12; Chin CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01987-8; Darton TC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01794; Darton TC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004926; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deng LQ, 2014, CELL, V159, P1290, DOI 10.1016/j.cell.2014.10.057; Dobinson HC, 2017, CLIN INFECT DIS, V64, P1066, DOI 10.1093/cid/cix042; Dunstan SJ, 2014, NAT GENET, V46, P1333, DOI 10.1038/ng.3143; Galan JE, 2016, P NATL ACAD SCI USA, V113, P6338, DOI 10.1073/pnas.1606335113; Gibani MM, 2019, CLIN INFECT DIS, V68, P1265, DOI 10.1093/cid/ciy670; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Jin C, 2017, LANCET, V390, P2472, DOI 10.1016/S0140-6736(17)32149-9; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Milligan R, 2018, COCHRANE DB SYST REV, V5; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Promega, 2018, WIZ GEN DNA PUR KIT; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Rivera LD, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0065-1; Sharma T, 2018, IMMUNOL RES, V66, P503, DOI 10.1007/s12026-018-9009-4; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Stanaway JD, 2019, LANCET INFECT DIS, V19, P369, DOI 10.1016/S1473-3099(18)30685-6; Tennant SM, 2015, VACCINE, V33, pC36, DOI 10.1016/j.vaccine.2015.04.029; U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2007, GUID IND TOX GRAD SC; Waddington CS, 2014, CLIN INFECT DIS, V58, P1230, DOI 10.1093/cid/ciu078; Wickham H., 2019, R PACKAGE VERSION 3; Wong VK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12827; Yang YA, 2018, NAT MICROBIOL, V3, P155, DOI 10.1038/s41564-017-0076-4	36	15	18	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1082	+		10.1038/s41591-019-0505-4	http://dx.doi.org/10.1038/s41591-019-0505-4			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31270506	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000474430400021
J	Hammerich, L; Marron, TU; Upadhyay, R; Svensson-Arvelund, J; Dhainaut, M; Hussein, S; Zhan, YG; Ostrowski, D; Yellin, M; Marsh, H; Salazar, AM; Rahman, AH; Brown, BD; Merad, M; Brody, JD				Hammerich, Linda; Marron, Thomas U.; Upadhyay, Ranjan; Svensson-Arvelund, Judit; Dhainaut, Maxime; Hussein, Shafinaz; Zhan, Yougen; Ostrowski, Dana; Yellin, Michael; Marsh, Henry; Salazar, Andres M.; Rahman, Adeeb H.; Brown, Brian D.; Merad, Miriam; Brody, Joshua D.			Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination	NATURE MEDICINE			English	Article							ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; T-CELLS; MYCOSIS-FUNGOIDES; LYMPHOMA-CELLS; STEM-CELLS; CANCER; RESPONSES; LIGAND; NIVOLUMAB	Indolent non-Hodgkin's lymphomas (iNHLs) are incurable with standard therapy and are poorly responsive to checkpoint blockade. Although lymphoma cells are efficiently killed by primed T cells, in vivo priming of anti-lymphoma T cells has been elusive. Here, we demonstrate that lymphoma cells can directly prime T cells, but in vivo immunity still requires cross-presentation. To address this, we developed an in situ vaccine (ISV), combining Flt3L, radiotherapy, and a TLR3 agonist, which recruited, antigen-loaded and activated intratumoral, cross-presenting dendritic cells (DCs). ISV induced anti-tumor CD8(+) T cell responses and systemic (abscopal) cancer remission in patients with advanced stage iNHL in an ongoing trial (NCT01976585). Non-responding patients developed a population of PD1(+) CD8(+) T cells after ISV, and murine tumors became newly responsive to PD1 blockade, prompting a follow-up trial of the combined therapy. Our data substantiate that recruiting and activating intratumoral, cross-priming DCs is achievable and critical to anti-tumor T cell responses and PD1-blockade efficacy.	[Hammerich, Linda; Marron, Thomas U.; Upadhyay, Ranjan; Svensson-Arvelund, Judit; Ostrowski, Dana; Brody, Joshua D.] Icahn Sch Med Mt Sinai, Dept Hematol Med Oncol, New York, NY 10029 USA; [Hammerich, Linda; Marron, Thomas U.; Upadhyay, Ranjan; Svensson-Arvelund, Judit; Dhainaut, Maxime; Rahman, Adeeb H.; Brown, Brian D.; Merad, Miriam; Brody, Joshua D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Dhainaut, Maxime; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Hussein, Shafinaz; Zhan, Yougen] Icahn Sch Med Mt Sinai, Dept Pathol Mol & Cell Based Med, New York, NY 10029 USA; [Yellin, Michael; Marsh, Henry] Celldex Therapeut Inc, Needham, MA USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brody, JD (corresponding author), Icahn Sch Med Mt Sinai, Dept Hematol Med Oncol, New York, NY 10029 USA.; Brody, JD (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.	joshua.brody@mssm.edu		Dhainaut, Maxime/0000-0003-3832-7095; Yellin, Michael/0000-0002-1164-7614; Upadhyay, Ranjan/0000-0002-1326-5898; Hammerich, Linda/0000-0003-0557-3927; Svensson-Arvelund, Judit/0000-0002-6260-0808	Damon Runyon Cancer Research Foundation Clinical Investigator Award [45367]; Investigator Studies Program (MSIP) Award [10677]; Cancer Research Institute - Clinic & Laboratory Integration Program (CLIP) [45367]; German research foundation (DFG) [HA 7431/1-1]; NIH [U19AI128949]	Damon Runyon Cancer Research Foundation Clinical Investigator Award; Investigator Studies Program (MSIP) Award; Cancer Research Institute - Clinic & Laboratory Integration Program (CLIP); German research foundation (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the ISMMS human immune monitoring core for help with mass cytometry experiments and Luminex assay; the ISMMS flow cytometry core; and the CCMS animal facility. We also thank N. Sadek and C. Kappauff for technical assistance and N. Bhardwaj for critical review of the manuscript. J.D.B. was supported by a Damon Runyon Cancer Research Foundation Clinical Investigator Award (no. 45367), by an Investigator Studies Program (MSIP) Award (no. 10677), and by a Cancer Research Institute - Clinic & Laboratory Integration Program (CLIP, no. 45367) Award. L.H. was supported by a research fellowship of the German research foundation (DFG, HA 7431/1-1). B.D.B. and M.M. were supported by NIH U19AI128949.	Abuodeh Y, 2016, CURR PROB CANCER, V40, P25, DOI 10.1016/j.currproblcancer.2015.10.001; Agudo J, 2018, IMMUNITY, V48, P271, DOI 10.1016/j.immuni.2018.02.001; Anandasabapathy N, 2015, BONE MARROW TRANSPL, V50, P924, DOI 10.1038/bmt.2015.74; Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397; Anders K, 2011, CANCER CELL, V20, P755, DOI 10.1016/j.ccr.2011.10.019; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Aoi T, 1997, IMMUNOLOGY, V91, P212, DOI 10.1046/j.1365-2567.1997.00253.x; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bachem A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00214; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Brody JD, 2010, J CLIN ONCOL, V28, P4324, DOI 10.1200/JCO.2010.28.9793; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chan WFN, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-10; Chang KC, 2007, CLIN CANCER RES, V13, P6666, DOI 10.1158/1078-0432.CCR-07-0504; Chaperot L, 1999, EXP HEMATOL, V27, P479, DOI 10.1016/S0301-472X(98)00059-9; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Chevalier N, 2016, LEUKEMIA LYMPHOMA, V57, P2150, DOI 10.3109/10428194.2015.1135432; de Charette M, 2016, EUR J CANCER, V68, P134, DOI 10.1016/j.ejca.2016.09.010; Ding W, 2017, BLOOD, V129, P3419, DOI 10.1182/blood-2017-02-765685; Disis ML, 2002, BLOOD, V99, P2845, DOI 10.1182/blood.V99.8.2845; El Tawdy AM, 2017, CLIN EXP DERMATOL, V42, P172, DOI 10.1111/ced.13008; Freedman RS, 2003, CLIN CANCER RES, V9, P5228; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gasparetto C, 2002, CYTOKINE, V18, P8, DOI 10.1006/cyto.2002.1009; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hargadon KM, 2006, J IMMUNOL, V177, P6081, DOI 10.4049/jimmunol.177.9.6081; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Kim YH, 2012, BLOOD, V119, P355, DOI 10.1182/blood-2011-05-355222; KURLANDER R, 1975, CANCER, V36, P926, DOI 10.1002/1097-0142(197509)36:3<926::AID-CNCR2820360313>3.0.CO;2-G; Lesokhin AM, 2016, J CLIN ONCOL, V34, P2698, DOI 10.1200/JCO.2015.65.9789; Levy R, 2014, J CLIN ONCOL, V32, P1797, DOI 10.1200/JCO.2012.43.9273; Liao J, 2017, CANCER IMMUNOL RES, V5, P560, DOI 10.1158/2326-6066.CIR-16-0221; Locke FL, 2017, MOL THER, V25, P285, DOI 10.1016/j.ymthe.2016.10.020; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Mayer CT, 2014, BLOOD, V124, P3081, DOI 10.1182/blood-2013-12-545772; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Merad M, 2002, BLOOD, V99, P1676, DOI 10.1182/blood.V99.5.1676; Morse MA, 2000, J CLIN ONCOL, V18, P3883, DOI 10.1200/JCO.2000.18.23.3883; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; REES GJG, 1981, CLIN RADIOL, V32, P475, DOI 10.1016/S0009-9260(81)80310-8; Rook AH, 2015, BLOOD, V126, P1452, DOI 10.1182/blood-2015-02-630335; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sancho D, 2008, J CLIN INVEST, V118, P2098, DOI 10.1172/JCI34584; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; SHAM RL, 1995, AM J MED, V98, P307, DOI 10.1016/S0002-9343(99)80380-5; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Spranger S, 2016, P NATL ACAD SCI USA, V113, pE7759, DOI 10.1073/pnas.1609376113; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wolkers MC, 2001, J IMMUNOL, V167, P3577, DOI 10.4049/jimmunol.167.7.3577; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; 2018, NAT MED, V24, P1178, DOI DOI 10.1038/S41591-018-0085-8; 2006, EUR J DERMATOL, V16, P636, DOI DOI 10.1684/EJD.2006.0088; 2016, CANCER DISCOV, V6, P71, DOI DOI 10.1158/2159-8290.CD-15-0510	63	198	204	8	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					814	+		10.1038/s41591-019-0410-x	http://dx.doi.org/10.1038/s41591-019-0410-x			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	30962585				2022-12-27	WOS:000468247800025
J	Blander, JM				Blander, J. Magarian			A new approach for inflammatory bowel disease therapy	NATURE MEDICINE			English	Editorial Material									[Blander, J. Magarian] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10065 USA; [Blander, J. Magarian] Weill Cornell Med, Div Gastroenterol & Hepatol, Joan & Sanford I Weill Dept Med, New York, NY 10065 USA; [Blander, J. Magarian] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA; [Blander, J. Magarian] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Blander, J. Magarian] Weill Cornell Med, Immunol & Microbial Pathogenesis Program, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Blander, JM (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10065 USA.; Blander, JM (corresponding author), Weill Cornell Med, Div Gastroenterol & Hepatol, Joan & Sanford I Weill Dept Med, New York, NY 10065 USA.; Blander, JM (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA.; Blander, JM (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Blander, JM (corresponding author), Weill Cornell Med, Immunol & Microbial Pathogenesis Program, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA.	jmblander@med.cornell.edu		Blander, Julie Magarian/0000-0001-9207-1700				Buckley A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029314; Cunningham KE, 2012, ANN NY ACAD SCI, V1258, P34, DOI 10.1111/j.1749-6632.2012.06526.x; Farkas AE, 2016, CURR PHARM DESIGN, V22, P5400, DOI 10.2174/1381612822666160726123857; Graham WV, 2019, NAT MED, V25, P690, DOI 10.1038/s41591-019-0393-7; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Neurath MF, 2017, NAT REV GASTRO HEPAT, V14, P269, DOI 10.1038/nrgastro.2016.208; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Roda G, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.63; Xiong YJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00292	12	3	3	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					545	546		10.1038/s41591-019-0416-4	http://dx.doi.org/10.1038/s41591-019-0416-4			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30936545				2022-12-27	WOS:000463342800013
J	Nelson, CE; Wu, YY; Gemberling, MP; Oliver, ML; Waller, MA; Bohning, JD; Robinson-Hamm, JN; Bulaklak, K; Rivera, RMC; Collier, JH; Asokan, A; Gersbach, CA				Nelson, Christopher E.; Wu, Yaoying; Gemberling, Matthew P.; Oliver, Matthew L.; Waller, Matthew A.; Bohning, Joel D.; Robinson-Hamm, Jacqueline N.; Bulaklak, Karen; Rivera, Ruth M. Castellanos; Collier, Joel H.; Asokan, Aravind; Gersbach, Charles A.			Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy	NATURE MEDICINE			English	Article							GENE-THERAPY; HEPATIC GENOTOXICITY; IMMUNE-RESPONSES; MOUSE MODEL; EXPRESSION; VECTORS; MUSCLE; INTEGRATION; DELIVERY; LIVER	Duchenne muscular dystrophy (DMD) is a monogenic disorder and a candidate for therapeutic genome editing. There have been several recent reports of genome editing in preclinical models of Duchenne muscular dystrophy(1-6), however, the long-term persistence and safety of these genome editing approaches have not been addressed. Here we show that genome editing and dystrophin protein restoration is sustained in the mdx mouse model of Duchenne muscular dystrophy for 1 year after a single intravenous administration of an adeno-associated virus that encodes CRISPR (AAV-CRISPR). We also show that AAV-CRISPR is immunogenic when administered to adult mice(7); however, humoral and cellular immune responses can be avoided by treating neonatal mice. Additionally, we describe unintended genome and transcript alterations induced by AAV-CRISPR that should be considered for the development of AAV-CRISPR as a therapeutic approach. This study shows the potential of AAV-CRISPR for permanent genome corrections and highlights aspects of host response and alternative genome editing outcomes that require further study.	[Nelson, Christopher E.; Wu, Yaoying; Gemberling, Matthew P.; Oliver, Matthew L.; Waller, Matthew A.; Bohning, Joel D.; Robinson-Hamm, Jacqueline N.; Bulaklak, Karen; Collier, Joel H.; Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Nelson, Christopher E.; Gemberling, Matthew P.; Waller, Matthew A.; Bohning, Joel D.; Robinson-Hamm, Jacqueline N.; Bulaklak, Karen; Gersbach, Charles A.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA; [Rivera, Ruth M. Castellanos] Univ North Carolina Chapel Hill, Gene Therapy Ctr, Chapel Hill, NC USA; [Asokan, Aravind] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Asokan, Aravind] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Gersbach, Charles A.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27708 USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Duke University	Gersbach, CA (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Gersbach, CA (corresponding author), Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA.; Gersbach, CA (corresponding author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27708 USA.	charles.gersbach@duke.edu	Wu, Yaoying/GRF-1413-2022; Wu, Yaoying/AAQ-4925-2021; Gersbach, Charles/Y-3412-2019	Wu, Yaoying/0000-0003-0570-2493; Wu, Yaoying/0000-0003-0570-2493; Nelson, Christopher/0000-0002-8423-8854	Sarepta Therapeutics; Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group; Muscular Dystrophy Association [MDA277360]; Duke-Coulter Translational Partnership Grant; Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award; NIH [R01AR069085]; NIH Director's New Innovator Award [DP2OD008586]; Office of the Assistant Secretary of Defense for Health Affairs, through the Duchenne Muscular Dystrophy Research Program [W81XWH-15-1-0469, W81XWH-16-1-0221]; Hartwell Foundation Postdoctoral Fellowship; NIH Pathway to Independence Award [K99EB023979]; National Science Foundation Graduate Research Fellowship; American Heart Association Predoctoral Fellowship [17PRE33350013]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB023979] Funding Source: NIH RePORTER	Sarepta Therapeutics; Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group; Muscular Dystrophy Association(Muscular Dystrophy Association); Duke-Coulter Translational Partnership Grant; Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Assistant Secretary of Defense for Health Affairs, through the Duchenne Muscular Dystrophy Research Program; Hartwell Foundation Postdoctoral Fellowship; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work has been supported by Sarepta Therapeutics, the Allen Distinguished Investigator Program through The Paul G. Allen Frontiers Group, the Muscular Dystrophy Association (grant MDA277360), a Duke-Coulter Translational Partnership Grant, a Duke/UNC-Chapel Hill CTSA Consortium Collaborative Translational Research Award, NIH grant R01AR069085, an NIH Director's New Innovator Award (DP2OD008586) and the Office of the Assistant Secretary of Defense for Health Affairs, through the Duchenne Muscular Dystrophy Research Program under awards W81XWH-15-1-0469 and W81XWH-16-1-0221. C.E.N. was supported by a Hartwell Foundation Postdoctoral Fellowship and the NIH Pathway to Independence Award (K99EB023979). J.N.R.-H. was supported by a National Science Foundation Graduate Research Fellowship and American Heart Association Predoctoral Fellowship (17PRE33350013).	Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bell P, 2005, MOL THER, V12, P299, DOI 10.1016/j.ymthe.2005.03.020; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chamberlain JR, 2017, MOL THER, V25, P1125, DOI 10.1016/j.ymthe.2017.02.019; Chandler RJ, 2015, J CLIN INVEST, V125, P870, DOI 10.1172/JCI79213; Charlesworth CT, 2019, NAT MED, V25, P249, DOI 10.1038/s41591-018-0326-x; Chen JJ, 2013, BIOMATERIALS, V34, P8776, DOI 10.1016/j.biomaterials.2013.07.063; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Dunbar CE, 2018, SCIENCE, V359, P175, DOI 10.1126/science.aan4672; Ferdosi S. R., 2018, PREPRINT; Flanigan KM, 2014, NEUROL CLIN, V32, P671, DOI 10.1016/j.ncl.2014.05.002; Giannoukos G, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4561-9; Gil-Farina I, 2016, MOL THER, V24, P1100, DOI 10.1038/mt.2016.52; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hu C, 2012, GENE THER, V19, P1166, DOI 10.1038/gt.2011.200; Iyombe-Engembe JP, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.58; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lampe SEG, 2014, JOVE-J VIS EXP, DOI 10.3791/52037; Laoharawee K, 2018, MOL THER, V26, P1127, DOI 10.1016/j.ymthe.2018.03.002; Lee EK, 2012, MOL THER, V20, P1844, DOI 10.1038/mt.2012.129; Long CZ, 2016, JAMA NEUROL, V73, P1349, DOI 10.1001/jamaneurol.2016.3388; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Nelson CE, 2017, NAT REV NEUROL, V13, P647, DOI 10.1038/nrneurol.2017.126; Nelson CE, 2016, ANNU REV CHEM BIOMOL, V7, P637, DOI 10.1146/annurev-chembioeng-080615-034711; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Robinson-Hamm JN, 2016, HUM GENET, V135, P1029, DOI 10.1007/s00439-016-1725-z; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Singh K, 2018, MOL THER, V26, P1241, DOI 10.1016/j.ymthe.2018.02.023; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Thakore PI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04048-4; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Zhang P, 2012, HUM GENE THER, V23, P460, DOI 10.1089/hum.2011.063; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	46	192	203	12	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					427	+		10.1038/s41591-019-0344-3	http://dx.doi.org/10.1038/s41591-019-0344-3			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30778238	Green Accepted			2022-12-27	WOS:000460643100020
J	He, JX; Baxter, SL; Xu, J; Xu, JM; Zhou, XT; Zhang, K				He, Jianxing; Baxter, Sally L.; Xu, Jie; Xu, Jiming; Zhou, Xingtao; Zhang, Kang			The practical implementation of artificial intelligence technologies in medicine	NATURE MEDICINE			English	Article							DEEP; CLASSIFICATION	The development of artificial intelligence (AI)-based technologies in medicine is advancing rapidly, but real-world clinical implementation has not yet become a reality. Here we review some of the key practical issues surrounding the implementation of AI into existing clinical workflows, including data sharing and privacy, transparency of algorithms, data standardization, and interoperability across multiple platforms, and concern for patient safety. We summarize the current regulatory environment in the United States and highlight comparisons with other regions in the world, notably Europe and China.	[He, Jianxing; Zhang, Kang] Guangzhou Med Univ, China State Key Lab, Affiliated Hosp 1, Dept Thorac Surg Oncol, Guangzhou, Guangdong, Peoples R China; [He, Jianxing; Zhang, Kang] Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China; [He, Jianxing; Zhang, Kang] Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Guangdong, Peoples R China; [Baxter, Sally L.; Zhang, Kang] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Baxter, Sally L.; Zhang, Kang] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Baxter, Sally L.] Univ Calif San Diego, Dept Biomed Informat, La Jolla, CA 92093 USA; [Baxter, Sally L.; Zhang, Kang] San Diego Vet Affairs Hlth Syst, La Jolla, CA 92161 USA; [Xu, Jie] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Xu, Jiming] Yidu Cloud Technol Inc, Beijing, Peoples R China; [Zhou, Xingtao] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Guangzhou Medical University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Capital Medical University; Fudan University	He, JX; Zhang, K (corresponding author), Guangzhou Med Univ, China State Key Lab, Affiliated Hosp 1, Dept Thorac Surg Oncol, Guangzhou, Guangdong, Peoples R China.; He, JX; Zhang, K (corresponding author), Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China.; He, JX; Zhang, K (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Guangzhou, Guangdong, Peoples R China.; Zhang, K (corresponding author), Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA.; Zhang, K (corresponding author), Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA.; Zhang, K (corresponding author), San Diego Vet Affairs Hlth Syst, La Jolla, CA 92161 USA.	hejx@vip.163.com; kang.zhang@gmail.com	Xu, Jie/AIE-0524-2022; Zhang, Kang/Y-2740-2019; zhou, xt/GWZ-9212-2022; zhou, xing/GQP-4516-2022; xu, jie/GQR-1913-2022	Zhang, Kang/0000-0002-4549-1697; xu, jie/0000-0002-2039-7055; He, Jianxing/0000-0003-1737-8192; Baxter, Sally/0000-0002-5271-7690	Guangzhou Medical University, Guangzhou Regenerative Medicine and Health Guangdong Laboratory [B185004102, B185004075]; NATIONAL LIBRARY OF MEDICINE [T15LM011271] Funding Source: NIH RePORTER	Guangzhou Medical University, Guangzhou Regenerative Medicine and Health Guangdong Laboratory; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded in part by the Innovative team (B185004102) and Backbone talent (B185004075) training program for high-level universities of Guangzhou Medical University, Guangzhou Regenerative Medicine and Health Guangdong Laboratory.	[Anonymous], 2017, VIRTUAL NURSES DRUG; [Anonymous], 2013, LONG IT TAK US FDA A; Artificial Intelligence for the American People, 2018, ART INT AM PEOPL; Char DS, 2018, NEW ENGL J MED, V378, P981, DOI 10.1056/NEJMp1714229; Cheng JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24454; Collier M., 2017, ARTIF INTELL; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Dreyer KJ, 2017, RADIOLOGY, V285, P713, DOI 10.1148/radiol.2017171183; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fonseca CG, 2011, BIOINFORMATICS, V27, P2288, DOI 10.1093/bioinformatics/btr360; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Goodman B, 2017, AI MAG, V38, P50, DOI 10.1609/aimag.v38i3.2741; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hashimoto DA, 2018, ANN SURG, V268, P70, DOI 10.1097/SLA.0000000000002693; Holdren J., 2016, PREPARING FUTURE ART; International Medical Device Regulators' Forum, 2013, SOFTW MED DEV SAMD K; Jiang F, 2017, STROKE VASC NEUROL, V2, P230, DOI 10.1136/svn-2017-000101; Jimenez-del-Toro O, 2016, IEEE T MED IMAGING, V35, P2459, DOI 10.1109/TMI.2016.2578680; Johnson KW, 2018, J AM COLL CARDIOL, V71, P2668, DOI 10.1016/j.jacc.2018.03.521; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Kruse CS, 2016, JMIR MED INF, V4, DOI 10.2196/medinform.5359; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; National Science and Technology Council, 2016, NAT ART INT RES DEV; Niu JQ, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5050066; Patrzyk PM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X17000255; Pelcyger B, 2017, ARTIFICIAL INTELLIGE; Sitapati A, 2017, WILEY INTERDISCIP RE, V9, P1; Slomka PJ, 2017, EXPERT REV MED DEVIC, V14, P197, DOI 10.1080/17434440.2017.1300057; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Tang A, 2018, CAN ASSOC RADIOL J, V69, P120, DOI 10.1016/j.carj.2018.02.002; Thakar S, 2018, RADIOLOGY BUSINESS; U.S. Food and Drug Administration, 2018, DEV SOFTW PREC PROGR; US FDA, 2017, SOFTW MED DEV SAMD C; US Food and Drug Administration, 2018, DIG HLTH INN ACT PLA; Wang D., 2016, DEEP LEARNING IDENTI	36	468	525	59	484	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					30	36		10.1038/s41591-018-0307-0	http://dx.doi.org/10.1038/s41591-018-0307-0			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617336	Green Accepted			2022-12-27	WOS:000455027700017
J	Koo, J; MacEwan, MR; Kang, SK; Won, SM; Stephen, M; Gamble, P; Xie, ZQ; Yan, Y; Chen, YY; Shin, J; Birenbaum, N; Chung, SJ; Kim, SB; Khalifeh, J; Harburg, DV; Bean, K; Paskett, M; Kim, J; Zohny, ZS; Lee, SM; Zhang, RY; Luo, KJ; Ji, BW; Banks, A; Lee, HM; Huang, YG; Ray, WZ; Rogers, JA				Koo, Jahyun; MacEwan, Matthew R.; Kang, Seung-Kyun; Won, Sang Min; Stephen, Manu; Gamble, Paul; Xie, Zhaoqian; Yan, Ying; Chen, Yu-Yu; Shin, Jiho; Birenbaum, Nathan; Chung, Sangjin; Kim, Sung Bong; Khalifeh, Jawad; Harburg, Daniel V.; Bean, Kelsey; Paskett, Michael; Kim, Jeonghyun; Zohny, Zohny S.; Lee, Seung Min; Zhang, Ruoyao; Luo, Kaijing; Ji, Bowen; Banks, Anthony; Lee, Hyuck Mo; Huang, Younggang; Ray, Wilson Z.; Rogers, John A.			Wireless bioresorbable electronic system enables sustained nonpharmacological neuroregenerative therapy	NATURE MEDICINE			English	Article							ACCELERATES AXON REGENERATION; PERIPHERAL-NERVE INJURIES; ELECTRICAL-STIMULATION; CONTROLLED-RELEASE; BIOCOMPATIBILITY; IMPLANTATION; DELIVERY; FK506; MUSCLE	Peripheral nerve injuries represent a significant problem in public health, constituting 2-5% of all trauma cases(1). For severe nerve injuries, even advanced forms of clinical intervention often lead to incomplete and unsatisfactory motor and/or sensory function(2). Numerous studies report the potential of pharmacological approaches (for example, growth factors, immunosuppressants) to accelerate and enhance nerve regeneration in rodent models(3-10). Unfortunately, few have had a positive impact in clinical practice. Direct intraoperative electrical stimulation of injured nerve tissue proximal to the site of repair has been demonstrated to enhance and accelerate functional recovery(11,12), suggesting a novel nonpharmacological, bioelectric form of therapy that could complement existing surgical approaches. A significant limitation of this technique is that existing protocols are constrained to intraoperative use and limited therapeutic benefits(13). Herein we introduce (i) a platform for wireless, programmable electrical peripheral nerve stimulation, built with a collection of circuit elements and substrates that are entirely bioresorbable and biocompatible, and (ii) the first reported demonstration of enhanced neuroregeneration and functional recovery in rodent models as a result of multiple episodes of electrical stimulation of injured nervous tissue.	[Koo, Jahyun; Lee, Seung Min; Huang, Younggang; Rogers, John A.] Northwestern Univ, Ctr Biointegrated Elect, Evanston, IL 60208 USA; [Koo, Jahyun; Xie, Zhaoqian; Lee, Seung Min; Luo, Kaijing; Ji, Bowen; Banks, Anthony; Huang, Younggang; Rogers, John A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [MacEwan, Matthew R.; Stephen, Manu; Gamble, Paul; Yan, Ying; Birenbaum, Nathan; Khalifeh, Jawad; Bean, Kelsey; Paskett, Michael; Zohny, Zohny S.; Ray, Wilson Z.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63130 USA; [MacEwan, Matthew R.; Birenbaum, Nathan; Ray, Wilson Z.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Kang, Seung-Kyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Kang, Seung-Kyun] Korea Adv Inst Sci & Technol, KAIST Inst Hlth Sci & Technol, Daejeon, South Korea; [Won, Sang Min; Chen, Yu-Yu; Shin, Jiho; Chung, Sangjin; Kim, Sung Bong; Harburg, Daniel V.; Zhang, Ruoyao; Banks, Anthony; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Xie, Zhaoqian; Luo, Kaijing; Ji, Bowen; Huang, Younggang; Rogers, John A.] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60201 USA; [Kim, Jeonghyun] Kwangwoon Univ, Dept Elect Convergence Engn, Seoul, South Korea; [Lee, Hyuck Mo] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Daejeon, South Korea; [Rogers, John A.] Northwestern Univ, Dept Elect Engn, Evanston, IL 60201 USA; [Rogers, John A.] Northwestern Univ, Dept Comp Sci, Evanston, IL 60201 USA; [Rogers, John A.] Northwestern Univ, Dept Chem, Evanston, IL 60201 USA; [Rogers, John A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Simpson Querrey Inst Nano Biotechnol, Evanston, IL 60201 USA; [Rogers, John A.] Northwestern Univ, McCormick Sch Engn, Evanston, IL 60201 USA; [Rogers, John A.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60201 USA; [Rogers, John A.] Northwestern Univ, Dept Neurol Surg, Evanston, IL 60201 USA	Northwestern University; Northwestern University; Washington University (WUSTL); Washington University (WUSTL); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Kwangwoon University; Korea Advanced Institute of Science & Technology (KAIST); Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Rogers, JA (corresponding author), Northwestern Univ, Ctr Biointegrated Elect, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Ray, WZ (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63130 USA.; Ray, WZ (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Rogers, JA (corresponding author), Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Elect Engn, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Comp Sci, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Simpson Querrey Inst Nano Biotechnol, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, McCormick Sch Engn, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, Feinberg Sch Med, Evanston, IL 60201 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Neurol Surg, Evanston, IL 60201 USA.	rayz@wudosis.wustl.edu; jrogers@northwestern.edu	Kim, Sung Bong/O-2051-2018; Rogers, John/L-2798-2016; Huang, Yonggang/B-6998-2009; Kang, Seung-Kyun/L-3053-2017; Ji, Bowen/AAI-6986-2020; Xie, Zhaoqian/AAD-5087-2019; huang, yonggang/O-6236-2019	Kim, Sung Bong/0000-0003-3082-349X; Xie, Zhaoqian/0000-0003-1320-817X; Birenbaum, Nathan/0000-0002-9195-8606; Koo, Jahyun/0000-0003-1503-0731; WANG, KE/0000-0003-2004-2745; Paskett, Michael/0000-0002-1188-5129	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2018R1C1B5043901]; NRF - Korean government (MEST) [2011-0028612]; National Natural Science Foundation of China [11402134]; National Science Foundation [1400169, 1534120, 1635443]; DARPA; Center for Bio-Integrated Electronics at Northwestern University	National Research Foundation of Korea (NRF) - Korean government (MSIT); NRF - Korean government (MEST); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Bio-Integrated Electronics at Northwestern University	S.-K.K. is supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF-2018R1C1B5043901). H.M.L. is supported by a grant from NRF funded by the Korean government (MEST) (2011-0028612). Z.X. acknowledges support from the National Natural Science Foundation of China (grant no. 11402134). Y.H. acknowledges support from National Science Foundation (grant nos. 1400169, 1534120, and 1635443). J.A.R. acknowledges support from DARPA and from the Center for Bio-Integrated Electronics at Northwestern University. We thank S.J. Robinson (Beckman Institute, University of Illinois at Urbana-Champaign) and K. Doty (Department of Comparative Biosciences Histology Service Laboratory,University of Illinois at Urbana-Champaign) for histology staining and images that greatly improved the manuscript.	Vieira MGA, 2011, EUR POLYM J, V47, P254, DOI 10.1016/j.eurpolymj.2010.12.011; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; BARR JO, 1986, PHYS THER, V66, P1515, DOI 10.1093/ptj/66.10.1515; Brushart TM, 2002, J NEUROSCI, V22, P6631; Christensen MB, 2016, BIOMATERIALS, V77, P235, DOI 10.1016/j.biomaterials.2015.11.012; Cuoco FA, 2000, IEEE T REHABIL ENG, V8, P35, DOI 10.1109/86.830947; Elzinga K, 2015, EXP NEUROL, V269, P142, DOI 10.1016/j.expneurol.2015.03.022; FORNAGE BD, 1986, J CLIN ULTRASOUND, V14, P619, DOI 10.1002/jcu.1870140808; Gamble P, 2016, MUSCLE NERVE, V54, P1114, DOI 10.1002/mus.25153; Gans C, 1982, Exerc Sport Sci Rev, V10, P160; Gordon T, 2016, NEUROTHERAPEUTICS, V13, P295, DOI 10.1007/s13311-015-0415-1; Gordon T, 2016, EUR J NEUROSCI, V43, P336, DOI 10.1111/ejn.13005; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Grill WM, 2000, J BIOMED MATER RES, V50, P215; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; Hingne PM, 2007, J PAIN, V8, P251, DOI 10.1016/j.jpain.2006.08.008; Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018; Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g; Kallainen LK, 2002, MUSCLE NERVE, V25, P31, DOI 10.1002/mus.1216; Kang SK, 2016, NATURE, V530, P71, DOI 10.1038/nature16492; Kemp SWP, 2017, EXP NEUROL, V287, P348, DOI 10.1016/j.expneurol.2016.04.011; Konofaos P, 2013, J RECONSTR MICROSURG, V29, P141, DOI 10.1055/s-0032-1333314; Labroo P, 2017, MUSCLE NERVE, V55, P570, DOI 10.1002/mus.25370; Labroo P, 2016, SHOCK, V46, P154, DOI 10.1097/SHK.0000000000000628; Lee S, 2018, MATER TODAY, V21, P207, DOI 10.1016/j.mattod.2017.12.005; Lee Y, 1998, AN678; Leventhal DK, 2006, J NEURAL ENG, V3, P102, DOI 10.1088/1741-2560/3/2/004; Maxwell DJ, 2005, ACTA BIOMATER, V1, P101, DOI 10.1016/j.actbio.2004.09.002; MENDEZ J, 1960, METABOLISM, V9, P184; NIX WA, 1983, BRAIN RES, V272, P21, DOI 10.1016/0006-8993(83)90360-8; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; PATEL NB, 1985, J NEUROSCI RES, V13, P245, DOI 10.1002/jnr.490130117; Petersson AEV, 2005, GREEN CHEM, V7, P837, DOI 10.1039/b510815b; Ray WZ, 2017, ACTA NEUROCHIR, V159, P1765, DOI 10.1007/s00701-017-3203-3; Rojas-Molina R., 2013, Journal of Medicinal Plants Research, V7, P702; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7; Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387; Srinivasan A, 2015, BIOMATERIALS, V41, P151, DOI 10.1016/j.biomaterials.2014.11.035; Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003; Willand MP, 2016, NEUROREHAB NEURAL RE, V30, P490, DOI 10.1177/1545968315604399; Winter KF, 1998, J NEUROSCI METH, V79, P79, DOI 10.1016/S0165-0270(97)00160-X; Winter W. G., 1981, T ORTHOP RES SOC, V6, P304; WODZICKA MANIKA, 1958, NEW ZEALAND JOUR AGRIC RES, V1, P582; Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766; Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004; Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847; ZIERHOFER MC, 1992, INT J ARTIF ORGANS, V15, P378, DOI 10.1177/039139889201500612	49	205	207	23	202	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2018	24	12					1830	+		10.1038/s41591-018-0196-2	http://dx.doi.org/10.1038/s41591-018-0196-2			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HD3DA	30297910				2022-12-27	WOS:000452392200011
J	Levy, JMM; McMahon, M				Levy, Jean M. Mulcahy; McMahon, Martin			Linking brain tumors and epileptic seizures	NATURE MEDICINE			English	Editorial Material							MECHANISMS		[Levy, Jean M. Mulcahy] Childrens Hosp Colorado, Morgan Adams Fdn Pediat Brain Tumor Res Program, Denver, CO 80045 USA; [Levy, Jean M. Mulcahy] Univ Colorado, Denver, CO 80202 USA; [McMahon, Martin] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [McMahon, Martin] Univ Utah, Dept Dermatol, Salt Lake City, UT 84112 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Levy, JMM (corresponding author), Childrens Hosp Colorado, Morgan Adams Fdn Pediat Brain Tumor Res Program, Denver, CO 80045 USA.; Levy, JMM (corresponding author), Univ Colorado, Denver, CO 80202 USA.; McMahon, M (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.; McMahon, M (corresponding author), Univ Utah, Dept Dermatol, Salt Lake City, UT 84112 USA.	jean.mulcahylevy@ucdenver.edu; martin.mcmahon@hci.utah.edu			NCI NIH HHS [R01 CA176839, R01 CA131261, K08 CA193982] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA176839, R01CA131261, K08CA193982] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen DY, 2018, J NEURO-ONCOL, V139, P13, DOI 10.1007/s11060-018-2862-0; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Johansson CH, 2014, PHARMACOL THERAPEUT, V142, P176, DOI 10.1016/j.pharmthera.2013.11.011; Kieran MW, 2015, J CLIN ONCOL, V33; Koh HY, 2018, NAT MED, V24, P1662, DOI 10.1038/s41591-018-0172-x; Krueger DA, 2016, NEUROLOGY, V87, P2408, DOI 10.1212/WNL.0000000000003400; Lee JH, 2018, NATURE, V560, P243, DOI 10.1038/s41586-018-0389-3; Lim JS, 2017, AM J HUM GENET, V100, P454, DOI 10.1016/j.ajhg.2017.01.030; Gonzalez FJL, 2015, NEUROLOGIA, V30, P439, DOI 10.1016/j.nrl.2014.04.012; Martinoni M, 2015, J CLIN NEUROSCI, V22, P1250, DOI 10.1016/j.jocn.2015.02.016; Marucci G, 2014, ANN CLIN TRANSL NEUR, V1, P130, DOI 10.1002/acn3.31; Mittapalli RK, 2013, J PHARMACOL EXP THER, V344, P655, DOI 10.1124/jpet.112.201475	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1638	1639		10.1038/s41591-018-0249-6	http://dx.doi.org/10.1038/s41591-018-0249-6			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30374199	Green Accepted			2022-12-27	WOS:000449404200009
J	Lynch, CJ; Liston, C				Lynch, Charles J.; Liston, Conor			New machine-learning technologies for computer-aided diagnosis	NATURE MEDICINE			English	Editorial Material							PREDICTION		[Lynch, Charles J.; Liston, Conor] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Liston, Conor] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA; [Liston, Conor] Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Liston, C (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.; Liston, C (corresponding author), Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA.; Liston, C (corresponding author), Weill Cornell Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10065 USA.	col2004@med.cornell.edu	, Conor Liston/GQH-8931-2022	Lynch, Charles/0000-0003-1936-9740				De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Lehman CD, 2015, JAMA INTERN MED, V175, P1828, DOI 10.1001/jamainternmed.2015.5231; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Titano JJ, 2018, NAT MED, V24, P1337, DOI 10.1038/s41591-018-0147-y; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	10	44	44	4	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1304	1305		10.1038/s41591-018-0178-4	http://dx.doi.org/10.1038/s41591-018-0178-4			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30177823				2022-12-27	WOS:000444174100005
J	Trotta, E; Bessette, PH; Silveria, SL; Ely, LK; Jude, KM; Le, DT; Holst, CR; Coyle, A; Potempa, M; Lanier, LL; Garcia, KC; Crellin, NK; Rondon, IJ; Bluestone, JA				Trotta, Eleonora; Bessette, Paul H.; Silveria, Stephanie L.; Ely, Lauren K.; Jude, Kevin M.; Le, Duy T.; Holst, Charles R.; Coyle, Anthony; Potempa, Marc; Lanier, Lewis L.; Garcia, K. Christopher; Crellin, Natasha K.; Rondon, Isaac J.; Bluestone, Jeffrey A.			A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism	NATURE MEDICINE			English	Article							LOW-DOSE INTERLEUKIN-2; SYSTEMIC-LUPUS-ERYTHEMATOSUS; VERSUS-HOST-DISEASE; SELECTIVE STIMULATION; ALPHA-RECEPTOR; IL-2; COMPLEXES; ACTIVATION; IMMUNOTHERAPY; TOLERANCE	Interleukin-2 (IL-2) has been shown to suppress immune pathologies by preferentially expanding regulatory T cells (T-regs). However, this therapy has been limited by off-target complications due to pathogenic cell expansion. Recent efforts have been focused on developing a more selective IL-2. It is well documented that certain anti-mouse IL-2 antibodies induce conformational changes that result in selective targeting of T-regs. We report the generation of a fully human anti-IL-2 antibody, F5111.2, that stabilizes IL-2 in a conformation that results in the preferential STAT5 phosphorylation of T-regs in vitro and selective expansion of T-regs in vivo. When complexed with human IL-2, F5111.2 induced remission of type 1 diabetes in the NOD mouse model, reduced disease severity in a model of experimental autoimmune encephalomyelitis and protected mice against xenogeneic graft-versus-host disease. These results suggest that IL-2-F5111.2 may provide an immunotherapy to treat autoimmune diseases and graft-versus-host disease.	[Trotta, Eleonora; Silveria, Stephanie L.; Bluestone, Jeffrey A.] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Bessette, Paul H.; Ely, Lauren K.; Crellin, Natasha K.; Rondon, Isaac J.] Pfizer Inc, Ctr Therapeut Innovat, San Francisco, CA USA; [Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Le, Duy T.] Univ Houston, Dept Pediat Immunol Allergy & Rheumatol, Houston, TX USA; [Holst, Charles R.] BioElectron Technol Corp, Mountain View, CA USA; [Coyle, Anthony] Pand Therapeut, Cambridge, MA USA; [Potempa, Marc; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Bluestone, Jeffrey A.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA	University of California System; University of California San Francisco; Pfizer; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; University of Houston System; University of Houston; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University	Bluestone, JA (corresponding author), Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA.; Bluestone, JA (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.	Jeff.Bluestone@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Jude, Kevin/0000-0002-3675-5136; Le, Duy/0000-0003-3399-1376; Holst, Charles/0000-0001-8010-1677	Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129, R37AI051321] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Pfizer for funding this study and participating in experiments and discussion, and the entire laboratory of J.A.B. and members of the laboratory of K.C.G. for support. In particular, we thank F. Van Gool and M. DuPage from the Bluestone laboratory for insightful discussions, D. Samuel from CTI-Pfizer for antibodies and protein preparation and UCSF Flow Core for its excellent technical assistance. We would also like to thank all of the healthy donors involved in this study.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Arenas-Ramirez N, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag3187; Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003; Arkin MR, 2003, P NATL ACAD SCI USA, V100, P1603, DOI 10.1073/pnas.252756299; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRARA JLM, 1993, CURR OPIN IMMUNOL, V5, P794, DOI 10.1016/0952-7915(93)90139-J; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; Hannon M, 2014, TRANSFUSION, V54, P353, DOI 10.1111/trf.12279; Hartemann A, 2013, LANCET DIABETES ENDO, V1, P295, DOI 10.1016/S2213-8587(13)70113-X; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; Jafari R, 2017, CURR MED CHEM, V24, P1228, DOI 10.2174/0929867324666170113112759; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SY, 2012, IMMUNOLOGY, V137, P305, DOI 10.1111/imm.12008; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Long SA, 2012, DIABETES, V61, P2340, DOI 10.2337/db12-0049; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitra S, 2015, IMMUNITY, V42, P826, DOI 10.1016/j.immuni.2015.04.018; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Saadoun D, 2014, NEW ENGL J MED, V370, P786, DOI 10.1056/NEJMx140003; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; von Spee-Mayer C, 2016, ANN RHEUM DIS, V75, P1407, DOI 10.1136/annrheumdis-2015-207776; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wu KF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31562; YANG JC, 1995, CANCER, V76, P687, DOI 10.1002/1097-0142(19950815)76:4<687::AID-CNCR2820760424>3.0.CO;2-M; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	51	109	112	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					1005	+		10.1038/s41591-018-0070-2	http://dx.doi.org/10.1038/s41591-018-0070-2			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29942088	Green Published, Green Accepted			2022-12-27	WOS:000438187700029
J	Radvanyi, LG				Radvanyi, Laszlo G.			IMMUNOTHERAPY Targeting the cancer mutanome of breast cancer	NATURE MEDICINE			English	Editorial Material							T-CELLS	A metastatic hormone receptor-positive breast cancer, usually resistant to immunotherapy, is successfully treated with tumor-infiltrating lymphocytes enriched for neoantigen reactivity, underscoring the broad potential of this immunotherapeutic approach.	[Radvanyi, Laszlo G.] Ontario Inst Canc Res, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Radvanyi, LG (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	laszlo.radvanyi@oicr.on.ca						Alvarez B, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700252; Bobisse S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03301-0; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Efremova M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01679; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Schumacher TN, 2016, CURR OPIN IMMUNOL, V41, P98, DOI 10.1016/j.coi.2016.07.005; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8	12	7	8	4	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					703	704		10.1038/s41591-018-0065-z	http://dx.doi.org/10.1038/s41591-018-0065-z			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29867234				2022-12-27	WOS:000434281300011
J	Xu, K; Acharya, P; Kong, R; Cheng, C; Chuang, GY; Liu, K; Louder, MK; O'Dell, S; Rawi, R; Sastry, M; Shen, CH; Zhang, BS; Zhou, TQ; Asokan, M; Bailer, RT; Chambers, M; Chen, XJ; Choi, CW; Dandey, VP; Doria-Rose, NA; Druz, A; Eng, ET; Farney, SK; Foulds, KE; Geng, H; Georgiev, IS; Gorman, J; Hill, KR; Jafari, AJ; Kwon, YD; Lai, YT; Lemmin, T; McKee, K; Ohr, TY; Ou, L; Peng, DJ; Rowshan, AP; Sheng, ZZ; Todd, JP; Tsybovsky, Y; Viox, EG; Wang, YR; Wei, H; Yang, YP; Zhou, AF; Chen, R; Yang, L; Scorpio, DG; McDermott, AB; Shapiro, L; Carragher, B; Potter, CS; Mascola, JR; Kwong, PD				Xu, Kai; Acharya, Priyamvada; Kong, Rui; Cheng, Cheng; Chuang, Gwo-Yu; Liu, Kevin; Louder, Mark K.; O'Dell, Sijy; Rawi, Reda; Sastry, Mallika; Shen, Chen-Hsiang; Zhang, Baoshan; Zhou, Tongqing; Asokan, Mangaiarkarasi; Bailer, Robert T.; Chambers, Michael; Chen, Xuejun; Choi, Chang W.; Dandey, Venkata P.; Doria-Rose, Nicole A.; Druz, Aliaksandr; Eng, Edward T.; Farney, S. Katie; Foulds, Kathryn E.; Geng, Hui; Georgiev, Ivelin S.; Gorman, Jason; Hill, Kurt R.; Jafari, Alexander J.; Kwon, Young D.; Lai, Yen-Ting; Lemmin, Thomas; McKee, Krisha; Ohr, Tiffany Y.; Ou, Li; Peng, Dongjun; Rowshan, Ariana P.; Sheng, Zizhang; Todd, John-Paul; Tsybovsky, Yaroslav; Viox, Elise G.; Wang, Yiran; Wei, Hui; Yang, Yongping; Zhou, Amy F.; Chen, Rui; Yang, Lu; Scorpio, Diana G.; McDermott, Adrian B.; Shapiro, Lawrence; Carragher, Bridget; Potter, Clinton S.; Mascola, John R.; Kwong, Peter D.			Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1	NATURE MEDICINE			English	Article							HUMAN MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; BROAD NEUTRALIZATION; STRUCTURAL BASIS; POTENT; GP41; ENV; IDENTIFICATION; VULNERABILITY; IMMUNIZATION	A central goal of HIV-1 vaccine research is the elicitation of antibodies capable of neutralizing diverse primary isolates of HIV-1. Here we show that focusing the immune response to exposed N-terminal residues of the fusion peptide, a critical component of the viral entry machinery and the epitope of antibodies elicited by HIV-1 infection, through immunization with fusion peptide-coupled carriers and prefusion stabilized envelope trimers, induces cross-clade neutralizing responses. In mice, these immunogens elicited monoclonal antibodies capable of neutralizing up to 31% of a cross-clade panel of 208 HIV-1 strains. Crystal and cryoelectron microscopy structures of these antibodies revealed fusion peptide conformational diversity as a molecular explanation for the cross-clade neutralization. Immunization of guinea pigs and rhesus macaques induced similarly broad fusion peptide-directed neutralizing responses, suggesting translatability. The N terminus of the HIV-1 fusion peptide is thus a promising target of vaccine efforts aimed at eliciting broadly neutralizing antibodies.	[Xu, Kai; Acharya, Priyamvada; Kong, Rui; Cheng, Cheng; Chuang, Gwo-Yu; Liu, Kevin; Louder, Mark K.; O'Dell, Sijy; Rawi, Reda; Sastry, Mallika; Shen, Chen-Hsiang; Zhang, Baoshan; Zhou, Tongqing; Asokan, Mangaiarkarasi; Bailer, Robert T.; Chambers, Michael; Chen, Xuejun; Choi, Chang W.; Doria-Rose, Nicole A.; Druz, Aliaksandr; Farney, S. Katie; Foulds, Kathryn E.; Geng, Hui; Gorman, Jason; Hill, Kurt R.; Jafari, Alexander J.; Kwon, Young D.; Lai, Yen-Ting; McKee, Krisha; Ohr, Tiffany Y.; Ou, Li; Peng, Dongjun; Rowshan, Ariana P.; Todd, John-Paul; Viox, Elise G.; Wang, Yiran; Yang, Yongping; Zhou, Amy F.; Scorpio, Diana G.; McDermott, Adrian B.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Acharya, Priyamvada; Dandey, Venkata P.; Eng, Edward T.; Wei, Hui; Carragher, Bridget; Potter, Clinton S.] New York Struct Biol Ctr, Simons Electron Microscopy Ctr, Natl Resource Automated Mol Microscopy, New York, NY USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Georgiev, Ivelin S.] Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lemmin, Thomas] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Sheng, Zizhang; Shapiro, Lawrence; Kwong, Peter D.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Sheng, Zizhang; Shapiro, Lawrence] Columbia Univ, Dept Syst Biol, New York, NY USA; [Tsybovsky, Yaroslav] Leidos Biomed Res Inc, Electron Microscopy Lab, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Chen, Rui; Yang, Lu] GenScript USA, Piscataway, NJ USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mascola, JR; Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Kwong, PD (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	jmascola@nih.gov; pdkwong@nih.gov	Gorman, Jason/AGG-9417-2022; Lemmin, Thomas/AAO-7849-2021; Zhou, Tongqing/A-6880-2010; Mascola, John/AAI-7193-2021; Cheng, Cheng/AAE-8255-2019; Sheng, Zizhang/AFR-8049-2022; Shapiro, Lawrence/AAE-7172-2019; Do Kwon, Young/A-6957-2010	Zhou, Tongqing/0000-0002-3935-4637; Sheng, Zizhang/0000-0002-3253-3309; Do Kwon, Young/0000-0002-1188-7458; Acharya, Priyamvada/0000-0002-0089-277X; Eng, Edward/0000-0002-8014-7269; McDermott, Adrian/0000-0003-0616-9117; Lemmin, Thomas/0000-0001-5705-4964	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; IAVI's NAC; federal funds from the Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; NIH [R01 AI131722, OD019994]; Simons Foundation NYSTAR [SF349247]; NIH National Institute of General Medical Sciences [GM103310]; Agouron Institute [F00316]; US Department of Energy, Basic Energy Sciences, Office of Science, [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024, ZICAI005113, R21AI138024, R01AI131722, ZICAI005111, ZICAI005114, ZIAAI005095, ZIGAI005099, ZIAAI005143, ZICAI005103, ZIAAI005012, ZIAAI005010, ZICAI005112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; IAVI's NAC; federal funds from the Frederick National Laboratory for Cancer Research, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation NYSTAR; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agouron Institute(Pfizer); US Department of Energy, Basic Energy Sciences, Office of Science,(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chrzas, U. Chinte, Z. Jin, and staff at SER-CAT (Southeast Regional Collaborative Access Team) for help with X-ray diffraction data collection; B. DeKosky for suggestions on lineage discrimination, W. Rice and SEMC staff for assistance with cryo-EM data collection; and J. Stuckey for assistance with figures. We thank D. Burton and M. Fineberg (International AIDS Vaccine Initiative (IAVI), Neutralizing Antibody Consortium (NAC)) for antibodies, including PGT122 used in cryo-EM studies, B. Haynes (The Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID)) for information on antibody CH07, R. Sanders (Academisch Medisch Centrum Universiteit van Amsterdam (AMC)) for information on antibody ACS202, B. Graham (Vaccine Research Center, NIAID, NIH) for murine antibody 5C4, and the WCMC/AMC/TSRI HIVRAD team for their contributions to the design and validation of near-native mimicry for soluble BG505 SOSIP.664 trimers. We thank members of the Structural Biology Section, Structural Bioinformatics Core Section, and Human Immunology Section of the Vaccine Research Center for helpful comments. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health. This work was also supported in part by IAVI's NAC (J.R.M and P.D.K.) and with federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E (Y.T.). I.S.G. received support from NIH grant R01 AI131722. Some of this work was performed at the Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy, located at the New York Structural Biology Center, supported by grants from the Simons Foundation (SF349247) NYSTAR, and the NIH National Institute of General Medical Sciences (GM103310), with additional support from Agouron Institute (F00316) and NIH (OD019994). Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/NMETH.3541, 10.1038/nmeth.3541]; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; Dandey VP, 2018, J STRUCT BIOL, V202, P161, DOI 10.1016/j.jsb.2018.01.002; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006148; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Furuyama W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20514; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Hastie KM, 2017, SCIENCE, V356, P923, DOI 10.1126/science.aam7260; Haynes Barton F., 2005, Human Antibodies, V14, P59; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Razinkov I, 2016, J STRUCT BIOL, V195, P190, DOI 10.1016/j.jsb.2016.06.001; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Trkola A, 2008, J VIROL, V82, P1591, DOI 10.1128/JVI.01792-07; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; Wei H, 2018, J STRUCT BIOL, V202, P170, DOI 10.1016/j.jsb.2018.01.001; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhao XL, 2017, CELL, V169, P891, DOI 10.1016/j.cell.2017.04.038; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	83	158	164	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					857	+		10.1038/s41591-018-0042-6	http://dx.doi.org/10.1038/s41591-018-0042-6			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29867235	Green Submitted, Bronze, Green Accepted			2022-12-27	WOS:000434281300030
J	Clement, K; Biebermann, H; Farooqi, IS; Van der Ploeg, L; Wolters, B; Poitou, C; Puder, L; Fiedorek, F; Gottesdiener, K; Kleinau, G; Heyder, N; Scheerer, P; Blume-Peytavi, U; Jahnke, I; Sharma, S; Mokrosinski, J; Wiegand, S; Muller, A; Weiss, K; Mai, K; Spranger, J; Gruters, A; Blankenstein, O; Krude, H; Kuhnen, P				Clement, Karine; Biebermann, Heike; Farooqi, I. Sadaf; Van der Ploeg, Lex; Wolters, Barbara; Poitou, Christine; Puder, Lia; Fiedorek, Fred; Gottesdiener, Keith; Kleinau, Gunnar; Heyder, Nicolas; Scheerer, Patrick; Blume-Peytavi, Ulrike; Jahnke, Irina; Sharma, Shubh; Mokrosinski, Jacek; Wiegand, Susanna; Mueller, Anne; Weiss, Katja; Mai, Knut; Spranger, Joachim; Grueters, Annette; Blankenstein, Oliver; Krude, Heiko; Kuehnen, Peter			MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency	NATURE MEDICINE			English	Article							PROTEIN-COUPLED RECEPTOR; MELANOCORTIN RECEPTORS; CRYSTAL-STRUCTURE; OBESITY; SETMELANOTIDE; THERAPIES	Genetic defects underlying the melanocortin-4 receptor (MC4R) signaling pathway lead to severe obesity. Three severely obese LEPR-deficient individuals were administered the MC4R agonist setmelanotide, resulting in substantial and durable reductions in hyperphagia and body weight over an observation period of 45-61 weeks. Compared to formerly developed and tested MC4R agonists, setmelanotide has the unique capability of activating nuclear factor of activated T cell (NFAT) signaling and restoring function of this signaling pathway for selected MC4R variants. Our data demonstrate the potency of setmelanotide in treatment of individuals with diverse MC4R-related pathway deficiencies.	[Clement, Karine; Poitou, Christine] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, INSERM,NutriOm Team, Paris, France; [Biebermann, Heike; Wolters, Barbara; Puder, Lia; Mueller, Anne; Blankenstein, Oliver; Krude, Heiko; Kuehnen, Peter] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Expt Pediat Endocrinol, Berlin, Germany; [Biebermann, Heike; Puder, Lia; Kleinau, Gunnar; Heyder, Nicolas; Scheerer, Patrick; Blume-Peytavi, Ulrike; Jahnke, Irina; Wiegand, Susanna; Mueller, Anne; Weiss, Katja; Mai, Knut; Spranger, Joachim; Grueters, Annette; Blankenstein, Oliver; Krude, Heiko; Kuehnen, Peter] Berlin Inst Hlth, Berlin, Germany; [Farooqi, I. Sadaf; Mokrosinski, Jacek] Univ Cambridge, Metab Res Labs, Cambridge, England; [Farooqi, I. Sadaf; Mokrosinski, Jacek] Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Van der Ploeg, Lex; Fiedorek, Fred; Gottesdiener, Keith; Sharma, Shubh] Rhythm Pharmaceut, Boston, MA USA; [Kleinau, Gunnar; Heyder, Nicolas; Scheerer, Patrick] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Med Phys & Biophys,Grp Prot Xray Crystallog, Berlin, Germany; [Scheerer, Patrick; Mai, Knut; Spranger, Joachim] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Blume-Peytavi, Ulrike; Jahnke, Irina] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Clin Res Ctr Hair & Skin Sci,Dept Dermatol & Alle, Berlin, Germany; [Wiegand, Susanna] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Ctr Chron Sick Children, Berlin, Germany; [Weiss, Katja] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Pediat Cardiol, Berlin, Germany; [Mai, Knut; Spranger, Joachim] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Mai, Knut; Spranger, Joachim] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Charite Ctr Cardiovasc Res, Berlin, Germany; [Grueters, Annette] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Pediat Endocrinol & Diabet, Berlin, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhnen, P (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Expt Pediat Endocrinol, Berlin, Germany.; Kuhnen, P (corresponding author), Berlin Inst Hlth, Berlin, Germany.	peter.kuehnen@charite.de	Poitou, Christine/GVT-6117-2022; Mokrosinski, Jacek/M-1963-2019; Mai, Knut/W-9904-2019; Blankenstein, Oliver/AAS-7611-2020; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Kleinau, Gunnar/GPX-6330-2022; O'Rahilly, Stephen/ABF-6509-2020	Poitou, Christine/0000-0001-7769-6331; Mokrosinski, Jacek/0000-0001-5008-0457; Mai, Knut/0000-0003-0126-3155; Blankenstein, Oliver/0000-0003-1803-5589; O'Rahilly, Stephen/0000-0003-2199-4449; Weiss, Katja/0000-0002-0658-8074; Scheerer, Patrick/0000-0001-5028-2075; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Farooqi, Sadaf/0000-0001-7609-3504; Biebermann, Heike/0000-0002-2024-7778; Wiegand, Susanna/0000-0001-8341-9533; Kuhnen, Peter/0000-0003-0211-176X; Heyder, Nicolas/0000-0002-8755-5433; Muller, Anne/0000-0002-6256-8860	German Research Foundation (DFG) [KU 2673/2-1, SPP1629: BI839/5-2, KR1701/5-1, KF0218, HI 865/2-1]; Bundesministerium far Bildung and Forschung (BMBF) (NGFN- Plus) [01GS0820]; Helmholtz Association (ICEMED) [WB19]; Institute of Cardiometabolism and Nutrition; Assistance Publique Hopitaux de Paris; Institut Benjamin Delessert; Charite /Berlin Institute of Health (BIH) Clinical Scientist Program; Berlin Institute of Health (BIH); DFG [SFB740-B6, SFB1078-B6]; DFG Cluster of Excellence 'Unifying Concepts in Catalysis'; Wellcome Trust	German Research Foundation (DFG)(German Research Foundation (DFG)); Bundesministerium far Bildung and Forschung (BMBF) (NGFN- Plus)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association (ICEMED); Institute of Cardiometabolism and Nutrition; Assistance Publique Hopitaux de Paris; Institut Benjamin Delessert; Charite /Berlin Institute of Health (BIH) Clinical Scientist Program; Berlin Institute of Health (BIH); DFG(German Research Foundation (DFG)); DFG Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust)	We thank D. Schnabel for his support and A. Stielow, S. Zvorc, S. Jyrch, and C. Cetindag (Charite Universitasmedizin Berlin, Germany) and H. Guermoudi, V. Lemoine and F. Marchelli (Pitie-Sapetriere hospital, Paris, France) for excellent study assistance. This work was supported by grants from the German Research Foundation (DFG) (KU 2673/2-1; SPP1629: BI839/5-2, KR1701/5-1; KF0218 and HI 865/2-1), Bundesministerium far Bildung and Forschung (BMBF) (NGFN- Plus, 01GS0820), the Helmholtz Association (ICEMED) (WB19) and the Institute of Cardiometabolism and Nutrition (K.C.) as well as Assistance Publique Hopitaux de Paris (clinical research contracts to K.C. and C.P.) and Institut Benjamin Delessert. P.K. was supported by the Charite /Berlin Institute of Health (BIH) Clinical Scientist Program. H.K. and K.M. were supported by the Berlin Institute of Health (BIH). P.S. was supported by the DFG (SFB740-B6, SFB1078-B6), and G.K. and P.S. were supported by the DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (Research Field E). I.S.F. was supported by the Wellcome Trust.	Bischof JM, 2016, BRIT J PHARMACOL, V173, P2614, DOI 10.1111/bph.13540; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Collet TH, 2017, MOL METAB, V6, P1321, DOI 10.1016/j.molmet.2017.06.015; Dinter J, 2015, J MOL ENDOCRINOL, V54, P205, DOI 10.1530/JME-15-0003; Ericson MD, 2017, BBA-MOL BASIS DIS, V1863, P2414, DOI 10.1016/j.bbadis.2017.03.020; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2014, J ENDOCRINOL, V223, pT63, DOI 10.1530/JOE-14-0480; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Huvenne H, 2015, J CLIN ENDOCR METAB, V100, pE757, DOI 10.1210/jc.2015-1036; Jackson VM, 2014, EXPERT OPIN INV DRUG, V23, P1055, DOI 10.1517/13543784.2014.918952; Koehbach J, 2013, P NATL ACAD SCI USA, V110, P21183, DOI 10.1073/pnas.1311183110; Krishna R, 2009, CLIN PHARMACOL THER, V86, P659, DOI 10.1038/clpt.2009.167; Kuhnen P, 2016, NEW ENGL J MED, V375, P240, DOI 10.1056/NEJMoa1512693; Li YQ, 2016, J CLIN INVEST, V126, P40, DOI 10.1172/JCI76348; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; Yang LK, 2017, BBA-MOL BASIS DIS, V1863, P2486, DOI 10.1016/j.bbadis.2017.04.010	23	145	149	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					551	+		10.1038/s41591-018-0015-9	http://dx.doi.org/10.1038/s41591-018-0015-9			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736023				2022-12-27	WOS:000432126800010
J	Cocco, E; Schram, AM; Kulick, A; Misale, S; Won, HH; Yaeger, R; Razavi, P; Ptashkin, R; Hechtman, JF; Toska, E; Cownie, J; Somwar, R; Shifman, S; Mattar, M; Selcuklu, SD; Samoila, A; Guzman, S; Tuch, BB; Ebata, K; de Stanchina, E; Nagy, RJ; Lanman, RB; Houck-Loomis, B; Patel, JA; Berger, MF; Ladanyi, M; Hyman, DM; Drilon, A; Scaltriti, M				Cocco, Emiliano; Schram, Alison M.; Kulick, Amanda; Misale, Sandra; Won, Helen H.; Yaeger, Rona; Razavi, Pedram; Ptashkin, Ryan; Hechtman, Jaclyn F.; Toska, Eneda; Cownie, James; Somwar, Romel; Shifman, Sophie; Mattar, Marissa; Selcuklu, S. Duygu; Samoila, Aliaksandra; Guzman, Sean; Tuch, Brian B.; Ebata, Kevin; de Stanchina, Elisa; Nagy, Rebecca J.; Lanman, Richard B.; Houck-Loomis, Brian; Patel, Juber A.; Berger, Michael F.; Ladanyi, Marc; Hyman, David M.; Drilon, Alexander; Scaltriti, Maurizio			Resistance to TRK inhibition mediated by convergent MAPK pathway activation	NATURE MEDICINE			English	Article							ACQUIRED-RESISTANCE; TARGETED THERAPY; EGFR; BRAF; MUTATIONS; FUSION; AMPLIFICATION; ENTRECTINIB; MECHANISMS; CRIZOTINIB	TRK fusions are found in a variety of cancer types, lead to oncogenic addiction, and strongly predict tumor-agnostic efficacy of TRK inhibition(1-8). With the recent approval of the first selective TRK inhibitor, larotrectinib, for patients with any TRK-fusion-positive adult or pediatric solid tumor, to identify mechanisms of treatment failure after initial response has become of immediate therapeutic relevance. So far, the only known resistance mechanism is the acquisition of on-target TRK kinase domain mutations, which interfere with drug binding and can potentially be addressable through second-generation TRK inhibitors(9-11). Here, we report off-target resistance in patients treated with TRK inhibitors and in patient-derived models, mediated by genomic alterations that converge to activate the mitogen-activated protein kinase (MAPK) pathway. MAPK pathway-directed targeted therapy, administered alone or in combination with TRK inhibition, re-established disease control. Experimental modeling further suggests that upfront dual inhibition of TRK and MEK may delay time to progression in cancer types prone to the genomic acquisition of MAPK pathway-activating alterations. Collectively, these data suggest that a subset of patients will develop off-target mechanisms of resistance to TRK inhibition with potential implications for clinical management and future clinical trial design.	[Cocco, Emiliano; Razavi, Pedram; Toska, Eneda; Cownie, James; Somwar, Romel; Shifman, Sophie; Berger, Michael F.; Ladanyi, Marc; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Cocco, Emiliano; Ptashkin, Ryan; Hechtman, Jaclyn F.; Somwar, Romel; Shifman, Sophie; Berger, Michael F.; Ladanyi, Marc; Scaltriti, Maurizio] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Schram, Alison M.; Yaeger, Rona; Razavi, Pedram; Hyman, David M.; Drilon, Alexander] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Schram, Alison M.; Hyman, David M.; Drilon, Alexander] Weill Cornell Med Coll, New York, NY 10065 USA; [Kulick, Amanda; Misale, Sandra; Yaeger, Rona; Mattar, Marissa; Guzman, Sean; de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA; [Kulick, Amanda; Mattar, Marissa; Guzman, Sean] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Core Facil, 1275 York Ave, New York, NY 10021 USA; [Won, Helen H.; de Stanchina, Elisa; Houck-Loomis, Brian; Patel, Juber A.; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Selcuklu, S. Duygu; Samoila, Aliaksandra] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA; [Tuch, Brian B.; Ebata, Kevin] Loxo Oncol, San Francisco, CA USA; [Nagy, Rebecca J.; Lanman, Richard B.] Guardant Hlth Inc, Dept Med Affairs, Redwood City, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Scaltriti, M (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Scaltriti, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.; Drilon, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Drilon, A (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	drilona@mskcc.org; scaltrim@mskcc.org	Toska, Eneda/AAQ-4369-2020; Toska, Eneda/AAO-1711-2020; Lanman, Richard B/D-8290-2016; Ladanyi, Marc/AAG-8585-2019	Toska, Eneda/0000-0002-8974-9792; Lanman, Richard B/0000-0001-8122-4329; Loomis, Brian/0000-0002-1863-1199; Ebata, Kevin/0000-0001-7166-7513; Schram, Alison/0000-0002-6070-2413; Hechtman, Jaclyn/0000-0003-2645-0985	National Cancer Institute (NCI) under the MSKCC [P30 CA008748, R01CA226864]; Cycle for Survival; LOXO Oncology; NIH [T32 CA009207]; ASCO; NATIONAL CANCER INSTITUTE [R01CA226864, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute (NCI) under the MSKCC; Cycle for Survival; LOXO Oncology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute (NCI) under the MSKCC Support Grant/Core Grant (P30 CA008748) and the R01CA226864 (to M.S. and A.D.). This work was also partially funded by the Cycle for Survival (to A.D.) and LOXO Oncology. The study was also supported by NIH T32 CA009207 (to A.M.S). A.M.S. is a recipient of the ASCO Young Investigator Award. E.C. is a recipient of a MSK society scholar prize.	Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Carlino MS, 2015, CLIN CANCER RES, V21, P98, DOI 10.1158/1078-0432.CCR-14-0759; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chang MT, 2018, CANCER DISCOV, V8, P174, DOI 10.1158/2159-8290.CD-17-0321; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cocco E, 2018, NAT REV CLIN ONCOL, V15, P731, DOI 10.1038/s41571-018-0113-0; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Drilon A, 2018, CANCER DISCOV, V8, P1227, DOI 10.1158/2159-8290.CD-18-0484; Drilon A, 2017, CANCER DISCOV, V7, P963, DOI 10.1158/2159-8290.CD-17-0507; Drilon A, 2017, CANCER DISCOV, V7, P400, DOI 10.1158/2159-8290.CD-16-1237; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Heist RS, 2016, J THORAC ONCOL, V11, P1242, DOI 10.1016/j.jtho.2016.06.013; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Hyman DM, 2019, NATURE, V566, pE11, DOI 10.1038/s41586-019-0974-0; Laetsch TW, 2018, LANCET ONCOL, V19, P705, DOI 10.1016/S1470-2045(18)30119-0; Le XN, 2018, CLIN CANCER RES, V24, P6195, DOI 10.1158/1078-0432.CCR-18-1542; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; Misale S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9305; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Nathenson M, 2018, ANN ONCOL, V29; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Pietrantonio F, 2016, CANCER DISCOV, V6, P963, DOI 10.1158/2159-8290.CD-16-0297; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Russo M, 2016, CANCER DISCOV, V6, P36, DOI 10.1158/2159-8290.CD-15-0940; Sanchez-Vega F, 2019, CANCER DISCOV, V9, P199, DOI 10.1158/2159-8290.CD-18-0598; Schram AM, 2017, NAT REV CLIN ONCOL, V14, P735, DOI 10.1038/nrclinonc.2017.127; Siravegna G, 2015, NAT MED, V21, P827, DOI 10.1038/nm0715-827b; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Tkac J, 2016, MOL CELL, V61, P405, DOI 10.1016/j.molcel.2015.12.013; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Vaishnavi A, 2015, CANCER DISCOV, V5, P25, DOI 10.1158/2159-8290.CD-14-0765; Yaeger R, 2017, CANCER RES, V77, P6513, DOI 10.1158/0008-5472.CAN-17-0768; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333	36	92	94	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1422	+		10.1038/s41591-019-0542-z	http://dx.doi.org/10.1038/s41591-019-0542-z			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31406350	Green Accepted			2022-12-27	WOS:000484832800026
J	Bhattacharjee, NV; Schaeffer, LE; Marczak, LB; Ross, JM; Swartz, SJ; Albright, J; Gardner, WM; Shields, C; Sligar, A; Schipp, MF; Pickering, BV; Henry, NJ; Johnson, KB; Louie, C; Cork, MA; Steuben, KM; Lazzar-Atwood, A; Lu, D; Kinyoki, DK; Osgood-Zimmerman, A; Earl, L; Mosser, JF; Deshpande, A; Burstein, R; Woyczynski, LP; Wilson, KF; VanderHeide, JD; Wiens, KE; Reiner, RC; Piwoz, EG; Rawat, R; Sartorius, B; Weaver, ND; Nixon, MR; Smith, DL; Kassebaum, NJ; Gakidou, E; Lim, SS; Mokdad, AH; Murray, CJL; Dwyer-Lindgren, L; Hay, SI				Bhattacharjee, Natalia V.; Schaeffer, Lauren E.; Marczak, Laurie B.; Ross, Jennifer M.; Swartz, Scott J.; Albright, James; Gardner, William M.; Shields, Chloe; Sligar, Amber; Schipp, Megan F.; Pickering, Brandon V.; Henry, Nathaniel J.; Johnson, Kimberly B.; Louie, Celia; Cork, Michael A.; Steuben, Krista M.; Lazzar-Atwood, Alice; Lu, Dan; Kinyoki, Damaris K.; Osgood-Zimmerman, Aaron; Earl, Lucas; Mosser, Jonathan F.; Deshpande, Aniruddha; Burstein, Roy; Woyczynski, Lauren P.; Wilson, Katherine F.; VanderHeide, John D.; Wiens, Kirsten E.; Reiner, Robert C., Jr.; Piwoz, Ellen G.; Rawat, Rahul; Sartorius, Benn; Weaver, Nicole Davis; Nixon, Molly R.; Smith, David L.; Kassebaum, Nicholas J.; Gakidou, Emmanuela; Lim, Stephen S.; Mokdad, Ali H.; Murray, Christopher J. L.; Dwyer-Lindgren, Laura; Hay, Simon I.			Mapping exclusive breastfeeding in Africa between 2000 and 2017	NATURE MEDICINE			English	Article							TRANSMISSION; ATTAINMENT; MORTALITY; COUNTRIES	Exclusive breastfeeding (EBF)-giving infants only breast-milk (and medications, oral rehydration salts and vitamins as needed) with no additional food or drink for their first six months of life-is one of the most effective strategies for preventing child mortality(1-4). Despite these advantages, only 37% of infants under 6 months of age in Africa were exclusively breastfed in 2017(5), and the practice of EBF varies by population. Here, we present a fine-scale geospatial analysis of EBF prevalence and trends in 49 African countries from 2000-2017, providing policy-relevant administrative-and nationallevel estimates. Previous national-level analyses found that most countries will not meet the World Health Organization's Global Nutrition Target of 50% EBF prevalence by 2025(6). Our analyses show that even fewer will achieve this ambition in all subnational areas. Our estimates provide the ability to visualize subnational EBF variability and identify populations in need of additional breastfeeding support.	[Bhattacharjee, Natalia V.; Schaeffer, Lauren E.; Marczak, Laurie B.; Ross, Jennifer M.; Albright, James; Gardner, William M.; Shields, Chloe; Sligar, Amber; Schipp, Megan F.; Pickering, Brandon V.; Henry, Nathaniel J.; Johnson, Kimberly B.; Louie, Celia; Cork, Michael A.; Steuben, Krista M.; Lazzar-Atwood, Alice; Lu, Dan; Kinyoki, Damaris K.; Osgood-Zimmerman, Aaron; Earl, Lucas; Mosser, Jonathan F.; Deshpande, Aniruddha; Burstein, Roy; Woyczynski, Lauren P.; Wilson, Katherine F.; VanderHeide, John D.; Wiens, Kirsten E.; Reiner, Robert C., Jr.; Weaver, Nicole Davis; Nixon, Molly R.; Smith, David L.; Kassebaum, Nicholas J.; Gakidou, Emmanuela; Lim, Stephen S.; Mokdad, Ali H.; Murray, Christopher J. L.; Dwyer-Lindgren, Laura; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Ross, Jennifer M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ross, Jennifer M.; Swartz, Scott J.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Mosser, Jonathan F.; Reiner, Robert C., Jr.; Sartorius, Benn; Smith, David L.; Gakidou, Emmanuela; Lim, Stephen S.; Mokdad, Ali H.; Murray, Christopher J. L.; Dwyer-Lindgren, Laura; Hay, Simon I.] Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA; [Piwoz, Ellen G.; Rawat, Rahul] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sartorius, Benn] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Kassebaum, Nicholas J.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; University of London; London School of Hygiene & Tropical Medicine; University of Washington; University of Washington Seattle	Hay, SI (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.; Hay, SI (corresponding author), Univ Washington, Dept Hlth Metr Sci, Seattle, WA 98195 USA.	sihay@uw.edu	Hay, Simon Iain/F-8967-2015; Henry, Nathaniel/ABD-4631-2020; Kinyoki, Damaris/AAH-1633-2020; Mokdad, Ali H./AAD-1232-2022; Smith, David/L-8850-2013	Hay, Simon Iain/0000-0002-0611-7272; Henry, Nathaniel/0000-0001-8150-4988; Mokdad, Ali H./0000-0002-4994-3339; Marczak, Laurie/0000-0001-5979-4261; Mosser, Jonathan/0000-0001-9093-3186; Schaeffer, Lauren/0000-0002-4321-3503; Gardner, William/0000-0002-7607-3586; Wiens, Kirsten E./0000-0003-4093-4054; Valadan Tahbaz, Sahel/0000-0001-8038-6350; Davis Weaver, Nicole/0000-0002-7205-9621; Ross, Jennifer/0000-0001-5677-939X; Smith, David/0000-0003-4367-3849	Bill & Melinda Gates Foundation [OPP1132415]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was primarily supported by grant OPP1132415 from the Bill & Melinda Gates Foundation.	Akachi Y, 2018, INT J EPIDEMIOL, V47, P740, DOI 10.1093/ije/dyx262; [Anonymous], 2018, EXCL BREASTF 6 MONTH; [Anonymous], 2005, BAB FRIENDL HOSP IN; [Anonymous], 1998, HIV INF FEED GUID DE; [Anonymous], 2018, GLOB BREASTF COLL SC; [Anonymous], COMB MODIS 5 1 MCD12; [Anonymous], 2004, GLOB LAK WETL DAT LE; [Anonymous], 2015, GLOB ADM UN LAYERS G; Anttila-Hughes J. K., 2018, MORTALITY NESTLES MA; Baker P, 2016, PUBLIC HEALTH NUTR, V19, P2540, DOI 10.1017/S1368980016001117; Becquet R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007397; Bhatt S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0520; Burgert CR, 2013, GEOGRAPHIC DISPLACEM; Chai Y, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001032; Champeny M, 2016, MATERN CHILD NUTR, V12, P126, DOI 10.1111/mcn.12272; Colson KE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0308-5; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dun-Dery EJ, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0083-8; Dwyer-Lindgren L, 2019, NATURE, V570, P189, DOI 10.1038/s41586-019-1200-9; Fanzo J, 2018, GLOBAL NUTR REPORT S; Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0; Graetz N, 2018, NATURE, V555, P48, DOI 10.1038/nature25761; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Issaka AI, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014145; Jacquemin M., 2010, URBANIZATION SOCIAL; Kavle JA, 2017, PUBLIC HEALTH NUTR, V20, P3120, DOI 10.1017/S1368980017002531; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kung'u JK, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12577; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Lozano R, 2018, LANCET, V392, P2091, DOI 10.1016/s0140-6736(18)32281-5; Lugina H. I., 2011, AFRICAN MIDWIFERY WO, V5, P4, DOI DOI 10.12968/AJMW.2011.5.1.4; LUMLEY T., 2010, COMPLEX SURVEYS GUID; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; PIWOZ EG, 1995, J NUTR, V125, P57; Pullum TW, 2014, GLOB HEALTH-SCI PRAC, V2, P355, DOI 10.9745/GHSP-D-14-00061; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; Reiner RC, 2018, NEW ENGL J MED, V379, P1128, DOI 10.1056/NEJMoa1716766; Renfrew Mary J, 2012, Cochrane Database Syst Rev, pCD001141, DOI 10.1002/14651858.CD001141.pub4; Roberts TJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-254; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Stein M.L., 1999, INTERPOLATION SPATIA; UNICEF, 2016, 1 HOUR LIF MAK CAS I; White AB, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011323; WHO, 2016, UPD HIV INF FEED DUR; WHO-WORLD HEALTH ORGANIZATION, 2014, GLOB NUTR TARG 2025; Wiegand H., 1965, SURVEY SAMPLING, V1, P88, DOI [DOI 10.1002/BIMJ.19680100122, 10.1002/bimj.19680100122]; World Health Organization, 2008, HIV TRANSM BREASTF R; World Health Organization, 2017, PROGR DRINKING WATER; World Health Organization, 1981, INT COD MARK BREAST; World Health Organization, 2020, MARK BREAST MILK SUB; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization UNICEF, 2013, END PREV CHILD DEATH; Yourkavitch J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201870	59	37	37	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2019	25	8					1205	+		10.1038/s41591-019-0525-0	http://dx.doi.org/10.1038/s41591-019-0525-0			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IQ0BI	31332393	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000480414600017
J	Sicklick, JK; Kato, S; Okamura, R; Schwaederle, M; Hahn, ME; Williams, CB; De, P; Krie, A; Piccioni, DE; Miller, VA; Ross, JS; Benson, A; Webster, J; Stephens, PJ; Lee, JJ; Fanta, PT; Lippman, SM; Leyland-Jones, B; Kurzrock, R				Sicklick, Jason K.; Kato, Shumei; Okamura, Ryosuke; Schwaederle, Maria; Hahn, Michael E.; Williams, Casey B.; De, Pradip; Krie, Amy; Piccioni, David E.; Miller, Vincent A.; Ross, Jeffrey S.; Benson, Adam; Webster, Jennifer; Stephens, Philip J.; Lee, J. Jack; Fanta, Paul T.; Lippman, Scott M.; Leyland-Jones, Brian; Kurzrock, Razelle			Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study	NATURE MEDICINE			English	Article							UNIVERSITY-OF-CALIFORNIA; CELL LUNG-CANCER; PRECISION-ONCOLOGY; TUMOR BOARD; MUTATIONS; LANDSCAPE; MEDICINE; EXPRESSION; REVEALS; KRAS	Cancer treatments have evolved from indiscriminate cytotoxic agents to selective genome-and immune-targeted drugs that have transformed the outcomes of some malignancies(1). Tumor complexity and heterogeneity suggest that the 'precision medicine' paradigm of cancer therapy requires treatment to be personalized to the individual patient(2-6). To date, precision oncology trials have been based on molecular matching with predetermined monotherapies(7-14). Several of these trials have been hindered by very low matching rates, often in the 5-10% range(15), and low response rates. Low matching rates may be due to the use of limited gene panels, restrictive molecular matching algorithms, lack of drug availability, or the deterioration and death of end-stage patients before therapy can be implemented. We hypothesized that personalized treatment with combination therapies would improve outcomes in patients with refractory malignancies. As a first test of this concept, we implemented a cross-institutional prospective study (I-PREDICT, NCT02534675) that used tumor DNA sequencing and timely recommendations for individualized treatment with combination therapies. We found that administration of customized multidrug regimens was feasible, with 49% of consented patients receiving personalized treatment. Targeting of a larger fraction of identified molecular alterations, yielding a higher 'matching score', was correlated with significantly improved disease control rates, as well as longer progression-free and overall survival rates, compared to targeting of fewer somatic alterations. Our findings suggest that the current clinical trial paradigm for precision oncology, which pairs one driver mutation with one drug, may be optimized by treating molecularly complex and heterogeneous cancers with combinations of customized agents.	[Sicklick, Jason K.] Univ Calif San Diego, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA; [Sicklick, Jason K.; Kato, Shumei; Okamura, Ryosuke; Schwaederle, Maria; Piccioni, David E.; Fanta, Paul T.; Lippman, Scott M.; Kurzrock, Razelle] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Sicklick, Jason K.; Kato, Shumei; Okamura, Ryosuke; Schwaederle, Maria; Piccioni, David E.; Fanta, Paul T.; Lippman, Scott M.; Kurzrock, Razelle] Univ Calif San Diego, Ctr Personalized Canc Therapy, La Jolla, CA 92093 USA; [Kato, Shumei; Okamura, Ryosuke; Schwaederle, Maria; Fanta, Paul T.; Lippman, Scott M.; Kurzrock, Razelle] Univ Calif San Diego, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA; [Hahn, Michael E.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Williams, Casey B.; De, Pradip; Krie, Amy; Leyland-Jones, Brian] Avera Canc Inst, Sioux Falls, SD USA; [Piccioni, David E.] Univ Calif San Diego, Dept Neurosci, Div Neurooncol, La Jolla, CA 92093 USA; [Miller, Vincent A.; Ross, Jeffrey S.; Webster, Jennifer] Fdn Med Inc, Cambridge, MA USA; [Ross, Jeffrey S.] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA; [Benson, Adam] Scipher Med, Waltham, MA USA; [Stephens, Philip J.] GRAIL Inc, Menlo Pk, CA USA; [Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Foundation Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Texas System; UTMD Anderson Cancer Center	Sicklick, JK (corresponding author), Univ Calif San Diego, Dept Surg, Div Surg Oncol, La Jolla, CA 92093 USA.; Sicklick, JK; Kurzrock, R (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.; Sicklick, JK; Kurzrock, R (corresponding author), Univ Calif San Diego, Ctr Personalized Canc Therapy, La Jolla, CA 92093 USA.; Kurzrock, R (corresponding author), Univ Calif San Diego, Dept Med, Div Hematol Oncol, La Jolla, CA 92093 USA.	jsicklick@ucsd.edu; rkurzrock@ucsd.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Kurzrock, Razelle/AAU-9782-2020; Lee, Jack/P-7331-2019	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Lee, Jack/0000-0002-4584-929X; Sicklick, Jason/0000-0003-4403-0271; Okamura, Ryosuke/0000-0001-7352-8621	Foundation Medicine, Inc.; Joan and Irwin Jacobs Philanthropic Fund; Jon Schneider Memorial Cancer Research Fund; National Institutes of Health (NIH) [P30CA023100, P30CA016672]; NIH [K08CA168999, R21CA192072]; David Foundation; Kristen Ann Carr Fund; Pedal the Cause; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA023100, R21CA192072, K08CA168999] Funding Source: NIH RePORTER	Foundation Medicine, Inc.; Joan and Irwin Jacobs Philanthropic Fund; Jon Schneider Memorial Cancer Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Foundation; Kristen Ann Carr Fund; Pedal the Cause; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Wrolstad, M. Scur, and J. Porter for their critical roles in clinical trial and data management, L. Marquez for medication acquisition, D. Sandler, C. M. Tang, H. Yoon, M. Yerba and S. Silverman for assistance with manuscript preparation, T. Reya for her critical review of the manuscript, and most importantly, the patients and their families. This work was supported in part by Foundation Medicine, Inc. (J.K.S., R.O., B.L.-J., R.K.), as well as the Joan and Irwin Jacobs Philanthropic Fund (R.K.), the Jon Schneider Memorial Cancer Research Fund (J.K.S., P.T.F.), and National Institutes of Health (NIH) grant nos. P30CA023100 (J.K.S., S. M. L., R.K.) and P30CA016672 (J. J. L.). The authors also acknowledge the support of NIH grant nos. K08CA168999 and R21CA192072, as well as Pedal the Cause, The David Foundation, and Kristen Ann Carr Fund (J.K.S.).	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Chen AP, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.2539; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Dhani N, 2009, CLIN CANCER RES, V15, P1873, DOI 10.1158/1078-0432.CCR-08-2034; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Goodman AM, 2018, JAMA ONCOL, V4, P1237, DOI 10.1001/jamaoncol.2018.1701; Goodman AM, 2017, MOL CANCER THER, V16, P2598, DOI 10.1158/1535-7163.MCT-17-0386; Hartmaier RJ, 2017, CANCER RES, V77, P2464, DOI 10.1158/0008-5472.CAN-16-2479; Helsten T, 2016, MOL CANCER THER, V15, P1682, DOI 10.1158/1535-7163.MCT-16-0071; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Jacobsen E, 2017, NEW ENGL J MED, V377, P2398, DOI 10.1056/NEJMc1713676; Jia J, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e24296; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kato S, 2017, J NATL COMPR CANC NE, V15, P863, DOI 10.6004/jnccn.2017.0127; Kato S, 2015, CELL CYCLE, V14, P1252, DOI 10.1080/15384101.2015.1014149; Koehler K, 2016, ANN ONCOL, V27, P539, DOI 10.1093/annonc/mdv598; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le Tourneau C, 2015, LANCET ONCOL, V16, P1324, DOI 10.1016/S1470-2045(15)00188-6; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu S, 2016, ONCOTARGET, V7, P11310, DOI 10.18632/oncotarget.7023; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Nikanjam M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1338997; Nikanjam M, 2017, ONCOLOGIST, V22, P576, DOI 10.1634/theoncologist.2016-0357; Nikanjam M, 2016, INT J CANCER, V139, P2135, DOI 10.1002/ijc.30262; Parker BA, 2015, J ONCOL PRACT, V11, P442, DOI 10.1200/JOP.2015.004127; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a; Said R, 2013, ONCOTARGET, V4, P705, DOI 10.18632/oncotarget.974; Schwaederle M, 2016, MOL CANCER THER, V15, P743, DOI 10.1158/1535-7163.MCT-15-0795; Schwaederle M, 2015, CANCER RES, V75, P1187, DOI 10.1158/0008-5472.CAN-14-2305; Schwaederle M, 2014, ONCOLOGIST, V19, P631, DOI 10.1634/theoncologist.2013-0405; Sicklick JK, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.2512; Stephens P, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.e23049; Sun JX, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005965; Tsimberidou Apostolia-Maria, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00002; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Wheler J, 2014, CANCER RES, V74, P7181, DOI 10.1158/0008-5472.CAN-14-2329; Wheler JJ, 2016, MOL CANCER THER, V15, P2475, DOI 10.1158/1535-7163.MCT-16-0196; Wheler JJ, 2016, CANCER RES, V76, P3690, DOI 10.1158/0008-5472.CAN-15-3043; Wood K, 2016, JAMA ONCOL, V2, P805, DOI 10.1001/jamaoncol.2016.0405	46	272	282	9	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					744	+		10.1038/s41591-019-0407-5	http://dx.doi.org/10.1038/s41591-019-0407-5			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31011206	Green Submitted, Green Accepted			2022-12-27	WOS:000468247800017
J	Stower, H				Stower, Hannah			Exome sequencing for chronic kidney disease diagnosis	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					197	197		10.1038/s41591-019-0361-2	http://dx.doi.org/10.1038/s41591-019-0361-2			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728531	Bronze			2022-12-27	WOS:000457842100005
J	Zetterberg, H; Schott, JM				Zetterberg, Henrik; Schott, Jonathan M.			Biomarkers for Alzheimer's disease beyond amyloid and tau	NATURE MEDICINE			English	Editorial Material									[Zetterberg, Henrik] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Schott, Jonathan M.] Natl Hosp Neurol & Neurosurg, Dementia Res Ctr, Box 16, London, England	University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Zetterberg, H (corresponding author), Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal, Sweden.; Zetterberg, H (corresponding author), Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden.; Zetterberg, H (corresponding author), UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England.; Zetterberg, H (corresponding author), UCL, UK Dementia Res Inst, London, England.	henrik.zetterberg@gu.se	Schott, Jonathan M/A-9065-2011	Schott, Jonathan M/0000-0003-2059-024X	MRC [UKDRI-1003] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashton NJ, 2018, BIOMARK MED, V12, P799, DOI 10.2217/bmm-2017-0433; Bergman J., 2016, NEUROL NEUROIMMUNOL, V3; Cummings Jeffrey, 2018, Alzheimers Dement (N Y), V4, P195, DOI 10.1016/j.trci.2018.03.009; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Jansen WJ, 2018, JAMA PSYCHIAT, V75, P84, DOI 10.1001/jamapsychiatry.2017.3391; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Maia LF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006446; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Okamura N, 2018, CLIN TRANSL IMAGING, V6, P305, DOI 10.1007/s40336-018-0290-y; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Sato C, 2018, NEURON, V98, P861, DOI 10.1016/j.neuron.2018.04.035	12	24	25	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					201	203		10.1038/s41591-019-0348-z	http://dx.doi.org/10.1038/s41591-019-0348-z			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30728536	Green Submitted			2022-12-27	WOS:000457842100012
J	Wang, ZM; Aguilar, EG; Luna, JI; Dunai, C; Khuat, LT; Le, CT; Mirsoian, A; Minnar, CM; Stoffel, KM; Sturgill, IR; Grossenbacher, SK; Withers, SS; Rebhun, RB; Hartigan-O'Connor, DJ; Mendez-Lagares, G; Tarantal, AF; Isseroff, RR; Griffith, TS; Schalper, KA; Merleev, A; Saha, A; Maverakis, E; Kelly, K; Aljumaily, R; Ibrahimi, S; Mukherjee, S; Machiorlatti, M; Vesely, SK; Longo, DL; Blazar, BR; Canter, RJ; Murphy, WJ; Monjazeb, AM				Wang, Ziming; Aguilar, Ethan G.; Luna, Jesus I.; Dunai, Cordelia; Khuat, Lam T.; Le, Catherine T.; Mirsoian, Annie; Minnar, Christine M.; Stoffel, Kevin M.; Sturgill, Ian R.; Grossenbacher, Steven K.; Withers, Sita S.; Rebhun, Robert B.; Hartigan-O'Connor, Dennis J.; Mendez-Lagares, Gema; Tarantal, Alice F.; Isseroff, R. Rivkah; Griffith, Thomas S.; Schalper, Kurt A.; Merleev, Alexander; Saha, Asim; Maverakis, Emanual; Kelly, Karen; Aljumaily, Raid; Ibrahimi, Sami; Mukherjee, Sarbajit; Machiorlatti, Michael; Vesely, Sara K.; Longo, Dan L.; Blazar, Bruce R.; Canter, Robert J.; Murphy, William J.; Monjazeb, Arta M.			Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade	NATURE MEDICINE			English	Article							INHIBITORY RECEPTOR PD-1; BODY-MASS INDEX; LEPTIN RESISTANCE; IMMUNE-RESPONSE; EXHAUSTION; STAT3; IMMUNOTHERAPY; PEMBROLIZUMAB; INFLAMMATION; SENSITIVITY	The recent successes of immunotherapy have shifted the paradigm in cancer treatment, but because only a percentage of patients are responsive to immunotherapy, it is imperative to identify factors impacting outcome. Obesity is reaching pandemic proportions and is a major risk factor for certain malignancies, but the impact of obesity on immune responses, in general and in cancer immunotherapy, is poorly understood. Here, we demonstrate, across multiple species and tumor models, that obesity results in increased immune aging, tumor progression and PD-1-mediated T cell dysfunction which is driven, at least in part, by leptin. However, obesity is also associated with increased efficacy of PD-1/PD-L1 blockade in both tumor-bearing mice and clinical cancer patients. These findings advance our understanding of obesity-induced immune dysfunction and its consequences in cancer and highlight obesity as a biomarker for some cancer immunotherapies. These data indicate a paradoxical impact of obesity on cancer. There is heightened immune dysfunction and tumor progression but also greater anti-tumor efficacy and survival after checkpoint blockade which directly targets some of the pathways activated in obesity.	[Wang, Ziming; Aguilar, Ethan G.; Luna, Jesus I.; Dunai, Cordelia; Khuat, Lam T.; Le, Catherine T.; Mirsoian, Annie; Minnar, Christine M.; Stoffel, Kevin M.; Sturgill, Ian R.; Grossenbacher, Steven K.; Isseroff, R. Rivkah; Merleev, Alexander; Maverakis, Emanual; Murphy, William J.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Withers, Sita S.; Rebhun, Robert B.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Hartigan-O'Connor, Dennis J.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Hartigan-O'Connor, Dennis J.; Mendez-Lagares, Gema] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Hartigan-O'Connor, Dennis J.; Mendez-Lagares, Gema; Tarantal, Alice F.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Tarantal, Alice F.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Isseroff, R. Rivkah] Sacramento VA Med Ctr, Dermatol Serv, Mather, CA USA; [Griffith, Thomas S.] Univ Minnesota, Dept Urol, Ctr Immunol, Masonic Canc Ctr,Microbiol,Immunol, Minneapolis, MN USA; [Griffith, Thomas S.] Univ Minnesota, Canc Biol Grad Program, Minneapolis, MN USA; [Schalper, Kurt A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Schalper, Kurt A.] Yale Univ, Sch Med, Translat Immunooncol Lab, New Haven, CT 06510 USA; [Merleev, Alexander; Maverakis, Emanual] Univ Calif Davis, Immune Monitoring Core, Comprehens Canc Ctr, Sacramento, CA 95817 USA; [Saha, Asim; Blazar, Bruce R.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Saha, Asim] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Kelly, Karen; Murphy, William J.] Univ Calif Davis, Sch Med, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA; [Aljumaily, Raid; Ibrahimi, Sami; Mukherjee, Sarbajit] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Sect Hematol & Oncol, Oklahoma City, OK USA; [Machiorlatti, Michael; Vesely, Sara K.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Longo, Dan L.] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Canter, Robert J.] Univ Calif Davis, Sch Med, Dept Surg, Div Surg Oncol,Comprehens Canc Ctr, Sacramento, CA 95817 USA; [Monjazeb, Arta M.] Univ Calif Davis, Comprehens Canc Ctr, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Yale University; Yale University; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis	Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.; Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, Div Hematol & Oncol, Dept Internal Med, Sacramento, CA 95817 USA.	wmjmurphy@ucdavis.edu	Griffith, Thomas/ABF-8225-2020; Isseroff, Roslyn Rivkah/AAD-8478-2021; Mukherjee, Sarbajit/I-3927-2019; Withers, Sita/AGY-7574-2022; Méndez-Lagares, Gema/X-9467-2018; Merleev, Alexander/W-2802-2019; Longo, Dan L./F-6022-2011	Isseroff, Roslyn Rivkah/0000-0001-7813-0858; Méndez-Lagares, Gema/0000-0002-6297-5693; Withers, Sita/0000-0002-4107-3877; Machiorlatti, Michael/0000-0002-9180-3647; Rebhun, Robert/0000-0002-8047-3494; Kelly, Karen/0000-0002-2235-6636; Le, Catherine/0000-0002-0175-570X; Sturgill, Ian R/0000-0003-1869-6344; Dunai, Cordelia/0000-0001-5799-2387	NIH [R01 CA095572, R01 CA195904, R01 CA214048, P01 CA065493, R01 HL085794]; California National Primate Research Center [OD011107]; UC Davis Comprehensive Cancer Center Support Grant (CCSG) [P30 CA093373]; UC Davis Mouse Metabolic Phenotyping Center (MMPC) [DK092993]; Intramural Research Program of the NIH; Intramural Research Program of the NHLBI; Center for Cancer Research; Intramural Research Program of the NCI; NATIONAL CANCER INSTITUTE [R01CA195904, P30CA093373, P30CA225520, R01CA095572, R01CA214048, P01CA065493, T32CA009138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL085794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California National Primate Research Center; UC Davis Comprehensive Cancer Center Support Grant (CCSG); UC Davis Mouse Metabolic Phenotyping Center (MMPC); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank W. Ma and M. Metcalf from the Murphy lab, D. Rowland, A. Chaudhari and Z. Harmany from the UC Davis CMGI and J. Chen in the UC Davis Pathology Core for their technical expertise and help. We would also like to thank the other members in the Murphy lab for providing feedback and suggestions during preparation of the manuscript. This was work funded by NIH grant R01 CA095572, R01 CA195904, R01 CA214048, P01 CA065493, R01 HL085794, the California National Primate Research Center base operating grant (OD011107), the UC Davis Comprehensive Cancer Center Support Grant (CCSG) (P30 CA093373) and the UC Davis Mouse Metabolic Phenotyping Center (MMPC) grant (DK092993). The content of this publication does not necessarily reflect the view or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, NCI, NHLBI and Center for Cancer Research.	Albiges L, 2016, J CLIN ONCOL, V34, P3655, DOI 10.1200/JCO.2016.66.7311; Amjadi F, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-21; Austin JW, 2014, J IMMUNOL, V192, P4876, DOI 10.4049/jimmunol.1302750; Bally APR, 2016, J IMMUNOL, V196, P2431, DOI 10.4049/jimmunol.1502643; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bouchlaka MN, 2013, J EXP MED, V210, P2223, DOI 10.1084/jem.20131219; Bu LL, 2017, J DENT RES, V96, P1027, DOI 10.1177/0022034517712435; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Cava C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020274; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chinai JM, 2015, TRENDS PHARMACOL SCI, V36, P587, DOI 10.1016/j.tips.2015.06.005; Clements VK, 2018, J LEUKOCYTE BIOL, V103, P395, DOI 10.1002/JLB.4HI0517-210R; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee JH, 2001, INT J OBESITY, V25, P1471, DOI 10.1038/sj.ijo.0801736; Li HY, 2017, CANCER IMMUNOL RES, V5, P767, DOI 10.1158/2326-6066.CIR-16-0365; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lord GM, 2002, J LEUKOCYTE BIOL, V72, P330; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Mehnert JM, 2017, CLIN CANCER RES, V23, P4970, DOI 10.1158/1078-0432.CCR-16-3063; Mirsoian A, 2014, J EXP MED, V211, P2373, DOI 10.1084/jem.20140116; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saucillo DC, 2014, J IMMUNOL, V192, P136, DOI 10.4049/jimmunol.1301158; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Tao WJ, 2013, NAT REV CLIN ONCOL, V10, P519, DOI 10.1038/nrclinonc.2013.120; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Villarroel-Espindola F, 2018, CLIN CANCER RES, V24, P1562, DOI 10.1158/1078-0432.CCR-17-2542; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	54	343	347	8	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					141	+		10.1038/s41591-018-0221-5	http://dx.doi.org/10.1038/s41591-018-0221-5			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30420753	Green Accepted, Green Submitted			2022-12-27	WOS:000455027700032
J	Carmona, J				Carmona, Javier			Biomarkers for checkpoint blockade	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1637	1637		10.1038/s41591-018-0257-6	http://dx.doi.org/10.1038/s41591-018-0257-6			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401861	Bronze			2022-12-27	WOS:000449404200005
J	Gammage, PA; Viscomi, C; Simard, ML; Costa, ASH; Gaude, E; Powell, CA; Van Haute, L; McCann, B; Rebelo-Guiomar, P; Cerutti, R; Zhang, L; Rebar, EJ; Zeviani, M; Frezza, C; Stewart, JB; Minczuk, M				Gammage, Payam A.; Viscomi, Carlo; Simard, Marie-Lune; Costa, Ana S. H.; Gaude, Edoardo; Powell, Christopher A.; Van Haute, Lindsey; McCann, Beverlyj; Rebelo-Guiomar, Pedro; Cerutti, Raffaele; Zhang, Lei; Rebar, Edward J.; Zeviani, Massimo; Frezza, Christian; Stewart, James B.; Minczuk, Michal			Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo	NATURE MEDICINE			English	Article							SEQUENCE-SPECIFIC MODIFICATION; SELECTIVE DEGRADATION; DNA; ELIMINATION; EXPRESSION; DELETIONS; GERMLINE; THERAPY; NUCLEAR; CELLS	Mutations of the mitochondrial genome ( mtDNA) underlie a substantial portion of mitochondrial disease burden. These disorders are currently incurable and effectively untreatable, with heterogeneous penetrance, presentation and prognosis. To address the lack of effective treatment for these disorders, we exploited a recently developed mouse model that recapitulates common molecular features of heteroplasmic mtDNA disease in cardiac tissue: the m.5024C>T tRNA(Ala) mouse. Through application of a programmable nuclease therapy approach, using systemically administered, mitochondrially targeted zinc-finger nucleases (mtZFN) delivered by adeno-associated virus, we induced specific elimination of mutant mtDNA across the heart, coupled to a reversion of molecular and biochemical phenotypes. These findings constitute proof of principle that mtDNA heteroplasmy correction using programmable nucleases could provide a therapeutic route for heteroplasmic mitochondrial diseases of diverse genetic origin.	[Gammage, Payam A.; Viscomi, Carlo; Powell, Christopher A.; Van Haute, Lindsey; McCann, Beverlyj; Rebelo-Guiomar, Pedro; Cerutti, Raffaele; Zeviani, Massimo; Minczuk, Michal] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Simard, Marie-Lune; Stewart, James B.] Max Planck Inst Biol Ageing, Cologne, Germany; [Costa, Ana S. H.; Gaude, Edoardo; Frezza, Christian] Univ Cambridge, MRC Canc Unit, Cambridge, England; [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, Porto, Portugal; [Zhang, Lei; Rebar, Edward J.] Sangamo Therapeut Inc, Richmond, CA USA	University of Cambridge; Max Planck Society; University of Cambridge; Universidade do Porto	Gammage, PA; Minczuk, M (corresponding author), Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.	payam.gammage@mrc-mbu.cam.ac.uk; michal.minczuk@mrc-mbu.cam.ac.uk	viscomi, Carlo/R-1940-2016; Rebelo-Guiomar, Pedro/AAT-3575-2021; Frezza, Christian/G-2174-2010; Stewart, James B/C-9633-2011; Zeviani, Massimo/AAU-2632-2021; Costa, Ana/H-2852-2012; Minczuk, Michal/G-1638-2014	Rebelo-Guiomar, Pedro/0000-0002-5060-7519; Frezza, Christian/0000-0002-3293-7397; Stewart, James B/0000-0002-2902-4968; Zeviani, Massimo/0000-0002-9067-5508; Gammage, Payam Anthony/0000-0003-1968-1726; Costa, Ana/0000-0001-8932-6370; Gaude, Edoardo/0000-0001-8523-7792; Viscomi, Carlo/0000-0001-6050-0566; Minczuk, Michal/0000-0001-8242-1420; Van Haute, Lindsey/0000-0001-7809-1473	Medical Research Council [MC_U105697135, MC_UU_00015/4, MC_UU_12022/6, MC_UU_00015/5]; ERC Advanced Grant [FP7-322424]; NRJ-Institut de France; Max Planck Society; Fundacao para a Ciencia e a Tecnologia [PD/BD/105750/2014]; MRC [MC_UU_12022/6, MC_UU_00015/4, MC_UU_00015/5, MC_UU_00015/8, MC_U105697135] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC Advanced Grant(European Research Council (ERC)); NRJ-Institut de France; Max Planck Society(Max Planck SocietyFoundation CELLEX); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MC_U105697135 and MC_UU_00015/4 to M.M., MC_UU_12022/6 to C.F. and MC_UU_00015/5 to M.Z.), ERC Advanced Grant (FP7-322424 to M.Z.), NRJ-Institut de France (to M. Z.) and the Max Planck Society (to J.B.S.). P.R.-G. was supported by 'Fundacao para a Ciencia e a Tecnologia' (PD/BD/105750/2014). We acknowledge the important contribution to model development made by N.-G. Larsson, which was essential to this work. We are grateful to the personnel at Phenomics Animal Care Facility, Cambridge, UK, for their technical support in managing our mouse colonies. We are grateful to M. Rice, Phenomics Animal Care Facility, for technical assistance with viral administration. We thank R. Dirksen (MPI, Cologne, Germany) for isolation and immortalization of the MEFs. All FACS experiments were performed at the NIHR BRC Cell Phenotyping Hub, Cambridge, UK, by C. Bowman, E. Perez, J. Markovic Djuric and A. Petrunkina-Harrison.	Alexeyev M., 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A012641; Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Beilstein K, 2015, ACS SYNTH BIOL, V4, P526, DOI 10.1021/sb500270h; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Floros VI, 2018, NAT CELL BIOL, V20, P144, DOI 10.1038/s41556-017-0017-8; Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001; Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676; Gammage PA, 2016, METHODS MOL BIOL, V1351, P145, DOI 10.1007/978-1-4939-3040-1_11; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Gaude E, 2018, MOL CELL, V69, P581, DOI 10.1016/j.molcel.2018.01.034; Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Jazayeri M, 2003, J BIOL CHEM, V278, P9823, DOI 10.1074/jbc.M211730200; Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037; Mackay GM, 2015, METHOD ENZYMOL, V561, P171, DOI 10.1016/bs.mie.2015.05.016; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Minczuk M, 2010, NAT PROTOC, V5, P342, DOI 10.1038/nprot.2009.245; Pearce SF, 2017, ELIFE, V6, DOI 10.7554/eLife.27596; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Viscomi C, 2015, BBA-BIOENERGETICS, V1847, P544, DOI 10.1016/j.bbabio.2015.03.001; Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yamada M, 2016, CELL STEM CELL, V18, P749, DOI 10.1016/j.stem.2016.04.001; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27	33	137	143	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1691	+		10.1038/s41591-018-0165-9	http://dx.doi.org/10.1038/s41591-018-0165-9			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30250142	Green Accepted, Green Submitted			2022-12-27	WOS:000449404200020
J	Koh, HY; Kim, SH; Jang, J; Kim, H; Han, S; Lim, JS; Son, G; Choi, J; Park, BO; Heo, WD; Han, J; Lee, HJ; Lee, D; Kang, HC; Shong, M; Paik, SB; Kim, DS; Lee, JH				Koh, Hyun Yong; Kim, Se Hoon; Jang, Jaeson; Kim, Hyungguk; Han, Sungwook; Lim, Jae Seok; Son, Geurim; Choi, Junjeong; Park, Byung Ouk; Heo, Won Do; Han, Jinju; Lee, Hyunjoo Jenny; Lee, Daeyoup; Kang, Hoon-Chul; Shong, Minho; Paik, Se-Bum; Kim, Dong Seok; Lee, Jeong Ho			BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors	NATURE MEDICINE			English	Article							INTELLECTUAL DISABILITY; EPILEPSY; EXPRESSION; MECHANISMS; RECEPTOR; GENE; GANGLIOGLIOMAS; MALFORMATIONS; VEMURAFENIB; MATURATION	Pediatric brain tumors are highly associated with epileptic seizures(1). However, their epileptogenic mechanisms remain unclear. Here, we show that the oncogenic BRAF somatic mutation p.Val600Glu (V600E) in developing neurons underlies intrinsic epileptogenicity in ganglioglioma, one of the leading causes of intractable epilepsy(2). To do so, we developed a mouse model harboring the BRAF(V600E) somatic mutation during early brain development to reflect the most frequent mutation, as well as the origin and timing thereof. Therein, the BRAF(V600E) mutation arising in progenitor cells during brain development led to the acquisition of intrinsic epileptogenic properties in neuronal lineage cells, whereas tumorigenic properties were attributed to high proliferation of glial lineage cells. RNA sequencing analysis of patient brain tissues with the mutation revealed that BRAF(V600E)-induced epileptogenesis is mediated by RE1-silencing transcription factor (REST), which is a regulator of ion channels and neurotransmitter receptors associated with epilepsy. Moreover, we found that seizures in mice were significantly alleviated by an FDA-approved BRAF(V600E) inhibitor, vemurafenib, as well as various genetic inhibitions of Rest. Accordingly, this study provides direct evidence of a BRAF somatic mutation contributing to the intrinsic epileptogenicity in pediatric brain tumors and suggests that BRAF and REST could be treatment targets for intractable epilepsy.	[Koh, Hyun Yong; Lim, Jae Seok; Han, Jinju; Lee, Jeong Ho] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Kim, Se Hoon] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Jang, Jaeson; Paik, Se-Bum] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Kim, Hyungguk; Lee, Hyunjoo Jenny] Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea; [Han, Sungwook; Heo, Won Do; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Son, Geurim; Han, Jinju; Lee, Jeong Ho] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon, South Korea; [Choi, Junjeong] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon, South Korea; [Park, Byung Ouk; Heo, Won Do] Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea; [Kang, Hoon-Chul] Yonsei Univ, Severance Childrens Hosp, Epilepsy Res Inst, Dept Pediat,Coll Med,Pediat Epilepsy Clin,Div Ped, Seoul, South Korea; [Shong, Minho] Chungnam Natl Univ, Dept Internal Med, Sch Med, Daejeon, South Korea; [Paik, Se-Bum] Korea Adv Inst Sci & Technol, Program Brain & Cognit Engn, Daejeon, South Korea; [Kim, Dong Seok] Yonsei Univ, Severance Childrens Hosp, Brain Korea Project Med Sci 21, Dept Neurosurg,Pediat Epilepsy Clin,Coll Med, Seoul, South Korea; [Lee, Jeong Ho] Inst for Basic Sci Korea, Ctr Synapt Brain Dysfunct, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Institute for Basic Science - Korea (IBS); Yonsei University; Yonsei University Health System; Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Institute for Basic Science - Korea (IBS)	Lee, JH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea.; Lee, JH (corresponding author), Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon, South Korea.; Lee, JH (corresponding author), Inst for Basic Sci Korea, Ctr Synapt Brain Dysfunct, Daejeon, South Korea.	jhlee4246@kaist.ac.kr	Lee, Hyunjoo Jenny/G-5020-2015; Lee, Daeyoup/C-1653-2011; Paik, Se-Bum/B-8277-2013; Han, Jinju/D-9091-2017; /H-7803-2012; Heo, Won-Do/C-1696-2011; Lee, Jeong Ho/G-7361-2012; Koh, Hyun Yong/AAX-4374-2020; PARK, BYUNG OUK/AAB-3590-2020	Lee, Daeyoup/0000-0003-2006-1823; Paik, Se-Bum/0000-0002-4078-305X; Koh, Hyun Yong/0000-0002-3995-4341; Kang, Hoon-Chul/0000-0002-3659-8847; shong, minho/0000-0002-0247-7115; Jang, Jaeson/0000-0002-1142-5659; HAN, Jinju/0000-0003-1844-2301; Kim, Se Hoon/0000-0001-7516-7372	Suh Kyungbae Foundation; Citizens United for Research in Epilepsy; Korean Health Technology Research and Development (R&D) Project, Ministry of Health & Welfare, Republic of Korea [H15C3143, H16C0415]; Korean Health Technology Research and Development (R&D) Project, KAIST [G04170025]; Korean Health Technology Research and Development (RD) Project [IBS-R002-D1]	Suh Kyungbae Foundation; Citizens United for Research in Epilepsy; Korean Health Technology Research and Development (R&D) Project, Ministry of Health & Welfare, Republic of Korea; Korean Health Technology Research and Development (R&D) Project, KAIST; Korean Health Technology Research and Development (RD) Project	We thank K. S. Kim at the School of Medicine in Chungnam National University for breeding the Braf<SUP>lsl-V637E/+</SUP> mice, G. Mandel at Howard Hughes Medical Institute in Oregon Health and Science University for providing plasmid DNA of dnREST, and S. M. Park and W. K. Kim at the Korea Advanced Institute of Science and Technology (KAIST) for coordinating the clinical information. This work was supported by the Suh Kyungbae Foundation (to J.H.L.) and grants from the Citizens United for Research in Epilepsy (to J.H.L.) and the Korean Health Technology Research and Development (R&D) Project, Ministry of Health & Welfare, Republic of Korea (H15C3143 to J.H.L. and H16C0415 to D.S.K. and J.H.L.), KAIST (G04170025 to J.H.) and IBS-R002-D1 (to J.H.L).	Aridon P, 2006, AM J HUM GENET, V79, P342, DOI 10.1086/506459; Aronica E, 2007, EPILEPSY RES, V74, P33, DOI 10.1016/j.eplepsyres.2006.12.002; Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Aronica E, 2009, NEUROBIOL DIS, V36, P81, DOI 10.1016/j.nbd.2009.06.016; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Berkovic S, 2012, EPILEPSIA, V53, P1457, DOI 10.1111/j.1528-1167.2012.03511.x; Blumcke I, 2016, NAT REV NEUROL, V12, P732, DOI 10.1038/nrneurol.2016.173; Blumcke I, 2002, J NEUROPATH EXP NEUR, V61, P575; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Hardt M, 2011, GENES CELLS, V16, P141, DOI 10.1111/j.1365-2443.2010.01482.x; Kerkhof M, 2013, EPILEPSIA, V54, P12, DOI 10.1111/epi.12437; Kim SK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.384057; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lim JS, 2017, AM J HUM GENET, V100, P454, DOI 10.1016/j.ajhg.2017.01.030; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; Mei Y, 2016, NATURE, V530, P481, DOI 10.1038/nature16971; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Mittapalli RK, 2012, J PHARMACOL EXP THER, V342, P33, DOI 10.1124/jpet.112.192195; Nadeau H, 2002, J NEUROPHYSIOL, V88, P409, DOI 10.1152/jn.2002.88.1.409; Nava C, 2014, NAT GENET, V46, P640, DOI 10.1038/ng.2952; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Odawara A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26181; Park YS, 2008, CLIN NEUROL NEUROSUR, V110, P667, DOI 10.1016/j.clineuro.2008.03.017; Perucca E, 2001, EPILEPSIA, V42, P31, DOI 10.1046/j.1528-1157.2001.042suppl.3031.x; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sakji-Dupre L, 2015, MELANOMA RES, V25, P302, DOI 10.1097/CMR.0000000000000162; Samadani U, 2007, EPILEPSIA, V48, P646, DOI 10.1111/j.1528-1167.2007.00925.x; Sauvageot CM, 2002, CURR OPIN NEUROBIOL, V12, P244, DOI 10.1016/S0959-4388(02)00322-7; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Spurlock CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7932; Srivastava S, 2014, AM J MED GENET A, V164, P2914, DOI 10.1002/ajmg.a.36714; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Thom M, 2012, BRAIN PATHOL, V22, P350, DOI 10.1111/j.1750-3639.2012.00582.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vajda I, 2008, BIOPHYS J, V94, P5028, DOI 10.1529/biophysj.107.112730; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zurolo E, 2011, BRAIN, V134, P1015, DOI 10.1093/brain/awr032	50	45	48	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1662	+		10.1038/s41591-018-0172-x	http://dx.doi.org/10.1038/s41591-018-0172-x			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30224756				2022-12-27	WOS:000449404200016
J	Rackaityte, E; Lynch, SV				Rackaityte, Elze; Lynch, Susan V.			Rules of engagement in the gut microbiome	NATURE MEDICINE			English	Editorial Material							METABOLISM; PROBIOTICS; INFECTION; DISEASE	Susan V. LynchElze RackaityteIn humans, niche-specific gastrointestinal microbiomes influence the colonization success of probiotic microbes. Microbiome reconstitution following antimicrobial perturbation is most successful using preperturbation autofecal microbial transplant.	[Rackaityte, Elze; Lynch, Susan V.] Univ Calif San Francisco, Div Gastroenterol, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lynch, SV (corresponding author), Univ Calif San Francisco, Div Gastroenterol, Dept Med, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu						Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Fonseca W, 2017, MUCOSAL IMMUNOL, V10, P1569, DOI 10.1038/mi.2017.13; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Metchnikoff Elie, 1910, PROLONGATION LIFE OP; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041	12	2	2	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1642	1644		10.1038/s41591-018-0242-0	http://dx.doi.org/10.1038/s41591-018-0242-0			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401869				2022-12-27	WOS:000449404200012
J	Svedberg, FR; Guilliams, M				Svedberg, Freya R.; Guilliams, Martin			CARDIOVASCULAR DISEASES Cellular origin of human cardiac macrophage populations	NATURE MEDICINE			English	Editorial Material							CELLS		[Svedberg, Freya R.; Guilliams, Martin] VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Special, Ghent, Belgium; [Svedberg, Freya R.; Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Guilliams, M (corresponding author), VIB Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Special, Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	martin.guilliams@irc.vib-ugent.be	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570; Svedberg, Freya/0000-0002-7401-0741				Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Bonnardel J, 2018, CURR OPIN IMMUNOL, V50, P64, DOI 10.1016/j.coi.2017.12.001; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Molawi K, 2014, J EXP MED, V211, P2151, DOI 10.1084/jem.20140639; Nayak DK, 2016, AM J TRANSPLANT, V16, P2300, DOI 10.1111/ajt.13819; Rozenblatt-Rosen O, 2017, NATURE, V550, P451, DOI 10.1038/550451a; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Van der Borght K, 2018, CELL IMMUNOL, V330, P105, DOI 10.1016/j.cellimm.2018.03.011	11	3	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1091	1092		10.1038/s41591-018-0143-2	http://dx.doi.org/10.1038/s41591-018-0143-2			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082862				2022-12-27	WOS:000440955500010
J	Brundin, L; Bergkvist, L; Brundin, P				Brundin, Lena; Bergkvist, Liza; Brundin, Patrik			Fire prevention in the Parkinson's disease brain	NATURE MEDICINE			English	Editorial Material							DEPRESSION; EXENATIDE; TARGET		[Brundin, Lena; Bergkvist, Liza; Brundin, Patrik] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA	Van Andel Institute	Brundin, P (corresponding author), Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA.	patrik.brundin@vai.org		Brundin, Lena/0000-0002-8327-6242; Bergkvist, Liza/0000-0001-7433-2647				Athauda D, 2018, J PARKINSON DIS, V8, P247, DOI 10.3233/JPD-181329; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; De Pablo-Fernandez E., NEUROLOGY; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.13, 10.1111/ene.14108]; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Witoelar A, 2017, JAMA NEUROL, V74, P780, DOI 10.1001/jamaneurol.2017.0469; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5	13	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					900	902		10.1038/s41591-018-0109-4	http://dx.doi.org/10.1038/s41591-018-0109-4			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29988138				2022-12-27	WOS:000438187700013
J	Savas, P; Virassamy, B; Ye, CZ; Salim, A; Mintoff, CP; Caramia, F; Salgado, R; Byrne, DJ; Teo, ZL; Dushyanthen, S; Byrne, A; Wein, L; Luen, SJ; Poliness, C; Nightingale, SS; Skandarajah, AS; Gyorki, DE; Thornton, CM; Beavis, PA; Fox, SB; Cuningham, K; Darcy, PK; Speed, TP; Mackay, LK; Neeson, PJ; Loi, S				Savas, Peter; Virassamy, Balaji; Ye, Chengzhong; Salim, Agus; Mintoff, Christopher P.; Caramia, Franco; Salgado, Roberto; Byrne, David J.; Teo, Zhi L.; Dushyanthen, Sathana; Byrne, Ann; Wein, Lironne; Luen, Stephen J.; Poliness, Catherine; Nightingale, Sophie S.; Skandarajah, Anita S.; Gyorki, David E.; Thornton, Chantel M.; Beavis, Paul A.; Fox, Stephen B.; Cuningham, Kathleen; Darcy, Phillip K.; Speed, Terence P.; Mackay, Laura K.; Neeson, Paul J.; Loi, Sherene		Fdn Consortium Res Familial Breast	Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis	NATURE MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; DIFFERENTIAL EXPRESSION ANALYSIS; TRASTUZUMAB; RESPONSES; SURVIVAL; FEATURES; IMMUNITY; STAGE	The quantity of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) is a robust prognostic factor for improved patient survival, particularly in triple-negative and HER2-overexpressing BC subtypes(1). Although T cells are the predominant TIL population(2), the relationship between quantitative and qualitative differences in T cell subpopulations and patient prognosis remains unknown. We performed single-cell RNA sequencing (scRNA-seq) of 6,311 T cells isolated from human BCs and show that significant heterogeneity exists in the infiltrating T cell population. We demonstrate that BCs with a high number of TiLs contained CD8(+) T cells with features of tissue-resident memory T (T-RM) cell differentiation and that these CD8(+) T-RM cells expressed high levels of immune checkpoint molecules and effector proteins. A CD8(+) T-RM gene signature developed from the scRNA-seq data was significantly associated with improved patient survival in early-stage triple-negative breast cancer (TNBC) and provided better prognostication than CD8 expression alone. Our data suggest that CD8(+) T-RM cells contribute to BC immuno-surveillance and are the key targets of modulation by immune checkpoint inhibition. Further understanding of the development, maintenance and regulation of T-RM cells will be crucial for successful immunotherapeutic development in BC.	[Savas, Peter; Virassamy, Balaji; Mintoff, Christopher P.; Caramia, Franco; Salgado, Roberto; Teo, Zhi L.; Dushyanthen, Sathana; Byrne, Ann; Wein, Lironne; Luen, Stephen J.; Beavis, Paul A.; Darcy, Phillip K.; Neeson, Paul J.; Loi, Sherene] Univ Melbourne, Div Res, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Savas, Peter; Teo, Zhi L.; Beavis, Paul A.; Fox, Stephen B.; Darcy, Phillip K.; Neeson, Paul J.; Loi, Sherene] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Ye, Chengzhong; Salim, Agus; Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic, Australia; [Ye, Chengzhong] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Ye, Chengzhong] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Salim, Agus] La Trobe Univ, Dept Math & Stat, Melbourne, Vic, Australia; [Salgado, Roberto] GZA Ziekenhuizen, Dept Pathol, Antwerp, Belgium; [Byrne, David J.; Fox, Stephen B.] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Poliness, Catherine; Nightingale, Sophie S.; Skandarajah, Anita S.; Gyorki, David E.; Thornton, Chantel M.] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia; [Skandarajah, Anita S.] Royal Melbourne Hosp, Dept Surg, Melbourne, Vic, Australia; [Skandarajah, Anita S.] Royal Womens Hosp, Melbourne, Vic, Australia; [Speed, Terence P.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Mackay, Laura K.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Tsinghua University; La Trobe University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Neeson, PJ; Loi, S (corresponding author), Univ Melbourne, Div Res, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.; Neeson, PJ; Loi, S (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.	paul.neeson@petermac.org; sherene.loi@petermac.org	Neeson, Paul/ABD-4686-2020; Salgado, Roberto/AAG-6677-2020; Mackay, Laura K/HGC-6580-2022; Salim, Agus/P-1407-2014; Loi, Sherene/H-1979-2016	Mackay, Laura K/0000-0002-8496-6632; Salim, Agus/0000-0003-3999-7701; Savas, Peter/0000-0001-5999-428X; Ye, Chengzhong/0000-0002-5710-1078; Byrne, Ann/0000-0002-7108-7161; Skandarajah, Anita/0000-0001-7702-4850; Dushyanthen, Sathana/0000-0003-2215-1005; Loi, Sherene/0000-0001-6137-9171; Beavis, Paul/0000-0002-2116-013X; Nightingale, Sophie/0000-0002-1797-2629	National Health and Medical Research Council of Australia (NHMRC); National Breast Cancer Foundation (NBCF), Cancer Australia; National Institute of Health (United States); Breast Cancer Research Foundation [13CRF]; Cancer Council Victoria John Colebatch Fellowship; National Breast Cancer Foundation; NHMRC [1106967, 17-005, 1079329, 1136680, 1132373, 1054618]; NBCF [1094388]; Cancer Therapeutics CRC; Peter Mac Foundation; University of Melbourne; Queensland Cancer Fund; Cancer Councils of New South Wales, Victoria, Tasmania and South Australia; Cancer Foundation of Western Australia	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation (NBCF), Cancer Australia; National Institute of Health (United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Cancer Council Victoria John Colebatch Fellowship; National Breast Cancer Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NBCF; Cancer Therapeutics CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Peter Mac Foundation; University of Melbourne(University of Melbourne); Queensland Cancer Fund; Cancer Councils of New South Wales, Victoria, Tasmania and South Australia(Cancer Council New South Wales); Cancer Foundation of Western Australia(Cancer Council Western Australia)	We wish to thank H. Thorne, E. Itiiedermayr, all the kConFab research nurses and staff, the heads and staff of the Family Cancer Clinics and the Clinical Follow Up Study (which has received funding from the National Health and Medical Research Council of Australia (NHMRC), the National Breast Cancer Foundation (NBCF), Cancer Australia and the National Institute of Health (United States) for their contributions to this research, and the many families who contribute to kConFab. We wish to thank the FACS core facility staff R. Rossi, Milovac and S. Curcio, and T. Tan and P. Petrone for additional FAGS assistance. We also thank S. Ellis for assistance with confocal imaging, G.M. Arnau for facilitating RNA-seq, and the Anatomical Pathology staff at the Peter MacCallum Cancer Centre. Special thanks also to J, Jabbari and the Australian Genome Research Facility for making the single-cell sequencing possible.r This study was funded by the Breast Cancer Research Foundation (13CRF), NY. S.L. is supported by the Cancer Council Victoria John Colebatch Fellowship and the National Breast Cancer Foundation. P.S. is supported by the NHMRC and the NBCF (Post Graduate Scholarship 1094388), the Cancer Therapeutics CRC and the Peter Mac Foundation. Z.L.T. is supported by the NHMRC (Early Career Fellowship 1106967). D.G. is supported by the Peter Mac Foundation. PA.& is supported by the NHMRC (Early Career Fellowship 17-005), S.J.L is supported by the University of Melbourne. &RE la supported by the NHMRC (Practitioner Fellowship 1079329). kConFab is supported by a grant from NBCF, and previously NHMRC, the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. P.K.D is supported by the NHMRC (Senior Research Fellowship 1136680 and Program Grant 1132373). TS. is supported by the NHMRC (Program Grant 1054618). RJ.N. is supported by the NHMRC (Program Grant 1132373).	Adams S, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.1008; Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Bishara AJ, 2017, BEHAV RES METHODS, V49, P294, DOI 10.3758/s13428-016-0702-8; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Ganesan AP, 2017, NAT IMMUNOL, V18, P940, DOI 10.1038/ni.3775; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hombrink P, 2016, NAT IMMUNOL, V17, P1467, DOI 10.1038/ni.3589; Huang M., 2017, PREPRINT, DOI [10.1101/138677, DOI 10.1101/138677]; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Loi S, 2017, ANN ONCOL, V28; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Loi S., 2013, CANC RES, V73; Loi S., 2015, CANC RES, V76; Luen SJ, 2017, LANCET ONCOL, V18, P52, DOI [10.1016/S1470-2045(16)30631-3, 10.1016/s1470-2045(16)30631-3]; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nizard M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15221; Nolan E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4922; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Risso D, 2017, BIORXIV, DOI [10.1101/125112, DOI 10.1101/125112]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Salgado R, 2015, JAMA ONCOL, V1, P448, DOI 10.1001/jamaoncol.2015.0830; Savas P, 2016, NAT REV CLIN ONCOL, V13, P228, DOI 10.1038/nrclinonc.2015.215; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schmid P, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-2986; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; TOPALIAN SL, 1987, J IMMUNOL METHODS, V102, P127, DOI 10.1016/S0022-1759(87)80018-2; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Ye C., 2017, BIORXIV, DOI [10.1101/225177, DOI 10.1101/225177]	57	445	460	14	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					986	993		10.1038/s41591-018-0078-7	http://dx.doi.org/10.1038/s41591-018-0078-7			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29942092				2022-12-27	WOS:000438187700027
J	Thommen, DS; Koelzer, VH; Herzig, P; Roller, A; Trefny, M; Dimeloe, S; Kiialainen, A; Hanhart, J; Schill, C; Hess, C; Prince, SS; Wiese, M; Lardinois, D; Ho, PC; Klein, C; Karanikas, V; Mertz, KD; Schumacher, TN; Zippelius, A				Thommen, Daniela S.; Koelzer, Viktor H.; Herzig, Petra; Roller, Andreas; Trefny, Marcel; Dimeloe, Sarah; Kiialainen, Anna; Hanhart, Jonathan; Schill, Catherine; Hess, Christoph; Prince, Spasenija Savic; Wiese, Mark; Lardinois, Didier; Ho, Ping-Chih; Klein, Christian; Karanikas, Vaios; Mertz, Kirsten D.; Schumacher, Ton N.; Zippelius, Alfred			A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade	NATURE MEDICINE			English	Article							EXHAUSTION; DYSFUNCTION; MELANOMA; ANTIGEN; ACTIVATION; EXPRESSION; LYMPHOCYTES; REPERTOIRE; EXPANSION; IMMUNITY	Evidence from mouse chronic viral infection models suggests that CD8(+) T cell subsets characterized by distinct expression levels of the receptor PD-1 diverge in their state of exhaustion and potential for reinvigoration by PD-1 blockade. However, it remains unknown whether T cells in human cancer adopt a similar spectrum of exhausted states based on PD-1 expression levels. We compared transcriptional, metabolic and functional signatures of intratumoral CD8(+) T lymphocyte populations with high (PD-1(T)), intermediate (PD-1(N)) and no PD-1 expression (PD-1(-)) from non-small-cell lung cancer patients. PD-1(T) T cells showed a markedly different transcriptional and metabolic profile from PD-1(N) and PD-1(-) lymphocytes, as well as an intrinsically high capacity for tumor recognition. Furthermore, while PD-1(T) lymphocytes were impaired in classical effector cytokine production, they produced CXCL13, which mediates immune cell recruitment to tertiary lymphoid structures. Strikingly, the presence of PD-1(T) cells was strongly predictive for both response and survival in a small cohort of non-small-cell lung cancer patients treated with PD-1 blockade. The characterization of a distinct state of tumor-reactive, PD-1-bright lymphocytes in human cancer, which only partially resembles that seen in chronic infection, provides potential avenues for therapeutic intervention.	[Thommen, Daniela S.; Herzig, Petra; Trefny, Marcel; Zippelius, Alfred] Univ Hosp Basel, Dept Biomed, Canc Immunol, Basel, Switzerland; [Thommen, Daniela S.; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Koelzer, Viktor H.; Hanhart, Jonathan; Mertz, Kirsten D.] Cantonal Hosp Baselland, Inst Pathol, Liestal, Switzerland; [Koelzer, Viktor H.] Univ Oxford, Mol & Populat Genet Lab, Oxford, England; [Roller, Andreas; Kiialainen, Anna] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland; [Dimeloe, Sarah; Hess, Christoph] Univ Hosp Basel, Dept Biomed, Immunobiol, Basel, Switzerland; [Schill, Catherine] Cantonal Hosp Baselland, Oncol, Liestal, Switzerland; [Prince, Spasenija Savic] Univ Hosp Basel, Inst Pathol, Basel, Switzerland; [Wiese, Mark; Lardinois, Didier] Univ Hosp Basel, Dept Surg, Basel, Switzerland; [Ho, Ping-Chih] Univ Lausanne, Ludwig Ctr Canc Res, Epalinges, Switzerland; [Klein, Christian; Karanikas, Vaios] Roche Innovat Ctr Zurich, Roche Pharmaceut Res & Early Dev, Zurich, Switzerland; [Zippelius, Alfred] Univ Hosp Basel, Med Oncol, Basel, Switzerland	University of Basel; Netherlands Cancer Institute; Kantonsspital Baselland; University of Oxford; Roche Holding; University of Basel; Kantonsspital Baselland; University of Basel; University of Basel; University of Lausanne; Roche Holding; University of Basel	Thommen, DS; Zippelius, A (corresponding author), Univ Hosp Basel, Dept Biomed, Canc Immunol, Basel, Switzerland.; Thommen, DS (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Zippelius, A (corresponding author), Univ Hosp Basel, Med Oncol, Basel, Switzerland.	d.thommen@nki.nl; alfred.zippelius@usb.ch	Thommen, Daniela/AAS-1669-2020; Klein, Christian/G-1336-2010; Schumacher, Ton/Y-2432-2019; Mertz, Kirsten/AAY-1660-2020; Trefny, Marcel/AAH-3956-2019	Thommen, Daniela/0000-0002-7431-2854; Klein, Christian/0000-0001-7594-7280; Schumacher, Ton/0000-0003-0517-8804; Mertz, Kirsten/0000-0002-3074-6925; Trefny, Marcel/0000-0001-6755-7899; Koelzer, Viktor/0000-0001-9206-4885; Dimeloe, Sarah/0000-0002-4598-6518	Swiss National Science Foundation [P300PB_164755, 320030_162575, 31003A_163204]; Research Funds University of Basel; Lichtenstein-Stiftung; FAG-Basel; Dutch Cancer Society Queen Wilhelmina Award [NKI 2013-6122]; ERC grant SENSIT	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Research Funds University of Basel; Lichtenstein-Stiftung; FAG-Basel; Dutch Cancer Society Queen Wilhelmina Award; ERC grant SENSIT	We thank D. Labes and E. Traunecker for exemplary technical assistance with cell sorting, E Franco and T. Chao for performing electron microscopy analysis, L. Tietze (Ortenau Klinikum, Germany) for contribution of tumor samples, B. Dolder-Schlienger for technical assistance, and E Uhlenbrock and D. Pinschewer for discussions and critical reading of the manuscript. This work was supported by grants from the Swiss National Science Foundation (P300PB_164755 to D.S.T., 320030 162575 to A.Z. and 31003A_163204 to P.C.H.), the Research Funds University of Basel (D.S.T.), the Lichtenstein-Stiftung (D.S.T), the FAG-Basel (D.S.T.), the Dutch Cancer Society Queen Wilhelmina Award NKI 2013-6122 (T.N.S.) and ERC grant SENSIT (T.N.S.).	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Becker R, 1988, COMPUTER SCI SERIES; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gunnlaugsdottir B, 2005, INT IMMUNOL, V17, P35, DOI 10.1093/intimm/dxh183; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Heemskerk B, 2013, EMBO J, V32, P194, DOI 10.1038/emboj.2012.333; Henson SM, 2009, BLOOD, V113, P6619, DOI 10.1182/blood-2009-01-199588; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Inozume T, 2010, J IMMUNOTHER, V33, P956, DOI 10.1097/CJI.0b013e3181fad2b0; Kansy BA, 2017, CANCER RES, V77, P6353, DOI 10.1158/0008-5472.CAN-16-3167; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scharping NE, 2016, IMMUNITY, V45, P701, DOI 10.1016/j.immuni.2016.08.009; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schreiner J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1062969; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Thommen DS, 2015, CANCER IMMUNOL RES, V3, P1344, DOI 10.1158/2326-6066.CIR-15-0097; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Wang Y, 2016, CANCER DISCOV, V6, P1022, DOI 10.1158/2159-8290.CD-15-1412; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	56	489	504	13	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2018	24	7					994	+		10.1038/s41591-018-0057-z	http://dx.doi.org/10.1038/s41591-018-0057-z			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GM5NV	29892065	Green Accepted			2022-12-27	WOS:000438187700028
J	Beekman, R; Chapaprieta, V; Russinol, N; Vilarrasa-Blasi, R; Verdaguer-Dot, N; Martens, JHA; Duran-Ferrer, M; Kulis, M; Serra, F; Javierre, BM; Wingett, SW; Clot, G; Queiros, AC; Castellano, G; Blanc, J; Gut, M; Merkel, A; Heath, S; Vlasova, A; Ullrich, S; Palumbo, E; Enjuanes, A; Martin-Garcia, D; Bea, S; Pinyol, M; Aymerich, M; Royo, R; Puiggros, M; Torrents, D; Datta, A; Lowy, E; Kostadima, M; Roller, M; Clarke, L; Flicek, P; Agirre, X; Prosper, F; Baumann, T; Delgado, J; Lopez-Guillermo, A; Fraser, P; Yaspo, ML; Guigo, R; Siebert, R; Marti-Renom, MA; Puente, XS; Lopez-Otin, C; Gut, I; Stunnenberg, HG; Campo, E; Martin-Subero, JI				Beekman, Renee; Chapaprieta, Vicente; Russinol, Nuria; Vilarrasa-Blasi, Roser; Verdaguer-Dot, Nuria; Martens, Joost H. A.; Duran-Ferrer, Marti; Kulis, Marta; Serra, Francois; Javierre, Biola M.; Wingett, Steven W.; Clot, Guillem; Queiros, Ana C.; Castellano, Giancarlo; Blanc, Julie; Gut, Marta; Merkel, Angelika; Heath, Simon; Vlasova, Anna; Ullrich, Sebastian; Palumbo, Emilio; Enjuanes, Anna; Martin-Garcia, David; Bea, Silvia; Pinyol, Magda; Aymerich, Marta; Royo, Romina; Puiggros, Montserrat; Torrents, David; Datta, Avik; Lowy, Ernesto; Kostadima, Myrto; Roller, Masa; Clarke, Laura; Flicek, Paul; Agirre, Xabier; Prosper, Felipe; Baumann, Tycho; Delgado, Julio; Lopez-Guillermo, Armando; Fraser, Peter; Yaspo, Marie-Laure; Guigo, Roderic; Siebert, Reiner; Marti-Renom, Marc A.; Puente, Xose S.; Lopez-Otin, Carlos; Gut, Ivo; Stunnenberg, Hendrik G.; Campo, Elias; Martin-Subero, Jose I.			The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia	NATURE MEDICINE			English	Article							DNA HYPOMETHYLATION; CANCER EPIGENOME; SUPER-ENHANCERS; GENOME; EXPRESSION; ACTIVATION; MUTATIONS; METHYLOME; CELLS; STATE	Chronic lymphocytic leukemia (CLL) is a frequent hematological neoplasm in which underlying epigenetic alterations are only partially understood. Here, we analyze the reference epigenome of seven primary CLLs and the regulatory chromatin landscape of 107 primary cases in the context of normal B cell differentiation. We identify that the CLL chromatin landscape is largely influenced by distinct dynamics during normal B cell maturation. Beyond this, we define extensive catalogues of regulatory elements de novo reprogrammed in CLL as a whole and in its major clinico-biological subtypes classified by IGHV somatic hypermutation levels. We uncover that IGHV-unmutated CLLs harbor more active and open chromatin than IGHV-mutated cases. Furthermore, we show that de novo active regions in CLL are enriched for NFAT, FOX and TCF/LEF transcription factor family binding sites. Although most genetic alterations are not associated with consistent epigenetic profiles, CLLs with MYD88 mutations and trisomy 12 show distinct chromatin configurations. Furthermore, we observe that non-coding mutations in IGHV-mutated CLLs are enriched in H3K27ac-associated regulatory elements outside accessible chromatin. Overall, this study provides an integrative portrait of the CLL epigenome, identifies extensive networks of altered regulatory elements and sheds light on the relationship between the genetic and epigenetic architecture of the disease.	[Beekman, Renee; Russinol, Nuria; Clot, Guillem; Queiros, Ana C.; Enjuanes, Anna; Martin-Garcia, David; Bea, Silvia; Pinyol, Magda; Campo, Elias; Martin-Subero, Jose I.] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Beekman, Renee; Clot, Guillem; Vlasova, Anna; Ullrich, Sebastian; Palumbo, Emilio; Enjuanes, Anna; Martin-Garcia, David; Bea, Silvia; Pinyol, Magda; Aymerich, Marta; Agirre, Xabier; Prosper, Felipe; Baumann, Tycho; Delgado, Julio; Lopez-Guillermo, Armando; Puente, Xose S.; Lopez-Otin, Carlos; Campo, Elias; Martin-Subero, Jose I.] Univ Barcelona, Ctr Invest Biomed Red Canc, Barcelona, Spain; [Chapaprieta, Vicente; Vilarrasa-Blasi, Roser; Verdaguer-Dot, Nuria; Duran-Ferrer, Marti; Campo, Elias; Martin-Subero, Jose I.] Univ Barcelona, Fac Med, Dept Fonaments Clin, Barcelona, Spain; [Martens, Joost H. A.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, FNWI, NCMLS, Mol Biol, Nijmegen, Netherlands; [Kulis, Marta; Campo, Elias] Fundacio Clin Recerca Biomed, Barcelona, Spain; [Serra, Francois; Blanc, Julie; Gut, Marta; Merkel, Angelika; Heath, Simon; Vlasova, Anna; Ullrich, Sebastian; Palumbo, Emilio; Guigo, Roderic; Gut, Ivo] UPF, Barcelona, Spain; [Serra, Francois; Marti-Renom, Marc A.] BIST, CNAG CRG, Struct Genom Grp, Barcelona, Spain; [Serra, Francois; Marti-Renom, Marc A.] BIST, Ctr Genom Regulat CRG, Gene Regulat Stem Cells & Canc Program, Barcelona, Spain; [Javierre, Biola M.; Wingett, Steven W.; Fraser, Peter] Babraham Inst, Nucl Dynam Program, Babraham Res Campus, Cambridge, England; [Castellano, Giancarlo] Hosp Clin Barcelona, CDB, Core Biol Mol, Barcelona, Spain; [Blanc, Julie; Gut, Marta; Merkel, Angelika; Heath, Simon; Gut, Ivo] BIST, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain; [Vlasova, Anna; Ullrich, Sebastian; Palumbo, Emilio; Guigo, Roderic] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Bioinformat & Genom Program, Barcelona, Spain; [Aymerich, Marta] Univ Barcelona, IDIBAPS, Hosp Clin, Unitat Hematol, Barcelona, Spain; [Royo, Romina; Puiggros, Montserrat; Torrents, David] Univ Barcelona, Spanish Natl Bioinformat Inst, Programa Conjunto Biol Computac, BSC,IRB, Barcelona, Spain; [Torrents, David; Marti-Renom, Marc A.] ICREA, Barcelona, Spain; [Datta, Avik; Lowy, Ernesto; Kostadima, Myrto; Roller, Masa; Clarke, Laura; Flicek, Paul] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, CIMA, Area Oncol, Pamplona, Spain; [Prosper, Felipe] Univ Navarra, Clin Univ Navarra, Pamplona, Spain; [Baumann, Tycho; Delgado, Julio; Lopez-Guillermo, Armando] IDIBAPS, Hosp Clin, Serv Hematol, Barcelona, Spain; [Fraser, Peter] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Berlin, Germany; [Siebert, Reiner] Univ Ulm, Inst Human Genet, Ulm, Germany; [Siebert, Reiner] Univ Hosp Ulm, Ulm, Germany; [Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Campo, Elias] Hosp Clin Barcelona, Hematopathol Sect, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Barcelona; University of Barcelona; Radboud University Nijmegen; University of Barcelona; Hospital Clinic de Barcelona; Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Barcelona; Hospital Clinic de Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; ICREA; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Navarra; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; State University System of Florida; Florida State University; Max Planck Society; Ulm University; Ulm University; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona	Martin-Subero, JI (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.; Martin-Subero, JI (corresponding author), Univ Barcelona, Ctr Invest Biomed Red Canc, Barcelona, Spain.; Martin-Subero, JI (corresponding author), Univ Barcelona, Fac Med, Dept Fonaments Clin, Barcelona, Spain.	imartins@clinic.cat	Guigo, Roderic/D-1303-2010; López-Otín, Carlos/AAB-2106-2020; Siebert, Reiner/A-8049-2010; Heath, Simon C/J-4138-2012; Prosper, Felipe/H-6859-2017; ENJUANES, Anna/H-3245-2015; Beekman, Renée/AAF-2088-2020; Delgado, Julio/D-4891-2013; Martens, Joost/D-4966-2012; Agirre, Xabier/ABE-4110-2020; bea, silvia/K-7699-2014; JAVIERRE, BIOLA M/A-2974-2017; Clot, Guillem/AAD-9087-2020; Gut, Ivo/ABF-3188-2020; Puente, Xosé S./ADB-0672-2022; Martín, David/AAC-9334-2020; Lopez-Guillermo, Armando/Z-5684-2019; Serra, Francois Jose/A-8789-2011; Marti-Renom, Marc A./Y-8803-2019; Campo, Elias/AAC-5593-2019	Guigo, Roderic/0000-0002-5738-4477; López-Otín, Carlos/0000-0001-6964-1904; Heath, Simon C/0000-0002-9550-0897; Prosper, Felipe/0000-0001-6115-8790; ENJUANES, Anna/0000-0002-4679-6687; Beekman, Renée/0000-0001-7081-7874; Delgado, Julio/0000-0002-5157-4376; Martens, Joost/0000-0003-2008-6537; bea, silvia/0000-0001-7192-2385; JAVIERRE, BIOLA M/0000-0002-8682-6748; Clot, Guillem/0000-0003-2588-7413; Gut, Ivo/0000-0001-7219-632X; Puente, Xosé S./0000-0001-9525-1483; Martín, David/0000-0002-0289-5915; Serra, Francois Jose/0000-0003-3895-4742; Marti-Renom, Marc A./0000-0002-0151-4279; Campo, Elias/0000-0001-9850-9793; Vilarrasa-Blasi, Roser/0000-0002-3384-0693; Kulis, Marta/0000-0001-8104-9620; Clarke, Laura/0000-0002-5989-6898; Queiros, Ana/0000-0001-8585-4803; Kostadima, Myrto Areti/0000-0002-1818-4050; Verdaguer, Nuria/0000-0002-6523-3038; Roller, Masa/0000-0001-5667-3317; Castellano, Giancarlo/0000-0002-5715-7733; Chapaprieta, Vicente/0000-0002-4910-5394; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Duran-Ferrer, Marti/0000-0003-1666-5819; Lowy Gallego, Ernesto/0000-0001-9312-1159; Flicek, Paul/0000-0002-3897-7955; Wingett, Steven/0000-0002-2343-0711; Merkel, Angelika/0000-0001-5164-6803; Baumann, Tycho Stephan/0000-0003-4421-0088	European Union's Seventh Framework Programme through the Blueprint Consortium [282510]; International Cancer Genome Consortium (Chronic Lymphocytic Leukemia Genome consortium); European Hematology Association (Non-Clinical Advanced Research Fellowship); World Wide Cancer Research Foundation [16-1285]; Spanish Ministerio de Economia y Competitividad (MINECO) part of Plan Nacional de I+D+I [SAF2015-64885-R, PMP15/00007]; ISCIII-Sub-Directorate General for Evaluation; European Regional Development Fund (FEDER-"Una manera de hacer Europa"); Generalitat de Catalunya Suport Grups de Recerca [AGAUR 2014-SGR-795]; CERCA Programme/Generalitat de Catalunya; CIBERONC; EU (Marie Sklodowska-Curie Inter European Fellowship); Lady TATA Memorial Trust (International Award); Accio instrumental d'incorporacio de cientifics i tecnolegs PERIS 2016 from the Generalitat de Catalunya; AOI grant of the Spanish Association Against Cancer	European Union's Seventh Framework Programme through the Blueprint Consortium; International Cancer Genome Consortium (Chronic Lymphocytic Leukemia Genome consortium); European Hematology Association (Non-Clinical Advanced Research Fellowship); World Wide Cancer Research Foundation; Spanish Ministerio de Economia y Competitividad (MINECO) part of Plan Nacional de I+D+I; ISCIII-Sub-Directorate General for Evaluation; European Regional Development Fund (FEDER-"Una manera de hacer Europa"); Generalitat de Catalunya Suport Grups de Recerca; CERCA Programme/Generalitat de Catalunya; CIBERONC; EU (Marie Sklodowska-Curie Inter European Fellowship); Lady TATA Memorial Trust (International Award); Accio instrumental d'incorporacio de cientifics i tecnolegs PERIS 2016 from the Generalitat de Catalunya; AOI grant of the Spanish Association Against Cancer	This work was funded by the European Union's Seventh Framework Programme through the Blueprint Consortium (grant agreement 282510), the International Cancer Genome Consortium (Chronic Lymphocytic Leukemia Genome consortium to E.C. and C.L.-O.), the European Hematology Association (Non-Clinical Advanced Research Fellowship to J.I.M.-S.), the World Wide Cancer Research Foundation Grant No. 16-1285 (to J.I.M.-S.), the Spanish Ministerio de Economia y Competitividad (MINECO) Grant No. SAF2015-64885-R (to E.C.) and Grant No. PMP15/00007, part of Plan Nacional de I+D+I and co-financed by the ISCIII-Sub-Directorate General for Evaluation and the European Regional Development Fund (FEDER-"Una manera de hacer Europa") (to E.C.), the Generalitat de Catalunya Suport Grups de Recerca AGAUR 2014-SGR-795 (to E.C.), the CERCA Programme/Generalitat de Catalunya and CIBERONC. R.B. was supported by fellowships from the EU (Marie Sklodowska-Curie Inter European Fellowship) and the Lady TATA Memorial Trust (International Award), N.R. by the Accio instrumental d'incorporacio de cientifics i tecnolegs PERIS 2016 from the Generalitat de Catalunya and M.Ku. by an AOI grant of the Spanish Association Against Cancer. E.C. is an Academia Researcher of the "Institucio Catalana de Recerca i Estudis Avancats" (ICREA) of the Generalitat de Catalunya. This work was partially developed at the Centro Esther Koplowitz (CEK, Barcelona, Spain). We are indebted to the HCB-IDIBAPS Biobank-Tumor Bank and Hematopathology Collection for sample procurement.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Ay F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1236-7; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Burns A, 2017, LEUKEMIA; Cahill N, 2013, LEUKEMIA, V27, P150, DOI 10.1038/leu.2012.245; Cairns J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0992-2; Ceribelli M, 2016, CANCER CELL, V30, P764, DOI 10.1016/j.ccell.2016.10.002; Chun HJE, 2016, CANCER CELL, V29, P394, DOI 10.1016/j.ccell.2016.02.009; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Ecker S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1156-8; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fabbri G, 2016, NAT REV CANCER, V16, P145, DOI 10.1038/nrc.2016.8; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Fiziev P, 2017, CELL REP, V19, P875, DOI 10.1016/j.celrep.2017.03.078; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gutierrez A, 2010, BLOOD, V116, P2975, DOI 10.1182/blood-2010-02-269878; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Juhling F, 2016, GENOME RES, V26, P256, DOI 10.1101/gr.196394.115; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kipps TJ, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2016.96, 10.1038/nrdp.2017.8]; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Martinez-Trillos A, 2016, BLOOD, V127, P1611, DOI 10.1182/blood-2015-10-678490; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; McCarthy BA, 2015, IMMUNOL RES, V63, P90, DOI 10.1007/s12026-015-8688-3; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Merkel A., 2017, BIORXIV; Minici C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15746; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; Muratani M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5361; Murphy EJ, 2017, LEUKEMIA, V31, P1348, DOI 10.1038/leu.2017.34; Navarro A., 2017, HAEMATOLOGICA; Nihira K, 2010, CELL DEATH DIFFER, V17, P689, DOI 10.1038/cdd.2009.174; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Pedersen BS, 2017, AM J HUM GENET, V100, P406, DOI 10.1016/j.ajhg.2017.01.017; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Queiros AC, 2015, LEUKEMIA, V29, P598, DOI 10.1038/leu.2014.252; Queiros AC, 2016, CANCER CELL, V30, P806, DOI 10.1016/j.ccell.2016.09.014; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rendeiro AF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11938; Riches JC, 2014, BLOOD, V123, P4101, DOI 10.1182/blood-2014-01-552307; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Serra F, 2016, BIORXIV, DOI [10.1101/036764, DOI 10.1101/036764]; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thongjuea S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt373; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Wolf C, 2018, INT J CANCER, V142, P322, DOI 10.1002/ijc.31057; Wu W, 2016, ONCOTARGET, V7, P21631, DOI 10.18632/oncotarget.7795; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137	73	104	104	0	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					868	+		10.1038/s41591-018-0028-4	http://dx.doi.org/10.1038/s41591-018-0028-4			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29785028	Green Accepted			2022-12-27	WOS:000434281300031
J	Rooney, C; Sauer, T				Rooney, Cliona; Sauer, Tim			IMMUNOTHERAPY Modeling cytokine release syndrome	NATURE MEDICINE			English	Editorial Material							T-CELL THERAPY; ADOPTIVE IMMUNOTHERAPY	Complete leukemic responses to chimeric antigen receptor-modified T cells are invariably accompanied by severe toxicity. Recently developed animal models allow mechanistic dissection and prevention of toxicity without loss of therapeutic benefit.	[Rooney, Cliona; Sauer, Tim] Baylor Coll Med, Dept Pediat, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine	Rooney, C (corresponding author), Baylor Coll Med, Dept Pediat, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	crooney@bcm.edu	Rooney, Cliona/ABD-5475-2021					Bedoya F, 2017, MOL THER, V25, P314, DOI 10.1016/j.ymthe.2016.11.011; Cruz CR, 2010, CYTOTHERAPY, V12, P743, DOI 10.3109/14653241003709686; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hay KA, 2017, BLOOD, V130, P2295, DOI 10.1182/blood-2017-06-793141; Morgan RA, 2012, MOL THER, V20, P882, DOI 10.1038/mt.2012.73; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Porter D, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0571-y; Schmiegelow K, 2016, LANCET ONCOL, V17, pE231, DOI 10.1016/S1470-2045(16)30035-3; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shum T, 2017, CANCER DISCOV, V7, P1238, DOI 10.1158/2159-8290.CD-17-0538; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621	12	11	14	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2018	24	6					705	706		10.1038/s41591-018-0068-9	http://dx.doi.org/10.1038/s41591-018-0068-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GI3OQ	29808004				2022-12-27	WOS:000434281300012
J	Ting, DSW; Liu, Y; Burlina, P; Xu, XX; Bressler, NM; Wong, TY				Ting, Daniel S. W.; Liu, Yong; Burlina, Philippe; Xu, Xinxing; Bressler, Neil M.; Wong, Tien Y.			Al for medical imaging goes deep	NATURE MEDICINE			English	Editorial Material							MACULAR DEGENERATION; DIABETIC-RETINOPATHY; LEARNING-SYSTEM; CLASSIFICATION; TUBERCULOSIS; DISEASES; IMAGES		[Ting, Daniel S. W.; Wong, Tien Y.] Natl Univ Singapore, Duke NUS Med Sch, Singapore Natl Eye Ctr, Singapore, Singapore; [Ting, Daniel S. W.; Liu, Yong; Xu, Xinxing] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Burlina, Philippe] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD USA; [Burlina, Philippe; Bressler, Neil M.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA	National University of Singapore; Singapore National Eye Center; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; Johns Hopkins Medicine	Ting, DSW (corresponding author), Natl Univ Singapore, Duke NUS Med Sch, Singapore Natl Eye Ctr, Singapore, Singapore.; Ting, DSW (corresponding author), ASTAR, Inst High Performance Comp, Singapore, Singapore.	daniel.ting.s.w@singhealth.com.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Bidwai, Pooja Vishal/0000-0002-3077-4395				Burlina PM, 2017, JAMA OPHTHALMOL, V135, P1170, DOI 10.1001/jamaophthalmol.2017.3782; Chew EY, 2015, OPHTHALMOLOGY, V122, P2155, DOI 10.1016/j.ophtha.2015.08.007; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Ting DSW, 2018, RADIOLOGY, V286, P729, DOI 10.1148/radiol.2017172407; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Ting DSW, 2017, LANCET, V389, P2165, DOI 10.1016/S0140-6736(17)31194-7; Yi PH, 2018, J AM COLL RADIOL, V15, P781, DOI 10.1016/j.jacr.2017.12.037	12	85	88	2	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					539	540		10.1038/s41591-018-0029-3	http://dx.doi.org/10.1038/s41591-018-0029-3			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736024				2022-12-27	WOS:000432126800008
J	Gopalakrishna, KP; Macadangdang, BR; Rogers, MB; Tometich, JT; Firek, BA; Baker, R; Ji, JY; Burr, AHP; Ma, CR; Good, M; Morowitz, MJ; Hand, TW				Gopalakrishna, Kathyayini P.; Macadangdang, Benjamin R.; Rogers, Matthew B.; Tometich, Justin T.; Firek, Brian A.; Baker, Robyn; Ji, Junyi; Burr, Ansen H. P.; Ma, Congrong; Good, Misty; Morowitz, Michael J.; Hand, Timothy W.			Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants	NATURE MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; BREAST-MILK; SECRETORY ANTIBODIES; MICROBIOTA; BACTERIA; GROWTH; CELLS; IMMUNITY; INNATE; MICE	Neonates are protected from colonizing bacteria by antibodies secreted into maternal milk. Necrotizing enterocolitis (NEC) is a disease of neonatal preterm infants with high morbidity and mortality that is associated with intestinal inflammation driven by the microbiota(1-3). The incidence of NEC is substantially lower in infants fed with maternal milk, although the mechanisms that underlie this benefit are not clear(4-6). Here we show that maternal immunoglobulin A (IgA) is an important factor for protection against NEC. Analysis of IgA binding to fecal bacteria from preterm infants indicated that maternal milk was the predominant source of IgA in the first month of life and that a relative decrease in IgA-bound bacteria is associated with the development of NEC. Sequencing of IgAbound and unbound bacteria revealed that before the onset of disease, NEC was associated with increasing domination by Enterobacteriaceae in the IgA-unbound fraction of the microbiota. Furthermore, we confirmed that IgA is critical for preventing NEC in a mouse model, in which pups that are reared by IgA-deficient mothers are susceptible to disease despite exposure to maternal milk. Our findings show that maternal IgA shapes the host-microbiota relationship of preterm neonates and that IgA in maternal milk is a critical and necessary factor for the prevention of NEC.	[Gopalakrishna, Kathyayini P.; Macadangdang, Benjamin R.; Tometich, Justin T.; Ji, Junyi; Burr, Ansen H. P.; Ma, Congrong; Hand, Timothy W.] UPMC Childrens Hosp Pittsburgh, Richard King Mellon Fdn Inst Pediat Res, Dept Pediat, Pittsburgh, PA 15224 USA; [Gopalakrishna, Kathyayini P.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Macadangdang, Benjamin R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Neonatol & Dev Biol, Los Angeles, CA 90095 USA; [Rogers, Matthew B.; Firek, Brian A.; Morowitz, Michael J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Baker, Robyn] UPMC Magee Womens Hosp, Div Newborn Med, Pittsburgh, PA USA; [Ji, Junyi] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Burr, Ansen H. P.; Hand, Timothy W.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Good, Misty] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Hand, TW (corresponding author), UPMC Childrens Hosp Pittsburgh, Richard King Mellon Fdn Inst Pediat Res, Dept Pediat, Pittsburgh, PA 15224 USA.; Hand, TW (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.	timothy.hand@chp.edu	Hand, Timothy W/AAH-1216-2021	Hand, Timothy W/0000-0002-2684-9462; Ji, Junyi/0000-0002-5764-198X	UPMC Children's Hospital of Pittsburgh; National Institutes of Health [K08DK101608, R03DK111473, R01DK118568]; March of Dimes Foundation [5-FY17-79]; Children's Discovery Institute of Washington University; St Louis Children's Hospital; Richard King Mellon Foundation Institute for Pediatric Research;  [R01AI092531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK111473, R01DK118568, K08DK101608] Funding Source: NIH RePORTER	UPMC Children's Hospital of Pittsburgh; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Children's Discovery Institute of Washington University; St Louis Children's Hospital; Richard King Mellon Foundation Institute for Pediatric Research; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Pittsburgh In Situ Hybridization Laboratory for the preparation of tissue slides and the University of Pittsburgh Division of Laboratory Animal Research for assistance with animal husbandry; M. Band, C. Wright, T. Akraiko and the Roy J. Carver Biotechnology Center DNA Sequencing Center at the University of Illinois for assistance with NextGen Sequencing. Igha<SUP>-/-</SUP> mice were provided by Y. Belkaid. We thank A. Poholek, L. Konnikova, S. Canna and the members of the Hand and Morowitz laboratories for discussion and critical reading of the manuscript, N. Palm for advice on IgSeq analysis and D. Kostka for advice on deconvolution of IgSeq samples. This project was supported in part by the UPMC Children's Hospital of Pittsburgh. M.G. is supported by K08DK101608, R03DK111473 and R01DK118568 from the National Institutes of Health, March of Dimes Foundation grant no. 5-FY17-79, the Children's Discovery Institute of Washington University and St Louis Children's Hospital. M. J. M. and the collection of samples are supported by R01AI092531. T.W.H. is supported by the Richard King Mellon Foundation Institute for Pediatric Research.	BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Brower-Sinning R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105046; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cortez J, 2018, J PERINATOL, V38, P71, DOI 10.1038/jp.2017.149; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EIBL MM, 1988, NEW ENGL J MED, V319, P1, DOI 10.1056/NEJM198807073190101; Foster J, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0378-2; Gauger EJ, 2007, INFECT IMMUN, V75, P3315, DOI 10.1128/IAI.00052-07; Good M, 2015, MUCOSAL IMMUNOL, V8, P1166, DOI 10.1038/mi.2015.30; Good M, 2016, BRIT J NUTR, V116, P1175, DOI 10.1017/S0007114516002944; Good M, 2014, AM J PHYSIOL-GASTR L, V306, pG1021, DOI 10.1152/ajpgi.00452.2013; Hackam D, 2018, SEMIN PEDIATR SURG, V27, P11, DOI 10.1053/j.sempedsurg.2017.11.003; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; He YM, 2018, NAT MED, V24, P224, DOI 10.1038/nm.4467; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Le Doare K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00361; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mirpuri J, 2014, GUT MICROBES, V5, P28, DOI 10.4161/gmic.26489; Moor K, 2017, NATURE, V544, P498, DOI 10.1038/nature22058; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Olm M. R., 2019, PREPRINT, DOI [10.1101/558676v1, DOI 10.1101/558676V1]; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pammi M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0248-8; Patel CB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00172; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Radulescu A, 2010, J PEDIATR SURG, V45, P1933, DOI 10.1016/j.jpedsurg.2010.05.002; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; ROGNUM TO, 1992, PEDIATR RES, V32, P145, DOI 10.1203/00006450-199208000-00003; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wisgrill L, 2018, CLIN EXP IMMUNOL, V192, P315, DOI 10.1111/cei.13108; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022	48	108	112	4	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1110	U233		10.1038/s41591-019-0480-9	http://dx.doi.org/10.1038/s41591-019-0480-9			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31209335	Green Accepted			2022-12-27	WOS:000474430400025
J	Stower, H				Stower, Hannah			Therapeutic selfies	NATURE MEDICINE			English	Editorial Material																			0	0	0	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					710	710		10.1038/s41591-019-0456-9	http://dx.doi.org/10.1038/s41591-019-0456-9			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31068705	Bronze			2022-12-27	WOS:000468247800008
J	Suez, J; Zmora, N; Segal, E; Elinav, E				Suez, Jotham; Zmora, Niv; Segal, Eran; Elinav, Eran			The pros, cons, and many unknowns of probiotics	NATURE MEDICINE			English	Article							ANTIBIOTIC-ASSOCIATED DIARRHEA; CLOSTRIDIUM-DIFFICILE INFECTION; LACTOBACILLUS-PLANTARUM 299V; IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CLINICAL-TRIAL; GUT MICROBIAL METABOLITE; MUCIN GENE-EXPRESSION; LACTIC-ACID BACTERIA; QUALITY-OF-LIFE; DOUBLE-BLIND	Consumption of over-the-counter probiotics for promotion of health and well-being has increased worldwide in recent years. However, although probiotic use has been greatly popularized among the general public, there are conflicting clinical results for many probiotic strains and formulations. Emerging insights from microbiome research enable an assessment of gut colonization by probiotics, strain-level activity, interactions with the indigenous microbiome, safety and impacts on the host, and allow the association of probiotics with physiological effects and potentially useful medical indications. In this Perspective, we highlight key advances, challenges and limitations in striving toward an unbiased interpretation of the large amount of data regarding over-the-counter probiotics, and propose avenues to improve the quality of evidence, transparency, public awareness and regulation of their use.	[Suez, Jotham; Zmora, Niv; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, Rehovot, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Digest Ctr, Tel Aviv, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Internal Med Dept, Tel Aviv, Israel; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Elinav, Eran] DKFZ, Canc Microbiome Res Div, Heidelberg, Germany	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ)	Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel.; Elinav, E (corresponding author), DKFZ, Canc Microbiome Res Div, Heidelberg, Germany.	eran.segal@weizmann.ac.il; eran.elinav@weizmann.ac.il	Elinav, Eran/ABE-8881-2020; Segal, Eran/AAF-4855-2019; Suez, Jotham/AAZ-5433-2020	Elinav, Eran/0000-0002-5775-2110; Suez, Jotham/0000-0003-3836-972X; Segal, Eran/0000-0002-6859-1164	Strauss Institute; Gilead Sciences International Research Scholars Program in Liver Disease; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council; Israel Science Foundation; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development; Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation; European Foundation for the Study of Diabetes	Strauss Institute; Gilead Sciences International Research Scholars Program in Liver Disease; Crown Human Genome Center; Else Kroener Fresenius Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; Marie Curie Integration grant; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Minerva Foundation; Rising Tide Foundation; Helmholtz Foundation(Helmholtz Association); European Foundation for the Study of Diabetes	We thank the members of the Elinav and Segal laboratories for discussions and apologize to authors whose work was not included due to space constraints. J.S. is the recipient of the Strauss Institute research fellowship. N.Z. is supported by the Gilead Sciences International Research Scholars Program in Liver Disease. E.S. is supported by the Crown Human Genome Center; the Else Kroener Fresenius Foundation; Donald L. Schwarz, Sherman Oaks, CA; Jack N. Halpern, NY, NY; Leesa Steinberg, Canada; and grants funded by the European Research Council and the Israel Science Foundation. E.E. is supported by Y. and R. Ungar, the Abisch Frenkel Foundation for the Promotion of Life Sciences, the Gurwin Family Fund for Scientific Research, the Leona M. and Harry B. Helmsley Charitable Trust, the Crown Endowment Fund for Immunological Research, the estate of J. Gitlitz, the estate of L. Hershkovich, the Benoziyo Endowment Fund for the Advancement of Science, the Adelis Foundation, J. L. and V. Schwartz, A. and G. Markovitz, A. and C. Adelson, the French National Center for Scientific Research (CNRS), D.L. Schwarz, the V. R. Schwartz Research Fellow Chair, L. Steinberg, J. N. Halpern, A. Edelheit, grants funded by the European Research Council, a Marie Curie Integration grant, the German-Israeli Foundation for Scientific Research and Development, the Israel Science Foundation, the Minerva Foundation, the Rising Tide Foundation, the Helmholtz Foundation, and the European Foundation for the Study of Diabetes.	Abildgaard A, 2019, EUR NEUROPSYCHOPHARM, V29, P98, DOI 10.1016/j.euroneuro.2018.10.011; Aceti A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080904; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; Alander M, 2001, INT DAIRY J, V11, P817, DOI 10.1016/S0958-6946(01)00100-5; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Andriantsoanirina V, 2014, ANAEROBE, V28, P212, DOI 10.1016/j.anaerobe.2014.07.002; [Anonymous], 2018, GLOB PROB MARK IS SE; [Anonymous], 2018, DEV APPR PROC DRUGS; [Anonymous], 2012, ADV MICROBIOL-IRVINE, DOI DOI 10.4236/AIM.2012.23051; Ardita CS, 2014, APPL ENVIRON MICROB, V80, P5068, DOI 10.1128/AEM.01039-14; Arthur JC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02868; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bafeta A, 2018, ANN INTERN MED, V169, P240, DOI 10.7326/M18-0343; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Benton D, 2007, EUR J CLIN NUTR, V61, P355, DOI 10.1038/sj.ejcn.1602546; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Brahe LK, 2015, BRIT J NUTR, V114, P406, DOI 10.1017/S0007114515001786; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brecht M, 2016, NEONATOLOGY, V109, P186, DOI 10.1159/000441965; Bruzzese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087796; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Burton KJ, 2017, BRIT J NUTR, V117, P1312, DOI 10.1017/S0007114517000885; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Canani RB, 2007, BMJ-BRIT MED J, V335, P340, DOI 10.1136/bmj.39272.581736.55; Carvour ML, 2019, AM J INFECT CONTROL, V47, P2, DOI 10.1016/j.ajic.2018.07.014; Charbonneau D, 2013, GUT MICROBES, V4, P201, DOI 10.4161/gmic.24196; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Corr SC, 2007, P NATL ACAD SCI USA, V104, P7617, DOI 10.1073/pnas.0700440104; Costabile A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187964; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Crittenden R., 2002, Microbial Ecology in Health and Disease, V14, P22, DOI 10.1080/089106002760003314; de Vrese M, 2001, AM J CLIN NUTR, V73, p421S, DOI 10.1093/ajcn/73.2.421s; de Vrieze J, 2018, SCIENCE, V361, P1185, DOI 10.1126/science.361.6408.1184; De Wolfe TJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204253; Degirolamo C, 2014, CELL REP, V7, P12, DOI 10.1016/j.celrep.2014.02.032; Degnan FH, 2012, GUT MICROBES, V3, P485, DOI 10.4161/gmic.22158; Dermyshi E, 2017, NEONATOLOGY, V112, P9, DOI 10.1159/000454668; Didari T, 2014, EXPERT OPIN DRUG SAF, V13, P227, DOI 10.1517/14740338.2014.872627; Dietrich CG, 2014, WORLD J GASTROENTERO, V20, P15837, DOI 10.3748/wjg.v20.i42.15837; Dogi CA, 2006, J DAIRY RES, V73, P357, DOI [10.1017/S0022029906001993, 10.1017/s0022029906001993]; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Draper K, 2017, BENEF MICROBES, V8, P507, DOI 10.3920/BM2016.0146; El Hage R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01889; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Falagas ME, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.10.021; Feizizadeh S, 2014, PEDIATRICS, V134, pE176, DOI 10.1542/peds.2013-3950; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Ferrario C, 2014, J NUTR, V144, P1787, DOI 10.3945/jn.114.197723; Firmesse O, 2008, J MOL MICROB BIOTECH, V14, P90, DOI 10.1159/000106087; Ford AC, 2018, ALIMENT PHARM THER, V48, P1044, DOI 10.1111/apt.15001; Freedman SB, 2018, NEW ENGL J MED, V379, P2015, DOI [10.1056/NEJMoa1802597, 10.1056/nejmoa1802597]; Freedman SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128754; Fujimori S, 2009, NUTRITION, V25, P520, DOI 10.1016/j.nut.2008.11.017; Fujimura S, 2006, LETT APPL MICROBIOL, V43, P578, DOI 10.1111/j.1472-765X.2006.02017.x; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fukushima Y, 1998, INT J FOOD MICROBIOL, V42, P39, DOI 10.1016/S0168-1605(98)00056-7; Galdeano CM, 2006, CLIN VACCINE IMMUNOL, V13, P219, DOI 10.1128/CVI.13.2.219-226.2006; Ganguli K, 2013, AM J PHYSIOL-GASTR L, V304, pG132, DOI 10.1152/ajpgi.00142.2012; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; Garcia-Albiach R, 2008, AM J CLIN NUTR, V87, P91, DOI 10.1093/ajcn/87.1.91; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Garrido D, 2005, FEMS MICROBIOL LETT, V248, P249, DOI 10.1016/j.femsle.2005.05.045; Gaudier E, 2005, J NUTR, V135, P2753; Georgieva M, 2015, J IMAB, V21, P895, DOI 10.5272/jimab.2015214.895; Gianotti L, 2010, WORLD J GASTROENTERO, V16, P167, DOI 10.3748/wjg.v16.i2.167; Goldenberg J. Z., 2015, COCHRANE DB SYST REV, V11; Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3; Goossens D, 2003, ALIMENT PHARM THER, V18, P495, DOI 10.1046/j.1365-2036.2003.01708.x; Goossens DAM, 2006, ALIMENT PHARM THER, V23, P255, DOI 10.1111/j.1365-2036.2006.02749.x; Grazul H, 2016, GUT MICROBES, V7, P101, DOI 10.1080/19490976.2016.1138197; Gueimonde M, 2007, INT J FOOD MICROBIOL, V113, P228, DOI 10.1016/j.ijfoodmicro.2006.05.017; Guyonnet D, 2007, ALIMENT PHARM THER, V26, P475, DOI 10.1111/j.1365-2036.2007.03362.x; Hao QK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006895.pub3; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; He F, 2001, CURR MICROBIOL, V43, P351, DOI 10.1007/s002840010315; Hempel Susanne, 2011, Evid Rep Technol Assess (Full Rep), P1; Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hod K, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13456; Hoffmann DE, 2014, FOOD DRUG LAW J, V69, P237; Horvath A, 2016, ALIMENT PHARM THER, V44, P926, DOI 10.1111/apt.13788; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Jafarnejad S, 2016, NUTR CLIN PRACT, V31, P502, DOI 10.1177/0884533616639399; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Jones C, 2013, EUR J GASTROEN HEPAT, V25, P1424, DOI 10.1097/MEG.0b013e328363e26e; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kabbani TA, 2017, GUT MICROBES, V8, P17, DOI 10.1080/19490976.2016.1267890; Kaikiri H, 2017, INT J FOOD SCI NUTR, V68, P941, DOI 10.1080/09637486.2017.1318116; Kajander K, 2007, ALIMENT PHARM THER, V26, P463, DOI 10.1111/j.1365-2036.2007.03391.x; Kankaanpaa PE, 2001, FEMS MICROBIOL LETT, V194, P149, DOI 10.1016/S0378-1097(00)00519-X; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kelly JR, 2017, BRAIN BEHAV IMMUN, V61, P50, DOI 10.1016/j.bbi.2016.11.018; Khalesi S, 2019, EUR J CLIN NUTR, V73, P24, DOI 10.1038/s41430-018-0135-9; Khanna R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1350; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; King S, 2019, EUR J PUBLIC HEALTH, V29, P494, DOI 10.1093/eurpub/cky185; Klarin B, 2008, ACTA ANAESTH SCAND, V52, P1096, DOI 10.1111/j.1399-6576.2008.01748.x; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Kolber MR, 2014, AM J GASTROENTEROL, V109, P1081, DOI 10.1038/ajg.2014.109; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Korpela K, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0567-4; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Lagrafeuille R, 2018, BENEF MICROBES, V9, P87, DOI 10.3920/BM2017.0002; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Lemann M., 2009, J PEDIAT GASTROENTER, V48, pE1; Li JR, 2011, P NATL ACAD SCI USA, V108, P3360, DOI 10.1073/pnas.1017431108; Li STT, 2009, CLIN PEDIATR, V48, P295, DOI 10.1177/0009922808327057; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Lu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23522; Lu MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163743; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Mattar AF, 2002, PEDIATR SURG INT, V18, P586, DOI 10.1007/s00383-002-0855-7; McFarland L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005074; McFarland LV, 2015, BENEF MICROBES, V6, P189, DOI 10.3920/BM2014.0034; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; McKenzie YA, 2016, J HUM NUTR DIET, V29, P576, DOI 10.1111/jhn.12386; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Medellin-Pena MJ, 2007, APPL ENVIRON MICROB, V73, P4259, DOI 10.1128/AEM.00159-07; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Merenstein D, 2010, EUR J CLIN NUTR, V64, P669, DOI 10.1038/ejcn.2010.65; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Mohan R, 2006, J CLIN MICROBIOL, V44, P4025, DOI 10.1128/JCM.00767-06; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; Murata M, 2018, BENEF MICROBES, V9, P855, DOI [10.3920/BM2017.0197, 10.3920/bm2017.0197]; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Olek A, 2017, J PEDIATR-US, V186, P82, DOI 10.1016/j.jpeds.2017.03.047; Oliveira BCM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01408-18; Olsen R, 2016, NEONATOLOGY, V109, P105, DOI 10.1159/000441274; Ouwehand AC, 2008, FEMS IMMUNOL MED MIC, V53, P18, DOI 10.1111/j.1574-695X.2008.00392.x; Ouwehand AC, 2014, VACCINE, V32, P458, DOI 10.1016/j.vaccine.2013.11.053; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Pelto L, 1998, CLIN EXP ALLERGY, V28, P1474, DOI 10.1046/j.1365-2222.1998.00449.x; Pereg D, 2005, AM J INFECT CONTROL, V33, P122, DOI 10.1016/j.ajic.2004.11.001; Perez-Burgos A, 2015, J PHYSIOL-LONDON, V593, P3943, DOI 10.1113/JP270229; Persborn M, 2013, ALIMENT PHARM THER, V38, P772, DOI 10.1111/apt.12451; Quin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26423-3; Rafiq R, 2007, GASTROENTEROLOGY, V132, pA187; Rao SC, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3684; Reis DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199041; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Ricci A., 2018, EFSA J, V16, DOI DOI 10.2903/J.EFSA.2018.5131; Rijkers GT, 2011, BRIT J NUTR, V106, P1291, DOI 10.1017/S000711451100287X; Rochet V, 2006, BRIT J NUTR, V95, P421, DOI 10.1079/BJN20051625; Roessler A, 2008, CLIN EXP ALLERGY, V38, P93, DOI 10.1111/j.1365-2222.2007.02876.x; Rousseaux C, 2007, NAT MED, V13, P35, DOI 10.1038/nm1521; Ruszczynski M, 2008, ALIMENT PHARM THER, V28, P154, DOI 10.1111/j.1365-2036.2008.03714.x; Sabico S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1354-x; Saldanha LG, 2008, CLIN INFECT DIS, V46, pS119, DOI 10.1086/523328; Sarkar A, 2016, TRENDS NEUROSCI, V39, P763, DOI 10.1016/j.tins.2016.09.002; Schiavi E, 2016, APPL ENVIRON MICROB, V82, P7185, DOI 10.1128/AEM.02238-16; Schnadower D, 2018, NEW ENGL J MED, V379, P2002, DOI [10.1056/nejmoa1802598, 10.1056/NEJMoa1802598]; Shan LS, 2013, BENEF MICROBES, V4, P329, DOI 10.3920/BM2013.0008; Shen NT, 2017, GASTROENTEROLOGY, V152, P1889, DOI 10.1053/j.gastro.2017.02.003; Shepherd ES, 2018, NATURE, V557, P434, DOI 10.1038/s41586-018-0092-4; Shibahara-Sone H, 2016, BENEF MICROBES, V7, P319, DOI 10.3920/BM2015.0138; Shimizu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139795; Shinkai S, 2013, BRIT J NUTR, V109, P1856, DOI 10.1017/S0007114512003753; Sierra S, 2010, ANAEROBE, V16, P195, DOI 10.1016/j.anaerobe.2010.02.001; Simon MC, 2015, DIABETES CARE, V38, P1827, DOI 10.2337/dc14-2690; Smith TJ, 2013, BRIT J NUTR, V109, P1999, DOI 10.1017/S0007114512004138; Smith TJ, 2011, J AM COLL NUTR, V30, P259, DOI 10.1080/07315724.2011.10719968; Sniffen JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209205; Sommer F, 2017, NAT REV MICROBIOL, V15, P630, DOI 10.1038/nrmicro.2017.58; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spinler JK, 2016, ANAEROBE, V40, P54, DOI 10.1016/j.anaerobe.2016.05.008; Stadlbauer V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141399; Suez J, 2020, GUT MICROBES, V11, P77, DOI 10.1080/19490976.2019.1586039; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Suwal S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02675; Szajewska H, 2015, ALIMENT PHARM THER, V42, P793, DOI 10.1111/apt.13344; Szajewska H, 2013, ALIMENT PHARM THER, V38, P467, DOI 10.1111/apt.12403; Szajewska H, 2016, J PEDIATR GASTR NUTR, V62, P495, DOI 10.1097/MPG.0000000000001081; Szajewska H, 2014, J PEDIATR GASTR NUTR, V58, P531, DOI 10.1097/MPG.0000000000000320; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Thompson JA, 2015, CELL REP, V10, P1861, DOI 10.1016/j.celrep.2015.02.049; Topcuoglu S, 2015, J MATERN-FETAL NEO M, V28, P1491, DOI 10.3109/14767058.2014.958462; Tsai CC, 2005, INT J FOOD MICROBIOL, V102, P185, DOI 10.1016/j.ijfoodmicro.2004.12.014; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Veiga P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06328; Viggars AP, 2017, GASTROENTEROLOGY, V153, P1451, DOI [10.1053/j.gastro.2017.05.067, 10.1053/j.gastro.2017.05.037]; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; Wang CX, 2015, ANN NUTR METAB, V67, P257, DOI 10.1159/000441066; Wang ZJ, 2017, MICROB PATHOGENESIS, V109, P156, DOI 10.1016/j.micpath.2017.05.035; West NP, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-30; Williams MD, 2010, J CLIN GASTROENTEROL, V44, P631, DOI 10.1097/MCG.0b013e3181d47f5b; Wilms E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167775; Yamada M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27408-y; Yan F, 2017, MUCOSAL IMMUNOL, V10, P117, DOI 10.1038/mi.2016.43; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yanagihara S, 2017, INT IMMUNOL, V29, P357, DOI 10.1093/intimm/dxx043; Yang Y, 2015, APPL ENVIRON MICROB, V81, P5743, DOI 10.1128/AEM.01525-15; Yun B, 2014, J DAIRY SCI, V97, P4745, DOI 10.3168/jds.2014-7921; Zeng J, 2008, ALIMENT PHARM THER, V28, P994, DOI 10.1111/j.1365-2036.2008.03818.x; Zhang CH, 2016, ISME J, V10, P2235, DOI 10.1038/ismej.2016.13; Zhang GQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002581; Zmora N, 2018, CELL, V174, P1388, DOI 10.1016/j.cell.2018.08.041; Zoppi G, 2001, CURR THER RES CLIN E, V62, P418, DOI 10.1016/S0011-393X(01)89006-8; 2005, CLIN NUTR, V24, P481, DOI DOI 10.1016/J.CLNU.2005.02.006	222	394	417	53	294	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					716	729		10.1038/s41591-019-0439-x	http://dx.doi.org/10.1038/s41591-019-0439-x			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31061539				2022-12-27	WOS:000468247800013
J	Yang, W; Lee, KW; Srivastava, RM; Kuo, FS; Krishna, C; Chowell, D; Makarov, V; Hoen, D; Dalin, MG; Wexler, L; Ghossein, R; Katabi, N; Nadeem, Z; Cohen, MA; Tian, SK; Robine, N; Arora, K; Geiger, H; Agius, P; Bouvier, N; Huberman, K; Vanness, K; Havel, JJ; Sims, JS; Samstein, RM; Mandal, R; Tepe, J; Ganly, I; Ho, AL; Riaz, N; Wong, RJ; Shukla, N; Chan, TA; Morris, LGT				Yang, Wei; Lee, Ken-Wing; Srivastava, Raghvendra M.; Kuo, Fengshen; Krishna, Chirag; Chowell, Diego; Makarov, Vladimir; Hoen, Douglas; Dalin, Martin G.; Wexler, Leonard; Ghossein, Ronald; Katabi, Nora; Nadeem, Zaineb; Cohen, Marc A.; Tian, S. Ken; Robine, Nicolas; Arora, Kanika; Geiger, Heather; Agius, Phaedra; Bouvier, Nancy; Huberman, Kety; Vanness, Katelynd; Havel, Jonathan J.; Sims, Jennifer S.; Samstein, Robert M.; Mandal, Rajarsi; Tepe, Justin; Ganly, Ian; Ho, Alan L.; Riaz, Nadeem; Wong, Richard J.; Shukla, Neerav; Chan, Timothy A.; Morris, Luc G. T.			Immunogenic neoantigens derived from gene fusions stimulate T cell responses	NATURE MEDICINE			English	Article							TUMOR-ANTIGENS; SOMATIC MUTATIONS; BCR-ABL; CANCER; LANDSCAPE; IMMUNOTHERAPY; INDUCTION; PEPTIDES; BLOCKADE; PROTEIN	Anti-tumor immunity is driven by self versus non-self discrimination. Many immunotherapeutic approaches to cancer have taken advantage of tumor neoantigens derived from somatic mutations. Here, we demonstrate that gene fusions are a source of immunogenic neoantigens that can mediate responses to immunotherapy. We identified an exceptional responder with metastatic head and neck cancer who experienced a complete response to immune checkpoint inhibitor therapy, despite a low mutational load and minimal pre-treatment immune infiltration in the tumor. Using whole-genome sequencing and RNA sequencing, we identified a novel gene fusion and demonstrated that it produces a neoantigen that can specifically elicit a host cytotoxic T cell response. In a cohort of head and neck tumors with low mutation burden, minimal immune infiltration and prevalent gene fusions, we also identified gene fusion-derived neoantigens that generate cytotoxic T cell responses. Finally, analyzing additional datasets of fusion-positive cancers, including checkpoint-inhibitor-treated tumors, we found evidence of immune surveillance resulting in negative selective pressure against gene fusion-derived neoantigens. These findings highlight an important class of tumor-specific antigens and have implications for targeting gene fusion events in cancers that would otherwise be less poised for response to immunotherapy, including cancers with low mutational load and minimal immune infiltration.	[Yang, Wei; Lee, Ken-Wing; Havel, Jonathan J.; Chan, Timothy A.; Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Yang, Wei; Srivastava, Raghvendra M.; Kuo, Fengshen; Chowell, Diego; Makarov, Vladimir; Hoen, Douglas; Havel, Jonathan J.; Sims, Jennifer S.; Mandal, Rajarsi; Riaz, Nadeem; Chan, Timothy A.; Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA; [Krishna, Chirag] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Dalin, Martin G.] Univ Gothenburg, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Wexler, Leonard] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Ghossein, Ronald; Katabi, Nora; Shukla, Neerav] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Nadeem, Zaineb; Cohen, Marc A.; Mandal, Rajarsi; Tepe, Justin; Ganly, Ian; Wong, Richard J.; Morris, Luc G. T.] Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA; [Tian, S. Ken; Robine, Nicolas; Arora, Kanika; Geiger, Heather; Agius, Phaedra] New York Genome Ctr, New York, NY USA; [Bouvier, Nancy; Huberman, Kety; Vanness, Katelynd] Mem Sloan Kettering Canc Ctr, Integrated Genom Operat, 1275 York Ave, New York, NY 10021 USA; [Samstein, Robert M.; Riaz, Nadeem; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Ho, Alan L.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Gothenburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chan, TA; Morris, LGT (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chan, TA; Morris, LGT (corresponding author), Mem Sloan Kettering Canc Ctr, Immunogen & Precis Oncol Platform, 1275 York Ave, New York, NY 10021 USA.; Morris, LGT (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA.; Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org; morrisl@mskcc.org	Chan, Timothy A/ABD-5850-2021; Arora, Kanika/ABC-8522-2021	Arora, Kanika/0000-0001-9537-8708; Riaz, Nadeem/0000-0001-9873-5862; Samstein, Robert/0000-0001-6860-2401; Robine, Nicolas/0000-0001-5698-8183; Kuo, Fengshen/0000-0003-1797-2896	NIH/NCI Cancer Center Support Grant [P30 CA008748]; Cycle for Survival; Frederick Adler Chair at MSKCC; Jayme Flowers Fund; Damon Runyon Cancer Research Foundation; NIH [K08 DE024774, R01 DE027738, R01 CA205426, R35 CA232097]; Adenoid Cystic Carcinoma Cancer Research Foundation; Geoffrey Beene Junior Faculty Chair; Pershing Square Sohn Cancer Research Alliance; STARR Cancer Consortium; PaineWebber Chair at MSKCC; Sebastian Nativo Fund; NATIONAL CANCER INSTITUTE [P30CA008748, R35CA232097, T32CA160001, R01CA205426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE024774, R01DE027738] Funding Source: NIH RePORTER	NIH/NCI Cancer Center Support Grant; Cycle for Survival; Frederick Adler Chair at MSKCC; Jayme Flowers Fund; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adenoid Cystic Carcinoma Cancer Research Foundation; Geoffrey Beene Junior Faculty Chair; Pershing Square Sohn Cancer Research Alliance(Pershing Square Sohn Cancer Research Alliance); STARR Cancer Consortium; PaineWebber Chair at MSKCC; Sebastian Nativo Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors wish to acknowledge our patients and their families who selflessly contributed time and samples to support this research, the patients and investigators who contributed to the TCGA studies analyzed here, McKenzy and Beth Hupke, members of the Timothy Chan Laboratory for insightful discussions, members of the MSKCC Immunogenomics and Precision Oncology Platform and the Molecular Cytology Core Facility of MSKCC. This work was supported by the NIH/NCI Cancer Center Support Grant no. P30 CA008748 (to MSKCC), Cycle for Survival (R.J.W., L.G.T.M. and T.A.C.), the Frederick Adler Chair at MSKCC, the Jayme Flowers Fund, the Sebastian Nativo Fund, the Damon Runyon Cancer Research Foundation, NIH grant nos. K08 DE024774 and NIH R01 DE027738 (L.G.T.M.), the Adenoid Cystic Carcinoma Cancer Research Foundation, (T.A.C., A.L.H. and L.G.T.M.), The Geoffrey Beene Junior Faculty Chair (A.L.H.), NIH grant nos. R01 CA205426 and NIH R35 CA232097, the Pershing Square Sohn Cancer Research Alliance, the STARR Cancer Consortium and the PaineWebber Chair at MSKCC (T.A.C.).	Adams AK, 2015, ONCOGENE, V34, P868, DOI 10.1038/onc.2014.15; Angelova M, 2018, CELL, V175, P751, DOI 10.1016/j.cell.2018.09.018; Buzyn A, 1997, EUR J IMMUNOL, V27, P2066, DOI 10.1002/eji.1830270834; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Dalin MG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01178-z; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; GAMBACORTIPASSERINI C, 1993, BLOOD, V81, P1369; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Ilyas S, 2015, J IMMUNOL, V195, P5117, DOI 10.4049/jimmunol.1501657; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Makita M, 2002, LEUKEMIA, V16, P2400, DOI 10.1038/sj.leu.2402742; Mandal R, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89829; Marty R, 2017, CELL, V171, P1272, DOI 10.1016/j.cell.2017.09.050; McGranahan N, 2017, CELL, V170, P825, DOI 10.1016/j.cell.2017.08.012; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Qin H, 2016, ONCOGENE, V35, P5686, DOI 10.1038/onc.2016.118; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Sato Y, 2002, J IMMUNOL, V169, P1611, DOI 10.4049/jimmunol.169.3.1611; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Scholtalbers J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0240-5; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Shukla SA, 2018, CELL, V173, P624, DOI 10.1016/j.cell.2018.03.026; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; van den Broeke LT, 2006, CANCER RES, V66, P1818, DOI 10.1158/0008-5472.CAN-05-2549; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yotnda P, 1998, J CLIN INVEST, V102, P455, DOI 10.1172/JCI3126	44	155	157	2	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2019	25	5					767	+		10.1038/s41591-019-0434-2	http://dx.doi.org/10.1038/s41591-019-0434-2			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HY6NU	31011208	Green Accepted			2022-12-27	WOS:000468247800020
J	Moreno-Jimenez, EP; Flor-Garcia, M; Terreros-Roncal, J; Rabano, A; Cafini, F; Pallas-Bazarra, N; Avila, J; Llorens-Martin, M				Moreno-Jimenez, Elena P.; Flor-Garcia, Miguel; Terreros-Roncal, Julia; Rabano, Alberto; Cafini, Fabio; Pallas-Bazarra, Noemi; Avila, Jesus; Llorens-Martin, Maria			Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease	NATURE MEDICINE			English	Article							DENTATE GYRUS; MATURATION; NEURONS	The hippocampus is one of the most affected areas in Alzheimer's disease (AD)(1). Moreover, this structure hosts one of the most unique phenomena of the adult mammalian brain, namely, the addition of new neurons throughout life(2). This process, called adult hippocampal neurogenesis (AHN), confers an unparalleled degree of plasticity to the entire hippocampal circuitry(3,4). Nonetheless, direct evidence of AHN in humans has remained elusive. Thus, determining whether new neurons are continuously incorporated into the human dentate gyrus (DG) during physiological and pathological aging is a crucial question with outstanding therapeutic potential. By combining human brain samples obtained under tightly controlled conditions and state-of-the-art tissue processing methods, we identified thousands of immature neurons in the DG of neurologically healthy human subjects up to the ninth decade of life. These neurons exhibited variable degrees of maturation along differentiation stages of AHN. In sharp contrast, the number and maturation of these neurons progressively declined as AD advanced. These results demonstrate the persistence of AHN during both physiological and pathological aging in humans and provide evidence for impaired neurogenesis as a potentially relevant mechanism underlying memory deficits in AD that might be amenable to novel therapeutic strategies.	[Moreno-Jimenez, Elena P.; Flor-Garcia, Miguel; Terreros-Roncal, Julia; Pallas-Bazarra, Noemi; Avila, Jesus; Llorens-Martin, Maria] UAM, CSIC, CBMSO, Dept Mol Neuropathol, Madrid, Spain; [Moreno-Jimenez, Elena P.; Flor-Garcia, Miguel; Terreros-Roncal, Julia; Llorens-Martin, Maria] Univ Autonoma Madrid, Dept Mol Biol, Fac Sci, Madrid, Spain; [Moreno-Jimenez, Elena P.; Flor-Garcia, Miguel; Terreros-Roncal, Julia; Pallas-Bazarra, Noemi; Avila, Jesus; Llorens-Martin, Maria] Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain; [Rabano, Alberto] CIEN Fdn, Dept Neuropathol, Madrid, Spain; [Cafini, Fabio] Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; European University of Madrid	Llorens-Martin, M (corresponding author), UAM, CSIC, CBMSO, Dept Mol Neuropathol, Madrid, Spain.; Llorens-Martin, M (corresponding author), Univ Autonoma Madrid, Dept Mol Biol, Fac Sci, Madrid, Spain.; Llorens-Martin, M (corresponding author), Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain.	m.llorens@csic.es	Avila, Jesus/I-2610-2015; Llorens-Martin, Maria/R-4613-2017; Cafini, Fabio/AAA-7938-2020	Avila, Jesus/0000-0002-6288-0571; Llorens-Martin, Maria/0000-0001-9129-5198; Cafini, Fabio/0000-0002-5442-1674; Pallas Bazarra, Noemi/0000-0002-0175-5080; Moreno-Jimenez, Elena P./0000-0002-9865-4875; Flor-Garcia, Miguel/0000-0002-6938-9689	Spanish Ministry of Economy and Competitiveness [SAF-2017-82185-R, RYC-2015-171899, SAF-2014-53040-P]; Alzheimer's Association [2015-NIRG-340709, AARG-17-528125]; Association for Frontotemporal Degeneration; Comunidad de Madrid [PEJD-2017-PRE/BMD-3439]; Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED, Spain); Fundacion Ramon Areces; Banco de Santander; Universidad Autonoma de Madrid doctoral fellowship (FPI-UAM 2017 program)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Alzheimer's Association(Alzheimer's Association); Association for Frontotemporal Degeneration; Comunidad de Madrid(Comunidad de Madrid); Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED, Spain); Fundacion Ramon Areces; Banco de Santander; Universidad Autonoma de Madrid doctoral fellowship (FPI-UAM 2017 program)	The authors would like to thank the patients and their families for generously donating brain samples. Moreover, they would like to thank I. Rodal for help with human sample extraction and processing, E. Garcia, R. Cuadros and the confocal microscopy facility of the CBMSO for technical assistance, and P. Moreno for help with illustration design. A number of human samples were generously provided by the Biobanco del Hospital Universitario Reina Sofia (Cordoba, Spain). The authors are grateful to R. Sanchez for providing some of these samples. They would also like to thank J. Gleeson (University of California, San Diego) for providing an antiDCX antibody. This study was supported by the following: the Spanish Ministry of Economy and Competitiveness (SAF-2017-82185-R and RYC-2015-171899, M.L.-M.; SAF-2014-53040-P, J.A.); the Alzheimer's Association (2015-NIRG-340709 and AARG-17-528125, M.L.-M.); the Association for Frontotemporal Degeneration (2016 Basic Science Pilot Grant Award, M.L.-M.); the Comunidad de Madrid (PEJD-2017-PRE/BMD-3439, M.L.-M.); and the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED, Spain, J.A.). Institutional grants from the Fundacion Ramon Areces and the Banco de Santander to CBMSO are also acknowledged. The salary of E.P.M.-J. was supported by a Comunidad de Madrid researcher contract (PEJD-2017-PRE/BMD-3439). The salary of J.T.-R. was supported by a Universidad Autonoma de Madrid doctoral fellowship (FPI-UAM 2017 program).	ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Anacker C, 2018, NATURE, V559, P98, DOI 10.1038/s41586-018-0262-4; [Anonymous], 2012, BIOPRESERV BIOBANK, V10, P79, DOI DOI 10.1089/BIO.2012.1022; Bischofberger J, 2007, NAT NEUROSCI, V10, P273, DOI 10.1038/nn0307-273; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Bolos M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0200-1; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 1990, Fortschr Med, V108, P621; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Cipriani S, 2018, CEREB CORTEX, V28, P2458, DOI 10.1093/cercor/bhy096; Diez- Fraile A., 2012, INTECHOPEN, V1, P320; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2018, CELL STEM CELL, V23, P25, DOI 10.1016/j.stem.2018.04.004; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.92; Llorens-Martin M, 2013, MOL PSYCHIATR, V18, P451, DOI 10.1038/mp.2013.4; Llorens-Martin M, 2012, J ALZHEIMERS DIS, V29, P921, DOI 10.3233/JAD-2012-112057; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; Martinez-Martin P, 2010, J ALZHEIMERS DIS, V21, P337, DOI 10.3233/JAD-2010-101149; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Wesnes KA, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt250; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	34	664	677	26	238	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					554	+		10.1038/s41591-019-0375-9	http://dx.doi.org/10.1038/s41591-019-0375-9			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30911133	Green Submitted			2022-12-27	WOS:000463342800015
J	Schalper, KA; Rodriguez-Ruiz, ME; Diez-Valle, R; Lopez-Janeiro, A; Porciuncula, A; Idoate, MA; Inoges, S; De Andrea, C; de Cerio, ALD; Tejada, S; Berraondo, P; Villarroel-Espindola, F; Choi, J; Gurpide, A; Giraldez, M; Goicoechea, I; Perez-Larraya, JG; Sanmamed, MF; Perez-Gracia, JL; Melero, I				Schalper, Kurt A.; Rodriguez-Ruiz, Maria E.; Diez-Valle, Ricardo; Lopez-Janeiro, Alvaro; Porciuncula, Angelo; Idoate, Miguel A.; Inoges, Susana; De Andrea, Carlos; Lopez-Diaz de Cerio, Ascension; Tejada, Sonia; Berraondo, Pedro; Villarroel-Espindola, Franz; Choi, Jungmin; Gurpide, Alfonso; Giraldez, Miriam; Goicoechea, Iosune; Gallego Perez-Larraya, Jaime; Sanmamed, Miguel F.; Perez-Gracia, Jose L.; Melero, Ignacio			Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma	NATURE MEDICINE			English	Article							ADJUVANT TEMOZOLOMIDE; PHASE-III; RADIOTHERAPY; BEVACIZUMAB; SURGERY; GLIOMA; ERADICATION; CONCOMITANT; REGRESSION; EXPRESSION	Glioblastoma is the most common primary central nervous system malignancy and has a poor prognosis. Standard first-line treatment, which includes surgery followed by adjuvant radio-chemotherapy, produces only modest benefits to survival(1,2). Here, to explore the feasibility, safety and immunobiological effects of PD-1 blockade in patients undergoing surgery for glioblastoma, we conducted a single-arm phase II clinical trial (NCT02550249) in which we tested a presurgical dose of nivolumab followed by postsurgical nivolumab until disease progression or unacceptable toxicity in 30 patients (27 salvage surgeries for recurrent cases and 3 cases of primary surgery for newly diagnosed patients). Availability of tumor tissue pre- and post-nivolumab dosing and from additional patients who did not receive nivolumab allowed the evaluation of changes in the tumor immune microenvironment using multiple molecular and cellular analyses. Neoadjuvant nivolumab resulted in enhanced expression of chemokine transcripts, higher immune cell infiltration and augmented TCR clonal diversity among tumor-infiltrating T lymphocytes, supporting a local immunomodulatory effect of treatment. Although no obvious clinical benefit was substantiated following salvage surgery, two of the three patients treated with nivolumab before and after primary surgery remain alive 33 and 28 months later.	[Schalper, Kurt A.; Porciuncula, Angelo; Villarroel-Espindola, Franz; Sanmamed, Miguel F.] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Rodriguez-Ruiz, Maria E.; Gurpide, Alfonso; Goicoechea, Iosune; Sanmamed, Miguel F.; Perez-Gracia, Jose L.] Clin Univ Navarra, Dept Oncol, Pamplona, Spain; [Rodriguez-Ruiz, Maria E.; Perez-Gracia, Jose L.; Melero, Ignacio] Ctr Invest Biomed Red Oncol CIBERONC, Madrid, Spain; [Rodriguez-Ruiz, Maria E.; Perez-Gracia, Jose L.; Melero, Ignacio] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain; [Diez-Valle, Ricardo; Tejada, Sonia; Melero, Ignacio] Clin Univ Navarra, Dept Neurosurg, Pamplona, Spain; [Diez-Valle, Ricardo; Inoges, Susana; Lopez-Diaz de Cerio, Ascension; Melero, Ignacio] Clin Univ Navarra, Dept Immunol, Pamplona, Spain; [Lopez-Janeiro, Alvaro; Idoate, Miguel A.; De Andrea, Carlos] Clin Univ Navarra, Dept Pathol, Pamplona, Spain; [Berraondo, Pedro] Univ Navarra, CIMA, Pamplona, Spain; [Choi, Jungmin] Yale Sch Med, Dept Genet, New Haven, CT USA; [Giraldez, Miriam] Clin Univ Navarra, Dept Pharm, Pamplona, Spain; [Gallego Perez-Larraya, Jaime] Clin Univ Navarra, Dept Neurol, Pamplona, Spain	Yale University; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; University of Navarra; University of Navarra; University of Navarra; Yale University; University of Navarra; University of Navarra	Melero, I (corresponding author), Ctr Invest Biomed Red Oncol CIBERONC, Madrid, Spain.; Melero, I (corresponding author), Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.; Melero, I (corresponding author), Clin Univ Navarra, Dept Neurosurg, Pamplona, Spain.; Melero, I (corresponding author), Clin Univ Navarra, Dept Immunol, Pamplona, Spain.	imelero@unav.es	Inogés, Susana/AAW-6785-2021; Perez-Gracia, Jose Luis/I-8372-2017; Idoate, Miguel-Ángel/D-8502-2019; Villarroel-Espindola, Franz/GLU-4201-2022; Berraondo, Pedro/J-3154-2012; Melero, Ignacio/T-7600-2019; Rodriguez-Ruiz, Maria Esperanza/K-7227-2017; Giraldez, Miriam/AID-6836-2022; F Sanmamed, Miguel/I-5572-2017	Perez-Gracia, Jose Luis/0000-0003-4941-9075; Idoate, Miguel-Ángel/0000-0002-1596-1192; Berraondo, Pedro/0000-0001-7410-1865; Melero, Ignacio/0000-0002-1360-348X; Rodriguez-Ruiz, Maria Esperanza/0000-0002-9765-2499; Giraldez, Miriam/0000-0002-1448-6860; Choi, Jungmin/0000-0002-8614-0973; LOPEZ JANEIRO, ALVARO/0000-0002-5744-3115; F Sanmamed, Miguel/0000-0002-7295-6074; Villarroel-Espindola, Franz/0000-0003-0080-2444	Department of Defense LCRP Career Development Award [W81XWH-16-1-0160]; NIH Lung SPORE in Lung Cancer [P50CA196530]; Stand Up To Cancer Translational Research [SU2C-AACR-DT17-15, SU2C-AACR-DT22-17]; MINECO [SAF2014-52361-R, 2017-83267-C2-1-R]; Fundacion de la Asociacion Espanola Contra el Cancer (AECC); Fundacion BBVA; Bristol-Myers Squibb	Department of Defense LCRP Career Development Award; NIH Lung SPORE in Lung Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer Translational Research; MINECO(Spanish Government); Fundacion de la Asociacion Espanola Contra el Cancer (AECC); Fundacion BBVA(BBVA Foundation); Bristol-Myers Squibb(Bristol-Myers Squibb)	We thank R. Latek and D. McDonald from Bristol-Myers Squibb and the study coordinators and staff from our Clinical Research Unit, E. Guirado, L. Resano and B. Palencia for project coordination. We also thank Laura Johnson and Josh Haimes from ArcherDx for experimental and technical support. Financial support was through the Immunoncology Network (I-ON) supported by Bristol-Myers Squibb. Additional funds came to K.A.S. from Department of Defense LCRP Career Development Award W81XWH-16-1-0160, NIH Lung SPORE in Lung Cancer P50CA196530, and Stand Up To Cancer Translational Research Grants SU2C-AACR-DT17-15 and SU2C-AACR-DT22-17, and to I.M. from MINECO (SAF2014-52361-R and 2017-83267-C2-1-R), Fundacion de la Asociacion Espanola Contra el Cancer (AECC), Fundacion BBVA. M.E.R.-R. received a Rio Hortega contract from ISCIII.	Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Antonios JP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87059; Ashizawa T, 2017, CLIN CANCER RES, V23, P149, DOI 10.1158/1078-0432.CCR-16-0122; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Cloughesy T. F., NAT MED; Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim JE, 2017, CLIN CANCER RES, V23, P124, DOI 10.1158/1078-0432.CCR-15-1535; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Lang FF, 2018, J CLIN ONCOL, V36, P1419, DOI 10.1200/JCO.2017.75.8219; Liau LM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1507-6; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Liu YJ, 2018, CANCER IMMUNOL IMMUN, V67, P1181, DOI 10.1007/s00262-018-2175-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Melero I, 2016, CANCER DISCOV, V6, P1312, DOI 10.1158/2159-8290.CD-16-1109; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nduom EK, 2016, NEURO-ONCOLOGY, V18, P195, DOI 10.1093/neuonc/nov172; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Reardon DA, 2016, CANCER IMMUNOL RES, V4, P124, DOI 10.1158/2326-6066.CIR-15-0151; Reardona DA, 2017, NEURO-ONCOLOGY, V19, P21, DOI 10.1093/neuonc/nox036.071; Reiss SN, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0302-x; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Shannon CE, 1997, M D COMPUT, V14, P306; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Wainwright DA, 2014, CLIN CANCER RES, V20, P5290, DOI 10.1158/1078-0432.CCR-14-0514; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Wick W, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418790452; Wick W, 2017, NEW ENGL J MED, V377, P1954, DOI 10.1056/NEJMoa1707358; Wick W, 2014, NAT REV NEUROL, V10, P372, DOI 10.1038/nrneurol.2014.100; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	40	309	317	4	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2019	25	3					470	+		10.1038/s41591-018-0339-5	http://dx.doi.org/10.1038/s41591-018-0339-5			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HO1CO	30742120				2022-12-27	WOS:000460643100026
J	Yao, Z; Gao, YJ; Su, WJ; Yaeger, R; Tao, J; Na, N; Zhang, Y; Zhang, C; Rymar, A; Tao, A; Timaul, NM; Mcgriskin, R; Outmezguine, NA; Zhao, H; Chang, Q; Qeriqi, B; Barbacid, M; de Stanchina, E; Hyman, DM; Bollag, G; Rosen, N				Yao, Zhan; Gao, Yijun; Su, Wenjing; Yaeger, Rona; Tao, Jessica; Na, Na; Zhang, Ying; Zhang, Chao; Rymar, Andrey; Tao, Anthony; Timaul, Neilawattie M.; Mcgriskin, Rory; Outmezguine, Nathaniel A.; Zhao, HuiYong; Chang, Qing; Qeriqi, Besnik; Barbacid, Mariano; de Stanchina, Elisa; Hyman, David M.; Bollag, Gideon; Rosen, Neal			RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling	NATURE MEDICINE			English	Article							DIFFERENT MECHANISMS; ANTITUMOR-ACTIVITY; KINASE; RESISTANCE; DIMERIZATION; ACTIVATION; GENERATION; FUSIONS	Activating BRAF mutants and fusions signal as RAS-independent constitutively active dimers with the exception of BRAF V600 mutant alleles which can function as active monomers(1). Current RAF inhibitors are monomer selective, they potently inhibit BRAF V600 monomers but their inhibition of RAF dimers is limited by induction of negative cooperativity when bound to one site in the dimer(1-3). Moreover, acquired resistance to these drugs is usually due to molecular lesions that cause V600 mutants to dimerize(4-8). We show here that PLX8394, a new RAF inhibitor(9), inhibits ERK signaling by specifically disrupting BRAF-containing dimers, including BRAF homodimers and BRAF-CRAF heterodimers, but not CRAF homodimers or ARAF-containing dimers. Differences in the amino acid residues in the amino (N)-terminal portion of the kinase domain of RAF isoforms are responsible for this differential vulnerability. As a BRAF-specific dimer breaker, PLX8394 selectively inhibits ERK signaling in tumors driven by dimeric BRAF mutants, including BRAF fusions and splice variants as well as BRAF V600 monomers, but spares RAF function in normal cells in which CRAF homodimers can drive signaling. Our work suggests that drugs with these properties will be safe and useful for treating tumors driven by activating BRAF mutants or fusions.	[Yao, Zhan; Gao, Yijun; Su, Wenjing; Na, Na; Timaul, Neilawattie M.; Mcgriskin, Rory; Outmezguine, Nathaniel A.; Zhao, HuiYong; Chang, Qing; Qeriqi, Besnik; de Stanchina, Elisa; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA; [Yao, Zhan; Yaeger, Rona; Tao, Jessica; Hyman, David M.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Yaeger, Rona; Hyman, David M.] Weill Cornell Med Coll, New York, NY USA; [Zhang, Ying; Zhang, Chao; Rymar, Andrey; Bollag, Gideon] Plexxikon Inc, Berkeley, CA USA; [Tao, Anthony] NYU, Coll Arts & Sci, Ctr Neural Sci, New York, NY USA; [Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Programme, Madrid, Spain; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Ctr Mech Based Therapeut, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Plexxikon; New York University; Memorial Sloan Kettering Cancer Center	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Mech Based Therapeut, 1275 York Ave, New York, NY 10021 USA.	rosenn@mskcc.org	na, na/GVS-8521-2022; Yao, Zhan/AAK-6756-2020; Rosen, Neal/ABF-2677-2020; Na, Na/AAZ-2637-2021; su, wenjing/V-4772-2018	Na, Na/0000-0002-9394-8209; Gao, Yijun/0000-0003-4978-3205; YAO, ZHAN/0000-0001-5391-5691; chang, qing/0000-0002-8290-6687	National Institutes of Health (NIH) [P01 CA129243, R35 CA210085]; Melanoma Research Alliance [237059, 348724]; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; Stand Up To Cancer -American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]; NIH MSKCC Cancer Center Support Grant [P30 CA008748, T32 CA009207]; Conquer Cancer Foundation of the American Society of Clinical Oncology; Arlene and Joseph Taub Foundation; Spanish Ministry of Economy and Competitiveness [SAF2011-30173, SAF2014-59864-R]; AXA Research Fund; NATIONAL CANCER INSTITUTE [T32CA009207, P01CA129243, R35CA210085, P30CA008748] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U54OD020355] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; Stand Up To Cancer -American Cancer Society Lung Cancer Dream Team Translational Research Grant; NIH MSKCC Cancer Center Support Grant; Conquer Cancer Foundation of the American Society of Clinical Oncology; Arlene and Joseph Taub Foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government); AXA Research Fund(AXA Research Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to L.M. Desrochers, I. Mellinghoff, and A. Ventura for useful discussions. We thank S. Lowe for the vectors of the retrovirus-based inducible expression system. This research was supported by grants (to N.R.) from the National Institutes of Health (NIH) (P01 CA129243; R35 CA210085); the Melanoma Research Alliance (237059 and 348724); the Commonwealth Foundation for Cancer Research and the Center for Experimental Therapeutics at Memorial Sloan Kettering Cancer Center; and the Stand Up To Cancer -American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C-AACR-DT17-15). Support was also received from the NIH MSKCC Cancer Center Support Grant P30 CA008748 and T32 CA009207 (to J.T.). Additional funding was provided by a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award (to J.T.) and Career Development Award (to R.Y.). We would like to acknowledge the support of the Arlene and Joseph Taub Foundation and of P. and T. McInerney, without whom this work would not have been possible. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2011-30173 and SAF2014-59864-R) (to M.B.). M.B. is the recipient of an endowed chair from the AXA Research Fund.	Basile KJ, 2014, PIGM CELL MELANOMA R, V27, P479, DOI 10.1111/pcmr.12218; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jain P, 2017, ONCOGENE, V36, P6348, DOI 10.1038/onc.2017.276; Karoulia Z, 2017, NAT REV CANCER, V17, P676, DOI 10.1038/nrc.2017.79; Karoulia Z, 2016, CANCER CELL, V30, P485, DOI 10.1016/j.ccell.2016.06.024; Nakamura A, 2013, CANCER RES, V73, P7043, DOI 10.1158/0008-5472.CAN-13-1825; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nieto P, 2017, NATURE, V548, P239, DOI 10.1038/nature23297; Okimoto RA, 2016, P NATL ACAD SCI USA, V113, P13456, DOI 10.1073/pnas.1610456113; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Takahashi M, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00132-17; Yaeger R, 2017, CANCER RES, V77, P6513, DOI 10.1158/0008-5472.CAN-17-0768; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	24	88	88	3	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					284	+		10.1038/s41591-018-0274-5	http://dx.doi.org/10.1038/s41591-018-0274-5			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30559419	Green Accepted			2022-12-27	WOS:000457842100026
J	Robert, C				Robert, Caroline			Is earlier better for melanoma checkpoint blockade?	NATURE MEDICINE			English	Article							ADJUVANT DABRAFENIB; STAGE-III; TRAMETINIB; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB; CANCER; TRIAL	A neoadjuvant approach relying on the administration of combined anti-CTLA-4-anti-PD-1 treatment before lymph node surgery is evaluated in two phase 1 trials. Encouraging clinical, pathological and immunological responses to neoadjuvant therapy were observed, suggesting that this concept warrants further exploration; however, any future approach must address the unacceptably high toxicity of the regimens evaluated in these trials.	[Robert, Caroline] Paris Sud Univ, Le Kremlin Bicetre, France; [Robert, Caroline] Oncol Dept, Villejuf, France; [Robert, Caroline] INSERM, U981, Villejuf, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Robert, C (corresponding author), Paris Sud Univ, Le Kremlin Bicetre, France.	caroline.robert@gustaveroussy.fr	Robert, Caroline/G-6157-2018	Robert, Caroline/0000-0002-9493-0238				Amaria RN, 2018, NAT MED, V24, P1649, DOI 10.1038/s41591-018-0197-1; Amaria RN, 2018, LANCET ONCOL, V19, P181, DOI 10.1016/S1470-2045(18)30015-9; Blank CU, 2018, NAT MED, V24, P1655, DOI 10.1038/s41591-018-0198-0; Chen Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010634; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Gershenwald JE, 2017, CA-CANCER J CLIN, V67, P472, DOI 10.3322/caac.21409; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; MacLean Matthew, 2018, Oncotarget, V9, P24470, DOI 10.18632/oncotarget.25327; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2018, J CLIN ONCOL, V36, P1668, DOI 10.1200/JCO.2017.75.6270; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Tetzlaff MT, 2018, ANN ONCOL, V29, P1861, DOI 10.1093/annonc/mdy226; Weber J, 2017, NEW ENGL J MED, V377, P1824, DOI 10.1056/NEJMoa1709030; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	20	19	20	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2018	24	11					1645	1648		10.1038/s41591-018-0250-0	http://dx.doi.org/10.1038/s41591-018-0250-0			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GZ4VS	30401867				2022-12-27	WOS:000449404200013
J	Villiger, L; Grisch-Chan, HM; Lindsay, H; Ringnalda, F; Pogliano, CB; Allegri, G; Fingerhut, R; Haberle, J; Matos, J; Robinson, MD; Thony, B; Schwank, G				Villiger, Lukas; Grisch-Chan, Hiu Man; Lindsay, Helen; Ringnalda, Femke; Pogliano, Chiara B.; Allegri, Gabriella; Fingerhut, Ralph; Haberle, Johannes; Matos, Joao; Robinson, Mark D.; Thony, Beat; Schwank, Gerald			Treatment of a metabolic liver disease by in vivo genome base editing in adult mice	NATURE MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS CAS9; ALTERED PAM SPECIFICITIES; GENE-THERAPY; HOMOLOGOUS RECOMBINATION; CRYSTAL-STRUCTURE; DNA CLEAVAGE; HUMAN-CELLS; STEM-CELLS; GUIDE RNA; PHENYLKETONURIA	CRISPR-Cas-based genome editing holds great promise for targeting genetic disorders, including inborn errors of hepatocyte metabolism. Precise correction of disease-causing mutations in adult tissues in vivo, however, is challenging. It requires repair of Cas9-induced double-stranded DNA (dsDNA) breaks by homology-directed mechanisms, which are highly inefficient in nondividing cells. Here we corrected the disease phenotype of adult phenylalanine hydroxylase (pah)(enu2) mice, a model for the human autosomal recessive liver disease phenylketonuria (PKU)(1), using recently developed CRISPR-Cas-associated base editors(2-4). These systems enable conversion of C.G to T.A base pairs and vice versa, independent of dsDNA break formation and homology-directed repair (HDR). We engineered and validated an intein-split base editor, which allows splitting of the fusion protein into two parts, thereby circumventing the limited cargo capacity of adeno-associated virus (AAV) vectors. Intravenous injection of AAV-base editor systems resulted in Pah(enu2) gene correction rates that restored physiological blood phenylalanine (L-Phe) levels below 120 mu mol/l [5]. We observed mRNA correction rates up to 63%, restoration of phenylalanine hydroxylase (PAH) enzyme activity, and reversion of the light fur phenotype in Pah(enu2) mice. Our findings suggest that targeting genetic diseases in vivo using AAV-mediated delivery of base-editing agents is feasible, demonstrating potential for therapeutic application.	[Villiger, Lukas; Ringnalda, Femke; Schwank, Gerald] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland; [Grisch-Chan, Hiu Man; Allegri, Gabriella; Fingerhut, Ralph; Thony, Beat] Univ Childrens Hosp Zurich, Div Metab, Zurich, Switzerland; [Grisch-Chan, Hiu Man; Allegri, Gabriella; Fingerhut, Ralph; Thony, Beat] Childrens Res Ctr, Zurich, Switzerland; [Lindsay, Helen; Robinson, Mark D.] Univ Zurich, SIB Swiss Inst Bioinformat, Zurich, Switzerland; [Lindsay, Helen; Haberle, Johannes; Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Pogliano, Chiara B.; Matos, Joao] Swiss Fed Inst Technol, Inst Biochem, Dept Biol, Zurich, Switzerland; [Haberle, Johannes] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Haberle, Johannes; Thony, Beat] Neurosci Ctr Zurich, Zurich, Switzerland; [Fingerhut, Ralph] Univ Childrens Hosp, Swiss Newborn Screening Lab, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University Children's Hospital Zurich; Swiss Institute of Bioinformatics; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University Children's Hospital Zurich	Schwank, G (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Zurich, Switzerland.	schwankg@ethz.ch	Schwank, Gerald/AAE-6640-2020; Robinson, Mark D./O-2254-2019; Schwank, Gerald/A-8586-2018; Fingerhut, Ralph/AAY-5061-2021; Matos, Joao/C-1488-2014	Schwank, Gerald/0000-0003-0767-2953; Robinson, Mark D./0000-0002-3048-5518; Schwank, Gerald/0000-0003-0767-2953; Fingerhut, Ralph/0000-0002-9674-8931; Matos, Joao/0000-0002-3754-3709; Ringnalda, Femke Cecilia Akke Sipkje/0000-0002-0684-4613; Haberle, Johannes/0000-0003-0635-091X; Lindsay, Helen/0000-0001-8614-1661; Grisch-Chan, Hiu Man/0000-0002-5343-2013; Thony, Beat/0000-0002-8420-4769	SNSF [31003A_160230]; Swiss National Science Foundation	SNSF(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank J.-C. Paterna from the Viral Vector Facility of the Neuroscience Center Zurich for supplying vectors, the Functional Genomics Centre Zurich for sequencing in vivo samples, M. Rodriguez, A. Apladas, N. Rimann for their support with animal work, A. Garcete and I. Kleiber from the immunohistology laboratory for surgical research of the University Hospital Zurich for immunhistochemistry of liver samples. pJLSaKKH-BE3 and pBK-YEl-BE3 were a gift from D. Liu (Addgene plasmid no. 85170 and no. 85174). WN10151 was a gift from E. Welker (Addgene plasmid no. 80441). pX601-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA;U6::BsaI-sgRNA was a gift from F. Zhang (Addgene plasmid no. 61591), pLenti CMV GFP Puro (658-5) was a gift from E. Campeau and P. Kaufman (Addgene plasmid no. 17448). pCMV-VSV-G was a gift from B. Weinberg (Addgene plasmid no. 8454) and psPAX2 was a gift from D. Trono (Addgene plasmid no. 12260). This work was funded by the SNSF (31003A_160230). L.V. holds an MD/PhD scholarship from the Swiss National Science Foundation.	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Chadwick AC, 2017, ARTERIOSCL THROM VAS, V37, P1741, DOI 10.1161/ATVBAHA.117.309881; Davidoff AM, 2003, BLOOD, V102, P480, DOI 10.1182/blood-2002-09-2889; Ding Z, 2006, GENE THER, V13, P587, DOI 10.1038/sj.gt.3302684; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gao X, 2018, NATURE, V553, P217, DOI 10.1038/nature25164; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Harding CO, 2006, GENE THER, V13, P457, DOI 10.1038/sj.gt.3302678; Heintz C, 2012, MOL GENET METAB, V105, P559, DOI 10.1016/j.ymgme.2011.12.025; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li H., 2013, ARXIV13033997 Q BIO; Li XS, 2018, NAT BIOTECHNOL, V36, P324, DOI 10.1038/nbt.4102; Lindsay H, 2016, NAT BIOTECHNOL, V34, P701, DOI 10.1038/nbt.3628; Ma H, 2017, NATURE, V548, P413, DOI 10.1038/nature23305; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Martynyuk AE, 2010, MOL GENET METAB, V99, pS100, DOI 10.1016/j.ymgme.2009.10.181; Martynyuk AE, 2007, EPILEPSIA, V48, P1143, DOI 10.1111/j.1528-1167.2007.01115.x; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; Nair N, 2014, BLOOD, V123, P3195, DOI 10.1182/blood-2013-10-534032; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Pages H, 2019, BIOSTRINGS EFFICIENT; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148; SCRIVER CR, 1980, NEW ENGL J MED, V303, P1394, DOI 10.1056/NEJM198012113032404; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Thony B, 2014, HUM GENE THER, V25, P573, DOI 10.1089/hum.2014.029; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Viecelli HM, 2014, HEPATOLOGY, V60, P1035, DOI 10.1002/hep.27104; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2016, NAT BIOTECHNOL, V34, P328, DOI 10.1038/nbt.3471; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	46	193	208	5	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1519	+		10.1038/s41591-018-0209-1	http://dx.doi.org/10.1038/s41591-018-0209-1			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30297904	Green Accepted			2022-12-27	WOS:000446577900013
J	Zanconato, F; Battilana, G; Forcato, M; Filippi, L; Azzolin, L; Manfrin, A; Quaranta, E; Di Biagio, D; Sigismondo, G; Guzzardo, V; Lejeune, P; Haendler, B; Krijgsveld, J; Fassan, M; Bicciato, S; Cordenonsi, M; Piccolo, S				Zanconato, Francesca; Battilana, Giusy; Forcato, Mattia; Filippi, Letizia; Azzolin, Luca; Manfrin, Andrea; Quaranta, Erika; Di Biagio, Daniele; Sigismondo, Gianluca; Guzzardo, Vincenza; Lejeune, Pascale; Haendler, Bernard; Krijgsveld, Jeroen; Fassan, Matteo; Bicciato, Silvio; Cordenonsi, Michelangelo; Piccolo, Stefano			Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4	NATURE MEDICINE			English	Article							BRAF INHIBITOR RESISTANCE; NEGATIVE BREAST-CANCER; SELECTIVE-INHIBITION; MAMMARY-GLAND; BROMODOMAIN; GENE; CHROMATIN; GROWTH; METASTASIS; EXPRESSION	Cancer cells rely on dysregulated gene expression. This establishes specific transcriptional addictions that may be therapeutically exploited. Yet, the mechanisms that are ultimately responsible for these addictions are poorly understood. Here, we investigated the transcriptional dependencies of transformed cells to the transcription factors YAP and TAZ. YAP/TAZ physically engage the general coactivator bromodomain-containing protein 4 (BRD4), dictating the genome-wide association of BRD4 to chromatin. YAP/TAZ flag a large set of enhancers with super-enhancer-like functional properties. YAP/TAZ-bound enhancers mediate the recruitment of BRD4 and RNA polymerase II at YAP/TAZ-regulated promoters, boosting the expression of a host of growth-regulating genes. Treatment with small-molecule inhibitors of BRD4 blunts YAP/TAZ pro-tumorigenic activity in several cell or tissue contexts, causes the regression of pre-established, YAP/TAZ-addicted neoplastic lesions and reverts drug resistance. This work sheds light on essential mediators, mechanisms and genome-wide regulatory elements that are responsible for transcriptional addiction in cancer and lays the groundwork for a rational use of BET inhibitors according to YAP/TAZ biology.	[Zanconato, Francesca; Battilana, Giusy; Filippi, Letizia; Azzolin, Luca; Manfrin, Andrea; Quaranta, Erika; Di Biagio, Daniele; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Dept Mol Med, Sch Med, Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Sigismondo, Gianluca; Krijgsveld, Jeroen] German Canc Res Ctr, Heidelberg, Germany; [Sigismondo, Gianluca; Krijgsveld, Jeroen] Heidelberg Univ, Heidelberg, Germany; [Guzzardo, Vincenza; Fassan, Matteo] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Sch Med, Padua, Italy; [Lejeune, Pascale; Haendler, Bernard] Bayer AG, Drug Discovery, Berlin, Germany; [Piccolo, Stefano] FIRC Inst Mol Oncol, IFOM, Milan, Italy	University of Padua; Universita di Modena e Reggio Emilia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Padua; Bayer AG; IFOM - FIRC Institute of Molecular Oncology	Cordenonsi, M; Piccolo, S (corresponding author), Univ Padua, Dept Mol Med, Sch Med, Padua, Italy.; Piccolo, S (corresponding author), FIRC Inst Mol Oncol, IFOM, Milan, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Manfrin, Andrea/AAC-1066-2020; Bicciato, Silvio/C-9825-2009; Forcato, Mattia/B-7733-2015; Fassan, Matteo/F-5152-2012; CORDENONSI, MICHELANGELO/K-7692-2016	Manfrin, Andrea/0000-0002-1519-6582; Bicciato, Silvio/0000-0002-1944-7078; Forcato, Mattia/0000-0002-7383-6576; Quaranta, Erika Giorgia/0000-0001-8112-2461; PICCOLO, STEFANO/0000-0002-2037-0004; Fassan, Matteo/0000-0001-6515-5482; CORDENONSI, MICHELANGELO/0000-0002-8253-5724	AIRC Special Program Molecular Clinical Oncology '5 per mille'; AIRC PI-Grant; Epigenetics Flagship project CNR-MIUR; European Research Council under the European Union's Horizon 2020 research and innovation programme (DENOVOSTEM grant) [670126]	AIRC Special Program Molecular Clinical Oncology '5 per mille'(Fondazione AIRC per la ricerca sul cancro); AIRC PI-Grant(Fondazione AIRC per la ricerca sul cancro); Epigenetics Flagship project CNR-MIUR; European Research Council under the European Union's Horizon 2020 research and innovation programme (DENOVOSTEM grant)	We are grateful to J. C. Marine (Leuven Center for Cancer Biology), J. Kim (KAIST) for the gift of the cell lines; D. J. Pan (University of Texas), A. R. Clarke (Cardiff University), F. Camargo (Boston Children's Hospital) and P. Chambon (University of Strasbourg) for the gifts of mice. MMTV-cre mice were purchased from The Jackson Laboratory, where they were kindly deposited by L. Hennighausen. This work is supported by the AIRC Special Program Molecular Clinical Oncology '5 per mille', by an AIRC PI-Grant to S.P. and by the Epigenetics Flagship project CNR-MIUR. This project has received funding from the European Research Council under the European Union's Horizon 2020 research and innovation programme (DENOVOSTEM grant agreement no. 670126).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrieu Guillaume, 2016, Drug Discov Today Technol, V19, P45, DOI 10.1016/j.ddtec.2016.06.004; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bernasconi E, 2017, BRIT J HAEMATOL, V178, P936, DOI 10.1111/bjh.14803; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fontanals-Cirera B, 2017, MOL CELL, V68, P731, DOI 10.1016/j.molcel.2017.11.004; Galli GG, 2015, MOL CELL, V60, P328, DOI 10.1016/j.molcel.2015.09.001; Garcia-Gutierrez P, 2012, J CELL SCI, V125, P3671, DOI 10.1242/jcs.105841; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MH, 2016, EMBO J, V35, P462, DOI 10.15252/embj.201592081; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BS, 2017, BIOCHEM BIOPH RES CO, V491, P493, DOI 10.1016/j.bbrc.2017.07.007; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Oh H, 2014, CELL REP, V8, P448, DOI 10.1016/j.celrep.2014.06.017; Panciera T, 2016, CELL STEM CELL, V19, P725, DOI 10.1016/j.stem.2016.08.009; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rafiee MR, 2016, MOL CELL, V64, P624, DOI 10.1016/j.molcel.2016.09.019; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Storz P, 2017, NAT REV GASTRO HEPAT, V14, P296, DOI 10.1038/nrgastro.2017.12; Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948; Swellam M, 2015, IUBMB LIFE, V67, P61, DOI 10.1002/iub.1346; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Villicana C, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-18; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Xu YL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026674; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuo Q, 2018, ONCOGENE, V37, P3275, DOI 10.1038/s41388-018-0205-4	76	156	159	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2018	24	10					1599	+		10.1038/s41591-018-0158-8	http://dx.doi.org/10.1038/s41591-018-0158-8			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GW0RW	30224758	Green Accepted, Green Submitted			2022-12-27	WOS:000446577900023
J	Bunse, L; Pusch, S; Bunse, T; Sahm, F; Sanghvi, K; Friedrich, M; Alansary, D; Sonner, JK; Green, E; Deumelandt, K; Kilian, M; Neftel, C; Uhlig, S; Kessler, T; von Landenberg, A; Berghoff, AS; Marsh, K; Steadman, M; Zhu, DW; Nicolay, B; Wiestler, B; Breckwoldt, MO; Al-Ali, R; Karcher-Bausch, S; Bozza, M; Oezen, I; Kramer, M; Meyer, J; Habel, A; Eisel, J; Poschet, G; Weller, M; Preusser, M; Nadji-Ohl, M; Thon, N; Burger, MC; Harter, PN; Ratliff, M; Harbottle, R; Benner, A; Schrimpf, D; Okun, J; Herold-Mende, C; Turcan, S; Kaulfuss, S; Hess-Stumpp, H; Bieback, K; Cahill, DP; Plate, KH; Hanggi, D; Dorsch, M; Suva, ML; Niemeyer, BA; von Deimling, A; Wick, W; Platten, M				Bunse, Lukas; Pusch, Stefan; Bunse, Theresa; Sahm, Felix; Sanghvi, Khwab; Friedrich, Mirco; Alansary, Dalia; Sonner, Jana K.; Green, Edward; Deumelandt, Katrin; Kilian, Michael; Neftel, Cyril; Uhlig, Stefanie; Kessler, Tobias; von Landenberg, Anna; Berghoff, Anna S.; Marsh, Kelly; Steadman, Mya; Zhu, Dongwei; Nicolay, Brandon; Wiestler, Benedikt; Breckwoldt, Michael O.; Al-Ali, Ruslan; Karcher-Bausch, Simone; Bozza, Matthias; Oezen, Iris; Kramer, Magdalena; Meyer, Jochen; Habel, Antje; Eisel, Jessica; Poschet, Gernot; Weller, Michael; Preusser, Matthias; Nadji-Ohl, Minou; Thon, Niklas; Burger, Michael C.; Harter, Patrick N.; Ratliff, Miriam; Harbottle, Richard; Benner, Axel; Schrimpf, Daniel; Okun, Jurgen; Herold-Mende, Christel; Turcan, Sevin; Kaulfuss, Stefan; Hess-Stumpp, Holger; Bieback, Karen; Cahill, Daniel P.; Plate, Karl H.; Haenggi, Daniel; Dorsch, Marion; Suva, Mario L.; Niemeyer, Barbara A.; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate	NATURE MEDICINE			English	Article							ISOCITRATE DEHYDROGENASE MUTATIONS; ACTIVATED PROTEIN-KINASE; MUTANT; EXPRESSION; GLIOMA; ACID; 2-HYDROXYGLUTARATE; METABOLISM; INHIBITION; GENE	The oncometabolite (R)-2-hydroxyglutarate (R-2-HG) produced by isocitrate dehydrogenase (IDH) mutations promotes gliomagenesis via DNA and histone methylation. Here, we identify an additional activity of R-2-HG: tumor cell-derived R-2-HG is taken up by T cells where it induces a perturbation of nuclear factor of activated T cells transcriptional activity and polyamine biosynthesis, resulting in suppression of T cell activity. IDM-mutant gliomas display reduced T cell abundance and altered calcium signaling. Antitumor immunity to experimental syngeneic Mill-mutant tumors induced by IDH1-specific vaccine or checkpoint inhibition is improved by inhibition of the neomorphic enzymatic function of mutant IDH1. These data attribute a novel, non-tumor cell-autonomous role to an oncometabolite in shaping the tumor immune microenvironment.	[Bunse, Lukas; Bunse, Theresa; Sanghvi, Khwab; Friedrich, Mirco; Sonner, Jana K.; Green, Edward; Deumelandt, Katrin; Kilian, Michael; von Landenberg, Anna; Breckwoldt, Michael O.; Karcher-Bausch, Simone; Oezen, Iris; Kramer, Magdalena; Platten, Michael] German Canc Res Ctr, Clin Cooperat Unit CCU Neuroimmunol & Brain Tumor, German Canc Consortium DKTK, Heidelberg, Germany; [Bunse, Lukas; Kessler, Tobias; Wick, Wolfgang; Platten, Michael] Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Germany; [Bunse, Lukas; Bunse, Theresa; Kessler, Tobias; Wick, Wolfgang; Platten, Michael] DKTK, Natl Ctr Tumor Dis Heidelberg, Heidelberg, Germany; [Bunse, Lukas; Sanghvi, Khwab; Deumelandt, Katrin; Kilian, Michael; von Deimling, Andreas] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; Meyer, Jochen; Habel, Antje; Eisel, Jessica; Schrimpf, Daniel; von Deimling, Andreas] Heidelberg Univ, Med Ctr, Dept Neuropathol, Heidelberg, Germany; [Pusch, Stefan; Sahm, Felix; Meyer, Jochen; Habel, Antje; Eisel, Jessica; Schrimpf, Daniel] DKFZ, DKTK CCU Neuropathol, Heidelberg, Germany; [Bunse, Theresa; Platten, Michael] Univ Hosp, Dept Neurol, Mannheim, Germany; [Bunse, Theresa; Platten, Michael] Med Fac Mannhe, Mannheim, Germany; [Alansary, Dalia; Niemeyer, Barbara A.] Saarland Univ, Ctr Integrat Physiol & Mol Med, Sch Med, Mol Biophys, Homburg, Germany; [Neftel, Cyril; Suva, Mario L.] Harvard & MIT, Broad Inst, Boston, MA USA; [Neftel, Cyril; Suva, Mario L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Neftel, Cyril; Suva, Mario L.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Neftel, Cyril; Suva, Mario L.] Harvard Med Sch, Boston, MA USA; [Uhlig, Stefanie; Bieback, Karen] FlowCore Mannhe & Inst Transfus Med & Immunol, Mannheim, Germany; [Kessler, Tobias; Berghoff, Anna S.; Ratliff, Miriam; Wick, Wolfgang] DKFZ, DKTK CCU Neurooncol, Heidelberg, Germany; [Berghoff, Anna S.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Berghoff, Anna S.; Preusser, Matthias] Med Univ Vienna, Comprehens Canc Ctr, CNS Tumors Unit, Vienna, Austria; [Marsh, Kelly; Steadman, Mya; Zhu, Dongwei; Nicolay, Brandon; Dorsch, Marion] Agios Pharmaceut Inc, Cambridge, MA USA; [Wiestler, Benedikt] Tech Univ Munich, Dept Diagnost & Intervent Neuroradiol, Klinikum Rechts Isar, Neurokopf Zentrum, Munich, Germany; [Breckwoldt, Michael O.] Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany; [Al-Ali, Ruslan; Turcan, Sevin] Heidelberg Univ, Med Ctr, Max Eder Jr Grp Low Grade Gliomas, Heidelberg, Germany; [Bozza, Matthias; Harbottle, Richard] DKFZ, DNA Vectors Unit, Heidelberg, Germany; [Poschet, Gernot] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany; [Weller, Michael] Univ Hosp, Dept Neurol, Zurich, Switzerland; [Weller, Michael] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Preusser, Matthias] Med Univ Vienna, Dept Med 1, Clin Div Oncol, Vienna, Austria; [Nadji-Ohl, Minou] Stuttgart Clin, Dept Neurosurg, Stuttgart, Germany; [Thon, Niklas] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Klinikum Grosshadern, Munich, Germany; [Burger, Michael C.] Goethe Univ Hosp, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany; [Burger, Michael C.; Harter, Patrick N.; Plate, Karl H.] DKTK Partner Site Frankfurt Mainz, Frankfurt, Germany; [Harter, Patrick N.; Plate, Karl H.] Goethe Univ, Univ Hosp, Edinger Inst, Inst Neurol, Frankfurt, Germany; [Harter, Patrick N.; Plate, Karl H.] Goethe Univ, Med Fac, Frankfurt, Germany; [Ratliff, Miriam; Haenggi, Daniel] Univ Hosp Mannhe, Neurosurg Clin, Mannheim, Germany; [Benner, Axel] DKFZ, Div Biostat, Heidelberg, Germany; [Okun, Jurgen] Univ Childrens Hosp, Metab Ctr Heidelberg, Heidelberg, Germany; [Herold-Mende, Christel] Heidelberg Univ, Med Ctr, Dept Neurosurg, Div Expt Neurosurg, Heidelberg, Germany; [Kaulfuss, Stefan; Hess-Stumpp, Holger] Bayer AG, Res & Dev, Berlin, Germany; [Cahill, Daniel P.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Universitatsklinikum des Saarlandes; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Vienna; Medical University of Vienna; Agios Pharmaceuticals; Technical University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital; University of Zurich; Medical University of Vienna; University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; Bayer AG; Harvard University; Harvard Medical School; Massachusetts General Hospital	Platten, M (corresponding author), German Canc Res Ctr, Clin Cooperat Unit CCU Neuroimmunol & Brain Tumor, German Canc Consortium DKTK, Heidelberg, Germany.; Platten, M (corresponding author), Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Germany.	m.platten@dkfz.de	Bunse, Lukas/L-2975-2016; Suva, Mario/AAY-7798-2020; Bunse, Theresa/AAD-1719-2019; Sahm, Felix/GQY-8202-2022; Pusch, Stefan/H-3152-2019; Thon, Niklas/AAI-9069-2021; Wick, Wolfgang/AAA-2545-2020; Turcan, Sevin/AAF-1095-2019; Niemeyer, Barbara A./AAL-8972-2021; Platten, Michael/F-2902-2013; Al-Ali, Ruslan/AAF-8934-2020; von Deimling, Andreas/F-7774-2013; Preusser, Matthias/C-8530-2011	Bunse, Lukas/0000-0002-4490-7574; Suva, Mario/0000-0001-9898-5351; Sahm, Felix/0000-0001-5441-1962; Pusch, Stefan/0000-0002-3407-4249; Thon, Niklas/0000-0003-0011-5281; Wick, Wolfgang/0000-0002-6171-634X; Turcan, Sevin/0000-0002-0885-5607; Platten, Michael/0000-0002-4746-887X; Al-Ali, Ruslan/0000-0002-0189-3774; von Deimling, Andreas/0000-0002-5863-540X; Preusser, Matthias/0000-0003-3541-2315; Weller, Michael/0000-0002-1748-174X; Poschet, Gernot/0000-0002-5344-0865; Alansary, Dalia/0000-0002-7541-6057; Harbottle, Richard/0000-0002-3332-8024; Wiestler, Benedikt/0000-0002-2963-7772; Berghoff, Anna Sophie/0000-0001-9379-6797; Ratliff, Miriam/0000-0002-9464-6544; Niemeyer, Barbara A./0000-0002-6963-0575; Friedrich, Mirco/0000-0002-6401-3623; Kessler, Tobias/0000-0001-8350-7074; Cahill, Daniel/0000-0003-2552-6546	DKFZ Light Microscopy Facility; microarray unit of the DKFZ Genomics and Proteomics Core Facility; Transgenic Service of the Center for Preclinical Research; DKFZ; DKFZ-Bayer Alliance; Metabolomics Core Technology Platform of the Excellence Cluster CellNetworks; epigenetics@dkfz program; DKFZ-MOST program [2526]; Helmholtz Program Immunology and Inflammation; Dr. Rolf M. Schwiete Foundation; German Research Foundation (DFG) [FOR2289: PL315/3-1]; Sonderforderlinie 'Neuroinflammation' of the Ministry of Science of Baden Wurttemberg; German Ministry of Education and Science (National Center for Tumor Diseases Heidelberg NCT 3.0 program 'Precision immunotherapy of brain tumors'); German Ministry of Education and Science (DKTK program); Joint Funding Program MGH-Heidelberg Alliance in Neuro-Oncology; Wilhelm Sander Foundation [2012.118.1]; German Cancer Aid [70112399, 110624]; DFG [ZUK 49/2]; German Cancer Aid; Heidelberg Medical Faculty; Helmholtz International Graduate School; Medical Faculty and University Hospital Mannheim; University Hospital Heidelberg; Faculty of Medicine of the Technical University of Munich (KKF grant); Marie-Curie fellowship;  [FOR2289];  [SFB894]	DKFZ Light Microscopy Facility; microarray unit of the DKFZ Genomics and Proteomics Core Facility; Transgenic Service of the Center for Preclinical Research; DKFZ(Helmholtz Association); DKFZ-Bayer Alliance; Metabolomics Core Technology Platform of the Excellence Cluster CellNetworks; epigenetics@dkfz program; DKFZ-MOST program; Helmholtz Program Immunology and Inflammation; Dr. Rolf M. Schwiete Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Sonderforderlinie 'Neuroinflammation' of the Ministry of Science of Baden Wurttemberg; German Ministry of Education and Science (National Center for Tumor Diseases Heidelberg NCT 3.0 program 'Precision immunotherapy of brain tumors'); German Ministry of Education and Science (DKTK program); Joint Funding Program MGH-Heidelberg Alliance in Neuro-Oncology; Wilhelm Sander Foundation; German Cancer Aid(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Heidelberg Medical Faculty; Helmholtz International Graduate School; Medical Faculty and University Hospital Mannheim; University Hospital Heidelberg; Faculty of Medicine of the Technical University of Munich (KKF grant); Marie-Curie fellowship(European Commission); ; 	We acknowledge the support of the DKFZ Light Microscopy Facility, the microarray unit of the DKFZ Genomics and Proteomics Core Facility, the Transgenic Service of the Center for Preclinical Research, DKFZ, and the DKFZ-Bayer Alliance. We thank the Metabolomics Core Technology Platform of the Excellence Cluster CellNetworks for support with UPLC-based metabolite quantification. The results published here are in part based on data generated by the TCGA Research Network: http://cancergenome.nih.gov/. A2DR1 mice were provided by Institute Pasteur. We thank S. Kircher for flow cytometric analyses; H.Y. Ngyuen, L. Dorner, K. Rauschenbach, and M. Fischer for technical support; and J. Jung for graphics design. This work was supported by the epigenetics@dkfz program to L.B., the DKFZ-MOST program (project number 2526) and the Helmholtz Program Immunology and Inflammation, the Dr. Rolf M. Schwiete Foundation and the German Research Foundation (DFG) (FOR2289: PL315/3-1), the Sonderforderlinie 'Neuroinflammation' of the Ministry of Science of Baden Wurttemberg and the German Ministry of Education and Science (National Center for Tumor Diseases Heidelberg NCT 3.0 program 'Precision immunotherapy of brain tumors' and the DKTK program) to M.Pl. the Joint Funding Program MGH-Heidelberg Alliance in Neuro-Oncology to M.Pl. and M. S., the Wilhelm Sander Foundation (2012.118.1) and the German Cancer Aid (70112399) to M.Pl. and A.v.D., the German Cancer Aid (110624) to W.W., the ZUK 49/2 from the DFG to G.P., FOR2289 to B.A.N. and D.A., SFB894 to B.A.N., and the German Cancer Aid to S.T.. L.B. and M.F. are members of the MD/PhD program at Heidelberg University. L. B. was funded by Heidelberg Medical Faculty. T.B., K.S., J.K.S., and M.Ki. are supported by the Helmholtz International Graduate School, T.B. is supported by the Medical Faculty and University Hospital Mannheim. F.S. is supported by a postdoctoral fellowship of the University Hospital Heidelberg. B.W. is supported by the Faculty of Medicine of the Technical University of Munich (KKF grant). E.G. is supported by a Marie-Curie fellowship.	Amankulor NM, 2017, GENE DEV, V31, P774, DOI 10.1101/gad.294991.116; Balss J, 2012, ACTA NEUROPATHOL, V124, P883, DOI 10.1007/s00401-012-1060-y; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Bardella C, 2016, CANCER CELL, V30, P578, DOI 10.1016/j.ccell.2016.08.017; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Brown CE, 2015, CLIN CANCER RES, V21, P4062, DOI 10.1158/1078-0432.CCR-15-0428; Burstenbinder K, 2007, PLANT J, V49, P238, DOI 10.1111/j.1365-313X.2006.02942.x; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Bunse L, 2015, J CLIN INVEST, V125, P593, DOI 10.1172/JCI77780; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan SM, 2015, NAT MED, V21, P178, DOI 10.1038/nm.3788; Chen JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32428; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Erez A, 2015, NAT REV CANCER, V15, P440, DOI 10.1038/nrc3949; Esmaeili M, 2014, CANCER RES, V74, P4898, DOI 10.1158/0008-5472.CAN-14-0008; Fathi AT, 2016, ONCOLOGIST, V21, P214, DOI 10.1634/theoncologist.2015-0342; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; Grassian AR, 2014, CANCER RES, V74, P3317, DOI 10.1158/0008-5472.CAN-14-0772-T; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karlstaedt A, 2016, P NATL ACAD SCI USA, V113, P10436, DOI 10.1073/pnas.1601650113; Kohanbash G, 2017, J CLIN INVEST, V127, P1425, DOI 10.1172/JCI90644; Kolker S, 2002, EUR J NEUROSCI, V16, P21, DOI 10.1046/j.1460-9568.2002.02055.x; Kumai T, 2017, CANCER IMMUNOL RES, V5, P72, DOI 10.1158/2326-6066.CIR-16-0194; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Ledderose C, 2014, J BIOL CHEM, V289, P25936, DOI 10.1074/jbc.M114.575308; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Muhlhausen C, 2008, J INHERIT METAB DIS, V31, P188, DOI 10.1007/s10545-008-0825-x; Mullen AR, 2012, TRENDS ENDOCRIN MET, V23, P552, DOI 10.1016/j.tem.2012.06.009; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Olivera-Bravo S, 2015, HUM MOL GENET, V24, P4504, DOI 10.1093/hmg/ddv175; Pajor AM, 2007, MOL PHARMACOL, V72, P1330, DOI 10.1124/mol.107.035352; Passariello CL, 2012, BBA-MOL CELL RES, V1823, P800, DOI 10.1016/j.bbamcr.2011.12.013; Pellegatta S, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0180-0; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Pusch S, 2017, ACTA NEUROPATHOL, V133, P629, DOI 10.1007/s00401-017-1677-y; Ray RM, 2015, CELL SIGNAL, V27, P1850, DOI 10.1016/j.cellsig.2015.06.002; Reardon DA, 2016, CANCER IMMUNOL RES, V4, P124, DOI 10.1158/2326-6066.CIR-15-0151; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sahm F, 2017, LANCET ONCOL, V18, P682, DOI 10.1016/S1470-2045(17)30155-9; Sahm F, 2012, BRAIN PATHOL, V22, P26, DOI 10.1111/j.1750-3639.2011.00506.x; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Schumacher T, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/2162402X.2014.974392; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Tateishi K, 2015, CANCER CELL, V28, P773, DOI 10.1016/j.ccell.2015.11.006; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Waitkus MS, 2016, NEURO-ONCOLOGY, V18, P16, DOI 10.1093/neuonc/nov136; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wick W, 2016, NEURO-ONCOLOGY, V18, P1529, DOI 10.1093/neuonc/now133; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228	71	229	231	7	42	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1192	+		10.1038/s41591-018-0095-6	http://dx.doi.org/10.1038/s41591-018-0095-6			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29988124				2022-12-27	WOS:000440955500025
J	Laurans, L; Venteclef, N; Haddad, Y; Chajadine, M; Alzaid, F; Metghalchi, S; Sovran, B; Denis, RGP; Dairou, J; Cardellini, M; Moreno-Navarrete, JM; Straub, M; Jegou, S; McQuitty, C; Viel, T; Esposito, B; Tavitian, B; Callebert, J; Luquet, SH; Federici, M; Fernandez-Real, JM; Burcelin, R; Launay, JM; Tedgui, A; Mallat, Z; Sokol, H; Taleb, S				Laurans, Ludivine; Venteclef, Nicolas; Haddad, Yacine; Chajadine, Mouna; Alzaid, Fawaz; Metghalchi, Sarvenaz; Sovran, Bruno; Denis, Raphael G. P.; Dairou, Julien; Cardellini, Marina; Moreno-Navarrete, Jose-Maria; Straub, Marjolene; Jegou, Sarah; McQuitty, Claire; Viel, Thomas; Esposito, Bruno; Tavitian, Bertrand; Callebert, Jacques; Luquet, Serge H.; Federici, Massimo; Manuel Fernandez-Real, Jose; Burcelin, Remy; Launay, Jean-Marie; Tedgui, Alain; Mallat, Ziad; Sokol, Harry; Taleb, Soraya			Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; TRYPTOPHAN-METABOLISM; IMMUNE ACTIVATION; T-CELLS; INFLAMMATION; DISEASE; OBESITY; HOMEOSTASIS; KYNURENINE	The association between altered gut microbiota, intestinal permeability, inflammation and cardiometabolic diseases is becoming increasingly clear but remains poorly understood(1,2). Indoleamine 2,3-dioxygenase is an enzyme induced in many types of immune cells, including macrophages in response to inflammatory stimuli, and catalyzes the degradation of tryptophan along the kynurenine pathway. Indoleamine 2,3-dioxygenase activity is better known for its suppression of effector T cell immunity and its activation of regulatory T cells(3,4). However, high indoleamine 2,3-dioxygenase activity predicts worse cardiovascular outcomes(5-9) and may promote atherosclerosis and vascular inflammations(6), suggesting a more complex role in chronic inflammatory settings. Indoleamine 2,3-dioxygenase activity is also increased in obesity(10-13), yet its role in metabolic disease is still unexplored. Here, we show that obesity is associated with an increase of intestinal indoleamine 2,3-dioxygenase activity, which shifts tryptophan metabolism from indole derivative and interleukin-22 production toward kynurenine production. Indoleamine 2,3-dioxygenase deletion or inhibition improves insulin sensitivity, preserves the gut mucosal barrier, decreases endotoxemia and chronic inflammation, and regulates lipid metabolism in liver and adipose tissues. These beneficial effects are due to rewiring of tryptophan metabolism toward a microbiota-dependent production of interleukin-22 and are abrogated after treatment with a neutralizing anti-interleukin-22 antibody. In summary, we identify an unexpected function of indoleamine 2,3-dioxygenase in the fine tuning of intestinal tryptophan metabolism with major consequences on microbiota-dependent control of metabolic disease, which suggests indoleamine 2,3-dioxygenase as a potential therapeutic target.	[Laurans, Ludivine; Haddad, Yacine; Chajadine, Mouna; Metghalchi, Sarvenaz; Viel, Thomas; Esposito, Bruno; Tavitian, Bertrand; Tedgui, Alain; Mallat, Ziad; Taleb, Soraya] INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France; [Laurans, Ludivine; Haddad, Yacine; Chajadine, Mouna; Metghalchi, Sarvenaz; Viel, Thomas; Esposito, Bruno; Tavitian, Bertrand; Tedgui, Alain; Mallat, Ziad; Taleb, Soraya] Univ Paris 05, Paris, France; [Venteclef, Nicolas; Alzaid, Fawaz] Univ Paris Diderot, Univ Paris Descartes, Sorbonne Paris Cite, UPMC,Univ Paris 06,Sorbonne Univ,INSERM,UMRS 1138, Paris, France; [Venteclef, Nicolas; Alzaid, Fawaz] Ctr Rech Cordeliers, Paris, France; [Sovran, Bruno; Sokol, Harry] Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, Jouy En Josas, France; [Denis, Raphael G. P.; Luquet, Serge H.] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Unite Biol Fonct & Adaptat,UMR 8251, Paris, France; [Dairou, Julien] Univ Paris 05, Sorbonne Paris Cite, Lab Chim Biochim Pharmacol & Toxicol, UMR CNRS 8601, Paris, France; [Cardellini, Marina; Federici, Massimo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Moreno-Navarrete, Jose-Maria; Manuel Fernandez-Real, Jose] Hosp Girona Dr Josep Trueta, Dept Diabet & Endocrinol, Girona, Spain; [Moreno-Navarrete, Jose-Maria] Inst Salud Carlos III, CIBERobn Pathophysiol Obes & Nutr, Madrid, Spain; [Straub, Marjolene; Jegou, Sarah; McQuitty, Claire; Sokol, Harry] PSL Res Univ, Sorbonne Univ, Ecole Normale Super, Hop St Antoine,AP HP,CNRS,INSERM,Lab Biomol, Paris, France; [Callebert, Jacques; Launay, Jean-Marie] Hop Lariboisiere, AP HP, INSERM UMR942, Serv Biochim, Paris, France; [Burcelin, Remy] INSERM UMR1048, Inst Malad Metab & Cardiovasc, Toulouse, France; [Mallat, Ziad] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge, England; [Sokol, Harry] Sorbonne Univ, St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; University of Rome Tor Vergata; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Taleb, S (corresponding author), INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France.; Taleb, S (corresponding author), Univ Paris 05, Paris, France.	soraya.taleb@inserm.fr	Taleb, Soraya/K-8176-2017; Sokol, Harry/E-2290-2019; burcelin, remy/M-6013-2014; Viel, Thomas/K-4576-2013; Denis, Raphael/ABE-1758-2020; Luquet, serge/AAT-1809-2021; Tavitian, Bertrand M/P-6578-2018; Mallat, Ziad/D-4041-2012; Moreno-Navarrete, José María/H-9772-2015; Fernández-Real, Jose Manuel/AGH-3599-2022; sokol, harry/ABA-8991-2020; Cardellini, Marina/AAC-1096-2019; callebert, jacques/L-4569-2017; Moreno-Navarrete, José María/ABG-5548-2021; Federici, Massimo/G-9940-2012	Taleb, Soraya/0000-0002-6650-619X; Sokol, Harry/0000-0002-2914-1822; Denis, Raphael/0000-0002-7677-7460; Luquet, serge/0000-0001-8668-6645; Tavitian, Bertrand M/0000-0002-5349-8194; Mallat, Ziad/0000-0003-0443-7878; Moreno-Navarrete, José María/0000-0002-2883-511X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; sokol, harry/0000-0002-2914-1822; Moreno-Navarrete, José María/0000-0002-2883-511X; Federici, Massimo/0000-0003-4989-5194; launay, jean-marie/0000-0003-4809-1020; Viel, Thomas/0000-0002-0756-9166; Alzaid, Fawaz/0000-0003-3056-3640	INSERM; Fondation pour la Recherche Medicale; Fondation de France; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [ERC-2016-StG-71577]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC))	This work was supported by INSERM, Fondation pour la Recherche Medicale (A.T.) and Fondation de France (S.T.). H.S. received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (ERC-2016-StG-71577). We are grateful to S. Billon-Crossouard from the Platform of Mass Spectrometry of Nantes University for SCFA analysis. We acknowledge the technical platform metabolism of the Unit "Biologie Fonctionnelle et Adaptative" (University Paris Diderot, Sorbonne Paris Cite, BFA, UMR 8251 CNRS, 75205 Paris, France) for metabolic analysis and the animal core facility "Buffon" of the University Paris Diderot Paris 7/Institut Jacques Monod, Paris for animal husbandry. We are thankful to the Genomics Platform of Translational Research Department, Institut Curie, PSL Research University for sharing their expertise and helping us with NanoString analysis. We thank members of our animal and histology facilities. We thank B. Gaye for his help with statistical analysis. We thank N. Vodovar for discussions and C. Heymes for his help with human sample preparation.	Agudelo LZ, 2018, CELL METAB, V27, P378, DOI 10.1016/j.cmet.2018.01.004; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Brandacher G, 2006, OBES SURG, V16, P541, DOI 10.1381/096089206776945066; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cansell C, 2014, MOL PSYCHIATR, V19, P1095, DOI 10.1038/mp.2014.31; Cherayil BJ, 2009, INFLAMM BOWEL DIS, V15, P1391, DOI 10.1002/ibd.20910; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eussen SJPM, 2015, INT J CARDIOL, V189, P18, DOI 10.1016/j.ijcard.2015.03.413; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Ferchaud-Roucher V, 2005, AM J PHYSIOL-ENDOC M, V289, pE716, DOI 10.1152/ajpendo.00430.2004; Ferraresi C, 2015, LASER MED SCI, V30, P1259, DOI 10.1007/s10103-015-1723-8; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Gulhane M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28990; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Maneglier B, 2004, CLIN CHEM, V50, P2166, DOI 10.1373/clinchem.2004.037465; Mangge H, 2014, CURR MED CHEM, V21, P1931, DOI 10.2174/0929867321666140304105526; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metghalchi S, 2015, CELL METAB, V22, P460, DOI 10.1016/j.cmet.2015.07.004; Moyer BJ, 2016, TOXICOL APPL PHARM, V300, P13, DOI 10.1016/j.taap.2016.03.011; Murakami Y, 2013, INT J TRYPTOPHAN RES, P47, DOI 10.4137/IJTR.S11558; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Pedersen ER, 2015, ARTERIOSCL THROM VAS, V35, P455, DOI 10.1161/ATVBAHA.114.304674; Pedersen ER, 2011, ARTERIOSCL THROM VAS, V31, P698, DOI 10.1161/ATVBAHA.110.219329; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Salazar MR, 2012, AM J CARDIOL, V109, P1749, DOI 10.1016/j.amjcard.2012.02.016; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Speakman JR, 2013, DIS MODEL MECH, V6, P293, DOI 10.1242/dmm.009860; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wirleitner B, 2003, EUR J CLIN INVEST, V33, P550, DOI 10.1046/j.1365-2362.2003.01186.x; Wolowczuk I., 2012, AM J PHYSIOL-REG I, V303, pR135, DOI DOI 10.1152/ajpregu.00373.2011; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; YOSHIDA R, 1981, P NATL ACAD SCI-BIOL, V78, P129, DOI 10.1073/pnas.78.1.129; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	48	131	135	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1113	+		10.1038/s41591-018-0060-4	http://dx.doi.org/10.1038/s41591-018-0060-4			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29942089	Green Submitted			2022-12-27	WOS:000440955500016
J	Serrano, M; Barzilai, N				Serrano, Manuel; Barzilai, Nir			Targeting senescence	NATURE MEDICINE			English	Editorial Material							CELLULAR SENESCENCE; CELLS		[Serrano, Manuel] IRB Barcelona, Barcelona, Spain; [Serrano, Manuel] BIST, Barcelona, Spain; [Serrano, Manuel] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Barzilai, Nir] Albert Einstein Coll Med, Inst Aging Res, New York, NY 10461 USA; [Barzilai, Nir] Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA; [Barzilai, Nir] Albert Einstein Coll Med, Dept Genet, New York, NY 10461 USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; ICREA; Yeshiva University; Yeshiva University; Yeshiva University	Barzilai, N (corresponding author), Albert Einstein Coll Med, Inst Aging Res, New York, NY 10461 USA.; Barzilai, N (corresponding author), Albert Einstein Coll Med, Dept Med, New York, NY 10461 USA.; Barzilai, N (corresponding author), Albert Einstein Coll Med, Dept Genet, New York, NY 10461 USA.	nir.barzilai@einstein.yu.edu	Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312	Institute for Research in Biomedicine (IRB-Barcelona); "la Caixa" Foundation; Spanish Ministry of Economy; European Regional Development Fund; European Research Council (European Union); Severo Ochoa Award of Excellence from the Spanish Ministry of Economy; National Institutes of Health [P01AG021654]; Nathan Shock Center of Excellence for the Biology of Aging [P30AG038072]; Glenn Center for the Biology of Human Aging (Paul Glenn Foundation for Medical Research)	Institute for Research in Biomedicine (IRB-Barcelona); "la Caixa" Foundation(La Caixa Foundation); Spanish Ministry of Economy(Spanish Government); European Regional Development Fund(European Commission); European Research Council (European Union)(European Research Council (ERC)European Commission); Severo Ochoa Award of Excellence from the Spanish Ministry of Economy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock Center of Excellence for the Biology of Aging; Glenn Center for the Biology of Human Aging (Paul Glenn Foundation for Medical Research)	M.S. was funded by the Institute for Research in Biomedicine (IRB-Barcelona), by the "la Caixa" Foundation, by grants from the Spanish Ministry of Economy (cofunded by the European Regional Development Fund) and by the European Research Council (from the European Union's Horizon 2020 research and innovation programme). The IRB-Barcelona is recipient of a Severo Ochoa Award of Excellence from the Spanish Ministry of Economy. N.B. is the recipient of grants from the National Institutes of Health (P01AG021654), the Nathan Shock Center of Excellence for the Biology of Aging (P30AG038072) and the Glenn Center for the Biology of Human Aging (Paul Glenn Foundation for Medical Research). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Newman JC, 2016, J GERONTOL A-BIOL, V71, P1424, DOI 10.1093/gerona/glw149; Sapieha P, 2018, TRENDS CELL BIOL, V28, P595, DOI 10.1016/j.tcb.2018.03.003; Taguchi J, 2017, CELL STEM CELL, V20, P293, DOI 10.1016/j.stem.2017.02.001; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	12	14	14	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1092	1094		10.1038/s41591-018-0141-4	http://dx.doi.org/10.1038/s41591-018-0141-4			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082861				2022-12-27	WOS:000440955500011
J	Stower, H				Stower, Hannah			STEM CELL THERAPIES Cell therapy for spinal cord injury	NATURE MEDICINE			English	Editorial Material																			0	1	1	6	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1088	1088		10.1038/s41591-018-0155-y	http://dx.doi.org/10.1038/s41591-018-0155-y			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	30082867	Bronze			2022-12-27	WOS:000440955500008
J	Majzner, RG; Mackall, CL				Majzner, Robbie G.; Mackall, Crystal L.			Clinical lessons learned from the first leg of the CAR T cell journey	NATURE MEDICINE			English	Review							CHIMERIC ANTIGEN RECEPTORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL; ANTITUMOR-ACTIVITY; TUMOR-ANTIGEN; ADOPTIVE IMMUNOTHERAPY; 4-1BB COSTIMULATION; HODGKIN-LYMPHOMA; SURFACE-ANTIGEN; THERAPY	Chimeric antigen receptor (CAR) T cell therapy for B cell malignancies has surpassed expectations, driving an ever-expanding number of clinical trials and the first US Food and Drug Administration approvals of cell therapies for the treatment of cancer. This experience has illuminated some generalizable requirements for CAR T cell efficacy as well as the interplay between disease biology and clinical outcomes. Major CAR intrinsic variables affecting T cell behavior have been defined, and mechanisms of tumor resistance are increasingly understood. Here, we review the clinical experience with CAR T cells amassed to date, including but not limited to B cell malignancies, emphasizing factors associated with efficacy, resistance and major barriers to success. We also discuss how these insights are driving next-generation clinical trials, including those in solid tumors.	[Majzner, Robbie G.; Mackall, Crystal L.] Dept Pediat, Stanford, CA 94305 USA; [Majzner, Robbie G.; Mackall, Crystal L.] Stanford Canc Inst, Stanford, CA 94305 USA; [Mackall, Crystal L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University	Mackall, CL (corresponding author), Dept Pediat, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Stanford Canc Inst, Stanford, CA 94305 USA.; Mackall, CL (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	cmackall@stanford.edu			St. Baldrick&apos;s Foundation (St. Baldrick&apos;s Foundation, Inc) [SU2C534 AACR-DT-27-17] Funding Source: Medline	St. Baldrick&apos;s Foundation (St. Baldrick&apos;s Foundation, Inc)		ABRAMSON JS, 2017, BLOOD S1, V130; Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Alabanza L, 2017, MOL THER, V25, P2452, DOI 10.1016/j.ymthe.2017.07.013; ALBINO AP, 1981, J EXP MED, V154, P1764, DOI 10.1084/jem.154.6.1764; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; Amrolia PJ, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-118616; Beatty GL, 2018, GASTROENTEROLOGY, V155, P29, DOI 10.1053/j.gastro.2018.03.029; Beatty GL, 2014, CANCER IMMUNOL RES, V2, P112, DOI 10.1158/2326-6066.CIR-13-0170; Bhoj VG, 2016, BLOOD, V128, P360, DOI 10.1182/blood-2016-01-694356; Bielamowicz K, 2018, NEURO-ONCOLOGY, V20, P506, DOI 10.1093/neuonc/nox182; Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Brudno J, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-113731; Brudno JN, 2018, J CLIN ONCOL, V36, P2267, DOI 10.1200/JCO.2018.77.8084; Brudno JN, 2016, BLOOD, V127, P3321, DOI 10.1182/blood-2016-04-703751; Brudno JN, 2016, ASH ABSTR, V128, P999; Budde L, 2017, BLOOD, V130; Byrd TT, 2018, CANCER RES, V78, P489, DOI 10.1158/0008-5472.CAN-16-1911; Caruso HG, 2015, CANCER RES, V75, P3505, DOI 10.1158/0008-5472.CAN-15-0139; Chen YH, 2019, CLIN CANCER RES, V25, P2915, DOI 10.1158/1078-0432.CCR-18-1811; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Cui YZ, 2009, BLOOD, V114, P3831, DOI 10.1182/blood-2009-03-212134; Cummins KD, 2019, SEMIN HEMATOL, V56, P155, DOI 10.1053/j.seminhematol.2018.08.008; D'Angelo SP, 2018, CANCER DISCOV, V8, P944, DOI 10.1158/2159-8290.CD-17-1417; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; DeSelm C, 2018, MOL THER, V26, P2542, DOI 10.1016/j.ymthe.2018.09.008; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Feucht J, 2019, NAT MED, V25, P82, DOI 10.1038/s41591-018-0290-5; Finney HM, 1998, J IMMUNOL, V161, P2791; Finney OC, 2019, J CLIN INVEST, V129, P2123, DOI 10.1172/JCI125423; Fischer J, 2017, J IMMUNOTHER, V40, P187, DOI 10.1097/CJI.0000000000000169; FOUSEK K, 2017, BLOOD S1, V130; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; GARDNER R, 2018, BLOOD S, V132, DOI DOI 10.1182/BLOOD-2018-99-113126; Gardner RA, 2017, BLOOD, V129, P3322, DOI 10.1182/blood-2017-02-769208; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Geyer MB, 2018, MOL THER, V26, P1896, DOI 10.1016/j.ymthe.2018.05.018; Ghorashian S, 2017, BLOOD, V130; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Gomes-Silva D, 2017, CELL REP, V21, P17, DOI 10.1016/j.celrep.2017.09.015; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Heczey A, 2017, MOL THER, V25, P2214, DOI 10.1016/j.ymthe.2017.05.012; Hegde M, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.10508; Hegde M, 2016, J CLIN INVEST, V126, P3036, DOI 10.1172/JCI83416; Hege KM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0222-9; HOSSAIN N, 2018, BLOOD S, V132, DOI DOI 10.1182/BLOOD-2018-99-110142; Hu BL, 2017, CELL REP, V20, P3025, DOI 10.1016/j.celrep.2017.09.002; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jacoby E, 2018, AM J HEMATOL, V93, P1485, DOI 10.1002/ajh.25274; Jacoby E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12320; Jensen MC, 2010, BIOL BLOOD MARROW TR, V16, P1245, DOI 10.1016/j.bbmt.2010.03.014; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Junghans RP, 2016, PROSTATE, V76, P1257, DOI 10.1002/pros.23214; Kagoya Y, 2018, NAT MED, V24, P352, DOI 10.1038/nm.4478; Katz SC, 2015, CLIN CANCER RES, V21, P3149, DOI 10.1158/1078-0432.CCR-14-1421; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Kloss CC, 2018, MOL THER, V26, P1855, DOI 10.1016/j.ymthe.2018.05.003; Kochenderfer JN, 2017, MOL THER, V25, P2245, DOI 10.1016/j.ymthe.2017.07.004; Kochenderfer JN, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.71.3024; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kueberuwa G, 2018, MOL THER-ONCOLYTICS, V8, P41, DOI 10.1016/j.omto.2017.12.003; Labanieh L, 2018, NAT BIOMED ENG, V2, P377, DOI 10.1038/s41551-018-0235-9; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lanitis E, 2013, CANCER IMMUNOL RES, V1, P43, DOI 10.1158/2326-6066.CIR-13-0008; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.218.218; Li GB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121322; Liu XJ, 2016, CANCER RES, V76, P1578, DOI 10.1158/0008-5472.CAN-15-2524; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Mackall C, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.3000; Mackall CL, 2018, SCIENCE, V359, P990, DOI 10.1126/science.aas9434; Majzner RG, 2019, CLIN CANCER RES, V25, P2560, DOI 10.1158/1078-0432.CCR-18-0432; Maloney DG, 2017, BLOOD, V130; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3011; Maude SL, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3007; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Mount CW, 2018, NAT MED, V24, P572, DOI 10.1038/s41591-018-0006-x; Mueller KT, 2018, CLIN CANCER RES, V24, P6175, DOI 10.1158/1078-0432.CCR-18-0758; Mueller KT, 2017, BLOOD, V130, P2317, DOI 10.1182/blood-2017-06-786129; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Nellan A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0340-z; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Orlando EJ, 2018, NAT MED, V24, P1504, DOI 10.1038/s41591-018-0146-z; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Pellegatta S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2731; Peng WY, 2010, CLIN CANCER RES, V16, P5458, DOI 10.1158/1078-0432.CCR-10-0712; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Priceman SJ, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1380764; Priceman SJ, 2018, CLIN CANCER RES, V24, P95, DOI 10.1158/1078-0432.CCR-17-2041; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Raje N, 2019, NEW ENGL J MED, V380, P1726, DOI 10.1056/NEJMoa1817226; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Ruella M, 2017, CANCER DISCOV, V7, P1154, DOI 10.1158/2159-8290.CD-16-0850; Salter AI, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat6753; Sampson JH, 2014, CLIN CANCER RES, V20, P972, DOI 10.1158/1078-0432.CCR-13-0709; Schultz LM, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117445; SCHUSTER SJ, 2017, BLOOD S1, V130; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Shah NN, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-110194; Shalabi H, 2018, HAEMATOLOGICA, V103, pE215, DOI 10.3324/haematol.2017.183459; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sharma P, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.1018; Shum T, 2017, CANCER DISCOV, V7, P1238, DOI 10.1158/2159-8290.CD-17-0538; Sommermeyer D, 2017, LEUKEMIA, V31, P2191, DOI 10.1038/leu.2017.57; Sotillo E, 2015, CANCER DISCOV, V5, P1282, DOI 10.1158/2159-8290.CD-15-1020; Straathof K, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-CT145; Tchou J, 2017, CANCER IMMUNOL RES, V5, P1152, DOI 10.1158/2326-6066.CIR-17-0189; Thistlethwaite FC, 2017, CANCER IMMUNOL IMMUN, V66, P1425, DOI 10.1007/s00262-017-2034-7; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Turtle CJ, 2017, J CLIN ONCOL, V35, P3010, DOI 10.1200/JCO.2017.72.8519; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Walker AJ, 2017, MOL THER, V25, P2189, DOI 10.1016/j.ymthe.2017.06.008; Wang Y, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1440169; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Ying ZT, 2019, NAT MED, V25, P947, DOI 10.1038/s41591-019-0421-7; Yu H, 2017, AM J HEMATOL, V92, pE11, DOI 10.1002/ajh.24594; Zhang CC, 2017, MOL THER, V25, P1248, DOI 10.1016/j.ymthe.2017.03.010; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	142	217	227	10	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1341	1355		10.1038/s41591-019-0564-6	http://dx.doi.org/10.1038/s41591-019-0564-6			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501612				2022-12-27	WOS:000484832800015
J	Stower, H				Stower, Hannah			Nosocomial transmission of antibiotic resistance	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2019	25	9					1330	1330		10.1038/s41591-019-0589-x	http://dx.doi.org/10.1038/s41591-019-0589-x			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IW2TC	31501606	Bronze			2022-12-27	WOS:000484832800008
J	Barker, RA; Farrell, K; Guzman, NV; He, XL; Lazic, SE; Moore, S; Morris, R; Tyers, P; Wijeyekoon, R; Daft, D; Hewitt, S; Dayal, V; Foltynie, T; Kefalopoulou, Z; Mahlknecht, P; Lao-Kaim, NP; Piccini, P; Bjartmarz, H; Bjorklund, A; Lindvall, O; Nelander-Wahlestedt, J; Parmar, M; Paul, G; Widner, H; Church, A; Dunnett, S; Peall, K; Rosser, A; Gurruchaga, JM; Palfi, S; Piroth, T; Winkler, C				Barker, Roger A.; Farrell, Krista; Guzman, Natalie Valle; He, Xiaoling; Lazic, Stanley E.; Moore, Sarah; Morris, Robert; Tyers, Pamela; Wijeyekoon, Ruwani; Daft, Danielle; Hewitt, Sam; Dayal, Viswas; Foltynie, Thomas; Kefalopoulou, Zinovia; Mahlknecht, Philipp; Lao-Kaim, Nick P.; Piccini, Paola; Bjartmarz, Hjalmar; Bjorklund, Anders; Lindvall, Olle; Nelander-Wahlestedt, Jenny; Parmar, Malin; Paul, Gesine; Widner, Hakan; Church, Alistair; Dunnett, Stephen; Peall, Kathryn; Rosser, Anne; Gurruchaga, Jean Marc; Palfi, Stephane; Piroth, Tobias; Winkler, Christian		TRANSEURO Consortium	Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease	NATURE MEDICINE			English	Article							TRANSPLANTATION; NEURONS; TISSUE; PROGRESSION; THERAPY; GRAFTS; FUTURE	Clinical studies of Parkinson's disease (PD) using a dopamine cell replacment strategy have been tried for more than 30 years. The outcomes following transplantation of human fetal ventral mesencephalic tissue (hfVM) have been variable, with some patients coming off their anti-PD treatment for many years and others not responding and/or developing significant side effects, including graft-induced dyskinesia. This led to a re-appraisal of the best way to do such trials, which resulted in a new European-Union-funded allograft trial with fetal dopamine cells across several centers in Europe. This new trial, TRANSEURO (NCT01898390), is an open-label study in which some individuals in a large observational cohort of patients with mild PD who were undergoing identical assessments were randomly selected to receive transplants of hfVM. The TRANSEURO trial is currently ongoing as researchers have completed both recruitment into a large multicenter observational study of younger onset early-stage PD and transplantation of hfVM in 11 patients. While completion of TRANSEURO is not expected until 2021, we feel that sharing the rationale for the design of TRANSEURO, along with the lessons we have learned along the way, can help inform researchers and facilitate planning of transplants of dopamine-producing cells derived from human pluripotent stem cells for future clinical trials.	[Barker, Roger A.] Univ Cambridge, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Cambridge, England; [Barker, Roger A.] Univ Cambridge, WT MRC Cambridge Stem Cell Inst, Cambridge, England; [Barker, Roger A.; Farrell, Krista; Guzman, Natalie Valle; He, Xiaoling; Moore, Sarah; Tyers, Pamela; Wijeyekoon, Ruwani; Daft, Danielle; Hewitt, Sam] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England; [Lazic, Stanley E.; Church, Alistair; Dunnett, Stephen; Peall, Kathryn; Rosser, Anne] Cardiff Univ, Sch Biosci, Brain Repair Grp, Cardiff, S Glam, Wales; [Morris, Robert] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Hills Rd, Cambridge, England; [Dayal, Viswas; Foltynie, Thomas; Kefalopoulou, Zinovia; Mahlknecht, Philipp] UCL, Queen Sq Inst Neurol, Dept Clin & Movement Neurosci, London, England; [Dayal, Viswas; Foltynie, Thomas; Kefalopoulou, Zinovia; Mahlknecht, Philipp] Natl Hosp Neurol & Neurosurg, London, England; [Lao-Kaim, Nick P.; Piccini, Paola] Imperial Coll London, Div Brain Sci, Ctr Neuroinflammat & Neurodegenerat, Neurol Imaging Unit, Hammersmith Campus, London, England; [Bjartmarz, Hjalmar; Bjorklund, Anders; Nelander-Wahlestedt, Jenny; Parmar, Malin] Lund Univ, BMC, Wallenberg Neurosci Ctr, Lund, Sweden; [Bjartmarz, Hjalmar; Bjorklund, Anders; Lindvall, Olle; Nelander-Wahlestedt, Jenny; Parmar, Malin] Lund Univ, BMC, Lund Stem Cell Ctr, Lund, Sweden; [Lindvall, Olle] Univ Hosp, Lab Stem Cells & Restorat Neurol, Lund, Sweden; [Paul, Gesine; Widner, Hakan] Skane Univ Hosp, Neurol Clin, Lund, Sweden; [Gurruchaga, Jean Marc; Palfi, Stephane] Grp Hosp Henri Mondor Albert Chenevier, AP HP, PePsy Dept, Dept Neurosurg, Creteil, France; [Piroth, Tobias; Winkler, Christian] Freiburg Univ, Dept Stereotact Neurosurg, Lab Mol Neurosurg, Freiburg, Germany	University of Cambridge; University of Cambridge; University of Cambridge; Cardiff University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Freiburg	Barker, RA (corresponding author), Univ Cambridge, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Cambridge, England.; Barker, RA (corresponding author), Univ Cambridge, WT MRC Cambridge Stem Cell Inst, Cambridge, England.; Barker, RA (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge, England.	rab46@cam.ac.uk	Mahlknecht, Philipp/AAI-6137-2020; Björklund, Anders/ABA-1326-2020; Moore, Sarah/GOG-8152-2022; Politis, Marios/GYQ-9446-2022	Mahlknecht, Philipp/0000-0003-0671-0516; Parmar, Malin/0000-0001-5002-4199; Hewitt, Samuel/0000-0002-9219-6324; Rosser, Anne/0000-0002-4716-4753; /0000-0001-9815-5665; Barker, Roger Alistair/0000-0001-8843-7730; Bjorklund, Anders/0000-0002-5676-6203; Piccini, Paola/0000-0003-4162-6141	EU [242003]; Cure Parkinson's Trust [RG81537]; John Black Charitable Trust; NIHR funding of Biomedical Research Centres at UCL [146281]; Multipark; MRC [MR/P008593/1] Funding Source: UKRI	EU(European Commission); Cure Parkinson's Trust; John Black Charitable Trust; NIHR funding of Biomedical Research Centres at UCL; Multipark; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by an EU FP7 grant (242003) as well as funding from the Cure Parkinson's Trust (RG81537), John Black Charitable Trust and Multipark. The work was also supported by NIHR funding of Biomedical Research Centres at UCL and Cambridge (146281). R.A.B. is an NIHR Senior Investigator (NF-SI-0616-10011) and a PI in the MRC/WT Stem Cell Institute (203151/Z/16/Z).	Barker RA, 2015, NAT REV NEUROL, V11, P492, DOI 10.1038/nrneurol.2015.123; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Brundin P, 2000, BRAIN, V123, P1380, DOI 10.1093/brain/123.7.1380; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Galpern WR, 2012, LANCET NEUROL, V11, P643, DOI 10.1016/S1474-4422(12)70064-9; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goya RL, 2011, NEUROBIOL DIS, V41, P407, DOI 10.1016/j.nbd.2010.10.008; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kelly CM, 2011, CELL TRANSPLANT, V20, P503, DOI 10.3727/096368910X546580; Kirkeby A, 2017, PROG BRAIN RES, V230, P165, DOI 10.1016/bs.pbr.2016.11.011; Kordower JH, 1996, J COMP NEUROL, V370, P203; Li WH, 2018, MOVEMENT DISORD, V33, P117, DOI 10.1002/mds.27183; Li W, 2016, P NATL ACAD SCI USA, V113, P6544, DOI 10.1073/pnas.1605245113; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; Liu GQ, 2017, LANCET NEUROL, V16, P620, DOI 10.1016/S1474-4422(17)30122-9; Liu X, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00508; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Piccini P, 2000, ANN NEUROL, V48, P689, DOI 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N; Piroth T, 2014, CELL TRANSPLANT, V23, P995, DOI 10.3727/096368913X666449; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Rath A, 2013, CELL TRANSPLANT, V22, P1281, DOI 10.3727/096368912X654984; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P509, DOI 10.1038/nrn.2017.91; Scheiner ZS, 2014, J BIOL CHEM, V289, P4571, DOI 10.1074/jbc.R113.509588	29	81	82	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2019	25	7					1045	1053		10.1038/s41591-019-0507-2	http://dx.doi.org/10.1038/s41591-019-0507-2			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IH3ZC	31263283	Green Submitted			2022-12-27	WOS:000474430400016
J	Luban, J				Luban, Jeremy			The hidden cost of genetic resistance to HIV-1	NATURE MEDICINE			English	Editorial Material							INDIVIDUALS		[Luban, Jeremy] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Luban, Jeremy] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luban, J (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.; Luban, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	jeremy.luban@umassmed.edu		Luban, Jeremy/0000-0001-5650-4054				Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Falcon A, 2015, J GEN VIROL, V96, P2074, DOI 10.1099/vir.0.000165; Gupta RK, 2019, NATURE, V568, P244, DOI 10.1038/s41586-019-1027-4; Hutter G, 2014, NEW ENGL J MED, V371, P2437, DOI 10.1056/NEJMc1412279; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Ryder SP, 2018, CRISPR J, V1, P355, DOI 10.1089/crispr.2018.29039.spr; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Verheyen J, 2019, CLIN INFECT DIS, V68, P684, DOI 10.1093/cid/ciy565; Wei XZ, 2019, NAT MED, V25, P909, DOI 10.1038/s41591-019-0459-6	12	4	4	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					878	879		10.1038/s41591-019-0481-8	http://dx.doi.org/10.1038/s41591-019-0481-8			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31160816				2022-12-27	WOS:000470844400014
J	Yachida, S; Mizutani, S; Shiroma, H; Shiba, S; Nakajima, T; Sakamoto, T; Watanabe, H; Masuda, K; Nishimoto, Y; Kubo, M; Hosoda, F; Rokutan, H; Matsumoto, M; Takamaru, H; Yamada, M; Matsuda, T; Iwasaki, M; Yamaji, T; Yachida, T; Soga, T; Kurokawa, K; Toyoda, A; Ogura, Y; Hayashi, T; Hatakeyama, M; Nakagama, H; Saito, Y; Fukuda, S; Shibata, T; Yamada, T				Yachida, Shinichi; Mizutani, Sayaka; Shiroma, Hirotsugu; Shiba, Satoshi; Nakajima, Takeshi; Sakamoto, Taku; Watanabe, Hikaru; Masuda, Keigo; Nishimoto, Yuichiro; Kubo, Masaru; Hosoda, Fumie; Rokutan, Hirofumi; Matsumoto, Minori; Takamaru, Hiroyuki; Yamada, Masayoshi; Matsuda, Takahisa; Iwasaki, Motoki; Yamaji, Taiki; Yachida, Tatsuo; Soga, Tomoyoshi; Kurokawa, Ken; Toyoda, Atsushi; Ogura, Yoshitoshi; Hayashi, Tetsuya; Hatakeyama, Masanori; Nakagama, Hitoshi; Saito, Yutaka; Fukuda, Shinji; Shibata, Tatsuhiro; Yamada, Takuji			Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer	NATURE MEDICINE			English	Article							FUSOBACTERIUM-NUCLEATUM; MOLECULAR-FEATURES; CATABOLIC PATHWAY; FERMENTATION; METABOLITES; BACTERIA; ACIDS; 16S	In most cases of sporadic colorectal cancers, tumorigenesis is a multistep process, involving genomic alterations in parallel with morphologic changes. In addition, accumulating evidence suggests that the human gut microbiome is linked to the development of colorectal cancer. Here we performed fecal metagenomic and metabolomic studies on samples from a large cohort of 616 participants who underwent colonoscopy to assess taxonomic and functional characteristics of gut microbiota and metabolites. Microbiome and metabolome shifts were apparent in cases of multiple polypoid adenomas and intramucosal carcinomas, in addition to more advanced lesions. We found two distinct patterns of microbiome elevations. First, the relative abundance of Fusobacterium nucleatum spp. was significantly (P < 0.005) elevated continuously from intramucosal carcinoma to more advanced stages. Second, Atopobium parvulum and Actinomyces odontolyticus, which co-occurred in intramucosal carcinomas, were significantly (P < 0.005) increased only in multiple polypoid adenomas and/or intramucosal carcinomas. Metabolome analyses showed that branched-chain amino acids and phenylalanine were significantly (P < 0.005) increased in intramucosal carcinomas and bile acids, including deoxycholate, were significantly (P < 0.005) elevated in multiple polypoid adenomas and/or intramucosal carcinomas. We identified metagenomic and metabolomic markers to discriminate cases of intramucosal carcinoma from the healthy controls. Our large-cohort multi-omics data indicate that shifts in the microbiome and metabolome occur from the very early stages of the development of colorectal cancer, which is of possible etiological and diagnostic importance.	[Yachida, Shinichi; Toyoda, Atsushi] Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan; [Yachida, Shinichi; Shiba, Satoshi; Hosoda, Fumie; Rokutan, Hirofumi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan; [Mizutani, Sayaka; Shiroma, Hirotsugu; Watanabe, Hikaru; Masuda, Keigo; Nishimoto, Yuichiro; Kubo, Masaru; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan; [Nakajima, Takeshi; Sakamoto, Taku; Matsumoto, Minori; Takamaru, Hiroyuki; Yamada, Masayoshi; Matsuda, Takahisa; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Iwasaki, Motoki; Yamaji, Taiki] Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Tokyo, Japan; [Yachida, Tatsuo] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Takamatsu, Kagawa, Japan; [Soga, Tomoyoshi; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Kurokawa, Ken] Natl Inst Genet, Genome Evolut Lab, Shizuoka, Japan; [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Shizuoka, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka, Fukuoka, Japan; [Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Tokyo, Japan; [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Ebina, Kanagawa, Japan; [Fukuda, Shinji] Univ Tsukuba, Med Res Ctr, Ibaraki, Japan; [Fukuda, Shinji; Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan	Osaka University; National Cancer Center - Japan; Tokyo Institute of Technology; National Cancer Center - Japan; National Cancer Center - Japan; Kagawa University; Keio University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyushu University; University of Tokyo; National Cancer Center - Japan; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tokyo	Yachida, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan.; Yachida, S (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan.; Yamada, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.	syachida@cgi.med; takuji@bio.titech.ac.jp	shiba, satoshi/AAL-4953-2021; Shibata, Tatsuhiro/AAO-1278-2021; Shibata, Tatsuhiro/ABA-8234-2020; Shiba, Satoshi/AAJ-2157-2021; Hayashi, Tetsuya/ABA-1074-2020; NAKAJIMA, Takeshi/HCH-0703-2022	Shiba, Satoshi/0000-0001-5159-5719; Fukuda, Shinji/0000-0001-5161-9880; Yachida, Shinichi/0000-0001-5507-4566; NAKAJIMA, TAKESHI/0000-0002-6825-3165; Yamada, Masayoshi/0000-0003-3979-5560; Yuichiro, Nishimoto/0000-0002-4522-8717	National Cancer Center Research and Development Fund [25-A-4, 28-A-4, 29-A-6]; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) [JP18ek0109187, JP18jk0210009]; AMED-CREST [JP18gm0710003]; JST (Japan Science and Technology Agency)-PRESTO [JPMJPR1537, JPMJPR1507]; JSPS (Japan Society for the Promotion of Science) KAKENHI [16H04901, 17H05654, 18H04805, 16J10135, 142558, 221S0002]; Joint Research Project of the Institute of Medical Science, the University of Tokyo [2017-2107]; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University; Takeda Science Foundation; Suzuken Memorial Foundation [H25-2-11]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED-CREST; JST (Japan Science and Technology Agency)-PRESTO; JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Joint Research Project of the Institute of Medical Science, the University of Tokyo; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation	We thank all patients and their families who participated in this study, S. Goto for technical advice and A. Kaya, C. Shima, K. Igarashi, R. Usui, K. Murakami, I. Take, M. Sezawa, M. Iwahara, M. Komori, Z. Nakagawa, Y. Ohara and K. Kamezaki for expert technical assistance. Computations were partially performed on the NIG supercomputer at the ROIS National Institute of Genetics. This work was supported by grants from the National Cancer Center Research and Development Fund (25-A-4 and 28-A-4 to S.Y., S.F and T. Yamada and 29-A-6 to T. Yamada and T. Shibata); Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (AMED) (JP18ek0109187 to S.Y., S.M., Y.S., S.F. and T. Yamada; JP18jk0210009 to S.Y. and T. Shibata); AMED-CREST (JP18gm0710003 to S.Y. and T. Soga.); JST (Japan Science and Technology Agency)-PRESTO (JPMJPR1537 to S.F. and JPMJPR1507 to T. Yamada); JSPS (Japan Society for the Promotion of Science) KAKENHI (16H04901, 17H05654 and 18H04805 to S.F.; 16J10135, 142558 and 221S0002 to T. Yamada); Joint Research Project of the Institute of Medical Science, the University of Tokyo (2017-2107 to S.Y. and T. Shibata); Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University (to S.Y.); the Takeda Science Foundation (to S.Y.) and Suzuken Memorial Foundation (H25-2-11 to S.Y.).	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashktorab H, 2017, GASTROENTEROLOGY, V153, P910, DOI 10.1053/j.gastro.2017.08.018; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Emiola A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07240-8; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Ito M, 2015, INT J CANCER, V137, P1258, DOI 10.1002/ijc.29488; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398; Kononen E, 2015, CLIN MICROBIOL REV, V28, P419, DOI 10.1128/CMR.00100-14; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17851-8; Loubinoux J, 2002, ORAL MICROBIOL IMMUN, V17, P321, DOI 10.1034/j.1399-302X.2002.170510.x; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101; Mishima E, 2017, KIDNEY INT, V92, P634, DOI 10.1016/j.kint.2017.02.011; Mori H, 2018, DIGEST ENDOSC, V30, P25, DOI 10.1111/den.13042; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Nishimoto Y, 2016, GUT, V65, P1574, DOI 10.1136/gutjnl-2016-311937; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; SUZUKI K, 1986, J NATL CANCER I, V76, P1129; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Bui TPN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10062; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001; Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800; ZARLING EJ, 1987, J LAB CLIN MED, V109, P566; Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645	60	381	402	41	312	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2019	25	6					968	+		10.1038/s41591-019-0458-7	http://dx.doi.org/10.1038/s41591-019-0458-7			27	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	IC3FK	31171880	Green Published			2022-12-27	WOS:000470844400029
J	Logtenberg, MEW; Jansen, JHM; Raaben, M; Toebes, M; Franke, K; Brandsma, AM; Matlung, HL; Fauster, A; Gomez-Eerland, R; Bakker, NAM; van der Schot, S; Marijt, KA; Verdoes, M; Haanen, JBAG; van den Berg, JH; Neefjes, J; van den Berg, TK; Brummelkamp, TR; Leusen, JHW; Scheeren, FA; Schumacher, TN				Logtenberg, Meike E. W.; Jansen, J. H. Marco; Raaben, Matthijs; Toebes, Mireille; Franke, Katka; Brandsma, Arianne M.; Matlung, Hanke L.; Fauster, Astrid; Gomez-Eerland, Raquel; Bakker, Noor A. M.; van der Schot, Simone; Marijt, Koen A.; Verdoes, Martijn; Haanen, John B. A. G.; van den Berg, Joost H.; Neefjes, Jacques; van den Berg, Timo K.; Brummelkamp, Thijn R.; Leusen, Jeanette H. W.; Scheeren, Ferenc A.; Schumacher, Ton N.			Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRP alpha axis and a target for cancer immunotherapy	NATURE MEDICINE			English	Article							SIGNAL-REGULATORY PROTEIN; AMYLOID BETA-PEPTIDES; CD47 BLOCKADE; ANTIBODIES; CELLS; IDENTIFICATION; PHAGOCYTOSIS; INHIBITION; RITUXIMAB	Cancer cells can evade immune surveillance through the expression of inhibitory ligands that bind their cognate receptors on immune effector cells. Expression of programmed death ligand 1 in tumor microenvironments is a major immune checkpoint for tumor-specific T cell responses as it binds to programmed cell death protein-1 on activated and dysfunctional T cells(1). The activity of myeloid cells such as macrophages and neutrophils is likewise regulated by a balance between stimulatory and inhibitory signals. In particular, cell surface expression of the CD47 protein creates a 'don't eat me' signal on tumor cells by binding to SIRP alpha expressed on myeloid cells(2-5). Using a haploid genetic screen, we here identify glutaminyl-peptide cyclotransferase-like protein (QPCTL) as a major component of the CD47-SIRP alpha checkpoint. Biochemical analysis demonstrates that QPCTL is critical for pyroglutamate formation on CD47 at the SIRP alpha binding site shortly after biosynthesis. Genetic and pharmacological interference with QPCTL activity enhances antibody-dependent cellular phagocytosis and cellular cytotoxicity of tumor cells. Furthermore, interference with QPCTL expression leads to a major increase in neutrophil-mediated killing of tumor cells in vivo. These data identify QPCTL as a novel target to interfere with the CD47 pathway and thereby augment antibody therapy of cancer.	[Logtenberg, Meike E. W.; Toebes, Mireille; van der Schot, Simone; Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Jansen, J. H. Marco; Brandsma, Arianne M.; Leusen, Jeanette H. W.] UMC Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Raaben, Matthijs; Fauster, Astrid; Brummelkamp, Thijn R.] Netherlands Canc Inst, Oncode Inst, Div Biochem, Amsterdam, Netherlands; [Franke, Katka; Matlung, Hanke L.; van den Berg, Timo K.] Sanquin Res, Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Franke, Katka; Matlung, Hanke L.; van den Berg, Timo K.] Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Gomez-Eerland, Raquel; Bakker, Noor A. M.; Haanen, John B. A. G.; van den Berg, Joost H.] Netherlands Canc Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands; [Marijt, Koen A.; Scheeren, Ferenc A.] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands; [Verdoes, Martijn] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Verdoes, Martijn; Neefjes, Jacques; Schumacher, Ton N.] Inst Chem Immunol, Amsterdam, Netherlands; [Neefjes, Jacques] Leiden Univ, Med Ctr, Oncode Inst, Dept Cell & Chem Biol, Leiden, Netherlands	Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; University of Amsterdam; University of Amsterdam; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schumacher, TN (corresponding author), Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands.; Schumacher, TN (corresponding author), Inst Chem Immunol, Amsterdam, Netherlands.	t.schumacher@nki.nl	Verdoes, Martijn/AAD-5239-2022; , Jeanette/AAG-3736-2019; Schumacher, Ton/Y-2432-2019; Matlung, Hanke/ABH-5649-2020; Haanen, John/AAD-8534-2022; van den Berg, Timo K/AAC-2479-2022; Neefjes, Jacques J.C./H-8780-2017; Haanen, John/AAD-8578-2022; Verdoes, Martijn/A-4911-2015	Verdoes, Martijn/0000-0001-8753-3528; Schumacher, Ton/0000-0003-0517-8804; Haanen, John/0000-0001-5884-7704; Neefjes, Jacques J.C./0000-0001-6763-2211; Verdoes, Martijn/0000-0001-8753-3528; Leusen, Jeanette/0000-0003-4982-6914; Scheeren, Ferenc/0000-0002-8304-9023; Brandsma, Arianne/0000-0002-7969-4046; Logtenberg, Meike/0000-0002-8981-1189	European Research Council (ERC) advanced grant SENSIT; Institute for Chemical Immunology; ERC; Dutch Cancer Society/Koningin Wilhelmina Fonds kankerbestrijding (KWF) [10300]; KWF [NKI 2015-7609, 11537, UU 2015-7650]; Leiden University Medical Center fellowship; Errol McDowell Cancer Foundation; Netherlands Organization for Scientific Research (NWO) Vici Grant [016.Vici.170.033]; Cancer Genomics Center (CGC.nl); Ammodo KNAW Award 2015 for Biomedical Sciences	European Research Council (ERC) advanced grant SENSIT(European Research Council (ERC)); Institute for Chemical Immunology; ERC(European Research Council (ERC)European Commission); Dutch Cancer Society/Koningin Wilhelmina Fonds kankerbestrijding (KWF); KWF; Leiden University Medical Center fellowship; Errol McDowell Cancer Foundation; Netherlands Organization for Scientific Research (NWO) Vici Grant(Netherlands Organization for Scientific Research (NWO)); Cancer Genomics Center (CGC.nl); Ammodo KNAW Award 2015 for Biomedical Sciences	We thank R. Mezzadra, M. Wellenstein, C. Sun and members of the Schumacher, Brummelkamp, Scheeren, Leusen, van den Berg and Haanen laboratories for discussions, and O. van Tellingen, the Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL) Preclinical Intervention Unit and the NKI-AVL flow facility for technical support and input. This work was supported by European Research Council (ERC) advanced grant SENSIT (to T.N.S.), the Institute for Chemical Immunology (to T.N.S., J.N. and M.V.), ERC starting grant CHEMCHECK (to M.V.), Dutch Cancer Society/Koningin Wilhelmina Fonds kankerbestrijding (KWF) grant 10300 (to T.K.v.d.B.), KWF grant 11537 (to H.L.M.), a Leiden University Medical Center fellowship and the Errol McDowell Cancer Foundation (to F.A.S.), Netherlands Organization for Scientific Research (NWO) Vici Grant 016.Vici.170.033, KWF grant NKI 2015-7609, the Cancer Genomics Center (CGC.nl) and the Ammodo KNAW Award 2015 for Biomedical Sciences (to T.R.B.), and KWF grant UU 2015-7650 (to J.H.W.L.).	Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Ansell S, 2016, BLOOD, V128; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Boross P, 2013, EMBO MOL MED, V5, P1213, DOI 10.1002/emmm.201201929; Bracke M, 2001, BLOOD, V97, P3478, DOI 10.1182/blood.V97.11.3478; Brandsma AM, 2015, CANCER IMMUNOL RES, V3, P1316, DOI 10.1158/2326-6066.CIR-15-0099-T; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen J, 2017, NATURE, V544, P493, DOI 10.1038/nature22076; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Gong QY, 2018, ADV SCI, V5, DOI 10.1002/advs.201700664; Grizenkova J, 2012, P NATL ACAD SCI USA, V109, P13722, DOI 10.1073/pnas.1208917109; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Ho CCM, 2015, J BIOL CHEM, V290, P12650, DOI 10.1074/jbc.M115.648220; Hoffmann T, 2017, J PHARMACOL EXP THER, V362, P119, DOI 10.1124/jpet.117.240614; Huang KF, 2008, BIOCHEM J, V411, P181, DOI 10.1042/BJ20071073; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Ingram JR, 2017, P NATL ACAD SCI USA, V114, P10184, DOI 10.1073/pnas.1710776114; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jimenez-Sanchez M, 2015, NAT CHEM BIOL, V11, P347, DOI [10.1038/nchembio.1790, 10.1038/NCHEMBIO.1790]; KUIJPERS TW, 1991, BLOOD, V78, P1105; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu XJ, 2015, NAT MED, V21, P1209, DOI 10.1038/nm.3931; Lues Inge, 2015, Alzheimers Dement (N Y), V1, P182, DOI 10.1016/j.trci.2015.08.002; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Matlung HL, 2017, IMMUNOL REV, V276, P145, DOI 10.1111/imr.12527; Meyer S, 2016, MABS-AUSTIN, V8, P87, DOI 10.1080/19420862.2015.1106658; Morty RE, 2006, BIOCHEM J, V394, P635, DOI 10.1042/BJ20051593; NEEFJES JJ, 1986, HUM IMMUNOL, V16, P169, DOI 10.1016/0198-8859(86)90046-7; Ring NG, 2017, P NATL ACAD SCI USA, V114, pE10578, DOI 10.1073/pnas.1710877114; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Scheltens P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0431-6; Schilling S, 2003, J BIOL CHEM, V278, P49773, DOI 10.1074/jbc.M309077200; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Sockolosky JT, 2016, P NATL ACAD SCI USA, V113, pE2646, DOI 10.1073/pnas.1604268113; Stephan A, 2009, FEBS J, V276, P6522, DOI 10.1111/j.1742-4658.2009.07337.x; Tekirian TL, 1999, J NEUROCHEM, V73, P1584, DOI 10.1046/j.1471-4159.1999.0731584.x; Weiskopf K, 2017, EUR J CANCER, V76, P100, DOI 10.1016/j.ejca.2017.02.013; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	54	90	93	6	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					612	+		10.1038/s41591-019-0356-z	http://dx.doi.org/10.1038/s41591-019-0356-z			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30833751	Green Accepted			2022-12-27	WOS:000463342800023
J	Stower, H				Stower, Hannah			The breast milk microbiome	NATURE MEDICINE			English	Editorial Material																			0	2	2	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2019	25	4					541	541		10.1038/s41591-019-0427-1	http://dx.doi.org/10.1038/s41591-019-0427-1			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HR7OA	30948849	Bronze			2022-12-27	WOS:000463342800006
J	Wagner, DL; Amini, L; Wendering, DJ; Burkhardt, LM; Akyuz, L; Reinke, P; Volk, HD; Schmueck-Henneresse, M				Wagner, Dimitrios L.; Amini, Leila; Wendering, Desiree J.; Burkhardt, Lisa-Marie; Akyuez, Levent; Reinke, Petra; Volk, Hans-Dieter; Schmueck-Henneresse, Michael			High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population	NATURE MEDICINE			English	Article							IMMUNE-RESPONSES; TOLERANCE; ANTIGEN; DNA; EXPRESSION; MECHANISM; EXPANSION; PROSPECTS; THERAPY; 4-1BB	The discovery of the highly efficient site-specific nuclease system CRISPR-Cas9 from Streptococcus pyogenes has galvanized the field of gene therapy(1,2). The immunogenicity of Cas9 nuclease has been demonstrated in mice(3,4). Preexisting immunity against therapeutic gene vectors or their cargo can decrease the efficacy of a potentially curative treatment and may pose significant safety issues(3-6). S. pyogenes is a common cause for infectious diseases in humans, but it remains unclear whether it induces a T cell memory against the Cas9 nuclease(7,8). Here, we show the presence of a preexisting ubiquitous effector T cell response directed toward the most widely used Cas9 homolog from S. pyogenes (SpCas9) within healthy humans. We characterize SpCas9-reactive T cells within the CD4/CD8 compartments for multi-effector potency, cytotoxicity, and lineage determination. In-depth analysis of SpCas9-reactive T cells reveals a high frequency of SpCas9-reactive regulatory T cells that can mitigate SpCas9-reactive effector T cell proliferation and function in vitro. Our results shed light on T cell-mediated immunity toward CRISPR-associated nucleases and offer a possible solution to overcome the problem of preexisting immunity.	[Wagner, Dimitrios L.; Amini, Leila; Wendering, Desiree J.; Burkhardt, Lisa-Marie; Akyuez, Levent; Volk, Hans-Dieter; Schmueck-Henneresse, Michael] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Wagner, Dimitrios L.; Amini, Leila; Wendering, Desiree J.; Reinke, Petra; Volk, Hans-Dieter; Schmueck-Henneresse, Michael] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Wagner, Dimitrios L.] BIH, Berlin, Germany; [Reinke, Petra; Volk, Hans-Dieter; Schmueck-Henneresse, Michael] Charite Univ Med Berlin, Berlin Ctr Adv Therapies BeCAT, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmueck-Henneresse, M (corresponding author), Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany.; Schmueck-Henneresse, M (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.; Schmueck-Henneresse, M (corresponding author), Charite Univ Med Berlin, Berlin Ctr Adv Therapies BeCAT, Berlin, Germany.	michael.schmueck-henneresse@charite.de	volk, hans-dieter/AAV-8053-2021; Amini, Leila/AAV-8042-2021; WAGNER, DIMITRIOS L/O-8290-2019	volk, hans-dieter/0000-0002-7743-6668; Amini, Leila/0000-0003-4855-5905; WAGNER, DIMITRIOS L/0000-0002-2189-3579; Reinke, Petra/0000-0003-0771-4375; Wendering, Desiree Jacqueline/0000-0002-1399-787X; Schmueck-Henneresse, Michael/0000-0001-5964-9179	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB-TR36]; German Federal Ministry of Education and Research (BCRT grant); kick-box grant for young scientists by the Einstein Center for Regenerative Therapies; Berlin Institute of Health	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BCRT grant); kick-box grant for young scientists by the Einstein Center for Regenerative Therapies; Berlin Institute of Health	The study was generously supported in parts by the Deutsche Forschungsgemeinschaft (German Research Foundation, SFB-TR36-project A3 grant to H.-D.V., P.R., M.S.H.), the German Federal Ministry of Education and Research (BCRT grant, all authors), a kick-box grant for young scientists by the Einstein Center for Regenerative Therapies (D.L.W.), and the Berlin Institute of Health medical doctoral research stipend (D.L.W.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to acknowledge the assistance of the BCRT Flow & Mass Cytometry Lab, D. Kunkel and J. Hartwig; G. Grutz and the team of the Core Unit Biomarker-Immunological Study Lab, BCRT, Charite-Universitatsmedizin Berlin; M. Streitz for flow cytometry assistance and CMV lysates; K. Vogt for technical assistance with the TSDR analyses; A. Jurisch, K. Grzeschik, and R. Noster for technical assistance; and A. Floriane Hennig and U. Kornak (Institute for Medical Genetics and Human Genetics, Charite - Universitatsmedizin Berlin) for the PX458_T2mali DNA plasmid. We thank the groups of M. Seifert and A. Thiel (both BCRT, Charite-Universitatsmedizin Berlin) for supplying the reagents, and T. Roch and M. Frentsch for critical discussions.	Arruda VR, 2009, MOL THER, V17, P1492, DOI 10.1038/mt.2009.150; Bacher P, 2014, MUCOSAL IMMUNOL, V7, P916, DOI 10.1038/mi.2013.107; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chandran S, 2017, AM J TRANSPLANT, V17, P2945, DOI 10.1111/ajt.14415; Charlesworth C. T., 2018, IDENTIFICATION PREEX; Chew WL, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1408; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Guilherme L, 2006, AUTOIMMUNITY, V39, P31, DOI 10.1080/08916930500484674; Hamano R, 2011, EUR J IMMUNOL, V41, P2010, DOI 10.1002/eji.201041205; Hammoud B, 2013, J IMMUNOTHER, V36, P93, DOI 10.1097/CJI.0b013e31827b87cc; Harrison OJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a018341; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johnson DR, 2010, CLIN INFECT DIS, V50, P481, DOI 10.1086/650167; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977; Lei H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00184; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Moosmann A, 2002, BLOOD, V100, P1755, DOI 10.1182/blood.V100.5.1755.h81702001755_1755_1764; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schmueck-Henneresse M, 2015, J IMMUNOL, V194, P5559, DOI 10.4049/jimmunol.1402090; Schoenbrunn A, 2012, J IMMUNOL, V189, P5985, DOI 10.4049/jimmunol.1201090; Sen ES, 2014, ARCH DIS CHILDHOOD-E, V99, P231, DOI 10.1136/archdischild-2013-304884; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Simhadri VL, 2018, MOL THER-METH CLIN D, V10, P105, DOI 10.1016/j.omtm.2018.06.006; Vakulskas CA, 2018, NAT MED, V24, P1216, DOI 10.1038/s41591-018-0137-0; Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168	44	190	192	5	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2019	25	2					242	+		10.1038/s41591-018-0204-6	http://dx.doi.org/10.1038/s41591-018-0204-6			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HK3TW	30374197	Green Submitted			2022-12-27	WOS:000457842100020
J	Esteva, A; Robicquet, A; Ramsundar, B; Kuleshov, V; DePristo, M; Chou, K; Cui, C; Corrado, G; Thrun, S; Dean, J				Esteva, Andre; Robicquet, Alexandre; Ramsundar, Bharath; Kuleshov, Volodymyr; DePristo, Mark; Chou, Katherine; Cui, Claire; Corrado, Greg; Thrun, Sebastian; Dean, Jeff			A guide to deep learning in healthcare	NATURE MEDICINE			English	Article							COMPUTER-AIDED DETECTION; NEURAL-NETWORKS; CLASSIFICATION; PATHOGENICITY; PREDICTION; CANCER; DNA	Here we present deep-learning techniques for healthcare, centering our discussion on deep learning in computer vision, natural language processing, reinforcement learning, and generalized methods. We describe how these computational techniques can impact a few key areas of medicine and explore how to build end-to-end systems. Our discussion of computer vision focuses largely on medical imaging, and we describe the application of natural language processing to domains such as electronic health record data. Similarly, reinforcement learning is discussed in the context of robotic-assisted surgery, and generalized deep-learning methods for genomics are reviewed.	[Esteva, Andre; Robicquet, Alexandre; Ramsundar, Bharath; Kuleshov, Volodymyr; Thrun, Sebastian] Stanford Univ, Stanford, CA 94305 USA; [DePristo, Mark; Chou, Katherine; Cui, Claire; Corrado, Greg; Dean, Jeff] Google Res, San Jose, CA USA	Stanford University; Google Incorporated	Esteva, A (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	andre.esteva@gmail.com						Abadi M., 2016, TENSORFLOW LARGE SCA; Abbeel P., 2004, ICML, V1; Abril MK, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw144; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Angermueller C, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1189-z; Barreira CM, 2018, INT STROK C 2018, V49, P2021, DOI DOI 10.1161/STR.49.SUPPL_1.WP61; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Che ZP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24271-9; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Cheng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21808; Choi Edward, 2016, JMLR Workshop Conf Proc, V56, P301; Cicero M, 2017, INVEST RADIOL, V52, P281, DOI 10.1097/RLI.0000000000000341; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Dudley J. T, 2014, PACIFIC S BIOCOMPUTI, P342; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haenssle H A, 2019, Ann Oncol, V30, p130e, DOI 10.1093/annonc/mdy520; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hirschberg J, 2015, SCIENCE, V349, P261, DOI 10.1126/science.aaa8685; Jamaludin Amir, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P166, DOI 10.1007/978-3-319-46723-8_20; Jin A, 2018, TOOL DETECTION OPERA; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kannan A, 2016, P 22 ACM SIGKDD INT; Kassahun Y, 2016, INT J COMPUT ASS RAD, V11, P553, DOI 10.1007/s11548-015-1305-z; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koh PW, 2017, BIOINFORMATICS, V33, pI225, DOI 10.1093/bioinformatics/btx243; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu V, 2010, MED CARE, V48, P739, DOI 10.1097/MLR.0b013e3181e359f3; Liu Y, 2017, COMMUN MATH BIOL NEU, DOI 10.1080/10408398.2017.1329704; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Mao QQ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017833; Mayer H, 2008, ADV ROBOTICS, V22, P1521, DOI 10.1163/156855308X360604; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Ratliff ND, 2009, AUTON ROBOT, V27, P25, DOI 10.1007/s10514-009-9121-3; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schulman J, 2013, IEEE INT C INT ROBOT, P4111, DOI 10.1109/IROS.2013.6696945; Shickel B, 2018, IEEE J BIOMED HEALTH, V22, P1589, DOI 10.1109/JBHI.2017.2767063; Shvets AA, 2018, 2018 17TH IEEE INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P624, DOI 10.1109/ICMLA.2018.00100; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Stanford Health, 2017, STANF MED 2017 HLTH; Suresh H., 2017, CLIN INTERVENTION PR, P322; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; The Office of the National Coordinator for Health Information Technology, 2017, QUICK STATS HLTH IT; Tran D., 2018, INT C LEARN REPR; Travers C., 2017, BIORXIV, DOI [10.1101/142760, DOI 10.1101/142760]; Vinyals O, 2015, PROC CVPR IEEE, P3156, DOI 10.1109/CVPR.2015.7298935; Wu Yonghui, 2016, ABS160908144 CORR; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519	64	911	948	70	535	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2019	25	1					24	29		10.1038/s41591-018-0316-z	http://dx.doi.org/10.1038/s41591-018-0316-z			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	HG5OR	30617335				2022-12-27	WOS:000455027700016
J	Ortiz, AM; Flynn, JK; DiNapoli, SR; Vujkovic-Cvijin, I; Starke, CE; Lai, SH; Long, ME; Sortino, O; Vinton, CL; Mudd, JC; Johnston, L; Busman-Sahay, K; Belkaid, Y; Estes, JD; Brenchley, JM				Ortiz, Alexandra M.; Flynn, Jacob K.; DiNapoli, Sarah R.; Vujkovic-Cvijin, Ivan; Starke, Carly E.; Lai, Stephen H.; Long, MacKenzie E.; Sortino, Ornella; Vinton, Carol L.; Mudd, Joseph C.; Johnston, Leslie; Busman-Sahay, Kathleen; Belkaid, Yasmine; Estes, Jacob D.; Brenchley, Jason M.			Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques	NATURE MEDICINE			English	Article							T-CELLS; HIV; COMMUNITIES	Intestinal microbial dysbiosis has been described in individuals with an HIV-1 infection and may underlie persistent inflammation in chronic infection, thereby contributing to disease progression. Herein, we induced an HIV-1-like intestinal dysbiosis in rhesus macaques (Macaca mulatta) with vancomycin treatment and assessed the contribution of dysbiosis to SIV disease progression. Dysbiotic and control animals had similar disease progression, indicating that intestinal microbial dysbiosis similar to that observed in individuals with HIV is not sufficient to accelerate untreated lentiviral disease progression.	[Ortiz, Alexandra M.; Flynn, Jacob K.; DiNapoli, Sarah R.; Starke, Carly E.; Lai, Stephen H.; Long, MacKenzie E.; Sortino, Ornella; Vinton, Carol L.; Mudd, Joseph C.; Brenchley, Jason M.] NIAID, Barrier Immun Sect, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Vujkovic-Cvijin, Ivan; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA; [Johnston, Leslie; Busman-Sahay, Kathleen; Estes, Jacob D.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Busman-Sahay, Kathleen; Estes, Jacob D.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Belkaid, Yasmine] NIAID, Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Estes, Jacob D.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Oregon Health & Science University; Oregon National Primate Research Center	Brenchley, JM (corresponding author), NIAID, Barrier Immun Sect, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jbrenchl@niaid.nih.gov	Starke, Carly/AAG-3485-2019; Vujkovic-Cvijin, Ivan/AAT-6248-2020; Brenchley, Jason/AAC-5085-2019	Starke, Carly/0000-0002-9548-9368; Vujkovic-Cvijin, Ivan/0000-0002-8611-4900; DiNapoli, Sarah/0000-0002-3675-9030; Brenchley, Jason/0000-0001-8357-2984	Division of Intramural Research/NIAID/NIH; Oregon National Primate Research Center NIH [P51OD011092]; federal funds from the National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001029, ZICAI001233, ZIAAI001115] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Division of Intramural Research/NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oregon National Primate Research Center NIH; federal funds from the National Cancer Institute, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to acknowledge H. Kendall, J. Swerczek, R. Herbert, and all the veterinary staff at the NIH animal center. We would like to thank M. Quinones, J. Davis, S. Sen and G. Trinchieri, and the NIAID Microbiome Program for technical and analytical assistance. Funding for this study was provided in part by the Division of Intramural Research/NIAID/NIH, by the Oregon National Primate Research Center NIH grant award P51OD011092, and with federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services (DHHS), nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; d'Ettorre G, 2017, IMMUN INFLAMM DIS, V5, P244, DOI 10.1002/iid3.160; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Hager CL, 2018, CURR OPIN HIV AIDS, V13, P69, DOI 10.1097/COH.0000000000000432; Hao XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9020; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mudd JC, 2016, J INFECT DIS, V214, pS58, DOI 10.1093/infdis/jiw258; Noguera-Julian M, 2016, EBIOMEDICINE, V5, P135, DOI 10.1016/j.ebiom.2016.01.032; Ortiz AM, 2016, MUCOSAL IMMUNOL, V9, P458, DOI 10.1038/mi.2015.75; Ortiz AM, 2018, CURR OPIN HIV AIDS, V13, P15, DOI [10.1097/COH.0000000000000424, 10.1097/coh.0000000000000424]; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Vujkovic-Cvijin I, 2017, GUT MICROBES, V8, P440, DOI 10.1080/19490976.2017.1334034	22	24	24	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1313	+		10.1038/s41591-018-0132-5	http://dx.doi.org/10.1038/s41591-018-0132-5			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30061696	Green Accepted			2022-12-27	WOS:000444174100010
J	Vinel, C; Lukjanenko, L; Batut, A; Deleruyelle, S; Pradere, JP; Le Gonidec, S; Dortignac, A; Geoffre, N; Pereira, O; Karaz, S; Lee, U; Camus, M; Chaoui, K; Mouisel, E; Bigot, A; Mouly, V; Vigneau, M; Pagano, AF; Chopard, A; Pillard, F; Guyonnet, S; Cesari, M; Burlet-Schiltz, O; Pahor, M; Feige, JN; Vellas, B; Valet, P; Dray, C				Vinel, Claire; Lukjanenko, Laura; Batut, Aurelie; Deleruyelle, Simon; Pradere, Jean-Philippe; Le Gonidec, Sophie; Dortignac, Alizee; Geoffre, Nancy; Pereira, Ophelie; Karaz, Sonia; Lee, Umji; Camus, Mylene; Chaoui, Karima; Mouisel, Etienne; Bigot, Anne; Mouly, Vincent; Vigneau, Mathieu; Pagano, Allan F.; Chopard, Angele; Pillard, Fabien; Guyonnet, Sophie; Cesari, Matteo; Burlet-Schiltz, Odile; Pahor, Marco; Feige, Jerome N.; Vellas, Bruno; Valet, Philippe; Dray, Cedric			The exerkine apelin reverses age-associated sarcopenia	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; ADIPOSE-TISSUE; REGENERATIVE CAPACITY; PHYSICAL-ACTIVITY; SATELLITE CELLS; MICE; EXERCISE; MASS; RECEPTOR; FRAILTY	Sarcopenia, the degenerative loss of skeletal muscle mass, quality and strength, lacks early diagnostic tools and new therapeutic strategies to prevent the frailty-to-disability transition often responsible for the medical institutionalization of elderly individuals. Herein we report that production of the endogenous peptide apelin, induced by muscle contraction, is reduced in an age-dependent manner in humans and rodents and is positively associated with the beneficial effects of exercise in older persons. Mice deficient in either apelin or its receptor (APLNR) presented dramatic alterations in muscle function with increasing age. Various strategies that restored apelin signaling during aging further demonstrated that this peptide considerably enhanced muscle function by triggering mitochondriogenesis, autophagy and anti-inflammatory pathways in myofibers as well as enhancing the regenerative capacity by targeting muscle stem cells. Taken together, these findings revealed positive regulatory feedback between physical activity, apelin and muscle function and identified apelin both as a tool for diagnosis of early sarcopenia and as the target of an innovative pharmacological strategy to prevent age-associated muscle weakness and restore physical autonomy.	[Vinel, Claire; Batut, Aurelie; Deleruyelle, Simon; Pradere, Jean-Philippe; Le Gonidec, Sophie; Dortignac, Alizee; Geoffre, Nancy; Pereira, Ophelie; Mouisel, Etienne; Pillard, Fabien; Valet, Philippe; Dray, Cedric] Univ Paul Sabatier, Univ Toulouse, INSERM U1048, Inst Malad Metabol & Cardiovasc, Toulouse, France; [Lukjanenko, Laura; Karaz, Sonia; Lee, Umji; Feige, Jerome N.] Ecole Polytech Fed Lausanne, Aging Dept, Nestle Inst Hlth Sci SA, Innovat Pk, Lausanne, Switzerland; [Camus, Mylene; Chaoui, Karima; Burlet-Schiltz, Odile] Univ Paul Sabatier, Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, Toulouse, France; [Bigot, Anne; Mouly, Vincent] Univ Paris 06, Paris 6 UM76, Univ Paris 6,Inst Myol, UMR7215,CNRS,Pitie Salpetriere,INSERM,UMRS 974,U9, Paris, France; [Vigneau, Mathieu] Inst Technol Avancees Sci Vivant USR3505, Ctr Pierre Potier, Toulouse, France; [Pagano, Allan F.; Chopard, Angele] Univ Montpellier, INRA, Dynam Musculaire & Metab UMR866, Montpellier, France; [Guyonnet, Sophie; Cesari, Matteo; Vellas, Bruno] Gerontopole Toulouse Purpan UMR 1027, Toulouse, France; [Pahor, Marco] Univ Florida, Coll Med, Inst Aging, Gainesville, FL USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; INRAE; Universite de Montpellier; State University System of Florida; University of Florida	Dray, C (corresponding author), Univ Paul Sabatier, Univ Toulouse, INSERM U1048, Inst Malad Metabol & Cardiovasc, Toulouse, France.	cedric.dray@inserm.fr	Cesari, Matteo/A-4649-2008; dray, cedric/N-7440-2017; Valet, Philippe/N-7472-2017; F., Pagano Allan/AAQ-3930-2020	Cesari, Matteo/0000-0002-0348-3664; Valet, Philippe/0000-0001-6520-7393; Mouisel, Etienne/0000-0002-4676-5709; Schiltz, Odile/0000-0002-3606-2356; Le Gonidec, Sophie/0000-0002-8141-690X; PILLARD, Fabien/0000-0003-3381-9744; DRAY, Cedric/0000-0002-4712-791X; Pradere, Jean-Philippe/0000-0003-1734-1429; Bigot, anne/0000-0003-0337-5425; Pereira, Ophelie/0000-0002-5283-0845; Lee, Umji/0000-0003-0758-0979; PAGANO, Allan F./0000-0003-0717-2377; Vinel, Claire/0000-0003-3329-321X; Vigneau, Mathieu/0000-0002-7442-0249	INSEAM (Institut National de la Sante et de la Recherche Medicale); Region Occitanie; Fondation de la Recherche Medicale (FRM); European funds (Fonds Europeens de Developpement Regional, FEDER), Toulouse Metropole; French Ministry of Research through the Investissement d'Avenir Infrastructures Nationales en Biologie et Sante program (ProFI, Proteomics French Infrastructure project) [ANR-10-INBS-08]	INSEAM (Institut National de la Sante et de la Recherche Medicale); Region Occitanie(Region Occitanie); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European funds (Fonds Europeens de Developpement Regional, FEDER), Toulouse Metropole; French Ministry of Research through the Investissement d'Avenir Infrastructures Nationales en Biologie et Sante program (ProFI, Proteomics French Infrastructure project)	We thank V. Minville, I. Castan-Laurell, A. Yart, B. Masri, and L. Casteilla for their fruitful discussions. We also specially thank all of the personnel of the ANEXPLO animal facility (Toulouse, France) and transcriptomic GeTQ plateform (Toulouse, France); J. Rouquette, head of the ITAV Imaging Service (Centre Pierre Potier, Toulouse, France); S. and the NIHS flow cytometry facility (Lausanne, Switzerland). We thank J. Iacovani and J. Christensen for corrections to the article and M. Rossell for technical assistance. Mice deficient for AMPK activity (DN-AMPK) in skeletal muscles were kindly provided by the laboratory of M. J. Birnbaum (University of Pennsylvania Medical School, Philadelphia, USA). This work has been funded by INSEAM (Institut National de la Sante et de la Recherche Medicale), the Region Occitanie and the Fondation de la Recherche Medicale (FRM). This project was supported in part by European funds (Fonds Europeens de Developpement Regional, FEDER), Toulouse Metropole, and the French Ministry of Research through the Investissement d'Avenir Infrastructures Nationales en Biologie et Sante program (ProFI, Proteomics French Infrastructure project, ANR-10-INBS-08).	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Ambrose C, 2015, AGEING RES REV, V23, P139, DOI 10.1016/j.arr.2015.03.005; Anker SD, 2016, J CACHEXIA SARCOPENI, V7, P512, DOI 10.1002/jcsm.12147; Attane C, 2011, J MOL ENDOCRINOL, V46, P21, DOI 10.1677/JME-10-0105; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bertrand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078874; Besse-Patin A, 2014, INT J OBESITY, V38, P707, DOI 10.1038/ijo.2013.158; Cartee GD, 2016, CELL METAB, V23, P1034, DOI 10.1016/j.cmet.2016.05.007; Castan-Laurell I, 2008, EUR J ENDOCRINOL, V158, P905, DOI 10.1530/EJE-08-0039; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Chandrasekaran B, 2010, J CARD FAIL, V16, P556, DOI 10.1016/j.cardfail.2010.02.004; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Dray C, 2013, GASTROENTEROLOGY, V144, P771, DOI 10.1053/j.gastro.2013.01.004; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fujie S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093545; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Giannoulis MG, 2012, ENDOCR REV, V33, P314, DOI 10.1210/er.2012-1002; Han K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086902; Hauser MA, 2000, MOL THER, V2, P16, DOI 10.1006/mthe.2000.0089; Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211; Jacobs RA, 2013, J GERONTOL A-BIOL, V68, P1010, DOI 10.1093/gerona/gls335; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jia YX, 2006, REGUL PEPTIDES, V133, P147, DOI 10.1016/j.regpep.2005.09.033; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; Martinez BP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0570-x; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V285, pE82, DOI 10.1152/ajpendo.00275.2002; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; Newman AB, 2003, J AM GERIATR SOC, V51, P1602, DOI 10.1046/j.1532-5415.2003.51534.x; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Papachristou E, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0169-y; Pasco JA, 2015, CURR OSTEOPOROS REP, V13, P351, DOI 10.1007/s11914-015-0279-7; Paturi S, 2010, MECH AGEING DEV, V131, P202, DOI 10.1016/j.mad.2010.01.008; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pitkin SL, 2010, PHARMACOL REV, V62, P331, DOI 10.1124/pr.110.002949; Rai R, 2017, CELL REP, V21, P1471, DOI 10.1016/j.celrep.2017.10.057; Robertson DA, 2013, AGEING RES REV, V12, P840, DOI 10.1016/j.arr.2013.06.004; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Samper-Ternent R, 2008, J AM GERIATR SOC, V56, P1845, DOI 10.1111/j.1532-5415.2008.01947.x; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Snijders T, 2014, AGE, V36, DOI 10.1007/s11357-014-9699-z; Snijders T, 2012, EXP PHYSIOL, V97, P762, DOI 10.1113/expphysiol.2011.063313; Son JS, 2017, MUSCLE NERVE, V56, P1155, DOI 10.1002/mus.25596; Stewart VH, 2014, SCAND J MED SCI SPOR, V24, pe1, DOI 10.1111/sms.12123; Tai PWL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-25; Vellas B, 2014, J Prev Alzheimers Dis, V1, P13; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; Westerblad H, 2011, ANTIOXID REDOX SIGN, V15, P2487, DOI 10.1089/ars.2011.3909; Xie F, 2015, ACTA BIOCH BIOPH SIN, V47, P969, DOI 10.1093/abbs/gmv111; Yamamoto T, 2011, BBA-GEN SUBJECTS, V1810, P853, DOI 10.1016/j.bbagen.2011.05.004; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhang HY, 2014, J CELL MOL MED, V18, P542, DOI 10.1111/jcmm.12208	63	145	150	6	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2018	24	9					1360	+		10.1038/s41591-018-0131-6	http://dx.doi.org/10.1038/s41591-018-0131-6			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GT0XF	30061698				2022-12-27	WOS:000444174100017
J	Anathy, V; Lahue, KG; Chapman, DG; Chia, SB; Casey, DT; Aboushousha, R; van der Velden, JLJ; Elko, E; Hoffman, SM; McMillan, DH; Jones, JT; Nolin, JD; Abdalla, S; Schneider, R; Seward, DJ; Roberson, EC; Liptak, MD; Cousins, ME; Butnor, KJ; Taatjes, DJ; Budd, RC; Irvin, CG; Ho, YS; Hakem, R; Brown, KK; Matsui, R; Bachschmid, MM; Gomez, JL; Kaminski, N; van der Vliet, A; Janssen-Heininger, YMW				Anathy, Vikas; Lahue, Karolyn G.; Chapman, David G.; Chia, Shi B.; Casey, Dylan T.; Aboushousha, Reem; van der Velden, Jos L. J.; Elko, Evan; Hoffman, Sidra M.; McMillan, David H.; Jones, Jane T.; Nolin, James D.; Abdalla, Sarah; Schneider, Robert; Seward, David J.; Roberson, Elle C.; Liptak, Matthew D.; Cousins, Morgan E.; Butnor, Kelly J.; Taatjes, Douglas J.; Budd, Ralph C.; Irvin, Charles G.; Ho, Ye-Shih; Hakem, Razq; Brown, Kevin K.; Matsui, Reiko; Bachschmid, Markus M.; Gomez, Jose L.; Kaminski, Naftali; van der Vliet, Albert; Janssen-Heininger, Yvonne M. W.			Reducing protein oxidation reverses lung fibrosis	NATURE MEDICINE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ENDOPLASMIC-RETICULUM STRESS; LOWER RESPIRATORY-TRACT; ORAL N-ACETYLCYSTEINE; S-GLUTATHIONYLATION; EPITHELIAL-CELLS; FAS ANTIGEN; APOPTOSIS; MICE; MECHANISMS	Idiopathic pulmonary fibrosis is characterized by excessive deposition of collagen in the lung, leading to chronically impaired gas exchange and death(1-3). Oxidative stress is believed to be critical in this disease pathogenesis(4-6), although the exact mechanisms remain enigmatic. Protein S-glutathionylation (PSSG) is a post-translational modification of proteins that can be reversed by glutaredoxin-1 (GLRX)(7). It remains unknown whether GLRX and PSSG play a role in lung fibrosis. Here, we explored the impact of GLRX and PSSG status on the pathogenesis of pulmonary fibrosis, using lung tissues from subjects with idiopathic pulmonary fibrosis, transgenic mouse models and direct administration of recombinant Glrx to airways of mice with existing fibrosis. We demonstrate that GLRX enzymatic activity was strongly decreased in fibrotic lungs, in accordance with increases in PSSG. Mice lacking Glrx were far more susceptible to bleomycin- or adenovirus encoding active transforming growth factor beta-1 (AdTGFB1)-induced pulmonary fibrosis, whereas transgenic overexpression of Glrx in the lung epithelium attenuated fibrosis. We furthermore show that endogenous GLRX was inactivated through an oxidative mechanism and that direct administration of the Glrx protein into airways augmented Glrx activity and reversed increases in collagen in mice with TGFB1- or bleomycin-induced fibrosis, even when administered to fibrotic, aged animals. Collectively, these findings suggest the therapeutic potential of exogenous GLRX in treating lung fibrosis.	[Anathy, Vikas; Lahue, Karolyn G.; Chia, Shi B.; Casey, Dylan T.; Aboushousha, Reem; van der Velden, Jos L. J.; Elko, Evan; Hoffman, Sidra M.; McMillan, David H.; Jones, Jane T.; Nolin, James D.; Abdalla, Sarah; Schneider, Robert; Seward, David J.; Butnor, Kelly J.; Taatjes, Douglas J.; van der Vliet, Albert; Janssen-Heininger, Yvonne M. W.] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA; [Chapman, David G.; Budd, Ralph C.; Irvin, Charles G.] Univ Vermont, Dept Med, Burlington, VT USA; [Roberson, Elle C.] Univ Vermont, Honors Coll, Burlington, VT USA; [Liptak, Matthew D.; Cousins, Morgan E.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI USA; [Hakem, Razq] Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON, Canada; [Hakem, Razq] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Brown, Kevin K.] Natl Jewish Hlth, Pulm Crit Care & Sleep Sect, Dept Med, Denver, CO USA; [Brown, Kevin K.] Univ Colorado, Denver, CO 80202 USA; [Matsui, Reiko; Bachschmid, Markus M.] Boston Univ, Dept Med, Boston, MA 02215 USA; [Gomez, Jose L.; Kaminski, Naftali] Yale Sch Med, Dept Med, New Haven, CT USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont; Wayne State University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Jewish Health; University of Colorado System; University of Colorado Denver; Boston University; Yale University	Janssen-Heininger, YMW (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA.	yvonne.janssen@uvm.edu	Liptak, Matthew/AAJ-2533-2021; Brown, Kevin/ABF-2544-2020	Liptak, Matthew/0000-0002-4951-6636; Kaminski, Naftali/0000-0001-5917-4601; Chapman, David/0000-0002-8211-1817; Bachschmid, Markus Michael/0000-0002-0748-5528; Aboushousha, Reem/0000-0003-2284-2180; Gomez, Jose/0000-0002-6521-6318; Casey, Dylan/0000-0002-6634-0708; van der Velden, Jos/0000-0002-2451-3180; Nolin, James/0000-0002-6611-1550; Hakem, Razqallah/0000-0001-5948-7931; Roberson, Elle/0000-0001-7466-7447	NIH [R35HL135828, R01HL079331, R01HL060014, R03HL095404, R01HL122383, R01HL05646, T32HL076122, R01DK103750, 1UL1TR001430, R01HL133013, R03 AG051857, P30GM103532]; ATS; Parker B. Francis fellowships; NCRR [1S10RR019246]; American Heart Association [16GRNT27660006]; FAMRI Young Clinical Scientist Award [113393, 1K01HL125474-01, U01HL108642, RC2 HL101715]; NATIONAL CANCER INSTITUTE [R01CA219156] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019246] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122383, R01HL138708, R35HL135828, R01HL133013, R03HL095404, R01HL137268, K01HL125474, R01HL085464, U01HL108642, R01HL085646, R01HL060014, RC2HL101715, R01HL079331, T32HL076122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG051857] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ATS; Parker B. Francis fellowships; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); FAMRI Young Clinical Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by NIH R35HL135828, R01HL079331, R01HL060014 and R03HL095404 (Y.M.W.J.-H.), an ATS unrestricted grant and NIH R01HL122383 (V.A.), Parker B. Francis fellowships (V.A. and J.L.J.v.d.V.), NIH R01HL05646 (A.v.d.V.), T32HL076122 (D.H.M. and J.T.J.), NCRR 1S10RR019246 (D.J.T.), American Heart Association 16GRNT27660006, NIH R01DK103750 and 1UL1TR001430 (M.M.B.), NIH R01HL133013 and R03 AG051857 (R.M.), P30GM103532 (C.G.I.), FAMRI Young Clinical Scientist Award 113393 and 1K01HL125474-01 (J.L.G.) and U01HL108642 and RC2 HL101715 (N.K.). Analysis of biological specimens and data provided by the Lung Tissue Research Consortium (LTRC) was supported by R03HL095404 (Y.M.W.J.-H.). We would like to thank J. Whitsett (University of Cincinnati) for generously providing the CCSP-rtTA, TetOP-Cre mice, J. Gauldie for providing AdTGFB1, N. Bishop for help with imaging of GLRX and collagen, J. M. Siddesha for technical support and P. Vacek for statistical support.	Aesif SW, 2009, AM J PATHOL, V175, P36, DOI 10.2353/ajpath.2009.080736; Anathy V, 2014, AM J RESP CRIT CARE, V189, P463, DOI 10.1164/rccm.201310-1905OC; Anathy V, 2012, MOL CELL BIOL, V32, P3464, DOI 10.1128/MCB.00125-12; Anathy V, 2009, J CELL BIOL, V184, P241, DOI 10.1083/jcb.200807019; Barkauskas CE, 2014, AM J PHYSIOL-CELL PH, V306, pC987, DOI 10.1152/ajpcell.00321.2013; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Beeh KM, 2002, EUR RESPIR J, V19, P1119, DOI 10.1183/09031936.02.00262402; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370, DOI 10.1164/ajrccm/139.2.370; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Coppo L, 2016, ANAL BIOCHEM, V499, P24, DOI 10.1016/j.ab.2016.01.012; Degryse AL, 2011, AM J PHYSIOL-LUNG C, V300, pL887, DOI 10.1152/ajplung.00397.2010; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Fonseca C, 2012, HISTOCHEM CELL BIOL, V138, P435, DOI 10.1007/s00418-012-0966-8; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; Hagiwara S, 2000, AM J RESP CRIT CARE, V162, P225, DOI 10.1164/ajrccm.162.1.9903129; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Janssen-Heininger YMW, 2010, ANN NY ACAD SCI, V1203, P23, DOI 10.1111/j.1749-6632.2010.05553.x; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kinnula VL, 2008, ANTIOXID REDOX SIGN, V10, P727, DOI 10.1089/ars.2007.1942; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Kropski JA, 2018, J CLIN INVEST, V128, P64, DOI 10.1172/JCI93560; Kurundkar A, 2016, REDOX BIOL, V9, P67, DOI 10.1016/j.redox.2016.06.005; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Liang JR, 2016, NAT MED, V22, P1285, DOI 10.1038/nm.4192; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Martinez FJ, 2014, NEW ENGL J MED, V370, P2093, DOI 10.1056/NEJMoa1401739; MEYER A, 1994, EUR RESPIR J, V7, P431, DOI 10.1183/09031936.94.07030431; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mora AL, 2017, NAT REV DRUG DISCOV, V16, DOI [10.1038/nrd.2017.225, 10.1038/nrd.2017.170]; Mora AL, 2017, J CLIN INVEST, V127, P405, DOI 10.1172/JCI87440; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; R Core Team, 2011, R LANG ENV STAT COMP; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rahman I, 1999, FREE RADICAL BIO MED, V27, P60, DOI 10.1016/S0891-5849(99)00035-0; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; SHAHZEIDI S, 1991, EUR RESPIR J, V4, P845; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09	54	55	59	3	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1128	+		10.1038/s41591-018-0090-y	http://dx.doi.org/10.1038/s41591-018-0090-y			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29988126	Green Accepted			2022-12-27	WOS:000440955500018
J	Dudley, DM; Van Rompay, KK; Coffey, LL; Ardeshir, A; Keesler, RI; Bliss-Moreau, E; Grigsby, PL; Steinbach, RJ; Hirschs, AJ; MacAllister, RP; Pecoraro, HL; Colgin, LM; Hodge, T; Streblows, DN; Tardif, S; Patterson, JL; Tamhankar, M; Seferovic, M; Aagaard, KM; Sanchez-San Martin, C; Chiu, CY; Panganiban, AT; Veazey, RS; Wang, XL; Manesss, NJ; Gilbert, MH; Bohm, RP; Waldort, KMA; Gale, M; Rajagopal, L; Hotchkiss, CE; Mohr, EL; Capuano, SV; Simmons, HA; Mejia, A; Friedrich, TC; Golos, TG; O'Connor, DH				Dudley, Dawn M.; Van Rompay, Koen K.; Coffey, Lark L.; Ardeshir, Amir; Keesler, Rebekah, I; Bliss-Moreau, Eliza; Grigsby, Peta L.; Steinbach, Rosemary J.; Hirschs, Alec J.; MacAllister, Rhonda P.; Pecoraro, Heidi L.; Colgin, Lois M.; Hodge, Travis; Streblows, Daniel N.; Tardif, Suzette; Patterson, Jean L.; Tamhankar, Manasi; Seferovic, Maxim; Aagaard, Kjersti M.; Sanchez-San Martin, Claudia; Chiu, Charles Y.; Panganiban, Antonito T.; Veazey, Ronald S.; Wang, Xiaolei; Manesss, Nicholas J.; Gilbert, Margaret H.; Bohm, Rudolf P.; Waldort, Kristina M. Adams; Gale, Michael, Jr.; Rajagopal, Lakshmi; Hotchkiss, Charlotte E.; Mohr, Emma L.; Capuano, Saverio V., III; Simmons, Heather A.; Mejia, Andres; Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.			Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates	NATURE MEDICINE			English	Article							PREGNANCY OUTCOMES; TERRITORIES; BRAZIL; BRAIN; RATES	Zika virus (ZIKV) infection is associated with congenital defects and pregnancy loss. Here, we found that 26% of nonhuman primates infected with Asian/American ZIKV in early gestation experienced fetal demise later in pregnancy despite showing few clinical signs of infection. Pregnancy loss due to asymptomatic ZIKV infection may therefore be a common but under-recognized adverse outcome related to maternal ZIKV infection.	[Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Van Rompay, Koen K.; Ardeshir, Amir; Keesler, Rebekah, I; Bliss-Moreau, Eliza] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Van Rompay, Koen K.; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Grigsby, Peta L.; Steinbach, Rosemary J.] Oregon Natl Primate Res Ctr, Dept Reprod & Dev Sci, Portland, OR USA; [Hirschs, Alec J.; Streblows, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA; [Hirschs, Alec J.; Streblows, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Portland, OR 97006 USA; [MacAllister, Rhonda P.; Hodge, Travis] Oregon Natl Primate Res Ctr, Div Comparat Med, Portland, OR USA; [Pecoraro, Heidi L.; Colgin, Lois M.] Oregon Natl Primate Res Ctr, Pathol Serv Unit, Div Comparat Med, Portland, OR USA; [Tardif, Suzette] Southwest Fdn Biomed Res, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA; [Patterson, Jean L.; Tamhankar, Manasi] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA; [Seferovic, Maxim; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sanchez-San Martin, Claudia; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA; [Panganiban, Antonito T.; Manesss, Nicholas J.] Tulane Natl Primate Res Ctr, Div Microbiol, New Orleans, LA 70130 USA; [Panganiban, Antonito T.] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA; [Veazey, Ronald S.; Wang, Xiaolei] Tulane Natl Primate Res Ctr, Div Comparat Pathol, New Orleans, LA USA; [Gilbert, Margaret H.; Bohm, Rudolf P.] Tulane Natl Primate Res Ctr, Div Vet Med, New Orleans, LA USA; [Waldort, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA; [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rajagopal, Lakshmi] Ctr Global Infect Dis Res, Seattle Childrens Res Inst, Seattle, WA USA; [Hotchkiss, Charlotte E.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Capuano, Saverio V., III; Simmons, Heather A.; Mejia, Andres; Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci & Obstet & Gynecol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Texas Biomedical Research Institute; Texas Biomedical Research Institute; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tulane University; Tulane University; Tulane University; Tulane University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; Van Rompay, KK (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.; Van Rompay, KK (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.; Streblows, DN (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.; Streblows, DN (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Portland, OR 97006 USA.; Tardif, S (corresponding author), Southwest Fdn Biomed Res, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA.; Panganiban, AT (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, New Orleans, LA 70130 USA.; Panganiban, AT (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA.; Waldort, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.	kkvanrompay@ucdavis.edu; streblow@ohsu.edu; stardif@txbiomed.org; apanagani@tulane.edu; adamsk@u.washington.edu; dhoconno@wisc.edu	Simmons, Heather/U-6081-2019; Ardeshir, Amir/Q-1258-2017; Mohr, Emma/ABD-2994-2020	Ardeshir, Amir/0000-0002-4330-4659; Mohr, Emma/0000-0003-0742-305X; Steinbach, Rosemary/0000-0003-0257-7308; Coffey, Lark/0000-0002-0718-5146	DHHS/PHS/NIH [R01Al116382-01A1]; Pediatric Infectious Diseases Society; Office of Research Infrastructure Programs/OD grant [P51OD011106]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; CNPRC pilot research grant [1R21AI129479-01]; Office of Research Infrastructure Programs/OD [P51OD011107]; FDA contract [HHSF223201610542P]; Pathology, Microbiology and Immunology Department; National Institutes of Health Office of Research Infrastructure Programs [P51OD011092]; NIH [R01 AI099795-05, R01HL105704, R21AI129455]; National Institutes of Health Office of Research Infrastructure Program [P51OD011104, P51 OD010425, P51 ODOD011133]; University of Washington Department of Obstetrics Gynecology; Seattle Children's Research Institute; National Institutes of Health [R01AI100989, AI083019, AI104002]; Texas Biomedical Research Institute;  [R21HD091032]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD091032] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI099795, R01AI104002, R01AI116382, R21AI129479, R01AI100989, R21AI129455] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, P51OD011107, P51OD011092, P51OD011106, P51OD011133, P51OD010425] Funding Source: NIH RePORTER	DHHS/PHS/NIH; Pediatric Infectious Diseases Society; Office of Research Infrastructure Programs/OD grant; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CNPRC pilot research grant; Office of Research Infrastructure Programs/OD; FDA contract; Pathology, Microbiology and Immunology Department; National Institutes of Health Office of Research Infrastructure Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research Infrastructure Program; University of Washington Department of Obstetrics Gynecology; Seattle Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Biomedical Research Institute; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Veterinary Services, Colony Management, Scientific Protocol Implementation, and Pathology Services staff at the WNPRC for their contribution to this study. We thank M. Harke, K. Brunner, T. Frost, M. Schotzko, W Newton, K. Antony, S. Kohn, C. Newman, L. Stewart, M. Koenig, M. Breitbach, and M. Mohns for technical assistance and for monitoring the ZIKV-infected pregnant animals at WNPRC. We thank J. Eickhoff for help with statistical analysis. We thank T. Morgan for help with interpreting pathology. Studies at WNPRC were supported by DHHS/PHS/NIH R01Al116382-01A1 to D.H.O. and by the Pediatric Infectious Diseases Society to E.L.M. We thank E. Kallas for providing information on 2016 live-birth rates in Brazil. This work was also supported in part by the Office of Research Infrastructure Programs/OD grant (P51OD011106) awarded to WNPRC, Madison-Wisconsin. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grants RR15459-01 and RR020141-01. The studies at CNPRC were supported by a CNPRC pilot research grant, 1R21AI129479-01 (K.K.V.R.), the Office of Research Infrastructure Programs/OD (P51OD011107) (CNPRC), FDA contract HHSF223201610542P (L.L.C.) and start-up funds from the Pathology, Microbiology and Immunology Department to L.L.C. We thank V. Bakula, I. Cazares, M. Christensen, C. Cruzen, A. Gibbons, D. Lemos, A. Singapuri, J. Usachenko, W von Morgenland, J. Watanabe, J. Yee, A. Murphy, and the staff of Clinical Labs, Veterinary and Colony Research Services for technical assistance. Work at the ONPRC was supported by the National Institutes of Health Office of Research Infrastructure Programs grant (P51OD011092) to ONPRC and R21HD091032 to D.N.S. We thank L. Drew Martin, B. Dozier and N. Sternberger for their veterinary expertise, and the dedicated staff in the ONPRC Department of Comparative Medicine for assistance with animal care. The studies at Tulane National Primate Research Center (TNPRC) were supported by NIH grant R01 AI099795-05 to X.W. and by the National Institutes of Health Office of Research Infrastructure Program grant (P51OD011104) to TNPRC. We thank F. Schiro, R. Blair, and P. Aye for technical assistance. At WaNPRC, the work was primarily supported by generous private philanthropic gifts, including those from five donors from Florida who wish to remain anonymous. Further support was obtained from the University of Washington Department of Obstetrics & Gynecology, the Seattle Children's Research Institute, and National Institutes of Health grants R01AI100989 (L.R. and K.A.W.), AI083019 (M.G.), and AI104002 (M.G.). The National Institutes of Health Office of Research Infrastructure Programs (P51 OD010425) also supported this project. We thank J. Ogle, W Lee, and J. Thiel for technical assistance in monitoring the animals. Work at SNPRC was supported by NIH grants R01HL105704 and R21AI129455 (C.Y.C.), National Institutes of Health Office of Research Infrastructure Programs grant P51 ODOD011133 to SNPRC, and the Texas Biomedical Research Institute. We thank D. Layne-Colon for marmoset pregnancy management, ultrasonography, and collection and processing of placental and fetal material. We also thank S. Davis for technical support; M. Suter for guidance in the placental studies and analysis; and X. de Lamballerie (European Virus Archive) and B. Russell (CDC) for providing ZIKV strains.	Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010; Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148; de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Esposito DL, 2017, AM J TROP MED HYG, V97, P610; GOLUB MS, 1988, LAB ANIM SCI, V38, P435; Heger W, 1988, NONHUMAN PRIMATES DE; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc; Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041; Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1; Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	26	56	58	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2018	24	8					1104	+		10.1038/s41591-018-0088-5	http://dx.doi.org/10.1038/s41591-018-0088-5			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GP5ZF	29967348	Green Accepted, Green Submitted			2022-12-27	WOS:000440955500014
J	Ramaswamy, V; Taylor, MD				Ramaswamy, Vijay; Taylor, Michael D.			CAR T cells for childhood diffuse midline gliomas	NATURE MEDICINE			English	Editorial Material							GLIOBLASTOMA		[Ramaswamy, Vijay] Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Taylor, MD (corresponding author), Hosp Sick Children, Div Neurosurg, Toronto, ON, Canada.	mdtaylor@sickkids.ca		Ramaswamy, Vijay/0000-0002-6557-895X				Ahmed N, 2017, JAMA ONCOL, V3, P1094, DOI 10.1001/jamaoncol.2017.0184; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Grasso CS, 2015, NAT MED, V21, P827, DOI 10.1038/nm0715-827a; Jones C, 2014, NAT REV CANCER, V14, P651, DOI 10.1038/nrc3811; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Mackay A, 2017, CANCER CELL, V32, P520, DOI 10.1016/j.ccell.2017.08.017; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Mount CW, 2018, NAT MED, V24, P572, DOI 10.1038/s41591-018-0006-x; O'Rourke DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaa0984; Waligora M, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002505; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	11	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2018	24	5					534	535		10.1038/s41591-018-0031-9	http://dx.doi.org/10.1038/s41591-018-0031-9			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	GF7CY	29736025				2022-12-27	WOS:000432126800005
